PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pathak, D; Shields, LY; Mendelsohn, BA; Haddad, D; Lin, W; Gerencser, AA; Kim, H; Brand, MD; Edwards, RH; Nakamura, K				Pathak, Divya; Shields, Lauren Y.; Mendelsohn, Bryce A.; Haddad, Dominik; Lin, Wei; Gerencser, Akos A.; Kim, Hwajin; Brand, Martin D.; Edwards, Robert H.; Nakamura, Ken			The Role of Mitochondrially Derived ATP in Synaptic Vesicle Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL MITOCHONDRIA; PARKINSON DISEASE; POOL VESICLES; ENERGY; GLUCOSE; DYSFUNCTION; NEURONS; EXOCYTOSIS; CONTRIBUTE; INCREASES	Synaptic mitochondria are thought to be critical in supporting neuronal energy requirements at the synapse, and bioenergetic failure at the synapse may impair neural transmission and contribute to neurodegeneration. However, little is known about the energy requirements of synaptic vesicle release or whether these energy requirements go unmet in disease, primarily due to a lack of appropriate tools and sensitive assays. To determine the dependence of synaptic vesicle cycling on mitochondrially derived ATP levels, we developed two complementary assays sensitive to mitochondrially derived ATP in individual, living hippocampal boutons. The first is a functional assay for mitochondrially derived ATP that uses the extent of synaptic vesicle cycling as a surrogate for ATP level. The second uses ATP FRET sensors to directly measure ATP at the synapse. Using these assays, we show that endocytosis has high ATP requirements and that vesicle reacidification and exocytosis require comparatively little energy. We then show that to meet these energy needs, mitochondrially derived ATP is rapidly dispersed in axons, thereby maintaining near normal levels of ATP even in boutons lacking mitochondria. As a result, the capacity for synaptic vesicle cycling is similar in boutons without mitochondria as in those with mitochondria. Finally, we show that loss of a key respiratory subunit implicated in Leigh disease markedly decreases mitochondrially derived ATP levels in axons, thus inhibiting synaptic vesicle cycling. This proves that mitochondria-based energy failure can occur and be detected in individual neurons that have a genetic mitochondrial defect.	[Pathak, Divya; Shields, Lauren Y.; Mendelsohn, Bryce A.; Haddad, Dominik; Lin, Wei; Kim, Hwajin; Nakamura, Ken] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Shields, Lauren Y.; Edwards, Robert H.; Nakamura, Ken] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Shields, Lauren Y.; Edwards, Robert H.; Nakamura, Ken] Univ Calif San Francisco, Grad Programs Neurosci & Biomed Sci, San Francisco, CA 94158 USA; [Mendelsohn, Bryce A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Gerencser, Akos A.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Buck Institute for Research on Aging	Nakamura, K (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	ken.nakamura@gladstone.ucsf.edu	Brand, Martin D/A-9423-2012; Regan, Clinton/E-6250-2012	Brand, Martin D/0000-0003-4418-6153; Nakamura, Ken/0000-0002-9192-182X	National Institutes of Health [RR018928]; Betty Brown's Family; Joan and David Traitel Family Trust; Burroughs-Wellcome Medical Scientist Fund; National Institutes of Health from NINDS [1KO8NS062954-01A1, 1RO1NS091902-01, P30NS069496]; National Science Foundation; Pediatric Scientist Development Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091902, P30NS069496, K08NS062954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Betty Brown's Family; Joan and David Traitel Family Trust; Burroughs-Wellcome Medical Scientist Fund; National Institutes of Health from NINDS; National Science Foundation(National Science Foundation (NSF)); Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RR018928 (to the Gladstone Institutes). This work was also supported by Betty Brown's Family and the Joan and David Traitel Family Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Burroughs-Wellcome Medical Scientist Fund Career Award and National Institutes of Health Grants 1KO8NS062954-01A1, 1RO1NS091902-01, and P30NS069496 from the NINDS.; Supported by a National Science Foundation graduate research fellowship.; Supported by the Pediatric Scientist Development Program.	BALL WJ, 1975, J BACTERIOL, V121, P975, DOI 10.1128/JB.121.3.975-982.1975; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Berthet A, 2014, J NEUROSCI, V34, P14304, DOI 10.1523/JNEUROSCI.0930-14.2014; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Budzinski KL, 2011, BIOPHYS J, V101, P1580, DOI 10.1016/j.bpj.2011.08.032; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Choi SW, 2012, J NEUROSCI, V32, P16775, DOI 10.1523/JNEUROSCI.2414-12.2012; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Egashira Y, 2015, J NEUROSCI, V35, P3701, DOI 10.1523/JNEUROSCI.4160-14.2015; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Foss SM, 2013, J NEUROSCI, V33, P10647, DOI 10.1523/JNEUROSCI.5662-12.2013; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Imamura Hiromi, 2009, Tanpakushitsu Kakusan Koso, V54, P1937; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kuiper JWP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-73; Kuner T, 2008, P NATL ACAD SCI USA, V105, P347, DOI 10.1073/pnas.0707197105; Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nagase M, 2014, J NEUROSCI, V34, P2605, DOI 10.1523/JNEUROSCI.4687-12.2014; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; Pathak D, 2013, ANN NEUROL, V74, P506, DOI 10.1002/ana.24014; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Rex A, 2009, PHYSIOL BEHAV, V98, P467, DOI 10.1016/j.physbeh.2009.07.015; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SMYTHE E, 1989, J CELL BIOL, V108, P843, DOI 10.1083/jcb.108.3.843; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Tanaka T, 2014, J BIOL CHEM, V289, P2205, DOI 10.1074/jbc.M113.499111; Tsuyama T, 2013, ANAL CHEM, V85, P7889, DOI 10.1021/ac4015325; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Waters J, 2003, PFLUG ARCH EUR J PHY, V447, P363, DOI 10.1007/s00424-003-1182-0; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Yasuda T, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-16; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029	62	140	143	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22325	22336		10.1074/jbc.M115.656405	http://dx.doi.org/10.1074/jbc.M115.656405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26126824	Green Published, hybrid			2022-12-26	WOS:000361171500002
J	Huang, SP; Liu, SF; Fu, JJ; Wang, TT; Yao, XL; Kumar, A; Liu, G; Fu, MG				Huang, Shengping; Liu, Shufeng; Fu, Jia J.; Wang, T. Tony; Yao, Xiaolan; Kumar, Anil; Liu, Gang; Fu, Mingui			Monocyte Chemotactic Protein-induced Protein 1 and 4 Form a Complex but Act Independently in Regulation of Interleukin-6 mRNA Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; KAPPA-B ACTIVATION; T-CELLS; MCPIP1; GW182; INFLAMMATION; INHIBITION; EXPRESSION; INFECTION; REGNASE-1	It was recently demonstrated that MCPIP1 is a critical factor that controls inflammation and immune homeostasis; however, the relationship between MCPIP1 and other members of this protein family is largely unknown. Here, we report that MCPIP1 interacts with MCPIP4 to form a protein complex, but acts independently in the regulation of IL-6 mRNA degradation. In an effort to identify MCPIP1-interacting proteins by co-immunoprecipitation (Co-IP) and mass-spec analysis, MCPIP4 was identified as a MCPIP1-interacting protein, which was further confirmed by Co-IP and mammalian two-hybrid assay. Immunofluorescence staining showed that MCPIP4 was co-localized with MCPIP1 in the GW-body, which features GW182 and Argonaute 2. Further studies showed that MCPIP1 and MCPIP4 act independently in regulation of IL-6 mRNA degradation. These results suggest that MCPIP1 and MCPIP4 may additively contribute to control IL-6 production in vivo.	[Huang, Shengping; Fu, Jia J.; Fu, Mingui] Univ Missouri, Shock Trauma Res Ctr, Sch Med, Kansas City, MO 64108 USA; [Huang, Shengping; Fu, Jia J.; Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64108 USA; [Liu, Shufeng; Wang, T. Tony] SRI Int, Biosci Div, Harrisonburg, VA 22802 USA; [Yao, Xiaolan] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Liu, Gang] Univ Alabama Birmingham, Sch Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; SRI International; University of Missouri System; University of Missouri Kansas City; University of Alabama System; University of Alabama Birmingham	Fu, MG (corresponding author), Univ Missouri, Shock Trauma Res Ctr, Sch Med, Kansas City, MO 64108 USA.	fum@umkc.edu	Regan, Clinton/E-6250-2012	Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633	National Institutes of Health [AI103618, HL105473, HL076206, DA025528, DA025011, AA020806, DK088787]; UMKC SOM Dean's Support Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105473, R01HL076206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK088787, R01DK088787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025528, R01DA025011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMKC SOM Dean's Support Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grant AI103618 (to M. F.) and a UMKC SOM Dean's Support Fund (to M. F.). This work was also supported by National Institutes of Health Grants HL105473 and HL076206 (to G. L.), National Institutes of Health Grants DA025528, DA025011, and AA020806 (to A. K.), and National Institutes of Health Grant DK088787 (to T. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2013, COLD SH Q B, V78, P51, DOI 10.1101/sqb.2013.78.019877; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chan EKL, 2013, ADV EXP MED BIOL, V768, P261, DOI 10.1007/978-1-4614-5107-5_15; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Huang SP, 2013, CELL SIGNAL, V25, P1228, DOI 10.1016/j.cellsig.2013.02.009; Huang SP, 2012, CELL SIGNAL, V24, P569, DOI 10.1016/j.cellsig.2011.10.011; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jura J, 2012, BBA-MOL CELL RES, V1823, P1905, DOI 10.1016/j.bbamcr.2012.06.029; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lin RJ, 2014, J IMMUNOL, V193, P4159, DOI 10.4049/jimmunol.1400337; Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019; Liu L, 2013, BIOCHEM J, V451, P55, DOI 10.1042/BJ20130019; Liu SF, 2013, P NATL ACAD SCI USA, V110, P19083, DOI 10.1073/pnas.1316208110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Miao RD, 2013, IMMUNOL CELL BIOL, V91, P368, DOI 10.1038/icb.2013.11; Minagawa K, 2007, BRIT J HAEMATOL, V139, P161, DOI 10.1111/j.1365-2141.2007.06752.x; Minagawa K, 2014, J IMMUNOL, V192, P1512, DOI 10.4049/jimmunol.1301619; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Owerbach D, 2004, DIABETES, V53, P1890, DOI 10.2337/diabetes.53.7.1890; Qi DF, 2011, J BIOL CHEM, V286, P41692, DOI 10.1074/jbc.M111.276006; Qi YF, 2010, FEBS LETT, V584, P3065, DOI 10.1016/j.febslet.2010.05.040; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tan DZ, 2014, NAT STRUCT MOL BIOL, V21, P679, DOI 10.1038/nsmb.2857; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Wang M, 2007, CANCER RES, V67, P93, DOI 10.1158/0008-5472.CAN-06-2723; Xu JW, 2012, NUCLEIC ACIDS RES, V40, P6957, DOI 10.1093/nar/gks359; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	38	20	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20782	20792		10.1074/jbc.M114.635870	http://dx.doi.org/10.1074/jbc.M114.635870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134560	Green Published, hybrid			2022-12-26	WOS:000360011800016
J	Ji, CJ; Kim, JH; Won, YB; Lee, YE; Choi, TW; Ju, SY; Youn, H; Helmann, JD; Lee, JW				Ji, Chang-Jun; Kim, Jung-Hoon; Won, Young-Bin; Lee, Yeh-Eun; Choi, Tae-Woo; Ju, Shin-Yeong; Youn, Hwan; Helmann, John D.; Lee, Jin-Won			Staphylococcus aureus PerR Is a Hypersensitive Hydrogen Peroxide Sensor using Iron-mediated Histidine Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS RESISTANCE; TRANSCRIPTION FACTOR; MODEL HOST; FUR; REGULATOR; PROTEIN; IDENTIFICATION; SUPEROXIDE; MECHANISMS; EXPRESSION	In many Gram-positive bacteria PerR is a major peroxide sensor whose repressor activity is dependent on a bound metal cofactor. The prototype for PerR sensors, the Bacillus subtilis PerRBS protein, represses target genes when bound to either Mn2+ or Fe2+ as corepressor, but only the Fe2+-bound form responds to H2O2. The orthologous protein in the human pathogen Staphylococcus aureus, PerR(SA), plays important roles in H2O2 resistance and virulence. However, PerR(SA) is reported to only respond to Mn2+ as corepressor, which suggests that it might rely on a distinct, iron-independent mechanism for H2O2 sensing. Here we demonstrate that PerR(SA) uses either Fe2+ or Mn2+ as corepressor, and that, like PerRBS, the Fe2+-bound form of PerR(SA) senses physiological levels of H2O2 by iron-mediated histidine oxidation. Moreover, we show that PerR(SA) is poised to sense very low levels of endogenous H2O2, which normally cannot be sensed by B. subtilis PerRBS. This hypersensitivity of PerR(SA) accounts for the apparent lack of Fe2+-dependent repressor activity and consequent Mn2+-specific repressor activity under aerobic conditions. We also provide evidence that the activity of PerR(SA) is directly correlated with virulence, whereas it is inversely correlated with H2O2 resistance, suggesting that PerR(SA) may be an attractive target for the control of S. aureus pathogenesis.	[Ji, Chang-Jun; Kim, Jung-Hoon; Won, Young-Bin; Lee, Yeh-Eun; Choi, Tae-Woo; Ju, Shin-Yeong; Lee, Jin-Won] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Ji, Chang-Jun; Kim, Jung-Hoon; Won, Young-Bin; Lee, Yeh-Eun; Choi, Tae-Woo; Ju, Shin-Yeong; Lee, Jin-Won] Hanyang Univ, Res Ctr Nat Sci, Seoul 133791, South Korea; [Youn, Hwan] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Hanyang University; Hanyang University; California State University System; California State University Fresno; Cornell University	Helmann, JD (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	jdh9@cornell.edu; jwl@hanyang.ac.kr	Kim, Jung-Hoon/A-6409-2017; LEE, JIN-WON/L-1116-2016; Regan, Clinton/E-6250-2012	Kim, Jung-Hoon/0000-0003-2775-4518; LEE, JIN-WON/0000-0002-1201-8254; Ju, Shinyeong/0000-0001-5483-4690	National Institutes of Health [GM059323]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2011-0017199, NRF-2009-0068133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF) - Korea government (MSIP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM059323 (to J. D. H.) and National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) Grants NRF-2011-0017199 and NRF-2009-0068133 (to J.-W. L.). The authors declare that they have no conflict of interest.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Duarte V, 2013, FUTURE MED CHEM, V5, P1177, DOI 10.4155/fmc.13.92; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Faulkner MJ, 2012, J BACTERIOL, V194, P1226, DOI 10.1128/JB.06566-11; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2007, J MICROBIOL METH, V70, P186, DOI 10.1016/j.mimet.2007.04.007; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P5036, DOI 10.1093/nar/gkr095; Morrissey JA, 2004, INFECT IMMUN, V72, P972, DOI 10.1128/IAI.72.2.972-979.2004; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wen YT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007013; Won YB, 2010, B KOREAN CHEM SOC, V31, P1573, DOI 10.5012/bkcs.2010.31.6.1573; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	41	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20374	20386		10.1074/jbc.M115.664961	http://dx.doi.org/10.1074/jbc.M115.664961			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134568	Green Published, hybrid			2022-12-26	WOS:000359608900035
J	Bradshaw, PL; Colville, JF; Linder, HP				Bradshaw, Peter L.; Colville, Jonathan F.; Linder, H. Peter			Optimising Regionalisation Techniques: Identifying Centres of Endemism in the Extraordinarily Endemic-Rich Cape Floristic Region	PLOS ONE			English	Article							PARSIMONY ANALYSIS; BIOGEOGRAPHICAL REGIONS; COMPOSITIONAL DISSIMILARITY; SPECIES RICHNESS; VASCULAR PLANTS; BETA-DIVERSITY; AREAS; PATTERNS; HISTORY; FLORA	We used a very large dataset (>40% of all species) from the endemic-rich Cape Floristic Region (CFR) to explore the impact of different weighting techniques, coefficients to calculate similarity among the cells, and clustering approaches on biogeographical regionalisation. The results were used to revise the biogeographical subdivision of the CFR. We show that weighted data (down-weighting widespread species), similarity calculated using Kulczinsky's second measure, and clustering using UPGMA resulted in the optimal classification. This maximized the number of endemic species, the number of centres recognized, and operational geographic units assigned to centres of endemism (CoEs). We developed a dendrogram branch order cut-off (BOC) method to locate the optimal cut-off points on the dendrogram to define candidate clusters. Kulczinsky's second measure dendrograms were combined using consensus, identifying areas of conflict which could be due to biotic element overlap or transitional areas. Post-clustering GIS manipulation substantially enhanced the endemic composition and geographic size of candidate CoEs. Although there was broad spatial congruence with previous phytogeographic studies, our techniques allowed for the recovery of additional phytogeographic detail not previously described for the CFR.	[Bradshaw, Peter L.] South African Natl Pk, Pk Planning & Dev Unit, Port Elizabeth, South Africa; [Bradshaw, Peter L.] Nelson Mandela Metropolitan Univ, Dept Bot, Port Elizabeth, South Africa; [Colville, Jonathan F.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, South Africa; [Colville, Jonathan F.] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa; [Linder, H. Peter] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland	Nelson Mandela University; South African National Biodiversity Institute; University of Cape Town; University of Zurich	Bradshaw, PL (corresponding author), South African Natl Pk, Pk Planning & Dev Unit, Port Elizabeth, South Africa.	peter.bradshaw@nmmu.ac.za	Linder, Hans Peter/F-5316-2010					Adnan M, 2014, GEOCOMPUTATION, P49; ANDERSON S, 1994, Q REV BIOL, V69, P451, DOI 10.1086/418743; Bolus H, 1886, OFFICIAL HDB CAPE GO; BORCHERT R, 1981, BOT GAZ, V142, P394, DOI 10.1086/337238; Born J, 2007, J BIOGEOGR, V34, P147, DOI 10.1111/j.1365-2699.2006.01595.x; Bradshaw P., 2009, ENDEMISM RICHNESS CA; Brooks DR, 2003, J BIOGEOGR, V30, P819, DOI 10.1046/j.1365-2699.2003.00848.x; Cabrera A, 1973, BIOGEOGRAFIA AM LATI, V13; Carine MA, 2009, J BIOGEOGR, V36, P593, DOI 10.1111/j.1365-2699.2008.02016.x; Casado MA, 1997, PLANT ECOL, V131, P193, DOI 10.1023/A:1009788022662; Cavieres LA, 2002, BIODIVERS CONSERV, V11, P1301, DOI 10.1023/A:1016001714358; Cowling R. M., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P273; Cowling R.M., 1992, ECOLOGY FYNBOS NUTR, P62; COWLING RM, 1987, S AFR J SCI, V83, P106; COWLING RM, 1983, J BIOGEOGR, V10, P393, DOI 10.2307/2844748; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; COWLING RM, 1990, J VEG SCI, V1, P699, DOI 10.2307/3235578; Crisci JV, 2006, AUST SYST BOT, V19, P1, DOI 10.1071/SB05006; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Croizat L, 1965, WEBBIA, V20, P573; CROVELLO TJ, 1981, TAXON, V30, P563, DOI 10.2307/1219938; Juarez HSD, 2009, BIOL J LINN SOC, V97, P373, DOI 10.1111/j.1095-8312.2009.01212.x; Drege JF, 1844, BESONDERE BEIGABE FL, V2; Ebach MC, 2012, ZOOTAXA, P1; Edwards D., 1971, MITTEILUNGEN BOT STA, V10, P501; Escalante T, 2009, BIOL J LINN SOC, V98, P468, DOI 10.1111/j.1095-8312.2009.01293.x; ESRI, 2013, ARCGIS DESKT 10 2; Exell AW, 1974, SERIE BOT, V1, P105; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Fattorini S, 2010, J BIOGEOGR, V37, P1061, DOI 10.1111/j.1365-2699.2009.02252.x; Fayle TM, 2010, ECOL MODEL, V221, P2237, DOI 10.1016/j.ecolmodel.2010.06.013; Finnie TJR, 2007, J BIOGEOGR, V34, P1848, DOI 10.1111/j.1365-2699.2007.01750.x; Furrer R, 2010, SPAM SPARSE MATRIX R; Garzon-Orduna IJ, 2008, J BIOGEOGR, V35, P903, DOI 10.1111/j.1365-2699.2007.01842.x; Germishuizen G., 2003, PLANTS SO AFRICA ANN; Giokas S, 2008, J BIOGEOGR, V35, P893, DOI 10.1111/j.1365-2699.2007.01840.x; GOLDBLATT P, 1978, ANN MO BOT GARD, V65, P369, DOI 10.2307/2398858; Gonzalez-Orozco CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092558; Gonzalez-Orozco CE, 2014, DIVERS DISTRIB, V20, P46, DOI 10.1111/ddi.12129; Gonzalez-Orozco CE, 2013, J BIOGEOGR, V40, P2156, DOI 10.1111/jbi.12153; Good R., 1974, GEOGRAPHY FLOWERING; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Hand D., 2001, ADAP COMP MACH LEARN; HAROLD AS, 1994, SYST BIOL, V43, P261, DOI 10.2307/2413466; Hazel J, 1977, GEOLOGICAL SOC AM B, V81, P3237; Heikinheimo H, 2007, J BIOGEOGR, V34, P1053, DOI 10.1111/j.1365-2699.2006.01664.x; Hennig C, 2007, DESIGN DISSIMILARITY; Hilton-Taylor C, 1996, RED DATA LIST SO AFR; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; JANSON S, 1981, OECOLOGIA, V49, P371, DOI 10.1007/BF00347601; Jardine N., 1972, Taxonomy, phytogeography and evolution., P381; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jurasinski G., 2012, SIMBA COLLECTION FUN; Jurgens N, 1997, BIODIVERS CONSERV, V6, P495, DOI 10.1023/A:1018325026863; Kier G, 2001, BIODIVERS CONSERV, V10, P1513, DOI 10.1023/A:1011812528849; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; KRUGER FJ, 1980, VEGETATIO, V41, P85, DOI 10.1007/BF00121419; Laffan SW, 2013, J BIOGEOGR, V40, P570, DOI 10.1111/jbi.12001; Laffan SW, 2003, J BIOGEOGR, V30, P511, DOI 10.1046/j.1365-2699.2003.00875.x; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Lawson BE, 2010, APPL VEG SCI, V13, P473, DOI 10.1111/j.1654-109X.2010.01085.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Levyns M.R., 1964, T ROY SOC S AFR, V37, P85, DOI [10.1080/00359196409519059, DOI 10.1080/00359196409519059]; Linder H. P., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P229; Linder H. P., 1985, SPECIES SPECIATION, V4, P53; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2001, SYST BIOL, V50, P892, DOI 10.1080/106351501753462867; Linder HP, 1998, BOT J LINN SOC, V128, P319; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Major J., 1988, ANAL BIOGEOGRAPHY, P117, DOI DOI 10.1007/978-94-009-0435-4; Manning J., 2012, PLANTS GREATER CAPE; Marloth R, 1908, WISSENSCHAFFLICHE ER, P1; Mast AR, 2003, SYST BIOL, V52, P271, DOI 10.1080/10635150390192799; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Moline PM, 2006, J BIOGEOGR, V33, P47, DOI 10.1111/j.1365-2699.2005.01369.x; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Morrone JJ, 2014, J BIOGEOGR, V41, P842, DOI 10.1111/jbi.12251; Mucina L., 2006, VEGETATION S AFRICA, P801; Murguia M, 2003, ANN BOT FENN, V40, P415; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson G., 1981, SYSTEMATICS BIOGEORA; Oksanen J., 2017, COMMUNITY ECOLOGY PA; OLIVER EGH, 1983, BOTHALIA, V14, P427, DOI DOI 10.4102/abc.v14i3/4.1189; Peng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037726; PLATNICK NI, 1992, SYSTEMATICS, ECOLOGY, AND THE BIODIVERSITY CRISIS, P15; R Core Team, 2016, R FDN STAT COMP; Ramdhani S, 2008, J BIOGEOGR, V35, P2258, DOI 10.1111/j.1365-2699.2008.01982.x; RAUP DM, 1979, J PALEONTOL, V53, P1213; Rosen B.R., 1988, P23; Rosen B.R., 1988, P437; Rovito SM, 2004, J BIOGEOGR, V31, P1623, DOI 10.1111/j.1365-2699.2004.01100.x; Rueda M, 2010, J BIOGEOGR, V37, P2067, DOI 10.1111/j.1365-2699.2010.02388.x; Salvador S, 2004, PROC INT C TOOLS ART, P576; Santos CMD, 2005, J BIOGEOGR, V32, P1284, DOI 10.1111/j.1365-2699.2005.01269.x; Sfenthourakis S, 2006, GLOBAL ECOL BIOGEOGR, V15, P39, DOI 10.1111/j.1466-822x.2005.00192.x; SHI GR, 1993, PALAEOGEOGR PALAEOCL, V105, P199, DOI 10.1016/0031-0182(93)90084-V; SIMBERLOFF D, 1978, AM NAT, V112, P713, DOI 10.1086/283313; Simmons MT, 1996, BIODIVERS CONSERV, V5, P551, DOI 10.1007/BF00137609; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SLINGSBY P, 1985, S AFR J BOT, V51, P30, DOI 10.1016/S0254-6299(16)31698-2; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Thuiller W, 2006, ECOGRAPHY, V29, P733, DOI 10.1111/j.0906-7590.2006.04674.x; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; van Wyk AE., 2001, REGIONS FLORISTIC EN; Villeger S, 2012, ECOL INDIC, V18, P552, DOI 10.1016/j.ecolind.2012.01.009; Weimarck H., 1941, LUNDS U ARSSKR, V37, P1, DOI DOI 10.1016/J.TREE.2012.10.002; White F., 1978, Monographiae Biologicae, V31, P463; White F., 1983, VEGETATION AFRICA DE, P356; WILLIAMS PH, 1994, P ROY SOC B-BIOL SCI, V256, P67, DOI 10.1098/rspb.1994.0050	120	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132538	10.1371/journal.pone.0132538	http://dx.doi.org/10.1371/journal.pone.0132538			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147438	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000358157600299
J	Fernandez-Bustamante, A; Agazio, A; Wilson, P; Elkins, N; Domaleski, L; He, QB; Baer, KA; Moss, AFD; Wischmeyer, PE; Repine, JE				Fernandez-Bustamante, Ana; Agazio, Amanda; Wilson, Paul; Elkins, Nancy; Domaleski, Luke; He, Qianbin; Baer, Kaily A.; Moss, Angela F. D.; Wischmeyer, Paul E.; Repine, John E.			Brief Glutamine Pretreatment Increases Alveolar Macrophage CD163/Heme Oxygenase-1/p38-MAPK Dephosphorylation Pathway and Decreases Capillary Damage but Not Neutrophil Recruitment in IL-1/LPS-Insufflated Rats	PLOS ONE			English	Article							ACUTE LUNG INJURY; SCAVENGER RECEPTOR CD163; HEME OXYGENASE-1; MURINE MACROPHAGES; EXPERIMENTAL-MODEL; PLASMA GLUTAMINE; EPITHELIAL-CELLS; ACTIVATION; EXPRESSION; INDUCTION	Background Glutamine (GLN) attenuates acute lung injury (ALI) but its effect on alveolar macrophages is unknown. We hypothesized that GLN pretreatment would induce the anti-inflammatory CD163/heme oxygenase (HO)-1/p38-MAPK dephosphorylation pathway in alveolar macrophages and reduce ALI in rats insufflated with interleukin-1 (IL-1) and lipopolysaccharide (LPS). Methods Male Sprague-Dawley rats were randomized to the following groups: GLN-IL-1/LPS-, GLN + IL-1/LPS-, GLN-IL-1/LPS+, and GLN+ IL-1/LPS+. GLN pretreatment was given via gavage (1g/kg L-alanyl-L-glutamine) daily for 2 days. ALI was subsequently induced by insufflating 50ng IL-1 followed by 5mg/kg E. coli LPS. After 24h, bronchoalveolar lavage (BAL) protein, lactate dehydrogenase (LDH) and neutrophil concentrations were analyzed. BAL alveolar macrophage CD163+ expression, HO-1 and p38-MAPK concentrations were measured, as well as alveolar macrophage tumor necrosis factor (TNF)-alpha and interleukin (IL)-10 concentrations. Histology and immunofluorescence studies were also performed. Results Following IL-1/LPS insufflation, GLN pretreated rats had significantly decreased BAL protein and LDH concentrations, but not BAL neutrophil counts, compared to non-GLN pretreated rats. The number of alveolar macrophages and the number of CD163+ macrophages were significantly increased in GLN pretreated IL-1/LPS-insufflated rats compared to non-GLN pretreated, IL-1/LPS-insufflated rats. GLN pretreatment before IL-1/LPS also significantly increased HO-1 concentrations and dephosphorylated p38-MAPK levels but not cytokine levels in alveolar macrophages. Immunofluorescence localized CD163 and HO-1 in alveolar macrophages. Conclusion Short- term GLN pretreatment activates the anti-inflammatory CD163/HO-1/p38-MAPK dephosphorylation pathway of alveolar macrophages and decreases capillary damage but not neutrophil recruitment in IL-1/LPS-insufflated rats.	[Fernandez-Bustamante, Ana; Agazio, Amanda; He, Qianbin; Wischmeyer, Paul E.] Univ Colorado SOM, Dept Anesthesiol, Aurora, CO 80045 USA; [Repine, John E.] Univ Colorado SOM, Dept Med, Aurora, CO USA; [Fernandez-Bustamante, Ana; Agazio, Amanda; Wilson, Paul; Elkins, Nancy; Domaleski, Luke; He, Qianbin; Baer, Kaily A.; Repine, John E.] Univ Colorado SOM, Webb Waring Ctr, Aurora, CO USA; [Moss, Angela F. D.] Univ Colorado SOM, Adult & Child Ctr Hlth Outcomes & Delivery Sci AC, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Fernandez-Bustamante, A (corresponding author), Univ Colorado SOM, Dept Anesthesiol, Aurora, CO 80045 USA.	Ana.Fernandez-Bustamante@ucdenver.edu		Fernandez-Bustamante, Ana/0000-0002-2996-7704; Agazio, Amanda/0000-0003-3344-7901	Foundation for Anesthesia Education and Research clinical/translational mentored research training grant [MRTG-CT_2/15/2012]; Department of Defense award [W81-XWH-11-2-0045]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research clinical/translational mentored research training grant; Department of Defense award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AFB (PI) and JER (mentor) received an award from the Foundation for Anesthesia Education and Research clinical/translational mentored research training grant (MRTG-CT_2/15/2012) (http://faer.org). This work was partially supported by the Department of Defense award W81-XWH-11-2-0045 (JER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akila P, 2012, CLIN CHIM ACTA, V413, P669, DOI 10.1016/j.cca.2012.01.028; An L, 2011, EUR J PHARMACOL, V661, P102, DOI 10.1016/j.ejphar.2011.04.032; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Bharucha AE, 2010, CLIN PHARMACOL THER, V87, P187, DOI 10.1038/clpt.2009.221; Boe DM, 2010, ALCOHOL CLIN EXP RES, V34, P1723, DOI 10.1111/j.1530-0277.2010.01259.x; Bordbar A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.21; BOWMAN CM, 1983, INFLAMMATION, V7, P331, DOI 10.1007/BF00916297; Chen HL, 2012, INFLAMMATION, V35, P1087, DOI 10.1007/s10753-011-9415-4; Chien CC, 2012, SHOCK, V38, P549, DOI 10.1097/SHK.0b013e31826b2826; D'Alessio FR, 2012, J IMMUNOL, V189, P2234, DOI 10.4049/jimmunol.1102606; de Oliveira GP, 2014, SHOCK, V41, P222, DOI 10.1097/SHK.0000000000000102; Fernandez-Bustamante A, 2013, INFLAMMATION, V36, P1030, DOI 10.1007/s10753-013-9635-x; Freitas A, 2006, BRIT J PHARMACOL, V149, P345, DOI 10.1038/sj.bjp.0706882; Furst P, 1997, NUTRITION, V13, P731, DOI 10.1016/S0899-9007(97)83035-3; FURST P, 1990, JPEN-PARENTER ENTER, V14, pS118, DOI 10.1177/014860719001400417; Galera SC, 2010, NUTRITION, V26, P375, DOI 10.1016/j.nut.2009.05.013; Geng GQ, 2011, INJURY, V42, P72, DOI 10.1016/j.injury.2009.09.027; Graversen JH, 2012, MOL THER, V20, P1550, DOI 10.1038/mt.2012.103; Hack V, 1997, AM J PHYSIOL-ENDOC M, V272, pE788, DOI 10.1152/ajpendo.1997.272.5.E788; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Hou YC, 2013, J NUTR BIOCHEM, V24, P1555, DOI 10.1016/j.jnutbio.2013.01.004; Hu YM, 2014, SHOCK, V41, P115, DOI 10.1097/SHK.0000000000000086; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ito Y, 2009, BIOGERONTOLOGY, V10, P173, DOI 10.1007/s10522-008-9164-4; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kallweit AR, 2012, JPEN-PARENTER ENTER, V36, P551, DOI 10.1177/0148607112445579; Kwon WY, 2010, BRIT J NUTR, V103, P890, DOI 10.1017/S0007114509992509; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; LEFF JA, 1994, AM J PHYSIOL, V266, pL2, DOI 10.1152/ajplung.1994.266.1.L2; Li WQ, 2013, INT IMMUNOPHARMACOL, V16, P248, DOI 10.1016/j.intimp.2013.02.022; Ma LY, 2012, NUTRITION, V28, P1186, DOI 10.1016/j.nut.2012.04.001; Marwood S, 2011, RESP PHYSIOL NEUROBI, V177, P41, DOI 10.1016/j.resp.2011.03.010; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy C, 1998, CLIN SCI, V95, P397, DOI 10.1042/CS19980194; Newsholme F, 1999, J NUTR BIOCHEM, V10, P316; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Niederlechner S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-88; PARRYBILLINGS M, 1992, ARCH SURG-CHICAGO, V127, P1237; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Peng CK, 2011, PULM PHARMACOL THER, V24, P153, DOI 10.1016/j.pupt.2010.07.002; Perng WC, 2010, CLIN EXP PHARMACOL P, V37, P56, DOI 10.1111/j.1440-1681.2009.05239.x; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Salman AE, 2014, J ANESTH, V28, P354, DOI 10.1007/s00540-013-1745-y; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Sheng WS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-51; Shi Q, 2009, PHARMACOLOGY, V84, P1, DOI 10.1159/000220767; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Singleton KD, 2006, SHOCK, V25, P295, DOI 10.1097/01.shk.0000196548.10634.02; Sufit A, 2012, JPEN-PARENTER ENTER, V36, P556, DOI 10.1177/0148607112448823; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Thomsen JH, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/523652; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Wernerman J, 2011, ACTA ANAESTH SCAND, V55, P812, DOI 10.1111/j.1399-6576.2011.02453.x; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wischmeyer PE, 2009, AM J PHYSIOL-LUNG C, V296, pL286, DOI 10.1152/ajplung.00003.2009; Yin H, 2011, INT IMMUNOPHARMACOL, V11, P2112, DOI 10.1016/j.intimp.2011.09.004; Yin H, 2010, MOL IMMUNOL, V47, P2443, DOI 10.1016/j.molimm.2010.06.013; Zhang F, 2009, NUTRITION, V25, P692, DOI 10.1016/j.nut.2008.11.032; Zhang SC, 2013, PHARMACOLOGY, V91, P59, DOI 10.1159/000343809; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	63	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130764	10.1371/journal.pone.0130764	http://dx.doi.org/10.1371/journal.pone.0130764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147379	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600046
J	Guo, R; Tang, LL; Mao, YP; Zhou, GQ; Qi, ZY; Liu, LZ; Lin, AH; Liu, MZ; Ma, J; Sun, Y				Guo, Rui; Tang, Ling-Long; Mao, Yan-Ping; Zhou, Guan-Qun; Qi, Zhen-Yu; Liu, Li-Zhi; Lin, Ai-Hua; Liu, Meng-Zhong; Ma, Jun; Sun, Ying			Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities	PLOS ONE			English	Article							RADIATION-THERAPY; NECK CANCER; RADIOTHERAPY; RISK; HEAD; UPDATE; IMRT	Background To investigate the clinical efficacy and treatment toxicity of volume-modulated arc therapy (VMAT) for nasopharyngeal carcinoma (NPC). Material and Methods 205 VMAT-treated NPC patients from our cancer center were prospectively entrolled. All patients received 68-70 Gy irradiation based on the planning target volume of the primary gross tumor volume. Acute and late toxicities were graded according to the Common Terminology Criteria for Adverse Events v3.0 and Radiation Therapy Oncology Group Late Radiation Morbidity Scoring Criteria. Results The median follow-up period was 37.3 months (range, 6.3-45.1 months). The 3-year estimated local failure-free survival, regional failure-free survival, locoregional failure-free survival, distant metastasis-free survival, disease-free survival and overall survival were 95.5%, 97.0%, 94.0%, 92.1%, 86.8% and 97.0%, respectively. Cox regression analysis showed primary gross tumor volume, N stage and EBV-DNA to be independent predictors of VMAT outcomes (P < 0.05). The most common acute and late side effects were grade 2-3 mucositis (78%) and xerostomia (83%, 61%, 34%, and 9% at 3, 6, 12 and 24 months after VMAT), respectively. Conclusions VMAT for the primary treatment of NPC achieved very high locoregional control with a favorable toxicity profile. The time-saving benefit of VMAT will enable more patients to receive precision radiotherapy.	[Guo, Rui; Tang, Ling-Long; Mao, Yan-Ping; Zhou, Guan-Qun; Qi, Zhen-Yu; Liu, Meng-Zhong; Ma, Jun; Sun, Ying] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Dept Radiat Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Li-Zhi] Sun Yat Sen Univ, Ctr Canc, Imaging Diag & Intervent Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Li-Zhi] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Guo, R (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Dept Radiat Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	drjunma@hotmail.com; sunying@sysucc.org.cn			Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B10]; Innovation Team Development Plan of the Ministry of Education [IRT1297]; National Natural Science Foundation of China [81372409]; Natural Science Foundation of Guangdong Province [S2013010012220]; Science and Technology Project of Guangzhou City, China [132000507]	Health & Medical Collaborative Innovation Project of Guangzhou City, China; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; Innovation Team Development Plan of the Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Project of Guangzhou City, China	This work was supported by grants from the Health & Medical Collaborative Innovation Project of Guangzhou City, China (201400000001), the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2014BAI09B10), the Innovation Team Development Plan of the Ministry of Education (No. IRT1297), the National Natural Science Foundation of China (No. 81372409), the Natural Science Foundation of Guangdong Province (No. S2013010012220), and the Science and Technology Project of Guangzhou City, China (No. 132000507).	Bakst RL, 2011, INT J RADIAT ONCOL, V80, P148, DOI 10.1016/j.ijrobp.2010.01.026; Bertelsen A, 2010, RADIOTHER ONCOL, V95, P142, DOI 10.1016/j.radonc.2010.01.011; Dijkema T, 2010, INT J RADIAT ONCOL, V78, P449, DOI 10.1016/j.ijrobp.2009.07.1708; Doornaert P, 2011, INT J RADIAT ONCOL, V79, P429, DOI 10.1016/j.ijrobp.2009.11.014; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Guo R, 2012, RADIOTHER ONCOL, V104, P294, DOI 10.1016/j.radonc.2012.09.001; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Hall EJ, 2006, INT J RADIAT ONCOL, V65, P1, DOI 10.1016/j.ijrobp.2006.01.027; Hoogeman MS, 2008, INT J RADIAT ONCOL, V70, P609, DOI 10.1016/j.ijrobp.2007.08.066; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnston M, 2011, CLIN ONCOL-UK, V23, P503, DOI 10.1016/j.clon.2011.02.002; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Liang SB, 2009, INT J RADIAT ONCOL, V75, P742, DOI 10.1016/j.ijrobp.2008.11.053; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Patil VM, 2010, J CANCER RES THER, V6, P442, DOI 10.4103/0973-1482.77082; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075304; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Verbakel WFAR, 2009, INT J RADIAT ONCOL, V74, P252, DOI 10.1016/j.ijrobp.2008.12.033; Wang WY, 2013, CANCER-AM CANCER SOC, V119, P963, DOI 10.1002/cncr.27853; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; YU CX, 1995, PHYS MED BIOL, V40, P1435, DOI 10.1088/0031-9155/40/9/004; Zeng L, 2014, BRIT J CANCER, V110, P49, DOI 10.1038/bjc.2013.720; Zhou GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067488	29	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129679	10.1371/journal.pone.0129679	http://dx.doi.org/10.1371/journal.pone.0129679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146828	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600023
J	Hilz, MJ; Intravooth, T; Moeller, S; Wang, RH; Lee, DH; Koehn, J; Linker, RA				Hilz, Max J.; Intravooth, Tassanai; Moeller, Sebastian; Wang, Ruihao; Lee, De-Hyung; Koehn, Julia; Linker, Ralf A.			Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ORAL FINGOLIMOD; CARDIAC RATE; FTY720; TRIAL; RHYTHM	Background In multiple sclerosis (MS) patients, Fingolimod may induce prolonged heart-rate slowing which might be caused by MS-related central autonomic lesions. Objectives To evaluate whether MS-patients with prolonged heart-rate slowing (> six hours) upon Fingolimod show cardiovascular-autonomic dysfunction before Fingolimod-initiation. Methods Before Fingolimod-initiation, we recorded electrocardiographic RR-intervals (RRIs) and blood-pressure (BP) at rest, upon standing-up, during metronomic deep-breathing, Valsalva-maneuver, and "sustained-handgrip-exercise" in 21 patients with relapsing-remitting MS, and 20 healthy persons. We calculated sympathetic and parasympathetic cardiovascular parameters, including low-(LF) and high-frequency (HF) powers of RRI-and BP-oscillations, RRI-RMSSDs, RRI-and BP-changes during handgrip-exercise, parasympathetic heart-rate-slowing in relation to BP-overshoot after Valsalva-strain-release. We compared values of healthy persons and patients with and without prolonged heart-rate slowing after Fingolimod-initiation (ANOVA; significance: p<0.05). Results Upon Fingolimod-initiation, 7/21 patients had prolonged HR-slowing. Before Fingolimod, these patients had higher resting BP and higher BP increase during handgrip-exercise than had the other participants (p<0.05). They did not reduce parasympathetic HR-parameters upon standing-up. After Valsalva-strain-release, their parasympathetic HR-slowing in response to BP-overshoot was four times higher than in the other participants (p<0.05). Conclusions The autonomic cardiovascular dysfunction in MS-patients with delayed HR-re-acceleration upon Fingolimod-initiation suggests that MS-related central autonomic lesions compromise HR-re-acceleration upon Fingolimod.	[Hilz, Max J.; Intravooth, Tassanai; Moeller, Sebastian; Wang, Ruihao; Lee, De-Hyung; Koehn, Julia; Linker, Ralf A.] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany	University of Erlangen Nuremberg	Hilz, MJ (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany.	max.hilz@uk-erlangen.de	Linker, Ralf/AAD-8884-2020	Wang, Ruihao/0000-0003-4792-5572; Intravooth, Tassanai/0000-0002-6188-4503	Genzyme; Sanofi company; Novartis Pharma GmbH; Bayer HealthCare Pharmaceuticals; Biogen Idec; Merck Serono; TEVA Pharmaceutical Industries LTD; Roche	Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi company; Novartis Pharma GmbH; Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Biogen Idec(Biogen); Merck Serono(Merck & Company); TEVA Pharmaceutical Industries LTD(Teva Pharmaceutical Industries); Roche(Roche Holding)	The authors of this manuscript have read the journal's policy and have the following competing interests: Max. J. Hilz received speaker honoraria and research support from Genzyme, a Sanofi company, Novartis Pharma GmbH, and Bayer HealthCare Pharmaceuticals. Tassanai Intravooth received travel grants from Genzyme, a Sanofi company. De-Hyung Lee received travel grants or speaker honoraria from Bayer HealthCare Pharmaceuticals, Biogen Idec, Merck Serono, Novartis Pharma GmbH, and TEVA Pharmaceutical Industries LTD, as well as research support from Novartis Pharma GmbH. Julia Koehn received travel grants from Genzyme, a Sanofi company and Bayer HealthCare Pharmaceuticals. Ralf A. Linker received travel grants or speaker honoraria from Bayer HealthCare Pharmaceuticals, Biogen Idec, Merck Serono, Novartis Pharma GmbH, Roche, and TEVA Pharmaceutical Industries LTD, as well as research support from Novartis Pharma GmbH, Biogen Idec, and Merck Serono. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Benarroch E.E., 1997, CLIN AUTONOMIC DISOR, P17; Benarroch EE, 1993, CLIN AUTONOMIC DISOR, P209; Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Eckberg D, 1992, HUMAN BAROREFLEXES H; Faber H, 2013, MULT SCLER J, V19, P126, DOI 10.1177/1352458512447596; Fazekas F, 2012, WIEN MED WOCHENSCHR, V162, P354, DOI 10.1007/s10354-012-0123-y; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Gold R, 2014, J NEUROL, V261, P267, DOI 10.1007/s00415-013-7115-8; Hilz MJ, 2008, STROKE, V39, P2421, DOI 10.1161/STROKEAHA.108.518613; Hilz MJ, 2006, BRAIN, V129, P3343, DOI 10.1093/brain/awl299; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; Hilz MJ., 2002, NEUROMUSCULAR FUNCTI, P1899; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kovarik JM, 2008, BRIT J CLIN PHARMACO, V66, P199, DOI 10.1111/j.1365-2125.2008.03199.x; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Low PA, 2008, CLIN AUTONOMIC DISOR, P130; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; MELCHER A, 1981, AM J PHYSIOL, V241, pH838, DOI 10.1152/ajpheart.1981.241.6.H838; Merkelbach S, 2006, J NEUROL, V253, P21, DOI 10.1007/s00415-005-1105-z; Nada A, 2013, AM HEART J, V165, P489, DOI 10.1016/j.ahj.2013.01.011; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rossi S, 2014, MULT SCLER, DOI 10.1177/1352458514538885; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Sanya EO, 2005, CLIN AUTON RES, V15, P213, DOI 10.1007/s10286-005-0274-7; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Schmouder R, 2006, J CLIN PHARMACOL, V46, P895, DOI 10.1177/0091270006289853; Schmouder R, 2012, EUR J CLIN PHARMACOL, V68, P355, DOI 10.1007/s00228-011-1146-9; Singer BA, 2013, THER ADV NEUROL DISO, V6, P269, DOI 10.1177/1756285613491520; THOMAIDES TN, 1993, J NEUROL, V240, P139, DOI 10.1007/BF00857517; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P768, DOI 10.1002/jmri.21679; Ziemssen T, 2013, J NEURAL TRANSM, V120, pS27, DOI 10.1007/s00702-013-1054-5	36	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132139	10.1371/journal.pone.0132139	http://dx.doi.org/10.1371/journal.pone.0132139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147106	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600205
J	Hu, WL; Swanson, BA; Heller, GZ				Hu, Wenli; Swanson, Brett A.; Heller, Gillian Z.			A Statistical Method for the Analysis of Speech Intelligibility Tests	PLOS ONE			English	Article							NOISE; THRESHOLD	Speech intelligibility tests are conducted on hearing-impaired people for the purpose of evaluating the performance of a hearing device under varying listening conditions and device settings or algorithms. The speech reception threshold (SRT) is typically defined as the signal-to-noise ratio (SNR) at which a subject scores 50% correct on a speech intelligibility test. An SRT is conventionally measured with an adaptive procedure, in which the SNR of successive sentences is adjusted based on the subject's scores on previous sentences. The SRT can be estimated as the mean of a subset of the SNR levels, or by fitting a psychometric function. A set of SRT results is typically analyzed with a repeated measures analysis of variance. We propose an alternative approach for analysis, a zero-and-one inflated beta regression model, in which an observation is a single sentence score rather than an SRT. A parametrization of the model is defined that allows efficient maximum likelihood estimation of the parameters. Fitted values from this model, when plotted against SNR, are analogous to a mean psychometric function in the traditional approach. Confidence intervals for the fitted value curves are obtained by parametric bootstrap. The proposed approach was applied retrospectively to data from two studies that assessed the speech perception of cochlear implant recipients using different sound processing algorithms under different listening conditions. The proposed approach yielded mean SRTs for each condition that were consistent with the traditional approach, but were more informative. It provided the mean psychometric curve of each condition, revealing differences in slope, i.e. differential performance at different parts of the SNR spectrum. Another advantage of the new method of analysis is that results are stated in terms of differences in percent correct scores, which is more interpretable than results from the traditional analysis.	[Hu, Wenli; Heller, Gillian Z.] Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia; [Swanson, Brett A.] Cochlear Ltd, Sydney, NSW, Australia	Macquarie University; Cochlear	Heller, GZ (corresponding author), Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia.	gillian.heller@mq.edu.au		Swanson, Brett/0000-0003-1732-2332; Heller, Gillian/0000-0003-1270-1499	Cochlear Ltd.	Cochlear Ltd.	The authors received no specific funding for this work. Cochlear Ltd., provided support in the form of a salary for author BAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Brand T, 2002, J ACOUST SOC AM, V111, P2801, DOI 10.1121/1.1479152; Davison AC, 1997, CAMBRIDGE SERIES STA; Dawson PW, 2013, EAR HEARING, V34, P592, DOI 10.1097/AUD.0b013e31828576fb; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Hersbach AA, 2013, J ACOUST SOC AM, V133, P2412, DOI 10.1121/1.4794391; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Ospina R, 2006, ZERO INFLATED BETA D; Ospina R, 2010, STAT PAP, V51, P111, DOI 10.1007/s00362-008-0125-4; PLOMP R, 1979, AUDIOLOGY, V18, P43; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	13	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132409	10.1371/journal.pone.0132409	http://dx.doi.org/10.1371/journal.pone.0132409			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147290	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600261
J	Santos, PC; Lehmann, LM; Lorenzi, C; Hirsch, C; Telmo, PL; Mattos, GT; Cadore, PS; Klafke, GB; Berne, MEA; Goncalves, CV; Scaini, CJ				Santos, Paula Costa; Lehmann, Lis Maurente; Lorenzi, Carolina; Hirsch, Carolina; Telmo, Paula Lima; Mattos, Gabriela Torres; Cadore, Priscila Silva; Klafke, Gabriel Baracy; Aires Berne, Maria Elisabeth; Goncalves, Carla Vitola; Scaini, Carlos James			The Seropositivity of Toxocara spp. Antibodies in Pregnant Women Attented at the University Hospital in Southern Brazil and the Factors Associated with Infection	PLOS ONE			English	Article							RISK-FACTORS; VERTICAL TRANSMISSION; SEROLOGICAL DIAGNOSIS; DOT-ELISA; FREQUENCY; SCHOOLCHILDREN; POPULATION; PREVALENCE; INGESTION; CHILDREN	Background Human toxocariasis is a parasitic zoonosis with a worldwide distribution but is underdiagnosed with an underestimated impact on human health. The ingestion of embryonated eggs of Toxocara spp. present on the hands or in contaminated food or water is the main mode of infection. The only record of Toxocara congenital infection in humans occurred in a premature infant. Helminth infections during pregnancy may be associated with reproductive disorders. Studies investigating the occurrence of toxocariasis in pregnancy are scarce, as is research on the possible implications of these parasites in reproductive health. The aim of this study was to determine the seroprevalence of antibodies to Toxocara spp. in pregnant women and to identify risk factors associated with its infection. Methodology/Principal Findings The cross-sectional study of the seropositivity of specific antibodies for Toxocara spp. was performed on 280 pregnant women. Serum samples were examined with enzyme-linked immunoassay. Epidemiological data were obtained through a questionnaire containing information about obstetric history, general life style choices, and the social and economic status of the women. The prevalence of Toxocara spp. IgG in pregnant women was 6.4%. Some of the risk factors associated with the infection were owning dogs (p = 0.003), living in the city centre (p = 0.028), living at the city beach (p = 0.003), and having a family income at or below minimum wage (p < 0.001). There was no association between reproductive disorders and Toxocara seropositivity. Conclusions/Significance The seroprevalence of 6.4% for Toxocara spp. in pregnant women shows that there was exposure to the parasite. The study demonstrates the need for attention for the completion of clinical diagnosis parameters, as well as the expansion of highly specific serological studies in different regions to understand the impact of toxocariasis in pregnancy.	[Santos, Paula Costa; Lehmann, Lis Maurente; Lorenzi, Carolina; Hirsch, Carolina; Telmo, Paula Lima; Mattos, Gabriela Torres; Cadore, Priscila Silva; Klafke, Gabriel Baracy; Scaini, Carlos James] Fed Univ Rio Grande FURG Rio Grande, Area Interdisciplinary Biomed Sci AICB, Fac Med FAMED, Parasitol Lab, Rio Grande, RS, Brazil; [Goncalves, Carla Vitola] Univ Hosp Rio Grande Rio Grande, Obstet Ctr, Rio Grande, RS, Brazil; [Aires Berne, Maria Elisabeth] Univ Fed Pelotas, Dept Microbiol & Parasitol, Inst Biol, Parasitol Lab, Pelotas, RS, Brazil	Universidade Federal de Pelotas	Santos, PC (corresponding author), Fed Univ Rio Grande FURG Rio Grande, Area Interdisciplinary Biomed Sci AICB, Fac Med FAMED, Parasitol Lab, Rio Grande, RS, Brazil.	paulavet10@hotmail.com	Santos, Paula/P-2969-2017	Santos, Paula/0000-0002-8599-4176				Akao N, 1990, T ROY SOC TROP MED H, V724, P84; Alderete JMS, 2003, MEM I OSWALDO CRUZ, V98, P593, DOI 10.1590/S0074-02762003000500002; Anderson BC, 1996, J AM VET MED ASSOC, V208, P185; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; CAMARGO ED, 1992, REV I MED TROP, V34, P55, DOI 10.1590/S0036-46651992000100010; Campos Júnior Dioclécio, 2003, Rev. Soc. Bras. Med. Trop., V36, P509, DOI 10.1590/S0037-86822003000400013; Capuano Divani Maria, 2006, Rev. bras. epidemiol., V9, P81; Choi D, 2008, KOREAN J PARASITOL, V46, P139, DOI 10.3347/kjp.2008.46.3.139; Cong W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003082; de Avila LFD, 2012, VET PARASITOL, V187, P337, DOI 10.1016/j.vetpar.2012.01.002; de Savigny D.H., 1975, Journal Parasit, V61, P781, DOI 10.2307/3279492; DESAVIGNY DH, 1979, J CLIN PATHOL, V32, P284, DOI 10.1136/jcp.32.3.284; Figueiredo Silvana D. P., 2005, J. Pediatr. (Rio J.), V81, P126, DOI [10.2223/JPED.1317, 10.1590/S0021-75572005000300007]; Gasanova T. A., 2003, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P11; Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x; Hoffmeister B, 2007, AM J TROP MED HYG, V76, P600, DOI 10.4269/ajtmh.2007.76.600; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Maffrand R, 2006, ANAIS PEDIAT BARCELO, V64, P595, DOI DOI 10.1157/13089928; Maizels R, 1991, PARASITE ANTIGENS PA; Manini MP, 2012, VET PARASITOL, V188, P48, DOI 10.1016/j.vetpar.2012.03.011; Marchioro Ariella Andrade, 2011, Rev. paul. pediatr., V29, P80; Mendonca LR, 2013, ACTA TROP, V128, P90, DOI 10.1016/j.actatropica.2013.06.018; MENDONCA LR, 2012, PLOS NEGLECTED TROPI, V0006, DOI DOI 10.1371/J0URNAL.PNTD.0001886; Morimatsu Y, 2006, AM J TROP MED HYG, V75, P303, DOI 10.4269/ajtmh.2006.75.303; Mpairwe H, 2014, PARASITE IMMUNOL, V36, P328, DOI 10.1111/pim.12101; Negri Elaine Cristina, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P211, DOI 10.1016/S2221-1691(13)60052-0; Paludo Márcia L., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P343, DOI 10.1590/S0036-46652007000600002; Pereira LC, 2007, THESIS U BRASILIA; Reiterova K, 2003, PARASITE IMMUNOL, V25, P361, DOI 10.1046/j.1365-3024.2003.00642.x; Roldan WH, 2008, REV I MED TROP, V50, P273, DOI 10.1590/S0036-46652008000500005; Roldan WH, 2009, REV INST MED TROP SP, V51, P67, DOI 10.1590/S0036-46652009000200002; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; Scaini Carlos James, 2003, Rev. Soc. Bras. Med. Trop., V36, P617, DOI 10.1590/S0037-86822003000500013; Moreiral GMSG, 2014, TRENDS PARASITOL, V30, P456, DOI 10.1016/j.pt.2014.07.003; Schoenardie ER, 2013, J PARASITOL, V99, P537, DOI 10.1645/GE-3182; Schoenardie ER, 2013, REV BRAS PARASITOL V, V22, P623, DOI 10.1590/S1984-29612013000400030; SHOOP WL, 1991, PARASITOL TODAY, V7, P51, DOI 10.1016/0169-4758(91)90189-U; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Souza RF, 2011, REV SOC BRAS MED TRO, V44, P516, DOI 10.1590/S0037-86822011000400024; Taylor MRH, 1996, J INFECTION, V32, P231, DOI 10.1016/S0163-4453(96)80025-9; [No title captured]	42	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131058	10.1371/journal.pone.0131058	http://dx.doi.org/10.1371/journal.pone.0131058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146833	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600059
J	Hoogendam, JP; Zweemer, RP; Verkooijen, HM; de Jong, PA; van den Bosch, MAAJ; Verheijen, RHM; Veldhuis, WB				Hoogendam, Jacob P.; Zweemer, Ronald P.; Verkooijen, Helena M.; de Jong, Pim A.; van den Bosch, Maurice A. A. J.; Verheijen, Rene H. M.; Veldhuis, Wouter B.			No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients	PLOS ONE			English	Article							INCIDENTAL FINDINGS; CARCINOMA; GUIDELINES; DIAGNOSIS	Aim Evidence supporting the recommendation to include chest radiography in the work-up of all cervical cancer patients is limited. We investigated the diagnostic value of routine chest radiography in cervical cancer staging. Methods All consecutive cervical cancer patients who presented at our tertiary referral center in the Netherlands (January 2006 - September 2013), and for whom >= 6 months follow-up was available, were included. As part of the staging procedure, patients underwent a routine two-directional digital chest radiograph. Findings were compared to a composite reference standard consisting of all imaging studies and histology obtained during the 6 months following radiography. Results Of the 402 women who presented with cervical cancer, 288 (71.6%) underwent chest radiography and had >= 6 months follow-up. Early clinical stage (I/II) cervical cancer was present in 244/288 (84.7%) women, while 44 (15.3%) presented with advanced disease (stage III/IV). The chest radiograph of 1 woman - with advanced pre-radiograph stage (IVA) disease - showed findings consistent with pulmonary metastases. Radiographs of 7 other women - 4 early, 3 advanced stage disease - were suspicious for pulmonary metastases which was confirmed by additional imaging in only 1 woman (with pre-radiograph advanced stage (IIIB) disease) and excluded in 6 cases, including all women with early stage disease. In none of the 288 women were thoracic skeletal metastases identified on imaging or during 6 months follow up. Radiography was unremarkable in 76.4% of the study population, and showed findings unrelated to the cervical carcinoma in 21.2%. Conclusion Routine chest radiography was of no value for any of the early stage cervical cancer patients presenting at our tertiary center over a period of 7.7 years.	[Hoogendam, Jacob P.; Zweemer, Ronald P.; Verheijen, Rene H. M.] Univ Med Ctr Utrecht, Div Oncol, Dept Gynaecol Oncol, Utrecht, Netherlands; [Verkooijen, Helena M.; de Jong, Pim A.; van den Bosch, Maurice A. A. J.; Veldhuis, Wouter B.] Univ Med Ctr Utrecht, Imaging Div, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Hoogendam, JP (corresponding author), Univ Med Ctr Utrecht, Div Oncol, Dept Gynaecol Oncol, Utrecht, Netherlands.	j.hoogendam@umcutrecht.nl	de Jong, Pim A/G-7220-2014	de Jong, Pim A/0000-0003-4840-6854; Zweemer, Ronald/0000-0003-1829-7773; Veldhuis, Wouter/0000-0002-9798-6843				[Anonymous], 2013, NCCN CLIN PRACT GUID; BARTER JF, 1990, GYNECOL ONCOL, V38, P347, DOI 10.1016/0090-8258(90)90071-R; Belhadj H, 2014, INT J GYNECOL OBSTET, V125, P97, DOI 10.1016/j.ijgo.2014.02.003; Burt JR, 2008, ARCH INTERN MED, V168, P756, DOI 10.1001/archinte.168.7.756; Colombo N, 2012, ANN ONCOL, V23, P27, DOI 10.1093/annonc/mds268; Comprehensive Cancer Centre the Netherlands (IKNL), 2012, NAT CERV CANC GUID V; Ferlay J, 2013, IARC CANCERBASE; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; GORDON RE, 1983, CANCER, V52, P559, DOI 10.1002/1097-0142(19830801)52:3<559::AID-CNCR2820520330>3.0.CO;2-5; GRIFFIN TW, 1976, AM J ROENTGENOL, V127, P825, DOI 10.2214/ajr.127.5.825; Gunasekera P. C., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P65; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; IMACHI M, 1989, GYNECOL ONCOL, V33, P189, DOI 10.1016/0090-8258(89)90549-0; Kesic V, 2014, ALGORITHMS MANAGEMEN; Massad LS, 2000, GYNECOL ONCOL, V76, P383, DOI 10.1006/gyno.1999.5714; Moore DH, 2006, OBSTET GYNECOL, V107, P1152, DOI 10.1097/01.AOG.0000215986.48590.79; Oaknin A, 2012, CLIN TRANSL ONCOL, V14, P516, DOI 10.1007/s12094-012-0834-y; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; Scottish Intercollegiate Guidelines Network (SIGN), 2008, MAN CERV CANC NAT CL; TELLIS CJ, 1982, CANCER-AM CANCER SOC, V48, P1705, DOI 10.1002/1097-0142(19820415)49:8<1705::AID-CNCR2820490828>3.0.CO;2-6; United States government department of health National Institutes of Health and National Cancer Institute, 2008, COMM TERM CRIT ADV E; WHO, 2006, COMPR CERV CANC CONT	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131899	10.1371/journal.pone.0131899	http://dx.doi.org/10.1371/journal.pone.0131899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135733	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400080
J	Huang, Q; Shang, GL; Deng, HH; Liu, J; Mei, Y; Xu, YC				Huang, Qian; Shang, Guilian; Deng, Haohua; Liu, Jie; Mei, Yan; Xu, Yancheng			High Mannose-Binding Lectin Serum Levels Are Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; VASCULAR COMPLICATIONS; CARDIOVASCULAR EVENTS; ELEVATED LEVELS; PREVALENCE; SUSCEPTIBILITY; MORTALITY; MOLECULE; DISEASE; RISK	Objective To investigate mannose-binding lectin (MBL) serum levels in type 2 diabetic patients with and without diabetic retinopathy (DR). Methods Serum MBL levels were determined in type 2 diabetic patients (N=324) as well as in 300 healthy control Subjects. Multivariate analyses were performed using logistic regression models. Receiver operating characteristic curves (ROC) was used to test the overall predict accuracy of MBL and other markers. Results Diabetic patients with DR and vision-threatening diabetic retinopathy (VTDR) had significantly higher MBL levels on admission (P<0.0001 and P<0.0001). MBL improved the area under the receiver operating characteristic curve of the diabetes duration for DRfrom 0.82 (95% confidence interval [CI], 0.77-0.86) to 0.88(95% CI, 0.82-0.96; P<0.01) and for VDTR from 0.85(95% CI, 0.77-0.92) to 0.90(95% CI, 0.83-0.96; P<0.01). Multivariate logistic regression analysis adjusted for common risk factors showed that serum MBL levels(per log-unit increase) was an independent predictor of DR (OR=3.45; 95% CI: 1.42-7.05) and VTDR (OR= 4.42; 95% CI: 1.51-8.18). Conclusion MBL is a novel, independent diagnostic marker of DR in type 2 diabetic patients, suggesting that MBL may be involved in the pathogenesis of DR in diabetic patients.	[Huang, Qian; Deng, Haohua; Liu, Jie; Xu, Yancheng] Wuhan Univ, Zhongnan Hosp, Dept Endocrinol, Wuhan 430072, Hubei Province, Peoples R China; [Shang, Guilian] Wuhan Univ Sci Technol, Tianyou Hosp, Dept Rheumatol, Wuhan, Hubei Province, Peoples R China; [Mei, Yan] Wuhan Univ, Sch Stomatol, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University; Wuhan University of Science & Technology; Wuhan University	Xu, YC (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Endocrinol, Wuhan 430072, Hubei Province, Peoples R China.	houzhaoyely@163.com		Xu, Yancheng/0000-0002-3298-5110				Acosta J, 2000, P NATL ACAD SCI USA, V97, P5450, DOI 10.1073/pnas.97.10.5450; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bay JT, 2013, KIDNEY INT, V83, P264, DOI 10.1038/ki.2012.373; Bouwman LH, 2005, DIABETES, V54, P3002, DOI 10.2337/diabetes.54.10.3002; Chang WC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-64; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from ste-reoscopic color fundus photographs-an extension of the modified Airlie House classification, 1991, OPHTHALMOLOGY, V98, pS786; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Elawa G, 2011, SAUDI MED J, V32, P784; Ezekowitz RAB, 1998, AM J HUM GENET, V62, P6, DOI 10.1086/301696; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Fortpied J, 2010, DIABETES-METAB RES, V26, P254, DOI 10.1002/dmrr.1079; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P4857, DOI 10.1210/jc.2003-030742; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; Hsu SIH, 2003, J AM SOC NEPHROL, V14, pS186, DOI 10.1097/01.ASN.0000070032.58017.20; Jack DL, 2001, J INFECT DIS, V184, P1152, DOI 10.1086/323803; Keller TT, 2006, ARTERIOSCL THROM VAS, V26, P2345, DOI 10.1161/01.ATV.0000240517.69201.77; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Looker HC, 2012, DIABETOLOGIA, V55, P2335, DOI 10.1007/s00125-012-2596-z; Man XJ, 2015, J DIABETES COMPLICAT, V29, P55, DOI 10.1016/j.jdiacomp.2014.09.013; Nagi DK, 1997, DIABETIC MED, V14, P449, DOI 10.1002/(SICI)1096-9136(199706)14:6<449::AID-DIA367>3.0.CO;2-D; Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6; Ozkan H, 2012, J PERINATOL, V32, P210, DOI 10.1038/jp.2011.79; Pavlov VI, 2012, AM J PATHOL, V180, P104, DOI 10.1016/j.ajpath.2011.09.026; Petersen SV, 2001, MOL IMMUNOL, V38, P133; Siezenga MA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-60; Tapp RJ, 2003, DIABETES CARE, V26, P1731, DOI 10.2337/diacare.26.6.1731; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; Wang ZY, 2014, NEUROCHEM RES, V39, P248, DOI 10.1007/s11064-013-1214-x; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zhang ZG, 2015, MOL NEUROBIOL, V51, P230, DOI 10.1007/s12035-014-8682-0	41	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130665	10.1371/journal.pone.0130665	http://dx.doi.org/10.1371/journal.pone.0130665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136138	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400022
J	Jiang, X; Kanda, T; Wu, S; Nakamoto, S; Nakamura, M; Sasaki, R; Haga, Y; Wakita, T; Shirasawa, H; Yokosuka, O				Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Nakamoto, Shingo; Nakamura, Masato; Sasaki, Reina; Haga, Yuki; Wakita, Takaji; Shirasawa, Hiroshi; Yokosuka, Osamu			Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-kappa B-Nuclear Translocation	PLOS ONE			English	Article							NS5A PROTEIN; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; CORE PROTEIN; CANCER CELLS; PROTEASOME; DEGRADATION; EXPRESSION; INFECTION; KINASE	Background Hepatitis C virus (HCV) infection is one of the major causes of cirrhosis and hepatocellular carcinoma. HCV nonstructural protein 5A (NS5A) is an attractive antiviral target and plays an important role in HCV replication as well as hepatocarcinogenesis. The aim of this study was to assess the effect of HCV NS5A protein in the abrogation of apoptotic cell death induced by the proteasome inhibitor MG132. Methods Apoptotic responses to MG132 and the expression of molecules involved in NF-kappa B signaling pathways in human hepatocytes were investigated with or without the expression of HCV NS5A. Results HCV NS5A protected HepG2 cells against MG132-induced apoptosis, in line with NF-kappa B-nuclear translocation. A similar NF-kappa B-nuclear translocation was observed in Huh7 cells infected with HCV JFH1. In agreement with this, after treatment with MG132, HCV NS5A could elevate the transcription of several NF-kappa B target genes such as BCL2 and BCLXL to inhibit MG132-induced apoptosis in hepatocytes. HCV HCV NS5A also enhanced phosphorylation of I kappa B alpha. Consistent with a conferred prosurvival advantage, HCV NS5A reduced MG132-induced poly(adenosine diphosphate-ribose) polymerase cleavage. Conclusions HCV NS5A expression enhances phosphorylation of I kappa B alpha, liberates NF-kappa B for nuclear translocation and downregulates MG132-induced apoptotic pathways in human hepatocytes. It is possible that the disruption of proteasome-associated apoptosis plays a role in the pathogenesis of HCV infection.	[Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Nakamura, Masato; Sasaki, Reina; Haga, Yuki; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan; [Jiang, Xia; Kanda, Tatsuo; Wu, Shuang; Nakamura, Masato; Sasaki, Reina; Haga, Yuki; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Nephrol, Chiba, Japan; [Nakamoto, Shingo; Shirasawa, Hiroshi] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Chiba University; Chiba University; Chiba University; National Institute of Infectious Diseases (NIID)	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	Merck Sharp Dohme (MSD); KAKEN from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590955]	Merck Sharp Dohme (MSD)(Merck & Company); KAKEN from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was funded by Merck Sharp & Dohme (MSD) and a KAKEN Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24590955), awarded to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Brzoska K, 2015, MUTAGENESIS; Cervello M, 2004, INT J MOL MED, V13, P741; Chen YC, 2013, PROSTATE, V73, P1270, DOI 10.1002/pros.22641; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Emanuele S, 2002, INT J ONCOL, V21, P857; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Ferrarini M, 2008, J IMMUNOL, V181, P5857, DOI 10.4049/jimmunol.181.9.5857; Franck N, 2005, J VIROL, V79, P2700, DOI 10.1128/JVI.79.5.2700-2708.2005; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Ghosh AK, 2000, VIRUS RES, V67, P173, DOI 10.1016/S0168-1702(00)00141-6; Ghosh AK, 2000, J BIOL CHEM, V275, P7184, DOI 10.1074/jbc.275.10.7184; Haqshenas G, 2013, VIRUS RES, V176, P211, DOI 10.1016/j.virusres.2013.06.009; Hintermann E, 2010, J AUTOIMMUN, V35, P424, DOI 10.1016/j.jaut.2010.09.003; Hou WH, 2010, GASTROENTEROLOGY, V138, P1909, DOI 10.1053/j.gastro.2009.11.001; Jiang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113499; Kanda T, 2006, J VIROL, V80, P4633, DOI 10.1128/JVI.80.9.4633-4639.2006; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Kanda T, 2009, J VIROL, V83, P8463, DOI 10.1128/JVI.00751-09; Katsounas A, 2011, INT REV IMMUNOL, V30, P366, DOI 10.3109/08830185.2011.593105; Kim JY, 2000, BIOCHEM BIOPH RES CO, V273, P140, DOI 10.1006/bbrc.2000.2909; Kuo TC, 2011, BIOCHEM PHARMACOL, V82, P184, DOI 10.1016/j.bcp.2011.04.008; La Frazia S, 2006, ANTIVIR THER, V11, P995; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Langhans B, 2013, J HEPATOL, V59, P229, DOI 10.1016/j.jhep.2013.04.011; Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; McDade TP, 1999, SURGERY, V126, P371, DOI 10.1016/S0039-6060(99)70179-0; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; Moriishi K, 2010, HEPATOLOGY, V52, P411, DOI 10.1002/hep.23680; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Planz O, 2013, ANTIVIR RES, V98, P457, DOI 10.1016/j.antiviral.2013.04.008; Ray RB, 1996, VIROLOGY, V226, P176, DOI 10.1006/viro.1996.0644; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stevenson NJ, 2013, FEBS LETT, V587, P1571, DOI 10.1016/j.febslet.2013.03.041; Suzuki R, 2001, VIROLOGY, V280, P301, DOI 10.1006/viro.2000.0785; Tamura R, 2011, J INFECT DIS, V204, P793, DOI 10.1093/infdis/jir381; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Waris G, 2002, BIOCHEM PHARMACOL, V64, P1425, DOI 10.1016/S0006-2952(02)01300-X; Zanotto A, 2012, INVEST NEW DRUG, V30, P2252, DOI 10.1007/s10637-012-9804-z	51	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131973	10.1371/journal.pone.0131973	http://dx.doi.org/10.1371/journal.pone.0131973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133378	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400085
J	Uryash, A; Bassuk, J; Kurlansky, P; Altamirano, F; Lopez, JR; Adams, JA				Uryash, Arkady; Bassuk, Jorge; Kurlansky, Paul; Altamirano, Francisco; Lopez, Jose R.; Adams, Jose A.			Antioxidant Properties of Whole Body Periodic Acceleration (pGz)	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; PASSIVE EXERCISE; DIABETIC CARDIOMYOPATHY; SUPEROXIDE-DISMUTASE; SHEAR; ACTIVATION; EXPRESSION; CIRCULATION; SUPPLEMENTS	The recognition that oxidative stress is a major component of several chronic diseases has engendered numerous trials of antioxidant therapies with minimal or no direct benefits. Nanomolar quantities of nitric oxide released into the circulation by pharmacologic stimulation of eNOS have antioxidant properties but physiologic stimulation as through increased pulsatile shear stress of the endothelium has not been assessed. The present study utilized a non-invasive technology, periodic acceleration (pGz) that increases pulsatile shear stress such that upregulation of cardiac eNOS occurs, We assessed its efficacy in normal mice and mouse models with high levels of oxidative stress, e.g. Diabetes type 1 and mdx (Duchene Muscular Dystrophy). pGz increased protein expression and upregulated eNOS in hearts. Application of pGz was associated with significantly increased expression of endogenous antioxidants (Glutathioneperoxidase-1(GPX-1), Catalase (CAT), Superoxide, Superoxide Dismutase 1(SOD1). This led to an increase of total cardiac antioxidant capacity along with an increase in the antioxidant response element transcription factor Nrf2 translocation to the nucleus. pGz decreased reactive oxygen species in both mice models of oxidative stress. Thus, pGz is a novel non-pharmacologic method to harness endogenous antioxidant capacity.	[Uryash, Arkady; Bassuk, Jorge; Adams, Jose A.] Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA; [Altamirano, Francisco; Lopez, Jose R.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Kurlansky, Paul] Columbia Univ, Dept Surg, New York, NY USA	Mount Sinai Medical Center; University of California System; University of California Davis; Columbia University	Adams, JA (corresponding author), Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA.	tony-adams@msmc.com	Adams, Jose Antonio/ABC-2699-2021; Altamirano, Francisco/I-1928-2013; Adams, Jose Antonio/AAI-2342-2020	Adams, Jose Antonio/0000-0002-9401-2226; Altamirano, Francisco/0000-0002-1612-2729; Adams, Jose Antonio/0000-0002-9401-2226	Florida Heart Research Institute	Florida Heart Research Institute	This study was funded by a Grant to JAA from the Florida Heart Research Institute (www.floridaheart.org).	Adams JA, 2005, J APPL PHYSIOL, V98, P1083, DOI 10.1152/japplphysiol.00662.2004; Adams JA, 2010, LIFE SCI, V86, P707, DOI 10.1016/j.lfs.2010.02.022; Altamirano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106590; Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361; Bjelakovic G, 2014, CURR OPIN CLIN NUTR, V17, P40, DOI 10.1097/MCO.0000000000000009; Bocci V, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00004; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; Cardozo LFMF, 2013, BIOCHIMIE, V95, P1525, DOI 10.1016/j.biochi.2013.04.012; Carnicer R, 2013, ANTIOXID REDOX SIGN, V18, P1078, DOI 10.1089/ars.2012.4824; Chen JX, 2014, J FOOD BIOCHEM, V38, P337, DOI 10.1111/jfbc.12058; Cingolani HE, 2013, AM J PHYSIOL-HEART C, V304, pH175, DOI 10.1152/ajpheart.00508.2012; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Costas JM, 2010, MUSCLE NERVE, V42, P881, DOI 10.1002/mus.21783; Elrod JW, 2008, P NATL ACAD SCI USA, V105, P11430, DOI 10.1073/pnas.0800700105; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Forstermann U, 2011, BRIT J PHARMACOL, V164, P213, DOI 10.1111/j.1476-5381.2010.01196.x; Fukuda S, 2010, AM HEART J, V159, P620, DOI 10.1016/j.ahj.2009.12.034; Gimenes C, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/457848; Golbidi S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/789607; Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Hourde C, 2013, AM J PATHOL, V182, P1509, DOI 10.1016/j.ajpath.2013.01.020; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Jones CI, 2007, ANN BIOMED ENG, V35, P683, DOI 10.1007/s10439-007-9279-9; Katusic ZS, 2014, EUR HEART J, V35, P888, DOI 10.1093/eurheartj/eht544; Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008; Lei J, 2013, NITRIC OXIDE-BIOL CH, V35, P175, DOI 10.1016/j.niox.2013.09.004; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Li RS, 2009, BIOCHEM BIOPH RES CO, V388, P406, DOI 10.1016/j.bbrc.2009.08.022; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Miyamoto S, 2011, AM J CARDIOL, V107, P168, DOI 10.1016/j.amjcard.2010.09.007; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Nakamura A, 2002, FEBS LETT, V520, P18, DOI 10.1016/S0014-5793(02)02739-4; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rokutanda T, 2011, ARTERIOSCL THROM VAS, V31, P2872, DOI 10.1161/ATVBAHA.111.229773; Sackner MA, 2005, CHEST, V127, P30, DOI 10.1378/chest.127.1.30; Sackner MA, 2012, J PARKINSONISM RESTL, V2, P1, DOI 10.7157/jprls.2012.v2n1pp1-5; Sag CM, 2013, FREE RADICAL BIO MED, V63, P338, DOI 10.1016/j.freeradbiomed.2013.05.035; Sakaguchi M, 2012, J CARDIOL, V60, P283, DOI 10.1016/j.jjcc.2012.05.006; Selsby JT, 2013, J APPL PHYSIOL, V115, P660, DOI 10.1152/japplphysiol.00252.2013; Sun CC, 2015, J APPL PHYSIOL, V118, P224, DOI 10.1152/japplphysiol.00744.2014; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Takeshita S, 2000, BIOCHEM BIOPH RES CO, V273, P66, DOI 10.1006/bbrc.2000.2898; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Uryash A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121069; Uryash A, 2012, LIFE SCI, V91, P178, DOI 10.1016/j.lfs.2012.06.031; Uryash A, 2009, J APPL PHYSIOL, V106, P1840, DOI 10.1152/japplphysiol.91612.2008; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vassort G, 2010, CARDIOVASC TOXICOL, V10, P73, DOI 10.1007/s12012-010-9064-0; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Wu H., 2012, CARDIOVASC ENG TECHN, V3, P292; Ye YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056803; Zhang M, 2014, CARDIOVASC RES, V102, P249, DOI 10.1093/cvr/cvu050; Zhang YX, 2011, AM J PHYSIOL-HEART C, V301, pH634, DOI 10.1152/ajpheart.01315.2010	60	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131392	10.1371/journal.pone.0131392	http://dx.doi.org/10.1371/journal.pone.0131392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133377	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400045
J	Miteva, DA; Loucks, CJ; Pattanayak, SK				Miteva, Daniela A.; Loucks, Colby J.; Pattanayak, Subhrendu K.			Social and Environmental Impacts of Forest Management Certification in Indonesia	PLOS ONE			English	Article							MATCHING ESTIMATORS; EAST KALIMANTAN; BIODIVERSITY; PRODUCTS	In response to unsustainable timber production in tropical forest concessions, voluntary forest management certification programs such as the Forest Stewardship Council (FSC) have been introduced to improve environmental, social, and economic performance over existing management practices. However, despite the proliferation of forest certification over the past two decades, few studies have evaluated its effectiveness. Using temporally and spatially explicit village-level data on environmental and socio-economic indicators in Kalimantan (Indonesia), we evaluate the performance of the FSC-certified timber concessions compared to non-certified logging concessions. Employing triple difference matching estimators, we find that between 2000 and 2008 FSC reduced aggregate deforestation by 5 percentage points and the incidence of air pollution by 31%. It had no statistically significant impacts on fire incidence or core areas, but increased forest perforation by 4 km(2) on average. In addition, we find that FSC reduced firewood dependence (by 33%), respiratory infections (by 32%) and malnutrition (by 1 person) on average. By conducting a rigorous statistical evaluation of FSC certification in a biodiversity hotspot such as Indonesia, we provide a reference point and offer methodological and data lessons that could aid the design of ongoing and future evaluations of a potentially critical conservation policy.	[Miteva, Daniela A.] Nature Conservancy, Ft Collins, CO 80524 USA; [Loucks, Colby J.] World Wildlife Fund US, Washington, DC USA; [Pattanayak, Subhrendu K.] Duke Univ, Durham, NC USA	Nature Conservancy; Duke University	Miteva, DA (corresponding author), Nature Conservancy, Ft Collins, CO 80524 USA.	dmiteva@tnc.org		Miteva, Daniela/0000-0002-9123-646X	Duke University, WWF-US	Duke University, WWF-US	Funding was provided by Duke University, WWF-US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; [Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 2011, MODIS VEGETATION CON; Araujo M, 2009, FOREST POLICY ECON, V11, P579, DOI 10.1016/j.forpol.2009.07.008; Arbainsyah, 2014, BIODIVERS CONSERV, V23, P2445, DOI 10.1007/s10531-014-0732-4; Auld G, 2008, ANNU REV ENV RESOUR, V33, P187, DOI 10.1146/annurev.environ.33.013007.103754; Blackman A., 2010, RESOURCES FUTURE; Blackman A, 2011, CONSERV BIOL, V25, P1176, DOI 10.1111/j.1523-1739.2011.01774.x; Brandt JS, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/4/044007; Brotto L, 2010, BIODIVERSITY CONSERV; Burgess R, 2012, Q J ECON, V127, P1707, DOI 10.1093/qje/qjs034; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Cannon CH, 1998, SCIENCE, V281, P1366, DOI 10.1126/science.281.5381.1366; Casson A, 2002, WORLD DEV, V30, P2133, DOI 10.1016/S0305-750X(02)00125-0; Cerutti PO, 2011, FOREST POLICY ECON, V13, P184, DOI 10.1016/j.forpol.2010.11.005; de Lima A. C. B., 2008, IMPACT FSC FOREST CE; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards DP, 2009, CONSERV BIOL, V23, P1628, DOI 10.1111/j.1523-1739.2009.01330.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraro PJ, 2012, REV ENV ECON POLICY, V6, P20, DOI 10.1093/reep/rer019; FIRMS NASA, 2012, MODIS ACT FIR DET; Forest Council Stewardship, 2014, GLOB FSC CERT TYP DI; Forest Council Stewardship, 2012, FSC PRINC CRIT; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Greenstone M, 2009, J ENVIRON ECON MANAG, V57, P21, DOI 10.1016/j.jeem.2008.02.004; Griscom B, 2014, GLOBAL CHANGE BIOL, V20, P923, DOI 10.1111/gcb.12386; Gullison RE, 2003, ORYX, V37, P153, DOI 10.1017/S0030605303000346; Huboyo HS, 2014, ATMOS ENVIRON, V82, P343, DOI 10.1016/j.atmosenv.2013.10.044; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Indonesia's Bureau of Statitics, 2014, VILL POT STAT; Kiker CF, 1997, ECOL ECON, V20, P37, DOI 10.1016/S0921-8009(96)00076-6; Lawson S., 2014, FOR TRENDS REP SERIE; Lee JSH, 2014, CONSERV LETT, V7, P25, DOI 10.1111/conl.12039; LEI, 2013, MEM UND LEI FSC; Medjibe VP, 2013, ENVIRON MANAGE, V51, P524, DOI 10.1007/s00267-012-0006-4; Milder JC, 2015, CONSERV BIOL, V29, P309, DOI 10.1111/cobi.12411; Minnemeyer S, 2009, INTERACTIVE ATLAS IN; Miteva D. A., 2014, NATURE BALANCE, P251; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Parent JR, 2013, LANDSCAPE FRAGMENTAT; Pattanayak S.K., 2009, ROUGH GUIDE IMPACT E; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; Rainforest Alliance, 2014, CERT FOR OP SUMM IND; RAND, 2014, VILL POT STAT; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; Resosudarmo Ida Aju Pradnja, 2005, DEMOCRATIC DECENTRAL, P110; Romero C., 2013, OVERVIEW CURRENT KNO; Ruslandi Klassen A, 2014, FOREST STEWARDSHIP C; Sargent M, 2014, THESIS DUKE U; Sekhon JS, 2009, ANNU REV POLIT SCI, V12, P487, DOI 10.1146/annurev.polisci.11.060606.135444; Sills EO, 2003, FOR SCI, V72, P259; Slik JWF, 2002, BIODIVERS CONSERV, V11, P85, DOI 10.1023/A:1014036129075; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Steering Committee of the State-of-Knowledge Assessment of Standards and Certification, 2012, SUST ROL LIM CERT; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vincent JR, 1994, CAUSES TROPICAL DEFO, P298; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; Zagt R. J., 2010, BIODIVERSITY CONSERV	64	80	80	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129675	10.1371/journal.pone.0129675	http://dx.doi.org/10.1371/journal.pone.0129675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26132491	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000033
J	Sasaki, Y; Ohta, M; Desai, D; Figueiredo, JL; Whelan, MC; Sugano, T; Yamabi, M; Yano, W; Faits, T; Yabusaki, K; Zhang, HM; Mlynarchik, AK; Inoue, K; Mizuno, K; Aikawa, M				Sasaki, Yusuke; Ohta, Masayuki; Desai, Dhruv; Figueiredo, Jose-Luiz; Whelan, Mary C.; Sugano, Tomohiro; Yamabi, Masaki; Yano, Wataru; Faits, Tyler; Yabusaki, Katsumi; Zhang, Hengmin; Mlynarchik, Andrew K.; Inoue, Keisuke; Mizuno, Ken; Aikawa, Masanori			Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin Resistance	PLOS ONE			English	Article							CHRONIC INFLAMMATION; LIPID-METABOLISM; GROWTH-FACTOR; OBESITY; CELLS; INHIBITOR; BINDING; MICE	Objectives Angiopoietin-like protein 2 (ANGPTL2), a recently identified pro-inflammatory cytokine, is mainly secreted from the adipose tissue. This study aimed to explore the role of ANGPTL2 in adipose tissue inflammation and macrophage activation in a mouse model of diabetes. Methodology/Principal Findings Adenovirus mediated lacZ (Ad-LacZ) or human ANGPTL2 (Ad-ANGPTL2) was delivered via tail vein in diabetic db/db mice. Ad-ANGPTL2 treatment for 2 weeks impaired both glucose tolerance and insulin sensitivity as compared to Ad-LacZ treatment. Ad-ANGPTL2 treatment significantly induced pro-inflammatory gene expression in white adipose tissue. We also isolated stromal vascular fraction from epididymal fat pad and analyzed adipose tissue macrophage and T lymphocyte populations by flow cytometry. Ad-ANGPTL2 treated mice had more adipose tissue macrophages (F4/80+CD11b+) and a larger M1 macrophage subpopulation (F4/80+CD11b+CD11c+). Moreover, Ad-ANGPTL2 treatment increased a CD8-positive T cell population in adipose tissue, which preceded increased macrophage accumulation. Consistent with our in vivo results, recombinant human ANGPTL2 protein treatment increased mRNA levels of pro-inflammatory gene products and production of TNF-alpha protein in the human macrophage-like cell line THP-1. Furthermore, Ad-ANGPTL2 treatment induced lipid accumulation and increased fatty acid synthesis, lipid metabolism related gene expression in mouse liver. Conclusion ANGPTL2 treatment promotes macrophage accumulation and activation. These results suggest potential mechanisms for insulin resistance.	[Sasaki, Yusuke; Ohta, Masayuki; Desai, Dhruv; Figueiredo, Jose-Luiz; Whelan, Mary C.; Sugano, Tomohiro; Yamabi, Masaki; Yano, Wataru; Faits, Tyler; Yabusaki, Katsumi; Zhang, Hengmin; Mlynarchik, Andrew K.; Inoue, Keisuke; Mizuno, Ken; Aikawa, Masanori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Interdisciplinary Cardiovasc Sci, Boston, MA 02115 USA; [Sasaki, Yusuke; Ohta, Masayuki; Sugano, Tomohiro; Yamabi, Masaki; Yano, Wataru; Yabusaki, Katsumi; Inoue, Keisuke; Mizuno, Ken] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kowa Company, Ltd.	Aikawa, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Interdisciplinary Cardiovasc Sci, Boston, MA 02115 USA.	maikawa@rics.bwh.harvard.edu		Aikawa, Masanori/0000-0002-9275-2079; SASAKI, YUSUKE/0000-0001-7379-8066; Faits, Tyler/0000-0002-7524-6166; Yano, Wataru/0000-0002-6866-8520	Kowa Company, Ltd., Japan	Kowa Company, Ltd., Japan	Kowa Company, Ltd., Japan. The funder provided support in the forms of salaries for authors YS, MO, TS, MY, WY, KY, KI and KM, and a research grant to MA. But the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Deng M, 2014, BLOOD, V124, P924, DOI 10.1182/blood-2014-01-549162; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kadomatsu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057921; Kadomatsu T, 2011, FEBS J, V278, P559, DOI 10.1111/j.1742-4658.2010.07979.x; Kajimoto K, 2012, ENDOCRINOLOGY, V153, P5629, DOI 10.1210/en.2012-1456; Kitazawa M, 2011, ENDOCRINOLOGY, V152, P2558, DOI 10.1210/en.2010-1407; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Kubota Y, 2005, P NATL ACAD SCI USA, V102, P13502, DOI 10.1073/pnas.0501902102; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suzuki H, 1999, ATHEROSCLEROSIS, V146, P259, DOI 10.1016/S0021-9150(99)00146-X; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yabusaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089627; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	36	29	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131176	10.1371/journal.pone.0131176	http://dx.doi.org/10.1371/journal.pone.0131176			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132105	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000097
J	Schulte, LM; Krauss, M; Lotters, S; Schulze, T; Brack, W				Schulte, Lisa M.; Krauss, Martin; Loetters, Stefan; Schulze, Tobias; Brack, Werner			Decoding and Discrimination of Chemical Cues and Signals: Avoidance of Predation and Competition during Parental Care Behavior in Sympatric Poison Frogs	PLOS ONE			English	Article							RANA-CATESBEIANA TONGUE; CONTINGENCY-TABLES; EPITHELIAL RESPONSES; DENDROBATES-PUMILIO; OOPHAGA-PUMILIO; SEA-ANEMONE; IDENTIFICATION; SYNOMONE; VERTEBRATES; KAIROMONES	The evolution of chemical communication and the discrimination between evolved functions (signals) and unintentional releases (cues) are among the most challenging issues in chemical ecology. The accurate classification of inter- or intraspecific chemical communication is often puzzling. Here we report on two different communication systems triggering the same parental care behavior in the poison frog Ranitomeya variabilis. This species deposits its tadpoles and egg clutches in phytotelmata and chemically recognizes and avoids sites with both predatory conspecific and non-predatory heterospecific tadpoles (of the species Hyloxalus azureiventris). Combining chemical analyses with in-situ bioassays, we identified the molecular formulas of the chemical compounds triggering this behavior. We found that both species produce distinct chemical compound combinations, suggesting two separate communication systems. Bringing these results into an ecological context, we classify the conspecific R. variabilis compounds as chemical cues, advantageous only to the receivers (the adult frogs), not the emitters (the tadpoles). The heterospecific compounds, however, are suggested to be chemical signals (or cues evolving into signals), being advantageous to the emitters (the heterospecific tadpoles) and likely also to the receivers (the adult frogs). Due to these assumed receiver benefits, the heterospecific compounds are possibly synomones which are advantageous to both emitter and receiver - a very rare communication system between animal species, especially vertebrates.	[Schulte, Lisa M.; Loetters, Stefan] Univ Trier, Dept Biogeog, Trier, Germany; [Krauss, Martin; Schulze, Tobias; Brack, Werner] Helmholtz Ctr Environm Res, Dept Effect Directed Anal, Leipzig, Germany	Universitat Trier; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Schulte, LM (corresponding author), Vrije Univ Brussel, Amphibian Evolut Lab, Brussels, Belgium.	lisa_schulte@gmx.de	Schulze, Tobias/B-1553-2010; Schulte, Lisa Maria/AAG-1712-2021; Krauss, Martin/E-1672-2012; Schulte, Lisa M./AAL-4579-2020	Schulze, Tobias/0000-0002-9744-8914; Schulte, Lisa Maria/0000-0001-5863-1057; Krauss, Martin/0000-0002-0362-4244; Brack, Werner/0000-0001-9269-6524	Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft [LO 1681/1-1]	Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Studienstiftung des Deutschen Volkes https://www.studienstiftung.de/; Deutsche Forschungsgemeinschaft LO 1681/1-1 http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta WC., 1992, CHEM COMMUNICATION L; Amezquita A, 2013, EVOL ECOL, V27, P769, DOI 10.1007/s10682-013-9635-1; [Anonymous], 2014, PHEROMONES ANIMAL BE; AUGNER M, 1994, OIKOS, V70, P322, DOI 10.2307/3545769; Boeve JL, 1996, PHYTOCHEMISTRY, V42, P373, DOI 10.1016/0031-9422(95)00948-5; Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BRODIE ED, 1978, J HERPETOL, V12, P264, DOI 10.2307/1563424; Brown JL, 2008, J EVOLUTION BIOL, V21, P1534, DOI 10.1111/j.1420-9101.2008.01609.x; Brown JL, 2008, BEHAVIOUR, V145, P1139, DOI 10.1163/156853908785387647; Brown JL, 2009, ANIM BEHAV, V77, P547, DOI 10.1016/j.anbehav.2008.10.002; Dicke M, 1988, FUNCT ECOL, V2, P131, DOI 10.2307/2389687; Ferland-Raymond B, 2010, BIOCHEM SYST ECOL, V38, P169, DOI 10.1016/j.bse.2009.12.035; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fraker ME, 2009, HORM BEHAV, V55, P520, DOI 10.1016/j.yhbeh.2009.01.007; FRITZ G, 1981, BIOTROPICA, V13, P158, DOI 10.2307/2387719; Gosner K. L., 1960, Herpetologica, V16, P183; Gotelli NJ, 2013, ECOSIMR 1 00; Greenberg B, 1987, United States Patent, Patent No. 4638763; Harrewijn Paul, 1995, Chemoecology, V5-6, P55, DOI 10.1007/BF01259434; Haynes KF, 2002, CHEMOECOLOGY, V12, P99, DOI 10.1007/s00049-002-8332-2; Hug C, 2014, ENVIRON POLLUT, V184, P25, DOI 10.1016/j.envpol.2013.07.048; Killick R, 2011, R PACKAGE CHANGEPOIN; Killick R., 2011, CHANGEPOINT R PACKAG; Kiyonori Y, 1986, COMP BIOCH PHYSL A, V85, P501; KONNO K, 1990, HETEROCYCLES, V30, P247, DOI 10.3987/COM-89-S17; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; Mizuno T, 2014, ZOOL SCI, V31, P795, DOI 10.2108/zs140126; MURATA M, 1986, SCIENCE, V234, P585, DOI 10.1126/science.234.4776.585; Nordlund DA, 1976, J CHEM ECOL, V2, P211, DOI 10.1007/BF00987744; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richards-Zawacki CL, 2013, EVOL ECOL, V27, P783, DOI 10.1007/s10682-013-9636-0; SABELIS MW, 1988, OIKOS, V53, P247, DOI 10.2307/3566070; Sachs L, 1974, ANGEW STAT PLANUNG A; Saleh N, 2007, ARTHROPOD-PLANT INTE, V1, P119, DOI 10.1007/s11829-007-9011-6; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; Saporito RA, 2009, HETEROCYCLES, V79, P277, DOI 10.3987/REV-08-SR(D)11; Sbarbati A, 2006, CELLS TISSUES ORGANS, V183, P206, DOI 10.1159/000096511; Schlee D, 1999, OKOLOGISCHE BIOCH; Schulte L, 2014, ANIM COGN, V17, P267, DOI 10.1007/s10071-013-0659-2; Schulte LM, 2014, ETHOL ECOL EVOL, V26, P58, DOI 10.1080/03949370.2013.850453; Schulte LM, 2013, EVOL ECOL, V27, P711, DOI 10.1007/s10682-013-9637-z; Schulte LM, 2011, ANIM BEHAV, V81, P1147, DOI 10.1016/j.anbehav.2011.02.019; SOEDA H, 1994, COMP BIOCHEM PHYS A, V107, P85; SOEDA H, 1991, COMP BIOCHEM PHYS A, V100, P315, DOI 10.1016/0300-9629(91)90476-S; Steiger S, 2011, P ROY SOC B-BIOL SCI, V278, P970, DOI 10.1098/rspb.2010.2285; Stynoski JL, 2014, ECOLOGY, V95, P587, DOI 10.1890/13-0927.1; Summers K, 1999, OECOLOGIA, V119, P557, DOI 10.1007/s004420050819; Summers Kyle, 2004, Miscellaneous Publications Museum of Zoology University of Michigan, V193, P55; SZELISTOWSKI WA, 1985, BIOTROPICA, V17, P345, DOI 10.2307/2388601; Tan KH, 2000, J CHEM ECOL, V26, P533, DOI 10.1023/A:1005477926244; Ulrich N, 2011, J CHROMATOGR A, V1218, P8192, DOI 10.1016/j.chroma.2011.09.031; VARGA LUDWIG, 1928, BIOL ZENTRALBL, V48, P143; Weiss I, 2013, NATURE COMMUNICATION, V4, P1; Whitman DW, 1990, INSECT DEFENSES ADAP, P229; WILLIAMS DA, 1976, BIOMETRIKA, V63, P33, DOI 10.2307/2335081; Wilson E. O., 1970, P133; Wolf S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-148; WOOLF B, 1957, ANN HUM GENET, V21, P397, DOI 10.1111/j.1469-1809.1972.tb00293.x; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; ZIMMERMANN H, 1988, Salamandra, V24, P125	64	8	9	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129929	10.1371/journal.pone.0129929	http://dx.doi.org/10.1371/journal.pone.0129929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132416	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000046
J	Beaudry, JB; Cordi, S; Demarez, C; Lepreux, S; Pierreux, CE; Lemaigre, FP				Beaudry, Jean-Bernard; Cordi, Sabine; Demarez, Celine; Lepreux, Sebastien; Pierreux, Christophe E.; Lemaigre, Frederic P.			Proliferation-Independent Initiation of Biliary Cysts in Polycystic Liver Diseases	PLOS ONE			English	Article							INTRAHEPATIC BILE-DUCTS; CPK MOUSE MODEL; KIDNEY-DISEASE; HEPATIC CYSTOGENESIS; PRIMARY CILIUM; ANIMAL-MODEL; MORPHOGENESIS; DYSGENESIS; PATHOLOGY; GENETICS	Biliary cysts in adult patients affected by polycystic liver disease are lined by cholangiocytes that proliferate, suggesting that initiation of cyst formation depends on proliferation. Here, we challenge this view by analyzing cyst-lining cell proliferation and differentiation in Cpk mouse embryos and in livers from human fetuses affected by Autosomal Recessive Polycystic Kidney Disease (ARPKD), at early stages of cyst formation. Proliferation of fetal cholangiocyte precursors, measured by immunostaining in human and mouse livers, was low and did not differ between normal and ARPKD or Cpk livers, excluding excessive proliferation as an initiating cause of liver cysts. Instead, our analyses provide evidence that the polycystic livers exhibit increased and accelerated differentiation of hepatoblasts into cholangiocyte precursors, eventually coalescing into large biliary cysts. Lineage tracing experiments, performed in mouse embryos, indicated that the cholangiocyte precursors in Cpk mice generate cholangiocytes and periportal hepatocytes, like in wild-type animals. Therefore, contrary to current belief, cyst formation in polycystic liver disease does not necessarily depend on overproliferation. Combining our prenatal data with available data from adult livers, we propose that polycystic liver can be initiated by proliferation-independent mechanisms at a fetal stage, followed by postnatal proliferation-dependent cyst expansion.	[Beaudry, Jean-Bernard; Cordi, Sabine; Demarez, Celine; Pierreux, Christophe E.; Lemaigre, Frederic P.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Lepreux, Sebastien] Univ Bordeaux 2, INSERM U889, F-33076 Bordeaux, France	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Lemaigre, FP (corresponding author), Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium.	frederic.lemaigre@uclouvain.be		Lemaigre, Frederic/0000-0002-3609-434X	Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO)) [PVII-47]; D.G. Higher Education and Scientific Research of the French Community of Belgium [10/15-029]; Alphonse and Jean Forton Fund [2011-R10150-004]; Fonds de la Recherche Scientifique Medicale [3.4536.10F]	Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO)); D.G. Higher Education and Scientific Research of the French Community of Belgium; Alphonse and Jean Forton Fund; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO, grant PVII-47; http://www.belspo.be/), the D.G. Higher Education and Scientific Research of the French Community of Belgium (grant 10/15-029), the Alphonse and Jean Forton Fund (grant 2011-R10150-004; http://www.kbs-frb.be/fund.aspx?id=293586&langtype=2060), and the Fonds de la Recherche Scientifique Medicale (grant 3.4536.10F; http://www.fnrs.be/). CEP is research associate of the F.R.S.-FNRS (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Cheung ID, 2012, DEV BIOL, V361, P68, DOI 10.1016/j.ydbio.2011.10.004; Cnossen WR, 2014, P NATL ACAD SCI USA, V111, P5343, DOI 10.1073/pnas.1309438111; Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952; Denamur E, 2010, KIDNEY INT, V77, P350, DOI 10.1038/ki.2009.440; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Guay-Woodford LM, 2000, HUM MOL GENET, V9, P769, DOI 10.1093/hmg/9.5.769; Harris PC, 2004, MOL GENET METAB, V81, P75, DOI 10.1016/j.ymgme.2003.10.010; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Johnson CA, 2003, J MED GENET, V40, P311, DOI 10.1136/jmg.40.5.311; Lai XY, 2009, PROTEOMICS, V9, P3775, DOI 10.1002/pmic.200800379; Masyuk AI, 2008, DEV DYNAM, V237, P2007, DOI 10.1002/dvdy.21530; Masyuk T, 2006, HEPATOLOGY, V43, P906, DOI 10.1002/hep.21199; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Moser M, 2005, HEPATOLOGY, V41, P1113, DOI 10.1002/hep.20655; Muchatuta MN, 2009, EXP BIOL MED, V234, P17, DOI 10.3181/0807-RM-215; Muff MA, 2006, LAB INVEST, V86, P940, DOI 10.1038/labinvest.3700448; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Onori P, 2010, DIGEST LIVER DIS, V42, P261, DOI 10.1016/j.dld.2010.01.006; Overgaard CE, 2009, MOL BIOL CELL, V20, P102, DOI 10.1091/mbc.E08-07-0741; PREMINGER GM, 1982, J UROLOGY, V127, P556, DOI 10.1016/S0022-5347(17)53911-7; Raynaud P, 2011, HEPATOLOGY, V53, P1959, DOI 10.1002/hep.24292; Raynaud P, 2011, INT J BIOCHEM CELL B, V43, P245, DOI 10.1016/j.biocel.2009.07.020; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Seth A, 2014, DEVELOPMENT, V141, P538, DOI 10.1242/dev.099481; Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022; Strazzabosco M, 2011, GASTROENTEROLOGY, V140, P1855, DOI 10.1053/j.gastro.2011.04.030; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takashima Y, 2015, HEPATOLOGY, V61, P1003, DOI 10.1002/hep.27436; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Tao BL, 2009, J AM SOC NEPHROL, V20, P2570, DOI 10.1681/ASN.2009020188; Villeneuve Julien, 2009, Comp Hepatol, V8, P5, DOI 10.1186/1476-5926-8-5; Wills ES, 2014, TRENDS MOL MED, V20, P261, DOI 10.1016/j.molmed.2014.01.003; Woollard JR, 2007, KIDNEY INT, V72, P328, DOI 10.1038/sj.ki.5002294; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0132295	10.1371/journal.pone.0132295	http://dx.doi.org/10.1371/journal.pone.0132295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125584	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300070
J	Huang, YF; Midha, M; Chen, TH; Wang, YT; Smith, DG; Pei, KJC; Chiu, KP				Huang, Yu-Feng; Midha, Mohit; Chen, Tzu-Han; Wang, Yu-Tai; Smith, David Glenn; Pei, Kurtis Jai-Chyi; Chiu, Kuo Ping			Complete Taiwanese Macaque (Macaca cyclopis) Mitochondrial Genome: Reference-Assisted de novo Assembly with Multiple k-mer Strategy	PLOS ONE			English	Article							HIERARCHICAL STEEPNESS; DNA VARIATION; CD-HIT; GENERATION; FASCICULARIS; POPULATIONS; ALIGNMENTS; ANNOTATION; DISPERSAL; FUSCATA	The Taiwanese (Formosan) macaque (Macaca cyclopis) is the only nonhuman primate endemic to Taiwan. This primate species is valuable for evolutionary studies and as subjects in medical research. However, only partial fragments of the mitochondrial genome (mitogenome) of this primate species have been sequenced, not mentioning its nuclear genome. We employed next-generation sequencing to generate 2 x 90 bp paired-end reads, followed by reference-assisted de novo assembly with multiple k-mer strategy to characterize the M. cyclopis mitogenome. We compared the assembled mitogenome with that of other macaque species for phylogenetic analysis. Our results show that, the M. cyclopis mitogenome consists of 16,563 nucleotides encoding for 13 protein-coding genes, 2 ribosomal RNAs and 22 transfer RNAs. Phylogenetic analysis indicates that M. cyclopis is most closely related to M. mulatta lasiota (Chinese rhesus macaque), supporting the notion of Asia-continental origin of M. cyclopis proposed in previous studies based on partial mitochondrial sequences. Our work presents a novel approach for assembling a mitogenome that utilizes the capabilities of de novo genome assembly with assistance of a reference genome. The availability of the complete Taiwanese macaque mitogenome will facilitate the study of primate evolution and the characterization of genetic variations for the potential usage of this species as a non-human primate model for medical research.	[Huang, Yu-Feng; Midha, Mohit; Chen, Tzu-Han; Chiu, Kuo Ping] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Midha, Mohit; Chiu, Kuo Ping] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wang, Yu-Tai] Natl Ctr High Performance Comp, Hsinchu, Taiwan; [Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Pei, Kurtis Jai-Chyi] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Inst Wildlife Conservat, Pingtung, Taiwan; [Chiu, Kuo Ping] Natl Taiwan Univ, Coll Life Sci, Taipei 10764, Taiwan; [Chiu, Kuo Ping] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; University of California System; University of California Davis; National Pingtung University Science & Technology; National Taiwan University; National Central University	Huang, YF (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	yfh1202@sinica.edu.tw	midha, mohit/F-4848-2015; Huang, Yu-Feng/Y-5818-2019; Chiu, Kuo-Ping/AAG-8855-2020; Midha, Mohit/AAD-9858-2019	midha, mohit/0000-0001-7554-4086; Huang, Yu-Feng/0000-0001-5822-3635; Chiu, Kuo-Ping/0000-0001-9144-0674; Midha, Mohit/0000-0001-7554-4086	research grant from Academia Sinica	research grant from Academia Sinica	This work was supported by a research grant from Academia Sinica.	Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; Balasubramaniam KN, 2012, ANIM BEHAV, V83, P1207, DOI 10.1016/j.anbehav.2012.02.012; Balasubramaniam KN, 2012, AM J PRIMATOL, V74, P915, DOI 10.1002/ajp.22044; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Biswal DK, 2013, PEERJ, V1, DOI 10.7717/peerj.207; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chu JH, 2005, CONSERV GENET, V6, P101, DOI 10.1007/s10592-004-7749-2; Chu JH, 2007, MOL PHYLOGENET EVOL, V43, P418, DOI 10.1016/j.ympev.2006.11.022; Disotell TR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-226; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Elton S, 2014, QUATERNARY SCI REV, V96, P117, DOI 10.1016/j.quascirev.2014.04.025; Fernandes F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-230; FOODEN J, 1976, FOLIA PRIMATOL, V25, P225, DOI 10.1159/000155715; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gan HM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-19; Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x; Ho SYW, 2010, MITOCHONDRION, V10, P1, DOI 10.1016/j.mito.2009.09.005; Jiang J, 2016, MITOCHONDRIAL DNA A, V27, P226, DOI 10.3109/19401736.2014.880901; Kawamoto Y, 2007, PRIMATES, V48, P27, DOI 10.1007/s10329-006-0013-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li DM, 2009, GENE, V429, P31, DOI 10.1016/j.gene.2008.10.010; Li Qing-qing, 2004, Zoological Research, V25, P385; Li QQ, 2005, BIOCHEM GENET, V43, P375, DOI 10.1007/s10528-005-6777-z; Li RL, 2015, MITOCHONDR DNA, V26, P284, DOI 10.3109/19401736.2013.825777; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liedigk R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0176-1; Liedigk R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037418; Liu ZT, 2016, MITOCHONDRIAL DNA A, V27, P1742, DOI 10.3109/19401736.2014.961149; Lloyd RE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-496; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith DG, 2007, AM J PRIMATOL, V69, P182, DOI 10.1002/ajp.20337; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tosi AJ, 2002, INT J PRIMATOL, V23, P161, DOI 10.1023/A:1013258109954; Wang JK, 2016, MITOCHONDRIAL DNA A, V27, P1717, DOI 10.3109/19401736.2014.961137; Wu AQ, 2016, MITOCHONDRIAL DNA A, V27, P32, DOI 10.3109/19401736.2013.869680; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhao Liang, 2012, Zoological Research, V33, pE47, DOI 10.3724/SP.J.1141.2012.E03-04E47	49	1	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130673	10.1371/journal.pone.0130673	http://dx.doi.org/10.1371/journal.pone.0130673			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125617	Green Submitted, Green Published, gold			2022-12-26	WOS:000358151300022
J	Li, YJ; Li, JL; Zhang, L; Yu, CN; Lin, M; Gao, F; Zhou, GH; Zhang, Y; Fan, YF; Nuldnali, L				Li, Yanjiao; Li, Jiaolong; Zhang, Lin; Yu, Changning; Lin, Meng; Gao, Feng; Zhou, Guanghong; Zhang, Yu; Fan, Yuanfang; Nuldnali, Lina			Effects of Dietary Energy Sources on Post Mortem Glycolysis, Meat Quality and Muscle Fibre Type Transformation of Finishing Pigs	PLOS ONE			English	Article							CHAIN GENE-EXPRESSION; SKELETAL-MUSCLE; LONGISSIMUS-DORSI; PERFORMANCE; TRAITS; PORK; FAT; PH	Dietary energy source can influence muscle glycogen storage at slaughter. However, few studies have demonstrated whether the diet-induced change of muscle glycogen is achieved by the transformation of muscle fibre type. This study investigated the effects of dietary energy sources on meat quality, post mortem glycolysis and muscle fibre type transformation of finishing pigs. Seventy-two barrows with an average body weight of 65.0 +/- 2.0 kg were selected and were allotted to three iso-energetic and iso-nitrogenous diets A, B or C, and each treatment consisted of three replicates (pens) of eight pigs each. Diet A contained 44.1% starch, 5.9% crude fat and 12.6% neutral detergent fiber (NDF); diet B contained 37.6% starch, 9.5% crude fat and 15.4% NDF; and diet C contained 30.9% starch, 14.3% crude fat and 17.8% NDF. The duration of the experiment was 28 days. After feed withdrawal 12 h, 24 pigs (eight per treatment) were slaughtered, samples from M. longissimus lumborum (LL) were collected for subsequent analysis. The results showed that pigs fed diet C had lesser average daily gain, average daily feed intake and back fat depth than those fed diet A (P<0.05). Diet C increased pH(45min) (P<0.05) and decreased drip loss (P<0.05) in LL muscles compared with diet A. Meat from pigs fed diet A showed increased contents of lactate and greater glycolytic potential (GP) compared with those fed diet C (P<0.05). Greater mRNA expression of myosin heavy-chain (MyHC)-I and IIa and lesser expression of MyHC-IIx and IIb (P<0.05) in LL muscles were found in pigs fed diet C, than in pigs fed diet A. In addition, pigs fed diet C resulted in downregulationof miR23a and upregulation of miR409 and miR208b (P<0.05), associated with conserved changes of their corresponding targets. These findings indicated that diets containing low starch and high fibre were beneficial in reducing muscle glycolysis, improving meat quality of finishing pigs. This reduction of GP may be partially associated with the improvement of oxidative fibre composition in LL muscle, and the change in myofibre type may be correlated with the change in the miRNA expression.	[Li, Yanjiao; Li, Jiaolong; Zhang, Lin; Yu, Changning; Lin, Meng; Gao, Feng; Zhou, Guanghong; Zhang, Yu; Fan, Yuanfang; Nuldnali, Lina] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Li, Yanjiao; Li, Jiaolong; Zhang, Lin; Gao, Feng] Nanjing Agr Univ, Key Lab Anim Origin Food Prod & Safety Guarantee, Nanjing 210095, Jiangsu, Peoples R China; [Yu, Changning; Lin, Meng; Zhou, Guanghong] Nanjing Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Gao, F (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.	gaofeng0629@sina.com	Zhang, Lin/AAL-3573-2020	Zhang, Lin/0000-0003-1555-1086	Twelfth Five-year Plan Period of China [2012BAD28B03]; Three Agricultural Projects of Jiangsu province of China [SX(2011) 146]; Fundamental Research Funds for the Central Universities of China [KYZ201222]	Twelfth Five-year Plan Period of China; Three Agricultural Projects of Jiangsu province of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by the Twelfth Five-year Plan Period of China (2012BAD28B03), the Three Agricultural Projects of Jiangsu province of China (SX(2011) 146) and the Fundamental Research Funds for the Central Universities of China (KYZ201222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NUTR REQ COUNC NUTR; [Anonymous], 2000, OFF METH AN AOAC AN; [Anonymous], 2012, CHINA FEED; Bee G, 2006, J ANIM SCI, V84, P191, DOI 10.2527/2006.841191x; Bertol TM, 2011, J ANIM SCI, V89, P1561, DOI 10.2527/jas.2010-2942; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Engel JJ, 2001, J ANIM SCI, V79, P1491; Gondret F, 2014, J ANIM SCI, V92, P4865, DOI 10.2527/jas.2014-7995; Hagiwara N, 2007, DEV DYNAM, V236, P2062, DOI 10.1002/dvdy.21223; Hanke N, 2008, BBA-MOL CELL RES, V1783, P813, DOI 10.1016/j.bbamcr.2007.12.012; Hanke N, 2011, BBA-MOL CELL RES, V1813, P377, DOI 10.1016/j.bbamcr.2010.12.021; Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5; Joo ST, 2013, MEAT SCI, V95, P828, DOI 10.1016/j.meatsci.2013.04.044; Kerr BJ, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-11; Kim GD, 2013, MEAT SCI, V94, P267, DOI 10.1016/j.meatsci.2013.02.001; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Men XM, 2013, ANIMAL, V7, P1486, DOI 10.1017/S1751731113000992; MONIN G, 1985, MEAT SCI, V13, P49, DOI 10.1016/S0309-1740(85)80004-8; Nakazato K., 2012, J PHYS FITNESS SPORT, V1, P655, DOI [10.7600/jpfsm.1.655, DOI 10.7600/JPFSM.1.655]; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Quiniou N, 2012, J ANIM SCI, V90, P4362, DOI 10.2527/jas.2011-4004; Rosenvold K, 2001, MEAT SCI, V59, P397, DOI 10.1016/S0309-1740(01)00092-4; Rosenvold K, 2001, J ANIM SCI, V79, P382; Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Scheffler TL, 2013, MEAT SCI, V95, P85, DOI 10.1016/j.meatsci.2013.04.013; Stahly T. S., 1984, Fats in animal nutrition. Proceedings of the 37th Nottingham Easter School, P313; Tsika G, 2004, MOL CELL BIOL, V24, P10777, DOI 10.1128/MCB.24.24.10777-10791.2004; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Yla-Ajos M, 2006, MEAT SCI, V72, P532, DOI 10.1016/j.meatsci.2005.09.004; Zhang L, 2009, POULTRY SCI, V88, P2033, DOI 10.3382/ps.2009-00128	40	21	27	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131958	10.1371/journal.pone.0131958	http://dx.doi.org/10.1371/journal.pone.0131958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125946	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300065
J	Treglia, ML; Fisher, RN; Fitzgerald, LA				Treglia, Michael L.; Fisher, Robert N.; Fitzgerald, Lee A.			Integrating Multiple Distribution Models to Guide Conservation Efforts of an Endangered Toad	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; ANAXYRUS-CALIFORNICUS; OCCURRENCE RECORDS; LAND-COVER; HABITAT; CLASSIFICATION; RESTORATION; ACCURACY	Species distribution models are used for numerous purposes such as predicting changes in species' ranges and identifying biodiversity hotspots. Although implications of distribution models for conservation are often implicit, few studies use these tools explicitly to inform conservation efforts. Herein, we illustrate how multiple distribution models developed using distinct sets of environmental variables can be integrated to aid in identification sites for use in conservation. We focus on the endangered arroyo toad (Anaxyrus californicus), which relies on open, sandy streams and surrounding floodplains in southern California, USA, and northern Baja California, Mexico. Declines of the species are largely attributed to habitat degradation associated with vegetation encroachment, invasive predators, and altered hydrologic regimes. We had three main goals: 1) develop a model of potential habitat for arroyo toads, based on long-term environmental variables and all available locality data; 2) develop a model of the species' current habitat by incorporating recent remotely-sensed variables and only using recent locality data; and 3) integrate results of both models to identify sites that may be employed in conservation efforts. We used a machine learning technique, Random Forests, to develop the models, focused on riparian zones in southern California. We identified 14.37% and 10.50% of our study area as potential and current habitat for the arroyo toad, respectively. Generally, inclusion of remotely-sensed variables reduced modeled suitability of sites, thus many areas modeled as potential habitat were not modeled as current habitat. We propose such sites could be made suitable for arroyo toads through active management, increasing current habitat by up to 67.02%. Our general approach can be employed to guide conservation efforts of virtually any species with sufficient data necessary to develop appropriate distribution models.	[Treglia, Michael L.; Fitzgerald, Lee A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Appl Biodivers Sci Program, Biodivers Res & Teaching Collect, College Stn, TX 77843 USA; [Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA USA	Texas A&M University System; Texas A&M University College Station; United States Department of the Interior; United States Geological Survey	Treglia, ML (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.		Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240; Fitzgerald, Lee/0000-0001-5648-9480	National Science Foundation Integrative Graduate Education and Research Traineeship (Division of Graduate Education Grant) [0654377]; Tom Slick Doctoral Fellowship (Texas AM University); Williams Research Grant (Herpetologists' League); Sylvia Scholarship (Mensa Foundation); Office of Integrative Activities [1301789] Funding Source: National Science Foundation	National Science Foundation Integrative Graduate Education and Research Traineeship (Division of Graduate Education Grant); Tom Slick Doctoral Fellowship (Texas AM University); Williams Research Grant (Herpetologists' League); Sylvia Scholarship (Mensa Foundation); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	MLT was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship (Division of Graduate Education Grant #0654377), a Tom Slick Doctoral Fellowship (Texas A&M University), an E.E. Williams Research Grant (Herpetologists' League), and a Sylvia Scholarship (Mensa Foundation). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD., 2021, STREAM ECOLOGY STRUC, DOI [DOI 10.1007/978-3-030-61286-3, 10.1007/978-3-030-61286-3]; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Atkinson AJ, 2003, MCB CAMP PENDLETON A, P2; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barrows CW, 2008, BIOL CONSERV, V141, P1885, DOI 10.1016/j.biocon.2008.05.006; Barto WS, 1999, PREDICTING POTENTIAL; Biggs TW, 2010, LANDSCAPE URBAN PLAN, V96, P78, DOI 10.1016/j.landurbplan.2010.02.005; Bohner J., 2013, SYSTEM AUTOMATED GEO; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown CJ, 2014, DIVERS DISTRIB, V20, P538, DOI 10.1111/ddi.12159; Chawla NV, 2003, LECT NOTES ARTIF INT, V2838, P107, DOI 10.1007/978-3-540-39804-2_12; Clewell A, 1997, RESTOR ECOL, V5, P350, DOI 10.1046/j.1526-100X.1997.00548.x; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dayton GH, 2006, BIOL CONSERV, V132, P40, DOI 10.1016/j.biocon.2006.03.012; Ervin Edward L., 2013, Bulletin Southern California Academy of Sciences, V112, P197; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Franklin J, 2009, MAPPING SPECIES DIST; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Gesch D. B., 2007, DIGITAL ELEVATION MO, P99; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Griffin PC, 2001, J WILDLIFE MANAGE, V65, P633, DOI 10.2307/3803014; Gruber S, 2009, DEV SOIL SCI, V33, P171, DOI 10.1016/S0166-2481(08)00007-X; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hammerson G, 2004, IUCN 2013 IUCN RED L; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hollingsworth BD, 2009, DISTRIBUTION ARROYO; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; King RS, 2011, ECOL APPL, V21, P1659, DOI 10.1890/10-1357.1; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lovich RE, 2009, PHYLOGEOGRAPHY CONSE; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Miller DAW, 2012, J ANIM ECOL, V81, P1288, DOI 10.1111/j.1365-2656.2012.02001.x; Miller JR, 2007, RESTOR ECOL, V15, P382, DOI 10.1111/j.1526-100X.2007.00234.x; Mitrovich MJ, 2011, J HERPETOL, V45, P319; Murphy MA, 2010, ECOLOGY, V91, P252, DOI 10.1890/08-0879.1; NASA Landsat Program, 2010, NASA LANDS PROGR; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; R Core Team, 2021, R LANGUAGE ENV STAT; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Regan HM, 2008, DIVERS DISTRIB, V14, P462, DOI 10.1111/j.1472-4642.2007.00447.x; Riley SPD, 2005, CONSERV BIOL, V19, P1894, DOI 10.1111/j.1523-1739.2005.00295.x; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Senay SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071218; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; Song C, 2001, REMOTE SENS ENVIRON, V75, P230, DOI 10.1016/S0034-4257(00)00169-3; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; Sweet S.S., 2005, AMPHIBIAN DECLINES C, P396; Syphard AD, 2011, J ENVIRON MANAGE, V92, P1882, DOI 10.1016/j.jenvman.2011.03.014; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Treglia ML, 2014, MULTISCALE CONSERVAT; U. S. Fish and Wildlife Service, 2009, FED REGISTER, V74, P52612; U. S. Fish and Wildlife Service, 2014, FED REGISTER, V79, P17106; U. S. Fish and Wildlife Service, 1994, FED REGISTER, V59, P64859; U. S. Fish and Wildlife Service, 2009, ARR TOAD BUF CAL MIC; U.S. Geological Survey, 2012, WAT BOUND DAT; Wang HH, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv039; Wells J, 1997, SENSITIVE SPECIES SU; Wickham JD, 2013, REMOTE SENS ENVIRON, V130, P294, DOI 10.1016/j.rse.2012.12.001; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673	72	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131628	10.1371/journal.pone.0131628	http://dx.doi.org/10.1371/journal.pone.0131628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125634	Green Submitted, Green Published, gold			2022-12-26	WOS:000358151300050
J	Ouyang, J; Yu, W; Liu, J; Zhang, N; Florens, L; Chen, JK; Liu, H; Washburn, M; Pei, DQ; Xie, T				Ouyang, Juan; Yu, Wei; Liu, Jing; Zhang, Nian; Florens, Laurence; Chen, Jiekai; Liu, He; Washburn, Michael; Pei, Duanqing; Xie, Ting			Cyclin-dependent Kinase-mediated Sox2 Phosphorylation Enhances the Ability of Sox2 to Establish the Pluripotent State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; SELF-RENEWAL; DNA-BINDING; CDK2; INHIBITION; PEPTIDES; INK4/ARF; CANCER; G1	Sox2 is a key factor in maintaining self-renewal of embryonic stem cells (ESCs) and adult stem cells as well as in reprogramming differentiated cells back into pluripotent or multipotent stem cells. Although previous studies have shown that Sox2 is phosphorylated in human ESCs, the biological significance of Sox2 phosphorylation in ESC maintenance and reprogramming has not been well understood. In this study we have identified new phosphorylation sites on Sox2 and have further demonstrated that Cdk2-mediated Sox2 phosphorylation at Ser-39 and Ser-253 is required for establishing the pluripotent state during reprogramming but is dispensable for ESC maintenance. Mass spectrometry analysis of purified Sox2 protein has identified new phosphorylation sites on two tyrosine and six serine/Threonine residues. Cdk2 physically interacts with Sox2 and phosphorylates Sox2 at Ser-39 and Ser-253 in vitro. Surprisingly, Sox2 phosphorylation at Ser-39 and Ser-253 is dispensable for ESC self-renewal and cell cycle progression. In addition, Sox2 phosphorylation enhances its ability to establish the pluripotent state during reprogramming by working with Oct4 and Klf4. Finally, Cdk2 can also modulate the ability of Oct4, Sox2, and Klf4 in reprogramming fibroblasts back into pluripotent stem cells. Therefore, this study has for the first time demonstrated that Sox2 phosphorylation by Cdk2 promotes the establishment but not the maintenance of the pluripotent state. It might also help explain why the inactivation of CDK inhibitors such as p53, p21, and Arf/Ink4 promotes the induction of pluripotent stem cells.	[Ouyang, Juan] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Wei; Zhang, Nian; Florens, Laurence; Washburn, Michael; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Ouyang, Juan; Liu, Jing; Chen, Jiekai; Liu, He; Pei, Duanqing] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomedicine & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Washburn, Michael] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Xie, Ting] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Tsinghua University; Stowers Institute for Medical Research; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Pei, DQ (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomedicine & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn; tgx@stowers.org		Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	Tsinghua-Peking Joint Center for Life Sciences; National Basic Research Program of China [2012CB966802]; Stowers Institute for Medical Research	Tsinghua-Peking Joint Center for Life Sciences; National Basic Research Program of China(National Basic Research Program of China); Stowers Institute for Medical Research	This work was supported by the Tsinghua-Peking Joint Center for Life Sciences (to J.O.), the National Basic Research Program of China 2012CB966802 (to D.P.), and the Stowers Institute for Medical Research (to T.X). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi K, 2012, CURR OPIN GENET DEV, V22, P416, DOI 10.1016/j.gde.2012.07.001; Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Florens Laurence, 2006, V328, P159; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Koledova Z, 2010, STEM CELLS DEV, V19, P181, DOI 10.1089/scd.2009.0065; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Spelat R, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386755; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039606; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang WW, 2011, J CELL BIOCHEM, V112, P942, DOI 10.1002/jcb.23010; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165	49	28	30	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22782	22794		10.1074/jbc.M115.658195	http://dx.doi.org/10.1074/jbc.M115.658195			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26139602	Green Published, hybrid			2022-12-26	WOS:000361171500041
J	Chen, Y; Zhang, HS; Fong, GH; Xi, QL; Wu, GH; Bai, CG; Ling, ZQ; Fan, L; Xu, YM; Qin, YQ; Yuan, TL; Sun, H; Fang, J				Chen, Ying; Zhang, Hai-Sheng; Fong, Guo-Hua; Xi, Qiu-Lei; Wu, Guo-Hao; Bai, Chen-Guang; Ling, Zhi-Qiang; Fan, Li; Xu, Yi-Ming; Qin, Yan-Qing; Yuan, Tang-Long; Sun, Heng; Fang, Jing			PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROLYL; DOMAIN; COLITIS; EGLN3; HIF; INHIBITION; DIFFERENTIATION; HYDROXYLATION; PERMEABILITY	Prolyl hydroxylase domain proteins (PHDs) control cellular adaptation to hypoxia. PHDs are found involved in inflammatory bowel disease (IBD); however, the exact role of PHD3, a member of the PHD family, in IBD remains unknown. We show here that PHD3 plays a critical role in maintaining intestinal epithelial barrier function. We found that genetic ablation of Phd3 in intestinal epithelial cells led to spontaneous colitis in mice. Deletion of PHD3 decreases the level of tight junction protein occludin, leading to a failure of intestinal epithelial barrier function. Further studies indicate that PHD3 stabilizes occludin by preventing the interaction between the E3 ligase Itch and occludin, in a hydroxylase-independent manner. Examination of biopsy of human ulcerative colitis patients indicates that PHD3 is decreased with disease severity, indicating that PHD3 down-regulation is associated with progression of this disease. We show that PHD3 protects intestinal epithelial barrier function and reveal a hydroxylase-independent function of PHD3 in stabilizing occludin. These findings may help open avenues for developing a therapeutic strategy for IBD.	[Chen, Ying; Zhang, Hai-Sheng; Fan, Li; Xu, Yi-Ming; Qin, Yan-Qing; Yuan, Tang-Long; Sun, Heng; Fang, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Lab Food Safety Res, Shanghai 200031, Peoples R China; [Fong, Guo-Hua] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Xi, Qiu-Lei; Wu, Guo-Hao] Fudan Univ, Zhongshan Hosp, Dept Surg, Sch Med, Shanghai 200030, Peoples R China; [Bai, Chen-Guang] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Dept Pathol, Hangzhou 310022, Zhejiang, Peoples R China; [Ling, Zhi-Qiang] Zhejiang Canc Ctr, Hangzhou 310022, Zhejiang, Peoples R China; [Fang, Jing] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Connecticut; Fudan University; Naval Medical University; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Fang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Lab Food Safety Res, Shanghai 200031, Peoples R China.	jfang@sibs.ac.cn		Wu, Guohao/0000-0001-9490-4200	National Natural Science Foundation of China [31270829]; Science and Technology Commission of Shanghai Municipality [13JC1406200]; Shanghai Institutes for Biochemistry and Cell Biology [2012CSP003]; CAS/SAFEA International Partnership Program for Creative Research Teams; NATIONAL EYE INSTITUTE [R01EY019721] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Institutes for Biochemistry and Cell Biology; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Natural Science Foundation of China Grants 31270829 and 31270829, Science and Technology Commission of Shanghai Municipality Grant 13JC1406200, Shanghai Institutes for Biochemistry and Cell Biology Grant 2012CSP003, and the CAS/SAFEA International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Braus NA, 2009, CLIN IMMUNOL, V132, P1, DOI 10.1016/j.clim.2009.02.006; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; JONES SC, 1995, GUT, V36, P724, DOI 10.1136/gut.36.5.724; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Sheridan B. S., 2012, CURR PROTOC IMMUNOL, V99; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Taniguchi CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008523; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	50	38	40	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20580	20589		10.1074/jbc.M115.653584	http://dx.doi.org/10.1074/jbc.M115.653584			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124271	Green Published, hybrid			2022-12-26	WOS:000359608900053
J	Connelly, SJ; Walling, K; Wilbert, SA; Catlin, DM; Monaghan, CE; Hlynchuk, S; Meehl, PG; Resch, LN; Carrera, JV; Bowles, SM; Clark, MD; Tan, LT; Cody, JA				Connelly, Sandra J.; Walling, Kelly; Wilbert, Steven A.; Catlin, Diane M.; Monaghan, Cailin E.; Hlynchuk, Sofiya; Meehl, Pamela G.; Resch, Lauren N.; Carrera, J. Valerie; Bowles, Stephanie M.; Clark, Michael D.; Tan, Loraine T.; Cody, Jeremy A.			UV-Stressed Daphnia pulex Increase Fitness through Uptake of Vitamin D-3	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; B RADIATION; DNA; ZOOPLANKTON; REPRODUCTION; EXPOSURE; SURVIVAL; CC	Ultraviolet radiation is known to be highly variable in aquatic ecosystems. It has been suggested that UV-exposed organisms may demonstrate enough phenotypic plasticity to maintain the relative fitness of natural populations. Our long-term objective is to determine the potential photoprotective effect of vitamin D-3 on Daphnia pulex exposed to acute or chronic UV radiation. Herein we report our initial findings in this endeavor. D. pulex survival and reproduction (fitness) was monitored for 5 d as a proof of concept study. Significantly higher fitness was observed in the D. pulex with D-3 than those without (most extreme effects observed were 0% survival in the absence of D-3 and 100% with 10 ppm D-3). Vitamin D-3 was isolated from the culture media, the algal food (Pseudokirchneriella), and the D. pulex and quantified using high performance liquid chromatography (HPLC). Vitamin D-3 was fluorescently labeled using a phenothiazinium dye and added to cultures of D. pulex. Images demonstrating the uptake of D-3 into the tissues and carapace of the D. pulex were acquired. Our initial findings suggest a positive role for D-3 in ecosystems as both UV-stressed algae and Daphnia sequester D-3, and D. pulex demonstrate increased fitness in the presence of D-3.	[Connelly, Sandra J.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Walling, Kelly] Rochester Inst Technol, Sch Hlth Sci & Technol, Rochester, NY 14623 USA; [Wilbert, Steven A.] Rochester Inst Technol, Coll Imaging Arts & Sci, Rochester, NY 14623 USA; [Catlin, Diane M.; Monaghan, Cailin E.; Hlynchuk, Sofiya; Meehl, Pamela G.; Resch, Lauren N.; Carrera, J. Valerie; Bowles, Stephanie M.; Clark, Michael D.; Tan, Loraine T.; Cody, Jeremy A.] Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA	Rochester Institute of Technology; Rochester Institute of Technology; Rochester Institute of Technology; Rochester Institute of Technology	Connelly, SJ (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	Sandra.Connelly@rit.edu			Rochester Institute of Technology: College of Science (RIT) Faculty Development Awards; College of Science (RIT) Undergraduate Summer Scholars Fellowship Awards; RIT Honors Program Undergraduate Student Summer Scholarship Award; RIT Ronald E. McNair Post-Baccalaureate Achievement Program; RIT School of Chemistry and Materials Science Dr. Terry Morrill Endowed Student Research Fund; RIT School of Chemistry and Materials Science Daniel Pasto Award; RIT Office of Sponsored Research Sponsored Research Grants; RIT School of Chemistry and Materials Science; Thomas H. Gosnell School of Life Sciences; National Science Foundation Major Research Instrumentation Program [1126629]	Rochester Institute of Technology: College of Science (RIT) Faculty Development Awards; College of Science (RIT) Undergraduate Summer Scholars Fellowship Awards; RIT Honors Program Undergraduate Student Summer Scholarship Award; RIT Ronald E. McNair Post-Baccalaureate Achievement Program; RIT School of Chemistry and Materials Science Dr. Terry Morrill Endowed Student Research Fund; RIT School of Chemistry and Materials Science Daniel Pasto Award; RIT Office of Sponsored Research Sponsored Research Grants; RIT School of Chemistry and Materials Science; Thomas H. Gosnell School of Life Sciences; National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors received funding to support from the following entities within Rochester Institute of Technology: College of Science (RIT) Faculty Development Awards; the College of Science (RIT) Undergraduate Summer Scholars Fellowship Awards; the RIT Honors Program Undergraduate Student Summer Scholarship Award; the RIT Ronald E. McNair Post-Baccalaureate Achievement Program; the RIT School of Chemistry and Materials Science Dr. Terry Morrill Endowed Student Research Fund; the RIT School of Chemistry and Materials Science Daniel Pasto Award; the RIT Office of Sponsored Research Sponsored Research Grants; the RIT School of Chemistry and Materials Science; the Thomas H. Gosnell School of Life Sciences; and the National Science Foundation Major Research Instrumentation Program (#1126629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Brunetto MR, 2004, TALANTA, V64, P1364, DOI 10.1016/j.talanta.2004.04.035; Cody JA, 2012, TETRAHEDRON LETT, V53, P4896, DOI 10.1016/j.tetlet.2012.07.012; CONKLIN DE, 1977, BIOL BULL, V152, P337, DOI 10.2307/1540422; Connelly SJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P144, DOI 10.1111/j.1751-1097.2008.00408.x; Curino A, 2001, PHYTOCHEMISTRY, V58, P81, DOI 10.1016/S0031-9422(01)00090-5; De Lange HJ, 2003, FRESHWATER BIOL, V48, P678, DOI 10.1046/j.1365-2427.2003.01036.x; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Gouveia GR, 2005, PHOTOCHEM PHOTOBIOL, V81, P398, DOI 10.1562/2004-05-26-RA-179.1; Grad G, 2001, LIMNOL OCEANOGR, V46, P584, DOI 10.4319/lo.2001.46.3.0584; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Hurtubise RD, 1998, LIMNOL OCEANOGR, V43, P1082, DOI 10.4319/lo.1998.43.6.1082; KEATING KI, 1985, J CRUSTACEAN BIOL, V5, P130, DOI 10.2307/1548225; KERFOOT WC, 1982, ECOLOGY, V63, P538, DOI 10.2307/1938969; Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Meyer-Rochow V B, 2000, Int J Circumpolar Health, V59, P38; Miguel NCD, 2002, MICRON, V33, P627, DOI 10.1016/S0968-4328(02)00030-6; Mitchell D, 1991, ENV UV PHOTOBIOLOGY, P345; Noval M, 2015, PHOTOBIOLOGY SCI LIG, P365; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Peraza MA, 1998, ENVIRON HEALTH PERSP, V106, P203, DOI 10.2307/3433921; Persaud AD, 2007, FRESHWATER BIOL, V52, P2121, DOI 10.1111/j.1365-2427.2007.01833.x; Rautio M, 2002, LIMNOL OCEANOGR, V47, P295, DOI 10.4319/lo.2002.47.1.0295; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; Wallin H, 2000, MUTAT RES-FUND MOL M, V447, P317, DOI 10.1016/S0027-5107(99)00214-6; Wang T, 2001, J PHOTOCH PHOTOBIO B, V62, P118, DOI 10.1016/S1011-1344(01)00160-9; Williamson CE, 2001, ECOL APPL, V11, P1843, DOI 10.1890/1051-0761(2001)011[1843:BADEOU]2.0.CO;2; Williamson CE, 2014, NAT CLIM CHANGE, V4, P434, DOI [10.1038/nclimate2225, 10.1038/NCLIMATE2225]; WITKIN EM, 1969, ANNU REV GENET, V3, P525, DOI 10.1146/annurev.ge.03.120169.002521; ZELLMER ID, 1995, HYDROBIOLOGIA, V307, P153, DOI 10.1007/BF00032007	34	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131847	10.1371/journal.pone.0131847	http://dx.doi.org/10.1371/journal.pone.0131847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147286	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600153
J	Shi, AP; Dong, J; Hilsenbeck, S; Bi, LR; Zhang, H; Li, Y				Shi, Aiping; Dong, Jie; Hilsenbeck, Susan; Bi, Lirong; Zhang, Hong; Li, Yi			The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia	PLOS ONE			English	Article							MAMMARY-GLAND DIFFERENTIATION; TRANSCRIPTION FACTORS; SIGNAL TRANSDUCER; MENSTRUAL-CYCLE; RISK-FACTORS; CELL-PROLIFERATION; CANCER PROGNOSIS; HORMONE-THERAPY; ELEVATED LEVELS; ACTIVATION	Signal Transducer and Activation of Transcription factors (STAT3 and STAT5) play important roles in breast epithelial cell differentiation, proliferation, and apoptosis. They have been investigated extensively in established breast cancer, but their activation status in precancerous lesions has not been reported. Formalin-fixed, paraffin-embedded archival tissues from 59 cases of atypical ductal hyperplasia (ADH) and 31 cases of normal human breast tissue as well as 21 cases of usual ductal hyperplasias (UDH) were obtained from the First Hospital of Jilin University, China, and stained for pSTAT3 and pSTAT5 by immunohistochemistry. The median percentage of pSTAT5+ cells in ADH was 12%, not significantly deviant from that in normal breast. The median percentage of pSTAT3+ cells in ADH was 30%, significantly higher than that of normal breast. pSTAT3 and pSTAT5 were exclusive of each other-they were detected in different ADHs or in different cells within the same ADHs. In addition, both pSTAT3 and pSTAT5 were produced in similar percentages of cells in ADHs from cancer-free patients vs. ADHs that were adjacent to an invasive cancer. Our finding of a complementary expression pattern of pSTAT3 and pSTAT5 in ADH suggests that these two transcription factors may have feedback inhibitory effects on each other during early stages of breast cancer evolution, and that disruption of this inverse relationship may be important in the progression from early lesions to cancer, which exhibits positive association between pSTAT3 and pSTAT5.	[Shi, Aiping; Bi, Lirong] Jilin Univ, Dept Breast Surg, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Shi, Aiping; Dong, Jie; Hilsenbeck, Susan; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Dong, Jie] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hilsenbeck, Susan] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Li, Yi] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Zhang, Hong] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Jilin University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Li, Y (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.	liyi@bcm.edu	; Li, Yi/A-7635-2009	shi, aiping/0000-0002-7272-453X; Li, Yi/0000-0002-9976-518X	NIH [P50CA186784, CA124820, P50CA058183]; Susan G. Komen grant [IIR12223625]; DOD CDMRP [BC112704, BC123368]; Bethune project B of Jilin University [2012217]; NATIONAL CANCER INSTITUTE [R01CA124820, P50CA058183, P50CA186784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); DOD CDMRP(United States Department of Defense); Bethune project B of Jilin University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by NIH grants (P50CA186784, CA124820, and P50CA058183), a Susan G. Komen grant (IIR12223625), and DOD CDMRP grants (BC112704 and BC123368) (YL); Bethune project B of Jilin University (fund #2012217) (AS).	Allred DC, 2000, J MAMMARY GLAND BIOL, V5, P351, DOI 10.1023/A:1009573710675; BARTOW SA, 1987, CANCER, V60, P2751, DOI 10.1002/1097-0142(19871201)60:11<2751::AID-CNCR2820601127>3.0.CO;2-M; Bednorz NL, 2011, ENDOCRINOLOGY, V152, P1935, DOI 10.1210/en.2011-0053; Charpin C, 2009, INT J CANCER, V124, P2124, DOI 10.1002/ijc.24177; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; DEPOTTER CR, 1987, HISTOPATHOLOGY, V11, P1307; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dong J, 2010, DEV BIOL, V346, P196, DOI 10.1016/j.ydbio.2010.07.027; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Fahrenkamp D, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-014-0081-7; FERGUSON DJP, 1981, BRIT J CANCER, V44, P177, DOI 10.1038/bjc.1981.168; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GOING JJ, 1988, AM J PATHOL, V130, P193; Haricharan S, 2014, MOL CELL ENDOCRINOL, V382, P560, DOI 10.1016/j.mce.2013.03.014; Haricharan S, 2013, ELIFE, V2, DOI 10.7554/eLife.00996; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Hartmann LC, 2015, THE NEW ENGLAND JOUR, V372, P78, DOI [10.1056/NEJMsr1407164, DOI 10.1056/NEJMSR1407164]; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hoshi K, 1995, Gan To Kagaku Ryoho, V22 Suppl 1, P36; Hughes Katherine, 2012, JAKSTAT, V1, P151, DOI 10.4161/jkst.19691; JOSHI K, 1986, AM J PATHOL, V124, P199; KAMEL OW, 1989, AM J PATHOL, V134, P107; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; LONGACRE TA, 1986, AM J SURG PATHOL, V10, P382, DOI 10.1097/00000478-198606000-00003; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; MEYER JS, 1977, HUM PATHOL, V8, P67, DOI 10.1016/S0046-8177(77)80066-X; Mustonen M, 1997, HISTOPATHOLOGY, V31, P347, DOI 10.1046/j.1365-2559.1997.2710877.x; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nevalainen MT, 2002, MOL ENDOCRINOL, V16, P1108, DOI 10.1210/mend.16.5.0839; NIELSEN M, 1984, CANCER-AM CANCER SOC, V54, P612, DOI 10.1002/1097-0142(1984)54:4<612::AID-CNCR2820540403>3.0.CO;2-B; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PAGE DL, 1993, BREAST CANCER RES TR, V28, P157, DOI 10.1007/BF00666428; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; POTTEN CS, 1988, BRIT J CANCER, V58, P163, DOI 10.1038/bjc.1988.185; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; RUSSO J, 1987, J NATL CANCER I, V78, P413; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Santen RJ, 2014, J STEROID BIOCHEM, V142, P52, DOI 10.1016/j.jsbmb.2013.06.010; Sato T, 2011, AM J CANCER RES, V1, P347; Schmitt FC, 1995, EUR J CANCER, V31A, P2049, DOI 10.1016/0959-8049(95)00430-0; Sinha VC, 2015, MOL CANCER RES, V13, P231, DOI 10.1158/1541-7786.MCR-14-0481-T; Vakkala M, 1999, BRIT J CANCER, V81, P592, DOI 10.1038/sj.bjc.6690735; Visscher DW, 1996, ANAL CELL PATHOL, V12, P115; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Walker SR, 2014, MOL CELL ENDOCRINOL, V382, P616, DOI 10.1016/j.mce.2013.03.010; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Wang Q S, 1985, Natl Cancer Inst Monogr, V69, P39; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Wei W, 2014, STEM CELLS, V32, P2571, DOI 10.1002/stem.1752; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; YUAN JM, 1988, CANCER RES, V48, P1949	54	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132214	10.1371/journal.pone.0132214	http://dx.doi.org/10.1371/journal.pone.0132214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146825	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600221
J	Yang, H; Wang, Q; Zheng, L; Lin, M; Zheng, XB; Lin, F; Yang, LY				Yang, Hui; Wang, Qian; Zheng, Lei; Lin, Min; Zheng, Xiang-bin; Lin, Fen; Yang, Li-Ye			Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; GENOME-WIDE ASSOCIATION; SERUM BILIRUBIN; UNCONJUGATED HYPERBILIRUBINEMIA; UDP-GLUCURONOSYLTRANSFERASE; MICROSATELLITE POLYMORPHISM; UGT1A1; PROMOTER; VARIANTS; SUSCEPTIBILITY	The potential for genetic variation to modulate neonatal hyperbilirubinemia risk is increasingly being recognized. A case-control study was designed to assess comprehensive contributions of the multiple genetic modifiers of bilirubin metabolism on significant neonatal hyperbilirubinemia in Chinese descendents. Eleven common mutations and polymor-phisms across five bilirubin metabolism genes, namely those encoding UGT1A1, HMOX1, BLVRA, SLCO1B1 and SLCO1B3, were determined using the high resolution melt (HRM) assay or PCR-capillary electrophoresis analysis. A total of 129 hyperbilirubinemic infants and 108 control subjects were evaluated. Breastfeeding and the presence of the minor A allele of rs4148323 (UGTA*6) were correlated with an increased risk of hyperbilirubinemia (OR=2.17, P=0.02 for breastfeeding; OR=9.776, P=0.000 for UGTA*6 homozygote; OR=3.151, P=0.000 for UGTA*6 heterozygote); whereas, increasing gestational age and the presence of -TA(7) repeat variant of UGT1A1 decreased the risk (OR=0.721, P=0.003 for gestational age; OR=0.313, P=0.002 for heterozygote TA(6)/TA(7)). In addition, the SLCO1B1 and SLCO1B3 polymorphisms also contributed to an increased risk of hyperbilirubinemia. This detailed analysis revealed the impact of multiple genetic modifiers on neonatal hyperbilirubinemia. This may support the use of genetic tests for clinical risk assessment. Furthermore, the established HRM assay can serve as an effective method for large-scale investigation.	[Yang, Hui; Wang, Qian; Zheng, Lei] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Yang, Hui; Lin, Min; Zheng, Xiang-bin; Lin, Fen; Yang, Li-Ye] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Wang, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	nfky_well@163.com; yangleeyee@sina.com			Medical Research Fund of Guangdong Province [B2013444, A2014902]; Science and Technology Research Fund of Guangdong Province [2012B031800001]; Science and Technology Research Fund of Chaozhou [2014S08]	Medical Research Fund of Guangdong Province; Science and Technology Research Fund of Guangdong Province; Science and Technology Research Fund of Chaozhou	This study has been financed with aid from the Medical Research Fund of Guangdong Province (B2013444, HY), the Medical Research Fund of Guangdong Province (A2014902, LY), the Science and Technology Research Fund of Guangdong Province (2012B031800001, LY), and the Science and Technology Research Fund of Chaozhou (2014S08, LY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Bhutani Vinod K, 2004, J Perinatol, V24, P650, DOI 10.1038/sj.jp.7211152; Bozkaya OG, 2010, ACTA PAEDIATR, V99, P679, DOI 10.1111/j.1651-2227.2009.01678.x; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Chou HC, 2011, PEDIATR RES, V69, P170, DOI 10.1203/PDR.0b013e31820263d2; Dai XY, 2013, GENET EPIDEMIOL, V37, P293, DOI 10.1002/gepi.21711; de Azevedo LA, 2012, PEDIATR RES, V72, P169, DOI 10.1038/pr.2012.60; Editorial Board of Chinese Journal of Pediatrics; Subspecialty Group of Neonatology The Society of Pediatrics Chinese Medical Association, 2010, ZHONGHUA ER KE ZA ZH, V48, P685; Fujiwara R, 2012, GASTROENTEROLOGY, V142, P109, DOI 10.1053/j.gastro.2011.09.045; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hanchard NA, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-57; Huang CS, 2002, PEDIATR RES, V52, P601, DOI 10.1203/01.PDR.0000028058.44773.24; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; KANG H, 2005, KOREAN J PEDIAT, V48, P380; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Kaplan M, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e47; Kaplan Michael, 2005, Current Pharmacogenomics, V3, P21, DOI 10.2174/1570160053174992; Kaplan M, 2014, NEONATOLOGY, V106, P323, DOI 10.1159/000365744; Kaplan M, 2011, NEONATOLOGY, V100, P354, DOI 10.1159/000330055; Katayama Y, 2015, PEDIATR INT, V57, P645, DOI 10.1111/ped.12591; Kringen MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090248; Lin R, 2009, HUM MUTAT, V30, P609, DOI 10.1002/humu.20895; Lin ZL, 2008, PEDIATRICS, V122, pE156, DOI 10.1542/peds.2007-3249; Liu JB, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-49; Long J, 2011, PEDIATR INT, V53, P530, DOI 10.1111/j.1442-200X.2011.03337.x; Newman TB, 2000, ARCH PEDIAT ADOL MED, V154, P1140, DOI 10.1001/archpedi.154.11.1140; Ota Y, 2011, PEDIATR RES, V70, P453, DOI 10.1203/PDR.0b013e31822f242e; Pan MC, 2013, MOL BIOL REP, V40, P3073, DOI 10.1007/s11033-012-2381-6; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; Sato H, 2013, J HUM GENET, V58, P7, DOI 10.1038/jhg.2012.116; Skierka JM, 2013, J PEDIATR-US, V162, P1146, DOI 10.1016/j.jpeds.2012.11.042; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; SPSS Inc, 1999, SPSS ADV MOD; Tiwari PK, 2013, EUR J PEDIATR, V172, P1627, DOI 10.1007/s00431-013-2091-7; Watchko Jon F, 2002, Semin Neonatol, V7, P143, DOI 10.1053/siny.2002.0102; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Yang H, 2015, INT J LAB HEMATOL, V37, P410, DOI 10.1111/ijlh.12303; Zhou YY, 2009, NEONATOLOGY, V96, P150, DOI 10.1159/000209851; Zhou YY, 2014, J PEDIATR-US, V165, P1154, DOI 10.1016/j.jpeds.2014.08.041; Zhou YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104251	41	23	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132034	10.1371/journal.pone.0132034	http://dx.doi.org/10.1371/journal.pone.0132034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146841	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600185
J	Glovaci, I; Chapman, CA				Glovaci, Iulia; Chapman, C. Andrew			Activation of Phosphatidylinositol-Linked Dopamine Receptors Induces a Facilitation of Glutamate-Mediated Synaptic Transmission in the Lateral Entorhinal Cortex	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; I ADENYLYL-CYCLASE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INTRACELLULAR CALCIUM-RELEASE; LAYER-II; PARAHIPPOCAMPAL REGION; GLUR1 SUBUNIT; AMPA RECEPTOR; D1 RECEPTORS; N-TYPE	The lateral entorhinal cortex receives strong inputs from midbrain dopamine neurons that can modulate its sensory and mnemonic function. We have previously demonstrated that 1 mu M dopamine facilitates synaptic transmission in layer II entorhinal cortex cells via activation of D-1-like receptors, increased cAMP-PKA activity, and a resulting enhancement of AMPA-receptor mediated currents. The present study assessed the contribution of phosphatidylinositol (PI)-linked D-1 receptors to the dopaminergic facilitation of transmission in layer II of the rat entorhinal cortex, and the involvement of phospholipase C activity and release of calcium from internal stores. Whole-cell patch-clamp recordings of glutamate-mediated evoked excitatory postsynaptic currents were obtained from pyramidal and fan cells. Activation of D-1-like receptors using SKF38393, SKF83959, or 1 mu M dopamine induced a reversible facilitation of EPSCs which was abolished by loading cells with either the phospholipase C inhibitor U-73122 or the Ca2+ chelator BAPTA. Neither the L-type voltage-gated Ca2+ channel blocker nifedipine, nor the L/N-type channel blocker cilnidipine, blocked the facilitation of synaptic currents. However, the facilitation was blocked by blocking Ca2+ release from internal stores via inositol 1,4,5-trisphosphate (InsP(3)) receptors or ryanodine receptors. Follow-up studies demonstrated that inhibiting CaMKII activity with KN-93 failed to block the facilitation, but that application of the protein kinase C inhibitor PKC(19-36) completely blocked the dopamine-induced facilitation. Overall, in addition to our previous report indicating a role for the cAMP-PKA pathway in dopamine-induced facilitation of synaptic transmission, we demonstrate here that the dopaminergic facilitation of synaptic responses in layer II entorhinal neurons also relies on a signaling cascade dependent on PI-linked D-1 receptors, PLC, release of Ca2+ from internal stores, and PKC activation which is likely dependent upon both DAG and enhanced intracellular Ca2+. These signaling pathways may collaborate to enhance sensory and mnemonic function in the entorhinal cortex during tonic release of dopamine.	[Glovaci, Iulia; Chapman, C. Andrew] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Chapman, CA (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada.	andrew.chapman@concordia.ca			Natural Sciences and Engineering Research Council of Canada [2014-05407]; Doctoral Research Scholarship from Fonds Quebecois de la Recherche sur la Nature et les Technologies [176730]; Fonds de Recherche du Quebec - Sante (FRQS) [5833]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Doctoral Research Scholarship from Fonds Quebecois de la Recherche sur la Nature et les Technologies; Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants to CAC from the Natural Sciences and Engineering Research Council of Canada (Grant number 2014-05407; www.nserc-crsng.gc.ca). IG was funded by a Doctoral Research Scholarship from Fonds Quebecois de la Recherche sur la Nature et les Technologies (Grant number 176730; www.frqnt.gouv.qc.ca). CAC is a member of the Center for Studies in Behavioral Neurobiology, funded by the Fonds de Recherche du Quebec - Sante (FRQS number 5833; www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulGhani MA, 1996, J NEUROPHYSIOL, V76, P2691, DOI 10.1152/jn.1996.76.4.2691; AKIL M, 1994, NEUROSCIENCE, V60, P857, DOI 10.1016/0306-4522(94)90268-2; ARNT J, 1992, EUR J PHARMACOL, V213, P259, DOI 10.1016/0014-2999(92)90690-6; Bender KJ, 2010, NEURON, V68, P500, DOI 10.1016/j.neuron.2010.09.026; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bjorklund A., 1984, CLASSICAL NEUROTRA 1, V2, P55; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P185, DOI 10.1016/j.tins.2007.03.004; Braun AP, 2009, CHANNELS, V3, P381, DOI 10.4161/chan.3.6.10877; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Caruana DA, 2006, J NEUROPHYSIOL, V96, P3006, DOI 10.1152/jn.00572.2006; Caruana Douglas A., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/203514; Cepeda C, 1998, J NEUROPHYSIOL, V79, P82, DOI 10.1152/jn.1998.79.1.82; Chergui K, 1999, NEUROPHARMACOLOGY, V38, P223, DOI 10.1016/S0028-3908(98)00187-7; Chu HY, 2010, BRAIN RES, V1343, P20, DOI 10.1016/j.brainres.2010.04.043; Clark AM, 2012, J NEUROSCI, V32, P6869, DOI 10.1523/JNEUROSCI.0887-12.2012; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Galarraga E, 1997, NEUROREPORT, V8, P2183, DOI 10.1097/00001756-199707070-00019; Glovaci I, 2014, NEUROSCIENCE, V258, P74, DOI 10.1016/j.neuroscience.2013.10.076; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; GROSS RA, 1990, P NATL ACAD SCI USA, V87, P7025, DOI 10.1073/pnas.87.18.7025; Hargreaves EL, 2007, HIPPOCAMPUS, V17, P826, DOI 10.1002/hipo.20316; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; Hernandez A, 2007, NEUROSCI LETT, V425, P188, DOI 10.1016/j.neulet.2007.08.026; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; Horne JH, 1997, SCIENCE, V276, P1690, DOI 10.1126/science.276.5319.1690; Hutter JA, 2013, BEHAV BRAIN RES, V252, P266, DOI 10.1016/j.bbr.2013.05.057; JAFFE DB, 1994, J NEUROPHYSIOL, V72, P471, DOI 10.1152/jn.1994.72.1.471; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Jin LQ, 2001, J NEUROCHEM, V78, P981, DOI 10.1046/j.1471-4159.2001.00470.x; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; Kelly KM, 2001, NEUROBIOL AGING, V22, P17, DOI 10.1016/S0197-4580(00)00178-0; Keppel G., 2004, DESIGN ANAL RES HDB; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; KREBS EG, 1994, TRENDS BIOCHEM SCI, V19, P439, DOI 10.1016/0968-0004(94)90125-2; Kumar PA, 2001, NEUROSCI LETT, V299, P181, DOI 10.1016/S0304-3940(01)01493-8; LAI Y, 1993, J NEUROCHEM, V61, P1333, DOI 10.1111/j.1471-4159.1993.tb13626.x; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee SM, 2014, NEUROPHARMACOLOGY, V86, P145, DOI 10.1016/j.neuropharm.2014.05.042; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Lezcano N, 2002, J NEUROPHYSIOL, V87, P2167, DOI 10.1152/jn.00541.2001; Li CC, 2014, J PHYSIOL-LONDON, V592, P4329, DOI 10.1113/jphysiol.2014.277715; LOUGHLIN SE, 1984, NEUROSCIENCE, V11, P425, DOI 10.1016/0306-4522(84)90034-4; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Ming YL, 2006, J NEUROCHEM, V98, P1316, DOI 10.1111/j.1471-4159.2006.03961.x; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Panchalingam S, 2001, NEUROPHARMACOLOGY, V40, P826, DOI 10.1016/S0028-3908(01)00011-9; Partridge JG, 2002, J NEUROSCI, V22, P2541, DOI 10.1523/JNEUROSCI.22-07-02541.2002; Petrulis A, 2005, NEUROSCIENCE, V130, P259, DOI 10.1016/j.neuroscience.2004.09.001; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; PRALONG E, 1993, EUR J NEUROSCI, V5, P760, DOI 10.1111/j.1460-9568.1993.tb00540.x; Puig MV, 2012, NEURON, V74, P874, DOI 10.1016/j.neuron.2012.04.018; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; SHARP AH, 1993, J NEUROSCI, V13, P3051; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Stenkamp K, 1998, NEUROSCI LETT, V255, P119, DOI 10.1016/S0304-3940(98)00721-6; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Tahvildari B, 2005, J COMP NEUROL, V491, P123, DOI 10.1002/cne.20706; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; UNDIE AS, 1994, J NEUROCHEM, V62, P2045; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; Wan HM, 1999, J NEUROSCI, V19, P1142; Wang HB, 2003, J NEUROSCI, V23, P9710; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wayman GA, 1996, MOL CELL BIOL, V16, P6075; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yang SN, 2000, HIPPOCAMPUS, V10, P57, DOI 10.1002/(SICI)1098-1063(2000)10:1<57::AID-HIPO6>3.3.CO;2-S; Yger M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00056; Young CE, 2004, J NEUROSCI, V24, P8, DOI 10.1523/JNEUROSCI.1650-03.2004; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016; Zhen XC, 2004, MOL PHARMACOL, V66, P1500, DOI 10.1124/mol.104.002279	101	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131948	10.1371/journal.pone.0131948	http://dx.doi.org/10.1371/journal.pone.0131948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133167	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000358154400084
J	Jeffery, LE; Qureshi, OS; Gardner, D; Hou, TZ; Briggs, Z; Soskic, B; Baker, J; Raza, K; Sansom, DM				Jeffery, Louisa E.; Qureshi, Omar S.; Gardner, David; Hou, Tie Z.; Briggs, Zoe; Soskic, Blagoje; Baker, Jennifer; Raza, Karim; Sansom, David M.			Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function	PLOS ONE			English	Article							CONVENTIONAL T-CELLS; GROWTH-FACTOR-BETA; DENDRITIC CELLS; 1,25-DIHYDROXYVITAMIN D-3; COSTIMULATORY MOLECULES; IMMUNE DYSREGULATION; AUTOIMMUNE-DISEASES; LANGERHANS CELLS; INTERFERON-GAMMA; TH17 CELLS	The immune suppressive protein CTLA-4 is constitutively expressed by Tregs and induced in effector T cells upon activation. Its crucial role in adaptive immunity is apparent from the fatal autoimmune pathology seen in CTLA-4 knockout mice. However, little is known regarding factors that regulate CTLA-4 expression and their effect upon its function to remove CD80 and CD86 from antigen presenting cells by transendocytosis. Th17 cells are emerging as significant players in autoimmunity as well as other diseases. Therefore, in this study we have examined the effects of Th17 polarising conditions on CTLA-4 expression and function in human T cells and show that Th17 conditions can suppress the expression of CTLA-4 and its transendocytic function. In contrast to Th17 cells, vitamin D is inversely associated with autoimmune disease. We have previously shown a striking ability of 1,25 dihydroxyvitamin D-3 (1,25(OH)(2)D-3) to enhance CTLA-4, however, its effects upon B7 transendocytosis and its activity in the context of inflammation remained unknown. Here we show that induction of CTLA-4 by 1,25(OH)(2)D-3 can actually be enhanced in the presence of Th17 polarising cytokines. Furthermore, its transendocytic function was maintained such that T cells generated in the presence of Th17 conditions and 1,25(OH)(2)D-3 were highly effective at capturing CTLA-4 ligands from antigen presenting cells and suppressing T cell division. Taken together, these data reveal an inhibitory effect of Th17 polarising conditions upon CTLA-4-mediated regulation and show that 1,25(OH)(2)D-3 counteracts this effect. Given the importance of CTLA-4-mediated suppression in the control of autoimmune diseases, our novel data highlight the importance of vitamin D in inflammatory settings.	[Jeffery, Louisa E.; Qureshi, Omar S.; Gardner, David; Briggs, Zoe; Baker, Jennifer; Raza, Karim] Univ Birmingham, Sch Med, Inst Biomed Res, Med Res Council Ctr Immune Regulat,Sch Immun & In, Birmingham, W Midlands, England; [Hou, Tie Z.; Soskic, Blagoje; Sansom, David M.] UCL, UCL Inst Immun & Transplantat, London, England; [Raza, Karim] Sandwell & West Birmingham Hosp NHS Trust, Dept Rheumatol, Birmingham, W Midlands, England	University of Birmingham; University of London; University College London	Raza, K (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Med Res Council Ctr Immune Regulat,Sch Immun & In, Birmingham, W Midlands, England.	k.raza@bham.ac.uk	Qureshi, Omar/CAF-4545-2022; Raza, Karim/AAN-3089-2021	Raza, Karim/0000-0003-1570-1232; Sansom, David/0000-0001-6506-3115	Arthritis Research UK [DKAA RCAN14657]; Versus Arthritis [19364] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	Arthritis Research UK funded the project. Grant number DKAA RCAN14657. Funding was awarded to DS and KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/607073; Adorini L, 2003, J CELL BIOCHEM, V88, P227, DOI 10.1002/jcb.10340; Agmon-Levin N, 2013, CLIN REV ALLERG IMMU, V45, P256, DOI 10.1007/s12016-012-8342-y; Alegre ML, 1996, J IMMUNOL, V157, P4762; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; Berer A, 2000, EXP HEMATOL, V28, P575, DOI 10.1016/S0301-472X(00)00143-0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Butty V, 2007, P NATL ACAD SCI USA, V104, P570, DOI 10.1073/pnas.0610124104; Cantorna MT, 2012, ARCH BIOCHEM BIOPHYS, V523, P103, DOI 10.1016/j.abb.2011.11.001; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Flores-Borja F, 2008, P NATL ACAD SCI USA, V105, P19396, DOI 10.1073/pnas.0806855105; Fritsche J, 2003, BLOOD, V102, P3314, DOI 10.1182/blood-2002-11-3521; Gatenby P, 2013, CURR OPIN RHEUMATOL, V25, P184, DOI 10.1097/BOR.0b013e32835cfc16; Ghaderi A, 2011, IRAN J IMMUNOL, V8, P127, DOI IJIv8i3A1; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Kriegel MA, 2011, SEMIN ARTHRITIS RHEU, V40, P512, DOI 10.1016/j.semarthrit.2010.07.009; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lee YH, 2005, HUM GENET, V116, P361, DOI 10.1007/s00439-004-1244-1; Li M, 2012, J GASTROEN HEPATOL, V27, P1159, DOI 10.1111/j.1440-1746.2012.07118.x; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064531; Luczynski W, 2009, ACTA BIOCHIM POL, V56, P361; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marwaha AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00129; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; Mayne CG, 2011, EUR J IMMUNOL, V41, P822, DOI 10.1002/eji.201040632; Ozawa H, 1996, EUR J IMMUNOL, V26, P648, DOI 10.1002/eji.1830260321; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shankar Gopi, 2003, J Transl Med, V1, P7, DOI 10.1186/1479-5876-1-7; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang CJ, 2012, J IMMUNOL, V189, P1118, DOI 10.4049/jimmunol.1200972; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yang CY, 2013, CLIN REV ALLERG IMMU, V45, P217, DOI 10.1007/s12016-013-8361-3; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yokozeki H, 1997, BRIT J DERMATOL, V136, P831, DOI 10.1111/j.1365-2133.1997.tb03921.x; Zheng Y, 2008, J IMMUNOL, V181, P1683, DOI 10.4049/jimmunol.181.3.1683	62	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131539	10.1371/journal.pone.0131539	http://dx.doi.org/10.1371/journal.pone.0131539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134669	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400053
J	Mathews, JA; Kasahara, DI; Ribeiro, L; Wurmbrand, AP; Ninin, FMC; Shore, SA				Mathews, Joel A.; Kasahara, David I.; Ribeiro, Luiza; Wurmbrand, Allison P.; Ninin, Fernanda M. C.; Shore, Stephanie A.			gamma delta T Cells Are Required for M2 Macrophage Polarization and Resolution of Ozone-Induced Pulmonary Inflammation in Mice	PLOS ONE			English	Article							INDUCED LUNG INFLAMMATION; DENDRITIC CELLS; SUBACUTE OZONE; AMBIENT LEVELS; EXPOSURE; RESPONSES; INJURY; SUSCEPTIBILITY; NEUTRALIZATION; PHAGOCYTOSIS	We examined the role of gamma delta T cells in the induction of alternatively activated M2 macrophages and the resolution of inflammation after ozone exposure. Wildtype (WT) mice and mice deficient in gamma delta T cells (TCR delta(-/-) mice) were exposed to air or to ozone (0.3 ppm for up to 72h) and euthanized immediately or 1, 3, or 5 days after cessation of exposure. In WT mice, M2 macrophages accumulated in the lungs over the course of ozone exposure. Pulmonary mRNA abundance of the M2 genes, Arg1, Retnla, and Clec10a, also increased after ozone. In contrast, no evidence of M2 polarization was observed in TCR delta(-/-) mice. WT but not TCR delta(-/-) mice expressed the M2c polarizing cytokine, IL-17A, after ozone exposure and WT mice treated with an IL-17A neutralizing antibody exhibited attenuated ozone-induced M2 gene expression. In WT mice, ozone-induced increases in bronchoalveolar lavage neutrophils and macrophages resolved quickly after cessation of ozone exposure returning to air exposed levels within 3 days. However, lack of M2 macrophages in TCR delta(-/-) mice was associated with delayed clearance of inflammatory cells after cessation of ozone and increased accumulation of apoptotic macrophages in the lungs. Delayed restoration of normal lung architecture was also observed in TCR delta(-/-) mice. In summary, our data indicate that gamma delta T cells are required for the resolution of ozone-induced inflammation, likely because gamma delta T cells, through their secretion of IL-17A, contribute to changes in macrophage polarization that promote clearance of apoptotic cells.	[Mathews, Joel A.; Kasahara, David I.; Ribeiro, Luiza; Wurmbrand, Allison P.; Ninin, Fernanda M. C.; Shore, Stephanie A.] Harvard TH Chan Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mathews, JA (corresponding author), Harvard TH Chan Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Dept Environm Hlth, Boston, MA 02115 USA.	joel.mathews@gmail.com			National Institutes of Health (NIH) [F32ES02256, HL007118, ES013307, ES000002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013307, P30ES000002] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health (NIH) grants F32ES02256, HL007118, ES013307, and ES000002. NIH.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AK, 2010, EUR RESPIR J, V36, P428, DOI 10.1183/09031936.00145309; Bauer AK, 2011, ENV HLTH PERSPECT, V119; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; CASTLEMAN WL, 1977, EXP MOL PATHOL, V26, P384, DOI 10.1016/0014-4800(77)90041-7; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Chiu HF, 2009, INHAL TOXICOL, V21, P32, DOI 10.1080/08958370802441198 ; Dalton JE, 2004, J IMMUNOL, V173, P3660, DOI 10.4049/jimmunol.173.6.3660; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; Dormans JAMA, 1999, INHAL TOXICOL, V11, P309; Fleischmann R, 2013, RHEUMATOLOGY, V52, pi49; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Groves AM, 2013, AM J PHYSIOL-LUNG C, V305, pL555, DOI 10.1152/ajplung.00027.2013; Hirsh MI, 2008, AM J RESP CELL MOL, V39, P509, DOI 10.1165/rcmb.2008-0090TR; Inagaki-Ohara K, 2011, IMMUNOLOGY, V134, P448, DOI 10.1111/j.1365-2567.2011.03503.x; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kasahara DI, 2014, AM J PHYSIOL-LUNG C, V306, pL508, DOI 10.1152/ajplung.00235.2013; Kasahara DI, 2012, J IMMUNOL, V188, P4558, DOI 10.4049/jimmunol.1102363; Kasahara DI, 2013, PLOS ONE IN PRESS; Kirby AC, 2007, J PATHOL, V212, P29, DOI 10.1002/path.2149; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; KLEEBERGER SR, 1993, AM J PHYSIOL, V264, pL15, DOI 10.1152/ajplung.1993.264.1.L15; Koohsari H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-21; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mathews JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097707; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Ponomarev ED, 2005, J IMMUNOL, V174, P4678, DOI 10.4049/jimmunol.174.8.4678; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Serhan CN, 2012, FRONTIERS IMMUNOLOGY, V3; Shore SA, 2011, INHAL TOXICOL, V23, P878, DOI 10.3109/08958378.2011.622316; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SKEEN MJ, 1993, J EXP MED, V178, P971, DOI 10.1084/jem.178.3.971; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sunil VR, 2012, TOXICOL APPL PHARM, V263, P195, DOI 10.1016/j.taap.2012.06.009; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Triche EW, 2006, ENVIRON HEALTH PERSP, V114, P911, DOI 10.1289/ehp.8559; Verbout NG, 2013, J ALLERGY, V2013, P13; Wands JM, 2005, J LEUKOCYTE BIOL, V78, P1086, DOI 10.1189/jlb.0505244; Williams AS, 2013, ENVIRON HEALTH PERSP, V121, P551, DOI 10.1289/ehp.1205880; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009; Yang H, 2004, J IMMUNOL, V172, P4151, DOI 10.4049/jimmunol.172.7.4151; Zhao QY, 1998, AM J PHYSIOL-LUNG C, V274, pL39, DOI 10.1152/ajplung.1998.274.1.L39; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	58	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131236	10.1371/journal.pone.0131236	http://dx.doi.org/10.1371/journal.pone.0131236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135595	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400039
J	Molatlhegi, RP; Phulukdaree, A; Anand, K; Gengan, RM; Tiloke, C; Chuturgoon, AA				Molatlhegi, Refilwe P.; Phulukdaree, Alisa; Anand, Krishnan; Gengan, Robert M.; Tiloke, Charlette; Chuturgoon, Anil A.			Cytotoxic Effect of a Novel Synthesized Carbazole Compound on A549 Lung Cancer Cell Line	PLOS ONE			English	Article							OXIDATIVE STRESS; APOPTOSIS	Increased death rates due to lung cancer have necessitated the search for potential novel anticancer compounds such as carbazole derivatives. Carbazoles are aromatic heterocyclic compounds with anticancer, antibacterial and anti-inflammatory activity. The study investigated the ability of the novel carbazole compound (Z)-4-[9-ethyl-9aH-carbazol-3-yl) amino] pent-3-en-2-one (ECAP) to induce cytotoxicity of lung cancer cells and its mechanism of action. ECAP was synthesized as a yellow powder with melting point of 240-247 degrees C. The 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), lipid peroxidation and comet assays were used to assess the cytotoxic effect of the compound on A549 lung cancer cells. Protein expression was determined using western blots, apoptosis was measured by luminometry (caspase-3/7, -8 and -9) assay and flow cytometry was used to measure phosphatidylserine (PS) externalisation. ECAP induced a p53 mediated apoptosis of lung cancer cells due to a significant reduction in the expression of antioxidant defence proteins (Nrf2 and SOD), Hsp70 (p < 0.02) and Bcl-2 (p < 0.0006), thereby up-regulating reactive oxygen species (ROS) production. This resulted in DNA damage (p < 0.0001), upregulation of Bax expression and caspase activity and induction of apoptosis in lung cancer cells. The results show the anticancer potential of ECAP on lung cancer.	[Molatlhegi, Refilwe P.; Tiloke, Charlette; Chuturgoon, Anil A.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Discipline Med Biochem, Durban, South Africa; [Phulukdaree, Alisa] Univ Pretoria, Sch Med, Dept Physiol, ZA-0002 Pretoria, South Africa; [Anand, Krishnan; Gengan, Robert M.] Durban Univ Technol, Fac Sci Appl, Dept Chem, Durban, South Africa	University of Kwazulu Natal; University of Pretoria; Durban University of Technology	Chuturgoon, AA (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Discipline Med Biochem, Durban, South Africa.	chutur@ukzn.ac.za	Anand, K/AAC-8390-2020; Tiloke, Charlette/ABE-8725-2020; Chuturgoon, Anil/AAE-5068-2021	Anand, K/0000-0002-8886-8482; 	College of Health Sciences, University of KwaZulu-Natal	College of Health Sciences, University of KwaZulu-Natal	RM acknowledges College of Health Sciences, University of KwaZulu-Natal for funding this project.	Bai L, 2006, J CANC MOL, V2, P141; Bello B, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-667, 10.1186/1471-2458-11-209]; Crespo-Ortiz M.P, 2012, BIOMED RES INT, V2011; Ed DN, FACT SHEET LUNG CANC, P1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Govender R, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-5; Guo SP, 2009, BIOORGAN MED CHEM, V17, P7126, DOI 10.1016/j.bmc.2009.08.061; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kouznetsov VV, 2012, LETT DRUG DES DISCOV, V9, P680; Laronze M, 2005, BIOORGAN MED CHEM, V13, P2263, DOI 10.1016/j.bmc.2004.12.045; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu ZJ, 2007, TETRAHEDRON, V63, P347, DOI 10.1016/j.tet.2006.10.071; Mandal C, 2012, 2 WORLD C CANC SCI T; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MOHAN S, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/689865; Nandy B. C., 2014, Journal of Biomedical and Pharmaceutical Research, V3, P42; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Petri S, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878030; Renschler MF, 2004, EUR J CANCER, V40, P1934, DOI 10.1016/j.ejca.2004.02.031; Roy MK, 2005, BRIT J PHARMACOL, V145, P145, DOI 10.1038/sj.bjp.0706137; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Tiloke C, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-226; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033772; Wang MR, 2012, EXP DIABETES RES, DOI 10.1155/2012/647914; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Whitacre CM, 1999, CLIN CANCER RES, V5, P665	28	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0129874	10.1371/journal.pone.0129874	http://dx.doi.org/10.1371/journal.pone.0129874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134408	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400011
J	Najafi, S; Potestio, R				Najafi, Saeed; Potestio, Raffaello			Two Adhesive Sites Can Enhance the Knotting Probability of DNA	PLOS ONE			English	Article							RING POLYMERS; DYNAMICS SIMULATION; PROTEIN-STRUCTURE; KNOTS; TOPOISOMERASES; TOPOLOGY; KNOTTEDNESS; SEQUENCE; CAPSIDS	Self-entanglement, or knotting, is entropically favored in long polymers. Relatively short polymers such as proteins can knot as well, but in this case the entanglement is mainly driven by fine-tuned, sequence-specific interactions. The relation between the sequence of a long polymer and its topological state is here investigated by means of a coarse-grained model of DNA. We demonstrate that the introduction of two adhesive regions along the sequence of a self-avoiding chain substantially increases the probability of forming a knot.	[Najafi, Saeed; Potestio, Raffaello] Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society	Potestio, R (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.	potestio@mpip-mainz.mpg.de	Najafi, Saeed Kazemi/M-8948-2019; Potestio, Raffaello/H-6457-2013	Najafi, Saeed Kazemi/0000-0003-4434-0018; Potestio, Raffaello/0000-0001-6408-9380				Arsuaga J, 2005, P NATL ACAD SCI USA, V102, P9165, DOI 10.1073/pnas.0409323102; Arsuaga J, 2002, P NATL ACAD SCI USA, V99, P5373, DOI 10.1073/pnas.032095099; Baiesi M, 2014, MACROMOLECULES, V47, P8466, DOI 10.1021/ma5020287; Beccara SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003002; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Coluzza I, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075501; Coluzza I, 2013, SOFT MATTER, V9, P938, DOI 10.1039/c2sm26967h; Courant R, 1998, INTRO CALCULUS ANAL, V1; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Delbr?ck M., 1962, MATH PROBLEMS BIOL S, V14, P55, DOI 10.1090/psapm/014/9958; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Halverson JD, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3587138; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Hoste J., 1999, THISTLETHWAITE; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Jamroz M, 2015, NUCLEIC ACIDS RES, V43, pD306, DOI 10.1093/nar/gku1059; Khatib F, 2006, BIOINFORMATICS, V22, pE252, DOI 10.1093/bioinformatics/btl236; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Marenduzzo D, 2009, P NATL ACAD SCI USA, V106, P22269, DOI [10.1073/pnas.0907524106, 10.1073/pnas.0907S24106]; Micheletti C, 2008, BIOPHYS J, V95, P3591, DOI [10.1529/biophysj.108.137653, 10.1529/biophysj.l08.137653]; Micheletti C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162886; Micheletti C, 2015, P NATL ACAD SCI USA, V112, P2052, DOI 10.1073/pnas.1418445112; Micheletti C, 2014, ACS MACRO LETT, V3, P876, DOI 10.1021/mz500402s; Micheletti C, 2011, PHYS REP, V504, P1, DOI 10.1016/j.physrep.2011.03.003; MICHELS JPJ, 1986, P ROY SOC LOND A MAT, V403, P269, DOI 10.1098/rspa.1986.0012; Orlandini E, 2007, REV MOD PHYS, V79, P611, DOI 10.1103/RevModPhys.79.611; Podtelezhnikov AA, 1999, P NATL ACAD SCI USA, V96, P12974, DOI 10.1073/pnas.96.23.12974; Poier P, 2014, MACROMOLECULES, V47, P3394, DOI 10.1021/ma5006414; Potestio R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000864; Reith D, 2012, NUCLEIC ACIDS RES, V40, P5129, DOI 10.1093/nar/gks157; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; RYBENKOV VV, 1993, P NATL ACAD SCI USA, V90, P5307, DOI 10.1073/pnas.90.11.5307; Sacca B, 2012, ANGEW CHEM INT EDIT, V51, P58, DOI 10.1002/anie.201105846; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; SUMNERS DW, 1988, J PHYS A-MATH GEN, V21, P1689, DOI 10.1088/0305-4470/21/7/030; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Tubiana L, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052602; Tubiana L, 2011, PROG THEOR PHYS SUPP, P192; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Virnau P, 2013, BIOCHEM SOC T, V41, P528, DOI 10.1042/BST20120357; Vologodskii A, 2006, BIOPHYS J, V90, P1594, DOI 10.1529/biophysj.105.074682; Vologodskii A. V., 1974, SOVIET J EXP THEOR P, V39, P1059; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; Wust T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.028102	60	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132132	10.1371/journal.pone.0132132	http://dx.doi.org/10.1371/journal.pone.0132132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136125	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400102
J	Qin, DJ; Tang, CX; Yang, L; Lei, H; Wei, W; Wang, YY; Ma, CM; Gao, FH; Xu, HZ; Wu, YL				Qin, Dong-Jun; Tang, Cai-Xia; Yang, Li; Lei, Hu; Wei, Wei; Wang, Ying-Ying; Ma, Chun-Min; Gao, Feng-Hou; Xu, Han-Zhang; Wu, Ying-Li			Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer Cells	PLOS ONE			English	Article							SHOCK-PROTEIN 90; TRITERPENOID CDDO; SYNTHETIC TRITERPENOIDS; BARDOXOLONE METHYL; APOPTOSIS; EXPRESSION; PREVENTION; ESTER	Synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9(11)-dien-28-oate (CDDO-Me) has been shown as a promising agent against ovarian cancer. However, the underlying mechanism is not well understood. Here, we demonstrate that CDDO-Me directly interacts with Hsp90 in cells by cellular thermal shift assay. CDDO-Me treatment leads to upregulation of Hsp70 and degradation of Hsp90 clients (ErbB2 and Akt), indicating the inhibition of Hsp90 by CDDO-Me in cells. Knockdown of Hsp90 significantly inhibits cell proliferation and enhances the anti-proliferation effect of CDDO-Me in H08910 ovarian cancer cells. Dithiothreitol inhibits the interaction of CDDO-Me with Hsp90 in cells and abrogates CDDOMe induced upregulation of Hsp70, degradation of Akt and cell proliferation inhibition. This suggests the anti-ovarian cancer effect of CDDO-Me is possibly mediated by the formation of Michael adducts between CDDO-Me and reactive nucleophiles on Hsp90. This study identifies Hsp90 as a novel target protein of CDDO-Me, and provides a novel insight into the mechanism of action of CDDO-Me in ovarian cancer cells.	[Qin, Dong-Jun; Tang, Cai-Xia; Yang, Li; Lei, Hu; Wei, Wei; Wang, Ying-Ying; Ma, Chun-Min; Xu, Han-Zhang; Wu, Ying-Li] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp,Chinese Minist Educ, Fac Basic Med,Key Lab Cell Differentiat & Apoptos, Sch Med,Hongqiao Int Inst Med,Chem Biol Div Shang, Shanghai 200030, Peoples R China; [Gao, Feng-Hou] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Inst Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, HZ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Tongren Hosp,Chinese Minist Educ, Fac Basic Med,Key Lab Cell Differentiat & Apoptos, Sch Med,Hongqiao Int Inst Med,Chem Biol Div Shang, Shanghai 200030, Peoples R China.	smollyxu@126.com; wuyingli@shsmu.edu.cn	Lei, Hu/AAR-7795-2021; Wei, Weijun/AAZ-3551-2021	Lei, Hu/0000-0003-3288-5205; 	National Basic Research Program of China (973 Program) [2015CB910403, 2013CB910903]; National Natural Science Foundation of China [91313303, 31100980, 81272886]; Science and Technology Committee of Shanghai [11JC1406500, 13431900501, 13ZR1456900]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee)	National Basic Research Program of China (973 Program) (NO. 2015CB910403, 2013CB910903), National Natural Science Foundation of China (91313303, 31100980, 81272886), Science and Technology Committee of Shanghai (11JC1406500, 13431900501, 13ZR1456900).	Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Cheng JC, 2013, BIOCHEM BIOPH RES CO, V434, P81, DOI 10.1016/j.bbrc.2013.03.062; Chu SH, 2013, MOL BIOL REP, V40, P1, DOI 10.1007/s11033-012-1930-3; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Deeb D, 2013, MOLECULES, V18, P3250, DOI 10.3390/molecules18033250; Deeb D, 2012, BIOCHEM BIOPH RES CO, V422, P561, DOI 10.1016/j.bbrc.2012.05.024; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P681, DOI 10.1007/s00280-008-0785-8; Elstrand MB, 2012, HUM PATHOL, V43, P529, DOI 10.1016/j.humpath.2011.05.022; Gao XH, 2011, ANTICANCER RES, V31, P3673; Gritsina G, 2015, MOL CANCER THER, V14, P1035, DOI 10.1158/1535-7163.MCT-14-0800; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Hyer ML, 2008, CANCER RES, V68, P2927, DOI 10.1158/0008-5472.CAN-07-5759; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jiao YS, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-125; Kim EH, 2012, CANCER PREV RES, V5, P89, DOI 10.1158/1940-6207.CAPR-11-0359; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liu HQ, 2013, CLIN CANCER RES, V19, P5053, DOI 10.1158/1078-0432.CCR-13-1115; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Shanmugam MK, 2014, CANCER LETT, V346, P206, DOI 10.1016/j.canlet.2014.01.016; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang YY, 2014, DRUG DES DEV THER, V8, P2075, DOI 10.2147/DDDT.S68872; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; Wang Y, 2015, FUTURE MED CHEM, V7, P87, DOI [10.4155/FMC.14.154, 10.4155/fmc.14.154]; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	33	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132337	10.1371/journal.pone.0132337	http://dx.doi.org/10.1371/journal.pone.0132337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134508	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400112
J	Wei, L; Surma, M; Gough, G; Shi, S; Lambert-Cheatham, N; Chang, J; Shi, JJ				Wei, Lei; Surma, Michelle; Gough, Gina; Shi, Stephanie; Lambert-Cheatham, Nathan; Chang, Jiang; Shi, Jianjian			Dissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; PROGENITOR-CELL FUNCTION; BINDING PROTEIN RHO; INDUCED APOPTOSIS; INDUCED CARDIOMYOPATHY; HYDROGEN-PEROXIDE; N-ACETYLCYSTEINE; REACTIVE OXYGEN; LIM-KINASE	We have recently reported that ROCK1 deficiency in mouse embryonic fibroblasts (MEF) has superior anti-apoptotic and pro-survival effects than antioxidants against doxorubicin, a chemotherapeutic drug. Although oxidative stress is the most widely accepted mechanism, our studies suggest that ROCK1-dependent actin cytoskeleton remodeling plays a more important role in mediating doxorubicin cytotoxicity on MEFs. To further explore the contributions of ROCK1-dependent actin cytoskeleton remodeling in response to stress, this study investigates the mechanistic differences between the cytotoxic effects of doxorubicin versus hydrogen peroxide (H2O2), with a focus on cytoskeleton alterations, apoptosis and necrosis induction. We found that both types of stress induce caspase activation but with different temporal patterns and magnitudes in MEFs: H2O2 induces the maximal levels (2 to 4-fold) of activation of caspases 3, 8, and 9 within 4 h, while doxorubicin induces much higher maximal levels (15 to 25-fold) of caspases activation at later time points (16-24 h). In addition, necrosis induced by H2O2 reaches maximal levels within 4 h while doxorubicin-induced necrosis largely occurs at 16-24 h secondary to apoptosis. Moreover, both types of stress induce actin cytoskeleton remodeling but with different characteristics: H2O2 induces disruption of stress fibers associated with cytosolic translocation of phosphorylated myosin light chain (p-MLC) from stress fibers, while doxorubicin induces cortical F-actin formation associated with cortical translocation of p-MLC from central stress fibers. Furthermore, N-acetylcysteine (an antioxidant) is a potent suppressor for H2O2-induced cytotoxic effects including caspase activation, necrosis, and cell detachment, but shows a much reduced inhibition on doxorubicin-induced changes. On the other hand, ROCK1 deficiency is a more potent suppressor for the cytotoxic effects induced by doxorubicin than by H2O2. These results support the notion that doxorubicin induces caspase activation, necrosis, and actin cytoskeleton alterations largely through ROCK1-dependent and oxidative stress-independent pathways.	[Wei, Lei; Surma, Michelle; Gough, Gina; Shi, Stephanie; Lambert-Cheatham, Nathan; Shi, Jianjian] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, Indianapolis, IN 46202 USA; [Chang, Jiang] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	Indiana University System; Indiana University-Purdue University Indianapolis; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Wei, L (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, Indianapolis, IN 46202 USA.	lewei@iu.edu; jishi@iu.edu		Lambert-Cheatham, Nathan/0000-0002-9587-715X	National Institutes of Health [HL107537]; American Heart Association, Midwest Affiliate [12GRNT12060525]; Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Midwest Affiliate(American Heart Association); Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (HL107537), a Grant-in-Aid award from American Heart Association, Midwest Affiliate (12GRNT12060525), and by the Riley Children's Foundation.	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Childs AC, 2002, CANCER RES, V62, P4592; COLOMBO R, 1990, CANCER BIOCHEM BIOPH, V11, P217; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; Feng ZQ, 2010, COLLOID SURFACE B, V75, P67, DOI 10.1016/j.colsurfb.2009.08.010; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lindsey ML, 2014, AM J PHYSIOL-HEART C, V307, pH1379, DOI 10.1152/ajpheart.00099.2014; Lipshultz SE, 2013, NAT REV CLIN ONCOL, V10, P697, DOI 10.1038/nrclinonc.2013.195; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Millea PJ, 2009, AM FAM PHYSICIAN, V80, P265; Moon C, 2010, AM J RESP CRIT CARE, V181, P374, DOI 10.1164/rccm.200907-1061OC; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; RAJAGOPALAN S, 1988, CANCER RES, V48, P4766; Ranek MJ, 2009, CURR HYPERTENS REP, V11, P389, DOI 10.1007/s11906-009-0068-8; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Shi JJ, 2013, CELL CYCLE, V12, P1492, DOI 10.4161/cc.24699; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi J, 2011, CURR PEDIATR REV, V7, P329, DOI 10.2174/157339611796892265; Shi JJ, 2012, AM J PHYSIOL-HEART C, V302, pH1603, DOI 10.1152/ajpheart.00844.2011; Simunek T, 2009, PHARMACOL REP, V61, P154; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Surma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090758; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; van Dalen EC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub4; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhu WQ, 2008, PEDIATR RES, V64, P488, DOI 10.1203/PDR.0b013e318184d732; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	45	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131763	10.1371/journal.pone.0131763	http://dx.doi.org/10.1371/journal.pone.0131763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134406	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400071
J	Beloti, VH; Alves, GR; Araujo, DFD; Picoli, MM; Moral, RD; Demetrio, CGB; Yamamoto, PT				Beloti, Vitor Hugo; Alves, Gustavo Rodrigues; Dias Araujo, Diogo Feliciano; Picoli, Mateus Manara; Moral, Rafael de Andrade; Borges Demetrio, Clarice Garcia; Yamamoto, Pedro Takao			Lethal and Sublethal Effects of Insecticides Used on Citrus, on the Ectoparasitoid Tamarixia radiata	PLOS ONE			English	Article							SAO-PAULO STATE; EGG PARASITOIDS; HYMENOPTERA; PESTICIDES; SELECTIVITY; TOXICITY; TRICHOGRAMMATIDAE; EULOPHIDAE; MANAGEMENT; PSYLLIDAE	Huanglongbing (HLB) is a disease associated with the bacteria "Candidatus Liberibacter spp." and has been devastating citrus orchards around the world. Its management involves control of the insect vector, the Asian citrus psyllid Diaphorina citri Kuwayama. However, the indiscriminate use of chemicals has caused pest outbreaks and eliminated the natural enemies of the vector, such as the parasitoid Tamarixia radiata (Waterston), the main agent for biological control of D. citri. This study assessed the lethal and sublethal effects of insecticides recommended for integrated production of citrus on the parasitoid T. radiata. When adult parasitoids were exposed to residues of 25 insecticides, 20% of them, i.e., gamma-cyhalothrin, etofenprox, azadirachtin, tebufenozide and pyriproxyfen, were considered as harmless (Class 1), 12% as slightly harmful (Class 2), 12% as moderately harmful (Class 3) and 56% as harmful (Class 4), according to the classification proposed by the IOBC/WPRS. Afterward, 14 insecticides (5 harmless and 9 harmful) were sprayed on the parasitoid pupae. Of the 14 insecticides tested, only the organophosphates dimethoate and chlorpyrifos affected the parasitoid emergence. The effects of insecticides on the parasitism capacity of adults exposed to residues of azadirachtin, etofenprox, gamma-cyhalothrin, pyriproxyfen and tebufenozide (harmless) were also evaluated. Tebufenozide and gamma-cyhalothrin affected the parasitism of the F-0 generation, but did not affect the emergence of the F-1 and F-2 generations. Therefore, for an effective IPM program, selective insecticides or harmful pesticides to adult parasitoids could be used in the field, provided that the adults do not occur naturally and the chemical applications do not coincide with parasitoid releases.	[Beloti, Vitor Hugo; Alves, Gustavo Rodrigues; Picoli, Mateus Manara; Yamamoto, Pedro Takao] Univ Sao Paulo ESALQ USP, Dept Entomol & Acarol, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil; [Dias Araujo, Diogo Feliciano] Univ Sao Paulo FFCLRP USP, Dept Biol, Fac Philosophy Sci & Letters Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Moral, Rafael de Andrade; Borges Demetrio, Clarice Garcia] Univ Sao Paulo ESALQ USP, Dept Agr Stat & Experimentat, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Beloti, VH (corresponding author), Univ Sao Paulo ESALQ USP, Dept Entomol & Acarol, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil.	vitorbeloti@usp.br	de Andrade Moral, Rafael/M-3184-2016; Alves, Gustavo Rodrigues/AAO-6633-2021; Yamamoto, Pedro/R-9785-2019; Demétrio, Clarice Garcia Borges/M-7892-2019; Yamamoto, Pedro Takao/C-5069-2012; Demétrio, Clarice G.B./I-5263-2012	de Andrade Moral, Rafael/0000-0002-0875-3563; Yamamoto, Pedro/0000-0001-8993-371X; Demétrio, Clarice Garcia Borges/0000-0002-3609-178X; Yamamoto, Pedro Takao/0000-0001-8993-371X; Demétrio, Clarice G.B./0000-0002-3609-178X; Alves, Gustavo Rodrigues/0000-0003-1150-8275	CAPES Foundation (Brazilian Ministry of Education); Sao Paulo State Foundation for Research Aid (FAPESP); "Luiz de Queiroz" College of Agriculture/University of Sao Paulo (ESALQ/USP)	CAPES Foundation (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo State Foundation for Research Aid (FAPESP); "Luiz de Queiroz" College of Agriculture/University of Sao Paulo (ESALQ/USP)	Funding provided by the CAPES Foundation (Brazilian Ministry of Education); Sao Paulo State Foundation for Research Aid (FAPESP); "Luiz de Queiroz" College of Agriculture/University of Sao Paulo (ESALQ/USP).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; [Anonymous], 2005, P 2 INT CITR CANK HL; AUBERT B, 1987, FRUITS, V42, P149; Bacci L, 2007, PEST MANAG SCI, V63, P699, DOI 10.1002/ps.1393; Bacci L, 2009, CIENC AGROTEC, V33, P2045, DOI 10.1590/S1413-70542009000700058; Belasque J, 2010, J PLANT PATHOL, V92, P285; Biondi A, 2015, CHEMOSPHERE, V128, P142, DOI 10.1016/j.chemosphere.2015.01.034; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Brunner JF, 2001, J ECON ENTOMOL, V94, P1075, DOI 10.1603/0022-0493-94.5.1075; Carmo EL, 2010, BIOCONTROL, V55, P455, DOI 10.1007/s10526-010-9269-y; Carvalho GA, 2010, REV COLOMB ENTOMOL, V36, P195; Chen XF, 2013, J ECON ENTOMOL, V106, P136, DOI [10.1603/EC12158, 10.1093/jee/106.1.136]; CHIEN CC, 1995, P S RES DEV CITR TAI, P245; Chu Y. I., 1991, Integrated control of plant virus diseases. Proceedings of the International Workshop TARI, Taichung, Taiwan, April 9-14, 1990., P135; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; Consoli FL, 2001, J APPL ENTOMOL, V125, P37, DOI 10.1046/j.1439-0418.2001.00513.x; Degrande PE, 2002, CONTROLE BIOL BRASIL, P71; Demetrio C.G., 2014, ECOL MODEL, P219, DOI DOI 10.1007/978-3-319-06877-0_9; DINIZ AJF, 2012, CITRICULTURA ATUAL, V87, P12; Giolo Fabrizio Pinheiro, 2007, Cienc. Rural, V37, P308, DOI 10.1590/S0103-84782007000200003; Gomez-Torres ML, 2012, J ECON ENTOMOL, V105, P338, DOI 10.1603/EC11280; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Goulart RM, 2012, PEST MANAG SCI, V68, P240, DOI 10.1002/ps.2251; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2010, BIOCONTROL, V55, P601, DOI 10.1007/s10526-010-9283-0; Haseeb M, 2004, BIOCONTROL, V49, P33, DOI 10.1023/B:BICO.0000009377.75941.d7; Mann RS, 2012, ASIAN CITRUS PSYLID; Martinez AM, 2015, ENVIRON ENTOMOL, V44, P3, DOI 10.1093/ee/nvu015; McCullagh P, 1989, GEN LINEAR MODELS; Moscardini VF, 2008, ACTA SCI-AGRON, V30, P177, DOI 10.4025/actasciagron.v30i2.1723; Moura A. P., 2006, BioControl, V51, P769, DOI 10.1007/s10526-006-0001-x; Nava DE, 2007, J APPL ENTOMOL, V131, P709, DOI 10.1111/j.1439-0418.2007.01230.x; Pratissoli D., 2003, Revista Brasileira de Milho e Sorgo, V2, P120; R Development Core Team, 2014, R LANG ENV STAT COMP; Ribeiro LD, 2014, EXP APPL ACAROL, V64, P87, DOI 10.1007/s10493-014-9810-2; Rodrigues J. C. V., 2002, Laranja, V23, P77; Rosa J.I.F, 2012, TAMARIXIA RADIATA; Shankarganesh K, 2013, NATL ACAD SCI LETT, V36, P581, DOI 10.1007/s40009-013-0172-9; Skelley LH, 2004, BIOL CONTROL, V29, P14, DOI 10.1016/S1049-9644(03)00129-4; Souza JR, 2013, CHIL J AGR RES, V73, P122, DOI 10.4067/S0718-58392013000200006; Suh CPC, 2000, J ECON ENTOMOL, V93, P577, DOI 10.1603/0022-0493-93.3.577; Sun Chao, 2008, Zhongguo Shuidao Kexue, V22, P93; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Van de Veire M, 2002, BIOCONTROL, V47, P101, DOI 10.1023/A:1014473023912; Wang De-Sen, 2010, Chinese Bulletin of Entomology, V47, P379; Yamamoto P. T., 2003, Laranja, V24, P353	48	35	36	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132128	10.1371/journal.pone.0132128	http://dx.doi.org/10.1371/journal.pone.0132128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132327	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358153000158
J	Poon, MW; He, J; Fang, XW; Zhang, Z; Wang, WX; Wang, JW; Qiu, FF; Tse, HF; Li, W; Liu, ZG; Lian, QZ				Poon, Ming-Wai; He, Jia; Fang, Xiaowei; Zhang, Zhao; Wang, Weixin; Wang, Junwen; Qiu, Fangfang; Tse, Hung-Fat; Li, Wei; Liu, Zuguo; Lian, Qizhou			Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming	PLOS ONE			English	Article							MOUSE SOMATIC-CELLS; STEM-CELLS; HUMAN FIBROBLASTS; DNA METHYLATION; GENERATION; INDUCTION	A variety of pluripotency reprogramming frequencies from different somatic cells has been observed, indicating cell origin is a critical contributor for efficiency of pluripotency reprogramming. Identifying the cell sources for efficient induced pluripotent stem cells (iPSCs) generation, and defining its advantages or disadvantages on reprogramming, is therefore important. Human ocular tissue-derived conjunctival epithelial cells (OECs) exhibited endogenous expression of reprogramming factors OCT4A (the specific OCT 4 isoform on pluripotency reprogramming) and SOX2. We therefore determined whether OECs could be used for high efficiency of iPSCs generation. We compared the endogenous expression levels of four pluripotency factors and the pluripotency reprograming efficiency of human OECs with that of ocular stromal cells (OSCs). Real-time PCR, microarray analysis, Western blotting and immunostaining assays were employed to compare OECiPSCs with OSCiPSCs on molecular bases of reprogramming efficiency and preferred lineage-differentiation potential. Using the traditional KMOS (KLF4, C-MYC, OCT4 and SOX2) reprogramming protocol, we confirmed that OECs, endogenously expressing reprogramming factors OCT4A and SOX2, yield very high efficiency of iPSCs generation (similar to 1.5%). Furthermore, higher efficiency of retinal pigmented epithelial differentiation (RPE cells) was observed in OECiPSCs compared to OSCiPSCs or skin fibroblast iMR90iPSCs. The findings in this study suggest that conjunctival-derived epithelial (OECs) cells can be easier converted to iPSCs than conjunctival-derived stromal cells (OSCs). This cell type may also have advantages in retinal pigmented epithelial differentiation.	[Poon, Ming-Wai; Fang, Xiaowei; Tse, Hung-Fat; Lian, Qizhou] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Poon, Ming-Wai; He, Jia; Zhang, Zhao; Lian, Qizhou] Univ Hong Kong, HKU Shenzhen Inst Res & Innovat, Hong Kong, Hong Kong, Peoples R China; [Poon, Ming-Wai; He, Jia; Fang, Xiaowei; Zhang, Zhao; Lian, Qizhou] Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Fang, Xiaowei; Qiu, Fangfang; Li, Wei; Liu, Zuguo] Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen 361005, Fujian, Peoples R China; [Wang, Weixin; Wang, Junwen] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Xiamen University; University of Hong Kong	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen 361005, Fujian, Peoples R China.	zuguoliu@xmu.edu.cn; qzlian@hku.hk	Wang, Junwen/D-3700-2011; Tse, Hung-Fat/C-4426-2009; Qiu, Fangfang/GLT-3181-2022; he, jiaju/GQZ-1108-2022; Lian, Qizhou/Y-1613-2019; Li, Wei/P-8985-2015; Qiu, Fangfang/GLT-3151-2022	Wang, Junwen/0000-0002-4432-4707; Tse, Hung-Fat/0000-0002-9578-7808; Qiu, Fangfang/0000-0002-3584-0275; Li, Wei/0000-0001-7458-2590; Qiu, Fangfang/0000-0002-3584-0275; Lian, Qizhou/0000-0001-8189-7160; Tse, Hung Fat/0000-0003-4665-7887	NSFC/RGC Joint Research Scheme [N_HKU 716/09]; National Natural Science Foundation of China [31270967, 30931160432]; University of Hong Kong [201111159183, 201109176184, 201309176129]; Chinese National Key Scientific Research Project [2013CB967003]	NSFC/RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong); Chinese National Key Scientific Research Project	This study was partly supported by grants from the NSFC/RGC Joint Research Scheme (N_HKU 716/09 to Q Lian), the National Natural Science Foundation of China (31270967 to Q Lian, NSFC-RGC No. 30931160432 to Z Liu), small project funding from The University of Hong Kong (201111159183 to Q Lian, 201109176184 & 201309176129 to MW Poon), and the Chinese National Key Scientific Research Project (2013CB967003 to W Li). We thank Prof. Xin-yuan Guan and Ms Na Jin for karyotyping supports. Thanks are also given to the State Key Laboratory of Pharmaceutical Biotechnology, the University of Hong Kong, Hong Kong SAR.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Harun MHN, 2013, HUM CELL, V26, P35, DOI 10.1007/s13577-011-0025-0; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Liu Shu-Ping, 2014, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V22, P580, DOI 10.7534/j.issn.1009-2137.2014.03.002; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Papini S, 2005, DIFFERENTIATION, V73, P61, DOI 10.1111/j.1432-0436.2005.07302006.x; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rasmussen MA, 2014, STEM CELL REP, V3, P404, DOI 10.1016/j.stemcr.2014.07.006; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Warthemann R, 2012, MOL HUM REPROD, V18, P605, DOI 10.1093/molehr/gas032; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang J, 2014, GRAEF ARCH CLIN EXP, V252, P423, DOI 10.1007/s00417-014-2575-9; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zanudin A, 2013, PEDIATR PHYS THER, V25, P30, DOI 10.1097/PEP.0b013e31827aa424; Zhou SY, 2010, CURR EYE RES, V35, P978, DOI 10.3109/02713683.2010.516465; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131288	10.1371/journal.pone.0131288	http://dx.doi.org/10.1371/journal.pone.0131288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131692	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000108
J	Suh, SS; Park, M; Hwang, J; Kil, EJ; Jung, SW; Lee, S; Lee, TK				Suh, Sung-Suk; Park, Mirye; Hwang, Jinik; Kil, Eui-Joon; Jung, Seung Won; Lee, Sukchan; Lee, Taek-Kyun			Seasonal Dynamics of Marine Microbial Community in the South Sea of Korea	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; NORTHERN GULF; DIVERSITY; BACTERIOPLANKTON; PROCHLOROCOCCUS; EUTROPHICATION; BIOGEOGRAPHY; TEMPERATURE; ECOSYSTEMS; SEQUENCES	High-resolution 16S rRNA tag pyrosequencing was used to obtain seasonal snapshots of the bacterial diversity and community structure at two locations in Gosung Bay (South Sea, Korea) over a one year period. Seasonal sampling from the water column at each site revealed highly diverse bacterial communities containing up to 900 estimated Operational Taxonomic Units (OTUs). The Alphaproteobacteria and Gammaproteobacteria were the most abundant groups, and the most frequently recorded OTUs were members of Pelagibacter and Glaciecola. In particular, it was observed that Arcobacter, a genus of the Epsilonproteobacteria, dominated during summer. In addition, Psedoalteromonadaceae, Vibrionaceae and SAR11-1 were predominant members of the OTUs found in all sampling seasons. Environmental factors significantly influenced the bacterial community structure among season, with the phosphate and nitrate concentrations contributing strongly to the spatial distribution of the Alphaproteobacteria; the Gammaproteobacteria, Flavobacteria, and Actinobacteria all showed marked negative correlations with all measured nutrients, particularly silicon dioxide and chlorophyll-a. The results suggest that seasonal changes in environmental variables contribute to the dynamic structure of the bacterial community in the study area.	[Suh, Sung-Suk; Park, Mirye; Hwang, Jinik; Jung, Seung Won; Lee, Taek-Kyun] Korea Inst Ocean Sci & Technol, South Sea Environm Res Dept, Geoje 656830, South Korea; [Park, Mirye; Hwang, Jinik; Lee, Taek-Kyun] Korea Univ Sci & Technol, Taejon 305350, South Korea; [Kil, Eui-Joon; Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon 440746, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Sungkyunkwan University (SKKU)	Lee, TK (corresponding author), Korea Inst Ocean Sci & Technol, South Sea Environm Res Dept, Geoje 656830, South Korea.	tklee@kiost.ac	Kil, Eui-Joon/AAZ-9823-2020; Jung, Seung Won/L-9467-2016	Jung, Seung Won/0000-0002-7473-7924; Kil, Eui-Joon/0000-0002-7256-3879	Korea Institute of Ocean Science Technology [PE99315]	Korea Institute of Ocean Science Technology	This research study was carried out within the coordinated research project No. PE99315 supported financially by the Korea Institute of Ocean Science & Technology.	Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; Campbell BJ, 2013, ISME J, V7, P210, DOI 10.1038/ismej.2012.93; Caron DA, 2009, BIOSCIENCE, V59, P287, DOI 10.1525/bio.2009.59.4.7; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chong CW, 2012, ANTARCT SCI, V24, P249, DOI 10.1017/S0954102012000028; Chow CET, 2013, ISME J, V7, P2259, DOI 10.1038/ismej.2013.122; Church M.J., 2008, MICROB ECOL OCEAN, P335, DOI DOI 10.1002/9780470281840.CH10; Emami K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038515; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Ghiglione JF, 2012, ENVIRON MICROBIOL, V14, P617, DOI 10.1111/j.1462-2920.2011.02601.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Humphrey G, 1997, PHYTOPLANKTON PIGMEN, V10, P616; Johnson CN, 2010, APPL ENVIRON MICROB, V76, P7076, DOI 10.1128/AEM.00697-10; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kim M, 2014, J APPL MICROBIOL, V117, P699, DOI 10.1111/jam.12572; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lehtoranta J, 2009, AMBIO, V38, P303, DOI 10.1579/09-A-656.1; Lindstrom ES, 2001, MICROBIAL ECOL, V42, P598, DOI 10.1007/s00248-001-0031-y; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; NEDWELL DB, 1994, APPL ENVIRON MICROB, V60, P1984, DOI 10.1128/AEM.60.6.1984-1992.1994; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Suh SS, 2014, J MICROBIOL, V52, P834, DOI 10.1007/s12275-014-4287-6; Tinta T, 2015, ENVIRON MICROBIOL, V17, P3581, DOI 10.1111/1462-2920.12519; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yang CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08476; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3	43	42	43	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131633	10.1371/journal.pone.0131633	http://dx.doi.org/10.1371/journal.pone.0131633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121668	Green Submitted, gold, Green Published			2022-12-26	WOS:000358150400132
J	Chen, K; Li, EC; Li, TY; Xu, C; Wang, XD; Lin, HZ; Qin, JG; Chen, LQ				Chen, Ke; Li, Erchao; Li, Tongyu; Xu, Chang; Wang, Xiaodan; Lin, Heizhao; Qin, Jian G.; Chen, Liqiao			Transcriptome and Molecular Pathway Analysis of the Hepatopancreas in the Pacific White Shrimp Litopenaeus vannamei under Chronic Low-Salinity Stress	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CHINESE MITTEN CRAB; RNA-SEQ DATA; GLUTAMATE-DEHYDROGENASE; ERIOCHEIR-SINENSIS; PENAEUS-VANNAMEI; LIPID-METABOLISM; ACID-METABOLISM; NA+/K+-ATPASE; ION-TRANSPORT	The Pacific white shrimp Litopenaeus vannamei is a euryhaline penaeid species that shows ontogenetic adaptations to salinity, with its larvae inhabiting oceanic environments and postlarvae and juveniles inhabiting estuaries and lagoons. Ontogenetic adaptations to salinity manifest in L. vannamei through strong hyper-osmoregulatory and hypo-osmoregulatory patterns and an ability to tolerate extremely low salinity levels. To understand this adaptive mechanism to salinity stress, RNA-seq was used to compare the transcriptomic response of L. vannamei to changes in salinity from 30 (control) to 3 practical salinity units (psu) for 8 weeks. In total, 26,034 genes were obtained from the hepatopancreas tissue of L. vannamei using the Illumina HiSeq 2000 system, and 855 genes showed significant changes in expression under salinity stress. Eighteen top Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were significantly involved in physiological responses, particularly in lipid metabolism, including fatty-acid biosynthesis, arachidonic acid metabolism and glycosphingolipid and glycosaminoglycan metabolism. Lipids or fatty acids can reduce osmotic stress in L. vannamei by providing additional energy or changing the membrane structure to allow osmoregulation in relevant organs, such as the gills. Steroid hormone biosynthesis and the phosphonate and phosphinate metabolism pathways were also involved in the adaptation of L. vannamei to low salinity, and the differential expression patterns of 20 randomly selected genes were validated by quantitative real-time PCR (qPCR). This study is the first report on the long-term adaptive transcriptomic response of L. vannamei to low salinity, and the results will further our understanding of the mechanisms underlying osmoregulation in euryhaline crustaceans.	[Chen, Ke; Li, Erchao; Li, Tongyu; Xu, Chang; Wang, Xiaodan; Chen, Liqiao] E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200062, Peoples R China; [Lin, Heizhao] Shenzhen Base South China Sea Fisheries Res Inst, Shenzhen, Peoples R China; [Qin, Jian G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	East China Normal University; Flinders University South Australia	Li, EC (corresponding author), E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200062, Peoples R China.	ecli@bio.ecnu.edu.cn; lqchen@bio.ecnu.edu.cn	Wang, Xiaodan/AAH-1305-2021; Li, Tongyu/GQA-7514-2022	Chen, Liqiao/0000-0003-0138-7828; LI, Erchao/0000-0001-8495-2241; Qin, Jianguang/0000-0003-2448-8058	National Natural Science Foundation of China [31472291, 31172422]; Special Fund for Agro-scientific Research in the Public Interest [201003020, 201203065]; National 'Twelfth Five-Year' Plan for Science AMP; Technology Support [2012BAD25B03]; National Basic Research Program (973Program) [2014CB138803]; Shanghai University Knowledge Service Platform Shanghai Ocean University aquatic animal breeding center [ZF1206]; E-Institute of Shanghai Municipal Education Commission [E03009]; ECNU innovation fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National 'Twelfth Five-Year' Plan for Science AMP; Technology Support; National Basic Research Program (973Program)(National Basic Research Program of China); Shanghai University Knowledge Service Platform Shanghai Ocean University aquatic animal breeding center; E-Institute of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); ECNU innovation fund	This research was supported by grants from the National Natural Science Foundation of China (No. 31472291, 31172422), the Special Fund for Agro-scientific Research in the Public Interest (No. 201003020, 201203065), National 'Twelfth Five-Year' Plan for Science & Technology Support (2012BAD25B03), the National Basic Research Program (973Program, No. 2014CB138803), Shanghai University Knowledge Service Platform Shanghai Ocean University aquatic animal breeding center (ZF1206), and partly by the E-Institute of Shanghai Municipal Education Commission (No. E03009) and ECNU innovation fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BECKMAN B, 1992, FISH PHYSIOL BIOCHEM, V10, P213, DOI 10.1007/BF00004515; Bhoite S, 2013, MAR FRESHW BEHAV PHY, V46, P287, DOI 10.1080/10236244.2013.832525; Birukawa N, 2005, ZOOL SCI, V22, P1245, DOI 10.2108/zsj.22.1245; BLUM K, 2012, GOOGLE PATENTS; Buckle LF, 2006, REV BIOL TROP, V54, P745; Capdevila JH, 2000, J LIPID RES, V41, P163; CASTILLE FL, 1981, PHYSIOLOGY, V68, P75; Charmantier G, 2001, AM ZOOL, V41, P1078, DOI 10.1668/0003-1569(2001)041[1078:OOOICT]2.0.CO;2; Charmantier Guy, 2009, P165; Chen K, 2014, J SHELLFISH RES, V33, P825, DOI 10.2983/035.033.0317; Chu YJ, 2012, NUCLEIC ACID THER, V22, P271, DOI 10.1089/nat.2012.0367; Clavero-Salas A, 2007, FISH SHELLFISH IMMUN, V23, P459, DOI 10.1016/j.fsi.2007.01.010; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis D.A., 2002, AVANCES NUTR ACUICOL, P3; Deering MJ, 1997, AQUACULTURE, V151, P131, DOI 10.1016/S0044-8486(96)01480-9; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; Diaz F, 2001, MAR FRESHW BEHAV PHY, V34, P93, DOI 10.1080/10236240109379062; FAO, 2004, AMERICA; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Frye C A, 2009, Minerva Ginecol, V61, P541; Gao WH, 2012, AQUACULTURE, V364, P186, DOI 10.1016/j.aquaculture.2012.08.024; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta BBP, 2002, CURR SCI INDIA, V83, P1103; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hurtado MA, 2007, COMP BIOCHEM PHYS A, V147, P703, DOI 10.1016/j.cbpa.2006.07.002; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Lago-Leston A, 2007, AQUACULTURE, V270, P343, DOI 10.1016/j.aquaculture.2007.04.014; Lemos D, 2001, J EXP MAR BIOL ECOL, V261, P55, DOI 10.1016/S0022-0981(01)00260-X; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Li EC, 2007, AQUACULTURE, V265, P385, DOI 10.1016/j.aquaculture.2007.02.018; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Li EC, 2011, CHIN J OCEANOL LIMN, V29, P343, DOI 10.1007/s00343-011-0093-8; Li EC, 2009, J CRUSTACEAN BIOL, V29, P379, DOI 10.1651/08-3104.1; Martins TG, 2006, AQUACULTURE, V252, P525, DOI 10.1016/j.aquaculture.2005.07.022; Palacios E, 2004, AQUACULTURE, V234, P497, DOI 10.1016/j.aquaculture.2003.12.001; Palacios E, 2004, J EXP MAR BIOL ECOL, V299, P201, DOI 10.1016/j.jembe.2003.09.007; Palstra AP, 2013, FISH SHELLFISH IMMUN, V8, DOI 10.1371/journal.pone.0053171; Pan LQ, 2007, AQUACULTURE, V273, P711, DOI 10.1016/j.aquaculture.2007.07.218; Pan LQ, 2014, J OCEAN U CHINA, V13, P453, DOI 10.1007/s11802-014-2013-y; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ponce-Palafox J, 1997, AQUACULTURE, V157, P107, DOI 10.1016/S0044-8486(97)00148-8; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Rainbow PS, 2001, J EXP MAR BIOL ECOL, V264, P1, DOI 10.1016/S0022-0981(01)00289-1; Ranallo RF, 1998, SPORTS MED, V26, P29, DOI 10.2165/00007256-199826010-00003; Robalino J, 2007, PHYSIOL GENOMICS, V29, P44, DOI 10.1152/physiolgenomics.00165.2006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romano N, 2012, AQUACULTURE, V334, P12, DOI 10.1016/j.aquaculture.2011.12.035; Sang HM, 2004, AQUACULTURE, V234, P601, DOI 10.1016/j.aquaculture.2004.01.008; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shinji J, 2012, FISHERIES SCI, V78, P833, DOI 10.1007/s12562-012-0514-4; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; SODERQUIST CA, 1994, GOOGLE PATENTS; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Tocher Douglas R., 1995, Biochemistry and Molecular Biology of Fishes, V4, P119; Trowbridge JM, 2002, J BIOL CHEM, V12, p117R; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Van Anholt RD, 2004, J EXP BIOL, V207, P3419, DOI 10.1242/jeb.01166; Wang YH, 2013, MOL BIOL REP, V40, P6213, DOI 10.1007/s11033-013-2733-x; Xia JH, 2013, DNA RES, V20, P449, DOI 10.1093/dnares/dst022; Xue SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076718	69	87	90	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131503	10.1371/journal.pone.0131503	http://dx.doi.org/10.1371/journal.pone.0131503			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147449	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600101
J	Parker, LM; O'Connor, WA; Raftos, DA; Portner, HO; Ross, PM				Parker, Laura M.; O'Connor, Wayne A.; Raftos, David A.; Poertner, Hans-Otto; Ross, Pauline M.			Persistence of Positive Carryover Effects in the Oyster, Saccostrea glomerata, following Transgenerational Exposure to Ocean Acidification	PLOS ONE			English	Article							ACID-BASE-BALANCE; LIFE-HISTORY; CARBON-DIOXIDE; CO2; IMPACT; GROWTH; EPIGENETICS; HYPERCAPNIA; SEAWATER; FERTILIZATION	Ocean acidification (OA) is predicted to have widespread implications for marine organisms, yet the capacity for species to acclimate or adapt over this century remains unknown. Recent transgenerational studies have shown that for some marine species, exposure of adults to OA can facilitate positive carryover effects to their larval and juvenile offspring that help them to survive in acidifying oceanic conditions. But whether these positive carryover effects can persist into adulthood or the next generation is unknown. Here we tested whether positive carryover effects found in larvae of the oyster, Saccostrea glomerata following transgenerational exposure to elevated CO2, could persist into adulthood and whether subsequent transgenerational exposure of adults to elevated CO2 would facilitate similar adaptive responses in the next generation of larvae and juveniles. Following our previous transgenerational exposure of parental adults and first generation (F1) larvae to ambient (385 mu atm) and elevated (856 mu atm) CO2, newly settled F1 juveniles were transferred to the field at ambient CO2 for 14 months, until they reached reproductive maturity. At this time, the F1 adults were returned to the laboratory and the previous transgenerational CO2 exposure was repeated to produce F2 offspring. We found that the capacity of adults to regulate extracellular pH at elevated CO2 was improved if they had a prior history of transgenerational exposure to elevated CO2. In addition, subsequent transgenerational exposure of these adults led to an increase in the resilience of their larval and juvenile offspring. Offspring with a history of transgenerational exposure to elevated CO2 had a lower percentage abnormality, faster development rate, faster shell growth and increased heart rate at elevated CO2 compared with F2 offspring with no prior history of exposure to elevated CO2. Our results suggest that positive carryover effects originating	[Parker, Laura M.; Ross, Pauline M.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW 2751, Australia; [O'Connor, Wayne A.] Port Stephens Fisheries Ctr, NSW Dept Primary Ind, Taylors Beach, NSW, Australia; [Raftos, David A.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Poertner, Hans-Otto] Hermann von Helmholtz Assoc Natl Res Ctr e V HGF, Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Western Sydney University; NSW Department of Primary Industries; Macquarie University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ross, PM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Hawkesbury K12,Locked Bag 1797, Sydney, NSW 2751, Australia.	pm.ross@uws.edu.au	Pörtner, Hans-O./K-9429-2016; /AAL-3738-2021; O'Connor, Wayne/AAL-8097-2020	Pörtner, Hans-O./0000-0001-6535-6575; Parker, Laura/0000-0003-3139-1844; Ross, Pauline/0000-0002-8714-5194; O'Connor, Wayne/0000-0002-0972-4668	Australian Research Council [DI100100158]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (http://www.arc.gov.au) Grant number: DI100100158 to LMP, PMR, WAO, DAR, HOP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Burton T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0311; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Crews D, 2010, HORM-INT J ENDOCRINO, V9, P41, DOI 10.14310/horm.2002.1251; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Foo SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042497; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; Hammer KM, 2011, MAR ENVIRON RES, V72, P135, DOI 10.1016/j.marenvres.2011.07.002; Hettinger A, 2013, BIOGEOSCI DISCUSS, V10, P5781, DOI [10.5194/bgd-10-5781-2013, DOI 10.5194/BGD-10-5781-2013]; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Ivanina AV, 2013, AQUAT TOXICOL, V140, P123, DOI 10.1016/j.aquatox.2013.05.019; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lischka S, 2010, BIOGEOSCIENCES, V7, P8177, DOI DOI 10.5194/BGD-7-8177-2010; Marchant HK, 2010, J MAR BIOL ASSOC UK, V90, P1379, DOI 10.1017/S0025315410000457; Matozzo V, 2013, MAR POLLUT BULL, V72, P34, DOI 10.1016/j.marpolbul.2013.05.004; McCarthy MM, 2008, FRONT NEUROENDOCRIN, V29, P341, DOI 10.1016/j.yfrne.2008.01.002; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miller GM, 2012, NAT CLIM CHANGE, V2, P858, DOI 10.1038/NCLIMATE1599; Moran AL, 2009, BIOL BULL-US, V216, P226, DOI 10.1086/BBLv216n3p226; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Munday PL, 2014, F1000 PRIME REPORTS, V6, DOI 10.12703/P6-99; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; O'Connor WA, 2008, NEW SOUTH WALES DEPA, V20; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pespeni MH, 2013, EVOLUTION, V67, P1901, DOI 10.1111/evo.12036; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; Pistevos JCA, 2011, OIKOS, V120, P675, DOI 10.1111/j.1600-0706.2010.19470.x; Podolsky RD, 2006, INTEGR COMP BIOL, V46, P577, DOI 10.1093/icb/icl026; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2000, J EXP BIOL, V203, P2417; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Range P, 2011, J EXP MAR BIOL ECOL, V396, P177, DOI 10.1016/j.jembe.2010.10.020; Riviere G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00129; Schade FM, 2014, MAR BIOL, V161, P1667, DOI 10.1007/s00227-014-2450-6; Schlegel P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053118; Shirayama Y, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002618; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Trenaman R, 2014, AQUACULTURE PRODUCTI; Underwood AJ, 1997, EXPERIMENTS IN ECOLO; Vandegehuchte MB, 2014, MUTAT RES-GEN TOX EN, V764, P36, DOI 10.1016/j.mrgentox.2013.08.008; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Videla JA, 1998, MAR BIOL, V132, P635, DOI 10.1007/s002270050428; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Welch MJ, 2014, NAT CLIM CHANGE, V4, P1086, DOI 10.1038/NCLIMATE2400; Wilson ME, 2013, INT J DEV NEUROSCI	70	116	116	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132276	10.1371/journal.pone.0132276	http://dx.doi.org/10.1371/journal.pone.0132276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147612	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600229
J	Rice, WL; Li, W; Mamuya, F; McKee, M; Paunescu, TG; Lu, HAJ				Rice, William L.; Li, Wei; Mamuya, Fahmy; McKee, Mary; Paunescu, Teodor G.; Lu, Hua A. Jenny			Polarized Trafficking of AQP2 Revealed in Three Dimensional Epithelial Culture	PLOS ONE			English	Article							AQUAPORIN-2 WATER CHANNEL; CANINE KIDNEY-CELLS; COLLECTING DUCT; PLASMA-MEMBRANE; RAT-KIDNEY; BRATTLEBORO RATS; APICAL MEMBRANE; MDCK CYSTS; PHOSPHORYLATION; VASOPRESSIN	In renal collecting duct (CD) principal cells (PCs), vasopressin (VP) acts through its receptor, V2R, to increase intracellular cAMP leading to phosphorylation and apical membrane accumulation of the water channel aquaporin 2 (AQP2). The trafficking and function of basolaterally located AQP2 is, however, poorly understood. Here we report the successful application of a 3-dimensional Madin-Darby canine kidney (MDCK) epithelial model to study polarized AQP2 trafficking. This model recapitulates the luminal architecture of the CD and bi-polarized distribution of AQP2 as seen in kidney. Without stimulation, AQP2 is located in the subapical and basolateral regions. Treatment with VP, forskolin (FK), or 8-(4-Chlorophenylthio)-20-O-methyladenosine 30,50-cyclic monophosphate monosodium hydrate (CPT-cAMP) leads to translocation of cytosolic AQP2 to the apical membrane, but not to the basolateral membrane. Treating cells with methyl-beta-cyclodextrin (m beta CD) to acutely block endocytosis causes accumulation of AQP2 on the basolateral membrane, but not on the apical membrane. Our data suggest that AQP2 may traffic differently at the apical and basolateral domains in this 3D epithelial model. In addition, application of a panel of phosphorylation specific AQP2 antibodies reveals the polarized, subcellular localization of differentially phosphorylated AQP2 at S256, S261, S264 and S269 in the 3D culture model, which is consistent with observations made in the CDs of VP treated animals, suggesting the preservation of phosphorylation dependent regulatory mechanism of AQP2 trafficking in this model. Therefore we have established a 3D culture model for the study of trafficking and regulation of both the apical and basolaterally targeted AQP2. The new model will enable further characterization of the complex mechanism regulating bi-polarized trafficking of AQP2 in vitro.	[Lu, Hua A. Jenny] Massachusetts Gen Hosp, Dept Med, Ctr Syst Biol, Program Membrane Biol,Div Nephrol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lu, HAJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Syst Biol, Program Membrane Biol,Div Nephrol, Boston, MA 02114 USA.	Halu@partners.org	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Paunescu, Teodor/AAX-7533-2020	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Paunescu, Teodor/0000-0003-0227-9028	National Institutes of Health [NIH 5T32 DK007540-24]; NIH [R01 DK096015, R01 DK38452, R01 DK096586]; Gottschalk research grant from the American Society of Nephrology (ASN); Nephcure Foundation grant; Boston Area Diabetes and Endocrinology Research Center [NIH DK-57521]; Center for the Study of Inflammatory Bowel Disease [NIH DK-43351]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452, P30DK043351, R01DK096586, T32DK007540, P30DK057521, R01DK096015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gottschalk research grant from the American Society of Nephrology (ASN); Nephcure Foundation grant; Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WL Rice is supported by an National Institutes of Health training grant (NIH 5T32 DK007540-24). HAJ Lu is supported by an NIH R01 DK096015 and a Gottschalk research grant from the American Society of Nephrology (ASN) and the Nephcure Foundation grant. Additional material support was from NIH grant R01 DK38452 (D. Brown) and R01 DK096586 (D. Brown). The Microscopy Core Facility of the Program in Membrane Biology receives additional support from the Boston Area Diabetes and Endocrinology Research Center (NIH DK-57521) and from the Center for the Study of Inflammatory Bowel Disease (NIH DK-43351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi F, 2012, J NEPHROL, V25, P473, DOI 10.5301/jn.5000060; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bouley R, 2011, J AM SOC NEPHROL, V22, P59, DOI 10.1681/ASN.2009121267; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Chen Y, 2012, J AM SOC NEPHROL, V23, P1506, DOI 10.1681/ASN.2012010079; Christensen BM, 2003, AM J PHYSIOL-RENAL, V284, pF701, DOI 10.1152/ajprenal.00234.2002; Coleman RA, 2000, AM J PHYSIOL-RENAL, V279, pF874, DOI 10.1152/ajprenal.2000.279.5.F874; de Seigneux S, 2007, AM J PHYSIOL-RENAL, V293, pF87, DOI 10.1152/ajprenal.00431.2006; Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493; Deen PMT, 2002, AM J PHYSIOL-RENAL, V282, pF330, DOI 10.1152/ajprenal.0168.2001; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Gade Wayne, 2006, Clin Lab Sci, V19, P80; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Jeon US, 2003, NEPHRON EXP NEPHROL, V93, pE36, DOI 10.1159/000066651; KATSURA T, 1995, P NATL ACAD SCI USA, V92, P7212, DOI 10.1073/pnas.92.16.7212; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Li W, 2011, AM J PHYSIOL-RENAL, V301, pF309, DOI 10.1152/ajprenal.00001.2011; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Cano-Penalver JL, 2014, FASEB J, V28, P3645, DOI 10.1096/fj.13-249250; MANGOOKARIM R, 1989, P NATL ACAD SCI USA, V86, P6007, DOI 10.1073/pnas.86.15.6007; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Paunescu TG, 2013, AM J PHYSIOL-RENAL, V305, pF1783, DOI 10.1152/ajprenal.00622.2012; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Tamma G, 2011, AM J PHYSIOL-CELL PH, V300, pC636, DOI 10.1152/ajpcell.00433.2009; van Balkom BWM, 2003, J BIOL CHEM, V278, P1101, DOI 10.1074/jbc.M207339200; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; van Beest M, 2006, BBA-BIOMEMBRANES, V1758, P1126, DOI 10.1016/j.bbamem.2006.03.007; WANG AZ, 1990, J CELL SCI, V95, P137; WANG AZ, 1990, J CELL SCI, V95, P153; Xie LK, 2010, AM J PHYSIOL-RENAL, V298, pF1018, DOI 10.1152/ajprenal.00580.2009; YAMAMOTO T, 1995, AM J PHYSIOL-CELL PH, V268, pC1546, DOI 10.1152/ajpcell.1995.268.6.C1546; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yui N, 2013, AM J PHYSIOL-CELL PH, V304, pC38, DOI 10.1152/ajpcell.00109.2012; Yui N, 2009, AM J PHYSIOL-CELL PH, V297, pC1389, DOI 10.1152/ajpcell.00098.2009	48	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131719	10.1371/journal.pone.0131719	http://dx.doi.org/10.1371/journal.pone.0131719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147297	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000358157600135
J	Lewitus, E; Huttner, WB				Lewitus, Eric; Huttner, Wieland B.			Neurodevelopmental LincRNA Microsyteny Conservation and Mammalian Brain Size Evolution	PLOS ONE			English	Article							LONG NONCODING RNAS; CEREBRAL CORTICAL DEVELOPMENT; OUTER SUBVENTRICULAR ZONE; MOLECULAR EVOLUTION; POSITIVE SELECTION; NEOCORTEX; EXPRESSION; PRIMATE; MECHANISMS; DIVERSITY	The mammalian neocortex has undergone repeated selection for increases and decreases in size and complexity, often over relatively short evolutionary time. But because probing developmental mechanisms across many species is experimentally unfeasible, it is unknown whether convergent morphologies in distantly related species are regulated by conserved developmental programs. In this work, we have taken advantage of the abundance of available mammalian genomes to find evidence of selection on genomic regions putatively regulating neurogenesis in large-versus small-brained species. Using published fetal human RNA-seq data, we show that the gene-neighborhood (i.e., microsynteny) of long intergenic non-coding RNAs (lincRNAs) implicated in cortical development is differentially conserved in large-brained species, lending support to the hypothesis that lincRNAs regulating neurogenesis are selectively lost in small-brained species. We provide evidence that this is not a phenomenon attributable to lincRNA expressed in all tissue types and is therefore likely to represent an adaptive function in the evolution of neurogenesis. A strong correlation between transcription factor-adjacency and lincRNA sequence conservation reinforces this conclusion.	[Lewitus, Eric; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Lewitus, E (corresponding author), Ecole Normale Super, Inst Biol IBENS, 46 Rue Ulm, F-75005 Paris, France.	lewitus@biologie.ens.fr; huttner@mpi-cbg.de	Huttner, Wieland B./P-4080-2018		DFG [SFB 655, A2]; ERC [250197]; DFG-funded Center for Regenerative Therapies Dresden; Fonds der Chemischen Industrie; Max Planck Gesellschaft	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); DFG-funded Center for Regenerative Therapies Dresden(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Max Planck Gesellschaft(Max Planck Society)	W.B.H. was supported by grants from the DFG (SFB 655, A2) and the ERC (250197), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie. EL was supported by the Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2008, MOL BIOL EVOL, V25, P2247, DOI 10.1093/molbev/msn184; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basu S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S14; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Bininda-Emonds ORP, 2007, EVOL BIOINFORM, V3, P59; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Boddy AM, 2012, J EVOLUTION BIOL, V25, P981, DOI 10.1111/j.1420-9101.2012.02491.x; Borrell V, 2014, NEUROSCI RES, V86, P14, DOI 10.1016/j.neures.2014.04.004; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Douzery EJP, 2014, MOL BIOL EVOL, V31, P1923, DOI 10.1093/molbev/msu132; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00345; Fedrigo O, 2011, BRAIN BEHAV EVOLUT, V78, P315, DOI 10.1159/000329852; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Grafen A., 1989, BIOL SCI, V326, P119, DOI DOI 10.1098/RSTB.1989.0106; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hubisz MJ, 2014, CURR OPIN GENET DEV, V29, P15, DOI 10.1016/j.gde.2014.07.005; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Kalinka AT, 2012, TRENDS ECOL EVOL, V27, P385, DOI 10.1016/j.tree.2012.03.007; Kamm GB, 2013, MOL BIOL EVOL, V30, P1088, DOI 10.1093/molbev/mst023; Kapusta A, 2014, TRENDS GENET, V30, P439, DOI 10.1016/j.tig.2014.08.004; Kelava I, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00016; Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Kostka D, 2010, GENOME BIOL EVOL, V2, P518, DOI 10.1093/gbe/evq037; Krubitzer L, 2005, CURR OPIN NEUROBIOL, V15, P444, DOI 10.1016/j.conb.2005.07.003; Lewitus E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002000; Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424; Lewitus E, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00002; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9; Molnar Z, 2011, BRAIN BEHAV EVOLUT, V78, P94, DOI 10.1159/000327325; Montgomery SH, 2012, EVOLUTION, V66, P927, DOI 10.1111/j.1558-5646.2011.01487.x; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Somel M, 2014, CURR OPIN GENET DEV, V29, P110, DOI 10.1016/j.gde.2014.09.001; Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Washietl S, 2014, GENOME RES, V24, P616, DOI 10.1101/gr.165035.113; Xu SX, 2012, P ROY SOC B-BIOL SCI, V279, P4433, DOI 10.1098/rspb.2012.1729	48	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131818	10.1371/journal.pone.0131818	http://dx.doi.org/10.1371/journal.pone.0131818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134977	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400075
J	Moulton, VR; Gillooly, AR; Perl, MA; Markopoulou, A; Tsokos, GC				Moulton, Vaishali R.; Gillooly, Andrew R.; Perl, Marcel A.; Markopoulou, Anastasia; Tsokos, George C.			Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3 zeta in Human T Cells	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECEPTOR ZETA-CHAIN; TCR-ZETA; SR PROTEINS; 3'-UNTRANSLATED REGION; MESSENGER-RNA; CD3 COMPLEX; EXPRESSION; PROMOTER; PHOSPHORYLATION	T lymphocytes from many patients with systemic lupus erythematosus (SLE) express decreased levels of the T cell receptor (TCR)-associated CD3 zeta (zeta) signaling chain, a feature directly linked to their abnormal phenotype and function. Reduced mRNA expression partly due to defective alternative splicing, contributes to the reduced expression of CD3 zeta chain. We previously identified by oligonucleotide pulldown and mass spectrometry approaches, the serine arginine-rich splicing factor 1 (SRSF1) binding to the 3'untranslated region (UTR) of CD3 zeta mRNA. We showed that SRSF1 regulates alternative splicing of the 3'UTR of CD3 zeta to promote expression of the normal full length 3'UTR over an unstable splice variant in human T cells. In this study we show that SRSF1 regulates transcriptional activation of CD3 zeta. Specifically, overexpression and silencing of SRSF1 respectively increases and decreases CD3 zeta total mRNA and protein expression in Jurkat and primary T cells. Using promoter-luciferase assays, we show that SRSF1 enhances transcriptional activity of the CD3 zeta promoter in a dose dependent manner. Chromatin immunoprecipitation assays show that SRSF1 is recruited to the CD3 zeta promoter. These results indicate that SRSF1 contributes to transcriptional activation of CD3 zeta. Thus our study identifies a novel mechanism whereby SRSF1 regulates CD3 zeta expression in human T cells and may contribute to the T cell defect in SLE.	[Moulton, Vaishali R.; Gillooly, Andrew R.; Perl, Marcel A.; Markopoulou, Anastasia; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Moulton, VR (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol,Dept Med, Boston, MA 02215 USA.	vmoulton@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360; Gillooly, Andrew/0000-0002-5798-4763	National Institutes of Health [AR060781, AI42269]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was funded by the National Institutes of Health (www.nih.gov) grants AR060781 to VM, and AI42269 to GT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brundula V, 1999, ARTHRITIS RHEUM-US, V42, P1908, DOI 10.1002/1529-0131(199909)42:9<1908::AID-ANR17>3.0.CO;2-7; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chowdhury B, 2005, J BIOL CHEM, V280, P18959, DOI 10.1074/jbc.M501048200; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Juang YT, 2002, J IMMUNOL, V169, P6048, DOI 10.4049/jimmunol.169.10.6048; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Krishnan S, 2005, J IMMUNOL, V175, P3417, DOI 10.4049/jimmunol.175.5.3417; Krishnan S, 2003, J IMMUNOL, V171, P3325, DOI 10.4049/jimmunol.171.7.3325; Lemaire R, 1999, EUR J IMMUNOL, V29, P823, DOI 10.1002/(SICI)1521-4141(199903)29:03<823::AID-IMMU823>3.0.CO;2-C; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Liossis SNC, 1998, J CLIN INVEST, V101, P1448, DOI 10.1172/JCI1457; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mo S, 2013, TRANSCRIPTION, V4; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Moulton VR, 2014, J BIOL CHEM, V289, P4126, DOI 10.1074/jbc.M113.518662; Moulton VR, 2013, P NATL ACAD SCI USA, V110, P1845, DOI 10.1073/pnas.1214207110; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Moulton VR, 2010, J BIOL CHEM, V285, P12490, DOI 10.1074/jbc.M109.091660; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; Nambiar MP, 2002, ARTHRITIS RHEUM-US, V46, P163, DOI 10.1002/1529-0131(200201)46:1<163::AID-ART10065>3.0.CO;2-J; Nambiar MP, 2001, J AUTOIMMUN, V16, P133, DOI 10.1006/jaut.2000.0475; Perl A, 2010, AUTOIMMUNITY, V43, P1, DOI 10.3109/08916930903374741; Rellahan BL, 1998, J IMMUNOL, V160, P2794; RELLAHAN BL, 1994, J EXP MED, V180, P1529, DOI 10.1084/jem.180.4.1529; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359	34	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131073	10.1371/journal.pone.0131073	http://dx.doi.org/10.1371/journal.pone.0131073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134847	gold, Green Submitted, Green Published			2022-12-26	WOS:000358154400034
J	Abdelfattah, A; Nicosia, MGL; Cacciola, SO; Droby, S; Schena, L				Abdelfattah, Ahmed; Nicosia, Maria Giulia Li Destri; Cacciola, Santa Olga; Droby, Samir; Schena, Leonardo			Metabarcoding Analysis of Fungal Diversity in the Phyllosphere and Carposphere of Olive (Olea europaea)	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; SWEET CHERRIES; MICROBIAL ECOLOGY; POSTHARVEST ROTS; DNA BARCODE; 1ST REPORT; SEARCH; GRAPES; REGION; GENUS	The fungal diversity associated with leaves, flowers and fruits of olive (Olea europaea) was investigated in different phenological stages (May, June, October and December) using an implemented metabarcoding approach. It consisted of the 454 pyrosequencing of the fungal ITS2 region and the subsequent phylogenetic analysis of relevant genera along with validated reference sequences. Most sequences were identified up to the species level or were associated with a restricted number of related taxa enabling supported speculations regarding their biological role. Analyses revealed a rich fungal community with 195 different OTUs. Ascomycota was the dominating phyla representing 93.6% of the total number of detected sequences followed by unidentified fungi (3.6%) and Basidiomycota (2.8%). A higher level of diversity was revealed for leaves compared to flowers and fruits. Among plant pathogens the genus Colletotrichum represented by three species (C. godetiae syn. C. clavatum, C. acutatum s.s and C. karstii) was the most abundant on ripe fruits but it was also detected in other organs. Pseudocercospora cladosporioides was detected with a high frequency in all leaf samples and to a less extent in ripe fruits. A much lower relative frequency was revealed for Spilocaea oleagina and for other putative pathogens including Fusarium spp., Neofusicoccum spp., and Alternariaspp. Among non-pathogen taxa, Aureobasidium pullulans, the species complex of Cladosporium cladosporioides and Devriesia spp. were the most represented. This study highlights the existence of a complex fungal consortium including both phytopathogenic and potentially antagonistic microorganisms that can have a significant impact on olive productions.	[Abdelfattah, Ahmed; Nicosia, Maria Giulia Li Destri; Schena, Leonardo] Univ Med Reggio Calabria, Dipartimento Agr, I-89124 Reggio Di Calabria, Italy; [Cacciola, Santa Olga] Univ Catania, Dipartimento Gest Sistemi Agroalimentari & Ambien, I-95123 Catania, Italy; [Droby, Samir] Volcani Ctr, Dept Postharvest Sci ARO, IL-50250 Bet Dagan, Israel	Universita Mediterranea di Reggio Calabria; University of Catania; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Schena, L (corresponding author), Univ Med Reggio Calabria, Dipartimento Agr, I-89124 Reggio Di Calabria, Italy.	lschena@unirc.it	Li Destri Nicosia, Maria Giulia/AGG-0569-2022; Abdelfattah, Ahmed/P-1943-2015; Schena, Leonardo/A-7492-2018; , Santa Olga Cacciola/H-7416-2019	Abdelfattah, Ahmed/0000-0001-6090-7200; Schena, Leonardo/0000-0002-9737-2593; Li Destri Nicosia, Maria Giulia/0000-0001-5201-0057	LINFA - PON Ricerca e competitivita [PON03PE_00026_1]	LINFA - PON Ricerca e competitivita	This work was funded by grant LINFA (PON03PE_00026_1) - PON Ricerca e competitivita 2007-2013.	Agosteo GE, 2011, OLIVE DIS DISORDERS, V1, P143; Aleklett K, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0166; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS JH, 1994, CAN J MICROBIOL, V40, P6, DOI 10.1139/m94-002; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Bensch R, 2013, BIOL OPEN; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Cacciola SO, 2012, J PLANT PATHOL, V94, P29; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crous PW, 2013, STUD MYCOL, P37, DOI 10.3114/sim0005; Crous PW, 2009, STUD MYCOL, P17, DOI 10.3114/sim.2009.64.02; Crous PW, 2014, IMA FUNGUS, V5, P141, DOI 10.5598/imafungus.2014.05.01.14; Damm U, 2012, STUD MYCOL, P1, DOI 10.3114/sim0002; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; DESHPANDE MS, 1992, ENZYME MICROB TECH, V14, P514, DOI 10.1016/0141-0229(92)90122-5; Dugan FM, 2013, SCHLECHTENDALIA, V11, P1; Eberhardt U, 2010, NEW PHYTOL, V187, P266, DOI 10.1111/j.1469-8137.2010.03329.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frisullo S, 2011, OLIVE DIS DISORDERS, P291; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Grabowski M, 2007, FOLIA HORTICULTURAE, V19; Graniti A., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P457, DOI 10.1111/j.1365-2338.1993.tb01353.x; Ippolito A, 2005, POSTHARVEST BIOL TEC, V36, P245, DOI 10.1016/j.postharvbio.2005.02.007; Kim YK, 2014, PLANT DIS, V98, P424, DOI 10.1094/PDIS-07-13-0740-PDN; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Li WH, 2013, MYCOL PROG, V12, P733, DOI 10.1007/s11557-012-0885-z; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mechaber WL, 1996, P NATL ACAD SCI USA, V93, P4600, DOI 10.1073/pnas.93.10.4600; Merget B, 2012, JOVE-J VIS EXP, DOI 10.3791/3806; Moral J, 2008, PLANT DIS, V92, P1421, DOI 10.1094/PDIS-92-10-1421; Moral J, 2009, PHYTOPATHOLOGY, V99, P548, DOI 10.1094/PHYTO-99-5-0548; Morgan DP, 2004, PLANT DIS, V88, P1047, DOI 10.1094/PDIS.2004.88.9.1047C; Mosca S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114031; Nelson S, 2008, SOOTY MOLD; Nigro F, 2011, OLIVE DIS DISORDERS, P247; Nigro F, 2002, 4 INT S OL GROW, P586; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Oliveros JC, 2007, AN INTERACTIVE TOOL; Orgiazzi A., 2013, Diversity, V5, P73; Ottesen AR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-114; Pappas A. C., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P405, DOI 10.1111/j.1365-2338.1993.tb01344.x; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ruano-Rosa D, 2007, PLANT PATHOL, V56, P251, DOI 10.1111/j.1365-3059.2006.01546.x; Schena L, 2003, POSTHARVEST BIOL TEC, V30, P209, DOI 10.1016/S0925-5214(03)00111-X; Schena L, 2011, OLIVE DIS DISORDERS; Schoch CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau061; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2004, CAN J BOT, V82, P914, DOI [10.1139/B04-070, 10.1139/b04-070]; Sharma K. R., 1976, Microbiology of aerial plant surfaces., P375; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Talhinhas P, 2011, PLANT PATHOL, V60, P483, DOI 10.1111/j.1365-3059.2010.02397.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tashiro N, 2013, J GEN PLANT PATHOL, V79, P158, DOI 10.1007/s10327-013-0430-1; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0; Wang XN, 2013, J AGR FOOD CHEM, V61, P4551, DOI 10.1021/jf400212y; Watanabe M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-322; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Wijayawardene NN, 2014, FUNGAL DIVERS, V69, P1, DOI 10.1007/s13225-014-0309-2; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02	70	82	83	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131069	10.1371/journal.pone.0131069	http://dx.doi.org/10.1371/journal.pone.0131069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132745	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000091
J	Fricker, T; Elsner, JB				Fricker, Tyler; Elsner, James B.			Kinetic Energy of Tornadoes in the United States	PLOS ONE			English	Article							INTENSITY; WIDTH	Tornadoes can cause catastrophic destruction. Here total kinetic energy (TKE) as a metric of destruction is computed from the fraction of the tornado path experiencing various damage levels and a characteristic wind speed for each level. The fraction of the path is obtained from a model developed for the Nuclear Regulatory Commission that combines theory with empirical data. TKE is validated as a useful metric by comparing it to other indexes and loss indicators. Half of all tornadoes have TKE exceeding 62.1 GJ and a quarter have TKE exceeding 383.2 GJ. One percent of the tornadoes have TKE exceeding 31.9 TJ. April has more energy than May with fewer tornadoes; March has more energy than June with half as many tornadoes. September has the least energy but November and December have the fewest tornadoes. Alabama ranks number one in terms of tornado energy with 2.48 PJ over the period 2007-2013. TKE can be used to help better understand the changing nature of tornado activity.	[Fricker, Tyler; Elsner, James B.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Elsner, JB (corresponding author), Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA.	jelsner@fsu.edu		Elsner, James/0000-0001-6805-7431; Fricker, Tyler/0000-0002-8186-7399				Agee E, 2014, J APPL METEOROL CLIM, V53, P1494, DOI 10.1175/JAMC-D-13-0235.1; Brooks HE, 2004, WEATHER FORECAST, V19, P310, DOI 10.1175/1520-0434(2004)019<0310:OTROTP>2.0.CO;2; Diffenbaugh NS, 2013, P NATL ACAD SCI USA, V110, P16361, DOI 10.1073/pnas.1307758110; Dixon PG, 2011, B AM METEOROL SOC, V92, P433, DOI 10.1175/2010BAMS3102.1; Doswell CA, 2009, ATMOS RES, V93, P554, DOI 10.1016/j.atmosres.2008.11.003; Edwards R, 2013, B AM METEOROL SOC, V94, P641, DOI 10.1175/BAMS-D-11-00006.1; Elsner JB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024018; Elsner JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107571; Fricker T, 2014, GEOPHYS RES LETT, V41, P4340, DOI 10.1002/2014GL060441; Fujita T, 1973, 8 C SEV LOC STORMS D, P142; FUJITA TT, 1981, J ATMOS SCI, V38, P1511, DOI 10.1175/1520-0469(1981)038<1511:TADITC>2.0.CO;2; Grazulis T. P., 1990, SIGNIFICANT TORNADOE; Kuligowski ED, 2011, NCSTAR3 NIST; Ramsdell Jr J. V., 2007, NUREGCR4461 PAC NW N; Rupinski P., 2011, TUSCALOOSA NEWS  MAY; Schielicke L, 2009, ATMOS RES, V93, P11, DOI 10.1016/j.atmosres.2008.09.021; Thompson R. L., 1998, 19 C SEV LOC STORMS; Wurman J, 2005, MON WEATHER REV, V133, P97, DOI 10.1175/MWR-2856.1	18	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131090	10.1371/journal.pone.0131090	http://dx.doi.org/10.1371/journal.pone.0131090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132830	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000092
J	Hennecke, S; Beck, J; Bornemann-Kolatzki, K; Neumann, S; Escobar, HM; Nolte, I; Hammer, SC; Hewicker-Trautwein, M; Junginger, J; Kaup, FJ; Brenig, B; Schutz, E				Hennecke, Silvia; Beck, Julia; Bornemann-Kolatzki, Kirsten; Neumann, Stephan; Escobar, Hugo Murua; Nolte, Ingo; Hammer, Susanne Conradine; Hewicker-Trautwein, Marion; Junginger, Johannes; Kaup, Franz-Josef; Brenig, Bertram; Schuetz, Ekkehard			Prevalence of the Prefoldin Subunit 5 Gene Deletion in Canine Mammary Tumors	PLOS ONE			English	Article							C-MYC; BREAST-CANCER; MM-1; CANDIDATES; PROTEIN	Background A somatic deletion at the proximal end of canine chromosome 27 (CFA27) was recently reported in 50% of malignant mammary tumors. This region harbours the tumor suppressor gene prefoldin subunit 5 (PFDN5) and the deletion correlated with a higher Ki-67 score. PFDN5 has been described to repress c-MYC and is, therefore, a candidate tumor-suppressor and cancer-driver gene in canine mammary cancer. Aim of this study was to confirm the recurrent deletion in a larger number of tumors. Methods Droplet digital PCR for PFDN5 was performed in DNA from 102 malignant, 40 benign mammary tumors/dysplasias, 11 non-neoplastic mammary tissues and each corresponding genomic DNA from leukocytes. The copy number of PFDN5 was normalized to a reference amplicon on canine chromosome 32 (CFA32). Z-scores were calculated, based on Gaussian distributed normalized PFDN5 copy numbers of the leukocyte DNA. Z-scores <= -3.0 in tissue were considered as being indicative of the PFDN5 deletion and called as such. The Ki-67 proliferation index was assessed in a subset of 79 tissue samples by immunohistochemistry. Results The deletion was confirmed in 24% of all malignant tumors, detected in only 7.5% of the benign tumors and was not present in any normal mammary tissue sample. The subgroup of solid carcinomas (n = 9) showed the highest frequency of the deletion (67%) and those malignomas without microscopical high fraction of benign tissue (n = 71) had a 32% frequency (p < 0.01 vs. benign samples). The Ki-67 score was found to be significantly higher (p<0.05) in the PFDN5-deleted group compared to malignant tumors without the deletion. Conclusions A somatic deletion of the PFDN5 gene is recurrently present in canine mammary cancer, supporting a potential role in carcinogenesis. The association of this deletion with higher Ki-67 indicates an increased proliferation rate and thus a link to tumor aggressiveness can be hypothesized. The confirmation of earlier results warrants further studies on PFDN5 as cancer-driver gene.	[Hennecke, Silvia; Neumann, Stephan; Brenig, Bertram; Schuetz, Ekkehard] Georg August Univ Goettingen, Inst Vet Med, Gottingen, Germany; [Beck, Julia; Bornemann-Kolatzki, Kirsten; Schuetz, Ekkehard] Chronix Biomed, Gottingen, Germany; [Escobar, Hugo Murua; Nolte, Ingo; Hammer, Susanne Conradine] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Hewicker-Trautwein, Marion; Junginger, Johannes] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Kaup, Franz-Josef] German Primate Ctr, Gottingen, Germany; [Escobar, Hugo Murua; Hammer, Susanne Conradine] Univ Rostock, Clin 3, Hematol Oncol & Palliat Med, D-18055 Rostock, Germany	University of Gottingen; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Deutsches Primatenzentrum (DPZ); University of Rostock	Beck, J (corresponding author), Chronix Biomed, Gottingen, Germany.	jbeck@chronixbiomedical.de		Junginger, Johannes/0000-0002-4965-4553; Brenig, Bertram/0000-0002-7635-9656	Chronix Biomedical; Institute of Veterinary Medicine of the University of Gottingen	Chronix Biomedical; Institute of Veterinary Medicine of the University of Gottingen	The study was funded by Chronix Biomedical and the Institute of Veterinary Medicine of the University of Gottingen. Study design, data collection and analysis, decision to publish and preparation of the manuscript was conducted by employees of these institutions. Authors JB, KBK, and ES are employed by the commercial company Chronix Biomedical GmbH. Chronix Biomedical provided support in the form of salaries for authors JB, KBK, and ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Beck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075485; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; GERDES J, 1991, AM J PATHOL, V138, P867; Guimaraes GS, 2006, GENE CHROMOSOME CANC, V45, P540, DOI 10.1002/gcc.20316; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Hahn KA, 2002, CANC DOGS CATS MED S, P49; Howarth KD, 2011, GENOME RES, V21, P525, DOI 10.1101/gr.114116.110; Junginger J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-23; Kimura Y, 2007, INT J ONCOL, V31, P829; Klopfleisch R, 2011, VET PATHOL, V48, P98, DOI 10.1177/0300985810390826; Liu DL, 2014, CANCER RES, V74, P5045, DOI 10.1158/0008-5472.CAN-14-0392; Millan-Zambrano G, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140085; Misdorp RWE W., 1999, HISTOLOGICAL CLASSIF; Misdorp W, 2002, TUMORS MAMMARY GLAND; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Queiroga FL, 2011, IN VIVO, V25, P455; Reis EM, 2005, CANCER RES, V65, P1693, DOI 10.1158/0008-5472.CAN-04-3506; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schummer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009122; Sleeckx N, 2011, REPROD DOMEST ANIM, V46, P1112, DOI 10.1111/j.1439-0531.2011.01816.x; Sorenmo KU, 2011, VET PATHOL, V48, P85, DOI 10.1177/0300985810389480; Sorenmo KU, 2009, VET COMP ONCOL, V7, P162, DOI 10.1111/j.1476-5829.2009.00184.x; Stratmann N, 2008, VET SURG, V37, P82, DOI 10.1111/j.1532-950X.2007.00351.x; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131280	10.1371/journal.pone.0131280	http://dx.doi.org/10.1371/journal.pone.0131280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132936	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000106
J	Maurer, JJ; Martin, G; Hernandez, S; Cheng, Y; Gerner-Smidt, P; Hise, KB; D'Angelo, MT; Cole, D; Sanchez, S; Madden, M; Valeika, S; Presotto, A; Lipp, EK				Maurer, John J.; Martin, Gordon; Hernandez, Sonia; Cheng, Ying; Gerner-Smidt, Peter; Hise, Kelley B.; D'Angelo, Melissa Tobin; Cole, Dana; Sanchez, Susan; Madden, Marguerite; Valeika, Steven; Presotto, Andrea; Lipp, Erin K.			Diversity and Persistence of Salmonella enterica Strains in Rural Landscapes in the Southeastern United States	PLOS ONE			English	Article							GEL-ELECTROPHORESIS PROTOCOLS; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; GENETIC RELATEDNESS; MULTISTATE OUTBREAK; SURFACE-WATER; DAIRY-CATTLE; RISK-FACTORS; INFECTIONS; POULTRY	Salmonellosis cases in the in the United States show distinct geographical trends, with the southeast reporting among the highest rates of illness. In the state of Georgia, USA, non-outbreak associated salmonellosis is especially high in the southern low-lying coastal plain. Here we examined the distribution of Salmonella enterica in environmental waters and associated wildlife in two distinct watersheds, one in the Atlantic Coastal Plain (a high case rate rural area) physiographic province and one in the Piedmont (a lower case rate rural area). Salmonella were isolated from the two regions and compared for serovar and strain diversity, as well as distribution, between the two study areas, using both a retrospective and prospective design. Thirty-seven unique serovars and 204 unique strain types were identified by pulsed-field gel electrophoresis (PFGE). Salmonella serovars Braenderup, Give, Hartford, and Muenchen were dominant in both watersheds. Two serovars, specifically S. Muenchen and S. Rubislaw, were consistently isolated from both systems, including water and small mammals. Conversely, 24 serovars tended to be site-specific (64.8%, n = 37). Compared to the other Salmonella serovars isolated from these sites, S. Muenchen and S. Rubislaw exhibited significant genetic diversity. Among a subset of PFGE patterns, approximately half of the environmental strain types matched entries in the USA PulseNet database of human cases. Ninety percent of S. Muenchen strains from the Little River basin (the high case rate area) matched PFGE entries in PulseNet compared to 33.33% of S. Muenchen strains from the North Oconee River region (the lower case rate area). Underlying the diversity and turnover of Salmonella strains observed for these two watersheds is the persistence of specific Salmonella serovars and strain types that may be adapted to these watersheds and landscapes.	[Maurer, John J.; Hernandez, Sonia; Cheng, Ying] Univ Georgia, Dept Populat Hlth, Athens, GA 30602 USA; [Martin, Gordon; Cole, Dana; Lipp, Erin K.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Hernandez, Sonia] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Gerner-Smidt, Peter; Hise, Kelley B.; Cole, Dana] Ctr Dis Control & Prevent, Atlanta, GA USA; [D'Angelo, Melissa Tobin] Georgia Dept Publ Hlth, Atlanta, GA USA; [Sanchez, Susan] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Madden, Marguerite; Presotto, Andrea] Univ Georgia, Dept Geog, Athens, GA 30602 USA; [Valeika, Steven] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lipp, EK (corresponding author), Univ Georgia, Dept Populat Hlth, Athens, GA 30602 USA.	elipp@uga.edu		Lipp, Erin/0000-0002-8066-0636	National Institutes of Health (National Institute of Allergy and Infectious Disease) [1R15AI089565-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089565] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Allergy and Infectious Disease)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 1R15AI089565-01 from the National Institutes of Health (National Institute of Allergy and Infectious Disease) to EKL, JJM, SH, SS, MM and SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulreesh HH, 2005, WATER RES, V39, P2877, DOI 10.1016/j.watres.2005.05.004; [Anonymous], 2013, NATL SALMONELLA SURV; [Anonymous], 2007, MMWR-MORBID MORTAL W, V56, P909; [Anonymous], [No title captured]; [Anonymous], 2009, SALMONELLA ANN SUMMA; [Anonymous], 2014, ATLAS SALMONELLA US; Ashbolt R, 2006, EPIDEMIOL INFECT, V134, P1257, DOI 10.1017/S0950268806006224; BAIRDPARKER AC, 1990, LANCET, V336, P1231, DOI 10.1016/0140-6736(90)92844-8; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; Benjamin L, 2013, INT J FOOD MICROBIOL, V165, P65, DOI 10.1016/j.ijfoodmicro.2013.04.003; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Borchardt MA, 2003, ENVIRON HEALTH PERSP, V111, P742, DOI 10.1289/ehp.5914; Brands DA, 2005, APPL ENVIRON MICROB, V71, P893, DOI 10.1128/AEM.71.2.893-897.2005; Callaway TR, 2005, J DAIRY SCI, V88, P3603, DOI 10.3168/jds.S0022-0302(05)73045-9; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P929; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1044; Centers for Disease Control and Prevention [CDC], 2013, NAT SALM SURV ANN RE; CHERRY WB, 1972, APPL MICROBIOL, V24, P334, DOI 10.1128/AEM.24.3.334-340.1972; Clarkson LS, 2010, EPIDEMIOL INFECT, V138, P340, DOI 10.1017/S0950268809990586; Compton JA, 2008, J CLIN MICROBIOL, V46, P3084, DOI 10.1128/JCM.00685-08; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Denno DM, 2009, J INFECT DIS, V199, P467, DOI 10.1086/596555; Dorea FC, 2010, APPL ENVIRON MICROB, V76, P7820, DOI 10.1128/AEM.01320-10; Edrington TS, 2004, MICROB DRUG RESIST, V10, P51, DOI 10.1089/107662904323047808; Federal Register, 1996, FED REG, V61, P38805; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; HAJNA AA, 1956, APPL MICROBIOL, V4, P341, DOI 10.1128/AEM.4.6.341-345.1956; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Handeland K, 2008, VET MICROBIOL, V132, P129, DOI 10.1016/j.vetmic.2008.05.002; Hedberg CW, 1999, EPIDEMIOL INFECT, V122, P385, DOI 10.1017/S0950268899002393; Heinitz ML, 2000, J FOOD PROTECT, V63, P579, DOI 10.4315/0362-028X-63.5.579; Hernandez E, 2012, EURO SURVEILL, V17; Hernandez SM, 2012, APPL ENVIRON MICROB, V78, P7290, DOI 10.1128/AEM.01408-12; Hudson CR, 2000, J CLIN MICROBIOL, V38, P1860, DOI 10.1128/JCM.38.5.1860-1865.2000; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Innocent GT, 2005, EPIDEMIOL INFECT, V133, P1033, DOI 10.1017/S0950268805003687; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; Jokinen C, 2011, WATER RES, V45, P1247, DOI 10.1016/j.watres.2010.10.001; Kistemann T, 2004, EPIDEMIOL INFECT, V132, P495, DOI 10.1017/S0950268803001729; Koort JMK, 2002, J CLIN MICROBIOL, V40, P3497, DOI 10.1128/JCM.40.9.3497-3498.2002; Li BG, 2014, APPL ENVIRON MICROB, V80, P6355, DOI 10.1128/AEM.02063-14; Liljebjelke KA, 2005, FOODBORNE PATHOG DIS, V2, P90, DOI 10.1089/fpd.2005.2.90; Lockhart JM, 2008, J WILDLIFE DIS, V44, P988, DOI 10.7589/0090-3558-44.4.988; Lynch Michael, 2006, Morbidity and Mortality Weekly Report, V55, P1; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meinersmann RJ, 2008, MICROB ECOL, V55, P444, DOI 10.1007/s00248-007-9290-6; Michel P, 1999, EPIDEMIOL INFECT, V122, P193, DOI 10.1017/S0950268899002083; Mohle-Boetani JC, 2009, EPIDEMIOL INFECT, V137, P357, DOI 10.1017/S0950268808000411; Nygard K, 2004, EPIDEMIOL INFECT, V132, P317, DOI 10.1017/S0950268803001900; Olsen SJ, 2001, J INFECT DIS, V183, P753, DOI 10.1086/318832; Pedroso AA, 2013, INT J ENV RES PUB HE, V10, P4534, DOI 10.3390/ijerph10104534; Proctor ME, 2001, J CLIN MICROBIOL, V39, P3461, DOI 10.1128/JCM.39.10.3461-3465.2001; Rajabi Masoumeh, 2011, Int J Microbiol, V2011, P461321, DOI 10.1155/2011/461321; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5595, DOI 10.1128/AEM.68.11.5595-5599.2002; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Safranek T., 2009, Morbidity and Mortality Weekly Report, V58, P500; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Smith KE, 2005, VECTOR-BORNE ZOONOT, V5, P133, DOI 10.1089/vbz.2005.5.133; STONE GG, 1994, J CLIN MICROBIOL, V32, P1742, DOI 10.1128/JCM.32.7.1742-1749.1994; Thomas JL, 2013, J APPL MICROBIOL, V114, P907, DOI 10.1111/jam.12079; Tyson A, 2012, U GEORGIA COPERATIVE, P1152; Uesugi AR, 2007, J FOOD PROTECT, V70, P1784, DOI 10.4315/0362-028X-70.8.1784; Vereen E, 2013, WATER RES, V47, P6075, DOI 10.1016/j.watres.2013.07.028; Vieira AR, 2009, AVIAN DIS, V53, P55, DOI 10.1637/8364-051608-Reg.1; Walters SP, 2013, APPL ENVIRON MICROB, V79, P4199, DOI 10.1128/AEM.00930-13; WALTMAN WD, 1991, AVIAN DIS, V35, P88, DOI 10.2307/1591299; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1; Zhao S, 2006, FOODBORNE PATHOG DIS, V3, P106, DOI 10.1089/fpd.2006.3.106; 2004, MMWR MORB MORTAL WKL, V53, P484	71	42	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128937	10.1371/journal.pone.0128937	http://dx.doi.org/10.1371/journal.pone.0128937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131552	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000023
J	Myint, K; Li, Y; Paxton, J; McKeage, M				Myint, Khine; Li, Yan; Paxton, James; McKeage, Mark			Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; COLORECTAL-CANCER PATIENTS; ROOT GANGLION NEURONS; ANTICANCER DRUGS; IN-VITRO; PLASMA ULTRAFILTRATE; LEUKOTRIENE C-4; CELLS; CISPLATIN; CARBOPLATIN	The platinum-based anticancer drug oxaliplatin is important clinically in cancer treatment. However, the role of multidrug resistance-associated protein 2 (MRP2) in controlling oxaliplatin membrane transport, in vivo handling, toxicity and therapeutic responses is unclear. In the current study, preparations of MRP2-expressing and control membrane vesicles, containing inside-out orientated vesicles, were used to directly characterise the membrane transport of oxaliplatin-derived platinum measured by inductively coupled plasma mass spectrometry. Oxaliplatin inhibited the ATP-dependent accumulation of the model MRP2 fluorescent probe, 5(6)-carboxy-2,' 7'-dichlorofluorescein, in MRP2-expressing membrane vesicles. MRP2-expressing membrane vesicles accumulated up to 19-fold more platinum during their incubation with oxaliplatin and ATP as compared to control membrane vesicles and in the absence of ATP. The rate of ATP-dependent MRP2-mediated active transport of oxaliplatin-derived platinum increased non-linearly with increasing oxaliplatin exposure concentration, approaching a plateau value (Vmax) of 2680 pmol Pt/mg protein/10 minutes (95% CI, 2010 to 3360 pmol Pt/mg protein/10 minutes), with the half-maximal platinum accumulation rate (Km) at an oxaliplatin exposure concentration of 301 mu M (95% CI, 163 to 438 mu M), in accordance with Michaelis-Menten kinetics (r(2) = 0.954). MRP2 inhibitors (myricetin and MK571) reduced the ATP-dependent accumulation of oxaliplatin-derived platinum in MRP2-expressing membrane vesicles in a concentration-dependent manner. To identify whether oxaliplatin, or perhaps a degradation product, was the likely substrate for this active transport, HPLC studies were undertaken showing that oxaliplatin degraded slowly in membrane vesicle incubation buffer containing chloride ions and glutathione, with approximately 95% remaining intact after a 10 minute incubation time and a degradation half-life of 2.24 hours (95% CI, 2.08 to 2.43 hours). In conclusion, MRP2 mediates the ATP-dependent active membrane transport of oxaliplatin-derived platinum. Intact oxaliplatin and its anionic monochloro oxalate ring-opened intermediate appear likely candidates as substrates for MRP2-mediated transport.	[Myint, Khine; Paxton, James; McKeage, Mark] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand; [Paxton, James; McKeage, Mark] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Li, Yan] Auckland Univ Technol, Sch Appl Sci, Auckland, New Zealand	University of Auckland; University of Auckland; Auckland University of Technology	McKeage, M (corresponding author), Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand.	m.mckeage@auckland.ac.nz		MCKEAGE, MARK/0000-0002-7329-5503; , Yan/0000-0001-6717-0838; Li, Yan/0000-0002-2781-2119; Paxton, James/0000-0002-2530-7047	New Zealand Aid Programme Scholarship; Cancer Society of New Zealand [10/23]; Health Research Council of New Zealand [12/254]	New Zealand Aid Programme Scholarship; Cancer Society of New Zealand; Health Research Council of New Zealand(Health Research Council of New Zealand)	Funding for this project was from a New Zealand Aid Programme Scholarship (KM) and grants from the Cancer Society of New Zealand (Project Grant 10/23) (MM) and Health Research Council of New Zealand (Project Grant 12/254) (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Beretta GL, 2010, BIOCHEM PHARMACOL, V79, P1108, DOI 10.1016/j.bcp.2009.12.002; Bible KC, 1999, ANAL BIOCHEM, V267, P217, DOI 10.1006/abio.1998.2980; Brouwers EEM, 2006, J MASS SPECTROM, V41, P1186, DOI 10.1002/jms.1087; Burger H, 2010, BRIT J PHARMACOL, V159, P898, DOI 10.1111/j.1476-5381.2009.00569.x; Cassidy J, 2004, J CLIN ONCOL, V22, P2084, DOI 10.1200/JCO.2004.11.069; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cui YH, 1999, MOL PHARMACOL, V55, P929; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Fakih S, 2003, EUR J INORG CHEM, P1206, DOI 10.1002/ejic.200390156; Gatti L, 2009, MINI-REV MED CHEM, V9, P1102, DOI 10.2174/138955709788922656; Glavinas H, 2008, EXPERT OPIN DRUG MET, V4, P721, DOI 10.1517/17425255.4.6.721 ; Haufroid V, 2011, CURR DRUG TARGETS, V12, P631, DOI 10.2174/138945011795378487; Heredi-Szabo K, 2008, J BIOMOL SCREEN, V13, P295, DOI 10.1177/1087057108316702; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Ip V, 2008, J ANAL ATOM SPECTROM, V23, P881, DOI 10.1039/b716925f; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Jerremalm E, 2006, EUR J PHARM SCI, V28, P278, DOI 10.1016/j.ejps.2006.03.001; Jerremalm E, 2004, PHARM RES, V21, P891, DOI 10.1023/B:PHAM.0000026444.67883.83; Jong NN, 2011, J PHARMACOL EXP THER, V338, P537, DOI 10.1124/jpet.111.181297; Kawabe T, 1999, FEBS LETT, V456, P327, DOI 10.1016/S0014-5793(99)00979-5; Koike K, 1997, CANCER RES, V57, P5475; Larson CA, 99 ANN M AM ASS FOR; Li SL, 2011, PHARM RES-DORDR, V28, P610, DOI 10.1007/s11095-010-0312-6; Liu JJ, 2013, BIOCHEM PHARMACOL, V85, P207, DOI 10.1016/j.bcp.2012.10.023; Liu JJ, 2012, CURR CANCER DRUG TAR, V12, P962; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Mirakhorli M, 2013, MOL MED REP, V7, P613, DOI 10.3892/mmr.2012.1226; Mohn C, 2013, PHARMAZIE, V68, P622, DOI 10.1691/ph.2013.6523; Munic V, 2011, EUR J PHARM SCI, V43, P359, DOI 10.1016/j.ejps.2011.05.003; PENDYALA L, 1993, CANCER RES, V53, P5970; Platts JA, 2001, J MED CHEM, V44, P472, DOI 10.1021/jm001080k; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Schutte ME, 2006, TOXICOL APPL PHARM, V217, P204, DOI 10.1016/j.taap.2006.08.005; Screnci D, 1998, ATOM SPECTROSC, V19, P172; Screnci D, 2000, BRIT J CANCER, V82, P966, DOI 10.1054/bjoc.1999.1026; Sprowl JA, 2013, P NATL ACAD SCI USA, V110, P11199, DOI 10.1073/pnas.1305321110; Stein A, 2012, EXPERT OPIN PHARMACO, V13, P125, DOI 10.1517/14656566.2012.643870; Taniguchi K, 1996, CANCER RES, V56, P4124; Theile D, 2009, BIOCHEM PHARMACOL, V78, P1366, DOI 10.1016/j.bcp.2009.07.006; van Zanden JJ, 2005, BIOCHEM PHARMACOL, V69, P1657, DOI 10.1016/j.bcp.2005.03.001; van Zanden JJ, 2005, BIOCHEM PHARMACOL, V69, P699, DOI 10.1016/j.bcp.2004.11.002; Vlaming MLH, 2006, J PHARMACOL EXP THER, V318, P319, DOI 10.1124/jpet.106.101774; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wongwanakul R, 2013, FITOTERAPIA, V89, P80, DOI 10.1016/j.fitote.2013.05.019; Yokoo S, 2008, DRUG METAB DISPOS, V36, P2299, DOI 10.1124/dmd.108.023168; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Zamek-Gliszczynski MJ, 2012, DRUG METAB DISPOS, V40, P1825, DOI 10.1124/dmd.112.046508; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769	51	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130727	10.1371/journal.pone.0130727	http://dx.doi.org/10.1371/journal.pone.0130727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131551	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000079
J	Reinson, T; Henno, L; Toots, M; Ustav, M; Ustav, M				Reinson, Tormi; Henno, Liisi; Toots, Mart; Ustav, Mart, Jr.; Ustav, Mart			The Cell Cycle Timing of Human Papillomavirus DNA Replication	PLOS ONE			English	Article							POLYMERASE ALPHA-PRIMASE; DAMAGE RESPONSE; E1 HELICASE; MAINTENANCE; PROTEINS; DYNAMICS; VECTORS; CENTERS; REPAIR	Viruses manipulate the cell cycle of the host cell to optimize conditions for more efficient viral genome replication. One strategy utilized by DNA viruses is to replicate their genomes non-concurrently with the host genome; in this case, the viral genome is amplified outside S phase. This phenomenon has also been described for human papillomavirus (HPV) vegetative genome replication, which occurs in G2-arrested cells; however, the precise timing of viral DNA replication during initial and stable replication phases has not been studied. We developed a new method to quantitate newly synthesized DNA levels and used this method in combination with cell cycle synchronization to show that viral DNA replication is initiated during S phase and is extended to G2 during initial amplification but follows the replication pattern of cellular DNA during S phase in the stable maintenance phase. E1 and E2 protein overexpression changes the replication time from S only to both the S and G2 phases in cells that stably maintain viral episomes. These data demonstrate that the active synthesis and replication of the HPV genome are extended into the G2 phase to amplify its copy number and the duration of HPV genome replication is controlled by the level of the viral replication proteins E1 and E2. Using the G2 phase for genome amplification may be an important adaptation that allows exploitation of changing cellular conditions during cell cycle progression. We also describe a new method to quantify newly synthesized viral DNA levels and discuss its benefits for HPV research.	[Reinson, Tormi; Henno, Liisi; Toots, Mart; Ustav, Mart, Jr.; Ustav, Mart] Univ Tartu, Inst Technol, Dept Biomed Technol, EE-50411 Tartu, Estonia; [Ustav, Mart] Estonian Acad Sci, EE-10130 Tallinn, Estonia; [Ustav, Mart] Icosagen Cell Factory OU, EE-50411 Tartu, Estonia	University of Tartu; Estonian Academy of Sciences	Ustav, M (corresponding author), Univ Tartu, Inst Technol, Dept Biomed Technol, Nooruse 1, EE-50411 Tartu, Estonia.	mart.ustav@ut.ee	Ustav, Mart/G-6484-2017		European Regional Development Fund through Center of Excellence in Chemical Biology [3.2.0101.08-0017]; Estonian Science Foundation [9385, 9467]; Estonian Research Council [IUT 20-27]; Enterprise Estonia [EU42266]; Icosagen Cell Factory	European Regional Development Fund through Center of Excellence in Chemical Biology; Estonian Science Foundation; Estonian Research Council; Enterprise Estonia; Icosagen Cell Factory	This work was supported in part by the European Regional Development Fund through the Center of Excellence in Chemical Biology (3.2.0101.08-0017), by grants 9385 and 9467 from the Estonian Science Foundation, by institutional research funding IUT 20-27 from the Estonian Research Council and by grant EU42266 from Enterprise Estonia. Icosagen Cell Factory provided support in the form of salaries for authors [MU], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918; Anacker DC, 2014, J VIROL, V88, P8528, DOI 10.1128/JVI.00517-14; Banerjee NS, 2011, J BIOL CHEM, V286, P15473, DOI 10.1074/jbc.M110.197574; Bergvall M, 2013, VIROLOGY, V445, P35, DOI 10.1016/j.virol.2013.07.020; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Egawa N, 2012, J VIROL, V86, P3276, DOI 10.1128/JVI.06450-11; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001; Fradet-Turcotte A, 2011, J VIROL, V85, P8996, DOI 10.1128/JVI.00542-11; Galloway DA, 2009, GENE DEV, V23, P138, DOI 10.1101/gad.1765809; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Gillespie KA, 2012, J VIROL, V86, P9520, DOI 10.1128/JVI.00247-12; Hoffmann R, 2006, J VIROL, V80, P4431, DOI 10.1128/JVI.80.9.4431-4439.2006; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Kadaja M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000397; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kliszczak AE, 2011, SCI REP-UK, V1, DOI 10.1038/srep00095; Lo Piano A, 2011, VIRUS RES, V160, P1, DOI 10.1016/j.virusres.2011.06.009; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Orav M, 2013, J VIROL, V87, P12051, DOI 10.1128/JVI.01798-13; Orba Y, 2010, J BIOL CHEM, V285, P1544, DOI 10.1074/jbc.M109.064311; PARK P, 1994, P NATL ACAD SCI USA, V91, P8700, DOI 10.1073/pnas.91.18.8700; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003321; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Toots M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116151; USTAV M, 1991, EMBO J, V10, P449, DOI 10.1002/j.1460-2075.1991.tb07967.x; Vogel B, 2010, VIROLOGY, V400, P207, DOI 10.1016/j.virol.2010.01.026; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991	33	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131675	10.1371/journal.pone.0131675	http://dx.doi.org/10.1371/journal.pone.0131675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132923	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000134
J	Caspar, GL; Dhand, NK; McGreevy, PD				Caspar, Georgina L.; Dhand, Navneet K.; McGreevy, Paul D.			Human Preferences for Conformation Attributes and Head-And-Neck Positions in Horses	PLOS ONE			English	Article							GANGLION-CELLS; EQUINE; SKULL	Human preferences for certain morphological attributes among domestic animals may be entirely individual or, more generally, may reflect evolutionary pressures that favor certain conformation. Artificial selection for attributes, such as short heads and crested necks of horses, may have functional and welfare implications because there is evidence from other species that skull shape co-varies with behaviour. Crested necks can be accentuated by flexion of the neck, a quality that is often manipulated in photographs vendors use when selling horses. Equine head-and-neck positions acquired through rein tension can compromise welfare. Our investigation was designed to identify conformations and postures that people are attracted to when choosing their 'ideal' horse. Participants of an internet survey were asked to rate their preference for horse silhouettes that illustrated three gradations of five variables: facial shape, crest height, ear length, ear position and head-and-neck carriage. There were 1,234 usable responses. The results show that overall preferences are for the intermediate, rather than extreme, morphological choices (p=< 0.001). They also indicate that males are 2.5 times less likely to prefer thicker necks rather than the intermediate shape, and 4 times more likely to prefer the thinner neck shape. When compared to the novice participants, experienced participants were 1.9 times more likely to prefer a thicker neck shape than the intermediate neck shape and 2.8 times less likely to prefer a thinner neck shape than the intermediate neck shape. There was overall preference of 93% (n= 939) for the category of head carriage ` In front of the vertical'. However, novice participants were 1.8 times more likely to choose ` behind the vertical' than ` in front of the vertical'. Our results suggest that people prefer a natural head carriage, concave facial profile (dished face), larger ears and thicker necks. From these survey data, it seems that some innate preferences may run counter to horse health and welfare.	[Caspar, Georgina L.; Dhand, Navneet K.; McGreevy, Paul D.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Caspar, GL (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	georgina.caspar@sydney.edu.au	Dhand, Navneet K/H-5762-2019	Dhand, Navneet K/0000-0002-4362-3596; McGreevy, Paul/0000-0001-7220-8378				ASC, 2000, AUSTR SPORTS COMM HO; Brooks SA, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2010.02127.x; BSHA, 2012, BRIT SHOW HORS ASS J; Budiansky Stephen, 1997, NATURE HORSES EXPLOR; Evans KE, 2007, ANAT HISTOL EMBRYOL, V36, P151, DOI 10.1111/j.1439-0264.2006.00749.x; Evans KE, 2006, ANAT HISTOL EMBRYOL, V35, P221, DOI 10.1111/j.1439-0264.2005.00663.x; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Goodwin D, 1997, ANIM BEHAV, V53, P297, DOI 10.1006/anbe.1996.0370; Goodwin D, 2008, J APPL ANIM WELF SCI, V11, P204, DOI 10.1080/10888700802100918; Gouraud J-L, 2010, HORSE CAVE PAINTINGS; Hawson LA, 2010, J VET BEHAV, V5, P324, DOI 10.1016/j.jveb.2010.06.001; Hector C, 2010, MAKING MODERN WARMBL; Hutchings K, 2013, 9 INT EQ SCI C P NEW, P79; Kienapfel K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103140; Koenen EPC, 2004, LIVEST PROD SCI, V88, P77, DOI 10.1016/j.livprodsci.2003.10.011; Landry Donna, 2008, NOBLE BRUTES E HORSE; Lashley MJJO, 2014, VET J, V202, P462, DOI 10.1016/j.tvjl.2014.08.028; Link Y, 2013, P 9 INT EQ SCI C U D, P40; Lloyd AS, 2008, APPL ANIM BEHAV SCI, V112, P369, DOI 10.1016/j.applanim.2007.08.010; Lynghaug F, 2009, OFF HORS BREEDS STAN; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy P., 2010, EQUITATION SCI, V1st ed.; McGreevy P., 2004, EQUINE BEHAV GUIDE V, DOI 10.1016/B978-0-7020-2634-8.50006-X; McGreevy P, 2012, J VET BEHAV, V7, P142, DOI 10.1016/j.jveb.2011.08.001; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; McGreevy PD, 2010, J VET BEHAV, V5, P180, DOI 10.1016/j.jveb.2010.03.004; Mills Daniel, 2005, DOMESTIC HORSE ORIGI; Mills DS, 2005, DOMESTIC HORSE EVOLU, P23; Phillips M, 1986, CAPTAIN M PHILLIPS R; Pickeral T, 2006, HORSE 30000 YEARS HO; Rhodin M, 2009, EQUINE VET J, V41, P274, DOI 10.2746/042516409X394436; Schemann K, 2011, PREV VET MED, V102, P304, DOI 10.1016/j.prevetmed.2011.08.002; Sleutjens J, 2012, AM J VET RES, V73, P522, DOI 10.2460/ajvr.73.4.522; Street E, 2014, EARLY WRANING SYSTEM; Thomas Heather Smith, 2005, HORSE CONFORMATION H; TNFPCS, 2012, NEW FOR PON BREED; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; Visser K, 2011, J VET BEHAV, V6, P297, DOI DOI 10.1016/j.jveb.2011.05.016; Waran, 2007, HORSE BEHAV EVOLUTIO, P1; White R, 1998, ENVIRONMENT AND MENTAL HEALTH, P175; Wilson E. O., 1984, HARV U PRESS, DOI DOI 10.2307/J.CTVK12S6H; Wolframm I, 2013, J VET BEHAV, V2, pe25; Wynmalen H, 1938, EQUITATION; Zebisch A, 2013, J ANIMAL PHYSL ANIMA	44	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131880	10.1371/journal.pone.0131880	http://dx.doi.org/10.1371/journal.pone.0131880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126209	Green Published, gold			2022-12-26	WOS:000358151300060
J	Nguyen, TTX; Moehring, AJ				Nguyen, Trinh T. X.; Moehring, Amanda J.			Accurate Alternative Measurements for Female Lifetime Reproductive Success in Drosophila melanogaster	PLOS ONE			English	Article							FITNESS; PRODUCTIVITY; COLEOPTERA	Fitness is an individual's ability to survive and reproduce, and is an important concept in evolutionary biology. However, accurately measuring fitness is often difficult, and appropriate fitness surrogates need to be identified. Lifetime reproductive success, the total progeny an organism can produce in their lifetime, is thought to be a suitable proxy for fitness, but the measure of an organism's reproductive output across a lifetime can be difficult or impossible to obtain. Here we demonstrate that the short-term measure of reproductive success across five days provides a reasonable prediction of an individual's total lifetime reproductive success in Drosophila melanogaster. However, the lifetime reproductive success of a female that has only mated once is not correlated to the lifetime reproductive success of a female that is allowed to mate multiple times, demonstrating that these measures should not serve as surrogates nor be used to make inferences about one another.	[Nguyen, Trinh T. X.; Moehring, Amanda J.] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Moehring, AJ (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	amoehrin@uwo.ca	Moehring, Amanda/AAD-6437-2020	Moehring, Amanda/0000-0002-8088-4007	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) to AJM [http://www.nserc-crsng.gc.ca/index_eng.asp]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WW, 2007, P NATL ACAD SCI USA, V104, P4484, DOI 10.1073/pnas.0611152104; [Anonymous], AM J BIOSCI BIOENG; Billeter JC, 2012, P ROY SOC B-BIOL SCI, V279, P2417, DOI 10.1098/rspb.2011.2676; Brommer JE, 2004, AM NAT, V163, P505, DOI 10.1086/382547; Carazo P, 2014, NATURE, V505, P672, DOI 10.1038/nature12949; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Endler J.A., 1986, Monographs in Population Biology, pviii; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fleming DA, 2008, J STORED PROD RES, V44, P213, DOI 10.1016/j.jspr.2007.10.004; FOX CW, 1993, FUNCT ECOL, V7, P203, DOI 10.2307/2389888; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Hunt J, 2010, EVOLUTIONARY BEHAV E; Klepsatel P, 2013, J EVOLUTION BIOL, V26, P1508, DOI 10.1111/jeb.12155; Maklakov AA, 2005, P ROY SOC B-BIOL SCI, V272, P2485, DOI 10.1098/rspb.2005.3240; MANNING A, 1962, NATURE, V194, P252, DOI 10.1038/194252a0; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Maynard Smith, 1998, EVOL GENET; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; Parkash R, 2013, J ASIA-PAC ENTOMOL, V16, P147, DOI 10.1016/j.aspen.2012.12.004; Pekkala N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024560; R Core Team, 2021, R LANGUAGE ENV STAT; Reid JM, 2004, ANIM BEHAV, V68, P1055, DOI 10.1016/j.anbehav.2004.07.003; Reinhardt K, 2009, P NATL ACAD SCI USA, V106, P21743, DOI 10.1073/pnas.0905347106; Robson SKA, 2006, J EXP BIOL, V209, P3155, DOI 10.1242/jeb.02318; ROSENBERG A, 1982, PHILOS SCI, V49, P268, DOI 10.1086/289056; ROSEWELL J, 1987, BIOL J LINN SOC, V32, P373, DOI 10.1111/j.1095-8312.1987.tb00438.x; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Singh BN, 2001, ZOOL SCI, V18, P181, DOI 10.2108/zsj.18.181; Stearns S.C., 1992, pi; TEMPLETON AR, 1993, GENETICS, V134, P475; TURNER ME, 1983, EVOLUTION, V37, P714, DOI 10.1111/j.1558-5646.1983.tb05593.x; Vijendravarma RK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2744; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036	34	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0116679	10.1371/journal.pone.0116679	http://dx.doi.org/10.1371/journal.pone.0116679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125633	Green Submitted, gold, Green Published			2022-12-26	WOS:000358151300001
J	Wu, ZY; Xu, XQ; Xiong, WD; Wu, PZ; Chen, YP; Li, MR; Wu, GJ; Jiang, HW				Wu, Zhenying; Xu, Xueqin; Xiong, Wangdan; Wu, Pingzhi; Chen, Yaping; Li, Meiru; Wu, Guojiang; Jiang, Huawu			Genome-Wide Analysis of the NAC Gene Family in Physic Nut (Jatropha curcas L.)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; NO-APICAL-MERISTEM; COMPREHENSIVE ANALYSIS; MOLECULAR CHARACTERIZATION; CELL-DIVISION; ARABIDOPSIS; EXPRESSION; PROTEINS; SEQUENCE; DROUGHT	The NAC proteins (NAM, ATAF1/2 and CUC2) are plant-specific transcriptional regulators that have a conserved NAM domain in the N-terminus. They are involved in various biological processes, including both biotic and abiotic stress responses. In the present study, a total of 100 NAC genes (JcNAC) were identified in physic nut (Jatropha curcas L.). Based on phylogenetic analysis and gene structures, 83 JcNAC genes were classified as members of, or proposed to be diverged from, 39 previously predicted orthologous groups (OGs) of NAC sequences. Physic nut has a single intron-containing NAC gene subfamily that has been lost in many plants. The JcNAC genes are non-randomly distributed across the 11 linkage groups of the physic nut genome, and appear to be preferentially retained duplicates that arose from both ancient and recent duplication events. Digital gene expression analysis indicates that some of the JcNAC genes have tissue-specific expression profiles (e.g. in leaves, roots, stem cortex or seeds), and 29 genes differentially respond to abiotic stresses (drought, salinity, phosphorus deficiency and nitrogen deficiency). Our results will be helpful for further functional analysis of the NAC genes in physic nut.	[Wu, Zhenying; Xu, Xueqin; Xiong, Wangdan; Wu, Pingzhi; Chen, Yaping; Li, Meiru; Wu, Guojiang; Jiang, Huawu] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Wu, Zhenying; Xu, Xueqin; Xiong, Wangdan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, HW (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	hwjiang@scbg.ac.cn		Wu, Zhenying/0000-0003-1859-6431	National Basic Research Program of China (973 Program) [2010CB126603]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2EW-J-28]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (973 Program) (grant no. 2010CB126603) (http://www.973.gov.cn/), and the Knowledge Innovation Program of the Chinese Academy of Sciences (grant no. KSCX2EW-J-28) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cenci A, 2014, PLANT MOL BIOL, V85, P63, DOI 10.1007/s11103-013-0169-2; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Eswaran N, 2012, PLANT BIOLOGY, V14, P428, DOI 10.1111/j.1438-8677.2011.00529.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jiang HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036522; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Kim YS, 2007, PLANT SIGNAL BEHAV, V2, P15, DOI 10.4161/psb.2.1.3606; King AJ, 2009, J EXP BOT, V60, P2897, DOI 10.1093/jxb/erp025; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Renak D, 2012, SEX PLANT REPROD, V25, P39, DOI 10.1007/s00497-011-0178-8; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Satheesh V, 2014, MOL BIOL REP, V41, P7763, DOI 10.1007/s11033-014-3669-5; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wu PZ, 2015, PLANT J, V81, P810, DOI 10.1111/tpj.12761; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xiong WD, 2013, GENE, V524, P124, DOI 10.1016/j.gene.2013.04.047; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Zhang C, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0397-x; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097878	54	13	16	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131890	10.1371/journal.pone.0131890	http://dx.doi.org/10.1371/journal.pone.0131890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125188	Green Published, gold			2022-12-26	WOS:000358151300061
J	Zhang, YH; Rowehl, L; Krumsiek, JM; Orner, EP; Shaikh, N; Tarr, PI; Sodergren, E; Weinstock, GM; Boedeker, EC; Xiong, XJ; Parkinson, J; Frank, DN; Li, E; Gathungu, G				Zhang, Yuanhao; Rowehl, Leahana; Krumsiek, Julia M.; Orner, Erika P.; Shaikh, Nurmohammad; Tarr, Phillip I.; Sodergren, Erica; Weinstock, George M.; Boedeker, Edgar C.; Xiong, Xuejian; Parkinson, John; Frank, Daniel N.; Li, Ellen; Gathungu, Grace			Identification of Candidate Adherent-Invasive E-coli Signature Transcripts by Genomic/Transcriptomic Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DIFFERENTIAL EXPRESSION ANALYSIS; COMPARATIVE GENOMIC ANALYSIS; ILEAL CROHNS-DISEASE; CRISPR-CAS SYSTEMS; REAL-TIME PCR; E. COLI; GENE ONTOLOGY; HUMAN GUT; SEQUENCE	Adherent-invasive Escherichia coli (AIEC) strains are detected more frequently within mucosal lesions of patients with Crohn's disease (CD). The AIEC phenotype consists of adherence and invasion of intestinal epithelial cells and survival within macrophages of these bacteria in vitro. Our aim was to identify candidate transcripts that distinguish AIEC from non-invasive E. coli (NIEC) strains and might be useful for rapid and accurate identification of AIEC by culture-independent technology. We performed comparative RNA-Sequence (RNASeq) analysis using AIEC strain LF82 and NIEC strain HS during exponential and stationary growth. Differential expression analysis of coding sequences (CDS) homologous to both strains demonstrated 224 and 241 genes with increased and decreased expression, respectively, in LF82 relative to HS. Transition metal transport and siderophore metabolism related pathway genes were up-regulated, while glycogen metabolic and oxidation-reduction related pathway genes were down-regulated, in LF82. Chemotaxis related transcripts were up-regulated in LF82 during the exponential phase, but flagellum-dependent motility pathway genes were down-regulated in LF82 during the stationary phase. CDS that mapped only to the LF82 genome accounted for 747 genes. We applied an in silico subtractive genomics approach to identify CDS specific to AIEC by in corporating the genomes of 10 other previously phenotyped NIEC. From this analysis, 166 CDS mapped to the LF82 genome and lacked homology to any of the 11 human NIEC strains. We compared these CDS across 13 AIEC, but none were homologous in each. Four LF82 gene loci belonging to clustered regularly interspaced short palindromic repeats region (CRISPR)-CRISPR-associated (Cas) genes were identified in 4 to 6 AIEC and absent from all non-pathogenic bacteria. As previously reported, AIEC strains were enriched for pdu operon genes. One CDS, encoding an excisionase, was shared by 9 AIEC strains. Reverse transcription quantitative polymerase chain reaction assays for 6 genes were conducted on fecal and ileal RNA samples from 22 inflammatory bowel disease (IBD), and 32 patients without IBD (non-IBD). The expression of Cas loci was detected in a higher proportion of CD than non-IBD fecal and ileal RNA samples (p < 0.05). These results support a comparative genomic/transcriptomic approach towards identifying candidate AIEC signature transcripts.	[Zhang, Yuanhao] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Rowehl, Leahana; Orner, Erika P.; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Krumsiek, Julia M.; Gathungu, Grace] SUNY Stony Brook, Dept Pediat, Stony Brook, NY 11794 USA; [Shaikh, Nurmohammad; Tarr, Phillip I.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Tarr, Phillip I.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Genome Inst, St Louis, MO USA; [Boedeker, Edgar C.] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA; [Xiong, Xuejian] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Parkinson, John] Univ Toronto, Dept Biochem & Mol & Med Genet, Toronto, ON, Canada; [Frank, Daniel N.] Univ Colorado, Dept Med, Denver, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of New Mexico; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gathungu, G (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	grace.gathungu@stonybrookmedicine.edu	Orner, Erika P/O-9223-2016; Parkinson, John/A-4424-2008; Orner, Erika/AAY-7717-2020; Weinstock, George M/C-6314-2013	Orner, Erika P/0000-0002-6253-7298; Parkinson, John/0000-0001-9815-1189; Orner, Erika/0000-0002-6253-7298; Weinstock, George M/0000-0002-2997-4592	Stony Brook School of Medicine: Targeted Research Opportunity Program - FUSION Award [1121161-4-63845]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER	Stony Brook School of Medicine: Targeted Research Opportunity Program - FUSION Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Stony Brook School of Medicine: Targeted Research Opportunity Program - FUSION Award 1121161-4-63845, to Grace Gathungu and Ellen Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendros C, 2014, MBIO, V5, DOI 10.1128/mBio.00767-13; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Cieza RJ, 2015, INFECT IMMUN, V83, P1904, DOI 10.1128/IAI.03003-14; Clarke DJ, 2011, J BACTERIOL, V193, P4540, DOI 10.1128/JB.05374-11; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Darfeuille-Michaud A, 2002, INT J MED MICROBIOL, V292, P185, DOI 10.1078/1438-4221-00201; Dassopoulos T, 2007, INFLAMM BOWEL DIS, V13, P975, DOI 10.1002/ibd.20144; Delannoy S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Dogan B, 2013, INFLAMM BOWEL DIS, V19, P141, DOI 10.1002/ibd.22971; Eaves-Pyles T, 2008, INT J MED MICROBIOL, V298, P397, DOI 10.1016/j.ijmm.2007.05.011; Fabre L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002671; Flechard M, 2012, J BACTERIOL, V194, P4550, DOI 10.1128/JB.00089-12; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Jensen SR, 2011, J MICROBIOL METH, V86, P111, DOI 10.1016/j.mimet.2011.04.002; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krause DO, 2011, J BACTERIOL, V193, P583, DOI 10.1128/JB.01290-10; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Ximeng, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0416s103; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Meconi S, 2007, CELL MICROBIOL, V9, P1252, DOI 10.1111/j.1462-5822.2006.00868.x; Miquel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012714; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nash JHE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-667; Negroni A, 2012, INFLAMM BOWEL DIS, V18, P913, DOI 10.1002/ibd.21899; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Peregrin-Alvarez JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000523; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schippa S, 2012, CAN J MICROBIOL, V58, P426, DOI [10.1139/W2012-007, 10.1139/w2012-007]; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Sepehri S, 2009, INFLAMM BOWEL DIS, V15, P1737, DOI 10.1002/ibd.20966; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tong MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080702; Toro M, 2014, APPL ENVIRON MICROB, V80, P1411, DOI 10.1128/AEM.03018-13; Walter D, 1997, J BACTERIOL, V179, P1013, DOI 10.1128/jb.179.4.1013-1022.1997; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030044	74	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130902	10.1371/journal.pone.0130902	http://dx.doi.org/10.1371/journal.pone.0130902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125937	gold, Green Published			2022-12-26	WOS:000358151300030
J	Hamacher-Brady, A; Brady, NR				Hamacher-Brady, Anne; Brady, Nathan Ryan			Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH PROTEASES; BCL-2; CLEAVAGE; FAMILY; SMAC; IAP; BAX; DOMAIN; CHEMOTHERAPY	Efficient apoptosis requires Bax/Bak-mediated mitochondrial outer membrane permeabilization (MOMP), which releases death-promoting proteins cytochrome c and Smac to the cytosol, which activate apoptosis and inhibit X-linked inhibitor of apoptosis protein (XIAP) suppression of executioner caspases, respectively. We recently identified that in response to Bcl-2 homology domain 3 (BH3)-only proteins and mitochondrial depolarization, XIAP can permeabilize and enter mitochondria. Consequently, XIAP E3 ligase activity recruits endolysosomes into mitochondria, resulting in Smac degradation. Here, we explored mitochondrial XIAP action within the intrinsic apoptosis signaling pathway. Mechanistically, we demonstrate that mitochondrial XIAP entry requires Bax or Bak and is antagonized by pro-survival Bcl-2 proteins. Moreover, intramitochondrial Smac degradation by XIAP occurs independently of Drp1-regulated cytochrome c release. Importantly, mitochondrial XIAP actions are activated cell-intrinsically by typical apoptosis inducers TNF and staurosporine, and XIAP overexpression reduces the lag time between the administration of an apoptotic stimuli and the onset of mitochondrial permeabilization. To elucidate the role of mitochondrial XIAP action during apoptosis, we integrated our findings within a mathematical model of intrinsic apoptosis signaling. Simulations suggest that moderate increases of XIAP, combined with mitochondrial XIAP preconditioning, would reduce MOMP signaling. To test this scenario, we pre-activated XIAP at mitochondria via mitochondrial depolarization or by artificially targeting XIAP to the intermembrane space. Both approaches resulted in suppression of TNF-mediated caspase activation. Taken together, we propose that XIAP enters mitochondria through a novel mode of mitochondrial permeabilization and through Smac degradation can compete with canonical MOMP to act as an anti-apoptotic tuning mechanism, reducing the mitochondrial contribution to the cellular apoptosis capacity.	[Hamacher-Brady, Anne] German Canc Res Ctr, Lysosomal Syst Biol, D-69120 Heidelberg, Germany; [Brady, Nathan Ryan] German Canc Res Ctr, Syst Biol Cell Death Mech, D-69120 Heidelberg, Germany; [Brady, Nathan Ryan] Univ Heidelberg Hosp, Dept Surg, D-69120 Heidelberg, Germany; [Hamacher-Brady, Anne; Brady, Nathan Ryan] Heidelberg Univ, Bioquant, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hamacher-Brady, A (corresponding author), INF 267,BQ0045, D-69120 Heidelberg, Germany.	a.brady@dkfz.de; n.brady@dkfz.de	Hamacher-Brady, Anne/G-4268-2013	Brady, Nathan/0000-0002-1901-5996; Hamacher-Brady, Anne/0000-0001-5042-1338	German Cancer Research Center through SBCancer within the Helmholtz Alliance on Systems Biology - Initiative and Networking Fund of the Helmholtz Association; e:Bio Grant from the Federal Ministry of Education and Research, Germany [0316191]	German Cancer Research Center through SBCancer within the Helmholtz Alliance on Systems Biology - Initiative and Networking Fund of the Helmholtz Association; e:Bio Grant from the Federal Ministry of Education and Research, Germany	This work was supported by the German Cancer Research Center through SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association (to N. R. B.) and by e:Bio Grant 0316191 (LysoSys) from the Federal Ministry of Education and Research, Germany (to A. H.-B.). The authors declare that they have no conflicts of interest with the contents of this article.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bhola PD, 2009, BIOPHYS J, V97, P2222, DOI 10.1016/j.bpj.2009.07.056; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Ferreira CG, 2001, ANN ONCOL, V12, P799, DOI 10.1023/A:1011167113067; Flanagan L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.26; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hamacher-Brady A, 2014, CELL DEATH DIFFER, V21, P1862, DOI 10.1038/cdd.2014.101; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kawatani M, 2003, J BIOL CHEM, V278, P19732, DOI 10.1074/jbc.M213038200; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kushnareva Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001394; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Owens TW, 2010, J BIOL CHEM, V285, P1081, DOI 10.1074/jbc.M109.072322; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3157	43	31	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22005	22018		10.1074/jbc.M115.643064	http://dx.doi.org/10.1074/jbc.M115.643064			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26134559	Green Published, hybrid			2022-12-26	WOS:000360968500021
J	Noguchi, Y; Sakiyama, Y; Kawakami, H; Katayama, T				Noguchi, Yasunori; Sakiyama, Yukari; Kawakami, Hironori; Katayama, Tsutomu			The Arg Fingers of Key DnaA Protomers Are Oriented Inward within the Replication Origin oriC and Stimulate DnaA Subcomplexes in the Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; SINGLE-STRANDED-DNA; IN-VITRO; E. COLI; HOMOLOGOUS RECOMBINATION; SEQUENTIAL BINDING; NEGATIVE CONTROL; STRUCTURAL BASIS; GENE-EXPRESSION; ATP HYDROLYSIS	ATP-DnaA binds to multiple DnaA boxes in the Escherichia coli replication origin (oriC) and forms left-half and right-half subcomplexes that promote DNA unwinding and DnaB helicase loading. DnaA forms homo-oligomers in a head-to-tail manner via interactions between the bound ATP and Arg-285 of the adjacent protomer. DnaA boxes R1 and R4 reside at the outer edges of the DnaA-binding region and have opposite orientations. In this study, roles for the protomers bound at R1 and R4 were elucidated using chimeric DnaA molecules that had alternative DNA binding sequence specificity and chimeric oriC molecules bearing the alternative DnaA binding sequence at R1 or R4. In vitro, protomers at R1 and R4 promoted initiation regardless of whether the bound nucleotide was ADP or ATP. Arg-285 was shown to play an important role in the formation of subcomplexes that were active in oriC unwinding and DnaB loading. The results of in vivo analysis using the chimeric molecules were consistent with the in vitro data. Taken together, the data suggest a model in which DnaA subcomplexes form in symmetrically opposed orientations and in which the Arg-285 fingers face inward to mediate interactions with adjacent protomers. This mode is consistent with initiation regulation by ATP-DnaA and bidirectional loading of DnaB helicases.	[Noguchi, Yasunori; Sakiyama, Yukari; Kawakami, Hironori; Katayama, Tsutomu] Kyushu Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp	Kawakami, Hironori/H-6792-2017	Kawakami, Hironori/0000-0001-8971-1914; Katayama, Tsutomu/0000-0001-9994-1684	Japan Society of Promotion of Sciences [22370064, 26291004]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [26291004] Funding Source: KAKEN	Japan Society of Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (KAKENHI Grants 22370064 and 26291004) from the Japan Society of Promotion of Sciences and the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Asklund M, 2005, J MOL BIOL, V345, P717, DOI 10.1016/j.jmb.2004.10.092; BATES DB, 1995, NUCLEIC ACIDS RES, V23, P3119, DOI 10.1093/nar/23.16.3119; Bocchetta M, 2000, J MOL EVOL, V50, P366, DOI 10.1007/s002399910040; Chodavarapu S, 2013, NUCLEIC ACIDS RES, V41, P10254, DOI 10.1093/nar/gkt774; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Donczew R, 2014, J MOL BIOL, V426, P2769, DOI 10.1016/j.jmb.2014.05.018; Donczew R, 2012, NUCLEIC ACIDS RES, V40, P9647, DOI 10.1093/nar/gks742; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kasho K, 2014, NUCLEIC ACIDS RES, V42, P13134, DOI 10.1093/nar/gku1051; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; KATAYAMA T, 1994, J BIOL CHEM, V269, P12698; KATAYAMA T, 1994, J BIOL CHEM, V269, P22075; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kaur G, 2014, MOL MICROBIOL, V91, P1148, DOI 10.1111/mmi.12525; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Leonard AC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010116; Leonard AC, 2011, ANNU REV MICROBIOL, V65, P19, DOI 10.1146/annurev-micro-090110-102934; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Madiraju MVVS, 2006, MOL MICROBIOL, V59, P1876, DOI 10.1111/j.1365-2958.2006.05068.x; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Miller DT, 2009, P NATL ACAD SCI USA, V106, P18479, DOI 10.1073/pnas.0909472106; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Obita T, 2002, BIOCHEM BIOPH RES CO, V299, P42, DOI 10.1016/S0006-291X(02)02590-1; Ozaki S, 2006, GENES CELLS, V11, P425, DOI 10.1111/j.1365-2443.2006.00950.x; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2012, J BIOL CHEM, V287, P37458, DOI 10.1074/jbc.M112.372052; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Ozaki S, 2009, PLASMID, V62, P71, DOI 10.1016/j.plasmid.2009.06.003; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; Saxena R, 2013, INT J MOL SCI, V14, P8517, DOI 10.3390/ijms14048517; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Skarstad K, 1995, METHOD ENZYMOL, V262, P604; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stepankiw N, 2009, MOL MICROBIOL, V74, P467, DOI 10.1111/j.1365-2958.2009.06877.x; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Taylor JA, 2011, MOL MICROBIOL, V82, P312, DOI 10.1111/j.1365-2958.2011.07785.x; Weigel C, 1997, EMBO J, V16, P6574, DOI 10.1093/emboj/16.21.6574; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x; YUNG BYM, 1990, J BIOL CHEM, V265, P1282; Zorman S, 2012, NUCLEIC ACIDS RES, V40, P7375, DOI 10.1093/nar/gks371	65	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20295	20312		10.1074/jbc.M115.662601	http://dx.doi.org/10.1074/jbc.M115.662601			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26126826	hybrid, Green Published			2022-12-26	WOS:000359608900029
J	Allaire, SE; Sylvain, C; Lange, SF; Theriault, G; Lafrance, P				Allaire, Suzanne Edith; Sylvain, Claudia; Lange, Sebastien F.; Theriault, George; Lafrance, Pierre			Potential Efficiency of Riparian Vegetated Buffer Strips in Intercepting Soluble Compounds in the Presence of Subsurface Preferential Flows	PLOS ONE			English	Article							MACROPORE CHARACTERISTICS; AGRICULTURAL LANDSCAPES; SORPTION COEFFICIENTS; SOLUTE MOVEMENT; SOIL; CATCHMENT; WATER; ADSORPTION; MANAGEMENT; LIKELIHOOD	Buffer strips have been widely recognized as to promote infiltration, deposition and sorption of contaminants for protecting surface water against agricultural contamination. However, such strips do not intercept all contaminants, particularly soluble ones. Although preferential flow (PF) has been suggested as one factor among several decreasing the efficiency of buffer strips, the mechanisms involved are not well understood. This project examines buffer strip efficiency at intercepting solutes when subsurface PF occurs. Two soluble sorbed tracers, FD&C Blue #1 and rhodamine WT, were applied on an agricultural sandy loam soil to evaluate the ability of a naturally vegetated buffer strip to intercept soluble contaminants. Rhodamine was applied about 15 m from the creek, while the Blue was applied 15 m to 165 m from the creek. Tracer concentration was measured over a two-year period in both the creek and the buffer strip through soil and water samples. Although the tracers traveled via different pathways, they both quickly moved toward the creek, passing beneath the buffer strip through the soil matrix. Our results demonstrate that the risk of water contamination by soluble contaminants is high in such systems, even when a well-vegetated buffer strip is used. The design of buffer strips should be modified to account for underground bypass, either by using plants that have deep, fine roots that do not favour PF or by adding a filter extending deep underground that can be regularly changed.	[Allaire, Suzanne Edith; Sylvain, Claudia; Lange, Sebastien F.] Univ Laval, Dept Sols & Genie Agroalimentaire, Quebec City, PQ, Canada; [Theriault, George] Agr & Agri Food Canada, Soils & Crops Res & Dev Ctr, Quebec City, PQ, Canada; [Lafrance, Pierre] Ctr Eau Terre Environm, Inst Natl Rech Sci, Quebec City, PQ, Canada	Laval University; Agriculture & Agri Food Canada; University of Quebec; Institut national de la recherche scientifique (INRS)	Allaire, SE (corresponding author), Univ Laval, Dept Sols & Genie Agroalimentaire, Quebec City, PQ, Canada.	suzanne.allaire@fsaa.ulaval.ca			Agriculture and AgriFood Canada; NSERC Discovry grant	Agriculture and AgriFood Canada(Agriculture & Agri Food Canada); NSERC Discovry grant	This work was supported by the Agriculture and AgriFood Canada to GT and the NSERC Discovry grant to SEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zreig M, 2003, J ENVIRON QUAL, V32, P613, DOI 10.2134/jeq2003.0613; Allaire SE, 2011, J HYDROL, V403, P261, DOI 10.1016/j.jhydrol.2011.04.005; Allaire SE, 2009, J HYDROL, V378, P179, DOI 10.1016/j.jhydrol.2009.08.013; Allaire-Leung SE, 2000, J CONTAM HYDROL, V41, P283, DOI 10.1016/S0169-7722(99)00079-0; Allaire-Leung SE, 2000, J CONTAM HYDROL, V41, P303, DOI 10.1016/S0169-7722(99)00074-1; Allaire-Leung SE, 1999, J ENVIRON QUAL, V28, P1831, DOI 10.2134/jeq1999.00472425002800060020x; Anderson AE, 2005, EOS T AM GEOPHYS U S, V86; ANDERSON MG, 1990, PROCESS STUDIES HILL; BACHE BW, 1971, J SOIL SCI, V22, P289, DOI 10.1111/j.1365-2389.1971.tb01617.x; BARLING RD, 1994, ENVIRON MANAGE, V18, P543, DOI 10.1007/BF02400858; Blake GR, 1986, ASA MONOGR, V9, P362; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burt TP, 2005, PROG PHYS GEOG, V29, P297, DOI 10.1191/0309133305pp450ra; Correll D, 2002, VEGETATIVE STREAM RI; CPVQ (Conseil des productions vegetales du Quebec), 1997, METH AN SOLS FUM TIS, V533; Dadfar H, 2010, J HYDROL, V386, P142, DOI 10.1016/j.jhydrol.2010.03.016; Dadfar H, 2010, CAN J SOIL SCI, V90, P129, DOI 10.4141/CJSS09066; DILLAHA TA, 1989, T ASAE, V32, P513, DOI 10.13031/2013.31033; Dorioz JM, 2006, AGR ECOSYST ENVIRON, V117, P4, DOI 10.1016/j.agee.2006.03.029; FIHOQ (Federation Interdisciplinaire de l'Horticulture Ornementale du Quebec), 2013, GUID BONN PRAT AM TE; Flury M, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000109; FLURY M, 1995, SOIL SCI SOC AM J, V59, P22, DOI 10.2136/sssaj1995.03615995005900010003x; Hickey MBC, 2004, WATER QUAL RES J CAN, V39, P311, DOI 10.2166/wqrj.2004.042; Jin C-X, 2000, T AM SOC AGR ENG, V42, P1679; Ketelsen H, 1999, GEODERMA, V90, P131, DOI 10.1016/S0016-7061(98)00119-0; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Kookana RS, 2008, J AGR FOOD CHEM, V56, P3208, DOI 10.1021/jf073152n; Lacas JG, 2005, AGRON SUSTAIN DEV, V25, P253, DOI 10.1051/agro:2005001; Lamontagne L., 2010, ETUDE PEDOLOGIQUE BA; Liu XM, 2008, J ENVIRON QUAL, V37, P1667, DOI 10.2134/jeq2007.0437; McKergow LA, 2003, J HYDROL, V270, P253, DOI 10.1016/S0022-1694(02)00286-X; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; MDDELCC (Ministere du Developpement Durable de l'Environnement et de la Lutte aux changements Climatiques), 2009, PORTR QUAL EAUX SURF; Michaud AR, 2009, RESEAU ACTIONS CONCE; Polyakov Viktor, 2005, Environmental Reviews, V13, P129, DOI 10.1139/a05-010; Qi HH, 2011, WATER RESOUR MANAG, V25, P565, DOI 10.1007/s11269-010-9714-9; Roberts WM, 2012, J ENVIRON QUAL, V41, P389, DOI 10.2134/jeq2010.0543; SABATINI DA, 1991, GROUND WATER, V29, P341, DOI 10.1111/j.1745-6584.1991.tb00524.x; Sidle RC, 2001, HYDROL PROCESS, V15, P1675, DOI 10.1002/hyp.233; Simunek J, 2003, J HYDROL, V272, P14, DOI 10.1016/S0022-1694(02)00252-4; TRUDGILL ST, 1987, HYDROL PROCESS, V1, P149, DOI 10.1002/hyp.3360010204; Uchida T, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000261; Uhlenbrook S, 2006, HYDROL PROCESS, V20, P3581, DOI 10.1002/hyp.6564; Viaud V, 2004, ENVIRON MANAGE, V34, P559, DOI 10.1007/s00267-004-0271-y; Weber JB, 2004, CHEMOSPHERE, V55, P157, DOI 10.1016/j.chemosphere.2003.10.049; Wenger S., 1999, REV SCI LIT RIPARIAN; Wierenga PJ, 1986, AGRONOMY MON, V9; Zhang XY, 2010, J ENVIRON QUAL, V39, P76, DOI 10.2134/jeq2008.0496	48	12	13	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131840	10.1371/journal.pone.0131840	http://dx.doi.org/10.1371/journal.pone.0131840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147093	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600151
J	Ganjurjav, H; Gao, QZ; Zhang, WN; Liang, Y; Li, YW; Cao, XJ; Wan, YF; Li, Y; Danjiu, LB				Ganjurjav, Hasbagan; Gao, Qingzhu; Zhang, Weina; Liang, Yan; Li, Yawei; Cao, Xujuan; Wan, Yunfan; Li, Yue; Danjiu, Luobu			Effects of Warming on CO2 Fluxes in an Alpine Meadow Ecosystem on the Central Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SOIL RESPIRATION; CARBON EXCHANGE; TERRESTRIAL ECOSYSTEMS; GRASSLAND ECOSYSTEMS; RESPONSES; DIOXIDE; GROWTH; FOREST; WATER; TERM	To analyze CO2 fluxes under conditions of climate change in an alpine meadow on the central Qinghai-Tibetan Plateau, we simulated the effect of warming using open top chambers (OTCs) from 2012 to 2014. The OTCs increased soil temperature by 1.62 degrees C (P < 0.05), but decreased soil moisture (1.38%, P < 0.05) during the experiments. The response of ecosystem CO2 fluxes to warming was variable, and dependent on the year. Under conditions of warming, mean gross ecosystem productivity (GEP) during the growing season increased significantly in 2012 and 2014 (P < 0.05); however, ecosystem respiration (ER) increased substantially only in 2012 (P < 0.05). The net ecosystem CO2 exchange (NEE) increased marginally in 2012 (P = 0.056), did not change in 2013(P > 0.05), and increased significantly in 2014 (P = 0.034) under conditions of warming. The GEP was more sensitive to climate variations than was the ER, resulting in a large increase in net carbon uptake under warming in the alpine meadow. Under warming, the 3-year averages of GEP, ER, and NEE increased by 19.6%, 15.1%, and 21.1%, respectively. The seasonal dynamic patterns of GEP and NEE, but not ER, were significantly impacted by warming. Aboveground biomass, particularly the graminoid biomass increased significantly under conditions of warming. Soil moisture, soil temperature, and aboveground biomass were the main factors that affected the variation of the ecosystem CO2 fluxes. The effect of warming on inter-and intra-annual patterns of ecosystem CO2 fluxes and the mechanism of different sensitivities in GEP and ER to warming, require further researched.	[Ganjurjav, Hasbagan; Gao, Qingzhu; Zhang, Weina; Liang, Yan; Cao, Xujuan; Wan, Yunfan; Li, Yue] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Ganjurjav, Hasbagan; Gao, Qingzhu; Zhang, Weina; Liang, Yan; Cao, Xujuan; Wan, Yunfan; Li, Yue] Minist Agr, Key Lab Agroenvironm & Climate Change, Beijing, Peoples R China; [Li, Yawei] Clin Pharm Qinghai Hosp Tradit Chinese Med, Xining, Qinghai Provinc, Peoples R China; [Danjiu, Luobu] Nagqu Agr & Anim Husb Bur, Nagqu, Tibet Autonomou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Gao, QZ (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	gaoqingzhu@caas.cn	Ganjurjav, Hasbagan/AAA-9698-2019		National Key Project of Scientific and Technical Supporting Program of China [2012BAC01B02]; National Natural Science Foundation of China [31170460]; Nagqu Grassland Station; Institute of Agricultural Environment and Sustainable Development in agriculture	National Key Project of Scientific and Technical Supporting Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nagqu Grassland Station; Institute of Agricultural Environment and Sustainable Development in agriculture	Support was provided by the National Key Project of Scientific and Technical Supporting Program of China (2012BAC01B02), the National Natural Science Foundation of China (31170460) and the cooperation project with Nagqu Grassland Station and Institute of Agricultural Environment and Sustainable Development in agriculture.	ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; Biasi C, 2008, PLANT SOIL, V307, P191, DOI 10.1007/s11104-008-9596-2; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; De Boeck HJ, 2007, NEW PHYTOL, V175, P512, DOI 10.1111/j.1469-8137.2007.02122.x; Dias ATC, 2010, OECOLOGIA, V163, P805, DOI 10.1007/s00442-010-1569-5; Dong G, 2011, ECOHYDROLOGY, V4, P211, DOI 10.1002/eco.200; Gao QZ, 2014, MITIG ADAPT STRAT GL, V19, P199, DOI 10.1007/s11027-012-9434-y; Gao QZ, 2013, QUATERN INT, V304, P126, DOI 10.1016/j.quaint.2013.04.022; Gao QZ, 2006, REMOTE SENSING MONIT, V9, P1; Grogan P, 2000, OECOLOGIA, V125, P512, DOI 10.1007/s004420000490; Gunderson CA, 2000, TREE PHYSIOL, V20, P87; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Kato T, 2004, AGR FOREST METEOROL, V124, P121, DOI 10.1016/j.agrformet.2003.12.008; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; Klein JA, 2008, ECOSYSTEMS, V11, P775, DOI 10.1007/s10021-008-9160-1; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Liu YS, 2013, PLANT SOIL, V366, P491, DOI 10.1007/s11104-012-1442-x; Lu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059054; Mertens S, 2001, ECOSYSTEMS, V4, P226, DOI 10.1007/s10021-001-0006-3; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Nakano T, 2010, SOIL SCI PLANT NUTR, V56, P773, DOI 10.1111/j.1747-0765.2010.00502.x; Niu SL, 2010, ECOLOGY, V91, P3261, DOI 10.1890/09-1634.1; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; Peng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109319; Risch AC, 2006, OECOLOGIA, V147, P291, DOI 10.1007/s00442-005-0261-7; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Scott-Denton LE, 2003, SOIL BIOL BIOCHEM, V35, P525, DOI 10.1016/S0038-0717(03)00007-5; Shi FS, 2010, PHOTOSYNTHETICA, V48, P437, DOI 10.1007/s11099-010-0058-8; Tang JW, 2008, AGR FOREST METEOROL, V148, P171, DOI 10.1016/j.agrformet.2007.08.008; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wang XX, 2014, SOIL BIOL BIOCHEM, V76, P140, DOI 10.1016/j.soilbio.2014.05.014; Welker JM, 2004, GLOBAL CHANGE BIOL, V10, P1981, DOI 10.1111/j.1365-2486.2004.00857.x; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x	39	37	49	15	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132044	10.1371/journal.pone.0132044	http://dx.doi.org/10.1371/journal.pone.0132044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147223	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600188
J	Mancini, M; Leo, E; Takemaru, KI; Campi, V; Castagnetti, F; Soverini, S; De Benedittis, C; Rosti, G; Cavo, M; Santucci, MA; Martinelli, G				Mancini, Manuela; Leo, Elisa; Takemaru, Ken-Ichi; Campi, Virginia; Castagnetti, Fausto; Soverini, Simona; De Benedittis, Caterina; Rosti, Gianantonio; Cavo, Michele; Santucci, Maria Alessandra; Martinelli, Giovanni			14-3-3 Binding and Sumoylation Concur to the Down-Modulation of beta-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; TYROSINE KINASE; CML STEM; C-ABL; BCR; PROTEIN; ACTIVATION; IMATINIB; PREVENTS	The down-modulation of the beta-catenin antagonist Chibby 1 (CBY1) associated with the BCR-ABL1 fusion gene of chronic myeloid leukemia (CML) contributes to the aberrant activation of beta-catenin, particularly in leukemic stem cells (LSC) resistant to tyrosine kinase (TK) inhibitors. It is, at least partly, driven by transcriptional events and gene promoter hyper-methylation. Here we demonstrate that it also arises from reduced protein stability upon binding to 14-3-3 sigma adapter protein. CBY1/14-3-3 sigma interaction in BCR-ABL1+ cells is mediated by the fusion protein TK and AKT phosphorylation of CBY1 at critical serine 20, and encompasses the 14-3-3 sigma binding modes I and II involved in the binding with client proteins. Moreover, it is impaired by c-Jun N-terminal kinase (JNK) phosphorylation of 14-3-3 sigma at serine 186, which promotes dissociation of client proteins. The ubiquitin proteasome system UPS participates in reducing stability of CBY1 bound with 14-3-3 sigma through enhanced SUMOylation. Our results open new routes towards the research on molecular pathways promoting the proliferative advantage of leukemic hematopoiesis over the normal counterpart.	[Mancini, Manuela; Leo, Elisa; Campi, Virginia; Castagnetti, Fausto; Soverini, Simona; De Benedittis, Caterina; Rosti, Gianantonio; Cavo, Michele; Santucci, Maria Alessandra; Martinelli, Giovanni] Univ Bologna, Sch Med, Dept Expt Diagnost & Specialty Med DIMES, Inst Hematol L&A Seragnoli, Bologna, Italy; [Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Bologna; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mancini, M (corresponding author), Univ Bologna, Sch Med, Dept Expt Diagnost & Specialty Med DIMES, Inst Hematol L&A Seragnoli, Bologna, Italy.	mancini_manu@yahoo.com	CAVO, MICHELE/AAK-8274-2020; Simona, Soverini/A-3608-2016; DE BENEDITTIS, CATERINA/AGA-9478-2022; Martinelli, Giovanni/AAK-9211-2020	CAVO, MICHELE/0000-0003-4514-3227; Simona, Soverini/0000-0002-4508-0353; DE BENEDITTIS, CATERINA/0000-0003-4315-5996; Martinelli, Giovanni/0000-0002-1025-4210	University of Bologna (RFO funds); Ministero della Pubblica Istruzione e della Ricerca (PRIN funds); Umberto Veronesi Foundation; AIRC; FP7 NGS-PTL project; Progetto Regione-Universita; Fondazione del Monte di Bologna e Ravenna; BolognaAIL; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493] Funding Source: NIH RePORTER	University of Bologna (RFO funds); Ministero della Pubblica Istruzione e della Ricerca (PRIN funds)(Ministry of Education, Universities and Research (MIUR)); Umberto Veronesi Foundation(Fondazione Umberto Veronesi); AIRC(Fondazione AIRC per la ricerca sul cancro); FP7 NGS-PTL project; Progetto Regione-Universita; Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); BolognaAIL; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	University of Bologna (RFO funds), Ministero della Pubblica Istruzione e della Ricerca (PRIN funds), Umberto Veronesi Foundation, AIRC, FP7 NGS-PTL project, Progetto Regione-Universita 2010-12 (L. Bolondi), Fondazione del Monte di Bologna e Ravenna and BolognaAIL finantially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Aguirre RS, 2013, MOL PHARMACOL, V84, P218, DOI 10.1124/mol.113.085555; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Chang TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040193; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Einsele H, 2014, RECENT RESULTS CANC, V201, P325, DOI 10.1007/978-3-642-54490-3_20; Feligioni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028185; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006640; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Huang WQ, 2013, J BIOL CHEM, V288, P12766, DOI 10.1074/jbc.M112.429696; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Keeshan K, 2002, LEUKEMIA, V16, P1725, DOI 10.1038/sj.leu.2402576; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Leo E, 2014, J CELL BIOCH; Leo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081425; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Mancini M, 2004, LEUKEMIA, V18, P370, DOI 10.1038/sj.leu.2403207; Mancini M, 2014, CELL SIGNAL, V26, P1690, DOI 10.1016/j.cellsig.2014.04.010; Mancini M, 2013, CELL SIGNAL, V25, P1820, DOI 10.1016/j.cellsig.2013.05.019; Mancini M, 2011, J PHARMACOL EXP THER, V336, P596, DOI 10.1124/jpet.110.172536; Mancini M, 2010, J CELL BIOCHEM, V109, P320, DOI 10.1002/jcb.22380; Mancini M, 2009, TRAFFIC, V10, P637, DOI 10.1111/j.1600-0854.2009.00897.x; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Ryu J, 2010, BIOCHEM BIOPH RES CO, V393, P280, DOI 10.1016/j.bbrc.2010.01.122; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhou HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086195	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131074	10.1371/journal.pone.0131074	http://dx.doi.org/10.1371/journal.pone.0131074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147002	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600060
J	Uchiyama, M; Terunuma, J; Hanaoka, F				Uchiyama, Masashi; Terunuma, Junko; Hanaoka, Fumio			The Protein Level of Rev1, a TLS Polymerase in Fission Yeast, Is Strictly Regulated during the Cell Cycle and after DNA Damage	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE REV1; C-TERMINAL DOMAIN; SCHIZOSACCHAROMYCES-POMBE; TRANSLESION SYNTHESIS; LESION BYPASS; S-PHASE; CHROMATIN BINDING; COMPLEX-FORMATION; STRUCTURAL BASIS; 26S PROTEASOME	Translesion DNA synthesis provides an alternative DNA replication mechanism when template DNA is damaged. In fission yeast, Eso1 (pol eta), Kpa1/DinB (pol kappa), Rev1, and Pol zeta (a complex of Rev3 and Rev7) have been identified as translesion synthesis polymerases. The enzymatic characteristics and protein-protein interactions of these polymerases have been intensively characterized; however, how these proteins are regulated during the cell cycle remains unclear. Therefore, we examined the cell cycle oscillation of translesion polymerases. Interestingly, the protein levels of Rev1 peaked during G(1) phase and then decreased dramatically at the entry of S phase; this regulation was dependent on the proteasome. Temperature-sensitive proteasome mutants, such as mts2-U31 and mts3-U32, stabilized Rev1 protein when the temperature was shifted to the restrictive condition. In addition, deletion of pop1 or pop2, subunits of SCF ubiquitin ligase complexes, upregulated Rev1 protein levels. Besides these effects during the cell cycle, we also observed upregulation of Rev1 protein upon DNA damage. This upregulation was abolished when rad3, a checkpoint protein, was deleted or when the Rev1 promoter was replaced with a constitutive promoter. From these results, we hypothesize that translesion DNA synthesis is strictly controlled through Rev1 protein levels in order to avoid unwanted mutagenesis.	[Uchiyama, Masashi; Terunuma, Junko; Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Inst Biomol Sci, Toshima Ku, Tokyo 171, Japan	Gakushuin University	Hanaoka, F (corresponding author), Gakushuin Univ, Fac Sci, Inst Biomol Sci, Toshima Ku, Tokyo 171, Japan.	fumio.hanaoka@gakushuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22131008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (22131008 to FH) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Callegari AJ, 2010, P NATL ACAD SCI USA, V107, P8219, DOI 10.1073/pnas.1003449107; Carr AM, 1998, MICROBIOL-UK, V144, P5, DOI 10.1099/00221287-144-1-5; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; D'Souza S, 2006, MOL CELL BIOL, V26, P8173, DOI 10.1128/MCB.00202-06; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gao J, 2014, CURR GENET, V60, P109, DOI 10.1007/s00294-013-0406-x; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo DY, 2001, NUCLEIC ACIDS RES, V29, P2875, DOI 10.1093/nar/29.13.2875; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Harris P, 1996, MOL GEN GENET, V252, P284; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Hirano Y, 2006, CURR BIOL, V16, P586, DOI 10.1016/j.cub.2006.01.063; Jallepalli PV, 1998, P NATL ACAD SCI USA, V95, P8159, DOI 10.1073/pnas.95.14.8159; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kosarek JN, 2008, DNA REPAIR, V7, P439, DOI 10.1016/j.dnarep.2007.11.016; LARIMER FW, 1989, J BACTERIOL, V171, P230, DOI 10.1128/jb.171.1.230-237.1989; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lawrence CW, 2001, PHILOS T R SOC B, V356, P41, DOI 10.1098/rstb.2000.0001; Leatherwood J, 1996, NATURE, V379, P360, DOI 10.1038/379360a0; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Lopez-Girona A, 1998, MOL BIOL CELL, V9, P63, DOI 10.1091/mbc.9.1.63; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Masutani C, 2008, ADV EXP MED BIOL, V637, P93; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Matsuyama A, 2008, YEAST, V25, P371, DOI 10.1002/yea.1593; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morita T, 2004, YEAST, V21, P613, DOI 10.1002/yea.1104; MuziFalconi M, 1996, P NATL ACAD SCI USA, V93, P1566, DOI 10.1073/pnas.93.4.1566; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; NASMYTH KA, 1979, J MOL BIOL, V130, P273, DOI 10.1016/0022-2836(79)90541-2; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Ohmori H, 2009, ADV PROTEIN CHEM STR, V78, P99, DOI 10.1016/S1876-1623(09)78004-0; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Pozhidaeva A, 2012, BIOCHEMISTRY-US, V51, P5506, DOI 10.1021/bi300566z; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Pustovalova Y, 2013, J MOL BIOL, V425, P3091, DOI 10.1016/j.jmb.2013.05.029; Pustovalova Y, 2012, FEBS LETT, V586, P3051, DOI 10.1016/j.febslet.2012.07.021; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Sabbioneda S, 2007, DNA REPAIR, V6, P121, DOI 10.1016/j.dnarep.2006.09.002; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Vaisman A, 2002, MUTAT RES-FUND MOL M, V510, P9, DOI 10.1016/S0027-5107(02)00248-8; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Wilkinson CRM, 1999, PHILOS T R SOC B, V354, P1523, DOI 10.1098/rstb.1999.0496; Wiltrout ME, 2011, DNA REPAIR, V10, P169, DOI 10.1016/j.dnarep.2010.10.008; Wiltrout ME, 2011, GENETICS, V187, P21, DOI 10.1534/genetics.110.124172; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Xie W, 2012, PROTEIN CELL, V3, P864, DOI 10.1007/s13238-012-2102-x; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499	73	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130000	10.1371/journal.pone.0130000	http://dx.doi.org/10.1371/journal.pone.0130000			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147350	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600028
J	Clausen, KK; Madsen, J; Tombre, IM				Clausen, Kevin K.; Madsen, Jesper; Tombre, Ingunn M.			Carry-Over or Compensation? The Impact of Winter Harshness and Post-Winter Body Condition on Spring-Fattening in a Migratory Goose Species	PLOS ONE			English	Article							GEESE ANSER-BRACHYRHYNCHUS; GREATER SNOW GEESE; ABDOMINAL PROFILES; SEASONAL SURVIVAL; BREEDING SUCCESS; HABITAT QUALITY; BARNACLE GEESE; BLACK BRANT; TRADE-OFF; POPULATIONS	Environmental conditions at one point of the annual cycle of migratory species may lead to cross-seasonal effects affecting fitness in subsequent seasons. Based on a long-term mark-resighting dataset and scoring of body condition in an arctic breeding goose species, we demonstrate a substantial effect of winter harshness on post-winter body condition. However, this effect was compensated along the spring migration corridor, and did not persist long enough to influence future reproduction. This highlights the importance of temporal scale when assessing impacts of environmental effects, and suggests a state-dependent physiological mechanism adjusting energy accumulation according to internal energy stores carried into spring. In support of these findings, the development of body condition was unaffected by whether geese used supplementary feeding sites or not. While there was no effect of winter harshness on the average population pre-breeding body condition, individual variations in early spring body condition (probably related to different life-histories) were partly traceable throughout spring. This strongly indicates a carry-over effect on the individual level, possibly related to differences in dominance, site use, disturbance or migration strategy, which may potentially affect future reproduction.	[Clausen, Kevin K.; Madsen, Jesper] Aarhus Univ, Dept Biosci, DK-8410 Ronde, Denmark; [Tombre, Ingunn M.] Norwegian Inst Nat Res, Fram Ctr, Dept Arctic Ecol, N-9296 Tromso, Norway	Aarhus University; Norwegian Institute Nature Research	Clausen, KK (corresponding author), Aarhus Univ, Dept Biosci, Grenavej 14, DK-8410 Ronde, Denmark.	kc@bios.au.dk	Madsen, Jesper/J-7853-2013; Clausen, Kevin Kuhlmann/J-5683-2013	Madsen, Jesper/0000-0003-3246-0215; Clausen, Kevin Kuhlmann/0000-0003-3636-5442	Aarhus University; Danish Research Council; Norwegian Research Council; Danish Nature Agency; Norwegian Environment Agency; Nordland County Council, Norway; Nord-Trondelag County Council, Norway	Aarhus University; Danish Research Council(Det Frie Forskningsrad (DFF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Danish Nature Agency; Norwegian Environment Agency; Nordland County Council, Norway; Nord-Trondelag County Council, Norway	Over the years this work has been financially supported by Aarhus University, The Danish Research Council, The Norwegian Research Council, The Danish Nature Agency, The Norwegian Environment Agency and The Nordland and Nord-Trondelag County Councils, Norway. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alisauskas RT, 2002, J WILDLIFE MANAGE, V66, P181, DOI 10.2307/3802884; Andrewartha H.G., 1984, ECOLOGICAL WEB MORE; Bauer S, 2006, ARDEA, V94, P555; BLACK JM, 1989, ANIM BEHAV, V37, P199, DOI 10.1016/0003-3472(89)90110-3; Clausen KK, 2014, J ORNITHOL, V155, P951, DOI 10.1007/s10336-014-1080-6; Clausen P, 2001, ARDEA, V89, P101; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Drent R, 2003, OIKOS, V103, P274, DOI 10.1034/j.1600-0706.2003.12274.x; Drewien Roderick C., 1994, Wildfowl, V45, P22; Ekman JB, 1990, BEHAV ECOL, V1, P62, DOI 10.1093/beheco/1.1.62; ELY CR, 1992, CONDOR, V94, P857, DOI 10.2307/1369283; Feret M, 2005, CONDOR, V107, P694, DOI 10.1650/0010-5422(2005)107[0694:AAPUTA]2.0.CO;2; Forsman JT, 2003, J BIOGEOGR, V30, P55, DOI 10.1046/j.1365-2699.2003.00812.x; Fox AD, 2005, GLOBAL CHANGE BIOL, V11, P881, DOI 10.1111/j.1365-2486.2005.00941.x; Gauthier G, 2001, ECOLOGY, V82, P3105, DOI 10.2307/2679838; GRAY DR, 1993, ARCTIC, V46, P340; Guillemain M, 2008, IBIS, V150, P172; Harrison XA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077783; Hawley DM, 2012, FUNCT ECOL, V26, P701, DOI 10.1111/j.1365-2435.2012.01978.x; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Houston AI, 1999, MODELS ADAPTIVE BEHA; Inger R, 2010, J ANIM ECOL, V79, P974, DOI 10.1111/j.1365-2656.2010.01712.x; Juillet C, 2012, J APPL ECOL, V49, P1237, DOI 10.1111/j.1365-2664.2012.02199.x; Legagneux P, 2012, P ROY SOC B-BIOL SCI, V279, P876, DOI 10.1098/rspb.2011.1351; Lilliendahl K, 1996, CAN J ZOOL, V74, P1612, DOI 10.1139/z96-178; Loison A, 1998, OECOLOGIA, V116, P489, DOI 10.1007/s004420050614; Madsen J, 2006, J AVIAN BIOL, V37, P283, DOI 10.1111/j.2006.0908-8857.03555.x; Madsen J, 2002, IBIS, V144, P218, DOI 10.1046/j.1474-919X.2002.00045.x; Madsen J, 1999, WETLANDS INT PUBL, V48; Madsen J, 1984, NORSK POLARINSTITUTT, V181, P19; Madsen J, 2008, FODRING KORTNAEBBEDE; Madsen J, 1996, WILDLIFE BIOL, V2, P1; Madsen J, 2014, J APPL ECOL, V51, P183, DOI 10.1111/1365-2664.12183; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Norris DR, 2007, CONDOR, V109, P535; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; Ockendon N, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0669; OWEN M, 1992, ORNIS SCAND, V23, P451, DOI 10.2307/3676676; Owen M., 1989, P349; OWEN M, 1981, J WILDLIFE MANAGE, V45, P227, DOI 10.2307/3807891; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; R Core Team, 2018, R LANG ENV STAT COMP; RAVELING DG, 1979, AUK, V96, P234; Robb JR, 2001, J WILDLIFE MANAGE, V65, P755, DOI 10.2307/3803026; ROGERS CM, 1993, ECOLOGY, V74, P419, DOI 10.2307/1939303; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Schamber JL, 2012, AUK, V129, P205, DOI 10.1525/auk.2012.11249; Sedinger JS, 2006, ECOLOGY, V87, P151, DOI 10.1890/04-1013; Senner NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086588; TEUNISSEN W, 1985, ARDEA, V73, P109	52	21	21	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132312	10.1371/journal.pone.0132312	http://dx.doi.org/10.1371/journal.pone.0132312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134270	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400110
J	Flores-Tellez, TNJ; Lopez, TV; Garzon, VRV; Villa-Trevino, S				Flores-Tellez, Teresita N. J.; Lopez, Tania V.; Vasquez Garzon, Veronica Rocio; Villa-Trevino, Saul			Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma	PLOS ONE			English	Article							PHOSPHORYLATED EZRIN; GENE-EXPRESSION; PODOCALYXIN; CANCER; CLIC5; MEMBRANE; COMPLEX; CYTOSKELETON; METASTASIS; PREDICTOR	Background and Aim Prognostic markers are important for predicting the progression and staging of hepatocellular carcinoma (HCC). Ezrin (EZR) and Podocalyxin (PODXL) are proteins associated with invasion, migration and poor prognosis in various types of cancer. Recently, it has been observed that chloride intracellular channel 5 (CLIC5) forms a complex with EZR and PODXL and that it is required for podocyte structure and function. In this study, we evaluated the overexpression of EZR, PODXL and CLIC5 in HCC. Methods The modified resistant hepatocyte model (MRHR), human biopsies and HCC cell lines (HepG2, Huh7 and SNU387) were used in this study. Gene and protein expression levels were evaluated in the MRHR by qRT-PCR, Western blot and immunohistochemistry analyses, and protein expression in the human biopsies was evaluated by immunohistochemistry. Protein expression in the HCC cell lines was evaluated by immunofluorescence and Western blot, also the migration and invasive abilities of Huh7 cells were evaluated using shRNA-mediated inhibition. Results Our results indicated that these genes and proteins were overexpressed in HCC. Moreover, when the expression of CLIC5 and PODXL was inhibited in Huh7 cells, we observed decreased migration and invasion. Conclusion This study suggested that EZR, CLIC5 and PODXL could be biological markers to predict the prognosis of HCC and that these proteins participate in migration and invasion processes.	[Flores-Tellez, Teresita N. J.; Villa-Trevino, Saul] CINVESTAV, IPN, Ctr Invest & Estudios Adv, Dept Cellular Biol, Mexico City 07360, DF, Mexico; [Lopez, Tania V.] Inst Nacl Med Genom INMEGEN, Ciudad Mexico 14610, DF, Mexico; [Vasquez Garzon, Veronica Rocio] Univ Benito Juarez Oaxaca, Fac Med & Cirugia, Mexico City 68120, Oaxaca, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Medicina Genomica	Lopez, TV (corresponding author), Inst Nacl Med Genom INMEGEN, Perifer 4809, Ciudad Mexico 14610, DF, Mexico.	tvlopez@inmegen.gob.mx; svilla@cell.cinvestav.mx	VILLA, SAUL/AAU-3346-2020; López-Pérez, Tania Valentina/AAR-2631-2021	VILLA, SAUL/0000-0002-8292-8157; lopez perez, tania valentina/0000-0001-6381-9046; Vasquez-Garzon, Veronica Rocio/0000-0002-4861-8235	 [178558]		This work was supported by a scholarship (TNJFT), a grant contribution (178558).	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Calvin D., 2012, ADV CANC MANAGEMENT, P40; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Claperon A, 2013, CLIN RES HEPATOL GAS, V37, P142, DOI 10.1016/j.clinre.2013.02.001; Cui YZ, 2010, CANCER INVEST, V28, P242, DOI 10.3109/07357900903124498; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang YK, 2010, MOL CARCINOGEN, V49, P798, DOI 10.1002/mc.20653; Kelley TW, 2005, AM J CLIN PATHOL, V124, P134, DOI 10.1309/7BHLAHHU0N4MHT7Q; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Li FN, 2010, J CELL BIOCHEM, V110, P1013, DOI 10.1002/jcb.22615; Li FN, 2010, CELL BIOL INT, V34, P379, DOI 10.1042/CBI20090334; Li G, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.7; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Lin CW, 2014, CARCINOGENESIS, V35, P2425, DOI 10.1093/carcin/bgu139; Lin CW, 2014, INT J ONCOL, V45, P710, DOI 10.3892/ijo.2014.2427; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Paige M, 2014, BIOORGAN MED CHEM, V22, P478, DOI 10.1016/j.bmc.2013.11.003; Pang ST, 2004, UROLOGY, V63, P609, DOI 10.1016/j.urology.2003.09.068; Perez-Carreon JI, 2006, NEOPLASIA, V8, P373, DOI 10.1593/neo.05841; Pierchala BA, 2010, KIDNEY INT, V78, P868, DOI 10.1038/ki.2010.212; POWER C, 1987, CARCINOGENESIS, V8, P797, DOI 10.1093/carcin/8.6.797; RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Shukla A, 2014, ONCOGENE, V33, P842, DOI 10.1038/onc.2013.18; Singh H, 2007, FEBS J, V274, P6306, DOI 10.1111/j.1742-4658.2007.06145.x; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Stevenson RP, 2012, J CELL SCI, P7; Supiot S, 2013, WORLD J GASTROENTERO, V19, P3249, DOI 10.3748/wjg.v19.i21.3249; Wang L, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-44; Wegner B, 2010, AM J PHYSIOL-RENAL, V298, pF1492, DOI 10.1152/ajprenal.00030.2010; Yasuoka H, 2012, J CLIN PATHOL, V65, P399, DOI 10.1136/jclinpath-2011-200359; Yau C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3567; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5	42	26	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131605	10.1371/journal.pone.0131605	http://dx.doi.org/10.1371/journal.pone.0131605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135398	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400058
J	Kim, H; Thak, EJ; Lee, DJ; Agaphonov, MO; Kang, HA				Kim, Hyunah; Thak, Eun Jung; Lee, Dong-Jik; Agaphonov, Michael O.; Kang, Hyun Ah			Hansenula polymorpha Pmt4p Plays Critical Roles in O-Mannosylation of Surface Membrane Proteins and Participates in Heteromeric Complex Formation	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MANNOSYLTRANSFERASE FAMILY; CELL-SURFACE; PLASMINOGEN-ACTIVATOR; GLYCOSYLATION PATHWAY; ENDOPLASMIC-RETICULUM; AFFECT GROWTH; GENE FAMILY; YEAST; MORPHOGENESIS	O-mannosylation, the addition of mannose to serine and threonine residues of secretory proteins, is a highly conserved post-translational modification found in organisms ranging from bacteria to humans. Here, we report the functional and molecular characterization of the HpPMT4 gene encoding a protein O-mannosyltransferase in the thermotolerant methylotrophic yeast Hansenula polymorpha, an emerging host for the production of therapeutic recombinant proteins. Compared to the deletion of HpPMT1, deletion of another major PMT gene, HpPMT4, resulted in more increased sensitivity to the antibiotic hygromycin B, caffeine, and osmotic stresses, but did not affect the thermotolerance of H. polymorpha. Notably, the deletion of HpPMT4 generated severe defects in glycosylation of the surface sensor proteins HpWsc1p and HpMid2p, with marginal effects on secreted glycoproteins such as chitinase and HpYps1p lacking a GPI anchor. However, despite the severely impaired mannosylation of surface sensor proteins in the Hppmt4 Delta mutant, the phosphorylation of HpMpk1p and HpHog1p still showed a high increase upon treatment with cell wall disturbing agents or high concentrations of salts. The conditional Hppmt1pmt4 Delta double mutant strains displayed severely impaired growth, enlarged cell size, and aberrant cell separation, implying that the loss of HpPMT4 function might be lethal to cells in the absence of HpPmt1p. Moreover, the HpPmt4 protein was found to form not only a homomeric complex but also a heteromeric complex with either HpPmt1p or HpPmt2p. Altogether, our results support the function of HpPmt4p as a key player in O-mannosylation of cell surface proteins and its participation in the formation of heterodimers with other PMT members, besides homodimer formation, in H. polymorpha.	[Kim, Hyunah; Thak, Eun Jung; Lee, Dong-Jik; Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Agaphonov, Michael O.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia	Chung Ang University; Research Center of Biotechnology RAS; Russian Academy of Sciences	Kang, HA (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	hyunkang@cau.ac.kr	Agaphonov, Michael/U-7791-2018; THAK, EUN JUNG/GZA-5450-2022	Agaphonov, Michael/0000-0002-9270-9476; 	National Research Foundation of Korea (NRF) [NRF-2013M3A6A8073554]; Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [914007-4]; Russian Scientific Foundation [14-14-00361]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Russian Scientific Foundation(Russian Science Foundation (RSF))	The work was supported by the National Research Foundation of Korea (NRF), grant No NRF-2013M3A6A8073554 (Global Frontier Program for the Intelligent Synthetic Biology) and by the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, grant No. 914007-4 (Strategic Initiative for Microbiomes in Agriculture and Food). M. Agaphonov was supported by Russian Scientific Foundation grant 14-14-00361.	Agaphonov M, 2010, YEAST, V27, P189, DOI 10.1002/yea.1741; Agaphonov MO, 2005, YEAST, V22, P1037, DOI 10.1002/yea.1297; Agaphonov MO, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-15; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Arroyo J, 2011, MOL MICROBIOL, V79, P1529, DOI 10.1111/j.1365-2958.2011.07537.x; Avsar-Ban E, 2010, GLYCOBIOLOGY, V20, P1089, DOI 10.1093/glycob/cwq069; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; BOGDANOVA AI, 1995, YEAST, V11, P343, DOI 10.1002/yea.320110407; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Cheon SA, 2012, J MICROBIOL, V50, P341, DOI 10.1007/s12275-012-2097-2; Cheon SA, 2009, YEAST, V26, P507, DOI 10.1002/yea.1701; CHEREST H, 1992, GENETICS, V130, P51; Chigira Y, 2008, GLYCOBIOLOGY, V18, P303, DOI 10.1093/glycob/cwn008; Ecker M, 2003, EMBO REP, V4, P628, DOI 10.1038/sj.embor.embor864; Fernandez-Alvarez A, 2009, PLANT CELL, V21, P3397, DOI 10.1105/tpc.109.065839; Gellissen G, 2005, FEMS YEAST RES, V5, P1079, DOI 10.1016/j.femsyr.2005.06.004; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Gonzalez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065924; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Hamilton SR, 2013, GLYCOBIOLOGY, V23, P1192, DOI 10.1093/glycob/cwt056; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Hollenberg CP, 1997, CURR OPIN BIOTECH, V8, P554, DOI 10.1016/S0958-1669(97)80028-6; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Petkova MI, 2012, FUNGAL GENET BIOL, V49, P903, DOI 10.1016/j.fgb.2012.08.005; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Kang HA, 1998, YEAST, V14, P371, DOI 10.1002/(SICI)1097-0061(19980315)14:4<371::AID-YEA231>3.3.CO;2-T; Kim H, 2013, FUNGAL GENET BIOL, V58-59, P10, DOI 10.1016/j.fgb.2013.08.003; Kim MW, 2006, J BIOL CHEM, V281, P6261, DOI 10.1074/jbc.M508507200; Kim MW, 2004, GLYCOBIOLOGY, V14, P243, DOI 10.1093/glycob/cwh030; Kriangkripipat T, 2014, FEBS OPEN BIO, V4, P335, DOI 10.1016/j.fob.2014.03.006; Kriangkripipat T, 2009, EUKARYOT CELL, V8, P1475, DOI 10.1128/EC.00040-09; Kuroda K, 2008, APPL ENVIRON MICROB, V74, P446, DOI 10.1128/AEM.02106-07; LEVINE DW, 1973, APPL MICROBIOL, V26, P982, DOI 10.1128/AEM.26.6.982-990.1973; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Murakami-Sekimata A, 2009, GENES CELLS, V14, P205, DOI 10.1111/j.1365-2443.2008.01263.x; Nett JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068325; Oh Doo-Byoung, 2008, Biotechnology Journal, V3, P659, DOI 10.1002/biot.200700252; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Sanders SL, 1999, J CELL BIOL, V145, P1177, DOI 10.1083/jcb.145.6.1177; SIMON MN, 1995, NATURE, V376, P702, DOI 10.1038/376702a0; Sohn JH, 1996, J BACTERIOL, V178, P4420, DOI 10.1128/jb.178.15.4420-4428.1996; Sohn MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100725; Sohn MJ, 2012, YEAST, V29, P1, DOI 10.1002/yea.1912; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Timpel C, 2000, J BACTERIOL, V182, P3063, DOI 10.1128/JB.182.11.3063-3071.2000; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; van Dijk R, 2000, ENZYME MICROB TECH, V26, P793, DOI 10.1016/S0141-0229(00)00173-3; Wang H, 2013, WORLD J MICROB BIOT, V29, P447, DOI 10.1007/s11274-012-1197-9; Weber Y, 2004, EUKARYOT CELL, V3, P1164, DOI 10.1128/EC.3.5.1164-1168.2004; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Zakrzewska A, 2003, CURR GENET, V43, P11, DOI 10.1007/s00294-003-0368-5	73	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0129914	10.1371/journal.pone.0129914	http://dx.doi.org/10.1371/journal.pone.0129914			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134523	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400012
J	Llewellyn, KJ; Walker, N; Nguyen, C; Tan, B; BenMohamed, L; Kimonis, VE; Nalbandian, A				Llewellyn, Katrina J.; Walker, Naomi; Nguyen, Christopher; Tan, Baichang; BenMohamed, Lbachir; Kimonis, Virginia E.; Nalbandian, Angele			A Fine Balance of Dietary Lipids Improves Pathology of a Murine Model of VCP-Associated Multisystem Proteinopathy	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; KETOGENIC DIET; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; GENETIC-HETEROGENEITY; MUSCULAR-DYSTROPHY; AUTOPHAGY; BONE; EPILEPSY	The discovery of effective therapies and of disease mechanisms underlying valosin containing protein (VCP)-associated myopathies and neurodegenerative disorders remains elusive. VCP disease, caused by mutations in the VCP gene, are a clinically and genetically heterogeneous group of disorders with manifestations varying from hereditary inclusion body myopathy, Paget's disease of bone, frontotemporal dementia (IBMPFD), and amyotrophic lateral sclerosis (ALS). In the present study, we examined the effects of higher dietary lipid percentages on VCPR155H/R155H, VCPR155H/+ and Wild Type (WT) mice from birth until 15 months of age by immunohistochemical and biochemical assays. Findings illustrated improvement in the muscle strength, histology, and autophagy signaling pathway in the heterozygote mice when fed 9% lipid-enriched diets (LED). However, increasing the LED by 12%, 30%, and 48% showed no improvement in homozygote and heterozygote survival, muscle pathology, lipid accumulation or the autophagy cascade. These findings suggest that a balanced lipid supplementation may have a therapeutic strategy for patients with VCP-associated multisystem proteinopathies.	[Llewellyn, Katrina J.; Walker, Naomi; Nguyen, Christopher; Tan, Baichang; Kimonis, Virginia E.; Nalbandian, Angele] Univ Calif Irvine, Dept Pediat, Div Genet & Genom Med, Irvine, CA 92697 USA; [Llewellyn, Katrina J.; Kimonis, Virginia E.; Nalbandian, Angele] Univ Calif Irvine, Sue & Bill Gross Stem Inst, Irvine, CA 92697 USA; [BenMohamed, Lbachir] Univ Calif Irvine, Sch Med, Gavin Herbert Eye Inst, Lab Cellular & Mol Immunol, Irvine, CA 92697 USA; [BenMohamed, Lbachir] Univ Calif Irvine, Sch Med, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Nalbandian, A (corresponding author), Univ Calif Irvine, Dept Pediat, Div Genet & Genom Med, Irvine, CA 92697 USA.	a.nalbandian@uci.edu			National Institutes of Health (NIH) [R21 AR063360]; Muscular Dystrophy Association (MDA) [175682]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant R21 AR063360 and Muscular Dystrophy Association (MDA) 175682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Camargo N, 2012, FASEB J, V26, P4302, DOI 10.1096/fj.12-205807; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Heng MY, 2010, AUTOPHAGY, V6, P1206, DOI 10.4161/auto.6.8.13617; Jozwiak S, 2011, NEUROL NEUROCHIR POL, V45, P370; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kimonis VE, 2008, BIOCH BIOPHYSICA ACT; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kovach MJ, 2001, GENET MED, V3, P197, DOI 10.1097/00125817-200105000-00009; Lee HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036221; Li BM, 2013, EXP THER MED, V5, P611, DOI 10.3892/etm.2012.823; Llewellyn KJ, 2014, HUM MOL GENET, V23, P1333, DOI 10.1093/hmg/ddt523; Luan GM, 2012, BRAIN RES BULL, V89, P79, DOI 10.1016/j.brainresbull.2012.07.002; Lunemann JD, 2007, AUTOPHAGY, V3, P384; Moresi V, 2012, P NATL ACAD SCI USA, V109, P1649, DOI 10.1073/pnas.1121159109; Nalbandian A, 2012, MUSCLE NERV IN PRESS; Nalbandian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076187; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522; Nalbandian A, 2012, CTS-CLIN TRANSL SCI, V5, P226, DOI 10.1111/j.1752-8062.2012.00407.x; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Noh HS, 2008, EPILEPSIA, V49, P120, DOI 10.1111/j.1528-1167.2008.01855.x; Peuscher R, 2012, JIMD REP, V5, P127, DOI 10.1007/8904_2011_115; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Schiaffino S, 2008, AUTOPHAGY, V4, P727, DOI 10.4161/auto.6143; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Siva N, 2006, LANCET NEUROL, V5, P476, DOI 10.1016/S1474-4422(06)70462-8; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Yin HZ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.115	40	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131995	10.1371/journal.pone.0131995	http://dx.doi.org/10.1371/journal.pone.0131995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134519	gold, Green Published			2022-12-26	WOS:000358154400092
J	Borg, RJ; Samson, AL; Au, AEL; Scholzen, A; Fuchsberger, M; Kong, YY; Freeman, R; Mifsud, NA; Plebanski, M; Medcalf, RL				Borg, Rachael J.; Samson, Andre L.; Au, Amanda E. -L.; Scholzen, Anja; Fuchsberger, Martina; Kong, Ying Y.; Freeman, Roxann; Mifsud, Nicole A.; Plebanski, Magdalena; Medcalf, Robert L.			Dendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by Plasmin	PLOS ONE			English	Article							GROWTH-FACTOR; APOPTOTIC CELLS; PROTEIN-KINASE; TGF-BETA; PROMOTES; PATHWAY; CLEARANCE; MIGRATION; INJURY; SERUM	Removal of dead cells in the absence of concomitant immune stimulation is essential for tissue homeostasis. We recently identified an injury-induced protein misfolding event that orchestrates the plasmin-dependent proteolytic degradation of necrotic cells. As impaired clearance of dead cells by the innate immune system predisposes to autoimmunity, we determined whether plasmin could influence endocytosis and immune cell stimulation by dendritic cells - a critical cell that links the innate and adaptive immune systems. We find that plasmin generated on the surface of necrotic cells enhances their phagocytic removal by human monocyte-derived dendritic cells. Plasmin also promoted phagocytosis of protease-resistant microparticles by diverse mouse dendritic cell sub-types both in vitro and in vivo. Together with an increased phagocytic capacity, plasmin-treated dendritic cells maintain an immature phenotype, exhibit reduced migration to lymph nodes, increase their expression/release of the immunosuppressive cytokine TGF-beta, and lose their capacity to mount an allogeneic response. Collectively, our findings support a novel role for plasmin formed on dead cells and other phagocytic targets in maintaining tissue homeostasis by increasing the phagocytic function of dendritic cells while simultaneously decreasing their immunostimulatory capacity consistent with producing an immunosuppressive state.	[Borg, Rachael J.; Samson, Andre L.; Au, Amanda E. -L.; Freeman, Roxann; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Samson, Andre L.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3181, Australia; [Scholzen, Anja; Fuchsberger, Martina; Kong, Ying Y.; Plebanski, Magdalena] Monash Univ, Dept Immunol, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Mifsud, Nicole A.] Monash Univ, Dept Med, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Mifsud, Nicole A.] Alfred Med Res & Educ Precinct, Dept Allergy Immunol & Resp Med, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University; Monash University	Medcalf, RL (corresponding author), Monash Univ, Australian Ctr Blood Dis, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia.	Robert.medcalf@monash.edu	Scholzen, Anja/D-1046-2013; Medcalf, Robert L/E-9632-2011; Plebanski, Magdalena/AAU-3144-2021	Scholzen, Anja/0000-0001-6481-6090; Samson, Andre/0000-0002-0637-2716; Au, Amanda/0000-0003-3656-2673; Mifsud, Nicole/0000-0001-8647-2102; , Magdalena/0000-0001-6889-3667	National Health and Medical Research Council of Australia [606659]; National Health and Medical Research Council Principal Research Fellowship [10441520, 1059409]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported in part by a grant awarded to R.L.M. and A.L.S. from the National Health and Medical Research Council of Australia, grant #606659. R.L.M. and M.P. are also recipients of National Health and Medical Research Council Principal Research Fellowship (R.L.M.; #10441520 or a Senior Research Fellowship (M.P.; #1059409).	Appel S, 2005, CLIN CANCER RES, V11, P1928, DOI 10.1158/1078-0432.CCR-04-1713; Au AEL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.373; Becker JC, 2013, CANCER IMMUNOL IMMUN, V62, P1137, DOI 10.1007/s00262-013-1434-6; BURTIN P, 1985, INT J CANCER, V35, P307, DOI 10.1002/ijc.2910350305; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Das R, 2014, BLOOD, V124, P679, DOI 10.1182/blood-2014-01-549659; Guo YZ, 2008, ARTHRITIS RHEUM, V58, P764, DOI 10.1002/art.23263; Guo YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024774; Haka AS, 2013, ARTERIOSCL THROM VAS, V33, P1768, DOI 10.1161/ATVBAHA.112.301109; Ho-Tin-Noe B, 2009, MOL CELL NEUROSCI, V42, P288, DOI 10.1016/j.mcn.2009.08.001; KABAKOV AE, 1994, ARCH BIOCHEM BIOPHYS, V309, P247, DOI 10.1006/abbi.1994.1109; Kao JY, 2003, J IMMUNOL, V170, P3806, DOI 10.4049/jimmunol.170.7.3806; Karlson TD, 2013, METHODS, V60, P275, DOI 10.1016/j.ymeth.2013.02.009; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lee WC, 1998, TRANSPLANTATION, V66, P1810, DOI 10.1097/00007890-199812270-00040; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Li Q, 2010, MOL IMMUNOL, V47, P2405, DOI 10.1016/j.molimm.2010.03.015; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Li XH, 2010, ARTERIOSCL THROM VAS, V30, P582, DOI 10.1161/ATVBAHA.109.202044; Lighvani S, 2011, BLOOD, V118, P5622, DOI 10.1182/blood-2011-03-344242; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Machovich R, 1997, FEBS LETT, V407, P93, DOI 10.1016/S0014-5793(97)00303-7; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Mottram PL, 2007, MOL PHARMACEUT, V4, P73, DOI 10.1021/mp060096p; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Napirei M, 2004, ARTHRITIS RHEUM-US, V50, P1873, DOI 10.1002/art.20267; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Rosenwald M, 2012, J IMMUNOL, V189, P5722, DOI 10.4049/jimmunol.1200922; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Samson AL, 2012, CELL REP, V2, P889, DOI 10.1016/j.celrep.2012.08.026; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shen Y, 2012, BLOOD, V119, P5879, DOI 10.1182/blood-2012-01-407825; Silva MT, 2010, J LEUKOCYTE BIOL, V88, P885, DOI 10.1189/jlb.0410205; Suzuki J, 2008, EXPERT OPIN THER TAR, V12, P1313, DOI [10.1517/14728222.12.11.1313, 10.1517/14728222.12.11.1313 ]; TAMURA M, 1989, EXP EYE RES, V48, P761, DOI 10.1016/0014-4835(89)90062-6; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; WILSON E, 1987, P NATL ACAD SCI USA, V84, P2213, DOI 10.1073/pnas.84.8.2213; Xiang SD, 2008, EXPERT REV VACCINES, V7, P1103, DOI 10.1586/14760584.7.7.1103; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	44	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131216	10.1371/journal.pone.0131216	http://dx.doi.org/10.1371/journal.pone.0131216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132730	Green Published, gold			2022-12-26	WOS:000358153000104
J	Conrad, JL				Conrad, Jack L.			A New Eocene Casquehead Lizard (Reptilia, Corytophanidae) from North America	PLOS ONE			English	Article							SQUAMATA; SYSTEMATICS; CLIMATES	A new fossil showing affinities with extant Laemanctus offers the first clear evidence for a casquehead lizard (Corytophanidae) from the Eocene of North America. Along with Geiseltaliellus from roughly coeval rocks in central Europe, the new find further documents the tropical fauna present during greenhouse conditions in the northern mid-latitudes approximately 50 million years ago (Ma). Modern Corytophanidae is a neotropical clade of iguanian lizards ranging from southern Mexico to northern South America.	[Conrad, Jack L.] NYIT Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Conrad, Jack L.] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA	New York Institute Technology; American Museum of Natural History (AMNH)	Conrad, JL (corresponding author), NYIT Coll Osteopath Med, Dept Anat, Northern Blvd, Old Westbury, NY 11568 USA.	jack.conrad@gmail.com			Anatomy Department at NYIT College of Osteopathic Medicine; Division Of Earth Sciences [1258878] Funding Source: National Science Foundation	Anatomy Department at NYIT College of Osteopathic Medicine; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Jack L. Conrad received funding through startup funds from the Anatomy Department at NYIT College of Osteopathic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 2001, T GEOBIOL, V18, P165; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2006, HIST BIOL, V18, P405, DOI 10.1080/08912960600679570; Conrad JL, 2014, ANAT REC, V297, P545, DOI 10.1002/ar.22868; Conrad JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041767; Conrad JL, 2011, CLADISTICS, V27, P230, DOI 10.1111/j.1096-0031.2010.00330.x; Conrad JL, 2008, AM MUS NOVIT, P1, DOI 10.1206/596.1; Conrad JL, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3584[1:ACLCIS]2.0.CO;2; Conrad JL, 2006, J VERTEBR PALEONTOL, V26, P113, DOI 10.1671/0272-4634(2006)26[113:AESRSF]2.0.CO;2; Cuvier GLCF, 1817, REGNE ANIMAL DISTRIB; Demar DG, 2012, J VERTEBR PALEONTOL, V32, P86; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; ESTES R, 1980, PALAEOGEOGR PALAEOCL, V30, P325, DOI 10.1016/0031-0182(80)90064-4; Estes R, 1983, SAURIA TERRESTRIA AM; FROST D R, 1989, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Gao K., 1996, B CARNEGIE MUSEUM NA, V33, P1; Gao KQ, 2000, B AM MUS NAT HIST, P1; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gilmore C. W., 1928, Mem Nat Acad Sci Washington, V22, P1; Grande L, 1984, GEOLOGICAL SURVEY WY, V63, P1, DOI DOI 10.1021/MA0493168); GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Mahler DL, 2006, INTEGR COMP BIOL, V126; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Nydam RL, 2007, J HERPETOL, V41, P211, DOI 10.1670/0022-1511(2007)41[211:TSLFTL]2.0.CO;2; Nydam RL, 2002, J VERTEBR PALEONTOL, V22, P286, DOI 10.1671/0272-4634(2002)022[0286:LFTLCA]2.0.CO;2; Nydam RL, 2002, J VERTEBR PALEONTOL, V22, P645, DOI 10.1671/0272-4634(2002)022[0645:LOTMLF]2.0.CO;2; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Oppel M., 1811, ORDNUNGEN FAMILIEN G; Page R. D. M., 2001, NDE NEXUS DATA EDITO; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; ROSE KD, 2006, BEGINNING AGE MAMMAL; SAVAGE JM, 1966, COPEIA, P719; Smith KT, 2011, BONN ZOOL MONOGR, P9; SULLIVAN R M, 1979, Bulletin of the American Museum of Natural History, V163, P1; The Deep Scaly Project, 2008, COR CRIST; The Deep Scaly Project, 2006, AN CAR; The Deep Scaly Project, 2006, BAS BAS; Vanzolini P.E., 1985, Topics in Geobiology, V4, P475; Vieira GHC, 2005, ZOOL SCR, V34, P605, DOI 10.1111/j.1463-6409.2005.00208.x; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Zug G. R., 1971, Smithsonian Contributions to Zoology, VNo. 83, P1; Zug G. R., 2001, HERPETOLOGY, P57	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0127900	10.1371/journal.pone.0127900	http://dx.doi.org/10.1371/journal.pone.0127900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131767	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000011
J	de Bie, HMA; de Ruiter, MB; Ouwendijk, M; Oostrom, KJ; Wilke, M; Boersma, M; Veltman, DJ; Delemarre-van de Waal, HA				de Bie, Henrica M. A.; de Ruiter, Michiel B.; Ouwendijk, Mieke; Oostrom, Kim J.; Wilke, Marko; Boersma, Maria; Veltman, Dick J.; Delemarre-van de Waal, Henriette A.			Using fMRI to Investigate Memory in Young Children Born Small for Gestational Age	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; INTRAUTERINE GROWTH; WORKING-MEMORY; STREAM DEVELOPMENT; ADOLESCENTS; RESTRICTION; MOTION; CONNECTIVITY; PERFORMANCE; ACTIVATION	Objectives Intrauterine growth restriction (IUGR) can lead to infants being born small for gestational age (SGA). SGA is associated with differences in brain anatomy and impaired cognition. We investigated learning and memory in children born SGA using neuropsychological testing and functional Magnetic Resonance Imaging (fMRI). Study Design 18 children born appropriate for gestational age (AGA) and 34 SGA born children (18 with and 16 without postnatal catch-up growth) participated in this study. All children were between 4 and 7 years old. Cognitive functioning was assessed by IQ and memory testing (Digit/Word Span and Location Learning). A newly developed fMRI picture encoding task was completed by all children in order to assess brain regions involved in memory processes. Results Neuropsychological testing demonstrated that SGA children had IQ's within the normal range but lower than in AGA and poorer performances across measures of memory. Using fMRI, we observed memory related activity in posterior parahippocampal gyrus as well as the hippocampus proper. Additionally, activation was seen bilaterally in the prefrontal gyrus. Children born SGA showed less activation in the left parahippocampal region compared to AGA. Conclusions This is the first fMRI study demonstrating different brain activation patterns in 4-7 year old children born SGA, suggesting that intrauterine growth restriction continues to affect neural functioning in children later-on.	[de Bie, Henrica M. A.; Delemarre-van de Waal, Henriette A.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands; [de Ruiter, Michiel B.] Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Ouwendijk, Mieke; Oostrom, Kim J.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Psychol, Amsterdam, Netherlands; [Wilke, Marko] Univ Tubingen, Childrens Hosp, Dept Pediat Neurol & Dev Med, Tubingen, Germany; [Wilke, Marko] Univ Tubingen, Childrens Hosp, Expt Pediat Neuroimaging Neuroimaging Grp, Tubingen, Germany; [Boersma, Maria] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Delemarre-van de Waal, Henriette A.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands	Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ouwendijk, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat Psychol, Amsterdam, Netherlands.	m.ouwendijk@vumc.nl			Pfizer bv, the Netherlands	Pfizer bv, the Netherlands(Netherlands Government)	This work was financially supported by an educational grant from Pfizer bv, the Netherlands. The funder had no role in study design, data collection, decision to publish or preparing the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baron IS, 2012, CHILD NEUROPSYCHOL, V18, P586, DOI 10.1080/09297049.2011.631906; Bernal B, 2003, RADIOLOGY, V229, P651, DOI 10.1148/radiol.2293021746; Boersma M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00600; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Chemaly M, 2014, J CLIN ANESTH, V26, P551, DOI 10.1016/j.jclinane.2014.03.013; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; de Bie HMA, 2010, HORM RES PAEDIAT, V73, P6, DOI 10.1159/000271911; De Bie HMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024116; de Bie HMA, 2010, EUR J PEDIATR, V169, P1079, DOI 10.1007/s00431-010-1181-z; de Ruiter MB, 2012, DRUG ALCOHOL DEPEN, V121, P81, DOI 10.1016/j.drugalcdep.2011.08.010; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Egana-Ugrinovic G, 2014, ULTRASOUND OBST GYN, V44, P322, DOI 10.1002/uog.13360; Egana-Ugrinovic G, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.008; Ergaz Z, 2005, REPROD TOXICOL, V20, P301, DOI 10.1016/j.reprotox.2005.04.007; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gathers AD, 2004, NEUROREPORT, V15, P1549, DOI 10.1097/01.wnr.0000133299.84901.86; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ghetti S, 2010, J NEUROSCI, V30, P9548, DOI 10.1523/JNEUROSCI.3500-09.2010; Golby AJ, 2001, BRAIN, V124, P1841, DOI 10.1093/brain/124.9.1841; Greicius MD, 2003, HIPPOCAMPUS, V13, P164, DOI 10.1002/hipo.10064; Heinzel S, 2014, J NEUROSCI, V34, P1224, DOI 10.1523/JNEUROSCI.2463-13.2014; Horovitz SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067931; Karunanayaka PR, 2007, NEUROIMAGE, V34, P349, DOI 10.1016/j.neuroimage.2006.08.028; Kaufman AS, 1996, J CLIN CHILD PSYCHOL, V25, P97, DOI 10.1207/s15374424jccp2501_11; Klaric AS, 2013, J CHILD NEUROL, V28, P867, DOI 10.1177/0883073812452790; Klaver P, 2008, NEUROIMAGE, V39, P1815, DOI 10.1016/j.neuroimage.2007.11.009; Kotsoni E, 2006, J MAGN RESON IMAGING, V23, P877, DOI 10.1002/jmri.20578; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Lichtensteiger J, 2008, NEUROREPORT, V19, P1763, DOI 10.1097/WNR.0b013e328318ede3; Lister JP, 2005, HIPPOCAMPUS, V15, P393, DOI 10.1002/hipo.20065; LoBello SG, 2011, J SCH PSYCHOL, V29, P229; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lundgren EM, 2001, PEDIATR RES, V50, P91, DOI 10.1203/00006450-200107000-00017; LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610; Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2; Maril A, 2010, NEUROLOGY, V75, P2110, DOI 10.1212/WNL.0b013e318201526e; Martinussen M, 2009, J PEDIATR-US, V155, P848, DOI 10.1016/j.jpeds.2009.06.015; Menon V, 2005, COGNITIVE BRAIN RES, V25, P379, DOI 10.1016/j.cogbrainres.2005.07.007; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nagel BJ, 2005, J CLIN EXP NEUROPSYC, V27, P823, DOI 10.1080/13803390490919038; Noeker M, 2005, HORM RES, V64, P83, DOI 10.1159/000089322; O'Shaughnessy ES, 2008, J CHILD NEUROL, V23, P791, DOI 10.1177/0883073807313047; Ofen N, 2007, NAT NEUROSCI, V10, P1198, DOI 10.1038/nn1950; Padilla N, 2014, BRAIN RES, V1545, P1, DOI 10.1016/j.brainres.2013.12.007; Plante E, 2006, BRAIN LANG, V97, P332, DOI 10.1016/j.bandl.2005.12.004; Radlowski EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091951; Reber PJ, 2002, HIPPOCAMPUS, V12, P363, DOI 10.1002/hipo.10018; Rittey CD, 2003, J NEUROL NEUROSUR PS, V74, DOI 10.1136/jnnp.74.suppl_1.i30; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Sanz-Cortes M, 2013, FETAL DIAGN THER, V33, P122, DOI 10.1159/000346566; Schouten A, 2002, DEV MED CHILD NEUROL, V44, P803; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Szaflarski JP, 2006, ANN NEUROL, V59, P796, DOI 10.1002/ana.20817; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wilke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106498; Wilke M, 2012, NEUROIMAGE, V59, P2062, DOI 10.1016/j.neuroimage.2011.10.043; Yerys BE, 2009, HUM BRAIN MAPP, V30, P3426, DOI 10.1002/hbm.20767	64	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129721	10.1371/journal.pone.0129721	http://dx.doi.org/10.1371/journal.pone.0129721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132815	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000036
J	Newman, CE; Austin, CC				Newman, Catherine E.; Austin, Christopher C.			Thriving in the Cold: Glacial Expansion and Post-Glacial Contraction of a Temperate Terrestrial Salamander (Plethodon serratus)	PLOS ONE			English	Article							SOUTHEASTERN UNITED-STATES; PHYLOGENETIC ANALYSIS; HAPLOTYPE RECONSTRUCTION; BAYESIAN METHODS; RANGE EXPANSION; CONTACT ZONES; POPULATION; DIVERSIFICATION; INFERENCE; CLIMATE	The dynamic geologic history of the southeastern United States has played a major role in shaping the geographic distributions of amphibians in the region. In the phylogeographic literature, the predominant pattern of distribution shifts through time of temperate species is one of contraction during glacial maxima and persistence in refugia. However, the diverse biology and ecology of amphibian species suggest that a "one-size-fits-all" model may be inappropriate. Nearly 10% of amphibian species in the region have a current distribution comprised of multiple disjunct, restricted areas that resemble the shape of Pleistocene refugia identified for other temperate taxa in the literature. Here, we apply genetics and spatially explicit climate analyses to test the hypothesis that the disjunct regions of these species ranges are climatic refugia for species that were more broadly distributed during glacial maxima. We use the salamander Plethodon serratus as a model, as its range consists of four disjunct regions in the Southeast. Phylogenetic results show that P. serratus is comprised of multiple genetic lineages, and the four regions are not reciprocally monophyletic. The Appalachian salamanders form a clade sister to all other P. serratus. Niche and paleodistribution modeling results suggest that P. serratus expanded from the Appalachians during the cooler Last Glacial Maximum and has since been restricted to its current disjunct distribution by a warming climate. These data reject the universal applicability of the glacial contraction model to temperate taxa and reiterate the importance of considering the natural history of individual species.	[Newman, Catherine E.; Austin, Christopher C.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Newman, Catherine E.; Austin, Christopher C.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Newman, CE (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	newma014@gmail.com		Newman, Catherine/0000-0002-1862-7245	National Science Foundation [DEB 1146033]; Division Of Environmental Biology [1146033, 1405665] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation (DEB 1146033) to CCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CC, 2010, CONSERV GENET, V11, P889, DOI 10.1007/s10592-009-9931-z; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Avise John C., 1996, P431; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bartlein PJ, 1998, QUATERNARY SCI REV, V17, P549, DOI 10.1016/S0277-3791(98)00012-2; Baselga A, 2011, J BIOGEOGR; Bayer CSO, 2012, CONSERV GENET, V13, P443, DOI 10.1007/s10592-011-0297-7; Bisconti R, 2011, MOL ECOL, V20, P5313, DOI 10.1111/j.1365-294X.2011.05363.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Crespi EJ, 2010, HERPETOLOGICA, V66, P283, DOI 10.1655/HERPETOLOGICA-D-09-00002.1; Crnkovic A, 2002, P LOUISIANA ACAD SCI, V63, P44; Donovan MF, 2000, EVOLUTION, V54, P1449, DOI 10.1554/0014-3820(2000)054[1449:BOTSUS]2.0.CO;2; Dorcas M., 2008, FROGS TOADS SE; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fisher-Reid MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-300; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Glor RE, 2010, EVOLUTION N Y    NOV; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HIGHTON R, 1976, EVOLUTION, V30, P33, DOI 10.1111/j.1558-5646.1976.tb00879.x; Highton R, 1971, DISTRIBUTIONAL HIST, P139; Highton R, 2012, MOL PHYLOGENET EVOL; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kearns AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4994; Kozak KH, 2006, MOL ECOL, V15, P191, DOI 10.1111/j.1365-294X.2005.02757.x; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; LaMoreaux HK, 2009, PALAEOGEOGR PALAEOCL, V280, P300, DOI 10.1016/j.palaeo.2009.06.017; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu C, 2013, J BIOGEOGR; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mitchell JC, 2010, SALAMANDERS SE; Neigel J.E., 1986, P515; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; PHILLIPS CA, 1994, EVOLUTION, V48, P597, DOI 10.1111/j.1558-5646.1994.tb01347.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 4; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rissler LJ, 2010, MOL ECOL, V19, P5404, DOI 10.1111/j.1365-294X.2010.04879.x; Rovito SM, 2010, MOL ECOL; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Shepard DB, 2011, MOL PHYLOGENET EVOL, V59, P399, DOI 10.1016/j.ympev.2011.03.007; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Spinks PQ, 2013, MOL PHYLOGENET EVOL; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Thesing BD, 2012, PHYLOGENY ECOLOGICAL, P1; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2014, TRENDS ECOL EVOL, P1, DOI [10.1016/j.tree.2014.10.001, DOI 10.1016/J.TREE.2014.10.001]; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Zamudio KR, 2003, EVOLUTION, V57, P1631	68	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130131	10.1371/journal.pone.0130131	http://dx.doi.org/10.1371/journal.pone.0130131			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132077	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000054
J	Schook, LB; Collares, TV; Hu, WP; Liang, Y; Rodrigues, FM; Rund, LA; Schachtschneider, KM; Seixas, FK; Singh, K; Wells, KD; Walters, EM; Prather, RS; Counter, CM				Schook, Lawrence B.; Collares, Tiago V.; Hu, Wenping; Liang, Ying; Rodrigues, Fernanda M.; Rund, Laurie A.; Schachtschneider, Kyle M.; Seixas, Fabiana K.; Singh, Kuldeep; Wells, Kevin D.; Walters, Eric M.; Prather, Randall S.; Counter, Christopher M.			A Genetic Porcine Model of Cancer	PLOS ONE			English	Article							SOMATIC-CELLS; CLONED PIGS; TUMORIGENESIS; ALIGNMENT	The large size of the pig and its similarity in anatomy, physiology, metabolism, and genetics to humans make it an ideal platform to develop a genetically defined, large animal model of cancer. To this end, we created a transgenic "oncopig" line encoding Cre recombinase inducible porcine transgenes encoding KRAS(G12D) and TP53(R167H), which represent a commonly mutated oncogene and tumor suppressor in human cancers, respectively. Treatment of cells derived from these oncopigs with the adenovirus encoding Cre (AdCre) led to KRAS(G12D) and TP53(R167H) expression, which rendered the cells transformed in culture and tumorigenic when engrafted into immunocompromised mice. Finally, injection of AdCre directly into these oncopigs led to the rapid and reproducible tumor development of mesenchymal origin. Transgenic animals receiving AdGFP (green fluorescent protein) did not have any tumor mass formation or altered histopathology. This oncopig line could thus serve as a genetically malleable model for potentially a wide spectrum of cancers, while controlling for temporal or spatial genesis, which should prove invaluable to studies previously hampered by the lack of a large animal model of cancer.	[Schook, Lawrence B.; Rodrigues, Fernanda M.; Rund, Laurie A.; Schachtschneider, Kyle M.] Univ Illinois, Dept Anim Sci, Champaign Urbana, IL 61801 USA; [Schook, Lawrence B.] Univ Illinois, Dept Bioengn, Champaign Urbana, IL USA; [Schook, Lawrence B.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Collares, Tiago V.; Seixas, Fabiana K.] Univ Fed Pelotas, Technol Dev Ctr, Postgrad Program Biotechnol, Pelotas, RS, Brazil; [Hu, Wenping] China Agr Univ, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China; [Liang, Ying] Univ Kentucky, Dept Internal Med, Lexington, KY USA; [Singh, Kuldeep] Univ Illinois, Vet Diagnost Lab, Champaign Urbana, IL USA; [Wells, Kevin D.; Walters, Eric M.; Prather, Randall S.] Univ Missouri, Div Anim Sci, Natl Swine Res & Resource Ctr, Columbia, MO USA; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidade Federal de Pelotas; China Agricultural University; University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Columbia; Duke University; Duke University	Schook, LB (corresponding author), Univ Illinois, Dept Anim Sci, Champaign Urbana, IL 61801 USA.	schook@illinois.edu	Seixas, Fabiana Kommling/X-2706-2018; Collares, Tiago/K-2779-2019; Collares, Tiago/S-2117-2016	Seixas, Fabiana Kommling/0000-0003-4204-2500; Collares, Tiago/0000-0002-1535-3795; Collares, Tiago/0000-0002-1535-3795; Schook, Lawrence/0000-0002-6580-8364; rund, laurie/0000-0003-0761-7196; Prather, Randall/0000-0002-6012-4035; Counter, Christopher M/0000-0003-0748-3079; Schachtschneider, Kyle/0000-0002-7293-8642; Martins Rodrigues, Fernanda/0000-0002-2140-0690; Walters, Eric/0000-0002-7888-8666	China Scholarship Council (CSC); Brazilian Scholarship Program "Science Without Borders" promoted by the National Counsel of Technological and Scientific Development; American Cancer Society [ACS178898]; U.S. National Institutes of Health [CA123031, CA 153132, U42 OD011140]; Edward Spiegel Fund of the Lymphoma Foundation; United States Department of Agriculture (USDA) [AG 58-5438-2-307]; Edward William & Jane Marr Gutgsell Foundation; Cooperative Research Program for Agriculture Science & Technology Development [PJ009103]; Rural Development Administration, Republic of Korea; NATIONAL CANCER INSTITUTE [R01CA153132, R01CA123031] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000116, UL1TR000117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011140] Funding Source: NIH RePORTER	China Scholarship Council (CSC)(China Scholarship Council); Brazilian Scholarship Program "Science Without Borders" promoted by the National Counsel of Technological and Scientific Development; American Cancer Society(American Cancer Society); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Spiegel Fund of the Lymphoma Foundation; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Edward William & Jane Marr Gutgsell Foundation; Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following: China Scholarship Council (CSC): WH; Brazilian Scholarship Program "Science Without Borders" promoted by the National Counsel of Technological and Scientific Development (http://www.iie.org/Programs/Brazil-Scientific-Mobility): FMR, TVC and FKS; American Cancer Society (http://www.cancer.org/research/applyforaresearchgrant/) (ACS178898): YL; American Cancer Society (http://www.cancer.org/research/applyforaresearchgrant/) (ACS178898): CMC; U.S. National Institutes of Health (http://grants.nih.gov/grants/oer.htm) (CA123031) and the Edward Spiegel Fund of the Lymphoma Foundation (http://www.lymphomafoundation.org/): CMC; United States Department of Agriculture (USDA) (http://www.csrees.usda.gov/) (AG 58-5438-2-307), The U.S. National Institutes of Health (http://grants.nih.gov/grants/oer.htm) (CA 153132), the Edward William & Jane Marr Gutgsell Foundation (http://provost.illinois.edu/about/chairs.html), and the Cooperative Research Program for Agriculture Science & Technology Development (http://www.csrees.usda.gov/) (PJ009103); Rural Development Administration, Republic of Korea (http://www.rda.go.kr/foreign/eng/): LBS; and U.S. National Institutes of Health (U42 OD011140): RSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SJ, 2007, ONCOGENE, V26, P1038, DOI 10.1038/sj.onc.1209892; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cardiff RD, 2008, LAB INVEST, V88, P18, DOI 10.1038/labinvest.3700695; Cardiff RD, 2006, J NUTR, V136, p2673S, DOI 10.1093/jn/136.10.2673S; Cardiff Robert D, 2004, Toxicol Pathol, V32 Suppl 1, P31, DOI 10.1080/01926230490424662; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Gray MA, 2010, EXP BIOL MED, V235, P718, DOI 10.1258/ebm.2010.009339; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kendall SD, 2006, CELL CYCLE, V5, P1074, DOI 10.4161/cc.5.10.2734; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kuzmuk KN, 2011, GENETICS OF THE PIG, 2ND EDITION, P426, DOI 10.1079/9781845937560.0426; Lai LX, 2004, METH MOL B, V254, P149; Lai LX, 2003, CLONING STEM CELLS, V5, P233, DOI 10.1089/153623003772032754; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2009, DNA CELL BIOL, V28, P303, DOI 10.1089/dna.2008.0821; Li S, 2015, TRANSGENIC RES, V24, P509, DOI 10.1007/s11248-015-9866-8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; O'Hagan Ronan C, 2011, Genes Cancer, V2, P335, DOI 10.1177/1947601911408080; Pollock CB, 2007, MAMM GENOME, V18, P210, DOI 10.1007/s00335-007-9007-7; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Schook LB, 2008, DEV BIOLOGICALS, V132, P15, DOI 10.1159/000317140; Sieren JC, 2014, J CLIN INVEST, V124, P4052, DOI 10.1172/JCI75447; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zuber R, 2002, J CELL MOL MED, V6, P189, DOI 10.1111/j.1582-4934.2002.tb00186.x	32	93	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128864	10.1371/journal.pone.0128864	http://dx.doi.org/10.1371/journal.pone.0128864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132737	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000020
J	Ortiz, MC; Lefimil, C; Rodas, PI; Vernal, R; Lopez, M; Acuna-Castillo, C; Imarai, M; Escobar, A				Carolina Ortiz, Maria; Lefimil, Claudia; Rodas, Paula I.; Vernal, Rolando; Lopez, Mercedes; Acuna-Castillo, Claudio; Imarai, Monica; Escobar, Alejandro			Neisseria gonorrhoeae Modulates Immunity by Polarizing Human Macrophages to a M2 Profile	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; PROGRAMMED DEATH LIGAND-1; REGULATORY T-CELLS; DENDRITIC CELLS; CO-STIMULATION; FC-RECEPTORS; ACTIVATION; INFECTION; POLARIZATION; RESPONSES	Current data suggest that Neisseria gonorrhoeae is able to suppress the protective immune response at different levels, such as B and T lymphocytes and antigen-presenting cells. The present report is focused on gonococcus evasion mechanism on macrophages (M phi) and its impact in the subsequent immune response. In response to various signals M phi may undergo classical-M1 (M1-M phi) or alternative-M2 (M2-M phi) activation. Until now there are no reports of the gonococcus effects on human M phi polarization. We assessed the phagocytic ability of monocyte-derived M phi (MDM) upon gonococcal infection by immunofluorescence and gentamicin protection experiments. Then, we evaluated cytokine profile and M1/M2 specific-surface markers on M phi challenged with N. gonorrhoeae and their proliferative effect on T cells. Our findings lead us to suggest N. gonorrhoeae stimulates a M2-M phi phenotype in which some of the M2b and none of the M1-M phi-associated markers are induced. Interestingly, N. gonorrhoeae exposure leads to upregulation of a Programmed Death Ligand 1 (PD-L1), widely known as an immunosuppressive molecule. Moreover, functional results showed that N. gonorrhoeae-treated M phi are unable to induce proliferation of human T-cells, suggesting a more likely regulatory phenotype. Taken together, our data show that N. gonorroheae interferes with M phi polarization. This study has important implications for understanding the mechanisms of clearance versus long-term persistence of N. gonorroheae infection and might be applicable for the development of new therapeutic strategies.	[Carolina Ortiz, Maria; Lefimil, Claudia; Escobar, Alejandro] Univ Chile, Fac Odontol, Inst Invest Ciencias Odontol, Santiago, Chile; [Rodas, Paula I.] Univ Andres Bello, Fac Med, Ctr Integrat Med & Innovat Sci, Santiago, Chile; [Vernal, Rolando] Univ Chile, Fac Odontol, Dept Odontol Conservadora, Santiago, Chile; [Lopez, Mercedes] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Disciplinario Inmunol, Santiago, Chile; [Acuna-Castillo, Claudio; Imarai, Monica] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Lab Inmunol, Santiago, Chile	Universidad de Chile; Universidad Andres Bello; Universidad de Chile; Universidad de Chile; Universidad de Santiago de Chile	Escobar, A (corresponding author), Univ Chile, Fac Odontol, Inst Invest Ciencias Odontol, Santiago, Chile.	janodvm@gmail.com	Lefimil, Claudia A/B-1113-2015; Acuña-Castillo, Claudio/AAI-7090-2021; Vernal, Rolando/A-6285-2008; Escobar, Alejandro/I-2775-2013; Lopez, Mercedes/CAF-4801-2022; Rodas, Paula I./I-3631-2013	Acuña-Castillo, Claudio/0000-0003-3607-6077; Vernal, Rolando/0000-0002-1391-320X; Escobar, Alejandro/0000-0002-1587-4179; Rodas, Paula I./0000-0002-8071-1229; Imarai, Monica/0000-0001-8767-9180	Fondo Nacional de Ciencia y Tecnologia [FONDECYT 11110304]	Fondo Nacional de Ciencia y Tecnologia	This work was supported by grants from the Fondo Nacional de Ciencia y Tecnologia (FONDECYT 11110304). (http://www.conicyt.cl/fondecyt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; [Anonymous], NOVART FDN SYMP, DOI DOI 10.1002/0470871628.CH6; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Christodoulides M, 2000, MOL MICROBIOL, V35, P32, DOI 10.1046/j.1365-2958.2000.01694.x; Ding HL, 2006, CLIN IMMUNOL, V118, P258, DOI 10.1016/j.clim.2005.10.017; Dong HD, 1999, NAT MED, V5, P1365; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Escobar A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/127017; Farley TA, 2003, JAIDS-J ACQ IMM DEF, V33, P642, DOI 10.1097/00126334-200308150-00014; Feinen B, 2010, MUCOSAL IMMUNOL, V3, P312, DOI 10.1038/mi.2009.139; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; GomezDuarte OG, 1997, INFECT IMMUN, V65, P3857; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; HANDSFIELD HH, 1974, NEW ENGL J MED, V290, P117, DOI 10.1056/NEJM197401172900301; Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999; Hirata S, 2005, J IMMUNOL, V174, P1888, DOI 10.4049/jimmunol.174.4.1888; Hristodorov D, 2012, TOXINS, V4, P676, DOI 10.3390/toxins4090676; Imarai M, 2008, INFECT IMMUN, V76, P5456, DOI 10.1128/IAI.00552-08; Jounai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032588; Kiekens RCM, 2000, BRIT J DERMATOL, V142, P1106, DOI 10.1046/j.1365-2133.2000.03534.x; Kiszewski AE, 2006, CLIN EXP IMMUNOL, V143, P445, DOI 10.1111/j.1365-2249.2006.03020.x; Krupnick AS, 2005, J IMMUNOL, V175, P6265, DOI 10.4049/jimmunol.175.10.6265; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Liu Y, 2012, MUCOSAL IMMUNOL, V5, P320, DOI 10.1038/mi.2012.12; Liu Y, 2013, MUCOSAL IMMUNOL, P348; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Mihret Adane, 2011, BMC Res Notes, V4, P247, DOI 10.1186/1756-0500-4-247; Mozaffarian N, 2008, RHEUMATOLOGY, V47, P1335, DOI 10.1093/rheumatology/ken256; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Packiam M, 2010, INFECT IMMUN, V78, P433, DOI 10.1128/IAI.00711-09; Tumitan ARP, 2007, MICROBIOL IMMUNOL, V51, P1021, DOI 10.1111/j.1348-0421.2007.tb03986.x; Peng B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-347; Plant LJ, 2006, INFECT IMMUN, V74, P442, DOI 10.1128/IAI.74.1.442-448.2006; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sundquist M, 2005, J IMMUNOL, V175, P3287, DOI 10.4049/jimmunol.175.5.3287; Vernal R, 2008, ARCH ORAL BIOL, V53, P910, DOI 10.1016/j.archoralbio.2008.04.004; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; World Health Organization, 2012, GLOB ACT PLAN CONTR; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041260; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	54	24	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130713	10.1371/journal.pone.0130713	http://dx.doi.org/10.1371/journal.pone.0130713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125939	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300023
J	Hu, XS; Hu, Y				Hu, Xin-Sheng; Hu, Yang			Genomic Scans of Zygotic Disequilibrium and Epistatic SNPs in HapMap Phase III Populations	PLOS ONE			English	Article							COMPLEX ALLOZYME POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; WIDE ASSOCIATION; LOCI; SUSCEPTIBILITY; DISEASES; TRAIT	Previous theory indicates that zygotic linkage disequilibrium (LD) is more informative than gametic or composite digenic LD in revealing natural population history. Further, the difference between the composite digenic and maximum zygotic LDs can be used to detect epistatic selection for fitness. Here we corroborate the theory by investigating genome-wide zygotic LDs in HapMap phase III human populations. Results show that non-Africa populations have much more significant zygotic LDs than do Africa populations. Africa populations (ASW, LWK, MKK, and YRI) possess more significant zygotic LDs for the double-homozygotes (D-AABB) than any other significant zygotic LDs (D-AABb, D-AaBB, and D-AaBb), while non-Africa populations generally have more significant D-AaBb's than any other significant zygotic LDs (D-AABB, D-AABb, and D-AaBB). Average r-squares for any significant zygotic LDs increase generally in an order of populations YRI, MKK, CEU, CHB, LWK, JPT, CHD, TSI, GIH, ASW, and MEX. Average r-squares are greater for D-AABB and D-AaBb than for D-AaBB and D-AABb in each population. YRI and MKK can be separated from LWK and ASW in terms of the pattern of average r-squares. All population divergences in zygotic LDs can be interpreted with the model of Out of Africa for modern human origins. We have also detected 19735-95921 SNP pairs exhibiting strong signals of epistatic selection in different populations. Gene-gene interactions for some epistatic SNP pairs are evident from empirical findings, but many more epistatic SNP pairs await evidence. Common epistatic SNP pairs rarely exist among all populations, but exist in distinct regions (Africa, Europe, and East Asia), which helps to understand geographical genomic medicine.	[Hu, Xin-Sheng] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Hu, Yang] Univ Alberta, Dept Comp Sci, Edmonton, AB T6G 2S4, Canada	University of Oxford; University of Alberta	Hu, XS (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	xinsheng.hu@gmail.com						Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Cavalli-Sforza LL, 1999, HIST GEOGRAPHY HUMAN; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; COCKERHAM CC, 1973, THEOR POPUL BIOL, V4, P300, DOI 10.1016/0040-5809(73)90013-0; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Douroudis K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-11; Falconer D. S., 1996, INTRO QUANTITATIVE G; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Goldstein DB, 2001, CURR BIOL, V11, pR576, DOI 10.1016/S0960-9822(01)00348-7; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Hu XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100568; Hu XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080538; Hu XS, 2011, CURR GENOMICS, V12, P55, DOI 10.2174/138920211794520141; Jiang Q, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-65; KIRBY DA, 1995, P NATL ACAD SCI USA, V92, P9047, DOI 10.1073/pnas.92.20.9047; Lance GN, 1996, COMPUT J, V9, P60; Li J, 2011, BIOINFORMATICS, V27, pI222, DOI 10.1093/bioinformatics/btr227; Liu T, 2006, GENETICS, V174, P439, DOI 10.1534/genetics.106.060137; Lobkovsky AE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002302; McInerney-Leo AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/j.ajhg.2013.06.022; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Mortlock D, 2012, CURRENT PROTOCOLS HU, P1101; Motsinger AA, 2007, PHARMACOGENOMICS, V8, P1229, DOI 10.2217/14622416.8.9.1229; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sarmiento J, 2015, J IMMUNOL, V194, P615, DOI 10.4049/jimmunol.1302689; Schwartz-Marin Ernesto, 2010, IDENTITY INFORM SOC, V3, P489; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stringer C., 1996, AFRICAN EXODUS ORIGI; Suzuki R., 2011, PACKAGE PVCLUST HIER; Tattersall I, 2009, P NATL ACAD SCI USA, V106, P16018, DOI 10.1073/pnas.0903207106; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Wang Z, 2010, P 9 WORLD C GEN APPL; WEIR BS, 1974, GENETICS, V78, P911; WEIR BS, 1972, GENETICS, V72, P505; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Weir BS, 1996, GENETIC AATA ANAL 2; Wolpoff MH, 1996, SCIENCE, V274, P704; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wright S., 1977, EVOLUTION GENETICS P, V3; Yang RC, 2003, GENETICS, V165, P447; Yang RC, 2002, GENETICS, V161, P435; [No title captured]	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131039	10.1371/journal.pone.0131039	http://dx.doi.org/10.1371/journal.pone.0131039			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126177	Green Submitted, gold, Green Published			2022-12-26	WOS:000358151300032
J	Cardona, M; Lopez, JA; Serafin, A; Rongvaux, A; Inserte, J; Garcia-Dorado, D; Flavell, R; Llovera, M; Canas, X; Vazquez, J; Sanchis, D				Cardona, Maria; Antonio Lopez, Juan; Serafin, Anna; Rongvaux, Anthony; Inserte, Javier; Garcia-Dorado, David; Flavell, Richard; Llovera, Marta; Canas, Xavier; Vazquez, Jesus; Sanchis, Daniel			Executioner Caspase-3 and 7 Deficiency Reduces Myocyte Number in the Developing Mouse Heart	PLOS ONE			English	Article							CELL-DEATH; DIFFERENTIATED CARDIOMYOCYTES; ENDONUCLEASE-G; APOPTOSIS; EXPRESSION; MICE; PROLIFERATION; PROTEINS; DNA; HYPERTROPHY	Executioner caspase-3 and -7 are proteases promoting cell death but non-apoptotic roles are being discovered. The heart expresses caspases only during development, suggesting they contribute to the organ maturation process. Therefore, we aimed at identifying novel functions of caspases in heart development. We induced simultaneous deletion of executioner caspase-3 and -7 in the mouse myocardium and studied its effects. Caspase knockout hearts are hypoplastic at birth, reaching normal weight progressively through myocyte hypertrophy. To identify the molecular pathways involved in these effects, we used microarray-based transcriptomics and multiplexed quantitative proteomics to compare wild type and executioner caspase-deficient myocardium at different developmental stages. Transcriptomics showed reduced expression of genes promoting DNA replication and cell cycle progression in the neonatal caspase-deficient heart suggesting reduced myocyte proliferation, and expression of non-cardiac isoforms of structural proteins in the adult null myocardium. Proteomics showed reduced abundance of proteins involved in oxidative phosphorylation accompanied by increased abundance of glycolytic enzymes underscoring retarded metabolic maturation of the caspase-null myocardium. Correlation between mRNA expression and protein abundance of relevant genes was confirmed, but transcriptomics and proteomics indentified complementary molecular pathways influenced by caspases in the developing heart. Forced expression of wild type or proteolytically inactive caspases in cultured cardiomyocytes induced expression of genes promoting cell division. The results reveal that executioner caspases can modulate heart's cellularity and maturation during development, contributing novel information about caspase biology and heart development.	[Cardona, Maria; Llovera, Marta; Sanchis, Daniel] Univ Lleida IRBLLEIDA, Dept Ciencies Med Basiques, Lleida 25198, Spain; [Antonio Lopez, Juan; Vazquez, Jesus] CNIC, Madrid 28029, Spain; [Serafin, Anna] PCB PRBB Anim Facil Alliance Parc Cient Barcelona, Barcelona 08028, Spain; [Rongvaux, Anthony; Flavell, Richard] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Rongvaux, Anthony; Flavell, Richard] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Inserte, Javier; Garcia-Dorado, David] Hosp Univ Vall Hebron UAB, Inst Recerca, Barcelona 08035, Spain	Universitat de Lleida; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Yale University; Howard Hughes Medical Institute; Yale University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Sanchis, D (corresponding author), Univ Lleida IRBLLEIDA, Dept Ciencies Med Basiques, Av Rovira Roure 80, Lleida 25198, Spain.	daniel.sanchis@cmb.udl.cat	Inserte, Javier/S-6061-2019; Vazquez, Jesus/B-7697-2015; Lopez, Juan Antonio/G-7750-2015; Sanchis, Daniel/C-8077-2009; Llovera, Marta/AAE-4230-2021; Llovera, Marta/B-5585-2009	Inserte, Javier/0000-0002-4736-5010; Vazquez, Jesus/0000-0003-1461-5092; Lopez, Juan Antonio/0000-0002-9097-6060; Sanchis, Daniel/0000-0003-0047-8533; Llovera, Marta/0000-0001-8399-6867; Serafin, Anna/0000-0002-9486-8948	Ministerio de Economia y Competitividad (MINECO) [SAF2010_19125, SAF2013_44942, SAF2010-37926, ProteoRed-PT13/0001/0017]; Program Redes Tematicas de Investigacion Cooperativa en Salud (RETICS) Grants [RD12/0042/0035, RD12/0042/0056, RD12/0042/0021]; Red de Investigacion Cardiovascular, RIC; Instituto de Salud Carlos III (ISCIII) [FIS-PI121738]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2009SGR-346]	Ministerio de Economia y Competitividad (MINECO); Program Redes Tematicas de Investigacion Cooperativa en Salud (RETICS) Grants; Red de Investigacion Cardiovascular, RIC; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was partially supported by Ministerio de Economia y Competitividad (MINECO) (Grants SAF2010_19125 and SAF2013_44942 to D. S. and SAF2010-37926 and ProteoRed-PT13/0001/0017 to J.V.); Program Redes Tematicas de Investigacion Cooperativa en Salud (RETICS) Grants RD12/0042/0035, RD12/0042/0056 and RD12/0042/0021, Red de Investigacion Cardiovascular, RIC to DS, JV and DGD. and FIS-PI121738 to DGD. from Instituto de Salud Carlos III (ISCIII); Grant 2009SGR-346 from the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) to XC and DS. RAF is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Bahi N, 2006, J BIOL CHEM, V281, P22943, DOI 10.1074/jbc.M601025200; Brentnall M, 2014, J CELL SCI, V127, P2217, DOI 10.1242/jcs.135137; Buikema JW, 2013, DEVELOPMENT, V140, P4165, DOI 10.1242/dev.099325; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; DAY ML, 1987, HYPERTENSION, V9, P485, DOI 10.1161/01.HYP.9.5.485; Del Re DP, 2014, MOL CELL, V54, P639, DOI 10.1016/j.molcel.2014.04.007; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Ebelt H, 2008, CARDIOVASC RES, V80, P219, DOI 10.1093/cvr/cvn194; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Inserte J, 2009, J MOL CELL CARDIOL, V46, P160, DOI 10.1016/j.yjmcc.2008.11.011; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2006, J CELL BIOL, V173, P165, DOI 10.1083/jcb.200509092; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Madden SD, 2007, INT J DEV BIOL, V51, P415, DOI 10.1387/ijdb.062263sm; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Meng P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.326; Mlettinen TP, 2014, CURR BIOL, V24, P598, DOI 10.1016/j.cub.2014.01.071; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tamura T, 1998, J MOL CELL CARDIOL, V30, P2175, DOI 10.1006/jmcc.1998.0775; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Watanabe M, 2001, DEV BIOL, V240, P274, DOI 10.1006/dbio.2001.0466; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87; Zhang JS, 2007, FEBS LETT, V581, P5781, DOI 10.1016/j.febslet.2007.11.046; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536	49	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131411	10.1371/journal.pone.0131411	http://dx.doi.org/10.1371/journal.pone.0131411			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121671	Green Submitted, Green Published, gold			2022-12-26	WOS:000358150400106
J	Demmer, JK; Huang, H; Wang, SN; Demmer, U; Thauer, RK; Ermler, U				Demmer, Julius K.; Huang, Haiyan; Wang, Shuning; Demmer, Ulrike; Thauer, Rudolf K.; Ermler, Ulrich			Insights into Flavin-based Electron Bifurcation via the NADH-dependent Reduced Ferredoxin:NADP Oxidoreductase Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROOROTATE DEHYDROGENASE-B; CRYSTAL-STRUCTURE; DIHYDROPYRIMIDINE DEHYDROGENASE; FERREDOXIN-NADP(+) REDUCTASE; HETERODISULFIDE REDUCTASE; TRANSFERRING FLAVOPROTEIN; COMPLEX; PROTEIN; FORMATE; CLUSTER	NADH-dependent reduced ferredoxin: NADP oxidoreductase (NfnAB) is found in the cytoplasm of various anaerobic bacteria and archaea. The enzyme reversibly catalyzes the endergonic reduction of ferredoxin with NADPH driven by the exergonic transhydrogenation from NADPH onto NAD(+). Coupling is most probably accomplished via the mechanism of flavin-based electron bifurcation. To understand this process on a structural basis, we heterologously produced the NfnAB complex of Thermotoga maritima in Escherichia coli, provided kinetic evidence for its bifurcating behavior, and determined its x-ray structure in the absence and presence of NADH. The structure of NfnAB reveals an electron transfer route including the FAD (a-FAD), the [2Fe-2S] cluster of NfnA and the FAD (b-FAD), and the two [4Fe-4S] clusters of NfnB. Ferredoxin is presumably docked onto NfnB close to the [4Fe-4S] cluster distal to b-FAD. NAD(H) binds to a-FAD and NADP(H) consequently to b-FAD, which is positioned in the center of the NfnAB complex and the site of electron bifurcation. Arg(187) is hydrogen-bonded to N-5 and O-4 of the bifurcating b-FAD and might play a key role in adjusting a low redox potential of the FADH(center dot)/FAD pair required for ferredoxin reduction. A mechanism of FAD-coupled electron bifurcation by NfnAB is proposed.	[Demmer, Julius K.; Demmer, Ulrike; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Demmer, Julius K.; Huang, Haiyan; Wang, Shuning; Thauer, Rudolf K.] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany	Max Planck Society; Max Planck Society	Thauer, RK (corresponding author), Max Planck Inst Terr Mikrobiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	thauer@mpi-marburg.mpg.de; ulrich.ermler@biophys.mpg.de		Wang, Shuning/0000-0002-1166-078X; Demmer, Julius K./0000-0002-5232-3069	Max-Planck Society	Max-Planck Society(Max Planck Society)	This work was supported by the Max-Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Aliverti A, 1999, METH MOL B, V131, P9; ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bertsch J, 2013, J BIOL CHEM, V288, P11304, DOI 10.1074/jbc.M112.444919; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; CHEN JS, 1974, BIOCHIM BIOPHYS ACTA, V371, P283, DOI 10.1016/0005-2795(74)90025-7; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Corrado ME, 1996, EUR J BIOCHEM, V239, P662, DOI 10.1111/j.1432-1033.1996.0662u.x; Costa KC, 2013, J BACTERIOL, V195, P5160, DOI 10.1128/JB.00895-13; Costa KC, 2010, P NATL ACAD SCI USA, V107, P11050, DOI 10.1073/pnas.1003653107; Cottevieille M, 2008, J BIOL CHEM, V283, P8237, DOI 10.1074/jbc.M708529200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; Dickert S, 2000, EUR J BIOCHEM, V267, P3874, DOI 10.1046/j.1432-1327.2000.01427.x; Dobritzsch D, 2002, J BIOL CHEM, V277, P13155, DOI 10.1074/jbc.M111877200; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hagen WR, 2000, EUR J BIOCHEM, V267, P3640, DOI 10.1046/j.1432-1327.2000.01393.x; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Huang HY, 2012, J BACTERIOL, V194, P3689, DOI 10.1128/JB.00385-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2004, PHOTOSYNTH RES, V81, P303, DOI 10.1023/B:PRES.0000036884.57303.2e; Kaster AK, 2011, ARCHAEA, V2011, DOI 10.1155/2011/973848; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lebedev AA, 2006, ACTA CRYSTALLOGR D, V62, P83, DOI 10.1107/S0907444905036759; Lee M, 2010, J MOL BIOL, V404, P600, DOI 10.1016/j.jmb.2010.09.050; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Lie TJ, 2012, P NATL ACAD SCI USA, V109, P15473, DOI 10.1073/pnas.1208779109; MacedoRibeiro S, 1996, STRUCTURE, V4, P1291, DOI 10.1016/S0969-2126(96)00137-2; Mohsen AWA, 2004, BIOCHEMISTRY-US, V43, P6498, DOI 10.1021/bi036179i; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PIERIK AJ, 1992, EUR J BIOCHEM, V206, P697, DOI 10.1111/j.1432-1033.1992.tb16976.x; Ravasio S, 2001, BIOCHEMISTRY-US, V40, P5533, DOI 10.1021/bi0100889; Rowland P, 2000, STRUCTURE, V8, P1227, DOI 10.1016/S0969-2126(00)00530-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; SMITH ET, 1995, BIOCHEMISTRY-US, V34, P7161, DOI 10.1021/bi00021a030; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; WAHL RC, 1987, J BIOL CHEM, V262, P10489; Wang SN, 2013, J BACTERIOL, V195, P4373, DOI 10.1128/JB.00678-13; Wang SN, 2013, APPL ENVIRON MICROB, V79, P6176, DOI 10.1128/AEM.02015-13; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Weghoff MC, 2015, ENVIRON MICROBIOL, V17, P670, DOI 10.1111/1462-2920.12493	52	59	59	1	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21985	21995		10.1074/jbc.M115.656520	http://dx.doi.org/10.1074/jbc.M115.656520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26139605	Green Published, hybrid			2022-12-26	WOS:000360968500019
J	Tsalikis, J; Tattoli, I; Ling, A; Sorbara, MT; Croitoru, DO; Philpott, DJ; Girardin, SE				Tsalikis, Jessica; Tattoli, Ivan; Ling, Arthur; Sorbara, Matthew T.; Croitoru, David O.; Philpott, Dana J.; Girardin, Stephen E.			Intracellular Bacterial Pathogens Trigger the Formation of U Small Nuclear RNA Bodies (U Bodies) through Metabolic Stress Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; SMN COMPLEX; INNATE IMMUNITY; CAJAL BODY; PROTEIN; SURVIVAL; TRANSLATION; KINASE; SNRNAS; MTOR	Invasive bacterial pathogens induce an amino acid starvation (AAS) response in infected host cells that controls host defense in part by promoting autophagy. However, whether AAS has additional significant effects on the host response to intracellular bacteria remains poorly characterized. Here we showed that Shigella, Salmonella, and Listeria interfere with spliceosomal U snRNA maturation in the cytosol. Bacterial infection resulted in the rerouting of U snRNAs and their cytoplasmic escort, the survival motor neuron (SMN) complex, to processing bodies, thus forming U snRNA bodies (U bodies). This process likely contributes to the decline in the cytosolic levels of U snRNAs and of the SMN complex proteins SMN and DDX20 that we observed in infected cells. U body formation was triggered by membrane damage in infected cells and was associated with the induction of metabolic stresses, such as AAS or endoplasmic reticulum stress. Mechanistically, targeting of U snRNAs to U bodies was regulated by translation initiation inhibition and the ATF4/ATF3 pathway, and U bodies rapidly disappeared upon removal of the stress, suggesting that their accumulation represented an adaptive response to metabolic stress. Importantly, this process likely contributed to shape the host response to invasive bacteria because down-regulation of DDX20 expression using short hairpin RNA (shRNA) amplified ATF3- and NF-kappa B-dependent signaling. Together, these results identify a critical role for metabolic stress and invasive bacterial pathogens in U body formation and suggest that this process contributes to host defense.	[Tsalikis, Jessica; Tattoli, Ivan; Ling, Arthur; Croitoru, David O.; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M6G 2T6, Canada; [Tattoli, Ivan; Sorbara, Matthew T.; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M6G 2T6, Canada	University of Toronto; University of Toronto	Girardin, SE (corresponding author), Univ Toronto, Med Sci Bldg,Rm 6336, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca	Tattoli, Ivan/H-2600-2017	Tattoli, Ivan/0000-0001-7925-4609	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to D. J. P and S. E. G). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Nour M, 2014, IMMUNOL CELL BIOL, V92, P346, DOI 10.1038/icb.2014.3; Balachandran Siddharth, 2007, V383, P277, DOI 10.1007/978-1-59745-335-6_18; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Buckingham M, 2011, EXP CELL RES, V317, P2835, DOI 10.1016/j.yexcr.2011.09.001; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Chang TH, 2013, BBA-GENE REGUL MECH, V1829, P764, DOI 10.1016/j.bbagrm.2013.02.006; Custer SK, 2014, MOL CELL NEUROSCI, V61, P133, DOI 10.1016/j.mcn.2014.06.006; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Eulalio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017296; Garcera A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.209; Ghezala HA, 2012, NUCLEIC ACIDS RES, V40, P9557, DOI 10.1093/nar/gks762; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kumar V, 2000, J BIOL CHEM, V275, P10779, DOI 10.1074/jbc.275.15.10779; Kye MJ, 2014, HUM MOL GENET, V23, P6318, DOI 10.1093/hmg/ddu350; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu JL, 2007, P NATL ACAD SCI USA, V104, P11655, DOI 10.1073/pnas.0704977104; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Sahashi K, 2012, GENE DEV, V26, P1874, DOI 10.1101/gad.197418.112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shukla S, 2014, P NATL ACAD SCI USA, V111, pE3277, DOI 10.1073/pnas.1412614111; Suzuki T, 2010, J CELL BIOL, V190, P603, DOI 10.1083/jcb.201004109; Takata A, 2012, BIOCHEM BIOPH RES CO, V420, P564, DOI 10.1016/j.bbrc.2012.03.034; Tattoli I, 2013, EMBO J, V32, P3066, DOI 10.1038/emboj.2013.234; Tattoli I, 2012, BIOL OPEN, V1, P1215, DOI 10.1242/bio.20122840; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Tsalikis J, 2013, CELL MICROBIOL, V15, P1632, DOI 10.1111/cmi.12165; Valadkhan S, 2010, PROTEOMICS, V10, P4128, DOI 10.1002/pmic.201000354; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	45	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20904	20918		10.1074/jbc.M115.659466	http://dx.doi.org/10.1074/jbc.M115.659466			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134566	Green Published, hybrid			2022-12-26	WOS:000360011800026
J	Hernandez-Rocamora, VM; Alfonso, C; Margolin, W; Zorrilla, S; Rivas, G				Hernandez-Rocamora, Vctor M.; Alfonso, Carlos; Margolin, William; Zorrilla, Silvia; Rivas, German			Evidence That Bacteriophage lambda Kil Peptide Inhibits Bacterial Cell Division by Disrupting FtsZ Protofilaments and Sequestering Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETON PROTEINS; QUANTITATIVE-ANALYSIS; FILAMENT DYNAMICS; SIZE-DISTRIBUTION; MINCDE SYSTEM; POLYMERIZATION; CYTOKINESIS; BINDING; ASSAY; RING	The effects of Kil peptide from bacteriophage lambda on the assembly of Escherichia coli FtsZ into one subunit thick protofilaments were studied using combined biophysical and biochemical methods. Kil peptide has recently been identified as the factor from bacteriophage lambda responsible for the inhibition of bacterial cell division during lytic cycle, targeting FtsZ polymerization. Here, we show that this antagonist blocks FtsZ assembly into GTP-dependent protofilaments, producing a wide distribution of smaller oligomers compared with the average size of the intact protofilaments. The shortening of FtsZ protofilaments by Kil is detectable at concentrations of the peptide in the low micromolar range, the midpoint of the inhibition being close to its apparent affinity for GDP-bound FtsZ. This antagonist not only interferes with FtsZ assembly but also reverses the polymerization reaction. The negative regulation by Kil significantly reduces the GTPase activity of FtsZ protofilaments, and FtsZ polymers assembled in guanosine-5'-[(alpha,beta)-methyleno] triphosphate are considerably less sensitive to Kil. Our results suggest that, at high concentrations, Kil may use an inhibition mechanism involving the sequestration of FtsZ subunits, similar to that described for other inhibitors like the SOS response protein SulA or the moonlighting enzyme OpgH. This mechanism is different from those employed by the division site selection antagonists MinC and SlmA. This work provides new insight into the inhibition of FtsZ assembly by phages, considered potential tools against bacterial infection.	[Hernandez-Rocamora, Vctor M.; Alfonso, Carlos; Zorrilla, Silvia; Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Margolin, William] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Texas System; University of Texas Health Science Center Houston	Hernandez-Rocamora, VM (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	silvia@cib.csic.es; grivas@cib.csic.es	Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Regan, Clinton/E-6250-2012; Rivas, German/AAG-7458-2022; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Rivas, German/0000-0003-3450-7478; Zorrilla, Silvia/0000-0002-6309-9058; Hernandez-Rocamora, Victor M./0000-0003-2517-5707	National Institutes of Health [GM61074]; Human Frontier Science Program [RGP0050/2010]; Spanish Government [BIO2011-28941-C03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Spanish Government(Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61074 (to W. M.). This work was also supported by Human Frontier Science Program Grant RGP0050/2010 (to G. R. and W. M.) and Spanish Government Grant BIO2011-28941-C03 (to G. R. and S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahijado-Guzman R, 2013, J BIOL CHEM, V288, P27358, DOI 10.1074/jbc.M113.482943; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; Du SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004460; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Haeusser DP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004217; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Masuda H, 2012, FEMS MICROBIOL LETT, V328, P174, DOI 10.1111/j.1574-6968.2012.02496.x; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rivas German, 2013, Biophys Rev, V5, P63, DOI 10.1007/s12551-013-0115-1; Rosales T, 2008, ANAL BIOCHEM, V381, P270, DOI 10.1016/j.ab.2008.05.056; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROYER CA, 1990, ANAL BIOCHEM, V191, P287, DOI 10.1016/0003-2697(90)90221-T; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Skakun VV, 2005, EUR BIOPHYS J BIOPHY, V34, P323, DOI 10.1007/s00249-004-0453-9; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; Trusca D, 1998, J BACTERIOL, V180, P3946, DOI 10.1128/JB.180.15.3946-3953.1998; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yu XC, 1998, J BIOL CHEM, V273, P10216, DOI 10.1074/jbc.273.17.10216; Zorrilla S, 2008, BIOPHYS J, V95, P4403, DOI 10.1529/biophysj.108.135863	55	11	12	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20325	20335		10.1074/jbc.M115.653329	http://dx.doi.org/10.1074/jbc.M115.653329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124275	Green Published, hybrid			2022-12-26	WOS:000359608900031
J	Amaya, R; Pierides, A; Tarbell, JM				Amaya, Ronny; Pierides, Alexis; Tarbell, John M.			The Interaction between Fluid Wall Shear Stress and Solid Circumferential Strain Affects Endothelial Gene Expression	PLOS ONE			English	Article							FACTOR-KAPPA-B; CAROTID BIFURCATION; PHASE-ANGLE; IN-VITRO; HYPERCHOLESTEROLEMIC RABBITS; THERAPEUTIC IMPLICATIONS; SCAVENGER RECEPTOR; VE-CADHERIN; FAS LIGAND; ATHEROSCLEROSIS	Endothelial cells lining the walls of blood vessels are exposed simultaneously to wall shear stress (WSS) and circumferential stress (CS) that can be characterized by the temporal phase angle between WSS and CS (stress phase angle-SPA). Regions of the circulation with highly asynchronous hemodynamics (SPA close to -180 degrees) such as coronary arteries are associated with the development of pathological conditions such as atherosclerosis and intimal hyperplasia whereas more synchronous regions (SPA closer to 0 degrees) are spared of disease. The present study evaluates endothelial cell gene expression of 42 atherosclerosis-related genes under asynchronous hemodynamics (SPA=-180 degrees) and synchronous hemodynamics (SPA= 0 degrees). This study used a novel bioreactor to investigate the cellular response of bovine aortic endothelial cells (BAECS) exposed to a combination of pulsatile WSS and CS at SPA= 0 or SPA=-180. Using a PCR array of 42 genes, we determined that BAECS exposed to non-reversing sinusoidal WSS (10 +/- 10 dyne/cm(2)) and CS (4 +/- 4 %) over a 7 hour testing period displayed 17 genes that were up regulated by SPA = -180 degrees, most of them proatherogenic, including NF kappa B and other NF kappa B target genes. The up regulation of NF kappa B p50/p105 and p65 by SPA =-180 degrees was confirmed by Western blots and immunofluorescence staining demonstrating the nuclear translocation of NF kappa B p50/p105 and p65. These data suggest that asynchronous hemodynamics (SPA=-180 degrees) can elicit proatherogenic responses in endothelial cells compared to synchronous hemodynamics without shear stress reversal, indicating that SPA may be an important parameter characterizing arterial susceptibility to disease.	[Amaya, Ronny; Pierides, Alexis; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Tarbell, JM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu			National Institutes of Health [HL 086543]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL 086543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2010, ACTA PHARMACOL SIN, V31, P1103, DOI 10.1038/aps.2010.131; Barseghian A, 2011, J AM COLL CARDIOL, V57, P761, DOI 10.1016/j.jacc.2010.11.011; Berardi DE, 2009, CELL MOL BIOENG, V2, P320, DOI 10.1007/s12195-009-0073-7; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cancel LM, 2010, ATHEROSCLEROSIS, V208, P335, DOI 10.1016/j.atherosclerosis.2009.07.051; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Dancu MB, 2004, ARTERIOSCL THROM VAS, V24, P2088, DOI 10.1161/01.ATV.0000143855.85343.0e; Dancu MB, 2007, ATHEROSCLEROSIS, V192, P9, DOI 10.1016/j.atherosclerosis.2006.05.042; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Ishino S, 2007, ATHEROSCLEROSIS, V195, P48, DOI 10.1016/j.atherosclerosis.2006.11.031; Joshi AK, 2004, ARTERIOSCL THROM VAS, V24, P2408, DOI 10.1161/01.ATV.0000147118.97474.4b; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; KOSLOW AR, 1986, J BIOMECH ENG-T ASME, V108, P338, DOI 10.1115/1.3138625; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055; Li JJ, 2005, MED HYPOTHESES, V64, P694, DOI 10.1016/j.mehy.2004.11.043; Lucerna M, 2007, BLOOD, V109, P122, DOI 10.1182/blood-2006-07-031773; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Miao H, 2005, J VASC RES, V42, P77, DOI 10.1159/000083094; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Mofrad MRK, 2010, CELLULAR MECHANOTRAN, V465, pxii; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Nagase M, 1998, J BIOL CHEM, V273, P33702, DOI 10.1074/jbc.273.50.33702; Naj AC, 2010, CIRC-CARDIOVASC GENE, V3, P47, DOI 10.1161/CIRCGENETICS.109.903195; NEUHAUS KL, 1980, Z KARDIOL, V69, P235; Nuotio K, 2007, STROKE, V38, P1791, DOI 10.1161/STROKEAHA.106.478867; Oscuii HN, 2007, J MECH MED BIOL, V7, P433; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; Qiao DH, 2012, J BIOL CHEM, V287, P5898, DOI 10.1074/jbc.M111.325282; Qiu YC, 1996, ASAIO J, V42, pM702, DOI 10.1097/00002480-199609000-00078; Qiu YC, 2000, J VASC RES, V37, P147, DOI 10.1159/000025726; Sadeghi MR, 2011, J BIOMECH, V44, P2614, DOI 10.1016/j.jbiomech.2011.08.017; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Schneider DB, 2000, ARTERIOSCL THROM VAS, V20, P298, DOI 10.1161/01.ATV.20.2.298; Schulick AH, 1998, P NATL ACAD SCI USA, V95, P6983, DOI 10.1073/pnas.95.12.6983; Singh NP, 2007, MOL PHARMACOL, V71, P145, DOI 10.1124/mol.106.028365; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Steinman DA, 2002, MAGN RESON MED, V47, P149, DOI 10.1002/mrm.10025; Stoneman VEA, 2004, CLIN SCI, V107, P343, DOI 10.1042/CS20040086; Tada S, 2005, ANN BIOMED ENG, V33, P1202, DOI 10.1007/s10439-005-5630-1; Tada S, 2007, BIOPHYS J, V93, P3026, DOI 10.1529/biophysj.106.100685; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; Toda M, 2008, J BIOTECHNOL, V133, P239, DOI 10.1016/j.jbiotec.2007.08.009; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG DL, 1993, BIOCHEM BIOPH RES CO, V195, P1050, DOI 10.1006/bbrc.1993.2150; Wang WL, 2008, J CELL PHYSIOL, V214, P750, DOI 10.1002/jcp.21271; Wilson SH, 2000, ATHEROSCLEROSIS, V148, P23, DOI 10.1016/S0021-9150(99)00211-7; Yang ZH, 2006, CLIN MED RES, V4, P53, DOI 10.3121/cmr.4.1.53; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	58	31	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129952	10.1371/journal.pone.0129952	http://dx.doi.org/10.1371/journal.pone.0129952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147292	Green Published, gold			2022-12-26	WOS:000358157600027
J	Chen, Q; Sun, XD; Cao, H; Zhang, GC; Chen, LW; Hu, YN				Chen, Qiang; Sun, Xu-Dong; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Hu, Yun-Nan			Echocardiographic Evaluation of Changes in Cardiac Hemodynamics and Loading Conditions after Transthoracic Minimally Invasive Device Closure of Atrial Septal Defect	PLOS ONE			English	Article							RIGHT-VENTRICULAR FUNCTION; TRANSCATHETER CLOSURE; 3-DIMENSIONAL ECHOCARDIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CHILDREN; VOLUME; SYNCHRONICITY; OCCLUSION; OCCLUDER; IMPACTS	Purpose To evaluate transthoracic minimally invasive device closure of atrial septal defects by performing transthoracic echocardiography to measure changes in cardiac hemodynamics and loading conditions. Methods Between January 2012 and December 2012, we performed transthoracic minimally invasive device closure of atrial septal defects in 95 patients with secundum atrial septal defects (ASD), and performed transthoracic echocardiography to measure blood flow velocities at the tricuspid valve orifice and at the pulmonary valve orifice, sizes of the left and right atria and ventricles, right ventricular fractional area change, right ventricular Tei index, three-dimensional right ventricular ejection fraction, tricuspid annular plane systolic excursion and left ventricular ejection fractions before the procedure and 1 week, 3 months, and 1 year post-procedure. Results Varying degrees of improvement were observed post-procedure at later time points. The maximum blood flow velocity at the pulmonary valve orifice, mean flow velocity, velocity-time integral, and A peak and E peak blood flow velocity at the tricuspid valve orifice decreased significantly post-procedure (P < 0.05). In 3 months and 1 year's follow-up, the inner diameter of the middle portion of the pulmonary artery, and diameters of the right atrium and right ventricle decreased significantly post-procedure (P < 0.05). The diameters of the left atrium and left ventricle increased after the procedure (P < 0.05). One week after the procedure, the right ventricular fractional area change, three-dimensional right ventricular ejection fraction, right ventricular Tei index and tricuspid annular plane systolic excursion had significantly reduced compared with the preoperative data (P < 0.05). While these four parameters were still decreased at the 3 months and at 1 year's follow-up, but the differences were not statistically significant compared with the 1 week's postoperative data (P > 0.05). One week post-procedure, left ventricular ejection fraction had not changed significantly, but at 3 months and at 1 year post-procedure, left ejection fraction had increased significantly compared with the preoperative data (P < 0.05). Conclusion Echocardiographic evaluation has demonstrated that cardiac hemodynamics and loading conditions improved significantly after transthoracic minimally invasive device closure of atrial septal defects.	[Chen, Qiang; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Hu, Yun-Nan] Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China; [Sun, Xu-Dong] Fujian Med Univ, Union Hosp, Dept Cardiol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University	Chen, Q (corresponding author), Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China.	chenqiang2228@163.com			Chinese national program; Fujian provincial key clinical specialty construction program	Chinese national program; Fujian provincial key clinical specialty construction program	This research was sponsored by Chinese national and Fujian provincial key clinical specialty construction programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agac MT, 2012, ECHOCARDIOGR-J CARD, V29, P358, DOI 10.1111/j.1540-8175.2011.01558.x; Anavekar NS, 2008, AM J CARDIOL, V101, P607, DOI 10.1016/j.amjcard.2007.09.115; Aytemir K, 2013, CONGENIT HEART DIS, V8, P418, DOI 10.1111/chd.12057; Bartakian S, 2013, JACC-CARDIOVASC INTE, V6, P974, DOI 10.1016/j.jcin.2013.05.007; Chen Q, 2012, EUR J CARDIO-THORAC, V41, P121, DOI 10.1016/j.ejcts.2011.04.001; Chen QA, 2011, J THORAC CARDIOV SUR, V141, P631, DOI 10.1016/j.jtcvs.2010.07.077; Chen Q, 2010, ANN THORAC SURG, V89, P1250, DOI 10.1016/j.athoracsur.2010.01.004; Ding JD, 2009, ECHOCARDIOGR-J CARD, V26, P1146, DOI 10.1111/j.1540-8175.2009.00941.x; Ding JD, 2009, ACTA CARDIOL, V64, P303, DOI 10.2143/AC.64.3.2038014; Erdem A, 2013, INT J CARDIOVAS IMAG, V29, P53, DOI 10.1007/s10554-011-9933-z; Eroglu E, 2013, ECHOCARDIOGR-J CARD, V30, P324, DOI 10.1111/echo.12053; Gao CH, 2010, ECHOCARDIOGR-J CARD, V27, P324, DOI 10.1111/j.1540-8175.2009.01054.x; Grison A, 2007, J AM SOC ECHOCARDIOG, V20, P921, DOI 10.1016/j.echo.2007.01.018; Hongxin L, 2005, CHINESE J SURG, V43, P653; Jiang L, 1997, ECHOCARDIOGR-J CARD, V14, P189, DOI 10.1111/j.1540-8175.1997.tb00711.x; Kaya MG, 2010, PEDIATR CARDIOL, V31, P474, DOI 10.1007/s00246-009-9623-y; KIRKLIN JW, 1993, CARDIAC SURG, P609; Kucinska B, 2010, ARCH MED SCI, V6, P567, DOI 10.5114/aoms.2010.14469; Lee MS, 2013, CARDIOL CLIN, V31, P441, DOI 10.1016/j.ccl.2013.04.004; Ma XJ, 2008, ECHOCARDIOGR-J CARD, V25, P1101, DOI 10.1111/j.1540-8175.2008.00730.x; Manole S, 2012, MED ULTRASON, V14, P331; Mesihovic-Dinarevic Senka, 2012, Acta Med Acad, V41, P145, DOI 10.5644/ama2006-124.47; Nunez-Gil IJ, 2011, REV ESP CARDIOL, V64, P674, DOI [10.1016/j.recesp.2011.04.006, 10.1016/j.rec.2011.04.005]; Rigatelli G, 2012, AM J CARDIOVASC DIS, V2, P68; Takaya Y, 2013, J INTERV CARDIOL, V26, P195, DOI 10.1111/joic.12002; Tamborini G, 2010, J AM SOC ECHOCARDIOG, V23, P109, DOI 10.1016/j.echo.2009.11.026; Taniguchi M, 2013, INT J CARDIOVAS IMAG, V29, P1273, DOI 10.1007/s10554-013-0212-z; Tao L, 2006, ANN THORAC SURG, V81, P1417, DOI 10.1016/j.athoracsur.2005.09.081; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; Tomar M, 2011, ANN PEDIAT CARDIOL, V4, P22, DOI 10.4103/0974-2069.79618; Vitarelli A, 2012, INT J CARDIOVAS IMAG, V28, P1905, DOI 10.1007/s10554-012-0022-8; Watanabe N, 2012, J AM SOC ECHOCARDIOG, V25, P376, DOI 10.1016/j.echo.2012.01.002; Zanjani KS, 2011, IRAN J PEDIATR, V21, P473	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128475	10.1371/journal.pone.0128475	http://dx.doi.org/10.1371/journal.pone.0128475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147594	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600013
J	Cheng, QH; Zhang, JL; Wang, HW; Zhang, RJ; Yue, Y; Li, L				Cheng, Qinghao; Zhang, Jieli; Wang, Hongwu; Zhang, Rujin; Yue, Yun; Li, Lei			Effect of Acute Hypercapnia on Outcomes and Predictive Risk Factors for Complications among Patients Receiving Bronchoscopic Interventions under General Anesthesia	PLOS ONE			English	Article							FREQUENCY JET VENTILATION; SHORTENS EMERGENCE TIME; PERMISSIVE HYPERCAPNIA; RIGID BRONCHOSCOPY; HYPERVENTILATION; SURGERY	Background The aim of this study is to investigate the effect of acute hypercapnia on surgery outcomes among patients receiving bronchoscopic interventions under general anesthesia. Furthermore, independent predictive factors for surgery complications were analyzed. Method A total of 323 patients with airway stenosis were enrolled in this retrospective study. Each patient underwent interventional rigid bronchoscopy under general anesthesia. Arterial blood gas (ABG) was measured intraoperatively. In light of PaCO2 levels in ABG, patients were divided into three groups: Group C (control) (PaCO2:<= 60 mmHg), Group M (moderate) (PaCO2: 61-100 mmHg), and Group S (severe) (PaCO2: > 100 mmHg). Parameters, including PaO2 levels and recovery delays, were compared across three groups. Complications among patients receiving bronchoscopic interventions were evaluated as well. Independent predictive factors for surgery related complications were analyzed by multivariable regression method. Results Significant differences in weight (p=0.04), ASA IV (p=0.008), dyspnea index (p=0.003), COPD (p=0.02), dynamic airway collapse (p=0.002), severe stenosis severity (p=0.02), and stenosis locations among three groups were observed. Mild (PaCO2:similar to 60 mmHg) to moderate (PaCO2:60-100 mmHg) hypercapnia was not associated with delayed recovery, whereas severe hypercapnia (PaCO2:>100 mmHg) was associated with delayed recovery, as well as declined PaO2 (p=0.00) and elevated blood glucose levels (p=0.00). The complications of bronchoscopic interventions included postoperative congestive heart failure (14 cases, 4.3%), tracheorrhagia (8 cases, 2.5%), delayed recovery (19 cases, 5.9%), and transfers to ICU after surgery (10 cases, 3.1%). The multivariable regression analysis showed that procedure duration (p=0.003), lobectomy (p=0.007), dynamic airway collapse (p=0.01), severe bronchial stenosis (p=0.01) and hypercapnia (p=0.02) were independent predictive factors for surgery related complications. Conclusions Acute hypercapnia lower than 100 mmHg was not associated with detrimental consequences, whereas severe hypercapnia (PaCO2: >100 mmHg) was associated with lower levels of PaO2. Hypercapnia was an independent predictive factor for bronchoscopic intervention complication, which may help physicians to optimize the therapeutic choices.	[Cheng, Qinghao; Li, Lei] China Meitan Gen Hosp, Dept Anesthesiol, Beijing 100028, Peoples R China; [Zhang, Jieli; Wang, Hongwu] China Meitan Gen Hosp, Minimal Invas Tumor Therapy Ctr, Beijing 100028, Peoples R China; [Zhang, Rujin] Beijing United Family Hosp, Dept Anesthesiol, Beijing 100015, Peoples R China; [Yue, Yun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing 100020, Peoples R China	Capital Medical University	Li, L (corresponding author), China Meitan Gen Hosp, Dept Anesthesiol, Beijing 100028, Peoples R China.	lilei927@126.com						Bourgain JL, 2001, BRIT J ANAESTH, V87, P870, DOI 10.1093/bja/87.6.870; Buczkowski PW, 2007, BRIT J ANAESTH, V99, P891, DOI 10.1093/bja/aem312; Conacher ID, 2004, ANAESTHESIA, V59, P290, DOI 10.1111/j.1365-2044.2004.03610.x; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Fernandez-Bustamante A, 2006, J CLIN ANESTH, V18, P349, DOI 10.1016/j.jclinane.2005.12.011; Ginsberg Robert J., 1997, P858; Gopalakrishnan NA, 2007, ANESTH ANALG, V104, P815, DOI 10.1213/01.ane.0000255199.43961.87; Gorden JA, 2009, SEMIN THORAC CARDIOV, V21, P263, DOI 10.1053/j.semtcvs.2009.08.002; Hautmann H, 2000, ANESTH ANALG, V90, P1436, DOI 10.1097/00000539-200006000-00034; Jin FG, 2008, RESPIRATION, V76, P429, DOI 10.1159/000151656; Mas A, 2000, CRIT CARE MED, V28, P360, DOI 10.1097/00003246-200002000-00012; Morisaki H, 1999, ACTA ANAESTH SCAND, V43, P845, DOI 10.1034/j.1399-6576.1999.430811.x; Mukhtar AM, 2008, ANESTH ANALG, V106, P84, DOI 10.1213/01.ane.0000297419.02643.d7; Natalini G, 1999, EUR J ANAESTH, V16, P605, DOI 10.1046/j.1365-2346.1999.00548.x; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; Sakata DJ, 2007, ANESTH ANALG, V105, P79, DOI 10.1213/01.ane.0000265849.33203.60; Sakata DJ, 2007, ANESTH ANALG, V104, P587, DOI 10.1213/01.ane.0000255074.96657.39; SHIBATA K, 1994, ANESTHESIOLOGY, V81, P1454, DOI 10.1097/00000542-199412000-00021; Unzueta MC, 2003, ANESTH ANALG, V96, P298, DOI 10.1097/00000539-200301000-00059; Zhou Q, 2010, ANESTHESIOLOGY, V112, P288, DOI 10.1097/ALN.0b013e3181ca8257	20	16	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130771	10.1371/journal.pone.0130771	http://dx.doi.org/10.1371/journal.pone.0130771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147645	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600049
J	Cremona, A; Orsini, F; Corsetto, PA; Hoogenboom, BW; Rizzo, AM				Cremona, Andrea; Orsini, Francesco; Corsetto, Paola A.; Hoogenboom, Bart W.; Rizzo, Angela M.			Reversible Dissolution of Microdomains in Detergent-Resistant Membranes at Physiological Temperature	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BREAST-CANCER CELLS; LIPID RAFTS; PLASMA-MEMBRANE; CRITICAL FLUCTUATIONS; DOMAIN FORMATION; PHASE-BEHAVIOR; VESICLES; MODEL; ORGANIZATION	The formation of lipid microdomains ("rafts") is presumed to play an important role in various cellular functions, but their nature remains controversial. Here we report on microdomain formation in isolated, detergent-resistant membranes from MDA-MB-231 human breast cancer cells, studied by atomic force microscopy (AFM). Whereas microdomains were readily observed at room temperature, they shrunk in size and mostly disappeared at higher temperatures. This shrinking in microdomain size was accompanied by a gradual reduction of the height difference between the microdomains and the surrounding membrane, consistent with the behaviour expected for lipids that are laterally segregated in liquid ordered and liquid disordered domains. Immunolabeling experiments demonstrated that the microdomains contained flotillin-1, a protein associated with lipid rafts. The microdomains reversibly dissolved and reappeared, respectively, on heating to and cooling below temperatures around 37 degrees C, which is indicative of radical changes in local membrane order close to physiological temperature.	[Cremona, Andrea; Corsetto, Paola A.; Rizzo, Angela M.] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Orsini, Francesco] Univ Milan, Dipartimento Fis, Milan, Italy; [Hoogenboom, Bart W.] UCL, London Ctr Nanotechnol, London, England; [Hoogenboom, Bart W.] UCL, Dept Phys & Astron, London, England	University of Milan; University of Milan; University of London; University College London; University of London; University College London	Hoogenboom, BW (corresponding author), UCL, London Ctr Nanotechnol, London, England.	b.hoogenboom@ucl.ac.uk	CORSETTO, PAOLA ANTONIA/O-2244-2015; RIzzo, Angela Maria/E-4786-2012; Orsini, Francesco/S-1283-2017	CORSETTO, PAOLA ANTONIA/0000-0003-3849-8548; RIzzo, Angela Maria/0000-0002-8582-0432; Orsini, Francesco/0000-0001-5601-9825; Hoogenboom, Bart/0000-0002-8882-4324	Royal Society [JP09001]; BBSRC [BB/G011729/1, BB/J006254/1]; Biotechnology and Biological Sciences Research Council [BB/J006254/1] Funding Source: researchfish	Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Society, JP09001, (https://royalsociety.org) and BBSRC, BB/G011729/1 and BB/J006254/1, (http://bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton CR, 2011, BBA-BIOMEMBRANES, V1808, P307, DOI 10.1016/j.bbamem.2010.09.016; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Cai MJ, 2012, SMALL, V8, P1243, DOI 10.1002/smll.201102183; Charrier A, 2005, BIOPHYS J, V89, P1094, DOI 10.1529/biophysj.105.062463; Connell SD, 2013, FARADAY DISCUSS, V161, P91, DOI 10.1039/c2fd20119d; Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y; Coskun U, 2010, FEBS LETT, V584, P1685, DOI 10.1016/j.febslet.2009.12.043; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gousset K, 2002, J CELL PHYSIOL, V190, P117, DOI 10.1002/jcp.10039; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heberle FA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004630; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Honerkamp-Smith AR, 2008, BIOPHYS J, V95, P236, DOI 10.1529/biophysj.107.128421; Keller D, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.025701; Kraft ML, 2013, MOL BIOL CELL, V24, P2765, DOI 10.1091/mbc.E13-03-0165; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Orsini F, 2012, BBA-BIOMEMBRANES, V1818, P2943, DOI 10.1016/j.bbamem.2012.07.024; Owen DM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2273; Pathak P, 2011, BIOPHYS J, V101, P2417, DOI 10.1016/j.bpj.2011.08.059; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Podyma-Inoue KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032351; Prinetti A, 2001, J BIOL CHEM, V276, P21136, DOI 10.1074/jbc.M010666200; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; SCOTT RE, 1976, SCIENCE, V194, P743, DOI 10.1126/science.982043; Seantier B, 2008, CURR OPIN COLLOID IN, V13, P326, DOI 10.1016/j.cocis.2008.01.003; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sonnino S, 2013, CURR MED CHEM, V20, P4; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Tanigawa M, 2012, MOL CELL BIOL, V32, P2861, DOI 10.1128/MCB.06111-11; Tokumasu F, 2002, J ELECTRON MICROSC, V51, P1, DOI 10.1093/jmicro/51.1.1; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2007, P NATL ACAD SCI USA, V104, P17650, DOI 10.1073/pnas.0703513104; Yarrow F, 2005, J CRYST GROWTH, V275, pE1417, DOI 10.1016/j.jcrysgro.2004.11.237	43	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132696	10.1371/journal.pone.0132696	http://dx.doi.org/10.1371/journal.pone.0132696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147107	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600313
J	Noel, N; Lerolle, N; Lecuroux, C; Goujard, C; Venet, A; Saez-Cirion, A; Avettand-Fenoel, V; Meyer, L; Boufassa, F; Lambotte, O				Noel, Nicolas; Lerolle, Nathalie; Lecuroux, Camille; Goujard, Cecile; Venet, Alain; Saez-Cirion, Asier; Avettand-Fenoel, Veronique; Meyer, Laurence; Boufassa, Faroudy; Lambotte, Olivier		ANRS C021 CODEX Study Grp	Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; LOW-LEVEL VIREMIA; ANTIRETROVIRAL THERAPY; ELITE CONTROLLERS; RNA LEVELS; EX-VIVO; REPLICATION; INDIVIDUALS; INFECTION	Some HIV controllers (HICs) experience CD4+T cell count loss and/or lose their ability to control HIV. In this study, we investigated the rate of immunologic and/or virologic progression (ImmP/VirP) and its determinants in the ANRS CO21/CODEX cohort. Immunologic progression was defined as a lasting fall in CD4+T cell count below 350/mm(3) or more than 200/mm(3) with a baseline count below 600/mm(3). Virologic progression was defined as a HIV viral load (VL) above 2000 copies/mL on two consecutive determinations. Clinical characteristics, immune activation, ultrasensitive HIV VL and total HIV DNA were analyzed. Disease progression was observed in 15 of the 217 patients followed up between 2009 and 2013 (ImmP, n = 10; VirP, n = 5). Progressors had higher ultrasensitive HIV RNA levels at inclusion (i.e. 1-2 years before progression) than non-progressors. ImmP had also lower CD4+T cell nadir and CD4+T cell count at inclusion, and VirP had higher HIV DNA levels in blood. T cell activation and IP10 levels at inclusion were significantly higher in ImmP than in non-progressors. In summary, the lasting loss of CD4+T cells, residual HIV replication and basal levels of immune activation appear to be major determinants of progression in HICs. These factors should be considered for adjusting their follow-up.	[Noel, Nicolas; Lecuroux, Camille; Venet, Alain; Lambotte, Olivier] Univ Paris 11, UMR 1184, IMVA, Le Kremlin Bicetre, France; [Noel, Nicolas; Lerolle, Nathalie; Goujard, Cecile; Lambotte, Olivier] Hop Univ Paris Sud, Serv Med Interne, Assistance Publ Hop Paris, Le Kremlin Bicetre, France; [Noel, Nicolas; Lerolle, Nathalie; Goujard, Cecile; Meyer, Laurence; Lambotte, Olivier] Fac Med Paris Sud, Le Kremlin Bicetre, France; [Goujard, Cecile; Meyer, Laurence; Boufassa, Faroudy] Univ Paris 11, Ctr Rech Epidemiol & Sante Populat, INSERM, U1018, Le Kremlin Bicetre, France; [Saez-Cirion, Asier] Inst Pasteur, Unite HIV Inflammat & Persistance, Paris, France; [Avettand-Fenoel, Veronique] Univ Paris 05, Sorbonne Paris Cite, Fac Med, EA 7327, Paris, France; [Avettand-Fenoel, Veronique] Hop Necker Enfants Malad, Serv Virol, Assistance Publ Hop Paris, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Lambotte, O (corresponding author), Univ Paris 11, UMR 1184, IMVA, Le Kremlin Bicetre, France.	olivier.lambotte@bct.aphp.fr	Saez-Cirion, Asier/A-8640-2008; Lambotte, Olivier/GRT-0160-2022; Noel, Nicolas/AAK-3911-2021; Avettand-Fenoel, Véronique/O-6285-2017	Saez-Cirion, Asier/0000-0003-2406-7536; Avettand-Fenoel, Véronique/0000-0002-7022-2990; Noel, Nicolas/0000-0003-4055-617X	Fondation pour la Recherche Medicale (FRM); Agence Nationale pour la Recherchecontre le SIDA (ANRS); INSERM; Paris-Sud University	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherchecontre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris-Sud University	Nicolas Noel received a PhD fellowship from the Fondation pour la Recherche Medicale (FRM). This work was funded by the Agence Nationale pour la Recherchecontre le SIDA (ANRS), INSERM and Paris-Sud University.	Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boufassa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085516; Boufassa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018726; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Groves KC, 2012, JAIDS-J ACQ IMM DEF, V61, P407, DOI 10.1097/QAI.0b013e318269c414; Gurdasani D, 2014, AIDS, V28, P149, DOI 10.1097/QAD.0000000000000049; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lambotte O, 2012, J INFECTION, V64, P630, DOI 10.1016/j.jinf.2012.03.001; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; Lecuroux C, 2014, J VIROL, V88, P176, DOI 10.1128/JVI.02098-13; Madec Y, 2013, AIDS, V27, P2451, DOI 10.1097/01.aids.0000431945.72365.01; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Morlat P., 2013, PRISE CHARGE MED PER; Ndhlovu ZM, 2013, BLOOD, V121, P801, DOI 10.1182/blood-2012-06-436295; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Olson AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086719; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Rachinger A, 2008, CLIN INFECT DIS, V47, pE86, DOI 10.1086/592978; Ruiz-Mateos E, 2011, J VIRAL HEPATITIS, V18, pE350, DOI 10.1111/j.1365-2893.2010.01431.x; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sajadi MM, 2012, AIDS, V26, P1879, DOI 10.1097/QAD.0b013e328357f5d1; Sedaghat AR, 2009, CLIN INFECT DIS, V49, P1763, DOI 10.1086/648081; Vingert B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000780	36	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131922	10.1371/journal.pone.0131922	http://dx.doi.org/10.1371/journal.pone.0131922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146823	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600167
J	Ozawa, M; Himaki, T; Ookutsu, S; Mizobe, Y; Ogawa, J; Miyoshi, K; Yabuki, A; Fan, JL; Yoshida, M				Ozawa, Masayuki; Himaki, Takehiro; Ookutsu, Shoji; Mizobe, Yamato; Ogawa, Junki; Miyoshi, Kazuchika; Yabuki, Akira; Fan, Jianglin; Yoshida, Mitsutoshi			Production of Cloned Miniature Pigs Expressing High Levels of Human Apolipoprotein(a) in Plasma	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; TRANSGENIC MICE; ANIMAL-MODELS; ATHEROSCLEROSIS; LIPOPROTEIN(A); CLONING; DISEASE; DIET	High lipoprotein(a) [Lp(a)] levels are a major risk factor for the development of atherosclerosis. However, because apolipoprotein(a) [apo(a)], the unique component of Lp(a), is found only in primates and humans, the study of human Lp(a) has been hampered due to the lack of appropriate animal models. Using somatic cell nuclear transfer (SCNT) techniques, we produced transgenic miniature pigs expressing human apo(a) in the plasma. First, we placed the hemagglutinin (HA)-tagged cDNA of human apo(a) under the control of the beta actin promoter and cytomegalovirus enhancer, and then introduced this construct into kidney epithelial cells. Immunostaining of cells with anti-HA antibody allowed identification of cells stably expressing apo(a); one of the positive clones was used to provide donor cells for SCNT, yielding blastocysts that expressed apo(a). Immunohistochemical analysis of tissue sections and RT-PCR analysis of total RNA from organs of cloned piglet revealed that apo(a) is expressed in various tissues/organs including heart, liver, kidney, and intestine. More importantly, a transgenic line exhibited a high level (>400 mg/dL) of Lp(a) in plasma, and the transgenic apo(a) gene was transmitted to the offspring. Thus, we generated a human apo(a)-transgenic miniature pig that can be used as a model system to study advanced atherosclerosis related to human disease. The anatomical and physiological similarities between the swine and human cardiovascular systems will make this pig model a valuable source of information on the role of apo(a) in the formation of atherosclerosis, as well as the mechanisms underlying vascular health and disease.	[Ozawa, Masayuki] Kagoshima Univ, Dept Biochem & Mol Biol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Himaki, Takehiro; Ookutsu, Shoji; Mizobe, Yamato; Ogawa, Junki; Miyoshi, Kazuchika; Yoshida, Mitsutoshi] Kagoshima Univ, Fac Agr, Lab Anim Reprod, Kagoshima 890, Japan; [Yabuki, Akira] Kagoshima Univ, Lab Vet Clin Pathol, Joint Fac Vet Med, Kagoshima 890, Japan; [Fan, Jianglin] Univ Yamanashi, Dept Mol Pathol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan	Kagoshima University; Kagoshima University; Kagoshima University; University of Yamanashi	Ozawa, M (corresponding author), Kagoshima Univ, Dept Biochem & Mol Biol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	mozawa@m.kufm.kagoshima-u.ac.jp	Mizobe, Yamato/AAT-4580-2021	Fan, Jianglin/0000-0002-1737-6130	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [20580311]; Grants-in-Aid for Scientific Research [25450475] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Management Expenses Grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 20580311 to MY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Albers JJ, 1996, J LIPID RES, V37, P192; Ando A, 2005, XENOTRANSPLANTATION, V12, P121, DOI 10.1111/j.1399-3089.2005.00204.x; Berg K, 2002, ATHEROSCLEROSIS, V163, P99, DOI 10.1016/S0021-9150(01)00772-9; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; CHIESA G, 1992, J BIOL CHEM, V267, P24369; Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Ding YY, 2011, TRANSGENIC RES, V20, P867, DOI 10.1007/s11248-010-9467-5; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Fan JL, 1999, BIOCHEM BIOPH RES CO, V255, P639, DOI 10.1006/bbrc.1999.0242; Fan JL, 2001, ARTERIOSCL THROM VAS, V21, P88, DOI 10.1161/01.ATV.21.1.88; Himaki T, 2010, CELL REPROGRAM, V12, P127, DOI 10.1089/cell.2009.0066; JOKINEN MP, 1985, EXP MOL PATHOL, V42, P1, DOI 10.1016/0014-4800(85)90015-2; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; Longhurst JC, 1993, COLLATERAL CIRCULATI, P195; MAHER VMG, 1995, CURR OPIN LIPIDOL, V6, P229, DOI 10.1097/00041433-199508000-00007; Mahley RW, 1975, BIOCHEMISTRY-US, V14, P2871; Marcovina Santica M, 2002, Semin Vasc Med, V2, P335, DOI 10.1055/s-2002-35404; Mastromonaco GF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-41; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Meadus W. J., 2003, Biological Procedures Online, V5, P20, DOI 10.1251/bpo43; Miyoshi K, 2007, MOL REPROD DEV, V74, P1568, DOI 10.1002/mrd.20730; NAKANISHI Y, 1991, Japanese Journal of Swine Science, V28, P211; Nakayama A, 2007, CLONING STEM CELLS, V9, P523, DOI 10.1089/clo.2007.0021; Nishimura T, 2010, XENOTRANSPLANTATION, V17, P313, DOI 10.1111/j.1399-3089.2010.00599.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; SCANU AM, 1991, ANN INTERN MED, V115, P209, DOI 10.7326/0003-4819-115-3-209; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Turk JR, 2005, INT J EXP PATHOL, V86, P335, DOI 10.1111/j.0959-9673.2005.00446.x; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wang J, 2001, J LIPID RES, V42, P60; Wei JY, 2012, FEBS J, V279, P91, DOI 10.1111/j.1742-4658.2011.08401.x; Yabuki A, 2002, KIDNEY INT, V62, P2294, DOI 10.1046/j.1523-1755.2002.00688.x; YOSHIDA M, 1990, J REPROD FERTIL, V88, P1, DOI 10.1530/jrf.0.0880001; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	43	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132155	10.1371/journal.pone.0132155	http://dx.doi.org/10.1371/journal.pone.0132155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147378	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600208
J	Rodstrom, KEJ; Regenthal, P; Lindkvist-Petersson, K				Rodstrom, Karin E. J.; Regenthal, Paulina; Lindkvist-Petersson, Karin			Structure of Staphylococcal Enterotoxin E in Complex with TCR Defines the Role of TCR Loop Positioning in Superantigen Recognition	PLOS ONE			English	Article							T-CELL-RECEPTOR; MHC CLASS-II; PROTEIN-PROTEIN DOCKING; CRYSTAL-STRUCTURE; BETA-CHAIN; BACTERIAL SUPERANTIGEN; 3-DIMENSIONAL STRUCTURE; NAPTUMOMAB ESTAFENATOX; BINDING-SITES; PEPTIDE	T cells are crucial players in cell-mediated immunity. The specificity of their receptor, the T cell receptor (TCR), is central for the immune system to distinguish foreign from host antigens. Superantigens are bacterial toxins capable of inducing a toxic immune response by cross-linking the TCR and the major histocompatibility complex (MHC) class II and circumventing the antigen specificity. Here, we present the structure of staphylococcal enterotoxin E (SEE) in complex with a human T cell receptor, as well as the unligated T cell receptor structure. There are clear structural changes in the TCR loops upon superantigen binding. In particular, the HV4 loop moves to circumvent steric clashes upon complex formation. In addition, a predicted ternary model of SEE in complex with both TCR and MHC class II displays intermolecular contacts between the TCR alpha-chain and the MHC, suggesting that the TCR a-chain is of importance for complex formation.	[Rodstrom, Karin E. J.; Regenthal, Paulina; Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, BMC C13, S-22184 Lund, Sweden	Lund University	Lindkvist-Petersson, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C13, S-22184 Lund, Sweden.	karin.lindkvist@med.lu.se		Lindkvist, Karin/0000-0002-5209-3160; Rodstrom, Karin/0000-0002-2952-0400	Swedish Research Council [VR-2011-2891]; Cancer Foundation; Olle Engkvist Byggmastare foundation; Ake Wiberg foundation; AFA forsakring; Kungliga Fysiografiska Sallskapet; Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; Foundation in Memory of Lars Hierta; Novo Nordisk Fonden [NNF14OC0009807] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Foundation; Olle Engkvist Byggmastare foundation; Ake Wiberg foundation; AFA forsakring; Kungliga Fysiografiska Sallskapet; Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; Foundation in Memory of Lars Hierta; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Swedish Research Council (VR-2011-2891), the Cancer Foundation, the Olle Engkvist Byggmastare foundation, Ake Wiberg foundation, AFA forsakring, Kungliga Fysiografiska Sallskapet, the Wilhelm and Martina Lundgren Foundation, the Helge Ax:son Johnson Foundation and the Foundation in Memory of Lars Hierta. The funders had no role in study	ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Al-Daccak R, 1998, J IMMUNOL, V160, P225; Andersen PS, 1999, IMMUNITY, V10, P473, DOI 10.1016/S1074-7613(00)80047-3; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Bhati M, 2014, PROTEIN SCI, V23, P260, DOI 10.1002/pro.2412; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borghaei H, 2009, J CLIN ONCOL, V27, P4116, DOI 10.1200/JCO.2008.20.2515; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bricogne G., 2011, BUSTER VERSION X Y Z; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Cavallin A, 2000, J BIOL CHEM, V275, P1665, DOI 10.1074/jbc.275.3.1665; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Cho SW, 2005, STRUCTURE, V13, P1775, DOI 10.1016/j.str.2005.08.015; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; deAlba YB, 1997, EUR J IMMUNOL, V27, P92, DOI 10.1002/eji.1830270114; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Deng L, 2012, P NATL ACAD SCI USA, V109, P14960, DOI 10.1073/pnas.1207186109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fernandez MM, 2006, J BIOL CHEM, V281, P25356, DOI 10.1074/jbc.M603969200; Fernandez MM, 2011, J BIOL CHEM, V286, P1189, DOI 10.1074/jbc.M110.142471; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; Forsberg G, 2010, J IMMUNOTHER, V33, P492, DOI 10.1097/CJI.0b013e3181d75820; FRASER JD, 1992, P NATL ACAD SCI USA, V89, P5507, DOI 10.1073/pnas.89.12.5507; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gunther S, 2007, J MOL BIOL, V371, P210, DOI 10.1016/j.jmb.2007.05.038; Hakansson M, 2000, J MOL BIOL, V302, P527, DOI 10.1006/jmbi.2000.4093; Hargreaves REG, 1995, EUR J IMMUNOL, V25, P3437, DOI 10.1002/eji.1830251235; Hedlund G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079082; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; HUDSON KR, 1993, J EXP MED, V177, P175, DOI 10.1084/jem.177.1.175; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KARP DR, 1992, J EXP MED, V175, P415, DOI 10.1084/jem.175.2.415; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liao L, 1996, J EXP MED, V184, P1471, DOI 10.1084/jem.184.4.1471; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Lopez-Sagaseta J, 2013, J IMMUNOL, V191, P5268, DOI 10.4049/jimmunol.1301958; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neill RJ, 1996, INFECT IMMUN, V64, P3007, DOI 10.1128/IAI.64.8.3007-3015.1996; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Petersson K, 2004, SCAND J IMMUNOL, V59, P345, DOI 10.1111/j.0300-9475.2004.01404.x; Rodstrom KEJ, 2014, J IMMUNOL, V193, P1998, DOI 10.4049/jimmunol.1401268; Roggiani M, 1997, INFECT IMMUN, V65, P2868, DOI 10.1128/IAI.65.7.2868-2875.1997; Saline M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1117; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Shimizu A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03097; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; Sundstrom M, 1996, J BIOL CHEM, V271, P32212, DOI 10.1074/jbc.271.50.32212; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	85	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131988	10.1371/journal.pone.0131988	http://dx.doi.org/10.1371/journal.pone.0131988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147596	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600175
J	Saha, SC; Henderson, AJ; Powl, AM; Wallace, BA; de Planque, MRR; Morgan, H				Saha, Shimul Chandra; Henderson, Alexander J.; Powl, Andrew M.; Wallace, B. A.; de Planque, Maurits R. R.; Morgan, Hywel			Characterization of the Prokaryotic Sodium Channel Na(v)Sp Pore with a Microfluidic Bilayer Platform	PLOS ONE			English	Article								This paper describes the use of a newly-developed micro-chip bilayer platform to examine the electrophysiological properties of the prokaryotic voltage-gated sodium channel pore (Na(v)Sp) from Silicibacter pomeroyi. The platform allows up to 6 bilayers to be analysed simultaneously. Proteoliposomes were incorporated into suspended lipid bilayers formed within the microfluidic bilayer chips. The chips provide access to bilayers from either side, enabling the fast and controlled titration of compounds. Dose-dependent modulation of the opening probability by the channel blocking drug nifedipine was measured and its IC50 determined.	[Saha, Shimul Chandra; de Planque, Maurits R. R.; Morgan, Hywel] Univ Southampton, Elect & Comp Sci, Southampton SO17 1BJ, Hants, England; [de Planque, Maurits R. R.; Morgan, Hywel] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Henderson, Alexander J.; Powl, Andrew M.; Wallace, B. A.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	University of Southampton; University of Southampton; University of London; Birkbeck University London	Wallace, BA (corresponding author), Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England.	b.wallace@mail.cryst.bbk.ac.uk; hm@ecs.soton.ac.uk	Powl, Andrew/C-4443-2008; Wallace, B A/C-3753-2008	Powl, Andrew/0000-0003-3397-2837; Wallace, B A/0000-0001-9649-5092; de Planque, Maurits/0000-0002-8787-0513; Morgan, Hywel/0000-0003-4850-5676	UK Engineering and Physical Sciences Research Council [EP/H044795/1, EP/H043888/1]; Biotechnology and Biological Sciences Research Council [BB/L006790]; Biotechnology and Biological Sciences Research Council [BB/L006790/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H043888/1, EP/H044795/1] Funding Source: researchfish; BBSRC [BB/L006790/1] Funding Source: UKRI; EPSRC [EP/H043888/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a linked grant from the UK Engineering and Physical Sciences Research Council (EP/H044795/1 to HM and MRRDP and EP/H043888/1 to BAW), http://www.epsrc.ac.uk/. It was also supported by a grant from the Biotechnology and Biological Sciences Research Council (BB/L006790 to BAW).	Altamirano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081222; [Anonymous], PCLAMP 10 SOFTW; [Anonymous], SIGM; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Bagneris C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3465; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Crescentini M, 2015, IEEE T BIOM IN PRESS; D'Avanzo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061216; Kass RS, 2005, J CLIN INVEST, V115, P1986, DOI 10.1172/JCI26011; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; McCusker EC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C111.228122; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Saha SC, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4905313; Saha SC, 2014, SENSOR ACTUAT B-CHEM, V199, P76, DOI 10.1016/j.snb.2014.03.111; Scriabine A, 1985, DRUGS, V3, P197; Shaya D, 2011, P NATL ACAD SCI USA, V108, P12313, DOI 10.1073/pnas.1106811108; Studer A, 2011, BIOSENS BIOELECTRON, V26, P1924, DOI 10.1016/j.bios.2010.06.008; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e	19	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131286	10.1371/journal.pone.0131286	http://dx.doi.org/10.1371/journal.pone.0131286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147601	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358157600085
J	Lai, Y; Zhong, W; Yu, T; Xia, ZS; Li, JY; Ouyang, H; Shan, TD; Yang, HS; Chen, QK				Lai, Yu; Zhong, Wa; Yu, Tao; Xia, Zhong-Sheng; Li, Jie-Yao; Ouyang, Hui; Shan, Ti-Dong; Yang, Hong-Sheng; Chen, Qi-Kui			Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of beta-Catenin	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SMALL-BOWEL; C-MYC; CYCLOOXYGENASE-2; DAMAGE; PROLIFERATION; INHIBITION; MECHANISMS; EXPRESSION; INTEGRITY	Background The effect of rebamipide on repairing intestinal mucosal damage induced by nonsteroidal anti-inflammatory drugs and its mechanism remain unclear. In this study, we sought to explore the mechanism whereby rebamipide could promote the regeneration of aspirin-induced intestinal mucosal damage. Methods BALB/c mice were administered aspirin (200 mg/kg/d) for 5 days to induce acute small intestinal injury (SII). Subsequently, SII mice were treated with rebamipide (320 mg/kg/d) for 5 days. The structure of intestinal barrier was observed with transmission electron microscope, and Zo-1 and occludin expressions were detected. The proliferative index was indicated by the percentage of proliferating cell nuclear antigen positive cells. The prostaglandin E2 (PGE2) levels in the small intestine tissues were measured by an enzyme immunoassay. The mRNA and protein expression levels of cyclooxygenase (COX) and beta-catenin signal were detected in the small intestine using quantitative PCR and Western blot, respectively. Results COX expression was significantly down-regulated in aspirin induced SII (P < 0.05). In SII mice treated with rebamipide, histopathological findings of aspirin-induced intestinal inflammation were significantly milder and tight junctions between intestinal epithelial cells were improved significantly. The proliferative index increased after rebamipide treatment when compared with that in the control mice. The expressions of COX-2, beta-catenin, and c-myc and the PGE2 concentrations in small intestinal tissues were significantly increased in mice with rebamipide treatments (P < 0.05). Conclusion Rebamipide administration in aspirin-induced SII mice could improve the intestinal barrier structure and promote the regeneration of small intestinal epithelial injury through upregulating COX-2 expression and the accumulation of beta-catenin.	[Lai, Yu; Zhong, Wa; Yu, Tao; Xia, Zhong-Sheng; Li, Jie-Yao; Ouyang, Hui; Shan, Ti-Dong; Yang, Hong-Sheng; Chen, Qi-Kui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Yu, T (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastroenterol, 107 Yan Jiang Xi Rd, Guangzhou, Guangdong, Peoples R China.	yutao2014@126.com; qikuichen@yahoo.com			National Natural Science Foundation of China [81270442, 81370475]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81270442 and No. 81370475).	Amagase K, 2014, J GASTROEN HEPATOL, V29, P3, DOI 10.1111/jgh.12767; Arakawa T, 2005, DIGEST DIS SCI, V50, pS3, DOI 10.1007/s10620-005-2800-9; Arakawa T, 1998, DIGEST DIS SCI, V43, p5S; BRANDT RB, 1980, ANAL BIOCHEM, V102, P39, DOI 10.1016/0003-2697(80)90314-0; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; CHALCROFT JP, 1970, J CELL BIOL, V47, P49, DOI 10.1083/jcb.47.1.49; Endo H, 2012, DIGEST LIVER DIS, V44, P833, DOI 10.1016/j.dld.2012.05.016; Fujimori S, 2011, J GASTROENTEROL, V46, P57, DOI 10.1007/s00535-010-0332-3; Fukui A, 2012, AM J PHYSIOL-GASTR L, V303, pG927, DOI 10.1152/ajpgi.00236.2012; Furst W, 1999, ANAL BIOCHEM, V269, P214, DOI 10.1006/abio.1999.4005; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Handa O, 2014, J CLIN BIOCHEM NUTR, V54, P2, DOI 10.3164/jcbn.13-84; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huls G, 2003, LANCET, V362, P230, DOI 10.1016/S0140-6736(03)13915-3; Ikemura K, 2014, PHARMACOL THERAPEUT, V143, P217, DOI 10.1016/j.pharmthera.2014.03.002; JASKULSKI D, 1988, SCIENCE, V240, P1544, DOI 10.1126/science.2897717; Kimura Y, 1997, AM J PATHOL, V151, P45; Kishimoto S, 2000, DIGEST DIS SCI, V45, P1608, DOI 10.1023/A:1005525313856; Kurokawa S, 2014, J GASTROENTEROL, V49, P239, DOI 10.1007/s00535-013-0805-2; Li JY, 2014, J DIABETES COMPLICAT, V28, P689, DOI 10.1016/j.jdiacomp.2014.05.001; Lichtenberger LM, 2011, J PHYSIOL PHARMACOL, V62, P491; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Maiden L, 2007, CLIN GASTROENTEROL H, V5, P1040, DOI 10.1016/j.cgh.2007.04.031; Mizoguchi H, 2001, J GASTROEN HEPATOL, V16, P1112, DOI 10.1046/j.1440-1746.2001.02592.x; Mizukami K, 2011, WORLD J GASTROENTERO, V17, P5117, DOI 10.3748/wjg.v17.i46.5117; Niwa Y, 2008, J GASTROENTEROL, V43, P270, DOI 10.1007/s00535-007-2155-4; PARK PO, 1990, SURGERY, V107, P574; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Shiotani A, 2010, J GASTROEN HEPATOL, V25, pS31, DOI 10.1111/j.1440-1746.2009.06212.x; Sigthorsson G, 2002, GASTROENTEROLOGY, V122, P1913, DOI 10.1053/gast.2002.33647; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Sun XQ, 2001, WORLD J GASTROENTERO, V7, P555; Takeuchi K, 2010, J PHARMACOL SCI, V114, P248, DOI 10.1254/jphs.10R06CR; Takeuchi K, 2010, CLIN CHIM ACTA, V411, P459, DOI 10.1016/j.cca.2009.12.026; Tanaka A, 2002, J PHARMACOL EXP THER, V303, P1248, DOI 10.1124/jpet.102.041715; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tugendreich S, 2006, TOXICOL PATHOL, V34, P168, DOI 10.1080/01926230600611752; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Watanabe T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122330; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	43	24	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132031	10.1371/journal.pone.0132031	http://dx.doi.org/10.1371/journal.pone.0132031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135128	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400096
J	Liu, YN; Tan, DH; Shi, L; Liu, XW; Zhang, YB; Tong, CC; Song, DQ; Hou, MX				Liu, Yunen; Tan, Dehong; Shi, Lin; Liu, Xinwei; Zhang, Yubiao; Tong, Changci; Song, Dequn; Hou, Mingxiao			Blueberry Anthocyanins-Enriched Extracts Attenuate Cyclophosphamide-Induced Cardiac Injury	PLOS ONE			English	Article							OXIDATIVE STRESS; INDUCED CARDIOTOXICITY; MYOCARDIAL-INFARCTION; ANGIOTENSIN-II; INFLAMMATION; ACTIVATION; DAMAGE; MICE; RATS; APOPTOSIS	We sought to explore the effect of blueberry anthocyanins-enriched extracts (BAE) on cyclophosphamide (CTX)-induced cardiac injury. The rats were divided randomly into five groups including normal control, CTX 100 mg/kg, BAE 80mg/kg, CTX+BAE 20mg/kg and CTX+BAE 80mg/kg groups. The rats in the three BAE-treated groups were administered BAE for four weeks. Seven days after BAE administration, rats in CTX group and two BAE-treated groups were intraperitoneally injected with a single dose of 100 mg/kg CTX. Cardiac injury was assessed using physiological parameters, Echo, morphological staining, real-time PCR and western blot. In addition, cardiotoxicity indices, inflammatory cytokines expression and oxidative stress markers were also detected. Four weeks 20mg/kg and 80mg/kg dose of BAE treatment following CTX exposure attenuated mean arterial blood pressure, heart rate and activities of heart enzymes, improved cardiac dysfunction, left ventricular hypertrophy and fibrosis. Importantly, BAE also attenuated CTX-induced LV leukocyte infiltration and inflammatory cytokines expression, ameliorated oxidative stress as well as cardiomyocyte apoptosis. In conclusion, BAE attenuated the CTX-induced cardiac injury and the protective mechanisms were related closely to the anti-inflammatory, antioxidant and anti-inflammatory characteristics of BAE.	[Liu, Yunen; Shi, Lin; Liu, Xinwei; Zhang, Yubiao; Tong, Changci; Hou, Mingxiao] PLA, Lab Rescue Ctr Severe Wound & Trauma, Dept Emergency Med, Gen Hosp Shenyang Mil Command, Shenyang, Peoples R China; [Tan, Dehong; Song, Dequn] Shenyang Agr Univ, Coll Food, Shenyang 110161, Peoples R China	Shenyang Agricultural University	Hou, MX (corresponding author), PLA, Lab Rescue Ctr Severe Wound & Trauma, Dept Emergency Med, Gen Hosp Shenyang Mil Command, Shenyang, Peoples R China.	houmingxiao188@163.com	Yunen, Liu/X-4121-2019		Liaoning Province Key Scientific and Technological Project [2013225089]; PLA foundation of China during the Twelfth Five-year Plan Period [CSY12J002]	Liaoning Province Key Scientific and Technological Project; PLA foundation of China during the Twelfth Five-year Plan Period	This work was supported by the grants of Liaoning Province Key Scientific and Technological Project (No. 2013225089), and PLA foundation of China during the Twelfth Five-year Plan Period (CSY12J002).	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Ahmet I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007975; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BUHL SN, 1978, CLIN CHEM, V24, P828; Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005; Dange RB, 2014, CARDIOVASC RES, V103, P17, DOI 10.1093/cvr/cvu067; DAVIES MH, 1984, J PHARMACOL METHOD, V12, P191, DOI 10.1016/0160-5402(84)90059-7; De Vito P, 2014, PEPTIDES, V58, P108, DOI 10.1016/j.peptides.2014.06.011; DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155; El-Deeb WM, 2015, PARASITOLOGY, V142, P767, DOI 10.1017/S0031182014001899; El-Sheikh AAK, 2014, PPAR RES, V2014, DOI 10.1155/2014/626319; Elisia I, 2007, FOOD CHEM, V101, P1052, DOI 10.1016/j.foodchem.2006.02.060; Feng WG, 2000, BIOCHEM BIOPH RES CO, V269, P570, DOI 10.1006/bbrc.2000.2341; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gong P, 2014, ENVIRON TOXICOL PHAR, V37, P1015, DOI 10.1016/j.etap.2014.03.017; Hughes FM, 2014, AM J PHYSIOL-RENAL, V306, pF299, DOI 10.1152/ajprenal.00297.2013; Ismahil MA, 2011, AM J PHYSIOL-HEART C, V301, pH2050, DOI 10.1152/ajpheart.00120.2011; Joseph SV, 2014, J AGR FOOD CHEM, V62, P3886, DOI 10.1021/jf4044056; Kang PM, 2000, CIRC RES, V86, P1107; Karlsen A, 2007, J NUTR, V137, P1951; Li YW, 2014, GENE, V542, P46, DOI 10.1016/j.gene.2014.03.021; Li YC, 2007, FOOD SCI TECHNOL, V11, P029; Liang YT, 2013, EUR J NUTR, V52, P869, DOI 10.1007/s00394-012-0393-6; Lim S, 2000, AM J RESP CRIT CARE, V162, P1355, DOI 10.1164/ajrccm.162.4.9910097; Liu W, 2013, INT J MOL SCI, V14, P21447, DOI 10.3390/ijms141121447; Liu YX, 2012, BRIT J NUTR, V108, P16, DOI 10.1017/S000711451100523X; Ludeman SM, 1999, CURR PHARM DESIGN, V5, P627; McAnulty LS, 2011, APPL PHYSIOL NUTR ME, V36, P976, DOI [10.1139/H11-120, 10.1139/h11-120]; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; MOORE VL, 1981, J IMMUNOL, V127, P339; Moze S, 2011, J AGR FOOD CHEM, V59, P6998, DOI 10.1021/jf200765n; Mythili Y, 2005, MOL CELL BIOCHEM, V276, P39, DOI 10.1007/s11010-005-2735-7; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Ni HB, 2015, J SPINAL CORD MED, V38, P199, DOI 10.1179/2045772313Y.0000000179; Ogawa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069053; Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437; Pingitore A, 2006, J CARD FAIL, V12, P520, DOI 10.1016/j.cardfail.2006.05.009; Preiser JC, 2012, JPEN-PARENTER ENTER, V36, P147, DOI 10.1177/0148607111434963; Routray W, 2011, COMPR REV FOOD SCI F, V10, P303, DOI 10.1111/j.1541-4337.2011.00164.x; Rudic M, 2012, AUDIOL NEURO-OTOL, V17, P169, DOI 10.1159/000335098; Saleem M, 2000, FOOD CHEM TOXICOL, V38, P939, DOI 10.1016/S0278-6915(00)00088-0; Sayed-Ahmed MM, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/452902; SEGGEV JS, 1991, CLIN IMMUNOL IMMUNOP, V60, P289, DOI 10.1016/0090-1229(91)90071-H; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; Slatnar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047880; Sui XZ, 2014, INT J MOL MED, V33, P227, DOI 10.3892/ijmm.2013.1546; Swamy AHMV, 2013, INDIAN J PHARMACOL, V45, P44, DOI 10.4103/0253-7613.106434; Taneja AK, 2014, INT J CARDIOL, V175, P253, DOI 10.1016/j.ijcard.2014.05.018; Todorova V, 2009, NUTRITION, V25, P812, DOI 10.1016/j.nut.2009.01.004; WU AHB, 1982, CLIN CHEM, V28, P2017; Wu LH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq040; XUN CQ, 1994, BLOOD, V83, P2360; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002; Zhang HJ, 2013, AQUAT TOXICOL, V140, P11, DOI 10.1016/j.aquatox.2013.05.009; Zuppinger C, 2007, CARDIOVASC TOXICOL, V7, P61, DOI 10.1007/s12012-007-0016-2	57	38	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0127813	10.1371/journal.pone.0127813	http://dx.doi.org/10.1371/journal.pone.0127813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133371	Green Submitted, gold, Green Published			2022-12-26	WOS:000358154400005
J	Pethybridge, HR; Parrish, CC; Morrongiello, J; Young, JW; Farley, JH; Gunasekera, RM; Nichols, PD				Pethybridge, Heidi R.; Parrish, Christopher C.; Morrongiello, John; Young, Jock W.; Farley, Jessica H.; Gunasekera, Rasanthi M.; Nichols, Peter D.			Spatial Patterns and Temperature Predictions of Tuna Fatty Acids: Tracing Essential Nutrients and Changes in Primary Producers	PLOS ONE			English	Article							BRAIN-DEVELOPMENT; TROPHIC MARKERS; MARINE; PHYTOPLANKTON; METABOLISM; GROWTH; CARBON; SIZE; AQUACULTURE; INDICATORS	Fatty acids are among the least understood nutrients in marine environments, despite their profile as key energy components of food webs and that they are essential to all life forms. Presented here is a novel approach to predict the spatial-temporal distributions of fatty acids in marine resources using generalized additive mixed models. Fatty acid tracers (FAT) of key primary producers, nutritional condition indices and concentrations of two essential long-chain (>= C-20) omega-3 fatty acids (EFA) measured in muscle of albacore tuna, Thunnus alalunga, sampled in the south-west Pacific Ocean were response variables. Predictive variables were: location, time, sea surface temperature (SST) and chlorophyll-a (Chla), and phytoplankton biomass at time of catch and curved fork length. The best model fit for all fatty acid parameters included fish length and SST. The first oceanographic contour maps of EFA and FAT (FATscapes) were produced and demonstrated clear geographical gradients in the study region. Predicted changes in all fatty acid parameters reflected shifts in the size-structure of dominant primary producers. Model projections show that the supply and availability of EFA are likely to be negatively affected by increases in SST especially in temperate waters where a 12% reduction in both total fatty acid content and EFA proportions are predicted. Such changes will have large implications for the availability of energy and associated health benefits to high-order consumers. Results convey new concerns on impacts of projected climate change on fish-derived EFA in marine systems.	[Pethybridge, Heidi R.; Morrongiello, John; Young, Jock W.; Farley, Jessica H.; Gunasekera, Rasanthi M.; Nichols, Peter D.] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Parrish, Christopher C.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; [Morrongiello, John] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia; [Nichols, Peter D.] CSIRO, Food Nutr & Bioprod Flagship, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Memorial University Newfoundland; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Pethybridge, HR (corresponding author), CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia.	Heidi.Pethybridge@csiro.au	Nichols, Peter D/C-5128-2011; Pethybridge, Heidi/AAI-9824-2021; Gunasekera, Rasanthi/A-2318-2012; Pethybridge, Heidi/AEO-8594-2022; Morrongiello, John/E-8716-2011; Farley, Jessica/E-4957-2014	Gunasekera, Rasanthi/0000-0003-1990-2752; Pethybridge, Heidi/0000-0002-7291-5766; Morrongiello, John/0000-0002-9608-4151; Farley, Jessica/0000-0002-5047-746X	CSIRO Oceans and Atmospheric Flagship (through Capability Development Fund Ernst Frohlich Fellowship); 9th European Union Development Fund (SCIFISH project); Western and Central Pacific Fisheries Commission	CSIRO Oceans and Atmospheric Flagship (through Capability Development Fund Ernst Frohlich Fellowship); 9th European Union Development Fund (SCIFISH project); Western and Central Pacific Fisheries Commission	This work was supported by funding from CSIRO Oceans and Atmospheric Flagship (through the Capability Development Fund Ernst Frohlich Fellowship), the 9th European Union Development Fund (SCIFISH project), and the Western and Central Pacific Fisheries Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJANI P., 2001, AUSTR J COAST RES, V34, P60; Alvain S, 2013, REMOTE SENS ENVIRON, V132, P195, DOI 10.1016/j.rse.2013.01.014; Aranceta J, 2012, BRIT J NUTR, V107, pS8, DOI 10.1017/S0007114512001444; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P237, DOI 10.1007/978-0-387-89366-2_10; Barnes C, 2011, J PLANKTON RES, V33, P13, DOI 10.1093/plankt/fbq088; Bax NJ, 2001, MAR FRESHWATER RES, V52, P451, DOI 10.1071/MF00001; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Budge S. M., 2014, ICES J MAR SCI; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Claramunt G, 2007, FISH RES, V85, P248, DOI 10.1016/j.fishres.2007.01.009; Cunnane SC, 2014, J HUM EVOL, V77, P88, DOI 10.1016/j.jhevol.2014.05.001; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Deckelbaum RJ, 2012, J NUTR, V142, p587S, DOI 10.3945/jn.111.148080; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Food and Agriculture Organization/World Health Organization (FAO/WHO), 2010, 91 FAOWHO; Gladyshev MI, 2011, OECOLOGIA, V165, P521, DOI 10.1007/s00442-010-1843-6; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Goni N, 2011, MAR BIOL, V158, P1057, DOI 10.1007/s00227-011-1630-x; Hartog J.R., 2011, SDODE SPATIAL DYNAMI; HARWOOD JL, 1988, ANNU REV PLANT PHYS, V39, P101, DOI 10.1146/annurev.arplant.39.1.101; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Hobday AJ, 2010, PROG OCEANOGR, V86, P291, DOI 10.1016/j.pocean.2010.04.023; Jeffrey S.W., 1990, P310; Jiang HM, 2004, J PHYCOL, V40, P651, DOI 10.1111/j.1529-8817.2004.03112.x; Kiessling A, 2001, FOOD CHEM, V73, P271, DOI 10.1016/S0308-8146(00)00297-1; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Lewandowska AM, 2014, ECOL LETT, V17, P614, DOI 10.1111/ele.12265; Loef Martin, 2013, Journal of Nutrition in Gerontology and Geriatrics, V32, P1, DOI 10.1080/21551197.2012.752335; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nakamura MT, 2001, LIPIDS, V36, P961, DOI 10.1007/s11745-001-0806-5; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Painting SJ, 2013, BIOGEOCHEMISTRY, V113, P237, DOI 10.1007/s10533-012-9774-4; Park S, 2002, FRESHWATER BIOL, V47, P1377, DOI 10.1046/j.1365-2427.2002.00870.x; Parrish C.C., 2013, ISRN OCEANOGR, V2013, P604045, DOI [10.5402/2013/604045, DOI 10.5402/2013/604045]; Parrish CC, 2015, DEEP-SEA RES PT II, V113, P199, DOI 10.1016/j.dsr2.2013.12.003; Parrish CC, 2015, OECOLOGIA, V177, P85, DOI 10.1007/s00442-014-3131-3; Parrish CC, 2012, J PLANKTON RES, V34, P356, DOI 10.1093/plankt/fbs003; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Paulsen M, 2014, MAR BIOL, V161, P239, DOI 10.1007/s00227-013-2313-6; Perhar G, 2012, ENVIRON REV, V20, P155, DOI [10.1139/A2012-007, 10.1139/a2012-007]; Pethybridge H, 2014, MAR ECOL PROG SER, V512, P39, DOI 10.3354/meps10864; Pethybridge HP, 2015, PROG OCEANO IN PRESS; Polovina JJ, 2012, DEEP-SEA RES PT II, V77-80, P82, DOI 10.1016/j.dsr2.2012.04.006; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Renaud SM, 1995, J APPL PHYCOL, V7, P595, DOI 10.1007/BF00003948; Reuss N, 2002, MAR BIOL, V141, P423, DOI 10.1007/s00227-002-0841-6; Ridgway K., 2012, MARINE CLIMATE CHANG, P47; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rossi S, 2006, J PLANKTON RES, V28, P551, DOI 10.1093/plankt/fbi140; Sargent J.R., 1987, P119; Sargent John R., 2002, P181; Scholz B, 2013, DIATOM RES, V28, P337, DOI 10.1080/0269249X.2013.802997; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Thompson PA, 2009, MAR ECOL PROG SER, V394, P1, DOI 10.3354/meps08297; THOMPSON PA, 1992, J PHYCOL, V28, P481, DOI 10.1111/j.0022-3646.1992.00481.x; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; VISO AC, 1993, PHYTOCHEMISTRY, V34, P1521, DOI 10.1016/S0031-9422(00)90839-2; West J.B., 2010, UNDERSTANDING MOVEME; Wijendran V, 2004, ANNU REV NUTR, V24, P597, DOI 10.1146/annurev.nutr.24.012003.132106; Wood S., 2011, R PACKAGE VERSION, V0, P1; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Young JW, 2015, REV FISH BIOL FISHER, V25, P261, DOI 10.1007/s11160-014-9368-4; Young JW, 2001, MAR FRESHWATER RES, V52, P463, DOI 10.1071/MF99168	75	43	43	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131598	10.1371/journal.pone.0131598	http://dx.doi.org/10.1371/journal.pone.0131598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135308	Green Published, gold			2022-12-26	WOS:000358154400057
J	Schless, SH; Desloovere, K; Aertbelien, E; Molenaers, G; Huenaerts, C; Bar-On, L				Schless, Simon-Henri; Desloovere, Kaat; Aertbelien, Erwin; Molenaers, Guy; Huenaerts, Catherine; Bar-On, Lynn			The Intra- and Inter-Rater Reliability of an Instrumented Spasticity Assessment in Children with Cerebral Palsy	PLOS ONE			English	Article							REFLEX; ASHWORTH; SENSITIVITY; HYPERTONIA; PARAMETERS; STIFFNESS; VELOCITY; SIGNALS; SCALES; DEVICE	Aim Despite the impact of spasticity, there is a lack of objective, clinically reliable and valid tools for its assessment. This study aims to evaluate the reliability of various performance-and spasticity-related parameters collected with a manually controlled instrumented spasticity assessment in four lower limb muscles in children with cerebral palsy (CP). Method The lateral gastrocnemius, medial hamstrings, rectus femoris and hip adductors of 12 children with spastic CP (12.8 years, +/- 4.13 years, bilateral/unilateral involvement n = 7/5) were passively stretched in the sagittal plane at incremental velocities. Muscle activity, joint motion, and torque were synchronously recorded using electromyography, inertial sensors, and a force/torque load-cell. Reliability was assessed on three levels: (1) intra-and (2) inter-rater within session, and (3) intra-rater between session. Results Parameters were found to be reliable in all three analyses, with 90% containing intra-class correlation coefficients >0.6, and 70% of standard error of measurement values <20% of the mean values. The most reliable analysis was intra-rater within session, followed by intra-rater between session, and then inter-rater within session. The Adds evaluation had a slightly lower level of reliability than that of the other muscles. Conclusions Limited intrinsic/extrinsic errors were introduced by repeated stretch repetitions. The parameters were more reliable when the same rater, rather than different raters performed the evaluation. Standardisation and training should be further improved to reduce extrinsic error when different raters perform the measurement. Errors were also muscle specific, or related to the measurement set-up. They need to be accounted for, in particular when assessing pre-post interventions or longitudinal follow-up. The parameters of the instrumented spasticity assessment demonstrate a wide range of applications for both research and clinical environments in the quantification of spasticity.	[Schless, Simon-Henri; Desloovere, Kaat; Molenaers, Guy; Huenaerts, Catherine; Bar-On, Lynn] Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium; [Schless, Simon-Henri; Desloovere, Kaat; Bar-On, Lynn] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Aertbelien, Erwin] Katholieke Univ Leuven, Dept Mech Engn, Leuven, Belgium; [Molenaers, Guy] Katholieke Univ Leuven, Dept Dev, Leuven, Belgium; [Molenaers, Guy] Katholieke Univ Leuven, Dept Regenerat, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Orthopaed Med, Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Schless, SH (corresponding author), Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium.	simonhenri.schless@kuleuven.be	Bar-On, Lynn/GLT-6281-2022; Schless, Simon/HGA-3783-2022; Desloovere, Kaat/F-3240-2014; Aertbeliën, Erwin/L-5547-2018	Bar-On, Lynn/0000-0003-4793-2860; Schless, Simon/0000-0002-1785-8324; Desloovere, Kaat/0000-0002-8507-5276; Aertbeliën, Erwin/0000-0002-4514-0934	KU Leuven, Belgium [DBOF/12/058]; Flemish Agency for Innovation by Science and Technology [060799]; Flemish Research Foundation, FWO [12R4215N]	KU Leuven, Belgium(KU Leuven); Flemish Agency for Innovation by Science and Technology; Flemish Research Foundation, FWO(FWO)	This work was made possible by a grant from the Doctoral Scholarships Committee for International Collaboration with non EER-countries (DBOF) of the KU Leuven, Belgium, awarded to Prof. Kaat Desloovere, grant number DBOF/12/058. This work was also supported by a grant from Applied Biomedical Research from the Flemish Agency for Innovation by Science and Technology, grant number 060799, and funding from the Flemish Research Foundation, FWO: grant 12R4215N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On L, 2014, GAIT POSTURE, V40, P346, DOI 10.1016/j.gaitpost.2014.04.207; Bar-On L, 2013, GAIT POSTURE, V38, P141, DOI 10.1016/j.gaitpost.2012.11.003; Bar-On L, 2014, RES DEV DISABIL, V35, P3354, DOI 10.1016/j.ridd.2014.07.053; Bar-On L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091759; Bar-On L, 2014, ARCH PHYS MED REHAB, V95, P515, DOI 10.1016/j.apmr.2013.08.010; Benard MR, 2010, CLIN BIOMECH, V25, P802, DOI 10.1016/j.clinbiomech.2010.04.010; Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Burridge JH, 2005, DISABIL REHABIL, V27, P69, DOI 10.1080/09638280400014592; Calota A, 2008, CLIN NEUROPHYSIOL, V119, P2329, DOI 10.1016/j.clinph.2008.07.215; Cans C, 2000, DEV MED CHILD NEUROL; Chung SG, 2008, ARCH PHYS MED REHAB, V89, P700, DOI 10.1016/j.apmr.2007.09.051; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; de Vlugt E, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-35; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; JENSEN RK, 1986, J BIOMECH, V19, P359, DOI 10.1016/0021-9290(86)90012-6; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; Kim KS, 2011, MED ENG PHYS, V33, P62, DOI 10.1016/j.medengphy.2010.09.002; Lamontagne A, 1998, EVALUATION REFLEX NO, P78; Lee HM, 2004, J ELECTROMYOGR KINES, V14, P577, DOI 10.1016/j.jelekin.2004.02.002; Lynn BO, 2013, RES DEV DISABIL, V34, P386, DOI 10.1016/j.ridd.2012.08.019; Malhotra S, 2009, CLIN REHABIL, V23, P651, DOI 10.1177/0269215508101747; Mirbagheri MM, 2001, EXP BRAIN RES, V141, P446, DOI 10.1007/s00221-001-0901-z; Molenaers G, 2010, J CHILD ORTHOP, V4, P183, DOI 10.1007/s11832-010-0246-x; Pandyan AD, 2001, CLIN BIOMECH, V16, P859, DOI 10.1016/S0268-0033(01)00084-5; Phadke CP, 2012, DISABIL REHABIL, V34, P91, DOI 10.3109/09638288.2011.591882; Platz T, 2005, DISABIL REHABIL, V27, P7, DOI 10.1080/09638280400014634; Rabita G, 2005, CLIN NEUROPHYSIOL, V116, P93, DOI 10.1016/j.clinph.2004.07.029; RAUCH HE, 1965, AIAA J, V3, P1445, DOI 10.2514/3.3166; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Staude G, 1999, MED ENG PHYS, V21, P449, DOI 10.1016/S1350-4533(99)00067-3; Turk R, 2008, NEUROREHAB NEURAL RE, V22, P684, DOI 10.1177/1545968308315599; van den Noort JC, 2010, ARCH PHYS MED REHAB, V91, P615, DOI 10.1016/j.apmr.2009.12.022; van der Salm A, 2005, ARCH PHYS MED REHAB, V86, P1991, DOI 10.1016/j.apmr.2005.04.023; Voerman GE, 2007, DISABIL REHABIL, V29, P1870, DOI 10.1080/09638280601143752; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wu YN, 2010, DEV MED CHILD NEUROL, V52, P563, DOI 10.1111/j.1469-8749.2009.03602.x	45	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131011	10.1371/journal.pone.0131011	http://dx.doi.org/10.1371/journal.pone.0131011			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134673	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400033
J	Auber, A; Travers-Trolet, M; Villanueva, MC; Ernande, B				Auber, Arnaud; Travers-Trolet, Morgane; Villanueva, Maria Ching; Ernande, Bruno			Regime Shift in an Exploited Fish Community Related to Natural Climate Oscillations	PLOS ONE			English	Article							ATLANTIC MULTIDECADAL OSCILLATION; LONG-TERM CHANGES; NORTH-SEA; ENGLISH-CHANNEL; NARRAGANSETT BAY; EASTERN NORTH; STATION L4; ZOOPLANKTON; ECOSYSTEM; VARIABILITY	Identifying the various drivers of marine ecosystem regime shifts and disentangling their respective influence are critical tasks for understanding biodiversity dynamics and properly managing exploited living resources such as marine fish communities. Unfortunately, the mechanisms and forcing factors underlying regime shifts in marine fish communities are still largely unknown although climate forcing and anthropogenic pressures such as fishing have been suggested as key determinants. Based on a 24-year-long time-series of scientific surveys monitoring 55 fish and cephalopods species, we report here a rapid and persistent structural change in the exploited fish community of the eastern English Channel from strong to moderate dominance of small-bodied forage fish species with low temperature preferendum that occurred in the mid-1990s. This shift was related to a concomitant warming of the North Atlantic Ocean as attested by a switch of the Atlantic Multidecadal Oscillation from a cold to a warm phase. Interestingly, observed changes in the fish community structure were opposite to those classically induced by exploitation as larger fish species of higher trophic level increased in abundance. Despite not playing a direct role in the regime shift, fishing still appeared as a forcing factor affecting community structure. Moreover, although related to climate, the regime shift may have been facilitated by strong historic exploitation that certainly primed the system by favoring the large dominance of small-bodied fish species that are particularly sensitive to climatic variations. These results emphasize that particular attention should be paid to multidecadal natural climate variability and its interactions with both fishing and climate warming when aiming at sustainable exploitation and ecosystem conservation.	[Auber, Arnaud; Travers-Trolet, Morgane; Ernande, Bruno] IFREMER, Lab Ressources Halieut, F-62321 Boulogne Sur Mer, France; [Villanueva, Maria Ching] IFREMER, Unite Sci & Technol, F-29280 Plouzane, France	Ifremer; Ifremer	Auber, A (corresponding author), IFREMER, Lab Ressources Halieut, F-62321 Boulogne Sur Mer, France.	Arnaud.Auber@ifremer.fr	auber, arnaud/AAY-5532-2021; Ernande, Bruno/C-1182-2008; Auber, Arnaud/AAI-8794-2021; Villanueva, Maria Ching/B-5870-2016	Ernande, Bruno/0000-0002-0727-5774; Villanueva, Maria Ching/0000-0003-2562-3282; Travers-Trolet, Morgane/0000-0003-1493-662X; Auber, Arnaud/0000-0002-8415-1652	French Foundation for Research on Biodiversity [APP-SCEN-2010-II]; FRB (French Foundation for Research on Biodiversity)	French Foundation for Research on Biodiversity; FRB (French Foundation for Research on Biodiversity)	This work was supported by the EMIBIOS project through a grant from the French Foundation for Research on Biodiversity, 'Modeling and Scenarios of Biodiversity' call for proposals, grant number APP-SCEN-2010-II. AA, MT, MCV and BE received the FRB (French Foundation for Research on Biodiversity) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; Alheit J, 2014, J MARINE SYST, V133, P1, DOI 10.1016/j.jmarsys.2013.11.012; Alheit J, 2014, J MARINE SYST, V131, P21, DOI 10.1016/j.jmarsys.2013.11.002; Alheit J, 2012, PROG OCEANOGR, V96, P128, DOI 10.1016/j.pocean.2011.11.015; Astthorsson OS, 2012, ICES J MAR SCI, V69, P1289, DOI 10.1093/icesjms/fss084; Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2000, MAR ECOL PROG SER, V200, P93, DOI 10.3354/meps200093; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borkman DG, 2009, J PLANKTON RES, V31, P1407, DOI 10.1093/plankt/fbp072; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cahuin SM, 2009, ESTUAR COAST SHELF S, V84, P591, DOI 10.1016/j.ecss.2009.07.027; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; Condron A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024239; Coombs S, 2011, RUSSELL CYCLE UPDATE, P27; Czaja A, 1999, GEOPHYS RES LETT, V26, P2969, DOI 10.1029/1999GL900613; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Dawe EG, 2000, ICES J MAR SCI, V57, P1002, DOI 10.1006/jmsc.2000.0585; Dickson R.R., 2000, P92; Drinkwater KF, 2014, J MARINE SYST, V133, P117, DOI 10.1016/j.jmarsys.2013.11.001; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Edeline E, 2013, GLOBAL CHANGE BIOL, V19, P3062, DOI 10.1111/gcb.12299; Edwards M, 2002, MAR ECOL PROG SER, V239, P1, DOI 10.3354/meps239001; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Eloire D, 2010, J PLANKTON RES, V32, P657, DOI 10.1093/plankt/fbq009; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; FRENCH FW, 1986, J PHYCOL, V22, P411, DOI 10.1111/j.1529-8817.1986.tb02482.x; Friedland KD, 2014, J MARINE SYST, V133, P77, DOI 10.1016/j.jmarsys.2013.03.003; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Garcia-Soto C, 2012, J MAR BIOL ASSOC UK, V92, P213, DOI 10.1017/S0025315410002134; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Harris V, 2014, J MARINE SYST, V133, P55, DOI 10.1016/j.jmarsys.2013.07.001; Hasegawa H, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044219; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Hawkins SJ, 2013, MAR POLICY, V42, P91, DOI 10.1016/j.marpol.2013.02.001; Horsted S. A., 2000, J NW ATLANTIC FISHER, V28, P1; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; John EH, 2001, J SEA RES, V46, P223, DOI 10.1016/S1385-1101(01)00085-5; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Kristiansen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017456; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lindegren M, 2010, MAR ECOL PROG SER, V402, P239, DOI 10.3354/meps08454; MARKLE DF, 1980, CAN J FISH AQUAT SCI, V37, P49, DOI 10.1139/f80-005; McHugh M, 2011, J SEA RES, V65, P187, DOI 10.1016/j.seares.2010.09.006; Mieszkowska N, 2014, J MARINE SYST, V133, P70, DOI 10.1016/j.jmarsys.2012.11.008; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; National Oceanic and Atmospheric Administration (NOAA US), NAO VAL; National Oceanic and Atmospheric Administration (NOAA US), AMO VAL; Nye JA, 2014, J MARINE SYST, V133, P103, DOI 10.1016/j.jmarsys.2013.02.006; Ottersen G, 2004, MAR EC CLIM VAR; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Petitgas P, 2012, MAR ECOL PROG SER, V444, P1, DOI 10.3354/meps09451; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Plymouth Marine Laboratory (PML UK), GSNW VAL; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Reid PC, 2001, MAR ECOL PROG SER, V215, P283, DOI 10.3354/meps215283; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rochet MJ, 2005, ICES J MAR SCI, V62, P1647, DOI 10.1016/j.icesjms.2005.06.009; Rothschild BJ, 2012, ICES J MAR SCI, V69, P913, DOI 10.1093/icesjms/fsr196; RUSSELL FS, 1971, NATURE, V234, P468, DOI 10.1038/234468a0; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; SKOGEN MD, 1995, ESTUAR COAST SHELF S, V41, P545, DOI 10.1016/0272-7714(95)90026-8; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Spencer M, 2011, MAR ECOL-EVOL PERSP, V32, P10, DOI 10.1111/j.1439-0485.2010.00422.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; ter Hofstede R, 2010, MAR ECOL PROG SER, V414, P1, DOI 10.3354/meps08753; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Weijerman M, 2005, MAR ECOL PROG SER, V298, P21, DOI 10.3354/meps298021; Wynn RB, 2007, BIOL LETTERS, V3, P529, DOI 10.1098/rsbl.2007.0162	78	30	30	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129883	10.1371/journal.pone.0129883	http://dx.doi.org/10.1371/journal.pone.0129883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132268	Green Published, gold			2022-12-26	WOS:000358153000044
J	Beerli, RR; Hell, T; Merkel, AS; Grawunder, U				Beerli, Roger R.; Hell, Tamara; Merkel, Anna S.; Grawunder, Ulf			Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; RECOMBINANT IMMUNOTOXIN; MONOCLONAL-ANTIBODIES; STAPHYLOCOCCUS-AUREUS; PROTEIN LIGATION; SURFACE-PROTEINS; CANCER-THERAPY; IMMUNOGENICITY; FRAGMENTATION; PURIFICATION	Antibody drug conjugates (ADCs) have recently been proven to be highly potent anti-tumor drugs, typically exceeding the efficacy of conventional monoclonal antibodies (mAbs). ADCs are currently produced by chemical conjugation of a small-molecule toxin to the mAb through lysine or cysteine side chains. This leads to heterogeneous mixtures of ADCs in which variable numbers of drugs are conjugated to individual antibodies and in which the site of conjugation cannot be defined. Consequently, there is currently significant interest in further development of drug conjugation technologies, with a particular focus on site-specific payload conjugation. Here, we present an enzymatic conjugation platform based on the S. aureus sortase A-mediated transpeptidation reaction, allowing the efficient generation of ADCs with toxins conjugated to pre-defined sites at pre-defined drug-to-antibody ratios. For this, two modifications were introduced: first, immunoglobulin heavy (IgH) and light (IgL) chains were modified at their C-termini by addition of the sortase A recognition motif LPETG, and second, the small molecule tubulin polymerization inhibitors monomethylauristatin E (MMAE) and maytansine were modified by addition of a pentaglycine peptide, thus making them suitable substrates for sortase A-mediated transpeptidation. We demonstrate efficient generation and characterization of the anti-CD30 ADC Ac10-vcPAB-MMAE, an enzymatically conjugated counterpart of brentuximab vedotin (Adcetris), as well as several anti-HER-2 ADCs including trastuzumab-maytansine, the counterpart of trastuzumab emtansine (Kadcyla). ADCs generated in this manner were found to display in vitro cell killing activities indistinguishable from the classic conjugates. Further, when tested in vivo in a HER-2-overexpressing ovarian cancer xenograft mouse model, enzymatically generated trastuzumab-maytansine was found to lead to complete regression of established tumors, similar to Kadcyla.	[Beerli, Roger R.; Hell, Tamara; Merkel, Anna S.; Grawunder, Ulf] NBE Therapeut AG, Basel, Switzerland		Beerli, RR (corresponding author), NBE Therapeut AG, Hochbergerstr, Basel, Switzerland.	roger.beerli@nbe-therapeutics.com			NBE-Therapeutics AG	NBE-Therapeutics AG	NBE-Therapeutics AG provided support in the form of salaries for authors R.R.B., T.H., A.S.M. and U.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agarwal P, 2015, BIOCONJUGATE CHEM; Alewine C, 2015, ONCOLOGIST, V20, P176, DOI 10.1634/theoncologist.2014-0358; Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Dean GS, 1998, CLIN CANCER RES, V4, P2545; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Ducry L, 2010, BIOCONJUGATE CHEM, V21, P5, DOI 10.1021/bc9002019; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; KONDO T, 1988, J BIOL CHEM, V263, P9470; Kornberger P, 2014, MABS-AUSTIN, V6, P354, DOI 10.4161/mabs.27444; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Lambert JM, 2013, BRIT J CLIN PHARMACO, V76, P248, DOI 10.1111/bcp.12044; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Lyon RP, 2014, NAT BIOTECHNOL, V32, P1059, DOI 10.1038/nbt.2968; Madej MP, 2012, BIOTECHNOL BIOENG, V109, P1461, DOI 10.1002/bit.24407; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazor R, 2014, P NATL ACAD SCI USA, V111, P8571, DOI 10.1073/pnas.1405153111; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P329, DOI 10.1038/nrd4009; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Perez HL, 2014, DRUG DISCOV TODAY, V19, P869, DOI 10.1016/j.drudis.2013.11.004; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Piccart-Gebhart MJ, 2005, N ENGL J MED, V353; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rose JS, 2011, ONCOTARGETS THER, V4, P21, DOI 10.2147/OTT.S10188; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Swee LK, 2013, P NATL ACAD SCI USA, V110, P1428, DOI 10.1073/pnas.1214994110; Toki BE, 2002, J ORG CHEM, V67, P1866, DOI 10.1021/jo016187+; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Wahl AF, 2002, CANCER RES, V62, P3736	43	131	148	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131177	10.1371/journal.pone.0131177	http://dx.doi.org/10.1371/journal.pone.0131177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132162	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000098
J	Caspari, T; Hilditch, V				Caspari, Thomas; Hilditch, Victoria			Two Distinct Cdc2 Pools Regulate Cell Cycle Progression and the DNA Damage Response in the Fission Yeast S.pombe	PLOS ONE			English	Article							WEE1 PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; TYROSINE PHOSPHORYLATION; GEL-ELECTROPHORESIS; ACTIVATING KINASE; P34CDC2 KINASE; CDK REGULATION; S-PHASE; CHECKPOINT; MITOSIS	The activity of Cdc2 (CDK1) kinase, which coordinates cell cycle progression and DNA break repair, is blocked upon its phosphorylation at tyrosine 15 (Y15) by Wee1 kinase in the presence of DNA damage. How Cdc2 can support DNA repair whilst being inactivated by the DNA damage checkpoint remains to be explained. Human CDK1 is phosphorylated by Myt1 kinase at threonine 14 (T14) close to its ATP binding site before being modified at threonine 161 (T167(Sp)) in its T-loop by the CDK-activating kinase (CAK). While modification of T161 promotes association with the cyclin partner, phosphorylation of T14 inhibits the CDK1-cyclin complex. This inhibition is further enforced by the modification of Y15 by Wee1 in the presence of DNA lesions. In S.pombe, the dominant inhibition of Cdc2 is provided by the phosphorylation of Y15 and only a small amount of Cdc2 is modified at T14 when cells are in S phase. Unlike human cells, both inhibitory modifications are executed by Wee1. Using the novel IEFPT technology, which combines isoelectric focusing (IEF) with Phos-tag SDS electrophoresis (PT), we report here that S.pombe Cdc2 kinase exists in seven forms. While five forms are phosphorylated, two species are not. Four phospho-forms associate with cyclin B (Cdc13) of which only two are modified at Y15 by Wee1. Interestingly, only one Y15-modified species carries also the T14 modification. The fifth phospho-form has a low affinity for cyclin B and is neither Y15 nor T14 modified. The two unphosphorylated forms may contribute directly to the DNA damage response as only they associate with the DNA damage checkpoint kinase Chk1. Interestingly, cyclin B is also present in the unphosphorylated pool. We also show that the G146D mutation in Cdc2.1w, which renders Cdc2 insensitive to Wee1 inhibition, is aberrantly modified in a Wee1-dependent manner. In conclusion, our work adds support to the idea that two distinct Cdc2 pools regulate cell cycle progression and the response to DNA damage.	[Caspari, Thomas; Hilditch, Victoria] Bangor Univ, Sch Med Sci, Genome Biol Grp, Bangor LL57 2UW, Gwynedd, Wales	Bangor University	Caspari, T (corresponding author), Bangor Univ, Sch Med Sci, Genome Biol Grp, Bangor LL57 2UW, Gwynedd, Wales.	t.caspari@bangor.ac.uk		Caspari, Thomas/0000-0002-1450-4774	Higher Education Funding Council for Wales (HEFCW)	Higher Education Funding Council for Wales (HEFCW)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	This work was funded by the Core Teaching Grant to Bangor University from the Higher Education Funding Council for Wales (HEFCW).	ALFA CE, 1990, NATURE, V347, P680, DOI 10.1038/347680a0; Arndt Claudia, 2012, Methods Mol Biol, V869, P49, DOI 10.1007/978-1-61779-821-4_5; BARBET NC, 1993, NATURE, V364, P824, DOI 10.1038/364824a0; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; BOOHER R, 1986, MOL CELL BIOL, V6, P3523, DOI 10.1128/MCB.6.10.3523; CARR AM, 1995, CURR BIOL, V5, P1179, DOI 10.1016/S0960-9822(95)00234-X; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christensen PU, 2000, P NATL ACAD SCI USA, V97, P2579, DOI 10.1073/pnas.97.6.2579; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Coulonval K, 2011, MOL BIOL CELL, V22, P3971, DOI 10.1091/mbc.E11-02-0136; DENHAESE GJ, 1995, MOL BIOL CELL, V6, P371, DOI 10.1091/mbc.6.4.371; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; FANTES PA, 1981, J BACTERIOL, V146, P746, DOI 10.1128/JB.146.2.746-754.1981; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Frazer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021348; Friedman DB, 2009, METHOD ENZYMOL, V463, P515, DOI 10.1016/S0076-6879(09)63030-5; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Janes S, 2012, J CELL SCI, V125, P4487, DOI 10.1242/jcs.104075; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2009, ELECTROPHORESIS, V30, P550, DOI 10.1002/elps.200800386; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lee KM, 1999, CURR BIOL, V9, P441, DOI 10.1016/S0960-9822(99)80194-8; Lin SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002801; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NURSE P, 1980, GENETICS, V96, P627; POTASHKIN JA, 1988, CURR GENET, V14, P235, DOI 10.1007/BF00376743; Raleigh JM, 2000, J CELL SCI, V113, P1727; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Saeyd SAM, 2014, NUCLEIC ACIDS RES, V42, P7734, DOI 10.1093/nar/gku452; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; SPARKS JW, 1985, J BIOL CHEM, V260, P2042; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5	46	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130748	10.1371/journal.pone.0130748	http://dx.doi.org/10.1371/journal.pone.0130748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131711	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000080
J	Gabriele-Rivet, V; Arsenault, J; Badcock, J; Cheng, A; Edsall, J; Goltz, J; Kennedy, J; Lindsay, LR; Pelcat, Y; Ogden, NH				Gabriele-Rivet, Vanessa; Arsenault, Julie; Badcock, Jacqueline; Cheng, Angela; Edsall, Jim; Goltz, Jim; Kennedy, Joe; Lindsay, L. Robbin; Pelcat, Yann; Ogden, Nicholas H.			Different Ecological Niches for Ticks of Public Health Significance in Canada	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; LYME-DISEASE VECTOR; BASIC REPRODUCTIVE NUMBER; RANGE EXPANSION; HABITAT SUITABILITY; CLIMATE-CHANGE; IXODIDAE; SURVIVAL; MODEL; RISK	Tick-borne diseases are a growing public health concern as their incidence and range have increased in recent decades. Lyme disease is an emerging infectious disease in Canada due to northward expansion of the geographic range of Ixodes scapularis, the principal tick vector for the Lyme disease agent Borrelia burgdorferi, into central and eastern Canada. In this study the geographical distributions of Ixodid ticks, including I. scapularis, and environmental factors associated with their occurrence were investigated in New Brunswick, Canada, where few I. scapularis populations have been found to date. Density of host-seeking ticks was evaluated by drag sampling of woodland habitats in a total of 159 sites. Ixodes scapularis ticks (n = 5) were found on four sites, Ixodes muris (n = 1) on one site and Haemaphysalis leporispalustris (n = 243) on 41 sites. One of four adult I. scapularis ticks collected was PCR-positive for B. burgdorferi. No environmental variables were significantly associated with the presence of I. scapularis although comparisons with surveillance data in neighbouring provinces (Qubec and Nova Scotia) suggested that temperature conditions may be too cold for I. scapularis (< 2800 annual degree days above 0 degrees C [ DD > 0 degrees C]) across much of New Brunswick. In contrast, the presence of H. leporispalustris, which is a competent vector of tularaemia, was significantly (P < 0.05) associated with specific ranges of mean DD > 0 degrees C, mean annual precipitation, percentage of clay in site soil, elevation and season in a multivariable logistic regression model. With the exception of some localized areas, temperature conditions and deer density may be too low for the establishment of I. scapularis and Lyme disease risk areas in New Brunswick, while environmental conditions were suitable for H. leporispalustris at many sites. These findings indicate differing ecological niches for two tick species of public health significance.	[Gabriele-Rivet, Vanessa; Arsenault, Julie; Ogden, Nicholas H.] Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ J2S 7C6, Canada; [Arsenault, Julie] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada; [Badcock, Jacqueline] New Brunswick Dept Hlth, Hlth, Fredericton, NB, Canada; [Cheng, Angela] Environm Canada, Ottawa, ON K1A 0H3, Canada; [Edsall, Jim] Jim Edsall Insect Identificat Serv, Dartmouth, NS, Canada; [Goltz, Jim] New Brunswick Dept Aquaculture Agr & Food, Fredericton, NB, Canada; [Kennedy, Joe] New Brunswick Nat Resources, Fredericton, NB, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Pelcat, Yann; Ogden, Nicholas H.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, St Hyacinthe, PQ, Canada	Universite de Montreal; Universite de Montreal; Environment & Climate Change Canada; Public Health Agency of Canada; Public Health Agency of Canada	Ogden, NH (corresponding author), Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ J2S 7C6, Canada.	nicholas.ogden@phac-aspc.gc.ca	Arsenault, Julie/D-5077-2015	Arsenault, Julie/0000-0001-8382-7326; Lindsay, Robbin/0000-0001-7236-2930; Gabriele-Rivet, Vanessa/0000-0003-0813-7100	New Brunswick Department of Health; Department of Aquaculture, Agriculture Food	New Brunswick Department of Health; Department of Aquaculture, Agriculture Food	We thank the New Brunswick Department of Health and Department of Aquaculture, Agriculture & Food for their support in conducting this study.	Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061; BLACK D M, 1958, Can Med Assoc J, V78, P16; Bouchard C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-195; Brown J. H., 1945, CANADIAN ENT, V77, P176; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CAMPBELL A, 1980, J MED ENTOMOL, V17, P22, DOI 10.1093/jmedent/17.1.22; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Derr RE, 2000, P 25 ANN SAS US GROU; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Ditohfield J., 1960, Canadian Journal of Public Health, V51, P474; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Dolan MC, 2000, J MED ENTOMOL, V37, P766, DOI 10.1603/0022-2585-37.5.766; Eisen L, 2006, J MED ENTOMOL, V43, P415, DOI 10.1603/0022-2585(2006)043[0415:GDPAHS]2.0.CO;2; Estrada-Pena A, 2001, VET PARASITOL, V98, P111, DOI 10.1016/S0304-4017(01)00426-5; Furlanello C., 2003, P 3 INT WORKSH DISTR, P1; Ginsberg HS, 2004, ENVIRON ENTOMOL, V33, P1266, DOI 10.1603/0046-225X-33.5.1266; Ginsberg HS, 1996, EXP APPL ACAROL, V20, P533, DOI 10.1007/BF00048285; Goethert HK, 2003, J PARASITOL, V89, P1069, DOI 10.1645/GE-3149RN; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hamer SA, 2011, APPL ENVIRON MICROB, V77, P1999, DOI 10.1128/AEM.02479-10; Harrison BA, 1997, J VECTOR ECOL, V22, P6; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kollars TM, 2003, J MED ENTOMOL, V40, P103, DOI 10.1603/0022-2585-40.1.103; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Lee H.T., 1998, ECOLOGICAL LAND CLAS; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindgren E, 2006, LYME BORRELIOSIS EUR; Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189; Lindsay LR, 1995, THESIS U GUELPH ONTA; Lindsay R, 1998, Can Commun Dis Rep, V24, P121; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Madhav NK, 2004, J MED ENTOMOL, V41, P842, DOI 10.1603/0022-2585-41.5.842; McCabe GJ, 2004, VECTOR-BORNE ZOONOT, V4, P143, DOI 10.1089/1530366041210765; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; New Brunswick Department of Natural Resources, 2007, OUR LANDSC HER STOR; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden N H, 2014, Can Commun Dis Rep, V40, P83; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2006, J MED ENTOMOL, V43, P403, DOI 10.1603/0022-2585(2006)043[0403:IOGLAR]2.0.CO;2; Ogden NH, 2014, THE BIOL OF TICKS, P278; OGDEN NH, 2014, CANADA COMMUNICABLE, V40, P74; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Parola P, 2001, CLIN MICROBIOL INFEC, V7, P80, DOI 10.1046/j.1469-0691.2001.00200.x; Patrican LA, 1997, J MED ENTOMOL, V34, P52, DOI 10.1093/jmedent/34.1.52; PHILIP CORNELIUS B., 1938, PUBL HEALTH REPTS, V53, P574, DOI 10.2307/4582509; Public Health Agency of Canada, 2015, LYM DIS OTH TICK BOR; R Development Core Team, 2014, R LANG ENV STAT COMP; Rand PW, 2004, J MED ENTOMOL, V41, P779, DOI 10.1603/0022-2585-41.4.779; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Schulze TL, 2002, ENVIRON ENTOMOL, V31, P1085, DOI 10.1603/0046-225X-31.6.1085; Sonenshine D. E., 1994, ECOLOGICAL DYNAMICS; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Waller L.A., 2004, APPL SPATIAL STAT PU; Wobeser G, 2009, CAN VET J, V50, P1251; Wu XT, 2013, J THEOR BIOL, V319, P50, DOI 10.1016/j.jtbi.2012.11.014; Yoder JA, 2003, INT J ACAROL, V29, P271, DOI 10.1080/01647950308684339	65	26	26	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131282	10.1371/journal.pone.0131282	http://dx.doi.org/10.1371/journal.pone.0131282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131550	gold, Green Published			2022-12-26	WOS:000358153000107
J	Ibrahim, N; Teo, SSL; Din, NC; Gafor, AHA; Ismail, R				Ibrahim, Norhayati; Teo, Sharlene S. L.; Din, Normah Che; Gafor, Abdul Halim Abdul; Ismail, Rozmi			The Role of Personality and Social Support in Health-Related Quality of Life in Chronic Kidney Disease Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PSYCHOSOCIAL FACTORS; DIALYSIS OUTCOMES; MORTALITY; HOSPITALIZATION; ASSOCIATION; PREVALENCE; PREDICTORS; INITIATION; PATTERNS	Background Chronic kidney disease (CKD) is commonly associated with various negative health outcomes. The aim of this study was to examine the influence of personality and social support on health-related quality of life in patients with chronic kidney disease. Health-related quality of life (HRQoL) is the quality of life studied in relation to health, and it provides important information of patients' coping with their health issues. Method Participants comprised of 200 patients experiencing various stages of chronic kidney disease. All participants completed the Short-Form 36 (SF-36), Big Five Inventory (BFI) and the Medical Outcomes Study (MOS) Social Support questionnaires. Results Participants consisted of 108 males (54.0%) and 92 females (46.0%) with the mean age of 59.3 years (SD 14.5). Results showed that higher levels of extraversion and lower perceived affectionate social support were associated with higher physical HRQoL, whereas higher levels of neuroticism were associated with poorer mental HRQoL. Conclusion The current study found that certain personality traits, namely extraversion and neuroticism, were found to be associated with HRQoL. In addition, affectionate social support was also associated with higher HRQoL. Therefore, special attention should be paid to the personality of CKD patients, as well as the type of social support that they have, in planning interventions to improve their health outcomes.	[Ibrahim, Norhayati; Teo, Sharlene S. L.; Din, Normah Che] Natl Univ Malaysia UKM, Hlth Psychol Programme, Fac Hlth Sci, Kuala Lumpur, Malaysia; [Gafor, Abdul Halim Abdul] Natl Univ Malaysia UKM, Fac Med, Nephrol & SLE Unit, Kuala Lumpur, Malaysia; [Ismail, Rozmi] Natl Univ Malaysia UKM, Fac Social Sci & Humanities, Sch Psychol & Human Dev, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Teo, SSL (corresponding author), Natl Univ Malaysia UKM, Hlth Psychol Programme, Fac Hlth Sci, Kuala Lumpur, Malaysia.	sharlenesl.teo@gmail.com	Gafor, Abdul Halim Abdul/L-4405-2017	Gafor, Abdul Halim Abdul/0000-0003-3950-2844	National University of Malaysia (Universiti Kebangsaan Malaysia); NI [GGPM-2012-100]	National University of Malaysia (Universiti Kebangsaan Malaysia); NI	The current study was funded by the National University of Malaysia (Universiti Kebangsaan Malaysia), and the grant recipient was NI (Grant Code no.: GGPM-2012-100). The authors' source of support is internal, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awuah KT, 2013, KIDNEY INT SUPPL, V3, P227, DOI 10.1038/kisup.2013.20; Bakewell AB, 2002, KIDNEY INT, V61, P239, DOI 10.1046/j.1523-1755.2002.00096.x; Chobanian AV, JAMA, V42, P2560; CHRISTENSEN AJ, 1995, J BEHAV MED, V18, P305, DOI 10.1007/BF01857875; Christensen AJ, 2002, J CONSULT CLIN PSYCH, V70, P712, DOI 10.1037/0022-006X.70.3.712; Cohen SD, 2007, ADV CHRONIC KIDNEY D, V14, P335, DOI 10.1053/j.ackd.2007.04.007; Cruz MC, 2011, CLINICS, V66, P991, DOI 10.1590/S1807-59322011000600012; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goodwin R, 2002, PSYCHOL MED, V32, P325, DOI 10.1017/S0033291701005104; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Goodwin RD, 2006, J BEHAV MED, V29, P229, DOI 10.1007/s10865-006-9048-5; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hee O.C., 2014, INT J INNOVATION APP, V5, P309; Hooi LS, 2013, KIDNEY INT, V84, P1034, DOI 10.1038/ki.2013.220; Hudek-Knezevic J, 2009, CROAT MED J, V50, P394, DOI 10.3325/cmj.2009.50.394; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Korevaar JC, 2000, PERITON DIALYSIS INT, V20, P69; Leung J, 2014, PSYCHO-ONCOLOGY, V23, P1014, DOI 10.1002/pon.3523; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; MACLEAN HM, 1991, SOC SCI MED, V32, P689, DOI 10.1016/0277-9536(91)90148-6; Mahmud W., 2004, J MED SCI, V11, P26; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Ministry of Health Malaysia, 2011, MAN CHRON KIDN DIS A; Mujais SK, 2009, CLIN J AM SOC NEPHRO, V4, P1293, DOI 10.2215/CJN.05541008; Pagels AA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-71; Patel SS, 2005, SEMIN DIALYSIS, V18, P98, DOI 10.1111/j.1525-139X.2005.18203.x; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Perlman RL, 2003, SEMIN DIALYSIS, V16, P418, DOI 10.1046/j.1525-139X.2003.16093.x; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P1480, DOI 10.2215/CJN.01240210; Poppe C, 2013, NEPHROL DIAL TRANSPL, V28, P116, DOI 10.1093/ndt/gfs151; Prihodova L, 2010, TRANSPL INT, V23, P484, DOI 10.1111/j.1432-2277.2009.01003.x; Sararaks S, 2005, Med J Malaysia, V60, P163; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Soni RK, 2010, CURR OPIN NEPHROL HY, V19, P153, DOI 10.1097/MNH.0b013e328335f939; Spiegel BMR, 2008, CLIN J AM SOC NEPHRO, V3, P1759, DOI 10.2215/CJN.00820208; Tsai YC, 2010, NEPHROL DIAL TRANSPL, V25, P1621, DOI 10.1093/ndt/gfp671; Turiano NA, 2012, J GERONTOL B-PSYCHOL, V67, P4, DOI 10.1093/geronb/gbr072; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; Valderrabano F, 2001, AM J KIDNEY DIS, V38, P443, DOI 10.1053/ajkd.2001.26824; Vazquez I, 2005, QUAL LIFE RES, V14, P179, DOI 10.1007/s11136-004-3919-4; Ware J., 1993, SF 36 HLTH SURVEY MA; Wasserfallen JB, 2004, NEPHROL DIAL TRANSPL, V19, P1594, DOI 10.1093/ndt/gfh175; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; WILCOX VL, 1994, HEALTH PSYCHOL, V13, P170, DOI 10.1037/0278-6133.13.2.170; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	48	39	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129015	10.1371/journal.pone.0129015	http://dx.doi.org/10.1371/journal.pone.0129015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26131714	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000024
J	Morroy, G; van der Hoek, W; Albers, J; Coutinho, RA; Bleeker-Rovers, CP; Schneeberger, PM				Morroy, Gabriella; van der Hoek, Wim; Albers, Jelle; Coutinho, Roel A.; Bleeker-Rovers, Chantal P.; Schneeberger, Peter M.			Population Screening for Chronic Q-Fever Seven Years after a Major Outbreak	PLOS ONE			English	Article								Introduction From 2007 through 2010, the Netherlands experienced a large Q-fever epidemic, with 4,107 notifications. The most serious complication of Q-fever is chronic Q-fever. Method In 2014, we contacted all 2,161 adult inhabitants of the first village in the Netherlands affected by the Q-fever epidemic and offered to test for antibodies against Coxiella burnetii using immunofluorescence assay (IFA) to screen for chronic infections and assess whether large-scale population screening elsewhere is warranted. Results Of the 1,517 participants, 33.8% were IFA-positive. Six IFA-positive participants had an IgG phase I titer >= 1:512. Two of these six participants were previously diagnosed with chronic Q-fever. Chronic infection was diagnosed in one of the other four participants after clinical examination. Conclusions Seven years after the initial outbreak, seroprevalence remains high, but the yield of screening the general population for chronic Q-fever is low. A policy of screening known high-risk groups for chronic Q-fever in outbreak areas directly following an outbreak might be more efficient than population screening. A cost-effectiveness analysis should also be performed before initiating a population screening program for chronic Q-fever.	[Morroy, Gabriella; Albers, Jelle] Municipal Hlth Serv Hart voor Brabant, Dept Infect Dis Control, Shertogenbosch, Netherlands; [Morroy, Gabriella] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Acad Collaborat Ctr AMPHI, NL-6525 ED Nijmegen, Netherlands; [van der Hoek, Wim] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Epidemiol & Surveillance Unit, Bilthoven, Netherlands; [Coutinho, Roel A.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bleeker-Rovers, Chantal P.] Radboud Univ Nijmegen, Med Ctr, Radboud Expertise Ctr Q Fever, Dept Internal Med,Div Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol, Shertogenbosch, Netherlands	Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Jeroen Bosch Ziekenhuis	Morroy, G (corresponding author), Municipal Hlth Serv Hart voor Brabant, Dept Infect Dis Control, Shertogenbosch, Netherlands.	g.morroy@ggdhvb.nl	Bleeker-Rovers, Chantal P/D-4833-2009	Bleeker-Rovers, Chantal P/0000-0003-4900-6262	Dutch Ministry of Health, Welfare and Sport (VWS) [321632]	Dutch Ministry of Health, Welfare and Sport (VWS)	Financial support provided by Dutch Ministry of Health, Welfare and Sport (VWS) project number 321632. Reduction prices serological IFA testing Laboratory of Medical Microbiology Jeroen Bosch Hospital and of personnel by the Municipal Health Service, Hart voor Brabant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hussain-Yusuf H, 2012, QJM-INT J MED, V105, P1067, DOI 10.1093/qjmed/hcs119; Kampschreur LM, 2014, J CLIN MICROBIOL, V52, P1637, DOI 10.1128/JCM.03221-13; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; Morroy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060707; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Schimmer B, 2012, EPIDEMIOL INFECT, V140, P27, DOI 10.1017/S0950268811000136; van der Hoek W, 2012, EURO SURVEIL, V17; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P20059; Vranakis I, 2012, COMP IMMUNOL MICROB, V35, P123, DOI 10.1016/j.cimid.2011.11.006; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Wielders CCH, THESIS UTRECHT U; Wielders CCH, 2013, EUR J CLIN INVEST, V43, P616, DOI 10.1111/eci.12073; WILSON HG, 1976, CIRCULATION, V53, P680, DOI 10.1161/01.CIR.53.4.680	15	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131777	10.1371/journal.pone.0131777	http://dx.doi.org/10.1371/journal.pone.0131777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132155	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000140
J	Xiong, F				Xiong, Fei			A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma	PLOS ONE			English	Article							BLOOD-FLOW; SURVEILLANCE; CANCER	Hepatocellular carcinoma is one of the most common malignancies worldwide, with a high risk of portal vein tumor thrombus (PVTT). Some promising results have been achieved for venous metastases of hepatocellular carcinoma; however, the etiology of PVTT is largely unknown, and it is unclear why the incidence of PVTT is not proportional to its distance from the carcinoma. We attempted to address this issue using physical concepts and mathematical tools. Finally, we discuss the relationship between the probability of a collision event and the microenvironment of the PVTT. Our formulae suggest that the collision probability can alter the tumor microenvironment by increasing the number of tumor cells.	[Xiong, Fei] Sichuan Acad Med Sci, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China; [Xiong, Fei] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Xiong, F (corresponding author), Sichuan Acad Med Sci, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China.	feiji19841984@gmail.com			Department of Gastroenterology in Sichuan Provincial Hospital	Department of Gastroenterology in Sichuan Provincial Hospital	The work partially supported by Department of Gastroenterology in Sichuan Provincial Hospital.	Andreana L, 2009, WORLD J HEPATOL, V1, P48, DOI 10.4254/wjh.v1.i1.48; BERNSTEIN SE, 1959, P SOC EXP BIOL MED, V101, P769; Botar CC, 2011, IFMBE PROC, V36, P332, DOI 10.1007/978-3-642-22586-4_70; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Feynman RP, 1970, FEYNMAN LECT PHYS MA; Giancoli D., 2004, PEARSON, V6, P508; Gokturk HS, 2009, SOUTH MED J, V102, P1013, DOI 10.1097/SMJ.0b013e3181b50057; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Landau L. D., 1976, COURSE THEORETICAL P, V1; Muller P., 2006, EQUATION OCEANIC MOT; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Park KW, 2008, J GASTROEN HEPATOL, V23, P467, DOI 10.1111/j.1440-1746.2007.05112.x; Pedley TJ, 1997, SCI MAR, V61, P7; Phillips R., 2008, PHYS BIOL CELL; Pirisi M, 1998, J CANCER RES CLIN, V124, P397, DOI 10.1007/s004320050189; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; Schiff ER, 2011, SCHIFFS DIS LIVER; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Stuart KE, 1996, CANCER, V77, P2217, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Thomas G.B., 2004, THOMAS CALCULUS, V11; Van Steenkiste C, 2010, LAB INVEST, V90, P1558, DOI 10.1038/labinvest.2010.138; Wachsberg RH, 2002, RADIOGRAPHICS, V22, P123, DOI 10.1148/radiographics.22.1.g02ja20123; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Woods FS, 1934, ADV CALCULUS; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Yilmaz F, 2008, KOREA-AUST RHEOL J, V20, P197	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130366	10.1371/journal.pone.0130366	http://dx.doi.org/10.1371/journal.pone.0130366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131562	Green Published, gold			2022-12-26	WOS:000358153000065
J	Chen, F; He, J; Zhang, JQ; Chen, GK; Thomas, V; Ambrosone, CB; Bandera, EV; Berndt, SI; Bernstein, L; Blot, WJ; Cai, QY; Carpten, J; Casey, G; Chanock, SJ; Cheng, I; Chu, LS; Deming, SL; Driver, WR; Goodman, P; Hayes, RB; Hennis, AJM; Hsing, AW; Hu, JJ; Ingles, SA; John, EM; Kittles, RA; Kolb, S; Leske, MC; Millikan, RC; Monroe, KR; Murphy, A; Nemesure, B; Neslund-Dudas, C; Nyante, S; Ostrander, EA; Press, MF; Rodriguez-Gil, JL; Rybicki, BA; Schumacher, F; Stanford, JL; Signorello, LB; Strom, SS; Stevens, V; Van Den Berg, D; Wang, ZM; Witte, JS; Wu, SY; Yamamura, Y; Zheng, W; Ziegler, RG; Stram, AH; Kolonel, LN; Le Marchand, L; Henderson, BE; Haiman, CA; Stram, DO				Chen, Fang; He, Jing; Zhang, Jianqi; Chen, Gary K.; Thomas, Venetta; Ambrosone, Christine B.; Bandera, Elisa V.; Berndt, Sonja I.; Bernstein, Leslie; Blot, William J.; Cai, Qiuyin; Carpten, John; Casey, Graham; Chanock, Stephen J.; Cheng, Iona; Chu, Lisa; Deming, Sandra L.; Driver, W. Ryan; Goodman, Phyllis; Hayes, Richard B.; Hennis, Anselm J. M.; Hsing, Ann W.; Hu, Jennifer J.; Ingles, Sue A.; John, Esther M.; Kittles, Rick A.; Kolb, Suzanne; Leske, M. Cristina; Millikan, Robert C.; Monroe, Kristine R.; Murphy, Adam; Nemesure, Barbara; Neslund-Dudas, Christine; Nyante, Sarah; Ostrander, Elaine A.; Press, Michael F.; Rodriguez-Gil, Jorge L.; Rybicki, Ben A.; Schumacher, Fredrick; Stanford, Janet L.; Signorello, Lisa B.; Strom, Sara S.; Stevens, Victoria; Van Den Berg, David; Wang, Zhaoming; Witte, John S.; Wu, Suh-Yuh; Yamamura, Yuko; Zheng, Wei; Ziegler, Regina G.; Stram, Alexander H.; Kolonel, Laurence N.; Le Marchand, Loic; Henderson, Brian E.; Haiman, Christopher A.; Stram, Daniel O.			Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC PATHWAY; KERNEL; SIMILARITY; REGRESSION	Height has an extremely polygenic pattern of inheritance. Genome-wide association studies (GWAS) have revealed hundreds of common variants that are associated with human height at genome-wide levels of significance. However, only a small fraction of phenotypic variation can be explained by the aggregate of these common variants. In a large study of African-American men and women (n = 14,419), we genotyped and analyzed 966,578 autosomal SNPs across the entire genome using a linear mixed model variance components approach implemented in the program GCTA (Yang et al Nat Genet 2010), and estimated an additive heritability of 44.7% (se: 3.7%) for this phenotype in a sample of evidently unrelated individuals. While this estimated value is similar to that given by Yang et al in their analyses, we remain concerned about two related issues: (1) whether in the complete absence of hidden relatedness, variance components methods have adequate power to estimate heritability when a very large number of SNPs are used in the analysis; and (2) whether estimation of heritability may be biased, in real studies, by low levels of residual hidden relatedness. We addressed the first question in a semi-analytic fashion by directly simulating the distribution of the score statistic for a test of zero heritability with and without low levels of relatedness. The second question was addressed by a very careful comparison of the behavior of estimated heritability for both observed (self-reported) height and simulated phenotypes compared to imputation R-2 as a function of the number of SNPs used in the analysis. These simulations help to address the important question about whether today's GWAS SNPs will remain useful for imputing causal variants that are discovered using very large sample sizes in future studies of height, or whether the causal variants themselves will need to be genotyped de novo in order to build a prediction model that ultimately captures a large fraction of the variability of height, and by implication other complex phenotypes. Our overall conclusions are that when study sizes are quite large (5,000 or so) the additive heritability estimate for height is not apparently biased upwards using the linear mixed model; however there is evidence in our simulation that a very large number of causal variants (many thousands) each with very small effect on phenotypic variance will need to be discovered to fill the gap between the heritability explained by known versus unknown causal variants. We conclude that today's GWAS data will remain useful in the future for causal variant prediction, but that finding the causal variants that need to be predicted may be extremely laborious.	[Chen, Fang; He, Jing; Zhang, Jianqi; Chen, Gary K.; Casey, Graham; Ingles, Sue A.; Monroe, Kristine R.; Schumacher, Fredrick; Van Den Berg, David; Stram, Alexander H.; Henderson, Brian E.; Haiman, Christopher A.; Stram, Daniel O.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Chen, Fang; He, Jing; Zhang, Jianqi; Chen, Gary K.; Casey, Graham; Ingles, Sue A.; Monroe, Kristine R.; Press, Michael F.; Schumacher, Fredrick; Van Den Berg, David; Stram, Alexander H.; Henderson, Brian E.; Haiman, Christopher A.; Stram, Daniel O.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Thomas, Venetta; Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Thomas, Venetta; Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [Berndt, Sonja I.; Chanock, Stephen J.; Hsing, Ann W.; Nyante, Sarah; Wang, Zhaoming; Ziegler, Regina G.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Bernstein, Leslie] Beckman Res Inst, Div Canc Etiol, Dept Populat Sci, City Of Hope, CA USA; [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Blot, William J.; Cai, Qiuyin; Deming, Sandra L.; Zheng, Wei] Vanderbilt Univ, Dept Med, Div Epidemiol, Vanderbilt Epidemiol Ctr, Nashville, TN USA; [Blot, William J.; Cai, Qiuyin; Deming, Sandra L.; Zheng, Wei] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Carpten, John] Translat Genom Res Inst, Phoenix, AZ USA; [Cheng, Iona; Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Chu, Lisa; John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [Driver, W. Ryan; Stevens, Victoria] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Goodman, Phyllis; Kolb, Suzanne; Stanford, Janet L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hayes, Richard B.] NYU, Dept Environm Med, Div Epidemiol, Langone Med Ctr, New York, NY 10016 USA; [Hennis, Anselm J. M.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Hennis, Anselm J. M.] Univ W Indies, Fac Med Sci, Bridgetown, Barbados; [Hennis, Anselm J. M.; Leske, M. Cristina; Nemesure, Barbara; Wu, Suh-Yuh] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [John, Esther M.] Stanford Univ, Div Epidemiol, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [John, Esther M.] Stanford Canc Inst, Stanford, CA USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA; [Millikan, Robert C.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Millikan, Robert C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Murphy, Adam] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Neslund-Dudas, Christine; Rybicki, Ben A.] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Press, Michael F.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Witte, John S.; Yamamura, Yuko] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA	University of Southern California; University of Southern California; University of Miami; University of Miami; Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University; Translational Genomics Research Institute; Cancer Research Center of Hawaii; University of Hawaii System; Cancer Prevention Institute of California; American Cancer Society; Fred Hutchinson Cancer Center; New York University; NYU Langone Medical Center; University West Indies Mona Jamaica; University of the West Indies Open Campus; University West Indies Mona Jamaica; University of the West Indies Open Campus; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University; Stanford Cancer Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Southern California; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco	Stram, DO (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	stram@usc.edu	Van Den Berg, David J/G-8598-2017; Jorge L. Rodriguez-Gil, D.Phil/AAD-3523-2020; Berndt, Sonja I/J-8423-2016; Bandera, Elisa V/M-4169-2014; zhang, weihua/GXV-1334-2022; Schumacher, Fredrick/R-6043-2019; Zheng, Wei/O-3351-2013; Kwok, Adrienne/AAU-4106-2020; Wang, Zhaoming/R-5527-2018	Van Den Berg, David J/0000-0002-5404-5218; Jorge L. Rodriguez-Gil, D.Phil/0000-0002-1125-1281; Bandera, Elisa V/0000-0002-8789-2755; Schumacher, Fredrick/0000-0002-3073-7463; Zheng, Wei/0000-0003-1226-070X; Wang, Zhaoming/0000-0001-7556-3869; Hayes, Richard/0000-0002-0918-661X; Ostrander, Elaine/0000-0001-6075-9738; Nyante, Sarah/0000-0002-1770-5993; Rybicki, Benjamin/0000-0003-3190-3467	African American Prostate Cancer (AAPC) GWAS study, NCI [5R01CA165862]; Era of Hope Scholar Award, Department of Defense Breast Cancer Research Program [5U19CA148537]; Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE), NCI [U01HG004802-04, 1U01HG007397-01]; Population Architecture using Genomics and Epidemiology (PAGE), NHGRI [15UB8402]; New Methods for Genomic Studies in African American Women, California Breast Cancer Research Program [RC2CA148085]; NATIONAL CANCER INSTITUTE [UG1CA189974, U10CA037429, R01CA165862, UM1CA182883, R01CA092447, U19CA148537, RC2CA148085] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007397, ZIAHG200377, U01HG004802, ZIAHG200325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	African American Prostate Cancer (AAPC) GWAS study, NCI; Era of Hope Scholar Award, Department of Defense Breast Cancer Research Program(United States Department of Defense); Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE), NCI; Population Architecture using Genomics and Epidemiology (PAGE), NHGRI; New Methods for Genomic Studies in African American Women, California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	5R01CA165862 African American Prostate Cancer (AAPC) GWAS study, NCI; Era of Hope Scholar Award (to CAH), Department of Defense Breast Cancer Research Program; 5U19CA148537 Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE), NCI; U01HG004802-04 and 1U01HG007397-01, Population Architecture using Genomics and Epidemiology (PAGE), NHGRI; 15UB8402, New Methods for Genomic Studies in African American Women, California Breast Cancer Research Program; RC2CA148085, Expanding resources for understanding the genetic basis for prostate cancer in African Americans.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; ANDERSON TW, 1973, ANN STAT, V1, P135, DOI 10.1214/aos/1193342389; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Browning SR, 2011, AM J HUM GENET, V89, P191, DOI 10.1016/j.ajhg.2011.05.025; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Hill WG, 2010, PHILOS T R SOC B, V365, P73, DOI 10.1098/rstb.2009.0203; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Schaid DJ, 2010, HUM HERED, V70, P109, DOI 10.1159/000312641; Schaid DJ, 2010, HUM HERED, V70, P132, DOI 10.1159/000312643; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Wang HS, 2010, HUM GENET, V128, P165, DOI 10.1007/s00439-010-0841-4; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6	26	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131106	10.1371/journal.pone.0131106	http://dx.doi.org/10.1371/journal.pone.0131106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125186	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300033
J	Correia-Costa, L; Santos, AC; Severo, M; Guerra, A; Schaefer, F; Afonso, AC; Barros, H; Azevedo, A				Correia-Costa, Liane; Santos, Ana Cristina; Severo, Milton; Guerra, Antonio; Schaefer, Franz; Afonso, Alberto Caldas; Barros, Henrique; Azevedo, Ana			Sex-Specific Mediating Role of Insulin Resistance and Inflammation in the Effect of Adiposity on Blood Pressure of Prepubertal Children	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; LOW-GRADE INFLAMMATION; ESSENTIAL-HYPERTENSION; WAIST CIRCUMFERENCE; OBESE CHILDREN; SCHOOL-CHILDREN; BIRTH-WEIGHT; CHILDHOOD	Objective To evaluate the association between obesity indices and blood pressure (BP) at 4 years of age, in each sex, and to quantify to which extent this association is mediated by inflammation and insulin resistance (IR). Materials and Methods We studied 1250 4-year-old children selected from the population-based birth cohort Generation XXI. Associations between body mass index (BMI) z-score and waist-to-height ratio (WHtR), office BP, inflammation (high sensitivity C-reactive protein) and IR (HOMA-IR index) were assessed. Path Analysis, a modified multivariate regression approach, was applied to test causal models and quantify direct and indirect effects of predictors of systolic (SBP) and diastolic BP (DBP). Results SBP and DBP increased significantly with BMI and WHtR in both sexes. There was a strong direct association (explaining 74.1-93.2% of the total association) of both measures of adiposity with SBP, in both sexes. This association was additionally indirectly mediated by IR, particularly regarding WHtR (20.5% in girls and 9.4% in boys). Mediation by inflammation did not reach statistical significance in either sex. Regarding DBP, the direct effect of adiposity was strong (>95% for BMI and WHtR in boys) and the mediation by IR was much smaller in boys than in girls. Discussion The direct association between adiposity and BP in healthy 4-year-old children is strong and IR plays an important mediating role. The strength of effects of IR and inflammation suggests sex differences in the complex interplay between BP, adiposity and inflammation.	[Correia-Costa, Liane; Santos, Ana Cristina; Severo, Milton; Afonso, Alberto Caldas; Barros, Henrique; Azevedo, Ana] Univ Porto, Inst Publ Hlth, EPIUnit, P-4100 Oporto, Portugal; [Correia-Costa, Liane; Afonso, Alberto Caldas] Ctr Hosp Sao Joao, Integrated Pediat Hosp, Div Pediat Nephrol, Oporto, Portugal; [Santos, Ana Cristina; Severo, Milton; Barros, Henrique; Azevedo, Ana] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Guerra, Antonio] Ctr Hosp Sao Joao, Integrated Pediat Hosp, Div Pediat Nutr, Oporto, Portugal; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Div Pediat Nephrol, Heidelberg, Germany	Universidade do Porto; Sao Joao Hospital; Universidade do Porto; Sao Joao Hospital; Ruprecht Karls University Heidelberg	Correia-Costa, L (corresponding author), Univ Porto, Inst Publ Hlth, EPIUnit, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	liane@med.up.pt	Santos, Ana/AAY-2314-2020; Azevedo, Ana/AAA-2287-2020; Severo, Milton/I-3497-2012; Guerra, António/L-8025-2013; Barros, Henrique/Q-8609-2019; santos, ana/GWV-5678-2022; Barros, Henrique/A-5488-2008	Azevedo, Ana/0000-0002-7368-9609; Severo, Milton/0000-0002-5787-4871; Guerra, António/0000-0002-7951-3911; Barros, Henrique/0000-0003-4699-6571; Correia-Costa, Liane/0000-0002-8216-090X; Santos, Ana/0000-0002-2992-5299	Fundacao para a Ciencia e a Tecnologia [PIC/IC/83038/2007, PTDC/DTP-PIC/0239/2012]; ERA-EDTA Research Programme; Fundacao Calouste Gulbenkian; KfH Foundatio	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ERA-EDTA Research Programme; Fundacao Calouste Gulbenkian(European Commission); KfH Foundatio	This work was supported by Fundacao para a Ciencia e a Tecnologia (PIC/IC/83038/2007; PTDC/DTP-PIC/0239/2012) and Fundacao Calouste Gulbenkian. Franz Schaefer was supported by the ERA-EDTA Research Programme and the KfH Foundation for Preventive Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2012, INT J PUBLIC HEALTH, V57, P837, DOI 10.1007/s00038-012-0340-6; [Anonymous], 2004, PEDIATRICS S, V114, P555; Assadi F, 2007, PEDIATR CARDIOL, V28, P280, DOI 10.1007/s00246-006-0173-2; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Barba G, 2008, AM J HYPERTENS, V21, P1007, DOI 10.1038/ajh.2008.228; Brown DE, 2010, AM J HUM BIOL, V22, P675, DOI 10.1002/ajhb.21064; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chiolero A, 2013, BLOOD PRESSURE, V22, P17, DOI 10.3109/08037051.2012.701376; Courant F, 2010, J CLIN ENDOCR METAB, V95, P82, DOI 10.1210/jc.2009-1140; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; Elkiran O, 2013, INT J CARDIOL, V165, P528, DOI 10.1016/j.ijcard.2011.09.080; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; Flynn J, 2013, PEDIATR NEPHROL, V28, P1059, DOI 10.1007/s00467-012-2344-0; Galcheva SV, 2011, EUR J ENDOCRINOL, V164, P553, DOI 10.1530/EJE-10-1124; Gamborg M, 2009, AM J EPIDEMIOL, V169, P1167, DOI 10.1093/aje/kwp047; Gopinath B, 2011, ANN EPIDEMIOL, V21, P351, DOI 10.1016/j.annepidem.2011.02.002; He Q, 2000, HYPERTENSION, V36, P165, DOI 10.1161/01.HYP.36.2.165; He Q, 2002, J CLIN ENDOCR METAB, V87, P2164, DOI 10.1210/jc.87.5.2164; JIANG XZ, 1993, AM J HYPERTENS, V6, P564, DOI 10.1093/ajh/6.7.564; Jimenez MV, 2007, EUR J ENDOCRINOL, V156, P497, DOI 10.1530/EJE-06-0662; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lakoski SG, 2006, AM HEART J, V152, P593, DOI 10.1016/j.ahj.2006.02.015; Larsen PS, 2013, PAEDIATR PERINAT EP, V27, P393, DOI 10.1111/ppe.12060; Lurbe E, 2008, HYPERTENSION, V51, P635, DOI 10.1161/HYPERTENSIONAHA.107.099234; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Montecucco F, 2011, J NEPHROL, V24, P23, DOI 10.5301/JN.2010.4729; Murphy MJ, 2004, PEDIATRICS, V113, P82, DOI 10.1542/peds.113.1.82; Pausova Z, 2012, HYPERTENSION, V59, P572, DOI 10.1161/HYPERTENSIONAHA.111.180372; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pruijm M, 2013, J HUM HYPERTENS, V27, P169, DOI 10.1038/jhh.2012.12; Reilly JJ, 2010, OBES REV, V11, P645, DOI 10.1111/j.1467-789X.2009.00709.x; Shi LJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE990, DOI 10.1152/ajpendo.00374.2010; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Soriano-Guillen L, 2008, EUR J ENDOCRINOL, V159, pR1, DOI 10.1530/EJE-08-0212; Staiano AE, 2013, OBESITY, V21, P1251, DOI 10.1002/oby.20210; Steinthorsdottir SD, 2011, J CLIN HYPERTENS, V13, P774, DOI 10.1111/j.1751-7176.2011.00496.x; Syrenicz A, 2006, NEUROENDOCRINOL LETT, V27, P459; Tam CS, 2010, OBES REV, V11, P118, DOI 10.1111/j.1467-789X.2009.00674.x; Tam CS, 2010, HORM RES PAEDIAT, V73, P128, DOI 10.1159/000277632; Taylor RW, 2011, OBESITY, V19, P1062, DOI 10.1038/oby.2010.217; Watts K, 2008, J PAEDIATR CHILD H, V44, P709, DOI 10.1111/j.1440-1754.2008.01411.x; Willig AL, 2010, AM J HYPERTENS, V23, P904, DOI 10.1038/ajh.2010.82; Zuo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054615	48	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0132097	10.1371/journal.pone.0132097	http://dx.doi.org/10.1371/journal.pone.0132097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125190	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300068
J	Kong, LZ; Xie, ZL; Lu, LX; Qu, TS; Wu, XH; Yan, J; Li, L				Kong, Lingzhi; Xie, Zilong; Lu, Lingxi; Qu, Tianshu; Wu, Xihong; Yan, Jun; Li, Liang			Similar Impacts of the Interaural Delay and Interaural Correlation on Binaural Gap Detection	PLOS ONE			English	Article							AUDITORY-NERVE DATA; INFERIOR COLLICULUS; TIME DIFFERENCES; CORRELATION DISCRIMINATION; CROSS-CORRELATION; NOISE; SENSITIVITY; UNMASKING; FREQUENCY; MASKING	The subjective representation of the sounds delivered to the two ears of a human listener is closely associated with the interaural delay and correlation of these two-ear sounds. When the two-ear sounds, e.g., arbitrary noises, arrive simultaneously, the single auditory image of the binaurally identical noises becomes increasingly diffuse, and eventually separates into two auditory images as the interaural correlation decreases. When the interaural delay increases from zero to several milliseconds, the auditory image of the binaurally identical noises also changes from a single image to two distinct images. However, measuring the effect of these two factors on an identical group of participants has not been investigated. This study examined the impacts of interaural correlation and delay on detecting a binaurally uncorrelated fragment (interaural correlation = 0) embedded in the binaurally correlated noises (i.e., binaural gap or break in interaural correlation). We found that the minimum duration of the binaural gap for its detection (i.e., duration threshold) increased exponentially as the interaural delay between the binaurally identical noises increased linearly from 0 to 8 ms. When no interaural delay was introduced, the duration threshold also increased exponentially as the interaural correlation of the binaurally correlated noises decreased linearly from 1 to 0.4. A linear relationship between the effect of interaural delay and that of interaural correlation was described for listeners participating in this study: a 1 ms increase in interaural delay appeared to correspond to a 0.07 decrease in interaural correlation specific to raising the duration threshold. Our results imply that a tradeoff may exist between the impacts of interaural correlation and interaural delay on the subjective representation of sounds delivered to two human ears.	[Kong, Lingzhi; Xie, Zilong; Lu, Lingxi; Li, Liang] Peking Univ, Dept Psychol, PKU IDG McGovern Inst Brain Res, Beijing Inst Brain Disorders, Beijing 100871, Peoples R China; [Kong, Lingzhi; Xie, Zilong; Lu, Lingxi; Qu, Tianshu; Wu, Xihong; Li, Liang] Peking Univ, Speech & Hearing Res Ctr, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Kong, Lingzhi; Yan, Jun] Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada	Peking University; Peking University; University of Calgary	Li, L (corresponding author), Peking Univ, Dept Psychol, PKU IDG McGovern Inst Brain Res, Beijing Inst Brain Disorders, Beijing 100871, Peoples R China.	liangli@pku.edu.cn		Xie, Zilong/0000-0002-6851-7554	National Natural Science Foundation of China [31170985, 61175043]; Research Special Fund for Public Welfare Industry of Health [201202001]; National High Technology Research and Development Program of China [2014GX02D01144]; Campbell McLaurin Chair Grant for Hearing Deficiencies; Alberta Innovates-Health Solutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Special Fund for Public Welfare Industry of Health; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Campbell McLaurin Chair Grant for Hearing Deficiencies; Alberta Innovates-Health Solutions	This work was supported by the National Natural Science Foundation of China (31170985), the Research Special Fund for Public Welfare Industry of Health (201202001), the National Natural Science Foundation of China (61175043), the National High Technology Research and Development Program of China (863 Program 2014GX02D01144), the Campbell McLaurin Chair Grant for Hearing Deficiencies, and the Alberta Innovates-Health Solutions.	Akeroyd MA, 1999, J ACOUST SOC AM, V105, P2807, DOI 10.1121/1.426897; *ANSI, 2004, ANSIS36; BILSEN FA, 1974, J ACOUST SOC AM, V55, P292, DOI 10.1121/1.1914500; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; BLODGETT HC, 1956, J ACOUST SOC AM, V28, P639, DOI 10.1121/1.1908430; Boehnke SE, 2002, J ACOUST SOC AM, V112, P1617, DOI 10.1121/1.1504857; Coffey CS, 2006, HEARING RES, V221, P1, DOI 10.1016/j.heares.2006.06.005; COLBURN HS, 1973, J ACOUST SOC AM, V54, P1458, DOI 10.1121/1.1914445; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; COLBURN HS, 1995, SPRINGER HDB AUDITOR, V6, P332; Culling JF, 2001, J ACOUST SOC AM, V110, P1020, DOI 10.1121/1.1383296; Culling JF, 2007, J ACOUST SOC AM, V122, P2803, DOI 10.1121/1.2785035; DURLACH NI, 1986, J ACOUST SOC AM, V79, P1548, DOI 10.1121/1.393681; Edmonds BA, 2009, J ACOUST SOC AM, V125, P3865, DOI 10.1121/1.3120412; Fitzpatrick DC, 2000, J NEUROSCI, V20, P1605; Fitzpatrick DC, 2009, JARO-J ASSOC RES OTO, V10, P579, DOI 10.1007/s10162-009-0177-8; Freyman RL, 1999, J ACOUST SOC AM, V106, P3578, DOI 10.1121/1.428211; GABRIEL KJ, 1981, J ACOUST SOC AM, V69, P1394, DOI 10.1121/1.385821; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Hartmann WM, 2011, J ACOUST SOC AM, V130, P292, DOI 10.1121/1.3596475; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; Huang Y, 2009, J EXP PSYCHOL HUMAN, V35, P1618, DOI 10.1037/a0015791; Huang Y, 2009, J ACOUST SOC AM, V126, P300, DOI 10.1121/1.3147504; Huang Y, 2008, NEUROREPORT, V19, P1673, DOI 10.1097/WNR.0b013e32831576c7; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kong LZ, 2012, J ACOUST SOC AM, V132, pEL114, DOI 10.1121/1.4734241; Krumbholz K, 2009, J ACOUST SOC AM, V125, P1067, DOI 10.1121/1.3056557; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063106; Li L, 2004, J EXP PSYCHOL HUMAN, V30, P1077, DOI 10.1037/0096-1523.30.6.1077; Li L, 2009, EAR HEARING, V30, P273, DOI 10.1097/AUD.0b013e318198703d; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; Mossop JE, 1998, J ACOUST SOC AM, V104, P1574, DOI 10.1121/1.424369; Palmer AR, 1999, J NEUROPHYSIOL, V81, P722, DOI 10.1152/jn.1999.81.2.722; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; Rakerd B, 2006, J ACOUST SOC AM, V119, P1597, DOI 10.1121/1.2161438; Rakerd B, 2010, J ACOUST SOC AM, V128, P3052, DOI 10.1121/1.3493447; Shackleton TM, 2005, JARO-J ASSOC RES OTO, V6, P244, DOI 10.1007/s10162-005-0005-8; Stern Richard M., 1995, P347, DOI 10.1016/B978-012505626-7/50012-1; Trahiotis C, 2005, SPR HDB AUD, V25, P238, DOI 10.1007/0-387-28863-5_7; YIN TCT, 1987, J NEUROPHYSIOL, V58, P562, DOI 10.1152/jn.1987.58.3.562	41	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0126342	10.1371/journal.pone.0126342	http://dx.doi.org/10.1371/journal.pone.0126342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125970	Green Submitted, Green Published, gold			2022-12-26	WOS:000358151300002
J	Sarkar, A; Dai, Y; Haque, MM; Seeger, F; Ghosh, A; Garcin, ED; Montfort, WR; Hazen, SL; Misra, S; Stuehr, DJ				Sarkar, Anindya; Dai, Yue; Haque, Mohammad Mahfuzul; Seeger, Franziska; Ghosh, Arnab; Garcin, Elsa D.; Montfort, William R.; Hazen, Stanley L.; Misra, Saurav; Stuehr, Dennis J.			Heat Shock Protein 90 Associates with the Per-Arnt-Sim Domain of Heme-free Soluble Guanylate Cyclase IMPLICATIONS FOR ENZYME MATURATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); fluorescence anisotropy; heat shock protein 90 (hsp90); hydrogen exchange mass spectrometry; protein-protein interaction; signal transduction; H-NOX domain; PAS domain; heme insertion; structural modeling	ARYL-HYDROCARBON RECEPTOR; MOLECULAR CHAPERONE HSP90; NITRIC-OXIDE SYNTHASE; CRYSTAL-STRUCTURE; STRUCTURAL-ANALYSIS; INDUCED ACTIVATION; ESCHERICHIA-COLI; KINASE-ACTIVITY; CLIENT PROTEIN; ALPHA-SUBUNIT	Background: hsp90 binds to heme-free sGC1 subunit to enable heme insertion during maturation, but the mechanism is unclear. Results: Their interaction involves the hsp90 M domain and the Per-Arnt-Sim (PAS) domain of apo-sGC1. Conclusion: hsp90 may modulate the apo-sGC1 through its PAS domain, suggesting a means to aid heme insertion. Significance: This work expands our knowledge of how hsp90 regulates PAS-containing client proteins like sGC. Heat shock protein 90 (hsp90) drives heme insertion into the 1 subunit of soluble guanylate cyclase (sGC) 1, which enables it to associate with a partner sGC1 subunit and mature into a nitric oxide (NO)-responsive active form. We utilized fluorescence polarization measurements and hydrogen-deuterium exchange mass spectrometry to define molecular interactions between the specific human isoforms hsp90 and apo-sGC1. hsp90 and its isolated M domain, but not its isolated N and C domains, bind with low micromolar affinity to a heme-free, truncated version of sGC1 (sGC1(1-359)-H105F). Surprisingly, hsp90 and its M domain bound to the Per-Arnt-Sim (PAS) domain of apo-sGC-1(1-359), which lies adjacent to its heme-binding (H-NOX) domain. The interaction specifically involved solvent-exposed regions in the hsp90 M domain that are largely distinct from sites utilized by other hsp90 clients. The interaction strongly protected two regions of the sGC1 PAS domain and caused local structural relaxation in other regions, including a PAS dimerization interface and a segment in the H-NOX domain. Our results suggest a means by which the hsp90 interaction could prevent apo-sGC1 from associating with its partner sGC1 subunit while enabling structural changes to assist heme insertion into the H-NOX domain. This mechanism would parallel that in other clients like the aryl hydrocarbon receptor and HIF1, which also interact with hsp90 through their PAS domains to control protein partner and small ligand binding interactions.	[Sarkar, Anindya; Dai, Yue; Haque, Mohammad Mahfuzul; Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Misra, Saurav] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Seeger, Franziska; Garcin, Elsa D.] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA; [Montfort, William R.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; University of Arizona	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Dai, Yue/AAD-9906-2019; Garcin, Elsa D/C-1556-2013; Regan, Clinton/E-6250-2012; Hazen, Stanley L/ABD-5845-2021	Dai, Yue/0000-0001-9368-7769; Garcin, Elsa D/0000-0003-0501-8421; GHOSH, ARNAB/0000-0002-7498-1994; Misra, Saurav/0000-0002-1385-8554; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM097041, GM051491, HL076491]; American Heart Association [10SDG2600345, 13PRE17000045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062969, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097041, R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM097041 and GM051491 (to D. J. S.) and HL076491 (to S. L. H.). This work was also supported by American Heart Association Awards 10SDG2600345 (to E. D. G.) and 13PRE17000045 (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Blacklock K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086547; Campbell MG, 2014, P NATL ACAD SCI USA, V111, P2960, DOI 10.1073/pnas.1400711111; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; da Silva VCH, 2012, J PROTEOMICS, V75, P2790, DOI 10.1016/j.jprot.2011.12.028; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Heid SE, 2000, MOL PHARMACOL, V57, P82; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Lee HC, 2009, PROTEIN PEPTIDE LETT, V16, P642, DOI 10.2174/092986609788490113; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Mukai K, 2011, PROTEIN PEPTIDE LETT, V18, P1251, DOI 10.2174/092986611797642733; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; Peng HM, 2012, J BIOL CHEM, V287, P1556, DOI 10.1074/jbc.M111.323295; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Purohit R, 2014, BIOCHEMISTRY-US, V53, P101, DOI 10.1021/bi4015133; Purohit R, 2013, PROTEIN SCI, V22, P1439, DOI 10.1002/pro.2331; Ratzke C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5192; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schneider S, 2007, NAT PROD REP, V24, P621, DOI 10.1039/b604186h; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Stankiewicz Marta, 2012, Biomol Concepts, V3, P79, DOI 10.1515/bmc.2011.054; Street TO, 2012, J MOL BIOL, V415, P3, DOI 10.1016/j.jmb.2011.10.038; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Tsuji N, 2014, FEBS OPEN BIO, V4, P796, DOI 10.1016/j.fob.2014.09.003; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Whitesell L, 2014, P NATL ACAD SCI USA, V111, P18297, DOI 10.1073/pnas.1421323111; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022	68	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21615	21628		10.1074/jbc.M115.645515	http://dx.doi.org/10.1074/jbc.M115.645515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26134567	Green Published, hybrid			2022-12-26	WOS:000360637600034
J	Gijsberts, CM; Seneviratna, A; Hoefer, IE; Agostoni, P; Rittersma, SZH; Pasterkamp, G; Hartman, M; de Carvalho, LP; Richards, AM; Asselbergs, FW; de Kleijn, DPV; Chan, MY				Gijsberts, Crystel M.; Seneviratna, Aruni; Hoefer, Imo E.; Agostoni, Pierfrancesco; Rittersma, Saskia Z. H.; Pasterkamp, Gerard; Hartman, Mikael; de Carvalho, Leonardo Pinto; Richards, A. Mark; Asselbergs, Folkert W.; de Kleijn, Dominique P. V.; Chan, Mark Y.			Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ETHNIC-DIFFERENCES; SYNTAX SCORE; RISK-FACTORS; CARDIOVASCULAR RISK; CAUCASIAN PATIENTS; HEART-DISEASE; ASIAN INDIANS; SOUTH ASIANS; OUTCOMES	Background Coronary artery disease (CAD) is a global problem with increasing incidence in Asia. Prior studies reported inter-ethnic differences in the prevalence of CAD rather than the severity of CAD. The angiographic "synergy between percutaneous coronary intervention (PCI) with taxus and cardiac surgery" (SYNTAX) score quantifies CAD severity and predicts outcomes. We studied CAD severity and all-cause mortality in four globally populous ethnic groups: Caucasians, Chinese, Indians and Malays. Methods We quantified SYNTAX scores of 1,000 multi-ethnic patients undergoing PCI in two tertiary hospitals in the Netherlands (Caucasians) and Singapore (Chinese, Indians and Malays). Within each ethnicity we studied 150 patients with stable CAD and 100 with ST-elevated myocardial infarction (STEMI). We made inter-ethnic comparisons of SYNTAX scores and all-cause mortality. Results Despite having a younger age (mean age Indians: 56.8 and Malays: 57.7 vs. Caucasians: 63.7 years), multivariable adjusted SYNTAX scores were significantly higher in Indians and Malays than Caucasians with stable CAD: 13.4 [11.9-14.9] and 13.4 [12.0-14.8] vs. 9.4 [8.1-10.8], p<0.001. Among STEMI patients, SYNTAX scores were highest in Chinese and Malays: 17.7 [15.9-19.5] and 18.8 [17.1-20.6] vs. 15.5 [13.5-17.4] and 12.7 [10.9-14.6] in Indians and Caucasians, p<0.001. Over a median follow-up of 709 days, 67 deaths (stable CAD: 37, STEMI: 30) occurred. Among STEMI patients, the SYNTAX score independently predicted all-cause mortality: HR 2.5 [1.7-3.8], p<0.001 for every 10-point increase. All-cause mortality was higher in Indian and Malay STEMI patients than Caucasians, independent of SYNTAX score (adjusted HR 7.2 [1.5-34.7], p= 0.01 and 5.8 [1.2-27.2], p=0.02). Conclusion Among stable CAD and STEMI patients requiring PCI, CAD is more severe in Indians and Malays than in Caucasians, despite having a younger age. Moreover, Indian and Malay STEMI patients had a greater adjusted risk of all-cause mortality than Caucasians, independent of SYNTAX score.	[Gijsberts, Crystel M.; Hoefer, Imo E.; Pasterkamp, Gerard; de Kleijn, Dominique P. V.] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Gijsberts, Crystel M.; de Kleijn, Dominique P. V.] Netherlands Heart Inst ICIN, Utrecht, Netherlands; [Seneviratna, Aruni; de Carvalho, Leonardo Pinto; Richards, A. Mark; Chan, Mark Y.] Natl Univ Singapore Hosp, Dept Cardiac, Singapore, Singapore; [Agostoni, Pierfrancesco; Rittersma, Saskia Z. H.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Hartman, Mikael; de Kleijn, Dominique P. V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [de Carvalho, Leonardo Pinto] Albert Einstein Hosp, Dept Cardiol, Sao Paulo, Brazil; [Richards, A. Mark; de Kleijn, Dominique P. V.; Chan, Mark Y.] Natl Univ Hlth Syst, Natl Univ Heart Ctr NUHCS, Cardiovasc Res Inst CVRI, Singapore, Singapore; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England	Utrecht University; Utrecht University Medical Center; National University of Singapore; Utrecht University; Utrecht University Medical Center; National University of Singapore; National University of Singapore; Hospital Israelita Albert Einstein; National University of Singapore; University of London; University College London	de Kleijn, DPV (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.	surdvp@nus.edu.sg	Agostoni, Pierfrancesco/A-3681-2008; Asselbergs, Folkert W./ABD-6752-2021; Chan, Yan Yee Mark/ABE-1929-2021; Hartman, Mikael/B-4324-2011	Agostoni, Pierfrancesco/0000-0002-1505-9369; Asselbergs, Folkert W./0000-0002-1692-8669; Chan, Yan Yee Mark/0000-0003-0389-7450; Seneviratna, Aruni/0000-0001-5010-1422; Hartman, Mikael/0000-0001-5726-9965	Royal Netherlands Academy of Arts and Sciences; National University Singapore Startup grant; Singapore National Medical Research Council Centre Grant; ATTRaCT grant BMRC [SPF 2014/003]	Royal Netherlands Academy of Arts and Sciences; National University Singapore Startup grant; Singapore National Medical Research Council Centre Grant(National Medical Research Council, Singapore); ATTRaCT grant BMRC	This work is supported by a strategic grant from the Royal Netherlands Academy of Arts and Sciences to the Interuniversity Cardiology Institute of the Netherlands, ICIN (DdK); National University Singapore Startup grant to DdK, Singapore National Medical Research Council Centre Grant to AMR, MYC and DdK and the ATTRaCT, SPF 2014/003 grant BMRC to DdK and AMR. These funding sources in no way influenced the analyses or the content of this manuscript.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Anand S S, 2000, Indian Heart J, V52, pS35; Austen W G, 1975, Circulation, V51, P5; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Capodanno D, 2009, CIRC-CARDIOVASC INTE, V2, P302, DOI 10.1161/CIRCINTERVENTIONS.108.847137; Chiu M, 2010, CAN MED ASSOC J, V182, P1334, DOI 10.1503/cmaj.110-2098; Chow CK, 2008, ATHEROSCLEROSIS, V199, P116, DOI 10.1016/j.atherosclerosis.2007.10.008; ENAS EA, 1995, CLIN CARDIOL, V18, P131, DOI 10.1002/clc.4960180305; Enas EA, INDIAN HEART J, V48, P343; Gasevic D, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-121; Genereux P, 2011, CIRC-CARDIOVASC INTE, V4, P553, DOI 10.1161/CIRCINTERVENTIONS.111.961862; Gijsberts CM, 2015, GLOB HEART, V10, P301, DOI 10.1016/j.gheart.2014.11.004; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jiang SS, 2008, ANGIOLOGY, V59, P442, DOI 10.1177/0003319707306302; Kanaya AM, 2014, ATHEROSCLEROSIS, V234, P102, DOI 10.1016/j.atherosclerosis.2014.02.017; Khan NA, 2010, CIRCULATION, V122, P1570, DOI 10.1161/CIRCULATIONAHA.109.850297; Klomp M, 2012, CORONARY ARTERY DIS, V23, P271, DOI 10.1097/MCA.0b013e328351aaed; Koulaouzidis G, 2013, INT J CARDIOL, V167, P2472, DOI 10.1016/j.ijcard.2012.05.102; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Maitra A, 2008, THROMB HAEMOSTASIS, V99, P944, DOI 10.1160/TH07-11-0686; Mak KH, 2003, EUR HEART J, V24, P151, DOI 10.1016/S0195-668X(02)00423-2; McManus RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e181; Meadows TA, 2011, MAYO CLIN PROC, V86, P960, DOI 10.4065/mcp.2011.0010; Ministry of Health, 2007, NATIONAL HEALTH SURV; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Paisano E., 1993, THE AMERICAN ASIANS; Palaniappan L, 2004, ANN EPIDEMIOL, V14, P499, DOI 10.1016/j.annepidem.2003.12.001; Qian F, 2012, CIRC-CARDIOVASC QUAL, V5, P126, DOI 10.1161/CIRCOUTCOMES.111.961987; R Core Team, 2021, R LANGUAGE ENV STAT; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Sianos Georgios, 2005, EuroIntervention, V1, P219; SYNTAX Steering Committee, 2012, SYNTAX SCORE CALCULA; Tan JHH, 2003, HUM GENET, V113, P106, DOI 10.1007/s00439-003-0943-3; Thompson JH, 2014, POPULATION CLOCK INT; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Vallapuri S, 2002, AM J CARDIOL, V90, P1147, DOI 10.1016/S0002-9149(02)02786-8; Wang JW, 2013, NETH HEART J, V21, P467, DOI 10.1007/s12471-013-0462-3; WHO, 2006, DEFINITION AND DIAGN; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Zaman MJS, 2013, HEART, V99, P729, DOI 10.1136/heartjnl-2012-302925; Zheng YL, 2010, CLIN RES CARDIOL, V99, P45, DOI 10.1007/s00392-009-0076-3	45	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131977	10.1371/journal.pone.0131977	http://dx.doi.org/10.1371/journal.pone.0131977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147437	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600173
J	Krakower, DS; Oldenburg, CE; Mitty, JA; Wilson, IB; Kurth, AE; Maloney, KM; Gallagher, D; Mayer, KH				Krakower, Douglas S.; Oldenburg, Catherine E.; Mitty, Jennifer A.; Wilson, Ira B.; Kurth, Ann E.; Maloney, Kevin M.; Gallagher, Donna; Mayer, Kenneth H.			Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS PREP; INJECTING DRUG-USERS; INTERIM GUIDANCE; UNITED-STATES; INFECTION; THERAPY; ATTITUDES; MEN; TRANSMISSION; EXPERIENCE	Background Antiretroviral treatment for HIV-infection before immunologic decline (early ART) and pre-exposure chemoprophylaxis (PrEP) can prevent HIV transmission, but routine adoption of these practices by clinicians has been limited. Methods Between September and December 2013, healthcare practitioners affiliated with a regional AIDS Education and Training Center in New England were invited to complete online surveys assessing knowledge, beliefs and practices regarding early ART and PrEP. Multivariable models were utilized to determine characteristics associated with prescribing intentions and practices. Results Surveys were completed by 184 practitioners. Respondent median age was 44 years, 58% were female, and 82% were white. Among ART-prescribing clinicians (61% of the entire sample), 64% were aware that HIV treatment guidelines from the Department of Health and Human Services recommended early ART, and 69% indicated they would prescribe ART to all HIV-infected patients irrespective of immunologic status. However, 77% of ART-prescribing clinicians would defer ART for patients not ready to initiate treatment. Three-fourths of all respondents were aware of guidance from the U.S. Centers for Disease Control and Prevention recommending PrEP provision, 19% had prescribed PrEP, and 58% of clinicians who had not prescribed PrEP anticipated future prescribing. Practitioners expressed theoretical concerns and perceived practical barriers to prescribing early ART and PrEP. Clinicians with higher percentages of HIV-infected patients (aOR 1.16 per 10% increase in proportion of patients with HIV-infection, 95% CI 1.01-1.34) and infectious diseases specialists (versus primary care physicians; aOR 3.32, 95% CI 0.98-11.2) were more likely to report intentions to prescribe early ART. Higher percentage of HIV-infected patients was also associated with having prescribed PrEP (aOR 1.19, 95% CI 1.06-1.34), whereas female gender (aOR 0.26, 95% CI 0.10-0.71) was associated with having not prescribed PrEP. Conclusions These findings suggest many clinicians have shifted towards routinely recommending early ART, but not PrEP, so interventions to facilitate PrEP provision are needed.	[Krakower, Douglas S.; Mitty, Jennifer A.; Maloney, Kevin M.; Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Krakower, Douglas S.; Mitty, Jennifer A.; Mayer, Kenneth H.] Harvard Univ, Sch Med, Boston, MA USA; [Krakower, Douglas S.; Mayer, Kenneth H.] Fenway Inst, Boston, MA USA; [Oldenburg, Catherine E.; Mayer, Kenneth H.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Kurth, Ann E.] NYU, New York, NY USA; [Gallagher, Donna] New England AIDS Educ & Training Ctr, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; New York University	Krakower, DS (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	dkrakowe@bidmc.harvard.edu	Wilson, Ira/F-9190-2016	Wilson, Ira/0000-0002-0246-738X	Virology Fellows Research Grant from Bristol-Myers Squibb; National Institute of Mental Health (NIMH) [K23 MH098795]; Harvard University Center for AIDS Research (CFAR), a National Institutes of Health (NIH) [P30 AI060354]; NIH; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institure of Child Health and Human Development; National Heart, Lung and Blood Institute; National Institute on Drug Abuse; NIMH; National Institute on Aging; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on General Medical Sciences; Fogerty International Center; Office of AIDS Research; National Institute of Drug Abuse T32 NRSA [T32DA0131911]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007535, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH092242, K23MH098795, R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Virology Fellows Research Grant from Bristol-Myers Squibb(Bristol-Myers Squibb); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Harvard University Center for AIDS Research (CFAR), a National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institure of Child Health and Human Development; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fogerty International Center; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Drug Abuse T32 NRSA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by a Virology Fellows Research Grant from Bristol-Myers Squibb and in part by a grant from the National Institute of Mental Health (NIMH) (K23 MH098795), both to Dr. Krakower. This publication was made possible with help from the Harvard University Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program (P30 AI060354), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institure of Child Health and Human Development, National Heart, Lung and Blood Institute, National Institute on Drug Abuse, NIMH, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on General Medical Sciences, Fogerty International Center, and Office of AIDS Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Catherine Oldenburg is supported by a National Institute of Drug Abuse T32 NRSA (T32DA0131911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Q, 2012, AM J PREV MED, V43, P461, DOI 10.1016/j.amepre.2012.07.040; [Anonymous], 2009, AVERTING CRISIS HIV; [Anonymous], 2012, FDA APPROVES 1 MED R; [Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P586; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P65; [Anonymous], 2014, GUIDELINES USE ANTIR, P1; Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Fowler FJ, 2009, SURVEY RES METHODS; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Hsu LC, 2014, J INFECT DIS, V209, P1310, DOI 10.1093/infdis/jit599; Iarossi G, 2006, POWER OF SURVEY DESIGN: A USER'S GUIDE FOR MANAGING SURVEYS, INTERPRETING RESULTS, AND INFLUENCING RESPONDENTS, P1, DOI 10.1596/978-0-8213-6392-8; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krakower D, 2012, FORUM COLLABORATIVE; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Kurth AE, 2012, JAIDS-J ACQ IMM DEF, V61, pE65, DOI [10.1097/QAI.0b013e31826a184c., 10.1097/QAI.0b013e31826a184c]; Landon BE, 2003, J GEN INTERN MED, V18, P233, DOI 10.1046/j.1525-1497.2003.20705.x; Nosyk B, 2013, AIDS, V27, P1159, DOI 10.1097/QAD.0b013e32835f1d68; Olubajo Babatunde, 2014, Interdiscip Perspect Infect Dis, V2014, P625670, DOI 10.1155/2014/625670; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Stone VE, 2001, J GEN INTERN MED, V16, P360, DOI 10.1046/j.1525-1497.2001.016006360.x; Tang EC, 2014, AIDS RES HUM RETROV, V30, P416, DOI [10.1089/aid.2013.0212, 10.1089/AID.2013.0212]; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tasselli S, 2014, MED CARE RES REV, V71, P619, DOI 10.1177/1077558714557079; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; Update to Interim Guidance for Preexposure Prophylaxis, 2013, MMWR MORB MORTAL WKL, V62, P463; US Public Health Service, 2014, PREEXPOSURE PROPHYLA; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030	41	74	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132398	10.1371/journal.pone.0132398	http://dx.doi.org/10.1371/journal.pone.0132398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26146824	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600257
J	Parrish, HL; Glassman, CR; Keenen, MM; Deshpande, NR; Bronnimann, MP; Kuhns, MS				Parrish, Heather L.; Glassman, Caleb R.; Keenen, Madeline M.; Deshpande, Neha R.; Bronnimann, Matthew P.; Kuhns, Michael S.			A Transmembrane Domain GGxxG Motif in CD4 Contributes to Its Lck-Independent Function but Does Not Mediate CD4 Dimerization	PLOS ONE			English	Article							T-CELL-RECEPTOR; BINDING-SITE; KINASE P56LCK; PEPTIDE-MHC; LIPID RAFTS; COMPLEX; ACTIVATION; ANTIGEN; IDENTIFICATION; REQUIREMENTS	CD4 interactions with class II major histocompatibility complex (MHC) molecules are essential for CD4(+) T cell development, activation, and effector functions. While its association with p56(lck) (Lck), a Src kinase, is important for these functions CD4 also has an Lck-independent role in TCR signaling that is incompletely understood. Here, we identify a conserved GGxxG motif in the CD4 transmembrane domain that is related to the previously described GxxxG motifs of other proteins and predicted to form a flat glycine patch in a transmembrane helix. In other proteins, these patches have been reported to mediate dimerization of transmembrane domains. Here we show that introducing bulky side-chains into this patch (GGxxG to GVxxL) impairs the Lck-independent role of CD4 in T cell activation upon TCR engagement of agonist and weak agonist stimulation. However, using Forster's Resonance Energy Transfer (FRET), we saw no evidence that these mutations decreased CD4 dimerization either in the unliganded state or upon engagement of pMHC concomitantly with the TCR. This suggests that the CD4 transmembrane domain is either mediating interactions with an unidentified partner, or mediating some other function such as membrane domain localization that is important for its role in T cell activation.	[Parrish, Heather L.; Glassman, Caleb R.; Keenen, Madeline M.; Deshpande, Neha R.; Bronnimann, Matthew P.; Kuhns, Michael S.] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Deshpande, Neha R.; Kuhns, Michael S.] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ USA; [Kuhns, Michael S.] Univ Arizona, Coll Med, Inst BIO5, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Kuhns, MS (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.	mkuhns@u.arizona.edu			NIH/NIAID, The Pew Charitable Trusts [1R01AI101053]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101053] Funding Source: NIH RePORTER	NIH/NIAID, The Pew Charitable Trusts; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH/NIAID 1R01AI101053, The Pew Charitable Trusts (http://www.pewtrusts.org/en/projects/pew-biomedical-scholars/program-details).	Beemiller P, 2012, NAT IMMUNOL, V13, P787, DOI 10.1038/ni.2364; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; CRISE B, 1992, J BIOL CHEM, V267, P13593; Dixon AM, 2014, J BIOL CHEM, V289, P11695, DOI 10.1074/jbc.M113.516997; Faingold O, 2012, J BIOL CHEM, V287, P33503, DOI 10.1074/jbc.M112.370817; Fournier M, 2010, MOL IMMUNOL, V47, P2594, DOI 10.1016/j.molimm.2010.06.010; Gaidukov L, 2011, J BIOL CHEM, V286, P18452, DOI 10.1074/jbc.M111.229872; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; Jia-huai Wang RM, 2001, PNAS, V98, P10799; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KIM KJ, 1979, J IMMUNOL, V122, P549; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Kuhns MS, 2012, IMMUNOLOGICAL REV, V250; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Moldovan MC, 2006, J IMMUNOL, V176, P5438, DOI 10.4049/jimmunol.176.9.5438; Moldovan MC, 2002, J IMMUNOL, V169, P6261, DOI 10.4049/jimmunol.169.11.6261; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; PERSCHL A, 1995, J CELL SCI, V108, P1033; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; REAY PA, 1994, J IMMUNOL, V152, P3946; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12726, DOI 10.1021/bi00166a003; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Vidal K, 1999, J IMMUNOL, V163, P4811; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097; Weinglass AB, 1999, P NATL ACAD SCI USA, V96, P11178, DOI 10.1073/pnas.96.20.11178; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132333	10.1371/journal.pone.0132333	http://dx.doi.org/10.1371/journal.pone.0132333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147390	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600244
J	Ran, C; He, SX; Yang, YL; Huang, L; Zhou, ZG				Ran, Chao; He, Suxu; Yang, Yalin; Huang, Lu; Zhou, Zhigang			A Novel Lipase as Aquafeed Additive for Warm-Water Aquaculture	PLOS ONE			English	Article							SALMON SALMO-SALAR; FATTY-ACID COMPOSITION; CRUDE PALM OIL; RAINBOW-TROUT; EXTRACELLULAR LIPASE; LIPID DIGESTIBILITY; MOLECULAR-BIOLOGY; SEQUENCE-ANALYSIS; FISH-OIL; PURIFICATION	A novel Acinetobacter lipase gene lipG1 was cloned from DNA extracted from intestinal sample of common carp (Cyprinus carpio), and expressed in E. coli BL21. The encoded protein was 406 amino acids in length. Phylogenetic analysis indicated that LipG1 and its relatives comprised a novel group of true lipases produced by Gram-negative bacteria. LipG1 showed maximal activity at 40 degrees C and pH 8.0 when pNP decanoate (C10) was used as the substrate, and remained high activity between 20 degrees C and 35 degrees C Activity of the lipase was promoted by Ca2+ and Mg2+, and inhibited by Zn2+ and Cu2+. Moreover, LipG1 is stable with proteases, most commercial detergents and organic solvents. Substrate specificity test indicated that LipG1can hydrolyse pNP esters with acyl chain length from C2 to C16, with preference for medium-chain pNP esters (C8, C10). Lastly, LipG1 was evaluated as an aquafeed additive for juvenile common carp (Cyprinus carpio). Results showed that supplementation of LipG1 significantly improved the gut and heptaopancreas lipase activity of fish fed with palm oil diet. Consistently, improved feed conversion ratio and growth performance were recorded in the LipG1 feeding group, to levels comparable to the group of fish fed with soybean oil diet. Collectively, LipG1 exhibited good potential as an aquafeed additive enzyme, and deserves further characterization as the representative of a novel group of lipases.	[Ran, Chao; He, Suxu; Yang, Yalin; Huang, Lu; Zhou, Zhigang] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhou, ZG (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	zhou_zg@msn.com			National Science and Technology Support Program Project of China [2012BAD25B02, 2013BAD10B01]; Beijing earmarked fund for Modern Agro-industry Technology Research System (SCGWZJ) [20121104-4]	National Science and Technology Support Program Project of China; Beijing earmarked fund for Modern Agro-industry Technology Research System (SCGWZJ)	This work was supported by the National Science and Technology Support Program Project of China (2012BAD25B02 and 2013BAD10B01) and Beijing earmarked fund for Modern Agro-industry Technology Research System (SCGWZJ 20121104-4). Z.Z. was the author who received the funding. The URL of funder's websites is not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EH, 2010, BIORESOURCE TECHNOL, V101, P3628, DOI 10.1016/j.biortech.2009.12.107; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; FAO, 2014, FISH STAT COLL; Han SJ, 2003, BIOCHIMIE, V85, P501, DOI 10.1016/S0300-9084(03)00057-9; He SX, 2010, ARCH MICROBIOL, V192, P985, DOI 10.1007/s00203-010-0627-z; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Johnsen RI, 2000, AQUACULT NUTR, V6, P255, DOI 10.1046/j.1365-2095.2000.00146.x; Kademi A, 2000, APPL MICROBIOL BIOT, V54, P173, DOI 10.1007/s002530000353; KOK RG, 1995, MOL MICROBIOL, V15, P803, DOI 10.1111/j.1365-2958.1995.tb02351.x; KOVEN WM, 1993, FISH PHYSIOL BIOCHEM, V10, P357, DOI 10.1007/BF00004502; Ng WK, 2004, AQUAC RES, V35, P1228, DOI 10.1111/j.1365-2109.2004.01131.x; Ng WK, 2000, AQUAC RES, V31, P337, DOI 10.1046/j.1365-2109.2000.00437.x; Ng WK, 2003, LIPIDS, V38, P1031, DOI 10.1007/s11745-006-1157-y; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Park IH, 2009, J MICROBIOL BIOTECHN, V19, P128, DOI 10.4014/jmb.0802.130; Samuelsen T, 2001, AQUACULTURE, V194, P161, DOI 10.1016/S0044-8486(00)00519-6; Snellman EA, 2004, J IND MICROBIOL BIOT, V31, P391, DOI 10.1007/s10295-004-0167-0; Snellman EA, 2002, EUR J BIOCHEM, V269, P5771, DOI 10.1046/j.1432-1033.2002.03235.x; Sullivan ER, 1999, GENE, V230, P277, DOI 10.1016/S0378-1119(99)00026-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timothy M, 2005, VIROL J, V2, P1; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Torstensen BE, 2000, LIPIDS, V35, P653, DOI 10.1007/s11745-000-0570-6; Varghese S, 2000, LIPIDS, V35, P757, DOI 10.1007/s11745-000-0582-2; Wang HK, 2011, FOOD TECHNOL BIOTECH, V49, P96; Zheng XM, 2011, APPL MICROBIOL BIOT, V90, P971, DOI 10.1007/s00253-011-3154-1; Zhou ZG, 2009, J WORLD AQUACULT SOC, V40, P450, DOI 10.1111/j.1749-7345.2009.00272.x	29	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132049	10.1371/journal.pone.0132049	http://dx.doi.org/10.1371/journal.pone.0132049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147311	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600189
J	Seino, S; Shinkai, S; Iijima, K; Obuchi, S; Fujiwara, Y; Yoshida, H; Kawai, H; Nishi, M; Murayama, H; Taniguchi, Y; Amano, H; Takahashi, R				Seino, Satoshi; Shinkai, Shoji; Iijima, Katsuya; Obuchi, Shuichi; Fujiwara, Yoshinori; Yoshida, Hideyo; Kawai, Hisashi; Nishi, Mariko; Murayama, Hiroshi; Taniguchi, Yu; Amano, Hidenori; Takahashi, Ryutaro			Reference Values and Age Differences in Body Composition of Community-Dwelling Older Japanese Men and Women: A Pooled Analysis of Four Cohort Studies	PLOS ONE			English	Article							FAT-FREE MASS; X-RAY ABSORPTIOMETRY; BIOELECTRICAL-IMPEDANCE ANALYSIS; MULTIFREQUENCY BIOIMPEDANCE; SKELETAL-MUSCLE; SARCOPENIA; POPULATION; DEXA; ACCURACY; INDEX	Objectives To determine age- and sex-specific body composition reference values and investigate age differences in these parameters for community-dwelling older Japanese men and women, using direct segmental multi-frequency bioelectrical impedance analysis. Methods We conducted a pooled analysis of data collected in four cohort studies between 2008 and 2012: Kusatsu Longitudinal Study, Hatoyama Cohort Study, Itabashi Cohort Study, and Kashiwa Cohort Study. The pooled analysis included cross-sectional data from 4478 non-disabled, community-dwelling adults aged 65-94 years (2145 men, 2333 women; mean age: 72.9 years in men and 72.6 years in women). Body weight, fat mass (FM), percentage FM, fat-free mass (FFM), and appendicular lean soft tissue mass were measured using the InBody 720 and 430 (Biospace Co. Ltd, Seoul, Korea). The values were then normalized by height in meters squared to determine body mass index (BMI), FM index (FMI), FFM index (FFMI), and skeletal muscle mass index (SMI). Results Simple means (standard deviation) of BMI, percentage FM, FMI, FFMI, and SMI were 23.4 (2.9) kg/m(2), 24.9 (6.3)%, 5.96 (2.09) kg/m(2), 17.4 (1.5) kg/m(2), and 7.29 (0.76) kg/m(2), respectively, in men and 22.7 (3.3) kg/m(2), 31.7 (7.1)%, 7.40 (2.61) kg/m(2), 15.3 (1.2) kg/m(2), and 5.86 (0.67) kg/m(2), respectively, in women. We then calculated quartiles and quintiles for these indices after stratifying for sex and 5-year age group. FFMI and SMI decreased significantly with age in both sexes (P < 0.001 for trends), but FFMI remained constant among the women with only a 1% decrease up to age 84 years. Percentage FM increased significantly, with age (P < 0.001 in men and P = 0.045 in women for trends), but FMI was unchanged in both sexes (P = 0.147 in men and P = 0.176 in women for trends). Conclusion The present data should be useful in the clinical evaluation of body composition of older Japanese and for international comparisons. The small age-related decrease in FFMI may be a noteworthy characteristic of body composition change in older Japanese women.	[Seino, Satoshi; Shinkai, Shoji; Obuchi, Shuichi; Fujiwara, Yoshinori; Yoshida, Hideyo; Kawai, Hisashi; Nishi, Mariko; Murayama, Hiroshi; Taniguchi, Yu; Amano, Hidenori; Takahashi, Ryutaro] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; University of Tokyo	Shinkai, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae, Tokyo, Japan.	sshinkai@tmig.or.jp		Seino, Satoshi/0000-0002-3620-8730	Tokyo Metropolitan Government; Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency; Japan Society for the Promotion of Science [17390194, 21390212]; Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [H23-Chouju-Ippan-001, H23-Chouju-Ippan-002, H24-Choju-Ippan-002]; Grants-in-Aid for Scientific Research [26310111] Funding Source: KAKEN	Tokyo Metropolitan Government(Tokyo Metropolitan Government); Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Tokyo Metropolitan Government, the Japan Arteriosclerosis Prevention Fund (http://jals.gr.jp/en/index.html), the Research Institute of Science and Technology for Society, the Japan Science and Technology Agency, Grants-in-Aid for Scientific Research (B) (2) 17390194 and 21390212 from the Japan Society for the Promotion of Science, and Health Labour Sciences Research Grants H23-Chouju-Ippan-001, H23-Chouju-Ippan-002, and H24-Choju-Ippan-002 from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Cawthon PM, 2013, GERONTOLOGIST, V53, P594, DOI 10.1093/gerona/glu023; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Coin A, 2008, CLIN NUTR, V27, P87, DOI 10.1016/j.clnu.2007.10.008; Coin A, 2013, J AM MED DIR ASSOC, V14, P507, DOI 10.1016/j.jamda.2013.02.010; Coin A, 2012, CLIN NUTR, V31, P506, DOI 10.1016/j.clnu.2012.01.012; Demura Shinichi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P93, DOI 10.2114/jpa.23.93; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dey DK, 2009, NUTRITION, V25, P613, DOI 10.1016/j.nut.2008.11.023; Franssen FME, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.03.012; Fujiwara Y, 2013, J GERIATR PSYCH NEUR, V26, P209, DOI 10.1177/0891988713497096; Genton L, 2011, CLIN NUTR, V30, P436, DOI 10.1016/j.clnu.2011.01.009; Han SS, 2010, J AM GERIATR SOC, V58, P312, DOI 10.1111/j.1532-5415.2009.02672.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Ito H, 2001, EUR J CLIN NUTR, V55, P462, DOI 10.1038/sj.ejcn.1601206; Kim CH, 2011, OBES RES CLIN PRACT, V5, pE210, DOI 10.1016/j.orcp.2011.01.004; Kim M, 2013, EUR J CLIN NUTR, V67, P395, DOI 10.1038/ejcn.2013.9; Kim M, 2014, GERIATR GER IN PRESS; Kitamura I, 2014, GERIATR GERONTOL INT, V14, P354, DOI 10.1111/ggi.12109; Kyle UG, 2001, EUR J CLIN NUTR, V55, P663, DOI 10.1038/sj.ejcn.1601198; Kyle UG, 2001, NUTRITION, V17, P534, DOI 10.1016/S0899-9007(01)00555-X; Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001; Lu Y, 2012, EUR J CLIN NUTR, V66, P1004, DOI 10.1038/ejcn.2012.86; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015; Rossi A, 2008, INT J OBESITY, V32, P1423, DOI 10.1038/ijo.2008.103; Seino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099487; Shafer KJ, 2009, NUTRITION, V25, P25, DOI 10.1016/j.nut.2008.07.004; Sillanpaa E, 2014, OBESITY, V22, P101, DOI 10.1002/oby.20583; Tagliabue A, 2001, ACTA DIABETOL, V38, P93, DOI 10.1007/s005920170020; Taniguchi Y, 2012, J GERONTOL A-BIOL, V67, P796, DOI 10.1093/gerona/glr243; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Visser M, 2003, J APPL PHYSIOL, V94, P2368, DOI 10.1152/japplphysiol.00124.2002; Yamada M, 2014, GERIATR GERONTOL INT, V14, P8, DOI 10.1111/ggi.12209	39	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131975	10.1371/journal.pone.0131975	http://dx.doi.org/10.1371/journal.pone.0131975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147341	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600172
J	Nagirnaja, L; Nommemees, D; Rull, K; Christiansen, OB; Nielsen, HS; Laan, M				Nagirnaja, Liina; Nommemees, Diana; Rull, Kristiina; Christiansen, Ole B.; Nielsen, Henriette S.; Laan, Maris			Annexin A5 Promoter Haplotype M2 Is Not a Risk Factor for Recurrent Pregnancy Loss in Northern Europe	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; ANXA5 GENE PROMOTER; SPONTANEOUS-ABORTION; VENOUS THROMBOSIS; FETAL LOSS; MISCARRIAGE; POLYMORPHISMS; ASSOCIATION; WOMEN; PREDISPOSITION	Introduction Annexin A5 is an essential component of placental integrity that may potentially mediate susceptibility to phenotypes of compromised pregnancy. A promoter haplotype termed M2 of the coding gene ANXA5 has been implicated in various pregnancy complications such as preeclampsia and recurrent pregnancy loss (RPL), however with inconclusive results. Study subjects and methods A retrospective case-control study combining resequencing and restriction fragment length polymorphism (RFLP) analysis was undertaken in 313 women with unexplained RPL and 214 fertile women from Estonia and Denmark to estimate the RPL disease risk of the M2 haplotype in Northern Europe. Comparative prevalence of the studied ANXA5 genetic variants in human populations was estimated based on the 1000 Genomes Project (n = 675, whole-genome sequencing data) and the KORA S3 500K dataset of South German samples (n = 1644, genome-wide genotyping data). Results Minor allele frequency of common polymorphisms in ANXA5 promoter was up to two-fold lower among Estonian RPL subjects than fertile controls. The M2 haplotype was not associated with RPL and a trend for decreased prevalence was observed among RPL patients compared to controls both in Estonia (8.1% vs 15.2%, respectively) and Denmark (9.7% vs 12.6%). The high M2 prevalence in fertile controls was consistent with estimations for European and East Asian populations (9.6%-16.0%). Conclusions This study cautions to consider the M2 haplotype as a deterministic factor in early pregnancy success because: i) no RPL disease risk was associated with the haplotype in two clinically well-characterized RPL case-control study samples, ii) high prevalence of the haplotype among fertile controls and world-wide populations is inconsistent with the previously proposed severe impact on early pregnancy success, iii) weak impact of M2 haplotype on the production of ANXA5 protein has been established by others.	[Nagirnaja, Liina; Nommemees, Diana; Rull, Kristiina; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, EE-50090 Tartu, Estonia; [Rull, Kristiina] Univ Tartu, Dept Obstet & Gynaecol, EE-50090 Tartu, Estonia; [Christiansen, Ole B.; Nielsen, Henriette S.] Univ Copenhagen Hosp, Rigshosp, Fertil Clin, DK-2100 Copenhagen, Denmark; [Christiansen, Ole B.] Aalborg Univ Hosp, Dept Obstet & Gynaecol, Aalborg, Denmark	University of Tartu; University of Tartu; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital	Laan, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, Ulikooli 18, EE-50090 Tartu, Estonia.	maris.laan@ut.ee	Rull, Kristiina/H-9555-2013; Nielsen, Henriette Svarre/E-3814-2014; Laan, Maris/A-4100-2011	Rull, Kristiina/0000-0002-3396-0716; Nielsen, Henriette Svarre/0000-0003-2106-8103; Laan, Maris/0000-0002-8519-243X; Nagirnaja, Liina/0000-0003-1948-2495	Estonian Science Foundation Grant [ETF9030]; Wellcome Trust International Senior Research Fellowship in Biomedical Science in Central Europe [070191/Z/03/A]; Estonian Ministry of Education and Science Core Grant [SF0180022s12]; European Union through European Regional Development Fund, project HAPPY PREGNANCY [3.2.0701.12-0047]	Estonian Science Foundation Grant; Wellcome Trust International Senior Research Fellowship in Biomedical Science in Central Europe; Estonian Ministry of Education and Science Core Grant; European Union through European Regional Development Fund, project HAPPY PREGNANCY	The project has been financed by the following grants to M.L.: Estonian Science Foundation Grant (ETF9030), www.etag.ee; Wellcome Trust International Senior Research Fellowship (070191/Z/03/A) in Biomedical Science in Central Europe, http://www.wellcome.ac.uk/; Estonian Ministry of Education and Science Core Grant (SF0180022s12), https://www.hm.ee/en; and by the European Union through the European Regional Development Fund, project HAPPY PREGNANCY, no. 3.2.0701.12-0047), http://ec.europa.eu/regional_ policy/thefunds/regional/index_en.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JL, 2009, CURR OPIN ENDOCRINOL, V16, P446, DOI 10.1097/MED.0b013e3283327fc5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bogdanova N, 2007, HUM MOL GENET, V16, P573, DOI 10.1093/hmg/ddm017; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Cao YL, 2013, GENE, V530, P248, DOI 10.1016/j.gene.2013.07.080; Carmeille R, 2015, BBA-MOL CELL RES, V1853, P2033, DOI 10.1016/j.bbamcr.2014.12.038; Christiansen OB, 2008, GYNECOL OBSTET INVES, V66, P257, DOI 10.1159/000149575; Christiansen OB, 1990, ACTA OBSTET GYN SCAN, V69, P597, DOI 10.3109/00016349009028702; Dahm AEA, 2015, J THROMB HAEMOST, V13, P409, DOI 10.1111/jth.12817; de Jong PG, 2015, BRIT J HAEMATOL, V169, P301, DOI 10.1111/bjh.13210; Doherty AS, 2002, DEV BIOL, V242, P255, DOI 10.1006/dbio.2001.0534; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Gourvas V, 2014, THROMB RES, V133, P495, DOI 10.1016/j.thromres.2013.12.027; Grandone E, 2010, THROMB HAEMOSTASIS, V103, P1102, DOI 10.1160/TH09-10-0697; Hayashi Y, 2013, FERTIL STERIL, V100, P1018, DOI 10.1016/j.fertnstert.2013.06.020; Hiddink L, 2012, THROMB RES, V129, P815, DOI 10.1016/j.thromres.2012.03.022; Hock TT, 2015, REPROD BIOMED ONLINE, V30, P434, DOI 10.1016/j.rbmo.2014.12.014; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Kolte AM, 2011, MOL HUM REPROD, V17, P379, DOI 10.1093/molehr/gar003; Kovalevsky G, 2004, ARCH INTERN MED, V164, P558, DOI 10.1001/archinte.164.5.558; Kruse C, 2004, HUM REPROD, V19, P1215, DOI 10.1093/humrep/deh200; Markoff A, 2010, PLACENTA, V31, P937, DOI 10.1016/j.placenta.2010.08.002; Matsubayashi H, 2001, FERTIL STERIL, V76, P694, DOI 10.1016/S0015-0282(01)02009-X; Miyamura H, 2011, MOL HUM REPROD, V17, P447, DOI 10.1093/molehr/gar008; Nagirnaja L, 2014, HUM MUTAT, V35, P972, DOI 10.1002/humu.22589; Nagirnaja L, 2012, MOL HUM REPROD, V18, P379, DOI 10.1093/molehr/gas018; Ota S, 2013, PLACENTA, V34, P1202, DOI 10.1016/j.placenta.2013.09.010; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; RAND JH, 1994, AM J OBSTET GYNECOL, V171, P1566, DOI 10.1016/0002-9378(94)90403-0; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; Rey E, 2003, LANCET, V361, P901, DOI 10.1016/S0140-6736(03)12771-7; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; Rogenhofer N, 2012, FERTIL STERIL, V98, P383, DOI 10.1016/j.fertnstert.2012.04.026; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rull K, 2013, FERTIL STERIL, V99, P1930, DOI 10.1016/j.fertnstert.2013.02.019; Rull Kristiina, 2012, Frontiers in Genetics, V3, P34, DOI 10.3389/fgene.2012.00034; Rull K, 2008, J CLIN ENDOCR METAB, V93, P4697, DOI 10.1210/jc.2008-1101; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tiscia G, 2009, THROMB HAEMOSTASIS, V102, P309, DOI 10.1160/TH09-02-0123; Tuttelmann F, 2013, FERTIL STERIL, V100, P1321, DOI 10.1016/j.fertnstert.2013.06.046; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131606	10.1371/journal.pone.0131606	http://dx.doi.org/10.1371/journal.pone.0131606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135579	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400059
J	Zhang, YP; Liu, YM; Zhang, JZ; Guo, YP; Ma, EB				Zhang, Yuping; Liu, Yaoming; Zhang, Jianzhen; Guo, Yaping; Ma, Enbo			Molecular Cloning and mRNA Expression of Heat Shock Protein Genes and Their Response to Cadmium Stress in the Grasshopper Oxya chinensis	PLOS ONE			English	Article							ANTIOXIDANT ENZYMES; CDNA CLONING; HSP70 GENE; MIDGE; HEAT-SHOCK-PROTEIN-90; EVOLUTIONARY; CHAPERONES; PATTERNS; RECEPTOR; COGNATE	Heat shock proteins (Hsps) are highly conserved molecular chaperones that are synthesized in response to stress. In this study, we cloned the full-length sequences of the Grp78 (glucose-regulated protein 78), Hsp70, Hsp90, and Hsp40 genes from the Chinese rice grasshopper Oxya chinensis. The full-length cDNA sequences of OcGrp78, OcHsp70, OcHsp90, and OcHsp40 contain open reading frames of 1947, 1920, 2172, and 1042 bp that encode proteins of 649, 640, 724, and 347 amino acids, respectively. Fluorescent real-time quantitative PCR (RT-qPCR) was performed to quantify the relative transcript levels of these Hsp genes in different tissues and developmental stages. The mRNAs encoding these four Hsp genes were present at all developmental stages and in all tissues examined but were expressed at varying levels. Additionally, we investigated the mRNA expression profiles of these four Hsps in O. chinensis subjected to Cadmium (Cd) stress. OcGrp78, OcHsp70, OcHsp90, and OcHsp40 mRNA expression was induced under acute Cd stress; the levels reached a maximum within a short time (6 h), were reduced significantly at 12 h, and were lowered to or below control levels by 48 h. Regarding induction efficiency, OcHsp70 was the most sensitive gene to acute Cd stress. Chronic Cd exposure showed that dietary Cd treatment induced increased OcGrp78, OcHsp90, and OcHsp40 expression. However, dietary Cd induced a significant reduction of OcHsp70 expression. In the period tested, no significant difference in the mortality of the grasshoppers was observed. Our results suggest that these four Hsps genes, especially OcHsp70, are sensitive to acute Cd stress and could be used as molecular markers for toxicology studies. However, our results also indicate that OcHsp70 is not suitable for use as a molecular marker of chronic Cd contamination.	[Zhang, Yuping; Liu, Yaoming; Zhang, Jianzhen; Ma, Enbo] Shanxi Univ, Inst Appl Biol, Taiyuan, Shanxi, Peoples R China; [Zhang, Yuping] Taiyuan Normal Univ, Dept Biol, Taiyuan, Shanxi, Peoples R China; [Guo, Yaping] Shanxi Univ, Coll Life Sci, Taiyuan, Shanxi, Peoples R China	Shanxi University; Taiyuan Normal University; Shanxi University	Guo, YP (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan, Shanxi, Peoples R China.	guoyp1955@163.com; maenbo2003@sxu.edu.cn			National Science Foundation of China [31071980, 31172161]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 31071980, 31172161 from National Science Foundation of China.	Boone AN, 2002, COMP BIOCHEM PHYS C, V132, P223, DOI 10.1016/S1532-0456(02)00066-2; Choi YK, 2008, COMP BIOCHEM PHYS C, V147, P286, DOI 10.1016/j.cbpc.2007.11.002; Denlinger David L., 2001, P155, DOI 10.1016/B978-044450608-5/50045-3; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gao Q, 2007, COMP BIOCHEM PHYS B, V147, P704, DOI 10.1016/j.cbpb.2007.04.010; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Henson MC, 2004, EXP BIOL MED, V229, P383, DOI 10.1177/153537020422900506; Hung JJ, 1998, J CELL BIOCHEM, V71, P21; Karouna-Renier NK, 2009, INSECT MOL BIOL, V18, P87, DOI 10.1111/j.1365-2583.2008.00853.x; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Kwong RWM, 2011, AQUAT TOXICOL, V102, P1, DOI 10.1016/j.aquatox.2010.12.010; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P447, DOI 10.1016/j.fsi.2010.10.023; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li LiJun, 2010, Journal of Agro-Environment Science, V29, P1448; Liu YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112759; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; Morales M, 2011, COMP BIOCHEM PHYS C, V153, P150, DOI 10.1016/j.cbpc.2010.10.003; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Planello R, 2010, SCI TOTAL ENVIRON, V408, P1598, DOI 10.1016/j.scitotenv.2010.01.004; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; RYBCZYNSKI R, 1995, MOL CELL ENDOCRINOL, V115, P73, DOI 10.1016/0303-7207(95)03672-T; Schill RO, 2003, BIOMETALS, V16, P391, DOI 10.1023/A:1022534326034; Shu YH, 2011, COMP BIOCHEM PHYS A, V158, P102, DOI 10.1016/j.cbpa.2010.09.006; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tachibana SI, 2005, J INSECT PHYSIOL, V51, P641, DOI 10.1016/j.jinsphys.2004.11.012; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Vollmer S, 2010, BIOCHEM PHARMACOL, V80, P2066, DOI 10.1016/j.bcp.2010.07.015; Wang HS, 2007, INSECT MOL BIOL, V16, P207, DOI 10.1111/j.1365-2583.2006.00715.x; Wang HaiHong, 2005, Scientia Agricultura Sinica, V38, P2023; Warchalowska-Sliwa E, 2005, ENVIRON POLLUT, V133, P373, DOI 10.1016/j.envpol.2004.05.013; [吴海花 WU Hai-hua], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P471; Yalin S, 2006, ECOTOX ENVIRON SAFE, V65, P140, DOI 10.1016/j.ecoenv.2005.06.006; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154; Yoshimi T, 2002, J BIOCHEM MOL TOXIC, V16, P10, DOI 10.1002/jbt.10018; Yoshimi T, 2009, ENVIRON TOXICOL PHAR, V28, P294, DOI 10.1016/j.etap.2009.05.008; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013; Zhang YP, 2011, ECOTOX ENVIRON SAFE, V74, P1355, DOI 10.1016/j.ecoenv.2011.03.002; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	40	9	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131244	10.1371/journal.pone.0131244	http://dx.doi.org/10.1371/journal.pone.0131244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135744	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400040
J	Ali, K; Ahmed, B; Dwivedi, S; Saquib, Q; Al-Khedhairy, AA; Musarrat, J				Ali, Khursheed; Ahmed, Bilal; Dwivedi, Sourabh; Saquib, Quaiser; Al-Khedhairy, Abdulaziz A.; Musarrat, Javed			Microwave Accelerated Green Synthesis of Stable Silver Nanoparticles with Eucalyptus globulus Leaf Extract and Their Antibacterial and Antibiofilm Activity on Clinical Isolates	PLOS ONE			English	Article							IN-VITRO; ESCHERICHIA-COLI; TOXICITY; NANOCOMPOSITE; RELEASE; PLANTS	A simple and rapid microwave assisted method of green synthesis of silver nanoparticles (AgNPs) was developed using aqueous leaf extract of Eucalyptus globulus (ELE), and their antibacterial and antibiofilm potential investigated. With this aim, the aqueous solutions of ELE and AgNO3 (1 mM) were mixed (1: 4 v/v), and microwave irradiated at 2450 Mhz, for 30 sec. The instant color change of the ELE-AgNO3 mixture from pale yellow to dark brown indicated ELE-AgNPs synthesis. The intensity of peak at 428 nm in UV-Vis spectra, due to the surface plasmon resonance of AgNPs, varied with the amount of ELE, AgNO3 concentration, pH and time of incubation. The biosynthesized ELE-AgNPs were characterized by UV-visible spectroscopy, XRD, TEM, SEM-EDX, FTIR and TGA analyses. The size of ELE-AgNPs was determined to be in range of 1.9-4.3 nm and 5-25 nm, with and without microwave treatment, respectively. SEM exhibited the capping of AgNPs with the ELE constituents, and validated by FTIR analysis. The FTIR data revealed the presence of plant organic constituents and metabolites bound to ELE-AgNPs, which contributes for their stability. The antimicrobial activity of ELE-AgNPs was assessed by growth and biofilm inhibition of extended spectrum beta-lactamase (ESBL) producing Pseudomonas aeruginosa, Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) clinical bacterial isolates. The results demonstrated that S. aureus were more sensitive to ELE-AgNPs than E. coli and P. aeruginosa. MRSA exhibited higher sensitive than MSSA, whereas P. aeruginosa were more sensitive than E. coli to ELE-AgNPs treatment. Also, significant (83 +/- 3% and 84 +/- 5%) biofilm inhibition was observed in case of S. aureus and P. aeruginosa, respectively. The results elucidated environmentally friendly, economical and quick method for production of colloidal bio-functionalized ELE-AgNPs, for effectual clinical applications, as broad spectrum antibacterial agents and biofilm inhibitors.	[Ali, Khursheed; Ahmed, Bilal; Dwivedi, Sourabh; Musarrat, Javed] Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India; [Saquib, Quaiser; Al-Khedhairy, Abdulaziz A.] King Saud Univ, Coll Sci, Dept Zool, Chair DNA Res, Riyadh 11451, Saudi Arabia	Aligarh Muslim University; King Saud University	Musarrat, J (corresponding author), Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India.	musarratj1@yahoo.com	AHMED, BILAL/M-4472-2017; Musarrat, Javed/N-4094-2019; Saquib, Quaiser/I-3043-2013; Saquib, Quaiser/GSO-1803-2022; Al-Khedhairy, Abdulaziz A A/F-8327-2011; Ali, Khursheed/T-3363-2019; Dwivedi, Sourabh/I-2060-2013	AHMED, BILAL/0000-0001-8047-9231; Saquib, Quaiser/0000-0001-7030-3777; Saquib, Quaiser/0000-0001-7030-3777; Al-Khedhairy, Abdulaziz A A/0000-0002-1210-6262; Ali, Khursheed/0000-0002-1578-1781; 	Chair for DNA research, King Saud University, Riyadh	Chair for DNA research, King Saud University, Riyadh	Financial support was provided through the Chair for DNA research, King Saud University, Riyadh, for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2003, COLLOID SURFACE B, P28; Akiyama H, 2001, J ANTIMICROB CHEMOTH, V48, P487, DOI 10.1093/jac/48.4.487; Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033; Annamalai N, 2011, WORLD J MICROB BIOT, V27, P2111, DOI 10.1007/s11274-011-0674-x; Ansari MA, 2015, WORLD J MICROB BIOT, V31, P153, DOI 10.1007/s11274-014-1757-2; Brooker MIH, 2004, FIELD GUIDE EUCALYPT, V3; Bruneton J, 1995, PHARMACOGNOSY PHYTOC, P265; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Cadahia E, 1997, PHYTOCHEM ANALYSIS, V8, P78; Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; Deepak V, 2011, METAL NANOPARTICLES IN MICROBIOLOGY, P17, DOI 10.1007/978-3-642-18312-6_2; Dobias J, 2013, ENVIRON SCI TECHNOL, V47, P4140, DOI 10.1021/es304023p; Dubey M, 2009, DIG J NANOMATER BIOS, V4, P537; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; Gurunathan S, 2009, COLLOID SURFACE B, V74, P328, DOI 10.1016/j.colsurfb.2009.07.048; Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008; Hindi KM, 2009, BIOMATERIALS, V30, P3771, DOI 10.1016/j.biomaterials.2009.03.044; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368; Jayapriya E., 2013, International Journal of ChemTech Research, V5, P2985; Jha AK, 2009, COLLOID SURFACE B, V73, P219, DOI 10.1016/j.colsurfb.2009.05.018; Joseph S, 2015, SPECTROCHIM ACTA A, V136, P1371, DOI 10.1016/j.saa.2014.10.023; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Klaus T, 1999, P NATL ACAD SCI USA, P96; Kudle KR, 2013, INT RES J PHARM; Laban G, 2010, ECOTOXICOLOGY, V19, P185, DOI 10.1007/s10646-009-0404-4; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; Loza K, 2014, J MATER CHEM B, V12, P1605; Marchiol L, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-101; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Mubarak AD, 2011, J NANOMATER, V6; Musarrat J, 2010, BIORESOURCE TECHNOL, V101, P8772, DOI 10.1016/j.biortech.2010.06.065; Nadagouda MN, 2011, ACCOUNTS CHEM RES, V44, P469, DOI 10.1021/ar1001457; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Paredes D, 2014, INT J NANOMED, V9, P1717, DOI 10.2147/IJN.S57156; Patel K, 2005, J CHEM SCI, V117, P53, DOI 10.1007/BF02704361; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Paul D, 2013, J FUNCT BIOMATER, V4, P358, DOI 10.3390/jfb4040358; Perala SRK, 2013, LANGMUIR, V29, P9863, DOI 10.1021/la401604q; Qu D, 2014, INT J NANOMED, V9, P1871, DOI 10.2147/IJN.S58732; Rai M, 2013, IET NANOBIOTECHNOL, V7, P117, DOI 10.1049/iet-nbt.2012.0031; Rakic S., 2004, Journal of Agricultural Sciences, Belgrade, V49, P97; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; REDDY MC, 2015, NANOBIOTECHNOLOGY, V14, P222, DOI DOI 10.5897/AJB2013.13299; Sastry M., 2003, CURR SCI, V85, P170; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Singh BR, 2011, COLLOID SURFACE B, V85, P207, DOI 10.1016/j.colsurfb.2011.02.030; Singh S, 2014, J MOL STRUCT, V1056, P194, DOI 10.1016/j.molstruc.2013.10.020; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sotiriou GA, 2011, CHEM ENG J, V170, P547, DOI 10.1016/j.cej.2011.01.099; Sulaiman Ghassan Mohammad, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P58, DOI 10.1016/S2221-1691(13)60024-6; Tolaymat TM, 2010, SCI TOTAL ENVIRON, V408, P999, DOI 10.1016/j.scitotenv.2009.11.003; Torresdey JLG, 2013, LANGMUIR, V19, P1357; Tyagi AK, 2011, FOOD CHEM, V126, P228, DOI 10.1016/j.foodchem.2010.11.002; van der Zande M, 2012, ACS NANO, V6, P7427, DOI 10.1021/nn302649p; Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042; Wilcoxon JP, 2006, CHEM SOC REV, V35, P1162, DOI 10.1039/b517312b; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Zhang YQ, 2013, COLLOID SURFACE A, V423, P63, DOI 10.1016/j.colsurfa.2013.01.059	67	70	70	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131178	10.1371/journal.pone.0131178	http://dx.doi.org/10.1371/journal.pone.0131178			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132199	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000099
J	Dutra, JDL; Filho, MAM; Rocha, GB; Simas, AM; Freire, RO				Dutra, Jose Diogo L.; Filho, Manoel A. M.; Rocha, Gerd B.; Simas, Alfredo M.; Freire, Ricardo O.			RM1 Semiempirical Quantum Chemistry: Parameters for Trivalent Lanthanum, Cerium and Praseodymium	PLOS ONE			English	Article							CAMBRIDGE STRUCTURAL DATABASE; CHEMICAL AM1 CALCULATION; SPARKLE MODEL; PHOTOPHYSICAL PROPERTIES; CRYSTAL-STRUCTURES; COMPLEXES; PREDICTION; LIGANDS; DESIGN	The RM1 model for the lanthanides is parameterized for complexes of the trications of lanthanum, cerium, and praseodymium. The semiempirical quantum chemical model core stands for the [Xe] 4f(n) electronic configuration, with n = 0,1,2 for La(III), Ce(III), and Pr(III), respectively. In addition, the valence shell is described by three electrons in a set of 5d, 6s, and 6p orbitals. Results indicate that the present model is more accurate than the previous sparkle models, although these are still very good methods provided the ligands only possess oxygen or nitrogen atoms directly coordinated to the lanthanide ion. For all other different types of coordination, the present RM1 model for the lanthanides is much superior and must definitely be used. Overall, the accuracy of the model is of the order of 0.07A for La(III) and Pr(III), and 0.08A for Ce(III) for lanthanide-ligand atom distances which lie mostly around the 2.3A to 2.6A inteal, implying an error around 3% only.	[Dutra, Jose Diogo L.; Filho, Manoel A. M.; Freire, Ricardo O.] Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, BR-49100000 Sao Cristovao, SE, Brazil; [Rocha, Gerd B.] Univ Fed Paraiba, CCEN, Dept Quim, BR-58059900 Joao Pessoa, PB, Brazil; [Dutra, Jose Diogo L.; Simas, Alfredo M.] Univ Fed Pernambuco, Dept Quim Fundamental, BR-50740540 Recife, PE, Brazil	Universidade Federal de Sergipe; Universidade Federal da Paraiba; Universidade Federal de Pernambuco	Freire, RO (corresponding author), Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, BR-49100000 Sao Cristovao, SE, Brazil.	rfreire@ufs.br	Filho, Manoel Alves Machado/R-2505-2019; Lisboa Dutra, José Diogo/I-7088-2013; Freire, Ricardo/AGR-4537-2022; Freire, Ricardo O/B-7685-2008; DUTRA, JOSE DIOGO LISBOA/AAJ-9870-2021; Simas, Alfredo M/B-1096-2008; Rocha, Gerd B/G-5115-2010	Freire, Ricardo/0000-0002-3603-3184; Freire, Ricardo O/0000-0002-3603-3184; DUTRA, JOSE DIOGO LISBOA/0000-0003-2123-2209; Simas, Alfredo M/0000-0003-3653-6328; Rocha, Gerd B/0000-0001-9805-9497	FAPITEC/SE; FACEPE(PRONEX); CNPq; CAPES; INCT-INAMI	FAPITEC/SE(Fundacao de Amparo a Pesquisa do Estado do Sergipe (FAPITEC)); FACEPE(PRONEX)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT-INAMI	This study was supported by FAPITEC/SE, FACEPE(PRONEX), CNPq, CAPES and INCT-INAMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar R, 2014, SPECTROCHIM ACTA A, V129, P365, DOI 10.1016/j.saa.2014.03.045; Alghool S, 2013, J THERM ANAL CALORIM, V112, P671, DOI 10.1007/s10973-012-2628-4; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P407, DOI 10.1107/S0108768102004895; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Bruno IJ, 2002, ACTA CRYSTALLOGR B, V58, P389, DOI 10.1107/S0108768102003324; da Costa NB, 2001, J MOL STRUC-THEOCHEM, V545, P131, DOI 10.1016/S0166-1280(01)00407-9; da Costa NB, 2007, J PHYS CHEM A, V111, P5015, DOI 10.1021/jp0672104; Dannenbauer N, 2013, Z ANORG ALLG CHEM, V639, P2737, DOI 10.1002/zaac.201300263; de Mesquita ME, 2002, INORG CHEM COMMUN, V5, P292, DOI 10.1016/S1387-7003(02)00382-9; DEANDRADE AVM, 1994, CHEM PHYS LETT, V227, P349, DOI 10.1016/0009-2614(94)00829-9; deAndrade AVM, 1996, J CHEM SOC FARADAY T, V92, P1835, DOI 10.1039/ft9969201835; DEANDRADE AVM, 1995, J ALLOY COMPD, V225, P55, DOI 10.1016/0925-8388(94)07009-1; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; dos Santos ER, 2010, J PHYS CHEM A, V114, P7928, DOI 10.1021/jp104038r; dos Santos ER, 2006, CHEM PHYS LETT, V418, P337, DOI 10.1016/j.cplett.2005.10.114; Dutra JDL, 2013, J CHEM THEORY COMPUT, V9, P3333, DOI 10.1021/ct301012h; Faustino WM, 2000, J MOL STRUC-THEOCHEM, V527, P245, DOI 10.1016/S0166-1280(00)00497-8; Filho MAM, 2014, J CHEM THEORY COMPUT, V10, P3031, DOI 10.1021/ct400909w; Filho MAM, 2013, RSC ADV, V3, P16747, DOI 10.1039/c3ra41406j; Freire RO, 2007, CHEM PHYS LETT, V441, P354, DOI 10.1016/j.cplett.2007.05.036; Freire RO, 2006, CHEM PHYS LETT, V425, P138, DOI 10.1016/j.cplett.2006.04.103; Freire RO, 2006, J PHYS CHEM A, V110, P5897, DOI 10.1021/jp057286k; Freire RO, 2010, J CHEM THEORY COMPUT, V6, P2019, DOI 10.1021/ct100192c; Freire RO, 2005, J MOL MODEL, V12, P16, DOI 10.1007/s00894-005-0280-7; Freire RO, 2005, INORG CHEM, V44, P3299, DOI 10.1021/ic048530+; Freire RO, 2005, J LUMIN, V111, P81, DOI 10.1016/j.jlumin.2004.07.001; Hong ZR, 2001, APPL PHYS LETT, V79, P1942, DOI 10.1063/1.1391239; Huang C, 2012, J DISPER SCI TECHNOL, V33, P1292, DOI 10.1080/01932691.2011.605681; Huang WL, 2013, EUR J INORG CHEM, V2013, P4090, DOI 10.1002/ejic.201300225; Jimenez-Reyes M, 2012, J RADIOANAL NUCL CH, V293, P273, DOI 10.1007/s10967-012-1730-1; Kaufman L., 2009, FINDING GROUPS DATA; Khorasani-Motlagh M, 2011, SPECTROCHIM ACTA A, V79, P978, DOI 10.1016/j.saa.2011.04.009; Kobayashi S, 2013, MOLECULES, V18, P6128, DOI 10.3390/molecules18066128; Li CH, 2014, THERMOCHIM ACTA, V581, P118, DOI 10.1016/j.tca.2014.02.021; Li XD, 2013, IEEE T PLASMA SCI, V41, P126, DOI 10.1109/TPS.2012.2226608; Park J, 2014, J MEMBRANE SCI, V469, P238, DOI 10.1016/j.memsci.2014.06.044; Pawlicki G, 2011, OPT MATER, V33, P1544, DOI 10.1016/j.optmat.2011.03.018; Pevec A, 2003, POLYHEDRON, V22, P575, DOI 10.1016/S0277-5387(02)01419-5; Qiu YC, 2009, INORG CHEM, V48, P3976, DOI 10.1021/ic8020518; Rastogi RB, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4024751; RIDLEY JE, 1976, THEOR CHIM ACTA, V42, P223, DOI 10.1007/BF00574445; Rocha GB, 2004, INORG CHEM, V43, P2346, DOI 10.1021/ic034882p; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Sharif S, 2012, J INORG ORGANOMET P, V22, P1165, DOI 10.1007/s10904-012-9715-7; Simas AM, 2007, LECT NOTES COMPUT SC, V4488, P312; Wang M, 2014, CHINESE J CATAL, V35, P524, DOI 10.1016/S1872-2067(14)60017-6; Yagyu T, 2014, INORG CHIM ACTA, V412, P114, DOI 10.1016/j.ica.2013.12.025; Zahir MH, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/494392; Zhao J, 2012, J CHEM CRYSTALLOGR, V42, P187, DOI 10.1007/s10870-011-0222-4	49	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0124372	10.1371/journal.pone.0124372	http://dx.doi.org/10.1371/journal.pone.0124372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132289	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000002
J	Lakovic, M; Poethke, HJ; Hovestadt, T				Lakovic, Milica; Poethke, Hans-Joachim; Hovestadt, Thomas			Dispersal Timing: Emigration of Insects Living in Patchy Environments	PLOS ONE			English	Article							DENSITY-DEPENDENT DISPERSAL; NATAL DISPERSAL; GLANVILLE FRITILLARY; POPULATION-DYNAMICS; UNSTABLE HABITATS; KIN COMPETITION; EVOLUTION; METAPOPULATION; INFORMATION; SELECTION	Dispersal is a life-history trait affecting dynamics and persistence of populations; it evolves under various known selective pressures. Theoretical studies on dispersal typically assume 'natal dispersal', where individuals emigrate right after birth. But emigration may also occur during a later moment within a reproductive season (' breeding dispersal'). For example, some female butterflies first deposit eggs in their natal patch before migrating to other site (s) to continue egg-laying there. How breeding compared to natal dispersal influences the evolution of dispersal has not been explored. To close this gap we used an individual-based simulation approach to analyze (i) the evolution of timing of breeding dispersal in annual organisms, (ii) its influence on dispersal (compared to natal dispersal). Furthermore, we tested (iii) its performance in direct evolutionary contest with individuals following a natal dispersal strategy. Our results show that evolution should typically result in lower dispersal under breeding dispersal, especially when costs of dispersal are low and population size is small. By distributing offspring evenly across two patches, breeding dispersal allows reducing direct sibling competition in the next generation whereas natal dispersal can only reduce trans-generational kin competition by producing highly dispersive offspring in each generation. The added benefit of breeding dispersal is most prominent in patches with small population sizes. Finally, the evolutionary contests show that a breeding dispersal strategy would universally out-compete natal dispersal.	[Lakovic, Milica; Poethke, Hans-Joachim; Hovestadt, Thomas] Univ Wurzburg, Biozentrum, Dept Anim Ecol & Trop Biol, Field Stn Fabrikschleichach, D-97070 Wurzburg, Germany; [Hovestadt, Thomas] Univ Ghent, Dept Biol TEREC, B-9000 Ghent, Belgium	University of Wurzburg; Ghent University	Lakovic, M (corresponding author), Univ Wurzburg, Biozentrum, Dept Anim Ecol & Trop Biol, Field Stn Fabrikschleichach, D-97070 Wurzburg, Germany.	milica.lakovic@biozentrum.uni-wuerzburg.de		Hovestadt, Thomas/0000-0001-7368-6013; Lakovic, Milica/0000-0003-0939-0300	German Research Foundation (DFG) [HO2051/3-1, SFB1047, C6]; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was funded by the German Research Foundation (DFG) grant: HO2051/3-1 and SFB1047 "Insect Timing", project C6, and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach LA, 2007, EVOL ECOL RES, V9, P663; Bach LA, 2006, ECOL MODEL, V192, P658, DOI 10.1016/j.ecolmodel.2005.07.026; Baguette M, 1996, ACTA OECOL, V17, P225; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Basskett M.L., 2012, ENCY THEORETICAL ECO, P192; Benton TG, 2000, EVOL ECOL RES, V2, P769; Bergman KO, 2001, BIOL CONSERV, V102, P183, DOI 10.1016/S0006-3207(01)00081-7; Beverton R.J.H., 1957, DYNAMICS EXPLOITED F, V1st; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bray Y, 2007, J ZOOL, V273, P426, DOI 10.1111/j.1469-7998.2007.00348.x; Cadet C, 2003, AM NAT, V162, P427, DOI 10.1086/378213; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; De Meester N, 2010, BEHAV ECOL, V21, P992, DOI 10.1093/beheco/arq088; Den Boer P. J., 1968, Acta Biotheoretica, V18, P165; DENBOER PJ, 1990, BIOL CONSERV, V54, P175, DOI 10.1016/0006-3207(90)90050-Y; Denno Robert F., 1995, P113, DOI 10.1016/B978-012159270-7/50007-5; Dieckmann U, 1999, TRENDS ECOL EVOL, V14, P88, DOI 10.1016/S0169-5347(98)01571-7; Doak P, 2000, ECOLOGY, V81, P1828, DOI 10.1890/0012-9658(2000)081[1828:PCORDF]2.0.CO;2; Duffey Eric, 1998, P187; Duplouy A, 2013, ECOL EVOL, V3, P5141, DOI 10.1002/ece3.885; Enfjall K, 2005, OIKOS, V108, P465, DOI 10.1111/j.0030-1299.2005.13261.x; Enfjall K, 2009, OIKOS, V118, P291, DOI 10.1111/j.1600-0706.2008.16863.x; Fonseca DM, 1996, OIKOS, V75, P49, DOI 10.2307/3546320; Frouz J, 2001, OIKOS, V93, P50, DOI 10.1034/j.1600-0706.2001.930105.x; GALL LF, 1984, BIOL CONSERV, V28, P111, DOI 10.1016/0006-3207(84)90031-4; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Gandon S, 1999, J THEOR BIOL, V199, P275, DOI 10.1006/jtbi.1999.0960; GILLESPIE JH, 1977, AM NAT, V111, P1010, DOI 10.1086/283230; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gyllenberg M, 2008, J MATH BIOL, V57, P285, DOI 10.1007/s00285-008-0158-2; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HANSSON L, 1991, BIOL J LINN SOC, V42, P89, DOI 10.1111/j.1095-8312.1991.tb00553.x; Hendrick P.W., 2009, GENETICS POPULATIONS; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Hovestadt Thomas, 2009, P97; Hovestadt T, 2010, ECOL MODEL, V221, P405, DOI 10.1016/j.ecolmodel.2009.11.005; KUNO E, 1981, OECOLOGIA, V49, P123, DOI 10.1007/BF00376909; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; LEVIN SA, 1984, THEOR POPUL BIOL, V26, P165, DOI 10.1016/0040-5809(84)90028-5; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Metz JAJ, 2001, P ROY SOC B-BIOL SCI, V268, P499, DOI 10.1098/rspb.2000.1373; MOTRO U, 1991, AM NAT, V137, P108, DOI 10.1086/285148; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Parker G.A., 1979, P123; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Poethke HJ, 2007, EVOL ECOL RES, V9, P41; Poethke HJ, 2003, AM NAT, V161, P631, DOI 10.1086/368224; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Powers KS, 2003, ETHOLOGY, V109, P725, DOI 10.1046/j.1439-0310.2003.00918.x; Rhainds M, 1997, CAN ENTOMOL, V129, P927, DOI 10.4039/Ent129927-5; Rhainds M, 2005, ECOL ENTOMOL, V30, P96, DOI 10.1111/j.0307-6946.2005.00663.x; Rhainds M, 2013, J INSECT BEHAV, V26, P850, DOI 10.1007/s10905-013-9400-x; Ronce O, 2000, THEOR POPUL BIOL, V58, P143, DOI 10.1006/tpbi.2000.1476; Rousset F, 2002, HEREDITY, V88, P371, DOI 10.1038/sj.hdy.6800065; Ruf D, 2011, ANIM BEHAV, V81, P1083, DOI 10.1016/j.anbehav.2011.02.028; Sei M, 2009, J INSECT BEHAV, V22, P87, DOI 10.1007/s10905-008-9156-x; TAYLOR PD, 1988, J THEOR BIOL, V130, P363, DOI 10.1016/S0022-5193(88)80035-3; Topping CJ, 1998, ENTOMOL EXP APPL, V87, P29, DOI 10.1023/A:1003259814676; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P723, DOI 10.1098/rspb.1999.0696; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015	67	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128672	10.1371/journal.pone.0128672	http://dx.doi.org/10.1371/journal.pone.0128672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132493	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000018
J	Milioli, HH; Vimieiro, R; Riveros, C; Tishchenko, I; Berretta, R; Moscato, P				Milioli, Heloisa Helena; Vimieiro, Renato; Riveros, Carlos; Tishchenko, Inna; Berretta, Regina; Moscato, Pablo			The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set	PLOS ONE			English	Article							DIFFERENTIATION ANTIGEN NY-BR-1; MESSENGER-RNA EXPRESSION; LEUCINE-ZIPPER KINASE; ALPHA-B-CRYSTALLIN; ARYLAMINE N-ACETYLTRANSFERASES; ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR GENE; BASAL-LIKE; MATRIX METALLOPROTEINASES; NEOADJUVANT CHEMOTHERAPY	Background The prediction of breast cancer intrinsic subtypes has been introduced as a valuable strategy to determine patient diagnosis and prognosis, and therapy response. The PAM50 method, based on the expression levels of 50 genes, uses a single sample predictor model to assign subtype labels to samples. Intrinsic errors reported within this assay demonstrate the challenge of identifying and understanding the breast cancer groups. In this study, we aim to: a) identify novel biomarkers for subtype individuation by exploring the competence of a newly proposed method named CM1 score, and b) apply an ensemble learning, as opposed to the use of a single classifier, for sample subtype assignment. The overarching objective is to improve class prediction. Methods and Findings The microarray transcriptome data sets used in this study are: the METABRIC breast cancer data recorded for over 2000 patients, and the public integrated source from ROCK database with 1570 samples. We first computed the CM1 score to identify the probes with highly discriminative patterns of expression across samples of each intrinsic subtype. We further assessed the ability of 42 selected probes on assigning correct subtype labels using 24 different classifiers from the Weka software suite. For comparison, the same method was applied on the list of 50 genes from the PAM50 method. Conclusions The CM1 score portrayed 30 novel biomarkers for predicting breast cancer subtypes, with the confirmation of the role of 12 well-established genes. Intrinsic subtypes assigned using the CM1 list and the ensemble of classifiers are more consistent and homogeneous than the original PAM50 labels. The new subtypes show accurate distributions of current clinical markers ER, PR and HER2, and survival curves in the METABRIC and ROCK data sets. Remarkably, the paradoxical attribution of the original labels reinforces the limitations of employing a single sample classifiers to predict breast cancer intrinsic subtypes.	[Milioli, Heloisa Helena; Vimieiro, Renato; Riveros, Carlos; Tishchenko, Inna; Berretta, Regina; Moscato, Pablo] Hunter Med Res Inst, Prior Res Ctr Bioinformat Biomarker Discovery & I, New Lambton Hts, NSW, Australia; [Milioli, Heloisa Helena] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Vimieiro, Renato] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil; [Riveros, Carlos; Tishchenko, Inna; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Universidade Federal de Pernambuco; University of Newcastle	Moscato, P (corresponding author), Hunter Med Res Inst, Prior Res Ctr Bioinformat Biomarker Discovery & I, New Lambton Hts, NSW, Australia.	Pablo.Moscato@newcastle.edu.au	Vimieiro, Renato/G-8109-2013	Vimieiro, Renato/0000-0002-7911-2456; Moscato, Pablo/0000-0003-2570-5966; Berretta, Regina/0000-0002-4420-3446; Milioli, Heloisa Helena/0000-0001-5104-487X	Australian Research Council (ARC) [FT120100060]; Australian Research Council [DP120102576]; Cancer Institute of New South Wales, Australia [13/DATA/1-03]	Australian Research Council (ARC)(Australian Research Council); Australian Research Council(Australian Research Council); Cancer Institute of New South Wales, Australia	PM is supported by Australian Research Council (ARC) Future Fellowship FT120100060 (http://arc.gov.au/). This project is partially funded by Australian Research Council Discovery Project DP120102576 (http://arc.gov.au/) and Cancer Institute of New South Wales, Australia, Grant 13/DATA/1-03 (http://www.cancerinstitute.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnati LF, 2007, J NEURAL TRANSM, V114, P21, DOI 10.1007/s00702-006-0564-9; Aguilar H, 2010, ONCOGENE, V29, P6071, DOI 10.1038/onc.2010.333; Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022; Ahn SG, 2013, INT J MOL SCI, V14, P23685, DOI 10.3390/ijms141223685; Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Ambs S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000281; Andres SA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-326; Arbitrario JP, 2010, CANCER CHEMOTH PHARM, V65, P707, DOI 10.1007/s00280-009-1076-8; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Balafoutas D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-271; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bastien RRL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-44; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Berretta R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012262; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Bolanz KA, 2008, MOL CANCER THER, V7, P271, DOI 10.1158/1535-7163.MCT-07-0478; Bowen CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058866; Browne EP, 2011, EPIGENETICS-US, V6, P1425, DOI 10.4161/epi.6.12.18280; Bu DW, 2013, CANCER EPIDEM BIOMAR, V22, P2212, DOI 10.1158/1055-9965.EPI-13-0208; Bush TL, 2013, MOL CANCER THER, V12, P2356, DOI 10.1158/1535-7163.MCT-12-1178; Campbell-Lloyd AJM, 2013, HEART LUNG CIRC, V22, P759, DOI 10.1016/j.hlc.2013.01.014; Canevari G, 2013, BIOCHEMISTRY-US, V52, P6380, DOI 10.1021/bi4005864; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Cheng CW, 2010, CLIN CHIM ACTA, V411, P234, DOI 10.1016/j.cca.2009.11.009; Cimino D, 2008, INT J CANCER, V123, P1327, DOI 10.1002/ijc.23660; Ciriello G, 2013, BREAST CANCER RES TR, V141, P409, DOI 10.1007/s10549-013-2699-3; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Colombo PE, 2010, BREAST CANCER RES, V13, P1; Cooper SJ, 2012, MOL CANCER THER, V11, P2105, DOI 10.1158/1535-7163.MCT-11-0873; Coradini D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/254085; Cortesi L, 2009, J PROTEOME RES, V8, P4916, DOI 10.1021/pr900239h; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; de Kruijf EM, 2014, MOL ONCOL, V8, P1014, DOI 10.1016/j.molonc.2014.03.022; Delassus GS, 2008, J CELL PHYSIOL, V217, P739, DOI 10.1002/jcp.21548; Delassus GS, 2011, J CELL PHYSIOL, V226, P3378, DOI 10.1002/jcp.22694; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Dumont N, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2457; Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382; Dunning MJ, 2010, LANCET ONCOL, V11, P717, DOI 10.1016/S1470-2045(10)70115-7; Eiro N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24010; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Fadare O, 2013, HUM PATHOL, V44, P1508, DOI 10.1016/j.humpath.2012.12.003; Fenne IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070096; Garcia MF, 2010, INT J EXP PATHOL, V91, P324, DOI 10.1111/j.1365-2613.2010.00709.x; Fiskus W, 2012, BREAST CANCER RES TR, V135, P433, DOI 10.1007/s10549-012-2171-9; Fleiss JL, 2004, MEASUREMENT INTERRAT, P598, DOI DOI 10.1002/0471445428.CH18; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fountzilas G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069256; Fu XY, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2849; Gauger KJ, 2014, CELL BIOL INT, V38, P124, DOI 10.1002/cbin.10176; Gauger KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-59; Giger O, 2010, PATHOL INT, V60, P726, DOI 10.1111/j.1440-1827.2010.02591.x; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Gostner JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-45; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Hegyi K, 2012, PATHOBIOLOGY, V79, P314, DOI 10.1159/000338082; Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Ikeda H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2598; Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109; Itatani Y, 2013, GASTROENTEROLOGY, V145, P1064, DOI 10.1053/j.gastro.2013.07.033; Jager D, 2007, APPL IMMUNOHISTO M M, V15, P77; Kabbage M, 2012, TUMOR BIOL, V33, P2279, DOI 10.1007/s13277-012-0490-4; Kalbfleisch JD, 2011, THE STATISTICAL ANAL; Kalous O, 2013, BREAST CANCER RES TR, V141, P397, DOI 10.1007/s10549-013-2702-z; Kasper G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-12; Katika MR, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3360; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Kim SJ, 2008, ANN ONCOL, V19, P68, DOI 10.1093/annonc/mdm358; Kim SJ, 2012, ANN ONCOL, V23, P891, DOI 10.1093/annonc/mdr340; Kim SJ, 2008, ONCOL REP, V19, P663; Kim SY, 2013, CELL CALCIUM, V53, P102, DOI 10.1016/j.ceca.2012.10.005; Klopocki E, 2004, INT J ONCOL, V25, P641; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kotoula V, 2013, VIRCHOWS ARCH, V462, P141, DOI 10.1007/s00428-012-1357-1; Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lan J, 2012, MOL BIOL REP, V39, P2739, DOI 10.1007/s11033-011-1029-2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landowski CP, 2011, PHARM RES-DORDR, V28, P322, DOI 10.1007/s11095-010-0249-9; Lasa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074079; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li XR, 2004, ONCOGENE, V23, P1474, DOI 10.1038/sj.onc.1207249; Li Y, 2013, BRIT J CANCER, V108, P99, DOI 10.1038/bjc.2012.494; Liebetrau AM, 1983, MEASURES OF ASSOCIAT, V32; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Liu L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-71; Liu N, 2012, MED ONCOL, V29, P2606, DOI 10.1007/s12032-012-0218-8; Liu Q, 2009, CHINESE MED J-PEKING, V122, P2763, DOI 10.3760/cma.j.issn.0366-6999.2009.22.017; Liu XF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-374; Liu ZZ, 2010, CLIN EXP METASTAS, V27, P251, DOI 10.1007/s10585-010-9323-2; Lochhead P, 2012, EUR J CANCER, V48, P3405, DOI 10.1016/j.ejca.2012.06.021; Lopez FJ, 2012, MED BIOL ENG COMPUT, V50, P981, DOI 10.1007/s11517-012-0914-8; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; Mackay A, 2011, JNCI-J NATL CANCER I, V103, P662, DOI 10.1093/jnci/djr071; Magnani L, 2014, MOL CELL ENDOCRINOL, V382, P633, DOI 10.1016/j.mce.2013.04.026; Mahasenan KV, 2012, J CHEM INF MODEL, V52, P1345, DOI 10.1021/ci300040c; Marsden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066813; Martens JWM, 2005, CANCER RES, V65, P4101, DOI 10.1158/0008-5472.CAN-05-0064; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Martin-Manso G, 2011, ARCH BIOCHEM BIOPHYS, V509, P147, DOI 10.1016/j.abb.2011.03.004; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; Meyer KB, 2012, NAT GENET, V44, P1176, DOI 10.1038/ng.2449; Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y; Miksicek RJ, 2002, CANCER RES, V62, P2736; Miller WR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2611; Min KW, 2013, ANN SURG ONCOL, V20, pS433, DOI 10.1245/s10434-012-2734-3; Moy I, 2014, ONCOGENE; Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x; Murphy KJ, 2010, J NEUROCHEM, V113, P601, DOI 10.1111/j.1471-4159.2010.06617.x; Nadal R, 2013, INT J CANCER, V133, P2398, DOI 10.1002/ijc.28263; Naderi A, 2012, NEOPLASIA, V14, P283, DOI 10.1593/neo.12294; Nguyen MH, 2010, CANCER RES, V70, P5337, DOI 10.1158/0008-5472.CAN-09-4372; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Peters AA, 2012, MOL CANCER THER, V11, P2158, DOI 10.1158/1535-7163.MCT-11-0965; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Portier BP, 2012, NEW BIOTECHNOL, V29, P665, DOI 10.1016/j.nbt.2012.03.011; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Qian Y, 2011, CLIN EXP MED, V11, P163, DOI 10.1007/s10238-010-0125-2; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Rawat A, 2013, CELL ONCOL, V36, P459, DOI 10.1007/s13402-013-0150-8; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Roll JD, 2013, EXP MOL PATHOL, V95, P276, DOI 10.1016/j.yexmp.2013.09.001; Romanelli A, 2012, MOL CANCER THER, V11, P2693, DOI 10.1158/1535-7163.MCT-12-0441-T; Ruan Q, 2011, MOL CANCER RES, V9, P1632, DOI 10.1158/1541-7786.MCR-11-0327; Salceda S, 2005, EXP CELL RES, V306, P128, DOI 10.1016/j.yexcr.2005.01.018; Samanta S, 2012, ONCOGENE, V31, P4689, DOI 10.1038/onc.2011.620; Samanta S, 2013, J BIOL CHEM, V288, P12569, DOI 10.1074/jbc.C112.442319; Sandhu R, 2014, INT J ONCOL, V44, P563, DOI 10.3892/ijo.2013.2197; Sano H, 2012, BREAST CANCER-TOKYO, V19, P37, DOI 10.1007/s12282-011-0263-8; Sasaki Y, 2012, CANCER BIOL THER, V13, P1512, DOI 10.4161/cbt.22280; Seil I, 2007, INT J CANCER, V120, P2635, DOI 10.1002/ijc.22620; Shulewitz M, 2006, ONCOGENE, V25, P4361, DOI 10.1038/sj.onc.1209470; Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]; Sim E, 2008, TOXICOLOGY, V254, P170, DOI 10.1016/j.tox.2008.08.022; Sizemore ST, 2012, J BIOL CHEM, V287, P24631, DOI 10.1074/jbc.M112.375865; Skliris GP, 2008, HISTOPATHOLOGY, V52, P355, DOI 10.1111/j.1365-2559.2007.02955.x; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Spicakova T, 2010, MOL CANCER THER, V9, P2970, DOI 10.1158/1535-7163.MCT-10-0780; Stossi F, 2012, ONCOGENE, V31, P1825, DOI 10.1038/onc.2011.370; Suh WK, 2006, MOL CELL BIOL, V26, P6403, DOI 10.1128/MCB.00755-06; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Tan J, 2013, ONCOGENE; Tanaka S, 2009, CANCER CHEMOTH PHARM, V64, P341, DOI 10.1007/s00280-008-0877-5; Taylor KJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2593; Therneau T.M., 2000, MODELING SURVIVAL DA; Theurillat JP, 2008, INT J CANCER, V122, P1585, DOI 10.1002/ijc.23241; Theurillat JP, 2007, CANCER IMMUNOL IMMUN, V56, P1723, DOI 10.1007/s00262-007-0316-1; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tkocz D, 2012, ONCOGENE, V31, P3667, DOI 10.1038/onc.2011.531; Torikoshi Y, 2013, J CANCER, V4, P697, DOI 10.7150/jca.6248; Tringler B, 2005, CLIN CANCER RES, V11, P1842, DOI 10.1158/1078-0432.CCR-04-1658; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Ur-Rehman S, 2013, BREAST CANCER RES TR, V139, P907, DOI 10.1007/s10549-013-2593-z; Valet F, 2013, BREAST, V22, P1052, DOI 10.1016/j.breast.2013.08.015; Valladares-Ayerbes M, 2009, J CANCER RES CLIN, V135, P1185, DOI 10.1007/s00432-009-0559-7; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Zalen S, 2006, J DERMATOL SCI, V43, P11, DOI 10.1016/j.jdermsci.2006.02.008; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varga Z, 2006, CLIN CANCER RES, V12, P2745, DOI 10.1158/1078-0432.CCR-05-2192; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Vinh N.X., 2009, P 26 ANN INT C MACH, P1073, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Waluk DP, 2012, J BIOL CHEM, V287, P16158, DOI 10.1074/jbc.M112.347260; Waluk DP, 2010, FASEB J, V24, P2795, DOI 10.1096/fj.09-148551; Wang J, 2013, EUR REV MED PHARMACO, V17, P596; Wang J, 2012, ONCOGENE, V31, P4798, DOI 10.1038/onc.2011.635; Wang K, 2013, TUMOR BIOL, V34, P33, DOI 10.1007/s13277-012-0507-z; Warsow G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081784; Weigelt B, 2004, BRIT J CANCER, V90, P1531, DOI 10.1038/sj.bjc.6601659; Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166; Witten I. H., 2005, DATA MINING PRACTICA; Won JR, 2013, MODERN PATHOL, V26, P1438, DOI 10.1038/modpathol.2013.97; Woodard AH, 2011, AM J CLIN PATHOL, V136, P428, DOI 10.1309/AJCPUFNMEZ3MK1BK; Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227; Xia Q, 2014, INT J ONCOL, V44, P735, DOI 10.3892/ijo.2013.2240; Xing P, 2011, J INVEST MED, V59, P803, DOI 10.2310/JIM.0b013e31821451a1; Yamamura J, 2004, CANCER SCI, V95, P887, DOI 10.1111/j.1349-7006.2004.tb02198.x; Yang ZQ, 2009, INT J CANCER, V125, P1613, DOI 10.1002/ijc.24518; Yeon S, 2012, MODERN PATHOL, V25, P185, DOI 10.1038/modpathol.2011.160; Yu YN, 2010, INT J ONCOL, V37, P483, DOI 10.3892/ijo_00000697; Zeng XH, 2011, BREAST CANCER RES TR, V125, P715, DOI 10.1007/s10549-010-0875-2; Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690; Zhang W, 2010, CANCER-AM CANCER SOC, V116, P2688, DOI 10.1002/cncr.25084; Zvelebil M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3403	230	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129711	10.1371/journal.pone.0129711	http://dx.doi.org/10.1371/journal.pone.0129711			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132585	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000034
J	Mine, M; Yamaguchi, K; Sugiura, T; Chigita, S; Yoshihama, N; Yoshihama, R; Hiyake, N; Kobayashi, Y; Mori, Y				Mine, Mariko; Yamaguchi, Kojiro; Sugiura, Tsuyoshi; Chigita, Satomi; Yoshihama, Naoya; Yoshihama, Rumi; Hiyake, Naomi; Kobayashi, Yosuke; Mori, Yoshihide			miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells	PLOS ONE			English	Article							METASTASIS SUPPRESSOR; CANCER; WNT; MICRORNA-203; RECEPTORS; INVASION; TARGETS; PROGRESSION; APOPTOSIS; PROTEIN	CD82/ KAI1, a member of the tetraspanin superfamily, is a suppressor of metastasis and CD82 inhibits canonical Wnt signaling via downregulation of several Frizzled (FZD) isoforms, resulting in accumulation of beta-catenin at the cell membrane. In this study, we investigated the mechanism through which CD82 inhibited FZD expression by examining the effects of microRNAs (miRNAs). The miRanda algorithm predicted 11 miRNAs from FZD sequences. Among these miRNAs, CD82 caused upregulation of miR-203 (by 2.095-fold) and downregulation of miR-338-3p (by 0.354-fold) as compared with control cells. Transfection with miR-203 and miR338-3p mimics or inhibitors revealed that miR-203 downregulated FZD2 mRNA (by 0.268-fold) and protein expression (by 0.701-fold). Moreover, transfection with the miR-203 mimic also inhibited cell migration. Therefore, these findings suggested that CD82 enhanced the expression of miR-203 and directly downregulate FZD2 expression, suppressing cancer metastasis by inhibition of the Wnt signaling pathway.	[Mine, Mariko; Chigita, Satomi; Yoshihama, Naoya; Yoshihama, Rumi; Hiyake, Naomi; Kobayashi, Yosuke; Mori, Yoshihide] Kyushu Univ Maidashi, Grad Sch Dent Sci, Dept Oral & Maxillofacial Surg, Div Maxillofacial Diagnost & Surg Sci,Higashi Ku, Fukuoka, Japan; [Yamaguchi, Kojiro; Sugiura, Tsuyoshi] Kagoshima Univ Sakuragaoka, Grad Sch Dent Sci, Dept Maxillofacial Diagnost & Surg Sci, Field Oral & Maxillofacial Rehabil, Kagoshima, Japan		Sugiura, T (corresponding author), Kagoshima Univ Sakuragaoka, Grad Sch Dent Sci, Dept Maxillofacial Diagnost & Surg Sci, Field Oral & Maxillofacial Rehabil, Kagoshima, Japan.	sugiura@dent.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKEN) [23390465, 15H05045, 25893174, 25861958]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKEN)	This study was supported by Grants-in Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKEN, grant no. 23390465 and 15H05045 to TS; grant no. 25893174 to SC; and grant no. 25861958 to YK) (http://kaken.nii.ac.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, CANCER LETT, V266, P163, DOI 10.1016/j.canlet.2008.02.058; Bazhin AV, 2010, CELL MOL LIFE SCI, V67, P817, DOI 10.1007/s00018-009-0214-0; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bu PY, 2014, EXP THER MED, V8, P309, DOI 10.3892/etm.2014.1708; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen ZG, 2014, MOL MED REP, V9, P503, DOI 10.3892/mmr.2013.1814; Chigita S, 2012, INT J ONCOL, V41, P2021, DOI 10.3892/ijo.2012.1671; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Dontula Ranadheer, 2013, Genes Cancer, V4, P285, DOI 10.1177/1947601913500141; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ke XF, 2014, BIOCHEM BIOPH RES CO, V450, P1297, DOI 10.1016/j.bbrc.2014.06.125; LEBELBINAY S, 1994, CELL IMMUNOL, V154, P468, DOI 10.1006/cimm.1994.1092; Lee EHL, 2008, CLIN MED INSIGHTS-ON, V2, P169; Milovanovic T, 2004, INT J ONCOL, V25, P1337; Noguchi S, 2016, VET COMP ONCOL, V14, P384, DOI 10.1111/vco.12118; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Okumura T, 2014, INT J ONCOL, V44, P1923, DOI 10.3892/ijo.2014.2365; Rhee CS, 2002, ONCOGENE, V21, P6598, DOI 10.1038/sj.onc.1205920; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takeshita N, 2012, INT J ONCOL, V41, P1653, DOI 10.3892/ijo.2012.1614; Taube JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02687; Ueno K, 2009, BRIT J CANCER, V101, P1374, DOI 10.1038/sj.bjc.6605307; Ueno K, 2013, INT J CANCER, V132, P1731, DOI 10.1002/ijc.27746; Wang SS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0681-x	30	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131350	10.1371/journal.pone.0131350	http://dx.doi.org/10.1371/journal.pone.0131350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132195	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000113
J	Shi, JP; Li, XN; Zhang, XY; Du, B; Jiang, WZ; Liu, MY; Wang, JJ; Wang, ZG; Ren, H; Qian, M				Shi, Jue-ping; Li, Xiao-ning; Zhang, Xiao-yu; Du, Bing; Jiang, Wen-zheng; Liu, Ming-yao; Wang, Jin-jin; Wang, Zhu-gang; Ren, Hua; Qian, Min			Gpr97 Is Dispensable for Inflammation in OVA-Induced Asthmatic Mice	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLERGIC-ASTHMA; IGE PRODUCTION; MURINE MODEL; AIRWAY INFLAMMATION; CHILDHOOD ASTHMA; MEDIATOR RELEASE; LUNG-FUNCTION; B-CELLS; EXPRESSION	Background Asthma is a complex inflammatory disorder involving the activation and invasion of various immune cells. GPR97 is highly expressed in some immunocytes, including mast cells and eosinophils, which play critical roles in asthma development. However, the role of Gpr97 in regulating airway inflammation in asthma has rarely been reported. In this study, we investigated the potential role of Gpr97 in the development of allergic asthma in mice. Methods Relevant airway asthmatic mouse models were constructed with both wild- type and Gpr97(-/-) mice sensitized to 250 mu g ovalbumin (OVA). The levels of interleukin IL-4, IL-6 and IFN-gamma, which are involved in OVA-induced asthma, in the bronchoalveolar lavage fluid (BALF) and the IgE level in the serum were examined by enzyme-linked immunosorbent assay (ELISA). The invasion of mast cells and eosinophils into lung tissues was assessed by immunohistochemical and eosinophil peroxidase activity assays, respectively. Goblet cell hyperplasia and mucus production were morphologically evaluated with periodic acidSchiff (PAS) staining. Results In our study, no obvious alteration in the inflammatory response or airway remodeling was found in the Gpr97-deficient mice with OVA-induced asthma. Neither the secretion of cytokines, including IL-4, IL-6 and IFN-gamma, nor inflammatory cell recruitment was altered in the Gpr97-deficient mice. Moreover, Gpr97 deficiency did not affect airway remodeling or mucus production in the asthma mouse model. Conclusion Our findings imply that Gpr97 might not be required for the development of airway inflammation in OVA-induced allergic asthma in mice.	[Shi, Jue-ping; Li, Xiao-ning; Zhang, Xiao-yu; Du, Bing; Jiang, Wen-zheng; Liu, Ming-yao; Ren, Hua; Qian, Min] E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Shi, Jue-ping; Li, Xiao-ning; Zhang, Xiao-yu; Du, Bing; Jiang, Wen-zheng; Liu, Ming-yao; Ren, Hua; Qian, Min] E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Wang, Jin-jin; Wang, Zhu-gang] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China	East China Normal University; East China Normal University	Ren, H (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	huaren@bio.ecnu.edu.cn; mqian@bio.ecnu.edu.cn	Zhang, Xiaoyu/K-6918-2019	Zhang, Xiaoyu/0000-0001-9772-5099; Du, Bing/0000-0002-5402-6527	National Basic Research Program of China [2012CB910401]; National Natural Science Foundation of China [31470040, 81272369, 81172816]; Doctoral Fund of Ministry of Education of China [20130076110013]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Among all the supported fund for this work, National Basic Research Program of China http://www.973.gov.cn/English/Index.aspx [2012CB910401] and the National Natural Science Foundation of China http://www.nsfc.gov.cn/ [grants 31470040, 81272369 and 81172816] were contributed for the experiment, study design, and data collection. The Doctoral Fund of Ministry of Education of China [20130076110013] and Fundamental Research Funds for the Central Universities played roles of preparing materials and fee for graduate students.	Allen IC, 2009, DIS MODEL MECH, V2, P519, DOI 10.1242/dmm.004333; Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Bradding Peter, 2008, Allergy Asthma Clin Immunol, V4, P84, DOI 10.1186/1710-1492-4-2-84; Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Cohn L, 1998, J IMMUNOL, V161, P3813; Doganci A, 2005, CLIN REV ALLERG IMMU, V28, P257, DOI 10.1385/CRIAI:28:3:257; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Ferkol Thomas, 2014, Ann Am Thorac Soc, V11, P404, DOI 10.1513/AnnalsATS.201311-405PS; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Halwani R, 2010, CURR OPIN PHARMACOL, V10, P236, DOI 10.1016/j.coph.2010.06.004; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hong GU, 2014, CELL SIGNAL, V26, P1105, DOI 10.1016/j.cellsig.2014.01.029; Hong GU, 2013, CELL SIGNAL, V25, P1514, DOI 10.1016/j.cellsig.2013.03.010; Kanchongkittiphon W, 2014, ASIAN PAC J ALLERGY, V32, P103; KELLY WJW, 1988, AM REV RESPIR DIS, V138, P26, DOI 10.1164/ajrccm/138.1.26; Park HJ, 2009, INT IMMUNOPHARMACOL, V9, P261, DOI 10.1016/j.intimp.2008.10.021; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Peng YM, 2011, J LEUKOCYTE BIOL, V90, P735, DOI 10.1189/jlb.0211092; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prescott SL, 2003, J PAEDIATR CHILD H, V39, P575, DOI 10.1046/j.1440-1754.2003.00237.x; Ro J, 2012, J IMMUNOLOGY, V188; Shifren Adrian, 2012, J Allergy (Cairo), V2012, P316049, DOI 10.1155/2012/316049; Siddiqui S, 2008, CURR ALLERGY ASTHM R, V8, P540, DOI 10.1007/s11882-008-0098-3; Storms WW, 2013, ANN ALLERG ASTHMA IM, V111, P408, DOI 10.1016/j.anai.2013.07.033; Sumoza-Toledo A, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-19; Tiwari M, 2014, J ETHNOPHARMACOL, V153, P326, DOI 10.1016/j.jep.2014.01.031; Valtcheva N, 2013, J BIOL CHEM, V288, P35736, DOI 10.1074/jbc.M113.512954; van der Vlugt LEPM, 2014, METHODS MOL BIOL, V1190, P127, DOI 10.1007/978-1-4939-1161-5_10; Wang JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.346; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Xia W, 2013, ALLERGY, V68, P509	35	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131461	10.1371/journal.pone.0131461	http://dx.doi.org/10.1371/journal.pone.0131461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132811	gold, Green Submitted, Green Published			2022-12-26	WOS:000358153000120
J	Gonzalez, CD; Ledo, C; Giai, C; Garofalo, A; Gomez, MI				Daniela Gonzalez, Cintia; Ledo, Camila; Giai, Constanza; Garofalo, Ailin; Gomez, Marisa I.			The Sbi Protein Contributes to Staphylococcus aureus Inflammatory Response during Systemic Infection	PLOS ONE			English	Article							IMMUNE EVASION; BINDING PROTEIN; INTERLEUKIN-6; RECEPTOR; COMPLEMENT; SEPSIS; IGG; EXPRESSION; BLOCKADE; IL-6	Staphylococcus aureus is an important human pathogen that causes infections that may present high morbidity and mortality. Among its many virulence factors protein A (SpA) and Staphylococcal binding immunoglobulin protein (Sbi) bind the Fc portion of IgG interfering with opsonophagocytosis. We have previously demonstrated that SpA interacts with the TNF-alpha receptor (TNFR) 1 through each of the five IgG binding domains and induces the production of pro-inflammatory cytokines and chemokines. The IgG binding domains of Sbi are homologous to those of SpA, which allow us to hypothesize that Sbi might also have a role in the inflammatory response induced by S. aureus. We demonstrate that Sbi is a novel factor that participates in the induction of the inflammatory response during staphylococcal infections via TNFR1 and EGFR mediated signaling as well as downstream MAPKs. The expression of Sbi significantly contributed to IL-6 production and modulated CXCL-1 expression as well as neutrophil recruitment to the site of infection, thus demonstrating for the first time its relevance as a pro-inflammatory staphylococcal antigen in an in vivo model.	[Daniela Gonzalez, Cintia; Giai, Constanza; Garofalo, Ailin; Gomez, Marisa I.] Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med IMPaM, CONICET, Buenos Aires, DF, Argentina; [Ledo, Camila; Gomez, Marisa I.] Univ Buenos Aires, Fac Med, Dept Microbiol Parasitol & Immunol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Gomez, MI (corresponding author), Univ Buenos Aires, Inst Invest Microbiol & Parasitol Med IMPaM, CONICET, Buenos Aires, DF, Argentina.	marisaigomez@gmail.com			Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 11-2263, PICT 13-1233]; Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires, Argentina [UBACyT 20020110100138]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires, Argentina(University of Buenos AiresSecretaria de Ciencia y Tecnologia (SECYT))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (PICT 11-2263 and PICT 13-1233) and the Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires, Argentina (UBACyT 20020110100138) to M.I.G.	Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Barille S, 2000, EUR CYTOKINE NETW, V11, P546; Becker S, 2014, P NATL ACAD SCI USA, V111, P1574, DOI 10.1073/pnas.1317181111; Benson MA, 2011, MOL MICROBIOL, V81, P659, DOI 10.1111/j.1365-2958.2011.07720.x; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; Dalrymple SA, 1996, INFECT IMMUN, V64, P3231, DOI 10.1128/IAI.64.8.3231-3235.1996; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; GENNARI R, 1995, CRIT CARE MED, V23, P1945, DOI 10.1097/00003246-199512000-00002; Giai C, 2013, INFECT IMMUN, V81, P4200, DOI 10.1128/IAI.00593-13; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; Gomez MI, 2005, J IMMUNOL, V175, P1930, DOI 10.4049/jimmunol.175.3.1930; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hume EBH, 2006, INVEST OPHTH VIS SCI, V47, P4926, DOI 10.1167/iovs.06-0340; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lowy FD, 2007, NAT MED, V13, P1418, DOI 10.1038/nm1207-1418; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; National Institutes of Health, 1996, GUID CAR US LAB AN; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Peake NJ, 2006, RHEUMATOLOGY, V45, P1485, DOI 10.1093/rheumatology/kel154; Postma B, 2005, J BIOL CHEM, V280, P2020, DOI 10.1074/jbc.M412230200; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Smith EJ, 2012, MOL MICROBIOL, V83, P789, DOI 10.1111/j.1365-2958.2011.07966.x; Smith EJ, 2011, INFECT IMMUN, V79, P3801, DOI 10.1128/IAI.05075-11; Turnbull IR, 2004, SHOCK, V21, P121, DOI 10.1097/01.shk.0000108399.56565.e7; Watkins RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019939; Yimin, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074287; Zhang LH, 1999, MICROBIOL-UK, V145, P177, DOI 10.1099/13500872-145-1-177; Zhang LH, 1998, MICROBIOL-UK, V144, P985, DOI 10.1099/00221287-144-4-985; Zhang LH, 2000, FEMS IMMUNOL MED MIC, V28, P211, DOI 10.1111/j.1574-695X.2000.tb01479.x	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131879	10.1371/journal.pone.0131879	http://dx.doi.org/10.1371/journal.pone.0131879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126119	Green Published, gold			2022-12-26	WOS:000358151300059
J	Stock, NK; Maly, M; Sebestova, H; Orlikova, H; Kozakova, J; Krizova, P				Stock, Nina Katharina; Maly, Marek; Sebestova, Helena; Orlikova, Hana; Kozakova, Jana; Krizova, Pavla			The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation	PLOS ONE			English	Article							CAPTURE-RECAPTURE ANALYSIS; MENINGOCOCCAL DISEASE; MODELS	Background Invasive pneumococcal disease (IPD) is caused by Streptococcus pneumoniae and mostly presents as pneumonia, sepsis or meningitis. A notable portion of IPD cases is vaccine preventable and the pneumococcal conjugate vaccine (PCV) was introduced into the routine childhood immunization programs in many countries during the last decades. Objectives Before PCV introduction in the Czech Republic in 2010, a national surveillance system for IPD was implemented in 2008 and further improved in 2011. In this study, we describe the new surveillance system for the first time and measure its sensitivity between 2010 and 2013 using the capture-recapture method. Furthermore, we describe the recent epidemiological trend of IPD, taking sensitivity estimates into account. Results and Conclusions Between 2010 and 2013 the estimated sensitivity of the overall IPD surveillance increased from 81% to 99%. The sensitivity of individual reporting sources increased from 72% to 87% for the laboratory system and from 31% to 89% for the epidemiological notification system. Crucial for this improvement was the introduction of quarterly report reminders in 2011. Due to positive source dependency, the presented sensitivity estimates are most probably overestimated and reflect the upper limit of reporting completeness. Stratification showed variation in sensitivity of reporting particularly according to region. An effect of the PVC vaccination in the Czech Republic is visible in the incidence of IPD in target age groups (<5y). This influence was not evident in the total IPD incidence and may interfere with increasing sensitivity of reporting. In 2013, an increase in the IPD incidence was observed. This finding requires further observation and a detailed vaccine impact analysis is needed to assess the current immunization strategy.	[Stock, Nina Katharina; Maly, Marek; Sebestova, Helena; Orlikova, Hana; Kozakova, Jana; Krizova, Pavla] Natl Inst Publ Hlth, Prague, Czech Republic; [Stock, Nina Katharina] ECDC, European Program Publ Hlth Microbiol EUPHEM, Stockholm, Sweden	National Institute of Public Health (SZU) - Czech Republic; European Centre for Disease Prevention & Control	Stock, NK (corresponding author), Natl Inst Publ Hlth, Prague, Czech Republic.	nkstock2015@gmail.com	Krizova, Pavla/M-6120-2015; Kozáková, Jana/A-3507-2016; Maly, Marek/G-8964-2014; Orlikova, Hana/N-2278-2015		SpIDnet project - ECDC [ECDC/2012/038]	SpIDnet project - ECDC	We thank the supervisors and coordinators from the ECDC EPIET and EUPHEM programs, our partners from the European SpIDnet project and its coordinator EpiConcept, as well as our colleagues from the National reference laboratory for streptococcal infections in Prague for assistance and collaboration in this project. Furthermore, we thank all colleagues and authorities involved in the Czech IPD reporting who helped to improve continuously the performance of the IPD surveillance within the last years. We thank Aftab Jasir, Androulla Efstratiou, Vladimir Prikazsky, Camelia Savulescu, Marta Valenciano and Germaine Hanquet for the critical review of this manuscript. This work was partially supported by the SpIDnet project (Assessing the impact of vaccination with the conjugate vaccines on the epidemiology of invasive pneumococcal disease in Europe) funded by ECDC (ECDC/2012/038).	[Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; DECLICH S, 1994, B WORLD HEALTH ORGAN, V72, P285; Donkor ES, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00007; ECDC, 2013, SURV INV BACT DIS EU; ECDC, 2012, SURV INV PNEUM DIS E; Farrington CP, 2002, STAT MED, V21, P3079, DOI 10.1002/sim.1223; Gjini A, 2004, EMERG INFECT DIS, V10, P87; Hanquet G, 2011, VACCINE, V29, P2856, DOI 10.1016/j.vaccine.2011.02.016; Hanquet G, 2010, VACCINE, V28, P3920, DOI 10.1016/j.vaccine.2010.03.069; HOOK EB, 1992, AM J EPIDEMIOL, V135, P1060, DOI 10.1093/oxfordjournals.aje.a116400; Howitz MF, 2008, EPIDEMIOL INFECT, V136, P1088, DOI 10.1017/S0950268807009466; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Motlova J, 2009, EPIDEMIOL INFECT, V137, P562, DOI 10.1017/S0950268808001301; Pebody R G, 2006, Euro Surveill, V11, P171, DOI 10.2807/esm.11.09.00646-en; R Core Team, 2021, R LANGUAGE ENV STAT; Randle E, 2011, ARCH DIS CHILDHOOD-E, V96, P183, DOI 10.1136/adc.2010.191718; Savulescu C, 2014, IMPACT OF HIGHER VAL; Schrauder A, 2007, EPIDEMIOL INFECT, V135, P657, DOI 10.1017/S0950268806007151; Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4; Tilling K, 2001, INT J EPIDEMIOL, V30, P12, DOI 10.1093/ije/30.1.12	23	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131117	10.1371/journal.pone.0131117	http://dx.doi.org/10.1371/journal.pone.0131117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125583	Green Submitted, Green Published, gold			2022-12-26	WOS:000358151300035
J	Audet, CM; Gutin, SA; Blevins, M; Chiau, E; Alvim, F; Jose, E; Vaz, LME; Shepherd, BE; Rose, CD				Audet, Carolyn M.; Gutin, Sarah A.; Blevins, Meridith; Chiau, Elvino; Alvim, Fernanda; Jose, Eurico; Vaz, Lara M. E.; Shepherd, Bryan E.; Rose, Carol Dawson			The Impact of Visual Aids and Enhanced Training on the Delivery of Positive Health, Dignity, and Prevention Messages to Adult Patients Living with HIV in Rural North Central Mozambique	PLOS ONE			English	Article							RISK-REDUCTION INTERVENTION; UNPROTECTED SEXUAL-BEHAVIOR; ANTIRETROVIRAL THERAPY; CLINICAL CARE; DEVELOPING-COUNTRIES; INFECTED PATIENTS; YOUNG-PEOPLE; SOUTH-AFRICA; CONDOM USE; PROVIDERS	Introduction Positive health, dignity, and prevention (PHDP) interventions target people living with HIV and AIDS (PLHIV) to promote well-being and prevent onward transmission. Concern that increased life expectancy and improved well-being would lead to increased risky sexual behaviour and subsequent HIV transmission motivated researchers to test novel strategies to support treatment adherence, encourage safer sex, STI treatment and partner testing, prevention of mother to child transmission, and support uptake of family planning. Methods We assessed the number and type of PHDP messages delivered to PLHIV before and after the implementation of an educational intervention for health providers combined with the distribution of visual job aids and monthly technical assistance. Results From April 21, 2013 to March 20, 2014, we documented 54,731 clinical encounters at three rural health centres in Zambezia province, Mozambique from 9,248 unique patients. The percentage of patients who received all seven PHDP messages during their last three visits was 1.9% pre-intervention vs. 13.6% post-intervention (p=<0.001). Younger patients (25 years vs. 35) and those with a recent HIV diagnosis (two weeks vs. two years) had higher odds of receiving any PHDP message (Odds Ratio [OR]: 1.22 and 2.79, respectively). Patients >59 days late collecting medications were not more likely to receive adherence messages than adherent patients (p=0.17). Discussion Targeting HIV prevention efforts to PLHIV is an effective HIV prevention approach to eliminate HIV transmission. Despite intensive training and support, PHDP message delivery remained unacceptably low in rural Mozambique. Patients at high risk for treatment abandonment were not more likely to be counselled about adherence and support measures, something that needs to be addressed. Conclusions We need to develop novel strategies to motivate health care providers to deliver these messages more consistently to all patients and develop a system that assists counsellors and clinicians to quickly and effectively determine which messages should be delivered.	[Audet, Carolyn M.; Blevins, Meridith; Vaz, Lara M. E.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Audet, Carolyn M.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Gutin, Sarah A.] Univ Calif San Francisco, Sch Nursing, Community Hlth Syst, San Francisco, CA 94143 USA; [Chiau, Elvino; Alvim, Fernanda; Jose, Eurico; Rose, Carol Dawson] Friends Global Hlth, Maputo, Mozambique; [Chiau, Elvino; Alvim, Fernanda; Jose, Eurico; Rose, Carol Dawson] Friends Global Hlth, Quelimane, Mozambique; [Audet, Carolyn M.; Blevins, Meridith; Vaz, Lara M. E.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; Vanderbilt University	Audet, CM (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	carolyn.m.audet@vanderbilt.edu		Gutin, Sarah/0000-0002-7634-1296	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services; Centers for Disease Control and Prevention (CDC) [1U2GPS002770-01, 5U2GPS002770-02, 5U2GPS002770-03, 5U2GPS002770-04]; Vanderbilt career development award [UL1TR000445]; NIMH [1K01MH107255-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH107255] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Vanderbilt career development award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement Numbers 1U2GPS002770-01, 5U2GPS002770-02, 5U2GPS002770-03 and 5U2GPS002770-04. The findings and conclusions presented in this manuscript are those of the authors and do not necessarily represent the official position of the CDC. CMA was supported, in part, by a Vanderbilt career development award, UL1TR000445 (PI Bernard) and NIMH No. 1K01MH107255-01.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1993, AM J PUBLIC HEALTH, V83, P705, DOI 10.2105/AJPH.83.5.705; [Anonymous], 2012, DAT SIZ HIV AIDS EP; Auerbach JD, 2004, JAIDS-J ACQ IMM DEF, V37, pS122, DOI 10.1097/01.qai.0000140611.82134.aa; Bachanas P, 2012, HIV PREVENTION PEOPL; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Cocohoba J, 2013, J MANAGE CARE PHARM, V19, P454, DOI 10.18553/jmcp.2013.19.6.454; Conselho Nacional de Combate ao HIV e SIDA, 2010, NAT STRAT HIV AIDS R; Cornman DH, 2008, JAIDS-J ACQ IMM DEF, V48, P553, DOI 10.1097/QAI.0b013e31817bebd7; Cornman DH, 2011, PSYCHOL HEALTH, V26, P1623, DOI 10.1080/08870446.2011.552180; da Silveira MF, 2006, J EVAL CLIN PRACT, V12, P102, DOI 10.1111/j.1365-2753.2005.00626.x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fisher JD, 2004, JAIDS-J ACQ IMM DEF, V37, pS78, DOI 10.1097/01.qai.0000140605.51640.5c; Fisher JD, 2014, JAIDS-J ACQ IMM DEF, V67, P499, DOI 10.1097/QAI.0000000000000348; Fisher JD, 2009, CURR OPIN HIV AIDS, V4, P279, DOI 10.1097/COH.0b013e32832c7ce5; Flickinger TE, 2013, AIDS PATIENT CARE ST, V27, P416, DOI 10.1089/apc.2012.0426; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Global Network of People Living with HIV UNAIDS, 2011, POS HLTH DIGN PREV P; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grimley DM, 2007, AIDS BEHAV, V11, pS39, DOI 10.1007/s10461-006-9196-1; Gutin SA, 2014, EVAL PROGRAM PLANN, V43, P38, DOI 10.1016/j.evalprogplan.2013.10.006; Hagopian A, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-3; Harrell FEJr, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1; Hilliard S, 2014, INT J WOMENS HEALTH, V6, P1057, DOI 10.2147/IJWH.S67038; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Kalichman SC, 2005, POSITIVE PREVENTION, pxxii; Kembabazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069634; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; KING R, 1995, AIDS, V9, pS45; Mhalu A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17342; Miranda J, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2723; Mmbaga EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041700; Morin SF, 2004, JAIDS-J ACQ IMM DEF, V36, P960, DOI 10.1097/00126334-200408010-00010; Myers JJ, 2010, AIDS BEHAV, V14, P483, DOI 10.1007/s10461-010-9679-y; National Institute of Statistics Mozambique, 2010, AD LIT RAT; Parker L, 2013, AIDS EDUC PREV, V25, P135, DOI 10.1521/aeap.2013.25.2.135; Parker L, 2013, EVAL PROGRAM PLANN, V36, P124, DOI 10.1016/j.evalprogplan.2012.09.002; Penn C, 2011, PATIENT EDUC COUNS, V83, P310, DOI 10.1016/j.pec.2011.02.018; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; PICKERING H, 1993, AIDS, V7, P271, DOI 10.1097/00002030-199302000-00017; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Rose CD, 2011, J ASSOC NURSE AIDS C, V22, P38, DOI 10.1016/j.jana.2010.04.001; Rose CD, 2010, JAIDS-J ACQ IMM DEF, V55, P572, DOI 10.1097/QAI.0b013e3181ee4c62; Roth DL, 2001, INT J STD AIDS, V12, P181, DOI 10.1258/0956462011916992; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; ROTHERAMBORUS MJ, 1997, AIDS BEHAV, V1, P43, DOI DOI 10.1023/A:1026213905034; Saberi P, 2012, PATIENT PREFER ADHER, V6, P297, DOI 10.2147/PPA.S30244; Safren SA, 2011, AIDS BEHAV, V15, P949, DOI 10.1007/s10461-010-9807-8; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sikkema KJ, 2011, J COMMUNITY PSYCHOL, V39, P717, DOI 10.1002/jcop.20463; Sikkema KJ, 2010, AIDS BEHAV, V14, P252, DOI 10.1007/s10461-009-9650-y; University of California San Francisco, 2012, POS PREV TOOLK SAN F; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Vergara AE, 2011, BASELINE SURVEY REPO; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Wamoyi J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-633; World Health Organization, 2013, WHO CONS GUID USE AR; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	65	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130676	10.1371/journal.pone.0130676	http://dx.doi.org/10.1371/journal.pone.0130676			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147115	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600043
J	Dubovskaya, OP; Tang, KW; Gladyshev, MI; Kirillin, G; Buseva, Z; Kasprzak, P; Tolomeev, AP; Grossart, HP				Dubovskaya, Olga P.; Tang, Kam W.; Gladyshev, Michail I.; Kirillin, Georgiy; Buseva, Zhanna; Kasprzak, Peter; Tolomeev, Aleksandr P.; Grossart, Hans-Peter			Estimating In Situ Zooplankton Non-Predation Mortality in an Oligo-Mesotrophic Lake from Sediment Trap Data: Caveats and Reality Check	PLOS ONE			English	Article							FRESH-WATER; NONCONSUMPTIVE MORTALITY; NONPREDATORY MORTALITY; CRUSTACEAN ZOOPLANKTON; SEASONAL DYNAMICS; COPEPOD CARCASSES; SINKING SPEED; ANILINE BLUE; DEAD; DAPHNIA	Background Mortality is a main driver in zooplankton population biology but it is poorly constrained in models that describe zooplankton population dynamics, food web interactions and nutrient dynamics. Mortality due to non-predation factors is often ignored even though anecdotal evidence of non-predation mass mortality of zooplankton has been reported repeatedly. One way to estimate non-predation mortality rate is to measure the removal rate of carcasses, for which sinking is the primary removal mechanism especially in quiescent shallow water bodies. Objectives and Results We used sediment traps to quantify in situ carcass sinking velocity and non-predation mortality rate on eight consecutive days in 2013 for the cladoceran Bosmina longirostris in the oligo-mesotrophic Lake Stechlin; the outcomes were compared against estimates derived from in vitro carcass sinking velocity measurements and an empirical model correcting in vitro sinking velocity for turbulence resuspension and microbial decomposition of carcasses. Our results show that the latter two approaches produced unrealistically high mortality rates of 0.58-1.04 d(-1), whereas the sediment trap approach, when used properly, yielded a mortality rate estimate of 0.015 d(-1), which is more consistent with concurrent population abundance data and comparable to physiological death rate from the literature. Ecological implications Zooplankton carcasses may be exposed to water column microbes for days before entering the benthos; therefore, non-predation mortality affects not only zooplankton population dynamics but also microbial and benthic food webs. This would be particularly important for carbon and nitrogen cycles in systems where recurring mid-summer decline of zooplankton population due to non-predation mortality is observed.	[Dubovskaya, Olga P.; Gladyshev, Michail I.; Tolomeev, Aleksandr P.] Russian Acad Sci, Siberian Branch, Inst Biophys, Krasnoyarsk 660036, Russia; [Dubovskaya, Olga P.; Gladyshev, Michail I.] Siberian Fed Univ, Krasnoyarsk 660041, Russia; [Tang, Kam W.] Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales; [Tang, Kam W.] Swansea Univ, Ctr Sustainable Aquat Res, Swansea SA2 8PP, W Glam, Wales; [Kirillin, Georgiy] MU, Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecohydrol, D-12587 Berlin, Germany; [Buseva, Zhanna] Natl Acad Sci Belarus Bioresources, Sci & Pract Ctr, Minsk 220072, BELARUS; [Kasprzak, Peter; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, D-16775 Neuglobsow, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, D-14469 Potsdam, Germany	Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Siberian Federal University; Swansea University; Swansea University; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam	Tang, KW (corresponding author), Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales.	k.w.tang@swansea.ac.uk	Dubovskaya, Olga/S-2163-2016; Kirillin, Georgiy/B-5410-2010; Tolomeev, Aleksandr/I-9601-2018	Kirillin, Georgiy/0000-0001-7337-3586; Buseva, Zhanna/0000-0001-8663-6808; Tolomeev, Aleksandr/0000-0002-9124-4566	Russian Foundation for Basic Research; Belarusian Republican Foundation for Fundamental Research [14-05-90005-Bel-a, B14R-066]; Humboldt Fellowship for Experienced Researchers (Germany); Russian Federal Tasks of Fundamental Research [51.1.1]; German Science Foundation [GR 1540/20-1, KI-853/8-1]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Belarusian Republican Foundation for Fundamental Research; Humboldt Fellowship for Experienced Researchers (Germany); Russian Federal Tasks of Fundamental Research; German Science Foundation(German Research Foundation (DFG))	This work was supported by joint projects of Russian Foundation for Basic Research and Belarusian Republican Foundation for Fundamental Research (No 14-05-90005-Bel-a to O.P.D and A.P.T., and No B14R-066 to Zh.B.). K.W.T. was supported by a Humboldt Fellowship for Experienced Researchers (Germany), M.I.G. was supported by Russian Federal Tasks of Fundamental Research (project No. 51.1.1), H.P.G. and G.K. were supported by grants from the German Science Foundation (GR 1540/20-1 and KI-853/8-1).	Aksnes DL, 1997, SARSIA, V82, P279, DOI 10.1080/00364827.1997.10413657; ALLDREDGE AL, 1988, LIMNOL OCEANOGR, V33, P339, DOI 10.4319/lo.1988.33.3.0339; ASPER VL, 1987, DEEP-SEA RES, V34, P1, DOI 10.1016/0198-0149(87)90117-8; Balushkina E.V., 1979, GEN BACKGROUNDS STUD, P169; Baumann HI, 2008, LIMNOLOGICA, V38, P350, DOI 10.1016/j.limno.2008.05.010; Bickel SL, 2009, FRESHWATER BIOL, V54, P971, DOI 10.1111/j.1365-2427.2008.02141.x; BLOESCH J, 1980, SCHWEIZ Z HYDROL, V42, P15, DOI 10.1007/BF02502505; Buesseler KO, 2007, J MAR RES, V65, P345, DOI 10.1357/002224007781567621; CADEE GC, 1992, POLAR BIOL, V12, P75; Casper S. J., 1985, LAKE STECHLIN TEMPER; Cerbin S, 2003, HYDROBIOLOGIA, V491, P111, DOI 10.1023/A:1024491011742; DEARDORFF JW, 1970, J ATMOS SCI, V27, P1211, DOI 10.1175/1520-0469(1970)027<1211:CVATSF>2.0.CO;2; Dubovskaya OP, 2009, ZH OBSHCH BIOL, V70, P168; Dubovskaya Olga P., 2008, Journal of Siberian Federal University Biology, V1, P145; Dubovskaya OP, 2003, HYDROBIOLOGIA, V504, P223, DOI 10.1023/B:HYDR.0000008522.88010.45; Dubovskaya OP, 1999, ZH OBSHCH BIOL, V60, P543; Dubovskaya OP, 2006, THESIS ZOOL I RUSSIA; Elliott DT, 2011, MAR ECOL PROG SER, V427, P1, DOI 10.3354/meps09063; Elliott DT, 2010, LIMNOL OCEANOGR, V55, P1821, DOI 10.4319/lo.2010.55.5.1821; Ferguson RI, 2004, J SEDIMENT RES, V74, P933, DOI 10.1306/051204740933; Frangoulis C, 2011, ESTUAR COAST SHELF S, V92, P456, DOI 10.1016/j.ecss.2011.02.005; GARDNER WD, 1985, DEEP-SEA RES, V32, P349, DOI 10.1016/0198-0149(85)90083-4; GLADYSHEV M I, 1985, Gidrobiologicheskii Zhurnal, V21, P65; Gladyshev MI, 1996, DOKL AKAD NAUK+, V348, P127; Gladyshev MI, 2003, J PLANKTON RES, V25, P999, DOI 10.1093/plankt/25.8.999; Gries T, 1999, LIMNOL OCEANOGR, V44, P459, DOI 10.4319/lo.1999.44.2.0459; GROSSART HP, 1993, LIMNOL OCEANOGR, V38, P532, DOI 10.4319/lo.1993.38.3.0532; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; HAKANSON L, 1984, SCHWEIZ Z HYDROL, V46, P171; HAKANSON L, 1989, HYDROBIOLOGIA, V176, P481, DOI 10.1007/BF00026583; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Hirst AG, 2002, MAR ECOL PROG SER, V230, P195, DOI 10.3354/meps230195; Hulsmann S, 2002, FRESHWATER BIOL, V47, P2313, DOI 10.1046/j.1365-2427.2002.00991.x; HUNTER JR, 1993, J COMPUT PHYS, V106, P366; Ivanova M.B., 1985, NAUKA, V220; Ivory JA, 2014, MAR ECOL PROG SER, V505, P107, DOI 10.3354/meps10775; Kiorboe T, 1998, HYDROBIOLOGIA, V363, P13, DOI 10.1023/A:1003173721751; Kirillin G, 2012, LIMNOL OCEANOGR, V57, P881, DOI 10.4319/lo.2012.57.3.0881; Koschel R, 2003, ADV LIMNOL, V58, P1; KRYLOV PI, 1988, ARCH HYDROBIOL, V113, P231; LAU YL, 1979, J FISH RES BOARD CAN, V36, P1288, DOI 10.1139/f79-184; Lebrato M, 2013, LIMNOL OCEANOGR, V58, P1113, DOI 10.4319/lo.2013.58.3.1113; McDonnell AMP, 2010, LIMNOL OCEANOGR, V55, P2085, DOI 10.4319/lo.2010.55.5.2085; MCQUEEN DJ, 1986, CAN J FISH AQUAT SCI, V43, P1571, DOI 10.1139/f86-195; Parsons T.R., 1988, BIOL OCEANOGRAPHIC P; PINELALLOUL B, 1995, HYDROBIOLOGIA, V300, P17; Prandke H, 1998, AQUAT SCI, V60, P191, DOI 10.1007/s000270050036; Sampei M, 2009, LIMNOL OCEANOGR, V54, P1894, DOI 10.4319/lo.2009.54.6.1894; Schulz M, 2003, ADV LIMNOL, V58, P215; SEEPERSAD B, 1978, J FISH RES BOARD CAN, V35, P1363, DOI 10.1139/f78-213; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; STAKER R D, 1974, Journal of the Arizona Academy of Science, V9, P85, DOI 10.2307/40023604; Stepanov VN, 1981, RES HYDROMECHANICAL; Tang K.W., 2013, COPEPODS DIVERSITY H, P255; Tang KW, 2006, ESTUAR COAST SHELF S, V68, P499, DOI 10.1016/j.ecss.2006.02.021; Tang KW, 2014, J PLANKTON RES, V36, P597, DOI 10.1093/plankt/fbu014; Tang KW, 2009, AQUAT MICROB ECOL, V57, P89, DOI 10.3354/ame01331; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000; Zadereev ES, 2010, AQUAT ECOL, V44, P531, DOI 10.1007/s10452-010-9329-5; Zelezinskaya LM, 1966, THESIS IBSS UAS ODES	60	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131431	10.1371/journal.pone.0131431	http://dx.doi.org/10.1371/journal.pone.0131431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146995	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600096
J	Pomelova, VG; Korenberg, EI; Kuznetsova, TI; Bychenkova, TA; Bekman, NI; Osin, NS				Pomelova, Vera G.; Korenberg, Edward I.; Kuznetsova, Tatiana I.; Bychenkova, Tatiana A.; Bekman, Natalya I.; Osin, Nikolay S.			C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; IMMUNODOMINANT CONSERVED REGION; IMMUNE-RESPONSES; VLSE LIPOPROTEIN; UNITED-STATES; BURGDORFERI; DIAGNOSIS; SERODIAGNOSIS; ANTIBODY; DISEASE	Background A single-tier immunoassay using the C6 peptide of VlsE (C6) from Borrelia burgdorferi sensu stricto (Bb) has been proposed as a potential alternative to conventional two-tier testing for the serologic diagnosis of Lyme disease in the United States and Europe. Objective To evaluate the performance of C6 peptide based multiplex Phosphorescence Analysis (PHOSPHAN) for the serologic confirmation of Lyme borreliosis (LB) in Russian patients. Methods Serum samples (n = 351) were collected from 146 patients with erythema migrans (EM); samples from 131 of these patients were taken several times prior to treatment and at different stages of recovery. The control group consisted of 197 healthy blood donors and 31 patients with other diseases, all from the same highly endemic region of Russia. All samples were analyzed by PHOSPHAN for IgM and IgG to Bb C6, recombinant OspC and VlsE proteins, and C6 peptides from B. garinii and B. afzelii. Results IgM and IgG to Bb C6 were identified in 43 and 95 out of 131 patients (32.8 and 72.5%, respectively); seroconversion of IgM antibodies was observed in about half of the patients (51.2%), and of IgG antibodies, in almost all of them (88.4%). Additional detection of OspC-IgM and VlsE-IgM or IgG to C6 from B. garinii or B. afzelii did not contribute significantly to the overall sensitivity of the multiplex immunoassay. Conclusions The multiplex phosphorescence immunoassay is a promising method for simultaneously revealing the spectrum of antibodies to several Borrelia antigens. Detection of IgM and IgG to Bb C6 in the sera of EM patients provides effective serologic confirmation of LB and, with high probability, indicates an active infection process.	[Pomelova, Vera G.; Bychenkova, Tatiana A.; Bekman, Natalya I.] State Res Inst Biol Engn, Dept Biol Microassay, Lab Mol Diagnost, Moscow, Russia; [Korenberg, Edward I.] NF Gamalei Inst Epidemiol & Microbiol, Dept Infect Nat Focal, Moscow, Russia; [Kuznetsova, Tatiana I.] Clin Infect Dis Hosp, Clin Immunol Lab, Perm, Russia; [Osin, Nikolay S.] Immunoscreen Closed Joint Stock Co, Moscow, Russia	Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Pomelova, VG (corresponding author), State Res Inst Biol Engn, Dept Biol Microassay, Lab Mol Diagnost, Moscow, Russia.	v.pomelova@immunoscreen.ru	Korenberg, Eduard/O-9575-2015	Korenberg, Eduard/0000-0002-4452-4231; Kuznetsova, Tatiana/0000-0002-6694-3656; Pomelova, Vera/0000-0003-3377-3731	US Department of Health and Human Services/International Science and Technology Center, Moscow (BTEP) [104/ISTC, 3135]; Immunoscreen Closed Joint Stock Company	US Department of Health and Human Services/International Science and Technology Center, Moscow (BTEP); Immunoscreen Closed Joint Stock Company	This study was supported by (BTEP #104/ISTC #3135) (www.hhs.gov) (www.istc.ru) the US Department of Health and Human Services/International Science and Technology Center, Moscow (VP EK TB NB NO). Immunoscreen Closed Joint Stock Company provided support in the form of salary for author NO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the Author Contributions section.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Bieniarz C, 1996, BIOCONJUGATE CHEM, V7, P88, DOI 10.1021/bc950080+; Branda JA, 2013, CLIN INFECT DIS, V57, P333, DOI 10.1093/cid/cit235; Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Embers ME, 2007, CLIN VACCINE IMMUNOL, V14, P931, DOI 10.1128/CVI.00075-07; Goettner G, 2005, J CLIN MICROBIOL, V43, P3602, DOI 10.1128/JCM.43.8.3602-3609.2005; Gomes-Solecki MJC, 2007, CLIN VACCINE IMMUNOL, V14, P875, DOI 10.1128/CVI.00122-07; Korenberg E., 1995, WHO WORKSH LYM BORR, P128; Korenberg E., 2013, INFECT NATURAL FOCAL; Korenberg Edward I., 2002, P175, DOI 10.1079/9780851996325.0175; Krupka I, 2009, CLIN VACCINE IMMUNOL, V16, P1546, DOI 10.1128/CVI.00201-09; Liang FT, 2000, J INFECT DIS, V182, P1455, DOI 10.1086/315862; Liang FT, 1999, J IMMUNOL, V163, P5566; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Osin NS, 2008, FRONTIERS RES, V1, P233; Philipp MT, 2001, J INFECT DIS, V184, P870, DOI 10.1086/323392; Pomelova VG, 2010, EPIDEMIOLOGY VACCINE, V1, P22; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; Schwantzer, 2012, ISRN IMMUNOL, P1, DOI [10.5402/2012/719821, DOI 10.5402/2012/719821]; Sillanpaa H, 2007, INT J MED MICROBIOL, V297, P45, DOI 10.1016/j.ijmm.2006.09.001; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; Tjernberg I, 2009, INT J MED MICROBIOL, V299, P439, DOI 10.1016/j.ijmm.2008.10.006; Vaz A, 2001, INFECT IMMUN, V69, P7437, DOI 10.1128/IAI.69.12.7437-7444.2001; Vorob'eva N. N., 1998, CLIN MANIFESTATIONS; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2014, MED MICROBIOL IMMUN, V203, P65, DOI 10.1007/s00430-013-0315-0; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003	34	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130048	10.1371/journal.pone.0130048	http://dx.doi.org/10.1371/journal.pone.0130048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147441	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600029
J	Cardoso, F; Castro, F; Moreira-Teixeira, L; Sousa, J; Torrado, E; Silvestre, R; Castro, AG; Saraiva, M; Pais, TF				Cardoso, Filipa; Castro, Flavia; Moreira-Teixeira, Lucia; Sousa, Jeremy; Torrado, Egidio; Silvestre, Ricardo; Castro, Antonio Gil; Saraiva, Margarida; Pais, Teresa F.			Myeloid Sirtuin 2 Expression Does Not Impact Long-Term Mycobacterium tuberculosis Control	PLOS ONE			English	Article							DEPENDENT GENE-EXPRESSION; HISTONE DEACETYLASE; ACTIVATION; TRANSCRIPTION; MITOCHONDRIA; RESPONSES	Sirtuins (Sirts) regulate several cellular mechanisms through deacetylation of several transcription factors and enzymes. Recently, Sirt2 was shown to prevent the development of inflammatory processes and its expression favors acute Listeria monocytogenes infection. The impact of this molecule in the context of chronic infections remains unknown. We found that specific Sirt2 deletion in the myeloid lineage transiently increased Mycobacterium tuberculosis load in the lungs and liver of conditional mice. Sirt2 did not affect long-term infection since no significant differences were observed in the bacterial burden at days 60 and 120 post-infection. The initial increase in M. tuberculosis growth was not due to differences in inflammatory cell infiltrates in the lung, myeloid or CD4(+) T cells. The transcription levels of IFN-gamma, IL-17, TNF, IL-6 and NOS2 were also not affected in the lungs by Sirt2-myeloid specific deletion. Overall, our results demonstrate that Sirt2 expression has a transitory effect in M. tuberculosis infection. Thus, modulation of Sirt2 activity in vivo is not expected to affect chronic infection with M. tuberculosis.	[Cardoso, Filipa; Castro, Flavia; Moreira-Teixeira, Lucia; Sousa, Jeremy; Torrado, Egidio; Silvestre, Ricardo; Castro, Antonio Gil; Saraiva, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Cardoso, Filipa; Castro, Flavia; Moreira-Teixeira, Lucia; Sousa, Jeremy; Torrado, Egidio; Silvestre, Ricardo; Castro, Antonio Gil; Saraiva, Margarida] ICVS, PT Govt Associate Lab 3Bs, Braga, Portugal; [Pais, Teresa F.] Inst Mol Med, Lisbon, Portugal	Universidade do Minho; Universidade de Lisboa	Pais, TF (corresponding author), Inst Mol Med, Ave Prof Egas Moniz, Lisbon, Portugal.	tfariapais@gmail.com	Silvestre, Ricardo/C-7243-2011; Castro, Flávia/AAH-2636-2020; Castro, Flavia/GYQ-9088-2022; Castro, Gil/T-7584-2018; Torrado, Egídio/T-5156-2018; Pais, Teresa F/J-4525-2013; Moreira-Teixeira, Lúcia/AAH-4216-2020; Saraiva, Margarida/E-8781-2011	Silvestre, Ricardo/0000-0002-9270-2717; Castro, Flávia/0000-0002-2273-2806; Castro, Gil/0000-0002-4684-4183; Torrado, Egídio/0000-0002-7462-8234; Pais, Teresa F/0000-0002-8855-4395; Moreira-Teixeira, Lúcia/0000-0002-4817-8196; Saraiva, Margarida/0000-0002-8180-1293; Sousa, Jeremy/0000-0002-1310-1201; Cardoso, Ana Filipa/0000-0003-2618-5093	Fundacao para a Ciencia e Tecnologia, Portugal; Programa Operacional Regional do Norte (ON.2-O Novo Norte); Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); FCT [SFRH/BPD/77399/201];  [PTDC/SAU-MII/101977/2008];  [PTDC/BIA-BCM/102776/2008]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/102776/2008, PTDC/SAU-MII/101977/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Programa Operacional Regional do Norte (ON.2-O Novo Norte); Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; ; Fundação para a Ciência e a Tecnologia	This work was funded by Fundacao para a Ciencia e Tecnologia, Portugal and cofunded by Programa Operacional Regional do Norte (ON.2-O Novo Norte), Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER). Project grants: PTDC/SAU-MII/101977/2008 (to AGC) and PTDC/BIA-BCM/102776/2008 (to MS). LMT was supported by FCT Grant SFRH/BPD/77399/201. MS is an Associate-FCT Investigator fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LEC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084481; Appelberg R, 2015, IMMUNOLOGY; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Carmona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067277; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cruz A, 2015, VACCINE, V33, P85, DOI 10.1016/j.vaccine.2014.11.013; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; He ML, 2014, CELL CYCLE, V13, P3328, DOI 10.4161/15384101.2014.968431; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee AS, 2014, BIOCHEM BIOPH RES CO, V450, P1363, DOI 10.1016/j.bbrc.2014.06.135; Li QH, 2014, J VIROL, V88, P6355, DOI 10.1128/JVI.00219-14; Lin JT, 2013, BIOCHEM BIOPH RES CO, V441, P897, DOI 10.1016/j.bbrc.2013.10.153; Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103573; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mellini P, 2015, EXPERT OPIN THER PAT, V25, P5, DOI 10.1517/13543776.2014.982532; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Pais TF, 2013, EMBO J, V32, P2603, DOI 10.1038/emboj.2013.200; Ren JH, 2014, J VIROL, V88, P2442, DOI 10.1128/JVI.02861-13; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Teixeira-Coelho M, 2014, EUR J IMMUNOL, V44, P856, DOI 10.1002/eji.201343734; Teixeira-Coelho M, 2011, INT IMMUNOL, V23, P89, DOI 10.1093/intimm/dxq459; Tobin DM, 2013, CURR OPIN PHARMACOL, V13, P641, DOI 10.1016/j.coph.2013.06.007; Torrado E, 2013, ADV EXP MED BIOL, V783, P121, DOI 10.1007/978-1-4614-6111-1_7; Tsusaka T, 2014, GENES CELLS, V19, P766, DOI 10.1111/gtc.12176; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu JW, 2013, INT J INFECT DIS, V17, pE539, DOI 10.1016/j.ijid.2013.01.027; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	36	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131904	10.1371/journal.pone.0131904	http://dx.doi.org/10.1371/journal.pone.0131904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135889	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400081
J	Dwivedi, GR; Srikanth, KD; Anand, P; Naikoo, J; Srilatha, NS; Rao, DN				Dwivedi, Gajendradhar R.; Srikanth, Kolluru D.; Anand, Praveen; Naikoo, Javed; Srilatha, N. S.; Rao, Desirazu N.			Insights into the Functional Roles of N-Terminal and C-Terminal Domains of Helicobacter pylori DprA	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; BACILLUS-SUBTILIS DPRA; STREPTOCOCCUS-PNEUMONIAE; NATURAL TRANSFORMATION; GENETIC-RECOMBINATION; PROTEIN; RECA; BINDING; COMPETENCE; SSDNA	DNA processing protein A (DprA) plays a crucial role in the process of natural transformation. This is accomplished through binding and subsequent protection of incoming foreign DNA during the process of internalization. DprA along with Single stranded DNA binding protein A (SsbA) acts as an accessory factor for RecA mediated DNA strand exchange. H. pylori DprA (HpDprA) is divided into an N-terminal domain and a C-terminal domain. In the present study, individual domains of HpDprA have been characterized for their ability to bind single stranded (ssDNA) and double stranded DNA (dsDNA). Oligomeric studies revealed that HpDprA possesses two sites for dimerization which enables HpDprA to form large and tightly packed complexes with ss and dsDNA. While the N-terminal domain was found to be sufficient for binding with ss or ds DNA, C-terminal domain has an important role in the assembly of poly-nucleoprotein complex. Using site directed mutagenesis approach, we show that a pocket comprising positively charged amino acids in the N-terminal domain has an important role in the binding of ss and dsDNA. Together, a functional cross talk between the two domains of HpDprA facilitating the binding and formation of higher order complex with DNA is discussed.	[Dwivedi, Gajendradhar R.; Srikanth, Kolluru D.; Anand, Praveen; Naikoo, Javed; Srilatha, N. S.; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rao, DN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@biochem.iisc.ernet.in		Anand, Praveen/0000-0002-2478-7042; Devi Dutt Srikanth, Kolluru/0000-0003-4369-667X	DST; Department of Atomic Energy, India [DAEO/BBC/DNR/0153]; DBT - IISc Partnership Program	DST(Department of Science & Technology (India)); Department of Atomic Energy, India(Department of Atomic Energy (DAE)); DBT - IISc Partnership Program	The authors thank Farha Khan for her help with size exclusion chromatography experiments. D. N. R. acknowledges DST for J.C. Bose Fellowship. The authors thank Prof. Nagasuma Chandra for helping with bioinformatics work. Funding from Department of Atomic Energy, India [DAEO/BBC/DNR/0153] is greatly appreciated. Funding provided for this work from DBT - IISc Partnership Program is acknowledged. All members of D.N.R. laboratory are acknowledged for useful discussions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 1999, J BACTERIOL, V181, P5572, DOI 10.1128/JB.181.18.5572-5580.1999; Berge M, 2002, MOL MICROBIOL, V45, P411, DOI 10.1046/j.1365-2958.2002.03013.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell EA, 1998, MOL MICROBIOL, V27, P929, DOI 10.1046/j.1365-2958.1998.00737.x; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Dwivedi GR, 2013, NUCLEIC ACIDS RES, V41, P3274, DOI 10.1093/nar/gkt024; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; KARUDAPURAM S, 1995, J BACTERIOL, V177, P3235, DOI 10.1128/jb.177.11.3235-3240.1995; Kumar R, 2010, FEBS J, V277, P1666, DOI 10.1111/j.1742-4658.2010.07593.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lisboa J, 2014, NUCLEIC ACIDS RES, V42, P7395, DOI 10.1093/nar/gku349; Mirouze N, 2013, P NATL ACAD SCI USA, V110, P352, DOI 10.1073/pnas.1219868110; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Quevillon-Cheruel S, 2012, P NATL ACAD SCI USA, V109, pE2466, DOI 10.1073/pnas.1205638109; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Schultz J, 1997, PROTEIN SCI, V6, P249; Sharma R, 2012, FEBS J, V279, P2134, DOI 10.1111/j.1742-4658.2012.08599.x; Sharma R, 2009, J MOL BIOL, V385, P1375, DOI 10.1016/j.jmb.2008.11.041; Smeets LC, 2000, FEMS IMMUNOL MED MIC, V27, P99; Tadesse S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-105; Takata T, 2005, FEMS MICROBIOL LETT, V252, P161, DOI 10.1016/j.femsle.2005.08.052; Wang W, 2014, NUCLEIC ACIDS RES, V42, P3478, DOI 10.1093/nar/gkt1334; Yadav T, 2014, J BIOL CHEM, V289, P27640, DOI 10.1074/jbc.M114.577924; Yadav T, 2013, J BIOL CHEM, V288, P22437, DOI 10.1074/jbc.M113.478347; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173	26	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131116	10.1371/journal.pone.0131116	http://dx.doi.org/10.1371/journal.pone.0131116			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135134	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400036
J	Felix, RC; Trindade, M; Pires, IRP; Fonseca, VG; Martins, RS; Silveira, H; Power, DM; Cardoso, JCR				Felix, Rute C.; Trindade, Marlene; Pires, Isa R. P.; Fonseca, Vera G.; Martins, Rute S.; Silveira, Henrique; Power, Deborah M.; Cardoso, Joao C. R.			Unravelling the Evolution of the Allatostatin-Type A, KISS and Galanin Peptide-Receptor Gene Families in Bilaterians: Insights from Anopheles Mosquitoes	PLOS ONE			English	Article							JUVENILE-HORMONE SYNTHESIS; PROTEIN-COUPLED RECEPTORS; CENTRAL-NERVOUS-SYSTEM; MOLECULAR-CLONING; DROSOPHILA-MELANOGASTER; GENOMIC ORGANIZATION; DIPLOPTERA-PUNCTATA; CAENORHABDITIS-ELEGANS; DIGESTIVE ENZYMES; ENDOCRINE-CELLS	Allatostatin type A receptors (AST-ARs) are a group of G-protein coupled receptors activated by members of the FGL-amide (AST-A) peptide family that inhibit food intake and development in arthropods. Despite their physiological importance the evolution of the AST-A system is poorly described and relatively few receptors have been isolated and functionally characterised in insects. The present study provides a comprehensive analysis of the origin and comparative evolution of the AST-A system. To determine how evolution and feeding modified the function of AST-AR the duplicate receptors in Anopheles mosquitoes, were characterised. Phylogeny and gene synteny suggested that invertebrate AST-A receptors and peptide genes shared a common evolutionary origin with KISS/GAL receptors and ligands. AST-ARs and KISSR emerged from a common gene ancestor after the divergence of GALRs in the bilaterian genome. In arthropods, the AST-A system evolved through lineage-specific events and the maintenance of two receptors in the flies and mosquitoes (Diptera) was the result of a gene duplication event. Speciation of Anophelesmosquitoes affected receptor gene organisation and characterisation of AST-AR duplicates (GPRALS1 and 2) revealed that in common with other insects, the mosquito receptors were activated by insect AST-A peptides and the iCa(2+)-signalling pathway was stimulated. GPRALS1 and 2 were expressed mainly in mosquito midgut and ovaries and transcript abundance of both receptors was modified by feeding. A blood meal strongly up-regulated expression of both GPRALS in the midgut (p < 0.05) compared to glucose fed females. Based on the results we hypothesise that the AST-A system in insects shared a common origin with the vertebrate KISS system and may also share a common function as an integrator of metabolism and reproduction. Highlights: AST-A and KISS/GAL receptors and ligands shared common ancestry prior to the protostome-deuterostome divergence. Phylogeny and gene synteny revealed that AST-AR and KISSR emerged after GALR gene divergence. AST-AR genes were present in the hemichordates but were lost from the chordates. In protostomes, AST-ARs persisted and evolved through lineage-specific events and duplicated in the arthropod radiation. Diptera acquired and maintained functionally divergent duplicate AST-AR genes.	[Felix, Rute C.; Trindade, Marlene; Fonseca, Vera G.; Martins, Rute S.; Power, Deborah M.; Cardoso, Joao C. R.] Univ Algarve, Ctr Marine Sci, Comparat Endocrinol & Integrat Biol, P-8005139 Faro, Portugal; [Pires, Isa R. P.; Silveira, Henrique] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, Inst Higiene & Med Trop, UEI Parasitol Med, P-1349008 Lisbon, Portugal	Universidade do Algarve; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Cardoso, JCR (corresponding author), Univ Algarve, Ctr Marine Sci, Comparat Endocrinol & Integrat Biol, Campus Gambelas, P-8005139 Faro, Portugal.	jccardo@ualg.pt	Félix, Rute/AAC-2912-2020; Silveira, Henrique/G-2229-2011; dos Reis Cardoso, Joao Carlos/M-4151-2013; Félix, Rute C/M-6164-2013; Martins, Rute Sofia Tavares/AAK-4776-2021; Silveira, Henrique/AAB-4948-2022; Power, Deborah M/D-3333-2011; Fonseca, Vera/F-5566-2010	Félix, Rute/0000-0002-4144-3452; Silveira, Henrique/0000-0002-7939-772X; dos Reis Cardoso, Joao Carlos/0000-0001-7890-0170; Félix, Rute C/0000-0002-4144-3452; Martins, Rute Sofia Tavares/0000-0001-5804-2981; Silveira, Henrique/0000-0002-7939-772X; Power, Deborah M/0000-0003-1366-0246; Fonseca, Vera/0000-0003-1021-7003; Pires, Isa/0000-0001-8359-9028	Foundation for Science and Technology, Portugal (FCT) [PTDC/BIA-BCM/114395/2009]; European Regional Development Fund (ERDF) COMPETE - Operational Competitiveness Programme; Portuguese funds through FCT Foundation for Science and Technology [PEst-C/MAR/LA0015/2013, UID/Multi/04326/2013, PEst-OE/SAU/LA0018/2013]; FCT [SFRH/BPD/89811/2012, SFRH/BPD/80447/2011, SFRH/BPD/66742/2009]; auxiliary research contract FCT Pluriannual funds [PEst-C/MAR/LA0015/2013, UID/Multi/04326/2013]; Fundação para a Ciência e a Tecnologia [PEst-OE/SAU/LA0018/2013, PTDC/BIA-BCM/114395/2009] Funding Source: FCT	Foundation for Science and Technology, Portugal (FCT)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) COMPETE - Operational Competitiveness Programme; Portuguese funds through FCT Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); auxiliary research contract FCT Pluriannual funds; Fundação para a Ciência e a Tecnologia	This study was co-financed by the Foundation for Science and Technology, Portugal (FCT) project PTDC/BIA-BCM/114395/2009 and the European Regional Development Fund (ERDF) COMPETE - Operational Competitiveness Programme and Portuguese funds through FCT Foundation for Science and Technology, under the project PEst-C/MAR/LA0015/2013, UID/Multi/04326/2013 and PEst-OE/SAU/LA0018/2013. RCF, VGF and RSM are in receipt of FCT post-doctoral grants SFRH/BPD/89811/2012, SFRH/BPD/80447/2011 and SFRH/BPD/66742/2009, respectively. JCRC is supported by an auxiliary research contract FCT Pluriannual funds attributed to CCMAR under the project PEst-C/MAR/LA0015/2013 and UID/Multi/04326/2013.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abdel-latief M, 2014, PEPTIDES, V53, P172, DOI 10.1016/j.peptides.2013.10.007; Aguilar R, 2003, REGUL PEPTIDES, V115, P171, DOI 10.1016/S0167-0115(03)00165-4; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2008, BIODIVERSITY MALARIA; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Audsley N, 2009, GEN COMP ENDOCR, V162, P93, DOI 10.1016/j.ygcen.2008.08.003; Audsley N, 2014, GENOMIC PEPTIDOMIC A; Auerswald L, 2001, BIOCHEM BIOPH RES CO, V282, P904, DOI 10.1006/bbrc.2001.4659; Baggerman G, 2005, J MASS SPECTROM, V40, P250, DOI 10.1002/jms.744; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Belles X, 1999, PEPTIDES, V20, P11, DOI 10.1016/S0196-9781(98)00155-7; BELLES X, 1994, REGUL PEPTIDES, V53, P237, DOI 10.1016/0167-0115(94)90172-4; Bendena WG, 1999, ANN NY ACAD SCI, V897, P311, DOI 10.1111/j.1749-6632.1999.tb07902.x; Bendena WG, 2008, P NATL ACAD SCI USA, V105, P1339, DOI 10.1073/pnas.0709492105; Bendena WG, 2012, CAN J ZOOL, V90, P521, DOI 10.1139/Z2012-012; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Bowser PRF, 2005, PEPTIDES, V26, P81, DOI 10.1016/j.peptides.2004.08.026; Brown RE, 2008, MOL CELL ENDOCRINOL, V281, P64, DOI 10.1016/j.mce.2007.10.011; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Cardoso JCR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092220; Cardoso Joao C R, 2012, Front Endocrinol (Lausanne), V3, P157, DOI 10.3389/fendo.2012.00157; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark L, 2008, J INSECT PHYSIOL, V54, P949, DOI 10.1016/j.jinsphys.2008.03.007; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Crawley JN, 1999, NEUROPEPTIDES, V33, P369, DOI 10.1054/npep.1999.0049; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Davey M, 1999, INSECT BIOCHEM MOLEC, V29, P1119, DOI 10.1016/S0965-1748(99)00092-2; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Ding Q, 1995, EUR J BIOCHEM, V234, P737, DOI 10.1111/j.1432-1033.1995.737_a.x; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Edwards MJ, 2000, INSECT MOL BIOL, V9, P33, DOI 10.1046/j.1365-2583.2000.00159.x; Alzugaray ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077520; Fang PH, 2012, PEPTIDES, V36, P331, DOI 10.1016/j.peptides.2012.05.016; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Felix RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024181; Felix RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-312; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Fuse M, 1999, PEPTIDES, V20, P1285, DOI 10.1016/S0196-9781(99)00133-3; Gruber CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032559; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang J, 2014, INSECT BIOCHEM MOLEC, V54, P61, DOI 10.1016/j.ibmb.2014.09.001; Hult EF, 2008, J INSECT PHYSIOL, V54, P959, DOI 10.1016/j.jinsphys.2008.04.007; Husson SJ, 2009, TRENDS PARASITOL, V25, P171, DOI 10.1016/j.pt.2008.12.009; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Kask K, 1996, EMBO J, V15, P236, DOI 10.1002/j.1460-2075.1996.tb00354.x; Kim DK, 2014, ENDOCRINOLOGY, V155, P1864, DOI 10.1210/en.2013-2106; Kokoza VA, 2001, GENE, V274, P47, DOI 10.1016/S0378-1119(01)00602-3; LANGE AB, 1995, J INSECT PHYSIOL, V41, P581, DOI 10.1016/0022-1910(95)00008-I; Larsen MJ, 2001, BIOCHEM BIOPH RES CO, V286, P895, DOI 10.1006/bbrc.2001.5476; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lehmann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004549; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P1126, DOI 10.1006/bbrc.2000.3062; Lenz C, 2000, BIOCHEM BIOPH RES CO, V273, P571, DOI 10.1006/bbrc.2000.2964; Lenz C, 2000, BIOCHEM BIOPH RES CO, V269, P91, DOI 10.1006/bbrc.2000.2251; Lenz C, 2001, BIOCHEM BIOPH RES CO, V286, P1117, DOI 10.1006/bbrc.2001.5475; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Liu ZH, 2010, J BIOMOL STRUCT DYN, V28, P97, DOI 10.1080/07391102.2010.10507346; LORENZ MW, 1995, REGUL PEPTIDES, V57, P227, DOI 10.1016/0167-0115(95)00036-B; Lungchukiet P, 2008, J INSECT PHYSIOL, V54, P981, DOI 10.1016/j.jinsphys.2008.04.018; Lungchukiet P, 2008, PEPTIDES, V29, P276, DOI 10.1016/j.peptides.2007.10.029; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Lwalaba D, 2010, ARCH INSECT BIOCHEM, V73, P14, DOI 10.1002/arch.20332; Maestro JL, 1998, ARCH INSECT BIOCHEM, V37, P269, DOI 10.1002/(SICI)1520-6327(1998)37:4&lt;269::AID-ARCH2&gt;3.0.CO;2-M; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Nicholas KB., 1997, GENEDOC TOOL EDITING; Niida A, 2006, BIOORG MED CHEM LETT, V16, P134, DOI 10.1016/j.bmcl.2005.09.054; Nirmala X, 2005, INSECT MOL BIOL, V14, P95, DOI 10.1111/j.1365-2583.2005.00535.x; Pasquier Jeremy, 2012, Front Endocrinol (Lausanne), V3, P173, DOI 10.3389/fendo.2012.00173; Pasquier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048931; PRATT GE, 1989, BIOCHEM BIOPH RES CO, V163, P1243, DOI 10.1016/0006-291X(89)91111-X; Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p; REICHWALD K, 1994, P NATL ACAD SCI USA, V91, P11894, DOI 10.1073/pnas.91.25.11894; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Robertson L, 2012, J EXP BIOL, V215, P3394, DOI 10.1242/jeb.073189; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savard J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-7; Secher T, 2001, J BIOL CHEM, V276, P47052, DOI 10.1074/jbc.M106675200; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Stay B, 2000, INSECT BIOCHEM MOLEC, V30, P653, DOI 10.1016/S0965-1748(00)00036-9; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tobe SS, 2000, J INSECT PHYSIOL, V46, P231, DOI 10.1016/S0022-1910(99)00175-4; VandenBroeck J, 1996, MOL CELL ENDOCRINOL, V122, P191, DOI 10.1016/0303-7207(96)03890-7; Vanderveken M, 2014, ARCH INSECT BIOCHEM, V85, P76, DOI 10.1002/arch.21144; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Veenstra JA, 1997, PEPTIDES, V18, P937, DOI 10.1016/S0196-9781(97)00032-6; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Wahab F, 2013, METABOLISM, V62, P898, DOI 10.1016/j.metabol.2013.01.015; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036059; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Woodring J, 2009, PHYSIOL ENTOMOL, V34, P144, DOI 10.1111/j.1365-3032.2008.00665.x; Wyder S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r242; Xia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010592; Yagi KJ, 2005, J INSECT PHYSIOL, V51, P357, DOI 10.1016/j.jinsphys.2004.12.006; Zandawala M, 2015, INSECT BIOCHEM MOLEC, V57, P1, DOI 10.1016/j.ibmb.2014.12.001; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P10, DOI 10.1016/j.ibmb.2011.10.002	116	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130347	10.1371/journal.pone.0130347	http://dx.doi.org/10.1371/journal.pone.0130347			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135459	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400018
J	Slavchev, A; Kovacs, Z; Koshiba, H; Nagai, A; Bazar, G; Krastanov, A; Kubota, Y; Tsenkova, R				Slavchev, Aleksandar; Kovacs, Zoltan; Koshiba, Haruki; Nagai, Airi; Bazar, Gyoergy; Krastanov, Albert; Kubota, Yousuke; Tsenkova, Roumiana			Monitoring of Water Spectral Pattern Reveals Differences in Probiotics Growth When Used for Rapid Bacteria Selection	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; LACTIC-ACID BACTERIA; DISCRIMINANT-ANALYSIS; ATOPIC-DERMATITIS; GIANT PANDA; AB-INITIO; IN-VITRO; CLUSTERS; DYNAMICS; CLASSIFICATION	Development of efficient screening method coupled with cell functionality evaluation is highly needed in contemporary microbiology. The presented novel concept and fast nondestructive method brings in to play the water spectral pattern of the solution as a molecular fingerprint of the cell culture system. To elucidate the concept, NIR spectroscopy with Aquaphotomics were applied to monitor the growth of sixteen Lactobacillus bulgaricus one Lactobacillus pentosus and one Lactobacillus gasseri bacteria strains. Their growth rate, maximal optical density, low pH and bile tolerances were measured and further used as a reference data for analysis of the simultaneously acquired spectral data. The acquired spectral data in the region of 1100-1850nm was subjected to various multivariate data analyses - PCA, OPLS-DA, PLSR. The results showed high accuracy of bacteria strains classification according to their probiotic strength. Most informative spectral fingerprints covered the first overtone of water, emphasizing the relation of water molecular system to cell functionality.	[Slavchev, Aleksandar; Kovacs, Zoltan; Koshiba, Haruki; Nagai, Airi; Bazar, Gyoergy; Kubota, Yousuke; Tsenkova, Roumiana] Kobe Univ, Grad Sch Agr Sci, Biomeasurement Technol Lab, Nada Ku, Kobe, Hyogo 6578501, Japan; [Slavchev, Aleksandar] Univ Food Technol, Dept Microbiol, Plovdiv 4002, Bulgaria; [Kovacs, Zoltan] Corvinus Univ Budapest, Fac Food Sci, Dept Phys & Control, H-1118 Budapest, Hungary; [Bazar, Gyoergy] Kaposvar Univ, Fac Agr & Environm Sci, Inst Food & Agr Prod Qualificat, H-7400 Kaposvar, Hungary; [Krastanov, Albert] Univ Food Technol, Dept Biotechnol, Plovdiv 4002, Bulgaria	Kobe University; University of Food Technology - Bulgaria; Corvinus University Budapest; Hungarian University of Agriculture & Life Sciences; Kaposvar University; University of Food Technology - Bulgaria	Tsenkova, R (corresponding author), Kobe Univ, Grad Sch Agr Sci, Biomeasurement Technol Lab, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	rtsen@kobe-u.ac.jp	Kovacs, Zoltan/A-9721-2012; Bazar, George/A-2986-2013; Krastanov, Albert/J-8706-2016; Kovacs, Zoltan/Q-6939-2019; Tsenkova, Roumiana/ABB-7980-2021; Krastanov, Albert/ABE-5856-2020	Kovacs, Zoltan/0000-0003-0641-8830; Bazar, George/0000-0001-9829-4366; Kovacs, Zoltan/0000-0003-0641-8830; Tsenkova, Roumiana/0000-0002-9733-7587; Krastanov, Albert/0000-0003-2794-1655	Japan Society for the Promotion of Science [L14562]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/), grant number L14562.	Angelis M De, 2004, REV ENV STRESS RESPO, P106, DOI [10.1002/pmic.200300497, DOI 10.1002/PMIC.200300497]; Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005; Berrueta LA, 2007, J CHROMATOGR A, V1158, P196, DOI 10.1016/j.chroma.2007.05.024; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Chatani E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101997; Church JS, 1999, VIB SPECTROSC, V19, P285, DOI 10.1016/S0924-2031(99)00015-6; COWE IA, 1985, APPL SPECTROSC, V39, P257, DOI 10.1366/0003702854248944; Czarnecki MA, 2000, J PHYS CHEM A, V104, P4906, DOI 10.1021/jp991753e; da Costa PA, 2009, ANAL CHIM ACTA, V631, P206, DOI 10.1016/j.aca.2008.10.049; Davis JG, 2012, NATURE, V491, P582, DOI 10.1038/nature11570; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; del Giudice MM, 2004, J CLIN GASTROENTEROL, V38, pS84, DOI 10.1097/01.mcg.0000133293.18576.d2; Deyerl HJ, 2000, FARADAY DISCUSS, V115, P147, DOI 10.1039/a909619a; DOWNEY G, 1990, APPL SPECTROSC, V44, P150, DOI 10.1366/0003702904085796; *FAO WHO, 2002, JOINT WORK GROUP REP; Fischer M, 1999, ANAL CHEM, V71, P2255, DOI 10.1021/ac990207e; Garcia-Ruiz A, 2014, FOOD MICROBIOL, V44, P220, DOI 10.1016/j.fm.2014.06.015; HAMMAKER RM, 1968, J PHYS CHEM-US, V72, P1837, DOI 10.1021/j100851a090; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Hollock M.R., 2012, APPL 2 DIMENSIONAL C; Isolauri E, 2004, CURR ALLERGY ASTHM R, V4, P270, DOI 10.1007/s11882-004-0070-9; Izutsu KI, 2006, J PHARM SCI-US, V95, P781, DOI 10.1002/jps.20580; Jinendra B, 2010, BIOCHEM BIOPH RES CO, V397, P685, DOI 10.1016/j.bbrc.2010.06.007; Kalliomaki MA, 2004, IMMUNOL ALLERGY CLIN, V24, P739, DOI 10.1016/j.iac.2004.06.006; Khalil OS, 1999, CLIN CHEM, V45, P165; Kinoshita K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00856; Kinoshita K, 2010, ANAL METHODS-UK, V2, P1671, DOI 10.1039/c0ay00333f; Liu H, 2008, SPECTROCHIM ACTA A, V71, P1228, DOI 10.1016/j.saa.2008.03.026; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Madigan MT, 2010, BROCK BIOL MICROORGA; Maeda H, 1999, CHEMOMETR INTELL LAB, V45, P121, DOI 10.1016/S0169-7439(98)00096-3; Maeda H., 1995, J NEAR INFRARED SPEC, V3, P191, DOI [10.1255/jnirs.69, DOI 10.1255/JNIRS.69]; MALLETT AK, 1989, J APPL BACTERIOL, V66, P433, DOI 10.1111/j.1365-2672.1989.tb05112.x; MARTEAU P, 1990, BRIT J NUTR, V64, P71, DOI 10.1079/BJN19900010; McFarland Lynne V, 2007, Travel Med Infect Dis, V5, P97, DOI 10.1016/j.tmaid.2005.10.003; Mizuse K, 2012, J PHYS CHEM A, V116, P4868, DOI 10.1021/jp302030d; Morita H, 2011, ANAL CHEM, V83, P4023, DOI 10.1021/ac103128p; Murayama K, 1998, VIB SPECTROSC, V18, P33, DOI 10.1016/S0924-2031(98)00034-4; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; Naes T., 2004, USER FRIENDLY GUIDE; Nakakimura Y, 2012, ANAL METHODS-UK, V4, P1389, DOI 10.1039/c2ay05771a; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Peiris KHS, 2009, J NEAR INFRARED SPEC, V17, P213, DOI 10.1255/jnirs.846; Perni S, 2005, FOOD MICROBIOL, V22, P491, DOI 10.1016/j.fm.2004.11.014; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; Pitino L, 2010, FOOD MICROBIOL, V27, P1121, DOI 10.1016/j.fm.2010.07.019; Rafter JJ, 2002, BRIT J NUTR, V88, pS219, DOI 10.1079/BJN2002686; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Reddy GU, 2012, SPECTROCHIM ACTA A, V96, P310, DOI 10.1016/j.saa.2012.04.093; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Segtnan VH, 2004, FOOD HYDROCOLLOID, V18, P1, DOI 10.1016/S0268-005X(02)00096-6; Segtnan VH, 2001, ANAL CHEM, V73, P3153, DOI 10.1021/ac010102n; Tran H-D, 2004, LACTIC ACID BACTERIA; Tsenkova RN, 2004, BIOCHEM BIOPH RES CO, V325, P1005, DOI 10.1016/j.bbrc.2004.10.135; Tsenkova R, 2009, J NEAR INFRARED SPEC, V17, P303, DOI 10.1255/jnirs.869; Tulumoglu S, 2013, ANAEROBE, V24, P36, DOI 10.1016/j.anaerobe.2013.09.006; Walker WA, 2000, J PEDIATR GASTR NUTR, V30, pS2, DOI 10.1097/00005176-200003002-00002; Weber JM, 2000, SCIENCE, V287, P2461, DOI 10.1126/science.287.5462.2461; Wei DQ, 1997, J CHEM PHYS, V106, P6086, DOI 10.1063/1.473607; Workman Jr J., 2000, HDB ORGANIC COMPOUND; Wu B, 2009, J PHYS CHEM B, V113, P12332, DOI 10.1021/jp905252j; XANTHEAS SS, 1995, J CHEM PHYS, V102, P4505, DOI 10.1063/1.469499; Zotta T, 2009, INT J FOOD MICROBIOL, V129, P211, DOI 10.1016/j.ijfoodmicro.2008.11.024	63	23	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130698	10.1371/journal.pone.0130698	http://dx.doi.org/10.1371/journal.pone.0130698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133176	Green Submitted, gold, Green Published			2022-12-26	WOS:000358154400024
J	Kamarajan, P; Hayami, T; Matte, B; Liu, Y; Danciu, T; Ramamoorthy, A; Worden, F; Kapila, S; Kapila, Y				Kamarajan, Pachiyappan; Hayami, Takayuki; Matte, Bibiana; Liu, Yang; Danciu, Theodora; Ramamoorthy, Ayyalusamy; Worden, Francis; Kapila, Sunil; Kapila, Yvonne			Nisin ZP, a Bacteriocin and Food Preservative, Inhibits Head and Neck Cancer Tumorigenesis and Prolongs Survival	PLOS ONE			English	Article							CELL-DEATH; ANTITUMOR-ACTIVITY; INDUCED APOPTOSIS; IN-VITRO; TUMOR; DIFFERENTIATION; MECHANISM; MASTITIS; CALPAIN; BINDING	The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a new approach that holds great promise. Nisin exemplifies this new approach because it has been used safely in humans for many years as a food preservative, and recent laboratory studies support its anti-tumor potential in head and neck cancer. Previously, we showed that nisin (2.5%, low content) has antitumor potential in head and neck squamous cell carcinoma (HNSCC) in vitro and in vivo. The current studies explored a naturally occurring variant of nisin (nisin ZP; 95%, high content) for its antitumor effects in vitro and in vivo. Nisin ZP induced the greatest level of apoptosis in HNSCC cells compared to low content nisin. HNSCC cells treated with increasing concentrations of nisin ZP exhibited increasing levels of apoptosis and decreasing levels of cell proliferation, clonogenic capacity, and sphere formation. Nisin ZP induced apoptosis through a calpain- dependent pathway in HNSCC cells but not in human oral keratinocytes. Nisin ZP also induced apoptosis dose-dependently in human umbilical vein endothelial cells (HUVEC) with concomitant decreases in vascular sprout formation in vitro and reduced intratumoral microvessel density in vivo. Nisin ZP reduced tumorigenesis in vivo and long-term treatment with nisin ZP extended survival. In addition, nisin treated mice exhibited normal organ histology with no evidence of inflammation, fibrosis or necrosis. In summary, nisin ZP exhibits greater antitumor effects than low content nisin, and thus has the potential to serve as a novel therapeutic for HNSCC.	[Kamarajan, Pachiyappan; Matte, Bibiana; Liu, Yang; Danciu, Theodora; Kapila, Yvonne] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Hayami, Takayuki; Kapila, Sunil] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA; [Worden, Francis] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kapila, Y (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	ykapila@umich.edu	Kapila, Yvonne/AAG-5418-2021; Kapila, Sunil/AAU-5155-2020	Ramamoorthy, Ayyalusamy/0000-0003-1964-1900	University of Michigan MCUBED [U036798]; Brazilian CAPES; CNPq; Peking University School; Hospital of Stomatology	University of Michigan MCUBED(University of Michigan System); Brazilian CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Peking University School(Peking University); Hospital of Stomatology	This study was supported by the University of Michigan MCUBED Funding #U036798 to YK, FPW, and AR. BM was supported by the Brazilian CAPES and CNPq sponsored, Science Without Borders Program. YL was supported by the Scholars Program from Peking University School and Hospital of Stomatology.	Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Artus C, 2006, ONCOGENE, V25, P5741, DOI 10.1038/sj.onc.1209581; Bai X, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0366-z; Bao JJ, 2002, CANCER RES, V62, P7264; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Brotz H, 2000, J ANTIMICROB CHEMOTH, V46, P1, DOI 10.1093/jac/46.1.1; Bsoul Samer A, 2005, J Contemp Dent Pract, V6, P1; Cao LT, 2007, J DAIRY SCI, V90, P3980, DOI 10.3168/jds.2007-0153; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Cornutt G, 2008, AM J CLIN ONCOL-CANC, V31, P399, DOI 10.1097/COC.0b013e31815e456d; Cui Q, 2007, ACTA PHARMACOL SIN, V28, P1057, DOI 10.1111/j.1745-7254.2007.00588.x; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Delves-Broughton J, 2005, NISIN FOOD PRESERVAT; Diwakarla S, 2009, J NEUROCHEM, V109, P198, DOI 10.1111/j.1471-4159.2009.05937.x; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; Farkas-Himsley Hannah, 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P643; FARKASHIMSLEY H, 1995, P NATL ACAD SCI USA, V92, P6996, DOI 10.1073/pnas.92.15.6996; Fernandez L, 2008, J HUM LACT, V24, P311, DOI 10.1177/0890334408317435; FRAZER AC, 1962, J SCI FOOD AGR, V13, P32, DOI 10.1002/jsfa.2740130106; Gasparoni A, 2004, ARCH ORAL BIOL, V49, P653, DOI 10.1016/j.archoralbio.2004.02.010; Giffard CJ, 1996, J MEMBRANE BIOL, V151, P293, DOI 10.1007/s002329900079; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Hu WG, 2011, CANCER RES, V71, P2298, DOI 10.1158/0008-5472.CAN-10-3016; Ihle NT, 2004, MOL CANCER THER, V3, P763; Jeong JC, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-44; Joo NE, 2012, CANCER MED-US, V1, P295, DOI 10.1002/cam4.35; Kamarajan P, 2013, CANCER MED-US, V2, P793, DOI 10.1002/cam4.147; Kamarajan P, 2012, CANCER-AM CANCER SOC, V118, P5800, DOI 10.1002/cncr.27655; Kang H, 2012, APOPTOSIS; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Karmakar Surajit, 2010, J Cancer Sci Ther, V2, P107; Kaur G, 2013, BRAZ J MICROBIOL, V44, P63, DOI 10.1590/S1517-83822013005000025; Koczulla AR, 2003, DRUGS, V63, P389, DOI 10.2165/00003495-200363040-00005; Lagos R, 2009, CURR PHARM BIOTECHNO, V10, P74, DOI 10.2174/138920109787048643; Lu JR, 2013, J GEN VIROL, V94, P1477, DOI 10.1099/vir.0.047753-0; MATSUMOTO K, 1989, J ORAL PATHOL MED, V18, P498, DOI 10.1111/j.1600-0714.1989.tb01350.x; Moll GN, 1997, J BACTERIOL, V179, P135, DOI 10.1128/jb.179.1.135-140.1997; MULDERS JWM, 1991, EUR J BIOCHEM, V201, P581, DOI 10.1111/j.1432-1033.1991.tb16317.x; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nonzee NJ, 2008, CANCER-AM CANCER SOC, V113, P1446, DOI 10.1002/cncr.23714; Ponce M. Lourdes, 2009, V467, P183, DOI 10.1007/978-1-59745-241-0_10; PONEC M, 1984, J INVEST DERMATOL, V83, P436, DOI 10.1111/1523-1747.ep12273538; PONEC M, 1987, BIOCHIM BIOPHYS ACTA, V921, P512, DOI 10.1016/0005-2760(87)90079-8; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; SAITO H, 1979, CANCER RES, V39, P5114; Sand SL, 2007, J MEMBRANE BIOL, V216, P61, DOI 10.1007/s00232-007-9030-3; Selimovic D, 2011, CARCINOGENESIS, V32, P1268, DOI 10.1093/carcin/bgr112; Shaikh F, 2012, BIOINFORMATION, V8, P589, DOI 10.6026/97320630008589; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith A, 2009, MOL CANCER THER, V8, P1666, DOI 10.1158/1535-7163.MCT-08-1012; TERTOOLEN LGJ, 1988, BIOCHEM BIOPH RES CO, V152, P491, DOI 10.1016/S0006-291X(88)80064-0; Tripathi P, 2012, INT J BIOCHEM CELL B, V44, P1852, DOI 10.1016/j.biocel.2012.06.025; Tsugu H, 2006, ANTICANCER RES, V26, P4043; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wu JQ, 2007, ANTIMICROB AGENTS CH, V51, P3131, DOI 10.1128/AAC.00629-07; Yates KR, 2012, BLOOD COAGUL FIBRIN, V23, P396, DOI 10.1097/MBC.0b013e3283538875; Yoo JO, 2012, J BIOL CHEM, V287, P14377, DOI 10.1074/jbc.M111.326074; You T, 2011, CELL MOL IMMUNOL, V8, P157, DOI 10.1038/cmi.2010.35; Zhang Y, 2004, J BIOL CHEM, V279, P48342, DOI 10.1074/jbc.M407953200; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49	61	100	106	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131008	10.1371/journal.pone.0131008	http://dx.doi.org/10.1371/journal.pone.0131008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132406	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000088
J	Sousa, T; Branco, R; Piedade, AP; Morais, PV				Sousa, Tania; Branco, Rita; Piedade, Ana Paula; Morais, Paula V.			Hyper Accumulation of Arsenic in Mutants of Ochrobactrum tritici Silenced for Arsenite Efflux Pumps	PLOS ONE			English	Article							CORYNEBACTERIUM-GLUTAMICUM; RESISTANT STRAIN; ARS OPERON; MECHANISMS; METABOLISM; BACTERIUM; GENES; CYCLE	Ochrobactrum tritici SCII24(T) is a highly As-resistant bacterium, with two previously described arsenic resistance operons, ars1 and ars2. Among a large number of genes, these operons contain the arsB and Acr3 genes that encode the arsenite efflux pumps responsible for arsenic resistance. Exploring the genome of O. tritici SCII24(T), an additional putative operon (ars3) was identified and revealed the presence of the Acr3_2 gene that encodes for an arsenite efflux protein but which came to prove to not be required for full As resistance. The genes encoding for arsenite efflux pumps, identified in this strain, were inactivated to develop microbial accumulators of arsenic as new tools for bioremediation. Six different mutants were produced, studied and three were more useful as biotools. O. tritici wild type and the Acr3-mutants showed the highest resistance to As(III), being able to grow up to 50 mM of arsenite. On the other hand, arsB-mutants were not able to grow at concentrations higher than 1 mM As(III), and were the most As(III) sensitive mutants. In the presence of 1 mM As(III), the strain with arsB and Acr3_1 mutated showed the highest intracellular arsenic concentration (up to 17 ng(As)/mg protein), while in assays with 5 mM As(III), the single arsB-mutant was able to accumulate the highest concentration of arsenic (up to 10 ng(As)/mg protein). Therefore, arsB is the main gene responsible for arsenite resistance in O. tritici. However, both genes arsB and Acr3_1 play a crucial role in the resistance mechanism, depending on the arsenite concentration in the medium. In conclusion, at moderate arsenite concentrations, the double arsB-and Acr3_1-mutant exhibited a great ability to accumulate arsenite and can be seen as a promising bioremediation tool for environmental arsenic detoxification.	[Sousa, Tania; Branco, Rita; Morais, Paula V.] IMAR CMA, Coimbra, Portugal; [Piedade, Ana Paula] Univ Coimbra, Dept Mech Engn, CEMUC, P-3030788 Coimbra, Portugal; [Morais, Paula V.] Univ Coimbra, Dept Life Sci, P-3030788 Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Morais, PV (corresponding author), IMAR CMA, Coimbra, Portugal.	pvmorais@ci.uc.pt	Piedade, Ana Paula/K-8637-2012; Morais, Paula Vasconcelos/C-9756-2014; Branco, Rita/AAQ-4007-2021	Piedade, Ana Paula/0000-0002-1588-0640; Morais, Paula Vasconcelos/0000-0002-1939-6389; Branco, Rita/0000-0003-0291-8029	FEDER through the program COMPETE; national funds through FCT, Fundacao para a Ciencia e a Tecnologia [PEst-496C/EME/UI0285/2014, CENTRO-07-0224-FEDER- 497 002001, PTDC/BIA-MIC/114958/2009];  [SFRH/BPD/48330/2008]	FEDER through the program COMPETE; national funds through FCT, Fundacao para a Ciencia e a Tecnologia; 	This research was funded by FEDER through the program COMPETE and by national funds through FCT, Fundacao para a Ciencia e a Tecnologia, under projects PEst-496C/EME/UI0285/2014 and CENTRO-07-0224-FEDER- 497 002001 and PTDC/BIA-MIC/114958/2009. TS is funded by a scholarship of the project. RB is funded by a post-doc grant (SFRH/BPD/48330/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branco R, 2009, APPL ENVIRON MICROB, V75, P5141, DOI 10.1128/AEM.02798-08; Branco R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-95; Bruhn DF, 1996, FEMS MICROBIOL LETT, V139, P149, DOI 10.1016/0378-1097(96)00134-6; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dhuldhaj UP, 2013, REV ENVIRON CONTAM T, V224, P1, DOI 10.1007/978-1-4614-5882-1_1; Elias M, 2012, NATURE, V491, P134, DOI 10.1038/nature11517; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Kostal J, 2004, APPL ENVIRON MICROB, V70, P4582, DOI 10.1128/AEM.70.8.4582-4587.2004; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kruger MC, 2013, APPL MICROBIOL BIOT, V97, P3827, DOI 10.1007/s00253-013-4838-5; Li XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092236; Lievremont D, 2009, BIOCHIMIE, V91, P1229, DOI 10.1016/j.biochi.2009.06.016; Mateos LM, 2006, INT MICROBIOL, V9, P207; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Muller D, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030053; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Oremland RS, 2002, BOOK SOIL P, P273; Rensing C., 2009, ENCY MICROBIOLOGY, P205, DOI [10.1016/B978-012373944-5.00053-5, DOI 10.1016/B978-012373944-5.00053-5]; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh S, 2008, APPL ENVIRON MICROB, V74, P2924, DOI 10.1128/AEM.02871-07; Su CM, 2005, ACS SYM SER, V915, P25, DOI 10.1021/bk-2005-0915.ch003; Tsai SL, 2009, CURR OPIN BIOTECH, V20, P659, DOI 10.1016/j.copbio.2009.09.013; Tuffin IM, 2006, APPL ENVIRON MICROB, V72, P2247, DOI 10.1128/AEM.72.3.2247-2253.2006; Villadangos AF, 2014, APPL MICROBIOL BIOT, V98, P10143, DOI 10.1007/s00253-014-6055-2; WHO, 2010, PREVENTING DISEASE T; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Xu C, 1998, J BIOCHEM-TOKYO, V123, P16	34	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131317	10.1371/journal.pone.0131317	http://dx.doi.org/10.1371/journal.pone.0131317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132104	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000111
J	Zhang, FG; Zeng, A				Zhang, Fu-Guo; Zeng, An			Information Filtering via Heterogeneous Diffusion in Online Bipartite Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; RECOMMENDER	The rapid expansion of Internet brings us overwhelming online information, which is impossible for an individual to go through all of it. Therefore, recommender systems were created to help people dig through this abundance of information. In networks composed by users and objects, recommender algorithms based on diffusion have been proven to be one of the best performing methods. Previous works considered the diffusion process from user to object, and from object to user to be equivalent. We show in this work that it is not the case and we improve the quality of the recommendation by taking into account the asymmetrical nature of this process. We apply this idea to modify the state-of-the-art recommendation methods. The simulation results show that the new methods can outperform these existing methods in both recommendation accuracy and diversity. Finally, this modification is checked to be able to improve the recommendation in a realistic case.	[Zhang, Fu-Guo] Jiangxi Univ Finance & Econ, Sch Informat Technol, Nanchang 330013, Peoples R China; [Zhang, Fu-Guo] Jiangxi Univ Finance & Econ, Jiangxi Key Lab Data & Knowledge Engn, Nanchang 330013, Peoples R China; [Zeng, An] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Jiangxi University of Finance & Economics; Jiangxi University of Finance & Economics; Beijing Normal University	Zeng, A (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	anzeng@bnu.edu.cn			National Natural Science Foundation of China [71361012, 71363022]; Foundation of Jiangxi Provincial Department of Education [GJJ. 12744]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Jiangxi Provincial Department of Education	This work is partially supported by National Natural Science Foundation of China (grant nos. 71361012 and 71363022), and by the Foundation of Jiangxi Provincial Department of Education (GJJ. 12744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; [Anonymous], 2009, NETFL 2006 ANN REP O; Fujimura K, 2005, LECT NOTES ARTIF INT, V3577, P59; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Guo Q, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/18001; Guo Q, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30095-1; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Jamali Mohsen, 2010, P 4 ACM C REC SYST, P135, DOI DOI 10.1145/1864708.1864736; Kantor P., 2010, RECOMMENDER SYSTEMS; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kohavi R., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P192; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Liao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112022; Liu C, 2012, PHYSICA A, V391, P5704, DOI 10.1016/j.physa.2012.06.034; Liu JG, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016118; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Marshall M, 2006, AGGREGATE KNOWLEDGE; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pan Y, 2010, PHYSICA A, V389, P2849, DOI 10.1016/j.physa.2010.03.006; Ren XL, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/063057; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sarwar B.M., 2001, P WWW; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006; Song WJ, 2014, PHYSICA A, V416, P192, DOI 10.1016/j.physa.2014.08.008; Xiao B, 2007, MIS QUART, V31, P137; Zeng A, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/58002; Zeng A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18005; Zhang FG, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58005; Zhang P, 2014, PHYS LETT A, V378, P2350, DOI 10.1016/j.physleta.2014.06.011; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	37	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0129459	10.1371/journal.pone.0129459	http://dx.doi.org/10.1371/journal.pone.0129459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125631	Green Submitted, Green Published, gold			2022-12-26	WOS:000358151300008
J	Ferreira, SM; Greaver, C; Knight, GA; Knight, MH; Smit, IPJ; Pienaar, D				Ferreira, Sam M.; Greaver, Cathy; Knight, Grant A.; Knight, Mike H.; Smit, Izak P. J.; Pienaar, Danie			Disruption of Rhino Demography by Poachers May Lead to Population Declines in Kruger National Park, South Africa	PLOS ONE			English	Article							BLACK RHINOCEROS; DENSITY; CONSERVATION; PRECISION; EVOLUTION; RESERVE; SIZE	The onslaught on the World's rhinoceroses continues despite numerous initiatives aimed at curbing it. When losses due to poaching exceed birth rates, declining rhino populations result. We used previously published estimates and growth rates for black rhinos (2008) and white rhinos (2010) together with known poaching trends at the time to predict population sizes and poaching rates in Kruger National Park, South Africa for 2013. Kruger is a stronghold for the south-eastern black rhino and southern white rhino. Counting rhinos on 878 blocks 3x3 km in size using helicopters, estimating availability bias and collating observer and detectability biases allowed estimates using the Jolly's estimator. The exponential escalation in number of rhinos poached per day appears to have slowed. The black rhino estimate of 414 individuals (95% confidence interval: 343-487) was lower than the predicted 835 individuals (95% CI: 754-956). The white rhino estimate of 8,968 individuals (95% CI: 8,394-9,564) overlapped with the predicted 9,417 individuals (95% CI: 7,69811,183). Density- and rainfall-dependent responses in birth- and death rates of white rhinos provide opportunities to offset anticipated poaching effects through removals of rhinos from high density areas to increase birth and survival rates. Biological management of rhinos, however, need complimentary management of the poaching threat as present poaching trends predict detectable declines in white rhino abundances by 2018. Strategic responses such as anti-poaching that protect supply from illegal harvesting, reducing demand, and increasing supply commonly require crime network disruption as a first step complimented by providing options for alternative economies in areas abutting protected areas.	[Ferreira, Sam M.; Greaver, Cathy; Smit, Izak P. J.; Pienaar, Danie] SANParks, Sci Serv, Skukuza, South Africa; [Ferreira, Sam M.] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Pietermaritzburg, South Africa; [Knight, Grant A.] SANParks, Aerial Support Serv, Skukuza, South Africa; [Knight, Mike H.] SANParks, Pk Planning & Dev Div, Port Elizabeth, South Africa	University of Kwazulu Natal	Ferreira, SM (corresponding author), SANParks, Sci Serv, Skukuza, South Africa.	sam.ferreira@sanparks.org			SANParks' Ivory Fund; US Fish and Wildlife Services Grant [F12AP00354]	SANParks' Ivory Fund; US Fish and Wildlife Services Grant	Funding: Funding provided by SANParks' Ivory Fund and the US Fish and Wildlife Services Grant Number F12AP00354.	[Anonymous], 2012, BIOMETRY PRINCIPLES; [Anonymous], 1982, ESTIMATION ANIMAL AB; Barnes RFW, 2002, AFR J ECOL, V40, P179, DOI 10.1046/j.1365-2028.2002.00376.x; Bennett Andrew F., 2009, Ecological Management & Restoration, V10, P192, DOI 10.1111/j.1442-8903.2009.00489.x; Bucini G, 2011, ECOSYSTEM FUNCTION S, P218; Buckland S. T, 1993, INTRO DISTANCE SAMPL; Carruthers Jane, 2008, Transactions of the Royal Society of South Africa, V63, P160; CAUGHLEY G, 1974, J WILDLIFE MANAGE, V38, P921, DOI 10.2307/3800067; CAUGHLEY G, 1977, J WILDLIFE MANAGE, V41, P605, DOI 10.2307/3799980; Child B, 2012, S AFR J SCI, V108, P1, DOI 10.4102/sajs.v108i7/8.1338; EBERHARDT LL, 1988, J APPL ECOL, V25, P373, DOI 10.2307/2403829; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; EDWARDS AWF, 1972, LIKELIHOOD; Ehrenfeld JG, 2000, RESTOR ECOL, V8, P2, DOI 10.1046/j.1526-100x.2000.80002.x; Emslie R., 1999, AFRICAN RHINO STATUS; Emslie RH, 1995, FINE TUNING RHINO MA; Everitt B. S., 2002, CAMBRIDGE DICT STAT; Ferreira SM, 2008, J WILDLIFE MANAGE, V72, P822, DOI 10.2193/2007-151; Ferreira SM, 2012, PACHYDERM, P52; Ferreira SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045989; Ferreira SM, 2011, S AFR J WILDL RES, V41, P192, DOI 10.3957/056.041.0206; Ferreira SM, 2009, S AFR J WILDL RES, V39, P181, DOI 10.3957/056.039.0205; Ferreira SM, 2013, UPDATE RHINO RES SUR; Fishman G. S., 1995, MONTE CARLO CONCEPTS; Gertenbach W.P.D., 1984, Koedoe, V26, P9; Greaver C, 2014, AUSTRAL ECOL, V39, P437, DOI 10.1111/aec.12101; Grimsdell JJR, 1981, ILCA ILRI MONOGRAPH, V4; Haas T.C., 2015, SECURITY INFORMATICS, V4, P2, DOI [10.1186/s13388-015-0018-8, DOI 10.1186/S13388-015-0018-8]; Han J, 1995, LECT NOTES COMPUT SC, V930, P195; HILLMANSMITH AKK, 1986, J ZOOL, V210, P355; HOOD G, 2005, POPTOOLS VERSION 2 6; Humphreys J, 2014, INT AFF, V90, P795, DOI 10.1111/1468-2346.12141; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Jones Marvin L., 1993, International Zoo Yearbook, V32, P159; Knight M., 2013, GOV GAZ S AFR, V36096, P5; Knight M, 2013, PACHYDERM, P7; Kruger JM, 2008, WILDLIFE RES, V35, P371, DOI 10.1071/WR07084; Linklater WL, 2008, J WILDLIFE MANAGE, V72, P1059, DOI 10.2193/2007-398; Linklater WL, 2010, S AFR J WILDL RES, V40, P58, DOI 10.3957/056.040.0107; Lunstrum E, 2014, ANN ASSOC AM GEOGR, V104, P816, DOI 10.1080/00045608.2014.912545; Milliken T., 2012, S AFRICA VIET NAM RH; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Pienaar DJ, 1993, THESIS U PRETORIA; Rachlow JL, 1998, ANIM CONSERV, V1, P101, DOI 10.1111/j.1469-1795.1998.tb00017.x; Redfern JV, 2002, S AFR J SCI, V98, P455; Schwabe F, 2013, ARBEITSBERICHTE GEOG, V175, P62; Smit IPJ, 2013, PACHYDERM, P91; Thomas R., 2010, TRAFFIC BULL, V23, P3; Thompson S.K., 2012, SAMPLING, V2nd; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Venter FJ, 2008, ECOSYSTEMS, V11, P173, DOI 10.1007/s10021-007-9116-x; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Walsh PD, 2001, J APPL ECOL, V38, P217, DOI 10.1046/j.1365-2664.2001.00578.x	54	30	30	2	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0127783	10.1371/journal.pone.0127783	http://dx.doi.org/10.1371/journal.pone.0127783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121681	Green Published, gold, Green Submitted			2022-12-26	WOS:000358150400007
J	Garces, MF; Sanchez, E; Cardona, LF; Simanca, EL; Gonzalez, I; Leal, LG; Mora, JA; Bedoya, A; Alzate, JP; Sanchez, AY; Eslava-Schmalbach, JH; Franco-Vega, R; Parra, MO; Ruiz-Parra, AI; Dieguez, C; Nogueiras, R; Caminos, JE				Garces, Maria F.; Sanchez, Elizabeth; Cardona, Luisa F.; Simanca, Elkin L.; Gonzalez, Ivan; Leal, Luis G.; Mora, Jose A.; Bedoya, Andres; Alzate, Juan P.; Sanchez, Angel Y.; Eslava-Schmalbach, Javier H.; Franco-Vega, Roberto; Parra, Mario O.; Ruiz-Parra, Ariel I.; Dieguez, Carlos; Nogueiras, Ruben; Caminos, Jorge E.			Maternal Serum Meteorin Levels and the Risk of Preeclampsia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; REGULATES ANGIOGENESIS; PLACENTAL ANGIOGENESIS; GROWTH-FACTOR; PREGNANCY; PROMOTES	Background Meteorin (METRN) is a recently described neutrophic factor with angiogenic properties. This is a nested case-control study in a longitudinal cohort study that describes the serum profile of METRN during different periods of gestation in healthy and preeclamptic pregnant women. Moreover, we explore the possible application of METRN as a biomarker. Methods and Findings Serum METRN was measured by ELISA in a longitudinal prospective cohort study in 37 healthy pregnant women, 16 mild preeclamptic women, and 20 healthy non-pregnant women during the menstrual cycle with the aim of assessing serum METRN levels and its correlations with other metabolic parameters. Immunostaining for METRN protein was performed in placenta. A multivariate logistic regression model was proposed and a classifier model was formulated for predicting preeclampsia in early and middle pregnancy. The performance in classification was evaluated using measures such as sensitivity, specificity, and the receiver operating characteristic (ROC) curve. In healthy pregnant women, serum METRN levels were significantly elevated in early pregnancy compared to middle and late pregnancy. METRN levels are significantly lower only in early pregnancy in preeclamptic women when compared to healthy pregnant women. Decision trees that did not include METRN levels in the first trimester had a reduced sensitivity of 56% in the detection of preeclamptic women, compared to a sensitivity of 69% when METRN was included. Conclusions The joint measurements of circulating METRN levels in the first trimester and systolic blood pressure and weight in the second trimester significantly increase the probabilities of predicting preeclampsia.	[Garces, Maria F.; Sanchez, Elizabeth; Cardona, Luisa F.; Simanca, Elkin L.; Gonzalez, Ivan; Leal, Luis G.; Caminos, Jorge E.] Univ Nacl Colombia, Sch Med, Dept Physiol, Bogota, Colombia; [Mora, Jose A.; Bedoya, Andres; Franco-Vega, Roberto] Univ Nacl Colombia, Sch Med, Dept Internal Med, Bogota, Colombia; [Alzate, Juan P.; Eslava-Schmalbach, Javier H.] Univ Nacl Colombia, Sch Med, Inst Clin Invest, Bogota, Colombia; [Sanchez, Angel Y.] Univ Nacl Colombia, Sch Med, Dept Pathol, Bogota, Colombia; [Parra, Mario O.; Ruiz-Parra, Ariel I.] Univ Nacl Colombia, Sch Med, Dept Obstet & Gynecol, Bogota, Colombia; [Dieguez, Carlos; Nogueiras, Ruben] Univ Santiago de Compostela, Sch Med, Inst Invest Sanitarias IDIS, Dept Physiol CIMUS, Santiago De Compostela, Spain; [Dieguez, Carlos; Nogueiras, Ruben] Inst Salud Carlos III, Biomed Res Ctr Physiopathol Obes & Nutr CIBERobn, Madrid, Spain	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Nogueiras, R (corresponding author), Univ Santiago de Compostela, Sch Med, Inst Invest Sanitarias IDIS, Dept Physiol CIMUS, Santiago De Compostela, Spain.	ruben.nogueiras@usc.es; jecaminosp@unal.edu.co	Nogueiras, Ruben/AAS-9427-2021; Eslava-Schmalbach, Javier/O-3954-2019; GARCES, MARIA FERNANDA/AAK-6740-2021	Nogueiras, Ruben/0000-0002-9976-9930; Eslava-Schmalbach, Javier/0000-0003-1502-2918; dieguez, carlos/0000-0002-0919-4337; Alzate, Juan Pablo/0000-0001-8344-494X; Simanca Castro, Elkin Leonardo/0000-0002-5412-8750	Direccion Nacional de Investigaciones (DIB); Vicerrectoria de Investigaciones of Universidad Nacional de Colombia; COLCIENCIAS [110154531660]; Ministerio de Economia y Competitividad [BFU2011-29102, BFU2012-35255]; Xunta de Galicia [EM 2012/039, 2012-CP069]; Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); FEDER; European Community's Seventh Framework Programme [245009: NeuroFAST, ERC-2011-StG-OBESITY53-281408]	Direccion Nacional de Investigaciones (DIB); Vicerrectoria de Investigaciones of Universidad Nacional de Colombia; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn); FEDER(European Commission); European Community's Seventh Framework Programme(European Commission)	This work has been supported by grants from the Direccion Nacional de Investigaciones (DIB) [JEC], the Vicerrectoria de Investigaciones of the Universidad Nacional de Colombia [JEC], COLCIENCIAS (Cod. 110154531660) [JEC], Ministerio de Economia y Competitividad (CD: BFU2011-29102; RN: BFU2012-35255), Xunta de Galicia (RN: EM 2012/039 and 2012-CP069) and Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn). CIBERobn is an initiative of the Instituto de Salud Carlos III ( ISCIII) of Spain which is supported by FEDER funds. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under the following grants: CD: no. 245009: NeuroFAST, and RN: ERC-2011-StG-OBESITY53-281408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RE, 2014, EUR J OBSTET GYN R B, V182, P194, DOI 10.1016/j.ejogrb.2014.09.027; Chen DB, 2014, MICROCIRCULATION, V21, P15, DOI 10.1111/micc.12093; Cunningham FG, 2015, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 4TH EDITION, P25, DOI 10.1016/B978-0-12-407866-6.00002-X; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Garces MF, 2014, CLIN ENDOCRINOL, V81, P141, DOI 10.1111/cen.12391; Garces MF, 2014, J CLIN ENDOCR METAB, V99, P2113, DOI 10.1210/jc.2013-4127; Jorgensen JR, 2009, J MOL NEUROSCI, V39, P104, DOI 10.1007/s12031-009-9189-4; Lee HS, 2010, J CELL SCI, V123, P1959, DOI 10.1242/jcs.063784; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Murthi P, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00133; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Park JA, 2008, GLIA, V56, P247, DOI 10.1002/glia.20600; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Song HS, 2002, BIOCHEM BIOPH RES CO, V290, P325, DOI 10.1006/bbrc.2001.6205; Tan EK, 2013, BEST PRACT RES CL OB, V27, P791, DOI 10.1016/j.bpobgyn.2013.08.001; von Dadelszen P, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0454-8; Wang K, 2012, J ENDOCRINOL, V212, P243, DOI 10.1530/JOE-11-0296; Wang ZL, 2012, J CEREBR BLOOD F MET, V32, P387, DOI 10.1038/jcbfm.2011.156; Witten I, 1999, WEKA PRACTICAL MACHI; ZWEIG MH, 1993, CLIN CHEM, V39, P561	23	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131013	10.1371/journal.pone.0131013	http://dx.doi.org/10.1371/journal.pone.0131013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121675	Green Published, gold, Green Submitted			2022-12-26	WOS:000358150400070
J	Miyata, S; Inoue, J; Shimizu, M; Sato, R				Miyata, Shingo; Inoue, Jun; Shimizu, Makoto; Sato, Ryuichiro			Xanthohumol Improves Diet-induced Obesity and Fatty Liver by Suppressing Sterol Regulatory Element-binding Protein (SREBP) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMULUS-LUPULUS L.; ENDOPLASMIC-RETICULUM; HEPATIC STEATOSIS; IN-VITRO; PROTEASOME PATHWAY; COPII PROTEINS; SMALL-MOLECULE; X-RECEPTOR; ER; TRANSPORT	Sterol regulatory element-binding proteins (SREBPs) are key transcription factors that stimulate the expression of genes involved in fatty acid and cholesterol biosynthesis. Here, we demonstrate that a prenylated flavonoid in hops, xanthohumol (XN), is a novel SREBP inactivator that reduces the de novo synthesis of fatty acid and cholesterol. XN independently suppressed the maturation of SREBPs of insulin-induced genes in a manner different from sterols. Our results suggest that XN impairs the endoplasmic reticulum-to-Golgi translocation of the SREBP cleavage-activating protein (SCAP)-SREBP complex by binding to Sec23/24 and blocking SCAP/SREBP incorporation into common coated protein II vesicles. Furthermore, in diet-induced obese mice, dietary XN suppressed SREBP-1 target gene expression in the liver accompanied by a reduction of the mature form of hepatic SREBP-1, and it inhibited the development of obesity and hepatic steatosis. Altogether, our data suggest that XN attenuates the function of SREBP-1 by repressing its maturation and that it has the potential of becoming a nutraceutical food or pharmacological agent for improving metabolic syndrome.	[Miyata, Shingo; Inoue, Jun; Shimizu, Makoto; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan	University of Tokyo	Inoue, J (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ajinoue@mail.ecc.u-tokyo.ac.jp; aroysato@mail.ecc.u-tokyo.ac.jp	INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754	Japan Science and Technology Agency; Tojuro Iijima Foundation for Food Science and Technology; Japanese Council for Science, Technology and Innovation; Cross-ministerial Strategic Innovation Promotion Program SIP [14533567]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Tojuro Iijima Foundation for Food Science and Technology; Japanese Council for Science, Technology and Innovation; Cross-ministerial Strategic Innovation Promotion Program SIP	This work was supported by research grants from Japan Science and Technology Agency (Research for Promoting Technological Seeds) (to J. I.), The Tojuro Iijima Foundation for Food Science and Technology (to J. I.), the Japanese Council for Science, Technology and Innovation, and Cross-ministerial Strategic Innovation Promotion Program SIP Project ID 14533567. The authors declare that they have no conflicts of interest with the contents of this article.	Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Casaschi A, 2004, J NUTR, V134, P1340, DOI 10.1093/jn/134.6.1340; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Doddapattar P, 2013, MOL NUTR FOOD RES, V57, P1718, DOI 10.1002/mnfr.201200794; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Guo J, 2006, DRUG METAB DISPOS, V34, P1152, DOI 10.1124/dmd.105.008250; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kirkwood JS, 2013, J BIOL CHEM, V288, P19000, DOI 10.1074/jbc.M112.445452; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Legette LL, 2013, PHYTOCHEMISTRY, V91, P236, DOI 10.1016/j.phytochem.2012.04.018; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lupinacci E, 2009, J AGR FOOD CHEM, V57, P7274, DOI 10.1021/jf901244k; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miranda CL, 2000, J AGR FOOD CHEM, V48, P3876, DOI 10.1021/jf0002995; Miyata S, 2012, FEBS LETT, V586, P1778, DOI 10.1016/j.febslet.2012.04.060; Mukai R, 2013, J NUTR, V143, P1558, DOI 10.3945/jn.113.176818; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nozawa H, 2005, BIOCHEM BIOPH RES CO, V336, P754, DOI 10.1016/j.bbrc.2005.08.159; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Possemiers S, 2005, J AGR FOOD CHEM, V53, P6281, DOI 10.1021/jf0509714; Possemiers S, 2006, J NUTR, V136, P1862, DOI 10.1093/jn/136.7.1862; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025; Stevens JF, 2000, PHYTOCHEMISTRY, V53, P759, DOI 10.1016/S0031-9422(00)00005-4; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Wunderlich S, 2005, MOL NUTR FOOD RES, V49, P874, DOI 10.1002/mnfr.200500051; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yui K, 2014, J OLEO SCI, V63, P159, DOI 10.5650/jos.ess13136; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	48	56	59	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20565	20579		10.1074/jbc.M115.656975	http://dx.doi.org/10.1074/jbc.M115.656975			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26140926	Green Published, hybrid			2022-12-26	WOS:000359608900052
J	Li, K; Cui, YC; Zhang, H; Liu, XP; Zhang, D; Wu, AL; Li, JJ; Tang, Y				Li, Kai; Cui, Yong-Chun; Zhang, Hong; Liu, Xiao-Peng; Zhang, Dong; Wu, Ai-Li; Li, Jian-Jun; Tang, Yue			Glutamine Reduces the Apoptosis of H9C2 Cells Treated with High-Glucose and Reperfusion through an Oxidation-Related Mechanism	PLOS ONE			English	Article							COMPLEX-I; MITOCHONDRIAL GLUTATHIONE; CARDIAC MITOCHONDRIA; SUPEROXIDE FORMATION; REDOX REGULATION; STRESS; INJURY; ANTIOXIDANT; METABOLISM; PROTEIN	Mitochondrial overproduction of reactive oxygen species (ROS) in diabetic hearts during ischemia/reperfusion injury and the anti-oxidative role of glutamine have been demonstrated. However, in diabetes mellitus the role of glutamine in cardiomyocytes during ischemia/reperfusion injury has not been explored. To examine the effects of glutamine and potential mechanisms, in the present study, rat cardiomyoblast H9C2 cells were exposed to high glucose (33 mM) and hypoxia-reoxygenation. Cell viability, apoptosis, intracellular glutamine, and mitochondrial and intracellular glutathione were determined. Moreover, ROS formation, complex I activity, membrane potential and adenosine triphosphate (ATP) content were also investigated. The levels of S-glutathionylated complex I and mitochondrial apoptosis-related proteins, including cytochrome c and caspase-3, were analyzed by western blot. Data indicated that high glucose and hypoxia-reoxygenation were associated with a dramatic decline of intercellular glutamine and increase in apoptosis. Glutamine supplementation correlated with a reduction in apoptosis and increase of glutathione and glutathione reduced/oxidized ratio in both cytoplasm and mitochondria, but a reduction of intracellular ROS. Glutamine supplementation was also associated with less S-glutathionylation and increased the activity of complex I, leading to less mitochondrial ROS formation. Furthermore, glutamine supplementation prevented from mitochondrial dysfunction presented as mitochondrial membrane potential and ATP levels and attenuated cytochrome c release into the cytosol and caspase-3 activation. We conclude that apoptosis induced by high glucose and hypoxia-reoxygenation was reduced by glutamine supplementation, via decreased oxidative stress and inactivation of the intrinsic apoptotic pathway.	[Li, Kai; Cui, Yong-Chun; Zhang, Hong; Liu, Xiao-Peng; Zhang, Dong; Wu, Ai-Li; Tang, Yue] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Beijing Key Lab Preclin Res & Evaluat Cardiovasc, Anim Expt Ctr,Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Kai; Cui, Yong-Chun; Zhang, Hong; Liu, Xiao-Peng; Zhang, Dong; Wu, Ai-Li; Tang, Yue] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Jian-Jun] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Div Dyslipidemia, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Li, JJ (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Div Dyslipidemia, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	lijianjun938@126.com; Tangyue1226@vip.sina.com	Cui, Yong/AAF-9300-2020		Beijing Science and Technology Committee Fund [Z101107052210004]; Peking Union Medical College Youth Fund [2012-XHQN04]; Peking Union Medical College Student Innovation Fund [2013-1002-45]	Beijing Science and Technology Committee Fund; Peking Union Medical College Youth Fund; Peking Union Medical College Student Innovation Fund	Beijing Science and Technology Committee Fund (Project No: Z101107052210004), YT. Peking Union Medical College Youth Fund (Project No: 2012-XHQN04), YCC. Peking Union Medical College Student Innovation Fund (Project No: 2013-1002-45), KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 2015, REDOX BIOL, V4, P14, DOI 10.1016/j.redox.2014.11.009; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bi J, 2008, NEUROSCI LETT, V442, P224, DOI 10.1016/j.neulet.2008.07.029; Cao HQ, 2012, APMIS, V120, P441, DOI 10.1111/j.1600-0463.2011.02825.x; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Eaton S, 2003, P NUTR SOC, V62, P745, DOI 10.1079/PNS2003284; Filippi C, 2015, NANOTOXICOLOGY, V9, P126, DOI 10.3109/17435390.2014.895437; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Ghosh S, 2005, AM J PHYSIOL-HEART C, V289, pH768, DOI 10.1152/ajpheart.00038.2005; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Lee Min Goo, 2009, Korean Circ J, V39, P243, DOI 10.4070/kcj.2009.39.6.243; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Lluis JM, 2005, J BIOL CHEM, V280, P3224, DOI 10.1074/jbc.M408244200; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Mapanga RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047322; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Mari M, 2013, BBA-GEN SUBJECTS, V1830, P3317, DOI 10.1016/j.bbagen.2012.10.018; Mates JM, 2009, INT J BIOCHEM CELL B, V41, P2051, DOI 10.1016/j.biocel.2009.03.003; Munzel T, 2010, EUR HEART J, V31, P2741, DOI 10.1093/eurheartj/ehq396; Natalicchio A, 2015, DIABETOLOGIA, V58, P1260, DOI 10.1007/s00125-015-3563-2; Naudi A, 2012, EXP DIABETES RES, DOI 10.1155/2012/696215; Ogunlesi F, 2004, BBA-MOL BASIS DIS, V1688, P112, DOI 10.1016/j.bbadis.2003.10.008; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Passarelli C, 2010, INT J MOL MED, V26, P95, DOI 10.3892/ijmm_00000439; Raza JA, 2003, INT J CARDIOL, V89, P123, DOI 10.1016/S0167-5273(02)00510-7; Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151; Santos DL, 2003, MOL CELL BIOCHEM, V246, P163, DOI 10.1023/A:1023475022025; Shen Garry X., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P106; Sugioka R, 2003, ONCOGENE, V22, P8432, DOI 10.1038/sj.onc.1207180; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Tsai CY, 2013, INT J CARDIOL, V168, P1286, DOI 10.1016/j.ijcard.2012.12.004; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Wischmeyer PE, 2003, JPEN-PARENTER ENTER, V27, P396, DOI 10.1177/0148607103027006396; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Xu F, 2014, PHARMACOLOGY, V93, P155, DOI 10.1159/000360181; Zabot GP, 2014, WORLD J GASTROENTERO, V20, P11406, DOI 10.3748/wjg.v20.i32.11406; Zhu SS, 2011, DIABETOLOGIA, V54, P2440, DOI 10.1007/s00125-011-2226-1; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	43	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132402	10.1371/journal.pone.0132402	http://dx.doi.org/10.1371/journal.pone.0132402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146991	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600258
J	Su, J; Liu, HY; Tan, XL; Ji, Y; Jiang, YX; Prabhakar, M; Rong, ZH; Zhou, HW; Zhang, GX				Su, Jin; Liu, Hai-yue; Tan, Xi-lan; Ji, Yong; Jiang, Yun-xia; Prabhakar, M.; Rong, Zu-hua; Zhou, Hong-wei; Zhang, Guo-xia			Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY MICROBIOTA; DIVERSITY; INFECTION; END	The changes in the microbial community structure during acute exacerbations of severe chronic obstructive pulmonary disease (COPD) in hospitalized patients remain largely uncharacterized. Therefore, further studies focused on the temporal dynamics and structure of sputum microbial communities during acute exacerbation of COPD (AECOPD) would still be necessary. In our study, the use of molecular microbiological techniques provided insight into both fungal and bacterial diversities in AECOPD patients during hospitalization. In particular, we examined the structure and varieties of lung microbial community in 6 patients with severe AECOPD by amplifying 16S rRNA V4 hyper-variable and internal transcribed spacer (ITS) DNA regions using barcoded primers and the Illumina sequencing platform. Sequence analysis showed 261 bacterial genera representing 20 distinct phyla, with an average number of genera per patient of >157, indicating high diversity. Acinetobacter, Prevotella, Neisseria, Rothia, Lactobacillus, Leptotrichia, Streptococcus, Veillonella, and Actinomyces were the most commonly identified genera, and the average total sequencing number per sputum sample was >10000 18S ITS sequences. The fungal population was typically dominated by Candia, Phialosimplex, Aspergillus, Penicillium, Cladosporium and Eutypella. Our findings highlight that COPD patients have personalized structures and varieties in sputum microbial community during hospitalization periods.	[Su, Jin; Liu, Hai-yue; Tan, Xi-lan; Ji, Yong; Jiang, Yun-xia; Prabhakar, M.; Rong, Zu-hua; Zhou, Hong-wei; Zhang, Guo-xia] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, State Key Lab Organ Failure Res,Dept Environm Hlt, Guangzhou, Guangdong, Peoples R China; [Su, Jin] Southern Med Univ, Nanfang Hosp, Dept Resp Phys, Guangzhou, Guangdong, Peoples R China; [Tan, Xi-lan] Southern Med Univ, Zhujiang Hosp, Dept Hosp Infect Management, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, GX (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, State Key Lab Organ Failure Res,Dept Environm Hlt, Guangzhou, Guangdong, Peoples R China.	guoxiazhang@126.com	Zhou, Hongwei/B-4193-2008		National Science Foundation of China (NSFC) [31270152, 31322003]; Educational Commission of Guangdong Province of China [2012KJCX0031]; School of Public Health and Tropical Medicine of Southern Medical University, China [GW201435, GW201431]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Educational Commission of Guangdong Province of China; School of Public Health and Tropical Medicine of Southern Medical University, China	This work was supported by the National Science Foundation of China (NSFC 31270152, 31322003) (http://www.nsfc.gov.cn/), who provided support for the lab materials; the Educational Commission of Guangdong Province of China (2012KJCX0031), (http://www.gdhed.edu.cn/), who provided support for the Illumina sequencing; and a grant from School of Public Health and Tropical Medicine of Southern Medical University, China (grant no. GW201435, GW201431) (http://portal.smu.edu.cn/gwxy/), who provided support for the AJE costs.	Adamantia L, 2014, EXPERT OPIN PHARMACO, V15, P2307, DOI 10.1517/14656566.2014.959927; Barberan J, 2014, REV IBEROAM MICOL, V31, P237, DOI 10.1016/j.riam.2014.07.004; Bhatt SP, 2013, AM J RESP CRIT CARE, V188, P1046, DOI 10.1164/rccm.201309-1651ED; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chhabra Sunil K, 2014, Indian J Chest Dis Allied Sci, V56, P93; Clark TW, 2015, EUR RESPIR J, V45, P76, DOI 10.1183/09031936.00092214; Daniels JMA, 2010, CHEST, V138, P1108, DOI 10.1378/chest.09-2927; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Du QX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113048; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gao JM, 2013, J THORAC DIS, V5, P549, DOI 10.3978/j.issn.2072-1439.2013.08.04; He Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-208; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; King Paul T, 2013, Transl Respir Med, V1, P13, DOI 10.1186/2213-0802-1-13; Kiser TH, 2014, AM J RESP CRIT CARE, V189, P1052, DOI 10.1164/rccm.201401-0058OC; Matsuda F, 2013, ANAL CHEM, V85, P8291, DOI 10.1021/ac401564v; Moller LVM, 1998, AM J RESP CRIT CARE, V157, P950; Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Pashley CH, 2014, MYCOPATHOLOGIA, V178, P457, DOI 10.1007/s11046-014-9804-y; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2000, CHEST, V118, P1557, DOI 10.1378/chest.118.6.1557; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sze MA, 2014, INT J CHRONIC OBSTR, V9, P229, DOI 10.2147/COPD.S38932; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tang C, 2014, RESPIROLOGY, V19, P50; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Wu XD, 2014, MOL BIOL REP, V41, P4743, DOI 10.1007/s11033-014-3345-9	34	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130736	10.1371/journal.pone.0130736	http://dx.doi.org/10.1371/journal.pone.0130736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147303	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600045
J	Hindman, B; Goeckeler, Z; Sierros, K; Wysolmerski, R				Hindman, Bridget; Goeckeler, Zoe; Sierros, Kostas; Wysolmerski, Robert			Non-Muscle Myosin II Isoforms Have Different Functions in Matrix Rearrangement by MDA-MB-231 Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; BIOMECHANICAL REGULATION; MECHANOTRANSDUCTION; CONTRACTION; MECHANICS; MIGRATION; STIFFNESS; TENSION; INVASIVENESS; FIBROBLASTS	The role of a stiffening extra-cellular matrix (ECM) in cancer progression is documented but poorly understood. Here we use a conditioning protocol to test the role of nonmuscle myosin II isoforms in cell mediated ECM arrangement using collagen constructs seeded with breast cancer cells expressing shRNA targeted to either the IIA or IIB heavy chain isoform. While there are several methods available to measure changes in the biophysical characteristics of the ECM, we wanted to use a method which allows for the measurement of global stiffness changes as well as a dynamic response from the sample over time. The conditioning protocol used allows the direct measurement of ECM stiffness. Using various treatments, it is possible to determine the contribution of various construct and cellular components to the overall construct stiffness. Using this assay, we show that both the IIA and IIB isoforms are necessary for efficient matrix remodeling by MDA-MB-231 breast cancer cells, as loss of either isoform changes the stiffness of the collagen constructs as measured using our conditioning protocol. Constructs containing only collagen had an elastic modulus of 0.40 Pascals (Pa), parental MDA-MB-231 constructs had an elastic modulus of 9.22 Pa, while IIA and IIB KD constructs had moduli of 3.42 and 7.20 Pa, respectively. We also calculated the cell and matrix contributions to the overall sample elastic modulus. Loss of either myosin isoform resulted in decreased cell stiffness, as well as a decrease in the stiffness of the cell-altered collagen matrices. While the total construct modulus for the IIB KD cells was lower than that of the parental cells, the IIB KD cell-altered matrices actually had a higher elastic modulus than the parental cell-altered matrices (4.73 versus 4.38 Pa). These results indicate that the IIA and IIB heavy chains play distinct and non-redundant roles in matrix remodeling.	[Hindman, Bridget; Wysolmerski, Robert] W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Goeckeler, Zoe; Wysolmerski, Robert] W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Ctr Cardiovasc & Resp Dis, Morgantown, WV 26506 USA; [Sierros, Kostas] W Virginia Univ, Mech & Aerosp Engn, Statler Coll Engn & Mineral Resources, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Wysolmerski, R (corresponding author), W Virginia Univ, Robert C Byrd Hlth Sci Ctr, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	rwysolmerski@hsc.wvu.edu		Hindman, Bridget/0000-0003-2153-5912	Bank One MBR Cancer Center Endowment [3V456]; Joyce & John Allen Experimental Therapeutic Fund [2R300]; Cancer CoBRE grant, National Center For Research Resources [P20RR016440]; National Heart, Lung, and Blood Institute [T32 HL090610]; National Science Foundation [1003907]; National Institute of General Medical Sciences [P30GM103488, P30GM103503]; National Center For Research Resources [P30RR031155]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031155, P20RR016440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL090610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103503, P30GM103488] Funding Source: NIH RePORTER; Office of Integrative Activities [1003907] Funding Source: National Science Foundation	Bank One MBR Cancer Center Endowment; Joyce & John Allen Experimental Therapeutic Fund; Cancer CoBRE grant, National Center For Research Resources; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Support was provided by: 3V456, Bank One MBR Cancer Center Endowment, RW; 2R300, Joyce & John Allen Experimental Therapeutic Fund, RW; Cancer CoBRE grant: P20RR016440, National Center For Research Resources, RW, www.nih.gov/about/almanac/organization/NCRR.htm; T32 HL090610, National Heart, Lung, and Blood Institute, BH, www.nhlbi.nih.gov/; Cooperative Agreement 1003907, National Science Foundation, BH, www.nsf.gov. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cancer CoBRE grant: P30GM103488, National Institute of General Medical Sciences, www.nigms.nih.gov. These funds support the WVU Microscope Imaging Facility whose services were used for data collection for this manuscript. Support was also provided by Neurosciences CoBRE grant P30RR031155, National Center For Research Resources. These funds support the development and maintenance of the multiphoton laser scanning microscope used in this study. P30GM103503, National Institute of General Medical Sciences [www.nigms.nih.gov]. These funds support the development and maintenance of the multiphoton laser scanning microscope used in this study.	Aguilar-Cuenca R, 2014, CELL MOL LIFE SCI, V71, P479, DOI 10.1007/s00018-013-1439-5; Baker EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020355; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Balcioglu HE, 2015, J CELL SCI, V128, P1316, DOI 10.1242/jcs.156950; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Betapudi V, 2011, J MOL BIOL, V407, P673, DOI 10.1016/j.jmb.2011.02.010; Billington N, 2013, J BIOL CHEM, V288, P33398, DOI 10.1074/jbc.M113.499848; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Fischer-Cripps AC, 2011, MECH ENG SER, P235, DOI 10.1007/978-1-4419-9872-9_13; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kirmizis D, 2010, INT J NANOMED, V5, P137; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Maciver SK, 1996, BIOESSAYS, V18, P179, DOI 10.1002/bies.950180304; Maeda J, 2008, BRIT J CANCER, V98, P596, DOI 10.1038/sj.bjc.6604197; Marquez JP, 2010, PHILOS T R SOC A, V368, P635, DOI 10.1098/rsta.2009.0240; Marquez JP, 2005, BIOPHYS J, V88, P778, DOI 10.1529/biophysj.104.041947; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Millerot-Serrurot E, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-26; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Ngo P, 2006, METH MOL B, V341, P103; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Saha S, 2011, FEBS J, V278, P4025, DOI 10.1111/j.1742-4658.2011.08306.x; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Society AC, 2013, BREAST CANC FACTS FI; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vernon RB, 2002, IN VITRO CELL DEV-AN, V38, P97, DOI 10.1290/1071-2690(2002)038<0097:AIMFTC>2.0.CO;2; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Xia ZK, 2012, DIS ESOPHAGUS, V25, P427, DOI 10.1111/j.1442-2050.2011.01261.x; Yamane Y, 2000, J ELECTRON MICROSC, V49, P463, DOI 10.1093/oxfordjournals.jmicro.a023830; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015; Yu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079776; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4	61	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131920	10.1371/journal.pone.0131920	http://dx.doi.org/10.1371/journal.pone.0131920			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136073	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400082
J	McGovern, VL; Massoni-Laporte, A; Wang, XY; Le, TT; Le, HT; Beattie, CE; Rich, MM; Burghes, AHM				McGovern, Vicki L.; Massoni-Laporte, Aurelie; Wang, Xueyong; Le, Thanh T.; Le, Hao T.; Beattie, Christine E.; Rich, Mark M.; Burghes, Arthur H. M.			Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the Delta 7 SMA Mouse	PLOS ONE			English	Article							SURVIVAL-MOTOR-NEURON; PROTEIN STABILITY; SINGLE NUCLEOTIDE; DETERMINING GENE; MESSENGER-RNA; SMN2 GENE; MICE; DELETION; MODEL; IDENTIFICATION	Spinal muscular atrophy is caused by loss of the SMN1 gene and retention of SMN2. The SMN2 copy number inversely correlates with phenotypic severity and is a modifier of disease outcome. The SMN2 gene essentially differs from SMN1 by a single nucleotide in exon 7 that modulates the incorporation of exon 7 into the final SMN transcript. The majority of the SMN2 transcripts lack exon 7 and this leads to a SMN protein that does not effectively oligomerize and is rapidly degraded. However the SMN2 gene does produce some fulllength SMN and the SMN2 copy number along with how much full- length SMN the SMN2 gene makes correlates with severity of the SMA phenotype. However there are a number of discordant SMA siblings that have identical haplotypes and SMN2 copy number yet one has a milder form of SMA. It has been suggested that Plastin3 (PLS3) acts as a sex specific phenotypic modifier where increased expression of PLS3 modifies the SMA phenotype in females. To test the effect of PLS3 overexpression we have over expressed full- length PLS3 in SMA mice. To ensure no disruption of functionality or post- translational processing of PLS3 we did not place a tag on the protein. PLS3 protein was expressed under the Prion promoter as we have shown previously that SMN expression under this promoter can rescue SMA mice. High levels of PLS3 mRNA were expressed in motor neurons along with an increased level of PLS3 protein in total spinal cord, yet there was no significant beneficial effect on the phenotype of SMA mice. Specifically, neither survival nor the fundamental electrophysiological aspects of the neuromuscular junction were improved upon overexpression of PLS3 in neurons.	Ohio State Univ, Wexner Med Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wang, Xueyong; Rich, Mark M.] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA; [Le, Hao T.; Beattie, Christine E.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA; [Burghes, Arthur H. M.] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Wright State University Dayton; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Burghes, AHM (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	burghes.1@osu.edu	Le, Thanh/GRY-4094-2022	McGovern, Vicki/0000-0003-3979-9596; Burghes, Arthur/0000-0001-9031-1555	National Institute of Child Health & Human Development [RO1-DH060586]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS057228] Funding Source: NIH RePORTER	National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by The National Institute of Child Health & Human Development RO1-DH060586 to AHMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Alvarez-Castelao B, 2012, BBA-MOL CELL RES, V1823, P524, DOI 10.1016/j.bbamcr.2011.11.010; Arnold WD, 2014, ANN CLIN TRANSL NEUR, V1, P34, DOI 10.1002/acn3.23; Bebee TW, 2010, FRONT BIOSCI-LANDMRK, V15, P1191, DOI 10.2741/3670; Begue E, 2013, SOJ IMMUNOLOGY, V1, P4; Bernal S, 2010, J MED GENET, V47, P640, DOI 10.1136/jmg.2010.079004; Bernal S, 2011, NEUROMUSCULAR DISORD, V21, P413, DOI 10.1016/j.nmd.2011.03.009; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Bowerman M, 2009, MOL CELL NEUROSCI, V42, P66, DOI 10.1016/j.mcn.2009.05.009; Burghes AH, 1997, AM J HUM GENET, V61; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Cao YY, 2014, J HUM GENET, V59, P24, DOI 10.1038/jhg.2013.111; Capon F, 1996, NEUROMUSCULAR DISORD, V6, P261, DOI 10.1016/0960-8966(96)00350-1; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; COBBEN JM, 1995, AM J HUM GENET, V57, P805; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hao LT, 2012, J NEUROSCI, V32, P5074, DOI 10.1523/JNEUROSCI.5808-11.2012; Hasanzad M, 2010, EUR J NEUROL, V17, P160, DOI 10.1111/j.1468-1331.2009.02693.x; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Hisano T, 1996, FEBS LETT, V397, P101, DOI 10.1016/S0014-5793(96)01150-7; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Iyer CC, 2014, NEUROMUSCULAR DISORD, V24, P436, DOI 10.1016/j.nmd.2014.02.007; Jones CL, 2012, J INVEST DERMATOL, V132, P2042, DOI 10.1038/jid.2012.106; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2011, HUM MOL GENET, V20, P3578, DOI 10.1093/hmg/ddr275; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Ledent P, 1997, FEBS LETT, V413, P194, DOI 10.1016/S0014-5793(97)00908-3; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lesbordes JC, 2003, HUM MOL GENET, V12, P1233, DOI 10.1093/hmg/ddg143; Li DK, 2014, SEMIN CELL DEV BIOL, V32, P22, DOI 10.1016/j.semcdb.2014.04.026; Ling K. K., 2011, PLOS ONE, V5, DOI DOI 10.1371/J0URNAL.P0NE.0015457; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lyon AN, 2014, HUM MOL GENET, V23, P1990, DOI 10.1093/hmg/ddt595; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Parano E, 1996, ANN NEUROL, V40, P247, DOI 10.1002/ana.410400219; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Rochette CF, 1997, NEUROGENETICS, V1, P141, DOI 10.1007/s100480050021; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; SCHMID P C, 1958, Z Kinderheilkd, V81, P13, DOI 10.1007/BF00438362; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Stratigopoulos G, 2010, ARCH NEUROL-CHICAGO, V67, P1252, DOI 10.1001/archneurol.2010.239; Szkandera J, 2013, TUMOR BIOL, V34, P2183, DOI 10.1007/s13277-013-0754-7; Tinker AV, 1998, NUCLEIC ACIDS RES, V26, P2935, DOI 10.1093/nar/26.12.2935; Tsai LK, 2008, NEUROBIOL DIS, V31, P361, DOI 10.1016/j.nbd.2008.05.014; Vezain M, 2010, HUM MUTAT, V31, pE1110, DOI 10.1002/humu.21173; Westerfield, 1995, ZEBRAFISH BOOK GUIDE	67	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132364	10.1371/journal.pone.0132364	http://dx.doi.org/10.1371/journal.pone.0132364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134627	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400113
J	Perotti, EA; Georgopoulos, K; Yoshida, T				Perotti, Elizabeth A.; Georgopoulos, Katia; Yoshida, Toshimi			An Ikaros Promoter Element with Dual Epigenetic and Transcriptional Activities	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMATIN REMODELER MI-2-BETA; DNA-BINDING PROTEINS; T-CELL DEVELOPMENT; LYMPHOCYTE DEVELOPMENT; GENE-EXPRESSION; LINEAGE COMMITMENT; GENOME-WIDE; COMPLEX; DIFFERENTIATION	Ikaros DNA binding factor plays critical roles in lymphocyte development. Changes in Ikaros expression levels during lymphopoiesis are controlled by redundant but also unique regulatory elements of its locus that are critical for this developmental process. We have recently shown that Ikaros binds its own locus in thymocytes in vivo. Here, we evaluated the role of an Ikaros binding site within its major lympho-myeloid promoter. We identified an Ikaros/Ets binding site within a promoter sub-region that was highly conserved in mouse and human. Deletion of this binding site increased the percentage of the reporter-expressing mouse lines, indicating that its loss provided a more permissive chromatin environment. However, once transcription was established, the lack of this site decreased transcriptional activity. These findings implicate a dual role for Ikaros/Ets1 binding on Ikzf1 expression that is exerted at least through its promoter.	[Perotti, Elizabeth A.; Georgopoulos, Katia; Yoshida, Toshimi] Harvard Univ, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Yoshida, T (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Sch Med, Charlestown, MA 02129 USA.	toshimi.yoshida@cbrc2.mgh.harvard.edu	Yoshida, Toshimi/GSN-8717-2022	Yoshida, Toshimi/0000-0001-7080-6913	National Institute of Health [537 R01 AI33062, 9R01CA162092-19, 5R01CA162092-22]; NATIONAL CANCER INSTITUTE [R01CA162092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033062] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the National Institute of Health, http://www.nih.gov/, 537 R01 AI33062 to KG, 9R01CA162092- 19 to KG, 5R01CA162092-22 to KG.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cobb BS, 2005, CURR TOP MICROBIOL, V290, P29; Consortium EP, 2011, PLOS BIOL, V9, P1; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Dupuis A, 2013, LEUKEMIA, V27, P503, DOI 10.1038/leu.2012.204; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Kaufmann C, 2003, EMBO J, V22, P2211, DOI 10.1093/emboj/cdg186; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Naito T, 2007, IMMUNITY, V27, P723, DOI 10.1016/j.immuni.2007.09.008; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; Shimono Y, 2003, J BIOL CHEM, V278, P51638, DOI 10.1074/jbc.M309198200; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; TYMMS MJ, 1994, MOL REPROD DEV, V39, P208, DOI 10.1002/mrd.1080390214; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Yoshida T, 2014, INT J HEMATOL, V100, P220, DOI 10.1007/s12185-014-1644-5; Yoshida T, 2013, BLOOD, V122, P3149, DOI 10.1182/blood-2013-01-474916; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131568	10.1371/journal.pone.0131568	http://dx.doi.org/10.1371/journal.pone.0131568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135129	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400056
J	Ranger, CM; Schultz, PB; Frank, SD; Chong, JH; Reding, ME				Ranger, Christopher M.; Schultz, Peter B.; Frank, Steven D.; Chong, Juang H.; Reding, Michael E.			Non-Native Ambrosia Beetles as Opportunistic Exploiters of Living but Weakened Trees	PLOS ONE			English	Article							ETHANOL-BAITED TRAPS; XYLOSANDRUS-GERMANUS COLEOPTERA; CURCULIONIDAE SCOLYTINAE; EXOTIC BARK; STRESS; ATTRACTION; EFFICACY; FUNGUS; ATTACK; PLANT	Exotic Xylosandrus spp. ambrosia beetles established in non-native habitats have been associated with sudden and extensive attacks on a diverse range of living trees, but factors driving their shift from dying/dead hosts to living and healthy ones are not well understood. We sought to characterize the role of host physiological condition on preference and colonization by two invaders, Xylosandrus germanus and Xylosandrus crassiusculus. When given free-choice under field conditions among flooded and non-flooded deciduous tree species of varying intolerance to flooding, beetles attacked flood-intolerant tree species over more tolerant species within 3 days of initiating flood stress. In particular, flood-intolerant flowering dogwood (Cornus florida) sustained more attacks than flood-tolerant species, including silver maple (Acer saccharinum) and swamp white oak (Quercus bicolor). Ethanol, a key host-derived attractant, was detected at higher concentrations 3 days after initiating flooding within stems of flood intolerant species compared to tolerant and non-flooded species. A positive correlation was also detected between ethanol concentrations in stem tissue and cumulative ambrosia beetle attacks. When adult X. germanus and X. crassiusculus were confined with no-choice to stems of flood-stressed and non-flooded C. florida, more ejected sawdust resulting from tunneling activity was associated with the flood-stressed trees. Furthermore, living foundresses, eggs, larvae, and pupae were only detected within galleries created in stems of flood-stressed trees. Despite a capability to attack diverse tree genera, X. germanus and X. crassiusculus efficiently distinguished among varying host qualities and preferentially targeted trees based on their intolerance of flood stress. Non-flooded trees were not preferred or successfully colonized. This study demonstrates the host-selection strategy exhibited by X. germanus and X. crassiusculus in non-native habitats involves detection of stress-induced ethanol emission and early colonization of living but weakened trees.	[Ranger, Christopher M.; Reding, Michael E.] USDA ARS, Hort Insects Res Lab, Wooster, OH 44691 USA; [Ranger, Christopher M.; Reding, Michael E.] Ohio State Univ, Dept Entomol, Ohio Agr Res & Dev Ctr, Wooster, OH 44691 USA; [Schultz, Peter B.] Virginia Polytech Inst & State Univ, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA USA; [Frank, Steven D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Chong, Juang H.] Clemson Univ, Pee Dee Res & Educ Ctr, Florence, SC 29506 USA	United States Department of Agriculture (USDA); University System of Ohio; Ohio State University; Virginia Polytechnic Institute & State University; University of North Carolina; North Carolina State University; Clemson University	Ranger, CM (corresponding author), USDA ARS, Hort Insects Res Lab, Wooster, OH 44691 USA.	christopher.ranger@ars.usda.gov	Ranger, Christopher/R-7367-2018	Ranger, Christopher/0000-0002-2012-6984	USDA Floriculture and Nursery Research Initiative; USDA ARS Research Project (National Program 304-Crop Protection and Quarantine) [3607-22000-012-00D]; Horticultural Research Institute	USDA Floriculture and Nursery Research Initiative; USDA ARS Research Project (National Program 304-Crop Protection and Quarantine); Horticultural Research Institute	This research was funded by the USDA Floriculture and Nursery Research Initiative and base funds associated with USDA ARS Research Project 3607-22000-012-00D (National Program 304-Crop Protection and Quarantine), and the Horticultural Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RL, 1978, PLANT DIS REP, V62, P751; [Anonymous], 1995, AGR HDB; Atkinson TH, 1988, XYLOSANDRUS CRASSIUS, V310; Biedermann PHW, 2009, ENVIRON ENTOMOL, V38, P1096, DOI 10.1603/022.038.0417; BORDEN JH, 1989, HOLARCTIC ECOL, V12, P501; BORDEN JH, 1968, CAN ENTOMOL, V100, P629, DOI 10.4039/Ent100629-6; Bouget C, 2005, J APPL ENTOMOL, V129, P300, DOI 10.1111/j.1439-0418.2005.00970.x; BROADFOOT WM, 1973, J FOREST, V71, P584; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; CABI/EPPO, 2009, XYL CRASS AS AMBR BE; CABI/EPPO, 2008, XYL GERM BLACK TIMB; Damesin C, 2002, NEW PHYTOL, V153, P159, DOI 10.1046/j.0028-646X.2001.00296.x; Day SD, 2000, TREE PHYSIOL, V20, P257; DOCHINGER LEON S., 1962, JOUR FOREST, V60, P331; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; DUNN JP, 1986, OECOLOGIA, V70, P596, DOI 10.1007/BF00379911; FRENCH JRJ, 1972, CAN ENTOMOL, V104, P1635, DOI 10.4039/Ent1041635-10; Galko J, 2014, BIOLOGIA, V69, P1376, DOI 10.2478/s11756-014-0443-z; Gilman EF, 1993, STYRAX JAPONICUS JAP; Gregoire Jean-Claude, 2003, Integrated Pest Management Reviews, V6, P237, DOI 10.1023/A:1025723402355; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Haack RA, 2013, CABI INVASIVE SER, P48, DOI 10.1079/9781845938291.0048; Hall RBW, 1998, ECOLOGY, V79, P847, DOI 10.1890/0012-9658(1998)079[0847:FAAPOF]2.0.CO;2; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; Harrington TC, 2014, MYCOLOGIA, V106, P835, DOI 10.3852/13-354; HEIDENREICH E., 1964, Zeitschrift fur Angewandte Entomologie, V54, P131; Henin JM, 2004, J PEST SCI, V77, P57, DOI 10.1007/s10340-003-0030-5; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; JOLY CA, 1982, J EXP BOT, V33, P799, DOI 10.1093/jxb/33.4.799; Jordal BH, 2001, GLOBAL ECOL BIOGEOGR, V10, P345, DOI 10.1046/j.1466-822X.2001.00242.x; Joseph G, 1997, INT J PLANT SCI, V158, P844, DOI 10.1086/297498; Kelsey RG, 2001, NORTHWEST SCI, V75, P70; KENNEDY RA, 1992, PLANT PHYSIOL, V100, P1, DOI 10.1104/pp.100.1.1; Keshavareddy G., 2008, Current Biotica, V2, P18; KESSLER KJ, 1974, PLANT DIS REP, V58, P1044; KIMMERER TW, 1987, PLANT PHYSIOL, V84, P1204, DOI 10.1104/pp.84.4.1204; KIMMERER TW, 1982, PLANT PHYSIOL, V69, P840, DOI 10.1104/pp.69.4.840; KOVACH J, 1985, Journal of Agricultural Entomology, V2, P238; Kuhnholz Susanne, 2003, Integrated Pest Management Reviews, V6, P209, DOI 10.1023/A:1025702930580; La Spina S, 2013, AGR FOREST ENTOMOL, V15, P157, DOI 10.1111/j.1461-9563.2012.00596.x; Laidlaw WG, 2003, ENVIRON ENTOMOL, V32, P477, DOI 10.1603/0046-225X-32.3.477; MACDONALD RC, 1991, PHYSIOL PLANTARUM, V82, P582, DOI 10.1111/j.1399-3054.1991.tb02950.x; Norris D.M., 1979, P53; Oliver JB, 2001, ENVIRON ENTOMOL, V30, P909, DOI 10.1603/0046-225X-30.5.909; Pennacchio Fabrizio, 2003, Redia, V86, P77; Ploetz RC, 2013, PLANT DIS, V97, P856, DOI 10.1094/PDIS-01-13-0056-FE; Rabaglia R, 2008, EARLY DETECTION RAPI; Rabaglia RJ, 2006, ANN ENTOMOL SOC AM, V99, P1034, DOI 10.1603/0013-8746(2006)99[1034:ROAXCC]2.0.CO;2; Rabaglia RJ, 2009, ZOOTAXA, P23, DOI 10.11646/zootaxa.2137.1.2; Ranger CM, 2015, BIOL INVASIONS, V17, P675, DOI 10.1007/s10530-014-0758-2; Ranger CM, 2014, AGR FOREST ENTOMOL, V16, P327, DOI 10.1111/afe.12062; Ranger CM, 2013, ENVIRON ENTOMOL, V42, P539, DOI 10.1603/EN13016; Ranger CM, 2013, AGR FOREST ENTOMOL, V15, P56, DOI 10.1111/j.1461-9563.2012.00591.x; Ranger CM, 2012, ENVIRON ENTOMOL, V41, P636, DOI 10.1603/EN11299; Ranger CM, 2011, J ECON ENTOMOL, V104, P1665, DOI 10.1603/EC11106; Ranger CM, 2011, J ECON ENTOMOL, V104, P574, DOI 10.1603/EC10243; Ranger CM, 2010, AGR FOREST ENTOMOL, V12, P177, DOI 10.1111/j.1461-9563.2009.00469.x; Ranney Thomas G., 1994, Journal of Environmental Horticulture, V12, P138; Reding Michael, 2010, Journal of Environmental Horticulture, V28, P85; Reding ME, 2013, J ECON ENTOMOL, V106, P289, DOI 10.1603/EC12315; RENWICK JAA, 1977, NATURWISSENSCHAFTEN, V64, P226, DOI 10.1007/BF00449980; SAS Institute, 2001, PROC US MAN VERS 6; SCHEDL KARL E., 1962, REV ENTOMOL MOCAMBIQUE, V5, P1; SCHOENEWEISS DF, 1975, ANNU REV PHYTOPATHOL, V13, P193, DOI 10.1146/annurev.py.13.090175.001205; Sigma-Aldrich, 2015, SPME FIB ASS CARB PO; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; Sreedharan K., 1991, Journal of Coffee Research, V21, P145; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; TRIPEPI RR, 1984, PLANT PHYSIOL, V76, P31, DOI 10.1104/pp.76.1.31; WEBER B C, 1983, Coleopterists Bulletin, V37, P114; WEBER BC, 1985, CAN ENTOMOL, V117, P1275, DOI 10.4039/Ent1171275-10; WEBER BC, 1984, FOREST SCI, V30, P864; WEBER BC, 1984, CAN ENTOMOL, V116, P281, DOI 10.4039/Ent116281-2; Wulf A., 2005, Forst und Holz, V60, P145	74	62	64	2	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131496	10.1371/journal.pone.0131496	http://dx.doi.org/10.1371/journal.pone.0131496			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134522	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400052
J	Amen, DG; Raji, CA; Willeumier, K; Taylor, D; Tarzwell, R; Newberg, A; Henderson, TA				Amen, Daniel G.; Raji, Cyrus A.; Willeumier, Kristen; Taylor, Derek; Tarzwell, Robert; Newberg, Andrew; Henderson, Theodore A.			Functional Neuroimaging Distinguishes Posttraumatic Stress Disorder from Traumatic Brain Injury in Focused and Large Community Datasets	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSCRANIAL MAGNETIC STIMULATION; EMISSION COMPUTED-TOMOGRAPHY; MENTAL-HEALTH PROBLEMS; PSYCHIATRIC-DISORDERS; PREFRONTAL CORTEX; POLICE OFFICERS; PTSD SYMPTOMS; PERFUSION; SPECT	Background Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are highly heterogeneous and often present with overlapping symptomology, providing challenges in reliable classification and treatment. Single photon emission computed tomography (SPECT) may be advantageous in the diagnostic separation of these disorders when comorbid or clinically indistinct. Methods Subjects were selected from a multisite database, where rest and on-task SPECT scans were obtained on a large group of neuropsychiatric patients. Two groups were analyzed: Group 1 with TBI (n=104), PTSD (n=104) or both (n=73) closely matched for demographics and comorbidity, compared to each other and healthy controls (N=116); Group 2 with TBI (n=7,505), PTSD (n=1,077) or both (n=1,017) compared to n=11,147 without either. ROIs and visual readings (VRs) were analyzed using a binary logistic regression model with predicted probabilities inputted into a Receiver Operating Characteristic analysis to identify sensitivity, specificity, and accuracy. One-way ANOVA identified the most diagnostically significant regions of increased perfusion in PTSD compared to TBI. Analysis included a 10-fold cross validation of the protocol in the larger community sample (Group 2). Results For Group 1, baseline and on-task ROIs and VRs showed a high level of accuracy in differentiating PTSD, TBI and PTSD+TBI conditions. This carefully matched group separated with 100% sensitivity, specificity and accuracy for the ROI analysis and at 89% or above for VRs. Group 2 had lower sensitivity, specificity and accuracy, but still in a clinically relevant range. Compared to subjects with TBI, PTSD showed increases in the limbic regions, cingulum, basal ganglia, insula, thalamus, prefrontal cortex and temporal lobes. Conclusions This study demonstrates the ability to separate PTSD and TBI from healthy controls, from each other, and detect their co-occurrence, even in highly comorbid samples, using SPECT. This modality may offer a clinical option for aiding diagnosis and treatment of these conditions.	[Amen, Daniel G.; Willeumier, Kristen; Taylor, Derek] Amen Clin Inc, Dept Res, Costa Mesa, CA 92626 USA; [Raji, Cyrus A.] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA; [Tarzwell, Robert] Univ British Columbia, Lions Gate Hosp, Fac Med, Dept Psychiat, N Vancouver, BC, Canada; [Newberg, Andrew] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Henderson, Theodore A.] Synapt Space, Denver, CO USA; [Henderson, Theodore A.] Int Soc Appl Neuroimaging, Denver, CO USA	University of California System; University of California Los Angeles; University of British Columbia; Jefferson University	Amen, DG (corresponding author), Amen Clin Inc, Dept Res, Costa Mesa, CA 92626 USA.	docamen@amenclinics.com		Willeumier, Kristen/0000-0002-1229-8516				Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P139, DOI 10.1080/02791072.2008.10400623; Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P131, DOI 10.1080/02791072.2008.10400622; Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; [Anonymous], INJURY PREVENTION AN; [Anonymous], 2009, GULF AND WAR HEALTH; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonne O, 2003, BIOL PSYCHIAT, V54, P1077, DOI 10.1016/S0006-3223(03)00525-0; Bremner J D, 1999, Semin Clin Neuropsychiatry, V4, P249; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P246; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Castel-Lacanal E, 2014, ANN FR ANESTH, V33, P83, DOI 10.1016/j.annfar.2013.11.006; Centers for Disease Control and Prevention, EB BASED INJURY STAT; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CHANG W, 1984, J NUCL MED, V25, P788; Chung YA, 2006, CLIN NEUROPHYSIOL, V117, P637, DOI 10.1016/j.clinph.2005.10.020; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Defense and Veterans Brain Injury Center, DOD WORLDWIDE NUMBER; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischer H, 2014, U S MILITARY CASUALT; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hastie TT, 2001, THE ELEMENTS OF STAT, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hermes E, 2014, EPIDEMIOL PSYCH SCI, V23, P281, DOI 10.1017/S2045796013000449; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Jacobs A, 1996, J NUCL MED, V37, P1605; Jain S, 2012, PSYCHIAT SERV, V63, P154, DOI 10.1176/appi.ps.201100199; Jeyaraj JA, 2013, BRAIN INJURY, V27, P1338, DOI 10.3109/02699052.2013.823650; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kim SY, 2012, PSYCHIAT RES-NEUROIM, V201, P214, DOI 10.1016/j.pscychresns.2011.08.007; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; Kitayama N, 2006, J AFFECT DISORDERS, V90, P171, DOI 10.1016/j.jad.2005.11.006; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Krystal JH, 2014, CELL, V157, P201, DOI 10.1016/j.cell.2014.02.042; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lee Bruce, 2005, NeuroRx, V2, P372; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lindauer RJL, 2008, PSYCHOL MED, V38, P543, DOI 10.1017/S0033291707001432; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Lucey JV, 1997, BRIT J PSYCHIAT, V171, P346, DOI 10.1192/bjp.171.4.346; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Mai JK, 1997, ATLAS OF THE HUMAN B; Maroon JC, 2012, PHYSICIAN SPORTSMED, V40, P73, DOI 10.3810/psm.2012.11.1990; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; National Institute of Mental Health, POST TRAUMATIC STRES; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pavel D, 2006, BRAIN COGNITION, V60, P211; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterson A, 2014, CAN J PSYCHIAT, V59, P294, DOI 10.1177/070674371405900602; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sachinvala N, 2000, MIL MED, V165, P473, DOI 10.1093/milmed/165.6.473; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seedat S, 2004, J AFFECT DISORDERS, V80, P45, DOI 10.1016/S0165-0327(03)00047-8; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Silver JM, 2011, TEXTBOOK OF TRAUMATI, P609; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Stamatakis EA, 1999, BEHAV NEUROL, V12, P29, DOI 10.1155/2000/681916; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielan T, 2008, INVISIBLE WOUNDS OF; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The American College of Radiology, 2014, ACR SPR PRACTICE PAR; Thomas JT, 1964, J AM STAT ASSOC, V61, P852; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Van Laere KJ, 2002, J NUCL MED, V43, P458; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Villarreal G, 2004, PSYCHIAT RES-NEUROIM, V131, P227, DOI 10.1016/j.pscychresns.2004.05.002; Wang HR, 2013, CLIN NEUROPHARMACOL, V36, P216, DOI 10.1097/WNF.0b013e3182aa365f; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Weniger G, 2008, ACTA PSYCHIAT SCAND, V118, P281, DOI 10.1111/j.1600-0447.2008.01246.x; Whipple E, 2014, ARCH CLIN NEUROPSYCH, V29; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zaroya G., 2005, US TODAY; Zubieta JK, 1999, J PSYCHIAT RES, V33, P259, DOI 10.1016/S0022-3956(98)00060-0	114	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129659	10.1371/journal.pone.0129659	http://dx.doi.org/10.1371/journal.pone.0129659			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132293	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000031
J	Catto, C; Dell'Orto, S; Villa, F; Villa, S; Gelain, A; Vitali, A; Marzano, V; Baroni, S; Forlani, F; Cappitelli, F				Catto, Cristina; Dell'Orto, Silvia; Villa, Federica; Villa, Stefania; Gelain, Arianna; Vitali, Alberto; Marzano, Valeria; Baroni, Sara; Forlani, Fabio; Cappitelli, Francesca			Unravelling the Structural and Molecular Basis Responsible for the Anti-Biofilm Activity of Zosteric Acid	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL BIOFILMS; SUBLETHAL CONCENTRATIONS; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; STATIONARY-PHASE; GENE-EXPRESSION; PROTEIN; WRBA; RESISTANCE	The natural compound zosteric acid, or p-(sulfoxy) cinnamic acid (ZA), is proposed as an alternative biocide-free agent suitable for preventive or integrative anti-biofilm approaches. Despite its potential, the lack of information concerning the structural and molecular mechanism of action involved in its anti-biofilm activity has limited efforts to generate more potent anti-biofilm strategies. In this study a 43-member library of small molecules based on ZA scaffold diversity was designed and screened against Escherichia coli to understand the structural requirements necessary for biofilm inhibition at sub-lethal concentrations. Considerations concerning the relationship between structure and anti-biofilm activity revealed that i) the para-sulfoxy ester group is not needed to exploit the anti-biofilm activity of the molecule, it is the cinnamic acid scaffold that is responsible for anti-biofilm performance; ii) the anti-biofilm activity of ZA derivatives depends on the presence of a carboxylate anion and, consequently, on its hydrogen-donating ability; iii) the conjugated aromatic system is instrumental to the anti-biofilm activities of ZA and its analogues. Using a protein pull-down approach, combined with mass spectrometry, the herein-defined active structure of ZA was matrix-immobilized, and was proved to interact with the E. coli NADH: quinone reductase, WrbA, suggesting a possible role of this protein in the biofilm formation process.	[Catto, Cristina; Villa, Federica; Baroni, Sara; Forlani, Fabio; Cappitelli, Francesca] Univ Milan, Dept Food Environm & Nut Sci, Milan, Italy; [Dell'Orto, Silvia; Villa, Stefania; Gelain, Arianna] Univ Milan, Dept Pharmaceut Sci, Milan, Italy; [Villa, Federica] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Vitali, Alberto] Mol Recognit UOS Rome, Inst Chem, Rome, Italy; [Marzano, Valeria] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Rome, Italy	University of Milan; University of Milan; Montana State University System; Montana State University Bozeman; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Forlani, F (corresponding author), Univ Milan, Dept Food Environm & Nut Sci, Milan, Italy.	fabio.forlani@unimi.it	Baroni, Sara/ABG-9441-2021; Vitali, Alberto/F-3667-2017; Villa, Federica/Z-5246-2019; Marzano, Valeria/K-5770-2016; Villa, Federica/B-8787-2017; Cappitelli, Francesca/H-1492-2015; Villa, Stefania/L-8984-2019; Forlani, Fabio/Y-4265-2019	Baroni, Sara/0000-0001-6649-3846; Vitali, Alberto/0000-0001-9828-4117; Villa, Federica/0000-0003-2930-4684; Marzano, Valeria/0000-0001-6364-2121; Villa, Federica/0000-0003-2930-4684; Cappitelli, Francesca/0000-0003-1237-1813; Villa, Stefania/0000-0002-0636-7589; Forlani, Fabio/0000-0001-9405-973X; CATTO', CRISTINA/0000-0002-3709-1802; Gelain, Arianna/0000-0001-9104-732X	Fondazione Cariplo [2011-0277]	Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Fondazione Cariplo, grant n. 2011-0277 (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Baek D, 2010, PLANT CELL ENVIRON, V33, P1383, DOI 10.1111/j.1365-3040.2010.02156.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cap M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/976753; Cappitelli F, 2014, FOOD ENG REV, V6, P29, DOI 10.1007/s12393-014-9077-8; Carey J, 2007, PROTEIN SCI, V16, P2301, DOI 10.1110/ps.073018907; Collet A, 2007, ANTON LEEUW INT J G, V91, P71, DOI 10.1007/s10482-006-9097-3; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Darouiche R, 2007, INT J ARTIF ORGANS, V30, P820, DOI 10.1177/039139880703000912; De P, 2011, J MED CHEM, V54, P1449, DOI 10.1021/jm101510d; Di Pasqua R, 2010, PROTEOMICS, V10, P1040, DOI 10.1002/pmic.200900568; Donlan RM, 2011, CLIN INFECT DIS, V52, P1038, DOI 10.1093/cid/cir077; European Food Safety Authority, 2012, EFSA J, V10, P2598; GARTEN S, 1971, BIOCHEM PHARMACOL, V20, P1661, DOI 10.1016/0006-2952(71)90294-2; Giada M., 2013, OXID STRESS CHRONIC, V2013, P87, DOI [10.5772/51687, DOI 10.5772/51687]; Grandori R, 1998, J BIOL CHEM, V273, P20960, DOI 10.1074/jbc.273.33.20960; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hirschmann F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00556; HOSODA S, 1974, J BIOL CHEM, V249, P6416; Hu MX, 2010, INDIAN J MICROBIOL, V50, P362, DOI 10.1007/s12088-011-0142-1; Jitareanu A, 2013, ROM BIOTECH LETT, V18, P8317; Kuczynska-Wisnik D, 2010, RES MICROBIOL, V161, P847, DOI 10.1016/j.resmic.2010.09.012; Kuczynska-Wisnik D, 2010, MICROBIOL-SGM, V156, P148, DOI 10.1099/mic.0.032334-0; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; Ogasawara H, 2011, J BACTERIOL, V193, P2587, DOI 10.1128/JB.01468-10; Papenbrock J., 2012, ISRN BOT, DOI DOI 10.5402/2012/103892; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Polo A, 2014, INT J MOL SCI, V15, P9497, DOI 10.3390/ijms15069497; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; SCENIHR Scientific Committee on Emerging and Newly Identified Health Risks., 2009, ASS ANT RES EFF BIOC; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Stanley MS, 2002, PHYTOPATHOLOGY, V92, P378, DOI 10.1094/PHYTO.2002.92.4.378; Szymanski W, 2009, J ORG CHEM, V74, P9152, DOI 10.1021/jo901833y; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Villa F, 2013, CURR TOP MED CHEM, V13, P3184, DOI 10.2174/15680266113136660225; Villa F, 2012, BIOFOULING, V28, P1107, DOI 10.1080/08927014.2012.734811; Villa F, 2012, BIOFOULING, V28, P823, DOI 10.1080/08927014.2012.715285; Villa F, 2012, ENVIRON MICROBIOL, V14, P1753, DOI 10.1111/j.1462-2920.2011.02678.x; Villa F, 2011, MICROB ECOL, V62, P584, DOI 10.1007/s00248-011-9876-x; Villa F, 2010, BIOFOULING, V26, P739, DOI 10.1080/08927014.2010.511197; Villa F, 2009, BIOTECHNOL LETT, V31, P1407, DOI 10.1007/s10529-009-0031-4; Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146, DOI 10.1177/039139880502801112; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	51	32	31	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131519	10.1371/journal.pone.0131519	http://dx.doi.org/10.1371/journal.pone.0131519			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132116	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000125
J	Covell, DG				Covell, David G.			Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER; TRANSCRIPTION FACTOR; CONNECTIVITY MAP; SENSITIVITY; RESISTANCE; MUTATIONS; DISEASE; GENES; IDENTIFICATION	Developing reliable biomarkers of tumor cell drug sensitivity and resistance can guide hypothesis-driven basic science research and influence pre-therapy clinical decisions. A popular strategy for developing biomarkers uses characterizations of human tumor samples against a range of cancer drug responses that correlate with genomic change; developed largely from the efforts of the Cancer Cell Line Encyclopedia (CCLE) and Sanger Cancer Genome Project (CGP). The purpose of this study is to provide an independent analysis of this data that aims to vet existing and add novel perspectives to biomarker discoveries and applications. Existing and alternative data mining and statistical methods will be used to a) evaluate drug responses of compounds with similar mechanism of action (MOA), b) examine measures of gene expression (GE), copy number (CN) and mutation status (MUT) biomarkers, combined with gene set enrichment analysis (GSEA), for hypothesizing biological processes important for drug response, c) conduct global comparisons of GE, CN and MUT as biomarkers across all drugs screened in the CGP dataset, and d) assess the positive predictive power of CGP-derived GE biomarkers as predictors of drug response in CCLE tumor cells. The perspectives derived from individual and global examinations of GEs, MUTs and CNs confirm existing and reveal unique and shared roles for these biomarkers in tumor cell drug sensitivity and resistance. Applications of CGP-derived genomic biomarkers to predict the drug response of CCLE tumor cells finds a highly significant ROC, with a positive predictive power of 0.78. The results of this study expand the available data mining and analysis methods for genomic biomarker development and provide additional support for using biomarkers to guide hypothesis-driven basic science research and pre-therapy clinical decisions.	NCI, Screening Technol Branch, Dev Therapeut Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Covell, DG (corresponding author), NCI, Screening Technol Branch, Dev Therapeut Program, Frederick, MD 21701 USA.	covelld@mail.nih.gov						Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; Boutin B, 2013, PROSTATE, V73, P1090, DOI 10.1002/pros.22658; Brand TM, 2014, MOL CANCER THER, V13, P1356, DOI 10.1158/1535-7163.MCT-13-1021; Chuang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037613; Dai LL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113377, 10.1371/journal.pone.0089064]; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fabi A, 2013, EXPERT OPIN PHARMACO, V14, P699, DOI 10.1517/14656566.2013.779672; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garnett MJ, 2012, DRUG DISCOV TODAY, V17, P188, DOI 10.1016/j.drudis.2012.01.025; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leslie A, 2003, CANCER RES, V63, P4656; Lin YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050701; Lui WO, 2008, CANCER RES, V68, P7156, DOI 10.1158/0008-5472.CAN-08-1085; Marampon F, 2011, MOL CANCER THER, V10, P159, DOI 10.1158/1535-7163.MCT-10-0631; Marsh DJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00144; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Miyanaga A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-262; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Niedner H, 2001, MOL PHARMACOL, V60, P1153, DOI 10.1124/mol.60.6.1153; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Sato A, 2011, STEM CELLS, V29, P1942, DOI 10.1002/stem.753; Sharma A, 2012, DRUGS, V72, P2207, DOI 10.2165/11640870-000000000-00000; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088291; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Woo IS, 2009, CANCER LETT, V276, P53, DOI 10.1016/j.canlet.2008.10.031; Xu JK, 2013, J BIOL CHEM, V288, P34799, DOI 10.1074/jbc.M113.495580; Xu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.27; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	49	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0127433	10.1371/journal.pone.0127433	http://dx.doi.org/10.1371/journal.pone.0127433			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132924	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000008
J	Kang, XJ; Yu, Q; Huang, YL; Song, B; Chen, YY; Gao, XC; He, WY; Sun, XF; Fan, Y				Kang, Xiangjin; Yu, Qian; Huang, Yuling; Song, Bing; Chen, Yaoyong; Gao, Xingcheng; He, Wenyin; Sun, Xiaofang; Fan, Yong			Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; BLOOD-CELLS; IPS CELLS; DERIVATION; CULTURE; MICE	Human-induced pluripotent stem cells (iPSCs) are derived from differentiated somatic cells using defined factors and provide a renewable source of autologous cells for cell therapy. Many reprogramming methods have been employed to generate human iPSCs, including the use of integrating vectors and non-integrating vectors. Maintenance of the genomic integrity of iPSCs is highly desirable if the cells are to be used in clinical applications. Here, using the Affymetrix Cytoscan HD array, we investigated the genomic aberration profiles of 19 human cell lines: 5 embryonic stem cell (ESC) lines, 6 iPSC lines derived using integrating vectors ("integrating iPSC lines"), 6 iPSC lines derived using non-integrating vectors ("non-integrating iPSC lines"), and the 2 parental cell lines from which the iPSCs were derived. The genome-wide copy number variation (CNV), loss of heterozygosity (LOH) and mosaicism patterns of integrating and non-integrating iPSC lines were investigated. The maximum sizes of CNVs in the genomes of the integrating iPSC lines were 20 times higher than those of the non-integrating iPSC lines. Moreover, the total number of CNVs was much higher in integrating iPSC lines than in other cell lines. The average numbers of novel CNVs with a low degree of overlap with the DGV and of likely pathogenic CNVs with a high degree of overlap with the ISCA (International Symposium on Computer Architecture) database were highest in integrating iPSC lines. Different single nucleotide polymorphisms (SNP) calls revealed that, using the parental cell genotype as a reference, integrating iPSC lines displayed more single nucleotide variations and mosaicism than did non-integrating iPSC lines. This study describes the genome stability of human iPSCs generated using either a DNA-integrating or non-integrating reprogramming method, of the corresponding somatic cells, and of hESCs. Our results highlight the importance of using a high-resolution method to monitor genomic aberrations in iPSCs intended for clinical applications to avoid any negative effects of reprogramming or cell culture.	[Kang, Xiangjin; Yu, Qian; Huang, Yuling; Song, Bing; Chen, Yaoyong; Gao, Xingcheng; He, Wenyin; Sun, Xiaofang; Fan, Yong] Guangzhou Med Univ, Key Lab Reprod & Genet, Key Lab Major Obstetr Dis Guangdong Prov, Guangdong Higher Educ Inst,Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China	Guangzhou Medical University	He, WY (corresponding author), Guangzhou Med Univ, Key Lab Reprod & Genet, Key Lab Major Obstetr Dis Guangdong Prov, Guangdong Higher Educ Inst,Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China.	31848346@qq.com; xiaofangsun@hotmail.com; yongfan011@gzhmu.edu.cn			National Natural Science Foundation of China [81370766, 81301184, 81401254, U1132005]; Guangdong Province Higher Education Funding [2013KJCX0149, Yq2013135]; Guangdong Province Science and Technology Project [2014A02011029]; China Postdoctoral Science Foundation [2013M542163]; Zhujiang Science and Technology Star Project of Guangzhou [2012J2200006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Higher Education Funding; Guangdong Province Science and Technology Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Zhujiang Science and Technology Star Project of Guangzhou	This work was supported by the National Natural Science Foundation of China (81370766, 81301184, 81401254, and U1132005), Guangdong Province Higher Education Funding (2013KJCX0149 and Yq2013135), Guangdong Province Science and Technology Project (2014A02011029), China Postdoctoral Science Foundation (2013M542163), and the Zhujiang Science and Technology Star Project of Guangzhou (2012J2200006).	Agarwal S, 2011, CELL RES, V21, P1157, DOI 10.1038/cr.2011.120; Asensi KD, 2014, J CELL MOL MED, V18, P824, DOI 10.1111/jcmm.12226; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Fan Y, 2012, J REPROD DEVELOP, V58, P404, DOI 10.1262/jrd.2011-046; Fan Y, 2010, J REPROD DEVELOP, V56, P533, DOI 10.1262/jrd.09-225M; Goh PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081622; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; He WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108350; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Luo YM, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-74; MacArthur CC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/564612; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042838; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	26	43	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131128	10.1371/journal.pone.0131128	http://dx.doi.org/10.1371/journal.pone.0131128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131765	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000095
J	Nunes, A; Gomes, JP; Karunakaran, KP; Brunham, RC				Nunes, Alexandra; Gomes, Joao P.; Karunakaran, Karuna P.; Brunham, Robert C.			Bioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; T-CELL ANTIGENS; OBLIGATE INTRACELLULAR PATHOGEN; INDUCE PROTECTIVE IMMUNITY; GENITAL-TRACT REINFECTION; DIRECT MEDICAL COST; GENOME SEQUENCES; PROCESSING SITE; MESSENGER-RNA; UNITED-STATES	Chlamydia trachomatis is the most important infectious cause of infertility in women with important implications in public health and for which a vaccine is urgently needed. Recent immunoproteomic vaccine studies found that four polymorphic membrane proteins (PmpE, PmpF, PmpG and PmpH) are immunodominant, recognized by various MHC class II haplotypes and protective in mouse models. In the present study, we aimed to evaluate genetic and protein features of Pmps (focusing on the N-terminal 600 amino acids where MHC class II epitopes were mapped) in order to understand antigen variation that may emerge following vaccine induced immune selection. We used several bioinformatics platforms to study: i) Pmps' phylogeny and genetic polymorphism; ii) the location and distribution of protein features (GGA(I, L)/FxxN motifs and cysteine residues) that may impact pathogen-host interactions and protein conformation; and iii) the existence of phase variation mechanisms that may impact Pmps' expression. We used a well-characterized collection of 53 fully-sequenced strains that represent the C. trachomatis serovars associated with the three disease groups: ocular (N=8), epithelial-genital (N=25) and lymphogranuloma venereum (LGV) (N=20). We observed that PmpF and PmpE are highly polymorphic between LGV and epithelial-genital strains, and also within populations of the latter. We also found heterogeneous representation among strains for GGA(I, L)/FxxN motifs and cysteine residues, suggesting possible alterations in adhesion properties, tissue specificity and immunogenicity. PmpG and, to a lesser extent, PmpH revealed low polymorphism and high conservation of protein features among the genital strains (including the LGV group). Uniquely among the four Pmps, pmpG has regulatory sequences suggestive of phase variation. In aggregate, the results suggest that PmpG may be the lead vaccine candidate because of sequence conservation but may need to be paired with another protective antigen (like PmpH) in order to prevent immune selection of phase variants.	[Nunes, Alexandra; Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Bioinformat Unit, Lisbon, Portugal; [Karunakaran, Karuna P.; Brunham, Robert C.] Univ British Columbia, Ctr Dis Control, Vaccine Res Lab, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Brunham, RC (corresponding author), Univ British Columbia, Ctr Dis Control, Vaccine Res Lab, Vancouver, BC V5Z 1M9, Canada.	robert.brunham@bccdc.ca	Nunes, Alexandra/ABE-3699-2020	Gomes, Joao Paulo/0000-0002-2697-2399; Nunes, Alexandra/0000-0001-6449-8053	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/75295/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	AN is a recipient of a post-doctoral fellowship (SFRH/BPD/75295/2010) from Fundacao para a Ciencia e a Tecnologia (FCT).	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; ALLEN JE, 1989, J BACTERIOL, V171, P285, DOI 10.1128/jb.171.1.285-291.1989; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Borges V, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01204-13; Borges V, 2015, INFECT GENET EVOL, V32, P74, DOI 10.1016/j.meegid.2015.02.026; Borges V, 2012, J BACTERIOL, V194, P6143, DOI 10.1128/JB.01291-12; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Brunham RC, 2013, VACCINE, V31, P1892, DOI 10.1016/j.vaccine.2013.01.024; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; CDC, 2014, SEX TRANSM DIS SURV; CHELLADURAI BS, 1991, NUCLEIC ACIDS RES, V19, P1759, DOI 10.1093/nar/19.8.1759; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; DANILITION SL, 1990, INFECT IMMUN, V58, P189, DOI 10.1128/IAI.58.1.189-196.1990; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DELAMAZA LM, 1991, INFECT IMMUN, V59, P1196, DOI 10.1128/IAI.59.3.1196-1201.1991; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Feher VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068934; Ferreira R, 2015, G3-GENES GENOM GENET, V5, P9, DOI 10.1534/g3.114.015354; Finco O, 2011, P NATL ACAD SCI USA, V108, P9969, DOI 10.1073/pnas.1101756108; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Hawkins RA, 2002, INFECT IMMUN, V70, P5132, DOI 10.1128/IAI.70.9.5132-5139.2002; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; IGIETSEME JU, 1991, INFECT IMMUN, V59, P1346, DOI 10.1128/IAI.59.4.1346-1351.1991; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jeffrey BM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-142; Johnson RM, 2012, INFECT IMMUN, V80, P2204, DOI 10.1128/IAI.06339-11; Jorgensen I, 2008, INFECT IMMUN, V76, P3940, DOI 10.1128/IAI.00632-08; Karunakaran KP, 2008, J IMMUNOL, V180, P2459, DOI 10.4049/jimmunol.180.4.2459; Karunakaran KP, 2015, VACCINE, V33, P2159, DOI 10.1016/j.vaccine.2015.02.055; Karunakaran KP, 2010, HUM VACCINES, V6, P676, DOI 10.4161/hv.6.8.12299; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kiselev AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005191; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Nei M., 2000, MOL EVOLUTION PHYLOG; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Nunes A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000878; Nunes A, 2014, INFECT GENET EVOL, V23, P49, DOI 10.1016/j.meegid.2014.01.029; Nunes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013171; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Perry LL, 1997, J IMMUNOL, V158, P3344; Pride D.T., 2000, SWAAP VERSION 1 0 0; Pultorak E, 2009, SEX TRANSM DIS, V36, P629, DOI 10.1097/OLQ.0b013e3181a96d23; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rekart ML, 2008, SEX TRANSM INFECT, V84, P87, DOI 10.1136/sti.2007.027938; ROBERTSON HD, 1977, P NATL ACAD SCI USA, V74, P822, DOI 10.1073/pnas.74.3.822; Rockey DD, 2000, INFECT IMMUN, V68, P5473, DOI 10.1128/IAI.68.10.5473-5479.2000; Rodriguez-Maranon MJ, 2002, PROTEIN SCI, V11, P1854, DOI 10.1110/ps.3650102; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; SCHACHTER J, 1978, NEW ENGL J MED, V298, P428, DOI 10.1056/NEJM197802232980805; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Shirai M, 2000, J INFECT DIS, V181, pS524, DOI 10.1086/315616; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; STEPHENS RS, 1988, J BACTERIOL, V170, P744, DOI 10.1128/jb.170.2.744-750.1988; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Tan C, 2010, CELL MICROBIOL, V12, P174, DOI 10.1111/j.1462-5822.2009.01389.x; Tan C, 2009, INFECT IMMUN, V77, P3218, DOI 10.1128/IAI.01566-08; Tan M., 2006, CHLAMYDIA GENOMICS P, P103; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vogel G, 2006, SCIENCE, V311, P592; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; WHO, 2012, GLOB INC PREV SEL CU; Yang X, 1998, J IMMUNOL, V161, P1439; Yu H, 2014, VACCINE, V32, P4672, DOI 10.1016/j.vaccine.2014.06.002; Yu H, 2012, INFECT IMMUN, V80, P1510, DOI 10.1128/IAI.06338-11; Yu H, 2009, J IMMUNOL, V182, P1602, DOI 10.4049/jimmunol.182.3.1602	88	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131695	10.1371/journal.pone.0131695	http://dx.doi.org/10.1371/journal.pone.0131695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131720	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000136
J	Venter, M; Venter, O; Edwards, W; Bird, MI				Venter, Michelle; Venter, Oscar; Edwards, Will; Bird, Michael I.			Validating Community-Led Forest Biomass Assessments	PLOS ONE			English	Article							TROPICAL FOREST; CARBON STOCKS; ABOVEGROUND CARBON; TREE ALLOMETRY; LOCAL PEOPLE; BALANCE; ERROR; CONSERVATION; ACCURACY; REGIONS	The lack of capacity to monitor forest carbon stocks in developing countries is undermining global efforts to reduce carbon emissions. Involving local people in monitoring forest carbon stocks could potentially address this capacity gap. This study conducts a complete expert remeasurement of community-led biomass inventories in remote tropical forests of Papua New Guinea. By fully remeasuring and isolating the effects of 4,481 field measurements, we demonstrate that programmes employing local people (non-experts) can produce forest monitoring data as reliable as those produced by scientists (experts). Overall, non-experts reported lower biomass estimates by an average of 9.1%, equivalent to 55.2 fewer tonnes of biomass ha(-1), which could have important financial implications for communities. However, there were no significant differences between forest biomass estimates of expert and non-expert, nor were there significant differences in some of the components used to calculate these estimates, such as tree diameter at breast height (DBH), tree counts and plot surface area, but were significant differences between tree heights. At the landscape level, the greatest biomass discrepancies resulted from height measurements (41%) and, unexpectedly, a few large missing trees contributing to a third of the overall discrepancies. We show that 85% of the biomass discrepancies at the tree level were caused by measurement taken on large trees (DBH >= 50cm), even though they consisted of only 14% of the stems. We demonstrate that programmes that engage local people can provide high-quality forest carbon data that could help overcome barriers to reducing forest carbon emissions in developing countries. Nonetheless, community-based monitoring programmes should prioritise reducing errors in the field that lead to the most important discrepancies, notably; overcoming challenges to accurately measure large trees.	[Venter, Michelle; Bird, Michael I.] James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld, Australia; [Venter, Michelle; Edwards, Will; Bird, Michael I.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Venter, Oscar; Edwards, Will] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Venter, Oscar] Univ Queensland, Ctr Excellence Environm Decis, Brisbane, Qld, Australia	James Cook University; James Cook University; James Cook University; University of Queensland	Venter, M (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld, Australia.	michelle.venter@my.jcu.edu.au	Venter, Oscar/ABE-1477-2021; Edwards, Will/GRS-5509-2022; Edwards, Will/M-6652-2015; Bird, Michael/G-5364-2010	Edwards, Will/0000-0001-8981-7479; Bird, Michael/0000-0003-1801-8703	Conservation International through a KFW grant; James Cook University	Conservation International through a KFW grant; James Cook University	This work was supported by Conservation International through a KFW grant, and James Cook University Graduate research funding schemes, under the grant, "For provisioning services in support of ecological and socioeconomic monitoring in the YUS conservation area, Papua New Guinea." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SOURCEBOOK LAND USE; Asner GP, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/021002; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Butt N, 2013, ECOL APPL, V23, P936, DOI 10.1890/11-2059.1; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Condit R, 1998, TROPICAL FOREST CENS; Cornelius J, 2012, YUS CONSERVATI UNPUB; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Elbroch M, 2011, CONSERV BIOL, V25, P1195, DOI 10.1111/j.1523-1739.2011.01740.x; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fox JC, 2010, BIOTROPICA, V42, P410, DOI 10.1111/j.1744-7429.2009.00617.x; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; Hijbeek R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067201; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Intergovernmental Panel on Climate Change (IPCC), 2006, AGR FORESTRY OTHER L; IPCC, 2006, GUID NAT GREENH GAS; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Lines ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1017, DOI 10.1111/j.1466-8238.2011.00746.x; MacDicken K., 1997, GUIDE MONITORING CAR; Malhi Y, 2010, CURR OPIN ENV SUST, V2, P237, DOI 10.1016/j.cosust.2010.08.002; Maniatis D, 2013, PHIL T ROYAL SOC B, V368; Maniatis Danae, 2010, Carbon Balance Manag, V5, P9, DOI 10.1186/1750-0680-5-9; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Molto Q, 2013, METHODS ECOL EVOL, V4, P175, DOI 10.1111/j.2041-210x.2012.00266.x; Oldekop JA, 2011, BIODIVERS CONSERV, V20, P2615, DOI 10.1007/s10531-011-0094-0; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SBSTA, 2009, TEXT DEC ME IN PRESS; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Skutsch M, 2011, COMMUNITY FOREST MON; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Sokal R. R, 1981, BIOMETRY; Van Laake P, 2011, REDUCING GREENHOUSE; Venter O, 2012, ANN NY ACAD SCI, V1249, P137, DOI 10.1111/j.1749-6632.2011.06306.x; Wagner F, 2010, BIOTROPICA, V42, P664, DOI 10.1111/j.1744-7429.2010.00644.x; Williams MS, 2000, CAN J FOREST RES, V30, P306, DOI 10.1139/cjfr-30-2-306	44	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130529	10.1371/journal.pone.0130529	http://dx.doi.org/10.1371/journal.pone.0130529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126186	gold, Green Published, Green Accepted			2022-12-26	WOS:000358151300018
J	AbuSamra, DB; Al-Kilani, A; Hamdan, SM; Sakashita, K; Gadhoum, SZ; Merzaban, JS				AbuSamra, Dina B.; Al-Kilani, Alia; Hamdan, Samir M.; Sakashita, Kosuke; Gadhoum, Samah Z.; Merzaban, Jasmeen S.			Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; cell adhesion; cell migration; glycobiology; glycoprotein; surface plasmon resonance (SPR); PSGL-1; selectin; selectin ligand; sialyl Lewis x	MAJOR E-SELECTIN; LEUKOCYTE RECRUITMENT; CELL-ADHESION; ENDOTHELIAL-CELLS; KINETIC-ANALYSIS; LECTIN DOMAIN; AFFINITY; GLYCOSYLATION; DIMERIZATION; MOLECULE-1	Background: E-selectin interactions with glycoprotein ligands mediate the initial capturing of cells out of flow. Results: Adopting a Biacore-based immunoprecipitation binding assay unraveled differential binding kinetics of monomeric (m) versus dimeric (d) E-selectin to endogenous ligands. Conclusion: Although mE-selectin binds transiently, dE-selectin binds with remarkably slow on- and off-rates. Significance: Transitioning from monomeric to dimeric E-selectin could enable fast but firm capturing of cells out of flow. Selectins (E-, P-, and L-selectins) interact with glycoprotein ligands to mediate the essential tethering/rolling step in cell transport and delivery that captures migrating cells from the circulating flow. In this work, we developed a real time immunoprecipitation assay on a surface plasmon resonance chip that captures native glycoforms of two well known E-selectin ligands (CD44/hematopoietic cell E-/L-selectin ligand and P-selectin glycoprotein ligand-1) from hematopoietic cell extracts. Here we present a comprehensive characterization of their binding to E-selectin. We show that both ligands bind recombinant monomeric E-selectin transiently with fast on- and fast off-rates, whereas they bind dimeric E-selectin with remarkably slow on- and off-rates. This binding requires the sialyl Lewis x sugar moiety to be placed on both O- and N-glycans, and its association, but not dissociation, is sensitive to the salt concentration. Our results suggest a mechanism through which monomeric selectins mediate initial fast on and fast off kinetics to help capture cells out of the circulating shear flow; subsequently, tight binding by dimeric/oligomeric selectins is enabled to significantly slow rolling.	[AbuSamra, Dina B.; Al-Kilani, Alia; Hamdan, Samir M.; Sakashita, Kosuke; Gadhoum, Samah Z.; Merzaban, Jasmeen S.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia	King Abdullah University of Science & Technology	Merzaban, JS (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia.	jasmeen.merzaban@kaust.edu.sa	Merzaban, Jasmeen/V-3147-2018	Merzaban, Jasmeen/0000-0002-7276-2907; Al-Kilani, Alia/0000-0002-6428-1185; Hamdan, Samir/0000-0001-5192-1852	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This work was supported by King Abdullah University of Science and Technology faculty baseline research funding and a university competitive research grant (to J.S.M. and S.M.H.). The authors declare no conflict of interest.	ALON R, 1995, J IMMUNOL, V154, P5356; ASA D, 1995, J BIOL CHEM, V270, P11662, DOI 10.1074/jbc.270.19.11662; Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Barkalow FJ, 2000, BLOOD, V96, P3070; Barthel SR, 2013, CANCER RES, V73, P942, DOI 10.1158/0008-5472.CAN-12-3264; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fuhlbrigge RC, 2002, J IMMUNOL, V168, P5645, DOI 10.4049/jimmunol.168.11.5645; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Klopocki AG, 2008, J BIOL CHEM, V283, P11493, DOI 10.1074/jbc.M709785200; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Lesley Jayne, 1998, Frontiers in Bioscience, V3, pD616; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Merzaban JS, 2015, GLYCOBIOLOGY, V25, P1392, DOI 10.1093/glycob/cwv046; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Mir GH, 2009, BLOOD, V114, P733, DOI 10.1182/blood-2009-03-210237; Molenaar TJM, 2002, BLOOD, V100, P3570, DOI 10.1182/blood-2002-02-0641; MOORE KL, 1994, J BIOL CHEM, V269, P23318; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Poeter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4738; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; Preston RC, 2016, J MOL CELL BIOL, V8, P62, DOI 10.1093/jmcb/mjv046; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Sackstein R, 2009, METHODS MOL BIOL, V536, P343, DOI 10.1007/978-1-59745-542-8_36; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Torgersen D, 1998, J BIOL CHEM, V273, P6254, DOI 10.1074/jbc.273.11.6254; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Wild MK, 2001, J BIOL CHEM, V276, P31602, DOI 10.1074/jbc.M104844200; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	53	19	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21213	21230		10.1074/jbc.M114.629451	http://dx.doi.org/10.1074/jbc.M114.629451			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26124272	Green Published, hybrid			2022-12-26	WOS:000360637600003
J	Couch, Y; Xie, Q; Lundberg, L; Sharp, T; Anthony, DC				Couch, Yvonne; Xie, Qin; Lundberg, Louise; Sharp, Trevor; Anthony, Daniel C.			A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BACILLE CALMETTE-GUERIN; TRYPTOPHAN DEPLETION; CEREBROSPINAL-FLUID; SICKNESS BEHAVIOR; MAJOR DEPRESSION; OPEN-FIELD; ACTIVATION; ANXIETY; INFLAMMATION	It is well documented that serotonin (5-HT) plays an important role in psychiatric illness. For example, myalgic encephalomyelitis (ME/CFS), which is often provoked by infection, is a disabling illness with an unknown aetiology and diagnosis is based on symptom-specific criteria. However, 5-HT2A receptor expression and peripheral cytokines are known to be upregulated in ME. We sought to examine the relationship between the 5-HT system and cytokine expression following systemic bacterial endotoxin challenge (LPS, 0.5mg/kg i.p.), at a time when the acute sickness behaviours have largely resolved. At 24 hours post-injection mice exhibit no overt changes in locomotor behaviour, but do show increased immobility in a forced swim test, as well as decreased sucrose preference and reduced marble burying activity, indicating a depressive-like state. While peripheral IDO activity was increased after LPS challenge, central activity levels remained stable and there was no change in total brain 5-HT levels or 5-HIAA/5-HT. However, within the brain, levels of TNF and 5-HT2A receptor mRNA within various regions increased significantly. This increase in receptor expression is reflected by an increase in the functional response of the 5-HT2A receptor to agonist, DOI. These data suggest that regulation of fatigue and depressive-like moods after episodes of systemic inflammation may be regulated by changes in 5-HT receptor expression, rather than by levels of enzyme activity or cytokine expression in the CNS.	[Couch, Yvonne; Xie, Qin; Lundberg, Louise; Sharp, Trevor; Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Lundberg, Louise] Publ Hlth England, Ctr Radiat Chem & Environm Hazards, Didcot OX11 0RQ, Oxon, England	University of Oxford; Public Health England	Couch, Y (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	yvonne.couch@rdm.ox.ac.uk	Anthony, Daniel/F-7765-2010	Anthony, Daniel/0000-0003-1380-6655; Sharp, Trevor/0000-0001-7434-9713	Biology and Biotechnology Research Society (UK)	Biology and Biotechnology Research Society (UK)	This work was supported by the Biology and Biotechnology Research Society (UK) in vivo additional studentship to YC/DA/TS.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Barton DA, 2008, ARCH GEN PSYCHIAT, V65, P38, DOI 10.1001/archgenpsychiatry.2007.11; Benedetti F, 2008, PROG NEURO-PSYCHOPH, V32, P1863, DOI 10.1016/j.pnpbp.2008.08.017; Bhagwagar Z, 2006, AM J PSYCHIAT, V163, P1580, DOI 10.1176/appi.ajp.163.9.1580; BLUTHE RM, 1991, EUR J PHARMACOL, V209, P281, DOI 10.1016/0014-2999(91)90184-R; Bluthe RM, 2000, EUR J NEUROSCI, V12, P4447, DOI 10.1046/j.1460-9568.2000.01348.x; Cadusseau J, 2014, CURR MED CHEM, V21, P511; Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9; Couch Y, 2013, NEUROIMAGE, V75, P177, DOI 10.1016/j.neuroimage.2013.02.046; Couch Y, 2013, BRAIN BEHAV IMMUN, V29, P136, DOI 10.1016/j.bbi.2012.12.017; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; GJERRIS A, 1987, J AFFECT DISORDERS, V12, P13, DOI 10.1016/0165-0327(87)90056-5; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Hale MW, 2008, NEUROSCIENCE, V157, P733, DOI 10.1016/j.neuroscience.2008.09.050; Hughes MM, 2012, BRAIN BEHAV IMMUN, V26, P979, DOI 10.1016/j.bbi.2012.05.010; Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006; Jiang Y, 2008, NEUROBIOL DIS, V32, P125, DOI 10.1016/j.nbd.2008.06.017; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Levine J, 1999, NEUROPSYCHOBIOLOGY, V40, P171, DOI 10.1159/000026615; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Maes M, 1995, J AFFECT DISORDERS, V36, P29, DOI 10.1016/0165-0327(95)00049-6; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P826; Maes M, 2012, PSYCHOTHER PSYCHOSOM, V81, P286, DOI 10.1159/000336803; Maes M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-66; MANN JJ, 1986, ARCH GEN PSYCHIAT, V43, P954; Miller KJ, 1998, ANN NY ACAD SCI, V861, P169, DOI 10.1111/j.1749-6632.1998.tb10188.x; Miyaoka T, 2012, PROG NEURO-PSYCHOPH, V37, P222, DOI 10.1016/j.pnpbp.2012.02.002; Moreau M, 2005, J INFECT DIS, V192, P537, DOI 10.1086/431603; Murphy CF, 2004, AM J GERIAT PSYCHIAT, V12, P50, DOI 10.1176/appi.ajgp.12.1.50; Nau F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075426; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Pitychoutis PM, 2009, NEUROSCIENCE, V159, P1216, DOI 10.1016/j.neuroscience.2009.01.072; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Serres F, 1999, EUR PSYCHIAT, V14, P451, DOI 10.1016/S0924-9338(99)00222-9; Simen BB, 2006, BIOL PSYCHIAT, V59, P775, DOI 10.1016/j.biopsych.2005.10.013; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Smith AK, 2008, PSYCHONEUROENDOCRINO, V33, P188, DOI 10.1016/j.psyneuen.2007.11.001; STANLEY M, 1983, LANCET, V1, P214; Stanley M, 1986, Ann N Y Acad Sci, V487, P122, DOI 10.1111/j.1749-6632.1986.tb27892.x; Strekalova T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-9; Sullivan GM, 2006, INT J NEUROPSYCHOPH, V9, P547, DOI 10.1017/S1461145705006231; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wu C, 1999, EXP NEUROL, V158, P529, DOI 10.1006/exnr.1999.7105; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461; Zhang XQ, 2009, J CHROMATOGR B, V877, P1678, DOI 10.1016/j.jchromb.2009.04.013; Zhang YQ, 2001, ACTA PHARMACOL SIN, V22, P923	54	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130643	10.1371/journal.pone.0130643	http://dx.doi.org/10.1371/journal.pone.0130643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147001	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600042
J	Crossey, E; Frietze, K; Narum, DL; Peabody, DS; Chackerian, B				Crossey, Erin; Frietze, Kathryn; Narum, David L.; Peabody, David S.; Chackerian, Bryce			Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; INHIBITORY MONOCLONAL-ANTIBODY; MALARIA VACCINE; ERYTHROCYTE INVASION; DIVERSE PEPTIDES; FULL-LENGTH; PROTEIN; AFFINITY; LOCALIZATION; EXPRESSION	We have developed a peptide display platform based on VLPs of the RNA bacteriophage MS2 that combines the high immunogenicity of VLP display with affinity selection capabilities. Random peptides can be displayed on the VLP surface by genetically inserting sequences into a surface-exposed loop of the viral coat protein. VLP-displayed peptides can then be isolated by selection using antibodies, and the VLP selectants can then be used directly as immunogens. Here, we investigated the ability of this platform to identify mimotopes of a highly conserved conformational epitope present on the Plasmodium falciparum blood-stage protein AMA1. Using 4G2, a monoclonal antibody that binds to this epitope and is a potent inhibitor of erythrocyte invasion, we screened three different VLP-peptide libraries and identified specific VLPs that bound strongly to the selecting mAb. We then tested the ability of a handful of selected VLPs to elicit anti-AMA1 antibody responses in mice. Most of the selected VLPs failed to reliably elicit AMA1 specific antibodies. However, one VLP consistently induced antibodies that cross-reacted with AMA1. Surprisingly, this VLP bound to 4G2 more weakly than the other selectants we identified. Taken together, these data demonstrate that VLP-peptide display can identify immunogenic mimics of a complex conformational epitope and illustrate the promise and challenges of this approach.	[Crossey, Erin; Frietze, Kathryn; Peabody, David S.; Chackerian, Bryce] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA	University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chackerian, B (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	bchackerian@salud.unm.edu		Narum, David/0000-0003-3041-5402	NIH [R01 AI083305]; NIAID, NIH; University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant [T31-AI007538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083305, T32AI007538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grant R01 AI083305 (to BC) and by the Intramural Research Program of NIAID, NIH. EC was supported by the University of New Mexico Biology of Infectious Diseases and Inflammation Training Grant (T31-AI007538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Beenhouwer DO, 2002, J IMMUNOL, V169, P6992, DOI 10.4049/jimmunol.169.12.6992; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Casey JL, 2004, INFECT IMMUN, V72, P1126, DOI 10.1128/IAI.72.2.1126-1134.2004; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Dutta S, 2010, INFECT IMMUN, V78, P661, DOI 10.1128/IAI.00866-09; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jennings GT, 2008, BIOL CHEM; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Laurens MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079323; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Olszewska W, 2000, VIROLOGY, V272, P98, DOI 10.1006/viro.2000.0285; Ord RL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-326; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; Peabody DS, 1997, ARCH BIOCHEM BIOPHYS, V347, P85, DOI 10.1006/abbi.1997.0312; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Sabo JK, 2007, INFECT IMMUN, V75, P61, DOI 10.1128/IAI.01041-06; Sok D, 2013, CELL, V155, P728, DOI 10.1016/j.cell.2013.10.009; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912	38	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132560	10.1371/journal.pone.0132560	http://dx.doi.org/10.1371/journal.pone.0132560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147502	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600300
J	Smith, AC; Hudson, MAR; Downes, CM; Francis, CM				Smith, Adam C.; Hudson, Marie-Anne R.; Downes, Constance M.; Francis, Charles M.			Change Points in the Population Trends of Aerial-Insectivorous Birds in North America: Synchronized in Time across Species and Regions	PLOS ONE			English	Article							DECLINES	North American populations of aerial insectivorous birds are in steep decline. Aerial insectivores (AI) are a group of bird species that feed almost exclusively on insects in flight, and include swallows, swifts, nightjars, and flycatchers. The causes of the declines are not well understood. Indeed, it is not clear when the declines began, or whether the declines are shared across all species in the group (e.g., caused by changes in flying insect populations) or specific to each species (e.g., caused by changes in species' breeding habitat). A recent study suggested that population trends of aerial insectivores changed for the worse in the 1980s. If there was such a change point in trends of the group, understanding its timing and geographic pattern could help identify potential causes of the decline. We used a hierarchical Bayesian, penalized regression spline, change point model to estimate group-level change points in the trends of 22 species of AI, across 153 geographic strata of North America. We found evidence for group-level change points in 85% of the strata. Change points for flycatchers (FC) were distinct from those for swallows, swifts and nightjars (SSN) across North America, except in the Northeast, where all AI shared the same group-level change points. During the 1980s, there was a negative change point acrossmost of North America, in the trends of SSN. For FC, the group-level change points were more geographically variable, and in many regions there were two: a positive change point followed by a negative change point. This group-level synchrony in AI population trends is likely evidence of a response to a common environmental factor(s) with similar effects on many species across broad spatial extents. The timing and geographic patterns of the change points that we identify here should provide a spring-board for research into the causes behind aerial insectivore declines.	[Smith, Adam C.; Hudson, Marie-Anne R.; Downes, Constance M.; Francis, Charles M.] Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada	Environment & Climate Change Canada; Canadian Wildlife Service	Smith, AC (corresponding author), Environm Canada, Canadian Wildlife Serv, Ottawa, ON K1A 0H3, Canada.	Adam.Smith@ec.gc.ca		Smith, Adam Clark/0000-0002-2829-4843				[Anonymous], 2004, DATA BIRD; Barry R, 2001, SYNOPTIC DYNAMIC CLI, P358; Beckage B, 2007, NEW PHYTOL, V174, P456, DOI 10.1111/j.1469-8137.2007.01991.x; Bled F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081867; Fraser KC, 2012, P ROY SOC B-BIOL SCI, V279, P4901, DOI 10.1098/rspb.2012.2207; Garcia-Perez B, 2014, AUK, V131, P351, DOI 10.1642/AUK-13-145.1; Garcia-Perez B, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00116.1; GEISSLER P H, 1990, U S Fish and Wildlife Service Biological Report, V90, P54; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Jahn AE, 2013, AUK, V130, P247, DOI 10.1525/auk.2013.13010; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Lunn DJ, 2009, STAT COMPUT, V19, P395, DOI 10.1007/s11222-008-9100-0; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; NABCI, 2012, STAT CAN BIRDS; Nebel S, 2010, AVIAN CONSERV ECOL, V5; Paquette SR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0649; Saracco JF, 2008, J WILDLIFE MANAGE, V72, P1665, DOI 10.2193/2008-129; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Smith Adam C., 2014, Canadian Field-Naturalist, V128, P119; SMITH GW, 1995, 5 US DEP INT NAT BIO; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thomas A., 2004, GEOBUGS USER MANUAL; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; Thomson JR, 2010, ECOL APPL, V20, P1431, DOI 10.1890/09-0998.1; Zimmerman GS, 2012, J WILDLIFE MANAGE, V76, P1165, DOI 10.1002/jwmg.351	25	42	41	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130768	10.1371/journal.pone.0130768	http://dx.doi.org/10.1371/journal.pone.0130768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147572	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600048
J	Garcia-Gutierrez, E; Almendros, C; Mojica, FJM; Guzman, NM; Garcia-Martinez, J				Garcia-Gutierrez, Enriqueta; Almendros, Cristobal; Mojica, Francisco J. M.; Guzman, Noemi M.; Garcia-Martinez, Jesus			CRISPR Content Correlates with the Pathogenic Potential of Escherichia coli	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; LATERAL GENE-TRANSFER; CAS SYSTEM; NATURAL TRANSFORMATION; ANTIBIOTIC-RESISTANCE; SPACER ACQUISITION; E. COLI; IMMUNITY; STRAINS; REPEATS	Guide RNA molecules (crRNA) produced from clustered regularly interspaced short palindromic repeat (CRISPR) arrays, altogether with effector proteins (Cas) encoded by cognate cas (CRISPR associated) genes, mount an interference mechanism (CRISPR-Cas) that limits acquisition of foreign DNA in Bacteria and Archaea. The specificity of this action is provided by the repeat intervening spacer carried in the crRNA, which upon hybridization with complementary sequences enables their degradation by a Cas endonuclease. Moreover, CRISPR arrays are dynamic landscapes that may gain new spacers from infecting elements or lose them for example during genome replication. Thus, the spacer content of a strain determines the diversity of sequences that can be targeted by the corresponding CRISPR-Cas system reflecting its functionality. Most Escherichia coli strains possess either type I-E or I-F CRISPR-Cas systems. To evaluate their impact on the pathogenicity of the species, we inferred the pathotype and pathogenic potential of 126 strains of this and other closely related species and analyzed their repeat content. Our results revealed a negative correlation between the number of I-E CRISPR units in this system and the presence of pathogenicity traits: the median number of repeats was 2.5-fold higher for commensal isolates (with 29.5 units, range 0-53) than for pathogenic ones (12.0, range 0-42). Moreover, the higher the number of virulence factors within a strain, the lower the repeat content. Additionally, pathogenic strains of distinct ecological niches (i.e., intestinal or extraintestinal) differ in repeat counts. Altogether, these findings support an evolutionary connection between CRISPR and pathogenicity in E. coli.	[Garcia-Gutierrez, Enriqueta; Almendros, Cristobal; Mojica, Francisco J. M.; Guzman, Noemi M.; Garcia-Martinez, Jesus] Univ Alicante, Dept Fisiol Genet & Microbiol, Alicante 03690, Spain	Universitat d'Alacant	Garcia-Martinez, J (corresponding author), Univ Alicante, Dept Fisiol Genet & Microbiol, Campus San Vicente, Alicante 03690, Spain.	jesus.garcia@ua.es	Gutierrez, Enriqueta Garcia/B-8901-2018; Mojica, Francisco/M-8478-2019; García-Martínez, Jesús/K-6557-2014; Mojica, Francisco J.M./K-2414-2014; Guzman, Noemi M/AAA-5348-2019; Garcia-Gutierrez, Enriqueta/O-2866-2019; Almendros, Cristobal/Q-1163-2016	Gutierrez, Enriqueta Garcia/0000-0001-5683-7924; García-Martínez, Jesús/0000-0002-8149-8052; Mojica, Francisco J.M./0000-0002-6660-4996; Garcia-Gutierrez, Enriqueta/0000-0001-5683-7924; Almendros, Cristobal/0000-0002-1582-8906; Guzman, Noemi M/0000-0002-3789-2095; Mangan, Rachel/0000-0002-2984-3699	Ministerio de Economia y Competitividad [BIO2011-24417]; Conselleria D'Educacio, Cultura i Esport, Generalitat Valenciana [ACOMP/2014/135]	Ministerio de Economia y Competitividad(Spanish Government); Conselleria D'Educacio, Cultura i Esport, Generalitat Valenciana	This work was supported by Grant BIO2011-24417 from the Ministerio de Economia y Competitividad(http://www.mineco.gob.es/portal/site/mineco/idi), and Grant ACOMP/2014/135 from the Conselleria D'Educacio, Cultura i Esport, Generalitat Valenciana (http://www.cece.gva.es/es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2007, WATER RES, V41, P3785, DOI 10.1016/j.watres.2006.12.026; Almendros C, 2014, MBIO, V5, DOI 10.1128/mBio.00767-13; Almendros C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050797; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beutin L, 1997, EPIDEMIOL INFECT, V118, P199, DOI 10.1017/S0950268897007413; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bin Kingombe CI, 2005, J FOOD PROTECT, V68, P239, DOI 10.4315/0362-028X-68.2.239; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Boyd EF, 1998, J BACTERIOL, V180, P1159, DOI 10.1128/JB.180.5.1159-1165.1998; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dobrindt U, 2005, INT J MED MICROBIOL, V295, P357, DOI 10.1016/j.ijmm.2005.07.009; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; GarciaMartinez J, 1996, FEMS IMMUNOL MED MIC, V14, P231, DOI 10.1016/0928-8244(96)00037-5; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Koch D, 2011, J BIOL CHEM, V286, P25317, DOI 10.1074/jbc.M111.222745; Krause DO, 2011, J BACTERIOL, V193, P583, DOI 10.1128/JB.01290-10; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Miquel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012714; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Mojica FJM, 2010, MOL MICROBIOL, V77, P1341, DOI 10.1111/j.1365-2958.2010.07326.x; Nash JHE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-667; Newton ILG, 2011, CURR MICROBIOL, V62, P198, DOI 10.1007/s00284-010-9693-3; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Ochoa Theresa J., 2011, Rev. perú. med. exp. salud publica, V28, P13; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Philippe H, 1999, MOL MICROBIOL, V31, P1007, DOI 10.1046/j.1365-2958.1999.01185.x; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Rivera FP, 2010, J CLIN MICROBIOL, V48, P3198, DOI 10.1128/JCM.00644-10; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sampson TR, 2014, P NATL ACAD SCI USA, V111, P11163, DOI 10.1073/pnas.1323025111; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; SCHMIDT H, 1995, J CLIN MICROBIOL, V33, P701, DOI 10.1128/JCM.33.3.701-705.1995; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Tanji Y, 2003, WATER RES, V37, P1136, DOI 10.1016/S0043-1354(02)00464-5; Tanji Y, 2002, J BIOSCI BIOENG, V94, P172, DOI 10.1263/jbb.94.172; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Toro M, 2014, APPL ENVIRON MICROB, V80, P1411, DOI 10.1128/AEM.03018-13; Touchon M, 2012, MICROBIOL-SGM, V158, P2997, DOI 10.1099/mic.0.060814-0; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Dang TND, 2013, INFECT GENET EVOL, V19, P212, DOI 10.1016/j.meegid.2013.07.017; Ventura M, 2011, GENES NUTR, V6, P205, DOI 10.1007/s12263-010-0188-4; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Yang CD, 2014, MOL MICROBIOL, V92, P1072, DOI 10.1111/mmi.12614; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	82	31	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131935	10.1371/journal.pone.0131935	http://dx.doi.org/10.1371/journal.pone.0131935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136211	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400083
J	Wasunna, B; Okiro, EA; Webster, J; Todd, J; Snow, RW; Jones, C				Wasunna, Beatrice; Okiro, Emelda A.; Webster, Jayne; Todd, Jim; Snow, Robert W.; Jones, Caroline			The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya	PLOS ONE			English	Article							EFFECTIVE MALARIA TREATMENT; ANTIMALARIAL COMBINATION THERAPY; UNCOMPLICATED MALARIA; HEALTH FACILITIES; 6-DOSE REGIMEN; DRUG POLICY; ADHERENCE; PROMPT; ACCEPTABILITY; PERFORMANCE	Background Access to prompt and effective treatment is the cornerstone for malaria control. Population Services International in collaboration with the Ministry of Health launched a malaria behaviour change communication intervention in Nyanza province, Kenya. The initiative aimed to improve: symptom recognition and prompt access to government health facilities for febrile children; effective treatment with the recommended first-line drug artemether-lumefantrine (AL) in public health facilities and adherence to the AL regimen. Methods Pre- and post-intervention cross-sectional household surveys were used to evaluate the impact of the intervention on prompt and correct use of AL for febrile children below five years of age. The primary outcome was the proportion of children below five years of age with fever in the last 14 days accessing AL within 48 hours of fever onset. Results There was an increase from 62.8% pre-intervention to 79.4% post-intervention (95% CI: 11.1, 22.1) in caregivers who reported seeking formal treatment promptly (on the same day, or next day) for their febrile children. However, there was a decrease in the use of government health facilities in the post-intervention period. There was a small increase in the proportion of children accessing AL within 48 hours of fever onset [18.4% vs 23.5% (0.1-10.0)]. Conclusion The findings of this evaluation demonstrate that interventions that target only one sector may have a limited impact on improvements in prompt and effective treatment where multiple sources of treatments are sought for febrile illness. Additionally, the context in which an intervention is implemented is likely to influence the process and outcomes.	[Wasunna, Beatrice] Kenya Govt Med Res Ctr, ESACIPAC, Nairobi, Kenya; [Okiro, Emelda A.; Snow, Robert W.] CGMRC, Kenya Med Res Inst, Dept Publ Hlth Res, Wellcome Trust Res Programme, Nairobi, Kenya; [Okiro, Emelda A.; Snow, Robert W.; Jones, Caroline] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, CCVTM, Oxford, England; [Webster, Jayne; Jones, Caroline] LSHTM, Dis Control Dept, London WCIE 7HT, England; [Todd, Jim] London Sch Hyg & Trop Med, Dept Populat Hlth, London WCIE 7HT, England; [Jones, Caroline] CGMR C, Kenya Med Res Inst, Hlth Syst & Social Sci Res, Wellcome Trust Res Programme, Kilifi, Kenya	Kenya Medical Research Institute; Kenya Medical Research Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute	Wasunna, B (corresponding author), Kenya Govt Med Res Ctr, ESACIPAC, POB 54840-00200, Nairobi, Kenya.	anyangob@gmail.com	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Todd, Jim/0000-0001-5918-4914; Webster, Jayne/0000-0002-0498-8883; Okiro, Emelda/0000-0001-9543-8360	Pfizer Inc's Mobilize against Malaria initiative [88A732140]; Wellcome Trust Major Overseas Programme grant [092654]; Kenya Medical Research Institute	Pfizer Inc's Mobilize against Malaria initiative; Wellcome Trust Major Overseas Programme grant(Wellcome Trust); Kenya Medical Research Institute	This study was principally funded by Pfizer Inc's Mobilize against Malaria initiative (Contract number 88A732140). RWS is a Wellcome Trust Principal Fellow (# 079080 & # 103602). EAO, RWS and CJ acknowledge the support provided by the Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme (number 092654) BW, EAO and RWS also acknowledge support from the Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSMITH B, 1992, HEALTH POLICY PLANN, V7, P329, DOI 10.1093/heapol/7.4.329; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; [Anonymous], GLOB MAL ACT PLAN; Beer N, 2009, TROP MED INT HEALTH, V14, P1; CBS, 2001, POP HOUS CENS COUNT, VII, P1; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; Chuma J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-243; Depoortere E, 2004, ANN TROP MED PARASIT, V98, P635, DOI 10.1179/000349804225021271; Dillip A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-144; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Gerstl S, 2010, T ROY SOC TROP MED H, V104, P328, DOI 10.1016/j.trstmh.2009.12.008; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Gitonga CW, 2008, TROP MED INT HEALTH, V13, P487, DOI 10.1111/j.1365-3156.2008.02026.x; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Kabanywanyi AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-48; Kachur SP, 2004, AM J TROP MED HYG, V71, P715, DOI 10.4269/ajtmh.2004.71.715; Kirkwood BR, 2003, ESSENTIAL MED STAT; Lawford H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-281; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; O'Meara WP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-186; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Pharmacy and Poisons Board (PPB) and Division of Malaria Control, 2007, ANT MED KEN AV QUAL; Simba DO, 2012, T ROY SOC TROP MED H, V106, P3, DOI 10.1016/j.trstmh.2011.09.006; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Souares A, 2008, T ROY SOC TROP MED H, V102, P751, DOI 10.1016/j.trstmh.2008.05.016; Souares A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-257; United Nations Children Fund, 2013, INV FUT DEF MAL WORL; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2001, TRAIN MIDDL LEV MAN; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; Working Group for Mortality Estimation in Emergencies, 2007, EMERGING THEMES EPID, V4, pe9; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130305	10.1371/journal.pone.0130305	http://dx.doi.org/10.1371/journal.pone.0130305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CS	26135143	gold, Green Published, Green Accepted			2022-12-26	WOS:000358154400016
J	Abubaker, A; Baharum, A; Alrefaei, M				Abubaker, Ahmad; Baharum, Adam; Alrefaei, Mahmoud			Automatic Clustering Using Multi-objective Particle Swarm and Simulated Annealing	PLOS ONE			English	Article							ALGORITHM; EVOLUTION; BEHAVIOR	This paper puts forward a new automatic clustering algorithm based on Multi-Objective Particle Swarm Optimization and Simulated Annealing, "MOPSOSA". The proposed algorithm is capable of automatic clustering which is appropriate for partitioning datasets to a suitable number of clusters. MOPSOSA combines the features of the multi-objective based particle swarm optimization (PSO) and the Multi-Objective Simulated Annealing (MOSA). Three cluster validity indices were optimized simultaneously to establish the suitable number of clusters and the appropriate clustering for a dataset. The first cluster validity index is centred on Euclidean distance, the second on the point symmetry distance, and the last cluster validity index is based on short distance. A number of algorithms have been compared with the MOPSOSA algorithm in resolving clustering problems by determining the actual number of clusters and optimal clustering. Computational experiments were carried out to study fourteen artificial and five real life datasets.	[Abubaker, Ahmad; Baharum, Adam] Univ Sains Malaysia, Sch Math Sci, George Town 11800, Malaysia; [Abubaker, Ahmad] Al Imam Muhammad Ibn Saud Islamic Univ, Dept Math & Stat, Riyadh 11623, Saudi Arabia; [Alrefaei, Mahmoud] Jordan Univ Sci & Technol, Dept Math & Stat, Irbid 22110, Jordan	Universiti Sains Malaysia; Imam Mohammad Ibn Saud Islamic University (IMSIU); Jordan University of Science & Technology	Abubaker, A (corresponding author), Univ Sains Malaysia, Sch Math Sci, George Town 11800, Malaysia.	ahm.abubaker@gmail.com	Alrefaei, Mahmoud/N-5131-2016	Alrefaei, Mahmoud/0000-0002-2291-9670; BAHARUM, ADAM/0000-0002-1541-982X				Bandyopadhyay S, 2002, PATTERN RECOGN, V35, P1197, DOI 10.1016/S0031-3203(01)00108-X; Bandyopadhyay S, 2008, IEEE T KNOWL DATA EN, V20, P1441, DOI 10.1109/TKDE.2008.79; Bandyopadhyay S, 2007, PATTERN RECOGN, V40, P3430, DOI 10.1016/j.patcog.2007.03.026; Bandyopadhyay Sanghamitra, 2007, P1, DOI 10.1007/3-540-49607-6_1; Benjamin C. M. Fung, 2003, P 3 SIAM INT C DAT M; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Deb K., 2001, MULTIOBJECTIVE OPTIM; Everitt B. S., 2001, CLUSTER ANAL; Goldberg D., 1987, GEN ALG THEIR APPL P; Halkidi M., 2001, P 2001 IEEE INT C DA; Handl J, 2007, IEEE T EVOLUT COMPUT, V11, P56, DOI 10.1109/TEVC.2006.877146; Hruschka ER, 2009, IEEE T SYST MAN CY C, V39, P133, DOI 10.1109/TSMCC.2008.2007252; Jaccard P., 1902, B SOC VAUD SCI NAT, V38, P69, DOI [DOI 10.5169/SEALS-266762, 10.5169/seals-266762]; Jain AK., 1988, TECHNOMETRICS; Jardine N., 1971, MATH TAXONOMY; Lichman M, 2013, UCI MACHINE LEARNING; Liu YM, 2005, INFORM-J COMPUT INFO, V29, P33; Liu YG, 2011, APPL MATH COMPUT, V218, P1267, DOI 10.1016/j.amc.2011.06.007; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Masoud H, 2013, APPL INTELL, V38, P289, DOI 10.1007/s10489-012-0373-9; Matake N, 2007, P 9 ANN C GEN EV COM; MITRA D, 1986, ADV APPL PROBAB, V18, P747, DOI 10.2307/1427186; PAL SK, 1994, INFORM SCIENCES, V76, P297, DOI 10.1016/0020-0255(94)90014-0; Saha S, 2013, APPL SOFT COMPUT, V13, P89, DOI 10.1016/j.asoc.2012.08.005; Saha S, 2012, APPL SOFT COMPUT, V12, P1555, DOI 10.1016/j.asoc.2011.12.013; Saha S, 2010, PATTERN RECOGN, V43, P738, DOI 10.1016/j.patcog.2009.07.004; Saha S, 2009, PATTERN RECOGN LETT, V30, P1392, DOI 10.1016/j.patrec.2009.07.015; Salazar-Lechuga M, 2005, C EV COMP CEC 2005 E, DOI [10.1016/j.biosystems.2015.05.002, DOI 10.1016/J.BIOSYSTEMS.2015.05.002]; Shieh HL, 2011, APPL MATH COMPUT, V218, P4365, DOI 10.1016/j.amc.2011.10.012; Suresh K, 2009, SENSORS-BASEL, V9, P3981, DOI 10.3390/s90503981; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TOUSSAINT GT, 1980, PATTERN RECOGN, V12, P261, DOI 10.1016/0031-3203(80)90066-7; Ulungu E.L., 1995, MCDM THEORY APPL, P229; [杨善林 YANG Shanlin], 2006, [系统工程理论与实践, Systems Engineering-Theory & Practice], V26, P97	34	27	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130995	10.1371/journal.pone.0130995	http://dx.doi.org/10.1371/journal.pone.0130995			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132309	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000087
J	Grice, J; Noyvert, B; Doglio, L; Elgar, G				Grice, Joseph; Noyvert, Boris; Doglio, Laura; Elgar, Greg			A Simple Predictive Enhancer Syntax for Hindbrain Patterning Is Conserved in Vertebrate Genomes	PLOS ONE			English	Article							HOX GENE-REGULATION; SEGMENTAL EXPRESSION; NONCODING ELEMENTS; PROTEINS; DNA; ORGANIZATION; EVOLUTION; DATABASE; RHOMBOMERE-4; SPECIFICITY	Background Determining the function of regulatory elements is fundamental for our understanding of development, disease and evolution. However, the sequence features that mediate these functions are often unclear and the prediction of tissue-specific expression patterns from sequence alone is non-trivial. Previous functional studies have demonstrated a link between PBX-HOX and MEIS/PREP binding interactions and hindbrain enhancer activity, but the defining grammar of these sites, if any exists, has remained elusive. Results Here, we identify a shared sequence signature (syntax) within a heterogeneous set of conserved vertebrate hindbrain enhancers composed of spatially co-occurring PBX-HOX and MEIS/PREP transcription factor binding motifs. We use this syntax to accurately predict hindbrain enhancers in 89% of cases (67/75 predicted elements) from a set of conserved non-coding elements (CNEs). Furthermore, mutagenesis of the sites abolishes activity or generates ectopic expression, demonstrating their requirement for segmentally restricted enhancer activity in the hindbrain. We refine and use our syntax to predict over 3,000 hindbrain enhancers across the human genome. These sequences tend to be located near developmental transcription factors and are enriched in known hindbrain activating elements, demonstrating the predictive power of this simple model. Conclusion Our findings support the theory that hundreds of CNEs, and perhaps thousands of regions across the human genome, function to coordinate gene expression in the developing hindbrain. We speculate that deeply conserved sequences of this kind contributed to the cooption of new genes into the hindbrain gene regulatory network during early vertebrate evolution by linking patterns of hox expression to downstream genes involved in segmentation and patterning, and evolutionarily newer instances may have continued to contribute to line-age-specific elaboration of the hindbrain.	[Grice, Joseph; Noyvert, Boris; Doglio, Laura; Elgar, Greg] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	Francis Crick Institute	Elgar, G (corresponding author), Francis Crick Inst, Mill Hill Lab, Ridgeway,Mill Hill, London NW7 1AA, England.	Greg.Elgar@crick.ac.uk		Elgar, Greg/0000-0001-7323-1596	Medical Research Council UK [U117597141]; Medical Research Council UK PhD studentship; Medical Research Council [MC_U117597141] Funding Source: researchfish; MRC [MC_U117597141] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council UK PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council UK core funding (U117597141) to GE, and by an Medical Research Council UK PhD studentship to JG (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2003, BIOINFORMATICS, V19, pII16, DOI 10.1093/bioinformatics/btg1054; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Burzynski GM, 2012, GENOME RES, V22, P2278, DOI 10.1101/gr.139717.112; Chan SK, 1997, DEVELOPMENT, V124, P2007; Choe SK, 2002, DEVELOPMENT, V129, P585; Chomette D, 2006, DEVELOPMENT, V133, P1253, DOI 10.1242/dev.02289; Clarke SL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002852; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; De Silva DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103357; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; Doglio L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003904; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Elgar Greg, 2009, Briefings in Functional Genomics & Proteomics, V8, P256, DOI 10.1093/bfgp/elp033; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hiller M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt557; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Knight RD, 2000, DEV GENES EVOL, V210, P518, DOI 10.1007/s004270000092; Knoepfler PS, 1996, NUCLEIC ACIDS RES, V24, P2288, DOI 10.1093/nar/24.12.2288; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Royo JL, 2011, P NATL ACAD SCI USA, V108, P14186, DOI 10.1073/pnas.1109037108; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Manzanares M, 2001, DEVELOPMENT, V128, P3595; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Natale A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-330; Nelson AC, 2013, DEVELOPMENT, V140, P1385, DOI 10.1242/dev.084459; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Parker HJ, 2014, NATURE, V514, P490, DOI 10.1038/nature13723; Parker HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085492; Parker HJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-637; Pauls S, 2012, DEV BIOL, V365, P310, DOI 10.1016/j.ydbio.2012.02.025; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Piasecka B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003476; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Prin F, 2014, DEVELOPMENT, V141, P1492, DOI 10.1242/dev.098954; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quina LA, 2012, DIS MODEL MECH, V5, P812, DOI 10.1242/dmm.009910; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Rubinstein M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0017; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sanges R, 2013, NUCLEIC ACIDS RES, V41, P3600, DOI 10.1093/nar/gkt030; Schilling TF, 2001, PHILOS T R SOC B, V356, P1599, DOI 10.1098/rstb.2001.0918; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Stedman A, 2009, DEV BIOL, V327, P566, DOI 10.1016/j.ydbio.2008.12.018; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Vavouri T, 2009, BIOESSAYS, V31, P727, DOI 10.1002/bies.200900014; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Vlachakis N, 2001, DEVELOPMENT, V128, P1299; Wada H, 1999, DEV BIOL, V213, P131, DOI 10.1006/dbio.1999.9369; Wang JL, 2009, MOL BIOL EVOL, V26, P487, DOI 10.1093/molbev/msn278; Waskiewicz AJ, 2002, DEV CELL, V3, P723, DOI 10.1016/S1534-5807(02)00319-2; Wassef MA, 2008, DEVELOPMENT, V135, P3369, DOI 10.1242/dev.023614; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Woolfe A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-100	73	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130413	10.1371/journal.pone.0130413	http://dx.doi.org/10.1371/journal.pone.0130413			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131856	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000067
J	Grudniewska, A; Klobucki, M; Dancewicz, K; Szczepanik, M; Gabrys, B; Wawrzenczyk, C				Grudniewska, Aleksandra; Klobucki, Marek; Dancewicz, Katarzyna; Szczepanik, Maryla; Gabrys, Beata; Wawrzenczyk, Czeslaw			Synthesis and Antifeedant Activity of Racemic and Optically Active Hydroxy Lactones with the p-Menthane System	PLOS ONE			English	Article							COLORADO POTATO BEETLE; FEEDING-DETERRENT ACTIVITY; ALPHITOBIUS-DIAPERINUS; TERPENOID LACTONES; LESSER MEALWORM; SESQUITERPENE LACTONES; CHEMICAL-COMPOSITION; TRANSMISSION; COLEOPTERA; RESISTANCE	Two racemic and two enantiomeric pairs of new delta-hydroxy-gamma-lactones based on the p-menthane system were prepared from racemic and optically active cis- and trans-piperitols. The Johnson-Claisen rearrangement of the piperitols, epoxidation of the gamma delta-unsaturated esters, and acidic lactonization of the epoxy esters were described. The structures of the compounds were confirmed spectroscopically. The antifeedant activities of the hydroxy lactones and racemic piperitone were evaluated against three insect pests: lesser mealworm, Alphitobius diaperinus (Panzer); Colorado potato beetle, Leptinotarsa decemlineata (Say); and peach-potato aphid, Myzus persicae (Sulz.). The chemical transformation of piperitone by the introduction of a lactone moiety and a hydroxy group changed its antifeedant properties. Behavioral bioassays showed that the feeding deterrent activity depended on the insect species and the structure of the compounds. All hydroxy lactones deterred the settling of M. persicae. Among chewing insects, the highest sensitivity showed A. diaperinus adults.	[Grudniewska, Aleksandra; Klobucki, Marek; Wawrzenczyk, Czeslaw] Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland; [Dancewicz, Katarzyna; Gabrys, Beata] Univ Zielona Gora, Dept Biol & Ecol, Zielona Gora, Poland; [Szczepanik, Maryla] Nicolaus Copernicus Univ, Dept Invertebrate Zool, Torun, Poland	Wroclaw University of Environmental & Life Sciences; University of Zielona Gora; Nicolaus Copernicus University	Grudniewska, A (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland.	aleksandra.grudniewska@up.wroc.pl	Wawrzeńczyk, Czesław CW/C-2679-2017; Grudniewska, Aleksandra/B-6696-2017; Gabrys, Beata/ABB-5330-2021; Maryla, Szczepanik/O-4694-2015; Grudniewska, Aleksandra/AAJ-9445-2020	Gabrys, Beata/0000-0001-8255-3570; Grudniewska, Aleksandra/0000-0003-1665-4423; Dancewicz, Katarzyna/0000-0001-6341-5914	European Union from the European Regional Development Found Grant [POIG.01.03.01-00-158/09]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	European Union from the European Regional Development Found Grant; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This work was financed by European Union from the European Regional Development Found Grant No. POIG.01.03.01-00-158/09 (http://www.biotransformacje.ch.pwr.wroc.pl). Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (http://know.wroc.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; Bourgeois MJ, 2001, HELV CHIM ACTA, V84, P2430, DOI 10.1002/1522-2675(20010815)84:8<2430::AID-HLCA2430>3.0.CO;2-O; Brault V, 2010, CR BIOL, V333, P524, DOI 10.1016/j.crvi.2010.04.001; Cis J, 2006, BIOCHEM SYST ECOL, V34, P862, DOI 10.1016/j.bse.2006.05.019; Dams I, 2004, EUR J ORG CHEM, V2004, P2662, DOI 10.1002/ejoc.200300800; Dams I, 2012, FLAVOUR FRAG J, V27, P237, DOI 10.1002/ffj.3085; Dancewicz K, 2008, J CHEM ECOL, V34, P530, DOI 10.1007/s10886-008-9448-9; Frazier JL, 1995, REGULATORY MECH INSE, P364, DOI [10.1007/978-1-4615-1775-7_13, DOI 10.1007/978-1-4615-1775-7_13]; Frerot E, 2002, FLAVOUR FRAG J, V17, P218, DOI 10.1002/ffj.1089; Gaudin JM, 2000, TETRAHEDRON, V56, P4769, DOI 10.1016/S0040-4020(00)00397-5; Goodwin Mark A, 1996, J Appl Poult Res, V5, P51, DOI 10.1093/japr/5.1.51; Grudniewska A, 2013, J AGR FOOD CHEM, V61, P3364, DOI 10.1021/jf3052219; Grudniewska A, 2013, MOLECULES, V18, P2778, DOI 10.3390/molecules18032778; Grudniewska A, 2011, RSC ADV, V1, P498, DOI 10.1039/c1ra00270h; Guth H, 1996, HELV CHIM ACTA, V79, P1559, DOI 10.1002/hlca.19960790606; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARDIE J, 1992, ENTOMOL EXP APPL, V62, P233, DOI 10.1007/BF00353442; HARMATHA J, 1984, BIOCHEM SYST ECOL, V12, P95, DOI 10.1016/0305-1978(84)90015-2; Harrewijn P., 1990, APHID PLANT GENOTYPE, P117; Koul O., 2004, INSECT ANTIFEEDANTS, P25; Lopez-Olguin J, 1999, PHYTOCHEMISTRY, V50, P749, DOI 10.1016/S0031-9422(98)00642-6; Mayoral AM, 1996, ENTOMOL EXP APPL, V78, P341, DOI 10.1111/j.1570-7458.1996.tb00799.x; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Naf R, 1998, FLAVOUR FRAG J, V13, P203, DOI 10.1002/(SICI)1099-1026(199805/06)13:3&lt;203::AID-FFJ725&gt;3.0.CO;2-0; NAWROT J, 1985, Herba Polonica, V31, P209; NAWROT J, 1986, ACTA ENTOMOL BOHEMOS, V83, P327; Paruch E, 2001, PEST MANAG SCI, V57, P776, DOI 10.1002/ps.353; Paruch E, 1998, EUR J ORG CHEM, V1998, P2677; Paruch E, 2000, J AGR FOOD CHEM, V48, P4973, DOI 10.1021/jf991307o; Pettersson J, 2007, APHIDS AS CROP PESTS, P87, DOI 10.1079/9780851998190.0087; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; Rasband W.S., 1997, IMAGE J; Rice SJ, 2009, J APPL ENTOMOL, V133, P67, DOI 10.1111/j.1439-0418.2008.01314.x; Roche AJ, 2009, POULTRY SCI, V88, P44, DOI 10.3382/ps.2008-00235; SOSA ME, 1994, J NAT PROD, V57, P1262, DOI 10.1021/np50111a012; SWAIN T, 1977, ANNU REV PLANT PHYS, V28, P479, DOI 10.1146/annurev.pp.28.060177.002403; Szczepanik M, 2008, ENTOMOL EXP APPL, V128, P337, DOI 10.1111/j.1570-7458.2008.00725.x; Szczepanik M, 2014, PEST MANAG SCI, V70, P953, DOI 10.1002/ps.3634; Szczepanik N, 2005, ENVIRON ENTOMOL, V34, P1433; TAKAHASHI K, 1980, AGR BIOL CHEM TOKYO, V44, P1535, DOI 10.1080/00021369.1980.10864154; Tjallingii W.F., 1995, P190; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Wawrzenczyk C., 2005, POL J ENVIRON STUD, V14, P69; Winska K, 2010, TETRAHEDRON-ASYMMETR, V21, P670, DOI 10.1016/j.tetasy.2010.02.031; Yukawa C, 2006, FLAVOUR FRAG J, V21, P234, DOI 10.1002/ffj.1563	45	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131028	10.1371/journal.pone.0131028	http://dx.doi.org/10.1371/journal.pone.0131028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132506	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000089
J	Jensen, KC; Hair, BB; Wienclaw, TM; Murdock, MH; Hatch, JB; Trent, AT; White, TD; Haskell, KJ; Berges, BK				Jensen, Kyle C.; Hair, Bryan B.; Wienclaw, Trevor M.; Murdock, Mark H.; Hatch, Jacob B.; Trent, Aaron T.; White, Tyler D.; Haskell, Kyler J.; Berges, Bradford K.			Isolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite Decontaminant	PLOS ONE			English	Article							UNITED-STATES; INFECTIONS; THERAPY; SUSCEPTIBILITY; VIRUSES; MUTATIONS; EMERGENCE; PATHOGENS; LAMBDA; PHAGES	Staphylococcus aureus (SA) is a commensal bacterium and opportunistic pathogen commonly associated with humans and is capable of causing serious disease and death including sepsis, pneumonia, and meningitis. Methicillin-resistant SA (MRSA) isolates are typically resistant to many available antibiotics with the common exception of vancomycin. The presence of vancomycin resistance in some SA isolates combined with the current heavy use of vancomycin to treat MRSA infections indicates that MRSA may achieve broad resistance to vancomycin in the near future. New MRSA treatments are clearly needed. Bacteriophages (phages) are viruses that infect bacteria, commonly resulting in death of the host bacterial cell. Phage therapy entails the use of phage to treat or prevent bacterial infections. In this study, 12 phages were isolated that can replicate in human SA and/or MRSA isolates as a potential way to control these infections. 5 phage were discovered through mitomycin C induction of prophage and 7 others as extracellular viruses. Primary SA strains were also isolated from environmental sources to be used as tools for phage discovery and isolation as well as to examine the target cell host range of the phage isolates by spot testing. Primary isolates were tested for susceptibility to oxacillin in order to determine which were MRSA. Experiments were performed to assess the host range and killing potential of newly discovered phage, and significant reductions in bacterial load were detected. We explored the utility of some phage to decontaminate fomites (glass and cloth) and found a significant reduction in colony forming units of MRSA following phage treatment, including tests of a phage cocktail against a cocktail of MRSA isolates. Our findings suggest that phage treatment can be used as an effective tool to decontaminate human MRSA from both hard surfaces and fabrics.	[Jensen, Kyle C.; Hair, Bryan B.; Wienclaw, Trevor M.; Murdock, Mark H.; Hatch, Jacob B.; Trent, Aaron T.; White, Tyler D.; Haskell, Kyler J.; Berges, Bradford K.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Berges, BK (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	brad.berges@gmail.com			Mentoring Environment Grant; Turkey Vaccine Award from Brigham Young University	Mentoring Environment Grant; Turkey Vaccine Award from Brigham Young University	This project was funded by a Mentoring Environment Grant and a Turkey Vaccine Award to BKB from Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1; Casewell MW, 1998, J HOSP INFECT, V40, pS3, DOI 10.1016/S0195-6701(98)90199-2; Centers fDCaP. Active Bacterial Core Surveillance (ABCs), 2012, ACT BACT COR SURV AB; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; HOFNUNG M, 1976, MOL GEN GENET, V145, P207, DOI 10.1007/BF00269595; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mann NH, 2008, RES MICROBIOL, V159, P400, DOI 10.1016/j.resmic.2008.04.003; McDougal LK, 2010, ANTIMICROB AGENTS CH, V54, P3804, DOI 10.1128/AAC.00351-10; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Pastagia M, 2012, EMERG INFECT DIS, V18, P1072, DOI 10.3201/eid1807.101371; Rashid Mohammed H, 2012, Bacteriophage, V2, P168; Robert J, 2006, J ANTIMICROB CHEMOTH, V57, P506, DOI 10.1093/jac/dki486; Rossi F, 2014, NEW ENGL J MED, V370, P1524, DOI 10.1056/NEJMoa1303359; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Srinivasiah S, 2008, RES MICROBIOL, V159, P349, DOI 10.1016/j.resmic.2008.04.010; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Summers William C, 2012, Bacteriophage, V2, P130; Viertel TM, 2014, J ANTIMICROB CHEMOTH, V69, P2326, DOI 10.1093/jac/dku173; WERTS C, 1994, J BACTERIOL, V176, P941, DOI 10.1128/JB.176.4.941-947.1994; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yossepowitch O, 2014, DIAGN MICR INFEC DIS, V78, P352, DOI 10.1016/j.diagmicrobio.2014.01.001	28	35	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131714	10.1371/journal.pone.0131714	http://dx.doi.org/10.1371/journal.pone.0131714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131892	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000137
J	Luis, EO; Arrondo, G; Vidorreta, M; Martinez, M; Loayza, F; Fernandez-Seara, MA; Pastor, MA				Luis, Elkin O.; Arrondo, Gonzalo; Vidorreta, Marta; Martinez, Martin; Loayza, Francis; Fernandez-Seara, Maria A.; Pastor, Maria A.			Successful Working Memory Processes and Cerebellum in an Elderly Sample: A Neuropsychological and fMRI Study	PLOS ONE			English	Article							AGE-RELATED-CHANGES; BASAL GANGLIA; FUNCTIONAL TOPOGRAPHY; PREFRONTAL CORTEX; PARIETAL CORTEX; TASKS; CONNECTIVITY; ORGANIZATION; MOTOR; NETWORKS	Background Imaging studies help to understand the evolution of key cognitive processes related to aging, such as working memory (WM). This study aimed to test three hypotheses in older adults. First, that the brain activation pattern associated to WM processes in elderly during successful low load tasks is located in posterior sensory and associative areas; second, that the prefrontal and parietal cortex and basal ganglia should be more active during high-demand tasks; third, that cerebellar activations are related to high-demand cognitive tasks and have a specific lateralization depending on the condition. Methods We used a neuropsychological assessment with functional magnetic resonance imaging and a core N-back paradigm design that was maintained across the combination of four conditions of stimuli and two memory loads in a sample of twenty elderly subjects. Results During low-loads, activations were located in the visual ventral network. In high loads, there was an involvement of the basal ganglia and cerebellum in addition to the frontal and parietal cortices. Moreover, we detected an executive control role of the cerebellum in a relatively symmetric fronto-parietal network. Nevertheless, this network showed a predominantly left lateralization in parietal regions associated presumably with an overuse of verbal storage strategies. The differential activations between conditions were stimuli-dependent and were located in sensory areas. Conclusion Successful WM processes in the elderly population are accompanied by an activation pattern that involves cerebellar regions working together with a fronto-parietal network.	[Luis, Elkin O.; Arrondo, Gonzalo; Vidorreta, Marta; Martinez, Martin; Loayza, Francis; Fernandez-Seara, Maria A.; Pastor, Maria A.] Univ Navarra, Ctr Appl Med Res CIMA, Div Neurosci, Neuroimaging Lab, E-31080 Pamplona, Spain; [Pastor, Maria A.] Univ Navarra, Clin Univ Navarra, Sch Med, Dept Neurol, E-31080 Pamplona, Spain; [Fernandez-Seara, Maria A.; Pastor, Maria A.] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Arrondo, Gonzalo] Univ Cambridge, Dept Psychiat, Cambridge, England	University of Navarra; University of Navarra; CIBERNED; Instituto de Salud Carlos III; University of Cambridge	Pastor, MA (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Div Neurosci, Neuroimaging Lab, E-31080 Pamplona, Spain.	mapastor@unav.es	Martinez, Martin/A-1126-2016; Fernandez-Seara, Maria A./K-1246-2014; Arrondo, Gonzalo/U-9534-2017; Pastor, Maria A./C-7851-2009; Loayza, Francis R./AAR-7985-2021; Luis Garcia, Elkin/AAW-2756-2020	Martinez, Martin/0000-0002-3053-7920; Fernandez-Seara, Maria A./0000-0001-8536-6295; Arrondo, Gonzalo/0000-0003-3085-8959; Pastor, Maria A./0000-0003-2404-9346; Loayza, Francis R./0000-0002-6283-3679; Luis Garcia, Elkin/0000-0002-7981-1177	CIBERNED, Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas; Instituto de Salud Carlos III, Madrid, Spain; UTE project Fundacion para la Investigacion Medica Aplicada FIMA, Spain; Government of Navarra	CIBERNED, Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas; Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); UTE project Fundacion para la Investigacion Medica Aplicada FIMA, Spain; Government of Navarra	M.A.P. has been funded by CIBERNED, Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain and by the UTE project Fundacion para la Investigacion Medica Aplicada FIMA, Spain. Elkin O. Luis is supported by an Education Department grant from the Government of Navarra (2011-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; BADDELEY AD, 1975, HUM FACTORS, V17, P446, DOI 10.1177/001872087501700503; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley A, 2011, J COGNITIVE NEUROSCI, V23, P3855, DOI 10.1162/jocn_a_00066; Balsters JH, 2010, NEUROIMAGE, V49, P2045, DOI 10.1016/j.neuroimage.2009.10.045; Baumann O, 2015, CEREBELLUM, V14, P197, DOI 10.1007/s12311-014-0627-7; Bernard JA, 2013, NEUROIMAGE, V83, P103, DOI 10.1016/j.neuroimage.2013.06.042; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Bower JM, 1997, PROG BRAIN RES, V114, P463; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; Della Sala S, 1999, NEUROPSYCHOLOGIA, V37, P1189, DOI 10.1016/S0028-3932(98)00159-6; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Desmond JE, 1997, J NEUROSCI, V17, P9675; Ding K, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/612086; Fakhri M, 2013, BEHAV NEUROL, V27, P235, DOI [10.1155/2013/103105, 10.3233/BEN-2012-110234]; Fakhri M, 2012, BEHAV NEUROL, V25, P351, DOI 10.1155/2012/824049; Fernandez-San Martin MI, 2002, INT J GERIATR PSYCH, V17, P279, DOI 10.1002/gps.588; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2005, INT REV NEUROBIOL, V66, P89, DOI 10.1016/S0074-7742(05)66003-5; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Grahn JA, 2009, ANN NY ACAD SCI, V1169, P35, DOI 10.1111/j.1749-6632.2009.04553.x; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hackert VH, 2002, NEUROIMAGE, V17, P1365, DOI 10.1006/nimg.2002.1248; Hautzel H, 2009, NEUROIMAGE, V47, P2073, DOI 10.1016/j.neuroimage.2009.06.005; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Kelly RM, 2003, J NEUROSCI, V23, P8432; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kirschen MP, 2010, BEHAV NEUROL, V23, P51, DOI [10.3233/BEN-2010-0266, 10.1155/2010/587450]; Leonards U, 2002, EXP BRAIN RES, V146, P172, DOI 10.1007/s00221-002-1175-9; Marvel CL, 2010, NEUROPSYCHOL REV, V20, P271, DOI 10.1007/s11065-010-9137-7; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mechelli A, 2000, P ROY SOC B-BIOL SCI, V267, P1909, DOI 10.1098/rspb.2000.1229; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Moore AB, 2013, BRAIN LANG, V125, P316, DOI 10.1016/j.bandl.2012.05.003; Newman SD, 2013, BRAIN TOPOGR, V26, P458, DOI 10.1007/s10548-012-0264-8; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Pena-Casanova J, 1997, Neurologia, V12, P61; Podell JE, 2012, NEUROIMAGE, V62, P2151, DOI 10.1016/j.neuroimage.2012.05.066; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Postle BR, 2000, J COGNITIVE NEUROSCI, V12, P2, DOI 10.1162/089892900564028; Rajah MN, 2008, BRAIN RES, V1199, P111, DOI 10.1016/j.brainres.2007.12.051; Ranganath C, 2004, J NEUROSCI, V24, P3917, DOI 10.1523/JNEUROSCI.5053-03.2004; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Suchan B, 2008, COGN PROCESS, V9, P45, DOI 10.1007/s10339-007-0186-7; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Thurling M, 2012, NEUROIMAGE, V62, P1537, DOI 10.1016/j.neuroimage.2012.05.037; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Ziemus B, 2007, NEUROPSYCHOLOGIA, V45, P2016, DOI 10.1016/j.neuropsychologia.2007.02.012	61	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131536	10.1371/journal.pone.0131536	http://dx.doi.org/10.1371/journal.pone.0131536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132286	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000128
J	Taveira, MD; Morita, ME; Yasuda, CL; Coan, AC; Secolin, R; da Costa, ALC; Cendes, F				Taveira, Mateus de Oliveira; Morita, Marcia Elisabete; Yasuda, Clarissa Lin; Coan, Ana Carolina; Secolin, Rodrigo; Cunha da Costa, Alberto Luiz; Cendes, Fernando			Neurocysticercotic Calcifications and Hippocampal Sclerosis: A Case-Control Study	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CALCIFIED NEUROCYSTICERCOSIS; LESIONS; ASSOCIATION; SEIZURES; ATROPHY	Objective The exact role of calcified neurocysticercotic lesions (CNLs) in epilepsy is yet unknown and controversial. Although the relationship between CNLs, epilepsy and mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) has already been addressed, to our knowledge, no study has actually provided strong statistical evidence, nor reported the ODDS ratio for these associations. Therefore, we designed this case-control study to assess the likelihood of having MTLE-HS versus other forms of epilepsy in the presence of CNLs. Methods In this case-control study we included 119 consecutive patients with epilepsy and 106 disease controls (headache) with previous CT scans. We subdivided cases into MTLE-HS and other epilepsies. We used brain CT scans to define presence or absence of CNLs. After exploratory analyses, we used logistic regression to analyze the association between CNLs, epilepsy subgroups and disease controls. Results CNLs were found in 31.09% of cases and in 11.32% of controls (p<0.001). The initial analysis comparing epilepsy versus controls revealed a significant association between CNLs and epilepsy (OR = 5.32; 95%CI = 2.43-11.54; p<0.001). However, when we compared MTLE-HS versus other epilepsies versus controls we confirmed that CNLs were associated with MTLE-HS (OR = 11.27, 95%CI = 4.73-26.85; p<0.001) but other epilepsies were not. We found no difference in the CNLs load and no difference in the location of the CNLs when we compared patients with MTLE-HS, other epilepsies and disease controls. Significance The inclusion of controls allowed us to estimate the likelihood of having epilepsy in the presence of CNLs. We found that patients with CNLs were 11 times more likely to have MTLE-HS; however, the presence of CNLs did not change the odds of having other types of epilepsy. These findings raise the possibility of neurocysticercosis playing a role in the pathophysiology of MTLE-HS and need further confirmation in other series.	[Taveira, Mateus de Oliveira] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil; [Morita, Marcia Elisabete; Yasuda, Clarissa Lin; Coan, Ana Carolina; Cunha da Costa, Alberto Luiz; Cendes, Fernando] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil; [Secolin, Rodrigo] Univ Estadual Campinas, Dept Med Genet, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Cendes, F (corresponding author), Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.	fcendes@unicamp.br	Cendes, Fernando/C-1301-2012; Secolin, Rodrigo/G-1738-2010; yasuda, clarissa l/B-7934-2013; de Oliveira Taveira, Mateus/AAR-8251-2020; Secolin, Rodrigo/AAG-2115-2019; yasuda, clarissa lin/D-4599-2018; Coan, Ana Carolina/F-4982-2012; Coan, Ana Carolina/AAA-7887-2020	Cendes, Fernando/0000-0001-9336-9568; Secolin, Rodrigo/0000-0002-2485-9560; yasuda, clarissa l/0000-0001-9084-7173; de Oliveira Taveira, Mateus/0000-0001-8091-6593; Secolin, Rodrigo/0000-0002-2485-9560; yasuda, clarissa lin/0000-0001-9084-7173; Coan, Ana Carolina/0000-0002-2888-929X; Coan, Ana Carolina/0000-0002-2888-929X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/21265-2, 2013/07559-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	MOT funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant # 2013/21265-2. FC funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant # 2013/07559-3.	Agapejev S, 2003, ARQ NEURO-PSIQUIAT, V61, P822, DOI 10.1590/S0004-282X2003000500022; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bianchin MM, 2006, EPILEPSIA, V47, P244; Bianchin MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060949; Bianchin MM, 2008, EPILEPSIA, V49, P487; Bianchin MM, 2012, PATHOG GLOB HEALTH, V106, P280, DOI 10.1179/2047773212Y.0000000027; Bianchin MM, 2006, LANCET NEUROL, V5, P20, DOI 10.1016/S1474-4422(05)70269-6; Bianchin MM, 2005, EPILEPSIA, V46, P236; Carpio A, 1998, EPILEPSIA, V39, P1025, DOI 10.1111/j.1528-1157.1998.tb01287.x; Cendes F, 2005, CURR OPIN NEUROL, V18, P173, DOI 10.1097/01.wco.0000162860.49842.90; da Gama CN, 2005, SEIZURE-EUR J EPILEP, V14, P85, DOI 10.1016/j.seizure.2004.10.005; de Souza A, 2010, J NEUROL SCI, V288, P135, DOI 10.1016/j.jns.2009.09.018; Del Brutto OH, 2015, AM J TROP MED HYG, V92, P64, DOI 10.4269/ajtmh.14-0453; Del Brutto OH, 2012, PATHOG GLOB HEALTH, V106, P299, DOI 10.1179/2047773212Y.0000000025; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Garcia HH, 2005, LANCET NEUROL, V4, P653, DOI 10.1016/S1474-4422(05)70194-0; Garcia HH, 2003, ACTA TROP, V87, P71, DOI 10.1016/S0001-706X(03)00057-3; Garcia-Noval J, 2001, ANN TROP MED PARASIT, V95, P167, DOI 10.1080/00034980120050260; Gupta RK, 2012, NEUROLOGY, V78, P618, DOI 10.1212/WNL.0b013e318248deae; Kobayashi E, 2002, ARCH NEUROL-CHICAGO, V59, P1891, DOI 10.1001/archneur.59.12.1891; Kobayashi E, 2001, ARQ NEURO-PSIQUIAT, V59, P255, DOI 10.1590/S0004-282X2001000200021; Leite JP, 2000, NEUROLOGY, V55, P1485, DOI 10.1212/WNL.55.10.1485; Lewis DV, 2005, EPILEPSIA, V46, P39, DOI 10.1111/j.1528-1167.2005.00306.x; MEYER A, 1954, J NEUROL NEUROSUR PS, V17, P276, DOI 10.1136/jnnp.17.4.276; Montano SM, 2005, NEUROLOGY, V65, P229, DOI 10.1212/01.wnl.0000168828.83461.09; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Nash TE, 2008, LANCET NEUROL, V7, P1099, DOI 10.1016/S1474-4422(08)70243-6; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Oliveira MCB, 2014, ARQ NEURO-PSIQUIAT, V72, P510, DOI 10.1590/0004-282X20140080; Rajshekhar V, 2006, NEUROLOGY, V67, P2135, DOI 10.1212/01.wnl.0000249113.11824.64; Rathore C, 2013, EPILEPSIA, V54, P1815, DOI 10.1111/epi.12349; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Singh G, 2000, EPILEPSIA, V41, P718, DOI 10.1111/j.1528-1157.2000.tb00234.x; Singla M, 2007, EPILEPTIC DISORD, V9, P292, DOI 10.1684/epd.2007.0122; da Silva AV, 2006, ARQ NEURO-PSIQUIAT, V64, P309, DOI 10.1590/S0004-282X2006000200026; Velasco TR, 2006, J NEUROL NEUROSUR PS, V77, P485, DOI 10.1136/jnnp.2005.078675; Wieser HG, 2004, EPILEPSIA, V45, P32	38	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131180	10.1371/journal.pone.0131180	http://dx.doi.org/10.1371/journal.pone.0131180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132287	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000100
J	Blyth, BJ; Kakinuma, S; Sunaoshi, M; Amasaki, Y; Hirano-Sakairi, S; Ogawa, K; Shirakami, A; Shang, Y; Tsuruoka, C; Nishimura, M; Shimada, Y				Blyth, Benjamin J.; Kakinuma, Shizuko; Sunaoshi, Masaaki; Amasaki, Yoshiko; Hirano-Sakairi, Shinobu; Ogawa, Kanae; Shirakami, Ayana; Shang, Yi; Tsuruoka, Chizuru; Nishimura, Mayumi; Shimada, Yoshiya			Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; COPY-NUMBER ALTERATIONS; ATOMIC-BOMB SURVIVORS; THYMIC LYMPHOMAS; HEAVY-ION; X-RAYS; RADIATION; NOTCH1; IKAROS; MUTATIONS	Monitoring mice exposed to carbon ion radiotherapy provides an indirect method to evaluate the potential for second cancer induction in normal tissues outside the radiotherapy target volume, since such estimates are not yet possible from historical patient data. Here, male and female B6C3F1 mice were given single or fractionated whole-body exposure(s) to a monoenergetic carbon ion radiotherapy beam at the Heavy Ion Medical Accelerator in Chiba, Japan, matching the radiation quality delivered to the normal tissue ahead of the tumour volume (average linear energy transfer = 13 keV. mu m(-1)) during patient radiotherapy protocols. The mice were monitored for the remainder of their lifespan, and a large number of T cell lymphomas that arose in these mice were analysed alongside those arising following an equivalent dose of Cs-137 gamma ray-irradiation. Using genome-wide DNA copy number analysis to identify genomic loci involved in radiation-induced lymphomagenesis and subsequent detailed analysis of Notch1, Ikzf1, Pten, Trp53 and Bcl11b genes, we compared the genetic profile of the carbon ion-and gamma ray-induced tumours. The canonical set of genes previously associated with radiation-induced T cell lymphoma was identified in both radiation groups. While the pattern of disruption of the various pathways was somewhat different between the radiation types, most notably Pten mutation frequency and loss of heterozygosity flanking Bcl11b, the most striking finding was the observation of large interstitial deletions at various sites across the genome in carbon ion-induced tumours, which were only seen infrequently in the gamma ray-induced tumours analysed. If such large interstitial chromosomal deletions are a characteristic lesion of carbon ion irradiation, even when using the low linear energy transfer radiation to which normal tissues are exposed in radiotherapy patients, understanding the dose-response and tissue specificity of such DNA damage could prove key to assessing second cancer risk in carbon ion radiotherapy patients.	[Blyth, Benjamin J.; Kakinuma, Shizuko; Sunaoshi, Masaaki; Amasaki, Yoshiko; Hirano-Sakairi, Shinobu; Ogawa, Kanae; Shirakami, Ayana; Shang, Yi; Tsuruoka, Chizuru; Nishimura, Mayumi; Shimada, Yoshiya] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Radiobiol Childrens Hlth Program, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Shimada, Y (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Radiobiol Childrens Hlth Program, Chiba 260, Japan.	y_shimad@nirs.go.jp	Sunaoshi, Masaaki/ABF-3504-2021	SUNAOSHI, Masaaki/0000-0003-3970-0701; Blyth, Benjamin/0000-0003-4754-6249	National Institute of Radiological Sciences, Japan; (Japan Society for the Promotion of Science) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [21610029]; Radiation Effects Association, Japan [H26-06];  [17B241];  [22B269]	National Institute of Radiological Sciences, Japan; (Japan Society for the Promotion of Science) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Radiation Effects Association, Japan; ; 	This work was performed with funding from the National Institute of Radiological Sciences, Japan (http://www.nirs.go.jp) to SK and Y. Shimada and was partly conducted under the Heavy Ion Medical Accelerator in Chiba Projects #17B241 and #22B269. A Grant-In-Aid for Scientific Research (#21610029) (Japan Society for the Promotion of Science) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (https://www.jsps.go.jp) was received by Y. Shimada. BJB received funding from a research grant (H26-06) from the Radiation Effects Association, Japan (http://www.rea.or.jp/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib A, 2012, J EXP MED, V209, P395, DOI 10.1084/jem.20110216; Ando K, 2009, INT J RADIAT BIOL, V85, P715, DOI 10.1080/09553000903072470; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Champagne DP, 2014, MUTAT RES-FUND MOL M, V761, P34, DOI 10.1016/j.mrfmmm.2014.01.007; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Demarest RM, 2011, BLOOD, V117, P2901, DOI 10.1182/blood-2010-05-286351; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; Eastmond D. A., 1997, CHEM RAD LEUKEMOGENE; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Friedrich T, 2015, RADIAT PROT DOSIM, V166, P61, DOI 10.1093/rpd/ncv147; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Genet SC, 2012, ONCOL REP, V28, P1591, DOI 10.3892/or.2012.1982; Go R, 2013, CANCER SCI, V104, P1009, DOI 10.1111/cas.12193; Gross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038960; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Haydu JE, 2012, BLOOD, V119, P5211, DOI 10.1182/blood-2011-10-388504; Imaoka T, 2007, INT J RADIAT ONCOL, V69, P194, DOI 10.1016/j.ijrobp.2007.05.026; Imaoka T, 2013, INT J RADIAT ONCOL, V85, P1134, DOI 10.1016/j.ijrobp.2012.08.035; Jeannet R, 2010, BLOOD, V116, P5443, DOI 10.1182/blood-2010-05-286658; Jen KY, 2012, BLOOD, V119, P805, DOI 10.1182/blood-2011-01-327619; Kang HM, 2006, CANCER GENET CYTOGEN, V166, P27, DOI 10.1016/j.cancergencyto.2005.08.002; Kastner Philippe, 2011, World J Biol Chem, V2, P108, DOI 10.4331/wjbc.v2.i6.108; Kaveh K, 2015, RADIAT ENVIRON BIOPH, V54, P25, DOI 10.1007/s00411-014-0576-z; Kawata T, 2001, ADV SPACE RES-SERIES, V27, P383, DOI 10.1016/S0273-1177(01)00006-0; Khong P-L., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.10.001; Kwon YW, 2012, MOL CANCER RES, V10, P834, DOI 10.1158/1541-7786.MCR-12-0025; Little MP, 2013, INT J RADIAT ONCOL, V85, P451, DOI 10.1016/j.ijrobp.2012.04.029; Little MP, 2009, RADIAT ENVIRON BIOPH, V48, P253, DOI 10.1007/s00411-009-0228-x; Llorente LG, 2014, PEDIATR BLOOD CANCER, V61, P788, DOI 10.1002/pbc.24852; Manem VSK, 2015, INT J RADIAT BIOL, V91, P209, DOI 10.3109/09553002.2014.980466; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Matsumoto K, 2009, MAGN RESON MED, V61, P1033, DOI 10.1002/mrm.21958; Mendes RD, 2014, BLOOD, V124, P567, DOI 10.1182/blood-2014-03-562751; Neumann M, 2015, ONCOTARGET, V6, P2754, DOI 10.18632/oncotarget.2218; Ofuchi T, 1999, J RADIAT RES, V40, P125, DOI 10.1269/jrr.40.125; Ohi H, 2007, ONCOGENE, V26, P5280, DOI 10.1038/sj.onc.1210325; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Olsson L, 2015, BRIT J HAEMATOL, V169, P479, DOI 10.1111/bjh.13342; Onozawa M, 2012, GENE CHROMOSOME CANC, V51, P525, DOI 10.1002/gcc.21942; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Pignalosa D, 2013, RADIOTHER ONCOL, V109, P256, DOI 10.1016/j.radonc.2013.09.021; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Remke M, 2009, BLOOD, V114, P1053, DOI 10.1182/blood-2008-10-186536; Rivina L, 2013, INT J ENV RES PUB HE, V10, P107, DOI 10.3390/ijerph10010107; Schlaff CD, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-88; Sekine E, 2008, MUTAT RES-GEN TOX EN, V652, P95, DOI 10.1016/j.mrgentox.2008.01.003; Sontani Y, 2011, LEUKEMIA RES, V35, P1512, DOI 10.1016/j.leukres.2011.07.024; Takabatake T, 2008, RADIAT RES, V169, P426, DOI 10.1667/RR1180.1; Takabatake T, 2006, RADIAT RES, V166, P61, DOI 10.1667/RR3575.1; Tauchi H, 2009, J RADIAT RES, V50, P441, DOI 10.1269/jrr.09033; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; Tsuji H, 2013, J RADIAT RES, V54, P453, DOI 10.1093/jrr/rrs128; Valentin J., 2005, Annals of the ICRP, V35, pIII, DOI 10.1016/j.icrp.2005.01.001; Wada M, 2013, J RADIAT RES, V54, P798, DOI 10.1093/jrr/rrt012; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Watanabe H, 1998, J RADIAT RES, V39, P93, DOI 10.1269/jrr.39.93; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xu XG, 2008, PHYS MED BIOL, V53, pR193, DOI 10.1088/0031-9155/53/13/R01; Yamaguchi Y, 2010, MUTAT RES-FUND MOL M, V686, P30, DOI 10.1016/j.mrfmmm.2009.12.011; Yoshida MA, 2007, CANCER GENET CYTOGEN, V179, P1, DOI 10.1016/j.cancergencyto.2007.06.016; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	67	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130666	10.1371/journal.pone.0130666	http://dx.doi.org/10.1371/journal.pone.0130666			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125582	gold, Green Submitted, Green Published			2022-12-26	WOS:000358151300021
J	Singer, H; Biswas, A; Nuesgen, N; Oldenburg, J; El-Maarri, O				Singer, Heike; Biswas, Arijit; Nuesgen, Nicole; Oldenburg, Johannes; El-Maarri, Osman			NLRP7, Involved in Hydatidiform Molar Pregnancy (HYDM1), Interacts with the Transcriptional Repressor ZBTB16	PLOS ONE			English	Article							PROTEIN; MUTATIONS; MOLES; PLZF; METHYLATION; DOMAIN; DIFFERENTIATION; REGULATOR; OOCYTE	Mutations in the maternal effect gene NLRP7 cause biparental hydatidiform mole (HYDM1). HYDM1 is characterized by abnormal growth of placenta and lack of proper embryonic development. The molar tissues are characterized by abnormal methylation patterns at differentially methylated regions (DMRs) of imprinted genes. It is not known whether this occurs before or after fertilization, but the high specificity of this defect to the maternal allele indicates a possible maternal germ line-specific effect. To better understand the unknown molecular mechanism leading to HYDM1, we performed a yeast two-hybrid screen against an ovarian library using NLRP7 as bait. We identified the transcriptional repressor ZBTB16 as an interacting protein of NLRP7 and verified this interaction in mammalian cells by immunoprecipitation and confocal microscopy. Native protein analysis detected NLRP7 and ZBTB16 in a 480kD protein complex and both proteins co-localize in the cytoplasm in juxtanuclear aggregates. HYDM1-causing mutations in NLRP7 did not show altered patterns of interaction with ZBTB16. Hence, the biological significance of the NLRP7-ZBTB16 interaction remains to be revealed. However, a clear effect of harvesting ZBTB16 to the cytoplasm when the NLRP7 protein is overexpressed may be linked to the pathology of the molar pregnancy disease.	[Singer, Heike; Biswas, Arijit; Nuesgen, Nicole; Oldenburg, Johannes; El-Maarri, Osman] Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany	University of Bonn	El-Maarri, O (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany.	osman.elmaarri@ukb.uni-bonn.de	Biswas, A./B-9673-2011; Oldenburg, Johannes/ABB-7817-2020	Biswas, Arijit/0000-0002-4103-5854; El-Maarri, Osman/0000-0002-6859-5819; Oldenburg, Johannes/0000-0002-1585-4100				Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Beygo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076953; Caliebe A, 2014, J MED GENET, V51, P407, DOI 10.1136/jmedgenet-2013-102149; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dias RP, 2013, EPIGENOMICS-UK, V5, P331, DOI [10.2217/EPI.13.28, 10.2217/epi.13.28]; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; El-Maarri O., 2004, METHOD MOL BIOL, P287; Hayward BE, 2009, HUM MUTAT, V30, pE629, DOI 10.1002/humu.20993; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Koken MHM, 1997, P NATL ACAD SCI; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Mahadevan S, 2014, HUM MOL GENET, V23, P706, DOI 10.1093/hmg/ddt457; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Messaed C, 2011, J BIOL CHEM, V286, P43313, DOI 10.1074/jbc.M111.306191; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Nguyen NMP, 2014, J MED GENET, V51, P623, DOI 10.1136/jmedgenet-2014-102546; Parry DA, 2011, AM J HUM GENET, V89, P451, DOI 10.1016/j.ajhg.2011.08.002; Peng H, 2012, PLOS ONE, DOI [10.1371/journal.pone.0030344.g001, DOI 10.1371/JOURNAL.PONE.0030344.G001]; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Reddy R, 2013, EUR J HUM GENET, V21, P957, DOI 10.1038/ejhg.2012.274; Singer H, 2014, MOL HUM REPROD, V20, P990, DOI 10.1093/molehr/gau060; Slim R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00242; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Zhang P, 2009, PLOS ONE, DOI [10.1371/journal.pone.0002755.g001, DOI 10.1371/JOURNAL.PONE.0002755.G001]; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	30	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130416	10.1371/journal.pone.0130416	http://dx.doi.org/10.1371/journal.pone.0130416			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121690	Green Published, Green Submitted, gold			2022-12-26	WOS:000358150400043
J	Ruiz, CA; Rossi, SG; Rotundo, RL				Ruiz, Carlos A.; Rossi, Susana G.; Rotundo, Richard L.			Rescue and Stabilization of Acetylcholinesterase in Skeletal Muscle by N-terminal Peptides Derived from the Noncatalytic Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH MEMBRANE ANCHOR; ENDOPLASMIC-RETICULUM; T-PEPTIDE; INTRACELLULAR-TRANSPORT; QUATERNARY ASSOCIATIONS; MOLECULAR-CLONING; GOLGI-APPARATUS; CHICKEN BRAIN; COLLAGEN TAIL; DEGRADATION	The vast majority of newly synthesized acetylcholinesterase (AChE) molecules do not assemble into catalytically active oligomeric forms and are rapidly degraded intracellularly by the endoplasmic reticulum-associated protein degradation pathway. We have previously shown that AChE in skeletal muscle is regulated in part post-translationally by the availability of the noncatalytic subunit collagen Q, and others have shown that expression of a 17-amino acid N-terminal proline-rich attachment domain of collagen Q is sufficient to promote AChE tetramerization in cells producing AChE. In this study we show that muscle cells, or cell lines expressing AChE catalytic subunits, incubated with synthetic proline-rich attachment domain peptides containing the endoplasmic reticulum retrieval sequence KDEL take up and retrogradely transport them to the endoplasmic reticulum network where they induce assembly of AChE tetramers. The peptides act to enhance AChE folding thereby rescuing them from reticulum degradation. This enhanced folding efficiency occurs in the presence of inhibitors of protein synthesis and in turn increases total cell-associated AChE activity and active tetramer secretion. Pulse-chase studies of isotopically labeled AChE molecules show that the enzyme is rescued from intracellular degradation. These studies provide a mechanistic explanation for the large scale intracellular degradation of AChE previously observed and indicate that simple peptides alone can increase the production and secretion of this critical synaptic enzyme in muscle tissue.	[Ruiz, Carlos A.; Rossi, Susana G.; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Rotundo, Richard L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA	University of Miami; University of Miami	Rotundo, RL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol, R-124,1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu			National Institutes of Health CounterACT Program from NINDS [NS057994]; National Institutes of Health CounterACT Program from NIA [AG05917]; U.S. Army Research Office Training Grant [ARO 49497-LS-HIS]; Ruth Kirschstein National Research Service Award for Individual Predoctoral Fellows; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health CounterACT Program from NINDS; National Institutes of Health CounterACT Program from NIA; U.S. Army Research Office Training Grant; Ruth Kirschstein National Research Service Award for Individual Predoctoral Fellows(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health CounterACT Program, Grant NS057994 from NINDS, and Grant AG05917 from NIA (to R. L. R.). A patent has been awarded to R. L. R. covering the synthesis and use of this PRAD peptide, which is being developed for therapeutic applications. R. L. R. has not received any monetary remuneration for this peptide.; Supported by U.S. Army Research Office Training Grant ARO 49497-LS-HIS (to R. L. R.) and a Ruth Kirschstein National Research Service Award for Individual Predoctoral Fellows.	Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Campanari ML, 2014, J MOL NEUROSCI, V53, P446, DOI 10.1007/s12031-013-0183-5; CHATEL JM, 1993, FEBS LETT, V319, P12, DOI 10.1016/0014-5793(93)80027-R; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Chen VP, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00036; Chen VP, 2011, J BIOL CHEM, V286, P32948, DOI 10.1074/jbc.M111.261248; Chitlaru T, 2001, BIOCHEM J, V354, P613, DOI 10.1042/0264-6021:3540613; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; Kronman C, 2000, J BIOL CHEM, V275, P29488, DOI 10.1074/jbc.M004298200; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; Lord JM, 1998, J CELL BIOL, V140, P733; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MIESENBOCK G, 1995, J CELL BIOL, V129, P309, DOI 10.1083/jcb.129.2.309; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; Ruiz CA, 2009, J BIOL CHEM, V284, P21488, DOI 10.1074/jbc.M109.030049; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SIMPSON JC, 1995, J BIOL CHEM, V270, P20078, DOI 10.1074/jbc.270.34.20078; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; WALES R, 1993, J BIOL CHEM, V268, P23986; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	41	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20774	20781		10.1074/jbc.M115.653741	http://dx.doi.org/10.1074/jbc.M115.653741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26139603	Green Published, hybrid			2022-12-26	WOS:000360011800015
J	Allen, SJ; Parthasarathy, G; Darke, PL; Diehl, RE; Ford, RE; Hall, DL; Johnson, SA; Reid, JC; Rickert, KW; Shipman, JM; Soisson, SM; Zuck, P; Munshi, SK; Lumb, KJ				Allen, Samantha J.; Parthasarathy, Gopal; Darke, Paul L.; Diehl, Ronald E.; Ford, Rachael E.; Hall, Dawn L.; Johnson, Scott A.; Reid, John C.; Rickert, Keith W.; Shipman, Jennifer M.; Soisson, Stephen M.; Zuck, Paul; Munshi, Sanjeev K.; Lumb, Kevin J.			Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSIN KINASE; GABA(B) RECEPTOR; BINDING-SITE; GRK4; POLYMORPHISMS; ACTIVATION; DOPAMINE; PHOSPHORYLATION; LOCALIZATION; COMPLEX	G-protein-coupled receptor (GPCR) kinases (GRKs) bind to and phosphorylate GPCRs, initiating the process of GPCR desensitization and internalization. GRK4 is implicated in the regulation of blood pressure, and three GRK4 polymorphisms (R65L, A142V, and A486V) are associated with hypertension. Here, we describe the 2.6 angstrom structure of human GRK4 alpha.A486V crystallized in the presence of 5'-adenylyl beta,gamma-imidodiphosphate. The structure of GRK4 alpha is similar to other GRKs, although slight differences exist within the RGS homology (RH) bundle subdomain, substrate-binding site, and kinase C-tail. The RH bundle subdomain and kinase C-terminal lobe form a strikingly acidic surface, whereas the kinase N-terminal lobe and RH terminal subdomain surfaces are much more basic. In this respect, GRK4 alpha is more similar to GRK2 than GRK6. A fully ordered kinase C-tail reveals interactions linking the C-tail with important determinants of kinase activity, including the alpha B helix, alpha D helix, and the P-loop. Autophosphorylation of wild-type GRK4 alpha is required for full kinase activity, as indicated by a lag in phosphorylation of a peptide from the dopamine D-1 receptor without ATP preincubation. In contrast, this lag is not observed in GRK4 alpha A486V. Phosphopeptide mapping by mass spectrometry indicates an increased rate of autophosphorylation of a number of residues in GRK4 alpha A486V relative to wild-type GRK4 alpha, including Ser-485 in the kinase C-tail.	[Allen, Samantha J.; Darke, Paul L.; Diehl, Ronald E.; Ford, Rachael E.; Hall, Dawn L.; Rickert, Keith W.; Shipman, Jennifer M.; Zuck, Paul; Munshi, Sanjeev K.; Lumb, Kevin J.] Merck Res Labs, Screening & Prot Sci, N Wales, PA 19454 USA; [Parthasarathy, Gopal; Johnson, Scott A.; Reid, John C.; Soisson, Stephen M.] Merck Res Labs, Struct Chem, West Point, PA 19486 USA	Merck & Company; Merck & Company	Allen, SJ (corresponding author), Merck Res Labs, NW1-105,502 Louise Ln, N Wales, PA 19454 USA.	samantha_allen@merck.com	Johnson, Scott A/A-6022-2009	Johnson, Scott A/0000-0002-0244-5201; Lumb, Kevin/0000-0003-2778-9956				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Beautrait A, 2014, J BIOL CHEM, V289, P25262, DOI 10.1074/jbc.M114.593178; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Felder RA, 2006, NAT CLIN PRACT NEPHR, V2, P637, DOI 10.1038/ncpneph0301; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; Freeman JLR, 1998, J BIOL CHEM, V273, P20653, DOI 10.1074/jbc.273.32.20653; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Harris RC, 2012, CURR HYPERTENS REP, V14, P138, DOI 10.1007/s11906-012-0253-z; Homan KT, 2013, CURR MED CHEM, V20, P39; Homan KT, 2015, J BIOL CHEM, V290, P20649, DOI 10.1074/jbc.M115.647370; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Kanaide M, 2007, J CELL PHYSIOL, V210, P237, DOI 10.1002/jcp.20863; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Keever LB, 2008, BIOCHEM BIOPH RES CO, V367, P649, DOI 10.1016/j.bbrc.2007.12.181; Komolov KE, 2015, J BIOL CHEM, V290, P20629, DOI 10.1074/jbc.M115.647297; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; Li LY, 2015, J BIOL CHEM, V290, P10775, DOI 10.1074/jbc.M115.644773; Liu CB, 2012, INT J MED SCI, V9, P274, DOI 10.7150/ijms.4171; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Rayner B, 2015, INT J MOL SCI, V16, P5741, DOI 10.3390/ijms16035741; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Sallese M, 1997, J BIOL CHEM, V272, P10188; Sanada H, 2006, CLIN CHEM, V52, P352, DOI 10.1373/clinchem.2005.059139; Sanada H, 1999, HYPERTENSION, V33, P1036, DOI 10.1161/01.HYP.33.4.1036; Sanada H, 2016, PHARMACOGENOMICS J, V16, P3, DOI 10.1038/tpj.2015.6; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Speirs HJL, 2004, J HYPERTENS, V22, P931, DOI 10.1097/00004872-200405000-00014; Sterne-Marr R, 2009, BIOCHEMISTRY-US, V48, P4285, DOI 10.1021/bi900151g; Tesmer JJG, 2012, ACTA CRYSTALLOGR F, V68, P622, DOI 10.1107/S1744309112017435; Tesmer JJG, 2010, J MED CHEM, V53, P1867, DOI 10.1021/jm9017515; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Vandell AG, 2012, HYPERTENSION, V60, P957, DOI 10.1161/HYPERTENSIONAHA.112.198721; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Xu H, 2014, MOL BIOL CELL, V25, P2105, DOI 10.1091/mbc.E13-09-0547; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870	50	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20360	20373		10.1074/jbc.M115.648907	http://dx.doi.org/10.1074/jbc.M115.648907			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134571	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000359608900034
J	Frank, DN; Bales, ES; Monks, J; Jackman, MJ; MacLean, PS; Ir, D; Robertson, CE; Orlicky, DJ; McManaman, JL				Frank, Daniel N.; Bales, Elise S.; Monks, Jenifer; Jackman, Matthew J.; MacLean, Paul S.; Ir, Diana; Robertson, Charles E.; Orlicky, David J.; McManaman, James L.			Perilipin-2 Modulates Lipid Absorption and Microbiome Responses in the Mouse Intestine	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; GUT MICROBIOME; BILE-ACIDS; DROPLETS; DATABASE; TOOLS; GENE; METABOLISM; EXPRESSION	Obesity and its co-morbidities, such as fatty liver disease, are increasingly prevalent worldwide health problems. Intestinal microorganisms have emerged as critical factors linking diet to host physiology and metabolic function, particularly in the context of lipid homeostasis. We previously demonstrated that deletion of the cytoplasmic lipid drop (CLD) protein Perilipin-2 (Plin2) in mice largely abrogates long-term deleterious effects of a high fat (HF) diet. Here we test the hypotheses that Plin2 function impacts the earliest steps of HF diet-mediated pathogenesis as well as the dynamics of diet-associated changes in gut microbiome diversity and function. WT and perilipin-2 null mice raised on a standard chow diet were randomized to either low fat (LF) or HF diets. After four days, animals were assessed for changes in physiological (body weight, energy balance, and fecal triglyceride levels), histochemical (enterocyte CLD content), and fecal microbiome parameters. Plin2-null mice had significantly lower respiratory exchange ratios, diminished frequencies of enterocyte CLDs, and increased fecal triglyceride levels compared with WT mice. Microbiome analyses, employing both 16S rRNA profiling and metagenomic deep sequencing, indicated that dietary fat content and Plin2 genotype were significantly and independently associated with gut microbiome composition, diversity, and functional differences. These data demonstrate that Plin2 modulates rapid effects of diet on fecal lipid levels, enterocyte CLD contents, and fuel utilization properties of mice that correlate with structural and functional differences in their gut microbial communities. Collectively, the data provide evidence of Plin2 regulated intestinal lipid uptake, which contributes to rapid changes in the gut microbial communities implicated in diet-induced obesity.	[Frank, Daniel N.; Ir, Diana; Robertson, Charles E.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA; [Frank, Daniel N.; Robertson, Charles E.] Univ Colorado, Sch Med, Microbiome Res Consortium, Aurora, CO USA; [Bales, Elise S.; Monks, Jenifer; McManaman, James L.] Univ Colorado, Sch Med, Div Basic Reprod Sci, Aurora, CO 80045 USA; [Jackman, Matthew J.; MacLean, Paul S.] Univ Colorado, Sch Med, Div Endocrinol & Metab, Aurora, CO USA; [Orlicky, David J.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Jackman, Matthew J.; MacLean, Paul S.; McManaman, James L.] Univ Colorado, Sch Med, Ctr Human Nutr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Sch Med, Div Basic Reprod Sci, Aurora, CO 80045 USA.	jim.mcmanaman@ucdenver.edu	MacLean, Paul/A-7887-2008; Monks, Jenifer/GLS-6662-2022	MacLean, Paul/0000-0002-1123-6612; Monks, Jenifer/0000-0002-7990-3389; ROBERTSON, CHARLES/0000-0002-4136-4121	National Institutes of Health [2RO1HD045962]; National Institutes of Health University of Colorado Cancer Center [P30CA046934]; National Institutes of Health Colorado Nutrition and Obesity Research Center [DK48520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075285] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health University of Colorado Cancer Center; National Institutes of Health Colorado Nutrition and Obesity Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by the National Institutes of Health 2RO1HD045962 (JLM), National Institutes of Health University of Colorado Cancer Center Support Grant P30CA046934, and National Institutes of Health Colorado Nutrition and Obesity Research Center DK48520. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Aitchison J., 1986, THE STATISTICAL ANAL; Alkanani AK, 2014, DIABETES, V63, P619, DOI 10.2337/db13-1007; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aron-Wisnewsky J, 2013, CLIN MICROBIOL INFEC, V19, P338, DOI 10.1111/1469-0691.12140; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Bougneres L, 2009, IMMUNITY, V31, P232, DOI 10.1016/j.immuni.2009.06.022; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Catenacci VA, 2009, CLIN CHEST MED, V30, P415, DOI 10.1016/j.ccm.2009.05.001; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Demignot S, 2014, BIOCHIMIE, V96, P48, DOI 10.1016/j.biochi.2013.07.009; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frank DN, 2011, HANDBOOK OF MOLECULA; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hullar MAJ, 2014, CANCER J, V20, P170, DOI 10.1097/PPO.0000000000000053; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Imai Y, 2012, PHYSIOL GENOMICS, V44, P1125, DOI 10.1152/physiolgenomics.00045.2012; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelder T, 2014, DIABETES, V4, pe122, DOI [10.1038/nutd.2014.18, DOI 10.1038/NUTD.2014.18]; Kelly CJ, 2012, NUTR CLIN PRACT, V27, P215, DOI 10.1177/0884533611434934; Kotera M, 2012, METHODS MOL BIOL, V802, P19, DOI 10.1007/978-1-61779-400-1_2; Kumar SPDS, 2014, ENDOCR J, V61, P457, DOI 10.1507/endocrj.EJ13-0455; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ling AL, 2014, ENVIRON SCI TECHNOL, V48, P7357, DOI 10.1021/es500763e; Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531; Liu XJ, 2014, BIOCHEM BIOPH RES CO, V450, P117, DOI 10.1016/j.bbrc.2014.05.072; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Magurran A.E., 2004, MEASURING BIOL DIVER; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Mehal WZ, 2012, HEPATOLOGY, V55, P1647, DOI 10.1002/hep.25704; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Monks J, 2007, BIOL REPROD; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Pruesse E, 2012, BIOINFORMATICS; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Schloss PD, 2007, ANNU REV MICROBIOL, V61, P23, DOI 10.1146/annurev.micro.61.011507.151712; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Seyer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058224; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Team RDC, 2006, R LANG ENV STAT COMP; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Wahlig JL, 2012, OBESITY, V20, P65, DOI 10.1038/oby.2011.196; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wong VWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062885; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	74	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131944	10.1371/journal.pone.0131944	http://dx.doi.org/10.1371/journal.pone.0131944			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147095	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600169
J	Hossain, MA; Xu, YF; Peshek, TJ; Ji, L; Abramson, AR; French, RH				Hossain, Mohammad Akram; Xu, Yifan; Peshek, Timothy J.; Ji, Liang; Abramson, Alexis R.; French, Roger H.			Microinverter Thermal Performance in the Real-World: Measurements and Modeling	PLOS ONE			English	Article							PV MODULE TEMPERATURE; OPERATING TEMPERATURE; BATTERIES	Real-world performance, durability and reliability of microinverters are critical concerns for microinverter-equipped photovoltaic systems. We conducted a data-driven study of the thermal performance of 24 new microinverters (Enphase M215) connected to 8 different brands of PV modules on dual-axis trackers at the Solar Durability and Lifetime Extension (SDLE) SunFarm at Case Western Reserve University, based on minute by minute power and thermal data from the microinverters and PV modules along with insolation and environmental data from July through October 2013. The analysis shows the strengths of the associations of microinverter temperature with ambient temperature, PV module temperature, irradiance and AC power of the PV systems. The importance of the covariates are rank ordered. A multiple regression model was developed and tested based on stable solar noon-time data, which gives both an overall function that predicts the temperature of microinverters under typical local conditions, and coefficients adjustments reecting refined prediction of the microinverter temperature connected to the 8 brands of PV modules in the study. The model allows for prediction of internal temperature for the Enphase M215 given similar climatic condition and can be expanded to predict microinverter temperature in fixed-rack and roof-top PV systems. This study is foundational in that similar models built on later stage data in the life of a device could reveal potential influencing factors in performance degradation.	[Hossain, Mohammad Akram; Abramson, Alexis R.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Hossain, Mohammad Akram; Xu, Yifan; Peshek, Timothy J.; French, Roger H.] Case Western Reserve Univ, Solar Durabil & Lifetime Extens SDLE Ctr, Cleveland, OH 44106 USA; [Xu, Yifan] Case Western Reserve Univ, Ctr Stat Res Comp & Collaborat, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Ji, Liang] Underwriters Labs, Northbrook, IL USA; [French, Roger H.] Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA; [French, Roger H.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Peshek, Timothy J.; French, Roger H.] Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	French, RH (corresponding author), Case Western Reserve Univ, Solar Durabil & Lifetime Extens SDLE Ctr, Cleveland, OH 44106 USA.	roger.french@case.edu	French, Roger H/E-1986-2011	French, Roger H/0000-0002-6162-0532; Hossain, Mohammad/0000-0002-8059-0789	Underwriters Laboratories; Ohio Third Frontier [Tech 11-060, Tech 12-004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	Underwriters Laboratories; Ohio Third Frontier; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Underwriters Laboratories provided the funding for the study. Mohammad A. Hossain and Dr. Timothy J. Peshek received the funding from them. This research was performed in the SDLE Center at Case Western Reserve University, established with Ohio Third Frontier funding under award Tech 11-060, Tech 12-004. Underwriters Laboratories helped to develop the study design.	Adler J, 2010, R NUTSHELL DESKTOP Q; [Anonymous], 1995, 61215 IEC; Armstrong S, 2010, APPL THERM ENG, V30, P1488, DOI 10.1016/j.applthermaleng.2010.03.012; Bird L, 2012, WORLD REN EN FOR P D; Bruckman LS, 2013, IEEE ACCESS, V1, P384, DOI 10.1109/ACCESS.2013.2267611; Bruckman LS, 2013, SPIE SOLAR ENERGY TE; California Energy Commission, 2014, LIST EL INV SB1 GUID; Campbell Scientific Inc., 2013, AM1632B 16 32 CHANN; Campbell Scientific Inc., 2014, CR1000 MEAS CONTR DA; Chan F. T., 2006, 2006 IEEE C CYBERNET, P1; Chan F, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, VOLS 1-7, P1583, DOI 10.1109/ISIE.2006.295708; Clement-Nyns K, 2011, ELECTR POW SYST RES, V81, P185, DOI 10.1016/j.epsr.2010.08.007; Deline C, 2011, CONTRACT, DOI DOI 10.2172/1004490; Deline C, 2012, CONTRACT; Denholm P, 2006, VERY LARGE SCALE DEP; Enphase Energy, 2009, REL ENPH MICR; Faiman D, 2008, PROG PHOTOVOLTAICS, V16, P307, DOI 10.1002/pip.813; Faraway J., 2004, LINEAR MODELS R; Feldman David, 2014, PHOTOVOLTAIC PV PRIC; FLIR Systems Inc., 2013, TECHN DAT FLIR T300; French RH, 2015, CURRENT OPINION SOLI; Harada K., 1993, IEEE Transactions on Power Electronics, V8, P355, DOI 10.1109/63.261004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hossain MA, 2014, SPIE SOLAR ENERGY TE; Hossain MA, 2014, PHOT SPEC C PVSC 201; Hossain MA., 2014, THERMAL CHARACTERIST; Hu XS, 2014, IEEE T IND INFORM, V10, P1948, DOI 10.1109/TII.2013.2284713; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2013, J POWER SOURCES, V239, P449, DOI 10.1016/j.jpowsour.2013.03.157; Hu Y., 2013, 2013 IEEE ENERGYTECH, P1, DOI DOI 10.1109/ENERGYTECH.2013.6645317; Hu Y., 2014, PV MODULE PERFORMANC; IEA Technology, 2010, ROADM SOL PHOT EN 20; Kaplani E, 2014, SOL ENERGY, V107, P443, DOI 10.1016/j.solener.2014.05.037; King DL., 2004, PHOTOVOLTAIC ARRAY P; Koehl M, 2011, SOL ENERG MAT SOL C, V95, P1638, DOI 10.1016/j.solmat.2011.01.020; Kulkarni CS, 2013, INT J PROGNOSTICS HL; Kurnik J, 2011, SOL ENERG MAT SOL C, V95, P373, DOI 10.1016/j.solmat.2010.04.022; Kurtz S, 2011, PROG PHOTOVOLTAICS, V19, P954, DOI 10.1002/pip.1103; Lemire HM, 2013, MRS ONLINE P LIB, V1537; Mattei M, 2006, RENEW ENERG, V31, P553, DOI 10.1016/j.renene.2005.03.010; Notton G, 2005, APPL THERM ENG, V25, P2854, DOI 10.1016/j.applthermaleng.2005.02.008; O'Neil C, 2013, DOING DATA SCI STRAT; Patil N, 2010, P 2 INT C REL SAF HA, P68, DOI DOI 10.1109/ICRESH.2010.5779635; Patil N, 2012, MICROELECTRON RELIAB, V52, P482, DOI 10.1016/j.microrel.2011.10.017; Petrone G, 2008, IEEE T IND ELECTRON, V55, P2569, DOI 10.1109/TIE.2008.924016; Photovoltaic Education Network, 2010, SOLAR TIME; R Core Team, 2021, R LANGUAGE ENV STAT; Seltman H.J., 2012, EXPT DESIGN ANAL; Skoplaki E, 2008, SOL ENERG MAT SOL C, V92, P1393, DOI 10.1016/j.solmat.2008.05.016; Smith R, 2011, SOLARPRO, V4, P90; Sorensen NR, 2013, IEEE J PHOTOVOLT, V3, P807, DOI 10.1109/JPHOTOV.2013.2244162; Weisberg S, 2014, APPL LINEAR REGRESSI, V4th; Wohlgemuth J, 2014, SPIE SOLAR ENERGY TE; Wohlgemuth J, 2014, 2014 IEEE 40TH PHOTOVOLTAIC SPECIALIST CONFERENCE (PVSC), P2191, DOI 10.1109/PVSC.2014.6925359	54	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131279	10.1371/journal.pone.0131279	http://dx.doi.org/10.1371/journal.pone.0131279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147339	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600082
J	Lasram, FB; Hattab, T; Halouani, G; Romdhane, MS; Le Loc'h, F				Lasram, Frida Ben Rais; Hattab, Tarek; Halouani, Ghassen; Romdhane, Mohamed Salah; Le Loc'h, Francois			Modeling of Beta Diversity in Tunisian Waters: Predictions Using Generalized Dissimilarity Modeling and Bioregionalisation Using Fuzzy Clustering	PLOS ONE			English	Article							SPECIES DISTRIBUTION; CLIMATE-CHANGE; COASTAL; BIODIVERSITY; ASSEMBLAGES; INDICATOR; PATTERNS; REGIONS; GABES; SCALE	Spatial patterns of beta diversity are a major focus of ecology. They can be especially valuable in conservation planning. In this study, we used a generalized dissimilarity modeling approach to analyze and predict the spatial patterns of beta diversity for commercially exploited, demersal marine species assemblages along the Tunisian coasts. For this study, we used a presence/absence dataset which included information on 174 species (invertebrates and fishes) and 9 environmental variables. We first performed the modeling analyses and assessed beta diversity using the turnover component of the Jaccard's dissimilarity index. We then performed nonmetric multidimensional scaling to map predicted beta diversity. To delineate the biogeographical regions, we used fuzzy cluster analysis. Finally, we also identified a set of indicator species which characterized the species assemblages in each identified biogeographical region. The predicted beta diversity map revealed two patterns: an inshore-offshore gradient and a south-north latitudinal gradient. Three biogeographical regions were identified and 14 indicator species. These results constitute a first contribution of the bioregionalisation of the Tunisian waters and highlight the issues associated with current fisheries management zones and conservation strategies. Results could be useful to follow an Ecosystem Based Management approach by proposing an objective spatial partitioning of the Tunisian waters. This partitioning could be used to prioritize the adjustment of the actual fisheries management entities, identify current data gaps, inform future scientific surveys and improve current MPA network.	[Lasram, Frida Ben Rais; Hattab, Tarek; Halouani, Ghassen; Romdhane, Mohamed Salah] Inst Natl Agron Tunisie, Unite Rech Ecosyst & Ressources Aquat UR03AGRO1, Tunis, Tunisia; [Hattab, Tarek] Univ Picardie Jules Verne, Unite Rech Ecol & Dynam Syst Anthropises EDYSAN, CNRS, FRE 3498, Amiens, France; [Hattab, Tarek; Halouani, Ghassen; Le Loc'h, Francois] Inst Univ Europeen Mer, Lab Sci Environm Marin, UMR 6539, LEMAR,CNRS,UBO,IRD,Ifremer, Plouzane, France	Universite de Carthage; Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Lasram, FB (corresponding author), Inst Natl Agron Tunisie, Unite Rech Ecosyst & Ressources Aquat UR03AGRO1, Tunis, Tunisia.	frida.lasram@gmail.com	Le Loc'h, François/A-5038-2008; Halouani, Ghassen/I-7487-2019; Romdhane, Mohamed Salah/GTB-5864-2022; Hattab, Tarek/K-2992-2014	Le Loc'h, François/0000-0002-3372-6997; Halouani, Ghassen/0000-0001-6610-293X; Romdhane, Mohamed Salah/0000-0002-3343-7554; Hattab, Tarek/0000-0002-1420-5758	IRD (GAMBAS project); Fondation Total (CHARMMED project)	IRD (GAMBAS project); Fondation Total (CHARMMED project)	The authors received funding from IRD (GAMBAS project) and Fondation Total (CHARMMED project).	Afli A., 2005, BIODIVERSITE MARINE; Albouy C, 2013, J BIOGEOGR, V40, P534, DOI 10.1111/jbi.12013; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Ben Ismail S, 2014, J MARINE SYST, V135, P14, DOI 10.1016/j.jmarsys.2013.06.010; Ben Mustapha K., 2007, MEDSUDMED TECHNICAL, P32; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Carstensen DW, 2013, ECOGRAPHY, V36, P1310, DOI 10.1111/j.1600-0587.2013.00329.x; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; De Caceres M, 2010, J VEG SCI, V21, P1138, DOI 10.1111/j.1654-1103.2010.01211.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; DGPA, 2012, DIR GEN PECH TUN; Diniz JAF, 2004, OECOLOGIA, V140, P633, DOI 10.1007/s00442-004-1577-4; DOUVERE F, 2001, MANAGEMENT, V44, P563, DOI DOI 10.1163/22116001-90000188; Duff TJ, 2014, J VEG SCI, V25, P323, DOI 10.1111/jvs.12092; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; FAO, 2003, TECHN GUID RESP FISH, P173; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Froese R., 2014, WORLD WIDE WEB ELECT; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gaertner JC, 2005, VIE MILIEU, V55, P81; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; Hattab T, 2015, J BIOGEOGR, V42, P1336, DOI 10.1111/jbi.12505; Hattab T, 2014, GLOBAL ECOL BIOGEOGR, V23, P1417, DOI 10.1111/geb.12217; Hattab T, 2013, J MARINE SYST, V128, P159, DOI 10.1016/j.jmarsys.2013.04.017; Hattab T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076430; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Jabeur C, 2000, AQUAT LIVING RESOUR, V13, P421; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Leaper R, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00089.1; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P., 2012, NUMERICAL ECOLOGY; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Monk J, 2011, CONT SHELF RES, V31, pS17, DOI 10.1016/j.csr.2010.02.012; NAJAR B, 2010, COMM INT EXPLOR SCI, V39, P601; Nieblas AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111251; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Papaconstantinou C., 2000, Mediterranean Marine Science, V1, P5; Reygondeau G, 2013, GLOBAL BIOGEOCHEM CY, V27, P1046, DOI 10.1002/gbc.20089; Rice J, 2011, OCEAN COAST MANAGE, V54, P110, DOI 10.1016/j.ocecoaman.2010.10.010; Roberts CM, 2003, ECOL APPL, V13, pS215; Rodriguez P, 2004, ECOGRAPHY, V27, P547, DOI 10.1111/j.0906-7590.2004.03788.x; SAMMARI C, 1995, B I NATL SC TECHNOL, V22, P10; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Shackell NL, 2012, ECOL APPL, V22, P336, DOI 10.1890/10-2093.1; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Whitehead Peter J. P, 1986, FISHES N E ATLANTIC; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Woodcock CE, 2000, INT J GEOGR INF SCI, V14, P153, DOI 10.1080/136588100240895; WoRMS Editorial Board, WORLD REG MAR SPEC	64	15	15	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131728	10.1371/journal.pone.0131728	http://dx.doi.org/10.1371/journal.pone.0131728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147371	gold, Green Published			2022-12-26	WOS:000358157600136
J	Saha, A; Jeon, M; Tan, AC; Kang, J				Saha, Ashis; Jeon, Minji; Tan, Aik Choon; Kang, Jaewoo			iCOSSY: An Online Tool for Context-Specific Subnetwork Discovery from Gene Expression Data	PLOS ONE			English	Article							KNOWLEDGE	Pathway analyses help reveal underlying molecular mechanisms of complex biological phenotypes. Biologists tend to perform multiple pathway analyses on the same dataset, as there is no single answer. It is often inefficient for them to implement and/or install all the algorithms by themselves. Online tools can help the community in this regard. Here we present an online gene expression analytical tool called iCOSSY which implements a novel pathway-based COntext-specific Subnetwork discoverY (COSSY) algorithm. iCOSSY also includes a few modifications of COSSY to increase its reliability and interpretability. Users can upload their gene expression datasets, and discover important subnetworks of closely interacting molecules to differentiate between two phenotypes (context). They can also interactively visualize the resulting subnetworks. iCOSSY is a web server that finds subnetworks that are differentially expressed in two phenotypes. Users can visualize the subnetworks to understand the biology of the difference.	[Saha, Ashis; Jeon, Minji; Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Tan, Aik Choon] Univ Colorado, Dept Med Med Oncol, Aurora, CO USA; [Kang, Jaewoo] Korea Univ, Interdisciplinary Grad Program Bioinformat, Seoul, South Korea	Korea University; University of Colorado System; University of Colorado Anschutz Medical Campus; Korea University	Kang, J (corresponding author), Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea.	kangj@korea.ac.kr	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369	National Research Foundation of Korea [NRF-2014R1A2A1A10051238, 2014M3C9A3063543, 2012R1A2A2A01014729, 2012M3C4A7033341]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF-2014R1A2A1A10051238, 2014M3C9A3063543, 2012R1A2A2A01014729, and 2012M3C4A7033341).	Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eddy JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000792; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geman Donald, 2004, Stat Appl Genet Mol Biol, V3, pArticle19; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lim K, 2014, BIOINFORMATICS, V30, P189, DOI 10.1093/bioinformatics/btt625; Marc C, KEGG DB SET ANNOTATI; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Ooms J, 2014, JSONLITE SMARTER JSO; Saha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084227; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Soh D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-449; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Urbanek S, RSERVE FAST WAY PROV; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Zhang JD, 2013, KEGGGRAPH APPL EXAMP	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131656	10.1371/journal.pone.0131656	http://dx.doi.org/10.1371/journal.pone.0131656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147457	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600119
J	Thamattoor, U; Thomas, T; Banandur, P; Rajaram, S; Duchesne, T; Abdous, B; Washington, R; Ramesh, BM; Moses, S; Alary, M				Thamattoor, Usha; Thomas, Tinku; Banandur, Pradeep; Rajaram, S.; Duchesne, Thierry; Abdous, Belkacem; Washington, Reynold; Ramesh, B. M.; Moses, Stephen; Alary, Michel			Multilevel Analysis of the Predictors of HIV Prevalence among Pregnant Women Enrolled in Annual HIV Sentinel Surveillance in Four States in Southern India	PLOS ONE			English	Article							FEMALE SEX WORKERS; HIGH-RISK; INFECTION; ASSOCIATION; POPULATION; EPIDEMIC; OUTCOMES; PROGRAM	Background Heterogeneity of the HIV epidemic across districts of south India is reflected in HIV positivity among antenatal clinic (ANC) attendees. Along with individual factors, contextual factors also need consideration for effective HIV interventions. Thus, identifying district and individual level factors that influence ANC HIV positivity assumes importance to intervene effectively. Methods Data on HIV sentinel surveillance among the ANC population were obtained from the National AIDS Control Organization (NACO) between years 2004 and 2007. Data from serial cross-sectional studies among female sex workers (FSWs) conducted during this time period in 24 districts were used to generate district level variables corresponding to parameters concerning this high risk population. Other district level data were obtained from various official/governmental agencies. Multilevel logistic regression was used to identify individual and district level factors associated with ANC-HIV positivity. Results The average ANC-HIV prevalence from 2004 to 2007 in the 24 integrated biological and behavioural assessments (IBBA) districts ranged from 0.25 to 3.25%. HIV positivity was significantly higher among ANC women with age >= 25 years [adjusted odds ratio (AOR): 1.49; 95% confidence interval (95% CI): 1.27 to 1.76] compared to those with age<25 years; illiterate (AOR: 1.62; 95% CI: 1.03 to 2.54) compared to literate; employed in agriculture (AOR: 1.34; 95% CI: 1.11 to 1.62) or with occupations like driver/helper/industry/factory workers/hotel staff (AOR: 1.59; 95% CI: 1.26 to 2.01) compared to unemployed. District level HIV prevalence among FSWs (AOR: 1.03; 95% CI: 1.0 to 1.05) and percentage women marrying under 18 years were significantly associated with ANC-HIV positivity (AOR: 1.02; 95% CI: 1.00 to 1.04). Conclusion Illiteracy of the woman, higher HIV prevalence among FSWs and early marriage were associated with HIV positivity among pregnant women in southern India. In addition to targeted HIV preventive interventions among FSWs, studying and changing the behavior of FSW clients and addressing structural drivers of the epidemic might indirectly help reduce HIV infection among women in southern India.	[Thamattoor, Usha; Thomas, Tinku; Washington, Reynold] St Johns Res Inst, Bangalore 560034, Karnataka, India; [Thamattoor, Usha; Thomas, Tinku; Banandur, Pradeep; Rajaram, S.; Ramesh, B. M.; Alary, Michel] CHARME II Project, Bangalore 560044, Karnataka, India; [Banandur, Pradeep] Natl Inst Med Sci NIMHANS, Dept Epidemiol, Bangalore 560029, Karnataka, India; [Rajaram, S.; Washington, Reynold; Ramesh, B. M.] Karnataka Hlth Promot Trust, Bangalore 560044, Karnataka, India; [Duchesne, Thierry; Abdous, Belkacem; Alary, Michel] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Duchesne, Thierry] Univ Laval, Dept Math & Stat, Quebec City, PQ G1K 7P4, Canada; [Abdous, Belkacem; Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada	St. John's National Academy of Health Sciences; St. John's Research Institute; National Institute of Mental Health & Neurosciences - India; Laval University; Laval University; Laval University; University of Manitoba	Thamattoor, U (corresponding author), St Johns Res Inst, Bangalore 560034, Karnataka, India.	ushakm@rediffmail.com	Washington, Reynold/AAD-7447-2020		Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the Bill & Melinda Gates Foundation. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation.	Alary M, 2010, SEX TRANSM INFECT, V86, pI10, DOI 10.1136/sti.2009.038323; [Anonymous], DET REG IBBA ROUND 1; [Anonymous], 2005, EARLY MARRIAGE HARMF; [Anonymous], 2008, AVAHAN THE INDIA AID; Banandur P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S13; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Bill & Melinda Gates Foundation, 2008, US IT LOS IT AV US D; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; Jenson R, 2003, JSTOR, V11, P9; Kumar GA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-65; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; Mehta SH, 2006, JAIDS-J ACQ IMM DEF, V41, P75, DOI 10.1097/01.qai.0000174653.17911.4a; Morgenstern H, 2008, MODERN EPIDEMIOLOGY, P511; Mukhopadhyay Chiranjoy, 2001, Journal of Communicable Diseases, V33, P136; NACO Online, 2007, HIV SENT SURV HIV ES; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Ramesh B, 2008, AIDS, V22, P10; Solomon E, 2011, AIDS CARE; Thilakavathi S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S3; UNAIDS, AS AIDS EP SUMM REG; UNAIDS. UNGASS country progress report United Kingdom, 2010, UNGASS COUNTR PROGR; *UNFPA, STAT WORLD POP 2005; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663	26	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131629	10.1371/journal.pone.0131629	http://dx.doi.org/10.1371/journal.pone.0131629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147208	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600116
J	Locke, C				Locke, Christina			Frac Sand Mines Are Preferentially Sited in Unzoned Rural Areas	PLOS ONE			English	Article							LOCATION DECISIONS; ENVIRONMENTAL-REGULATION; EXTRACTIVE INDUSTRIES; BUSINESS LOCATION; NEUTRAL MODELS; REGULATIONS; CHOICES; IMPACT; FIRMS	Shifting markets can cause unexpected, stochastic changes in rural landscapes that may take local communities by surprise. Preferential siting of new industrial facilities in poor areas or in areas with few regulatory restrictions can have implications for environmental sustainability, human health, and social justice. This study focuses on frac sand mining-the mining of high-quality silica sand used in hydraulic fracturing processes for gas and oil extraction. Frac sand mining gained prominence in the 2000s in the upper midwestern United States where nonmetallic mining is regulated primarily by local zoning. I asked whether frac sand mines were more commonly sited in rural townships without formal zoning regulations or planning processes than in those that undertook zoning and planning before the frac sand boom. I also asked if mine prevalence was correlated with socioeconomic differences across townships. After creating a probability surface to map areas most suitable for frac sand mine occurrence, I developed neutral landscape models from which to compare actual mine distributions in zoned and unzoned areas at three different spatial extents. Mines were significantly clustered in unzoned jurisdictions at the statewide level and in 7 of the 8 counties with at least three frac sand mines and some unzoned land. Subsequent regression analyses showed mine prevalence to be uncorrelated with land value, tax rate, or per capita income, but correlated with remoteness and zoning. The predicted mine count in unzoned townships was over two times higher than that in zoned townships. However, the county with the most mines by far was under a county zoning ordinance, perhaps indicating industry preferences for locations with clear, homogenous rules over patchwork regulation. Rural communities can use the case of frac sand mining as motivation to discuss and plan for sudden land-use predicaments, rather than wait to grapple with unfamiliar legal processes during a period of intense conflict.	Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Locke, C (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53705 USA.	clocke@wisc.edu			Forest and Wildlife Ecology Department at the University of Wisconsin, Madison; Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture [2012-67011-19876]	Forest and Wildlife Ecology Department at the University of Wisconsin, Madison; Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture National Institute of Food and Agriculture	This project was supported by the Forest and Wildlife Ecology Department at the University of Wisconsin, Madison (www.wisc.edu), and the Agriculture and Food Research Initiative Competitive Grant no. 2012-67011-19876 from the United States Department of Agriculture National Institute of Food and Agriculture (www.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[1000 Friends of Wisconsin 1000 Friends of Wisconsin], HISTORY 1000 FRIENDS; [Anonymous], 1965, LOGIC COLLECTIVE ACT; Bailey T, 1995, INTERACTIVE SPATIAL; BARTIK TJ, 1988, GROWTH CHANGE, V19, P22, DOI 10.1111/j.1468-2257.1988.tb00473.x; BARTIK TJ, 1985, J BUS ECON STAT, V3, P14, DOI 10.2307/1391685; Becker R, 2000, J POLIT ECON, V108, P379, DOI 10.1086/262123; Belknap Data Solutions Ltd, 1977, FACILITY LOCATION DE; Berger AL, 1996, COMPUT LINGUIST, V22, P39; Bohon SA, 2000, RURAL SOCIOL, V65, P376; Brunnermeier S., 2004, J ENVIRON DEV, V13, P6, DOI [10.1177/1070496503256500, DOI 10.1177/1070496503256500]; CARLTON DW, 1983, REV ECON STAT, V65, P440, DOI 10.2307/1924189; Dirr A, 2014, NEW FRAC SAND BILL S; Dusseault M., 2011, PETROL DRILL TECH, V39, P6; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitchen Janet M., 1991, ENDANGERED SPACES EN; FREUDENBURG WR, 1992, RURAL SOCIOL, V57, P305, DOI 10.1111/j.1549-0831.1992.tb00467.x; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Fujita M., 2001, SPATIAL EC CITIES RE; Gardner R. H., 1991, QUANTITATIVE METHODS; Gardner RH, 2007, LANDSCAPE ECOL, V22, P15, DOI 10.1007/s10980-006-9011-4; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gray WB, 1997, 5880 NAT BUR EC RE; Guillain R, 2010, ENVIRON PLANN B, V37, P961, DOI 10.1068/b35038; HAMILTON JT, 1995, J POLICY ANAL MANAG, V14, P107, DOI 10.2307/3325435; Hirt S, 2012, J PLAN LIT, V27, P375, DOI 10.1177/0885412212451029; IPPSR, 2004, REPORT NO POLICY BRI, V8; Ivey M, 2013, THE CAP TIMES; Jeppesen T, 2001, ANN REGIONAL SCI, V35, P523, DOI 10.1007/s001680100055; Konisky DM, 2007, AM J POLIT SCI, V51, P853, DOI 10.1111/j.1540-5907.2007.00285.x; Lambert D. M., 2006, Journal of Agricultural and Applied Economics, V38, P105; Levinson A, 1996, J PUBLIC ECON, V62, P5, DOI 10.1016/0047-2727(96)01572-1; Levinson A, 2008, INT ECON REV, V49, P223, DOI 10.1111/j.1468-2354.2008.00478.x; List JA, 2000, J REGIONAL SCI, V40, P453, DOI 10.1111/0022-4146.00183; List JA, 2003, OXFORD ECON PAP, V55, P657, DOI 10.1093/oep/55.4.657; Logan J. R, 2007, URBAN FORTUNES POLIT; Luhmann S, 2013, LA CROSSE TRIBU 0820; Marcon E, 2003, J ECON GEOGR, V3, P409, DOI 10.1093/jeg/lbg016; MCCONNELL VD, 1990, LAND ECON, V66, P67, DOI 10.2307/3146684; Millimet DL, 2003, J REGIONAL SCI, V43, P711, DOI 10.1111/j.0022-4146.2003.00317.x; Minnesota Department of Transportation, 2014, TRANSP SIL SAND IND; Minnesota Population Center, 2011, NAT HIST GEOGR INF S; MOLOTCH H, 1976, AM J SOCIOL, V82, P309, DOI 10.1086/226311; Neiman M, 2000, J AM PLANN ASSOC, V66, P295, DOI 10.1080/01944360008976108; NORD M, 1993, RURAL SOCIOL, V58, P492; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pearson TW, 2013, CULT AGRIC FOOD ENVI, V35, P30, DOI 10.1111/cuag.12003; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portney KE, 1991, HAZARDOUS WASTE TREA; Power TM, 2013, EC BENEFITS COSTS FR; Prengaman K, 2013, NEW STUDIES MEASURE; Prengaman K, 2013, FRAC SAND IND FAC DN; Risse W, 2012, G400503 U WISC STEV; Risse W, 2012, G400504 U WISC STEV; Risse W, 2012, G400502 U WISC STEV; Rudel T. K., 1989, SITUATIONS STRATEGIE; Saha R, 2005, SOC PROBL, V52, P618, DOI 10.1525/sp.2005.52.4.618; Shadbegian R, 2010, INT REV ENVIRON RESO, V4, P1, DOI 10.1561/101.00000029; Slack T, 2004, SOC NATUR RESOUR, V17, P129, DOI 10.1080/08941920490261258; Stoddard G, 2012, TOWN REGULATIONS FRA; Thisse J.F., 2004, HDB REGIONAL URBAN E, V4, P2063, DOI [DOI 10.1016/S1574-0080(04)80006-3, 10.1016/S1574-0080(04)80006-3]; U.S. Census, 2001, CENS 2000 SUMM FIL 1; U.S. Census, 2013, TIGER LIN SHAP; [U.S. Environmental Protection Agency US EPA], 2012, FIN PART PM2 5 DES; United States Geological Survey, 2012, SIL MIN YB 2002 2012; University of Wisconsin Extension, 2012, STUD EV GROUNDW IMPA; Venables WN., 2002, MODERN APPL STAT S 4; WALLACE NE, 1988, J URBAN ECON, V23, P307, DOI 10.1016/0094-1190(88)90021-6; Weissmann D, 2015, FRAC SAND CO CREATIV; Welsch R, 1980, REGRESSION DIAGNOSTI; West Central Wisconsin Regional Planning Commission, 2013, FRAC SAND MIN PROC T; Wisconsin Center for Investigative Journalism, 2013, WISC FRAC SAND MIN; Wisconsin Department of Administration, 2011, 2011 WISC LOC LAND U; Wisconsin Department of Natural Resources, 2014, OV NONM MIN WISC; Wisconsin Department of Natural Resources, 2011, GROUND CONT SUSC MOD; Wisconsin Department of Natural Resources, 2015, DNR OP PUBL COMM PER; Wisconsin Department of Natural Resources, 2012, SIL SAND MIN WISC; Wisconsin Department of Revenue, 2010, 2009 TOWN VILL CITY; Wisconsin Department of Revenue, 2007, 2007 SOA STAT ASS; Wisconsin Geological Survey, 2013, IND SAND POT INW SAN; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007	81	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131386	10.1371/journal.pone.0131386	http://dx.doi.org/10.1371/journal.pone.0131386			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CS	26136238	Green Submitted, gold, Green Published			2022-12-26	WOS:000358154400043
J	New, L; Bjerre, E; Millsap, B; Otto, MC; Runge, MC				New, Leslie; Bjerre, Emily; Millsap, Brian; Otto, Mark C.; Runge, Michael C.			A Collision Risk Model to Predict Avian Fatalities at Wind Facilities: An Example Using Golden Eagles, Aquila chrysaetos	PLOS ONE			English	Article							BIRD MORTALITY; ENERGY DEVELOPMENT; POPULATION-DYNAMICS; AVOIDANCE RATES; FARMS; PSEUDOREPLICATION; IMPACTS	Wind power is a major candidate in the search for clean, renewable energy. Beyond the technical and economic challenges of wind energy development are environmental issues that may restrict its growth. Avian fatalities due to collisions with rotating turbine blades are a leading concern and there is considerable uncertainty surrounding avian collision risk at wind facilities. This uncertainty is not reflected in many models currently used to predict the avian fatalities that would result from proposed wind developments. We introduce a method to predict fatalities at wind facilities, based on pre-construction monitoring. Our method can directly incorporate uncertainty into the estimates of avian fatalities and can be updated if information on the true number of fatalities becomes available from post-construction carcass monitoring. Our model considers only three parameters: hazardous footprint, bird exposure to turbines and collision probability. By using a Bayesian analytical framework we account for uncertainties in these values, which are then reflected in our predictions and can be reduced through subsequent data collection. The simplicity of our approach makes it accessible to ecologists concerned with the impact of wind development, as well as to managers, policy makers and industry interested in its implementation in real-world decision contexts. We demonstrate the utility of our method by predicting golden eagle (Aquila chrysaetos) fatalities at a wind installation in the United States. Using pre-construction data, we predicted 7.48 eagle fatalities year(-1) (95% CI: (1.1, 19.81)). The U.S. Fish and Wildlife Service uses the 80th quantile (11.0 eagle fatalities year-1) in their permitting process to ensure there is only a 20% chance a wind facility exceeds the authorized fatalities. Once data were available from two-years of post-construction monitoring, we updated the fatality estimate to 4.8 eagle fatalities year(-1) (95% CI: (1.76, 9.4); 80th quantile, 6.3). In this case, the increased precision in the fatality prediction lowered the level of authorized take, and thus lowered the required amount of compensatory mitigation.	[New, Leslie; Runge, Michael C.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [New, Leslie] Washington State Univ, Vancouver, WA USA; [Bjerre, Emily; Otto, Mark C.] US Fish & Wildlife Serv, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Millsap, Brian] US Fish & Wildlife Serv, Div Migratory Bird Management, Albuquerque, NM USA	United States Department of the Interior; United States Geological Survey; Washington State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	New, L (corresponding author), US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA.	leslie.new@wsu.edu	Runge, Michael C/E-7331-2011; New, Leslie/C-8796-2018	Runge, Michael C/0000-0002-8081-536X; Millsap, Brian/0000-0003-3969-249X				Ansolabehere S, 2012, DAEDALUS-US, V141, P61, DOI 10.1162/DAED_a_00146; Band W., 2007, P259; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bech N, 2012, ANIM BIODIV CONSERV, V35, P95; Bellenbaum J, 2013, J NAT CONSERV, V21, P393; Bispo R, 2013, ENVIRON ECOL STAT, V20, P147, DOI 10.1007/s10651-012-0212-5; Bright J, 2008, BIOL CONSERV, V141, P2342, DOI 10.1016/j.biocon.2008.06.029; Buckland ST, 2007, STAT SCI, V22, P44, DOI 10.1214/088342306000000673; Chamberlain DE, 2006, IBIS, V148, P198, DOI 10.1111/j.1474-919X.2006.00507.x; Coss RG, 2009, J COMP PSYCHOL, V123, P444, DOI 10.1037/a0016093; Dahl EL, 2013, WILDLIFE SOC B, V37, P66, DOI 10.1002/wsb.258; Desholm M, 2006, IBIS, V148, P76, DOI 10.1111/j.1474-919X.2006.00509.x; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; ECPG (Eagle Conservation Plan Guidance), 2013, TECHN APP D; El-Ashry MT, 2012, DAEDALUS-US, V141, P105, DOI 10.1162/DAED_a_00150; Farfan MA, 2009, BIODIVERS CONSERV, V18, P3743, DOI 10.1007/s10531-009-9677-4; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Fielding AH, 2006, BIOL CONSERV, V131, P359, DOI 10.1016/j.biocon.2006.02.011; Gelman A., 2004, BAYESIAN DATA ANAL; Guinard E, 2012, BIOL CONSERV, V147, P40, DOI 10.1016/j.biocon.2012.01.019; Harwood J, 2003, TRENDS ECOL EVOL, V95, P219; Hildingsson R, 2012, EUR POLIT SCI, V11, P18, DOI 10.1057/eps.2011.8; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Hull CL, 2013, WILDLIFE SOC B, V37, P49, DOI 10.1002/wsb.254; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Johnson GD, 2002, WILDLIFE SOC B, V30, P879; Johnston A, 2014, J APPL ECOL, V51, P31, DOI 10.1111/1365-2664.12191; Korner-Nievergelt F, 2011, WILDLIFE BIOL, V17, P350, DOI 10.2981/10-121; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Leung DYC, 2012, RENEW SUST ENERG REV, V16, P1031, DOI 10.1016/j.rser.2011.09.024; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; Madders M, 2006, IBIS, V148, P43, DOI 10.1111/j.1474-919X.2006.00506.x; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Miller TA, 2014, CONSERV BIOL, V28, P745, DOI 10.1111/cobi.12227; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Peron G, 2013, J APPL ECOL, V50, P902, DOI 10.1111/1365-2664.12100; R Core Team, 2021, R LANGUAGE ENV STAT; Schank JC, 2009, J COMP PSYCHOL, V123, P421, DOI 10.1037/a0013579; Smales I, 2013, WILDLIFE SOC B, V37, P59, DOI 10.1002/wsb.257; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Stewart GB, 2007, ENVIRON CONSERV, V34, P1, DOI 10.1017/S0376892907003554; Suen H K, 1989, ANAL QUANTITATIVE BE, DOI 10:4324/9781315801827; Tucker VA, 1996, J SOL ENERG-T ASME, V118, P253, DOI 10.1115/1.2871788; Walters C., 1986, ADAPTIVE MANAGEMENT; WATSON J, 2010, THE GOLDEN EAGLE; Whitfield D.P., 2009, COLLISION AVOIDANCE; Whitfield DP, 2004, BIOL CONSERV, V119, P319, DOI 10.1016/j.biocon.2003.11.015; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041	53	30	31	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130978	10.1371/journal.pone.0130978	http://dx.doi.org/10.1371/journal.pone.0130978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134412	gold, Green Submitted, Green Published			2022-12-26	WOS:000358154400031
J	Bjorkstrand, J; Agren, T; Frick, A; Engman, J; Larsson, EM; Furmark, T; Fredrikson, M				Bjorkstrand, Johannes; Agren, Thomas; Frick, Andreas; Engman, Jonas; Larsson, Elna-Marie; Furmark, Tomas; Fredrikson, Mats			Disruption of Memory Reconsolidation Erases a Fear Memory Trace in the Human Amygdala: An 18-Month Follow-Up	PLOS ONE			English	Article							ANXIETY DISORDERS; EXTINCTION; RESPONSES; ACTIVATION; CIRCUITS; RELAPSE; BURDEN; CORTEX	Fear memories can be attenuated by reactivation followed by disrupted reconsolidation. Using functional magnetic resonance imaging we recently showed that reactivation and reconsolidation of a conditioned fear memory trace in the basolateral amygdala predicts subsequent fear expression over two days, while reactivation followed by disrupted reconsolidation abolishes the memory trace and suppresses fear. In this follow-up study we demonstrate that the behavioral effect persists over 18 months reflected in superior reacquisition after undisrupted, as compared to disrupted reconsolidation, and that neural activity in the basolateral amygdala representing the initial fear memory predicts return of fear. We conclude that disrupting reconsolidation have long lasting behavioral effects and may permanently erase the fear component of an amygdala-dependent memory.	[Bjorkstrand, Johannes; Agren, Thomas; Frick, Andreas; Engman, Jonas; Furmark, Tomas; Fredrikson, Mats] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci Radiol, Dept Radiol, Uppsala, Sweden; [Fredrikson, Mats] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Uppsala University; Uppsala University; Karolinska Institutet	Bjorkstrand, J (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	johannes.bjorkstrand@psyk.uu.se	Agren, Thomas/AAC-4901-2022; Frick, Andreas/D-1882-2015	Frick, Andreas/0000-0003-2516-9075; Larsson, Elna-Marie/0000-0001-6308-1387	Swedish research council [521-2010-3284, 421-2009-2343]; Swedish Brain Foundation [FO2014-0151]; Boethius stiftelse [PSYK2010/143]; Swedish Council for Working Life and Social Research; Heumanska stiftelsen	Swedish research council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Boethius stiftelse; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Heumanska stiftelsen	This work was supported by the Swedish research council (http://www.vr.se/) registration numbers 521-2010-3284 and 421-2009-2343 to MF, the Swedish Brain Foundation (http://www.hjarnfonden.se/) registration number FO2014-0151 to MF, Boethius stiftelse, registration number PSYK2010/143 to TF, Swedish Council for Working Life and Social Research (http://www.forte.se/en/) registration number 2007-2116 to MF, and Heumanska stiftelsen, registration number 2014 to MF.	Agren T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.5; Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Boschen MJ, 2009, AUST NZ J PSYCHIAT, V43, P89, DOI 10.1080/00048670802607154; Boucsein W., 1992, ELECTRODERMAL ACTIVI, P96; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Cheng DT, 2007, LEARN MEMORY, V14, P485, DOI 10.1101/lm.632007; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FREDRIKSON M, 1993, BIOL PSYCHOL, V35, P153, DOI 10.1016/0301-0511(93)90011-V; Fredrikson M, 2013, MOD TR PHARMACOPSYCH, V29, P47, DOI 10.1159/000351938; Furmark T, 2002, ARCH GEN PSYCHIAT, V59, P425, DOI 10.1001/archpsyc.59.5.425; Furmark T, 1997, NEUROREPORT, V8, P3957, DOI 10.1097/00001756-199712220-00021; Golkar A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00080; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kindt M, 2013, BIOL PSYCHOL, V92, P43, DOI 10.1016/j.biopsycho.2011.09.016; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; LYKKEN DT, 1972, PSYCHOPHYSIOLOGY, V9, P373, DOI 10.1111/j.1469-8986.1972.tb03222.x; Mai J.K., 1997, ATLAS HUMAN BRAIN; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Neumann DL, 2010, BEHAV RES THER, V48, P565, DOI 10.1016/j.brat.2010.03.002; Oyarzun JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038849; Schiller D, 2013, P NATL ACAD SCI USA, V110, P20040, DOI 10.1073/pnas.1320322110; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schwabe L, 2012, BIOL PSYCHIAT, V71, P380, DOI 10.1016/j.biopsych.2011.10.028; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Steinfurth ECK, 2014, LEARN MEMORY, V21, P338, DOI 10.1101/lm.033589.113; Straube T, 2007, NEUROIMAGE, V34, P462, DOI 10.1016/j.neuroimage.2006.08.021; Tabbert K, 2005, INT J PSYCHOPHYSIOL, V57, P15, DOI 10.1016/j.ijpsycho.2005.01.007; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	40	42	46	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129393	10.1371/journal.pone.0129393	http://dx.doi.org/10.1371/journal.pone.0129393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132145	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000028
J	Evans, W; Mathis, JT; Ramsay, J; Hetrick, J				Evans, Wiley; Mathis, Jeremy T.; Ramsay, Jacqueline; Hetrick, Jeff			On the Frontline: Tracking Ocean Acidification in an Alaskan Shellfish Hatchery	PLOS ONE			English	Article							CARBON-DIOXIDE; CO2; PCO(2); DISTRIBUTIONS; SATURATION; OYSTER; SYSTEM; IMPACT; WATER; PH	The invasion of anthropogenic carbon dioxide (CO2) into the ocean is shifting the marine carbonate system such that saturation states of calcium carbonate (CaCO3) minerals are decreasing, and this is having a detrimental impact on early life stages of select shellfish species. The global, secular decrease in CaCO3 saturation states is occurring on top of a backdrop of large natural variability in coastal settings; progressively shifting the envelope of variability and leading to longer and more frequent exposure to adverse conditions. This is a great concern in the State of Alaska, a high-latitude setting vulnerable to rapid changes in the marine carbonate system, where an emerging shellfish industry plans major growth over the coming decades. Currently, the Alutiiq Pride Shellfish Hatchery (APSH) in Seward, Alaska is the only hatchery in the state, and produces many shellfish species with early life stages known to be sensitive to low CaCO3 saturation states. Here we present the first land-based OA measurements made in an Alaskan shellfish hatchery, and detail the trends in the saturation state of aragonite (Omega(arag)), the more soluble form of CaCO3, over a 10-month period in the APSH seawater supply. These data indicate the largest changes are on the seasonal time scale, with extended periods of sub-optimal Omega(arag) levels (Omega(arag) < 1.5) in winter and autumn associated with elevated water column respiration and short-lived runoff events, respectively. The data pinpoint a 5-month window of reprieve with favorable Omega(arag) conditions above the sub-optimal Omega(arag) threshold, which under predicted upper-bound CO2 emissions trajectories is estimated to close by 2040. To date, many species in production at APSH remain untested in their response to OA, and the data presented here establish the current conditions at APSH as well as provide a framework for hatchery-based measurements in Alaska. The current and expected conditions seen at APSH are essential to consider for this developing Alaskan industry.	[Evans, Wiley; Mathis, Jeremy T.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Evans, Wiley; Mathis, Jeremy T.] Univ Alaska Fairbanks, Ocean Acidificat Res Ctr, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Ramsay, Jacqueline; Hetrick, Jeff] Alutiiq Pride Shellfish Hatchery, Seward, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks	Evans, W (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	wiley.evans@noaa.gov	/AAL-3738-2021; Evans, Wiley/U-8250-2018	Evans, Wiley/0000-0002-5450-0903	Alaska Ocean Observing System (AOOS); National Oceanic and Atmospheric Administration (NOAA) Ocean Acidification Program (OAP)	Alaska Ocean Observing System (AOOS); National Oceanic and Atmospheric Administration (NOAA) Ocean Acidification Program (OAP)	This work was funded by the Alaska Ocean Observing System (AOOS) and the National Oceanic and Atmospheric Administration (NOAA) Ocean Acidification Program (OAP).	Adelsman H, 2012, OCEAN ACIDIFACTION K; AFDF, AL MAR IN GROW 1 BIL; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Beck J, 2015, SUPERCO2 SYSTEM 2015; Bednarsek N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0123; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Evans W, 2014, BIOGEOSCIENCES, V11, P365, DOI 10.5194/bg-11-365-2014; Evans W, 2013, CONT SHELF RES, V65, P52, DOI 10.1016/j.csr.2013.06.013; Evans W, 2013, ESTUAR COAST SHELF S, V117, P260, DOI 10.1016/j.ecss.2012.12.003; Evans W, 2012, PROG OCEANOGR, V101, P78, DOI 10.1016/j.pocean.2012.01.003; Evans W, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006625; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Feely R. A., 2012, SCI SUMMARY OCEAN AC; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2014, B AM METEOROLOGICAL, V95, P73; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Gray SEC, 2011, MAR CHEM, V125, P82, DOI 10.1016/j.marchem.2011.02.005; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Hales B, 2004, LIMNOL OCEANOGR-METH, V2, P356, DOI 10.4319/lom.2004.2.356; Harris KE, 2013, GEOPHYS RES LETT, V40, P2720, DOI 10.1002/grl.50460; IOOS, 2015, IOOS PAC REG OC AC 2; Kelly RP, 2014, AMBIO, V43, P592, DOI 10.1007/s13280-013-0442-2; Long WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060959; Marianda, 2015, TOT ALK DISS IN CARB; Mathis JT, 2015, PROG OCEANOGR, V136, P71, DOI 10.1016/j.pocean.2014.07.001; Mathis JT, 2015, OCEANOGRAPHY, V28, P122, DOI 10.5670/oceanog.2015.36; Mathis JT, 2015, J GEOPHYS RES UNPUB; McLaughlin K, 2014, GUIDANCE MANUAL ESTA; Millero FJ, 2007, CHEM REV, V107, P308, DOI 10.1021/cr0503557; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; NOAA/PMEL, 2015, GAKOA GULF AL OC AC; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pierrot D, 2009, DEEP-SEA RES PT II, V56, P512, DOI 10.1016/j.dsr2.2008.12.005; Ramsay J, 2015, ALUTIIQ PRIDE SHELLF; Raven J, 2005, OCEAN ACIDIFICATION; Riley J.P., 1967, CHEM GEOL, V2, P263, DOI [DOI 10.1016/0009-2541(67)90026-5, 10.1016/0009-2541(67)90026-5]; SBE, SEA BIRD EL SBE 45 M; Scigliano E, 2011, ONEARTH MAG     0817, V2011; TAKAHASHI T, 1961, J GEOPHYS RES, V66, P477, DOI 10.1029/JZ066i002p00477; Takahashi T, 2014, MAR CHEM, V164, P95, DOI 10.1016/j.marchem.2014.06.004; Van Heuven, 2011, ORNLCDIAC105B USDA C; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; Waldbusser GG, 2014, ANNU REV MAR SCI, V6, P221, DOI 10.1146/annurev-marine-121211-172238; Waldbusser GG, 2013, GEOPHYS RES LETT, V40, P2171, DOI 10.1002/grl.50449; Watanabe YW, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006199	50	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130384	10.1371/journal.pone.0130384	http://dx.doi.org/10.1371/journal.pone.0130384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131723	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000066
J	Hattori, Y; Tomonaga, M; Matsuzawa, T				Hattori, Yuko; Tomonaga, Masaki; Matsuzawa, Tetsuro			Distractor Effect of Auditory Rhythms on Self-Paced Tapping in Chimpanzees and Humans	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; PAN-TROGLODYTES; TURN-TAKING; EVOLUTION; MUSIC; ENTRAINMENT; COGNITION; DYNAMICS; MONKEYS	Humans tend to spontaneously align their movements in response to visual (e.g., swinging pendulum) and auditory rhythms (e.g., hearing music while walking). Particularly in the case of the response to auditory rhythms, neuroscientific research has indicated that motor resources are also recruited while perceiving an auditory rhythm (or regular pulse), suggesting a tight link between the auditory and motor systems in the human brain. However, the evolutionary origin of spontaneous responses to auditory rhythms is unclear. Here, we report that chimpanzees and humans show a similar distractor effect in perceiving isochronous rhythms during rhythmic movement. We used isochronous auditory rhythms as distractor stimuli during self-paced alternate tapping of two keys of an electronic keyboard by humans and chimpanzees. When the tempo was similar to their spontaneous motor tempo, tapping onset was influenced by intermittent entrainment to auditory rhythms. Although this effect itself is not an advanced rhythmic ability such as dancing or singing, our results suggest that, to some extent, the biological foundation for spontaneous responses to auditory rhythms was already deeply rooted in the common ancestor of chimpanzees and humans, 6 million years ago. This also suggests the possibility of a common attentional mechanism, as proposed by the dynamic attending theory, underlying the effect of perceiving external rhythms on motor movement.	[Hattori, Yuko; Tomonaga, Masaki; Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Hattori, Yuko] Kyoto Univ, Wildlife Res Ctr, Inuyama, Aichi, Japan	Kyoto University; Kyoto University	Hattori, Y (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	Yuko.Hattori@gmail.com	Matsuzawa, Tetsuro/ABE-9654-2021	Matsuzawa, Tetsuro/0000-0002-8147-2725	Leading Graduate Program in Primatology and Wildlife Science (PWS), Kyoto University;  [24000001];  [23220006];  [24700260];  [26730074]	Leading Graduate Program in Primatology and Wildlife Science (PWS), Kyoto University; ; ; ; 	This research was financially supported by Grant-in-Aids for Specially Promoted Research: No. 24000001 (PI: Tetsuro Matsuzawa), for Scientific Research (S): No. 23220006 (PI: Masaki Tomonaga), for Young Scientists (B): Nos. 24700260 and 26730074 (Yuko Hattori) and the Leading Graduate Program in Primatology and Wildlife Science (PWS), Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areadi AC, 1998, PRIMATES, V39, P505, DOI [10.1007/BF02557572, DOI 10.1007/BF02557572]; Areadi AC, 2004, PRIMATES, V45, P135, DOI [10.1007/s10329-003-0070-818, DOI 10.1007/S10329-003-0070-818]; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Chapin HL, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00224; Cook P, 2013, J COMP PSYCHOL, V127, P412, DOI 10.1037/a0032345; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Dunbar RIM, 2012, PHILOS T R SOC B, V367, P2192, DOI 10.1098/rstb.2012.0121; Eerola T., 2004, MIDI TOOLBOX MATLAB; Fedurek P, 2013, ANIM BEHAV, V86, P189, DOI 10.1016/j.anbehav.2013.05.010; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fitch WT, 2009, CURR BIOL, V19, pR403, DOI 10.1016/j.cub.2009.04.004; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Honing H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051369; Honing H, 2012, TOP COGN SCI, V4, P513, DOI 10.1111/j.1756-8765.2012.01210.x; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Ludwig VU, 2011, P NATL ACAD SCI USA, V108, P20661, DOI 10.1073/pnas.1112605108; Martinez L, 2009, BEHAV PROCESS, V82, P90, DOI 10.1016/j.beproc.2009.03.010; Matsusaka Takahisa, 2012, Pan Africa News, V19, P23; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; McDermott J, 2005, ANN NY ACAD SCI, V1060, P6, DOI 10.1196/annals.1360.002; Merchant H, 2014, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00274; Michaelis K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00252; Nelson M, 2004, P 2004 C NEW INT MUS; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Patel AD, 2006, MUSIC PERCEPT, V24, P99, DOI 10.1525/mp.2006.24.1.99; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Selezneva E, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00049; Takahashi DY, 2013, CURR BIOL, V23, P2162, DOI 10.1016/j.cub.2013.09.005; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Zar JH, 1999, BIOSTATISTICAL ANAL; Zarco W, 2009, J NEUROPHYSIOL, V102, P3191, DOI 10.1152/jn.00066.2009	42	26	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130682	10.1371/journal.pone.0130682	http://dx.doi.org/10.1371/journal.pone.0130682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26132703	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000077
J	Hu, XG; Jin, YQ; Wang, XR; Mao, JF; Li, Y				Hu, Xian-Ge; Jin, Yuqing; Wang, Xiao-Ru; Mao, Jian-Feng; Li, Yue			Predicting Impacts of Future Climate Change on the Distribution of the Widespread Conifer Platycladus orientalis	PLOS ONE			English	Article							ULTRAVIOLET-B RADIATION; SPECIES DISTRIBUTION; HABITAT FRAGMENTATION; UV-B; PHOTOSYNTHESIS; BIODIVERSITY; LANDSCAPE; DIVERSITY; MIGRATION; ECOSYSTEM	Chinese thuja (Platycladus orientalis) has a wide but fragmented distribution in China. It is an important conifer tree in reforestation and plays important roles in ecological restoration in the arid mountains of northern China. Based on high-resolution environmental data for current and future scenarios, we modeled the present and future suitable habitat for P. orientalis, evaluated the importance of environmental factors in shaping the species' distribution, and identified regions of high risk under climate change scenarios. The niche models showed that P. orientalis has suitable habitat of ca. 4.2x10(6) km(2) across most of eastern China and identified annual temperature, monthly minimum and maximum ultraviolet-B radiation and wet-day frequency as the critical factors shaping habitat availability for P. orientalis. Under the low concentration greenhouse gas emissions scenario, the range of the species may increase as global warming intensifies; however, under the higher concentrations of emissions scenario, we predicted a slight expansion followed by contraction in distribution. Overall, the range shift to higher latitudes and elevations would become gradually more significant. The information gained from this study should be an useful reference for implementing long-term conservation and management strategies for the species.	[Hu, Xian-Ge; Jin, Yuqing; Wang, Xiao-Ru; Mao, Jian-Feng; Li, Yue] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Hu, Xian-Ge; Jin, Yuqing; Wang, Xiao-Ru; Mao, Jian-Feng; Li, Yue] Beijing Forestry Univ, Coll Biol Sci & Technol, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Wang, Xiao-Ru] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Beijing Forestry University; Beijing Forestry University; Umea University	Mao, JF (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	jianfeng.mao@bjfu.edu.cn; liyue@bjfu.edu.cn	Mao, Jian-Feng/V-9251-2019; Wang, Xiao-Ru/H-6811-2012; Wang, Xiao-Ru/AAC-4444-2020	Mao, Jian-Feng/0000-0001-9735-8516; Wang, Xiao-Ru/0000-0002-6150-7046; Wang, Xiao-Ru/0000-0002-6150-7046	Fundamental Research Funds for the Central Universities [YX2013-41]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by "The Fundamental Research Funds for the Central Universities (NO. YX2013-41)".	BALLARE CL, 1995, PHYSIOL PLANTARUM, V93, P584, DOI 10.1111/j.1399-3054.1995.tb05104.x; Battaglia PR, 2000, INT J PLANT SCI, V161, P771, DOI 10.1086/314303; Beckmann M, 2014, METHODS ECOL EVOL, V5, P372, DOI 10.1111/2041-210X.12168; Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; CALDWELL M, 1995, AMBIO, V24, P166; Caldwell MM, 1998, J PHOTOCH PHOTOBIO B, V46, P40, DOI 10.1016/S1011-1344(98)00184-5; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Cheng J-Q, 1992, CHINESE WOODY PLANTS; CHU JM, 2012, J METEOROLOGY ENV, V28, P15; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Dong T. M., 1990, PLATYCLADUS ORIENTAL; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Guo Yan-Long, 2014, Chinese Journal of Plant Ecology, V38, P249, DOI 10.3724/SP.J.1258.2014.00022; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; He Q-T, 1996, J BEIJING FORESTRY U, V18, P23; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Jiang Z. P., 1997, ACTA PHYTOTAXONOMICA, V3, P236; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Khanum R, 2013, ACTA OECOL, V49, P23, DOI 10.1016/j.actao.2013.02.007; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Leng WF, 2008, J PLANT ECOL, V1, P203, DOI 10.1093/jpe/rtn013; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Li J-GX, 1986, FORESTRY SCI TECHNOL, V6, P005; Liang Y-C, 1990, SCI SILVAE SINICAE, V26, P308; Luo W-X, 1988, SHAANXI FOREST SCI T, V16, P1; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Meshinev T, 2000, PHYTOCOENOLOGIA, V30, P431; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Newman BJ, 2013, BIOL CONSERV, V159, P16, DOI 10.1016/j.biocon.2012.10.009; [潘根兴 PAN Genxing], 2011, [农业环境科学学报, Journal of Agro-Environment Science], V30, P1698; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qaderi MM, 2005, PHYSIOL PLANTARUM, V125, P247, DOI 10.1111/j.1399-3054.2005.00566.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Shi X-B, 1987, FOREST SCI TECHNOLOG, V7, P15; Stocker T F, 2013, CLIM CHANG 2013 PHYS; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Teklemariam T, 2003, ENVIRON EXP BOT, V50, P169, DOI 10.1016/S0098-8472(03)00024-8; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; W-Y Shi, 1986, J BEIJING FORESTRY U, V8, P74; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Wang JR, 1998, FOREST ECOL MANAG, V112, P233, DOI 10.1016/S0378-1127(98)00407-1; Wang LeiHong, 2011, Journal of Beijing Forestry University, V33, P70; Wang R-Z, 1990, J HEBEI FORESTRY SCI, V18, P30; Wang TL, 2012, FOREST ECOL MANAG, V279, P128, DOI 10.1016/j.foreco.2012.05.034; Weyant J., 2009, REPORT 2 6 VERSUS 2; Williams MI, 2013, J FOREST, V111, P287, DOI 10.5849/jof.13-016; Wu, 1988, SCI SILVAE SINICAE, V24, P446; Wu Jia-bing, 2009, Journal of Forestry Research (Harbin), V20, P383, DOI 10.1007/s11676-009-0066-3; Xu D-Y, 2002, FOREST SCI TECHNOLOG, P19; Xu Xiao-Ting, 2008, Zhiwu Shengtai Xuebao, V32, P1134, DOI 10.3773/j.issn.1005-264x.2008.05.018; YANG ZM, 1994, PLANT PHYSL COMMUNIC, V30, P241; Zhang YangJian, 2001, Journal of Forestry Research, V12, P97, DOI 10.1007/BF02867204; Zhao Y-L, 1994, YUNNAN GEOGRAPHIC EN, V6, P34	62	42	50	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132326	10.1371/journal.pone.0132326	http://dx.doi.org/10.1371/journal.pone.0132326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132163	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000168
J	Mehto, S; Antony, C; Khan, N; Arya, R; Selvakumar, A; Tiwari, BK; Vashishta, M; Singh, Y; Jameel, S; Natarajan, K				Mehto, Subhash; Antony, Cecil; Khan, Nabab; Arya, Rahul; Selvakumar, Arti; Tiwari, Brijendra K.; Vashishta, Mohit; Singh, Yogendra; Jameel, Shahid; Natarajan, Krishnamurthy			Mycobacterium tuberculosis and Human Immunodeficiency Virus Type 1 Cooperatively Modulate Macrophage Apoptosis via Toll Like Receptor 2 and Calcium Homeostasis	PLOS ONE			English	Article							T-CELLS; DC-SIGN; HIV-1; ACTIVATION; NEF; EXPRESSION; INHIBITION; INFECTION; PROTEIN	The emergence of drug resistant strains of Mycobacterium tuberculosis (M. tuberculosis) together with reports of co-infections with the human immunodeficiency virus (HIV) has renewed interest to better understand the intricate mechanisms prevalent during co-infections. In this study we report a synergistic effect of M. tuberculosis and HIV-1, and their antigens Rv3416 and Nef, respectively, in inhibiting apoptosis of macrophages. This inhibition involves the TLR2 pathway and second messengers that play complementing and contrasting roles in regulating apoptosis. Interestingly, the route of calcium influx into cells differentially regulates apoptosis during antigenic co-stimulation. While calcium released from intracellular stores was anti-apoptotic, calcium influx from the external milieu was pro-apoptotic. Further, molecular sensors of intracellular calcium release aid in antigen mediated inhibition of apoptosis. A cross-regulation between oxidative burst and differential routing of calcium influx governed apoptosis. Interestingly, the HIV-1 Nef supported anti-apoptotic responses in macrophages whereas Vpu had no significant effect. These results point to a synergistic liaison between M. tuberculosis and HIV-1 in regulating macrophage apoptosis.	[Mehto, Subhash; Antony, Cecil; Selvakumar, Arti; Vashishta, Mohit; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India; [Khan, Nabab; Arya, Rahul; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India; [Tiwari, Brijendra K.; Singh, Yogendra] CSIR Inst Genom & Integrat Biol, Delhi 110007, India	University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Mehto, S (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India.	Subhash.idi@gmail.com; knatarajan@acbr.du.ac.in	Antony, Cecil/AFE-5951-2022; Tiwari, Brijesh Kumar/K-6227-2013; khan, Nabab/Z-3970-2019; Antony, Cecil/O-7733-2017	Tiwari, Brijesh Kumar/0000-0002-4834-6831; khan, Nabab/0000-0002-8563-5341; Mehto, Subhash/0000-0002-5351-7850; Arya, Rahul/0000-0003-0867-6585; Antony, Cecil/0000-0001-7622-4586	Department of Biotechnology, Ministry of Science and Technology, Government of India; University of Delhi [BT/PR/5352/MED/29/478/2012]; CSIR-Senior Research Fellowship [09/045(1014)/2010-EMR-1]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University of Delhi(University of Delhi); CSIR-Senior Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Ministry of Science and Technology, Government of India to KN and SJ and grants from the University of Delhi to KN. BT/PR/5352/MED/29/478/2012. SM is a recipient of CSIR-Senior Research Fellowship (File No 09/045(1014)/2010-EMR-1).	Abbas W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.16; [Anonymous], 2013, MULT DRUG RES TUB MD; Aqil M, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23129; Aqil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074472; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Cardoso EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067036; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; Elbim C, 2001, J CLIN VIROL, V20, P99, DOI 10.1016/S1386-6532(00)00133-5; Foster JL, 2007, ADV PHARMACOL, V55, P389, DOI 10.1016/S1054-3589(07)55011-8; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; GMELIGMEYLING F, 1980, J IMMUNOL METHODS, V33, P1, DOI 10.1016/0022-1759(80)90077-0; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Khan KA, 2013, J INNATE IMMUN, V5, P639, DOI 10.1159/000350517; Kim JS, 2013, J LEUKOCYTE BIOL, V94, P733, DOI 10.1189/jlb.0912435; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Novis CL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-119; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Pennini ME, 2007, J IMMUNOL, V179, P6910, DOI 10.4049/jimmunol.179.10.6910; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sanchez D, 2010, CELL IMMUNOL, V260, P128, DOI 10.1016/j.cellimm.2009.10.007; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Singh B, 2003, CLIN EXP IMMUNOL, V134, P70, DOI 10.1046/j.1365-2249.2003.02258.x; Singhal J, 2012, J BIOL CHEM, V287, P11108, DOI 10.1074/jbc.M111.300319; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	38	9	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131767	10.1371/journal.pone.0131767	http://dx.doi.org/10.1371/journal.pone.0131767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132135	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000139
J	Zhang, P; Qi, YX; Yao, QP; Chen, XH; Wang, GL; Shen, BR; Han, Y; Gao, LZ; Jiang, ZL				Zhang, Ping; Qi, Ying-Xin; Yao, Qing-Ping; Chen, Xiao-Hu; Wang, Guo-Liang; Shen, Bao-Rong; Han, Yue; Gao, Li-Zhi; Jiang, Zong-Lai			Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors	PLOS ONE			English	Article							NORADRENERGIC NEURONS; STRESS; NPY; PREECLAMPSIA; PHOSPHORYLATION; ACTIVATOR; PRESSURE; INCREASE; STAT3; AORTA	The increased proliferation and migration of vascular smooth muscle cells (VSMCs) play important roles in pathophysiological remodeling of arteries during hypertension in pregnancy. However, the mechanisms involved in this process remain unclear. We hypothesized that Neuropeptide Y (NPY), which is a potent mitogenic peptide, participates in modulating proliferation and migration of VSMCs during hypertension in pregnancy. Using pregnant hypertensive rats, induced by intraperitoneal injection of L-nitro-arginine methylester (L-NAME), the plasma concentration of NPY was detected. Open angle, which reflects the non-uniform remodeling with high sensitivity, was used to detect the pathophysiological vascular remodeling in vivo. The results revealed that NPY concentration and artery open angle were both significantly increased in rats with hypertension in pregnant. The underlying mechanism of elevated NPY on vascular remodeling were further analyzed by using cultured VSMCs in vitro. In cultured VSMCs, NPY most effectively stimulated the migration and proliferation of VSMCs at 10(-6) mol/L, similar to the plasma concentration in L-NAME hypertension in pregnant rats. NPY up-regulated the expressions of both Y1 and Y5 receptors, increased the phosphorylations of STAT3 on Tyr705 and Ser727 residues, and induced the expression of c-Fos. The NPY-induced VSMCs proliferation was reduced by Y5 receptor antagonist, and fully blocked by combinations with other antagonist, such as Y2+Y5, Y1+Y5, and Y1+Y2+Y5. In contrast, the NPY-induced VSMC migration was blocked by either Y receptor antagonist or any combination of Y receptor antagonists. These results suggest that the elevated plasma concentration of NPY during hypertension in pregnancy may induce VSMC proliferation mainly via Y5 receptor, which subsequently modulate STAT3 and c-Fos signaling pathways to result in the vascular remodeling. These results also suggest that NPY mainly acts on VSMCs in vitro via Y1, Y5 receptors and in vascular tissues in vivo via Y5 receptor.	[Zhang, Ping; Qi, Ying-Xin; Yao, Qing-Ping; Chen, Xiao-Hu; Wang, Guo-Liang; Shen, Bao-Rong; Han, Yue; Gao, Li-Zhi; Jiang, Zong-Lai] Shanghai Jiao Tong Univ, Inst Mechanobiol & Biomed Engn, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Gao, LZ (corresponding author), Shanghai Jiao Tong Univ, Inst Mechanobiol & Biomed Engn, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	lzgao@sjtu.edu.cn			National Natural Science Foundation of China [11102112, 11372190]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	1 Grants to Ping Zhang from the National Natural Science Foundation of China, Nos. 11102112. 2 Grants to Li-Zhi Gao from the National Natural Science Foundation of China, Nos. 11372190.	Adamova Z, 2009, CURR CLIN PHARMACOL, V4, P172, DOI 10.2174/157488409789375320; ALLEN JM, 1983, J AUTONOM NERV SYST, V9, P559, DOI 10.1016/0165-1838(83)90013-9; Becskei C, 2010, AM J PHYSIOL-REG I, V299, pR632, DOI 10.1152/ajpregu.00674.2009; Chen D, 2014, BBA-MOL CELL RES, V1843, P454, DOI 10.1016/j.bbamcr.2013.11.024; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; DiBona GF, 1997, PHYSIOL REV, V77, P75, DOI 10.1152/physrev.1997.77.1.75; Feng QP, 2000, CLIN PHARMACOL THER, V67, P292, DOI 10.1067/mcp.2000.104610; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301; Han HC, 2006, J BIOMECH, V39, P2410, DOI 10.1016/j.jbiomech.2005.08.003; Han SP, 1998, PEPTIDES, V19, P351, DOI 10.1016/S0196-9781(97)00297-0; Harskamp RE, 2007, AM J MED SCI, V334, P291, DOI 10.1097/MAJ.0b013e3180a6f094; Jin L, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P206; Kouri FM, 2008, INT J BIOCHEM CELL B, V40, P1872, DOI 10.1016/j.biocel.2008.01.028; Kuo LE, 2007, PEPTIDES, V28, P435, DOI 10.1016/j.peptides.2006.08.035; Li JM, 2004, ARTERIOSCL THROM VAS, V24, P80, DOI 10.1161/01.ATV.0000104007.17365.1c; Lindheimer MD, 2010, J AM SOC HYPERTENS, V4, P68, DOI 10.1016/j.jash.2010.03.002; LUNDBERG JM, 1982, ACTA PHYSIOL SCAND, V116, P477, DOI 10.1111/j.1748-1716.1982.tb07171.x; Lv L, 2010, APOPTOSIS, V15, P41, DOI 10.1007/s10495-009-0409-8; MICHEL MC, 1995, J HYPERTENS, V13, P385; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Paddenberg R, 2006, HISTOCHEM CELL BIOL, V125, P497, DOI 10.1007/s00418-006-0158-5; PERNOW J, 1987, REGUL PEPTIDES, V19, P313, DOI 10.1016/0167-0115(87)90173-X; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Raimondi L, 2002, BIOCHEM PHARMACOL, V63, P2063, DOI 10.1016/S0006-2952(02)00986-3; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Shimada K, 2012, PEPTIDES, V34, P336, DOI 10.1016/j.peptides.2012.02.012; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Turgut NH, 2008, EUR J PHARMACOL, V589, P180, DOI 10.1016/j.ejphar.2008.04.034; WAHLESTEDT C, 1990, AM J PHYSIOL, V258, pR736, DOI 10.1152/ajpregu.1990.258.3.R736; WALKER P, 1991, TRENDS PHARMACOL SCI, V12, P111, DOI 10.1016/0165-6147(91)90518-W; Walsh SK, 2009, HYPERTENSION, V54, P345, DOI 10.1161/HYPERTENSIONAHA.109.132191; Wocial B., 1995, Blood Pressure, V4, P143, DOI 10.3109/08037059509077586; Yuan LJ, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-113; Zhao YJ, 2014, J HISTOCHEM CYTOCHEM, V62, P347, DOI 10.1369/0022155414521213; Zukowska Z, 2003, CAN J PHYSIOL PHARM, V81, P89, DOI 10.1139/Y03-006; Zukowska-Grojec Z, 1998, CIRC RES, V83, P187, DOI 10.1161/01.RES.83.2.187; ZukowskaGrojec Z, 1996, AM J PHYSIOL-HEART C, V270, pH796, DOI 10.1152/ajpheart.1996.270.2.H796; ZukowskaGrojec Z, 1995, ANN NY ACAD SCI, V771, P219, DOI 10.1111/j.1749-6632.1995.tb44683.x	44	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131124	10.1371/journal.pone.0131124	http://dx.doi.org/10.1371/journal.pone.0131124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131716	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000094
J	Cantaluppi, V; Dellepiane, S; Tamagnone, M; Medica, D; Figliolini, F; Messina, M; Manzione, AM; Gai, M; Tognarelli, G; Ranghino, A; Dolla, C; Ferrario, S; Tetta, C; Segoloni, GP; Camussi, G; Biancone, L				Cantaluppi, Vincenzo; Dellepiane, Sergio; Tamagnone, Michela; Medica, Davide; Figliolini, Federico; Messina, Maria; Manzione, Ana Maria; Gai, Massimo; Tognarelli, Giuliana; Ranghino, Andrea; Dolla, Caterina; Ferrario, Silvia; Tetta, Ciro; Segoloni, Giuseppe Paolo; Camussi, Giovanni; Biancone, Luigi			Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RENAL-TRANSPLANTATION; DISEASE PROGRESSION; CELLS; RECIPIENTS; NGAL; TERM; DIALYSIS; OUTCOMES; PROTECT	Background Delayed graft function (DGF) is an early complication of kidney transplantation (KT) associated with increased risk of early loss of graft function. DGF increases using kidneys from extended criteria donors (ECD). NGAL is a 25KDa protein proposed as biomarker of acute kidney injury. The aim of this study was to investigate the role of NGAL as an early and accurate indicator of DGF and Tacrolimus (Tac) toxicity and as a mediator of tissue regeneration in KT from ECD. Methods We evaluated plasma levels of NGAL in 50 KT patients from ECD in the first 4 days after surgery or after Tac introduction. Results Plasma levels of NGAL at day 1 were significantly higher in DGF group. In the non DGF group, NGAL discriminated between slow or immediate graft function and decreased more rapidly than serum creatinine. NGAL increased after Tac introduction, suggesting a role as marker of drug toxicity. In vitro, hypoxia and Tac induced NGAL release from tubular epithelial cells (TEC) favoring an autocrine loop that sustains proliferation and inhibits apoptosis (decrease of caspases and Bax/Bcl-2 ratio). Conclusions NGAL is an early and accurate biomarker of graft function in KT from ECD favoring TEC regeneration after ischemic and nephrotoxic injury.	[Cantaluppi, Vincenzo; Dellepiane, Sergio; Tamagnone, Michela; Medica, Davide; Figliolini, Federico; Messina, Maria; Manzione, Ana Maria; Gai, Massimo; Tognarelli, Giuliana; Ranghino, Andrea; Dolla, Caterina; Ferrario, Silvia; Segoloni, Giuseppe Paolo; Camussi, Giovanni; Biancone, Luigi] Univ Turin, Azienda Osped Citta Salute Sci Molinette, A Vercellone Kidney Transplantat Ctr, Dept Med Sci, Turin, Italy; [Tetta, Ciro] Fresenius Med Care, EMEALA Med Board, Bad Homburg, Germany	University of Turin	Cantaluppi, V (corresponding author), Univ Turin, Azienda Osped Citta Salute Sci Molinette, A Vercellone Kidney Transplantat Ctr, Dept Med Sci, Turin, Italy.	vincenzo.cantaluppi@unito.it	Dellepiane, Sergio/Z-2884-2019; Figliolini, Federico/AAQ-4983-2021; Cantaluppi, Vincenzo/K-8531-2016; Dellepiane, Sergio/CAA-5098-2022; Dellepiane, Sergio/AGK-6129-2022; Camussi, Giovanni/J-7624-2016; Medica, Davide/AAM-7691-2021	Cantaluppi, Vincenzo/0000-0002-4120-3555; Dellepiane, Sergio/0000-0002-7133-4740; Dellepiane, Sergio/0000-0002-7133-4740; Camussi, Giovanni/0000-0003-2795-232X; Medica, Davide/0000-0002-6171-8919; BIANCONE, Luigi/0000-0002-7700-6350; Figliolini, Federico/0000-0002-6142-2261	Italian Government MIUR PRIN project; 'Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project; Ricerca Finalizzata and Local University	Italian Government MIUR PRIN project; 'Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project; Ricerca Finalizzata and Local University	This work was supported by Italian Government MIUR PRIN project (G.C.), 'Regione Piemonte, Piattaforme Biotecnologiche PiSTEM project (G.C.) and Ricerca Finalizzata and Local University Grants ("ex-60%") (V.C., G.C., L.B.). Coauthor C.T. is employed by EMEALA Medical Board, Fresenius Medical Care. EMEALA Medical Board, Fresenius Medical Care provided support in the form of salary for author C.T., but it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	An SX, 2013, RENAL FAILURE, V35, P143, DOI 10.3109/0886022X.2012.741877; Bahmani P, 2010, CELL STRESS CHAPERON, V15, P395, DOI 10.1007/s12192-009-0154-5; Butala NM, 2013, TRANSPLANTATION, V95, P1008, DOI 10.1097/TP.0b013e3182855544; Cantaluppi V, 2008, J AM SOC NEPHROL, V19, P1904, DOI 10.1681/ASN.2007111209; Cantaluppi V, 2015, NEPHROL DIAL TRANSPL, V30, P410, DOI 10.1093/ndt/gfu364; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Einecke G, 2010, AM J TRANSPLANT, V10, P2241, DOI 10.1111/j.1600-6143.2010.03263.x; Flower DR, 1996, BIOCHEM J, V318, P1; Fuquay R, 2013, J AM SOC NEPHROL, V24, P1063, DOI 10.1681/ASN.2012060560; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Humar A, 2002, CLIN TRANSPLANT, V16, P425, DOI 10.1034/j.1399-0012.2002.02055.x; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Karpinski J, 1999, TRANSPLANTATION, V67, P1162, DOI 10.1097/00007890-199904270-00013; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Lim AI, 2013, J CELL PHYSIOL, V228, P917, DOI 10.1002/jcp.24267; Mariano F, 2008, CRIT CARE, V12, DOI 10.1186/cc6848; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1662, DOI 10.1111/j.1600-6143.2004.00573.x; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Pascual J, 2008, AM J KIDNEY DIS, V52, P553, DOI 10.1053/j.ajkd.2008.06.005; Rahimzadeh N, 2012, PEDIATR TRANSPLANT, V16, P796, DOI 10.1111/j.1399-3046.2012.01770.x; Rao PS, 2007, TRANSPLANTATION, V83, P1069, DOI 10.1097/01.tp.0000259621.56861.31; Ronco C, 2014, BLOOD PURIFICAT, V37, P271, DOI 10.1159/000360689; Rosengard BR, 2002, AM J TRANSPLANT, V2, P701, DOI 10.1034/j.1600-6143.2002.20804.x; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Sharif A, 2011, J AM SOC NEPHROL, V22, P2107, DOI 10.1681/ASN.2010111160; Shrestha K, CONGEST HEART FAIL, V18, P239; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Wasilewska A, 2010, PEDIATR NEPHROL, V25, P889, DOI 10.1007/s00467-009-1397-1; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yarlagadda SG, 2008, ADV CHRONIC KIDNEY D, V15, P248, DOI 10.1053/j.ackd.2008.04.005	36	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0129279	10.1371/journal.pone.0129279	http://dx.doi.org/10.1371/journal.pone.0129279			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125566	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300007
J	Boes, A; Spiegel, H; Voepel, N; Edgue, G; Beiss, V; Kapelski, S; Fendel, R; Scheuermayer, M; Pradel, G; Bolscher, JM; Behet, MC; Dechering, KJ; Hermsen, CC; Sauerwein, RW; Schillberg, S; Reimann, A; Fischer, R				Boes, Alexander; Spiegel, Holger; Voepel, Nadja; Edgue, Gueven; Beiss, Veronique; Kapelski, Stephanie; Fendel, Rolf; Scheuermayer, Matthias; Pradel, Gabriele; Bolscher, Judith M.; Behet, Marije C.; Dechering, Koen J.; Hermsen, Cornelus C.; Sauerwein, Robert W.; Schillberg, Stefan; Reimann, Andreas; Fischer, Rainer			Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate-Tackling the Cocktail Challenge	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MEROZOITE SURFACE PROTEIN-3; PLASMODIUM-FALCIPARUM; IMMUNOGENICITY; TRANSMISSION; ANTIBODIES; STAGE; GROWTH; PROTECTION; PARASITE	Combining key antigens from the different stages of the P. falciparum life cycle in the context of a multi-stage-specific cocktail offers a promising approach towards the development of a malaria vaccine ideally capable of preventing initial infection, the clinical manifestation as well as the transmission of the disease. To investigate the potential of such an approach we combined proteins and domains (11 in total) from the pre-erythrocytic, blood and sexual stages of P. falciparum into a cocktail of four different components recombinantly produced in plants. After immunization of rabbits we determined the domain-specific antibody titers as well as component-specific antibody concentrations and correlated them with stage specific in vitro efficacy. Using purified rabbit immune IgG we observed strong inhibition in functional in vitro assays addressing the pre-erythrocytic (up to 80%), blood (up to 90%) and sexual parasite stages (100%). Based on the component-specific antibody concentrations we calculated the IC50 values for the pre-erythrocytic stage (17-25 mu g/ml), the blood stage (4060 mu g/ml) and the sexual stage (1.75 mu g/ml). While the results underline the feasibility of a multi-stage vaccine cocktail, the analysis of component-specific efficacy indicates significant differences in IC50 requirements for stage-specific antibody concentrations providing valuable insights into this complex scenario and will thereby improve future approaches towards malaria vaccine cocktail development regarding the selection of suitable antigens and the ratios of components, to fine tune overall and stage-specific efficacy.	[Boes, Alexander; Spiegel, Holger; Voepel, Nadja; Edgue, Gueven; Beiss, Veronique; Kapelski, Stephanie; Fendel, Rolf; Schillberg, Stefan; Reimann, Andreas; Fischer, Rainer] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Fendel, Rolf; Pradel, Gabriele; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany; [Scheuermayer, Matthias] Zentrum Infekt Forsch, Wurzburg, Germany; [Bolscher, Judith M.; Dechering, Koen J.; Sauerwein, Robert W.] TropIQ Hlth Sci, Nijmegen, Netherlands; [Behet, Marije C.; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Fraunhofer Gesellschaft; RWTH Aachen University; Radboud University Nijmegen	Spiegel, H (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	holger.spiegel@ime.fraunhofer.de	Fendel, Rolf/K-3985-2013; Schillberg, Stefan/K-4211-2019; Hermsen, C.C./L-4368-2015; Sauerwein, Robert/C-8519-2013; Kapelski, Stephanie/AAG-7251-2021; Behet, Marije/D-7785-2016; Schillberg, Stefan/I-5449-2013	Fendel, Rolf/0000-0003-4716-0311; Behet, Marije/0000-0002-8683-4449; Beiss, Veronique/0000-0002-0953-053X; Boes, Alexander/0000-0001-7722-692X; Schillberg, Stefan/0000-0002-1896-4575	Fraunhofer Zukunftsstiftung; "Richtlinien zur Forderung des wissenschaftlichen Nachwuchses (RFwN) Ph.D. grant" from Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University; TropIQ Health Sciences	Fraunhofer Zukunftsstiftung; "Richtlinien zur Forderung des wissenschaftlichen Nachwuchses (RFwN) Ph.D. grant" from Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University; TropIQ Health Sciences	This work was supported by the Fraunhofer Zukunftsstiftung (http://www.fraunhofer.de/). SK was supported by a "Richtlinien zur Forderung des wissenschaftlichen Nachwuchses (RFwN) Ph.D. grant" from Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University (http://www.rwth-aachen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TropIQ Health Sciences provided support in the form of salaries for authors JMB, KLD and RWS but did	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alaro JR, 2012, INFECT IMMUN, V80, P2473, DOI 10.1128/IAI.00211-12; AMADOR R, 1992, J INFECT DIS, V166, P139, DOI 10.1093/infdis/166.1.139; BATHURST IC, 1993, VACCINE, V11, P449, DOI 10.1016/0264-410X(93)90287-8; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Beiss V, 2015, BIOTECHNOL BIOENG, V112, P1297, DOI 10.1002/bit.25548; Bergmann-Leitner E. S., 2014, Trials in Vaccinology, V3, P6, DOI 10.1016/j.trivac.2013.11.002; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; BISHOP A, 1946, PARASITOLOGY, V37, P85, DOI 10.1017/S0031182000013202; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Boes A, 2015, PLANT BIOTECHNOL J, V13, P222, DOI 10.1111/pbi.12255; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; CHAPPEL JA, 1994, INFECT IMMUN, V62, P4488, DOI 10.1128/IAI.62.10.4488-4494.1994; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 2001, INT J PARASITOL, V31, P753, DOI 10.1016/S0020-7519(01)00184-9; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Faber BW, 2013, INFECT IMMUN, V81, P1479, DOI 10.1128/IAI.01267-12; Farrance CE, 2011, CLIN VACCINE IMMUNOL, V18, P1351, DOI 10.1128/CVI.05105-11; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Feller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079920; Fischer R, 2013, CURR PHARM DESIGN, V19, P5471, DOI 10.2174/1381612811319310002; Gantt S, 2000, INFECT IMMUN, V68, P3667, DOI 10.1128/IAI.68.6.3667-3673.2000; Gregory JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037179; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Jones RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079538; Kapelski S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0577-7; Kapelski S, 2014, J LEUKOCYTE BIOL, V96, P1131, DOI 10.1189/jlb.4A0614-283RR; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; KASLOW DC, 1991, SCIENCE, V252, P1310, DOI 10.1126/science.1925544; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Mahajan B, 2010, INFECT IMMUN, V78, P4613, DOI 10.1128/IAI.00533-10; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; OEUVRAY C, 1994, BLOOD, V84, P1594; Organization WH, 2013, LD MALARIA REPORT 20; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Pol E, 2007, J MOL RECOGNIT, V20, P22, DOI 10.1002/jmr.804; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Tachibana M, 2011, CLIN VACCINE IMMUNOL, V18, P1343, DOI 10.1128/CVI.05104-11; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; Voepel N, 2014, BIOTECHNOL J, V9, P1435, DOI 10.1002/biot.201400350; Wang L, 2001, INFECT IMMUN, V69, P4390, DOI 10.1128/IAI.69.7.4390-4397.2001; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3; Zhou ZY, 2006, HUM VACCINES, V2, P14, DOI 10.4161/hv.2.1.2437	58	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131456	10.1371/journal.pone.0131456	http://dx.doi.org/10.1371/journal.pone.0131456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147206	Green Published, gold			2022-12-26	WOS:000358157600098
J	Doody, JS; Clulow, S; Kay, G; D'Amore, D; Rhind, D; Wilson, S; Ellis, R; Castellano, C; McHenry, C; Quayle, M; Hands, K; Sawyer, G; Bass, M				Doody, J. Sean; Clulow, Simon; Kay, Geoff; D'Amore, Domenic; Rhind, David; Wilson, Steve; Ellis, Ryan; Castellano, Christina; McHenry, Colin; Quayle, Michelle; Hands, Kim; Sawyer, Graeme; Bass, Michael			The Dry Season Shuffle: Gorges Provide Refugia for Animal Communities in Tropical Savannah Ecosystems	PLOS ONE			English	Article								In the wet-dry tropics, animal species face the major challenges of acquiring food, water or shelter during an extended dry season. Although large and conspicuous animals such as ungulates and waterfowl migrate to wetter areas during this time, little is known of how smaller and more cryptic animal species with less mobility meet these challenges. We fenced off the entire entrance of a gorge in the Australian tropical savanna, offering the unique opportunity to determine the composition and seasonal movement patterns of the small vertebrate community. The 1.7 km-long fence was converted to a trapline that was deployed for 18-21 days during the early dry season in each of two years, and paired traps on both sides of the fence allowed us to detect the direction of animal movements. We predicted that semi-aquatic species (e.g., frogs and turtles) would move upstream into the wetter gorge during the dry season, while more terrestrial species (e.g., lizards, snakes, mammals) would not. The trapline captured 1590 individual vertebrates comprising 60 species. There was a significant bias for captures on the outside of the fence compared to the inside for all species combined (outside/inside = 5.2, CI = 3.7-7.2), for all vertebrate classes, and for specific taxonomic groups. The opposite bias (inside/outside = 7.3, N = 25) for turtles during the early wet season suggested return migration heading into the wet season. Our study revealed that the small vertebrate community uses the gorge as a dry season refuge. The generality of this unreplicated finding could be tested by extending this type of survey to tropical savannahs worldwide. A better understanding of how small animals use the landscape is needed to reveal the size of buffer zones around wetlands required to protect both semi-aquatic and terrestrial fauna in gorges in tropical savannah woodland, and thus in ecosystems in general.	[Doody, J. Sean] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Doody, J. Sean; Clulow, Simon] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Kay, Geoff] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Kay, Geoff] Australian Capital Terr, Canberra, ACT, Australia; [D'Amore, Domenic] Daemen Coll, Dept Nat Sci, Amherst, NY USA; [Rhind, David; McHenry, Colin; Quayle, Michelle] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Wilson, Steve] Queensland Museum, South Brisbane, Qld, Australia; [Ellis, Ryan] Western Australian Museum, Dept Terr Zool, Welshpool, WA, Australia; [Castellano, Christina] Utahs Hogle Zoo, Salt Lake City, UT USA; [Hands, Kim] Stop Toad Fdn, Perth, Australia; [Sawyer, Graeme] Frogwatch NT, Wagaman, NT, Australia; [Bass, Michael] Kununurra Western Australia, Kimberley, NSW, Australia	University of Tennessee System; University of Tennessee Knoxville; University of Newcastle; Australian National University; Monash University; Queensland Museum; Western Australian Museum	Doody, JS (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	jseandoody@gmail.com		Clulow, Simon/0000-0002-5700-6345	Stop the Toad Foundation	Stop the Toad Foundation	We thank the following people for assistance in the field: L. Blaxland, D. Bower, C. Clulow, S. Corry, C. Depiazzi, M. Edgar, R. Gollan, J. Green, R. Gustard, B. Hanekom, J. Hosking, H. James, K. Klop-toker, M. Laverty, A. Lillyman, J. Lloyd, D. Meadows, J. Miller, J. Murphy, G. Scott, B. Stewart, L. Vanderwyk. We are especially indebted to the following for converting the cattle fence to a toad fence: U. Barker, C. Bish, S. Brocklehurst, R. Geary, A. Gervas, R. Grieg, T. Kay, B. Lavendar, F. Longbottom, G. Pike, J. Rassmussen, L. Simnett, B. Wallace, and E. Wink. The fence conversion was funded by the Stop the Toad Foundation. We are grateful to C. Depiazzi, J. Hoskings, and G. Scott for wet season data. We thank El Questro Wilderness Park and the Stop the Toad Foundation for logistical support, and K. Colyvas and F. Tuyl for statistical advice.	[Anonymous], 1979, FISHERIES ECOLOGY FL; BERNARDINO FS, 1992, BIOL CONSERV, V62, P71, DOI 10.1016/0006-3207(92)90928-G; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; Cloudsley-Thompson J. L., 1991, ECOPHYSIOLOGY DESERT; CRAWFORD DN, 1979, AUST WILDLIFE RES, V6, P97; Crough G, 1994, ABORIGINAL PEOPLE EC; Florance D, 2011, P ROY SOC B-BIOL SCI, V278, P2900, DOI 10.1098/rspb.2011.0032; GLODEK G S, 1978, Fieldiana Zoology, V73, P1; GORZULA SJ, 1978, OECOLOGIA, V35, P21, DOI 10.1007/BF00345539; Hero Jean-Marc, 2006, Pacific Conservation Biology, V12, P313; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; KUSHLAN JA, 1980, COPEIA, P930, DOI 10.2307/1444493; Laurie V., 2010, KIMBERLEY AUSTR LAST; LINDLEY DV, 1965, INTRO PROBABILITY 2; Maddock L., 1979, SERENGETI DYNAMICS E, P104; Madsen T, 1996, HERPETOLOGICA, V52, P146; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; MORTON SR, 1990, AUST WILDLIFE RES, V17, P573; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Ruetz CR, 2005, J ANIM ECOL, V74, P322, DOI 10.1111/j.1365-2656.2005.00926.x; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; SHINE R, 1985, HERPETOLOGICA, V41, P351; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; SINCLAIR ARE, 1985, OECOLOGIA, V65, P266, DOI 10.1007/BF00379227; STINSON DW, 1991, CONDOR, V93, P38, DOI 10.2307/1368603; Thompson G. G., 2005, Journal of the Royal Society of Western Australia, V88, P17; WEBB GJW, 1982, AUST J ZOOL, V30, P877, DOI 10.1071/ZO9820877; Winemiller Kirk O., 1996, P298; Withers PC, 1998, AUST J ZOOL, V46, P405, DOI 10.1071/ZO98013; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x	33	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131186	10.1371/journal.pone.0131186	http://dx.doi.org/10.1371/journal.pone.0131186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135472	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400038
J	Helmy, S; Mavrelos, D; Sawyer, E; Ben-Nagi, J; Koch, M; Day, A; Jurkovic, D				Helmy, Samir; Mavrelos, Dimitrios; Sawyer, Elinor; Ben-Nagi, Jara; Koch, Marianne; Day, Andrea; Jurkovic, Davor			Serum Human Chorionic Gonadotropin (beta-hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study	PLOS ONE			English	Article							MTX THERAPY; FERTILITY	Objective To establish clearance curves for serum beta-hCG in women with successfully expectantly managed tubal ectopic pregnancies. Design Retrospective cohort study. Non-viable tubal ectopic pregnancy was diagnosed on transvaginal ultrasound. If initial serum beta hCG was less than 5000 IU/L and patients were asymptomatic, expectant management was offered. Patients underwent serial beta hCG measurements until serum beta hCG was less than 20 IU/I, or the urine pregnancy test was negative. Setting Early Pregnancy and Gynaecology Assessment Unit, Kings College Hospital, London (December 1998 to July 2006). Patients We included 161 women with diagnosed non-viable tubal ectopic pregnancy who underwent successful expectant management. Main outcome measure Serum beta hCG level. Results Mean initial serum beta-hCG was 488 IU/L (41 - 4883) and median serum beta hCG clearance time was 19 days (5 - 82). The average half-life of beta hCG clearance was 82.5 hours (+/- SD 50.2) in patients with steadily declining serum beta-hCG levels compared to 106.7 hours (+/- SD 72.0) in patients with primarily plateauing beta-hCG levels in the declining phase. However, these differences were not significant (p>0.05). Conclusion We identified a median follow-up of 19 days until serum beta hCG clearance in women with tubal ectopic pregnancy and successful expectant management. Although non-significant, women with initially plateauing serum beta hCG showed a longer follow-up time until clearance compared to women with steadily declining beta hCG levels. This information may serve as a guideline enabling clinicians to predict the length of follow-up for women with tubal ectopic pregnancy and expectant management.	[Helmy, Samir; Koch, Marianne] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Helmy, Samir; Mavrelos, Dimitrios; Sawyer, Elinor; Ben-Nagi, Jara] Kings Coll London, Early Pregnancy & Gynaecol Assessment Unit, London WC2R 2LS, England; [Koch, Marianne] Karl Landsteiner Soc, Vienna, Austria; [Day, Andrea; Jurkovic, Davor] Univ Coll Hosp London UCL, Gynaecol Diagnost & Outpatient Treatment Unit, London, England	Medical University of Vienna; University of London; King's College London; University of London; University College London	Helmy, S (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	Samir.helmy@meduniwien.ac.at	Mavrelos, Dimitrios/I-2203-2019	Mavrelos, Dimitrios/0000-0003-4106-8514; Koch, Marianne/0000-0003-4748-2994	Early Pregnancy and Gynaecology Assessment Unit, King's College Hospital, London, United Kingdom; Karl Landsteiner Society, Institute for General Gynecology and Gynecologic Oncology	Early Pregnancy and Gynaecology Assessment Unit, King's College Hospital, London, United Kingdom; Karl Landsteiner Society, Institute for General Gynecology and Gynecologic Oncology	The authors acknowledge the support of the Early Pregnancy and Gynaecology Assessment Unit, King's College Hospital, London, United Kingdom, and financial support for open access publication provided by the Karl Landsteiner Society, Institute for General Gynecology and Gynecologic Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi M, 2005, FERTIL STERIL, V83, P376, DOI 10.1016/j.fertnstert.2004.06.068; Elson J, 2004, ULTRASOUND OBST GYN, V23, P552, DOI 10.1002/uog.1061; FERNANDEZ H, 1991, HUM REPROD, V6, P1474, DOI 10.1093/oxfordjournals.humrep.a137292; Hajenius PJ, 1997, LANCET, V350, P774, DOI 10.1016/S0140-6736(97)05487-1; Helmy S, 2015, EUR J OBSTET GYN R B, V184, P108, DOI 10.1016/j.ejogrb.2014.09.038; Helmy S, 2014, EUR J OBSTET GYN R B, V179, P175, DOI 10.1016/j.ejogrb.2014.05.033; Helmy S, COMP FERTILITY OUTCO; LUND J, 1955, J OBSTET GYNAECOL, V62, P70; Rantala M, 1997, FERTIL STERIL, V68, P1043, DOI 10.1016/S0015-0282(97)00414-7; SHALEV E, 1995, FERTIL STERIL, V63, P15, DOI 10.1016/S0015-0282(16)57289-6; Strobelt N, 2000, J REPROD MED, V45, P803; Zohav E, 1996, EUR J OBSTET GYN R B, V66, P1, DOI 10.1016/0301-2115(95)02370-4	12	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130598	10.1371/journal.pone.0130598	http://dx.doi.org/10.1371/journal.pone.0130598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135923	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400021
J	Lin, CS; Hung, SF; Huang, HS; Ma, MC				Lin, Chian-Shiung; Hung, Shun-Fa; Huang, Ho-Shiang; Ma, Ming-Chieh			Blockade of the N-Methyl-D-Aspartate Glutamate Receptor Ameliorates Lipopolysaccharide-Induced Renal Insufficiency	PLOS ONE			English	Article							NMDA RECEPTOR; D-SERINE; RAT KIDNEYS; SENSORY ACTIVATION; OXIDATIVE STRESS; SEPTIC SHOCK; EXPRESSION; FAILURE; TOXICITY; SEPSIS	N-methyl-D-aspartate (NMDA) receptor activation in rat kidney reduces renal perfusion and ultrafiltration. Hypoperfusion-induced ischemia is the most frequent cause of functional insufficiency in the endotoxemic kidney. Here, we used non-hypotensive rat model of lipopolysaccharide-induced endotoxemia to examine whether NMDA receptor hyperfunction contributes to acute kidney injury. Lipopolysaccharide-induced renal damage via increased enzymuria and hemodynamic impairments were ameliorated by co-treatment with the NMDA receptor blocker, MK-801. The NMDA receptor NR1 subunit in the rat kidney mainly co-localized with serine racemase, an enzyme responsible for synthesizing the NMDA receptor co-agonist, D-serine. The NMDA receptor hyperfunction in lipopolysaccharide-treated kidneys was demonstrated by NR1 and serine racemase upregulation, particularly in renal tubules, and by increased D-serine levels. Lipopolysaccharide also induced cell damage in cultured tubular cell lines and primary rat proximal tubular cells. This damage was mitigated by MK-801 and by small interfering RNA targeting NR1. Lipopolysaccharide increased cytokine release in tubular cell lines via toll-like receptor 4. The release of interleukin- 1 beta from these cells are the most abundant. An interleukin-1 receptor antagonist not only attenuated cell death but also abolished lipopolysaccharide-induced NR1 and serine racemase upregulation and increases in D-serine secretion, suggesting that interleukin-1 beta-mediated NMDA receptor hyperfunction participates in lipopolysaccharide-induced tubular damage. The results of this study indicate NMDA receptor hyperfunction via cytokine effect participates in lipopolysaccharide-induced renal insufficiency. Blockade of NMDA receptors may represent a promising therapeutic strategy for the treatment of sepsis-associated renal failure.	[Lin, Chian-Shiung] Liou Ying Hosp, Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Hung, Shun-Fa] Far Eastern Mem Hosp, Dept Urol, New Taipei, Taiwan; [Huang, Ho-Shiang] Natl Cheng Kung Univ Hosp, Dept Urol, Tainan 70428, Taiwan; [Ma, Ming-Chieh] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan	Chi Mei Hospital; Far Eastern Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Fu Jen Catholic University	Ma, MC (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.	med0041@mail.fju.edu.tw			Far Eastern Memorial Hospital [100FJU-FEMH-03]; Chi-Mei Medical Center [CMFJ10009, CMFJ10203]; Ministry of Science and Technology [NSC101-2314-B-030-002-MY3]	Far Eastern Memorial Hospital; Chi-Mei Medical Center; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Far Eastern Memorial Hospital (100FJU-FEMH-03), the Chi-Mei Medical Center (CMFJ10009; CMFJ10203), and the Ministry of Science and Technology (NSC101-2314-B-030-002-MY3).	Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Betzen C, 2009, FREE RADICAL BIO MED, V47, P1212, DOI 10.1016/j.freeradbiomed.2009.07.034; Crespi F, 2000, NEUROSCI LETT, V287, P219, DOI 10.1016/S0304-3940(00)01174-5; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Deng AH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013293.11876.4E; Deng AH, 2009, AM J PHYSIOL-RENAL, V296, pF976, DOI 10.1152/ajprenal.90391.2008; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Feng NH, 2008, AM J PHYSIOL-RENAL, V294, pF316, DOI 10.1152/ajprenal.00308.2007; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; GORDON FJ, 1987, AM J PHYSIOL, V252, pR628, DOI 10.1152/ajpregu.1987.252.3.R628; Huang HS, 2003, UROLOGY, V62, P1123, DOI 10.1016/S0090-4295(03)00764-7; Huang S, 2009, AM J PHYSIOL-RENAL, V296, pF34, DOI 10.1152/ajprenal.90309.2008; Jonassen TEN, 2002, J PHARMACOL EXP THER, V303, P364, DOI 10.1124/jpet.102.036194; Krug AW, 2007, AM J PHYSIOL-RENAL, V293, pF382, DOI 10.1152/ajprenal.00441.2006; Lee CY, 2011, J TRAUMA, V70, P1177, DOI 10.1097/TA.0b013e31820ca695; Leung JC, 2004, KIDNEY INT, V66, P167, DOI 10.1111/j.1523-1755.2004.00718.x; Leung JC, 2002, AM J PHYSIOL-REG I, V283, pR964, DOI 10.1152/ajpregu.00629.2001; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; Liu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007548; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Ma MC, 2008, HYPERTENSION, V52, P938, DOI 10.1161/HYPERTENSIONAHA.108.114116; MONASSIER L, 1994, BRIT J PHARMACOL, V111, P1347, DOI 10.1111/j.1476-5381.1994.tb14893.x; Morimoto E, 2002, EXP NEUROL, V177, P95, DOI 10.1006/exnr.2002.7991; Oppert M, 2008, NEPHROL DIAL TRANSPL, V23, P904, DOI 10.1093/ndt/gfm610; Parsons CG, 1996, EUR J NEUROSCI, V8, P446, DOI 10.1111/j.1460-9568.1996.tb01228.x; Piepot HA, 2000, KIDNEY INT, V57, P2502, DOI 10.1046/j.1523-1755.2000.00109.x; RAAB W, 1969, PHARMACOLOGY, V2, P82, DOI 10.1159/000136004; Rezzani R, 2002, HISTOCHEM J, V34, P27, DOI 10.1023/A:1021391724643; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Sikka P, 2010, J NEUROSCI RES, V88, P1829, DOI 10.1002/jnr.22332; Silbernagl S, 1999, AM J PHYSIOL-RENAL, V276, pF857, DOI 10.1152/ajprenal.1999.276.6.F857; Slomowitz LA, 2004, AM J PHYSIOL-REG I, V287, pR1184, DOI 10.1152/ajpregu.00169.2003; Sun J, 2004, ACTA ANAESTH SCAND, V48, P317, DOI 10.1111/j.0001-5172.2004.0312.x; Thamilselvan S, 1999, J AM SOC NEPHROL, V10, pS452; Williams RE, 2003, CHEM RES TOXICOL, V16, P1207, DOI 10.1021/tx030019q; Wolosker Herman, 2006, Sci STKE, V2006, ppe41, DOI 10.1126/stke.3562006pe41; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang CC, 2008, AM J PHYSIOL-RENAL, V294, pF1433, DOI 10.1152/ajprenal.00481.2007; Yang CC, 2007, J PHYSIOL-LONDON, V582, P407, DOI 10.1113/jphysiol.2006.122747; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; Zimmerhackl LB, 1998, AM J PHYSIOL-RENAL, V275, pF143, DOI 10.1152/ajprenal.1998.275.1.F143	44	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132204	10.1371/journal.pone.0132204	http://dx.doi.org/10.1371/journal.pone.0132204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133372	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400105
J	Nightingale, GF; Laland, KN; Hoppitt, W; Nightingale, P				Nightingale, Glenna F.; Laland, Kevin N.; Hoppitt, William; Nightingale, Peter			Bayesian Spatial NBDA for Diffusion Data with Home-Base Coordinates	PLOS ONE			English	Article							CULTURE; MODEL	Network-based diffusion analysis (NBDA) is a statistical method that allows the researcher to identify and quantify a social influence on the spread of behaviour through a population. Hitherto, NBDA analyses have not directly modelled spatial population structure. Here we present a spatial extension of NBDA, applicable to diffusion data where the spatial locations of individuals in the population, or of their home bases or nest sites, are available. The method is based on the estimation of inter-individual associations (for association matrix construction) from the mean inter-point distances as represented on a spatial point pattern of individuals, nests or home bases. We illustrate the method using a simulated dataset, and show how environmental covariates (such as that obtained from a satellite image, or from direct observations in the study area) can also be included in the analysis. The analysis is conducted in a Bayesian framework, which has the advantage that prior knowledge of the rate at which the individuals acquire a given task can be incorporated into the analysis. This method is especially valuable for studies for which detailed spatially structured data, but no other association data, is available. Technological advances are making the collection of such data in the wild more feasible: for example, bio-logging facilitates the collection of a wide range of variables from animal populations in the wild. We provide an R package, spatialnbda, which is hosted on the Comprehensive R Archive Network (CRAN). This package facilitates the construction of association matrices with the spatial x and y coordinates as the input arguments, and spatial NBDA analyses.	[Nightingale, Glenna F.] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Laland, Kevin N.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Hoppitt, William] Anglia Ruskin Univ, Sch Life Sci, Cambridge, England; [Nightingale, Peter] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews; Anglia Ruskin University; University of St Andrews	Nightingale, GF (corresponding author), Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland.	glenna.evans@gmail.com	Hoppitt, William/A-8216-2008	Hoppitt, William/0000-0003-0815-5720; Laland, Kevin/0000-0002-2457-0900; Nightingale, Peter/0000-0002-5052-8634	BBSRC grant [BB/D015812/1]; ERC Advanced grant (EVOCULTURE) [232823]; BBSRC [BB/D015812/1, BB/I007997/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015812/1, BB/I007997/1] Funding Source: researchfish	BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC Advanced grant (EVOCULTURE); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a BBSRC grant to KNL and WH (BB/D015812/1), and an ERC Advanced grant to KNL (EVOCULTURE, ref 232823).	Aplin L, 2012, P ROYAL SOC B; Atton N, 2012, P ROY SOC B-BIOL SCI, V279, P4272, DOI 10.1098/rspb.2012.1462; Baddeley A, 2000, AUST NZ J STAT, V42, P283, DOI 10.1111/1467-842X.00128; Baddeley AJ, 1995, ANN I STAT MATH, V47, P601, DOI 10.1007/BF01856536; Bradbury Jack W., 1998, pi; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Funwi-Gabga N, 2012, STOCH ENV RES RISK A, V26, P793, DOI 10.1007/s00477-011-0541-1; Grabarnik P, 2011, PROCEDIA ENVIRON SCI, V7, P62, DOI 10.1016/j.proenv.2011.07.012; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; Hoppitt W, 2010, LEARN BEHAV, V38, P243, DOI 10.3758/LB.38.3.243; Hoppitt W, 2010, J THEOR BIOL, V263, P544, DOI 10.1016/j.jtbi.2010.01.004; Illian J, 2008, STAT ANAL MODELLING; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; King R, 2012, J AGR BIOL ENVIR ST, V17, P601, DOI 10.1007/s13253-012-0111-0; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Madden JR, 2008, ANIM COGN, V11, P1, DOI 10.1007/s10071-007-0092-5; Nightingale G, 2014, QUANTIFYING DIFFUSIO; Picard N, 2009, SCAND J STAT, V36, P23, DOI 10.1111/j.1467-9469.2008.00612.x; Reader SM, 2004, LEARN BEHAV, V32, P90; Reader SM, 2003, ANIM BEHAV, V66, P729, DOI 10.1006/anbe.2003.2252; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Stoyan D, 1996, BIOMETRICAL J, V38, P259, DOI 10.1002/bimj.4710380302; Webster MM, 2013, J COMP PSYCHOL, V127, P154, DOI 10.1037/a0029602; Whiten A, 2002, IMITATION SEQUENTIAL; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	29	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130326	10.1371/journal.pone.0130326	http://dx.doi.org/10.1371/journal.pone.0130326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135317	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000358154400017
J	Ye, J; Hu, TX; Yang, CM; Li, HX; Yang, MZ; Ijaz, RN; Ye, ZB; Zhang, YY				Ye, Jie; Hu, Tixu; Yang, Congmei; Li, Hanxia; Yang, Mingze; Ijaz, Raina; Ye, Zhibiao; Zhang, Yuyang			Transcriptome Profiling of Tomato Fruit Development Reveals Transcription Factors Associated with Ascorbic Acid, Carotenoid and Flavonoid Biosynthesis	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; DEPENDENT REGULATION; PHYTOENE SYNTHASE; GENE-EXPRESSION; RNA-SEQ; ACCUMULATION; PATHWAY; ACTIVATION; GENOMICS; PROTEIN	Tomato (Solanum lycopersicum) serves as a research model for fruit development; however, while it is an important dietary source of antioxidant nutrients, the transcriptional regulation of genes that determine nutrient levels remains poorly understood. Here, the transcriptomes of fruit at seven developmental stages (7, 14, 21, 28, 35, 42 and 49 days after flowering) from two tomato cultivars (Ailsa Craig and HG6-61) were evaluated using the Illumina sequencing platform. A total of 26,397 genes, which were expressed in at least one developmental stage, were detected in the two cultivars, and the expression patterns of those genes could be divided into 20 groups using a K-mean cluster analysis. Gene Ontology term enrichment analysis indicated that genes involved in RNA regulation, secondary metabolism, hormone metabolism and cell wall metabolism were the most highly differentially expressed genes during fruit development and ripening. A co-expression analysis revealed several transcription factors whose expression patterns correlated with those of genes associated with ascorbic acid, carotenoid and flavonoid biosynthesis. This transcriptional correlation was confirmed by agroinfiltration mediated transient expression, which showed that most of the enzymatic genes in the ascorbic acid biosynthesis were regulated by the overexpression of each of the three transcription factors that were tested. The metabolic dynamics of ascorbic acid, carotenoid and flavonoid were investigated during fruit development and ripening, and some selected transcription factors showed transcriptional correlation with the accumulation of ascorbic acid, carotenoid and flavonoid. This transcriptome study provides insight into the regulatory mechanism of fruit development and presents candidate transcription factors involved in secondary metabolism.	[Ye, Jie; Hu, Tixu; Yang, Congmei; Li, Hanxia; Yang, Mingze; Ijaz, Raina; Ye, Zhibiao; Zhang, Yuyang] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, YY (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	yyzhang@mail.hzau.edu.cn			National Basic Research Program of China [2011CB10060]; National Natural Science Foundation of China [31171974, 31230064]; Fundamental Research Funds for the Central Universities [2014PY006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (No. 2011CB10060), the National Natural Science Foundation of China (31171974 and 31230064) and the Fundamental Research Funds for the Central Universities (2014PY006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Badejo AA, 2012, J EXP BOT, V63, P229, DOI 10.1093/jxb/err275; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; de Vries GE, 2000, Trends Plant Sci, V5, P7; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Fraser PD, 2001, PHYTOCHEMISTRY, V58, P75, DOI 10.1016/S0031-9422(01)00175-3; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Gao Y, 2011, J EXP BOT, V62, P3647, DOI 10.1093/jxb/err068; Gapper NE, 2013, PLANT MOL BIOL, V82, P575, DOI 10.1007/s11103-013-0050-3; Gest N, 2013, PLANT BIOTECHNOL J, V11, P344, DOI 10.1111/pbi.12020; Gonzali S, 2009, TRENDS PLANT SCI, V14, P237, DOI 10.1016/j.tplants.2009.02.001; Grassi S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-781; HAMILTON AJ, 1991, P NATL ACAD SCI USA, V88, P7434, DOI 10.1073/pnas.88.16.7434; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang M, 2014, J PLANT PHYSIOL, V171, P1205, DOI 10.1016/j.jplph.2014.03.010; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Kerchev PI, 2011, PLANT CELL, V23, P3319, DOI 10.1105/tpc.111.090100; Klee HJ, 2010, NEW PHYTOL, V187, P44, DOI 10.1111/j.1469-8137.2010.03281.x; Kolotilin I, 2007, PLANT PHYSIOL, V145, P389, DOI 10.1104/pp.107.102962; Kopertekh L, 2005, TRANSGENIC RES, V14, P793, DOI 10.1007/s11248-005-8293-7; Leclercq J, 2002, PLANT PHYSIOL, V130, P1132, DOI 10.1104/pp.009415; Lemaire-Chamley M, 2005, PLANT PHYSIOL, V139, P750, DOI 10.1104/pp.105.063719; Lima-Silva V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-187; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050785; Luo ZD, 2013, NEW PHYTOL, V198, P442, DOI 10.1111/nph.12175; MOHR WP, 1969, CAN J PLANT SCI, V49, P549, DOI 10.4141/cjps69-096; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; Osorio S, 2011, PLANT PHYSIOL, V157, P405, DOI 10.1104/pp.111.175463; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sandmann G, 2001, TRENDS PLANT SCI, V6, P14, DOI 10.1016/S1360-1385(00)01817-3; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang J, 2013, PLANT CELL, V25, P625, DOI 10.1105/tpc.112.106880; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang WY, 2009, PLANT PHYSIOL, V150, P942, DOI 10.1104/pp.109.138453; Zhang YY, 2014, PLANT MOL BIOL REP, V32, P52, DOI 10.1007/s11105-013-0602-3; Zhang ZJ, 2012, PLANT J, V71, P273, DOI 10.1111/j.1365-313X.2012.04996.x; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021	50	41	43	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130885	10.1371/journal.pone.0130885	http://dx.doi.org/10.1371/journal.pone.0130885			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133783	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400027
J	Arnould, JPY; Monk, J; Ierodiaconou, D; Hindell, MA; Semmens, J; Hoskins, AJ; Costa, DP; Abernathy, K; Marshall, GJ				Arnould, John P. Y.; Monk, Jacquomo; Ierodiaconou, Daniel; Hindell, Mark A.; Semmens, Jayson; Hoskins, Andrew J.; Costa, Daniel P.; Abernathy, Kyler; Marshall, Greg J.			Use of Anthropogenic Sea Floor Structures by Australian Fur Seals: Potential Positive Ecological Impacts of Marine Industrial Development?	PLOS ONE			English	Article							ARCTOCEPHALUS-PUSILLUS-DORIFERUS; PORPOISES PHOCOENA-PHOCOENA; GULF-OF-MEXICO; HABITAT LOSS; FISH ASSEMBLAGES; CONTINENTAL-SHELF; BASS STRAIT; OIL; SELECTION; MAMMALS	Human-induced changes to habitats can have deleterious effects on many species that occupy them. However, some species can adapt and even benefit from such modifications. Artificial reefs have long been used to provide habitat for invertebrate communities and promote local fish populations. With the increasing demand for energy resources within ocean systems, there has been an expansion of infrastructure in near-shore benthic environments which function as de facto artificial reefs. Little is known of their use by marine mammals. In this study, the influence of anthropogenic sea floor structures (pipelines, cable routes, wells and shipwrecks) on the foraging locations of 36 adult female Australian fur seals (Arctocephalus pusillus doriferus) was investigated. For 9 (25%) of the individuals, distance to anthropogenic sea floor structures was the most important factor in determining the location of intensive foraging activity. Whereas the influence of anthropogenic sea floor structures on foraging locations was not related to age and mass, it was positively related to flipper length/standard length (a factor which can affect manoeuvrability). A total of 26 (72%) individuals tracked with GPS were recorded spending time in the vicinity of structures (from <1% to >75% of the foraging trip duration) with pipelines and cable routes being the most frequented. No relationships were found between the amount of time spent frequenting anthropogenic structures and individual characteristics. More than a third (35%) of animals foraging near anthropogenic sea floor structures visited more than one type of structure. These results further highlight potentially beneficial ecological outcomes of marine industrial development.	[Arnould, John P. Y.; Monk, Jacquomo; Ierodiaconou, Daniel; Hoskins, Andrew J.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Monk, Jacquomo; Hindell, Mark A.; Semmens, Jayson] Univ Tasmania, Inst Marine & Antarct Sci, Hobart, Tas, Australia; [Costa, Daniel P.] UC Santa Cruz, Inst Marine Sci, Dept Ecol & Evolutionary Biol, Santa Cruz, CA USA; [Abernathy, Kyler; Marshall, Greg J.] Natl Geog Soc, Remote Imaging Dept, Washington, DC USA	Deakin University; University of Tasmania; University of California System; University of California Santa Cruz; National Geographic Society	Arnould, JPY (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	john.arnould@deakin.edu.au	Hoskins, Andrew/T-2694-2019; Costa, Daniel/E-2616-2013	Hoskins, Andrew/0000-0001-8907-6682; Hindell, Mark/0000-0002-7823-7185; Ierodiaconou, Daniel/0000-0002-7832-4801; Monk, Jacquomo/0000-0002-1874-0619; Semmens, Jayson/0000-0003-1742-6692; Costa, Daniel/0000-0002-0233-5782	Australian Research Council [DP0664167, DP110102065]; Office of Naval Research [N00014-10-1-0385]	Australian Research Council(Australian Research Council); Office of Naval Research(Office of Naval Research)	This work was supported by: Australian Research Council (http://arc.gov.au/) DP0664167 - JPYA, DPC; Australian Research Council (http://arc.gov.au/) DP110102065 - JPYA, MAH, JS; and Office of Naval Research (http://www.onr.navy.mil/) N00014-10-1-0385 - JPYA.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Arena P, 2011, J COASTAL RES, P375; Arnould JPY, 2006, LOW WAKE FI, P309; Arnould JPY, 2011, MAR ECOL PROG SER, V422, P291, DOI 10.3354/meps08933; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2002, AUST J ZOOL, V50, P53, DOI 10.1071/ZO01077; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Barton K, 2012, MUMIN MULTIMODEL INF; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; BOMBACE G, 1994, B MAR SCI, V55, P559; Campagna C, 2011, BIOSCIENCE, V61, P393, DOI 10.1525/bio.2011.61.5.8; Casper RM, 2009, ANIM BEHAV, V78, P1477, DOI 10.1016/j.anbehav.2009.09.023; Cenci E, 2011, ESTUAR COAST SHELF S, V91, P133, DOI 10.1016/j.ecss.2010.10.009; Costa DP, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P344; Costa DP, 2004, INT CONGR SER, V1275, P359, DOI 10.1016/j.ics.2004.08.058; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Ellis JI, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00589-080204; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fish FE, 2003, J EXP BIOL, V206, P667, DOI 10.1242/jeb.00144; Fowler AM, 2015, P NATL ACAD SCI USA, V112, pE102, DOI 10.1073/pnas.1422274112; Friedlander AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103709; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; GIBBS CF, 1992, EMU, V91, P395, DOI 10.1071/MU9910395; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Hoskins AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117997; Hoskins AJ, 2014, MAR ECOL PROG SER, V511, P285, DOI 10.3354/meps10935; Hoskins AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079484; Kirkwood R, 2008, MAR ECOL PROG SER, V369, P297, DOI 10.3354/meps07633; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Mikkelsen L, 2013, MAR ECOL PROG SER, V481, P239, DOI 10.3354/meps10260; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Pradella N, 2014, J FISH BIOL, V84, P247, DOI 10.1111/jfb.12274; Russell DJF, 2014, CURR BIOL, V24, pR638, DOI 10.1016/j.cub.2014.06.033; Scott ME, 2015, MAR FRESHWATER RES, V66, P429, DOI 10.1071/MF14064; Seaman W, 2007, HYDROBIOLOGIA, V580, P143, DOI 10.1007/s10750-006-0457-9; Stanley DR, 2003, AM FISH S S, V36, P123; Team RC, 2012, R LANG ENV STAT COMP; Thirgood SJ, 2000, P ROY SOC B-BIOL SCI, V267, P651, DOI 10.1098/rspb.2000.1051; Thrush SF, 1998, ECOL APPL, V8, P866, DOI 10.2307/2641273; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; Wang YP, 2008, CAN J ZOOL, V86, P676, DOI 10.1139/Z08-045; Warneke R. M., 1985, STUDIES SEA MAMMALS, P153; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Williams LM, 1997, J WILDLIFE MANAGE, V61, P359, DOI 10.2307/3802592; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962	53	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130581	10.1371/journal.pone.0130581	http://dx.doi.org/10.1371/journal.pone.0130581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132329	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000074
J	Dow, N; Chernick, A; Orsel, K; van Marle, G; van der Meer, F				Dow, Natalie; Chernick, Adam; Orsel, Karin; van Marle, Guido; van der Meer, Frank			Genetic Variability of Bovine Viral Diarrhea Virus and Evidence for a Possible Genetic Bottleneck during Vertical Transmission in Persistently Infected Cattle	PLOS ONE			English	Article							RNA-POLYMERASE; BVDV; DIVERSITY; BLOOD; PATHOGENESIS; POPULATION; E2; COMPARTMENTALIZATION; IDENTIFICATION; PHYLOGENIES	Bovine viral diarrhea virus (BVDV), a Pestivirus in the family Flaviviridae, is an economically important pathogen of cattle worldwide. The primary propagators of the virus are immunotolerant persistently infected (PI) cattle, which shed large quantities of virus throughout life. Despite the absence of an acquired immunity against BVDV in these PI cattle there are strong indications of viral variability that are of clinical and epidemiological importance. In this study the variability of E2 and NS5B sequences in multiple body compartments of PI cattle were characterized using clonal sequencing. Phylogenetic analyses revealed that BVDV exists as a quasispecies within PI cattle. Viral variants were clustered by tissue compartment significantly more often than expected by chance alone with the central nervous system appearing to be a particularly important viral reservoir. We also found strong indications for a genetic bottleneck during vertical transmission from PI animals to their offspring. These quasispecies analyses within PI cattle exemplify the role of the PI host in viral propagation and highlight the complex dynamics of BVDV pathogenesis, transmission and evolution.	[Dow, Natalie; Chernick, Adam; van Marle, Guido; van der Meer, Frank] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Orsel, Karin] Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, Calgary, AB, Canada; [van Marle, Guido] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Orsel, Karin; van der Meer, Frank] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Chernick, A (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada.	a.chernick@ucalgary.ca	van der Meer, Frank/AAX-3784-2020; van der Meer, Frank/T-3497-2019; van der Meer, Frank JUM/F-5011-2012; Chernick, Adam/B-4346-2015	van der Meer, Frank/0000-0003-3785-9639; van der Meer, Frank JUM/0000-0003-3785-9639; Chernick, Adam/0000-0002-4874-7133; van Marle, Guido/0000-0002-5148-6229; Orsel, Karin/0000-0002-6499-5188	Alberta Livestock and Meat Agency [RT707568]; Margaret Gunn Endowment for Animal Research [10005041]; University of Calgary	Alberta Livestock and Meat Agency; Margaret Gunn Endowment for Animal Research; University of Calgary	This research was funded by the Alberta Livestock and Meat Agency (RT707568, http://alma.alberta.ca/), the Margaret Gunn Endowment for Animal Research (10005041, http://www.ucalgary.ca/research/researchers/apply-grants/grants-internal/margaret-gunn-endowment) and the University of Calgary (http://www.ucalgary.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AMR, 1999, J VIROL, V73, P9213, DOI 10.1128/JVI.73.11.9213-9221.1999; Alexopoulou A., 2005, Current Drug Targets - Inflammation and Allergy, V4, P47, DOI 10.2174/1568010053622867; BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Blas-Machado U, 2004, VET PATHOL, V41, P190, DOI 10.1354/vp.41-2-190; Brown RJP, 2012, J VIROL, V86, P11956, DOI 10.1128/JVI.01079-12; BROWNLIE J, 1991, ARCH VIROL, P79; Chase CCL, 2013, BIOLOGICALS, V41, P52, DOI 10.1016/j.biologicals.2012.09.009; Chernick A, 2014, INFECT GENET EVOL, V28, P367, DOI 10.1016/j.meegid.2014.01.003; Choi KH, 2006, STRUCTURE, V14, P1107, DOI 10.1016/j.str.2006.05.020; Collins ME, 1999, VIROLOGY, V259, P85, DOI 10.1006/viro.1999.9697; Cossetti C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00117; Couvreur B, 2002, VIRUS RES, V85, P17, DOI 10.1016/S0168-1702(02)00014-X; Curti E, 2013, J VIROL, V87, P199, DOI 10.1128/JVI.06968-11; Deregt D, 1998, VIRUS RES, V53, P81, DOI 10.1016/S0168-1702(97)00129-9; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; El Omari K, 2013, CELL REP, V3, P30, DOI 10.1016/j.celrep.2012.12.001; EPSTEIN LG, 1991, VIROLOGY, V180, P583, DOI 10.1016/0042-6822(91)90072-J; Forns X, 1999, TRENDS MICROBIOL, V7, P402, DOI 10.1016/S0966-842X(99)01590-5; Fulton RW, 2002, CAN J VET RES, V66, P181; Gilbert SA, 1999, J CLIN MICROBIOL, V37, P2020, DOI 10.1128/JCM.37.6.2020-2023.1999; Hamers C, 2001, VET J, V161, P112, DOI 10.1053/tvjl.2000.0504; Hamers C, 1998, VET MICROBIOL, V61, P177, DOI 10.1016/S0378-1135(98)00185-0; HERTIG C, 1995, GENE, V153, P191, DOI 10.1016/0378-1119(94)00748-H; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jones LR, 2002, J GEN VIROL, V83, P2161, DOI 10.1099/0022-1317-83-9-2161; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KUNIN CM, 1961, J CLIN INVEST, V40, P1055; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Li HY, 2004, J VIROL, V78, P10582, DOI 10.1128/JVI.78.19.10582-10587.2004; Lowings P, 1996, J GEN VIROL, V77, P1311, DOI 10.1099/0022-1317-77-6-1311; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lucas M, 2001, INT J EXP PATHOL, V82, P269, DOI 10.1046/j.1365-2613.2001.00204.x; Maurer K, 2004, J VIROL, V78, P1792, DOI 10.1128/JVI.78.4.1792-1799.2004; MCCLURKIN AW, 1984, CAN J COMP MED, V48, P156; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Navas S, 1998, J VIROL, V72, P1640, DOI 10.1128/JVI.72.2.1640-1646.1998; Neill JD, 2011, VIRUS RES, V158, P140, DOI 10.1016/j.virusres.2011.03.024; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; PATON DJ, 1994, BRIT VET J, V150, P603, DOI 10.1016/S0007-1935(94)80047-2; PATON DJ, 1995, VET MICROBIOL, V43, P283, DOI 10.1016/0378-1135(94)00107-8; Peterhans E, 2013, BIOLOGICALS, V41, P39, DOI 10.1016/j.biologicals.2012.07.006; RADOSTITS OM, 1988, CAN VET J, V29, P513; Ridpath JF, 1998, MOL CELL PROBE, V12, P101, DOI 10.1006/mcpr.1998.0158; Ridpath JF, 2011, J VET DIAGN INVEST, V23, P185, DOI 10.1177/104063871102300201; ROEDER PL, 1986, VET REC, V118, P44, DOI 10.1136/vr.118.2.44; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; Shusta EV, 2002, J NEUROPATH EXP NEUR, V61, P597, DOI 10.1093/jnen/61.7.597; Simmons HE, 2013, VIRUS RES, V176, P259, DOI 10.1016/j.virusres.2013.06.016; SLATKIN M, 1989, GENETICS, V123, P603; STRAVER PJ, 1983, VET QUART, V5, P156, DOI 10.1080/01652176.1983.9693890; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurmond MC, 2005, BOVINE VIRAL DIARRHEA VIRUS: DIAGNOSIS, MANAGEMENT, AND CONTROL, P91, DOI 10.1002/9780470344453.ch5; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vilcek S, 1999, VIRUS GENES, V18, P107, DOI 10.1023/A:1008000231604; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378	69	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131972	10.1371/journal.pone.0131972	http://dx.doi.org/10.1371/journal.pone.0131972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132819	gold, Green Submitted, Green Published			2022-12-26	WOS:000358153000148
J	Gillespie, DOS; Allen, K; Guzman-Castillo, M; Bandosz, P; Moreira, P; McGill, R; Anwar, E; Lloyd-Williams, F; Bromley, H; Diggle, PJ; Capewell, S; O'Flaherty, M				Gillespie, Duncan O. S.; Allen, Kirk; Guzman-Castillo, Maria; Bandosz, Piotr; Moreira, Patricia; McGill, Rory; Anwar, Elspeth; Lloyd-Williams, Ffion; Bromley, Helen; Diggle, Peter J.; Capewell, Simon; O'Flaherty, Martin			The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; SODIUM-INTAKE; RISK-FACTORS; FOODS; INTERVENTIONS; INEQUALITIES; OUTCOMES; SCIENCE; IMPACT	Background Public health action to reduce dietary salt intake has driven substantial reductions in coronary heart disease (CHD) over the past decade, but avoidable socio-economic differentials remain. We therefore forecast how further intervention to reduce dietary salt intake might affect the overall level and inequality of CHD mortality. Methods We considered English adults, with socio-economic circumstances (SEC) stratified by quintiles of the Index of Multiple Deprivation. We used IMPACT(SEC), a validated CHD policy model, to link policy implementation to salt intake, systolic blood pressure and CHD mortality. We forecast the effects of mandatory and voluntary product reformulation, nutrition labelling and social marketing (e.g., health promotion, education). To inform our forecasts, we elicited experts' predictions on further policy implementation up to 2020. We then modelled the effects on CHD mortality up to 2025 and simultaneously assessed the socio-economic differentials of effect. Results Mandatory reformulation might prevent or postpone 4,500 (2,900-6,100) CHD deaths in total, with the effect greater by 500 (300-700) deaths or 85% in the most deprived than in the most affluent. Further voluntary reformulation was predicted to be less effective and inequality-reducing, preventing or postponing 1,500 (200-5,000) CHD deaths in total, with the effect greater by 100 (-100-600) deaths or 49% in the most deprived than in the most affluent. Further social marketing and improvements to labelling might each prevent or postpone 400-500 CHD deaths, but minimally affect inequality. Conclusions Mandatory engagement with industry to limit salt in processed-foods appears a promising and inequality-reducing option. For other policy options, our expert-driven forecast warns that future policy implementation might reach more deprived individuals less well, limiting inequality reduction. We therefore encourage planners to prioritise equity.	[Gillespie, Duncan O. S.; Guzman-Castillo, Maria; Bandosz, Piotr; Moreira, Patricia; McGill, Rory; Anwar, Elspeth; Lloyd-Williams, Ffion; Bromley, Helen; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England; [Allen, Kirk; Diggle, Peter J.] Univ Lancaster, Lancaster Med Sch, Lancaster LA1 4YG, England	University of Liverpool; Lancaster University	Gillespie, DOS (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.	duncan.gillespie@sheffield.ac.uk	Shao, Ruitai/AAU-7642-2021; Gillespie, Duncan/G-1401-2013; Bandosz, Piotr/E-4964-2017	Gillespie, Duncan/0000-0003-3450-5747; O'Flaherty, Martin/0000-0001-8944-4131; Diggle, Peter/0000-0003-3521-5020	National Institute of Health Research, School of Public Health Research [SPHR-LIL-PH1-MCD]; MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	National Institute of Health Research, School of Public Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institute of Health Research, School of Public Health Research (http://sphr.nihr.ac.uk/) through a grant (SPHR-LIL-PH1-MCD) to the LiLaC collaboration between the University of Liverpool and Lancaster University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PREVENTION OF CARDIO; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bromley H, 2014, IDENTIFYING THE MOST; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Castillo MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099482; CLARK CE, 1962, OPER RES, V10, P405, DOI 10.1287/opre.10.3.405; Cobb LK, 2014, CIRCULATION, V129, P1173, DOI 10.1161/CIR.0000000000000015; Collins M, 2014, VALUE HEALTH, V17, P517, DOI 10.1016/j.jval.2014.03.1722; Combris P, 2011, PUBLIC HEALTH, V125, P717, DOI 10.1016/j.puhe.2011.07.004; Croker H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-404; Desmond E, 2006, MEAT SCI, V74, P188, DOI 10.1016/j.meatsci.2006.04.014; Diderichsen F, 2001, CHALLENGING INEQUALI; Drichoutis AC, 2005, EUR REV AGRIC ECON, V32, P93, DOI 10.1093/erae/jbi003; Eyles H, 2013, PREV MED, V57, P555, DOI 10.1016/j.ypmed.2013.07.024; Giddens A, 1984, CONSTITUTION SOC; Hadorn D, 2014, INT J TECHNOL ASSESS, V30, P461, DOI 10.1017/S0266462314000427; He F. J., 2013, BMJ, V346; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; Ji C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002246; Ji C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005683; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; McGill R, 2015, BMC PUBLIC IN PRESS; McLaren L, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-44; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; McLeod M, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-15; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Michie S, 2013, HEALTH PSYCHOL REV, V7, P1, DOI 10.1080/17437199.2011.649445; Millett C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029836; National Institute for Health and Care Excellence, 2010, PREVENTION OF CARDIO; Neal B, 2013, CURR HYPERTENS REP, V15, P687, DOI 10.1007/s11906-013-0389-5; NICE, 2014, BEH CHANG IND APPR; Noble M, 2008, ENGLISH INDICES DEPR; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; O'Hagan A, 2012, ENVIRON MODELL SOFTW, V36, P35, DOI 10.1016/j.envsoft.2011.03.003; O'Keeffe C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002837; Oldroyd J, 2008, J EPIDEMIOL COMMUN H, V62, P573, DOI 10.1136/jech.2007.066357; Oppenheimer M, 2007, SCIENCE, V317, P1505, DOI 10.1126/science.1144831; Pechey R, 2013, SOC SCI MED, V92, P22, DOI 10.1016/j.socscimed.2013.05.012; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P901, DOI 10.1017/S1368980010001072; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub4; Sadler K, 2011, NATIONAL DIET AND NU; Sanghavi S, 2013, J RENAL NUTR, V23, P223, DOI 10.1053/j.jrn.2013.01.027; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Scholes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069935; Shankar B, 2013, HEALTH ECON, V22, P243, DOI 10.1002/hec.2772; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Taylor-Robinson D, 2008, J HEALTH SERV RES PO, V13, P209, DOI 10.1258/jhsrp.2008.008045; Tugwell P, 2006, BMJ-BRIT MED J, V332, P358, DOI 10.1136/bmj.332.7537.358; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	65	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0127927	10.1371/journal.pone.0127927	http://dx.doi.org/10.1371/journal.pone.0127927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26131981	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000358153000012
J	Haasis, MA; Ceria, JA; Kulpeng, W; Teerawattananon, Y; Alejandria, M				Haasis, Manuel Alexander; Ceria, Joyce Anne; Kulpeng, Wantanee; Teerawattananon, Yot; Alejandria, Marissa			Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; SEQUENTIAL INTRODUCTION; SEROTYPE REPLACEMENT; HERD-IMMUNITY; 7-VALENT; CHILDREN; DISEASE; IMMUNOGENICITY; VACCINATION; 10-VALENT	Objectives The objective of this study is to assess the value for money of introducing pneumococcal conjugate vaccines as part of the immunization program in a lower-middle income country, the Philippines, which is not eligible for GAVI support and lower vaccine prices. It also includes the newest clinical evidence evaluating the efficacy of PCV10, which is lacking in other previous studies. Methods A cost-utility analysis was conducted. A Markov simulation model was constructed to examine the costs and consequences of PCV10 and PCV13 against the current scenario of no PCV vaccination for a lifetime horizon. A health system perspective was employed to explore different funding schemes, which include universal or partial vaccination coverage subsidized by the government. Results were presented as incremental cost-effectiveness ratios (ICERs) in Philippine peso (Php) per QALY gained (1 USD = 44.20 Php). Probabilistic sensitivity analysis was performed to determine the impact of parameter uncertainty. Results With universal vaccination at a cost per dose of Php 624 for PCV10 and Php 700 for PCV13, both PCVs are cost-effective compared to no vaccination given the ceiling threshold of Php 120,000 per QALY gained, yielding ICERs of Php 68,182 and Php 54,510 for PCV10 and PCV13, respectively. Partial vaccination of 25% of the birth cohort resulted in significantly higher ICER values (Php 112,640 for PCV10 and Php 84,654 for PCV13) due to loss of herd protection. The budget impact analysis reveals that universal vaccination would cost Php 3.87 billion to 4.34 billion per annual, or 1.6 to 1.8 times the budget of the current national vaccination program. Conclusion The inclusion of PCV in the national immunization program is recommended. PCV13 achieved better value for money compared to PCV10. However, the affordability and sustainability of PCV implementation over the long-term should be considered by decision makers.	[Haasis, Manuel Alexander; Ceria, Joyce Anne] NCPAM, Dept Hlth, Manila, Philippines; [Kulpeng, Wantanee; Teerawattananon, Yot] Minist Publ Hlth, Dept Hlth, HITAP, Nonthaburi, Thailand; [Alejandria, Marissa] Univ Philippines, NIH, Inst Clin Epidemiol, Manila, Philippines	Philippine Department Health; Ministry of Public Health - Thailand; University of the Philippines System; University of the Philippines Manila	Haasis, MA (corresponding author), NCPAM, Dept Hlth, Manila, Philippines.			Teerawattananon, Yot/0000-0003-2217-2930	Rockefeller Foundation; National Institute for Health and Care Excellence (NICE) International; World Health Organization (WHO); Health Intervention and Technology Assessment Program (HITAP); Department of Health Philippines	Rockefeller Foundation; National Institute for Health and Care Excellence (NICE) International; World Health Organization (WHO)(World Health Organization); Health Intervention and Technology Assessment Program (HITAP); Department of Health Philippines	This work was supported by the Rockefeller Foundation, the National Institute for Health and Care Excellence (NICE) International, World Health Organization (WHO), Health Intervention and Technology Assessment Program (HITAP), and the Department of Health Philippines. The views expressed in the publication are those of the authors and not necessarily those of the supporting institutions. WHO and Rockefeller Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ASSESSMENT REPORT SY; [Anonymous], 2014, IMMUNIZATION STANDAR; [Anonymous], 2013, AVERAGE EXCHANGE RAT; Ben-Shimol S, 2014, CLIN INFECT DIS, V59, P1724, DOI 10.1093/cid/ciu683; Ben-Shimol S, 2014, VACCINE, V32, P3452, DOI 10.1016/j.vaccine.2014.03.065; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Butler JRG, 2004, VACCINE, V22, P1138, DOI 10.1016/j.vaccine.2003.09.036; Capeding MR, 2012, LAB BASED SURVEILLAN; Caro RM, 2011, PREVALENCE CLIN DIAG; Castaneda-Orjuela C, 2012, VACCINE, V30, P1936, DOI 10.1016/j.vaccine.2012.01.031; Central office for Health Information, 2011, DAT STRUCT INP 2006; Chomchai C, 2010, 5 AS C PED INF DIS S; Chuck AW, 2010, VACCINE, V28, P5485, DOI 10.1016/j.vaccine.2010.05.058; Dagan Ron, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P488, DOI 10.1097/01.moo.0000145958.12395.ec; Department of Health Philippines, 2014, VACC COV DAT; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Esposito S, 2010, CLIN VACCINE IMMUNOL, V17, P1017, DOI 10.1128/CVI.00062-10; Falup-Pecurariu Oana, 2012, Biomed J, V35, P450, DOI 10.4103/2319-4170.104409; Food and Drug Administration Philippines Center for Drug Registration and Research, 2014, VACCINE; Martinez FG, 2014, AN PEDIATR, V80, P173, DOI 10.1016/j.anpedi.2013.05.003; Hackel M, 2013, VACCINE, V31, P4881, DOI 10.1016/j.vaccine.2013.07.054; Hsieh YC, 2004, CLIN INFECT DIS, V38, P830, DOI 10.1086/381974; Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Kieninger DM, 2010, VACCINE, V28, P4192, DOI 10.1016/j.vaccine.2010.04.008; Kulpeng W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-122; Kulpeng W, 2013, VACCINE, V31, P2839, DOI 10.1016/j.vaccine.2013.03.047; Lloyd A, 2008, EUR J HEALTH ECON, V9, P7, DOI 10.1007/s10198-006-0013-6; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; MIMS Philippines, 2013, PREV 13 SYNFL; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Moore MR, 2014, UPDATE EFFECTIVENESS; Musher DM, 2006, NEW ENGL J MED, V354, P1522, DOI 10.1056/NEJMe068038; National Center for Pharmaceutical Access and Management Department of Health Philippines, MIN 4 M FORM EX COUN; Netsawang Supichaya, 2010, Journal of the Medical Association of Thailand, V93, pS6; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Philippine Statistics Authority National Statistics Office, 2010, POP AG GROUP SEX REG; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Capeding MR, 2013, PEDIATR INFECT DIS J, V32, pE383, DOI 10.1097/INF.0b013e318298dfd5; Rozenbaum MH, 2010, BMJ, V340; Ruckinger S, 2011, VACCINE, V29, P9600, DOI 10.1016/j.vaccine.2011.09.011; Salo H, 2005, SCAND J INFECT DIS, V37, P821, DOI 10.1080/00365540500321512; TAN CC, 2006, SANTO TOMAS J MED, V53, P37; Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657; Tyo KR, 2011, VACCINE, V29, P6686, DOI 10.1016/j.vaccine.2011.06.091; Uruena A, 2011, VACCINE, V29, P4963, DOI 10.1016/j.vaccine.2011.04.111; van Hoek AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039150; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; [World Health Organization Expanded Program on Immunization], 2009, WHO GLOB BURD DIS ES; Wu DBC, 2012, VALUE HEALTH, V15, pS15, DOI 10.1016/j.jval.2011.11.013	56	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131156	10.1371/journal.pone.0131156	http://dx.doi.org/10.1371/journal.pone.0131156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131961	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000096
J	Momplaisir, FM; Brady, KA; Fekete, T; Thompson, DR; Roux, AD; Yehia, BR				Momplaisir, Florence M.; Brady, Kathleen A.; Fekete, Thomas; Thompson, Dana R.; Roux, Ana Diez; Yehia, Baligh R.			Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; FINANCIAL INCENTIVES; CONTROLLED-TRIAL; PERINATAL TRANSMISSION; HIV-1-INFECTED WOMEN; ZIDOVUDINE TREATMENT; UNINFECTED INFANTS; HEALTH-CARE	Background HIV suppression at parturition is beneficial for maternal, fetal and public health. To eliminate mother-to-child transmission of HIV, an understanding of missed opportunities for antiretroviral therapy (ART) use during pregnancy and HIV suppression at delivery is required. Methodology We performed a retrospective analysis of 836 mother-to-child pairs involving 656 HIV-infected women in Philadelphia, 2005-2013. Multivariable regression examined associations between patient (age, race/ethnicity, insurance status, drug use) and clinical factors such as adequacy of prenatal care measured by the Kessner index which classifies prenatal care as inadequate, intermediate, or adequate prenatal care; timing of HIV diagnosis; and the outcomes: receipt of ART during pregnancy and viral suppression at delivery. Results Overall, 25% of the sample was diagnosed with HIV during pregnancy; 39%, 38%, and 23% were adequately, intermediately, and inadequately engaged in prenatal care. Eight-five percent of mother-to-child pairs received ART during pregnancy but only 52% achieved suppression at delivery. Adjusting for patient factors, pairs diagnosed with HIV during pregnancy were less likely to receive ART (AOR 0.39, 95% CI 0.25-0.61) and achieve viral suppression (AOR 0.70, 95% CI 0.49-1.00) than those diagnosed before pregnancy. Similarly, women with inadequate prenatal care were less likely to receive ART (AOR 0.06, 95% CI 0.03-0.11) and achieve viral suppression (AOR 0.31, 95% CI 0.20-0.47) than those with adequate prenatal care. Conclusions Targeted interventions to diagnose HIV prior to pregnancy and engage HIV-infected women in prenatal care have the potential to improve HIV related outcomes in the perinatal period.	[Momplaisir, Florence M.] Drexel Univ, Sch Med, Div Infect Dis & HIV Med, Philadelphia, PA 19104 USA; [Brady, Kathleen A.] Philadelphia Dept Publ Hlth, AIDS Act & Coordinating Off, Philadelphia, PA USA; [Brady, Kathleen A.; Yehia, Baligh R.] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [Fekete, Thomas] Temple Univ Hosp & Med Sch, Div Infect Dis, Philadelphia, PA 19140 USA; [Thompson, Dana R.] Christiana Care Hlth Syst, Ctr Womens & Childrens Hlth Res, Greenville, DC USA; [Roux, Ana Diez] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Yehia, Baligh R.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Drexel University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Christiana Care Health System; Drexel University; University of Pennsylvania	Momplaisir, FM (corresponding author), Drexel Univ, Sch Med, Div Infect Dis & HIV Med, Philadelphia, PA 19104 USA.	Florence.Momplaisir@drexelmed.edu	Fekete, Thomas/AFI-5367-2022					Binford MC, 2012, CURR HIV-AIDS REP, V9, P287, DOI 10.1007/s11904-012-0134-8; Branson B., 2006, REVISED RECOMMENDATI; Centers_for_Disease_Control_and_Prevention, 2005, HIV SURV SUPPL REP 2; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Dickover RE, 1996, JAMA-J AM MED ASSOC, V275, P599, DOI 10.1001/jama.275.8.599; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Economides A, 1998, CLIN DIAGN LAB IMMUN, V5, P230, DOI 10.1128/CDLI.5.2.230-234.1998; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Haukoos JS, 2005, ACAD EMERG MED, V12, P617, DOI 10.1111/j.1553-2712.2005.tb00916.x; Katz IT, 2015, ANN INTERN MED, V162, P90, DOI 10.7326/M13-2005; Katz IT, 2010, JAIDS-J ACQ IMM DEF, V54, P27, DOI 10.1097/QAI.0b013e3181caea89; Keller SC, 2014, AIDS PATIENT CARE ST, V28, P198, DOI 10.1089/apc.2014.0001; Kessner DM, 1973, INFANT DEATH ANAL MA, VI; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Merenstein D, 2009, AIDS PATIENT CARE ST, V23, P289, DOI 10.1089/apc.2008.0161; Naar-King S, 2009, AIDS CARE, V21, P868, DOI 10.1080/09540120802612824; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Nesheim S, 2012, PEDIATRICS, V130, P738, DOI 10.1542/peds.2012-0194; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009, GUIDELINES USE ANTIR; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, REC US ANT DRUGS PRE; Purcell DW, 2007, JAIDS-J ACQ IMM DEF, V46, pS35, DOI 10.1097/QAI.0b013e31815767c4; Romano MF, 2006, VIRAL IMMUNOL, V19, P363, DOI 10.1089/vim.2006.19.363; Siddiqui R, 2014, AIDS PATIENT CARE ST, V28, P248, DOI 10.1089/apc.2013.0321; SIMONON A, 1994, J ACQ IMMUN DEF SYND, V7, P952; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Taron-Brocard C, 2014, CLIN INFECT DIS, V59, P1332, DOI 10.1093/cid/ciu586; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Turner BJ, 2003, J GEN INTERN MED, V18, P248, DOI 10.1046/j.1525-1497.2003.20122.x; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; Whitmore SK, 2012, PEDIATRICS, V129, pE74, DOI 10.1542/peds.2010-3691; Yehia BR, 2013, AIDS BEHAV, P1, DOI [10.1007/s10461-012-0321-z, DOI 10.1007/S10461-012-0321-Z]; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	43	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132262	10.1371/journal.pone.0132262	http://dx.doi.org/10.1371/journal.pone.0132262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132142	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000167
J	Sachdeva, KS; Raizada, N; Gupta, RS; Nair, SA; Denkinger, C; Paramasivan, CN; Kulsange, S; Thakur, R; Dewan, P; Boehme, C; Arinaminpathy, N				Sachdeva, Kuldeep Singh; Raizada, Neeraj; Gupta, Radhey Shyam; Nair, Sreenivas Achuthan; Denkinger, Claudia; Paramasivan, Chinnambedu Nainarappan; Kulsange, Shubhangi; Thakur, Rahul; Dewan, Puneet; Boehme, Catharina; Arinaminpathy, Nimalan			The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; SURVEILLANCE; POPULATION; PREVALENCE; DIAGNOSIS; DELAYS; STATE; CARE	Background In India as elsewhere, multi-drug resistance (MDR) poses a serious challenge in the control of tuberculosis (TB). The End TB strategy, recently approved by the world health assembly, aims to reduce TB deaths by 95% and new cases by 90% between 2015 and 2035. A key pillar of this approach is early diagnosis of tuberculosis, including use of higher-sensitivity diagnostic testing and universal rapid drug susceptibility testing (DST). Despite limitations of current laboratory assays, universal access to rapid DST could become more feasible with the advent of new and emerging technologies. Here we use a mathematical model of TB transmission, calibrated to the TB epidemic in India, to explore the potential impact of a major national scale-up of rapid DST. To inform key parameters in a clinical setting, we take GeneXpert as an example of a technology that could enable such scale-up. We draw from a recent multi-centric demonstration study conducted in India that involved upfront Xpert MTB/ RIF testing of all TB suspects. Results We find that widespread, public-sector deployment of high-sensitivity diagnostic testing and universal DST appropriately linked with treatment could substantially impact MDR-TB in India. Achieving 75% access over 3 years amongst all cases being diagnosed for TB in the public sector alone could avert over 180,000 cases of MDR-TB (95% CI 44187 - 317077 cases) between 2015 and 2025. Sufficiently wide deployment of Xpert could, moreover, turn an increasing MDR epidemic into a diminishing one. Synergistic effects were observed with assumptions of simultaneously improving MDR-TB treatment outcomes. Our results illustrate the potential impact of new and emerging technologies that enable widespread, timely DST, and the important effect that universal rapid DST in the public sector can have on the MDR-TB epidemic in India.	[Sachdeva, Kuldeep Singh; Gupta, Radhey Shyam] Govt India, Cent TB Div, New Delhi, India; [Raizada, Neeraj; Denkinger, Claudia; Paramasivan, Chinnambedu Nainarappan; Kulsange, Shubhangi; Thakur, Rahul; Boehme, Catharina] Fdn Innovat New Diagnost, New Delhi, India; [Nair, Sreenivas Achuthan] WHO, India Country Off, New Delhi, India; [Dewan, Puneet] Bill & Melinda Gates Fdn, New Delhi, India; [Arinaminpathy, Nimalan] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England	Foundation For Innovative New Diagnostics; World Health Organization; Imperial College London	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	drneerajraizada@gmail.com		Arinaminpathy, Nimalan/0000-0001-9502-6876; Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797	United States Agency for International Development; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish	United States Agency for International Development(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the United States Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; Balaji V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009527; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Joseph MR, 2007, INT J TUBERC LUNG D, V11, P443; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Ministry of Health and Family Welfare Government of India, 2014, ANNUAL STATUS REPORT; Ministry of Health and Family Welfare India, 2010, REVISED NATIONAL TUB; Organisation W. H., 2013, GLOB TUB REP 2013, P306; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116721; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105346; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; SERGEEV R, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003815; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Sun AY, 2013, AM J EPIDEMIOL, V178, P1740, DOI 10.1093/aje/kwt210; Theron G, 2013, LANCET, V25, P62073; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; WHO, 2011, TOWARDS UNIVERSAL AC; World Health Organization, 2010, BRIEF HIST TUB CONTR; World Health Organization, 2015, REPORT ON THE PROPOS	38	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131438	10.1371/journal.pone.0131438	http://dx.doi.org/10.1371/journal.pone.0131438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132584	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000118
J	van der Linden, M; Falkenhorst, G; Perniciaro, S; Imohl, M				van der Linden, Mark; Falkenhorst, Gerhard; Perniciaro, Stephanie; Imoehl, Matthias			Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INDIRECT COHORT; IMPACT; EPIDEMIOLOGY; PROTECTION; TRENDS	This study describes the effects of the introduction of universal infant pneumococcal conjugate vaccination in 2006 on invasive pneumococcal disease (IPD) among children and adults in Germany with a focus on the dynamics of serotype distribution in vaccinated and non-vaccinated age groups. Over a period of 22 years (1992-2014), microbiological diagnostic laboratories from all over Germany have been sending isolates of IPD cases to the German National Reference Center for Streptococci on a voluntary basis. Streptococcus pneumoniae isolates were serotyped using Neufeld's Quellung method. Among children <16 years, the proportion of PCV7 serotypes among isolates from IPD cases decreased from 61.8% before vaccination (1997-2006) to 23.5% in the early vaccination period (2007-2010; p = 1.30E-72) and sank further to 5.2% in the late vaccination period (2010-2014; p = 4.59E-25). Similar reductions were seen for the separate age groups <2 years, 2-4 years and 5-15 years. Among adults, the proportion of PCV7 serotypes decreased from 43.4% in the pre-vaccination period (1992-2006) to 24.7% (p = 3.78E-88) in the early vaccination period and 8.2% (p = 5.97E-161) in the late vaccination period. Both among children and among adults, the non-PCV7 serotypes 1, 3, 7F and 19A significantly increased in the early vaccination period. After the switch from PCV7 to PVC10/PCV13 for infant vaccination in 2010, serotypes 1, 6A and 7F significantly decreased. A decrease in serotype 19A was only observed in 2013-2014, as compared to 2010-2011 (children p = 4.16E-04, adults p = 6.98E-06). Among adults, serotype 3, which strongly increased in the early vaccination period (p = 4.44E-15), remained at a constant proportion in the late vaccination period. The proportion of non-PCV13 vaccine serotypes increased over the whole vaccination period, with serotypes 10A, 12F, 23B, 24F and 38 most significantly increasing among children and serotypes 6C, 12F, 15A, 22F and 23B increasing among adults. Eight years of childhood pneumococcal conjugate vaccination have had a strong effect on the pneumococcal population in Germany, both among the target group for vaccination as well as among older children and adults.	[van der Linden, Mark; Perniciaro, Stephanie; Imoehl, Matthias] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany; [Falkenhorst, Gerhard] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Robert Koch Institute	van der Linden, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany.	mlinden@ukaachen.de	van der Linden, Mark/B-9305-2009; Imöhl, Matthias/P-5014-2014; Perniciaro, Stephanie R/J-3669-2017	van der Linden, Mark/0000-0002-6574-4313; Imöhl, Matthias/0000-0002-8372-0251; Perniciaro, Stephanie R/0000-0002-3146-2182	Pfizer Pharma GmbH; Sanofi Pasteur MSD Germany; Robert Koch Institut, Berlin, Germany	Pfizer Pharma GmbH(Pfizer); Sanofi Pasteur MSD Germany; Robert Koch Institut, Berlin, Germany	This study was in part funded by Pfizer Pharma GmbH and Sanofi Pasteur MSD Germany. PneumoWeb is maintained and supported by the Robert Koch Institut, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Camilli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100722; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4; Levy C, 2014, PEDIATR INFECT DIS J, V33, P1216, DOI 10.1097/INF.0000000000000451; Liyanapathirana V, 2015, DIAGN MICR INFEC DIS, V81, P66, DOI 10.1016/j.diagmicrobio.2014.09.028; Myint TTH, 2013, ADV THER, V30, P127, DOI 10.1007/s12325-013-0007-6; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P845, DOI 10.1007/s00103-013-1693-6; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Ruckinger S, 2010, VACCINE, V28, P5012, DOI 10.1016/j.vaccine.2010.05.021; Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Standige Impfkommission ( STIKO), 2006, EP B STIKO, P255; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; (STIKO) S, 2014, EPIDEMIOL B, V2014, P305; Theidel U, 2013, GESUNDHEITSWESEN, V75, P309, DOI 10.1055/s-0032-1321747; Van der Linden M, 2010, 7 INT S PNEUM PNEUM; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; van der Linden M, 2012, VACCINE, V30, P5880, DOI 10.1016/j.vaccine.2012.06.068; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiss S, 2015, EUROSURVEILLANCE, V20, P21057; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	30	89	91	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131494	10.1371/journal.pone.0131494	http://dx.doi.org/10.1371/journal.pone.0131494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132078	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000124
J	Migliaccio, O; Castellano, I; Cirino, P; Romano, G; Palumbo, A				Migliaccio, Oriana; Castellano, Immacolata; Cirino, Paola; Romano, Giovanna; Palumbo, Anna			Maternal Exposure to Cadmium and Manganese Impairs Reproduction and Progeny Fitness in the Sea Urchin Paracentrotus lividus	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; EMBRYO DEVELOPMENT; STRESS-PROTEINS; METALS; EXPRESSION; GENE; LOCALIZATION; RESISTANCE; POLLUTION; TOXICITY	Metal contamination represents one of the major sources of pollution in marine environments. In this study we investigated the short-term effects of ecologically relevant cadmium and manganese concentrations (10(-6) and 3.6 x 10(-5) M, respectively) on females of the sea urchin Paracentrotus lividus and their progeny, reared in the absence or presence of the metal. Cadmium is a well-known heavy metal, whereas manganese represents a potential emerging contaminant, resulting from an increased production of manganese-containing compounds. The effects of these agents were examined on both P. lividus adults and their offspring following reproductive state, morphology of embryos, nitric oxide (NO) production and differential gene expression. Here, we demonstrated that both metals differentially impaired the fertilization processes of the treated female sea urchins, causing modifications in the reproductive state and also affecting NO production in the ovaries. A detailed analysis of the progeny showed a high percentage of abnormal embryos, associated to an increase in the endogenous NO levels and variations in the transcriptional expression of several genes involved in stress response, skeletogenesis, detoxification, multi drug efflux processes and NO production. Moreover, we found significant differences in the progeny from females exposed to metals and reared in metal-containing sea water compared to embryos reared in non-contaminated sea water. Overall, these results greatly expanded previous studies on the toxic effects of metals on P. lividus and provided new insights into the molecular events induced in the progeny of sea urchins exposed to metals.	[Migliaccio, Oriana; Castellano, Immacolata; Palumbo, Anna] Staz Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Cirino, Paola] Staz Zool Anton Dohrn, Marine Resources Res Serv, Naples, Italy; [Romano, Giovanna] Staz Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli	Palumbo, A (corresponding author), Staz Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Villa Comunale, Naples, Italy.	anna.palumbo@szn.it	Castellano, Immacolata/AAD-5523-2019; Romano, Giovanna/F-4561-2015	Romano, Giovanna/0000-0002-4898-7153; Palumbo, Anna/0000-0002-5972-5589; Castellano, Immacolata/0000-0002-4274-6738; Cirino, Paola/0000-0002-0688-4199	Flagship RITMARE-The Italian Research for the Sea-coordinated by the Italian National Research Council; Italian Ministry of Education, University and Research within the National Research Program; SZN PhD fellowship; SZN post doc fellowship	Flagship RITMARE-The Italian Research for the Sea-coordinated by the Italian National Research Council; Italian Ministry of Education, University and Research within the National Research Program(Ministry of Education, Universities and Research (MIUR)); SZN PhD fellowship; SZN post doc fellowship	This work has been partially funded by the Flagship RITMARE-The Italian Research for the Sea-coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013. Oriana Migliaccio has been supported by a SZN PhD fellowship. Immacolata Castellano has been supported by a SZN post doc fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello M, 2007, CELL STRESS CHAPERON, V12, P44, DOI 10.1379/CSC-229R.1; ALLER RC, 1994, J MAR RES, V52, P259, DOI 10.1357/0022240943077091; Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911; Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; ANSTROM JA, 1987, DEVELOPMENT, V101, P255; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF MA IN PRESS; Au DWT, 2001, ENVIRON POLLUT, V111, P11, DOI 10.1016/S0269-7491(00)00036-1; Au DWT, 2001, ENVIRON POLLUT, V111, P1, DOI 10.1016/S0269-7491(00)00035-X; Bayed A, 2005, J MAR BIOL ASSOC UK, V85, P999, DOI 10.1017/S0025315405012026; Beiras R, 2003, CHEMOSPHERE, V52, P1209, DOI 10.1016/S0045-6535(03)00364-3; Bonaventura R, 2005, BIOCHEM BIOPH RES CO, V328, P150, DOI 10.1016/j.bbrc.2004.12.161; Bonaventura R, 2011, CELL STRESS CHAPERON, V16, P681, DOI 10.1007/s12192-011-0277-3; Carballeira C, 2012, MAR ENVIRON RES, V77, P12, DOI 10.1016/j.marenvres.2012.01.001; Chiarelli R, 2014, MAR ENVIRON RES, V93, P47, DOI 10.1016/j.marenvres.2013.06.001; CICAD, 2004, CONC INT CHEM ASS DO, V63; Costa C, 2012, DEV GENES EVOL, V222, P245, DOI 10.1007/s00427-012-0405-9; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Della Torre C, 2012, CHEM-BIOL INTERACT, V198, P9, DOI 10.1016/j.cbi.2012.04.008; Fan A.M., 1996, TOXICOLOGY METALS, P5; Fatoki OS, 2001, WATER SA, V27, P233; Filosto S, 2008, CELL BIOL TOXICOL, V24, P603, DOI 10.1007/s10565-008-9066-x; Foulkes EC, 2000, P SOC EXP BIOL MED, V223, P234, DOI 10.1046/j.1525-1373.2000.22334.x; GEORGE NC, 1991, DEV BIOL, V147, P334, DOI 10.1016/0012-1606(91)90291-A; Giudice G, 1999, DEV GROWTH DIFFER, V41, P375; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hamada T, 1997, APOPTOSIS, V2, P359, DOI 10.1023/A:1026401506914; HARMELIN J-G, 1981, Tethys, V10, P13; Killian CE, 1996, J BIOL CHEM, V271, P9150, DOI 10.1074/jbc.271.15.9150; Kobayashi N, 2005, CHEMOSPHERE, V61, P1198, DOI 10.1016/j.chemosphere.2005.02.071; Kobayashi N, 2004, CHEMOSPHERE, V55, P1403, DOI 10.1016/j.chemosphere.2003.11.052; Kremling K, 2001, DEEP-SEA RES PT I, V48, P2541, DOI 10.1016/S0967-0637(01)00036-X; KURELEC B, 1992, CRIT REV TOXICOL, V22, P23, DOI 10.3109/10408449209145320; Latchman DS, 1999, HANDB EXP PHARM, V136, P1; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Manzo S, 2010, ECOTOXICOLOGY, V19, P1209, DOI 10.1007/s10646-010-0506-z; Marrone V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031750; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Matranga V., 2009, CELLULAR BIOCHEMICAL, P1; Matranga V, 2010, ECOTOXICOLOGY, V19, P530, DOI 10.1007/s10646-009-0444-9; Migliaccio O., 2014, SEA URCHINS HABITAT, P1; Migliaccio O, 2014, AQUAT TOXICOL, V156, P125, DOI 10.1016/j.aquatox.2014.08.007; Naidenko Tamara, 1997, Publications of the Seto Marine Biological Laboratory, V38, P1; Pagano G., 1986, COMMUNITY TOXICITY T, P67; Perez-Lopez M, 2003, J ENVIRON SCI HEAL A, V38, P2845, DOI 10.1081/ESE-120025835; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinsino A, 2014, MAR ENVIRON RES, V93, P64, DOI 10.1016/j.marenvres.2013.08.004; Pinsino A, 2011, TOXICOL SCI, V123, P217, DOI 10.1093/toxsci/kfr152; Pinsino A, 2010, ECOTOXICOLOGY, V19, P555, DOI 10.1007/s10646-009-0432-0; Pohl C, 2005, J MARINE SYST, V56, P207, DOI 10.1016/j.jmarsys.2004.10.001; Quiniou F, 1999, MAR POLLUT BULL, V38, P401, DOI 10.1016/S0025-326X(98)90159-X; Radenac G, 2001, MAR ENVIRON RES, V51, P151, DOI 10.1016/S0141-1136(00)00092-1; Ragusa MA, 2013, MOL BIOL REP, V40, P2157, DOI 10.1007/s11033-012-2275-7; Roccheri MC, 2004, BIOCHEM BIOPH RES CO, V321, P80, DOI 10.1016/j.bbrc.2004.06.108; Roccheri MC, 2001, BIOCHEM BIOPH RES CO, V287, P1093, DOI 10.1006/bbrc.2001.5503; Roesijadi G., 1994, MOL BIOL BIOCH APPRO, P387; Romano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025980; Rottinger E, 2008, DEVELOPMENT, V135, P353, DOI 10.1242/dev.014282; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Russo R, 2003, CELL STRESS CHAPERON, V8, P232, DOI 10.1379/1466-1268(2003)008<0232:STCMBM>2.0.CO;2; Samali A, 1996, EXP CELL RES, V223, P163, DOI 10.1006/excr.1996.0070; Santamaria AB, 2008, INDIAN J MED RES, V128, P484; Soualili D, 2008, ICES J MAR SCI, V65, P132, DOI 10.1093/icesjms/fsm183; Tankere SPC, 1996, MAR POLLUT BULL, V32, P623, DOI 10.1016/0025-326X(96)00025-2; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Trefry J.H., 1984, GEO-MAR LETT, V4, P125, DOI [10.1007/BF02277083, DOI 10.1007/BF02277083]; Vaschenko M.A., 1999, Biologiya Morya (Vladivostok), V25, P96; Vaschenko MA, 2003, RUSS J ECOL+, V34, P418, DOI 10.1023/A:1027368618838; Vaschenko MA, 1999, BIOL MORYA, V20, P137; Warnau M, 1998, J SEA RES, V39, P267, DOI 10.1016/S1385-1101(97)00064-6; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; Zito F, 2003, DEV BIOL, V264, P217, DOI 10.1016/j.ydbio.2003.07.015	72	28	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131815	10.1371/journal.pone.0131815	http://dx.doi.org/10.1371/journal.pone.0131815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125595	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300056
J	Hinz, JM; Mao, P; McNeill, DR; Wilson, DM				Hinz, John M.; Mao, Peng; McNeill, Daniel R.; Wilson, David M., III			Reduced Nuclease Activity of Apurinic/Apyrimidinic Endonuclease ( APE1)Variants on Nucleosomes IDENTIFICATION OF ACCESS RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; URACIL-DNA GLYCOSYLASE; GLUCOCORTICOID RESPONSE ELEMENT; CORE PARTICLES; MAJOR HUMAN; BINDING; APE1; ACCESSIBILITY; COORDINATION; PROTEIN	Non-coding apurinic/apyrimidinic (AP) sites are generated at high frequency in genomic DNA via spontaneous hydrolytic, damage-induced or enzyme-mediated base release. AP endonuclease 1 (APE1) is the predominant mammalian enzyme responsible for initiating removal of mutagenic and cytotoxic abasic lesions as part of the base excision repair (BER) pathway. We have examined here the ability of wild-type (WT) and a collection of variant/mutant APE1 proteins to cleave at an AP site within a nucleosome core particle. Our studies indicate that, in comparison to the WT protein and other variant/mutant enzymes, the incision activity of the tumor-associated variant R237C and the rare population variant G241R are uniquely hypersensitive to nucleosome complexes in the vicinity of the AP site. This defect appears to stem from an abnormal interaction of R237C and G241R with abasic DNA substrates, but is not simply due to a DNA binding defect, as the site-specific APE1 mutant Y128A, which displays markedly reduced AP-DNA complex stability, did not exhibit a similar hypersensitivity to nucleosome structures. Notably, this incision defect of R237C and G241R was observed on a pre-assembled DNA glycosylase.AP-DNA complex as well. Our results suggest that the BER enzyme, APE1, has acquired distinct surface residues that permit efficient processing of AP sites within the context of protein-DNA complexes independent of classic chromatin remodeling mechanisms.	[Hinz, John M.; Mao, Peng] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [McNeill, Daniel R.; Wilson, David M., III] NIA, Lab Mol Gerontol, IRP, NIH, Baltimore, MD 21224 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Hinz, JM (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jmhinz@wsu.edu	Wilson, David M/AAK-5409-2021; Regan, Clinton/E-6250-2012	Wilson, David M/0000-0002-8945-0395; 	National Institutes of Health [ES020955, ES004106, ES002614]; National Institute of Environmental Health Sciences; Intramural Research Program at the National Institutes of Health, NIA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020955, R37ES002614, R01ES004106, R01ES002614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000743, ZIAAG000750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program at the National Institutes of Health, NIA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants ES020955 (to J. M. H.) and ES004106 and ES002614 (to M. Smerdon, Washington State University)), from the National Institute of Environmental Health Sciences, and the Intramural Research Program at the National Institutes of Health, NIA. The authors declare that they have no conflicts of interest with the contents of this article.	Baldwin MR, 2010, BIOCHEMISTRY-US, V49, P7879, DOI 10.1021/bi100889r; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Brenerman BM, 2014, CARCINOGENESIS, V35, P2643, DOI 10.1093/carcin/bgu225; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; Cabelof DC, 2012, CELL MOL LIFE SCI, V69, P727, DOI 10.1007/s00018-011-0839-7; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Chohan M, 2015, J MOL BIOL, V427, P298, DOI 10.1016/j.jmb.2014.12.001; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Illuzzi JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065922; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Kim WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090837; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LI Q, 1995, MOL CELL BIOL, V15, P4375; LIBERTINI LJ, 1980, NUCLEIC ACIDS RES, V8, P3517, DOI 10.1093/nar/8.16.3517; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meira LB, 2001, CANCER RES, V61, P5552; Menoni H, 2012, NUCLEIC ACIDS RES, V40, P692, DOI 10.1093/nar/gkr761; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; Odell ID, 2013, J CELL PHYSIOL, V228, P258, DOI 10.1002/jcp.24134; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017	43	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21067	21075		10.1074/jbc.M115.665547	http://dx.doi.org/10.1074/jbc.M115.665547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134573	Green Published, hybrid			2022-12-26	WOS:000360011800039
J	Hsu, WL; Chung, HW; Wu, CY; Wu, HI; Lee, YT; Chen, EC; Fang, WL; Chang, YC				Hsu, Wei-Lun; Chung, Hui-Wen; Wu, Chih-Yueh; Wu, Huei-Ing; Lee, Yu-Tao; Chen, En-Chan; Fang, Weilun; Chang, Yen-Chung			Glutamate Stimulates Local Protein Synthesis in the Axons of Rat Cortical Neurons by Activating alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors and Metabotropic Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; TRPC CHANNELS; GROWTH CONES; EXCITATORY SYNAPSES; NEUROTROPHIC FACTOR; SIGNALING PATHWAY; HIPPOCAMPAL SLICE; RAPAMYCIN MTOR; P70S6 KINASE	Glutamate is the principal excitatory neurotransmitter in the mammalian CNS. By analyzing the metabolic incorporation of azidohomoalanine, a methionine analogue, in newly synthesized proteins, we find that glutamate treatments up-regulate protein translation not only in intact rat cortical neurons in culture but also in the axons emitting from cortical neurons before making synapses with target cells. The process by which glutamate stimulates local translation in axons begins with the binding of glutamate to the ionotropic AMPA receptors and metabotropic glutamate receptor 1 and members of group 2 metabotropic glutamate receptors on the plasma membrane. Subsequently, the activated mammalian target of rapamycin (mTOR) signaling pathway and the rise in Ca2+, resulting from Ca2+ influxes through calcium-permeable AMPA receptors, voltage-gated Ca2+ channels, and transient receptor potential canonical channels, in axons stimulate the local translation machinery. For comparison, the enhancement effects of brain-derived neurotrophic factor (BDNF) on the local protein synthesis in cortical axons were also studied. The results indicate that Ca2+ influxes via transient receptor potential canonical channels and activated the mTOR pathway in axons also mediate BDNF stimulation to local protein synthesis. However, glutamate-and BDNF-induced enhancements of translation in axons exhibit different kinetics. Moreover, Ca2+ and mTOR signaling appear to play roles carrying different weights, respectively, in transducing glutamate-and BDNF-induced enhancements of axonal translation. Thus, our results indicate that exposure to transient increases of glutamate and more lasting increases of BDNF would stimulate local protein synthesis in migrating axons en route to their targets in the developing brain.	[Hsu, Wei-Lun; Chung, Hui-Wen; Wu, Huei-Ing; Chang, Yen-Chung] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan; [Lee, Yu-Tao; Chen, En-Chan; Fang, Weilun] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu 300, Taiwan; [Wu, Chih-Yueh; Chang, Yen-Chung] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu 300, Taiwan; [Chang, Yen-Chung] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu 300, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Chang, YC (corresponding author), Natl Tsing Hua Univ, Coll Life Sci, 101 Sect 2 Kuang Fu Rd, Hsinchu 300, Taiwan.	ycchang@life.nthu.edu.tw		Hsu, Wei-Lun/0000-0002-3998-9181	National Science Council, Taiwan, Republic of China [NSC 99-2311-B-007-009-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by National Science Council Grant NSC 99-2311-B-007-009-MY3, Taiwan, Republic of China. The authors declare that they have no conflicts of interest with the contents of this article.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Cheng HH, 2006, J NEUROSCI RES, V84, P244, DOI 10.1002/jnr.20898; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; CHOI DW, 1987, J NEUROSCI, V7, P357; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; DJURICIC B, 1994, METAB BRAIN DIS, V9, P235, DOI 10.1007/BF01991197; Eng H, 1999, J NEUROSCI, V19, P1; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Gordon-Weeks P. R., 2005, DEV CELL BIOL SERIES, V37; Gracias NG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4506; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Herkert M, 1998, EUR J NEUROSCI, V10, P1553, DOI 10.1046/j.1460-9568.1998.00164.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hsu YH, 2012, ANAL BIOCHEM, V427, P1, DOI 10.1016/j.ab.2012.04.017; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ibarretxe G, 2007, J NEUROSCI, V27, P7684, DOI 10.1523/JNEUROSCI.1070-07.2007; Inamura N, 2005, J NEUROCHEM, V95, P1438, DOI 10.1111/j.1471-4159.2005.03466.x; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kaplan BB, 2004, ANN NY ACAD SCI, V1018, P244, DOI 10.1196/annals.1296.029; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Kerschensteiner D, 2014, NEUROSCIENTIST, V20, P272, DOI 10.1177/1073858413510044; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kopach O, 2013, BRAIN RES BULL, V93, P47, DOI 10.1016/j.brainresbull.2012.11.004; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; KUMAR RV, 1991, EUR J BIOCHEM, V195, P313, DOI 10.1111/j.1432-1033.1991.tb15708.x; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lushnikova I, 2009, HIPPOCAMPUS, V19, P753, DOI 10.1002/hipo.20551; Marin P, 1997, J NEUROSCI, V17, P3445; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; Melemedjian OK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-70; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Moccia R, 2003, J NEUROSCI, V23, P9409; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Rajan I, 1998, J NEUROSCI, V18, P7836; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; Schenk U, 2003, EMBO J, V22, P558, DOI 10.1093/emboj/cdg059; Schmitz Y, 2009, J NEUROSCI, V29, P11973, DOI 10.1523/JNEUROSCI.2927-09.2009; Seeburg P., 1994, NMDA RECEPTOR, P147; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Takei N, 2009, J BIOL CHEM, V284, P26340, DOI 10.1074/jbc.M109.023010; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; VORNOV JJ, 1991, J NEUROCHEM, V56, P996, DOI 10.1111/j.1471-4159.1991.tb02020.x; Vuppalanchi D, 2012, MOL CELL NEUROSCI, V50, P136, DOI 10.1016/j.mcn.2012.04.001; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang PY, 2011, J NEUROSCI, V31, P9289, DOI 10.1523/JNEUROSCI.5639-10.2011; Wang YY, 2014, MOL CELL NEUROSCI, V61, P141, DOI 10.1016/j.mcn.2014.06.011; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu HI, 2010, LAB CHIP, V10, P647, DOI 10.1039/b918217a; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zheng JQ, 1996, J NEUROSCI, V16, P1140	83	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20748	20760		10.1074/jbc.M115.638023	http://dx.doi.org/10.1074/jbc.M115.638023			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134564	Green Published, hybrid			2022-12-26	WOS:000360011800013
J	Di Rosa, V; Frigato, E; Lopez-Olmeda, JF; Sanchez-Vazquez, FJ; Bertolucci, C				Di Rosa, Viviana; Frigato, Elena; Lopez-Olmeda, Jose F.; Sanchez-Vazquez, Francisco J.; Bertolucci, Cristiano			The Light Wavelength Affects the Ontogeny of Clock Gene Expression and Activity Rhythms in Zebrafish Larvae	PLOS ONE			English	Article							SOLE SOLEA-SENEGALENSIS; CIRCADIAN CLOCK; DANIO-RERIO; TRANSCRIPTION FACTORS; LOCOMOTOR-ACTIVITY; PINEAL-GLAND; IDENTIFICATION; EVOLUTION; SURVIVAL; SPECTRUM	Light plays a key role in synchronizing rhythms and setting the phase of early development. However, to date, little is known about the impact of light wavelengths during the ontogeny of the molecular clock and the behavioural rhythmicity. The aim of this research was to determine the effect of light of different wavelengths (white, blue and red) on the onset of locomotor activity and clock gene (per1b, per2, clock1, bmal1 and dbp) expression rhythms. For this purpose, 4 groups of zebrafish embryo/larvae were raised from 0 to 7 days post-fertilization (dpf) under the following lighting conditions: three groups maintained under light: dark (LD) cycles with white (full visible spectrum, LDW), blue (LDB), or red light (LDR), and one group raised under constant darkness (DD). The results showed that lighting conditions influenced activity rhythms. Larvae were arrhythmic under DD, while under LD cycles they developed wavelength-dependent daily activity rhythms which appeared earlier under LDB (4 dpf) than under LDW or LDR (5 dpf). The results also revealed that development and lighting conditions influenced clock gene expression. While clock1 rhythmic expression appeared in all lighting conditions at 7 dpf, per1b, per2 and dbp showed daily variations already at 3 dpf. Curiously, bmal1 showed consistent rhythmic expression from embryonic stage (0 dpf). Summarizing, the data revealed that daily rhythms appeared earlier in the larvae reared under LDB than in those reared under LDW and LDR. These results emphasize the importance of lighting conditions and wavelengths during early development for the ontogeny of daily rhythms of gene expression and how these rhythms are reflected on the behavioural rhythmicity of zebrafish larvae.	[Di Rosa, Viviana; Lopez-Olmeda, Jose F.; Sanchez-Vazquez, Francisco J.] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Frigato, Elena; Bertolucci, Cristiano] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	University of Murcia; University of Ferrara	Sanchez-Vazquez, FJ (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	javisan@um.es	Lopez-Olmeda, Jose Fernando/K-3848-2014; Bertolucci, Cristiano/H-1916-2015	Lopez-Olmeda, Jose Fernando/0000-0003-4920-5704; Bertolucci, Cristiano/0000-0003-0252-3107	Spanish MINECO [AGL2010-22139-C03-01, AGL2013-49027-C3-1-R]; FEDER fund; MINECO (Juan de la Cierva Program); University of Ferrara (Italy)	Spanish MINECO(Spanish Government); FEDER fund; MINECO (Juan de la Cierva Program)(Spanish Government); University of Ferrara (Italy)	This research was partially financed by the Spanish MINECO through the following projects (AGL2010-22139-C03-01 - "Cronosolea", and AGL2013-49027-C3-1-R - "Solembryo") cofunded with FEDER fund. JFLO was funded through a research fellowship granted by MINECO (Juan de la Cierva Program). EF and CB were supported by funding from the University of Ferrara (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Moshe Z, 2014, NUCLEIC ACIDS RES, V42, P3750, DOI 10.1093/nar/gkt1359; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; Bjorn L. O, 2002, PHOTOBIOLOGY THE SCI; Blanco-Vives B, 2012, J BIOL RHYTHM, V27, P135, DOI 10.1177/0748730411435303; Blanco-Vives B, 2010, AQUACULTURE, V306, P137, DOI 10.1016/j.aquaculture.2010.05.034; Brustein E, 2003, J PHYSIOL-PARIS, V97, P77, DOI 10.1016/j.jphysparis.2003.10.009; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Colwill RM, 2011, BEHAV PROCESS, V86, P222, DOI 10.1016/j.beproc.2010.12.003; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Davie A, 2011, CHRONOBIOL INT, V28, P177, DOI 10.3109/07420528.2010.550407; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fisher N. I., 1993, STAT ANAL; Gachon F, 2007, ANN MED, V39, P562, DOI 10.1080/07853890701491034; Haffter P, 1996, DEVELOPMENT, V123, P1; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Hut RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0433; Idda ML, 2012, PROG BRAIN RES, V199, P41, DOI 10.1016/B978-0-444-59427-3.00003-4; Idda ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034203; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loew E.R., 1990, P1; Lopez-Olmeda JF, 2006, CHRONOBIOL INT, V23, P537, DOI 10.1080/07420520600651065; Lythgoe J.N., 1988, P57; Martin-Robles AJ, 2012, CHRONOBIOL INT, V29, P1195, DOI 10.3109/07420528.2012.719963; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; Mracek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067858; Mracek P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051278; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nusslein-Volhard C., 2002, ZEBRAFISH A PRACTICA; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Ramos BCR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106252; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Vallone D, 2005, ZEBRAFISH, V2, P171, DOI 10.1089/zeb.2005.2.171; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Vera LM, 2010, AQUACULTURE, V307, P29, DOI 10.1016/j.aquaculture.2010.06.028; Vignet C, 2013, ZEBRAFISH, V10, P365, DOI 10.1089/zeb.2013.0871; Villamizar N, 2009, AQUACULTURE, V292, P80, DOI 10.1016/j.aquaculture.2009.03.045; Villamizar N, 2014, ZEBRAFISH, V11, P173, DOI 10.1089/zeb.2013.0926; Vuilleumier R, 2006, ENDOCRINOLOGY, V147, P2273, DOI 10.1210/en.2005-1565; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	60	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132235	10.1371/journal.pone.0132235	http://dx.doi.org/10.1371/journal.pone.0132235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147202	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600224
J	Jung, L; Mourthe, I; Grelle, CEV; Strier, KB; Boubli, JP				Jung, Linda; Mourthe, Italo; Grelle, Carlos E. V.; Strier, Karen B.; Boubli, Jean P.			Effects of Local Habitat Variation on the Behavioral Ecology of Two Sympatric Groups of Brown Howler Monkey (Alouatta clamitans)	PLOS ONE			English	Article							WOOLLY SPIDER MONKEYS; FOREST FRAGMENT; SEASONAL-VARIATIONS; ACTIVITY PATTERN; DIET; NORTHERN; MURIQUIS; PRIMATES; PIGRA; FUSCA	Although the brown howler monkey (Alouatta clamitans) is a relatively well-studied Neotropical primate, its behavioral and dietary flexibility at the intra-population level remains poorly documented. This study presents data collected on the behavior and ecology of two closely located groups of brown howlers during the same period at the RPPN Feliciano Miguel Abdala in southeastern Brazil. One group occupied a primary valley habitat, henceforth the Valley Group (VG), and the other group occupied a regenerating hillside habitat, the Hill Group (HG). We hypothesized differences in the behavior and ecological parameters between these sympatric groups due to the predicted harsher conditions on the hillside, compared to the valley. We measured several habitat parameters within the home range of both groups and collected data on the activity budget, diet and day range lengths, from August to November 2005, between dawn and dusk. In total, behavioral data were collected for 26 (318 h) and 28 (308 h) sampling days for VG and HG, respectively. As we predicted, HG spent significantly more time feeding and consumed less fruit and more leaves than VG, consistent with our finding that the hillside habitat was of lower quality. However, HG also spent less time resting and more time travelling than VG, suggesting that the monkeys had to expend more time and energy to obtain high-energy foods, such as fruits and flowers that were more widely spaced in their hill habitat. Our results revealed that different locations in this forest vary in quality and raise the question of how different groups secure their home ranges. Fine-grained comparisons such as this are important to prioritize conservation and management areas within a reserve.	[Jung, Linda] Thuringian State Inst Agr, Jena, Germany; [Mourthe, Italo] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Grelle, Carlos E. V.] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil; [Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Boubli, Jean P.] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio de Janeiro; University of Wisconsin System; University of Wisconsin Madison; University of Salford	Boubli, JP (corresponding author), Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England.	j.p.boubli@salford.ac.uk	Strier, Karen B./AAJ-3482-2020; Mourthe, Italo/I-9533-2014; Grelle, Carlos EV/A-9687-2017	Mourthe, Italo/0000-0001-6289-6517; boubli, Jean/0000-0002-5833-9264; Strier, Karen/0000-0003-2520-9110	Brazilian Ministry of Environment	Brazilian Ministry of Environment	This research was supported by a grant from the Brazilian Ministry of Environment.	Aguiar LC, 2003, NEOTROPICAL PRIMATES, V11, P78; Almeida-Silva Barbara, 2005, Neotropical Primates, V13, P25; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amato KR, 2014, AM J PRIMATOL, V76, P774, DOI 10.1002/ajp.22268; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Bicca-Marques JC, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P283; Boubli J.P., 2008, Primate Report, V75, P3; Boubli JP, 2011, ECOTROPICA, V17, P53; Boubli JP, 2010, ECOTROPICA, V16, P63; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; Chaves OM, 2013, AM J PRIMATOL, V75, P16, DOI 10.1002/ajp.22075; Chiarello Adriano Garcia, 1994, Oryx, V28, P37; CHIARELLO AG, 1993, PRIMATES, V34, P289, DOI 10.1007/BF02382623; CHIARELLO AG, 1994, PRIMATES, V35, P25, DOI 10.1007/BF02381483; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Clutton-Brock T. H., 1977, P585; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Dunn JC, 2010, INT J PRIMATOL, V31, P887, DOI 10.1007/s10764-010-9436-0; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; Estrada A, 1999, AM J PRIMATOL, V48, P167, DOI 10.1002/(SICI)1098-2345(1999)48:3&lt;167::AID-AJP1&gt;3.0.CO;2-6; Gregorin R, 2006, REV BRAS ZOOL, V23, P64, DOI 10.1590/S0101-81752006000100005; Hatton J., 1984, Oryx, V18, P24; HIXON MA, 1982, AM NAT, V119, P596, DOI 10.1086/283937; Julliot C., 1994, P67; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; Lambert J.E., 2007, PRIMATES PERSPECTIVE, P482, DOI DOI 10.1146/ANNUREV-ANTHRO-102313-025928; LEIGHTON M, 1982, BIOTROPICA, V14, P81, DOI 10.2307/2387735; Lopez GO, 2005, J TROP ECOL, V21, P445, DOI 10.1017/S0266467405002415; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mendes S.L., 1989, Revista Nordestina de Biologia, V6, P71; Milton K, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P5, DOI 10.1007/1-4020-3833-X_2; Milton K, 1998, INT J PRIMATOL, V19, P513, DOI 10.1023/A:1020364523213; Milton K., 1980, FORAGING STRATEGIES; Milton Katharine, 2008, Neotropical Primates, V15, P1, DOI 10.1896/044.015.0101; Miranda João M. D., 2004, Rev. Bras. Zool., V21, P821, DOI 10.1590/S0101-81752004000400016; Mourthe I, 2014, BRAZ J BIOL, V74, P720, DOI 10.1590/bjb.2014.0088; Munoz D, 2006, AM J PRIMATOL, V68, P127, DOI 10.1002/ajp.20211; NAGY KA, 1979, ECOLOGY, V60, P475, DOI 10.2307/1936066; Orihuela G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082197; Palacios E, 2001, AM J PRIMATOL, V55, P233, DOI 10.1002/ajp.1057; Pavelka MSM, 2004, PRIMATES, V45, P105, DOI 10.1007/s10329-003-0072-6; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; R Core Team, 2021, R LANGUAGE ENV STAT; Richard AF, 1985, PRIMATES NATURE; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Serio-Silva JC, 2002, J TROP ECOL, V18, P913, DOI 10.1017/S0266467402002596; Silver SC, 1998, AM J PRIMATOL, V45, P263, DOI 10.1002/(SICI)1098-2345(1998)45:3<263::AID-AJP3>3.0.CO;2-U; Strier Karen B., 2006, Primate Conservation, V20, P53, DOI 10.1896/0898-6207.20.1.53; STRIER KB, 1987, INT J PRIMATOL, V8, P575, DOI 10.1007/BF02735778; STRIER KB, 1991, AM J PRIMATOL, V23, P113, DOI 10.1002/ajp.1350230205; Strier KB, 2001, AM J PRIMATOL, V55, P87, DOI 10.1002/ajp.1042; STRIER KB, 1992, AM J PHYS ANTHROPOL, V88, P515, DOI 10.1002/ajpa.1330880407; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Valle YG, 2001, NEOTROP PRIMATES, V9, P112; Wallace RB, 2005, INT J PRIMATOL, V26, P1053, DOI 10.1007/s10764-005-6458-4	56	12	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129789	10.1371/journal.pone.0129789	http://dx.doi.org/10.1371/journal.pone.0129789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147203	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358157600026
J	Lee, SW; Park, HJ; Jeon, SH; Lee, C; Seong, RH; Park, SH; Hong, S				Lee, Sung Won; Park, Hyun Jung; Jeon, Sung Ho; Lee, Changjin; Seong, Rho Hyun; Park, Se-Ho; Hong, Seokmann			Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; IMMUNE DEVIATION; TRANSGENIC MICE; M2 MACROPHAGES; TH2 CELLS; ACTIVATION; MOUSE; INFLAMMATION; MICROGLIA	Although SWI3-related gene (SRG3), a chromatin remodeling factor, is critical for various biological processes including early embryogenesis and thymocyte development, it is unclear whether SRG3 is involved in the differentiation of CD4(+) T cells, the key mediator of adaptive immune responses. Because it is known that experimental autoimmune encephalomyelitis (EAE) development is determined by the activation of CD4(+) T helper cells, here, we investigated the role of SRG3 in EAE development using SRG3 transgenic mouse models exhibiting two distinct SRG3 expression patterns: SRG3 expression driven by either the CD2 or beta-actin promoter. We found that the outcome of EAE development was completely different depending on the expression pattern of SRG3. The specific over-expression of SRG3 using the CD2 promoter facilitated EAE via the induction of Th1 and Th17 cells, whereas the ubiquitous over-expression of SRG3 using the beta-actin promoter inhibited EAE by promoting Th2 differentiation and suppressing Th1 and Th17 differentiation. In addition, the ubiquitous over-expression of SRG3 polarized CD4(+) T cell differentiation towards the Th2 phenotype by converting dendritic cells (DCs) or macrophages to Th2 types. SRG3 over-expression not only reduced pro-inflammatory cytokine production by DCs but also shifted macrophages from the inducible nitric oxide synthase (iNOS)-expressing M1 phenotype to the arginase-1-expressing M2 phenotype during EAE. In addition, Th2 differentiation in beta-actin-SRG3 Tg mice during EAE was associated with an increase in the basophil and mast cell populations and in IL4 production. Furthermore, the increased frequency of Treg cells in the spinal cord of beta-actin-SRG3 Tg mice might induce the suppression of and accelerate the recovery from EAE symptoms. Taken together, our results provide the first evidence supporting the development of a new therapeutic strategy for EAE involving the modulation of SRG3 expression to induce M2 and Th2 polarization, thereby inhibiting inflammatory immune responses.	[Lee, Sung Won; Park, Hyun Jung; Hong, Seokmann] Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul 143747, South Korea; [Jeon, Sung Ho] Hallym Univ, Dept Life Sci, Chunchon 200702, South Korea; [Lee, Changjin; Seong, Rho Hyun] Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet, Res Ctr Funct Cellul, Seoul 151742, South Korea; [Lee, Sung Won; Park, Se-Ho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Sejong University; Hallym University; Seoul National University (SNU); Korea University	Hong, S (corresponding author), Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul 143747, South Korea.	shong@sejong.ac.kr	Jeon, Sung Ho/B-9728-2009	Seong, Rho/0000-0001-5699-0718	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education [2010-0023683]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education (# 2010-0023683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Akirav EM, 2009, J NEUROSCI RES, V87, P3511, DOI 10.1002/jnr.21981; Almolda B, 2011, FRONT BIOSCI-LANDMRK, V16, P1157, DOI 10.2741/3781; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brooks WH, 2010, J AUTOIMMUN, V34, pJ207, DOI 10.1016/j.jaut.2009.12.006; Cao L, 2013, NEUROSCI BULL, V29, P189, DOI 10.1007/s12264-013-1324-0; Cao Q, 2010, J AM SOC NEPHROL, V21, P933, DOI 10.1681/ASN.2009060592; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Furtado GD, 2001, IMMUNOL REV, V182, P122; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Han D, 2008, DEV BIOL, V315, P136, DOI 10.1016/j.ydbio.2007.12.024; Han SM, 2001, J IMMUNOL, V167, P805, DOI 10.4049/jimmunol.167.2.805; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jeong SM, 2010, J BIOL CHEM, V285, P2340, DOI 10.1074/jbc.M109.026997; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lee SW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/460706; Lee SW, 2013, EXP DERMATOL, V22, P561, DOI 10.1111/exd.12198; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Liblau R, 1997, INT IMMUNOL, V9, P799, DOI 10.1093/intimm/9.5.799; Liu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054841; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Nagelkerken L, 1998, BRAZ J MED BIOL RES, V31, P55, DOI 10.1590/S0100-879X1998000100007; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Sack BK, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.13; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wurster AL, 2011, MOL IMMUNOL, V48, P2178, DOI 10.1016/j.molimm.2011.07.016; Zhang H, 2010, J IMMUNOL, V184, P6629, DOI 10.4049/jimmunol.0904044; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132329	10.1371/journal.pone.0132329	http://dx.doi.org/10.1371/journal.pone.0132329			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147219	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600242
J	Sharma, V; Jordan, JJ; Ciribilli, Y; Resnick, MA; Bisio, A; Inga, A				Sharma, Vasundhara; Jordan, Jennifer J.; Ciribilli, Yari; Resnick, Michael A.; Bisio, Alessandra; Inga, Alberto			Quantitative Analysis of NF-kappa B Transactivation Specificity Using a Yeast-Based Functional Assay	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DNA-BINDING; P53; PROTEINS; PARTHENOLIDE; COMPLEX; MUTAGENESIS; SUBUNITS; DIVERSE; NETWORK	The NF-kappa B transcription factor family plays a central role in innate immunity and inflammation processes and is frequently dysregulated in cancer. We developed an NF-kappa B functional assay in yeast to investigate the following issues: transactivation specificity of NF-kappa B proteins acting as homodimers or heterodimers; correlation between transactivation capacity and in vitro DNA binding measurements; impact of co-expressed interacting proteins or of small molecule inhibitors on NF-kappa B-dependent transactivation. Full-length p65 and p50 cDNAs were cloned into centromeric expression vectors under inducible GAL1 promoter in order to vary their expression levels. Since p50 lacks a transactivation domain (TAD), a chimeric construct containing the TAD derived from p65 was also generated (p50TAD) to address its binding and transactivation potential. The p50TAD and p65 had distinct transactivation specificities towards seventeen different kappa B response elements (kappa B-REs) where single nucleotide changes could greatly impact transactivation. For four kappa B-REs, results in yeast were predictive of transactivation potential measured in the human MCF7 cell lines treated with the NF-kappa B activator TNF alpha. Transactivation results in yeast correlated only partially with in vitro measured DNA binding affinities, suggesting that features other than strength of interaction with naked DNA affect transactivation, although factors such as chromatin context are kept constant in our isogenic yeast assay. The small molecules BAY11-7082 and ethyl-pyruvate as well as expressed IkB alpha protein acted as NF-kappa B inhibitors in yeast, more strongly towards p65. Thus, the yeast-based system can recapitulate NF-kappa B features found in human cells, thereby providing opportunities to address various NF-kappa B functions, interactions and chemical modulators.	[Sharma, Vasundhara; Jordan, Jennifer J.; Ciribilli, Yari; Bisio, Alessandra; Inga, Alberto] Univ Trento, Lab Transcript Networks, Ctr Integrat Biol CIBIO, Trento, Italy; [Resnick, Michael A.] Natl Inst Environm Hlth Sci, Chromosome Stabil Grp, Res Triangle Pk, NC USA	University of Trento; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bisio, A (corresponding author), Univ Trento, Lab Transcript Networks, Ctr Integrat Biol CIBIO, Trento, Italy.	bisio@science.unitn.it; inga@science.unitn.it	Inga, Alberto/AAC-3815-2022; resnick, Michael/F-1668-2019; Ciribilli, Yari/K-2751-2018	Inga, Alberto/0000-0002-8767-1637; resnick, Michael/0000-0002-8473-7506; Ciribilli, Yari/0000-0001-9231-379X; BISIO, Alessandra/0000-0002-3326-1923; Sharma, Vasundhara/0000-0003-4419-7696	intramural project "ADARE" (NIH) [RFA RM 06 004]; Italian Association for Cancer Research, AIRC [IG 12869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065079] Funding Source: NIH RePORTER	intramural project "ADARE" (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research, AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by intramural project "ADARE" to MAR and Jonathan Freedman (NIH, RFA RM 06 004) and partially supported by the Italian Association for Cancer Research, AIRC (IG 12869 to AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020643; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beno I, 2011, NUCLEIC ACIDS RES, V39, P1919, DOI 10.1093/nar/gkq1044; Bergqvist S, 2008, PROTEIN SCI, V17, P2051, DOI 10.1110/ps.037481.108; Bisio A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-552; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Ciribilli Y, 2013, NUCL ACIDS RES; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Epinat JC, 1997, YEAST, V13, P599, DOI 10.1002/(SICI)1097-0061(19970615)13:7<599::AID-YEA109>3.0.CO;2-H; Ethayathulla AS, 2012, P NATL ACAD SCI US; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Han Y, 2004, J PHARM EXP THER; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2012, P NATL ACAD SCI USA, V109, P14387, DOI 10.1073/pnas.1205971109; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; KAMENS J, 1991, NEW BIOL, V3, P1005; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kennedy BK, 2002, NAT REV MOL CELL BIO, V3, P41, DOI 10.1038/nrm704; Krishnan N, 2013, FEBS J, V280, P2830, DOI 10.1111/febs.12283; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Monti P, 2014, ONCOTARGET, V5, P2116, DOI 10.18632/oncotarget.1845; Monti P, 2011, MOL CANCER RES, V9, P271, DOI 10.1158/1541-7786.MCR-10-0496; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Raimondi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069152; Saadane A, 2007, AM J RESP CELL MOL, V36, P728, DOI 10.1165/rcmb.2006-0323OC; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; SIKORSKI RS, 1989, GENETICS, V122, P19; Storici F, 2003, GENET ENG P, V25, P189; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Strickson S, 2013, BIOCHEM J, V451, P427, DOI 10.1042/BJ20121651; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Tomso DJ, 2005, P NATL ACAD SCI USA, V102, P6431, DOI 10.1073/pnas.0501721102; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yeo AT, 2012, CANCER LETT, V318, P53, DOI 10.1016/j.canlet.2011.11.035	57	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130170	10.1371/journal.pone.0130170	http://dx.doi.org/10.1371/journal.pone.0130170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147604	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600031
J	Wen, X; Zhang, DL; Liang, BS; Zhang, RB; Wang, ZJ; Wang, JJ; Liu, M; Huang, RW				Wen, Xue; Zhang, Delong; Liang, Bishan; Zhang, Ruibin; Wang, Zengjian; Wang, Junjing; Liu, Ming; Huang, Ruiwang			Reconfiguration of the Brain Functional Network Associated with Visual Task Demands	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; SMALL-WORLD NETWORKS; TOPOLOGICAL PATTERNS; MOTION ARTIFACT; WORKING-MEMORY; GLOBAL SIGNAL; CONNECTIVITY; FMRI; ORGANIZATION; ACTIVATION	Neuroimaging studies have demonstrated that the topological properties of resting-state brain functional networks are modulated through task performances. However, the reconfiguration of functional networks associated with distinct degrees of task demands is not well understood. In the present study, we acquired fMRI data from 18 healthy adult volunteers during resting-state (RS) and two visual tasks (i.e., visual stimulus watching, VSW; and visual stimulus decision, VSD). Subsequently, we constructed the functional brain networks associated with these three conditions and analyzed the changes in the topological properties (e.g., network efficiency, wiring-cost, modularity, and robustness) among them. Although the small-world attributes were preserved qualitatively across the functional networks of the three conditions, changes in the topological properties were also observed. Compared with the resting-state, the functional networks associated with the visual tasks exhibited significantly increased network efficiency and wiring-cost, but decreased modularity and network robustness. The changes in the task-related topological properties were modulated according to the task complexity (i.e., from RS to VSW and VSD). Moreover, at the regional level, we observed that the increased nodal efficiencies in the visual and working memory regions were positively associated with the increase in task complexity. Together, these results suggest that the increased efficiency of the functional brain network and higher wiring-cost were observed to afford the demands of visual tasks. These observations provide further insights into the mechanisms underlying the reconfiguration of the brain network during task performance.	[Wen, Xue; Liang, Bishan; Zhang, Ruibin; Wang, Zengjian; Wang, Junjing; Liu, Ming; Huang, Ruiwang] S China Normal Univ, Sch Psychol, Ctr Study Appl Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zhang, Delong] Guangdong Prov Hosp Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Delong] Guangzhou Univ Chinese Med, Postdoctoral Mobile Res Stn, Guangzhou, Guangdong, Peoples R China	South China Normal University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Liu, M (corresponding author), S China Normal Univ, Sch Psychol, Ctr Study Appl Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	lium@scnu.edu.cn; ruiwang.huang@gmail.com			National Natural Science Foundation of China [31371049, 81371535, 81428013, 81471654]; National Social Science Foundation of China [BBA110411]; Provincial Department of Construction Project of Key Research Base of Humanities and Social Sciences of China [11JJD190003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; Provincial Department of Construction Project of Key Research Base of Humanities and Social Sciences of China	This study was supported by funding from the National Natural Science Foundation of China under grant numbers 31371049, 81371535, 81428013 and 81471654; the National Social Science Foundation of China under grant number BBA110411; and the Provincial Department of Construction Project of Key Research Base of Humanities and Social Sciences of China under grant number 11JJD190003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bialonski S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022826; Blokland GAM, 2008, BIOL PSYCHOL, V79, P70, DOI 10.1016/j.biopsycho.2008.03.006; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Cao H, 2014, NEUROIMAGE, V84, P888, DOI 10.1016/j.neuroimage.2013.09.013; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Cohen JD, 1997, TEMPORAL DYNAMICS BR; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00493; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drobyshevsky A, 2006, NEUROIMAGE, V31, P732, DOI 10.1016/j.neuroimage.2005.12.016; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hosseini SMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067354; Jiang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082715; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Ma S, 2012, NEUROIMAGE, V62, P1694, DOI 10.1016/j.neuroimage.2012.05.048; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rzucidlo JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070275; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Toppi J, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/130985; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu J, 2013, NEUROSCIENCE, V250, P49, DOI 10.1016/j.neuroscience.2013.06.021; Yan CG, 2010, FRONTIERS SYSTEMS NE, V14, P13, DOI [10.3389/fnsys.2010.00013, DOI 10.3389/FNSYS.2010.00013]; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	64	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132518	10.1371/journal.pone.0132518	http://dx.doi.org/10.1371/journal.pone.0132518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146993	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600294
J	Amano, H; Kato, S; Ito, Y; Eshima, K; Ogawa, F; Takahashi, R; Sekiguchi, K; Tamaki, H; Sakagami, H; Shibuya, M; Majima, M				Amano, Hideki; Kato, Shintaro; Ito, Yoshiya; Eshima, Koji; Ogawa, Fumihiro; Takahashi, Ryo; Sekiguchi, Kazuki; Tamaki, Hideaki; Sakagami, Hiroyuki; Shibuya, Masabumi; Majima, Masataka			The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia	PLOS ONE			English	Article							SELECTIN-MEDIATED INTERACTION; TUMOR-ASSOCIATED ANGIOGENESIS; PROGENITOR CELLS; UP-REGULATION; STEM-CELLS; RECRUITMENT; VEGF; REVASCULARIZATION; ACTIVATION; PLATELETS	Vascular endothelial growth factor (VEGF) is one of the most potent angiogenesis stimulators. VEGF binds to VEGF receptor 1 (VEGFR1), inducing angiogenesis through the receptor's tyrosine kinase domain (TK), but the mechanism is not well understood. We investigated the role of VEGFR1 tyrosine kinase signaling in angiogenesis using the ischemic hind limb model. Relative to control mice, blood flow recovery was significantly impaired in mice treated with VEGFA-neutralizing antibody. VEGFR1 tyrosine kinase knockout mice (TK-/-) had delayed blood flow recovery from ischemia and impaired angiogenesis, and this phenotype was unaffected by treatment with a VEGFR2 inhibitor. Compared to wild typemice (WT), TK-/- mice had no change in the plasma level of VEGF, but the plasma levels of stromal-derived cell factor 1 (SDF-1) and stem cell factor, as well as the bone marrow (BM) level of pro-matrix metalloproteinase-9 (pro-MMP-9), were significantly reduced. The recruitment of cells expressing VEGFR1 and C-X-C chemokine receptor type 4 (CXCR4) into peripheral blood and ischemic muscles was also suppressed. Furthermore, WT transplanted with TK-/- BM significantly impaired blood flow recovery more than WT transplanted with WT BM. These results suggest that VEGFR1-TK signaling facilitates angiogenesis by recruiting CXCR4(+)VEGFR1(+) cells from BM.	[Amano, Hideki; Kato, Shintaro; Ogawa, Fumihiro; Takahashi, Ryo; Sekiguchi, Kazuki; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Kanagawa, Japan; [Ito, Yoshiya] Kitasato Univ, Sch Med, Dept Surg, Kanagawa, Japan; [Eshima, Koji] Kitasato Univ, Sch Med, Dept Immunol, Kanagawa, Japan; [Tamaki, Hideaki; Sakagami, Hiroyuki] Kitasato Univ, Sch Med, Dept Anat, Kanagawa, Japan; [Shibuya, Masabumi] Jobu Univ, Gakubunkan Inst Physiol & Med, Gunma, Japan	Kitasato University; Kitasato University; Kitasato University; Kitasato University	Majima, M (corresponding author), Kitasato Univ, Sch Med, Dept Pharmacol, Kanagawa, Japan.	mmajima@med.kitasato-.u.ac.jp	Ogawa, Fumihiro/AAY-7593-2020; Majima, Masataka/ABH-3063-2021; Ogawa, Fumihiro/AAA-8245-2020; Ogawa, Fumihiro/AAW-5619-2021	Ogawa, Fumihiro/0000-0002-7069-9334	Ministry of Education, Culture, Sports, Science and Technology [21390072, 23592073, 21791331]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, 21390072,23592073 and 21791331.	Amano H, 2005, MOL THER, V12, P716, DOI 10.1016/j.ymthe.2005.03.031; Amano H, 2005, CIRC RES, V97, P337, DOI 10.1161/01.RES.0000179534.17668.f8; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Amano H, 2013, AM J PATHOL, V182, P553, DOI 10.1016/j.ajpath.2012.10.026; Ballard VLT, 2007, CIRC RES, V100, P1116, DOI 10.1161/01.RES.0000261964.19115.e3; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bianco R, 2008, CLIN CANCER RES, V14, P5069, DOI 10.1158/1078-0432.CCR-07-4905; Bleuel H, 1996, PHARMACOLOGY, V52, P329, DOI 10.1159/000139398; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Di Q, 2013, INT J CARDIOL, V168, P2167, DOI 10.1016/j.ijcard.2013.01.240; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1997, ANN NY ACAD SCI, V52, P246; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fong GH, 1996, DEV DYNAM, V207, P1; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Grochot-Przeczek A, 2014, ANTIOXID REDOX SIGN, V20, P1677, DOI 10.1089/ars.2013.5426; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Imoukhuede PI, 2013, AM J PHYSIOL-HEART C, V304, pH1085, DOI 10.1152/ajpheart.00514.2012; Isern Joan, 2011, Curr Osteoporos Rep, V9, P210, DOI 10.1007/s11914-011-0075-y; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Kato S, 2010, J PHARMACOL SCI, V112, P167, DOI 10.1254/jphs.09262FP; Li TS, 2010, J THORAC CARDIOV SUR, V139, P459, DOI 10.1016/j.jtcvs.2009.07.053; Lombardi L, 2013, CRIT REV ONCOL HEMAT, V88, P696, DOI 10.1016/j.critrevonc.2013.08.005; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Matsui Y, 2012, CANCER SCI, V103, P700, DOI 10.1111/j.1349-7006.2012.02200.x; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Murdoch CE, 2014, J BIOL CHEM, V289, P8633, DOI 10.1074/jbc.M113.517219; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Nishi JI, 2008, CIRC RES, V103, P261, DOI 10.1161/CIRCRESAHA.108.174128; Nishida T, 2008, J GASTROENTEROL, V43, P124, DOI 10.1007/s00535-007-2137-6; Ogawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P720, DOI 10.1016/j.bbrc.2009.03.094; Ohkubo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105533; Sato T, 2014, J GASTROENTEROL, V49, P455, DOI 10.1007/s00535-013-0869-z; Sato T, 2013, BIOMED PHARMACOTHER, V67, P607, DOI 10.1016/j.biopha.2013.01.009; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wang F, 2011, J BIOL CHEM, V286, P9097, DOI 10.1074/jbc.M110.165605; Wedge SR, 2002, CANCER RES, V62, P4645; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	54	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131445	10.1371/journal.pone.0131445	http://dx.doi.org/10.1371/journal.pone.0131445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133989	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400048
J	Regal, JF; Lillegard, KE; Bauer, AJ; Elmquist, BJ; Loeks-Johnson, AC; Gilbert, JS				Regal, Jean F.; Lillegard, Kathryn E.; Bauer, Ashley J.; Elmquist, Barbara J.; Loeks-Johnson, Alex C.; Gilbert, Jeffrey S.			Neutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the Rat	PLOS ONE			English	Article							REDUCED UTERINE PERFUSION; ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE INHIBITION; NECROSIS-FACTOR-ALPHA; SPRAGUE-DAWLEY RATS; OXIDATIVE STRESS; COMPLEMENT ACTIVATION; NORMAL-PREGNANCY; BLOOD-PRESSURE; ANGIOGENIC IMBALANCE	Preeclampsia is characterized by reduced placental perfusion with placental ischemia and hypertension during pregnancy. Preeclamptic women also exhibit a heightened inflammatory state and greater number of neutrophils in the vasculature compared to normal pregnancy. Since neutrophils are associated with tissue injury and inflammation, we hypothesized that neutrophils are critical to placental ischemia-induced hypertension and fetal demise. Using the reduced uteroplacental perfusion pressure (RUPP) model of placental ischemia-induced hypertension in the rat, we determined the effect of neutrophil depletion on blood pressure and fetal resorptions. Neutrophils were depleted with repeated injections of polyclonal rabbit anti-rat polymorphonuclear leukocyte (PMN) antibody (antiPMN). Rats received either antiPMN or normal rabbit serum (Control) on 13.5, 15.5, 17.5, and 18.5 days post conception (dpc). On 14.5 dpc, rats underwent either Sham surgery or clip placement on ovarian arteries and abdominal aorta to reduce uterine perfusion pressure (RUPP). On 18.5 dpc, carotid arterial catheters were placed and mean arterial pressure (MAP) was measured on 19.5 dpc. Neutrophil-depleted rats had reduced circulating neutrophils from 14.5 to 19.5 dpc compared to Control, as well as decreased neutrophils in lung and placenta on 19.5 dpc. MAP increased in RUPP Control vs Sham Control rats, and neutrophil depletion attenuated this increase in MAP in RUPP rats without any effect on Sham rats. The RUPP-induced increase in fetal resorptions and complement activation product C3a were not affected by neutrophil depletion. Thus, these data are the first to indicate that neutrophils play an important role in RUPP hypertension and that cells of the innate immune system may significantly contribute to pregnancy-induced hypertension.	[Regal, Jean F.; Lillegard, Kathryn E.; Bauer, Ashley J.; Elmquist, Barbara J.; Loeks-Johnson, Alex C.; Gilbert, Jeffrey S.] Univ Minnesota, Med Sch Duluth, Dept Biomed Sci, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth	Regal, JF (corresponding author), Univ Minnesota, Med Sch Duluth, Dept Biomed Sci, Duluth, MN 55812 USA.	jregal@d.umn.edu		Regal, Jean/0000-0001-5713-0891	National Institutes of Health [R15 HL109843, R25 GM086669]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL109843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health, R15 grant, R15 HL109843, Principal Investigator Jean F. Regal, Co-investigator Jeffrey S Gilbert; National Institutes of Health, R25 GM086669, Principal Investigator Benjamin Clarke, provided stipend funding for undergraduate student Ashley J Bauer to participate in this research at the University of Minnesota Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2001, HYPERTENSION, V37, P485, DOI 10.1161/01.HYP.37.2.485; Alexander BT, 2001, HYPERTENSION, V37, P1191, DOI 10.1161/01.HYP.37.4.1191; Alijotas-Reig J, 2014, PLACENTA, V35, P241, DOI 10.1016/j.placenta.2014.02.004; Banek CT, 2013, AM J PHYSIOL-HEART C, V304, pH1159, DOI 10.1152/ajpheart.00903.2012; Bauer AJ, 2013, HYPERTENSION, V61, P1103, DOI 10.1161/HYPERTENSIONAHA.111.00226; Buhimschi IA, 2001, AM J OBSTET GYNECOL, V184, P686, DOI 10.1067/mob.2001.110448; BUTTERWORTH BH, 1991, BRIT J OBSTET GYNAEC, V98, P929, DOI 10.1111/j.1471-0528.1991.tb13516.x; Cadden KA, 2008, HYPERTENS PREGNANCY, V27, P396, DOI 10.1080/10641950801958067; Clark DA, 1998, J IMMUNOL, V160, P545; Clark P, 1998, SEMIN REPROD ENDOCR, V16, P57; Cornelius DC, 2013, HYPERTENSION, V62, P1068, DOI 10.1161/HYPERTENSIONAHA.113.01514; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Denny KJ, 2013, AM J REPROD IMMUNOL, V69, P3, DOI 10.1111/aji.12000; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; ELFERINK JGR, 1994, BIOCHEM PHARMACOL, V48, P865, DOI 10.1016/0006-2952(94)90356-5; FRASER DG, 1995, J PHARMACOL EXP THER, V273, P793; Gandley RE, 2008, HYPERTENSION, V52, P387, DOI 10.1161/HYPERTENSIONAHA.107.107532; George EM, 2013, AM J HYPERTENS, V26, P924, DOI 10.1093/ajh/hpt045; Gilbert J, 2007, AM J HYPERTENS, V20, P686, DOI 10.1016/j.amjhyper.2006.12.016; Gilbert JS, 2007, HYPERTENSION, V50, P1142, DOI 10.1161/HYPERTENSIONAHA.107.096594; Gilbert JS, 2010, HYPERTENSION, V55, P380, DOI 10.1161/HYPERTENSIONAHA.109.141937; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Gladigau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042176; GREER IA, 1991, OBSTET GYNECOL, V78, P28; Griffin K, 2012, AM J PHYSIOL-RENAL, V302, pF173, DOI 10.1152/ajprenal.00070.2011; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta Anurag Kumar, 2006, Archives of Gynecology and Obstetrics, V273, P239, DOI 10.1007/s00404-005-0093-z; Hartney JM, 2014, CIRC-CARDIOVASC GENE, V7, P659, DOI 10.1161/CIRCGENETICS.113.000504; Hempstock J, 2003, HUM PATHOL, V34, P1265, DOI 10.1016/j.humpath.2003.08.006; Jaremo P, 2000, EUR J CLIN INVEST, V30, P1113, DOI 10.1046/j.1365-2362.2000.00753.x; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Kim JC, 2000, COMP HAEMATOL INT, V10, P74, DOI 10.1007/s005800070011; Kirabo A, 2014, J CLIN INVEST, V124, P4642, DOI 10.1172/JCI74084; LaMarca B, 2008, HYPERTENSION, V52, P1168, DOI 10.1161/HYPERTENSIONAHA.108.120576; LaMarca B, 2008, HYPERTENSION, V52, P1161, DOI 10.1161/HYPERTENSIONAHA.108.120881; LaMarca B, 2013, PHYSIOLOGY, V28, P225, DOI 10.1152/physiol.00006.2013; LaMarca B, 2011, HYPERTENSION, V57, P865, DOI 10.1161/HYPERTENSIONAHA.110.167569; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Leik CE, 2004, HYPERTENSION, V44, P72, DOI 10.1161/01.HYP.0000130483.83154.37; Lillegard KE, 2014, J PHARMACOL EXP THER, V351, P344, DOI 10.1124/jpet.114.218123; Lillegard KE, 2013, MOL IMMUNOL, V56, P91, DOI 10.1016/j.molimm.2013.04.009; Llurba E, 2004, FREE RADICAL BIO MED, V37, P557, DOI 10.1016/j.freeradbiomed.2004.04.035; Lo JO, 2013, CURR OPIN OBSTET GYN, V25, P124, DOI 10.1097/GCO.0b013e32835e0ef5; Lurie S, 1998, GYNECOL OBSTET INVES, V45, P229, DOI 10.1159/000009973; Mattson DL, 2014, AM J PHYSIOL-RENAL, V307, pF499, DOI 10.1152/ajprenal.00258.2014; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Mazor R, 2007, J HYPERTENS, V25, P2249, DOI 10.1097/HJH.0b013e3282dd79b6; Murphy SR, 2013, AM J PHYSIOL-REG I, V304, pR130, DOI 10.1152/ajpregu.00069.2012; Novotny SR, 2012, AM J PHYSIOL-REG I, V302, pR1197, DOI 10.1152/ajpregu.00623.2011; Palei AC, 2013, ACTA PHYSIOL, V208, P224, DOI 10.1111/apha.12106; PITKIN RM, 1979, JAMA-J AM MED ASSOC, V242, P2696, DOI 10.1001/jama.242.24.2696; Pollock DM, 1998, AM J PHYSIOL-REG I, V275, pR1719, DOI 10.1152/ajpregu.1998.275.5.R1719; Proctor LM, 2009, INT IMMUNOPHARMACOL, V9, P800, DOI 10.1016/j.intimp.2009.03.002; Proctor LM, 2004, BRIT J PHARMACOL, V142, P756, DOI 10.1038/sj.bjp.0705819; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Regal JF, 2000, IMMUNOPHARMACOLOGY, V46, P15, DOI 10.1016/S0162-3109(99)00152-6; Rinaldi SF, 2014, J IMMUNOL, V192, P2315, DOI 10.4049/jimmunol.1302891; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Safronova VG, 2003, B EXP BIOL MED+, V136, P257, DOI 10.1023/B:BEBM.0000008977.57795.69; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Searle J, 2011, ARTERIOSCL THROM VAS, V31, P2972, DOI 10.1161/ATVBAHA.111.237784; Sedeek M, 2008, AM J HYPERTENS, V21, P1152, DOI 10.1038/ajh.2008.239; Shukla J, 2014, REPROD SCI, DOI [10.1177/1933719114557899.25394640, DOI 10.1177/1933719114557899.25394640]; Snydal S, 2014, J MIDWIFERY WOM HEAL, V59, P596, DOI 10.1111/jmwh.12260; Ssemaganda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085696; Vonnahme KA, 2005, J PHYSIOL-LONDON, V565, P101, DOI 10.1113/jphysiol.2004.082321; Wallace K, 2014, HYPERTENSION, V64, P1151, DOI 10.1161/HYPERTENSIONAHA.114.03590; Wang W, 2012, HYPERTENSION, V60, P712, DOI 10.1161/HYPERTENSIONAHA.112.191817; Weissgerber TL, 2014, AM J PHYSIOL-REG I, V306, pR796, DOI 10.1152/ajpregu.00544.2013; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110	71	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132063	10.1371/journal.pone.0132063	http://dx.doi.org/10.1371/journal.pone.0132063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135305	gold, Green Published			2022-12-26	WOS:000358154400097
J	Tian, XJ; Long, Y; Wang, J; Zhang, JW; Wang, YY; Li, WM; Peng, YF; Yuan, QH; Pei, XW				Tian, Xin-jie; Long, Yan; Wang, Jiao; Zhang, Jing-wen; Wang, Yan-yan; Li, Wei-min; Peng, Yu-fa; Yuan, Qian-hua; Pei, Xin-wu			De novo Transcriptome Assembly of Common Wild Rice (Oryza rufipogon Griff.) and Discovery of Drought-Response Genes in Root Tissue Based on Transcriptomic Data	PLOS ONE			English	Article							RNA-SEQ DATA; ABIOTIC STRESS; FUNCTIONAL-ANALYSIS; EXPRESSION ANALYSIS; REFERENCE GENOME; SYSTEMS BIOLOGY; CULTIVATED RICE; GRAIN-YIELD; SATIVA L.; TOLERANCE	Background The perennial O. rufipogon (common wild rice), which is considered to be the ancestor of Asian cultivated rice species, contains many useful genetic resources, including drought resistance genes. However, few studies have identified the drought resistance and tissuespecific genes in common wild rice. Results In this study, transcriptome sequencing libraries were constructed, including droughttreated roots (DR) and control leaves (CL) and roots (CR). Using Illumina sequencing technology, we generated 16.75 million bases of high-quality sequence data for common wild rice and conducted de novo assembly and annotation of genes without prior genome information. These reads were assembled into 119,332 unigenes with an average length of 715 bp. A total of 88,813 distinct sequences (74.42% of unigenes) significantly matched known genes in the NCBI NT database. Differentially expressed gene (DEG) analysis showed that 3617 genes were up-regulated and 4171 genes were down-regulated in the CR library compared with the CL library. Among the DEGs, 535 genes were expressed in roots but not in shoots. A similar comparison between the DR and CR libraries showed that 1393 genes were up-regulated and 315 genes were down-regulated in the DR library compared with the CR library. Finally, 37 genes that were specifically expressed in roots were screened after comparing the DEGs identified in the above-described analyses. Conclusion This study provides a transcriptome sequence resource for common wild rice plants and establishes a digital gene expression profile of wild rice plants under drought conditions using the assembled transcriptome data as a reference. Several tissue-specific and drought-stress-related candidate genes were identified, representing a fully characterized transcriptome and providing a valuable resource for genetic and genomic studies in plants.	[Tian, Xin-jie; Yuan, Qian-hua] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou 570228, Peoples R China; [Long, Yan; Wang, Jiao; Zhang, Jing-wen; Wang, Yan-yan; Li, Wei-min; Pei, Xin-wu] Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China; [Peng, Yu-fa] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100094, Peoples R China	Hainan University; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yuan, QH (corresponding author), Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou 570228, Peoples R China.	qhyuan@163.com; peixinwu@caas.cn	Zhang, Jing/GWZ-7332-2022; Pei, Xinwu/AAI-1736-2019; Yuan, Qianhua/A-3336-2015; Wang, Yanbo/HFZ-8018-2022; pei, xinwu/O-7083-2019; wang, yan/GSE-6489-2022; peng, yu/GXW-2071-2022	Pei, Xinwu/0000-0001-7828-3037; Yuan, Qianhua/0000-0002-0443-1567; 	National Special Program of Transgenic Research [2014ZX08011-001]	National Special Program of Transgenic Research	This work was supported by grants from the National Special Program of Transgenic Research (Nos. 2014ZX08011-001).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Dubey S, 2014, FUNCT INTEGR GENOMIC, V14, P401, DOI 10.1007/s10142-014-0361-8; Friedel S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00294; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo CK, 2013, PLANT MOL BIOL, V82, P239, DOI 10.1007/s11103-013-0057-9; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; ISHII T, 1994, GENOME, V37, P217, DOI 10.1139/g94-030; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jeung JU, 2007, THEOR APPL GENET, V115, P1163, DOI 10.1007/s00122-007-0642-x; Ji XM, 2005, PLANT MOL BIOL, V59, P945, DOI 10.1007/s11103-005-2415-8; Jo K, 2014, METHODS, V67, P364, DOI 10.1016/j.ymeth.2014.02.001; Kim H, 2014, J EXP BOT, V65, P453, DOI 10.1093/jxb/ert397; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li DJ, 2002, CHINESE SCI BULL, V47, P1533, DOI 10.1360/02tb9337; Liu AL, 2013, BMB REP, V46, P31, DOI 10.5483/BMBRep.2013.46.1.090; Liu FX, 2003, CHINESE SCI BULL, V48, P2068, DOI 10.1360/03wc0287; Lovisolo C, 2008, NEW PHYTOL, V180, P642, DOI 10.1111/j.1469-8137.2008.02592.x; Ma NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075997; Ma TL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-161; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Minh-Thu PT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-38; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rabello AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-485; Santos AP, 2011, OMICS, V15, P839, DOI 10.1089/omi.2011.0095; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Takehisa H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24409; Takehisa H, 2012, PLANT J, V69, P126, DOI 10.1111/j.1365-313X.2011.04777.x; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Wang F, 2006, PLANT BIOTECHNOL J, V4, P667, DOI 10.1111/j.1467-7652.2006.00210.x; Xiao JH, 1996, NATURE, V384, P223, DOI 10.1038/384223a0; Yamada M, 2005, J EXP BOT, V56, P1975, DOI 10.1093/jxb/eri195; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang QJ, 2014, P NATL ACAD SCI USA, V111, pE4954, DOI 10.1073/pnas.1418307111; Zhang X, 2006, PLANT MOL BIOL, V62, P247, DOI 10.1007/s11103-006-9018-x; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhou LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065139; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383	53	24	29	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131455	10.1371/journal.pone.0131455	http://dx.doi.org/10.1371/journal.pone.0131455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134138	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400049
J	Zhang, S; Zhang, Y; Yang, CH; Ju, ZH; Wang, XG; Jiang, Q; Sun, Y; Huang, JM; Zhong, JF; Wang, CF				Zhang, Shuai; Zhang, Yan; Yang, Chunhong; Ju, Zhihua; Wang, Xiuge; Jiang, Qiang; Sun, Yan; Huang, Jinming; Zhong, Jifeng; Wang, Changfa			The g.-165 T>C Rather than Methylation Is Associated with Semen Motility in Chinese Holstein Bulls by Regulating the Transcriptional Activity of the HIBADH Gene	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SPERM QUALITY TRAITS; GROWTH-HORMONE GENE; 3-HYDROXYISOBUTYRATE DEHYDROGENASE; DNA METHYLATION; EXPRESSION; PROMOTER; MARKERS; IDENTIFICATION; CATABOLISM	The 3-hydroxyisobutyrate dehydrogenase (HIBADH) is regarded as a human sperm-motility marker. However, the molecular mechanisms involved in the regulation of expression of the HIBADH gene in bulls remain largely unknown. HIBADH was detected in the testis, epididymis, and sperm via reverse transcription polymerase chain reaction and Western blot analysis. It is also expressed in the seminiferous epithelium, spermatids, and the entire epididymis, as detected by immunohistochemistry. Furthermore, HIBADH was expressed in the neck-piece and mid-piece of bull spermatids, as shown in the immunofluorescence assay. Using serially truncated bovine HIBADH promoters and luciferase constructs, we discovered an 878 bp (-703 bp to +175 bp) fragment that constitutes the core promoter region. One SNP g.-165 T>C of HIBADH was identified and genotyped in 307 Chinese Holstein bulls. Correlation analysis revealed that bulls with the TT genotype had higher initial sperm motility than those with the CC genotype (P < 0.05). Furthermore, the T- or C-containing loci (designated as pGL3-T and pGL3-C) were transiently transfected into MLTC-1 to test the effect of SNP on HIBADH expression. The luciferase reporter assay showed that the pGL3-T genotype exhibited 58% higher transcriptional activity than the pGL3-C genotype (P < 0.05). The bisulfite sequencing analysis revealed that the methylation pattern of the core promoter presented hypomethylation in the ejaculated semen in high-motility and low-motility bulls. The results demonstrated for the first time that the g.-165 T>C rather than methylation in the 5'-flanking region could affect the bovine sperm motility through the regulation of HIBADH gene transcriptional activity.	[Zhang, Shuai; Zhang, Yan; Yang, Chunhong; Ju, Zhihua; Wang, Xiuge; Jiang, Qiang; Sun, Yan; Huang, Jinming; Zhong, Jifeng; Wang, Changfa] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan 250131, Peoples R China; [Zhang, Shuai] Shandong Normal Univ, Coll Life Sci, Jinan 250014, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Normal University	Wang, CF (corresponding author), Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan 250131, Peoples R China.	wangcf1967@163.com		wang, changfa/0000-0002-5186-1703	Ministry of Science and Technology, P. R. China [2011BAD19B04]; Program of National Cow Industrial Technology System [CARS-37]; Well-bred Program of Shandong Province [2014LZ]	Ministry of Science and Technology, P. R. China(Ministry of Science and Technology, China); Program of National Cow Industrial Technology System; Well-bred Program of Shandong Province	This study was partially supported by the Support Program of the Ministry of Science and Technology, P. R. China (Grant no. 2011BAD19B04), the Program of National Cow Industrial Technology System (Grant no. CARS-37), the Well-bred Program of Shandong Province (Grant no. 2014LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2012, EUR HEART J, V33, P714, DOI 10.1093/eurheartj/ehr473; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cassinello J, 1998, J REPROD FERTIL, V113, P35; Chao HCA, 2011, J ASSIST REPROD GEN, V28, P851, DOI 10.1007/s10815-011-9602-0; Conlon Thomas M., 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-11; Dai LS, 2009, ANIM REPROD SCI, V114, P14, DOI 10.1016/j.anireprosci.2008.08.021; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084355; Gorbai A, 2009, AFR J MICROBIOL RES, V3, P809; Gorbani A, 2009, AFR J BIOTECHNOL, V8, P4811; Guo F, 2014, REPRODUCTION, V147, P241, DOI 10.1530/REP-13-0343; Hering DM, 2014, ANIM REPROD SCI, V146, P89, DOI 10.1016/j.anireprosci.2014.01.012; Huang SY, 2002, ANIM REPROD SCI, V70, P99, DOI 10.1016/S0378-4320(01)00202-0; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Krausz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044479; LEE SHC, 1986, BIOCHEM J, V233, P621, DOI 10.1042/bj2330621; Leushuis E, 2010, FERTIL STERIL, V94, P2631, DOI 10.1016/j.fertnstert.2010.03.021; Lin CL, 2006, ANIM REPROD SCI, V92, P349, DOI 10.1016/j.anireprosci.2005.05.023; Liu XY, 2012, AFR J MICROBIOL RES, V6, P594, DOI 10.5897/AJMR11.1429; Liu XY, 2011, ANIM REPROD SCI, V129, P14, DOI 10.1016/j.anireprosci.2011.10.003; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MARSHALL VD, 1972, J BACTERIOL, V110, P1073, DOI 10.1128/JB.110.3.1073-1081.1972; Martinez-Heredia J, 2008, HUM REPROD, V23, P783, DOI 10.1093/humrep/den024; Mathevon M, 1998, J DAIRY SCI, V81, P3321, DOI 10.3168/jds.S0022-0302(98)75898-9; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Miller MP, 2006, TOOLS FOR POPULATION; Murin R, 2008, J NEUROCHEM, V105, P1176, DOI 10.1111/j.1471-4159.2008.05298.x; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; OldsClarke P, 1996, J ANDROL, V17, P183; Pan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058795; Parmentier I, 1999, DOMEST ANIM ENDOCRIN, V17, P139, DOI 10.1016/S0739-7240(99)00031-4; ROUGRAFF PM, 1989, J BIOL CHEM, V264, P5899; ROUGRAFF PM, 1988, J BIOL CHEM, V263, P327; Saeki M, 2011, MOL GENET METAB, V102, P91, DOI 10.1016/j.ymgme.2010.08.019; Schagdarsurengin U, 2012, NAT REV UROL, V9, P609, DOI 10.1038/nrurol.2012.183; Shi RF, 2003, J SHANGHAI PHYS ED I, V27, P65, DOI DOI 10.16099/j.cnki.jsus.2003.05.027; Tasi YC, 2013, J ASSIST REPROD GEN, V30, P505, DOI 10.1007/s10815-013-9954-8; Wang PQ, 2011, GENET MOL RES, V10, P731, DOI 10.4238/vol10-2gmr1091; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wimmers K, 2005, ANIM GENET, V36, P152, DOI 10.1111/j.1365-2052.2005.01267.x; Yang WC, 2011, MOL BIOL REP, V38, P3411, DOI 10.1007/s11033-010-0450-2; Zhang X, 2014, ANIM GENET, V45, P641, DOI 10.1111/age.12182; Zhao C, 2007, FERTIL STERIL, V87, P436, DOI 10.1016/j.fertnstert.2006.06.057; Zheng WJ, 2004, J BIOL CHEM, V279, P31524, DOI 10.1074/jbc.M400365200	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0127670	10.1371/journal.pone.0127670	http://dx.doi.org/10.1371/journal.pone.0127670			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133183	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400004
J	Zhou, ZH; Diao, QQ; Shao, N; Liang, YK; Lin, L; Lei, Y; Zheng, LM				Zhou, Zhenghua; Diao, Qinqin; Shao, Nan; Liang, Youke; Lin, Li; Lei, Yan; Zheng, Lingmei			The Frequency of Unhealthy Food Advertising on Mainland Chinese Television (TV) and Children and Adolescents' Risk of Exposure to Them	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; MIDDLE-INCOME COUNTRIES; BODY-MASS INDEX; NUTRITION TRANSITION; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; CHRONIC DISEASES; EATING BEHAVIOR; SOFT DRINK; CONSUMPTION	Objective To conduct an analysis of the frequency of unhealthy food advertising on mainland Chinese television (TV) and children and adolescents' risk of exposure to them. Methods The frequencies of all types of advertisements (ads) on forty TV channels in mainland China, the exact ad broadcast times, and the name and brand of all snacks and western fast foods advertised were recorded from 0800 hours to 2400 hours on both a weekday and a weekend day in a week. The difference in the frequencies of the diverse types of ads over eight time intervals (each time interval was 2 hours) were compared, and the trends in ad frequencies during the time intervals were described. Results The TV channels broadcast 155 (91-183) (expressed as median [P-25-P-75]) food ads, 87 (38-123) snack ads, 49 (11-85) beverage ads, and 58 (25-76) ads of snacks suitable for limited consumption (SSLCs) in a day. The proportion of snack ads among food ads (SPF%) was 55.5% (40.3%-71.0%), and the proportion of SSLC ads among snack ads (LPS%) was 67.4% (55.4%-79.3%). The ad frequencies for food, snacks, SSLCs, and beverages demonstrated significant differences among the eight time intervals (all P=0.000). TV channels broadcast the most frequent ads for food, snacks, SSLCs, and beverages during the time interval from 2000 hours to 2200 hours among the eight time intervals. Conclusions Chinese children and adolescents may be at a high risk of exposure to unhealthy food advertising on TV. Reducing the exposure risk strongly requires multisectoral cooperation.	[Zhou, Zhenghua; Diao, Qinqin; Shao, Nan; Liang, Youke; Lin, Li; Lei, Yan; Zheng, Lingmei] North Sichuan Med Coll, Sch Prevent Med, Dept Nutr & Food Hyg, Nanchong 637000, Sichuan, Peoples R China	North Sichuan Medical University	Zhou, ZH (corresponding author), North Sichuan Med Coll, Sch Prevent Med, Dept Nutr & Food Hyg, Nanchong 637000, Sichuan, Peoples R China.	zzhnuph@163.com			North Sichuan Medical College [CBY12-B-ZP08]	North Sichuan Medical College	The present study was supported by the scientific research and development projects of North Sichuan Medical College (CBY12-B-ZP08). ZZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2014, OBES REV, V15, P49, DOI 10.1111/obr.12123; Adams J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031578; Andreyeva T, 2011, ECON HUM BIOL, V9, P221, DOI 10.1016/j.ehb.2011.02.004; Borzekowski DLG, 2001, J AM DIET ASSOC, V101, P42, DOI 10.1016/S0002-8223(01)00012-8; Boyland EJ, 2013, APPETITE, V62, P236, DOI 10.1016/j.appet.2012.01.032; Boyland EJ, 2011, INT J PEDIATR OBES, V6, P455, DOI 10.3109/17477166.2011.608801; Boyland EJ, 2011, PEDIATRICS, V128, pE93, DOI 10.1542/peds.2010-1859; Bureau of Disease Control and Prevention of the Ministry of Health National Institute for Nutrition and Food Safety of Chinese Center for Disease Control and Prevention Chinese Nutrition Society, 2008, GUID SNACKS CHIN CHI, P15; Chan K, 2013, J NUTR THERAPEUTICS, V2, P137; Chen FQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039197, 10.1371/journal.pone.0047380]; Chen RY, 2013, CHINA TV RATING YB 2; Deng RB, 2013, THESIS NANJING NORMA; Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122; Du TT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-327; Duan YF, 2011, CHINESE J HLTH ED, V27, P839; Fan YiOu, 2012, Acta Nutrimenta Sinica, V34, P15; Feng X, 2013, TELEVISION MARKET IN; Galbraith-Emami S, 2013, OBES REV, V14, P960, DOI 10.1111/obr.12060; Galcheva SV, 2008, ARCH DIS CHILD, V93, P857, DOI 10.1136/adc.2007.134437; Gordon-Larsen P, 2014, OBES REV, V15, P37, DOI 10.1111/obr.12121; Goris JM, 2010, PUBLIC HEALTH NUTR, V13, P1003, DOI 10.1017/S1368980009992850; Graff S, 2012, HEALTH AFFAIR, V31, P392, DOI 10.1377/hlthaff.2011.0609; Guran T, 2010, J PAEDIATR CHILD H, V46, P427, DOI 10.1111/j.1440-1754.2010.01753.x; Halford JCG, 2008, INT J PEDIATR OBES, V3, P31, DOI 10.1080/17477160701645152; Halford JCG, 2004, APPETITE, V42, P221, DOI 10.1016/j.appet.2003.11.006; Han E, 2013, APPETITE, V62, P225, DOI 10.1016/j.appet.2012.10.015; Hare-Bruun H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-311; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hawkes C, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00458.x; Huang LY, 2012, HEALTH PROMOT INT, V27, P187, DOI 10.1093/heapro/dar021; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P520, DOI 10.3967/0895-3988.2013.07.002; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P1, DOI 10.3967/0895-3988.2013.01.001; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Kelly B, 2007, PUBLIC HEALTH NUTR, V10, P1234, DOI 10.1017/S1368980007687126; Kelly B, 2011, AUST NZ J PUBL HEAL, V35, P131, DOI 10.1111/j.1753-6405.2011.00612.x; Kelly B, 2010, AM J PUBLIC HEALTH, V100, P1730, DOI 10.2105/AJPH.2009.179267; Klepp KI, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-46; Li Min, 2009, Acta Nutrimenta Sinica, V31, P94; Li Y, 2008, OBES REV, V9, P82, DOI 10.1111/j.1467-789X.2007.00444.x; Li Yuan, 2007, Wei Sheng Yan Jiu, V36, P200; Liu A.L., 2011, CHIN J SCH HLTH, V32, P1415; Liu AL, 2012, CHINESE J SCH HLTH, V33, P644; Liu AL, 2009, CHINESE J HLTH ED, V25, P667; LIU AL, 2009, CHINESE J HLTH ED, V25, P650; Ma GS, 2002, BIOMED ENVIRON SCI, V15, P291; Ma GS, 2011, CHINESE J HLTH ED, V27, P887; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Meng W, 2012, THESIS CHINA JILIANG; Pan XQ, 2011, ACTA PAEDIATR, V100, pE215, DOI 10.1111/j.1651-2227.2011.02369.x; Popkin BM, 2006, OBES REV, V7, P271, DOI 10.1111/j.1467-789X.2006.00230.x; Popkin BM, 2014, OBES REV, V15, P60, DOI 10.1111/obr.12120; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Powell LM, 2007, ARCH PEDIAT ADOL MED, V161, P553, DOI 10.1001/archpedi.161.6.553; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Shang XW, 2012, BIOMED ENVIRON SCI, V25, P125, DOI 10.3967/0895-3988.2012.02.001; Song Yi, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P789; The Central People's Government of the People's Republic of China, 2009, NOT 8 FOOD SAF REG S; The National Bureau of Statistics of the Poeple's Republic of China, 2011, TAB 2010 POP CENS PO; Utter J, 2006, PUBLIC HEALTH NUTR, V9, P606, DOI 10.1079/PHN2005899; Wang H, 2013, OBES REV, V14, P134, DOI 10.1111/obr.12106; Wang N, 2012, CHINESE MED J-PEKING, V125, P1500, DOI 10.3760/cma.j.issn.0366-6999.2012.08.024; Wang ZH, 2012, ASIA PAC J CLIN NUTR, V21, P253; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436; Wu D, 2012, TELEVISION ADVERTISI; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xu F, 2008, PUBLIC HEALTH NUTR, V11, P891, DOI 10.1017/S1368980007001280; Yu Dongmei, 2012, Wei Sheng Yan Jiu, V41, P410; Yu ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051949; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhao W, 2008, OBES REV, V9, P62, DOI 10.1111/j.1467-789X.2007.00440.x; Zhou XX, 2012, TELEVISION MARKET IN	73	6	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0128746	10.1371/journal.pone.0128746	http://dx.doi.org/10.1371/journal.pone.0128746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CS	26133984	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400008
J	Godini, A; Ghasemi, A; Zahediasl, S				Godini, Aliashraf; Ghasemi, Asghar; Zahediasl, Saleh			The Possible Mechanisms of the Impaired Insulin Secretion in Hypothyroid Rats	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; THYROID-HORMONE; GLUCOSE-HOMEOSTASIS; GLUCAGON-SECRETION; CYTOPLASMIC CA2+; TRANSGENIC MICE; MESSENGER-RNA; ISLETS; EXPRESSION; GLUT2	Although the insulin secretion deficit in hypothyroid male rats has been documented, the underling mechanisms of the effect of hypothyroidism on insulin secretion are not clear. Isolated islets of the PTU-induced hypothyroid and control rats were exposed to glibenclamide, acetylcholine, and nifedipine in the presence of glucose concentrations of 2.8 or 8.3 and 16.7 mmol/L. Glucokinase and hexokinase specific activity, glucokinase content, and glucose transporter 2 protein expression were also determined in the isolated islets. Isolated islets from the hypothyroid rats showed a defect in insulin secretion in response to high glucose. In the presence of glibenclamide or acetylcholine, the isolated islets from the hypothyroid and control rats stimulated by glucose concentration of 16.7 mmol/L secreted similar amounts of insulin. In the presence of glucose concentrations of 8.3 mmol/L and 16.7 mmol/L, nifedipine was able to diminish insulin secretion from isolated islets of both groups, indicating that probably the defect may not arise from L type calcium channels or the steps beyond depolarization or the elements involved in the acetylcoline signaling pathway. Glucokinase content and hexokinase specific activity were also the same in the control and hypothyroid groups. On the other hand, glucokinase specific activity and glucose transporter 2 protein expression were significantly (p<0.001 and p<0.01 respectively) lower in the islets isolated from the hypothyroid rats (6.50 +/- 0.46 mU/min/mg protein and 0.55 +/- 0.09 arbitrary unit) compared to the controls (10.93 +/- 0.83 mU/min/mg protein and 0.98 +/- 0.07 arbitrary unit) respectively. In conclusion, the results of this study indicated that hypothyroidism reduced insulin secretion from isolated pancreatic islets, which confirms the finding of the previous studies; in addition, the insulin secretion deficit observed in hypothyroid rats may arise from the abnormalities in some parts of the glucose sensor apparatus of the pancreatic islets including glucokinase activity and glucose transporter 2 protein expression.	[Godini, Aliashraf] Shahid Beheshti Univ Med Sci, Fac Med, Dept Physiol, Tehran, Iran; [Godini, Aliashraf] Shahid Beheshti Univ Med Sci, Fac Med, Neurophysiol Res Ctr, Tehran, Iran; [Ghasemi, Asghar; Zahediasl, Saleh] Shahid Beheshti Univ Med Sci, Endocrine Physiol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Ghasemi, Asghar; Zahediasl, Saleh] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Ghasemi, A (corresponding author), Shahid Beheshti Univ Med Sci, Endocrine Physiol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	Ghasemi@endocrine.ac.ir	Ghasemi, Asghar/O-4145-2017	Ghasemi, Asghar/0000-0001-6867-2151	Research Institute for Endocrine Sciences [447]; Shahid Beheshti University of Medical Sciences, Tehran, Iran	Research Institute for Endocrine Sciences; Shahid Beheshti University of Medical Sciences, Tehran, Iran	This work was supported by a grant (No. 447) from the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran, and contains some parts of the PhD thesis of Mr Aliashraf Godini in physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Blanchet E, 2012, FASEB J, V26, P40, DOI 10.1096/fj.11-186841; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Burcelin R, 2001, DIABETES, V50, P1282, DOI 10.2337/diabetes.50.6.1282; Cerf ME, 2007, MED SCI MONITOR, V13, pRA12; CORTIZO AM, 1985, ACTA PHYSIOL PHARM L, V35, P181; DIAZ GB, 1993, ARCH INT PHYSIOL BIO, V101, P263, DOI 10.3109/13813459309003922; Dillmann WH, 2002, THYROID, V12, P447, DOI 10.1089/105072502760143809; DUMM CLAG, 1984, ACTA ANAT, V119, P241; Eto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104184; FERBER S, 1994, J BIOL CHEM, V269, P11523; Garcia-Flores M, 2001, PFLUG ARCH EUR J PHY, V442, P662, DOI 10.1007/s004240100583; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; GILON P, 1993, J BIOL CHEM, V268, P22265; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Godini A, 2014, HORM METAB RES, V46, P710, DOI 10.1055/s-0034-1370962; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guillam MT, 2000, DIABETES, V49, P1485, DOI 10.2337/diabetes.49.9.1485; Henquin JC, 2004, DIABETES, V53, pS48, DOI 10.2337/diabetes.53.suppl_3.S48; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Karbalaei N, 2013, SCAND J CLIN LAB INV, V73, P87, DOI 10.3109/00365513.2012.743164; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kemp HF, 1997, MOL CELL ENDOCRINOL, V128, P97, DOI 10.1016/S0303-7207(97)04026-4; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LARSSONNYREN G, 1993, BIOSCIENCE REP, V13, P107, DOI 10.1007/BF01145963; Lehtihet M, 2003, AM J PHYSIOL-ENDOC M, V285, pE438, DOI 10.1152/ajpendo.00057.2003; Light P, 1998, J MEMBRANE BIOL, V162, P217; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Miura Y, 1997, ENDOCRINOLOGY, V138, P2769, DOI 10.1210/en.138.7.2769; Miura Y, 2001, TOXICOL APPL PHARM, V174, P1, DOI 10.1006/taap.2001.9185; NARKEWICZ MR, 1990, BIOCHEM J, V271, P585, DOI 10.1042/bj2710585; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; SHIMONI Y, 1995, J PHYSIOL-LONDON, V488, P673, DOI 10.1113/jphysiol.1995.sp020999; Suckale J, 2008, FRONT BIOSCI-LANDMRK, V13, P7156, DOI 10.2741/3218; TAL M, 1992, P NATL ACAD SCI USA, V89, P5744, DOI 10.1073/pnas.89.13.5744; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; Thorens B, 2003, PFLUG ARCH EUR J PHY, V445, P482, DOI 10.1007/s00424-002-0954-2; Thorens B, 2001, MOL MEMBR BIOL, V18, P265, DOI 10.1080/09687680110100995; TONOOKA N, 1980, ENDOCRINOL JAPON, V27, P27; Ueda H, 2003, BIOCHEM BIOPH RES CO, V312, P794, DOI 10.1016/j.bbrc.2003.10.189; VALERA A, 1994, J BIOL CHEM, V269, P28543; WEINSTEIN SP, 1994, ENDOCRINOLOGY, V135, P649, DOI 10.1210/en.135.2.649; Yu Z, 2012, BIO-MED MATER ENG, V22, P49, DOI 10.3233/BME-2012-0689; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zinke A, 2003, EXP CLIN ENDOCR DIAB, V111, P198, DOI 10.1055/s-2003-40463	59	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131198	10.1371/journal.pone.0131198	http://dx.doi.org/10.1371/journal.pone.0131198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132582	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000103
J	Griffing, SM; MacCannell, DR; Schmidtke, AJ; Freeman, MM; Hyytia-Trees, E; Gerner-Smidt, P; Ribot, EM; Bono, JL				Griffing, Sean M.; MacCannell, Duncan R.; Schmidtke, Amber J.; Freeman, Molly M.; Hyytiae-Trees, Eija; Gerner-Smidt, Peter; Ribot, Efrain M.; Bono, James L.			Canonical Single Nucleotide Polymorphisms (SNPs) for High-Resolution Subtyping of Shiga-Toxin Producing Escherichia coli (STEC) O157:H7	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; GENOMIC DIVERSITY; TYPING METHODS; PULSENET; EVOLUTION; SURVEILLANCE; INSERTIONS; DELETIONS; PROTOCOL; SYSTEMS	The objective of this study was to develop a canonical, parsimoniously-informative SNP panel for subtyping Shiga-toxin producing Escherichia coli (STEC) O157:H7 that would be consistent with epidemiological, PFGE, and MLVA clustering of human specimens. Our group had previously identified 906 putative discriminatory SNPs, which were pared down to 391 SNPs based on their prevalence in a test set. The 391 SNPs were screened using a high-throughput form of TaqMan PCR against a set of clinical isolates that represent the most diverse collection of O157:H7 isolates from outbreaks and sporadic cases examined to date. Another 30 SNPs identified by others were also screened using the same method. Two additional targets were tested using standard TaqMan PCR endpoint analysis. These 423 SNPs were reduced to a 32 SNP panel with the almost the same discriminatory value. While the panel partitioned our diverse set of isolates in a manner that was consistent with epidemiological data and PFGE and MLVA phylogenies, it resulted in fewer subtypes than either existing method and insufficient epidemiological resolution in 10 of 47 clusters. Therefore, another round of SNP discovery was undertaken using comparative genomic resequencing of pooled DNA from the 10 clusters with insufficient resolution. This process identified 4,040 potential SNPs and suggested one of the ten clusters was incorrectly grouped. After its removal, there were 2,878 SNPs, of which only 63 were previously identified and 438 occurred across multiple clusters. Among highly clonal bacteria like STEC O157:H7, linkage disequilibrium greatly limits the number of parsimoniously informative SNPs. Therefore, it is perhaps unsurprising that our panel accounted for the potential discriminatory value of numerous other SNPs reported in the literature. We concluded published O157:H7 SNPs are insufficient for effective epidemiological subtyping. However, the 438 multi-cluster SNPs we identified may provide the additional information required.	[Griffing, Sean M.; MacCannell, Duncan R.; Schmidtke, Amber J.; Freeman, Molly M.; Hyytiae-Trees, Eija; Gerner-Smidt, Peter; Ribot, Efrain M.] Ctr Dis Control & Prevent, PulseNet Next Generat Subtyping Methods Unit, Div Foodborne Waterborne & Environm Dis, Enter Dis Lab Branch, Atlanta, GA USA; [Bono, James L.] ARS, US Meat Anim Res Ctr, USDA, Clay Ctr, NE 68933 USA	Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA)	Bono, JL (corresponding author), ARS, US Meat Anim Res Ctr, USDA, Clay Ctr, NE 68933 USA.	Jim.Bono@ars.usda.gov	Trees, Eija/AAY-7538-2020	Trees, Eija/0000-0001-6694-2445; Schmidtke, Amber/0000-0003-3502-9500	American Society Microbiology/CDC Postdoctoral Research Fellowship	American Society Microbiology/CDC Postdoctoral Research Fellowship	Sean Griffing was funded through the support of the American Society Microbiology/CDC Postdoctoral Research Fellowship.	Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bono JL, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-98; Bono JL, 2012, MOL BIOL EVOL, V29, P2047, DOI 10.1093/molbev/mss072; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P258; Clawson ML, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r56; Cooper KLF, 2006, FOODBORNE PATHOG DIS, V3, P51, DOI 10.1089/fpd.2006.3.51; Erickson MC, 2007, J FOOD PROTECT, V70, P2426, DOI 10.4315/0362-028X-70.10.2426; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Gerner-Smidt P, 2005, J FOOD PROTECT, V68, P1926, DOI 10.4315/0362-028X-68.9.1926; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; Kudva IT, 2004, J CLIN MICROBIOL, V42, P2388, DOI 10.1128/JCM.42.6.2388-2397.2004; Kudva IT, 2002, J BACTERIOL, V184, P1873, DOI 10.1128/JB.184.7.1873-1879.2002; Leopold SR, 2010, INFECT GENET EVOL, V10, P1282, DOI 10.1016/j.meegid.2010.07.021; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Ohnishi M, 2002, P NATL ACAD SCI USA, V99, P17043, DOI 10.1073/pnas.262441699; Okinaka RT, 2008, EMERG INFECT DIS, V14, P653, DOI 10.3201/eid1404.070984; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131967	10.1371/journal.pone.0131967	http://dx.doi.org/10.1371/journal.pone.0131967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132731	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000147
J	Heggeseth, B; Harley, K; Warner, M; Jewell, N; Eskenazi, B				Heggeseth, Brianna; Harley, Kim; Warner, Marcella; Jewell, Nicholas; Eskenazi, Brenda			Detecting Associations between Early-Life DDT Exposures and Childhood Growth Patterns: A Novel Statistical Approach	PLOS ONE			English	Article							BODY-MASS INDEX; POLYCHLORINATED-BIPHENYLS; DEVELOPMENTAL TRAJECTORIES; LACTATIONAL EXPOSURE; PRENATAL EXPOSURE; OBESITY; CHILDREN; DICHLORODIPHENYLDICHLOROETHYLENE; DICHLORODIPHENYLTRICHLOROETHANE; OVERWEIGHT	It has been hypothesized that environmental exposures at key development periods such as in utero play a role in childhood growth and obesity. To investigate whether in utero exposure to endocrine-disrupting chemicals, dichlorodiphenyltrichloroethane (DDT) and its metabolite, dichlorodiphenyldichloroethane (DDE), is associated with childhood physical growth, we took a novel statistical approach to analyze data from the CHAMACOS cohort study. To model heterogeneity in the growth patterns, we used a finite mixture model in combination with a data transformation to characterize body mass index (BMI) with four groups and estimated the association between exposure and group membership. In boys, higher maternal concentrations of DDT and DDE during pregnancy are associated with a BMI growth pattern that is stable until about age five followed by increased growth through age nine. In contrast, higher maternal DDT exposure during pregnancy is associated with a flat, relatively stable growth pattern in girls. This study suggests that in utero exposure to DDT and DDE may be associated with childhood BMI growth patterns, not just BMI level, and both the magnitude of exposure and sex may impact the relationship.	[Heggeseth, Brianna] Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA; [Harley, Kim; Warner, Marcella; Eskenazi, Brenda] Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth, Berkeley, CA 94720 USA; [Jewell, Nicholas] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA	Williams College; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Heggeseth, B (corresponding author), Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA.	Brianna.c.Heggeseth@williams.edu			U.S. Environmental Protection Agency (US EPA) [RD83451301, R82670901]; National Institute for Environmental Health Sciences (NIEHS) [P01 ES009605, R01 ES017054]; National Institute for Occupational Safety and Health [R01 OH007400]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH007400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009605, R01ES017054, R01ES021369] Funding Source: NIH RePORTER	U.S. Environmental Protection Agency (US EPA)(United States Environmental Protection Agency); National Institute for Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by U.S. Environmental Protection Agency (US EPA) grants RD83451301 and R82670901, National Institute for Environmental Health Sciences (NIEHS) grants P01 ES009605 and R01 ES017054, and National Institute for Occupational Safety and Health grant R01 OH007400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Barr JR, 2003, J CHROMATOGR B, V794, P137, DOI 10.1016/S1570-0232(03)00451-3; Berkey CS, 2007, ANN EPIDEMIOL, V17, P44, DOI 10.1016/j.annepidem.2006.07.014; Bradman A, 2007, J EXPO SCI ENV EPID, V17, P388, DOI 10.1038/sj.jes.7500525; Carter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047065; Cupul-Uicab LA, 2013, ENVIRON HEALTH PERSP, V121, P1103, DOI 10.1289/ehp.1205901; Cupul-Uicab LA, 2010, ENVIRON RES, V110, P595, DOI 10.1016/j.envres.2010.06.001; De Boor C., 2001, PRACTICAL GUIDE SPLI; de Cock M, 2014, ENVIRON INT, V70, P15, DOI 10.1016/j.envint.2014.04.022; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eskenazi B, 2005, ENVIRON HEALTH PERSP, V113, P1419, DOI 10.1289/ehp.7670; Garced S, 2012, ENVIRON RES, V113, P58, DOI 10.1016/j.envres.2011.12.002; Gladen BC, 2000, J PEDIATR-US, V136, P490, DOI 10.1016/S0022-3476(00)90012-X; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Heggeseth B., 2013, LONGITUDINAL CLUSTER; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jones-Smith JC, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2012.32; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lassiter TL, 2008, ENVIRON HEALTH PERSP, V116, P1456, DOI 10.1289/ehp.11673; Magee CA, 2013, J DEV BEHAV PEDIATR, V34, P165, DOI [10.1097/DBP.0b013e318289aa51., 10.1097/DBP.0b013e318289aa51]; McLachlan G., 2000, WILEY SER PROB STAT; Mendez MA, 2011, ENVIRON HEALTH PERSP, V119, P272, DOI 10.1289/ehp.1002169; Muthen L. K., 2011, MPLUS USERS GUIDE; Newbold RR, 2007, MOL NUTR FOOD RES, V51, P912, DOI 10.1002/mnfr.200600259; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pan IJ, 2010, PAEDIATR PERINAT EP, V24, P262, DOI 10.1111/j.1365-3016.2010.01114.x; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Proust-Lima C, 2014, ICMM ESTIMATION EXTE; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; R Core Team, 2021, R LANGUAGE ENV STAT; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Valvi D, 2012, ENVIRON HEALTH PERSP, V120, P451, DOI 10.1289/ehp.1103862; Ventura AK, 2009, OBESITY, V17, P2067, DOI 10.1038/oby.2009.123; Verhulst SL, 2009, ENVIRON HEALTH PERSP, V117, P122, DOI 10.1289/ehp.0800003; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Warner M, 2014, AM J EPIDEMIOL, V179, P1312, DOI 10.1093/aje/kwu046; Warner M, 2013, ENVIRON HEALTH PERSP, V121, P631, DOI 10.1289/ehp.1205656; Ziyab AH, 2014, J EPIDEMIOL COMMUN H, V68, P934, DOI 10.1136/jech-2014-203808	42	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131443	10.1371/journal.pone.0131443	http://dx.doi.org/10.1371/journal.pone.0131443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125556	gold, Green Published			2022-12-26	WOS:000358151300048
J	Yang, Y; Wu, FY; Zhou, XL				Yang, Yang; Wu, Fuyun; Zhou, Xiaolin			Semantic Processing Persists despite Anomalous Syntactic Category: ERP Evidence from Chinese Passive Sentences	PLOS ONE			English	Article							TEMPORAL STRUCTURE; BRAIN; COMPREHENSION; LANGUAGE; INTEGRATION; HIERARCHY; P600	The syntax-first model and the parallel/interactive models make different predictions regarding whether syntactic category processing has a temporal and functional primacy over semantic processing. To further resolve this issue, an event-related potential experiment was conducted on 24 Chinese speakers reading Chinese passive sentences with the passive marker BEI (NP1 + BEI + NP2 + Verb). This construction was selected because it is the most-commonly used Chinese passive and very much resembles German passives, upon which the syntax-first hypothesis was primarily based. We manipulated semantic consistency (consistent vs. inconsistent) and syntactic category (noun vs. verb) of the critical verb, yielding four conditions: CORRECT (correct sentences), SEMANTIC (semantic anomaly), SYNTACTIC (syntactic category anomaly), and COMBINED (combined anomalies). Results showed both N400 and P600 effects for sentences with semantic anomaly, with syntactic category anomaly, or with combined anomalies. Converging with recent findings of Chinese ERP studies on various constructions, our study provides further evidence that syntactic category processing does not precede semantic processing in reading Chinese.	[Yang, Yang; Wu, Fuyun] Shanghai Int Studies Univ, Inst Linguist, Shanghai 200083, Peoples R China; [Zhou, Xiaolin] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Zhou, Xiaolin] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Zhou, Xiaolin] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Zhou, Xiaolin] Peking Univ, Key Lab Computat Linguist, Minist Educ, Beijing 100871, Peoples R China; [Zhou, Xiaolin] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Shanghai International Studies University; Peking University; Peking University; Peking University; Peking University; Peking University	Wu, FY (corresponding author), Shanghai Int Studies Univ, Inst Linguist, Shanghai 200083, Peoples R China.	fywu@shisu.edu.cn; xz104@pku.edu.cn			Shanghai Municipal Philosophy and Social Sciences Foundation [2010BYY003]; New Century Excellent Talents in University [NCET-12-0907]; Natural Science Foundation of China [30110972, 91232708]; National Basic Research Program of China (973 Program) [2010CB833904]	Shanghai Municipal Philosophy and Social Sciences Foundation; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by grants from Shanghai Municipal Philosophy and Social Sciences Foundation (2010BYY003) and New Century Excellent Talents in University (NCET-12-0907) to the second author, and by grants from the Natural Science Foundation of China (30110972, 91232708) and the National Basic Research Program of China (973 Program: 2010CB833904) to the third author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrilli A, 2002, NEUROSCI LETT, V322, P5, DOI 10.1016/S0304-3940(01)02528-9; Bates E., 1987, MECH LANGUAGE ACQUIS; Boland JE, 1997, LANG COGNITIVE PROC, V12, P423, DOI 10.1080/016909697386808; Chow WY, 2013, BRAIN RES, V1506, P76, DOI 10.1016/j.brainres.2013.02.016; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Fodor J. A, 1983, MODULARITY MIND; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; FRAZIER L, 1978, COGNITION, V6, P291, DOI 10.1016/0010-0277(78)90002-1; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Friederici AD, 1999, MEM COGNITION, V27, P438, DOI 10.3758/BF03211539; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2000, J MEM LANG, V43, P476, DOI 10.1006/jmla.2000.2709; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; HOLCOMB PJ, 1991, PSYCHOBIOLOGY, V19, P286; Huang Y, 2007, CHIN TEACH WORLD, V80, P76; Isel F, 2007, BIOL PSYCHOL, V74, P337, DOI 10.1016/j.biopsycho.2006.09.003; Jiang XM, 2012, NEUROPSYCHOLOGIA, V50, P1918, DOI 10.1016/j.neuropsychologia.2012.04.016; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1282, DOI 10.1016/j.neuropsychologia.2009.01.013; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lu J., 2004, CHIN LINGUIST, V8, P9; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MARSLENWILSON W, 1980, COGNITION, V8, P1, DOI 10.1016/0010-0277(80)90015-3; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Shen J.X., 2009, LINGUIST SCI, V8, P1; Shen Jiaxuan, 2007, J SINO TIBETAN LANGU, V1, P27; Stroud C, 2012, BRAIN LANG, V120, P108, DOI 10.1016/j.bandl.2011.02.001; TARABAN R, 1988, J MEM LANG, V27, P597, DOI 10.1016/0749-596X(88)90011-3; Wang Su-Fang, 2012, Enzyme Res, V2012, P192867, DOI 10.1155/2012/192867; Ye Z, 2006, BRAIN RES, V1071, P186, DOI 10.1016/j.brainres.2005.11.085; Yu J, 2008, NEUROREPORT, V19, P745, DOI 10.1097/WNR.0b013e3282fda21d; Zhang YX, 2013, BRAIN LANG, V126, P8, DOI 10.1016/j.bandl.2013.04.001; Zhang YX, 2010, J EXP PSYCHOL LEARN, V36, P765, DOI 10.1037/a0019254; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001; Zhou XL, 2009, LANG COGNITIVE PROC, V24, P929, DOI 10.1080/01690960903201281	43	12	12	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131936	10.1371/journal.pone.0131936	http://dx.doi.org/10.1371/journal.pone.0131936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BR	26125621	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300064
J	Jiang, TL; Zhao, JM; He, ML; Wang, K; Fowdur, M; Wu, Y				Jiang, Tenglong; Zhao, Jinming; He, Maolin; Wang, Kun; Fowdur, Mitra; Wu, Yang			Outcomes and Treatment of Lumbosacral Spinal Tuberculosis: A Retrospective Study of 53 Patients	PLOS ONE			English	Article							ANTEROLATERAL EXTRAPLEURAL APPROACH; SIMULTANEOUS ANTERIOR DECOMPRESSION; POSTERIOR INSTRUMENTATION; POTTS DISEASE; LUMBAR SPINE; FOLLOW-UP; FUSION; MANAGEMENT; CHILDREN; DEBRIDEMENT	Study Strategy A retrospective clinic study. Purpose To evaluate the efficacy of conservative and surgical treatment for lumbosacral tuberculosis. Methods This study retrospectively reviewed 53 patients with lumbosacral tuberculosis who were treated in our institution between January 2005 and January 2011. There were 29 males and 24 females with average ages of 37.53 +/- 17.28 years (range 6-72 years). 11 patients were given only anti-TB drugs; the remainder underwent anterior debridement, interbody fusion with and without instrumentation, or one-stage anterior debridement combined with posterior instrumentation. Outcome data for these patients included neurologic status, lumbosacral angle, erythrocyte sedimentation rate value(ESR) and C-reactive protein value (CRP) were assessed before and after treatment. Results The mean lumbosacral angles were 23.00 degrees+/-2.90 degrees in the conservatively treated patients and 22.36 degrees+/-3.92o in the surgically treated patients. At the final follow-up, this had improved to 24.10o+/-2.96 degrees in the conservatively treated patients and 28.13 degrees+/-1.93 degrees in the surgically treated patients (all P < 0.05). There were statistically significant differences before and after treatment in terms of ESR and CRP (all P < 0.05). All patients achieved bone fusion. The mean follow-up period was 32.34 +/- 8.13 months (range 18 to 55 months). The neurological deficit did not worsen in any of the patients. Conclusions It has been proven that conservative and surgical treatments are safe and effective and produce good clinical outcomes for patients with lumbosacral tuberculosis. The advantages of operation include thoroughness of debridement, decompression of the spinal cord, and adequate spinal stabilization.	[Jiang, Tenglong; He, Maolin; Wang, Kun; Fowdur, Mitra] Guangxi Med Univ, Affiliated Hosp 1, Div Spinal Surg, Nanning, Guangxi, Peoples R China; [Zhao, Jinming; Wu, Yang] Guangxi Med Univ, Affiliated Hosp 1, Dept Orthoped Trauma & Hand Surg, Nanning, Guangxi, Peoples R China; [Jiang, Tenglong; Zhao, Jinming; He, Maolin; Wang, Kun; Fowdur, Mitra; Wu, Yang] Guangxi Key Lab Regenerat Med, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	He, ML (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Div Spinal Surg, 6 Shuang Yong Rd, Nanning, Guangxi, Peoples R China.	274783289@qq.com			Guangxi Science Funds, China [2012GXNSFAA053087]	Guangxi Science Funds, China	The authors acknowledge support from the Guangxi Science Funds NO. 2012GXNSFAA053087, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GT, 1996, CLIN ORTHOP RELAT R, P225; CAMERON JAP, 1962, AM REV RESPIR DIS, V86, P76; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; HODGSON AR, 1960, BRIT J SURG, V48, P172, DOI 10.1002/bjs.18004820819; Jain AK, 2008, J BONE JOINT SURG BR, V90B, P1477, DOI 10.1302/0301-620X.90B11.20972; Jain AK, 2010, J BONE JOINT SURG BR, V92B, P905, DOI 10.1302/0301-620X.92B7.24668; Jain AK, 2007, CLIN ORTHOP RELAT R, P39, DOI 10.1097/BLO.0b013e318065b7c3; KIRKALDYWILLIS WH, 1965, J BONE JOINT SURG AM, VA 47, P87, DOI 10.2106/00004623-196547010-00005; KONSTAM PG, 1962, BRIT J SURG, V50, P26, DOI 10.1002/bjs.18005021908; Li M, 2011, SPINE J, V11, P726, DOI 10.1016/j.spinee.2011.06.009; Mehta JS, 2001, J BONE JOINT SURG BR, V83B, P859, DOI 10.1302/0301-620X.83B6.11142; Moon MS, 1997, SPINE, V22, P1791, DOI 10.1097/00007632-199708010-00022; MOON MS, 1987, INT ORTHOP, V11, P315, DOI 10.1007/BF00271307; MOON MS, 1995, SPINE, V20, P1910, DOI 10.1097/00007632-199509000-00013; MOON MS, 1996, CLIN ORTHOPAEDICS, V323, P122; Nene Abhay, 2005, Spine J, V5, P79, DOI 10.1016/j.spinee.2004.05.255; NUSSBAUM ES, 1995, J NEUROSURG, V83, P243, DOI 10.3171/jns.1995.83.2.0243; PUN WK, 1990, J BONE JOINT SURG BR, V72, P675, DOI 10.1302/0301-620X.72B4.2143192; Rajasekaran S, 2002, CLIN ORTHOP RELAT R, P85; Rajasekaran S, 1998, SPINE, V23, P1163, DOI 10.1097/00007632-199805150-00018; Rajasekaran S, 2001, J BONE JOINT SURG BR, V83B, P954, DOI 10.1302/0301-620X.83B7.12170; Snider GL, 1997, ANN INTERN MED, V126, P237, DOI 10.7326/0003-4819-126-3-199702010-00011; Sundararaj GD, 2009, J BONE JOINT SURG BR, V91B, P702, DOI 10.1302/0301-620X.91B5.22532; Sundararaj GD, 2003, J BONE JOINT SURG BR, V85B, P100, DOI 10.1302/0301-620X.85B1.13300; Swanson AN, 2006, CLIN ORTHOP RELAT R, P100, DOI 10.1097/01.blo.0000203447.44146.55; Tuli SM, 2007, CLIN ORTHOP RELAT R, P29, DOI 10.1097/BLO.0b013e318065b75e; Wang XY, 2014, EUR SPINE J, V23, P830, DOI 10.1007/s00586-013-3051-7; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	28	19	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130185	10.1371/journal.pone.0130185	http://dx.doi.org/10.1371/journal.pone.0130185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121685	gold, Green Published, Green Submitted			2022-12-26	WOS:000358150400034
J	Zhu, ST; Vik, SB				Zhu, Shaotong; Vik, Steven B.			Constraining the Lateral Helix of Respiratory Complex I by Cross-linking Does Not Impair Enzyme Activity or Proton Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI NDH-1; NADH-QUINONE OXIDOREDUCTASE; CONSERVED CHARGED RESIDUES; UBIQUINONE OXIDOREDUCTASE; 3-DIMENSIONAL STRUCTURE; MEMBRANE DOMAIN; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ATP SYNTHASE; SUBUNIT NUOL	Complex I (NADH: ubiquinone oxidoreductase) is a multisubunit, membrane-bound enzyme of the respiratory chain. The energy from NADH oxidation in the peripheral region of the enzyme is used to drive proton translocation across the membrane. One of the integral membrane subunits, nuoL in Escherichia coli, has an unusual lateral helix of similar to 75 residues that lies parallel to the membrane surface and has been proposed to play a mechanical role as a piston during proton translocation (Efremov, R. G., Baradaran, R., and Sazanov, L. A. (2010) Nature 465, 441-445). To test this hypothesis we have introduced 11 pairs of cysteine residues into Complex I; in each pair one is in the lateral helix, and the other is in a nearby region of subunit N, M, or L. The double mutants were treated with Cu2+ ions or with bi-functional methanethiosulfonate reagents to catalyze cross-link formation in membrane vesicles. The yields of cross-linked products were typically 50-90%, as judged by immunoblotting, but in no case did the activity of Complex I decrease by >10-20%, as indicated by deamino-NADH oxidase activity or rates of proton translocation. In contrast, several pairs of cysteine residues introduced at other interfaces of N:M and M: L subunits led to significant loss of activity, in particular, in the region of residue Glu-144 of subunit M. The results do not support the hypothesis that the lateral helix of subunit L functions like a piston, but rather, they suggest that conformational changes might be transmitted more directly through the functional residues of the proton translocation apparatus.	[Zhu, Shaotong; Vik, Steven B.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	Southern Methodist University	Vik, SB (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	svik@smu.edu	Regan, Clinton/E-6250-2012; zhu, shaotong/ABE-6352-2020	ZHU, SHAOTONG/0000-0002-5066-3166; Vik, Steven/0000-0002-5285-015X	National Institutes of Health [R15GM099014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15GM099014. The authors declare that they have no conflicts of interest with the contents of this article.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Belevich G, 2011, MOL MICROBIOL, V82, P1086, DOI 10.1111/j.1365-2958.2011.07883.x; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Guenebaut V, 1997, J MOL BIOL, V265, P409, DOI 10.1006/jmbi.1996.0753; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kaila VRI, 2014, P NATL ACAD SCI USA, V111, P6988, DOI 10.1073/pnas.1319156111; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; LEONARD K, 1987, J MOL BIOL, V194, P277, DOI 10.1016/0022-2836(87)90375-5; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi T, 2010, NATURE, V465, P428, DOI 10.1038/465428a; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; Sato M, 2013, J BIOL CHEM, V288, P24705, DOI 10.1074/jbc.M113.482968; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steimle S, 2012, FEBS LETT, V586, P699, DOI 10.1016/j.febslet.2012.01.056; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2012, J BIOL CHEM, V287, P42763, DOI 10.1074/jbc.M112.422824; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	40	22	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20761	20773		10.1074/jbc.M115.660381	http://dx.doi.org/10.1074/jbc.M115.660381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134569	Green Published, hybrid			2022-12-26	WOS:000360011800014
J	Cui, XB; Luan, JN; Chen, SY				Cui, Xiao-Bing; Luan, Jun-Na; Chen, Shi-You			RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID SYNTHESIS; SMOOTH-MUSCLE DIFFERENTIATION; ALCOHOLIC LIVER-DISEASE; NEURAL CREST CELLS; INSULIN-RESISTANCE; RESPONSE GENE; TRANSCRIPTION FACTOR; COMPLEMENT 32; SREBP-1C TRANSCRIPTION	Hepatic steatosis is associated with insulin resistance and metabolic syndrome because of increased hepatic triglyceride content. We have reported previously that deficiency of response gene to complement 32 (RGC-32) prevents high-fat diet (HFD)-induced obesity and insulin resistance in mice. This study was conducted to determine the role of RGC-32 in the regulation of hepatic steatosis. We observed that hepatic RGC-32 was induced dramatically by both HFD challenge and ethanol administration. RGC-32 knockout (RGC32(-/-)) mice were resistant to HFD- and ethanol-induced hepatic steatosis. The hepatic triglyceride content of RGC32(-/-) mice was decreased significantly compared with WT controls even under normal chow conditions. Moreover, RGC-32 deficiency decreased the expression of lipogenesis-related genes, sterol regulatory element binding protein 1c (SREBP-1c), fatty acid synthase, and stearoyl-CoA desaturase 1 (SCD1). RGC-32 deficiency also decreased SCD1 activity, as indicated by decreased desaturase indices of the liver and serum. Mechanistically, insulin and ethanol induced RGC-32 expression through the NF-kappa B signaling pathway, which, in turn, increased SCD1 expression in a SREBP-1c-dependent manner. RGC-32 also promoted SREBP-1c expression through activating liver X receptor. These results demonstrate that RGC-32 contributes to the development of hepatic steatosis by facilitating de novo lipogenesis through activating liver X receptor, leading to the induction of SREBP-1c and its target genes. Therefore, RGC-32 may be a potential novel drug target for the treatment of hepatic steatosis and its related diseases.	[Cui, Xiao-Bing; Luan, Jun-Na; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Chen, Shi-You] Hubei Med Univ, Inst Clin Med, Renmin Hosp, Shiyan 442000, Hubei, Peoples R China; [Chen, Shi-You] Hubei Med Univ, Dept Cardiol, Renmin Hosp, Shiyan 442000, Hubei, Peoples R China	University System of Georgia; University of Georgia	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA.	sc229@uga.edu	Regan, Clinton/E-6250-2012; Cui, Xiaobing/B-1583-2017	Cui, Xiaobing/0000-0003-1272-9563	National Institutes of Health [HL119053, HL123302]; National Natural Science Foundation of China [81328002]; American Heart Association [14POST20480015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107526, R01HL119053, R01HL123302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL119053 and HL123302. This work was also supported by National Natural Science Foundation of China Grant 81328002. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by American Heart Association Postdoctoral Fellowship 14POST20480015.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Badea TC, 1998, J BIOL CHEM, V273, P26977, DOI 10.1074/jbc.273.41.26977; Boileau P, 2002, DIABETES, V51, pS343, DOI 10.2337/diabetes.51.2007.S343; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Cui XB, 2015, J ENDOCRINOL, V224, P127, DOI 10.1530/JOE-14-0548; Cui XB, 2013, CARDIOVASC RES, V99, P632, DOI 10.1093/cvr/cvt121; Cui XB, 2012, CARDIOVASC RES, V93, P69, DOI 10.1093/cvr/cvr273; Dobrzyn A, 2005, OBES REV, V6, P169, DOI 10.1111/j.1467-789X.2005.00177.x; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fosbrink M, 2009, EXP MOL PATHOL, V86, P87, DOI 10.1016/j.yexmp.2008.12.005; Ge XD, 2014, J BIOL CHEM, V289, P22672, DOI 10.1074/jbc.M114.552141; Guo SZ, 2014, INT J CLIN EXP MED, V7, P2541; Hofacer R, 2012, PROSTAG LEUKOTR ESS, V86, P71, DOI 10.1016/j.plefa.2011.10.003; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Kim DS, 2011, CANCER-AM CANCER SOC, V117, P590, DOI 10.1002/cncr.25451; Kim E, 2011, DIABETES, V60, P1493, DOI 10.2337/db10-0393; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Li ZG, 2011, J BIOL CHEM, V286, P41323, DOI 10.1074/jbc.M111.259184; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Tateya S, 2013, DIABETES, V62, P1913, DOI 10.2337/db12-0325; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Vlaicu SI, 2010, EXP MOL PATHOL, V88, P67, DOI 10.1016/j.yexmp.2009.10.010; Wada S, 2008, J HEPATOL, V49, P441, DOI 10.1016/j.jhep.2008.04.026; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Xie WB, 2013, CIRC RES, V113, pE76, DOI 10.1161/CIRCRESAHA.113.301921; Yin HQ, 2007, TOXICOL APPL PHARM, V223, P225, DOI 10.1016/j.taap.2007.06.018; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	49	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20387	20395		10.1074/jbc.M114.630186	http://dx.doi.org/10.1074/jbc.M114.630186			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134570	hybrid, Green Published			2022-12-26	WOS:000359608900036
J	Hu, GF; Liu, YM; Zhang, XZ; Yao, FJ; Huang, Y; Ervin, EH; Zhao, BY				Hu, Guofu; Liu, Yiming; Zhang, Xunzhong; Yao, Fengjiao; Huang, Yan; Ervin, Erik H.; Zhao, Bingyu			Physiological Evaluation of Alkali-Salt Tolerance of Thirty Switchgrass (Panicum virgatum) Lines	PLOS ONE			English	Article							SALINITY TOLERANCE; CHLOROPHYLL FLUORESCENCE; OSMOTIC ADJUSTMENT; GAS-EXCHANGE; PHOTOSYNTHESIS; GROWTH; L.; STRESS; SEEDLINGS; GERMINATION	Soil salt-alkalization is a major limiting factor for crop production in many regions. (Panicum virgatum L.) is a warm-season C-4 perennial rhizomatous bunchgrass and a target lignocellulosic biofuel species. The objective of this study was to evaluate relative alkali-salt tolerance among 30 switchgrass lines. Tillers of each switchgrass line were transplanted into pots filled with fine sand. Two months after transplanting, plants at E5 developmental stage were grown in either half strength Hoagland's nutrient solution with 0 mM Na+ (control) or half strength Hoagland's nutrient solution with 150 mM Na+ and pH of 9.5 (alkali-salt stress treatment) for 20 d. Alkali-salt stress damaged cell membranes [higher electrolyte leakage (EL)], reduced leaf relative water content (RWC), net photosynthetic rate (Pn), stomatal conductance (g(s)), and transpiration rate (Tr). An alkali-salt stress tolerance trait index (ASTTI) for each parameter was calculated based on the ratio of the value under alkali-salt stress and the value under non-stress conditions for each parameter of each line. Relative alkali-salt tolerance was determined based on principal components analysis and cluster analysis of the physiological parameters and their ASTTI values. Significant differences in alkali-salt stress tolerance were found among the 30 lines. Lowland lines TEM-SEC, Alamo, TEM-SLC and Kanlow were classified as alkali-salt tolerant. In contrast, three lowland lines (AM-314/MS-155, BN-13645-64) and two upland lines (Caddo and Blackwell-1) were classified as alkali-salt sensitive. The results suggest wide variations exist in alkali-salt stress tolerance among the 30 switchgrass lines. The approach of using a combination of principal components and cluster analysis of the physiological parameters and related ASTTI is feasible for evaluating alkali-salt tolerance in switchgrass.	[Hu, Guofu; Yao, Fengjiao; Huang, Yan] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China; [Hu, Guofu; Liu, Yiming; Zhang, Xunzhong; Ervin, Erik H.] Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA; [Zhao, Bingyu] Virginia Polytech Inst & State Univ, Dept Hort, Blacksburg, VA 24061 USA	Northeast Agricultural University - China; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Hu, GF (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China.	xuzhang@vt.edu; bzhao07@vt.edu			U.S. Department of Energy; U.S. Department of Agriculture's Plant Feedstocks Genomics for Bioenergy Program; Virginia Tech's Virginia Agricultural Experiment Station [VA135872]	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture's Plant Feedstocks Genomics for Bioenergy Program; Virginia Tech's Virginia Agricultural Experiment Station	This work was funded by U.S. Department of Energy and U.S. Department of Agriculture's Plant Feedstocks Genomics for Bioenergy Program (to XZ and BZ). The study was also partially supported by Virginia Tech's Virginia Agricultural Experiment Station (VA135872 to BZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou E, 2008, BIOMASS BIOENERG, V32, P926, DOI 10.1016/j.biombioe.2008.01.015; Ali Z, 2007, S AFR J BOT, V73, P70, DOI 10.1016/j.sajb.2006.08.005; Barney JN, 2010, BIOMASS BIOENERG, V34, P124, DOI 10.1016/j.biombioe.2009.10.009; Cha-um S, 2010, PHILIPP AGRIC SCI, V93, P156; Cha-um S, 2009, AUST J CROP SCI, V3, P221; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083227; Chen W, 2011, PHOTOSYNTHETICA, V49, P417, DOI 10.1007/s11099-011-0050-y; Comis D, 2006, AGR RES, V6, P1169; [杜菲 Du Fei], 2011, [草地学报, Acta Agrestia Sinica], V19, P1018; [范希峰 FAN Xi-feng], 2010, [草业科学, Pratacultural Science], V27, P97; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Gerloff-Elias A, 2005, PLANT CELL ENVIRON, V28, P1218, DOI 10.1111/j.1365-3040.2005.01357.x; Guo R, 2011, CAN J PLANT SCI, V91, P1077, DOI [10.4141/CJPS10167, 10.4141/cjps10167]; Hardin CF, 2013, BIOENERG RES, V6, P755, DOI 10.1007/s12155-012-9292-1; Hoagland DR, 1950, CIRCULAR CALIF AGR E, V247; Houimli SIM, 2010, EUR ASIA J BIO SCI, V4, DOI [10.5053/ejobios.2010.4.0.12, DOI 10.5053/ejobios.2010.4.0.12]; Kanwal H, 2011, PAK J BOT, V43, P2693; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Kim S, 2012, BIOENERG RES, V5, P225, DOI 10.1007/s12155-011-9145-3; Kong-ngern Kanlaya, 2012, International Journal of Botany, V8, P54, DOI 10.3923/ijb.2012.54.65; Li R, 2010, ENVIRON EXP BOT, V68, P66, DOI 10.1016/j.envexpbot.2009.10.004; Li SS, 2012, J HUNAN AGR U, V6, P580; Liu YM, 2014, BIOENERG RES, V7, P1329, DOI 10.1007/s12155-014-9466-0; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Marcum KB, 1998, CROP SCI, V38, P1414; McLaughlin SB, 1998, BIOMASS BIOENERG, V14, P317, DOI 10.1016/S0961-9534(97)10066-6; McLaughlin SB, 1992, P ANN AUT TECHN DEV, P111; Mohsenian Y, 2012, PHOTOSYNTHETICA, V50, P411, DOI 10.1007/s11099-012-0054-2; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Netondo GW, 2004, CROP SCI, V44, P806, DOI 10.2135/cropsci2004.0806; Peng YL, 2008, J INTEGR PLANT BIOL, V50, P29, DOI 10.1111/j.1744-7909.2007.00607.x; Rao PS, 2008, PLANT BREEDING, V127, P256, DOI 10.1111/j.1439-0523.2007.01455.x; SAS Institute Inc., 2010, SAS V 9 3; Shahzad A, 2012, GENET MOL RES, V11, P679, DOI 10.4238/2012.March.19.2; Shi DC, 2005, PLANT SOIL, V271, P15, DOI 10.1007/s11104-004-1307-z; Shi DC, 2005, ENVIRON EXP BOT, V54, P8, DOI 10.1016/j.envexpbot.2004.05.003; Shi De-Cheng, 1992, Acta Botanica Sinica, V34, P386; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; Shi DeCheng, 1997, Acta Prataculturae Sinica, V6, P51; Srivastava AC, 2010, BIOENERG RES, V3, P278, DOI 10.1007/s12155-010-9080-8; Sumner ME, 1998, SODIC SOILS DISTRIBU; Tang C, 1999, AUST J EXP AGR, V39, P457, DOI 10.1071/EA98132; Tanji K.K., 1990, AGR SALINITY ASSESSM, P1; Tavakkoli E, 2012, J EXP BOT, V63, P3853, DOI 10.1093/jxb/ers085; Thomson JA, 2002, BOT J LINN SOC, V140, P237, DOI 10.1046/j.1095-8339.2002.00089.x; Wani AS, 2013, SAUDI J BIOL SCI, V20, P183, DOI 10.1016/j.sjbs.2013.01.006; WEATHERLEY P. E., 1950, NEW PHYTOL, V49, P81, DOI 10.1111/j.1469-8137.1950.tb05146.x; Wu ZH, 2014, PHOTOSYNTHETICA, V52, P157, DOI 10.1007/s11099-014-0002-4; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Yuan Y, 2014, BIORESOURCE TECHNOL, V174, P1, DOI 10.1016/j.biortech.2014.07.104	52	17	18	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0125305	10.1371/journal.pone.0125305	http://dx.doi.org/10.1371/journal.pone.0125305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146987	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600006
J	Woldesenbet, S; Jackson, D; Lombard, C; Dinh, TH; Puren, A; Sherman, G; Ramokolo, V; Doherty, T; Mogashoa, M; Bhardwaj, S; Chopra, M; Shaffer, N; Pillay, Y; Goga, A				Woldesenbet, Selamawit; Jackson, Debra; Lombard, Carl; Dinh, Thu-Ha; Puren, Adrian; Sherman, Gayle; Ramokolo, Vundli; Doherty, Tanya; Mogashoa, Mary; Bhardwaj, Sanjana; Chopra, Mickey; Shaffer, Nathan; Pillay, Yogan; Goga, Ameena		South African PMTCT Evaluation SAP	Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE)	PLOS ONE			English	Article							IMMUNIZATION CLINICS; HIV; PREGNANCY; WOMEN; CAPE	Objectives We examined uptake of prevention of mother-to-child HIV transmission (PMTCT) services, predictors of missed opportunities, and infant HIV transmission attributable to missed opportunities along the PMTCT cascade across South Africa. Methods A cross-sectional survey was conducted among 4-8 week old infants receiving first immunisations in 580 nationally representative public health facilities in 2010. This included maternal interviews and testing infants' dried blood spots for HIV. A weighted analysis was performed to assess uptake of antenatal and perinatal PMTCT services along the PMTCT cascade (namely: maternal HIV testing, CD4 count test/result, and receiving maternal and infant antiretroviral treatment) and predictors of dropout. The population attributable fraction associated with dropouts at each service point are estimated. Results Of 9,803 mothers included, 31.7% were HIV-positive as identified by reactive infant antibody tests. Of these 80.4% received some form of maternal and infant antiretroviral treatment. More than a third (34.9%) of mothers dropped out from one or more steps in the PMTCT service cascade. In a multivariable analysis, the following characteristics were associated with increased dropout from the PMTCT cascade: adolescent (<20 years) mothers, low socioeconomic score, low education level, primiparous mothers, delayed first antenatal visit, homebirth, and non-disclosure of HIV status. Adolescent mothers were twice (adjusted odds ratio: 2.2, 95% confidence interval: 1.5-3.3) as likely to be unaware of their HIV-positive status and had a significantly higher rate (85.2%) of unplanned pregnancies compared to adults aged >= 20 years (55.5%, p = 0.0001). A third (33.8%) of infant HIV infections were attributable to dropout in one or more steps in the cascade. Conclusion A third of transmissions attributable to missed opportunities of PMTCT services can be prevented by optimizing the uptake of PMTCT services. Identified risk factors for low PMTCT service uptake should be addressed through health facility and community-level interventions, including raising awareness, promoting women education, adolescent focused interventions, and strengthening linkages/referral-system between communities and health facilities.	[Woldesenbet, Selamawit; Lombard, Carl; Ramokolo, Vundli; Doherty, Tanya] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Jackson, Debra; Doherty, Tanya; Chopra, Mickey] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Jackson, Debra; Chopra, Mickey] United Nations Childrens Fund, New York, NY USA; [Dinh, Thu-Ha] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Puren, Adrian; Sherman, Gayle] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [Puren, Adrian] Univ Witwatersrand, Fac Hlth Sci, Div Virol & Communicable Dis, Johannesburg, South Africa; [Sherman, Gayle] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa; [Doherty, Tanya] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Mogashoa, Mary] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Pretoria, South Africa; [Bhardwaj, Sanjana] United Nations Childrens Fund, Pretoria, South Africa; [Shaffer, Nathan] World Hlth Org, Geneva, Switzerland; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Goga, Ameena] Univ Pretoria, Dept Paediat & Child Hlth, ZA-0002 Pretoria, South Africa; [Goga, Ameena] MRC, Hlth Syst Res Unit, Pretoria, South Africa	University of the Western Cape; UNICEF; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; World Health Organization; University of Pretoria	Woldesenbet, S (corresponding author), MRC, Hlth Syst Res Unit, Cape Town, South Africa.	woldeselam@gmail.com	Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Jackson, Debra/0000-0003-3307-632X; ramokolo, vundli/0000-0002-9596-1909; Lombard, Carl/0000-0002-2136-6533	CDC [1U2GPS001137-02, 1U2GPS001137-03]; United Nations Children's Fund (UNICEF); National Department of Health, South Africa; South Africa National Research Foundation; South African Centre for Epidemiological Modelling and Analysis (SACEMA); African Doctoral Dissertation Research Fellowship; MRC [1U2GPS001137-02, 1U2GPS001137-03]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United Nations Children's Fund (UNICEF); National Department of Health, South Africa; South Africa National Research Foundation(National Research Foundation - South Africa); South African Centre for Epidemiological Modelling and Analysis (SACEMA); African Doctoral Dissertation Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the President's Emergency Plan for AIDS Relief under the Cooperative Agreement between CDC and MRC (1U2GPS001137-02 and 1U2GPS001137-03)- A, The United Nations Children's Fund (UNICEF) - A, National Department of Health, South Africa-A, South Africa National Research Foundation-D, South African Centre for Epidemiological Modelling and Analysis (SACEMA) - S, African Doctoral Dissertation Research Fellowship-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, S AFRICAS NEW HIGHLY; [Anonymous], 2013, GLOBAL REPORT UNAIDS; [Anonymous], 2009, NATL ANTENATL SENTIN; Basu S, 1995, AM J EPIDEMIOL, V142, P1338, DOI 10.1093/oxfordjournals.aje.a117602; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fatti G., 2014, 4 INT WORKSH HIV WOM; Goga A., 2011, SAPMTCTE REPORT EARL; Goga A., 2014, J EPIDEMIOL COMMUNIT; Goga A, 2010, EVALUATION EFFECTIVE; Horwood C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074568; Horwood C, 2012, B WORLD HEALTH ORGAN, V90, P168, DOI 10.2471/BLT.11.092056; Hussain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027907; Jones DL, 2013, AIDS CARE, V25, P702, DOI 10.1080/09540121.2013.772280; Kim HY, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-138; Marazzi M., 2009, 5 INT AIDS SOC C HIV; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; NDOH, POLICY GUIDELINES IM; Reagon G., 2003, NATL PRIMARY HLTH CA; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Stinson K., 2014, LAY HLTH WORKER SUPP; Stinson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063328; Stinson K, 2012, JAIDS-J ACQ IMM DEF, V60, P199, DOI 10.1097/QAI.0b013e31824d985e; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Villar-Loubet OM, 2013, CULT HEALTH SEX, V15, P253, DOI 10.1080/13691058.2012.716166; World Health Organization, 2012, GUIDANCE COUPLES HIV	28	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132425	10.1371/journal.pone.0132425	http://dx.doi.org/10.1371/journal.pone.0132425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147598	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600265
J	Chang, YC; Lamichhane, AK; Bradley, J; Rodgers, L; Ngamskulrungroj, P; Kwon-Chung, KJ				Chang, Yun C.; Lamichhane, Ami Khanal; Bradley, James; Rodgers, Laura; Ngamskulrungroj, Popchai; Kwon-Chung, Kyung J.			Differences between Cryptococcus neoformans and Cryptococcus gattii in the Molecular Mechanisms Governing Utilization of D-Amino Acids as the Sole Nitrogen Source	PLOS ONE			English	Article							D-PROLINE ASSIMILATION; D-ASPARTATE OXIDASE; PHYSIOLOGICAL-ROLE; BRITISH-COLUMBIA; SEROTYPE-B; METABOLISM; YEAST; BACILLISPORUS; OUTBREAK; CANADA	The ability to grow on media containing certain D-amino acids as a sole nitrogen source is widely utilized to differentiate Cryptococcus gattii from C. neoformans. We used the C. neoformans H99 and C. gattii R265 strains to dissect the mechanisms of D-amino acids utilization. We identified three putative D-amino acid oxidase (DAO) genes in both strains and showed that each DAO gene plays different roles in D-amino acid utilization in each strain. Deletion of DAO2 retarded growth of R265 on eleven D-amino acids suggesting its prominent role on D-amino acid assimilation in R265. All three R265 DAO genes contributed to growth on D-Asn and D-Asp. DAO3 was required for growth and detoxification of D-Glu by both R265 and H99. Although growth of H99 on most D-amino acids was poor, deletion of DAO1 or DAO3 further exacerbated it on four D-amino acids. Overexpression of DAO2 or DAO3 enabled H99 to grow robustly on several D-amino acids suggesting that expression levels of the native DAO genes in H99 were insufficient for growth on D-amino acids. Replacing the H99 DAO2 gene with a single copy of the R265 DAO2 gene also enabled its utilization of several D-amino acids. Results of gene and promoter swaps of the DAO2 genes suggested that enzymatic activity of Dao2 in H99 might be lower compared to the R265 strain. A reduction in virulence was only observed when all DAO genes were deleted in R265 but not in H99 indicating a pathobiologically exclusive role of the DAO genes in R265. These results suggest that C. neoformans and C. gattii divergently evolved in D-amino acid utilization influenced by their major ecological niches.	[Chang, Yun C.; Lamichhane, Ami Khanal; Bradley, James; Rodgers, Laura; Kwon-Chung, Kyung J.] NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Ngamskulrungroj, Popchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University	Chang, YC (corresponding author), NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ychang@niaid.nih.gov	Ngamskulrungroj, Popchai/ABE-7699-2021; Ngamskulrungroj, Popchai/N-8545-2019	Ngamskulrungroj, Popchai/0000-0001-5162-5498; Bradley, James/0000-0001-5570-4679	National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000744] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funds from the intramural program of the National Institute of Allergy and Infectious Diseases, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT JE, 1978, SABOURAUDIA, V16, P167; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; CHAMPNEY WS, 1970, J BACTERIOL, V104, P107, DOI 10.1128/JB.104.1.107-116.1970; Chang YC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004292; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; DUFAIT R, 1987, MYCOSES, V30, P483, DOI 10.1111/j.1439-0507.1987.tb03833.x; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u; Gabler M, 2000, ENZYME MICROB TECH, V27, P605, DOI 10.1016/S0141-0229(00)00262-3; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Horner R, 1996, APPL ENVIRON MICROB, V62, P2106, DOI 10.1128/AEM.62.6.2106-2110.1996; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Khoronenkova SV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1511, DOI 10.1134/S0006297908130105; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Kwon-Chung J.K., 1992, MED MYCOL; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1978, INT J SYST BACTERIOL, V28, P616, DOI 10.1099/00207713-28-4-616; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Lee YH, 1996, LETT APPL MICROBIOL, V23, P283, DOI 10.1111/j.1472-765X.1996.tb00190.x; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; McClelland CA, 2005, FUNGAL GENET BIOL, V42, P904, DOI 10.1016/j.fgb.2005.07.003; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Molla G, 2003, YEAST, V20, P1061, DOI 10.1002/yea.1023; Mukamurangwa P, 1995, J MED VET MYCOL, V33, P419; Ngamskulrungroj P, 2012, MBIO, V3, DOI 10.1128/mBio.00103-12; Ngamskulrungroj P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034258; Nishikawa MM, 1996, J MED VET MYCOL, V34, P365; OHNISHI E, 1962, J BIOL CHEM, V237, P138; POLACHECK I, 1980, J BACTERIOL, V142, P15, DOI 10.1128/JB.142.1.15-20.1980; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; ROBINSON T, 1976, LIFE SCI, V19, P1097, DOI 10.1016/0024-3205(76)90244-7; Saleem A, 2012, AFR J MICROBIOL RES, V6, P4365, DOI 10.5897/AJMR-11-1470; SALKIN IF, 1982, J CLIN MICROBIOL, V15, P169, DOI 10.1128/JCM.15.1.169-171.1982; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Takahashi S, 2005, YEAST, V22, P1203, DOI 10.1002/yea.1303; Takahashi S, 2012, CURR MICROBIOL, V65, P764, DOI 10.1007/s00284-012-0227-z; Tishkov VI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P40, DOI 10.1007/s10541-005-0050-2; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131865	10.1371/journal.pone.0131865	http://dx.doi.org/10.1371/journal.pone.0131865			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132227	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000142
J	Lu, JY; Cheung, MLM; Li, M; Huang, BT; Xie, WJ; Xie, LX				Lu, Jia-Yang; Cheung, Michael Lok-Man; Li, Mei; Huang, Bao-Tian; Xie, Wen-Jia; Xie, Liang-Xi			Dosimetric Evaluation of a Simple Planning Technique for Improving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer	PLOS ONE			English	Article							DIRECT APERTURE OPTIMIZATION; QUALITY-OF-LIFE; RADIATION-THERAPY; ORAL MUCOSITIS; NECK-CANCER; CARCINOMA; IMRT; HEAD; PLANS; TOMOTHERAPY	Purpose To evaluate the dosimetric outcomes of a simple planning technique for improving intensit-ymodulated radiotherapy (IMRT) for nasopharyngeal cancer (NPC). Methods For 39 NPC cases, generally acceptable original plans were generated and were improved by the two planning techniques, respectively: (1) a basal-dose-compensation (BDC) technique, in which the treatment plans were re-optimized based on the original plans; (2) a local-dose-control (LDC) technique, in which the original plans were re-optimized with constraints for hot and cold spots. The BDC, original, and LDC plans were then compared regarding homogeneity index (HI) and conformity index (CI) of planning target volumes (PTVs), organ-at-risk (OAR) sparing and monitor units (MUs) per fraction. The whole planning times were also compared between the BDC and LDC plans. Results The BDC plans had superior HIs / CIs, by 13-24% / 3-243%, respectively, over the original plans. Compared to the LDC plans, the BDC plans provided better HIs only for PTVnx (the PTV of nasopharyngeal primary tumor) by 11% and better CIs for all PTVs by 2-134%. The BDC technique spared most OARs, by 1-9%. The average MUs of the BDC, original, and LDC plans were 2149, 2068 and 2179, respectively. The average whole planning times were 48 and 69 minutes for the BDC and LDC plans, respectively. Conclusions For the IMRT of nasopharyngeal cancer, the BDC planning technique can improve target dose homogeneity, conformity and OAR sparing, with better planning efficiency.	[Lu, Jia-Yang; Li, Mei; Huang, Bao-Tian; Xie, Wen-Jia; Xie, Liang-Xi] Shantou Univ, Canc Hosp, Coll Med, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China; [Cheung, Michael Lok-Man] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China	Shantou University; Chinese University of Hong Kong; Prince of Wales Hospital	Xie, LX (corresponding author), Shantou Univ, Canc Hosp, Coll Med, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China.	xieliangxi1@qq.com			National Natural Science Foundation of China [81171994]; Shantou University Medical College Clinical Research Enhancement Initiative [201425]; German Research Foundation; Open Access Publication Funds of the TU Dresden	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shantou University Medical College Clinical Research Enhancement Initiative; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This work was sponsored in part by both National Natural Science Foundation of China (Grant No. 81171994) and Shantou University Medical College Clinical Research Enhancement Initiative (Grant No. 201425). The authors' also acknowledge support from the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NJ, 2014, ACTA ONCOL, P1, DOI DOI 10.3109/0284186X.2014.958533; Broderick M, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-8; Budrukkar Ashwini N, 2004, Australas Radiol, V48, P45, DOI 10.1111/j.1440-1673.2004.01241.x; Chau RMC, 2008, CLIN ONCOL-UK, V20, P134, DOI 10.1016/j.clon.2007.10.006; Chen AM, 2012, BRIT J RADIOL, V85, pE537, DOI 10.1259/bjr/23807619; Cheng MC, 2014, MED DOSIM, V39, P246, DOI 10.1016/j.meddos.2014.03.003; Dobler B, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-33; Dogan N, 2006, MED PHYS, V33, P4033, DOI 10.1118/1.2357835; Ee VPC, 2013, ASIAN PAC J CANCER P, V14, P2243, DOI 10.7314/APJCP.2013.14.4.2243; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Hsiung CY, 2006, INT J RADIAT ONCOL, V66, P454, DOI 10.1016/j.ijrobp.2006.04.033; Jabbari S, 2005, INT J RADIAT ONCOL, V63, P725, DOI 10.1016/j.ijrobp.2005.02.045; Jang-Chun L, 2014, ACTA OTORHINOLARYNGO, V34, P241; Jeraj R, 2002, PHYS MED BIOL, V47, P391, DOI 10.1088/0031-9155/47/3/303; Jones S, 2008, MED DOSIM, V33, P86, DOI 10.1016/j.meddos.2007.04.002; Kan Monica W K, 2012, J Appl Clin Med Phys, V13, P3887, DOI 10.1120/jacmp.v13i6.3887; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Lee FKH, 2014, MED DOSIM, V39, P44, DOI 10.1016/j.meddos.2013.09.004; Li QL, 2013, TECHNOL CANCER RES T, V12, P403, DOI 10.7785/tcrt.2012.500340; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Rodriguez-Caballero A, 2012, INT J ORAL MAX SURG, V41, P225, DOI 10.1016/j.ijom.2011.10.011; Siala W, 2009, CANCER RADIOTHER, V13, P709, DOI 10.1016/j.canrad.2009.05.006; Suss P, 2013, PHYS MED BIOL, V58, P1855, DOI 10.1088/0031-9155/58/6/1855; Verbakel WFAR, 2012, INT J RADIAT ONCOL, V83, pE297, DOI 10.1016/j.ijrobp.2011.12.059; Vineberg KA, 2002, INT J RADIAT ONCOL, V52, P1159, DOI 10.1016/S0360-3016(01)02800-0; White P, 2013, J RADIAT RES, V54, P532, DOI 10.1093/jrr/rrs111; Wu SX, 2010, RADIOTHER ONCOL, V97, P113, DOI 10.1016/j.radonc.2010.08.003; Xhaferllari I, 2013, J APPL CLIN MED PHYS, V14, P176, DOI 10.1120/jacmp.v14i1.4052; Xue WQ, 2013, AM J EPIDEMIOL, V178, P325, DOI 10.1093/aje/kws479; Zacarias AS, 2009, J APPL CLIN MED PHYS, V10, P281, DOI 10.1120/jacmp.v10i4.3061; Zhang HB, 2013, CURR ONCOL, V20, pE577, DOI 10.3747/co.20.1485	31	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129461	10.1371/journal.pone.0129461	http://dx.doi.org/10.1371/journal.pone.0129461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132167	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000029
J	Nakamura, Y; Sugawara, T; Ohkusa, Y; Taniguchi, K; Miyazaki, C; Momoi, M; Okabe, N				Nakamura, Yuuki; Sugawara, Tamie; Ohkusa, Yasushi; Taniguchi, Kiyosu; Miyazaki, Chiaki; Momoi, Mariko; Okabe, Nobuhiko			Life-Threatening Abnormal Behavior Incidence in 10-19 Year Old Patients Administered Neuraminidase Inhibitors	PLOS ONE			English	Article							LANINAMIVIR OCTANOATE HYDRATE; INFLUENZA; SAFETY	Much discussion has surrounded the association between the administration of neuraminidase inhibitors (NI) and severe abnormal behaviors, including sudden running away and jumping from a high place, which can be life-threatening if no one intervenes. Using data on the number of abnormal behaviors and patients who had been prescribed NI in Japan, we calculated the incidence rate of severe abnormal behaviors among influenza patients who had been prescribed NI. Then, we evaluated the relative risk between the four types of NI on severe abnormal behavior. We found no significant difference in the incidence rates of abnormal behavior by the type of NI. Results implicate that the current policy of package inserts, which warn physicians that patients who were administered ANY type of NI might exhibit abnormal behavior, seems to be appropriate.	[Nakamura, Yuuki] Nihon Univ, Grad Sch Pharm, Funabashi, Chiba, Japan; [Sugawara, Tamie; Ohkusa, Yasushi] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Taniguchi, Kiyosu] Natl Hosp Org Mie Natl Hosp, Tsu, Mie, Japan; [Miyazaki, Chiaki] Fukuoka Welf Ctr Disabled, Fukuoka, Fukuoka, Japan; [Momoi, Mariko] Int Univ Hlth & Welf, Ohtawara, Tochigi, Japan; [Okabe, Nobuhiko] Kawasaki City Inst Publ Hlth, Kawasaki, Kanagawa 2100834, Japan	Nihon University; National Institute of Infectious Diseases (NIID); International University of Health & Welfare	Ohkusa, Y (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, Tokyo 1628640, Japan.	ohkusa@nih.go.jp			Health and Labor Sciences Research Grant from the Ministry of Health, Labour and Wealth [H22-Pharmaceuticals and Medical Devices-Assignment-023, H23-Global Health-Assignment-005, H24-Global Health-Assignment-001, H25-Global Health-Assignment-002]	Health and Labor Sciences Research Grant from the Ministry of Health, Labour and Wealth	This research was financially supported by a Health and Labor Sciences Research Grant from the Ministry of Health, Labour and Wealth (H22-Pharmaceuticals and Medical Devices-Assignment-023 in 2010, H23-Global Health-Assignment-005 in 2011, H24-Global Health-Assignment-001 in 2012, and H25-Global Health-Assignment-002 in 2013).	Chugai Pharmaceutical Co. Ltd, DEAR HEALTHC PROF LE; Fujita T, 2007, NIHON SYOUNIKAGAKKAI, V111, P1559; Health Insurance Bureau Ministry of Health Labour and Welfare, 2013, EXP M PROV INF MED C; Health Insurance Bureau Ministry of Health Labour and Welfare, 2011, EXP M PROV INF MED C; Hoffman KB, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4656; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Kashiwagi S, 2012, INT J ANTIMICROB AG, V40, P381, DOI 10.1016/j.ijantimicag.2012.06.017; Miura K, 2013, HOKEN IRYO KAGAKU, V62, P31; Morita H, 2007, INFECTION IMMUNITY C, V19, P455; Nakamura Y, 2015, KOUSEINOSHIHYOU, V62, P1; Nakamura Y, 2015, JPN J INFECT DIS, V68, P27, DOI 10.7883/yoken.JJID.2014.092; Nakamura Y, 2014, J INFECT CHEMOTHER, V20, P789, DOI 10.1016/j.jiac.2014.08.016; Nakano T, 2013, SCAND J INFECT DIS, V45, P469, DOI 10.3109/00365548.2012.763104; Nariai A, 2008, INFECT IMMUN CHILD, V20, P148; Shimizu E, 2014, JPN J PHARMACOEPIDEM, V19, P1; Subcommittee on Drug Safety of Committee on Drug Safety in the Pharmaceutical Affairs and Food Sanitation Council of the Ministry of Health Labour and Welfare, 2007, STUD ABN BEH INFL LI; Subcommittee on Drug Safety of Committee on Drug Safety in the Pharmaceutical Affairs and Food Sanitation Council of the Ministry of Health Labour and Welfare, 2011, US ANT VIR DRUGS; Subcommittee on Drug Safety of Committee on Drug Safety in the Pharmaceutical Affairs and Food Sanitation Council of the Ministry of Health Labour and Welfare, 2014, US ANT VIR DRUGS; Subcommittee on Drug Safety of Committee on Drug Safety in the Pharmaceutical Affairs and Food Sanitation Council of the Ministry of Health Labour and Welfare, 2013, US ANT VIR DRUGS; Subcommittee on Drug Safety of Committee on Drug Safety in the Pharmaceutical Affairs and Food Sanitation Council of the Ministry of Health Labour and Welfare, 2012, US ANT VIR DRUGS; Takahashi K, 2007, INFECT IMMUN CHILD, V19, P473; Takamiya H, 2007, INFECT IMMUN CHILD, V19, P479; Tanabe T, 2007, INFECT IMMUN CHILD, V19, P463; Tominaga M, 2007, J PEDIAT INFECT DIS, V19, P468; Toovey S, 2012, ADV THER, V29, P826, DOI 10.1007/s12325-012-0050-8; Yokota S, 2007, NIHON SYOUNIKAGAKKAI, V111, P1545	26	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129712	10.1371/journal.pone.0129712	http://dx.doi.org/10.1371/journal.pone.0129712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132729	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000035
J	Sugiura, M; Sato, S; Nouchi, R; Honda, A; Abe, T; Muramoto, T; Imamura, F				Sugiura, Motoaki; Sato, Shosuke; Nouchi, Rui; Honda, Akio; Abe, Tsuneyuki; Muramoto, Toshiaki; Imamura, Fumihiko			Eight Personal Characteristics Associated with the Power to Live with Disasters as Indicated by Survivors of the 2011 Great East Japan Earthquake Disaster	PLOS ONE			English	Article							SELF-COMPASSION	People perceive, judge, and behave differently in disasters and in a wide range of other difficult situations depending on their personal characteristics. The power to live, as captured by characteristics that are advantageous for survival in such situations, has thus far been modeled in arbitrary ways. Conceptualizing such characteristics in more objective ways may be helpful for systematic preparations for future disasters and life difficulties. Here, we attempted to identify the major factors of the power to live by summarizing the opinions of survivors of the 2011 Great East Japan Earthquake disaster. We conducted personal interviews with 78 survivors about their survival experiences and elicited their opinions about the power to live as relevant to those experiences. We then incorporated these opinions into a questionnaire that was completed by 1400 survivors. Factor analysis identified eight factors related to the power to live: leadership, problem solving, altruism, stubbornness, etiquette, emotional regulation, self-transcendence, and active well-being. All factors had sufficient internal construct validity, and six of them showed significant associations with one or more measures of survival success in the disaster, including immediate tsunami evacuation, problem solving in refugee situations, recovery during reconstruction, physical health, and mental health. Overall, the personal characteristics described by the eight factors largely overlap with those described in previous arbitrary models. Further research should investigate the domains, phases, and contexts in which each factor contributes to survival, address whether the factors are rooted in nature or in nurture, and explore their psychological or physiological bases.	[Sugiura, Motoaki; Sato, Shosuke; Nouchi, Rui; Muramoto, Toshiaki; Imamura, Fumihiko] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki; Nouchi, Rui] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nouchi, Rui] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Honda, Akio] Yamanashi Eiwa Coll, Fac Humanities, Kofu, Yamanashi, Japan; [Abe, Tsuneyuki] Tohoku Univ, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Sugiura, M (corresponding author), Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan.	motoaki@idac.tohoku.ac.jp	Nouchi, Rui/GQH-1608-2022; Abe, Tsuneyuki/ABD-9727-2020	Abe, Tsuneyuki/0000-0001-9694-357X; Nouchi, Rui/0000-0002-2078-9518; Honda, Akio/0000-0002-5399-4016	International Research Institute of Disaster Science, Tohoku University [H24-A-5, H25-A-4]; Japan Society for the Promotion of Science [FY2014]	International Research Institute of Disaster Science, Tohoku University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Data collection and analysis were supported by Special Project Researches (http://irides.tohoku.ac.jp/topics_project/index. html) (H24-A-5 and H25-A-4 to MS) from International Research Institute of Disaster Science, Tohoku University, and the preparation of the manuscript was supported by Topic-Setting Program to Advance Cutting-Edge Humanities and Social Sciences Research (http://www.jsps.go.jp/english/e-kadai/index.html) Area Cultivation; FY2014 to MS) from Japan Society for the Promotion of Science.	Baltes PB, 2008, PERSPECT PSYCHOL SCI, V3, P56, DOI 10.1111/j.1745-6916.2008.00062.x; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; HOFFMAN ML, 1981, J PERS SOC PSYCHOL, V40, P121, DOI 10.1037/0022-3514.40.1.121; Imamura F, 2009, J EARTHQ TSUNAMI, V3, P59, DOI 10.1142/S1793431109000457; JFBA, 2011, WHIT PAP ATT 2011; Lund J, 2004, SAFETY SCI, V42, P271, DOI 10.1016/S0925-7535(03)00045-6; Macik-Frey M, 2009, J ORGAN BEHAV, V30, P453, DOI 10.1002/job.561; Ministry of Education Culture Sports Science and Technology Japan, 2005, MIND BOD SUST ZEST L, V5, P86; Neely ME, 2009, MOTIV EMOTION, V33, P88, DOI 10.1007/s11031-008-9119-8; Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Ryff CD, 1998, PSYCHOL INQ, V9, P1, DOI 10.1207/s15327965pli0901_1; Sato S, 2014, J I SOCIAL SAFETY SC, V23, P7; Siebert A, 2010, SURVIVOR PERSONALITY; SIMS JH, 1972, SCIENCE, V176, P1386, DOI 10.1126/science.176.4042.1386; Smith JA, 2007, J AGING STUD, V21, P325, DOI 10.1016/j.jaging.2007.05.004; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; VAILLANT GE, 1978, PSYCHOSOM MED, V40, P420, DOI 10.1097/00006842-197808000-00006	18	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130349	10.1371/journal.pone.0130349	http://dx.doi.org/10.1371/journal.pone.0130349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26132753	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000063
J	Viljakainen, H; Andersson-Assarsson, JC; Armenio, M; Pekkinen, M; Pettersson, M; Valta, H; Lipsanen-Nyman, M; Makitie, O; Lindstrand, A				Viljakainen, Heli; Andersson-Assarsson, Johanna C.; Armenio, Miriam; Pekkinen, Minna; Pettersson, Maria; Valta, Helena; Lipsanen-Nyman, Marita; Makitie, Outi; Lindstrand, Anna			Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland	PLOS ONE			English	Article							FRAMESHIFT MUTATION; INSULIN-RESISTANCE; GENE; GENOME; MC4R; RISK	Background The salivary alpha-amylase locus (AMY1) is located in a highly polymorphic multi allelic copy number variable chromosomal region. A recent report identified an association between AMY1 copy numbers and BMI in common obesity. The present study investigated the relationship between AMY1 copy number, BMI and serum amylase in childhood-onset obesity. Patients Sixty-one subjects with a history of childhood-onset obesity (mean age 19.1 years, 54% males) and 71 matched controls (19.8 yrs, 45% males) were included. All anthropometric measures were greater in the obese; their mean BMI was 40 kg/m(2) (range 25-62 kg/m(2)) compared with 23 kg/m(2) in the controls (15-32 kg/m(2)). Results Mean AMY1 copy numbers did not differ between the obese and control subjects, but gender differences were observed; obese men showed the highest and obese women the lowest number of AMY1 copies (p=0.045). Further, only in affected females, AMY1 copy number correlated significantly with whole body fat percent (r=-0.512, p=0.013) and BMI (r=-0.416, p=0.025). Finally, a clear linear association between AMY1 copy number and serum salivary amylase was observed in all subgroups but again differences existed between obese males and females. Conclusions In conclusion, our findings suggest that AMY1 copy number differences play a role in childhood-onset obesity but the effect differs between males and females. Further studies in larger cohorts are needed to confirm these observations.	[Viljakainen, Heli; Valta, Helena; Lipsanen-Nyman, Marita; Makitie, Outi] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Viljakainen, Heli; Valta, Helena; Lipsanen-Nyman, Marita; Makitie, Outi] Helsinki Univ Hosp, Helsinki, Finland; [Andersson-Assarsson, Johanna C.] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Andersson-Assarsson, Johanna C.] Univ Gothenburg, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Armenio, Miriam; Pettersson, Maria; Makitie, Outi; Lindstrand, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Armenio, Miriam; Pettersson, Maria; Makitie, Outi; Lindstrand, Anna] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Pekkinen, Minna; Makitie, Outi] Folkhalsan Inst Genet, Helsinki, Finland; [Makitie, Outi; Lindstrand, Anna] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Gothenburg; University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lindstrand, A (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	anna.lindstrand@ki.se	Lindstrand, Anna/J-3566-2012; Lindstrand, Anna/AAT-9969-2021; Andersson-Assarsson, Johanna/M-2524-2019	Lindstrand, Anna/0000-0003-0806-5602; Lindstrand, Anna/0000-0003-0806-5602; Andersson-Assarsson, Johanna/0000-0001-9082-8589; Lipsanen-Nyman, Marita/0000-0003-4959-2310; Pettersson, Maria/0000-0003-3120-1625	Academy of Finland [250780]; Folkhalsan Research Foundation; Finnish Pediatric Research Foundation; Sigrid Juselius Foundation; Helsinki University Hospital Research Funds [TYH2013336]; Nilsson-Ehle Donationerna; Stockholm County Council; Ingabritt and Arne Lundberg Research Foundation [2014-0023]; Swedish Research Council [2012-1526, 2013-2603]; Swedish Childhood Cancer Foundation; Harald och Greta Jeanssons foundation; Ulf Lundahls Minnesfond/Swedish brain foundation	Academy of Finland(Academy of Finland); Folkhalsan Research Foundation; Finnish Pediatric Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital Research Funds; Nilsson-Ehle Donationerna; Stockholm County Council(Stockholm County Council); Ingabritt and Arne Lundberg Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Harald och Greta Jeanssons foundation; Ulf Lundahls Minnesfond/Swedish brain foundation	The study was supported by grants from: the Academy of Finland (grant 250780), www.aka.fi, OM; the Folkhalsan Research Foundation, www.folkhalsan.fi, OM; the Finnish Pediatric Research Foundation, www.lastentautientutkimussaatio.fi, OM; the Sigrid Juselius Foundation, www.sigridjuselius.fi/foundation, OM; the Helsinki University Hospital Research Funds (grant TYH2013336), www.hus.fi, OM; the Nilsson-Ehle Donationerna, www.fysiografen.se, AL; the Stockholm County Council, www.sll.se, AL and OM; the Ingabritt and Arne Lundberg Research Foundation (grant 2014-0023), www.lundbergsstiftelsen.se, JAA; the Swedish Research Council (grants 2012-1526 and 2013-2603), www.vr.se, AL and OM; the Swedish Childhood Cancer Foundation, www.barncancerfonden.se, OM; the Harald och Greta Jeanssons foundation, www.jeanssonsstiftelser.se, AL; the Ulf Lundahls Minnesfond/the Swedish brain foundation, www.hjarnfonden.se, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez JA, 2012, P NUTR SOC, V71, P276, DOI 10.1017/S0029665112000055; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bremer AA, 2009, ARCH PEDIAT ADOL MED, V163, P328, DOI 10.1001/archpediatrics.2009.21; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; FOGEL MR, 1973, J APPL PHYSIOL, V35, P263, DOI 10.1152/jappl.1973.35.2.263; Hosking J, 2013, OBESITY FACTS, V6, P43; KINZL J, 1993, INT J EAT DISORDER, V13, P117, DOI 10.1002/1098-108X(199301)13:1&lt;117::AID-EAT2260130114&gt;3.0.CO;2-8; KONDO T, 1988, INT J PANCREATOL, V3, P241; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Mandel AL, 2012, J NUTR, V142, P853, DOI 10.3945/jn.111.156984; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Powell LM, 2010, J NUTR, V140, P1175, DOI 10.3945/jn.109.111526; Santiago S, 2014, EUR J CLIN NUTR; Santos JL, 2012, J NUTRIGENET NUTRIGE, V5, P117, DOI 10.1159/000339951; SCHNEEMAN BO, 1983, J NUTR, V113, P921, DOI 10.1093/jn/113.4.921; Shalata A, 2013, AM J HUM GENET, V93, P1061, DOI 10.1016/j.ajhg.2013.10.025; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Viljakainen H, 2014, J CLIN ENDOCR METAB, V99, P2155, DOI 10.1210/jc.2013-3097; Wang JW, 2013, PEDIATR OBES, V8, P284, DOI 10.1111/j.2047-6310.2012.00108.x; WHO Expert Committee on Diabetes Mellitus, 1999, DEF DIAGN CLASS DI 1; Wikarek T, 2014, BRIT J NUTR, V111, P236, DOI 10.1017/S0007114513002389; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	32	52	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131883	10.1371/journal.pone.0131883	http://dx.doi.org/10.1371/journal.pone.0131883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132294	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000143
J	Anguita, C; Simeone, A				Anguita, Cristobal; Simeone, Alejandro			Influence of Seasonal Food Availability on the Dynamics of Seabird Feeding Flocks at a Coastal Upwelling Area	PLOS ONE			English	Article							SARDINE STRANGOMERA-BENTINCKI; SPECIES FORAGING FLOCKS; CENTRAL-SOUTHERN CHILE; SMALL PELAGIC FISH; INFORMATION-TRANSFER; COMMUNITY STRUCTURE; HUMBOLDT CURRENT; MARINE HABITAT; BIRD FLOCKS; KELP GULL	The formation of multi-species feeding flocks (MSFFs) through visual recruitment is considered an important strategy for obtaining food in seabirds and its functionality has been ascribed to enhanced foraging efficiency. Its use has been demonstrated in much of the world's oceans and includes numerous species. However, there is scant information on the temporal stability of the composition and abundance of MSFFs as well as the effect of seasonal food availability on their dynamics. Between July 2006 and September 2014, we conducted monthly at-sea seabird counts at Valparaiso Bay (32 degrees 56' to 33 degrees 01'S, 71 degrees 36' to 71 degrees 46'W) within the area of influence of the Humboldt Current in central Chile. This area is characterized by a marked seasonality in primary and secondary production associated with upwelling, mainly during austral spring-summer. Based on studies that provide evidence that flocking is most frequent when food is both scarce and patchy, we hypothesized that seabird MSFF attributes (i.e. frequency of occurrence, abundance and composition) will be modified according to the seasonal availability of food. Using generalized linear models (GLMs), our results show that the contrasting seasonality in food availability of the study area (using chlorophyll-a concentration as a proxy) had no significant influence on MSFF attributes, sparsely explaining their variations (P>0.05). Rather than seasonal food availability, the observed pattern for MSFF attributes at Valparaiso Bay suggests a substantial influence of reproductive and migratory (boreal and austral migrants) habits of birds that modulates MSFF dynamics consistently throughout the whole year in this highly variable and patchy environment. We highlight the importance of visual recruitment as a mechanism by which migratory and resident birds interact. This would allow them to reduce resource unpredictability, which in turn has a major impact on structuring seabird's MSFF dynamics.	[Anguita, Cristobal; Simeone, Alejandro] Univ Andres Bello, Fac Ecol & Recursos Nat, Dept Ecol & Biodiversidad, Santiago, Chile	Universidad Andres Bello	Simeone, A (corresponding author), Univ Andres Bello, Fac Ecol & Recursos Nat, Dept Ecol & Biodiversidad, Santiago, Chile.	asimeone@unab.cl		Cristobal, Anguita/0000-0001-6914-2742	Vicerrectoria de Investigacion y Doctorado, Universidad Andres Bello (Chile) [AR-03-05, DI-07-08, DI-48-10, DI132-12, DI-486-14]	Vicerrectoria de Investigacion y Doctorado, Universidad Andres Bello (Chile)	Financial support has been provided by research grants AR-03-05, DI-07-08, DI-48-10, DI132-12 and DI-486-14 from the Vicerrectoria de Investigacion y Doctorado, Universidad Andres Bello (Chile) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CM, 2008, CONT SHELF RES, V28, P2371, DOI 10.1016/j.csr.2008.05.006; Ainley DG, 1990, BOEKELHEIDE RJ SEABI; [Anonymous], 2015, CLASSIFICATION BIRD; Aravena G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090276; Ballance LT, 1997, ECOLOGY, V78, P1502, DOI 10.1890/0012-9658(1997)078[1502:SCSAAP]2.0.CO;2; BAYER RD, 1983, J FIELD ORNITHOL, V54, P196; BERNER TO, 1985, ECOLOGY, V66, P1229, DOI 10.2307/1939176; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; BRIGGS KT, 1987, STUD AVIAN BIOL, V11, P1; Brochier T, 2011, FISH FISH, V12, P94, DOI 10.1111/j.1467-2979.2010.00385.x; Burger J., 2010, ENERGY POWER ENG, V2, P143, DOI [10.4236/epe.2010.23021, DOI 10.4236/EPE.2010.23021]; Camphuysen C.J., 2004, Atlantic Seabirds, V6, P1; Camphuysen K, 1999, ARDEA, V87, P177; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; Creuwels JCS, 2007, POLAR BIOL, V30, P1083, DOI 10.1007/s00300-007-0276-0; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; CROXALL JP, 1976, IBIS, V118, P333, DOI 10.1111/j.1474-919X.1976.tb02024.x; Cubillos LA, 2002, FISH RES, V57, P117, DOI 10.1016/S0165-7836(01)00340-X; Cubillos LA, 2001, AQUAT LIVING RESOUR, V14, P115, DOI 10.1016/S0990-7440(01)01112-3; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DUFFY DC, 1983, AUK, V100, P800, DOI 10.1093/auk/100.4.800; DUFFY DC, 1989, COLON WATERBIRD, V12, P164, DOI 10.2307/1521337; Escribano R, 2007, PROG OCEANOGR, V75, P470, DOI 10.1016/j.pocean.2007.08.027; Escribano R, 2012, PROG OCEANOGR, V97, P174, DOI 10.1016/j.pocean.2011.11.006; Escribano R, 2012, PROG OCEANOGR, V92-95, P1, DOI 10.1016/j.pocean.2011.07.019; Garthe S, 1999, J FIELD ORNITHOL, V70, P28; Garthe Stefan, 2000, Vogelwelt, V121, P301; Garthe Stefan, 1996, Vogelwelt, V117, P303; Gomez F, 2012, FISH OCEANOGR, V21, P405, DOI 10.1111/j.1365-2419.2012.00632.x; Goodale E, 2010, TRENDS ECOL EVOL, V25, P354, DOI 10.1016/j.tree.2010.01.002; Gram WK, 1998, CONDOR, V100, P44, DOI 10.2307/1369895; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Harrison NM, 2011, ANIM BEHAV, V81, P675, DOI 10.1016/j.anbehav.2011.01.013; Harrison P., 1988, SEABIRDS IDENTIFICAT; Haynes Trevor B., 2011, Marine Ornithology, V39, P227; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hino Teruaki, 2009, Ornithological Science, V8, P43, DOI 10.2326/048.008.0107; Hobson KA, 2006, WILSON J ORNITHOL, V118, P164, DOI 10.1676/05-012.1; HOFFMAN W, 1981, AUK, V98, P437; Howell S., 2007, REFERENCE GUIDE GULL; Hunt GL, 1987, SEABIRDS FEEDING ECO; Ji RB, 2010, J PLANKTON RES, V32, P1355, DOI 10.1093/plankt/fbq062; Lack D., 1968, pvii; Ludynia K, 2005, WATERBIRDS, V28, P359, DOI 10.1675/1524-4695(2005)028[0359:SARVIT]2.0.CO;2; Maldonado-Coelho M, 2004, BIOL CONSERV, V116, P19, DOI 10.1016/S0006-3207(03)00169-1; Manriquez K, 2012, PROG OCEANOGR, V92-95, P121, DOI 10.1016/j.pocean.2011.07.020; Manriquez K, 2009, J PLANKTON RES, V31, P1075, DOI 10.1093/plankt/fbp053; Mills KL, 1998, CONDOR, V100, P277, DOI 10.2307/1370268; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; Nasca Patricia B., 2004, Hornero, V19, P29; Nemeth Z, 2014, AUK, V131, P186, DOI 10.1642/AUK-13-195.1; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Palma S., 1995, INVESTIGACIONES MARI, V23, P49; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Riquelme-Bugueno R, 2012, PROG OCEANOGR, V92-95, P146, DOI 10.1016/j.pocean.2011.07.003; Schlatter Roberto P., 1999, Estudios Oceanologicos, V18, P25; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shealer David A., 2002, P137; Sherley RB, 2013, ENDANGER SPECIES RES, V21, P89, DOI 10.3354/esr00510; Sievers H, 2000, REV BIOL MAR OCEANOG, V35, DOI [10.4067/S0718-19572000000100004, DOI 10.4067/S0718-19572000000100004]; Silva C, 2015, PROG OCEANOGR, V134, P343, DOI 10.1016/j.pocean.2015.03.004; Silva N, 2003, INVESTIGACIONES MARI, V31, P73; Silverman ED, 2004, MAR ECOL PROG SER, V277, P25, DOI 10.3354/meps277025; Silverman ED, 2001, IBIS, V143, P51, DOI 10.1111/j.1474-919X.2001.tb04169.x; Simeone A, 2014, REV CHIL HIST NAT, V87, DOI 10.1186/0717-6317-87-6; Spear Larry B., 2008, Marine Ornithology, V36, P125; Sridhar H, 2014, BEHAV ECOL SOCIOBIOL, V68, P185, DOI 10.1007/s00265-013-1633-3; Sridhar H, 2009, ANIM BEHAV, V78, P337, DOI 10.1016/j.anbehav.2009.05.008; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; Thiebault A, 2014, BEHAV ECOL, V25, P1302, DOI 10.1093/beheco/aru132; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; Vallina SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5299; Vargas CA, 2006, ECOLOGY, V87, P2992, DOI 10.1890/0012-9658(2006)87[2992:PFQDTW]2.0.CO;2; VEIT RR, 1991, AUK, V108, P790; Venables WN., 2002, MODERN APPL STAT S 4; Villablanca R, 2007, ICES J MAR SCI, V64, P1348, DOI 10.1093/icesjms/fsm120; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Wang Y., 2014, MVABUND STAT METHODS; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Webb A., 1992, IWRB Special Publication, P24; Weichler T, 2004, ICES J MAR SCI, V61, P148, DOI 10.1016/j.icesjms.2003.07.001; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; Yorio P., 1998, Marine Ornithology, V26, P11; Yorio Pablo, 2005, Hornero, V20, P53; Zuur Alain F., 2009, P1	91	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131327	10.1371/journal.pone.0131327	http://dx.doi.org/10.1371/journal.pone.0131327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125630	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300043
J	Funk, KE; Mirbaha, H; Jiang, H; Holtzman, DM; Diamond, MI				Funk, Kristen E.; Mirbaha, Hilda; Jiang, Hong; Holtzman, David M.; Diamond, Marc I.			Distinct Therapeutic Mechanisms of Tau Antibodies PROMOTING MICROGLIAL CLEARANCE VERSUS BLOCKING NEURONAL UPTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; microglia; neuron; Tau protein (Tau); tauopathy; clearance	BETA-AMYLOID PEPTIDE; EXTRACELLULAR TAU; MOUSE MODEL; ALZHEIMERS-DISEASE; PASSIVE-IMMUNIZATION; PROTEIN; PATHOLOGY; BRAIN; IMMUNOTHERAPY; PROPAGATION	Background: Vaccination against Tau reduces pathology in vivo; however, the mechanism of action remains unclear. Results: Antibodies promote uptake of Tau fibrils in microglia or block uptake in neurons in a size- and epitope-dependent manner. Conclusion: Antibodies have multiple potential mechanisms. Significance: Establishing specific mechanisms of antibody activity may help in design and optimization of more effective agents. Tauopathies are neurodegenerative diseases characterized by accumulation of Tau amyloids, and include Alzheimer disease and certain frontotemporal dementias. Trans-neuronal propagation of amyloid mediated by extracellular Tau may underlie disease progression. Consistent with this, active and passive vaccination studies in mouse models reduce pathology, although by unknown mechanisms. We previously reported that intracerebroventricular administration of three anti-Tau monoclonal antibodies (HJ8.5, HJ9.3, and HJ9.4) reduces pathology in a model overexpressing full-length mutant (P301S) human Tau. We now study effects of these three antibodies and a negative control antibody (HJ3.4) on Tau aggregate uptake into BV2 microglial-like cells and primary neurons. Antibody-independent Tau uptake into BV2 cells was blocked by heparin, consistent with a previously described role for heparan sulfate proteoglycans. Two therapeutic antibodies (HJ8.5 and HJ9.4) promoted uptake of full-length Tau fibrils into microglia via Fc receptors. Surprisingly, HJ9.3 promoted uptake of fibrils composed of the Tau repeat domain or Alzheimer disease-derived Tau aggregates, but failed to influence full-length recombinant Tau fibrils. Size fractionation of aggregates showed that antibodies preferentially promote uptake of larger oligomers (n approximate to 20-mer) versus smaller oligomers (n approximate to 10-mer) or monomer. No antibody inhibited uptake of full-length recombinant fibrils into primary neurons, but HJ9.3 blocked neuronal uptake of Tau repeat domain fibrils and Alzheimer disease-derived Tau. Antibodies thus have multiple potential mechanisms, including clearance via microglia and blockade of neuronal uptake. However these effects are epitope- and aggregate size-dependent. Establishing specific mechanisms of antibody activity in vitro may help in design and optimization of agents that are more effective in vivo.	[Funk, Kristen E.; Jiang, Hong; Holtzman, David M.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Mirbaha, Hilda; Diamond, Marc I.] Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA	Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas	Diamond, MI (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	marc.diamond@utsouthwestern.edu	Funk, Kristen/AAC-6334-2020; Regan, Clinton/E-6250-2012	Funk, Kristen/0000-0002-1912-1430; 	National Institutes of Health [P50AG005681, P01AG003991]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Nigel Cairns, Erin Householder, the technical support of the Betty Martz Laboratory for Neurodegenerative Research, and the Knight Alzheimer's Disease Research Center at Washington University in St. Louis for brain tissue, supported by the following National Institutes of Health grants: P50AG005681 (Knight Alzheimer's Disease Research Center) and P01AG003991 (Healthy Aging and Senile Dementia).	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001; Das P, 2003, J NEUROSCI, V23, P8532; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kopec KK, 1998, J NEUROCHEM, V71, P2123; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Majerova P, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0161-z; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; METZGER H, 1988, FASEB J, V2, P3, DOI 10.1096/fasebj.2.1.3275562; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Sue W, 2006, AM J CLIN NUTR, V83, p470S; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wisniewski T, 2014, BIOCHEM PHARMACOL, V88, P499, DOI 10.1016/j.bcp.2013.12.020; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046	46	80	83	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21652	21662		10.1074/jbc.M115.657924	http://dx.doi.org/10.1074/jbc.M115.657924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26126828	hybrid, Green Published			2022-12-26	WOS:000360637600037
J	Gemmecker, S; Schaub, P; Koschmieder, J; Brausemann, A; Drepper, F; Rodriguez-Franco, M; Ghisla, S; Warscheid, B; Einsle, O; Beyer, P				Gemmecker, Sandra; Schaub, Patrick; Koschmieder, Julian; Brausemann, Anton; Drepper, Friedel; Rodriguez-Franco, Marta; Ghisla, Sandro; Warscheid, Bettina; Einsle, Oliver; Beyer, Peter			Phytoene Desaturase from Oryza sativa: Oligomeric Assembly, Membrane Association and Preliminary 3D-Analysis	PLOS ONE			English	Article							PLASTID TERMINAL OXIDASE; ZETA-CAROTENE DESATURASE; BETA-CAROTENE; BIOSYNTHETIC-PATHWAY; MOLECULAR-OXYGEN; LYCOPENE CYCLASE; IN-VITRO; IDENTIFICATION; EXPRESSION; ISOMERASE	Recombinant phytoene desaturase (PDS-His6) from rice was purified to near-homogeneity and shown to be enzymatically active in a biphasic, liposome-based assay system. The protein contains FAD as the sole protein-bound redox-cofactor. Benzoquinones, not replaceable by molecular oxygen, serve as a final electron acceptor defining PDS as a 15-cis-phytoene (donor): plastoquinone oxidoreductase. The herbicidal PDS-inhibitor norflurazon is capable of arresting the reaction by stabilizing the intermediary FAD(red), while an excess of the quinone acceptor relieves this blockage, indicating competition. The enzyme requires its homo-oligomeric association for activity. The sum of data collected through gel permeation chromatography, non-denaturing polyacrylamide electrophoresis, chemical cross-linking, mass spectrometry and electron microscopy techniques indicate that the high-order oligomers formed in solution are the basis for an active preparation. Of these, a tetramer consisting of dimers represents the active unit. This is corroborated by our preliminary X-ray structural analysis that also revealed similarities of the protein fold with the sequence-inhomologous bacterial phytoene desaturase CRTI and other oxidoreductases of the GR2-family of flavoproteins. This points to an evolutionary relatedness of CRTI and PDS yielding different carotene desaturation sequences based on homologous protein folds.	[Gemmecker, Sandra; Schaub, Patrick; Koschmieder, Julian; Rodriguez-Franco, Marta; Beyer, Peter] Univ Freiburg, Fac Biol, Cell Biol, D-79106 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, Fac Biol Biochem & Funct Prote, D-79106 Freiburg, Germany; [Brausemann, Anton; Einsle, Oliver] Univ Freiburg, Fac Chem & Pharm, Inst Biochem, D-79106 Freiburg, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biol, Constance, Germany; [Warscheid, Bettina; Einsle, Oliver] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Konstanz; University of Freiburg	Beyer, P (corresponding author), Univ Freiburg, Fac Biol, Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	peter.beyer@biologie.uni-freiburg.de	Schaub, Patrick/C-8358-2018	Rodriguez Franco, Marta/0000-0003-1183-2075; Brausemann, Anton/0000-0001-9135-301X; Warscheid, Bettina/0000-0001-5096-1975; Einsle, Oliver/0000-0001-8722-2893; Drepper, Friedel/0000-0002-2043-5795; Schaub, Patrick/0000-0002-8529-4161	European Union Seventh Framework Programme (FP7) [244348]; HarvestPlus Research Consortium; Deutsche Forschungsgemeinschaft [EI-520/3]; Excellence Initiative of the German Federal and State Governments [EXC 294]	European Union Seventh Framework Programme (FP7); HarvestPlus Research Consortium; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	This work was supported by the European Union Seventh Framework Programme (FP7) Contract 244348, by the HarvestPlus Research Consortium (PB) and by the Deutsche Forschungsgemeinschaft (grant EI-520/3 to OE). Research in the laboratory of BW was supported by the Deutsche Forschungsgemeinschaft and the Excellence Initiative of the German Federal and State Governments Grant EXC 294 BIOSS Centre for Biological Signalling Studies (EXC 294 to BW). [URLs: Harvest Plus, www.harvestplus.org; EC Framework, http://ec.europa.eu/research/fp7/index_en.cfm; Deutsche Forschungsgemeinschaft, http://www.dfg.de/; Excellence initiative, http://www.dfg.de/en/research_funding/programmes/excellence_initiative/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Babili S, 2006, J EXP BOT, V57, P1007, DOI 10.1093/jxb/erj086; AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Atmeh RF, 2007, JORDAN J CHEM, V2, P169; Avendano-Vazquez AO, 2014, PLANT CELL, V26, P2524, DOI 10.1105/tpc.114.123349; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; CLOUGH JM, 1979, J CHEM SOC CHEM COMM, P616, DOI 10.1039/c39790000616; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cristodero M, 2013, MOL MICROBIOL, V90, P744, DOI 10.1111/mmi.12397; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feilke K, 2014, BBA-BIOENERGETICS, V1837, P1684, DOI 10.1016/j.bbabio.2014.07.016; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; FRASER PD, 1993, BIOCHEM J, V291, P687, DOI 10.1042/bj2910687; Gradinaru R, 2007, BIOCHEMISTRY-US, V46, P2497, DOI 10.1021/bi0614582; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; HAMILTON RL, 1980, J LIPID RES, V21, P981; Heyno E, 2009, J BIOL CHEM, V284, P31174, DOI 10.1074/jbc.M109.021667; HUGUENEY P, 1992, EUR J BIOCHEM, V209, P399, DOI 10.1111/j.1432-1033.1992.tb17302.x; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Lopez AB, 2008, PHYSIOL PLANTARUM, V133, P190, DOI 10.1111/j.1399-3054.2008.01058.x; MAYER MP, 1990, EUR J BIOCHEM, V191, P359, DOI 10.1111/j.1432-1033.1990.tb19130.x; NIEVELSTEIN V, 1995, EUR J BIOCHEM, V233, P864, DOI 10.1111/j.1432-1033.1995.864_3.x; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; Shumskaya M, 2013, PLANT SCI, V208, P58, DOI 10.1016/j.plantsci.2013.03.012; Suarez JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099894; Trouillard M, 2012, BBA-BIOENERGETICS, V1817, P2140, DOI 10.1016/j.bbabio.2012.08.006; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yu QJ, 2014, BBA-BIOENERGETICS, V1837, P1284, DOI 10.1016/j.bbabio.2014.04.007; Yu QJ, 2012, FEBS LETT, V586, P3415, DOI 10.1016/j.febslet.2012.07.060; Yu QJ, 2011, J BIOL CHEM, V286, P8666, DOI 10.1074/jbc.M110.208017; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843	53	24	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131717	10.1371/journal.pone.0131717	http://dx.doi.org/10.1371/journal.pone.0131717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147209	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600134
J	Hvidberg, MF; Brinth, LS; Olesen, AV; Petersen, KD; Ehlers, L				Hvidberg, Michael Falk; Brinth, Louise Schouborg; Olesen, Anne V.; Petersen, Karin D.; Ehlers, Lars			The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYNDROMES; EQ-5D; PREVALENCE; SCORES; HOSPITALIZATION; POPULATION; CATALOG	Introduction Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a common, severe condition affecting 0.2 to 0.4 per cent of the population. Even so, no recent international EQ-5D based health-related quality of life (HRQoL) estimates exist for ME/CFS patients. The main purpose of this study was to estimate HRQoL scores using the EQ-5D-3L with Danish time trade-off tariffs. Secondary, the aims were to explore whether the results are not influenced by other conditions using regression, to compare the estimates to 20 other conditions and finally to present ME/CFS patient characteristics for use in clinical practice. Material and methods All members of the Danish ME/CFS Patient Association in 2013 (n=319) were asked to fill out a questionnaire including the EQ-5D-3L. From these, 105 ME/CFS patients were identified and gave valid responses. Unadjusted EQ-5D-3L means were calculated and compared to the population mean as well as to the mean of 20 other conditions. Furthermore, adjusted estimates were calculated using ordinary least squares (OLS) regression, adjusting for gender, age, education, and co-morbidity of 18 self-reported conditions. Data from the North Denmark Health Profile 2010 was used as population reference in the regression analysis (n=23,392). Results The unadjusted EQ-5D-3L mean of ME/CFS was 0.47 [0.41-0.53] compared to a population mean of 0.85 [0.84-0.86]. The OLS regression estimated a disutility of -0.29 [-0.21;0.34] for ME/CFS patients in this study. The characteristics of ME/CFS patients are different from the population with respect to gender, relationship, employment etc. Conclusion The EQ-5D-3L-based HRQoL of ME/CFS is significantly lower than the population mean and the lowest of all the compared conditions. The adjusted analysis confirms that poor HRQoL of ME/CFS is distinctly different from and not a proxy of the other included conditions. However, further studies are needed to exclude the possible selection bias of the current study.	[Hvidberg, Michael Falk; Olesen, Anne V.; Petersen, Karin D.; Ehlers, Lars] Aalborg Univ, Danish Ctr Healthcare Improvements, Aalborg, Denmark; [Brinth, Louise Schouborg] Frederiksberg Univ Hosp, Coordinating Res Unit, Frederiksberg, Denmark	Aalborg University	Hvidberg, MF (corresponding author), Aalborg Univ, Danish Ctr Healthcare Improvements, Aalborg, Denmark.	michael@falkhvidberg.dk	Hvidberg, Michael Falk/HGE-5232-2022; Ehlers, Lars/P-7531-2019; Olesen, Anne Vingaard/C-8130-2018; Olesen, Anne Vingaard/AAL-7716-2021	Hvidberg, Michael Falk/0000-0003-0632-3866; Olesen, Anne Vingaard/0000-0002-1503-8269; Brinth, Louise/0000-0001-6546-1308; Petersen, Karin Dam/0000-0002-6491-1757; Ehlers, Lars Holger/0000-0001-6512-5566				[Anonymous], 2003, MEPS HC 0522000 MED; Fernandez AA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-S1-S1; Baker R, 2007, BMJ-BRIT MED J, V335, P446, DOI 10.1136/bmj.39302.509005.AE; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Brazier J, 2011, NICE DSU TECH SUPPOR; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Carter K, 2010, STROKE, V41, P2678, DOI 10.1161/STROKEAHA.110.598268; Cho HJ, 2009, BRIT J PSYCHIAT, V194, P117, DOI 10.1192/bjp.bp.108.051813; Christensen AI, 2014, DANES HLTH; Christensen AI, 2010, SCAND J PUBLIC HEALT, V2012, P391, DOI DOI 10.1177/1403494812451412; Christley Y, 2012, J EVAL CLIN PRACT, V18, P25, DOI 10.1111/j.1365-2753.2010.01512.x; Chu L., 2013, PATIENT SURVEY RESUL; Fjorback LO, 2013, J PSYCHOSOM RES, V74, P31, DOI 10.1016/j.jpsychores.2012.09.006; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; Hardt J, 2001, J PSYCHOSOM RES, V51, P431, DOI 10.1016/S0022-3999(01)00220-3; Hayes VS, 2013, HLTH PROFILE N DENMA; Haywood KL, 2012, QUAL LIFE RES, V21, P35, DOI 10.1007/s11136-011-9921-8; Hvidberg M, 2013, POSTER ISPOR DUBLIN, P1; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason L, 2010, AM J BIOCH BIOTECHNO, V6, P120, DOI [DOI 10.3844/AJBBSP.2010.120, DOI 10.3844/AJBBSP.2010.120.135]; Jason LA, 2011, B IACFS ME, V17, P88; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Myers C, 1999, QUAL LIFE RES, V8, P9, DOI 10.1023/A:1026459027453; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Nacul LC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-402; NICE, 2007, CHRONIC FATIGUE SYND; Pedersen J, 2011, SUNDHEDSPROFIL 2010; Reeves WC, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-19; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schroder A, 2012, BRIT J PSYCHIAT, V200, P499, DOI 10.1192/bjp.bp.111.098681; Sharpe M., 2005, J MENTAL HLTH, V14, P269, DOI [DOI 10.1080/09638230500136621, 10.1080/09638230500136621]; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Wittrup-Jensen KU, 2009, SCAND J PUBLIC HEALT, V37, P459, DOI 10.1177/1403494809105287	41	79	79	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132421	10.1371/journal.pone.0132421	http://dx.doi.org/10.1371/journal.pone.0132421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147503	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600264
J	Rojas, E; Hoyos, J; Oldfield, NJ; Lee, P; Flint, M; Jones, CH; Ala'Aldeen, DAA; Jansen, KU; Anderson, AS				Rojas, Eduardo; Hoyos, Johanna; Oldfield, Neil J.; Lee, Philip; Flint, Mike; Jones, C. Hal; Ala'Aldeen, Dlawer A. A.; Jansen, Kathrin U.; Anderson, Annaliesa S.			Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines	PLOS ONE			English	Article							REAL-TIME PCR; H-BINDING-PROTEIN; INVASIVE MENINGOCOCCAL DISEASE; CAPSULE NULL LOCUS; HERD-IMMUNITY; BACTERIAL-MENINGITIS; BURKINA-FASO; STRAINS; IDENTIFICATION; DIVERSITY	The reservoir for Neisseria meningitidis (Nm) is the human oropharynx. Implementation of Nm serogroup C (NmC) glycoconjugate vaccines directly reduced NmC carriage. Prophylactic vaccines are now available to prevent disease caused by the five major Nm disease causing serogroups (ABCWY). Nm serogroup B (NmB) vaccines are composed of antigens that are conserved across Nm serogroups and therefore have the potential to impact all Nm carriage. To assess the effect of these vaccines on carriage, standardized approaches to identify and group Nm are required. Real-time PCR (rt-PCR) capsule grouping assays that were internally controlled to confirm Nm species were developed for eight serogroups associated with carriage (A, B, C, E, W, X, Y and Z). The grouping scheme was validated using diverse bacterial species associated with carriage and then used to evaluate a collection of diverse Nm carriage isolates (n=234). A scheme that also included porA and ctrA probes was able to speciate the isolates, while ctrA also provided insights on the integrity of the polysaccharide loci. Isolates were typed for the Nm vaccine antigen factor H binding protein (fHbp), and were found to represent the known diversity of this antigen. The porA rt-PCR yielded positive results with all 234 of the Nm carriage isolates. Genogrouping assays classified 76.5% (179/234) of these isolates to a group, categorized 53 as nongenogroupable (NGG) and two as mixed results. Thirty seven NGG isolates evidenced a disrupted capsular polysaccharide operon judged by a ctrA negative result. Only 28.6% (67/234) of the isolates were serogrouped by slide agglutination (SASG), highlighting the reduced capability of carriage strains to express capsular polysaccharide. These rt-PCR assays provide a comprehensive means to identify and genogroup N. meningitidis in carriage studies used to guide vaccination strategies and to assess the impact of novel fHbp containing vaccines on meningococcal carriage.	[Rojas, Eduardo; Hoyos, Johanna; Lee, Philip; Flint, Mike; Jones, C. Hal; Jansen, Kathrin U.; Anderson, Annaliesa S.] Pfizer Inc, Vaccine Res & Dev, Pearl River, NY 10965 USA; [Oldfield, Neil J.; Ala'Aldeen, Dlawer A. A.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	Pfizer; University of Nottingham	Anderson, AS (corresponding author), Pfizer Inc, Vaccine Res & Dev, Pearl River, NY 10965 USA.	annaliesa.anderson@pfizer.com	Flint, Mike/L-8355-2019; Oldfield, Neil J/C-2599-2009	Oldfield, Neil J/0000-0001-7423-8378; Flint, Michael/0000-0002-5373-787X	Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was funded by Pfizer Inc. ER, JH, PL, MF, CHJ, KUJ and ASA are or were employed by Pfizer during this work and may own stock in the company. The funder provided support in the form of salaries for authors ER, JH, PL, MF, CHJ, KUJ, ASA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ala'Aldeen DAA, 2000, J CLIN MICROBIOL, V38, P2311; Anderson AS, 2011, EXPERT REV VACCINES, V10, P617, DOI [10.1586/ERV.11.50, 10.1586/erv.11.50]; Baethgen LF, 2003, J MED MICROBIOL, V52, P793, DOI 10.1099/jmm.0.05192-0; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Bennett DE, 2006, J CLIN MICROBIOL, V44, P1127, DOI 10.1128/JCM.44.3.1127-1131.2006; Bennett DE, 2004, J CLIN MICROBIOL, V42, P1764, DOI 10.1128/JCM.42.4.1764-1765.2004; Cavrini F, 2010, J CLIN MICROBIOL, V48, P3016, DOI 10.1128/JCM.00103-10; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Diggle MA, 2006, EXPERT REV MOL DIAGN, V6, P79, DOI 10.1586/14737159.6.1.79; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; FINNE J, 1983, LANCET, V2, P355; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Fraisier C, 2009, J CLIN MICROBIOL, V47, P2662, DOI 10.1128/JCM.02415-08; Frosch M., 2006, HDB MENINGOCOCCAL DI, P145, DOI DOI 10.1002/3527608508.CH8; Gasparini R, 2012, J Prev Med Hyg, V53, P50; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Guiver M, 2000, FEMS IMMUNOL MED MIC, V28, P173, DOI 10.1111/j.1574-695X.2000.tb01473.x; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Harris SL, 2011, HUM VACCINES, V7, P68, DOI 10.4161/hv.7.0.14564; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Jaton K, 2010, J CLIN MICROBIOL, V48, P4590, DOI 10.1128/JCM.01766-10; Jeppesen CA, 2015, J INFECT; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jordens JZ, 2005, J MED MICROBIOL, V54, P463, DOI 10.1099/jmm.0.45847-0; Khatami A, 2010, EXPERT REV VACCINES, V9, P285, DOI 10.1586/ERV.10.3; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Marsh JW, 2011, VACCINE, V29, P6049, DOI 10.1016/j.vaccine.2011.06.025; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Mueller JE, 2006, J INFECT DIS, V193, P812, DOI 10.1086/500511; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Read RC, 2014, CLIN MICROBIOL INFEC, V20, P391, DOI 10.1111/1469-0691.12647; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Richmond PC, 2012, LANCET INFECT DIS, V12, P597, DOI 10.1016/S1473-3099(12)70087-7; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; TOMMASSEN J, 1990, INFECT IMMUN, V58, P1355, DOI 10.1128/IAI.58.5.1355-1359.1990; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Tzanakaki G, 2003, FEMS IMMUNOL MED MIC, V39, P31, DOI 10.1016/S0928-8244(03)00175-5; Van der Ende A, 1999, INFECT IMMUN, V67, P2928, DOI 10.1128/IAI.67.6.2928-2934.1999; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Weinstock G, 2010, N SUBFLAVA; Whiley David M, 2003, Mol Diagn, V7, P141, DOI 10.2165/00066982-200307030-00001; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11; Zlotnick GW, 2015, HUM VACC IMMUNOTHER, V11, P5, DOI 10.4161/hv.34293	56	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132140	10.1371/journal.pone.0132140	http://dx.doi.org/10.1371/journal.pone.0132140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147212	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600206
J	Saad, MN; Mabrouk, MS; Eldeib, AM; Shaker, OG				Saad, Mohamed N.; Mabrouk, Mai S.; Eldeib, Ayman M.; Shaker, Olfat G.			Genetic Case-Control Study for Eight Polymorphisms Associated with Rheumatoid Arthritis	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; TRANSFORMING GROWTH-FACTOR-BETA-1 T869C; MTHFR GENE; INTEGRATED WORKBENCH; A1298C POLYMORPHISM; RISK-FACTOR; DISEASE; OSTEOPOROSIS; SUSCEPTIBILITY	Rheumatoid arthritis (RA) is an autoimmune disease which has a significant socio-economic impact. The aim of the current study was to investigate eight candidate RA susceptibility loci to identify the associated variants in Egyptian population. Eight single nucleotide polymorphisms (SNPs) (MTHFR-C677T and A1298C, TGF beta 1 T869C, TNFB A252G, and VDR-ApaI, BsmI, FokI, and TaqI) were tested by genotyping patients with RA (n = 105) and unrelated controls (n = 80). Associations were tested using multiplicative, dominant, recessive, and co-dominant models. Also, the linkage disequilibrium (LD) between the VDR SNPs was measured to detect any indirect association. By comparing RA patients with controls (TNFB, BsmI, and TaqI), SNPs were associated with RA using all models. MTHFR C677T was associated with RA using all models except the recessive model. TGF beta 1 and MTHFR A1298C were associated with RA using the dominant and the co-dominant models. The recessive model represented the association for ApaI variant. There were no significant differences for FokI and the presence of RA disease by the used models examination. For LD results, There was a high D' value between BsmI and FokI (D' = 0.91), but the r(2) value between them was poor. All the studied SNPs may contribute to the susceptibility of RA disease in Egyptian population except for FokI SNP.	[Saad, Mohamed N.] Menia Univ, Dept Biomed Engn, Al Minya, Egypt; [Mabrouk, Mai S.] Misr Univ Sci & Technol, Dept Biomed Engn, 6th Of October City, Egypt; [Eldeib, Ayman M.] Cairo Univ, Fac Engn, Syst & Biomed Engn Dept, Giza, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Med Biochem & Mol Biol Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Saad, MN (corresponding author), Menia Univ, Dept Biomed Engn, Al Minya, Egypt.	m.n.saad@ieee.org	Saad, Mohamed Nagy/AAF-7628-2019; O, Shaker/Y-6125-2019; Shaker, Olfat G/S-2010-2017; Issa, Randa @M.T/E-7144-2019	Saad, Mohamed Nagy/0000-0001-8229-0280; O, Shaker/0000-0002-3031-3599; Issa, Randa @M.T/0000-0003-0619-1234				Al-Rayes H, 2011, CLIN MED INSIGHTS-AR, V4, P55, DOI 10.4137/CMAMD.S6941; Alayli G, 2009, JOINT BONE SPINE, V76, P20, DOI 10.1016/j.jbspin.2008.02.012; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ates O, 2011, TURK J RHEUMATOL, V26, P145, DOI 10.5152/tjr.2011.021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berkun Y, 2004, ANN RHEUM DIS, V63, P1227, DOI 10.1136/ard.2003.016337; Chang WW, 2010, RHEUMATOLOGY, V49, P652, DOI 10.1093/rheumatology/kep417; Chatzikyriakidou A, 2013, SEMIN ARTHRITIS RHEU, V43, P29, DOI 10.1016/j.semarthrit.2012.12.003; Farouk HM, 2009, BRAZ J MED BIOL RES, V42, P831, DOI 10.1590/S0100-879X2009000900010; Munoz-Valle JF, 2012, RHEUMATOL INT, V32, P367, DOI 10.1007/s00296-010-1624-x; Garcia-Lozano JR, 2001, EUR J IMMUNOGENET, V28, P89, DOI 10.1046/j.1365-2370.2001.00233.x; Goertz B, 2003, CLIN EXP RHEUMATOL, V21, P333; Hitchon CA, 2012, J RHEUMATOL, V39, P1792, DOI 10.3899/jrheum.120387; Hughes LB, 2006, ANN RHEUM DIS, V65, P1213, DOI 10.1136/ard.2005.046797; Hussein YM, 2014, GENE, V536, P393, DOI 10.1016/j.gene.2013.11.042; Hussien YM, 2013, MOL BIOL REP, V40, P3675, DOI 10.1007/s11033-012-2443-9; Inanir A, 2013, IMMUNOL LETT, V152, P104, DOI 10.1016/j.imlet.2013.05.004; KARRAY EF, 2011, J INFECT DIS IMMUN, V3, P30; Karray EF, 2012, JOINT BONE SPINE, V79, P144, DOI 10.1016/j.jbspin.2011.06.003; Kim SY, 2004, SCAND J RHEUMATOL, V33, P389, DOI 10.1080/03009740410010344; Kobayashi T, 2009, J PERIODONTOL, V80, P792, DOI 10.1902/jop.2009.080573; Laird NM, 2010, FUNDAMENTALS MODERN, P99; Lee CK, 2001, J KOREAN MED SCI, V16, P188, DOI 10.3346/jkms.2001.16.2.188; Lee YH, 2010, CLIN DRUG INVEST, V30, P101, DOI 10.2165/11531070-000000000-00000; Brambila-Tapia AJL, 2012, DIS MARKERS, V32, P109, DOI [10.1155/2012/364894, 10.3233/DMA-2011-0868]; Lewis Cathryn M, 2012, Cold Spring Harb Protoc, V2012, P297, DOI 10.1101/pdb.top068163; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092272; Maalej A, 2005, GENES IMMUN, V6, P707, DOI 10.1038/sj.gene.6364260; Manni F, 2002, HUM BIOL, V74, P645, DOI 10.1353/hub.2002.0054; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Menegatti E, 2009, DIS MARKERS, V27, P217, DOI [10.1155/2009/435108, 10.3233/DMA-2009-0666]; Mosaad YM, 2014, HUM IMMUNOL, V75, P452, DOI 10.1016/j.humimm.2014.02.009; Mostowska A, 2013, MOL BIOL REP, V40, P803, DOI 10.1007/s11033-012-2118-6; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Panoulas VF, 2008, ANN RHEUM DIS, V67, P1550, DOI 10.1136/ard.2007.082594; Panoulas VF, 2009, RHEUMATOLOGY, V48, P113, DOI 10.1093/rheumatology/ken443; Pokorny V, 2003, ANN RHEUM DIS, V62, P907, DOI 10.1136/ard.62.9.907; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rass P, 2006, RHEUMATOL INT, V26, P964, DOI 10.1007/s00296-006-0106-7; Rubini M, 2008, CLIN EXP RHEUMATOL, V26, P163; Saad MN, 2016, J ADV RES, V7, P1, DOI 10.1016/j.jare.2015.01.008; Saad MN, 2015, GENE, V568, P124, DOI 10.1016/j.gene.2015.05.037; Saad MN, 2014, CAIRO INT BIOM ENG, P75, DOI 10.1109/CIBEC.2014.7020919; Santos MJ, 2011, J RHEUMATOL, V38, P1244, DOI 10.3899/jrheum.101170; Smriti Shukla, 2014, Advances in Genomics and Genetics, V4, P79; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Sugiura Y, 2002, ANN RHEUM DIS, V61, P826, DOI 10.1136/ard.61.9.826; Takeuchi F, 2005, CLIN EXP RHEUMATOL, V23, P494; Tizaoui K, 2014, CELL IMMUNOL, V290, P66, DOI 10.1016/j.cellimm.2014.05.002; Uitterlinden AG, 2004, J STEROID BIOCHEM, V89-90, P187, DOI 10.1016/j.jsbmb.2004.03.083; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; VANDEVYVER C, 1994, EUR J IMMUNOGENET, V21, P377, DOI 10.1111/j.1744-313X.1994.tb00208.x; Vinasco J, 1997, TISSUE ANTIGENS, V49, P74, DOI 10.1111/j.1399-0039.1997.tb02715.x; Wang Y, 2007, CHIN J PUBLIC HLTH, V23, P1405; Yoo JH, 2005, NUCLEIC ACIDS RES, V33, pW483, DOI 10.1093/nar/gki428; Yoo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-290; Zake LN, 2002, HUM IMMUNOL, V63, P418, DOI 10.1016/S0198-8859(02)00385-3; Zhang L, 2013, MOL BIOL REP, V40, P4811, DOI 10.1007/s11033-013-2577-4; Zhou TB, 2014, J RECEPT SIG TRANSD, V34, P469, DOI 10.3109/10799893.2014.919594; Zhu Y, 2006, JIANGSU MED J, V12, P1112	62	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131960	10.1371/journal.pone.0131960	http://dx.doi.org/10.1371/journal.pone.0131960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147289	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600171
J	Schiattarella, GG; Cerulo, G; De Pasquale, V; Cocchiaro, P; Paciello, O; Avallone, L; Belfiore, MP; Iacobellis, F; Di Napoli, D; Magliulo, F; Perrino, C; Trimarco, B; Esposito, G; Di Natale, P; Pavone, LM				Schiattarella, Gabriele Giacomo; Cerulo, Giuliana; De Pasquale, Valeria; Cocchiaro, Pasquale; Paciello, Orlando; Avallone, Luigi; Belfiore, Maria Paola; Iacobellis, Francesca; Di Napoli, Daniele; Magliulo, Fabio; Perrino, Cinzia; Trimarco, Bruno; Esposito, Giovanni; Di Natale, Paola; Pavone, Luigi Michele			The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; MOUSE MODEL; CARDIOVASCULAR CHANGES; GENE-THERAPY; SUDDEN-DEATH; DISEASE; AUTOPHAGY; CHILDREN; ECHOCARDIOGRAPHY; MANIFESTATIONS	Mucopolysaccharidosis (MPS) IIIB is a lysosomal disease due to the deficiency of the enzyme alpha-N-acetylglucosaminidase (NAGLU) required for heparan sulfate (HS) degradation. The disease is characterized by mild somatic features and severe neurological disorders. Very little is known on the cardiac dysfunctions in MPS IIIB. In this study, we used the murine model of MPS IIIB (NAGLU knockout mice, NAGLU(-/-)) in order to investigate the cardiac involvement in the disease. Echocardiographic analysis showed a marked increase in left ventricular (LV) mass, reduced cardiac function and valvular defects in NAGLU(-/-) mice as compared to wild-type (WT) littermates. The NAGLU(-/-) mice exhibited a significant increase in aortic and mitral annulus dimension with a progressive elongation and thickening of anterior mitral valve leaflet. A severe mitral regurgitation with reduction in mitral inflow E-wave-toA- wave ratio was observed in 32-week-old NAGLU(-/-) mice. Compared to WT mice, NAGLU(-/-) mice exhibited a significantly lower survival with increased mortality observed in particular after 25 weeks of age. Histopathological analysis revealed a significant increase of myocardial fiber vacuolization, accumulation of HS in the myocardial vacuoles, recruitment of inflammatory cells and collagen deposition within the myocardium, and an increase of LV fibrosis in NAGLU(-/-) mice compared to WT mice. Biochemical analysis of heart samples from affected mice showed increased expression levels of cardiac failure hallmarks such as calcium/calmodulin-dependent protein kinase II, connexin43, alpha-smooth muscle actin, a-actinin, atrial and brain natriuretic peptides, and myosin heavy polypeptide 7. Furthermore, heart samples from NAGLU(-/-) mice showed enhanced expression of the lysosome-associated membrane protein-2 (LAMP2), and the autophagic markers Beclin1 and LC3 isoform II (LC3II). Overall, our findings demonstrate that NAGLU(-/-) mice develop heart disease, valvular abnormalities and cardiac failure associated with an impaired lysosomal autophagic flux.	[Cerulo, Giuliana; De Pasquale, Valeria; Cocchiaro, Pasquale; Di Natale, Paola; Pavone, Luigi Michele] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Schiattarella, Gabriele Giacomo; Magliulo, Fabio; Perrino, Cinzia; Trimarco, Bruno; Esposito, Giovanni] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Cerulo, Giuliana; Cocchiaro, Pasquale; Paciello, Orlando; Avallone, Luigi] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Belfiore, Maria Paola; Iacobellis, Francesca] Univ Naples 2, Dept Radiol, Naples, Italy; [Di Napoli, Daniele] AORN Cardarelli, Ctr Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli	Pavone, LM (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	luigimichele.pavone@unina.it	Schiattarella, Gabriele G/M-9506-2017; Belfiore, Maria Paola/ABR-6442-2022; Pavone, Luigi Michele/H-3403-2012; Schiattarella, Gabriele/Z-2624-2019; De+Pasquale, Valeria/CAG-0544-2022; Perrino, Cinzia/K-3183-2016; Trimarco, Bruno BT/K-7851-2016; Esposito, Giovanni/F-2880-2010	Schiattarella, Gabriele G/0000-0002-7582-7171; Schiattarella, Gabriele/0000-0002-7582-7171; Perrino, Cinzia/0000-0002-2274-0048; Trimarco, Bruno BT/0000-0002-0701-6449; Esposito, Giovanni/0000-0003-0565-7127; Pavone, Luigi Michele/0000-0002-5145-7428; Iacobellis, Francesca/0000-0003-4604-7384; Magliulo, Fabio/0000-0003-3387-8517; De Pasquale, Valeria/0000-0001-5285-1980; Belfiore, Maria Paola/0000-0001-8219-1493	Italian Ministry of Health-Young Researcher Grant; Italian Ministry of Health-FIRB Grant (Futuro in Ricerca)	Italian Ministry of Health-Young Researcher Grant; Italian Ministry of Health-FIRB Grant (Futuro in Ricerca)	This study was supported in part by grants from the Italian Ministry of Health-Young Researcher Grant (2009) and from the Italian Ministry of Health-FIRB 2012 Grant (Futuro in Ricerca) to C.P.	Angrisano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106024; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Belfiore MP, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-39; Bigg PW, 2013, MOL GENET METAB, V110, P319, DOI 10.1016/j.ymgme.2013.06.013; Brands MMMG, 2013, J INHERIT METAB DIS, V36, P227, DOI 10.1007/s10545-011-9444-z; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Dangel JH, 1998, EUR J PEDIATR, V157, P534, DOI 10.1007/s004310050872; de Oliveira PG, 2013, INT J EXP PATHOL, V94, P305, DOI 10.1111/iep.12033; Di Natale P, 2005, BIOCHEM J, V388, P639, DOI 10.1042/BJ20041702; Fox JE, 2015, MOL GENET METAB, V114, P203, DOI 10.1016/j.ymgme.2014.10.017; Golda A, 2012, INT J CARDIOL, V158, P6, DOI 10.1016/j.ijcard.2011.06.097; Hishitani T, 2000, J PEDIATR-US, V136, P268, DOI 10.1016/S0022-3476(00)70117-X; Jordan MC, 2005, MOL GENET METAB, V86, P233, DOI 10.1016/j.ymgme.2005.05.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kostin S, 2000, Heart Fail Rev, V5, P271; Leal GN, 2010, CARDIOL YOUNG, V20, P254, DOI 10.1017/S104795110999062X; Lee SC, 2014, MOL GENET METAB, V112, P218, DOI 10.1016/j.ymgme.2014.04.005; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Lin HY, 2005, J INHERIT METAB DIS, V28, P1146, DOI 10.1007/s10545-005-0211-x; Martins AM, 2009, J PEDIATR-US, V155, pS32, DOI 10.1016/j.jpeds.2009.07.005; Mohan UR, 2002, ACTA PAEDIATR, V91, P799, DOI 10.1080/08035250213211; Muenzer J, 2014, MOL GENET METAB, V111, P63, DOI 10.1016/j.ymgme.2013.11.015; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Pavone LM, 2009, J MOL CELL CARDIOL, V47, P691, DOI 10.1016/j.yjmcc.2009.07.021; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Perrino C, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000086; Ponder KP, 2007, EXPERT OPIN BIOL TH, V7, P1333, DOI 10.1517/14712598.7.9.1333; Prasad VK, 2010, SEMIN HEMATOL, V47, P59, DOI 10.1053/j.seminhematol.2009.10.008; RENTERIA VG, 1976, AM J CARDIOL, V38, P487, DOI 10.1016/0002-9149(76)90468-9; Rigante D, 2002, CARDIOLOGY, V98, P18, DOI 10.1159/000064674; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Severs NJ, 2006, ADV CARDIOL, V42, P228, DOI 10.1159/000092572; Sleeper MM, 2004, CIRCULATION, V110, P815, DOI 10.1161/01.CIR.0000138747.82487.4B; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Wendel B, 2000, J CELL BIOCHEM, V79, P566, DOI 10.1002/1097-4644(20001215)79:4<566::AID-JCB50>3.0.CO;2-E	40	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131662	10.1371/journal.pone.0131662	http://dx.doi.org/10.1371/journal.pone.0131662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147524	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358157600120
J	Wong, G; Wong, I; Chan, K; Hsieh, YC; Wong, S				Wong, Grace; Wong, Isaac; Chan, Kamfai; Hsieh, Yicheng; Wong, Season			A Rapid and Low-Cost PCR Thermal Cycler for Low Resource Settings	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; CONTINUOUS-FLOW PCR; REACTION AMPLIFICATION; MICROFLUIDIC DEVICES; INFECTIOUS-DISEASES; SAMPLE PREPARATION; DNA AMPLIFICATION; ESCHERICHIA-COLI; CHIP	Background Many modern molecular diagnostic assays targeting nucleic acids are typically confined to developed countries or to the national reference laboratories of developing-world countries. The ability to make technologies for the rapid diagnosis of infectious diseases broadly available in a portable, low-cost format would mark a revolutionary step forward in global health. Many molecular assays are also developed based on polymerase chain reactions (PCR), which require thermal cyclers that are relatively heavy (>20 pounds) and need continuous electrical power. The temperature ramping speed of most economical thermal cyclers are relatively slow (2 to 3 degrees C/s) so a polymerase chain reaction can take 1 to 2 hours. Most of all, these thermal cyclers are still too expensive ($2k to $4k) for low-resource setting uses. Methodology/Principal Findings In this article, we demonstrate the development of a low-cost and rapid water bath based thermal cycler that does not require active temperature control or continuous power supply during PCR. This unit costs $130 to build using commercial off-the-shelf items. The use of two or three vacuum-insulated stainless-steel Thermos food jars containing heated water (for denaturation and annealing/extension steps) and a layer of oil on top of the water allow for significantly stabilized temperatures for PCR to take place. Using an Arduino-based microcontroller, we automate the "archaic" method of hand-transferring PCR tubes between water baths. Conclusions/Significance We demonstrate that this innovative unit can deliver high speed PCR (17 s per PCR cycle) with the potential to go beyond the 1,522 bp long amplicons tested in this study and can amplify from templates down to at least 20 copies per reaction. The unit also accepts regular PCR tubes and glass capillary tubes. The PCR efficiency of our thermal cycler is not different from other commercial thermal cyclers. When combined with a rapid nucleic acid detection approach, the thermos thermal cycler (TTC) can enable on-site molecular diagnostics in low-resource settings.	[Wong, Grace; Wong, Isaac; Chan, Kamfai; Hsieh, Yicheng; Wong, Season] Al Biosci Inc, College Stn, TX USA		Wong, S (corresponding author), Al Biosci Inc, College Stn, TX USA.	season.wong@aibiosciences.com			Small Business Innovative Research (SBIR) grants from the US National Institutes of Health [1R43AI106239-01A1, 1R43EB018641-01]; AI Biosciences, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI106239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R43EB018641] Funding Source: NIH RePORTER	Small Business Innovative Research (SBIR) grants from the US National Institutes of Health; AI Biosciences, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by the Small Business Innovative Research (SBIR) grants from the US National Institutes of Health, Grant #s 1R43AI106239-01A1 and 1R43EB018641-01 and AI Biosciences, Inc. The funder AI Biosciences, Inc., provided support in the form of salaries for authors GW, IW, KC, YH, and SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgrader P, 2003, ANAL CHEM, V75, P3446, DOI 10.1021/ac034062u; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Brooks HA, 2005, J VIROL METHODS, V127, P109, DOI 10.1016/j.jviromet.2005.03.017; Butler D, 2006, NATURE, V440, P6, DOI 10.1038/440006a; Chen ZY, 2004, ANAL CHEM, V76, P3707, DOI 10.1021/ac049914k; Cheng JY, 2005, ANALYST, V130, P931, DOI 10.1039/b501061f; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Chiou J, 2001, ANAL CHEM, V73, P2018, DOI 10.1021/ac001227f; Elenitoba-Johnson O, 2008, BIOTECHNIQUES, V44, P487, DOI 10.2144/000112722; Farrar JS, 2015, CLIN CHEM, V61, P145, DOI 10.1373/clinchem.2014.228304; Frey O, 2007, BIOMED MICRODEVICES, V9, P711, DOI 10.1007/s10544-007-9080-4; Hennig M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2051787; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Lin MH, 2001, CLIN BIOCHEM, V34, P661, DOI 10.1016/S0009-9120(01)00281-8; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Logan J., 2009, REAL TIME PCR CURREN; Lounsbury JA, 2013, LAB CHIP, V13, P1384, DOI 10.1039/c3lc41326h; MANNUCCI A, 1994, INT J LEGAL MED, V106, P190, DOI 10.1007/BF01371335; Nachamkin I, 1997, CLIN INFECT DIS, V24, P894, DOI 10.1093/clinids/24.5.894; Noble RT, 2010, APPL ENVIRON MICROB, V76, P7437, DOI 10.1128/AEM.00651-10; Obeid PJ, 2003, ANAL CHEM, V75, P288, DOI 10.1021/ac0260239; Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i; Oh MH, 2009, J FOOD PROTECT, V72, P1262, DOI 10.4315/0362-028X-72.6.1262; Pipper J, 2008, ANGEW CHEM INT EDIT, V47, P3900, DOI 10.1002/anie.200705016; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Sun K, 2002, SENSOR ACTUAT B-CHEM, V84, P283, DOI 10.1016/S0925-4005(02)00016-3; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Walker FM, 2014, ANAL CHEM, V86, P9236, DOI 10.1021/ac5022419; Wang H, 2006, ANAL CHEM, V78, P6223, DOI 10.1021/ac060568b; WEISSENSTEINER T, 2004, PCR TECHNOLOGY CURRE; Wheeler EK, 2011, ANALYST, V136, P3707, DOI 10.1039/c1an15365j; Wheeler EK, 2004, ANAL CHEM, V76, P4011, DOI 10.1021/ac034941g; WITTWER CT, 1989, NUCLEIC ACIDS RES, V17, P4353, DOI 10.1093/nar/17.11.4353; Xiang Q, 2005, BIOMED MICRODEVICES, V7, P273, DOI 10.1007/s10544-005-6069-8; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Yoon DS, 2002, J MICROMECH MICROENG, V12, P813, DOI 10.1088/0960-1317/12/6/312; Yu CY, 2007, J CHIN INST CHEM ENG, V38, P333, DOI 10.1016/j.jcice.2007.05.001; Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002; [No title captured]	44	37	38	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131701	10.1371/journal.pone.0131701	http://dx.doi.org/10.1371/journal.pone.0131701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146999	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600132
J	Al Nimer, F; Thelin, E; Nystrom, H; Dring, AM; Svenningsson, A; Piehl, F; Nelson, DW; Bellander, BM				Al Nimer, Faiez; Thelin, Eric; Nystrom, Harriet; Dring, Ann M.; Svenningsson, Anders; Piehl, Fredrik; Nelson, David W.; Bellander, Bo-Michael			Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; AMYOTROPHIC-LATERAL-SCLEROSIS; GLASGOW COMA SCALE; HEAD-INJURY; PREDICTIVE-VALUE; BARRIER CHANGES; SEVERITY SCORE; AXONAL INJURY; S100B LEVELS; BLOOD	Traumatic brain injury (TBI) is a common cause of death and disability, worldwide. Early determination of injury severity is essential to improve care. Neurofilament light (NF-L) has been introduced as a marker of neuroaxonal injury in neuroinflammatory/-degenerative diseases. In this study we determined the predictive power of serum (s-) and cerebrospinal fluid (CSF-) NF-L levels towards outcome, and explored their potential correlation to diffuse axonal injury (DAI). A total of 182 patients suffering from TBI admitted to the neurointensive care unit at a level 1 trauma center were included. S-NF-L levels were acquired, together with S100B and neuron-specific enolase (NSE). CSF-NF-L was measured in a subcohort (n = 84) with ventriculostomies. Clinical and neuro-radiological parameters, including computerized tomography (CT) and magnetic resonance imaging, were included in the analyses. Outcome was assessed 6 to 12 months after injury using the Glasgow Outcome Score (1-5). In univariate proportional odds analyses mean s-NF-L, -S100B and -NSE levels presented a pseudo-R-2 Nagelkerke of 0.062, 0.214 and 0.074 in correlation to outcome, respectively. In a multivariate analysis, in addition to a model including core parameters (pseudo-R-2 0.33 towards outcome; Age, Glasgow Coma Scale, pupil response, Stockholm CT score, abbreviated injury severity score, S100B), S-NF-L yielded an extra 0.023 pseudo-R-2 and a significantly better model (p = 0.006) No correlation between DAI or CT assessed-intracranial damage and NF-L was found. Our study thus demonstrates that SNF-L correlates to TBI outcome, even if used in models with S100B, indicating an independent contribution to the prediction, perhaps by reflecting different pathophysiological processes, not possible to monitor using conventional neuroradiology. Although we did not find a predictive value of NF-L for DAI, this cannot be completely excluded. We suggest further	[Al Nimer, Faiez; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Thelin, Eric; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Stockholm, Sweden; [Nystrom, Harriet] Karolinska Inst, Dept Clin Neurosci, Neuroradiol Sect, Stockholm, Sweden; [Dring, Ann M.; Svenningsson, Anders] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Umea University; Karolinska Institutet	Thelin, E (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Stockholm, Sweden.	eric.thelin@ki.se	Nimer, Faiez Al/ABB-9465-2020; Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364; Nelson, David/0000-0003-2530-8207; Al Nimer, Faiez/0000-0003-0937-5995; Svenningsson, Anders/0000-0003-0663-2220; Piehl, Fredrik/0000-0001-8329-5219	Roche Diagnostics	Roche Diagnostics	The authors have read the journal's policy and have the following competing interests: BM and ET received funds from Roche Diagnostics as compensation for lectures concerning other procedures/products in the past. However, the authors certify that this did not in any way influence their objectivity in the current study. Concerning the funding, authors ET and BM wish to declare that this did not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Barry DM, 2007, EXP CELL RES, V313, P2110, DOI 10.1016/j.yexcr.2007.03.011; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P243; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Bergman AS, 2009, VERIFICATIO IN PRESS; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Disanto G, 2016, J NEUROL NEUROSUR PS, V87, P126, DOI 10.1136/jnnp-2014-309690; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; JENNETT B, 1975, LANCET, V1, P480; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schmidt FM, 2015, WORLD J BIOL PSYCHIA, V16, P106, DOI 10.3109/15622975.2014.952776; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; SMITH ME, 1984, NEUROCHEM RES, V9, P1493, DOI 10.1007/BF00964675; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Thelin EP, 2012, S100B IS IMPORTANT O; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Tortelli R, 2012, EUR J NEUROL, V19, P1561, DOI 10.1111/j.1468-1331.2012.03777.x; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vajtr D, 2012, Soud Lek, V57, P7; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	70	76	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132177	10.1371/journal.pone.0132177	http://dx.doi.org/10.1371/journal.pone.0132177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136237	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400103
J	Dorado, S; Booe, T; Steichen, J; McInnes, AS; Windham, R; Shepard, A; Lucchese, AEB; Preischel, H; Pinckney, JL; Davis, SE; Roelke, DL; Quigg, A				Dorado, Samuel; Booe, Tyra; Steichen, Jamie; McInnes, Allison S.; Windham, Rachel; Shepard, Alicia; Lucchese, Allyson E. B.; Preischel, Hannah; Pinckney, James L.; Davis, Stephen E.; Roelke, Daniel L.; Quigg, Antonietta			Towards an Understanding of the Interactions between Freshwater Inflows and Phytoplankton Communities in a Subtropical Estuary in the Gulf of Mexico	PLOS ONE			English	Article							COASTAL MARINE ECOSYSTEMS; GALVESTON-BAY; FOOD WEBS; NUTRIENT; RIVER; TEXAS; FLOW; USA; EUTROPHICATION; PRODUCTIVITY	Subtropical estuaries worldwide face increased pressure on their ecosystem health and services due to increasing human population growth and associated land use/land cover changes, expansion of ports, and climate change. We investigated freshwater inflows (river discharge) and the physico-chemical characteristics of Galveston Bay (Texas, USA) as mechanisms driving variability in phytoplankton biomass and community composition between February 2008 and December 2009. Results of multivariate analyses (hierarchical cluster analysis, PERMANOVA, Mantel test, and nMDS ordination coupled to environmental vector fitting) revealed that temporal and spatial differences in phytoplankton community structure correlate to differences in hydrographic and water quality parameters. Spatially, phytoplankton biomass and community composition responded to nutrient loading from the San Jacinto River in the northwest region of the bay (consistent with nutrient limitation) while hydraulic displacement (and perhaps other processes) resulted in overall lower biomass in the Trinity River delta (northeast region). The influence of inflows on phytoplankton diminished along a north to south gradient in the bay. Temporally, temperature and variables associated with freshwater inflow (discharge volume, salinity, inorganic nitrogen and phosphorus concentrations) were major influences on phytoplankton dynamics. Dissolved inorganic nitrogen: phosphorus (DIN: DIP) ratios suggest that phytoplankton communities will be predominately nitrogen limited. Diatoms dominated during periods of moderate to high freshwater inflows in winter/spring and were more abundant in the upper bay while cyanobacteria dominated during summer/fall when inflow was low. Given the differential influences of freshwater inflow on the phytoplankton communities of Galveston Bay, alterations upstream (magnitude, timing, frequency) will likely have a profound effect on downstream ecological processes and corresponding ecosystem services.	[Dorado, Samuel; Booe, Tyra; Steichen, Jamie; Windham, Rachel; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Steichen, Jamie; McInnes, Allison S.; Shepard, Alicia; Lucchese, Allyson E. B.; Preischel, Hannah; Roelke, Daniel L.; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Pinckney, James L.] Univ S Carolina, Biol Sci, Columbia, SC 29208 USA; [Pinckney, James L.] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; [Davis, Stephen E.; Roelke, Daniel L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Davis, Stephen E.] Everglades Fdn, Palmetto Bay, FL 33157 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Texas A&M University System; Texas A&M University College Station	Quigg, A (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	quigga@tamug.edu	Steichen, Jamie/Y-1153-2019; Roelke, Daniel L/B-5766-2008; McInnes, Allison/H-5694-2016	Roelke, Daniel L/0000-0002-3166-3793; Pinckney, James/0000-0002-6056-6511; Steichen, Jamie/0000-0002-6752-869X; McInnes, Allison/0000-0002-8340-3133	Texas Sea Grant [NA06OAR4170076]; Texas Water Development Board [0904830894, 1004831016]; Texas Commission for Environmental Quality [CE-00F208-01-0]; Coastal Coordination Council under NOAA [NA08NOS4190458]	Texas Sea Grant; Texas Water Development Board; Texas Commission for Environmental Quality; Coastal Coordination Council under NOAA	This research was supported by grants from Texas Sea Grant (NA06OAR4170076), Texas Water Development Board (0904830894 and 1004831016), the Texas Commission for Environmental Quality (CE-00F208-01-0) and the Coastal Coordination Council under NOAA (NA08NOS4190458).	Anderson MJ, 2005, PERMANOVA FORTRAN CO; [Anonymous], 2010, CLUSTSIG SIGNIFICANT; Armstrong NE, 1993, GALVESTON BAY NATL E; Badylak S, 2004, J PLANKTON RES, V26, P1229, DOI 10.1093/plankt/fbh114; Borcard D, 2012, ECOLOGY, V93, P1473; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Buyukates Yesim, 2005, Journal of Applied Sciences, V5, P820; Buzan D, 2009, ESTUAR COAST, V32, P206, DOI 10.1007/s12237-008-9078-z; Chan TU, 2001, MAR FRESHWATER RES, V52, P869, DOI 10.1071/MF00088; Choudhury AK, 2011, ENVIRON MONIT ASSESS, V179, P531, DOI 10.1007/s10661-010-1761-4; Cloern JE, 2008, ECOL LETT, V11, P1294, DOI 10.1111/j.1461-0248.2008.01244.x; Cloern JE, 2010, ESTUAR COAST, V33, P230, DOI 10.1007/s12237-009-9195-3; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Dagg MJ, 2007, ESTUAR COAST, V30, P735, DOI 10.1007/BF02841331; DEJONGE VN, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P179; Dorado S, 2012, MAR ECOL PROG SER, V464, P37, DOI 10.3354/meps09854; Fisher TR, 1999, MAR BIOL, V133, P763, DOI 10.1007/s002270050518; Flemer DA, 2006, MAR POLLUT BULL, V52, P247, DOI 10.1016/j.marpolbul.2005.11.027; Floehr T, 2013, ENVIRON SCI POLLUT R, V20, P6934, DOI 10.1007/s11356-013-1666-1; Gonzalez LA, 2011, STATE BAY CHARACTERI; Guthrie CG, 2012, R0100010015 US ARM C; Hall NS, 2013, ESTUAR COAST SHELF S, V117, P70, DOI 10.1016/j.ecss.2012.10.004; Hetland RD, 2008, J MARINE SYST, V70, P49, DOI 10.1016/j.jmarsys.2007.03.002; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; JOHNS ND, 2004, BAYS PERIL FORECAST; Laurent A, 2012, BIOGEOSCIENCES, V9, P4707, DOI 10.5194/bg-9-4707-2012; Longley W.L, 1994, FRESHWATER INFLOWS T; MALONE TC, 1988, MAR ECOL PROG SER, V48, P235, DOI 10.3354/meps048235; MANTEL N, 1967, CANCER RES, V27, P209; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Milliman JD, 2008, GLOBAL PLANET CHANGE, V62, P187, DOI 10.1016/j.gloplacha.2008.03.001; Mitrovic SM, 2011, J PLANKTON RES, V33, P229, DOI 10.1093/plankt/fbq094; Montagna P.A., 2011, IMPACT GLOBAL WARMIN, P96, DOI DOI 10.7560/723306.8; Nixon SW, 2002, ESTUARIES, V25, P782, DOI 10.1007/BF02804905; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Olsen Y, 2001, CONT SHELF RES, V21, P2043, DOI 10.1016/S0278-4343(01)00041-3; Ornolfsdottir EB, 2004, J EXP MAR BIOL ECOL, V303, P197, DOI 10.1016/j.jembe.2003.11.016; Ornolfsdottir EB, 2004, J PLANKTON RES, V26, P325, DOI 10.1093/plankt/fbh035; Paerl HW, 2014, ESTUAR COAST, V37, P243, DOI 10.1007/s12237-014-9773-x; Paerl HW, 2003, BIOSCIENCE, V53, P953, DOI 10.1641/0006-3568(2003)053[0953:PPAIOE]2.0.CO;2; Pinckney J.L., 2006, FUNCTIONING MICROPHY, P141; Pinckney JL, 1996, J PLANKTON RES, V18, P1867, DOI 10.1093/plankt/18.10.1867; Quigg A, 2013, CE00F208010 US EPA; Quigg A, 2013, CONT SHELF RES, V60, P1, DOI 10.1016/j.csr.2013.04.015; Quigg A, 2011, AQUAT GEOCHEM, V17, P519, DOI 10.1007/s10498-011-9134-3; Quigg Antonietta, 2010, Memoirs of the Queensland Museum, V54, P355; R Core Team, 2012, R LANG ENV STAT COMP; Richter BD, 2007, ECOL SOC, V12; Roelke DL, 2013, MAR ECOL PROG SER, V477, P61, DOI 10.3354/meps10182; Russell MJ, 2006, ESTUAR COAST SHELF S, V68, P231, DOI 10.1016/j.ecss.2006.02.005; SANTSCHI PH, 1995, MAR ENVIRON RES, V40, P337, DOI 10.1016/0141-1136(95)92644-J; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Smayda T.J., 1980, PHYSL ECOLOGY PHYTOP, P493; Spatharis S, 2007, ESTUAR COAST SHELF S, V73, P807, DOI 10.1016/j.ecss.2007.03.016; STEICHEN J, 2014, B MAR POLL, V87, P201; Steichen JL, 2012, MAR POLLUT BULL, V64, P779, DOI 10.1016/j.marpolbul.2012.01.028; Sylvan JB, 2006, ENVIRON SCI TECHNOL, V40, P7548, DOI 10.1021/es061417t; Texas Water Development Board, 2007, GP81 TEX WAT DEV BOA; Thronson A, 2008, ESTUAR COAST, V31, P802, DOI 10.1007/s12237-008-9056-5; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Wahaab RA, 2004, BIOMED ENVIRON SCI, V17, P87; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wetz MS, 2011, LIMNOL OCEANOGR, V56, P627, DOI 10.4319/lo.2011.56.2.0627; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	64	33	33	5	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130931	10.1371/journal.pone.0130931	http://dx.doi.org/10.1371/journal.pone.0130931			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133991	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400028
J	Lindner, E; Weger, M; Ardjomand, N; Renner, W; El-Shabrawi, Y				Lindner, Ewald; Weger, Martin; Ardjomand, Navid; Renner, Wilfried; El-Shabrawi, Yosuf			Associations of Independent IL2RA Gene Variants with Intermediate Uveitis	PLOS ONE			English	Article							REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; SOLUBLE INTERLEUKIN-2-RECEPTOR; GRAVES-DISEASE; POLYMORPHISM; REGION; RATS	Purpose The genetic background for the concomitance of uveitis and other autoimmune diseases remains elusive. Here the role of two IL2RA gene variants (rs11594656 and rs12722495) was investigated in intermediate uveitis and HLAB27 acute anterior uveitis. Materials and Methods One hundred fifty-nine patients with HLAB27 acute anterior uveitis, 85 patients with intermediate uveitis, 138 HLAB27 negative controls and 100 HLAB27 positive controls were recruited for this case-control study. Main outcome measures were genotype distribution and allelic frequencies determined by polymerase chain reaction. Results The frequencies of carriers of the minor allele at rs11594656 and rs12722495 were significantly different in patients with intermediate uveitis compared to HLAB27 positive and negative controls combined (p<0.05). For rs12722495 the minor G allele was protective (genotypic OR: 0.29 [0.12-0.69]), and for rs11594656 the minor A allele conferred risk (genotypic OR: 1.59 [1.09-2.32]). No significant differences in genotype distribution were found between patients with HLAB27 acute anterior uveitis and HLAB27 positive or negative control subjects. Conclusions We found rs11594656 and rs12722495 to be associated with intermediate uveitis but not with HLAB27 acute anterior uveitis. The genetic heterogeneity found at the IL2RA locus could help explain patterns of concomitance with other autoimmune diseases.	[Lindner, Ewald; Weger, Martin; Ardjomand, Navid] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Renner, Wilfried] Med Univ Graz, Inst Clin Med, Graz, Austria; [Renner, Wilfried] Med Univ Graz, Chem Lab Diagnost, Graz, Austria; [El-Shabrawi, Yosuf] Klinikum Klagenfurt, Dept Ophthalmol, Klagenfurt, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Lindner, E (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	ewald.lindner@medunigraz.at	Lindner, Ewald/CAG-1831-2022; Lindner, Ewald/AEM-1071-2022	Lindner, Ewald/0000-0001-9651-8573; 				Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Cenit MC, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-52; Cheng Shi-ping, 2005, Chin J Integr Med, V11, P65; Chistiakov DA, 2011, SCAND J IMMUNOL, V74, P496, DOI 10.1111/j.1365-3083.2011.02608.x; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Garg G, 2012, J IMMUNOL, V188, P4644, DOI 10.4049/jimmunol.1100272; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kuuliala A, 2005, SCAND J RHEUMATOL, V34, P372, DOI 10.1080/03009740510026553; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; Le Scanff J, 2008, MULT SCLER J, V14, P415, DOI 10.1177/1352458507083444; Lindner E, 2011, INVEST OPHTH VIS SCI, V52, P8295, DOI 10.1167/iovs.11-8163; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Mao CM, 2011, J IMMUNOL, V186, P4734, DOI 10.4049/jimmunol.0904135; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; SRIVASTAVA MD, 1995, RES COMMUN MOL PATH, V87, P21; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8; Zein G, 2004, OCUL IMMUNOL INFLAMM, V12, P137, DOI 10.1080/09273940490895344	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130737	10.1371/journal.pone.0130737	http://dx.doi.org/10.1371/journal.pone.0130737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133380	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400025
J	Qi, Y; Liu, XP; Liu, CG; Wang, BL; Hess, KR; Symmans, WF; Shi, WW; Pusztai, L				Qi, Yuan; Liu, Xiuping; Liu, Chang-gong; Wang, Bailing; Hess, Kenneth R.; Symmans, W. Fraser; Shi, Weiwei; Pusztai, Lajos			Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments	PLOS ONE			English	Article							CANCER; DNA	Nucleotide alterations detected by next generation sequencing are not always true biological changes but could represent sequencing errors. Even highly accurate methods can yield substantial error rates when applied to millions of nucleotides. In this study, we examined the reproducibility of nucleotide variant calls in replicate sequencing experiments of the same genomic DNA. We performed targeted sequencing of all known human protein kinase genes (kinome) (similar to 3.2 Mb) using the SOLiD v4 platform. Seventeen breast cancer samples were sequenced in duplicate (n=14) or triplicate (n=3) to assess concordance of all calls and single nucleotide variant (SNV) calls. The concordance rates over the entire sequenced region were >99.99%, while the concordance rates for SNVs were 54.3-75.5%. There was substantial variation in basic sequencing metrics from experiment to experiment. The type of nucleotide substitution and genomic location of the variant had little impact on concordance but concordance increased with coverage level, variant allele count (VAC), variant allele frequency (VAF), variant allele quality and p-value of SNV-call. The most important determinants of concordance were VAC and VAF. Even using the highest stringency of QC metrics the reproducibility of SNV calls was around 80% suggesting that erroneous variant calling can be as high as 20-40% in a single experiment. The sequence data have been deposited into the European Genome-phenome Archive (EGA) with accession number EGAS00001000826.	[Qi, Yuan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Qi, Yuan] Univ Texas MD Anderson Canc Ctr, Dept Computat Biol, Houston, TX 77030 USA; [Liu, Xiuping; Liu, Chang-gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Wang, Bailing] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Hess, Kenneth R.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Symmans, W. Fraser] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Shi, Weiwei; Pusztai, Lajos] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06504 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yale University	Pusztai, L (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06504 USA.	lajos.pusztai@yale.edu	Pusztai, Lajos/AAB-2901-2019; Hess, Kenneth/K-6546-2019	Hess, Kenneth/0000-0003-1377-6070	Breast Cancer Research Foundation; UT MD Anderson Cancer Center [2P30 CA016672]; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; UT MDACC Breast SPORE grant of the National Institutes of Health [P50 CA116199]; Perot Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA116199] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; UT MD Anderson Cancer Center; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; UT MDACC Breast SPORE grant of the National Institutes of Health; Perot Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Breast Cancer Research Foundation to L.P.; the UT MD Anderson Cancer Center Support Grant (2P30 CA016672) and the Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine to Y.Q.; the UT MDACC Breast SPORE grant of the National Institutes of Health (P50 CA116199) to G.N.H.; and the Perot Foundation to G.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Heinrich V, 2012, NUCLEIC ACIDS RES, V40, P2426, DOI 10.1093/nar/gkr1073; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Londin ER, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-464; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	14	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0119230	10.1371/journal.pone.0119230	http://dx.doi.org/10.1371/journal.pone.0119230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136146	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400003
J	Skinner, PJ; Kim, HO; Bryant, D; Kinzel, NJ; Reilly, C; Priola, SA; Ward, AE; Goodman, PA; Olson, K; Seelig, DM				Skinner, Pamela J.; Kim, Hyeon O.; Bryant, Damani; Kinzel, Nikilyn J.; Reilly, Cavan; Priola, Suzette A.; Ward, Anne E.; Goodman, Patricia A.; Olson, Katherine; Seelig, Davis M.			Treatment of Prion Disease with Heterologous Prion Proteins	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRP ISOFORMS; CELLULAR PRP; SCRAPIE; CONVERSION; RESISTANT; MOUSE; TRANSMISSION; ACCUMULATION; INHIBITION	Prion diseases such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy in cattle, and scrapie in sheep are fatal neurodegenerative diseases for which there is no effective treatment. The pathology of these diseases involves the conversion of a protease sensitive form of the cellular prion protein (PrPC) into a protease resistant infectious form (PrPsc or PrPres). Both in vitro (cell culture and cell free conversion assays) and in vivo (animal) studies have demonstrated the strong dependence of this conversion process on protein sequence homology between the initial prion inoculum and the host's own cellular prion protein. The presence of non-homologous (heterologous) proteins is often inhibitory to this conversion process. We hypothesize that the presence of heterologous prion proteins from one species might therefore constitute an effective treatment for prion disease in another species. To test this hypothesis, we infected mice intracerebrally with murine adapted RML-Chandler scrapie and treated them with heterologous prion protein (purified bacterially expressed recombinant hamster prion protein) or vehicle alone. Treated animals demonstrated reduced disease associated pathology, decreased accumulation of protease-resistant disease-associated prion protein, with delayed onset of clinical symptoms and motor deficits. This was concomitant with significantly increased survival times relative to mock-treated animals. These results provide proof of principle that recombinant hamster prion proteins can effectively and safely inhibit prion disease in mice, and suggest that hamster or other non-human prion proteins may be a viable treatment for prion diseases in humans.	[Skinner, Pamela J.; Kim, Hyeon O.; Kinzel, Nikilyn J.; Goodman, Patricia A.; Olson, Katherine] Univ Minnesota, Vet & Biomed Sci Dept, St Paul, MN 55108 USA; [Bryant, Damani; Seelig, Davis M.] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Reilly, Cavan] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Priola, Suzette A.; Ward, Anne E.] NIAID, Rocky Mt Lab, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Skinner, PJ (corresponding author), Univ Minnesota, Vet & Biomed Sci Dept, St Paul, MN 55108 USA.	skinn002@umn.edu		Skinner, Pamela/0000-0003-3388-1687	University of Minnesota Academic Health Center; Intramural Research Program of the National Institute of Allergy & Infectious Disease, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000752] Funding Source: NIH RePORTER	University of Minnesota Academic Health Center; Intramural Research Program of the National Institute of Allergy & Infectious Disease, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a seed grant from the University of Minnesota Academic Health Center, PJS, and by the Intramural Research Program of the National Institute of Allergy & Infectious Disease, National Institutes of Health, SAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caughey B, 2003, BRIT MED BULL, V66, P109, DOI 10.1093/bmb/66.1.109; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; CSIZA CK, 1976, LAB ANIM SCI, V26, P781; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; Haik S, 2004, NEUROLOGY, V63, P2413, DOI 10.1212/01.WNL.0000148596.15681.4D; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; HOPE J, 1988, NATURE, V336, P390, DOI 10.1038/336390a0; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KIMBERLIN RH, 1976, SCI PROGRESS-UK, V63, P461; Kurt TD, 2014, J BIOL CHEM, V289, P10660, DOI 10.1074/jbc.M114.549030; Li L, 2010, IMMUNOTHERAPY-UK, V2, P269, DOI 10.2217/IMT.10.3; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; McKintosh E, 2003, J NEUROVIROL, V9, P183, DOI 10.1080/13550280390194082; Moore RA, 2009, CURR OPIN STRUC BIOL, V19, P14, DOI 10.1016/j.sbi.2008.12.007; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paylor R, 1998, LEARN MEMORY, V5, P302; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Priola SA, 1999, BIOMED PHARMACOTHER, V53, P27, DOI 10.1016/S0753-3322(99)80057-2; Priola SA, 2004, METH MOL B, V268, P517; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rigter A, 2005, J GEN VIROL, V86, P2627, DOI 10.1099/vir.0.80901-0; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Taylor D, 2002, CR BIOL, V325, P75, DOI 10.1016/S1631-0691(02)01386-0; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Toupet K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002773; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Vorberg I, 2004, J BIOL CHEM, V279, P29218, DOI 10.1074/jbc.M402576200; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; WESTAWAY D, 1986, NUCLEIC ACIDS RES, V14, P2035, DOI 10.1093/nar/14.5.2035; Whittle IR, 2006, ACTA NEUROCHIR, V148, P677, DOI 10.1007/s00701-006-0772-y; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	50	9	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131993	10.1371/journal.pone.0131993	http://dx.doi.org/10.1371/journal.pone.0131993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134409	gold, Green Submitted, Green Published			2022-12-26	WOS:000358154400091
J	Chiaratti, MR; Malik, S; Diot, A; Rapa, E; Macleod, L; Morten, K; Vatish, M; Boyd, R; Poulton, J				Chiaratti, Marcos R.; Malik, Sajida; Diot, Alan; Rapa, Elizabeth; Macleod, Lorna; Morten, Karl; Vatish, Manu; Boyd, Richard; Poulton, Joanna			Is Placental Mitochondrial Function a Regulator that Matches Fetal and Placental Growth to Maternal Nutrient Intake in the Mouse?	PLOS ONE			English	Article							KEARNS-SAYRE SYNDROME; LOW-PROTEIN DIET; DNA COPY NUMBER; ADULT HEALTH; DISEASE; DYSFUNCTION; METABOLISM; VIABILITY; EXPOSURE; OOCYTES	Background Effective fetal growth requires adequate maternal nutrition coupled to active transport of nutrients across the placenta, which, in turn requires ATP. Epidemiological and experimental evidence has shown that impaired maternal nutrition in utero results in an adverse postnatal phenotype for the offspring. Placental mitochondrial function might link maternal food intake to fetal growth since impaired placental ATP production, in response to poor maternal nutrition, could be a pathway linking maternal food intake to reduced fetal growth. Method We assessed the effects of maternal diet on placental water content, ATP levels and mitochondrial DNA (mtDNA) content in mice at embryonic (E) day 18 (E18). Females maintained on either low-(LPD) or normal-(NPD) protein diets were mated with NPD males. Results To investigate the possibility of an underlying mitochondrial stress response, we studied cultured human trophoblast cells (BeWos). High throughput imaging showed that amino acid starvation induces changes in mitochondrial morphology that suggest stress-induced mitochondrial hyperfusion. This is a defensive response, believed to increase mitochondrial efficiency, that could underlie the increase in ATP observed in placenta. Conclusions These findings reinforce the pathophysiological links between maternal diet and conceptus mitochondria, potentially contributing to metabolic programming. The quiet embryo hypothesis proposes that pre-implantation embryo survival is best served by a relatively low level of metabolism. This may extend to post-implantation trophoblast responses to nutrition.	[Chiaratti, Marcos R.; Malik, Sajida; Diot, Alan; Rapa, Elizabeth; Macleod, Lorna; Morten, Karl; Vatish, Manu; Poulton, Joanna] Univ Oxford, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Chiaratti, Marcos R.] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13565905 Sao Carlos, SP, Brazil; [Boyd, Richard] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Oxford; Universidade Federal de Sao Carlos; University of Oxford	Poulton, J (corresponding author), Univ Oxford, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	Joanna.Poulton@obs-gyn.ox.ac.uk	Poulton, Joanna/I-3913-2016; Poulton, Joanna/AAB-4828-2021; vatish, manu/AAY-8750-2020; Vatish, Manu/B-4458-2018; Chiaratti, Marcos R/C-2727-2012; MORTEN, Karl/GXM-6291-2022	vatish, manu/0000-0002-6012-2574; Chiaratti, Marcos R/0000-0001-8805-9469; Rapa, Elizabeth/0000-0001-8818-8148; Diot, Alan/0000-0001-5079-8274; Poulton, Joanna/0000-0002-2460-5587; Morten, Karl/0000-0001-6926-6550	Medical Research Council (United Kingdom); Wellcome Trust PhD studentship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil [06/03516-4]; Medical Research Council [MR/J010448/1, G0500695] Funding Source: researchfish; MRC [G0500695, MR/J010448/1] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust PhD studentship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by Medical Research Council (United Kingdom) PhD studentship and Career Establishment Grant Wellcome Trust PhD studentship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (06/03516-4), Brazil.	Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Bressan FF, 2009, PLACENTA, V30, P823, DOI 10.1016/j.placenta.2009.07.007; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; Chiaratti MR, 2010, BIOL REPROD, V83, P1, DOI 10.1095/biolreprod.110.084269; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Fowden AL, PROG BIOPHYS MOL BIO; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; HECKMANN KD, 1959, BIOCHIM BIOPHYS ACTA, V36, P203, DOI 10.1016/0006-3002(59)90085-X; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Johnson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093597; Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lattuada D, 2008, PLACENTA, V29, P1029, DOI 10.1016/j.placenta.2008.09.012; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Marchington D, 2009, J MED GENET; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Morten K, 2005, AM J PHYSIOL-ENDOC M, V289, pE1115, DOI 10.1152/ajpendo.00226.2005; OWENS JA, 1987, J DEV PHYSIOL, V9, P225; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Ozanne SE, 1998, DIABETOLOGIA, V41, P1337, DOI 10.1007/s001250051074; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; PARK KS, 2008, DIABETOLOGIA; Parker E, 2004, DIABET MED, V21; POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366; POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5; Symonds ME, 2009, P NUTR SOC, V68, P173, DOI 10.1017/S0029665109001049; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; TOSTESON DC, 1960, J GEN PHYSIOL, V44, P169, DOI 10.1085/jgp.44.1.169; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wasilewski M, 2012, CURR BIOL, V22, P1228, DOI 10.1016/j.cub.2012.04.054; Ye Z, 2013, DIABETOLOGIA, V56, P1907, DOI 10.1007/s00125-013-2945-6	51	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130631	10.1371/journal.pone.0130631	http://dx.doi.org/10.1371/journal.pone.0130631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132581	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000076
J	Sulpizio, S; Fasoli, F; Maass, A; Paladino, MP; Vespignani, F; Eyssel, F; Bentler, D				Sulpizio, Simone; Fasoli, Fabio; Maass, Anne; Paladino, Maria Paola; Vespignani, Francesco; Eyssel, Friederike; Bentler, Dominik			The Sound of Voice: Voice-Based Categorization of Speakers' Sexual Orientation within and across Languages	PLOS ONE			English	Article							ACCURACY; JUDGMENTS; GAY; MASCULINITY; PERCEPTION; FRENCH; PITCH	Empirical research had initially shown that English listeners are able to identify the speakers' sexual orientation based on voice cues alone. However, the accuracy of this voice-based categorization, as well as its generalizability to other languages (language-dependency) and to non-native speakers (language-specificity), has been questioned recently. Consequently, we address these open issues in 5 experiments: First, we tested whether Italian and German listeners are able to correctly identify sexual orientation of same-language male speakers. Then, participants of both nationalities listened to voice samples and rated the sexual orientation of both Italian and German male speakers. We found that listeners were unable to identify the speakers' sexual orientation correctly. However, speakers were consistently categorized as either heterosexual or gay on the basis of how they sounded. Moreover, a similar pattern of results emerged when listeners judged the sexual orientation of speakers of their own and of the foreign language. Overall, this research suggests that voice-based categorization of sexual orientation reflects the listeners' expectations of how gay voices sound rather than being an accurate detector of the speakers' actual sexual identity. Results are discussed with regard to accuracy, acoustic features of voices, language dependency and language specificity.	[Sulpizio, Simone; Paladino, Maria Paola; Vespignani, Francesco] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy; [Sulpizio, Simone] Fdn Marica De Vincenzi ONLUS, Rovereto, TN, Italy; [Fasoli, Fabio; Maass, Anne] Univ Padua, Dept Dev Psychol & Socializat, Padua, Italy; [Eyssel, Friederike; Bentler, Dominik] Univ Bielefeld, Ctr Excellence Cognit Interact Technol, D-33615 Bielefeld, Germany; [Eyssel, Friederike] NYU, Fac Psychol, Abu Dhabi, U Arab Emirates	University of Trento; University of Padua; University of Bielefeld	Sulpizio, S (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy.	simone.sulpizio@unitn.it	Fasoli, Fabio/W-7527-2019; Sulpizio, Simone/AAA-7077-2019; Vespignani, Francesco/AAF-6441-2019; Fasoli, Fabio/K-9215-2019	Sulpizio, Simone/0000-0002-4051-9494; Vespignani, Francesco/0000-0002-0474-6921; Fasoli, Fabio/0000-0002-8043-1630; Paladino, Maria Paola/0000-0002-1664-9475; Bentler, Dominik/0000-0003-0311-9253	Fondazione Cassa di Risparmio di Trento e Rovereto; German Research Foundation COE 277 [COE 277]	Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro); German Research Foundation COE 277	The research was supported by a grant of the Fondazione Cassa di Risparmio di Trento e Rovereto and by a grant of the German Research Foundation for COE 277.	Ambady N, 1999, J PERS SOC PSYCHOL, V77, P538, DOI 10.1037/0022-3514.77.3.538; Baayen R. H., 2008, ANAL LINGUISTIC DATA; BENNETT S, 1981, J ACOUST SOC AM, V69, P231, DOI 10.1121/1.385343; Bertinetto PM, 2012, COMP STUDIES RHYTHMI, P43; Boersma P., 2007, PRAAT SYSTEM DOING P; Cadinu M, 2013, SELF IDENTITY, V12, P582, DOI 10.1080/15298868.2012.712753; Cadinu MR, 1996, J PERS SOC PSYCHOL, V70, P661, DOI 10.1037/0022-3514.70.4.661; D'Errico F, 2013, INT CONF AFFECT, P552, DOI 10.1109/ACII.2013.97; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Di Meola C, 2007, LINGUISTICA TEDESCA, P290; Ericsdotter C, 2001, WORKING PAPERS DEP L, P34; Fasoli F, 2014, DISTRICARE IN PRESS; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Foulkes Paul, 2000, J SOCIOLING, V4, P30, DOI DOI 10.1111/1467-9481.00102; Freeman JB, 2008, J EXP PSYCHOL GEN, V137, P673, DOI 10.1037/a0013875; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; GAUDIO RP, 1994, AM SPEECH, V69, P30, DOI 10.2307/455948; Heffernan Kevin, 2004, TORONTO WORKING PAPE, V23; Hewlett N, 1998, J INT PHON ASSOC, V28, P63; Jacewicz E, 2009, LANG VAR CHANGE, V21, P233, DOI 10.1017/S0954394509990093; Klink R. R., 2000, MARKET LETT, V11, P5, DOI DOI 10.1023/A:1008184423824; Krauss RM, 2002, J EXP SOC PSYCHOL, V38, P618, DOI 10.1016/S0022-1031(02)00510-3; Levon E, 2006, AM SPEECH, V81, P56, DOI 10.1215/00031283-2006-003; McAleer P., 2014, PLOONE PUBLIC LIB, V9, P1, DOI [10.1371/journal.pone.0090779, DOI 10.1371/J0URNAL.P0NE.0090779]; Munson B, 2007, LANG SPEECH, V50, P125, DOI 10.1177/00238309070500010601; Munson B, 2006, J PHONETICS, V34, P202, DOI 10.1016/j.wocn.2005.05.003; Munson B, 2007, LANG LINGUIST COMPAS, V1, DOI 10.1111/j.1749-818x.2007.00028.x; Pierrehumbert JB, 2004, J ACOUST SOC AM, V116, P1905, DOI 10.1121/1.1788729; Podesva RJ, 2002, LANGUAGE AND SEXUALITY: CONTESTING MEANING IN THEORY AND PRACTICE, P175; Podesva RJ, 2011, AM SPEECH, V86, P32, DOI 10.1215/00031283-1277501; PRITCHARD RMO, 1987, EDUC RES, V29, P65, DOI 10.1080/0013188870290108; Renn P, 2002, THESIS U TEXAS AUSTI; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Schwieter JW, 2010, READINGS LANGUAGE ST, V2, P89; Smyth R, 2003, LANG SOC, V32, P329, DOI 10.1017/S0047404503323024; SMYTH R, 2008, TORONTO WORKING PAPE, V27, P129; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stuart-Smith J., 2003, P 15 INT C PHONETIC, V3-9, P1851; Stuart-Smith J, 1997, LAB PHONOLOGY, V9, P65; Sulpizio S, 2013, J EXP PSYCHOL LEARN, V39, P51, DOI 10.1037/a0028472; Tanaka A, 2010, PSYCHOL SCI, V21, P1259, DOI 10.1177/0956797610380698; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Tskhay KO, 2013, PERS SOC PSYCHOL REV, V17, P72, DOI 10.1177/1088868312461308; Valentova J, 2011, ARCH SEX BEHAV, V40, P1145, DOI 10.1007/s10508-011-9818-1; Valentova JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082417; Williams M, 2002, BRIT EDUC RES J, V28, P503, DOI 10.1080/0141192022000005805; Zimman L., 2013, J LANGUAGE SEXUALITY, V2, P1, DOI [10.1075/jls.2.1.01zim, DOI 10.1075/JLS.2.1.01ZIM]	48	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128882	10.1371/journal.pone.0128882	http://dx.doi.org/10.1371/journal.pone.0128882			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26132820	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000021
J	Weiss, SC; Skerra, A; Schiefner, A				Weiss, Simon C.; Skerra, Arne; Schiefner, Andre			Structural Basis for the Interconversion of Maltodextrins by MalQ, the Amylomaltase of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; enzyme mechanism; Escherichia coli (E; coli); protein crystallization; x-ray crystallography; acarbose; enzymatically derived inhibitor; maltose; maltodextrin metabolism	LARGE CYCLIC GLUCANS; ENZYME AMYLOMALTASE; MALTOSE UTILIZATION; THERMUS-AQUATICUS; METABOLISM; BINDING; SYSTEM; 4-ALPHA-GLUCANOTRANSFERASE; PHOSPHORYLASE; INTERMEDIATE	Background: Amylomaltase MalQ catalyzes the transglycosylation of maltose and maltodextrins in E. coli. Results: Three different x-ray structures and the product equilibrium concentrations for different substrates were determined. Conclusion: MalQ undergoes major conformational changes during catalysis, and its product spectrum depends on substrate chain length. Significance: Novel insights into the MalQ mechanism and its key role for maltose metabolism in E. coli were obtained. Amylomaltase MalQ is essential for the metabolism of maltose and maltodextrins in Escherichia coli. It catalyzes transglycosylation/disproportionation reactions in which glycosyl or dextrinyl units are transferred among linear maltodextrins of various lengths. To elucidate the molecular basis of transglycosylation by MalQ, we have determined three crystal structures of this enzyme, i.e. the apo-form, its complex with maltose, and an inhibitor complex with the transition state analog acarviosine-glucose-acarbose, at resolutions down to 2.1 angstrom. MalQ represents the first example of a mesophilic bacterial amylomaltase with known structure and exhibits an N-terminal extension of about 140 residues, in contrast with previously described thermophilic enzymes. This moiety seems unique to amylomaltases from Enterobacteriaceae and folds into two distinct subdomains that associate with different parts of the catalytic core. Intriguingly, the three MalQ crystal structures appear to correspond to distinct states of this enzyme, revealing considerable conformational changes during the catalytic cycle. In particular, the inhibitor complex highlights the requirement of both a 3-OH group and a 4-OH group (or 1-4-glycosidic bond) at the acceptor subsite +1 for the catalytically competent orientation of the acid/base catalyst Glu-496. Using an HPLC-based MalQ enzyme assay, we could demonstrate that the equilibrium concentration of maltodextrin products depends on the length of the initial substrate; with increasing numbers of glycosidic bonds, less glucose is formed. Thus, both structural and enzymatic data are consistent with the extremely low hydrolysis rates observed for amylomaltases and underline the importance of MalQ for the metabolism of maltodextrins in E. coli.	[Weiss, Simon C.; Skerra, Arne; Schiefner, Andre] Tech Univ Munich, Lehrstuhl Biol Chem, D-85350 Freising Weihenstephan, Germany	Technical University of Munich	Schiefner, A (corresponding author), Tech Univ Munich, Lehrstuhl Biol Chem, Emil Erlenmeyer Forum 5, D-85350 Freising Weihenstephan, Germany.	schiefner@wzw.tum.de	Skerra, Arne/A-2269-2013	Schiefner, Andre/0000-0001-5215-4122; Skerra, Arne/0000-0002-5717-498X	Deutsche Forschungsgemeinschaft [SCHI1 105/2-1]; Helmholtz-Zentrum Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz-Zentrum Berlin(Helmholtz Association)	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHI1 105/2-1 and Helmholtz-Zentrum Berlin. The authors declare that they have no conflict of interest with the contents of this article.	ALBER T, 1981, PHILOS T ROY SOC B, V293, P159, DOI 10.1098/rstb.1981.0069; AVIGAD G, 1977, J CHROMATOGR, V139, P343, DOI 10.1016/S0021-9673(00)89330-9; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BECKER S, 1994, J BIOL CHEM, V269, P2485; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Carvalho CC, 2015, BIOPOLYMERS, V103, P203, DOI 10.1002/bip.22584; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dippel R, 2005, J BACTERIOL, V187, P8332, DOI 10.1128/JB.187.24.8332-8339.2005; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Eckert K, 2009, J MOL BIOL, V394, P61, DOI 10.1016/j.jmb.2009.08.060; EHRMANN M, 1987, J BACTERIOL, V169, P3539, DOI 10.1128/jb.169.8.3539-3545.1987; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FREUNDLIEB S, 1988, J BIOL CHEM, V263, P314; GOLDBERG RN, 1991, BIOPHYS CHEM, V40, P69, DOI 10.1016/0301-4622(91)85030-T; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jung JH, 2011, PROTEINS, V79, P633, DOI 10.1002/prot.22911; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kartal O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.76; Lengsfeld C, 2009, J BACTERIOL, V191, P701, DOI 10.1128/JB.00767-08; LIEBL W, 1992, EUR J BIOCHEM, V207, P81, DOI 10.1111/j.1432-1033.1992.tb17023.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1950, Ann Inst Pasteur (Paris), V78, P65; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakatani H, 1999, BIOPOLYMERS, V50, P145, DOI 10.1002/(SICI)1097-0282(199908)50:2<145::AID-BIP3>3.3.CO;2-U; OReilly M, 1997, NAT STRUCT BIOL, V4, P405, DOI 10.1038/nsb0597-405; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PALMER TN, 1976, EUR J BIOCHEM, V69, P105, DOI 10.1111/j.1432-1033.1976.tb10863.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; Przylas I, 2000, EUR J BIOCHEM, V267, P6903, DOI 10.1046/j.1432-1033.2000.01790.x; PUGSLEY AP, 1988, MOL MICROBIOL, V2, P473, DOI 10.1111/j.1365-2958.1988.tb00053.x; Ruzanski C, 2013, J BIOL CHEM, V288, P28581, DOI 10.1074/jbc.M113.497867; Schwartz M, 1987, ESCHERICHIA COLI SAL, P1482; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; WIESMEYER H, 1960, BIOCHIM BIOPHYS ACTA, V39, P417, DOI 10.1016/0006-3002(60)90194-3; WIESMEYER H, 1960, BIOCHIM BIOPHYS ACTA, V39, P427, DOI 10.1016/0006-3002(60)90195-5; Xia T, 2015, APPL ENVIRON MICROB, V81, P3387, DOI 10.1128/AEM.04058-14	45	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21352	21364		10.1074/jbc.M115.667337	http://dx.doi.org/10.1074/jbc.M115.667337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26139606	hybrid, Green Published			2022-12-26	WOS:000360637600013
J	Linder, B; Weber, S; Dittmann, K; Adamski, J; Hahn, H; Uhmann, A				Linder, Benedikt; Weber, Susanne; Dittmann, Kai; Adamski, Jerzy; Hahn, Heidi; Uhmann, Anja			A Functional and Putative Physiological Role of Calcitriol in Patched1/Smoothened Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL CARCINOMA; STEROL-SENSING DOMAIN; SONIC HEDGEHOG; CHOLESTEROL HOMEOSTASIS; SIGNAL-TRANSDUCTION; VITAMIN-D; PROLIFERATION; PATHWAY; CYCLOPAMINE; MUTATIONS	The Patched1 (Ptch)-mediated inhibition of Smoothened (Smo) is still an open question. However, a direct Ptch/Smo interaction has been excluded, Smo modulators were identified, but the endogenous signal transmitting molecule remains undiscovered. Here, we demonstrate that calcitriol, the hormonally active form of vitamin D-3, is an excellent candidate for transmission of Ptch/Smo interaction. Our study reveals that Ptch expression is sufficient to release calcitriol from the cell and that calcitriol inhibits Smo action and ciliary translocation by acting on a site distinct from the 7-transmembrane domain or the cysteine-rich domain. Moreover calcitriol strongly synergizes with itraconazole (ITZ) in Smo inhibition, which did not result from elevated calcitriol bioavailability due to ITZ-mediated 24-hydroxylase inhibition but rather from a direct interaction of the compounds at the level of Smo. Together, we suggest that calcitriol represents a possible endogenous transmitter of Ptch/Smo interaction. Moreover calcitriol or calcitriol derivatives combined with ITZ might be a treatment option of Hedgehog-associated cancers.	[Linder, Benedikt; Hahn, Heidi; Uhmann, Anja] Univ Med Ctr, Inst Human Genet, Tumor Genet Grp, D-37073 Gottingen, Germany; [Weber, Susanne; Adamski, Jerzy] Univ Med Ctr, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Dittmann, Kai] Helmholtz Zentrum Muenchen, Inst Expt Genet, Dept Genome Anal Ctr, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany	University of Gottingen; University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Uhmann, A (corresponding author), Univ Med Ctr Goettingen, Inst Human Genet, Heinrich Dueker Weg 12, D-37073 Gottingen, Germany.	auhmann@gwdg.de	Linder, Benedikt/L-2516-2019	Linder, Benedikt/0000-0003-0908-571X; Adamski, Jerzy/0000-0001-9259-0199	Deutsche Forschungsgemeinschaft [UH 228/2-1, UH228/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants UH 228/2-1 and UH228/2-2 (to A. U.). The authors declare that they have no conflicts of interests with the contents of this article.	Bartik L, 2010, J NUTR BIOCHEM, V21, P1153, DOI 10.1016/j.jnutbio.2009.09.012; Bidet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023834; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen TC, 2012, ANTICANCER RES, V32, P291; Chou TC, 2005, COMPUSYN DRUG COMBIN; Christakos S, 2010, J STEROID BIOCHEM, V121, P183, DOI 10.1016/j.jsbmb.2010.03.005; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Eaton S, 2008, NAT REV MOL CELL BIO, V9, P437, DOI 10.1038/nrm2414; Ecke I, 2008, MOL CARCINOGEN, V47, P361, DOI 10.1002/mc.20394; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hausmann G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000146; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Ingham PW, 2000, CURR BIOL, V10, pR180, DOI 10.1016/S0960-9822(00)00346-8; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kota BP, 2011, BASIC CLIN PHARMACOL, V109, P97, DOI 10.1111/j.1742-7843.2011.00693.x; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marigo V, 1996, DEVELOPMENT, V122, P1225; Marklein D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052898; Muindi JR, 2010, ENDOCRINOLOGY, V151, P4301, DOI 10.1210/en.2009-1156; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nedelcu D, 2013, NAT CHEM BIOL, V9, P557, DOI [10.1038/NCHEMBIO.1290, 10.1038/nchembio.1290]; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tang JY, 2011, CANCER PREV RES, V4, P744, DOI 10.1158/1940-6207.CAPR-10-0285; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Uhmann Anja, 2012, Sarcoma, V2012, P357040, DOI 10.1155/2012/357040; Uhmann A, 2011, MOL CANCER THER, V10, P2179, DOI 10.1158/1535-7163.MCT-11-0422; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	49	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19614	19628		10.1074/jbc.M115.646141	http://dx.doi.org/10.1074/jbc.M115.646141			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26126827	Green Published, hybrid			2022-12-26	WOS:000359364600023
J	Barzenje, DA; Smastuen, MC; Liestol, K; Fossa, A; Delabie, J; Kolstad, A; Holte, H				Barzenje, Dlawer Abdulla; Smastuen, Milada Cvancarova; Liestol, Knut; Fossa, Alexander; Delabie, Jan; Kolstad, Arne; Holte, Harald			Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; LOW-GRADE; RESPONSE CRITERIA; COMPETING RISKS; CLASSIFICATION; COMMITTEE; THERAPY; DISEASE; TRIAL	Purpose To investigate outcome for patients with follicular lymphoma (FL) stage I-II treated at a population-based referral institution with a median follow-up of 15 years. Overall and causespecific survival was compared to that of a sex, age and residency matched individuals from normal population. Material and Methods 404 patients with early stage FL treated between 1980 and 2005 were retrospectively analyzed. Two of three patients had stage I disease. Based on clinical characteristics, first line treatments were radiotherapy (RT) (48% of patients), chemotherapy (CT) (16%), combined chemo-and radiotherapy (CRT) (16%) or observation (OBS) (15%). Survival was modeled with Kaplan-Meier methodology. Multivariate analyses were performed with the Cox model. Results Fifteen years overall survival (OS), progression free survival (PFS) and time to next treatment (TNT) were 50% (95% confidence interval [CI]: 45-55), 42% (95% CI: 36-47) and 48% (95% CI, 42-54), respectively. For patients treated with RT 97% achieved a complete remission, and 15 year OS, PFS and TNT were 57% (95% CI, 50-64), 46% (95% CI, 3954) and 49% (95% CI, 42-57), respectively. Relapse rate after RT and CRT was 49% and 36%, respectively. Only 2% of patients who received RT or CRT relapsed inside the radiation field and 5% had isolated near-field relapse. No statistical differences were found between treatment groups regarding death from cardiovascular disease or incidence of second cancer. Compared to a matched normal population, non-lymphoma cancer mortality was higher among patients given RT, hazard ratio 1.66 (95% CI: 1.14-2.42; P<0.01). Compared to other treatment modalities, patients selected for observation without treatment did not have inferior outcome. Conclusions A differentiated treatment strategy in early stage FL results in long term survival for the majority of patients. OBS is a valid initial choice for selected patients without lymphoma-related symptoms.	[Barzenje, Dlawer Abdulla] Ostfold Hosp Trust, Dept Oncol, Fredrikstad, Norway; [Smastuen, Milada Cvancarova] Oslo Univ Hosp, Dept Biostat, Oslo, Norway; [Liestol, Knut] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Fossa, Alexander; Kolstad, Arne; Holte, Harald] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Delabie, Jan] Oslo Univ Hosp, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Barzenje, DA (corresponding author), Ostfold Hosp Trust, Dept Oncol, Fredrikstad, Norway.	dlabar@so-hf.no	Holte, Harald/AAO-5647-2020	Delabie, Jan/0000-0001-5023-0689; Barzenje, Dlawer Abdulla/0000-0002-9364-6841	Ostfold Hospital Trust, Fredrikstad, Norway; Norwegian Cancer Society	Ostfold Hospital Trust, Fredrikstad, Norway; Norwegian Cancer Society(Norwegian Cancer Society)	Dlawer Abdulla Barzenje has been supported with grants from Ostfold Hospital Trust, Fredrikstad, Norway. Arne Kolstad and Harald Holte have both received a research grant from Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani R, 2004, J CLIN ONCOL, V22, P1454, DOI 10.1200/JCO.2004.10.086; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Andre M, 2004, BLOOD, V103, P1222, DOI 10.1182/blood-2003-04-1124; Campbell BA, 2010, CANCER-AM CANCER SOC, V116, P3797, DOI 10.1002/cncr.25117; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan WC, 1997, BLOOD, V89, P3909; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Friedberg JW, 2012, J CLIN ONCOL, V30, P3368, DOI 10.1200/JCO.2011.40.6546; GALLAGHER CJ, 1986, J CLIN ONCOL, V4, P1470, DOI 10.1200/JCO.1986.4.10.1470; GOMEZ GA, 1986, AM J CLIN ONCOL-CANC, V9, P40, DOI 10.1097/00000421-198602000-00011; Guadagnolo BA, 2006, INT J RADIAT ONCOL, V64, P928, DOI 10.1016/j.ijrobp.2005.08.010; HARRIS NL, 1994, BLOOD, V84, P1361; HUDSON BV, 1994, BRIT J CANCER, V69, P1088, DOI 10.1038/bjc.1994.213; KELSEY SM, 1994, MED ONCOL, V11, P19, DOI 10.1007/BF02990087; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Lowry L, 2011, RADIOTHER ONCOL, V100, P86, DOI 10.1016/j.radonc.2011.05.013; MacManus MP, 1996, J CLIN ONCOL, V14, P1282, DOI 10.1200/JCO.1996.14.4.1282; Martinelli G, 2010, J CLIN ONCOL, V28, P4480, DOI 10.1200/JCO.2010.28.4786; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; OLWENY CLM, 1990, J CLIN ONCOL, V8, P1598; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Seymour JF, 2003, J CLIN ONCOL, V21, P2115, DOI 10.1200/JCO.2003.07.111; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; SOUBEYRAN P, 1988, RADIOTHER ONCOL, V13, P91, DOI 10.1016/0167-8140(88)90030-8; Soubeyran P, 1996, ANN ONCOL, V7, P713; STANSFELD AG, 1988, LANCET, V1, P292; Swerdlow SH, 2008, WHO CLASSIFICATION T; Wilder RB, 2001, INT J RADIAT ONCOL, V51, P1219, DOI 10.1016/S0360-3016(01)01747-3; YAHALOM J, 1993, CANCER, V71, P2342, DOI 10.1002/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I	31	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131158	10.1371/journal.pone.0131158	http://dx.doi.org/10.1371/journal.pone.0131158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147646	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600067
J	Eeren, HV; Schawo, SJ; Scholte, RHJ; Busschbach, JJV; Hakkaart, L				Eeren, Hester V.; Schawo, Saskia J.; Scholte, Ron H. J.; Busschbach, Jan J. V.; Hakkaart, Leona			Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; EFFECTIVENESS ACCEPTABILITY CURVES; DECISION-ANALYTIC MODELS; STRUCTURAL UNCERTAINTY; EXPECTED VALUE; PERFECT INFORMATION; CRIMINAL OFFENDERS; FRAMEWORK; YOUTH; DISEASE	Objectives To investigate whether a value of information analysis, commonly applied in health care evaluations, is feasible and meaningful in the field of crime prevention. Methods Interventions aimed at reducing juvenile delinquency are increasingly being evaluated according to their cost-effectiveness. Results of cost-effectiveness models are subject to uncertainty in their cost and effect estimates. Further research can reduce that parameter uncertainty. The value of such further research can be estimated using a value of information analysis, as illustrated in the current study. We built upon an earlier published cost-effectiveness model that demonstrated the comparison of two interventions aimed at reducing juvenile delinquency. Outcomes were presented as costs per criminal activity free year. Results At a societal willingness-to-pay of (sic)71,700 per criminal activity free year, further research to eliminate parameter uncertainty was valued at (sic)176 million. Therefore, in this illustrative analysis, the value of information analysis determined that society should be willing to spend a maximum of (sic)176 million in reducing decision uncertainty in the cost-effectiveness of the two interventions. Moreover, the results suggest that reducing uncertainty in some specific model parameters might be more valuable than in others. Conclusions Using a value of information framework to assess the value of conducting further research in the field of crime prevention proved to be feasible. The results were meaningful and can be interpreted according to health care evaluation studies. This analysis can be helpful in justifying additional research funds to further inform the reimbursement decision in regard to interventions for juvenile delinquents.	[Eeren, Hester V.; Schawo, Saskia J.; Hakkaart, Leona] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands; [Eeren, Hester V.; Busschbach, Jan J. V.] Erasmus MC, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Eeren, Hester V.; Scholte, Ron H. J.; Busschbach, Jan J. V.] Viersprong Inst Studies Personal Disorders VISPD, Halsteren, Netherlands; [Scholte, Ron H. J.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Eeren, HV (corresponding author), Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands.	h.vaneeren.1@erasmusmc.nl	Busschbach, Jan/P-1584-2019	Busschbach, Jan/0000-0002-8602-0381; Hakkaart-van Roijen, Leona/0000-0003-0635-7388	Dutch Organisation for Health Research and Development in the Netherlands [80-82435-98-10104]	Dutch Organisation for Health Research and Development in the Netherlands	The study was financed by an unrestricted grant from the Dutch Organisation for Health Research and Development in the Netherlands (grant number 80-82435-98-10104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aos S., 2004, BENEFITS COSTS PREVE; Barrett B, 2012, BRIT J PSYCHIAT, V200, P336, DOI 10.1192/bjp.bp.109.068643; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Bilcke J, 2011, MED DECIS MAKING, V31, P675, DOI 10.1177/0272989X11409240; Bojke L, 2009, VALUE HEALTH, V12, P739, DOI 10.1111/j.1524-4733.2008.00502.x; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Brouwer W, 2000, J Health Serv Res Policy, V5, P114; Carlson JJ, 2013, MED DECIS MAKING, V33, P463, DOI 10.1177/0272989X13484388; Cary M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061070; Chassin L, 2013, J ADOLESCENT HEALTH, V52, P689, DOI 10.1016/j.jadohealth.2012.11.018; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 2001, INT J TECHNOL ASSESS, V17, P38, DOI 10.1017/S0266462301104058; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2012, HLTH TECHNOL ASSESS, V16; Claxton K, 2008, PHARMACOECONOMICS, V26, P781, DOI 10.2165/00019053-200826090-00008; Cohen MA, 2004, CRIMINOLOGY, V42, P89, DOI 10.1111/j.1745-9125.2004.tb00514.x; Cohen MA, 2010, CRIMINOL PUBLIC POL, V9, P279, DOI 10.1111/j.1745-9133.2010.00627.x; Cohen M, 2009, J QUANT CRIMINOL, V25, P25, DOI 10.1007/s10940-008-9057-3; Donker A, 2012, VOORSPELLENDE FACTOR; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Fenwick E, 2008, MED DECIS MAKING, V28, P21, DOI 10.1177/0272989X07308751; Frederix GWJ, 2014, PHARMACOECONOMICS, V32, P47, DOI 10.1007/s40273-013-0106-x; French MT, 2008, J SUBST ABUSE TREAT, V34, P272, DOI 10.1016/j.jsat.2007.04.008; Haji Ali Afzali H, 2015, PHARMACOECONOMICS; Jackson CH, 2011, MED DECIS MAKING, V31, P662, DOI 10.1177/0272989X11406986; Knapp M, 2008, COST EFFECTIVENESS M; McCollister KE, 2010, DRUG ALCOHOL DEPEN, V108, P98, DOI 10.1016/j.drugalcdep.2009.12.002; McCollister KE, 2004, JUSTICE Q, V21, P659, DOI 10.1080/07418820400095941; McCollister KE, 2003, J QUANT CRIMINOL, V19, P389, DOI 10.1023/B:JOQC.0000005441.49529.61; McCollister KR, 2003, LAW POLICY, V25, P63, DOI DOI 10.1111/1467-9930.00140; McDaid D., 2007, J MENTAL HLTH, V16, P223, DOI [10.1080/09638230701279881, DOI 10.1080/09638230701279881]; McKenna C, 2011, MED DECIS MAKING, V31, P853, DOI 10.1177/0272989X11399921; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Mohseninejad L, 2013, VALUE HEALTH, V16, P490, DOI 10.1016/j.jval.2012.12.007; Moolenaar DEG, 2009, EUR J CRIM POLICY RE, V15, P309, DOI 10.1007/s10610-009-9110-2; Netherlands Youth Institute, 2014, DAT EFF YOUTH INT; OECD Library, 2015, PURCH POW PAR GDP; Oostenbrink JB, 2008, VALUE HEALTH, V11, P1070, DOI 10.1111/j.1524-4733.2008.00389.x; Pratt J, 1995, STAT DECISON THEORY; Raiffa H., 1968, DECISION ANAL INTRO; Ravi D., 2011, METHODS FUTURE RES N, V5; Romeo R, 2005, J CHILD PSYCHOL PSYC, V46, P919, DOI 10.1111/j.1469-7610.2005.00407.x; Schawo SJ, 2012, J MENT HEALTH POLICY, V15, P187; Sculpher M, 2005, VALUE HEALTH, V8, P433, DOI 10.1111/j.1524-4733.2005.00033.x; Slot NW, 1992, KIND ADOLESCENT, V13, P62; Soeteman DI, 2008, TOMORROWS CRIMINALS, P215; Soeteman DI, 2011, VALUE HEALTH, V14, P229, DOI 10.1016/j.jval.2010.10.020; Statistics Netherlands (CBS), 2015, STAT NETH CONS PRIC; Statistics Netherlands (CBS), 2015, STATISTICS NETHERLAN; Strong M, 2014, MED DECIS MAKING, V34, P311, DOI 10.1177/0272989X13505910; Teplin LA, 2005, PEDIATRICS, V115, P1586, DOI 10.1542/peds.2004-1459; The Health Care Insurance Board (CVZ), 2006, GUID PHARM RES; van der Laan PH, 2006, INTERNATIONAL HANDBOOK OF JUVENILE JUSTICE, P145; Van der Veldt MCAE, 2011, FFT VERSTERLT EVALUA; Van Hout BA, 1998, HEALTH ECON, V7, P581, DOI 10.1002/(SICI)1099-1050(1998110)7:7<581::AID-HEC380>3.0.CO;2-U; Van Zutphen F, 2014, MAATREGEL INRICHTING; Versantvoort MC, 2005, KOSTEN BATEN JUSTITI; Walker S, 2012, VALUE HEALTH, V15, P570, DOI 10.1016/j.jval.2011.12.013; Yokota F, 2004, RISK ANAL, V24, P635, DOI 10.1111/j.0272-4332.2004.00464.x	61	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131255	10.1371/journal.pone.0131255	http://dx.doi.org/10.1371/journal.pone.0131255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26146831	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600077
J	Rodrigues, AS; Correia, M; Gomes, A; Pereira, SL; Perestrelo, T; Sousa, MI; Ramalho-Santos, J				Rodrigues, Ana Sofia; Correia, Marcelo; Gomes, Andreia; Pereira, Sandro L.; Perestrelo, Tania; Sousa, Maria Ines; Ramalho-Santos, Joao			Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; COLORECTAL-CANCER CELLS; TUMOR-SUPPRESSOR; KINASE M2; METABOLISM; DIFFERENTIATION; P53; INHIBITION; GLYCOLYSIS; APOPTOSIS	Introduction The pyruvate dehydrogenase (PDH) complex is localized in the mitochondrial matrix catalyzing the irreversible decarboxylation of pyruvate to acetyl-CoA and NADH. For proper complex regulation the E1-alpha subunit functions as an on/off switch regulated by phosphorylation/dephosphorylation. In different cell types one of the four-pyruvate dehydrogenase kinase isoforms (PDHK1-4) can phosphorylate this subunit leading to PDH inactivation. Our previous results with human Embryonic Stem Cells (hESC), suggested that PDHK could be a key regulator in the metabolic profile of pluripotent cells, as it is upregulated in pluripotent stem cells. Therefore, we wondered if metabolic modulation, via inexpensive pharmacological inhibition of PDHK, could impact metabolism and pluripotency. Methods/Results In order to assess the importance of the PDH cycle in mouse Embryonic Stem Cells (mESC), we incubated cells with the PDHK inhibitor dichloroacetate (DCA) and observed that in its presence ESC started to differentiate. Changes in mitochondrial function and proliferation potential were also found and protein levels for PDH (both phosphorylated and non-phosphorylated) and PDHK1 were monitored. Interestingly, we were also able to describe a possible pathway that involves Hif-1 alpha and p53 during DCA-induced loss of pluripotency. Results with ESCs treated with DCA were comparable to those obtained for cells grown without Leukemia Inhibitor Factor (LIF), used in this case as a positive control for differentiation. Conclusions DCA negatively affects ESC pluripotency by changing cell metabolism and elements related to the PDH cycle, suggesting that PDHK could function as a possible metabolic gatekeeper in ESC, and may be a good target to modulate metabolism and differentiation. Although further molecular biology-based experiments are required, our data suggests that inactive PDH favors pluripotency and that ESC have similar strategies as cancer cells to maintain a glycolytic profile, by using some of the signaling pathways found in the latter cells.	[Rodrigues, Ana Sofia; Correia, Marcelo; Gomes, Andreia; Perestrelo, Tania] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed, Coimbra, Portugal; [Rodrigues, Ana Sofia; Correia, Marcelo; Pereira, Sandro L.; Perestrelo, Tania; Sousa, Maria Ines; Ramalho-Santos, Joao] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Correia, Marcelo; Gomes, Andreia; Perestrelo, Tania] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal; [Gomes, Andreia] Biocant Ctr Innovat Biotechnol, Cantanhede, Portugal; [Sousa, Maria Ines; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Ramalho-Santos, J (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	jramalho@ci.uc.pt	Santos, João/HHZ-5595-2022; Ramalho-Santos, João/F-8641-2012; Rodrigues, Ana Sofia/ABA-9042-2020; Correia, Marcelo/W-4213-2017; Perestrelo, Tânia Marisa Melim/ABC-5495-2020	Ramalho-Santos, João/0000-0002-1172-4018; Rodrigues, Ana Sofia/0000-0001-7060-879X; Correia, Marcelo/0000-0002-3163-9582; Perestrelo, Tânia Marisa Melim/0000-0001-8995-6620; Sousa, Maria Ines/0000-0001-5443-5868; Cardoso Pereira, Sandro Lino/0000-0001-9498-3965	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal [PTDC/EBB-EBI/ 120634/2010, PDTC/QUI-BIQ/120652/2010]; Compete/FEDER/National Funds; QREN [Centro-01-0762-FEDER-00204]; FCT [PEst-C/SAU/LA0001/2011];  [SFRH/BD/33463/2008];  [SFRH/BD/51681/2011];  [SFRH/BD/51684/2011];  [SFRH/BD/51968/2012];  [SFRH/BPD/98995/2013]	Fundacao para a Ciencia e a Tecnologia (FCT) Portugal(Portuguese Foundation for Science and Technology); Compete/FEDER/National Funds; QREN; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; ; ; ; 	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) Portugal for grant support (PTDC/EBB-EBI/ 120634/2010 and PDTC/QUI-BIQ/120652/2010 co-funded by Compete/FEDER/National Funds; and scholarships attributed to ASR (SFRH/BD/33463/2008); to MC (SFRH/BD/51681/2011), to TP (SFRH/BD/51684/2011), AG (SFRH/BD/51968/2012) and SLP (SFRH/BPD/98995/2013) and also to QREN (Centro-01-0762-FEDER-00204). Center for Neuroscience and Cell Biology (CNC) funding is also supported by FCT (PEst-C/SAU/LA0001/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildgaard C, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0247-5; Amaral S, 2009, MITOCHONDRION, V9, P41, DOI 10.1016/j.mito.2008.11.005; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Babu E, 2011, ONCOGENE, V30, P4026, DOI 10.1038/onc.2011.113; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dingley S, 2012, METHODS MOL BIOL, V837, P231, DOI 10.1007/978-1-61779-504-6_16; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; Folmes CDL, 2013, J CARDIOVASC TRANSL, V6, P10, DOI 10.1007/s12265-012-9431-2; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lee S, 2009, AGING CELL, V8, P296, DOI 10.1111/j.1474-9726.2009.00477.x; Lin G, 2014, BRIT J CANCER, V111, P375, DOI 10.1038/bjc.2014.281; Luo WB, 2011, ONCOTARGET, V2, P551; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Mahler M, 2012, AUTOIMMUN REV, V11, P771, DOI 10.1016/j.autrev.2012.02.012; Manganelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029321; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nair RP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt186; Niewisch MR, 2012, CELL PHYSIOL BIOCHEM, V29, P373, DOI 10.1159/000338492; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; O'Connor MD, 2011, METHODS MOL BIOL, V690, P67, DOI 10.1007/978-1-60761-962-8_4; Ohtsuka M, 2006, GENES GENET SYST, V81, P143, DOI 10.1266/ggs.81.143; Parnas D, 1998, BRAIN RES PROTOC, V2, P333, DOI 10.1016/S1385-299X(98)00009-9; Pereira SL, 2014, HUM REPROD UPDATE, V20, P924, DOI 10.1093/humupd/dmu034; Pereira SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082095; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Rodrigues AR, 2012, MOL CELL ENDOCRINOL, V361, P69, DOI 10.1016/j.mce.2012.03.011; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; Strumilo S, 2005, ACTA BIOCHIM POL, V52, P759; Sun RC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-142; Sutendra G, 2013, ONCOGENE, V32, P1638, DOI 10.1038/onc.2012.198; Teslaa T, 2014, PLURIPOTENT STEM CEL; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Venigalla RKC, 2013, EMBO J, V32, P1008, DOI 10.1038/emboj.2013.40; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wicks RT, 2015, NEURO-ONCOLOGY, V17, P70, DOI 10.1093/neuonc/nou143; Xie Y, 2014, STEM CELL REP, V3, P743, DOI 10.1016/j.stemcr.2014.09.021; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	57	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131663	10.1371/journal.pone.0131663	http://dx.doi.org/10.1371/journal.pone.0131663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147621	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600121
J	Zhou, YR; Sun, P; Wang, T; Chen, KX; Zhu, WL; Wang, HY				Zhou, Yuren; Sun, Peng; Wang, Ting; Chen, Kaixian; Zhu, Weiliang; Wang, Heyao			Inhibition of Calcium Influx Reduces Dysfunction and Apoptosis in Lipotoxic Pancreatic beta-Cells via Regulation of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							FREE FATTY-ACIDS; INDUCED ER STRESS; INSULIN-SECRETION; GLUCOSE-INSENSITIVITY; GENE-EXPRESSION; PALMITATE; FAILURE; GPR40; ACTIVATION; MECHANISMS	Lipotoxicity plays an important role in pancreatic beta-cell failure during the development of type 2 diabetes. Prolonged exposure of beta-cells to elevated free fatty acids level could cause deterioration of beta-cell function and induce cell apoptosis. Therefore, inhibition of fatty acids-induced beta-cell dysfunction and apoptosis might provide benefit for the therapy of type 2 diabetes. The present study examined whether regulation of fatty acids-triggered calcium influx could protect pancreatic beta-cells from lipotoxicity. Two small molecule compounds, L-type calcium channel blocker nifedipine and potassium channel activator diazoxide were used to inhibit palmitic acid-induced calcium influx. And whether the compounds could reduce palmitic acid-induced beta-cell failure and the underlying mechanism were also investigated. It was found that both nifedipine and diazoxide protected MIN6 pancreatic beta-cells and primary cultured murine islets from palmitic acid-induced apoptosis. Meanwhile, the impaired insulin secretion was also recovered to varying degrees by these two compounds. Our results verified that nifedipine and diazoxide could reduce palmitic acid-induced endoplasmic reticulum stress to generate protective effects on pancreatic beta-cells. More importantly, it suggested that regulation of calcium influx by small molecule compounds might provide benefits for the prevention and therapy of type 2 diabetes.	[Zhou, Yuren; Sun, Peng; Wang, Ting; Chen, Kaixian; Zhu, Weiliang; Wang, Heyao] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Sun, Peng; Chen, Kaixian] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai University of Traditional Chinese Medicine	Wang, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	hywang@simm.ac.cn	Sun, Peng/AAU-2124-2021	Sun, Peng/0000-0002-7820-712X	Shanghai Natural Science Foundation [14ZR1447700]; National Natural Science Foundation of China [81473262, 81072681]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2012ZX09301001-001, 2013ZX09103001-001]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"	This work was supported by grant from Shanghai Natural Science Foundation (14ZR1447700), National Natural Science Foundation of China (81473262, 81072681), National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2012ZX09301001-001, 2013ZX09103001-001).	Arora DK, 2013, APOPTOSIS, V18, P1, DOI 10.1007/s10495-012-0763-9; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Cernea S, 2013, BIOCHEM MEDICA, V23, P266; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Diakogiannaki E, 2008, BIOCHEM SOC T, V36, P959, DOI 10.1042/BST0360959; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Gromada J, 2006, ENDOCRINOLOGY, V147, P672, DOI 10.1210/en.2005-1388; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hu H, 2009, BIOCHEM BIOPH RES CO, V390, P557, DOI 10.1016/j.bbrc.2009.10.004; Iglesias P, 2014, EUR J ENDOCRINOL, V170, pR147, DOI 10.1530/EJE-13-1012; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim YH, 2009, INT J TOXICOL, V28, P151, DOI 10.1177/1091581809336885; Kristinsson H, 2013, ENDOCRINOLOGY, V154, P4078, DOI 10.1210/en.2013-1352; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Remizov O, 2003, MOL CELL ENDOCRINOL, V212, P1, DOI 10.1016/j.mce.2003.09.026; RORSMAN P, 1989, P NATL ACAD SCI USA, V86, P4505, DOI 10.1073/pnas.86.12.4505; Sargsyan E, 2008, J ENDOCRINOL, V199, P41, DOI 10.1677/JOE-08-0251; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066744; Choi E, 2007, MOL CELL ENDOCRINOL, V272, P50, DOI 10.1016/j.mce.2007.04.004; Tan C, 2013, PURINERG SIGNAL, V9, P67, DOI 10.1007/s11302-012-9331-6; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wang T, 2014, J AGR FOOD CHEM, V62, P5038, DOI 10.1021/jf500387d; Wang W, 2003, J NEUROCYTOL, V32, P143, DOI 10.1023/B:NEUR.0000005599.10952.33; Wang Y, 2011, INT J MOL SCI, V12, P7569, DOI 10.3390/ijms12117569; Wu JW, 2012, J CELL BIOCHEM, V113, P1152, DOI 10.1002/jcb.23450; Yanagida K, 2002, PEPTIDES, V23, P135, DOI 10.1016/S0196-9781(01)00589-7; Zhang XD, 2010, BIOMED PHARMACOTHER, V64, P647, DOI 10.1016/j.biopha.2010.06.008	42	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132411	10.1371/journal.pone.0132411	http://dx.doi.org/10.1371/journal.pone.0132411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147439	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600263
J	Erlandson, MA; Manzoni, OJ; Bureau, I				Erlandson, Melissa A.; Manzoni, Olivier J.; Bureau, Ingrid			The Functional Organization of Neocortical Networks Investigated in Slices with Local Field Recordings and Laser Scanning Photostimulation	PLOS ONE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; RAT BARREL CORTEX; PYRAMIDAL CELLS; SYNAPTIC CONNECTIVITY; LAYER-V; SILENT SYNAPSES; NEURONS; CIRCUIT; MICROCIRCUITS; INTERNEURONS	The organization of cortical networks can be investigated functionally in brain slices. Laser scanning photostimulation (LSPS) with glutamate-uncaging allows for a rapid survey of all connections impinging on single cells recorded in patch-clamp. We sought to develop a variant of the method that would allow for a more exhaustive mapping of neuronal networks at every experiment. We found that the extracellular field recordings could be used to detect synaptic responses evoked by LSPS. One to two electrodes were placed in all six cortical layers of barrel cortex successively and maps were computed from the size of synaptic negative local field potentials. The field maps displayed a laminar organization similar to the one observed in maps computed from excitatory postsynaptic currents recorded in patch-clamp mode. Thus, LSPS combined with field recording is an interesting alternative to obtain for every animal tested a comprehensive map of the excitatory intracortical network.	[Erlandson, Melissa A.; Manzoni, Olivier J.; Bureau, Ingrid] INSERM, INMED U901, F-13258 Marseille, France; [Erlandson, Melissa A.; Manzoni, Olivier J.; Bureau, Ingrid] Aix Marseille Univ, UMRS 901, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Bureau, I (corresponding author), INSERM, INMED U901, F-13258 Marseille, France.	ingrid.bureau@inserm.fr	Manzoni, Olivier/M-7899-2016; Bureau, Ingrid/O-3941-2016	Manzoni, Olivier/0000-0002-5579-6208; Bureau, Ingrid/0000-0001-9166-2250	Agence Nationale de la Recherche [ANR-11-BSV4-0013]; Amidex under the ICN PhD program	Agence Nationale de la Recherche(French National Research Agency (ANR)); Amidex under the ICN PhD program	This work was supported by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), grant #ANR-11-BSV4-0013, to MAE, OJM and IB. MAE's thesis is funded by Amidex (http://amidex.univ-amu.fr/) under the ICN PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiades PG, 2012, J NEUROSCI, V32, P13085, DOI 10.1523/JNEUROSCI.1262-12.2012; Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Bakker R, 2009, NEURAL NETWORKS, V22, P1159, DOI 10.1016/j.neunet.2009.07.014; Bender KJ, 2003, J NEUROSCI, V23, P8759; Brill J, 2009, J NEUROSCI, V29, P7413, DOI 10.1523/JNEUROSCI.6098-08.2009; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Campagnola L, 2014, J NEUROSCI, V34, P2214, DOI 10.1523/JNEUROSCI.4669-13.2014; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Jin XM, 2014, J NEUROPHYSIOL, V112, P1703, DOI 10.1152/jn.00854.2013; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kato G, 2009, J NEUROSCI, V29, P5088, DOI 10.1523/JNEUROSCI.6175-08.2009; Kotter R, 1998, NEUROSCIENCE, V86, P265, DOI 10.1016/S0306-4522(98)00010-4; Lam YW, 2005, J NEUROPHYSIOL, V94, P2472, DOI 10.1152/jn.00206.2005; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Meng XY, 2014, J NEUROSCI, V34, P8855, DOI 10.1523/JNEUROSCI.0233-14.2014; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Qi G, 2015, CEREB CORTEX; Qiu SF, 2011, J NEUROSCI, V31, P5855, DOI 10.1523/JNEUROSCI.6569-10.2011; Rosselet C, 2011, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00126; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Staiger JF, 2000, NEUROSCI RES, V37, P49, DOI 10.1016/S0168-0102(00)00094-8; Staiger JF, 2014, BRAIN STRUCT FUNCT; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Sturm J, 2014, J NEUROSCI, V34, P15032, DOI 10.1523/JNEUROSCI.2276-14.2014; Suter BA, 2010, FRONT NEUROSCI, V4	41	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132008	10.1371/journal.pone.0132008	http://dx.doi.org/10.1371/journal.pone.0132008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134668	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400093
J	Bojang, A; Jafali, J; Egere, UE; Hill, PC; Antonio, M; Jeffries, D; Greenwood, BM; Roca, A				Bojang, Abdoulie; Jafali, James; Egere, Uzochukwu E.; Hill, Phillip C.; Antonio, Martin; Jeffries, David; Greenwood, Brian M.; Roca, Anna			Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia Determined within the Context of a Cluster Randomized Pneumococcal Vaccine Trial	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROTYPE REPLACEMENT; CLINICAL-FEATURES; INVASIVE-DISEASE; KILIFI DISTRICT; CHILDREN; EPIDEMIOLOGY; MENINGITIS; IMPACT	Background We conducted an ancillary study among individuals who had participated in a PCV-7 trial in rural Gambia, to determine the influence of season on the prevalence of pneumococcal carriage. Methods 636 individuals above 30 months of age were followed from 4 to 20 months after vaccination with PCV-7 or meningococcal-conjugate-vaccine. Nasopharyngeal swabs were collected periodically between November 2006 and June 2008. Overall, 4,495 NPS were collected. Results Prevalence of pneumococcal nasopharyngeal carriage in the study subjects (median age 11 years) was 55.0%; this prevalence decreased linearly with increasing age (p = 0.001). Prevalence of carriage was significantly higher during the dry than the rainy season for any pneumococcal carriage [57.6% versus 47.8% (p<0.001)], pneumococcal vaccine serotype carriage [10.3% versus 6.5% (p< 0.001)] and non-vaccine serotype carriage [49.7% versus 42.7% (p<0.001)]. Differences remained significant in the adjusted analysis. Conclusions In areas of Africa with marked variation in rainfall, seasonality of pneumococcal carriage needs to be considered when interpreting carriage data.	[Bojang, Abdoulie; Jafali, James; Egere, Uzochukwu E.; Hill, Phillip C.; Antonio, Martin; Jeffries, David; Roca, Anna] MRC Unit, Fajara, Gambia; [Hill, Phillip C.] Ctr Int Hlth, Sch Med, Dunedin, New Zealand; [Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Roca, A (corresponding author), MRC Unit, Fajara, Gambia.	aroca@mrc.gm	Egere, Uzochukwu/AET-1704-2022		Medical Research Council Unit, The Gambia; MRC [MC_U190085849, MC_U190074190, MC_U190081991] Funding Source: UKRI; Medical Research Council [MC_U190074190, MC_U190081991, MC_U190085849] Funding Source: researchfish	Medical Research Council Unit, The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council Unit, The Gambia. Study vaccines were donated by Wyeth Lederle Vaccines (Pfizer).	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bottomley C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0786; BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133, DOI 10.1080/02724936.1993.11747637; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Egere U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049143; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Gounder PP, 2013, J INFECT DIS; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Greenwood B, 2006, CLIN INFECT DIS, V43, P701, DOI 10.1086/506943; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Isaacman DJ, 2007, VACCINE, V25, P2420, DOI 10.1016/j.vaccine.2006.09.011; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Kanungo R, 2000, INDIAN J MED RES, V112, P100; Mehtala J, 2013, EPIDEMIOLOGY, V24, P522, DOI 10.1097/EDE.0b013e318294be89; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558; Olaleye BO, 1998, T ROY SOC TROP MED H, V92, P300, DOI 10.1016/S0035-9203(98)91021-5; REDD SC, 1992, LANCET, V340, P1140, DOI 10.1016/0140-6736(92)93160-O; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Rozenbaum MH, 2011, EXPERT REV VACCINES, V10, P187, DOI [10.1586/erv.10.163, 10.1586/ERV.10.163]; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; TUGWELL P, 1976, Q J MED, V45, P583; van der Linden M, 2012, VACCINE, V30, P5880, DOI 10.1016/j.vaccine.2012.06.068; van Hoek AJ, 2014, CLIN INFECT DIS, V58, P195, DOI 10.1093/cid/cit726; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	43	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129649	10.1371/journal.pone.0129649	http://dx.doi.org/10.1371/journal.pone.0129649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132206	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000358153000030
J	Huda, P; Binderup, T; Pedersen, MC; Midtgaard, SR; Elema, DR; Kjaer, A; Jensen, M; Arleth, L				Huda, Pie; Binderup, Tina; Pedersen, Martin Cramer; Midtgaard, Soren Roi; Elema, Dennis Ringkjobing; Kjaer, Andreas; Jensen, Mikael; Arleth, Lise			PET/CT Based In Vivo Evaluation of Cu-64 Labelled Nanodiscs in Tumor Bearing Mice	PLOS ONE			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; NANOPARTICLES; NANOMEDICINE; SCATTERING; CLEARANCE; DYNAMICS; MODEL	Cu-64 radiolabelled nanodiscs based on the 11 alpha-helix MSP1E3D1 protein and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine lipids were, for the first time, followed in vivo by positron emission tomography for evaluating the biodistribution of nanodiscs. A cancer tumor bearing mouse model was used for the investigations, and it was found that the approximately 13 nm nanodiscs, due to their size, permeate deeply into cancer tissue. This makes them promising candidates for both drug delivery purposes and as advanced imaging agents. For the radiolabelling, a simple approach for Cu-64 radiolabelling of proteins via a chelating agent, DOTA, was developed. The reaction was performed at sufficiently mild conditions to be compatible with labelling of the protein part of a lipid-protein particle while fully conserving the particle structure including the amphipathic protein fold.	[Huda, Pie; Pedersen, Martin Cramer; Midtgaard, Soren Roi; Arleth, Lise] Univ Copenhagen, Niels Bohr Inst, Struct Biophys, DK-2100 Copenhagen O, Denmark; [Binderup, Tina; Kjaer, Andreas] Rigshosp, Nucl Med & PET, Cluster Mol Imaging & Dept Clin Physiol, DK-2200 Copenhagen N, Denmark; [Binderup, Tina; Kjaer, Andreas] Univ Copenhagen, DK-2200 Copenhagen N, Denmark; [Elema, Dennis Ringkjobing; Jensen, Mikael] Tech Univ Denmark, Ctr Nucl Technol, Hevesy Lab, DK-4000 Roskilde, Denmark	University of Copenhagen; Niels Bohr Institute; Rigshospitalet; University of Copenhagen; Technical University of Denmark	Kjaer, A (corresponding author), Rigshosp, Nucl Med & PET, Cluster Mol Imaging & Dept Clin Physiol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	akjaer@sund.ku.dk; kmje@dtu.dk; arleth@nbi.ku.dk	Midtgaard, Søren/A-5533-2015; Midtgaard, Søren/O-7532-2019; Jensen, Mikael/I-8358-2012; Arleth, Lise/M-4705-2014; Kjaer, Andreas/E-8932-2015	Midtgaard, Søren/0000-0001-6694-0626; Midtgaard, Søren/0000-0001-6694-0626; Jensen, Mikael/0000-0002-9109-2187; Arleth, Lise/0000-0002-4694-4299; Kjaer, Andreas/0000-0002-2706-5547	University of Copenhagen; Danish Ministry of Science, Innovation and Higher Education; Novo Nordisk Fonden [NNF14OC0011361] Funding Source: researchfish; The Danish Cancer Society [R71-A4285] Funding Source: researchfish	University of Copenhagen; Danish Ministry of Science, Innovation and Higher Education; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This work was supported by the University of Copenhagen and Danish Ministry of Science, Innovation and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2009, CANCER BIOTHER RADIO, V24, P379, DOI 10.1089/cbr.2009.0674; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Chen XY, 2004, BIOCONJUGATE CHEM, V15, P41, DOI 10.1021/bc0300403; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; EISENBERG S, 1973, J LIPID RES, V14, P446; Grunberg J, 2005, CLIN CANCER RES, V11, P5112, DOI 10.1158/1078-0432.CCR-05-0227; Jensen AI, 2014, BIOMACROMOLECULES, V15, P1625, DOI 10.1021/bm401871w; Jones-Wilson TM, 1998, NUCL MED BIOL, V25, P523, DOI 10.1016/S0969-8051(98)00017-1; Jorgensen JT, 2013, NUCL MED BIOL, V40, P345, DOI 10.1016/j.nucmedbio.2013.01.002; Kolleck I, 2002, AM J RESP CELL MOL, V27, P57, DOI 10.1165/ajrcmb.27.1.4774; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Kynde SAR, 2014, ACTA CRYSTALLOGR D, V70, P371, DOI 10.1107/S1399004713028344; Lieutenant K, 2007, J APPL CRYSTALLOGR, V40, P1056, DOI 10.1107/S0021889807038253; Liu YY, 2007, INT J CANCER, V120, P2527, DOI 10.1002/ijc.22709; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Murphy AJ, 2013, CIRC RES, V113, pe1, DOI 10.1161/CIRCRESAHA.113.301112; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; OKU N, 1995, BBA-BIOMEMBRANES, V1238, P86, DOI 10.1016/0005-2736(95)00106-D; Patterson C, 2013, MOLECULES, V18, P5594, DOI 10.3390/molecules18055594; Pernot P, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012009; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Persson M, 2013, THERANOSTICS, V3, P618, DOI 10.7150/thno.6810; Petersen AL, 2011, BIOMATERIALS, V32, P2334, DOI 10.1016/j.biomaterials.2010.11.059; Ritchie TK, 2009, RECONSTITUTION OF ME; Schluep T, 2009, P NATL ACAD SCI USA, V106, P11394, DOI 10.1073/pnas.0905487106; Shaw AW, 2004, FEBS LETT, V556, P260, DOI 10.1016/S0014-5793(03)01400-5; Sheng JR, 2010, EXP NEUROL, V225, P320, DOI 10.1016/j.expneurol.2010.07.003; Shih AY, 2005, BIOPHYS J, V88, P548, DOI 10.1529/biophysj.104.046896; Skar-Gislinge N, 2011, PHYS CHEM CHEM PHYS, V13, P3161, DOI 10.1039/c0cp01074j; Skar-Gislinge N, 2010, J AM CHEM SOC, V132, P13713, DOI 10.1021/ja1030613; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109	38	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129310	10.1371/journal.pone.0129310	http://dx.doi.org/10.1371/journal.pone.0129310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132074	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000026
J	Shu, N; Gao, ZY; Chen, XG; Liu, HH				Shu, Na; Gao, Zhiyong; Chen, Xiangan; Liu, Haihua			Computational Model of Primary Visual Cortex Combining Visual Attention for Action Recognition	PLOS ONE			English	Article							RECEPTIVE-FIELD; OBJECT RECOGNITION; SIMPLE CELLS; MOTION; SUPPRESSION; FEATURES; DYNAMICS; NEURONS; CONTEXT; NOISE	Humans can easily understand other people's actions through visual systems, while computers cannot. Therefore, a new bio-inspired computational model is proposed in this paper aiming for automatic action recognition. The model focuses on dynamic properties of neurons and neural networks in the primary visual cortex (V1), and simulates the procedure of information processing in V1, which consists of visual perception, visual attention and representation of human action. In our model, a family of the three-dimensional spatial-temporal correlative Gabor filters is used to model the dynamic properties of the classical receptive field of V1 simple cell tuned to different speeds and orientations in time for detection of spatio-temporal information from video sequences. Based on the inhibitory effect of stimuli outside the classical receptive field caused by lateral connections of spiking neuron networks in V1, we propose surround suppressive operator to further process spatio-temporal information. Visual attention model based on perceptual grouping is integrated into our model to filter and group different regions. Moreover, in order to represent the human action, we consider the characteristic of the neural code: mean motion map based on analysis of spike trains generated by spiking neurons. The experimental evaluation on some publicly available action datasets and comparison with the state-of-the-art approaches demonstrate the superior performance of the proposed model.	[Shu, Na; Gao, Zhiyong; Chen, Xiangan; Liu, Haihua] South Cent Univ Nationalities, Sch Biomed Engn, Wuhan 430074, Peoples R China; [Gao, Zhiyong; Chen, Xiangan; Liu, Haihua] South Cent Univ Nationalities, Key Lab Cognit Sci State Ethn Affairs Commiss, Wuhan 430074, Peoples R China	South Central Minzu University; South Central Minzu University	Liu, HH (corresponding author), South Cent Univ Nationalities, Sch Biomed Engn, Wuhan 430074, Peoples R China.	liuhh@mail.scuec.edu.cn			National Natural Science Foundation of China [91320102, 60972158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under grant nos. 91320102 and 60972158.	Achanta R, 2009, PROC CVPR IEEE, P1597, DOI 10.1109/CVPRW.2009.5206596; Bayerl P, 2007, IEEE T PATTERN ANAL, V29, P246, DOI 10.1109/TPAMI.2007.24; Bayerl P, 2007, INT J COMPUT VISION, V72, P27, DOI 10.1007/s11263-006-8891-8; Berzhanskaya J, 2007, SPATIAL VISION, V20, P337, DOI 10.1163/156856807780919000; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bregonzio M, 2009, PROC CVPR IEEE, P1948, DOI 10.1109/CVPRW.2009.5206779; Casile A, 2005, J VISION, V5, P348, DOI 10.1167/5.4.6; Chakraborty B, 2012, COMPUT VIS IMAGE UND, V116, P396, DOI 10.1016/j.cviu.2011.09.010; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Elder JH, 2002, J VISION, V2, DOI 10.1167/2.4.5; Escobar MJ, 2012, COMPUT VIS IMAGE UND, V116, P593, DOI 10.1016/j.cviu.2012.01.002; Escobar MJ, 2009, INT J COMPUT VISION, V82, P284, DOI 10.1007/s11263-008-0201-1; Escobar MJ, 2009, P 3 LAT AM ROB S, P47; Finn IM, 2007, J NEUROSCI, V27, P9638, DOI 10.1523/JNEUROSCI.2119-07.2007; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gilbert A, 2011, IEEE T PATTERN ANAL, V33, P883, DOI 10.1109/TPAMI.2010.144; Heng Wang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3169, DOI 10.1109/CVPR.2011.5995407; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jhuang H, 2007, IEEE I CONF COMP VIS, P1253; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kornprobst P, 2005, IEEE IJCNN, P1687; Kovashka A, 2010, PROC CVPR IEEE, P2046, DOI 10.1109/CVPR.2010.5539881; KOWLER E, 1995, EYE MOVEMENTS, P215; Kruizinga P, 2000, BIOL CYBERN, V83, P313, DOI 10.1007/s004220000153; Laptev I, 2008, PROC CVPR IEEE, P3222, DOI 10.1109/cvpr.2008.4587756; Le Meur O, 2006, IEEE T PATTERN ANAL, V28, P802, DOI 10.1109/TPAMI.2006.86; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Ning HZ, 2009, IEEE T CIRC SYST VID, V19, P808, DOI 10.1109/TCSVT.2009.2017399; Pack CC, 2005, J NEUROPHYSIOL, V93, P1809, DOI 10.1152/jn.00629.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Petkov N, 2003, BIOL CYBERN, V88, P236, DOI 10.1007/s00422-002-0378-2; Petkov N, 2007, BIOL CYBERN, V97, P423, DOI 10.1007/s00422-007-0182-0; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Rodriguez MD, 2008, PROC CVPR IEEE, P3001, DOI 10.1109/cvpr.2008.4587727; Saito H, 1993, BRAIN MECH PERCEPTIO; Schindler K., 2008, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2008.4587730; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; Serre T, 2005, PROC CVPR IEEE, P994; Sillito AM, 1996, J PHYSIOL-PARIS, V90, P205, DOI 10.1016/S0928-4257(97)81424-6; Souvenir R., 2008, P IEEE C COMP VIS PA, P1; Soyer C, 2003, IEEE T SYST MAN CY B, V33, P937, DOI 10.1109/TSMCB.2003.810904; Stanley GB, 2013, NAT NEUROSCI, V16, P259, DOI 10.1038/nn.3330; Sun YR, 2003, ARTIF INTELL, V146, P77, DOI 10.1016/S0004-3702(02)00399-5; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Tang QL, 2007, PATTERN RECOGN, V40, P3100, DOI 10.1016/j.patcog.2007.02.009; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Turaga P, 2008, IEEE T CIRC SYST VID, V18, P1473, DOI 10.1109/TCSVT.2008.2005594; Varma M, 2009, P 26 ANN INT C MACH, P1065; Walther D, 2002, LECT NOTES COMPUT SC, V2525, P472; Wang Y, 2007, PROCEEDINGS OF THE SIXTH IEEE INTERNATIONAL CONFERENCE ON COGNITIVE INFORMATICS, P3; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001; Willems G, 2008, LECT NOTES COMPUT SC, V5303, P650, DOI 10.1007/978-3-540-88688-4_48; Wu XX, 2011, PROC CVPR IEEE, P489, DOI 10.1109/CVPR.2011.5995624; Yao JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016343; Yee H, 2001, ACM T GRAPHIC, V20, P39, DOI 10.1145/383745.383748; Yu AJ, 2002, NEURAL COMPUT, V14, P2857, DOI 10.1162/089976602760805313; Yuan C, 2013, P IEEE C COMP VIS PA, P725; Yuan JS, 2009, PROC CVPR IEEE, P2442, DOI [10.1109/CVPR.2009.5206671, 10.1109/CVPRW.2009.5206671]; Zeng B, 1997, IEEE T CIRC SYST VID, V7, P833, DOI 10.1109/76.644063; Zhang Z, 2012, IEEE T PATTERN ANAL, V34, P436, DOI 10.1109/TPAMI.2011.157	65	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130569	10.1371/journal.pone.0130569	http://dx.doi.org/10.1371/journal.pone.0130569			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132270	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000073
J	Wang, G; Xu, YM; Zhang, LN; Ye, DM; Feng, XX; Fu, TF; Bai, YH				Wang, Gang; Xu, Yiming; Zhang, Lina; Ye, Dongmei; Feng, Xianxuan; Fu, Tengfei; Bai, Yuehong			Enhancement of Apoptosis by Titanium Alloy Internal Fixations during Microwave Treatments for Fractures: An Animal Study	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PULSED SHORTWAVE DIATHERMY; METALLIC IMPLANTS; SAR DISTRIBUTION; IN-VITRO; CELLS; HYPERTHERMIA; EXPOSURE; RADIATION; BCL-2	Objective Microwaves are used in one method of physical therapy and can increase muscle tissue temperature which is useful for improving muscle, tendon and bone injuries. In the study, we sought to determine whether titanium alloy internal fixations influence apoptosis in tissues subjected to microwave treatments at 2,450 MHz and 40 W during the healing of fractures because this issue is not yet fully understood. Methods In this study, titanium alloy internal fixations were used to treat 3.0-mm transverse osteotomies in the middle of New Zealand rabbits' femurs. After the operation, 30-day microwave treatments were applied to the 3.0 mm transverse osteotomies 3 days after the operation. The changes in the temperatures of the muscle tissues in front of the implants or the 3.0 mm transverse osteotomies were measured during the microwave treatments. To characterize the effects of titanium alloy internal fixations on apoptosis in the muscles after microwave treatment, we performed TUNEL assays, fluorescent real-time (quantitative) PCR, western blotting analyses, reactive oxygen species (ROS) detection and transmission electron microscopy examinations. Results The temperatures were markedly increased in the animals with the titanium alloy implants. Apoptosis in the muscle cells of the implanted group was significantly more extensive than that in the non-implanted control group at different time points. Transmission electron microscopy examinations of the skeletal muscles of the implanted groups revealed muscular mitochondrial swelling, vacuolization. ROS, Bax and Hsp70 were up-regulated, and Bcl-2 was down-regulated in the implanted group. Conclusion Our results suggest that titanium alloy internal fixations caused greater muscular tissue cell apoptosis following 2,450 MHz, 40 W microwave treatments in this rabbit femur fracture models.	[Wang, Gang; Xu, Yiming; Ye, Dongmei; Feng, Xianxuan; Fu, Tengfei; Bai, Yuehong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai, Peoples R China; [Zhang, Lina] Shanghai Jiao Tong Univ, Sch Med, Dept Biostat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bai, YH (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Rehabil Med, Shanghai, Peoples R China.	aibyhw@126.com	Xu, yiming/E-5687-2012	Xu, yiming/0000-0002-7123-5793				Agarwal Ashok, 2005, Indian Journal of Experimental Biology, V43, P963; Ballardin M, 2011, MUTAT RES-FUND MOL M, V716, P1, DOI 10.1016/j.mrfmmm.2011.07.009; Barrier M, 2009, BIRTH DEFECTS RES A, V85, P732, DOI 10.1002/bdra.20610; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Brehmer M, 2000, BJU INT, V85, P535, DOI 10.1046/j.1464-410x.2000.00473.x; Christians ES, 2003, SEMIN CELL DEV BIOL, V14, P283, DOI 10.1016/j.semcdb.2003.09.021; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; DANILOV R K, 1980, Arkhiv Anatomii Gistologii i Embriologii, V78, P83; Draper DO, 2004, ATHLET THER TODAY, V9, P28; DWIVEDI RS, 1989, EXP CELL RES, V180, P253, DOI 10.1016/0014-4827(89)90229-2; Frasca G, 2011, CLIN REHABIL, V25, P1109, DOI 10.1177/0269215511400767; FREEMAN ML, 1990, RADIAT RES, V124, P288, DOI 10.2307/3577841; Giombini A, 2007, BRIT MED BULL, V83, P379, DOI 10.1093/bmb/ldm020; Goats G C, 1990, Br J Sports Med, V24, P212; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GUY AW, 1987, HEALTH PHYS, V53, P569, DOI 10.1097/00004032-198712000-00001; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Joubert V, 2006, INT J RADIAT BIOL, V82, P267, DOI 10.1080/09553000600649232; Ka H, 2003, CANCER LETT, V196, P143, DOI 10.1016/S0304-3835(03)00238-6; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Martin D, 2009, J MICROWAVE POWER EE, V43, P21; McIntosh RL, 2005, BIOELECTROMAGNETICS, V26, P377, DOI 10.1002/bem.20112; MESHORER A, 1983, ARCH PATHOL LAB MED, V107, P328; Motomura T, 2010, ONCOL REP, V24, P591, DOI 10.3892/or_00000896; Mougenot C, 2009, MAGN RESON MED, V61, P603, DOI 10.1002/mrm.21887; Nanri M, 2009, CLIN EXP NEPHROL, V13, P424, DOI 10.1007/s10157-009-0180-8; Palumbo R, 2008, RADIAT RES, V170, P327, DOI 10.1667/RR1098.1; Peng TI, 2004, ANN NY ACAD SCI, V1011, P112, DOI 10.1196/annals.1293.012; Primeau AJ, 2002, CAN J APPL PHYSIOL, V27, P349, DOI 10.1139/h02-020; Rabini A, 2012, EUR J PHYS REHAB MED, V48, P549; Ruggera PS, 2003, PHYS MED BIOL, V48, P2919, DOI 10.1088/0031-9155/48/17/312; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Seiger C, 2006, J ORTHOP SPORT PHYS, V36, P669, DOI 10.2519/jospt.2006.2198; Shields Nora, 2002, Physiother Res Int, V7, P191, DOI 10.1002/pri.259; Sokka SD, 2003, PHYS MED BIOL, V48, P223, DOI 10.1088/0031-9155/48/2/306; Song XL, 2011, CHINESE MED J-PEKING, V124, P1193, DOI 10.3760/cma.j.issn.0366-6999.2011.08.013; Tjalma WA, 2001, EUR J OBSTET GYN R B, V97, P223, DOI 10.1016/S0301-2115(00)00541-8; Virtanen H, 2007, PHYS MED BIOL, V52, P1221, DOI 10.1088/0031-9155/52/5/001; Virtanen H, 2005, PHYS MED BIOL, V50, P2689, DOI 10.1088/0031-9155/50/11/017; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YATVIN MB, 1977, INT J RADIAT BIOL, V32, P513, DOI 10.1080/09553007714551301; Ye DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075756; Zderic V, 2008, MED PHYS, V35, P4292, DOI 10.1118/1.2975149	43	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132046	10.1371/journal.pone.0132046	http://dx.doi.org/10.1371/journal.pone.0132046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132082	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000152
J	Balklava, Z; Niehage, C; Currinn, H; Mellor, L; Guscott, B; Poulin, G; Hoflack, B; Wassmer, T				Balklava, Zita; Niehage, Christian; Currinn, Heather; Mellor, Laura; Guscott, Benjamin; Poulin, Gino; Hoflack, Bernard; Wassmer, Thomas			The Amyloid Precursor Protein Controls PIKfyve Function	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VIVO; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; CASCADE HYPOTHESIS; FAMILY; TRANSPORT; ENDOSOME; MUTATION; GENE; TGN	While the Amyloid Precursor Protein (APP) plays a central role in Alzheimer's disease, its cellular function still remains largely unclear. It was our goal to establish APP function which will provide insights into APP's implication in Alzheimer's disease. Using our recently developed proteo-liposome assay we established the interactome of APP's intracellular domain (known as AICD), thereby identifying novel APP interactors that provide mechanistic insights into APP function. By combining biochemical, cell biological and genetic approaches we validated the functional significance of one of these novel interactors. Here we show that APP binds the PIKfyve complex, an essential kinase for the synthesis of the endosomal phosphoinositide phosphatidylinositol-3,5-bisphosphate. This signalling lipid plays a crucial role in endosomal homeostasis and receptor sorting. Loss of PIKfyve function by mutation causes profound neurodegeneration in mammals. Using C. elegans genetics we demonstrate that APP functionally cooperates with PIKfyve in vivo. This regulation is required for maintaining endosomal and neuronal function. Our findings establish an unexpected role for APP in the regulation of endosomal phosphoinositide metabolism with dramatic consequences for endosomal biology and important implications for our understanding of Alzheimer's disease.	[Balklava, Zita; Currinn, Heather; Guscott, Benjamin; Wassmer, Thomas] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Niehage, Christian; Hoflack, Bernard] Tech Univ Dresden, Biotechnol Zentrum, D-01307 Dresden, Germany; [Mellor, Laura; Poulin, Gino] Univ Manchester, Manchester M13 9PT, Lancs, England	Aston University; Technische Universitat Dresden; University of Manchester	Wassmer, T (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	t.wassmer@aston.ac.uk	HOFLACK, Bernard/AAZ-6668-2020; Balklava, Zita/AAU-6146-2021	Poulin, Gino/0000-0003-1016-348X; Balklava, Zita/0000-0001-9039-9710; Currinn, Heather/0000-0003-1314-1868	Alzheimer Research UK [ARUK-PHD-12/13]; BBSRC [BB/K014862/1, BB/J014834/1, BB/J014478/1]; Royal Society; Deutsche Forschungsgemeinschaft [TRR 83/1-2010, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1]; Alzheimers Research UK [ARUK-PhD2012-13] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/J014834/1, BB/K014862/1] Funding Source: researchfish	Alzheimer Research UK(Alzheimer's Research UK (ARUK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge funding from Alzheimer Research UK ARUK-PHD-12/13, (TW), BBSRC BB/K014862/1 (TW and ZB), the Royal Society (ZB) and the Deutsche Forschungsgemeinschaft TRR 83/1-2010, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1 (BH). The work performed by GP and LM was supported by the BBSRC (BB/J014834/1). LM is funded by a BBSRC DTP (BB/J014478/1).	Bach G, 2010, BIOCHEM SOC T, V38, P1432, DOI 10.1042/BST0381432; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; BRENNER S, 1974, GENETICS, V77, P71; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Caldwell JH, 2013, MECH DEVELOP, V130, P433, DOI 10.1016/j.mod.2012.11.001; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Castellani RJ, 2012, ARCH MED RES, V43, P694, DOI 10.1016/j.arcmed.2012.09.009; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Heber S, 2000, J NEUROSCI, V20, P7951; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Korte M, 2012, EXP BRAIN RES, V217, P435, DOI 10.1007/s00221-011-2894-6; Lazarov O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00081; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michell RH, 2009, EMBO J, V28, P86, DOI 10.1038/emboj.2008.270; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nakayama K, 2011, CELL MOL NEUROBIOL, V31, P887, DOI 10.1007/s10571-011-9688-z; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Niehage C, 2014, METHOD ENZYMOL, V534, P223, DOI 10.1016/B978-0-12-397926-1.00013-5; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Pocha Shirin Meher, 2011, Commun Integr Biol, V4, P749; Pocha SM, 2011, CURR BIOL, V21, P1111, DOI 10.1016/j.cub.2011.05.007; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Soldano A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001562; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zheng H., 2010, PLOS ONE, V5; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	47	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130485	10.1371/journal.pone.0130485	http://dx.doi.org/10.1371/journal.pone.0130485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125944	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358151300016
J	Bleser, G; Damen, D; Behera, A; Hendeby, G; Mura, K; Miezal, M; Gee, A; Petersen, N; Macaes, G; Domingues, H; Gorecky, D; Almeida, L; Mayol-Cuevas, W; Calway, A; Cohn, AG; Hogg, DC; Stricker, D				Bleser, Gabriele; Damen, Dima; Behera, Ardhendu; Hendeby, Gustaf; Mura, Katharina; Miezal, Markus; Gee, Andrew; Petersen, Nils; Macaes, Gustavo; Domingues, Hugo; Gorecky, Dominic; Almeida, Luis; Mayol-Cuevas, Walterio; Calway, Andrew; Cohn, Anthony G.; Hogg, David C.; Stricker, Didier			Cognitive Learning, Monitoring and Assistance of Industrial Workflows Using Egocentric Sensor Networks	PLOS ONE			English	Article							ACTIVITY RECOGNITION; FEEDBACK; TRACKING; ARROWS	Today, the workflows that are involved in industrial assembly and production activities are becoming increasingly complex. To efficiently and safely perform these workflows is demanding on the workers, in particular when it comes to infrequent or repetitive tasks. This burden on the workers can be eased by introducing smart assistance systems. This article presents a scalable concept and an integrated system demonstrator designed for this purpose. The basic idea is to learn workflows from observing multiple expert operators and then transfer the learnt workflow models to novice users. Being entirely learning-based, the proposed system can be applied to various tasks and domains. The above idea has been realized in a prototype, which combines components pushing the state of the art of hardware and software designed with interoperability in mind. The emphasis of this article is on the algorithms developed for the prototype: 1) fusion of inertial and visual sensor information from an on-body sensor network (BSN) to robustly track the user's pose in magnetically polluted environments; 2) learning-based computer vision algorithms to map the workspace, localize the sensor with respect to the workspace and capture objects, even as they are carried; 3) domain-independent and robust workflow recovery and monitoring algorithms based on spatiotemporal pairwise relations deduced from object and user movement with respect to the scene; and 4) context-sensitive augmented reality (AR) user feedback using a head-mounted display (HMD). A distinguishing key feature of the developed algorithms is that they all operate solely on data from the on-body sensor network and that no external instrumentation is needed. The feasibility of the chosen approach for the complete action-perception-feedback loop is demonstrated on three increasingly complex datasets representing manual industrial tasks. These limited size datasets indicate and highlight the potential of the chosen technology as a combined entity as well as point out limitations of the system.	[Bleser, Gabriele; Petersen, Nils; Stricker, Didier] German Res Ctr Artificial Intelligence, Dept Augmented Vis, Kaiserslautern, Germany; [Bleser, Gabriele; Miezal, Markus] Tech Univ, Dept Comp Sci, Kaiserslautern, Germany; [Damen, Dima; Gee, Andrew; Mayol-Cuevas, Walterio; Calway, Andrew] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Behera, Ardhendu; Cohn, Anthony G.; Hogg, David C.] Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; [Behera, Ardhendu] Edge Hill Univ, Dept Comp, Ormskirk, Lancs, England; [Hendeby, Gustaf] Swedish Def Res Agcy, Dept Sensor Informat, Linkoping, Sweden; [Hendeby, Gustaf] Linkoping Univ, Dept Elect Engn, S-58183 Linkoping, Sweden; [Mura, Katharina; Gorecky, Dominic] SmartFactory KL eV, Kaiserslautern, Germany; [Macaes, Gustavo; Domingues, Hugo; Almeida, Luis] Ctr Comp Graph, Dept Comp Vis Interact & Graph, Guimaraes, Portugal	University of Kaiserslautern; University of Bristol; University of Leeds; Edge Hill University; Saab Group; Linkoping University	Bleser, G (corresponding author), German Res Ctr Artificial Intelligence, Dept Augmented Vis, Kaiserslautern, Germany.	bleser@cs.uni-kl.de	Hendeby, Gustaf/E-5959-2016; Mayol-Cuevas, Walterio/AAD-6590-2019	Hendeby, Gustaf/0000-0002-1971-4295; Mayol-Cuevas, Walterio/0000-0001-8973-1931; Hogg, David/0000-0002-6125-9564; Damen, Dima/0000-0001-8804-6238	Seventh Framework Program: Theme ICT-2009.2.1 Cognitive Systems and Robotics, ICT - Information and Communications Technologies [ICT 248290]; COGNITO; Theme FoF.NMP.2013-5 Innovative design of personalised product-services and of their production processes based on collaborative environments [FoF - 609078]; EASY-IMP; EPSRC [EP/K031910/1] Funding Source: UKRI; MRC [MR/L01629X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K031910/1] Funding Source: researchfish	Seventh Framework Program: Theme ICT-2009.2.1 Cognitive Systems and Robotics, ICT - Information and Communications Technologies; COGNITO; Theme FoF.NMP.2013-5 Innovative design of personalised product-services and of their production processes based on collaborative environments; EASY-IMP; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was funded under the Seventh Framework Program: Theme ICT-2009.2.1 Cognitive Systems and Robotics, ICT - Information and Communications Technologies, Project number: ICT 248290, Project acronym: COGNITO; and Theme FoF.NMP.2013-5 Innovative design of personalised product-services and of their production processes based on collaborative environments, Project number: FoF - 609078, Project acronym: EASY-IMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; Aghazadeh O, 2011, P C COMP VIS PATT RE; [Anonymous], 2006, APPL SPATIAL COGNITI; Behera A, 2015, COGNITO ACTIVITY MON; Behera A, 2015, REAL TIME ACTIVITY R; Behera A, 2012, P AS C COMP VIS ACCV; Behera A, 2012, INT C MULT MOD MMM K; Benbelkacem S., 2010, P INT S ENV FRIENDL; Biocca F, 2006, P C HUM FACT COMP SY; Bleser G, 2011, P INT S MIX AUGM REA; Bleser G, 2010, P EUR SIGN PROC C EU; Bleser G., 2013, COGNITIVE WORKFLOW C; Bleser G, 2009, COMPUT GRAPH-UK, V33, P59, DOI 10.1016/j.cag.2008.11.004; Caudell T, 1992, P HAW INT C SYST SCI; Chang C.-C., LIBSVM LIB SUPPORT V; Chavarriaga R, 2013, PATTERN RECOGN LETT, V34, P2033, DOI 10.1016/j.patrec.2012.12.014; Damen D, 2012, P INT C INT ROB SYST; Damen D, 2015, REAL TIME SCALABLE T; Damen D, 2012, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2012, DOI 10.5244/C.26.23; Daniel MP, 2012, COGN PROCESS, V13, P303, DOI 10.1007/s10339-012-0521-5; Diaz-Rodriguez N, 2014, SENSORS-BASEL, V14, P18131, DOI 10.3390/s141018131; El-Gohary M, 2012, IEEE T BIO-MED ENG, V59, P2635, DOI 10.1109/TBME.2012.2208750; Erden MS, 2009, SCI TECHNOL WELD JOI, V14, P523, DOI 10.1179/136217109X437150; European project COGNITO, 2010, COGN WORKFL CAPT REN; European project SKILLS, 2007, MULT INT CAPT TRANSF; Fathi A, 2011, P COMP VIS PATT REC; Fathi Alireza, 2011, P INT C COMP VIS ICC; Ferrari V, 2010, INT J COMPUT VISION, V87, P284, DOI 10.1007/s11263-009-0270-9; Furth, 2011, HDB AUGMENTED REALIT; Gee AP, 2012, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2012, DOI 10.5244/C.26.113; Gorecky D, 2013, P INT C MAN SCI ED M; Goto M, 2010, P INT S MIX AUGM REA; Heiser J, 2006, COGNITIVE SCI, V30, P581, DOI 10.1207/s15516709cog0000_70; Henderson S, 2011, IEEE T VIS COMPUT GR, V17, P1355, DOI 10.1109/TVCG.2010.245; Hinterstoisser S, 2010, P COMP VIS PATT REC; Horz H., 2008, LANGUAGE WORK, V4, P43, DOI [10.7146/law.v3i4.6200, DOI 10.7146/LAW.V3I4.6200]; Huff M, 2012, LEARN INSTR, V22, P376, DOI 10.1016/j.learninstruc.2012.03.001; Jazwinski A. H, 1970, STOCHASTIC PROCESSES; Kitani KM, 2011, P C COMP VIS PATT RE; Kjellstrom H, 2008, P EUR C COMP VIS ECC; Knopfle C, 2005, P VIRT REAL BONN GER; Koppula H., 2013, P INT C MACH LEARN I; Koppula HS, 2013, INT J ROBOT RES, V32, P951, DOI 10.1177/0278364913478446; Laptev I., 2008, P C COMP VIS PATT RE; Lenz C, 2011, P INT C INT ROB SYST; Liu Ming-Yu, 2010, COMP VIS PATT REC CV; Malis E, 2004, P INT C ROB AUT ICRA; Mayer RE, 2003, J EDUC PSYCHOL, V95, P833, DOI 10.1037/0022-0663.95.4.833; Mayer RE., 2014, CAMBRIDGE HDB MULTIM, P345, DOI 10.1017/CBO9781139547369.017; Mayol-Cuevas W, 2005, P INT S WEAR COMP OS; Miezal M, 2012, P INT S MIX AUGM REA; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Morkos B, 2012, INT J INTERACT DES M, V6, P101, DOI 10.1007/s12008-012-0148-x; Mura K, 2012, P APPL HUM FACT ERG; Mura Katharina, 2013, Front Psychol, V4, P994, DOI 10.3389/fpsyg.2013.00994; Newcombe RA, 2011, INT SYM MIX AUGMENT, P127, DOI 10.1109/ISMAR.2011.6092378; Nielsen J, 1992, P C HUM FACT COMP SY; Nilsson S, 2006, P INT S MIX AUGM REA; Ong SK, 2008, INT J PROD RES, V46, P2707, DOI 10.1080/00207540601064773; Ott R, 2007, VISUAL COMPUT, V23, P843, DOI 10.1007/s00371-007-0159-y; Paivio, 1986, MENTAL REPRESENTATIO; Petersen N, 2012, IADIS INT C COMP GRA; Petersen N, 2012, COMPIMAGE ROM IT; Petersen N, 2012, P INT S MIX AUGM REA; Petersen N, 2009, LECT NOTES ARTIF INT, V5803, P106, DOI 10.1007/978-3-642-04617-9_14; Pinhanez CS, 1998, P C COMP VIS PATT RE; Reiss A, 2013, INT J UNIVERSAL ACCE; Roetenberg D., 2006, THESIS U TWENTE ENSC; Roggen D, 2011, PROCEDIA COMPUT SCI, V7, P173, DOI 10.1016/j.procs.2011.09.003; Ryoo M. S., 2009, P INT C COMP VIS ICC; Salehi S, 2013, IEEE INT C UB INT CO; Sato Y, 2002, P INT C INT ROB SYST; Schreiber W., 2011, VIRTUELLE TECHNIKEN; Scriven M, 1996, EVAL PRACT, V17, P151, DOI 10.1016/S0886-1633(96)90020-3; Sridhar M, 2010, AAAI C ART INT ATL U; Starner T, 1995, P INT S COMP VIS ISC; Stork S, 2010, ADV ENG INFORM, V24, P320, DOI 10.1016/j.aei.2010.05.010; Sun L, 2009, P COMP VIS PATT REC; Tsubuku Y, 2004, ADV MULTIMEDIA INFOR; Turaga P, 2008, IEEE T CIRC SYST VID, V18, P1473, DOI 10.1109/TCSVT.2008.2005594; Tversky B, 2000, LECT NOTES ARTIF INT, V1889, P221; van Genuchten E, 2012, COMPUT HUM BEHAV, V28, P2209, DOI 10.1016/j.chb.2012.06.028; Vedaldi A, 2010, P C COMP VIS PATT RE; Vignais N, 2013, APPL ERGON, V44, P566, DOI 10.1016/j.apergo.2012.11.008; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Ward JA, 2006, IEEE T PATTERN ANAL, V28, P1553, DOI 10.1109/TPAMI.2006.197; Zacks JM, 2003, J EXP PSYCHOL-APPL, V9, P88, DOI 10.1037/1076-898X.9.2.88	87	26	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0127769	10.1371/journal.pone.0127769	http://dx.doi.org/10.1371/journal.pone.0127769			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126116	Green Published, gold			2022-12-26	WOS:000358151300003
J	Perez-Losada, M; Castro-Nallar, E; Bendall, ML; Freishtat, RJ; Crandall, KA				Perez-Losada, Marcos; Castro-Nallar, Eduardo; Bendall, Matthew L.; Freishtat, Robert J.; Crandall, Keith A.			Dual Transcriptomic Profiling of Host and Microbiota during Health and Disease in Pediatric Asthma	PLOS ONE			English	Article							BACTERIAL MICROBIOME; GROWTH-FACTORS; CYTOKINES; EXPRESSION; GENE; ALIGNMENT; IDENTIFICATION; ASSOCIATION; BLOOD; CELLS	Background High-throughput sequencing (HTS) analysis of microbial communities from the respiratory airways has heavily relied on the 16S rRNA gene. Given the intrinsic limitations of this approach, airway microbiome research has focused on assessing bacterial composition during health and disease, and its variation in relation to clinical and environmental factors, or other microbiomes. Consequently, very little effort has been dedicated to describing the functional characteristics of the airway microbiota and even less to explore the microbehost interactions. Here we present a simultaneous assessment of microbiome and host functional diversity and host-microbe interactions from the same RNA-seq experiment, while accounting for variation in clinical metadata. Methods Transcriptomic (host) and metatranscriptomic (microbiota) sequences from the nasal epithelium of 8 asthmatics and 6 healthy controls were separated in silico and mapped to available human and NCBI-NR protein reference databases. Human genes differentially expressed in asthmatics and controls were then used to infer upstream regulators involved in immune and inflammatory responses. Concomitantly, microbial genes were mapped to metabolic databases (COG, SEED, and KEGG) to infer microbial functions differentially expressed in asthmatics and controls. Finally, multivariate analysis was applied to find associations between microbiome characteristics and host upstream regulators while accounting for clinical variation. Results and Discussion Our study showed significant differences in the metabolism of microbiomes from asthmatic and non-asthmatic children for up to 25% of the functional properties tested. Enrichment analysis of 499 differentially expressed host genes for inflammatory and immune responses revealed 43 upstream regulators differentially activated in asthma. Microbial adhesion (virulence) and Proteobacteria abundance were significantly associated with variation in the expression of the upstream regulator IL1A; suggesting that microbiome characteristics modulate host inflammatory and immune systems during asthma.	[Perez-Losada, Marcos; Castro-Nallar, Eduardo; Bendall, Matthew L.; Crandall, Keith A.] George Washington Univ, Computat Biol Inst, Ashburn, VA 20147 USA; [Perez-Losada, Marcos] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA; [Perez-Losada, Marcos] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Castro-Nallar, Eduardo] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Fac Ciencias Biol, Santiago, Chile	George Washington University; Children's National Health System; Universidade do Porto; Universidad Andres Bello	Perez-Losada, M (corresponding author), George Washington Univ, Computat Biol Inst, Ashburn, VA 20147 USA.	mlosada@gwu.edu	Bendall, Matthew/ABF-8123-2020; Castro-Nallar, Eduardo/I-5925-2019; Crandall, Keith A./H-2789-2019; Perez-Losada, Marcos/I-4407-2013	Bendall, Matthew/0000-0001-9816-5425; Castro-Nallar, Eduardo/0000-0003-4384-8661; Crandall, Keith A./0000-0002-0836-3389; Perez-Losada, Marcos/0000-0002-2585-4657; Freishtat, Robert/0000-0002-7411-2342	K12 Career Development Program [5 K12 HL119994]; CONICYT + PAI/ Concurso nacional apoyo al retorno de investigadores/as desde el extranjero, convocatoria + folio [82140008]; National Institute of Health to National Center for Advancing Translational Sciences [UL1TR000075]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL119994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007075] Funding Source: NIH RePORTER	K12 Career Development Program; CONICYT + PAI/ Concurso nacional apoyo al retorno de investigadores/as desde el extranjero, convocatoria + folio; National Institute of Health to National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	MP-L was funded in part by a K12 Career Development Program 5 K12 HL119994 award. EC-N was funded by "CONICYT + PAI/ Concurso nacional apoyo al retorno de investigadores/as desde el extranjero, convocatoria 2014 + folio 82140008". This study was supported by Award Number UL1TR000075 from the National Institute of Health to National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Benitez-Paez A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-311; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton AS, 2010, J ASTHMA, V47, P728, DOI 10.3109/02770903.2010.491142; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bluman AG., 2007, ELEMENTARY STAT STEP; Brar T, 2012, CURR OPIN PULM MED, V18, P14, DOI 10.1097/MCP.0b013e32834dccc0; Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Byrd AL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-262; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; Castro-Nallar E, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0121-1; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chiappara G, 2007, ALLERGY, V62, P787, DOI 10.1111/j.1398-9995.2007.01417.x; Closek CJ, 2014, ISME J, V8, P2411, DOI 10.1038/ismej.2014.85; Cui Lijia, 2014, Ann Am Thorac Soc, V11 Suppl 4, pS227, DOI 10.1513/AnnalsATS.201402-052PL; CZERKINSKY C, 1987, P NATL ACAD SCI USA, V84, P2449, DOI 10.1073/pnas.84.8.2449; de Vries SPW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072193; Desai D, 2012, ADV CLIN CHEM, V57, P57, DOI 10.1016/B978-0-12-394384-2.00003-6; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Farahani Rahim, 2014, Adv Biomed Res, V3, P127, DOI 10.4103/2277-9175.133249; Finiasz M, 2011, CURR MED CHEM, V18, P1476, DOI 10.2174/092986711795328346; Francis OE, 2013, GENOME RES, V23, P1721, DOI 10.1101/gr.150151.112; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hong CJ, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-33; Hoshino M, 1998, THORAX, V53, P21, DOI 10.1136/thx.53.1.21; Huang Yvonne J, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS48, DOI 10.1513/AnnalsATS.201306-187MG; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mehrotra AK, 2009, CURR MOL MED, V9, P384, DOI 10.2174/156652409787847209; Morgan XC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0637-x; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pawankar R, 2015, CURR OPIN ALLERGY CL, V15, P41, DOI 10.1097/ACI.0000000000000129; Platts-Mills TAE, 2001, AM J RESP CRIT CARE, V164, pS1, DOI 10.1164/ajrccm.164.supplement_1.2103024; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schwartz S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r32; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Spaniol V, 2009, J INFECT DIS, V200, P1593, DOI 10.1086/644640; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Teo SM, 2015, CELL HOST M IN PRESS; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vizcaya D, 2013, RESP MED, V107, P673, DOI 10.1016/j.rmed.2013.01.011; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wisniewski JA, 2011, ALLERGY ASTHMA PROC, V32, P83, DOI 10.2500/aap.2011.32.3428; Yayan J, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000199; Zou H, 2014, EXP THER MED, V8, P573, DOI 10.3892/etm.2014.1759	73	65	65	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131819	10.1371/journal.pone.0131819	http://dx.doi.org/10.1371/journal.pone.0131819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125632	Green Submitted, gold, Green Published			2022-12-26	WOS:000358151300057
J	Camoretti-Mercado, B; Pauer, SH; Yong, HM; Smith, DC; Deshpande, DA; An, SS; Liggett, SB				Camoretti-Mercado, Blanca; Pauer, Susan H.; Yong, Hwan Mee; Smith, Dan'elle C.; Deshpande, Deepak A.; An, Steven S.; Liggett, Stephen B.			Pleiotropic Effects of Bitter Taste Receptors on [Ca2+](i) Mobilization, Hyperpolarization, and Relaxation of Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							ALPHA(2A)-ADRENERGIC RECEPTOR; BETA(2)-ADRENERGIC RECEPTORS; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR ACTIVITY; HUMAN TISSUE; ASTHMA; ACTIVATION; AGONISTS; EXPRESSION; G(S)	Asthma is characterized by airway inflammation and airflow obstruction from human airway smooth muscle (HASM) constriction due to increased local bronchoconstrictive substances. We have recently found bitter taste receptors (TAS2Rs) on HASM, which increase [Ca2+](i) and relax the muscle. We report here that some, but not all, TAS2R agonists decrease [Ca2+](i) and relax HASM contracted by G-protein coupled receptors (GPCRs) that stimulate [Ca2+](i). This suggests both a second pathway by which TAS2Rs relax, and, a heterogeneity of the response phenotype. We utilized eight TAS2R agonists and five procontractile GPCR agonists in cultured HASM cells. We find that heterogeneity in the inhibitory response hinges on which procontractile GPCR is activated. For example, chloroquine inhibits [Ca2+](i) increases from histamine, but failed to inhibit [Ca2+](i) increases from endothelin-1. Conversely, aristolochic acid inhibited [Ca2+](i) increases from endothelin-1 but not histamine. Other dichotomous responses were found when [Ca2+](i) was stimulated by bradykinin, angiotensin, and acetylcholine. There was no association between [Ca2+](i) inhibition and TAS2R subtype, nor whether [Ca2+](i) was increased by Gq- or Gi-coupled GPCRs. Selected studies revealed a correlation between [Ca2+](i) inhibition and HASM cell-membrane hyperpolarization. To demonstrate physiologic correlates, ferromagnetic beads were attached to HASM cells and cell stiffness measured by magnetic twisting cytometry. Consistent with the [Ca2+] i inhibition results, chloroquine abolished the cell stiffening response (contraction) evoked by histamine but not by endothelin-1, while aristolochic acid inhibited cell stiffening from endothelin-1, but not from histamine. In studies using intact human bronchi, these same differential responses were found. Those TAS2R agonists that decreased [Ca2+](i), promoted hyperpolarization, and decreased HASM stiffness, caused relaxation of human airways. Thus TAS2Rs relax HASM in two ways: a low-efficiency de novo [Ca2+](i) stimulation, and, a high-efficiency inhibition of GPCR-stimulated [Ca2+](i). Furthermore, there is an interaction between TAS2Rs and some GPCRs that facilitates this [Ca2+](i) inhibition limb.	[Camoretti-Mercado, Blanca; Pauer, Susan H.; Smith, Dan'elle C.; Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Med, Tampa, FL 33620 USA; [Camoretti-Mercado, Blanca; Pauer, Susan H.; Smith, Dan'elle C.; Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Ctr Personalized Med & Genom, Tampa, FL USA; [Yong, Hwan Mee; An, Steven S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Deshpande, Deepak A.] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Deshpande, Deepak A.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jefferson University; Jefferson University; State University System of Florida; University of South Florida	Liggett, SB (corresponding author), Univ S Florida, Morsani Coll Med, Dept Med, Tampa, FL 33620 USA.	sliggett@health.usf.edu	An, Steven/AAM-3848-2020	An, Steven/0000-0003-4723-1888; Liggett, Stephen B./0000-0002-0128-3669	National Institutes of Health [P01HL114471, R01HL107361, K01HL092588]; NIH [R01HL045967]; American Asthma Foundation; Cracchiolo Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107361, K01HL092588, P01HL114471, R01HL045967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Cracchiolo Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health, http://www.nhlbi.nih.gov: P01HL114471 to SBL SSA, R01HL107361 to SSA, K01HL092588 to BC-M, and NIH R01HL045967 to SBL. American Asthma Foundation to DAD. Cracchiolo Family Foundation to SBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; An SS, 2012, AM J PHYSIOL-LUNG C, V303, pL304, DOI 10.1152/ajplung.00126.2012; An SS, 2012, NAT MED, V18, P650, DOI 10.1038/nm.2734; Barnes PJ, 1998, PHARMACOL REV, V50, P515; Beasley R, 1999, J ALLERGY CLIN IMMUN, V104, pS18, DOI 10.1016/S0091-6749(99)70270-8; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Comer BS, 2014, AM J PHYSIOL-LUNG C, V307, pL727, DOI 10.1152/ajplung.00174.2014; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; EASON MG, 1992, J BIOL CHEM, V267, P15795; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; EASON MG, 1994, MOL PHARMACOL, V45, P696; Eason MG, 1996, J BIOL CHEM, V271, P12826, DOI 10.1074/jbc.271.22.12826; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fairless R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058260; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; GREEN SA, 1996, GENETICS ASTHMA, P67; Hohendanner F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00035; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; Krzywinski M, 2014, NAT METHODS, V11, P977, DOI 10.1038/nmeth.3137; Liggett SB, 2006, J CLIN INVEST, V116, P875, DOI 10.1172/JCI28234; Liggett Stephen B, 2014, Trans Am Clin Climatol Assoc, V125, P64; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Lipworth BJ, 1997, DRUG SAFETY, V16, P295, DOI 10.2165/00002018-199716050-00002; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McGraw DW, 1999, J BIOL CHEM, V274, P32241, DOI 10.1074/jbc.274.45.32241; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Panebra A, 2007, AM J PHYSIOL-LUNG C, V293, pL453, DOI 10.1152/ajplung.00084.2007; PAUL RJ, 1996, GENETICS ASTHMA, P91; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pulkkinen V, 2012, AM J PHYSIOL-LUNG C, V303, pL956, DOI 10.1152/ajplung.00205.2012; Robinett KS, 2014, AM J RESP CELL MOL, V50, P678, DOI 10.1165/rcmb.2013-0439RC; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Salpeter SR, 2010, AM J MED, V123, P322, DOI 10.1016/j.amjmed.2009.07.035; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; SEARS MR, 1994, DRUG SAFETY, V11, P259, DOI 10.2165/00002018-199411040-00005; Syyong HT, 2011, J APPL PHYSIOL, V111, P642, DOI 10.1152/japplphysiol.00085.2011; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; VANDOP C, 1984, J BIOL CHEM, V259, P23; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Whiteaker KL, 2001, J BIOMOL SCREEN, V6, P305, DOI 10.1177/108705710100600504; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501	48	34	34	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131582	10.1371/journal.pone.0131582	http://dx.doi.org/10.1371/journal.pone.0131582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121686	Green Published, Green Submitted, gold			2022-12-26	WOS:000358150400124
J	Rollenhage, C; Macura, SL; Lathrop, MJ; Mackenzie, TA; Doncel, GF; Asin, SN				Rollenhage, Christiane; Macura, Sherrill L.; Lathrop, Melissa J.; Mackenzie, Todd A.; Doncel, Gustavo F.; Asin, Susana N.			Enhancing Interferon Regulatory Factor 7 Mediated Antiviral Responses and Decreasing Nuclear Factor Kappa B Expression Limit HIV-1 Replication in Cervical Tissues	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; IMMUNODEFICIENCY-VIRUS-INFECTION; EX-VIVO; TRANSCRIPTION; WOMEN; RECOGNITION; ACTIVATION; IRF-3; CELLS; MICROBICIDES	Establishment of a productive HIV-1 infection in the female reproductive tract likely depends on the balance between anti-viral and pro-inflammatory responses leading to activation and proliferation of HIV target cells. Immune modulators that boost anti-viral and depress proinflammatory immune responses may decrease HIV-1 infection or replication. Polyinosinic: polycytidylic [Poly (I:C)] has been reported to down-regulate HIV-1 replication in immune cell subsets and lymphoid tissues, yet the scope and mechanisms of poly (I:C) regulation of HIV-1 replication in the cervicovaginal mucosa, the main portal of viral entry in women remain unknown. Using a relevant, underexplored ex vivo cervical tissue model, we demonstrated that poly (I:C) enhanced Interferon Regulatory Factor (IRF) 7 mediated antiviral responses and decreased tissue Nuclear Factor Kappa B (NF kappa B) RNA expression. This pattern of cellular transcription factor expression correlated with decreased HIV-1 transcription and viral release. Reducing IRF7 expression up-regulated HIV-1 and NF kappa B transcription, providing proof of concept for the critical involvement of IRF7 in cervical tissues. By combining poly (I:C) with a suboptimal concentration of tenofovir, the leading anti-HIV prophylactic microbicide candidate, we demonstrated an earlier and greater decrease in HIV replication in poly (I:C)/tenofovir treated tissues compared with tissues treated with tenofovir alone, indicating overall improved efficacy. Poly (I:C) decreases HIV-1 replication by stimulating IRF7 mediated antiviral responses while reducing NF kappa B expression. Early during the infection, poly (I:C) improved the anti-HIV-1 activity of suboptimal concentrations of tenofovir likely to be present during periods of poor adherence i.e. inconsistent or inadequate drug use. Understanding interactions between anti-viral and pro-inflammatory immune responses in the genital mucosa will provide crucial insights for the identification of targets that can be harnessed to develop preventative combination strategies to improve the efficacy of topical or systemic antiviral prophylactic agents and protect women from HIV-1 and other sexually transmitted infections.	[Rollenhage, Christiane; Macura, Sherrill L.; Asin, Susana N.] VA Med Ctr, Res Serv, White River Jct, VT 05009 USA; [Lathrop, Melissa J.; Asin, Susana N.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA; [Rollenhage, Christiane; Mackenzie, Todd A.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Mackenzie, Todd A.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA; [Doncel, Gustavo F.] CONRAD, Eastern Virginia Med Sch, Norfolk, VA USA	Dartmouth College; Dartmouth College; Dartmouth College; Eastern Virginia Medical School	Asin, SN (corresponding author), VA Med Ctr, Res Serv, White River Jct, VT 05009 USA.	Susana.Asin@Dartmouth.EDU			Veteran Affairs Merit Review Program [BX001429-01A2]; Campbell Foundation; Dartmouth Clinical and Translational Science Institute; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR001086]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001429] Funding Source: NIH RePORTER	Veteran Affairs Merit Review Program; Campbell Foundation; Dartmouth Clinical and Translational Science Institute; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veteran Affairs Merit Review Program (SNA, Grant #BX001429-01A2) Campbell Foundation (CR) and The Dartmouth Clinical and Translational Science Institute (TAM), under award number UL1TR001086 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asin SN, 2009, J INFECT DIS, V200, P965, DOI 10.1086/605412; Bowie A, 2012, SCI SIGNAL, V5, P1, DOI [10.1126/scisignal.2002523, DOI 10.1126/SCISIGNAL.2002523]; Brichacek B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012831; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Brussel Audrey, 2005, Methods Mol Biol, V304, P139; Buitendijk M, 2014, AIDS RES HUM RETROV, V30, P457, DOI [10.1089/aid.2013.0199, 10.1089/AID.2013.0199]; Chattopadhyay S, 2014, J INTERFERON CYTOKIN, V34, P413, DOI [10.1089/jir.2014.0062, DOI 10.1089/JIR.2014.0062]; Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799; Fahey JV, 2002, J INFECT DIS, V185, P1606, DOI 10.1086/340512; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12019; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Ghosh M, 2009, AM J REPROD IMMUNOL, V62, P60, DOI 10.1111/j.1600-0897.2009.00713.x; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Hladik F, 1999, J IMMUNOL, V163, P2306; Inoue K, 2012, BIOCHEM BIOPH RES CO, V428, P494, DOI 10.1016/j.bbrc.2012.10.079; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; LI S, 1986, J IMMUNOL, V137, P3378; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Mansoor LE, 2014, AIDS BEHAV, V18, P811, DOI 10.1007/s10461-014-0751-x; Menachery VD, 2010, J VIROL, V84, P9685, DOI 10.1128/JVI.00706-10; Menachery VD, 2009, J VIROL, V83, P12399, DOI 10.1128/JVI.00888-09; Merbah M, 2011, AM J REPROD IMMUNOL, V65, P268, DOI 10.1111/j.1600-0897.2010.00967.x; Mselle TF, 2009, J VIROL, V83, P11188, DOI 10.1128/JVI.00562-09; Murphy AA, 2013, VIROLOGY, V444, P71, DOI 10.1016/j.virol.2013.05.034; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Perrot I, 2010, J IMMUNOL, V185, P2080, DOI 10.4049/jimmunol.1000532; Roberts L, 2012, BEST PRACT RES CL OB, V26, P441, DOI 10.1016/j.bpobgyn.2012.02.002; Rollenhagen C, 2014, MUCOSAL IMMUNOL, V7, P1165, DOI 10.1038/mi.2014.3; Rollenhagen C, 2011, MUCOSAL IMMUNOL, V4, P671, DOI 10.1038/mi.2011.34; Rollenhagen C, 2010, JAIDS-J ACQ IMM DEF, V54, P463, DOI 10.1097/QAI.0b013e3181e5e12c; Rustagi A, 2014, J MOL BIOL, V426, P1161, DOI 10.1016/j.jmb.2013.12.003; Sathe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083882; Sivro A, 2013, AIDS RES HUM RETROV, V29, P1428, DOI [10.1089/aid.2013.0098, 10.1089/AID.2013.0098]; Takahasi K, 2010, GENES CELLS, V15, P901, DOI 10.1111/j.1365-2443.2010.01427.x; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131919	10.1371/journal.pone.0131919	http://dx.doi.org/10.1371/journal.pone.0131919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121689	Green Submitted, Green Published, gold			2022-12-26	WOS:000358150400178
J	Slocumb, ME; Regalado, JM; Yoshizawa, M; Neely, GG; Masek, P; Gibbs, AG; Keene, AC				Slocumb, Melissa E.; Regalado, Josue M.; Yoshizawa, Masato; Neely, Greg G.; Masek, Pavel; Gibbs, Allen G.; Keene, Alex C.			Enhanced Sleep Is an Evolutionarily Adaptive Response to Starvation Stress in Drosophila	PLOS ONE			English	Article							DESICCATION RESISTANCE; TRADE-OFF; MELANOGASTER; SELECTION; CONSERVATION; ACQUISITION; METABOLISM; MECHANISMS; BEHAVIOR	Animals maximize fitness by modulating sleep and foraging strategies in response to changes in nutrient availability. Wild populations of the fruit fly, Drosophila melanogaster, display highly variable levels of starvation and desiccation resistance that differ in accordance with geographic location, nutrient availability, and evolutionary history. Further, flies potently modulate sleep in response to changes in food availability, and selection for starvation resistance enhances sleep, revealing strong genetic relationships between sleep and nutrient availability. To determine the genetic and evolutionary relationship between sleep and nutrient deprivation, we assessed sleep in flies selected for desiccation or starvation resistance. While starvation resistant flies have higher levels of triglycerides, desiccation resistant flies have enhanced glycogen stores, indicative of distinct physiological adaptations to food or water scarcity. Strikingly, selection for starvation resistance, but not desiccation resistance, leads to increased sleep, indicating that enhanced sleep is not a generalized consequence of higher energy stores. Thermotolerance is not altered in starvation or desiccation resistant flies, providing further evidence for context-specific adaptation to environmental stressors. F-2 hybrid flies were generated by crossing starvation selected flies with desiccation selected flies, and the relationship between nutrient deprivation and sleep was examined. Hybrids exhibit a positive correlation between starvation resistance and sleep, while no interaction was detected between desiccation resistance and sleep, revealing that prolonged sleep provides an adaptive response to starvation stress. Therefore, these findings demonstrate context-specific evolution of enhanced sleep in response to chronic food deprivation, and provide a model for understanding the evolutionary relationship between sleep and nutrient availability.	[Slocumb, Melissa E.; Regalado, Josue M.; Yoshizawa, Masato; Masek, Pavel; Keene, Alex C.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Gibbs, Allen G.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89119 USA; [Yoshizawa, Masato] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Neely, Greg G.] Garvan Inst, Div Neurosci, Sydney, NSW 2010, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Hawaii System; University of Hawaii Manoa; Garvan Institute of Medical Research	Keene, AC (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	akeene@unr.edu	Neely, Greg/AAB-4642-2020; Gibbs, Allen G/G-6939-2014; Yoshizawa, Masato/AAE-9415-2022; Yoshizawa, Masato/AFD-8467-2022	Neely, Greg/0000-0002-1957-9732; Gibbs, Allen G/0000-0001-5233-2056; Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-8455-8252	NIH [R15 NS080155, R01 NS0825152, R15-GM100395, P20 RR-016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS080155, R01NS085152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants R15 NS080155 and R01 NS0825152 to ACK; R15-GM100395 to AG; and P20 RR-016464 supporting PM.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; Archer MA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P386, DOI 10.1086/518354; Ballard JWO, 2008, J INSECT PHYSIOL, V54, P1371, DOI 10.1016/j.jinsphys.2008.07.009; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Burke MK, 2009, AM J PHYSIOL-REG I, V296, pR1847, DOI 10.1152/ajpregu.90551.2008; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Capellini I, 2008, FUNCT ECOL, V22, P847, DOI 10.1111/j.1365-2435.2008.01449.x; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Chippindale AK, 1998, EVOLUTION, V52, P1342, DOI 10.2307/2411304; Djawdan M, 1996, PHYSIOL ZOOL, V69, P1176, DOI 10.1086/physzool.69.5.30164252; Erion R, 2012, J BIOL CHEM, V287, P32406, DOI 10.1074/jbc.M112.360875; Folk DG, 2001, J EXP BIOL, V204, P3323; Gefen E, 2006, J EXP BIOL, V209, P3293, DOI 10.1242/jeb.02397; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Harbison ST, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006211; Harshman LG, 1999, J EVOLUTION BIOL, V12, P370, DOI 10.1046/j.1420-9101.1999.00024.x; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoffmann AA, 2005, J EVOLUTION BIOL, V18, P804, DOI 10.1111/j.1420-9101.2004.00871.x; Kayser MS, 2014, SCIENCE, V344, P269, DOI 10.1126/science.1250553; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lehmann FO, 2000, J EXP BIOL, V203, P1613; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; Masek P, 2014, J EXP BIOL, V217, P3122, DOI 10.1242/jeb.103309; McDonald DM, 2010, AGING-US, V2, P519, DOI 10.18632/aging.100181; Parkash R, 2012, COMP BIOCHEM PHYS A, V161, P102, DOI 10.1016/j.cbpa.2011.09.010; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5520; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SIBLY RM, 1991, FUNCT ECOL, V5, P184, DOI 10.2307/2389256; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; Vieira C, 2000, GENETICS, V154, P213; Vijendravarma RK, 2012, P ROY SOC B-BIOL SCI, V279, P3540, DOI 10.1098/rspb.2012.0966; Williams AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P10, DOI 10.1086/381467; Yurgel M, 2014, J COMP PHYSL A	42	29	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131275	10.1371/journal.pone.0131275	http://dx.doi.org/10.1371/journal.pone.0131275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147198	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600080
J	Zhuang, XT; Wang, LQ; Song, ZX; Xiao, W				Zhuang, Xiaotong; Wang, Lianqing; Song, Zixun; Xiao, Wei			A Novel Insertion Variant of CRYGD Is Associated with Congenital Nuclear Cataract in a Chinese Family	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT CATARACT; MISSENSE MUTATION; GENE; CRYBA1/A3; CRYAA	Objective To investigate a novel insertion variant of CRYGD identified in a Chinese family with nuclear congenital cataract. Methods A Chinese family with congenital nuclear cataract was recruited for the mutational screening of candidate genes by direct sequencing. Recombinant N-terminal Myc tagged wildtype or mutant CRYGD was expressed in HEK293T cells. The expression pattern, protein solubility and subcellular distribution were analyzed by western blotting and immunofluorescence. Principal Findings A novel insertion variant, c.451_452insGACT, in CRYGD was identified in the patients. It causes a frameshift and a premature termination of the polypeptide to become Y151*. A significantly reduced solubility was observed for this mutant. Unlike wildtype CRYGD, which existed mainly in the cytoplasm, Y151* was mis-located in the nucleus. Conclusions We have identified a novel mutation, c.451_452insGACT, in CRYGD, which is associated with nuclear cataract. This is the first insertion mutation of CRYGD found to cause autosomal dominant congenital cataract. The mutant protein, with loss of solubility and localization to the nucleus, is hypothesized to be the major cause of cataract in these patients.	[Zhuang, Xiaotong; Song, Zixun; Xiao, Wei] China Med Univ, Shengjing Hosp, Dept Ophthalmol, Shenyang, Peoples R China; [Zhuang, Xiaotong] Fourth Peoples Hosp Shenyang, Dept Ophthalmol, Shenyang, Peoples R China; [Wang, Lianqing] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China; [Wang, Lianqing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Lianqing] Cent Hosp Zibo, Cent Lab, Zibo, Peoples R China	China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xiao, W (corresponding author), China Med Univ, Shengjing Hosp, Dept Ophthalmol, Shenyang, Peoples R China.	xiaow@sj-hospital.org	Wang, Lianqing/AAX-5278-2020; Xiao, Wei/M-3847-2018	Wang, Lianqing/0000-0002-7161-4718; Xiao, Wei/0000-0001-5924-434X; Song, Zixun/0000-0003-0241-8518; song, zixun/0000-0002-6819-8178	National Natural Science Foundation of China [30973276]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (No. 30973276). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Brown AL, 1924, AM J OPHTHALMOL, V7, P1924; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gu ZS, 2010, MOL VIS, V16, P154; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Messina-Baas O, 2006, MOL VIS, V12, P995; Nandrot E, 2003, J MED GENET, V40, P262, DOI 10.1136/jmg.40.4.262; Pauli S, 2007, MOL VIS, V13, P962; Qi YH, 2004, HUM GENET, V114, P192, DOI 10.1007/s00439-003-1049-7; Santana A, 2009, MOL VIS, V15, P793; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; Su DM, 2012, MOL VIS, V18, P3057; Talla V, 2008, INVEST OPHTH VIS SCI, V49, P3483, DOI 10.1167/iovs.07-1114; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Vendra VPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070336; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Weisschuh N, 2012, MOL VIS, V18, P174; Willoughby CE, 2005, MOL VIS, V11, P587; Yao K, 2008, MOL VIS, V14, P1272; Zhang LY, 2007, MOL VIS, V13, P2096; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995	26	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131471	10.1371/journal.pone.0131471	http://dx.doi.org/10.1371/journal.pone.0131471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147294	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600099
J	Dorchin, N; Astrin, JJ; Bodner, L; Harris, KM				Dorchin, Netta; Astrin, Jonas J.; Bodner, Levona; Harris, Keith M.			Morphological and Molecular Revision of the Genus Ozirhincus (Diptera: Cecidomyiidae)-Long-Snouted Seed-Feeding Gall Midges on Asteraceae	PLOS ONE			English	Article							KADSURA-LONGIPEDUNCULATA SCHISANDRACEAE; DIPTERA CECIDOMYIIDAE; POLLINATION; SUBSTITUTION; PHYLOGENY; EVOLUTION; PRIMERS; POLLEN; FEMALE; ISRAEL	The Palaearctic gall-midge genus Ozirhincus is unique among the Cecidomyiidae for its morphology and biology. Unlike most other phytophagous gall midges, species in this genus do not induce galls but develop inside achenes of Asteraceae plants. The heads of adults are characterized by an unusually elongate proboscis, the function of which is unclear. Despite a lot of attention from taxonomists in the 19th and early 20th century, a proper revision of the genus has been hindered by complex host associations, the loss of most relevant type material, and the lack of a thorough comparative study of all life stages. The present revision integrated morphological, molecular, and life-history data to clearly define species boundaries within Ozirhincus, and delimit host-plant ranges for each of them. A phylogenetic analysis based on the mitochondrial COI and 16S genes confirmed the validity of four distinct species but did not resolve the relationships among them. All species are oligophages, and some may occur together on the same host plant. Species with wider host-plant ranges have wider European and circum-Mediterranean distribution ranges, whereas species with narrower host ranges are limited to Europe and the Russian Far East. As part of the present work, O. hungaricus is reinstated from synonymy, O. tanaceti is synonymized under O. longicollis, neotypes are designated for O. longicollis and O. millefolii, and a lectotype is designated for O. anthemidis.	[Dorchin, Netta; Bodner, Levona] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Astrin, Jonas J.] Alexander Koenig Zool Res Museum, Bonn, Germany; [Harris, Keith M.] Independent Researcher, Ripley, England	Tel Aviv University; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Dorchin, N (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	ndorchin@post.tau.ac.il	Astrin, Jonas J/N-5207-2018	Astrin, Jonas J/0000-0003-1961-1162	Israeli Taxonomy Initiative (ITI); Museum Alexander Koenig	Israeli Taxonomy Initiative (ITI); Museum Alexander Koenig	ND received a grant from the Israeli Taxonomy Initiative (ITI) (http://taxonomy.tau.ac.il/en/). Museum Alexander Koenig provided funds to JJA for molecular work (www.zfmk.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, PLANT FEEDING GALL M; Astrin JJ, 2008, INVERTEBR SYST, V22, P503, DOI 10.1071/IS07057; Barnes H. F., 1962, Transactions of the Society for British Entomology, V15, P1; Dorchin N, 2004, MOL PHYLOGENET EVOL, V30, P503, DOI 10.1016/S1055-7903(03)00232-X; Dorchin N, 2008, ZOOTAXA, P1; Dorchin N, 2011, ZOOTAXA, P28, DOI 10.11646/zootaxa.3044.1.2; Dorchin N, 2009, ZOOTAXA, P1; FEIL JP, 1992, BOT J LINN SOC, V110, P171, DOI 10.1111/j.1095-8339.1992.tb00290.x; FELT, 1907, NEW SPECIES CECIDOMY; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gagne Raymond J., 1996, Insecta Mundi, V10, P69; Gagne RJ, 2014, P ENTOMOL SOC WASH, V116, P378, DOI 10.4289/0013-8797.116.4.378; Gagne Raymond J., 2013, Memoirs of the American Entomological Society, V49, P1; GAGNE RJ, 1969, ANN ENTOMOL SOC AM, V62, P1348, DOI 10.1093/aesa/62.6.1348; Gagne RJ, 1994, GALL MIDGES NEOTROPI; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaschhof, 2014, UPDATE CATALOG CECID; JONES R G, 1983, Contributions of the American Entomological Institute, V21, P1; Kieffer JJ, 1889, ENT NACHR, V15, P208; KIEFFER JJ, 1898, B SOC HIST NATURELLE, V8, P1; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Loew H, 1850, DIPT BEITR 4; Luo SX, 2010, AM J BOT, V97, P1220, DOI 10.3732/ajb.1000077; Maddison WP, 2011, MESQUITE MODULAR SYS; McAlpine J. F., 1981, AGR CANADA MONOGRAPH, V27, P1; Mohn E, 1966, LIEFERUNG, V269, P1; Mohn E, 1968, LEIFERUNG, V273, P49; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; REDFERN M, 2011, PLANT GALLS; Rohfritsch O, 2008, ENTOMOL EXP APPL, V128, P208, DOI 10.1111/j.1570-7458.2008.00726.x; Rondani C, 1840, 2 SERV DITT IT PARM; Rubsaamen H, 1916, SITZ GESELL NAT FR B, V1915, P485; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SKUHRAVA M, 1989, ACTA ENTOMOL BOHEMOS, V86, P202; Verrall GH, 1889, WIENER ENTOMOLOGISCH, V8, P121; Vislobokov NA, 2014, AM J BOT, V101, P1519, DOI 10.3732/ajb.1400359; Wachtl FA, 1884, WIEN ENTOMOL Z, V3, P161; Winnertz J., 1853, LINNAEA ENTOMOLOGICA, V8, P154; Yuan LC, 2008, BIOL J LINN SOC, V93, P523, DOI 10.1111/j.1095-8312.2007.00897.x; Yukawa Junichi, 2005, P273; Yukawa J, 2011, ENTOMOL SCI, V14, P297, DOI 10.1111/j.1479-8298.2011.00446.x	42	5	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130981	10.1371/journal.pone.0130981	http://dx.doi.org/10.1371/journal.pone.0130981			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134526	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400032
J	Al-Shammri, SN; Hanna, MG; Chattopadhyay, A; Akanji, AO				Al-Shammri, Suhail N.; Hanna, Magdy G.; Chattopadhyay, Arpita; Akanji, Abayomi O.			Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study	PLOS ONE			English	Article							ORAL-CONTRACEPTIVES; CIGARETTE-SMOKING; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; FREQUENCY; RATES; ARABS	Introduction Immunological, genetic and environmental factors are believed to play important roles in the pathogenesis of Multiple Sclerosis (MS). There have been many studies on risk factors for MS but these have been mainly in Caucasian populations; robust studies in Arab populations remain relatively uncommon. This study therefore aimed to identify behavioral, sociocultural, and demographic factors associated with development of MS in Kuwait, a high income Arab country, currently undergoing a demographic transition. Subjects and methods In this case-control study, 195 Kuwaiti MS patients and 146 healthy age and sex-matched controls were recruited. Both groups of subjects were interviewed using a structured questionnaire, in relation to anthropometric, socio-cultural and demographic data, residence during the 1990/91 Gulf War and current and past medical history, including medications. We also clinically evaluated, and retrospectively reviewed medical records of patients to derive appropriate clinical information, including associated chronic medical illness requiring long-term treatment. Results On multiple logistic regression analysis after adjustment for potential confounders including age, gender and BMI, in all the subjects, a positive associations prevail with presence of MS and some sociocultural and demographic factors, which included non-Bedouin ethnicity (AOR 2, 95% CI 1.0-3.9, p 0.049), positive family history of MS (AOR 10.6, 95% CI 3.0-36.9), p < 0.001), and low daily sunlight exposure of < 15min/day (AOR 5.3, 95% CI 2.7-10.5 p < 0.001). In addition, while 41.8% of MS patients indicated at least one comorbidity, only 26.8% of the controls reported any associated physical illness, with the suggestion that presence of certain comorbidities might increase MS risk (AOR 2.4, 95% CI 1.3-4.7, p < 0.001). Other risk variables such as smoking status and mode of routine outdoor dressing were not significant in all the MS subjects taken as a whole, but demonstrated variably positive associations in the MS subgroup classified as those with established disease and those who were newly diagnosed and drug naive. Conclusions This study suggests that a positive family history of MS and presence of certain comorbidities appeared to be associated with an increased risk of developing MS. In contrast, relatively increased amount of daily sunlight exposure and Bedouin ethnicity appear to somewhat be protective. It is speculated that the relationship of sunlight exposure with MS might be due to vitamin D availability, and is deserving of further study.	[Al-Shammri, Suhail N.; Hanna, Magdy G.] Mubarak Al Kabir Hosp, Minist Hlth, Neurol Unit, Kuwait, Kuwait; [Al-Shammri, Suhail N.; Chattopadhyay, Arpita] Kuwait Univ, Fac Med, Dept Med, Div Neurol, Kuwait, Kuwait; [Akanji, Abayomi O.] Quinnipiac Univ, Dept Med Sci, Hamden, CT USA; [Akanji, Abayomi O.] Quinnipiac Univ, Sch Med, Hamden, CT USA	Mubarak Al-Kabeer Hospital; Kuwait University; Quinnipiac University; Quinnipiac University	Al-Shammri, SN (corresponding author), Mubarak Al Kabir Hosp, Minist Hlth, Neurol Unit, Kuwait, Kuwait.	suhail_n@gmx.com	Akanji, Abayomi/AAY-4732-2021		Research Administration, Kuwait University, Kuwait [MM03/09]; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Research Administration, Kuwait University, Kuwait; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a research grant from the Research Administration, Kuwait University, Kuwait. The grant no was MM03/09, URL: http://www.ovpr.kuniv.edu/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; Al Jumah M, 2011, MULT SCLER J, V17, P487, DOI 10.1177/1352458510390406; ALDIN ASN, 1990, J NEUROL SCI, V100, P137, DOI 10.1016/0022-510X(90)90024-H; Alonso A, 2011, MULT SCLER J, V17, P550, DOI 10.1177/1352458510397685; Alroughani R, 2014, MULT SCLER J, V20, P543, DOI 10.1177/1352458513504328; Alshubaili AF, 2005, EUR NEUROL, V53, P125, DOI 10.1159/000085556; Alsmadi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074913; Alter M, 2006, NEUROLOGY, V66, P1061, DOI 10.1212/01.wnl.0000204194.47925.0d; Asadollahi S, 2013, J CLIN NEUROSCI, V20, P1747, DOI 10.1016/j.jocn.2013.01.018; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Benamer HTS, 2009, J NEUROL SCI, V278, P1, DOI 10.1016/j.jns.2008.12.001; Carlens C, 2010, AM J RESP CRIT CARE, V181, P1217, DOI 10.1164/rccm.200909-1338OC; CASETTA I, 1994, NEUROEPIDEMIOLOGY, V13, P120, DOI 10.1159/000110369; Ghadirian T, 2001, CAN J PUBLIC HEALTH, V92, P281, DOI 10.1007/BF03404961; Handel AE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016149, 10.1371/journal.pone.0014606]; Horton M, 2010, NEUROEPIDEMIOLOGY, V35, P83, DOI 10.1159/000311013; Jafari N, 2011, J NEUROL SCI, V311, P78, DOI 10.1016/j.jns.2011.09.008; John SE, 2015, GENOM DATA, V3, P116, DOI 10.1016/j.gdata.2014.11.016; KURTZKE JF, 1980, NEUROLOGY, V30, P61, DOI 10.1212/WNL.30.7_Part_2.61; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEIBOWITZ U, 1967, BRAIN, V90, P871, DOI 10.1093/brain/90.4.871; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; Noseworthy JH, 1999, NATURE, V399, pA40, DOI 10.1038/399a040; Pekmezovic T, 2006, NEUROEPIDEMIOLOGY, V27, P212, DOI 10.1159/000096853; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; TEEBI AS, 1994, J MED GENET, V31, P224, DOI 10.1136/jmg.31.3.224; Thorogood M, 1998, BRIT J OBSTET GYNAEC, V105, P1296, DOI 10.1111/j.1471-0528.1998.tb10008.x; van der Mei IAF, 2001, NEUROEPIDEMIOLOGY, V20, P168, DOI 10.1159/000054783; VILLARDMACKINTOSH L, 1993, CONTRACEPTION, V47, P161, DOI 10.1016/0010-7824(93)90088-O; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Wingerchuk DM, 2012, THER ADV NEUROL DISO, V5, P13, DOI 10.1177/1756285611425694; Zorzon M, 2003, NEUROL SCI, V24, P242, DOI 10.1007/s10072-003-0147-6	34	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132106	10.1371/journal.pone.0132106	http://dx.doi.org/10.1371/journal.pone.0132106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132203	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000156
J	Geng, XF; Wang, GP; Qin, YL; Zang, XY; Li, PF; Geng, Z; Xue, DM; Dong, ZM; Ma, KX; Chen, GW; Xu, CS				Geng, Xiaofang; Wang, Gaiping; Qin, Yanli; Zang, Xiayan; Li, Pengfei; Geng, Zhi; Xue, Deming; Dong, Zimei; Ma, Kexue; Chen, Guangwen; Xu, Cunshuan			iTRAQ-Based Quantitative Proteomic Analysis of the Initiation of Head Regeneration in Planarians	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; INTEGRIN-LINKED KINASE; GENE-EXPRESSION; BRAIN REGENERATION; BLASTEMA POLARITY; TRANSCRIPTOME; ACTIVATION; MIGRATION; REVEALS; CANCER	The planarian Dugesia japonica has amazing ability to regenerate a head from the anterior ends of the amputated stump with maintenance of the original anterior-posterior polarity. Although planarians present an attractive system for molecular investigation of regeneration and research has focused on clarifying the molecular mechanism of regeneration initiation in planarians at transcriptional level, but the initiation mechanism of planarian head regeneration (PHR) remains unclear at the protein level. Here, a global analysis of proteome dynamics during the early stage of PHR was performed using isobaric tags for relative and absolute quantitation (iTRAQ)-based quantitative proteomics strategy, and our data are available via ProteomeXchange with identifier PXD002100. The results showed that 162 proteins were differentially expressed at 2 h and 6 h following amputation. Furthermore, the analysis of expression patterns and functional enrichment of the differentially expressed proteins showed that proteins involved in muscle contraction, oxidation reduction and protein synthesis were up-regulated in the initiation of PHR. Moreover, ingenuity pathway analysis showed that predominant signaling pathways such as ILK, calcium, EIF2 and mTOR signaling which were associated with cell migration, cell proliferation and protein synthesis were likely to be involved in the initiation of PHR. The results for the first time demonstrated that muscle contraction and ILK signaling might played important roles in the initiation of PHR at the global protein level. The findings of this research provide a molecular basis for further unraveling the mechanism of head regeneration initiation in planarians.	[Geng, Xiaofang; Wang, Gaiping; Qin, Yanli; Zang, Xiayan; Li, Pengfei; Geng, Zhi; Xu, Cunshuan] Henan Normal Univ, State Key Lab Cultivat Base Cell Differentiat Reg, Xinxiang, Henan Province, Peoples R China; [Geng, Xiaofang; Wang, Gaiping; Qin, Yanli; Zang, Xiayan; Li, Pengfei; Geng, Zhi; Xu, Cunshuan] Henan Normal Univ, Henan Engn Lab Bioengn & Drug Dev, Xinxiang, Henan Province, Peoples R China; [Wang, Gaiping; Qin, Yanli; Zang, Xiayan; Li, Pengfei; Geng, Zhi; Xue, Deming; Dong, Zimei; Ma, Kexue; Chen, Guangwen; Xu, Cunshuan] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan Province, Peoples R China	Henan Normal University; Henan Normal University; Henan Normal University	Chen, GW (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Henan Province, Peoples R China.	cellkeylab@126.com; chengw0183@sina.com			National Basic Research 973 Pre-Research Program of China [2012CB722304]; National Nature Science Foundation of China [31201093]; Major Scientific and Technological Projects of Henan [111100910600]; Natural Science Foundation of Henan [112300413204, 122300413207]	National Basic Research 973 Pre-Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Projects of Henan; Natural Science Foundation of Henan	This study was supported by National Basic Research 973 Pre-Research Program of China (No. 2012CB722304), National Nature Science Foundation of China (No. 31201093), Major Scientific and Technological Projects of Henan (No. 111100910600), Natural Science Foundation of Henan (No. 112300413204 and No. 122300413207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Alexander MS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-27; Alibardi L, 2014, PROG HISTOCHEM CYTO, V48, P143, DOI 10.1016/j.proghi.2013.12.001; Almuedo-Castillo M, 2012, INT J DEV BIOL, V56, P53, DOI 10.1387/ijdb.113451ma; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Boser A, 2013, CELL REP, V5, P1142, DOI 10.1016/j.celrep.2013.10.035; Chen XG, 2015, DEV GENES EVOL, V225, P79, DOI 10.1007/s00427-015-0494-3; Dong ZM, 2012, GENE EXPR PATTERNS, V12, P1, DOI 10.1016/j.gep.2011.08.001; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fernandez-Taboada E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-133; Fraguas S, 2014, DEVELOPMENT, V141, P1835, DOI 10.1242/dev.101345; Geng XF, 2014, DIFFERENTIATION, V88, P85, DOI 10.1016/j.diff.2014.10.002; Gentile L, 2011, DIS MODEL MECH, V4, P12, DOI 10.1242/dmm.006692; Gonzalez-Estevez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002619; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Ho E, 2012, CELL ADHES MIGR, V6, P168, DOI 10.4161/cam.20399; Hsieh HC, 2009, J PROTEOME RES, V8, P1004, DOI 10.1021/pr800696m; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iglesias M, 2011, DEV BIOL, V358, P68, DOI 10.1016/j.ydbio.2011.07.013; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kulkarni YM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-291; Li JQ, 2013, J CONTROL SCI ENG, V2013, DOI 10.1155/2013/657182; Nicholson J, 2012, J PROTEOME RES, V11, P5464, DOI 10.1021/pr300698d; Nishimura O, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-289; Nogi T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000464; Onal P, 2012, EMBO J, V31, P2755, DOI 10.1038/emboj.2012.110; PASCOLINI R, 1984, CELL TISSUE RES, V236, P345; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sakai T, 2002, INT J DEV BIOL, V46, P329; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Serrano I, 2012, EXP CELL RES, V318, P2470, DOI 10.1016/j.yexcr.2012.08.001; Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155; Solana J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r19; Sun YW, 2007, PROTEOMICS, V7, P4398, DOI 10.1002/pmic.200600913; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tasaki J, 2011, DEVELOPMENT, V138, P2417, DOI 10.1242/dev.060764; Tasaki J, 2011, DEV GROWTH DIFFER, V53, P389, DOI 10.1111/j.1440-169X.2011.01254.x; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang GP, 2012, GENE, V504, P41, DOI 10.1016/j.gene.2012.04.086; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Witchley JN, 2013, CELL REP, V4, P633, DOI 10.1016/j.celrep.2013.07.022; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	58	15	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132045	10.1371/journal.pone.0132045	http://dx.doi.org/10.1371/journal.pone.0132045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131905	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000151
J	Jansen, JK; Brady, GM; Hoef, JMV; Boveng, PL				Jansen, John K.; Brady, Gavin M.; Hoef, Jay M. Ver; Boveng, Peter L.			Spatially Estimating Disturbance of Harbor Seals (Phoca vitulina)	PLOS ONE			English	Article							POPULATION; CONSEQUENCES; RESPONSES; RICHARDII; BEHAVIOR	Tidewater glacial fjords in Alaska provide habitat for some of the largest aggregations of harbor seals (Phoca vitulina), with calved ice serving as platforms for birthing and nursing pups, molting, and resting. These fjords have also been popular destinations for tour ships for more than a century, with dramatic increases in vessel traffic since the 1980s. Seals on ice are known to flush into the water when approached by tour ships, but estimating the exposure to disturbance across populations is difficult. Using aerial transect sampling while simultaneously tracking vessel movements, we estimated the spatial overlap between seals on ice and cruise ships in Disenchantment Bay, Alaska, USA. By integrating previously estimated rates of disturbance as a function of distance with an 'intensity surface' modeled spatially from seal locations in the surveys, we calculated probabilities of seals flushing during three separate ship visits. By combining our estimate of seals flushed with a modeled estimate of the total fjord population, we predict that up to 14% of the seals (up to 11% of pups) hauled out would have flushed into the water, depending on the route taken by ships relative to seal aggregations. Such high potential for broad-scale disturbance by single vessels (when up to 4 ships visit per day) was unexpected and underscores the need to 1) better understand long-term effects of disturbance; 2) regularly monitor populations exposed to high vessel traffic; and 3) develop conservation measures to reduce seal-ship overlap.	[Jansen, John K.; Brady, Gavin M.; Hoef, Jay M. Ver; Boveng, Peter L.] Natl Ocean & Atmospher Adm, Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Jansen, JK (corresponding author), Natl Ocean & Atmospher Adm, Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA 98115 USA.	john.jansen@noaa.gov	Ver Hoef, Jay/C-8577-2017	Ver Hoef, Jay/0000-0003-4302-6895	NOAA Fisheries Service	NOAA Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this research was provided by NOAA Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen M, 2011, WORKSH P 19 BIENN C; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Cruise Line Agencies of Alaska, 2013, CRUIS SHIP CAL 2013, P25; Currey RJC, 2011, MAR MAMMAL SCI, V27, P554, DOI 10.1111/j.1748-7692.2010.00417.x; Diggle P., 2003, STAT ANAL SPATIAL PO; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; French SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017686; GERRODETTE T, 1990, CONSERV BIOL, V4, P423, DOI 10.1111/j.1523-1739.1990.tb00317.x; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Grigg EK, 2012, J MAMMAL, V93, P282, DOI 10.1644/11-MAMM-A-128.1; Harding KC, 2005, FUNCT ECOL, V19, P129, DOI 10.1111/j.0269-8463.2005.00945.x; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Hoover AA, 1983, THESIS U ALASKA FAIR; Jansen JK, 2006, 200602 AFSC NAT MAR, P75; Jansen JK, 2015, MAR MAMMAL SCI, V31, P66, DOI 10.1111/mms.12140; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; KNIGHT RL, 1984, J WILDLIFE MANAGE, V48, P999, DOI 10.2307/3801456; McDowell Group Inc, 2012, AL VIS STAT PROG 6 S; Moore SE, 2012, BIOSCIENCE, V62, P289, DOI 10.1525/bio.2012.62.3.10; OWEN M, 1972, J ANIM ECOL, V41, P79, DOI 10.2307/3507; PITCHER KW, 1981, CAN FIELD NAT, V95, P292; Rugh David J., 2010, Endangered Species Research, V12, P69, DOI 10.3354/esr00293; Schaeff CM, 1999, ANIM BEHAV, V57, P427, DOI 10.1006/anbe.1998.1001; Sharples RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037216; TNS, 2011, CRUIS LIN INT ASS 20; Ver Hoef J, 2014, J AGR BIOL ENVIR ST, P27; Womble JN, 2010, MAR MAMMAL SCI, V26, P686, DOI 10.1111/j.1748-7692.2009.00360.x; Young C., 2014, Tourism in Marine Environments, V10, P5, DOI 10.3727/154427314X14056884441626	30	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129798	10.1371/journal.pone.0129798	http://dx.doi.org/10.1371/journal.pone.0129798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132083	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000040
J	Weiss, M; Gumbel, D; Hanschmann, EM; Mandelkow, R; Gelbrich, N; Zimmermann, U; Walther, R; Ekkernkamp, A; Sckell, A; Kramer, A; Burchardt, M; Lillig, CH; Stope, MB				Weiss, Martin; Guembel, Denis; Hanschmann, Eva-Maria; Mandelkow, Robert; Gelbrich, Nadine; Zimmermann, Uwe; Walther, Reinhard; Ekkernkamp, Axel; Sckell, Axel; Kramer, Axel; Burchardt, Martin; Lillig, Christopher H.; Stope, Matthias B.			Cold Atmospheric Plasma Treatment Induces Anti-Proliferative Effects in Prostate Cancer Cells by Redox and Apoptotic Signaling Pathways	PLOS ONE			English	Article							IN-VIVO; OXIDATIVE STRESS; CARCINOMA-CELLS; CAUTIONARY NOTE; UP-REGULATION; LUNG-CANCER; PEROXIREDOXINS; PROLIFERATION; GLUTAREDOXIN; THIOREDOXIN	One of the promising possibilities of the clinical application of cold plasma, so-called cold atmospheric plasma (CAP), is its application on malignant cells and cancer tissue using its anti-neoplastic effects, primarily through the delivery of reactive oxygen and nitrogen species (ROS, RNS). In this study, we investigated the impact of CAP on cellular proliferation and consecutive molecular response mechanisms in established prostate cancer (PC) cell lines. PC cells showed a significantly reduced cell growth following CAP treatment as a result of both an immediate increase of intracellular peroxide levels and through the induction of apoptosis indicated by annexin V assay, TUNEL assay, and the evaluation of changes in nuclear morphology. Notably, co-administration of N-acetylcysteine (NAC) completely neutralized CAP effects by NAC uptake and rapid conversion to glutathione (GSH). Vitamin C could not counteract the CAP induced effects on cell growth. In summary, relatively short treatments with CAP of 10 seconds were sufficient to induce a significant inhibition of cancer proliferation, as observed for the first time in urogenital cancer. Therefore, it is important to understand the mode of CAP related cell death and clarify and optimize CAP as cancer therapy. Increased levels of peroxides can alter redox-regulated signaling pathways and can lead to growth arrest and apoptosis. We assume that the general intracellular redox homeostasis, especially the levels of cellular GSH and peroxidases such as peroxiredoxins affect the outcome of the CAP treatment.	[Weiss, Martin; Mandelkow, Robert; Gelbrich, Nadine; Zimmermann, Uwe; Burchardt, Martin; Stope, Matthias B.] Univ Med Greifswald, Dept Urol, Greifswald, Germany; [Guembel, Denis; Ekkernkamp, Axel; Sckell, Axel] Univ Med Greifswald, Dept Trauma & Reconstruct Surg, Greifswald, Germany; [Hanschmann, Eva-Maria; Walther, Reinhard; Lillig, Christopher H.] Univ Med Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Kramer, Axel] Univ Med Greifswald, Dept Hyg & Environm Med, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Stope, MB (corresponding author), Univ Med Greifswald, Dept Urol, Greifswald, Germany.	matthias.stope@uni-greifswald.de	Weiss, Martin/AAY-2993-2021; Hanschmann, Eva-Maria/AAS-9261-2021; Lillig, Christopher Horst/AAD-7098-2019	Lillig, Christopher Horst/0000-0003-2509-5117	Deutsche Forschungsgemeinschaft (DFG) [LI984/3-1]; Science Network Molecular Medicine, University Medicine Greifswald [FOMM-2013-06]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Science Network Molecular Medicine, University Medicine Greifswald	Parts of the work were funded by grants of CHL: (1) Deutsche Forschungsgemeinschaft (DFG), LI984/3-1 (http://www.dfg.de), (2) Science Network Molecular Medicine, University Medicine Greifswald, FOMM-2013-06 (http://www.medizin.uni-greifswald.de/fvmm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Arndt S, 2013, EXP DERMATOL, V22, P284, DOI 10.1111/exd.12127; Atale N, 2014, J MICROSC-OXFORD, V255, P7, DOI 10.1111/jmi.12133; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Bekeschus S, 2013, PLASMA PROCESS POLYM, V10, P706, DOI 10.1002/ppap.201300008; Chae HZ, 2012, ANTIOXID REDOX SIGN, V16, P506, DOI 10.1089/ars.2011.4260; Chakravarthy K, 2011, PLASMA MED, V1, P3; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512290-00014; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Coffey RNT, 2001, CANCER-AM CANCER SOC, V92, P2297, DOI 10.1002/1097-0142(20011101)92:9<2297::AID-CNCR1576>3.0.CO;2-B; Daeschlein G, 2012, J DTSCH DERMATOL GES, V10, P509, DOI 10.1111/j.1610-0387.2012.07857.x; Davison FD, 1995, HISTOCHEM J, V27, P983; Eidet JR, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-92; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kieft IE, 2004, BIOELECTROMAGNETICS, V25, P362, DOI 10.1002/bem.20005; Kim CH, 2010, APPL PHYS LETT, V96; Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039; Kim JY, 2010, BIOSENS BIOELECTRON, V26, P555, DOI 10.1016/j.bios.2010.07.043; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Kortenhorst MSQ, 2009, MOL CANCER THER, V8, P802, DOI 10.1158/1535-7163.MCT-08-1076; Aon-Bertolino ML, 2011, BBA-GEN SUBJECTS, V1810, P93, DOI 10.1016/j.bbagen.2010.06.011; Lipiec EW, 2012, GEN PHYSIOL BIOPHYS, V31, P11, DOI 10.4149/gpb_2012_001; Markovic J, 2010, FREE RADICAL RES, V44, P721, DOI 10.3109/10715762.2010.485989; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Ornberg RL, 2001, J HISTOCHEM CYTOCHEM, V49, P1059, DOI 10.1177/002215540104900815; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Partecke LI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-473; Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8; Sofer M, 2002, J UROLOGY, V167, P2453, DOI 10.1016/S0022-5347(05)65003-3; Sooriakumaran P, 2013, EUR UROL; Sun AM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-47; Sutherland SE, 2002, J UROLOGY, V167, P61, DOI 10.1016/S0022-5347(05)65383-9; Tang DG, 1998, CANCER RES, V58, P3466; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Tsuzuki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1902, DOI 10.1271/bbb.70114; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VANZANDWIJK N, 1995, J CELL BIOCHEM, P24; von Woedtke Thomas, 2012, NATO Advanced Research Workshop on Plasma for Bio-Decontamination, Medicine and Food Security. Proceedings, P67, DOI 10.1007/978-94-007-2852-3_6; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Yafi FA, 2012, BJU INT, V110, P1317, DOI 10.1111/j.1464-410X.2012.11133.x; Yamauchi K, 2005, CANCER RES, V65, P4246, DOI 10.1158/0008-5472.CAN-05-0069; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031	51	87	89	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130350	10.1371/journal.pone.0130350	http://dx.doi.org/10.1371/journal.pone.0130350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132846	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000064
J	Konishi, M; McLaren, DG; Engen, H; Smallwood, J				Konishi, Mahiko; McLaren, Donald George; Engen, Haakon; Smallwood, Jonathan			Shaped by the Past: The Default Mode Network Supports Cognition that Is Independent of Immediate Perceptual Input	PLOS ONE			English	Article							SOCIAL COGNITION; BRAIN; FUTURE; MEMORY; MIND; THOUGHT; SELF; CONNECTIVITY; PROSPECTION; EXPERIENCE	Although many different accounts of the functions of the default mode network (DMN) have been proposed, few can adequately account for the spectrum of different cognitive functions that utilize this network. The current study used functional magnetic resonance imaging (fMRI) to explore the hypothesis that the role of the DMN in higher order cognition is to allow cognition to be shaped by information from stored representations rather than information in the immediate environment. Using a novel task paradigm, we observed increased BOLD activity in regions of the medial prefrontal cortex and posterior cingulate cortex when individuals made decisions on the location of shapes from the prior trial and decreased BOLD activity when individuals made decisions on the location of shapes on the current trial. These data are inconsistent with views of the DMN as a task-negative system or one that is sensitive only to stimuli with strong personal or emotional ties. Instead the involvement of the DMN when people make decisions about where a shape was, rather than where it is now, supports the hypothesis that the core hubs of the DMN allow cognition to be guided by information other than the immediate perceptual input. We propose that a variety of different forms of higher order thought (such as imagining the future or considering the perspective of another person) engage the DMN because these more complex introspective forms of higher order thought all depend on the capacity for cognition to be shaped by representations that are not present in the external environment.	[Konishi, Mahiko; Smallwood, Jonathan] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Konishi, Mahiko; Smallwood, Jonathan] Univ York, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [McLaren, Donald George] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [McLaren, Donald George] Harvard Univ, Sch Med, Boston, MA USA; [Engen, Haakon] Max Plank Inst Human Cognit Brain Sci, Dept Social Neurosci, Leipzig, Germany	University of York - UK; University of York - UK; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Max Planck Society	Konishi, M (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	mk947@york.ac.uk	Konishi, Mahiko/AAF-5628-2019; Smallwood, Jonathan/ABE-8365-2020; Engen, Haakon/L-6612-2019	Konishi, Mahiko/0000-0001-8212-9964; McLaren, Donald/0000-0002-0566-4610; Smallwood, Jonathan/0000-0002-7298-2459				Allen M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00743; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Baird B, 2014, THE DECOUPLED MIND M; Barks SK, 2013, CEREB CORTEX; Benoit RG, 2011, J NEUROSCI, V31, P6771, DOI 10.1523/JNEUROSCI.6559-10.2011; Bentley WJ, 2014, CEREB CORTEX; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chao-Gan Y, 2010, FRONTIERS IN SYSTEMS, V4; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gaesser B, 2013, HIPPOCAMPUS, V23, P1150, DOI 10.1002/hipo.22152; Gerlach KD, 2011, NEUROIMAGE, V55, P1816, DOI 10.1016/j.neuroimage.2011.01.030; Gerlach KD, 2014, SOCIAL COGNITIVE AFF; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Huijbers W, 2013, J COGNITIVE NEUROSCI, V25, P1163, DOI 10.1162/jocn_a_00366; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Kuhn S, 2014, J CREATIVE BEHAV, V48, P152, DOI 10.1002/jocb.45; Landsiedel J, 2014, NEUROIMAGE; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Mevel K, 2011, INTERNATIONAL JOURNA, V2011; Meyer ML, 2012, P NATL ACAD SCI USA, V109, P1883, DOI 10.1073/pnas.1121077109; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Penny WD, 2011, STATISTICAL PARAMETR; Petersen SE, 2012, NEUROIMAGE, V62, P1177, DOI 10.1016/j.neuroimage.2011.09.084; Philippi CL, 2014, SOCIAL COGNITIVE AND; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schacter DL, 2007, BEHAV BRAIN SCI, V30, P331, DOI 10.1017/S0140525X07002178; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schacter DL, 2012, AM PSYCHOL, V67, P603, DOI 10.1037/a0029869; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smallwood J, 2011, BRAIN RES; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2013, CONSCIOUS COGN, V22, P1, DOI 10.1016/j.concog.2012.10.007; Smallwood J, 2013, NEUROIMAGE, V69, P120, DOI 10.1016/j.neuroimage.2012.12.012; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Spreng RN, 2014, J NEUROSCI, V34, P14108, DOI 10.1523/JNEUROSCI.2815-14.2014; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Spreng RN, 2012, BRAIN RES, V1428, P43, DOI 10.1016/j.brainres.2010.12.024; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stawarczyk D, 2015, HUMAN BRAIN MAPPING; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Vannini P, 2012, NEUROBIOL AGING, V33, P1237, DOI 10.1016/j.neurobiolaging.2011.01.003; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	72	105	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0132209	10.1371/journal.pone.0132209	http://dx.doi.org/10.1371/journal.pone.0132209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BR	26125559	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358151300069
J	Osawa, K; Miyoshi, T; Yamauchi, K; Koyama, Y; Nakamura, K; Sato, S; Kanazawa, S; Ito, H				Osawa, Kazuhiro; Miyoshi, Toru; Yamauchi, Kentarou; Koyama, Yasushi; Nakamura, Kazufumi; Sato, Shuhei; Kanazawa, Susumu; Ito, Hiroshi			Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; CAROTID ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; ANGIOGRAPHY; DIAGNOSIS; COMPLICATIONS; SEVERITY; NAFLD	Background Nonalcoholic fatty liver disease is associated with a risk of coronary artery disease (e.g., diabetes mellitus, dyslipidemia, metabolic syndrome). We evaluated whether nonalcoholic hepatic steatosis is associated with high-risk plaques as assessed by multidetector computed tomography (CT). Methods This retrospective study involved 414 participants suspected of having coronary artery disease. Nonalcoholic hepatic steatosis was defined as a liver-to-spleen fat ratio of <1.0 and the presence and appropriate characteristics of coronary-artery plaques as assessed by coronary CT angiography. High-risk plaques were identified, as were low-density plaques, positive remodeling, and spotty calcification. Results Compared with patients who did not have nonalcoholic hepatic steatosis, patients with nonalcoholic hepatic steatosis had more low-density plaques (21% vs. 44%, p<0.01), positive remodeling (41% vs. 58%, p = 0.01), and spotty calcification (12% vs. 36%, p<0.01). The number of high-risk plaques in patients with nonalcoholic hepatic steatosis was greater than in those without nonalcoholic hepatic steatosis (p<0.01). Patients with nonalcoholic hepatic steatosis were more likely to have high-risk plaques than were those with only an elevated level of visceral adipose tissue (>= 86 cm(2); 35% vs. 16%, p<0.01). Multivariate analyses that included nonalcoholic hepatic steatosis, amount of visceral adipose tissue, and the presence/absence of traditional risk factors demonstrated that nonalcoholic hepatic steatosis was an independent predictor of high-risk plaques (odds ratio: 4.60; 95% confidence interval: 1.94-9.07, p<0.01). Conclusions Diagnosis of nonalcoholic hepatic steatosis may be of value when assessing the risk of coronary artery disease.	[Osawa, Kazuhiro; Miyoshi, Toru; Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Yamauchi, Kentarou] Okayama Univ Hosp, Dept Radiol, Okayama, Japan; [Koyama, Yasushi] Sakurabashi Watanabe Hosp, Ctr Cardiovasc, Osaka, Japan; [Sato, Shuhei; Kanazawa, Susumu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama, Japan	Okayama University; Okayama University; Okayama University	Miyoshi, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	miyoshit@cc.okayama-u.ac.jp	Osawa, Kazuhiro/ABE-7537-2020					Adinolfi LE, 2014, WORLD J GASTROENTERO, V20, P3410, DOI 10.3748/wjg.v20.i13.3410; Akabame S, 2008, CIRC J, V72, P618; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Assy N, 2010, RADIOLOGY, V254, P393, DOI 10.1148/radiol.09090769; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Ballestri S, 2014, WORLD J GASTROENTERO, V20, P1724, DOI 10.3748/wjg.v20.i7.1724; Ballestri S, 2013, METAB SYNDR RELAT D, V11, P289, DOI 10.1089/met.2012.0149; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135; Jepsen P, 2003, HEPATO-GASTROENTEROL, V50, P2101; Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593; Kitagawa T, 2009, JACC-CARDIOVASC IMAG, V2, P153, DOI 10.1016/j.jcmg.2008.09.015; Lonardo A, 2015, EXPERT REV GASTROENT, V9, P629, DOI 10.1586/17474124.2015.965143; Loria P, 2014, ATHEROSCLEROSIS, V232, P99, DOI 10.1016/j.atherosclerosis.2013.10.030; Ma XZ, 2009, RADIOGRAPHICS, V29, P1253, DOI 10.1148/rg.295085186; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mellinger J. L., 2015, J HEPATOL; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Osawa K, 2014, HEART; Osawa K, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-61; Osawa K, 2013, CIRC J, V77, P146, DOI 10.1253/circj.CJ-12-0663; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Petta S, 2015, J HEPATOL, V62, P928, DOI 10.1016/j.jhep.2014.11.030; Petta S, 2012, HEPATOLOGY, V55, P1317, DOI 10.1002/hep.25508; Puchner SB, 2015, RADIOLOGY, V274, P693, DOI 10.1148/radiol.14140933; Rana JS, 2012, DIABETES CARE, V35, P1787, DOI 10.2337/dc11-2403; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; Targher G, 2005, DIABETIC MED, V22, P1354, DOI 10.1111/j.1464-5491.2005.01646.x; Targher G, 2013, SEMIN THROMB HEMOST, V39, P214, DOI 10.1055/s-0033-1334866; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Wong VWS, 2011, GUT, V60, P1721, DOI 10.1136/gut.2011.242016; Zeb I, 2012, ACAD RADIOL, V19, P811, DOI 10.1016/j.acra.2012.02.022	40	33	35	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131138	10.1371/journal.pone.0131138	http://dx.doi.org/10.1371/journal.pone.0131138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125952	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300037
J	Sawhney, S; Marks, A; Ali, T; Clark, L; Fluck, N; Prescott, GJ; Simpson, WG; Black, C				Sawhney, Simon; Marks, Angharad; Ali, Tariq; Clark, Laura; Fluck, Nick; Prescott, Gordon J.; Simpson, William G.; Black, Corri			Maximising Acute Kidney Injury Alerts - A Cross-Sectional Comparison with the Clinical Diagnosis	PLOS ONE			English	Article							ELECTRONIC ALERT; IMPACT	Background Acute kidney injury (AKI) is serious and widespread across healthcare (1 in 7 hospital admissions) but recognition is often delayed causing avoidable harm. Nationwide automated biochemistry alerts for AKI stages 1-3 have been introduced in England to improve recognition. We explored how these alerts compared with clinical diagnosis in different hospital settings. Methods We used a large population cohort of 4464 patients with renal impairment. Each patient had case-note review by a nephrologist, using RIFLE criteria to diagnose AKI and chronic kidney disease (CKD). We identified and staged AKI alerts using the new national NHS England AKI algorithm and compared this with nephrologist diagnosis across hospital settings. Results Of 4464 patients, 525 had RIFLE AKI, 449 had mild AKI, 2185 had CKD (without AKI) and 1305 were of uncertain chronicity. NHS AKI algorithm criteria alerted for 90.5% of RIFLE AKI, 72.4% of mild AKI, 34.1% of uncertain cases and 14.0% of patients who actually had CKD. The algorithm identified AKI particularly well in intensive care (95.5%) and nephrology (94.6%), but less well on surgical wards (86.4%). Restricting the algorithm to stage 2 and 3 alerts reduced the over-diagnosis of AKI in CKD patients from 14.0% to 2.1%, but missed or delayed alerts in two-thirds of RIFLE AKI patients. Conclusion Automated AKI detection performed well across hospital settings, but was less sensitive on surgical wards. Clinicians should be mindful that restricting alerts to stages 2-3 may identify fewer CKD patients, but including stage 1 provides more sensitive and timely alerting.	[Sawhney, Simon; Marks, Angharad; Prescott, Gordon J.; Black, Corri] Univ Aberdeen Appl Renal Res Collaborat, Aberdeen, Scotland; [Sawhney, Simon; Marks, Angharad; Clark, Laura; Fluck, Nick; Simpson, William G.] NHS Grampian, Aberdeen, Scotland; [Ali, Tariq] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center	Sawhney, S (corresponding author), Univ Aberdeen Appl Renal Res Collaborat, Aberdeen, Scotland.	simon.sawhney@abdn.ac.uk	Marks, Angharad/H-5657-2019	Marks, Angharad/0000-0003-1910-462X; Sawhney, Simon/0000-0002-7960-4573; Prescott, Gordon/0000-0002-9156-2361	Wellcome Trust [102729/Z/13/Z]; Medical Research Council [MR/K007017/1] Funding Source: researchfish; MRC [MR/K007017/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SS is supported by a Clinical Research Training Fellowship from the Wellcome Trust (Ref 102729/Z/13/Z).	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Bedford M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-95; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Kidney disease outcomes quality initiative (KDOQI), KIDNEY DIS OUTCOMES, V39, pS46, DOI [10.1053/ajkd.2002.30943, DOI 10.1053/AJKD.2002.30943]; *NHS ENGL, 2014, PAT SAF AL STAND EAR; Porter CJ, 2014, NEPHROL DIAL TRANSPL, V29, P1888, DOI 10.1093/ndt/gfu082; Selby NM, 2012, CLIN J AM SOC NEPHRO, V7, P533, DOI 10.2215/CJN.08970911; Siew ED, 2012, CLIN J AM SOC NEPHRO, V7, P712, DOI 10.2215/CJN.10821011; Stewart J, 2009, ADDING INSULT INJURY; Wallace K, 2014, CLIN MED, V14, P22, DOI 10.7861/clinmedicine.14-1-22; Wilson FP, 2015, LANCET	14	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131909	10.1371/journal.pone.0131909	http://dx.doi.org/10.1371/journal.pone.0131909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125553	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358151300062
J	Wang, WL; Sheu, SY; Chen, YS; Kao, ST; Fu, YT; Kuo, TF; Chen, KY; Yao, CH				Wang, Wen-Ling; Sheu, Shi-Yuan; Chen, Yueh-Sheng; Kao, Shung-Te; Fu, Yuan-Tsung; Kuo, Tzong-Fu; Chen, Kuo-Yu; Yao, Chun-Hsu			Enhanced Bone Tissue Regeneration by Porous Gelatin Composites Loaded with the Chinese Herbal Decoction Danggui Buxue Tang	PLOS ONE			English	Article							TRICALCIUM PHOSPHATE; CYTOTOXICITY; FABRICATION; INDUCTION; SCAFFOLDS; MEDICINE	Danggui Buxue Tang (DBT) is a traditional Chinese herbal decoction containing Radix Astragali and Radix Angelicae sinensis. Pharmacological results indicate that DBT can stimulate bone cell proliferation and differentiation. The aim of the study was to investigate the efficacy of adding DBT to bone substitutes on bone regeneration following bone injury. DBT was incorporated into porous composites (GGT) made from genipin-crosslinked gelatin and beta-triclacium phosphates as bone substitutes (GGTDBT). The biological response of mouse calvarial bone to these composites was evaluated by in vivo imaging systems (IVIS), micro-computed tomography (micro-CT), and histology analysis. IVIS images revealed a stronger fluorescent signal in GGTDBT-treated defect than in GGT-treated defect at 8 weeks after implantation. Micro-CT analysis demonstrated that the level of repair from week 4 to 8 increased from 42.1% to 71.2% at the sites treated with GGTDBT, while that increased from 33.2% to 54.1% at GGT-treated sites. These findings suggest that the GGTDBT stimulates the innate regenerative capacity of bone, supporting their use in bone tissue regeneration.	[Wang, Wen-Ling; Sheu, Shi-Yuan; Chen, Yueh-Sheng; Kao, Shung-Te; Fu, Yuan-Tsung; Yao, Chun-Hsu] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Wang, Wen-Ling; Kao, Shung-Te] China Med Univ Hosp, Dept Chinese Internal Med, Taichung, Taiwan; [Sheu, Shi-Yuan] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Sheu, Shi-Yuan] Chung Shan Med Univ Hosp, Dept Integrated Chinese & Western Med, Taichung, Taiwan; [Chen, Yueh-Sheng; Yao, Chun-Hsu] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Fu, Yuan-Tsung] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Chinese Med, Taichung, Taiwan; [Kuo, Tzong-Fu] Natl Taiwan Univ, Sch Vet Med, Dept Vet Med, Taipei 10764, Taiwan; [Chen, Kuo-Yu] Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Yunlin, Taiwan; [Yao, Chun-Hsu] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; National Taiwan University; National Yunlin University Science & Technology; Asia University Taiwan	Chen, KY (corresponding author), Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Yunlin, Taiwan.	chenkuo@yuntech.edu.tw; chyao@mail.cmu.edu.tw	Chen, Kuo-Yu/I-3646-2019	Chen, Kuo-Yu/0000-0002-1654-2715; KUO, TZONG-FU/0000-0002-6328-8967	National Science Council of the Republic of China, Taiwan [NSC98-2221-E-039-005-MY3]; China Medical University [CMU 101-AWARD-05, CMU101-S-01]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	The authors are grateful to National Science Council of the Republic of China, Taiwan (contract No. NSC98-2221-E-039-005-MY3) and China Medical University (contract No. CMU 101-AWARD-05 and CMU101-S-01) for their kind financial support on the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigi A, 2004, BIOMATERIALS, V25, P2893, DOI 10.1016/j.biomaterials.2003.09.059; Calori GM, 2011, INJURY, V42, pS56, DOI 10.1016/j.injury.2011.06.011; Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019; Chen KY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/283941; Chen KY, 2013, J BIOMED MATER RES A, V101, P954, DOI 10.1002/jbm.a.34397; Chen KY, 2009, BIOMATERIALS, V30, P1682, DOI 10.1016/j.biomaterials.2008.12.024; Choi RCY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen085; Dong GC, 2008, J BIOMED MATER RES A, V84A, P167, DOI 10.1002/jbm.a.31261; Gao Qiutao, 2007, Chin Med, V2, P12, DOI 10.1186/1749-8546-2-12; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290; Katsumura T, 1998, BIOMATERIALS, V19, P1839, DOI 10.1016/S0142-9612(98)00076-3; Lin FH, 2003, BIOMATERIALS, V24, P2413, DOI 10.1016/S0142-9612(03)00031-0; LIN FH, 1993, J BIOMED ENG, V15, P481, DOI 10.1016/0141-5425(93)90063-5; Lin FH, 1998, BIOMATERIALS, V19, P905, DOI 10.1016/S0142-9612(97)00202-0; Liu BS, 2003, J BIOMED MATER RES A, V67A, P1163, DOI 10.1002/jbm.a.20017; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948; Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012; Tsim KWK, 2004, ASIA PACIFIC BIOTECH, V8, P1316; Wang WL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/853234; Weir MD, 2010, J BIOMED MATER RES A, V94A, P223, DOI 10.1002/jbm.a.32665; Wong RWK, 2006, J ORAL MAXIL SURG, V64, P828, DOI 10.1016/j.joms.2006.01.017; Yang Q, 2002, CLIN CHIM ACTA, V324, P89, DOI 10.1016/S0009-8981(02)00210-3; Yao CH, 2005, J BIOMED MATER RES B, V75B, P277, DOI 10.1002/jbm.b.30294; Yao CH, 2005, BIOMATERIALS, V26, P3065, DOI 10.1016/j.biomaterials.2004.09.011; Yao CH, 2004, J BIOMED MATER RES A, V69A, P709, DOI 10.1002/jbm.a.30045; Yao CH, 2002, AM J CHINESE MED, V30, P471, DOI 10.1142/S0192415X02000557	28	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131999	10.1371/journal.pone.0131999	http://dx.doi.org/10.1371/journal.pone.0131999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126113	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300066
J	Lee, YJ; Han, ME; Baek, SJ; Kim, SY; Oh, SO				Lee, Yong Joo; Han, Myoung-Eun; Baek, Su-Jin; Kim, Seon-Young; Oh, Sae-Ock			Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells	PLOS ONE			English	Article							HISTONE H3; CHROMATIN MODIFICATIONS; COVALENT MODIFICATIONS; MOLECULAR REGULATION; METHYLATION; GENE; PROTEIN; TRIMETHYLATION; EXPRESSION; SUBUNIT	Various types of histone methylation have been associated with cancer progression. Depending on the methylation site in histone proteins, its effects on transcription are different. DPY30 is a common member of SET1/MLL histone H3K4 methyltransferase complexes. However, its expression and roles in gastric cancer have been poorly characterized. To determine whether DPY30 has pathophysiological roles in gastric cancer, its expression and roles were examined. Immunohistochemistry and real time PCR showed up-regulation of DPY30 expression in some gastric cancer cell lines and patients' tissues. Its knockdown by siRNA decreased the proliferation, migration, and invasion of gastric cancer cells, whereas its overexpression showed the opposite effects. These results indicate that DPY30 has critical roles in the proliferation, migration, and invasion of gastric cancer cells, and suggest DPY30 might be a therapeutic target in gastric cancer.	[Lee, Yong Joo; Han, Myoung-Eun; Oh, Sae-Ock] Pusan Natl Univ, Dept Anat, Sch Med, Busan, South Korea; [Han, Myoung-Eun] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Busan, South Korea; [Baek, Su-Jin; Kim, Seon-Young] KRIBB, Med Genom Res Ctr, Taejon, South Korea	Pusan National University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Oh, SO (corresponding author), Pusan Natl Univ, Dept Anat, Sch Med, Busan, South Korea.	hedgehog@pusan.ac.kr			Bio & Medical Technology Development Program [2012M3A9C6050213]; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST) [2012R1A1A3010521]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	Bio & Medical Technology Development Program; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Bio & Medical Technology Development Program (#2012M3A9C6050213, OSO) and Basic Science Research Foundation (#2012R1A1A3010521, HME) of the National Research Foundation (NRF) funded by the Korean government (MEST), and by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (#0920050, OSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chervona Y, 2012, AM J CANCER RES, V2, P589; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ernst P, 2012, BRIEF FUNCT GENOMICS, V11, P217, DOI 10.1093/bfgp/els017; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YQ, 2010, J SURG ONCOL, V101, P687, DOI 10.1002/jso.21455; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simboeck E, 2013, EMBO J, V32, P2217, DOI 10.1038/emboj.2013.159; South PF, 2010, J BIOL CHEM, V285, P595, DOI 10.1074/jbc.M109.042697; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Yang ZH, 2014, BLOOD, V124, P2025, DOI 10.1182/blood-2014-01-549220; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	27	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131863	10.1371/journal.pone.0131863	http://dx.doi.org/10.1371/journal.pone.0131863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147337	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600154
J	Furi, I; Kalmar, A; Wichmann, B; Spisak, S; Scholler, A; Bartak, B; Tulassay, Z; Molnar, B				Furi, Istvan; Kalmar, Alexandra; Wichmann, Barnabas; Spisak, Sandor; Schoeller, Andrea; Bartak, Barbara; Tulassay, Zsolt; Molnar, Bela			Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; NUCLEIC-ACIDS; INVASION; PROMOTES; PROTEIN; PLASMA; TOLL-LIKE-RECEPTOR-9; INFLAMMATION; RECOGNITION; BIOMARKER	Background Epithelial cells in malignant conditions release DNA into the extracellular compartment. Cell free DNA of tumor origin may act as a ligand of DNA sensing mechanisms and mediate changes in epithelial-stromal interactions. Aims To evaluate and compare the potential autocrine and paracrine regulatory effect of normal and malignant epithelial cell-related DNA on TLR9 and STING mediated pathways in HT-29 human colorectal adenocarcinoma cells and normal fibroblasts. Materials and Methods DNA isolated from normal and tumorous colonic epithelia of fresh frozen surgically removed tissue samples was used for 24 and 6 hour treatment of HT-29 colon carcinoma and HDF-alpha fibroblast cells. Whole genome mRNA expression analysis and qRT-PCR was performed for the elements/members of TLR9 signaling pathway. Immunocytochemistry was performed for epithelial markers (i.e. CK20 and E-cadherin), DNA methyltransferase 3a (DNMT3a) and NF kappa B (for treated HDFa cells). Results Administration of tumor derived DNA on HT29 cells resulted in significant (p<0.05) mRNA level alteration in 118 genes (logFc >= 1, p <= 0.05), including overexpression of metallothionein genes (i.e. MT1H, MT1X, MT1P2, MT2A), metastasis-associated genes (i.e. TACSTD2, MACC1, MALAT1), tumor biomarker (CEACAM5), metabolic genes (i.e. INSIG1, LIPG), messenger molecule genes (i.e. DAPP, CREB3L2). Increased protein levels of CK20, E-cadherin, and DNMT3a was observed after tumor DNA treatment in HT-29 cells. Healthy DNA treatment affected mRNA expression of 613 genes (logFc >= 1, p <= 0.05), including increased expression of key adaptor molecules of TLR9 pathway (e.g. MYD88, IRAK2, NF kappa B, IL8, IL-1 beta), STING pathway (ADAR, IRF7, CXCL10, CASP1) and the FGF2 gene. Conclusions DNA from tumorous colon epithelium, but not from the normal epithelial cells acts as a prometastatic factor to HT-29 cells through the overexpression of pro-metastatic genes through TLR9/MYD88 independent pathway. In contrast, DNA derived from healthy colonic epithelium induced TLR9 and STING signaling pathway in normal fibroblasts.	[Kalmar, Alexandra; Schoeller, Andrea; Bartak, Barbara] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Furi, Istvan; Wichmann, Barnabas; Spisak, Sandor; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences	Furi, I (corresponding author), Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary.	furiistvan88@gmail.com			Research and Technology Innovation Fund, Hungary [KMR_12-1-2012-0216]; Hungarian Scientific Research Fund [OTKA-K111743]	Research and Technology Innovation Fund, Hungary; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was funded by the Research and Technology Innovation Fund, Hungary, KMR_12-1-2012-0216 to BM and Hungarian Scientific Research Fund (OTKA-K111743 grant) to ZT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; AGGARWAL SK, 1975, P NATL ACAD SCI USA, V72, P928, DOI 10.1073/pnas.72.3.928; Ahn J, 2015, ONCOGENE, DOI [10.1038/onc.2014.457, DOI 10.1038/0NC.2014.457]; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Bronte V, 2014, IMMUNITY, V41, P679, DOI 10.1016/j.immuni.2014.11.004; Chen Z, 2005, MED HYPOTHESES, V65, P956, DOI 10.1016/j.mehy.2005.04.042; Cui Z, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-47; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Dong XY, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-45; Ewaschuk JB, 2007, INFECT IMMUN, V75, P2572, DOI 10.1128/IAI.01662-06; Furi I, 2013, SCI WORLD J, DOI 10.1155/2013/293296; Furi I, 2013, WORLD J GASTROENTERO, V19, P4119, DOI 10.3748/wjg.v19.i26.4119; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Jahr S, 2001, CANCER RES, V61, P1659; JUCKETT DA, 1982, CANCER RES, V42, P3565; Konig B, 2009, EUR J PHARMACOL, V605, P23, DOI 10.1016/j.ejphar.2009.01.009; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lee TH, 2014, BIOCHEM BIOPH RES CO, V451, P295, DOI 10.1016/j.bbrc.2014.07.109; Li JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106290; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Pinto A, 2011, CANCER IMMUNOL IMMUN, V60, P1211, DOI 10.1007/s00262-011-1057-8; RUSSELL JL, 1978, P NATL ACAD SCI USA, V75, P6211, DOI 10.1073/pnas.75.12.6211; Sha Hui-Lan, 2010, Zhonghua Zhong Liu Za Zhi, V32, P913; Temizoz B, 2015, EUR J IMMUNOL, V45, P1159, DOI 10.1002/eji.201445132; Torres VA, 2007, MOL CELL BIOL, V27, P7703, DOI 10.1128/MCB.01991-06; Tuomela J, 2013, BREAST CANCER RES TR, V142, P477, DOI 10.1007/s10549-013-2762-0; Vaisanen MR, 2010, PROSTATE, V70, P817, DOI 10.1002/pros.21115; Wen FS, 2013, CANCER RES, V73, P4256, DOI 10.1158/0008-5472.CAN-12-3287; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia YC, 2014, ONCOL LETT, V8, P1670, DOI 10.3892/ol.2014.2400; Yang MH, 2015, BBA-MOL BASIS DIS, V1852, P166, DOI 10.1016/j.bbadis.2014.11.013; Zhang YL, 2014, ONCOL REP, V31, P2298, DOI 10.3892/or.2014.3095; Zhu YT, 2012, EXP CELL RES, V318, P2520, DOI 10.1016/j.yexcr.2012.07.021; Zhu ZY, 2015, MOL CELL BIOCHEM, V400, P287, DOI 10.1007/s11010-014-2285-y	42	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131699	10.1371/journal.pone.0131699	http://dx.doi.org/10.1371/journal.pone.0131699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133168	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400064
J	Kendig, MD; Ekayanti, W; Stewart, H; Boakes, RA; Rooney, K				Kendig, Michael D.; Ekayanti, Winda; Stewart, Hayden; Boakes, Robert A.; Rooney, Kieron			Metabolic Effects of Access to Sucrose Drink in Female Rats and Transmission of Some Effects to Their Offspring	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; INCREASED BODY-WEIGHT; SPATIAL MEMORY; ADULT RATS; PREGNANCY; OBESITY; FRUCTOSE; FAT; CONSUMPTION; EXPOSURE	The aims of this study were, first, to examine the metabolic consequences for female rats of having unrestricted access to 10% sucrose solution and, second, to test for effects of this dietary intervention on their offspring. In Stage 1 females were mated following a 4-week period in which one group was given the sucrose in addition to their normal chow and a control group was given chow and water only. Sucrose was removed at parturition and the pups monitored until weaning. Despite the development of glucose intolerance in sucrose-fed mothers, no effects were detected on litter size or pup weights. In Stage 2 voluntary activity of offspring was assessed over postnatal days (PND) 51-60 and their glucose tolerance measured at PND89-94. Again no effect of maternal diet was detected. Only male offspring were used in Stage 3, which began when they were 13 weeks old. Four groups were given 10% sucrose solution for 48 days in a 2 x 2 design, in which one factor was maternal diet and the other was whether they were given 2-h access to an activity wheel on alternate days. Higher fasting glucose levels were found in offspring of sugar-fed mothers. Exercise increased insulin sensitivity in these rats but not in offspring of control mothers. Behavioural measures of memory in Stage 3 did not reveal any effects of maternal diet or exercise. Overall, this study suggested that, while providing 10% sucrose solution ad-libitum was sufficient to impair maternal metabolism, the impact of this dietary manipulation on offspring may be revealed only when the offspring's diet is similarly manipulated.	[Kendig, Michael D.; Boakes, Robert A.] Univ Sydney, Sch Psychol A18, Sydney, NSW 2006, Australia; [Ekayanti, Winda; Stewart, Hayden] Univ Sydney, Sch Mol Biosci, Human Nutr Unit, Sydney, NSW 2006, Australia; [Rooney, Kieron] Univ Sydney, Fac Hlth Sci C42, Exercise Hlth & Performance, Lidcombe, NSW 2142, Australia; [Rooney, Kieron] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Boakes, RA (corresponding author), Univ Sydney, Sch Psychol A18, Sydney, NSW 2006, Australia.	Bob.Boakes@sydney.edu.au	Rooney, Kieron/I-6252-2018; Kendig, Mike/K-3704-2019	Rooney, Kieron/0000-0001-6563-7617; Kendig, Mike/0000-0003-3337-6402; Boakes, Robert/0000-0002-4756-9638	Australian Research Council [DP110102547]	Australian Research Council(Australian Research Council)	This study was funded by an Australian Research Council Discovery Grant to Dr. R. A. Boakes, DP110102547. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016; BERDANIER CD, 1975, AM J CLIN NUTR, V28, P1416, DOI 10.1093/ajcn/28.12.1416; Bocarsly ME, 2012, PHYSIOL BEHAV, V107, P568, DOI 10.1016/j.physbeh.2012.04.024; Bocarsly ME, 2010, PHARMACOL BIOCHEM BE, V97, P101, DOI 10.1016/j.pbb.2010.02.012; Chan CYY, 2013, EUR J NUTR, V52, P1721, DOI 10.1007/s00394-012-0475-5; D'Alessandro ME, 2012, CLIN EXP PHARMACOL P, V39, P623, DOI 10.1111/j.1440-1681.2012.05720.x; Frazier CRM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003221; Hsu TM, 2015, HIPPOCAMPUS, V25, P227, DOI 10.1002/hipo.22368; JEN KLC, 1991, J NUTR, V121, P1999, DOI 10.1093/jn/121.12.1999; Kawasaki T, 2005, BRIT J NUTR, V93, P613, DOI 10.1079/BJN20051407; Kendig MD, 2014, PHYSIOL BEHAV, V130, P54, DOI 10.1016/j.physbeh.2014.03.021; Kendig MD, 2014, APPETITE, V77, P1, DOI 10.1016/j.appet.2014.02.011; Kendig MD, 2013, PHYSIOL BEHAV, V120, P164, DOI 10.1016/j.physbeh.2013.08.012; Kuang HZ, 2014, J NUTR BIOCHEM, V25, P985, DOI 10.1016/j.jnutbio.2014.04.012; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Morenga LT, 2013, BMJ-BRIT MED J, P346; Munilla MA, 2000, J NUTR, V130, P2883, DOI 10.1093/jn/130.12.2883; OLIVEROS L, 1995, BIOSCI BIOTECH BIOCH, V59, P412, DOI 10.1271/bbb.59.412; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rodriguez L, 2013, J NUTR BIOCHEM, V24, P1709, DOI 10.1016/j.jnutbio.2013.02.011; Rooney K, 2011, INT J OBESITY, V35, P883, DOI 10.1038/ijo.2011.96; Samuelsson AM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00014; Sanchez-Lozada LG, 2010, EUR J NUTR, V49, P1, DOI 10.1007/s00394-009-0042-x; Sheludiakova A, 2012, EUR J NUTR, V51, P445, DOI 10.1007/s00394-011-0228-x; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4; Vendruscolo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009296; World Health Organization, 2022, OB OV	29	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131107	10.1371/journal.pone.0131107	http://dx.doi.org/10.1371/journal.pone.0131107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134991	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400035
J	Varma, VP; Devi, L; Venna, NK; Murthy, CLN; Idris, MM; Goel, S				Varma, Vivek Phani; Devi, Lalitha; Venna, Naresh Kumar; Murthy, Ch Lakshmi N.; Idris, Mohammed M.; Goel, Sandeep			Ocular Fluid As a Replacement for Serum in Cell Cryopreservation Media	PLOS ONE			English	Article							EGG-YOLK; DNA INTEGRITY; HUMAN-SPERMATOZOA; STEM-CELLS; APOPTOSIS; SEMEN; EXPRESSION; PROTEIN; FETAL; FIBRONECTIN	Cryostorage is of immense interest in biomedical research, especially for stem cell-based therapies and fertility preservation. Several protocols have been developed for efficient cryopreservation of cells and tissues, and a combination of dimethyl sulfoxide (DMSO) and fetal bovine serum (FBS) is commonly used. However, there is a need for an alternative to FBS because of ethical reasons, high cost, and risk of contamination with blood-borne diseases. The objective of the present study was to examine the possibility of using buffalo (Bubalus bubalis) ocular fluid (BuOF) to replace FBS in cryomedia. Frozen-thawed cells, which were cryopreserved in a cryomedia with BuOF, were assessed for viability, early and late apoptosis, and proliferation. Three cell lines (CHO, HEK, and C18-4), mouse embryonic stem (mES) cells, and primary cells, such as mouse embryonic fibroblast (MEF) cells, human peripheral blood mononuclear cells (hPBMCs), and mouse bone marrow cells (mBMCs), were cryopreserved in cryomedia containing 10% DMSO (D10) with 20% FBS (D10S20) or D10 with 20% BuOF (D10O20). For all three cell lines and mES cells cryopreserved in either D10S20 or D10O20, thawed cells showed no difference in cell viability or cell recovery. Western blot analysis of frozen-thawed-cultured cells revealed that the expression of Annexin V and proliferating cell nuclear antigen (PCNA) proteins, and the ratio of BAX/BCL2 proteins were similar in all three cell lines, mES cells, and hPBMCs cryopreserved in D10S20 and D10O20. However, initial cell viability, cell recovery after culture, and PCNA expression were significantly lower in MEF cells, and the BAX/BCL2 protein ratio was elevated in mBMCs cryopreserved in D10O20. Biochemical and proteomic analysis of BuOF showed the presence of several components that may have roles in imparting the cryoprotective property of BuOF. These results encourage further research to develop an efficient serum-free cryomedia for several cell types using BuOF.	[Varma, Vivek Phani; Devi, Lalitha; Venna, Naresh Kumar; Murthy, Ch Lakshmi N.; Idris, Mohammed M.; Goel, Sandeep] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Goel, S (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	sandeep@ccmb.res.in	CHAVALI, Murthy/A-4909-2010; Goel, Sandeep/C-5985-2009	CHAVALI, Murthy/0000-0003-3910-2322; Goel, Sandeep/0000-0001-7485-5392; Varma D, Vivek Phani/0000-0003-4587-5719; Mallarapu, Lalitha devi/0000-0002-2269-0909	Council for Scientific and Industrial Research (CSIR), Government of India (GOI) [BSC0207]; Central Zoo Authority (CZA), GOI [GAP0389]	Council for Scientific and Industrial Research (CSIR), Government of India (GOI); Central Zoo Authority (CZA), GOI	This work was supported by the Council for Scientific and Industrial Research (CSIR), Government of India (GOI) (grant number BSC0207) and Central Zoo Authority (CZA), GOI (grant number GAP0389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirat L, 2004, THERIOGENOLOGY, V61, P895, DOI 10.1016/S0093-691X(03)00259-0; Ando Yukio, 2009, Rinsho Byori, V57, P228; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Averill-Bates D.A., 2014, CRYOBIOLOGY, V69, P512, DOI [10.1016/j.cryobiol.2014.09.332, DOI 10.1016/J.CRYOBIOL.2014.09.332]; Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8; Boe-Hansen GB, 2005, THERIOGENOLOGY, V63, P1789, DOI 10.1016/j.theriogenology.2004.08.004; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Camina JP, 1998, BIOCHEM BIOPH RES CO, V244, P696, DOI 10.1006/bbrc.1998.8320; CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726; De Rooij DG, 2000, J ANDROL, V21, P776; De Souza EM, 2008, EXP PARASITOL, V118, P331, DOI 10.1016/j.exppara.2007.09.004; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EYER J, 1990, BIOCHEM J, V270, P821, DOI 10.1042/bj2700821; Filipic B, 2002, ALTEX-ALTERN TIEREXP, V19, P15; Fukuda A, 1996, BIOCHEM BIOPH RES CO, V219, P76, DOI 10.1006/bbrc.1996.0184; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Germann A, 2011, BIOPRESERV BIOBANK, V9, P229, DOI 10.1089/bio.2010.0033; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Glander HJ, 1999, MOL HUM REPROD, V5, P109, DOI 10.1093/molehr/5.2.109; GLANDER HJ, 1987, ANDROLOGIA, V19, P456; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Han SW, 2006, ONCOGENE, V25, P4341, DOI 10.1038/sj.onc.1209460; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Hofmann MC, 2005, STEM CELLS, V23, P200, DOI 10.1634/stemcells.2003-0036; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hook VYH, 2002, BIOL CHEM, V383, P1067, DOI 10.1515/BC.2002.115; Hu JH, 2006, ASIAN AUSTRAL J ANIM, V19, P486, DOI 10.5713/ajas.2006.486; Hu JH, 2008, CRYOBIOLOGY, V57, P257, DOI 10.1016/j.cryobiol.2008.09.004; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jochems CEA, 2002, ATLA-ALTERN LAB ANIM, V30, P219, DOI 10.1177/026119290203000208; Khan KH, 2013, ADV PHARM BULL, V3, P257, DOI 10.5681/apb.2013.042; Koss MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096895; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Lakshmipathy U, 2004, STEM CELLS, V22, P531, DOI 10.1634/stemcells.22-4-531; Lane M, 2002, HUM REPROD, V17, P2686, DOI 10.1093/humrep/17.10.2686; Li P, 2010, THERIOGENOLOGY, V74, P413, DOI 10.1016/j.theriogenology.2010.02.024; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; Mellor DJ, 2003, NEW ZEAL VET J, V51, P2, DOI 10.1080/00480169.2003.36323; MILLER JW, 1994, AM J PATHOL, V145, P574; Milosevic J, 2005, STEM CELLS, V23, P681, DOI 10.1634/stemcells.2004-0135; Moussa M, 2002, THERIOGENOLOGY, V57, P1695, DOI 10.1016/S0093-691X(02)00682-9; Moustacas VS, 2011, THERIOGENOLOGY, V75, P300, DOI 10.1016/j.theriogenology.2010.08.016; Muller P, 2004, CELL TISSUE RES, V317, P45, DOI 10.1007/s00441-004-0894-6; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Osterling M, 1985, JOURNAL OF TISSUE CU, V9, P171, DOI [10.1007/BF01665926, DOI 10.1007/BF01665926]; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Pillet E, 2011, THERIOGENOLOGY, V75, P105, DOI 10.1016/j.theriogenology.2010.07.015; Rao BS, 2012, CRYOBIOLOGY, V64, P176, DOI 10.1016/j.cryobiol.2012.01.005; REID T, 1982, INVEST OPHTH VIS SCI, V22, P57; REISNER Y, 1978, P NATL ACAD SCI USA, V75, P2933, DOI 10.1073/pnas.75.6.2933; Sagun KC, 2005, FASEB J, V19, P1657, DOI 10.1096/fj.05-4107com; Sambor A, 2014, J IMMUNOL METHODS, V409, P107, DOI 10.1016/j.jim.2014.04.005; Samuelson Linda C, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4482; Sariozkan S, 2015, ANDROLOGIA, V47, P138, DOI 10.1111/and.12236; Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schmale K, 2006, J BIOTECHNOL, V124, P302, DOI 10.1016/j.jbiotec.2006.01.012; Schultz LB, 2000, COLD SPRING HARB SYM, V65, P489, DOI 10.1101/sqb.2000.65.489; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shukla MK, 2007, ANIM REPROD SCI, V97, P175, DOI 10.1016/j.anireprosci.2006.02.015; Spencer HT, 1996, BLOOD, V87, P2579, DOI 10.1182/blood.V87.6.2579.bloodjournal8762579; Stephenne X, 2010, WORLD J GASTROENTERO, V16, P1, DOI 10.3748/wjg.v16.i1.1; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; Tariq SA, 2007, MOL BIOTECHNOL, V37, P62, DOI 10.1007/s12033-007-0045-x; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toninello A, 2006, BBA-REV CANCER, V1765, P1, DOI 10.1016/j.bbcan.2005.09.001; Tsujimoto K, 2001, J BIOCHEM-TOKYO, V129, P979, DOI 10.1093/oxfordjournals.jbchem.a002946; Varela AS, 2009, ANIM REPROD SCI, V115, P323, DOI 10.1016/j.anireprosci.2008.11.002; Vera-Munoz O, 2009, THERIOGENOLOGY, V71, P895, DOI 10.1016/j.theriogenology.2008.10.010; VINCENT C, 1990, CRYOBIOLOGY, V27, P9, DOI 10.1016/0011-2240(90)90048-9; Wang P, 2014, ZYGOTE, V22, P239, DOI 10.1017/S096719941300004X; Webster L, 1998, BRIT J OPHTHALMOL, V82, P438, DOI 10.1136/bjo.82.4.438; Xiao M, 2003, J HEMATOTH STEM CELL, V12, P115, DOI 10.1089/152581603321210190; Yamaguchi M, 2005, INT J MOL MED, V15, P371; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zhao J, 2001, STEM CELLS, V19, P212, DOI 10.1634/stemcells.19-3-212	85	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131291	10.1371/journal.pone.0131291	http://dx.doi.org/10.1371/journal.pone.0131291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135924	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400041
J	Winberg, A; West, CE; Strinnholm, A; Nordstrom, L; Hedman, L; Ronmark, E				Winberg, Anna; West, Christina E.; Strinnholm, Asa; Nordstrom, Lisbeth; Hedman, Linnea; Ronmark, Eva			Assessment of Allergy to Milk, Egg, Cod, and Wheat in Swedish Schoolchildren: A Population Based Cohort Study	PLOS ONE			English	Article							MEDIATED FOOD ALLERGY; CELIAC-DISEASE; DOUBLE-BLIND; PREVALENCE; HYPERSENSITIVITY; IGE; CHILDREN; ADOLESCENTS; CHALLENGE; EPIDEMIOLOGY	Objectives Knowledge about the prevalence of allergies to foods in childhood and adolescence is incomplete. The purpose of this study was to investigate the prevalence of allergies to milk, egg, cod, and wheat using reported data, clinical examinations, and double-blind placebo-controlled food challenges, and to describe the phenotypes of reported food hypersensitivity in a cohort of Swedish schoolchildren. Methods In a population-based cohort of 12-year-old children, the parents of 2612 (96% of invited) completed a questionnaire. Specific IgE antibodies to foods were analyzed in a random sample (n=695). Children reporting complete avoidance of milk, egg, cod, or wheat due to perceived hypersensitivity and without physician-diagnosed celiac disease were invited to undergo clinical examination that included specific IgE testing, a celiac screening test, and categorization into phenotypes of food hypersensitivity according to preset criteria. Children with possible food allergy were further evaluated with double-blind challenges. Results In this cohort, the prevalence of reported food allergy to milk, egg, cod, or wheat was 4.8%. Food allergy was diagnosed in 1.4% of the children after clinical evaluation and in 0.6% following double-blind placebo-controlled food challenge. After clinical examination, children who completely avoided one or more essential foods due to perceived food hypersensitivity were categorized with the following phenotypes: allergy (29%), outgrown allergy (19%), lactose intolerance (40%), and unclear (12%). Conclusions There was a high discrepancy in the prevalence of allergy to milk, egg, cod and wheat as assessed by reported data, clinical evaluation, and double-blind food challenges. Food hypersensitivity phenotyping according to preset criteria was helpful for identifying children with food allergy.	[Winberg, Anna; West, Christina E.; Nordstrom, Lisbeth] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden; [Strinnholm, Asa; Hedman, Linnea; Ronmark, Eva] Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, OLIN Unit, Umea, Sweden	Umea University; Umea University	Winberg, A (corresponding author), Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden.	anna.winberg@umu.se		West, Christina/0000-0001-9599-2580; Hedman, Linnea/0000-0002-1630-3167	Swedish research council; Swedish Heart and Lung Foundation; VISARE Norr; Swedish Asthma and Allergy Foundation; Umea University; State Government; Jerring Foundation; Diagnostics, Uppsala, Sweden; Vasterbotten County Council (ALF)	Swedish research council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); VISARE Norr; Swedish Asthma and Allergy Foundation; Umea University; State Government; Jerring Foundation; Diagnostics, Uppsala, Sweden; Vasterbotten County Council (ALF)	Financial support was provided by the Swedish research council; the Swedish Heart and Lung Foundation; VISARE Norr; the Swedish Asthma and Allergy Foundation; by a regional agreement between Umea University and Vasterbotten County Council (ALF); the State Government funding for Health Care research (FoU); and by the Jerring Foundation. ThermoFisher Diagnostics, Uppsala, Sweden provided funding for parts of the IgE tests and for the tissue transglutaminase IgA antibody analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781; Allen KJ, 2012, IMMUNOL ALLERGY CLIN, V32, P35, DOI 10.1016/j.iac.2011.11.008; Almon R, 2007, SCAND J GASTROENTERO, V42, P165, DOI 10.1080/00365520600825257; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bjerg A, 2010, ALLERGY, V65, P48, DOI 10.1111/j.1398-9995.2009.02105.x; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Carroccio A, 1998, J AM COLL NUTR, V17, P631, DOI 10.1080/07315724.1998.10718813; Cummings AJ, 2010, ALLERGY, V65, P933, DOI 10.1111/j.1398-9995.2010.02342.x; Ivarsson A, 2013, PEDIATRICS, V131, pE687, DOI 10.1542/peds.2012-1015; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kaya A, 2013, PEDIAT ALLERG IMM-UK, V24, P456, DOI 10.1111/pai.12097; Keet CA, 2012, J ALLERGY CLIN IMMUN, V130, P1207, DOI 10.1016/j.jaci.2012.07.020; Keil T, 2008, CLIN EXP ALLERGY, V38, P1252, DOI 10.1111/j.1365-2222.2008.03048.x; Kusunoki T, 2009, PEDIAT ALLERG IMM-UK, V20, P642, DOI 10.1111/j.1399-3038.2009.00856.x; Meyer R, 2014, J HUM NUTR DIET, V27, P227, DOI 10.1111/jhn.12149; Niggemann B, 2012, J ALLERGY CLIN IMMUN, V130, P261, DOI 10.1016/j.jaci.2012.03.021; Niggemenn B, 2007, ALLERGY, V62, P729, DOI 10.1111/j.1398-9995.2007.01396.x; Nowak-Wegrzyn A, 2012, IMMUNOL ALLERGY CLIN, V32, pXV, DOI 10.1016/j.iac.2011.12.001; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Ojetti V, 2005, DIGESTION, V71, P106, DOI 10.1159/000084526; Ostblom E, 2008, CLIN EXP ALLERGY, V38, P1325, DOI 10.1111/j.1365-2222.2008.03010.x; Persson K, 2013, ACTA PAEDIATR, V102, P644, DOI 10.1111/apa.12172; Peters RL, 2012, PEDIAT ALLERG IMM-UK, V23, P347, DOI 10.1111/j.1399-3038.2011.01237.x; Roehr CC, 2004, CLIN EXP ALLERGY, V34, P1534, DOI 10.1111/j.1365-2222.2004.02080.x; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Sicherer SH, 2012, PEDIATRICS, V129, P193, DOI 10.1542/peds.2011-2382; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Strinnholm A, 2014, ACTA PAEDIATR, V103, P1290, DOI 10.1111/apa.12772; Venter C, 2008, ALLERGY, V63, P354, DOI 10.1111/j.1398-9995.2007.01570.x; Webb C, 2015, J PEDIAT GASTROENTER, V2, P2; Wilt Timothy J, 2010, Evid Rep Technol Assess (Full Rep), P1; Winberg A, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-32; Winberg A, 2013, PEDIAT ALLERG IMM-UK, V24, P282, DOI 10.1111/pai.12061	37	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131804	10.1371/journal.pone.0131804	http://dx.doi.org/10.1371/journal.pone.0131804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134827	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400074
J	Girdhar, K; Gruebele, M; Chemla, YR				Girdhar, Kiran; Gruebele, Martin; Chemla, Yann R.			The Behavioral Space of Zebrafish Locomotion and Its Neural Network Analog	PLOS ONE			English	Article							LARVAL ZEBRAFISH; REPERTOIRE; CIRCUITS; NEURONS	How simple is the underlying control mechanism for the complex locomotion of vertebrates? We explore this question for the swimming behavior of zebrafish larvae. A parameter- independent method, similar to that used in studies of worms and flies, is applied to analyze swimming movies of fish. The motion itself yields a natural set of fish "eigenshapes" as coordinates, rather than the experimenter imposing a choice of coordinates. Three eigenshape coordinates are sufficient to construct a quantitative "postural space" that captures >96% of the observed zebrafish locomotion. Viewed in postural space, swim bouts are manifested as trajectories consisting of cycles of shapes repeated in succession. To classify behavioral patterns quantitatively and to understand behavioral variations among an ensemble of fish, we construct a "behavioral space" using multidimensional scaling (MDS). This method turns each cycle of a trajectory into a single point in behavioral space, and clusters points based on behavioral similarity. Clustering analysis reveals three known behavioral patterns-scoots, turns, rests-but shows that these do not represent discrete states, but rather extremes of a continuum. The behavioral space not only classifies fish by their behavior but also distinguishes fish by age. With the insight into fish behavior from postural space and behavioral space, we construct a two-channel neural network model for fish locomotion, which produces strikingly similar postural space and behavioral space dynamics compared to real zebrafish.	[Girdhar, Kiran; Gruebele, Martin; Chemla, Yann R.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Gruebele, Martin; Chemla, Yann R.] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gruebele, M (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	mgruebel@illinois.edu; ychemla@illinois.edu	Girdhar, Kiran/J-6670-2019	Girdhar, Kiran/0000-0002-5622-042X; Chemla, Yann/0000-0001-9167-0234	National Science Foundation via award PFC: Center for Physics of Living Cells [PHY 1430124]; Direct For Mathematical & Physical Scien [0822613] Funding Source: National Science Foundation; Division Of Physics [1430124] Funding Source: National Science Foundation	National Science Foundation via award PFC: Center for Physics of Living Cells; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded by National Science Foundation, grant no. PHY 1430124, via award PFC: Center for Physics of Living Cells (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1430124).	Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Bianco IH, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00101; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Fero K, 2011, NEUROMETHODS, V52, P249, DOI 10.1007/978.1.60761.922.2_12; Fetcho JR, 2004, INTEGR COMP BIOL, V44, P57, DOI 10.1093/icb/44.1.57; Gallagher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059865; Goldberg D., 1999, Proceedings of the Third International Conference on Autonomous Agents, P100, DOI 10.1145/301136.301172; Granato M, 1996, DEVELOPMENT, V123, P399; Hill SA, 2005, NEUROCOMPUTING, V65, P61, DOI 10.1016/j.neucom.2004.10.092; Huang KH, 2013, CURR BIOL, V23, P1566, DOI 10.1016/j.cub.2013.06.044; Jordan D, 2013, P NATL ACAD SCI USA, V110, P14018, DOI 10.1073/pnas.1308282110; McClenahan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032295; Mirat O, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00107; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Portugues R, 2009, CURR OPIN NEUROBIOL, V19, P644, DOI 10.1016/j.conb.2009.10.007; Roussel N, 2007, IEEE T BIO-MED ENG, V54, P1786, DOI 10.1109/TBME.2007.894981; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tomlinson B., 2005, NEGATIVE BEHAV SPACE; Wall ME, 2001, BIOINFORMATICS, V17, P566, DOI 10.1093/bioinformatics/17.6.566; Westerfield M, 1993, THE ZEBRAFISH BOOK A; Williams CKI, 2002, MACH LEARN, V46, P11, DOI 10.1023/A:1012485807823	28	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128668	10.1371/journal.pone.0128668	http://dx.doi.org/10.1371/journal.pone.0128668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132396	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000017
J	Guerrini, R; Melani, F; Brancati, C; Ferrari, AR; Brovedani, P; Biggeri, A; Grisotto, L; Pellacani, S				Guerrini, Renzo; Melani, Federico; Brancati, Claudia; Ferrari, Anna Rita; Brovedani, Paola; Biggeri, Annibale; Grisotto, Laura; Pellacani, Simona			Dysgraphia as a Mild Expression of Dystonia in Children with Absence Epilepsy	PLOS ONE			English	Article							BLINK REFLEX; PATHOPHYSIOLOGY; CLASSIFICATION; MUTATIONS; CHANNEL	Background Absence epilepsy (AE) is etiologically heterogeneous and has at times been associated with idiopathic dystonia. Objectives Based on the clinical observation that children with AE often exhibit, interictally, a disorder resembling writer's cramp but fully definable as dysgraphia, we tested the hypothesis that in this particular population dysgraphia would represent a subtle expression of dystonia. Methods We ascertained the prevalence of dysgraphia in 82 children with AE (mean age 9.7) and average intelligence and compared them with 89 age-, gender- and class-matched healthy children (mean age 10.57) using tests for handwriting fluency and quality, based on which we divided patients and controls into four subgroups: AE/dysgraphia, AE without dysgraphia, controls with dysgraphia and healthy controls. We compared the blink reflex recovery cycle in children belonging to all four subgroups. Results We identified dysgraphia in 17/82 children with AE and in 7/89 controls (20.7 vs 7.8%; P = 0.016) with the former having a 3.4-times higher risk of dysgraphia regardless of age and gender (odd ratio: 3.49; 95% CI 1.2, 8.8%). The AE/dysgraphia subgroup performed worse than controls with dysgraphia in one test of handwriting fluency (P = 0.037) and in most trials testing handwriting quality (P<0.02). In children with AE/dysgraphia the blink reflex showed no suppression at short interstimulus intervals, with a difference for each value emerging when comparing the study group with the three remaining subgroups (P<0.001). Conclusions In children with AE, dysgraphia is highly prevalent and has a homogeneous, distinctive pathophysiological substrate consistent with idiopathic dystonia.	[Guerrini, Renzo; Melani, Federico; Brancati, Claudia; Pellacani, Simona] Univ Florence, Pediat Neurol & Neurogenet Unit & Labs, Dept Neurosci, A Meyer Childrens Hosp, I-50139 Florence, Italy; [Guerrini, Renzo; Ferrari, Anna Rita; Brovedani, Paola; Pellacani, Simona] IRCCS Stella Maris Fdn, I-56128 Pisa, Italy; [Biggeri, Annibale; Grisotto, Laura] Univ Florence, Dept Stat Informat Applicat G Parenti, I-50139 Florence, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; IRCCS Fondazione Stella Maris; University of Florence	Guerrini, R (corresponding author), Univ Florence, Pediat Neurol & Neurogenet Unit & Labs, Dept Neurosci, A Meyer Childrens Hosp, I-50139 Florence, Italy.	renzo.guerrini@meyer.it	Brovedani, Paola/ABD-8994-2020; Pellacani, Simona/AAB-9849-2022; Pellacani, Simona/HDL-7360-2022; Ferrari, Anna Rita/AAB-9899-2019	Brovedani, Paola/0000-0002-7172-2137; Pellacani, Simona/0000-0003-3578-8953; Ferrari, Anna Rita/0000-0002-5397-6184; Guerrini, Renzo/0000-0002-7272-7079	Italian Ministry of Health; European Union; Pisa Foundation	Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission); Pisa Foundation	R. Guerrini in the last 12 months received research support from the Italian Ministry of Health, the European Union and the Pisa Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No Financial Disclosures are reported by the remaining authors.	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ARAMIDEH M, 1995, J NEUROL NEUROSUR PS, V58, P692, DOI 10.1136/jnnp.58.6.692; Beery K. E., 2004, BEERY BUKTENICA DEV; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERKOVIC SF, 1987, NEUROLOGY, V37, P993, DOI 10.1212/WNL.37.6.993; Bisiacchi P.S., 2005, BVN 5 11 BATTERIA VA; Borean M, 2012, DGM P TEST VALUTAZIO; Deransart C, 1998, EPILEPSY RES, V32, P213, DOI 10.1016/S0920-1211(98)00053-9; DEUEL RK, 1995, J CHILD NEUROL, V10, pS6, DOI 10.1177/08830738950100S103; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Esteban A, 1999, NEUROPHYSIOL CLIN, V29, P7, DOI 10.1016/S0987-7053(99)80039-2; Guerrini R, 2002, EPILEPSIA, V43, P1224, DOI 10.1046/j.1528-1157.2002.13802.x; Guerrini R, 2001, EPILEPSIA, V42, P36, DOI 10.1046/j.1528-1157.2001.042suppl.3036.x; Guerrini R, 1999, ANN NEUROL, V45, P344, DOI 10.1002/1531-8249(199903)45:3<344::AID-ANA10>3.0.CO;2-9; Gugliotta M, 2009, BVN 12 18 BATTERIA V; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Karlsdottir R, 2002, PERCEPT MOTOR SKILL, V94, P623, DOI 10.2466/PMS.94.2.623-662; Leary LD, 2003, EPILEPSIA, V44, P701, DOI 10.1046/j.1528-1157.2003.05302.x; Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x; MCHALE K, 1992, AM J OCCUP THER, V46, P898, DOI 10.5014/ajot.46.10.898; Moeller F, 2008, EPILEPSIA, V49, P1510, DOI 10.1111/j.1528-1167.2008.01626.x; PAULETTI G, 1993, MOVEMENT DISORD, V8, P495, DOI 10.1002/mds.870080414; Paz JT, 2005, J NEUROSCI, V25, P2092, DOI 10.1523/JNEUROSCI.4689-04.2005; Quartarone A, 2013, MOVEMENT DISORD, V28, P958, DOI 10.1002/mds.25532; Riva D, 2000, BRAIN LANG, V71, P267, DOI 10.1006/brln.1999.2166; Sanger TD, 2010, MOVEMENT DISORD, V25, P1538, DOI 10.1002/mds.23088; Sartori G., 2007, DDE 2 BATTERIA VALUT; Slaght S, 2004, J NEUROSCI, V24, P6816, DOI 10.1523/JNEUROSCI.1449-04.2004; Smits-Engelsman BCM, 2001, HUM MOVEMENT SCI, V20, P161, DOI 10.1016/S0167-9457(01)00033-1; Suls A, 2009, ANN NEUROL, V66, P415, DOI 10.1002/ana.21724; TOLOSA E, 1988, MOVEMENT DISORD, V3, P61, DOI 10.1002/mds.870030108; Tressoldi P. E., 2000, BATTERIA VALUTAZIONE; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130883	10.1371/journal.pone.0130883	http://dx.doi.org/10.1371/journal.pone.0130883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132164	Green Published, gold			2022-12-26	WOS:000358153000084
J	Hsu, CW; Poche, RA; Saik, JE; Ali, S; Wang, S; Yosef, N; Calderon, GA; Scott, L; Vadakkan, TJ; Larina, IV; West, JL; Dickinson, ME				Hsu, Chih-Wei; Poche, Ross A.; Saik, Jennifer E.; Ali, Saniya; Wang, Shang; Yosef, Nejla; Calderon, Gisele A.; Scott, Larry, Jr.; Vadakkan, Tegy J.; Larina, Irina V.; West, Jennifer L.; Dickinson, Mary E.			Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; THERAPEUTIC ANGIOGENESIS; MYOCARDIAL-ISCHEMIA; CARDIAC-FUNCTION; PDGFR-BETA; CELL-DEATH; VEGF-A; TISSUE; MOUSE	Successful engineering of complex organs requires improved methods to promote rapid and stable vascularization of artificial tissue scaffolds. Toward this goal, tissue engineering strategies utilize the release of pro-angiogenic growth factors, alone or in combination, from biomaterials to induce angiogenesis. In this study we have used intravital microscopy to define key, dynamic cellular changes induced by the release of pro-angiogenic factors from polyethylene glycol diacrylate hydrogels transplanted in vivo. Our data show robust macrophage recruitment when the potent and synergistic angiogenic factors, PDGFBB and FGF2 were used as compared with VEGF alone and intravital imaging suggested roles for macrophages in endothelial tip cell migration and anastomosis, as well as pericyte-like behavior. Further data from in vivo experiments show that delivery of CSF1 with VEGF can dramatically improve the poor angiogenic response seen with VEGF alone. These studies show that incorporating macrophage-recruiting factors into the design of pro-angiogenic biomaterial scaffolds is a key strategy likely to be necessary for stable vascularization and survival of implanted artificial tissues.	[Hsu, Chih-Wei; Poche, Ross A.; Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA; [Hsu, Chih-Wei; Poche, Ross A.; Wang, Shang; Yosef, Nejla; Calderon, Gisele A.; Scott, Larry, Jr.; Vadakkan, Tegy J.; Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA; [Saik, Jennifer E.; Ali, Saniya; West, Jennifer L.; Dickinson, Mary E.] Rice Univ, Dept Bioengn, Houston, TX USA; [Ali, Saniya; West, Jennifer L.] Duke Univ, Dept Biomed Engn, Durham, NC USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University; Duke University	Dickinson, ME (corresponding author), Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA.	mdickins@bcm.edu	Hsu, Chih-Wei/ABI-1472-2020	Hsu, Chih-Wei/0000-0002-9591-9567; Calderon, Gisele/0000-0002-7267-8641; Poche, Ross/0000-0002-5228-2383; Wang, Shang/0000-0001-9447-719X	National Institute of Health [R01HL097520-01A1, R21EY020632, F32EY019436, R01HL120140]; Cancer Prevention Research Institute of Texas [RP120713-P3]; American Heart Association Predoctoral Fellowship [12PRE12030410]; NATIONAL EYE INSTITUTE [R21EY020632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120140, R01HL097520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016629, P20EB007076] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by: 1. National Institute of Health (http://www.nih.gov) R01HL097520-01A1 (MED, JLW); 2. National Institute of Health (http://www.nih.gov) R21EY020632 (MED); 3. Cancer Prevention Research Institute of Texas (http://www.cprit.state.tx.us) RP120713-P3 (MED); 4. American Heart Association Predoctoral Fellowship (http://www.heart.org) 12PRE12030410 (CWH); 5. National Institute of Health (http://www.nih.gov) F32EY019436 (RAP); 6. National Institute of Health (http://www.nih.gov) R01HL120140 (IVL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Andres G, 2009, J CELL MOL MED, V13, P2083, DOI 10.1111/j.1582-4934.2008.00415.x; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754; Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Chu HH, 2012, THER DELIV, V3, P693, DOI 10.4155/TDE.12.50; des Rieux A, 2011, J CONTROL RELEASE, V150, P272, DOI 10.1016/j.jconrel.2010.11.028; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509; Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097; Fung E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00353; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gould DJ, 2011, MICROCIRCULATION, V18, P136, DOI 10.1111/j.1549-8719.2010.00075.x; Hedman M, 2003, CIRCULATION, V107, P2677, DOI 10.1161/01.CIR.0000070540.80780.92; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Larina IV, 2009, ANAT REC, V292, P333, DOI 10.1002/ar.20821; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee RJ, 2000, CIRCULATION, V102, P898; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; Mahmud MS, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050901; Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Moldovan NI, 2000, CIRC RES, V87, P378; Molin D, 2007, CURR OPIN PHARMACOL, V7, P158, DOI 10.1016/j.coph.2006.10.006; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Poche R. A., 2010, COLD SPRING HARB PRO; Poche RA, 2015, DEV BIOL; Poche RA, 2009, DEV DYNAM, V238, P2318, DOI 10.1002/dvdy.21886; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Ripa RS, 2006, EUR HEART J, V27, P1785, DOI 10.1093/eurheartj/ehl117; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; SIEGBAHN A, 1990, J CLIN INVEST, V85, P916, DOI 10.1172/JCI114519; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Sudheendran N, 2011, LASER PHYS LETT, V8, P247, DOI 10.1002/lapl.201010120; Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6; Wang RKK, 2010, IEEE J SEL TOP QUANT, V16, P545, DOI 10.1109/JSTQE.2009.2033609; Wang S, 2014, BIOMED OPT EXPRESS, V5, P1980, DOI 10.1364/BOE.5.001980; Wang Y, 2011, NEUROINFORMATICS, V9, P193, DOI 10.1007/s12021-011-9110-5; Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021; Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479	77	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131643	10.1371/journal.pone.0131643	http://dx.doi.org/10.1371/journal.pone.0131643			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132702	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000132
J	Sanjo, H; Tokumaru, S; Akira, S; Taki, S				Sanjo, Hideki; Tokumaru, Shigeo; Akira, Shizuo; Taki, Shinsuke			Conditional Deletion of TAK1 in T Cells Reveals a Pivotal Role of TCR alpha beta(+) Intraepithelial Lymphocytes in Preventing Lymphopenia-Associated Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHRONIC ENTEROCOLITIS; MICE; TRANSCRIPTION; GUT; BET; HOMEOSTASIS; METABOLITES; GENERATION; SELECTION	The kinase TAK is required for the development of conventional and regulatory T cells. We previously reported that mice with conditional deletion of TAK1 in T cells (Lck-cre: TAK1(fl/fl) mice) exhibited severe T lymphopenia, and were nevertheless predisposed to spontaneous colitis with unknown etiology. Here we focused on the immunopathological mechanism in colitic Lck-cre: TAK1(fl/fl) mice. We found that 'leaky' CD4(+) T cells retaining TAK1 acquired inflammatory phenotypes that contribute to disease onset in Lck-cre: TAK1(fl/fl) mice. Furthermore, the gut microbiota-triggered signaling was also a key event leading to the pathogenesis. We discovered that Lck-cre: TAK1(fl/fl) mice were almost completely devoid of TCR alpha beta(+) CD8 alpha(+) intestinal intraepithelial lymphocytes (IELs) and this was largely due to the developmental defect of the thymic precursors by TAK1 deficiency. Remarkably, transfer of TCR alpha beta(+) CD8 alpha(+) IELs from wild-type mice ameliorated colitis in Lck-cre: TAK1(fl/fl) mice. Taken together, our current study highlighted the emerging role of TAK1 in configuring the gut-specialized T cell subset, which regulates mucosal homeostasis under lymphopenic conditions.	[Sanjo, Hideki; Tokumaru, Shigeo; Taki, Shinsuke] Shinshu Univ, Sch Med, Dept Mol & Cellular Immunol, Nagano, Japan; [Akira, Shizuo] Osaka Univ, Host Def Lab, Immunol Frontier Res Ctr, Osaka, Japan	Shinshu University; Osaka University	Sanjo, H (corresponding author), Shinshu Univ, Sch Med, Dept Mol & Cellular Immunol, Nagano, Japan.	hsanjo@shinshu-u.ac.jp	Akira, Shizuo/C-3134-2009	Taki, Shinsuke/0000-0001-5143-3496	Shinshu Public Utility Foundation for Promotion of Medical Sciences; AIBAWORKS; Grants-in-Aid for Scientific Research [15K08529] Funding Source: KAKEN	Shinshu Public Utility Foundation for Promotion of Medical Sciences; AIBAWORKS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by 1. HS; Shinshu Public Utility Foundation for Promotion of Medical Sciences; 2. HS; AIBAWORKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; ALGARTE M, 1995, EMBO J, V14, P5060, DOI 10.1002/j.1460-2075.1995.tb00188.x; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kunisawa J, 2007, IMMUNOL REV, V215, P136, DOI 10.1111/j.1600-065X.2006.00475.x; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Shui JW, 2012, NATURE, V488, P222, DOI 10.1038/nature11242; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tsuchiya T, 2003, J IMMUNOL, V171, P5507, DOI 10.4049/jimmunol.171.10.5507; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yu SH, 2008, P NATL ACAD SCI USA, V105, P20834, DOI 10.1073/pnas.0808700106	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128761	10.1371/journal.pone.0128761	http://dx.doi.org/10.1371/journal.pone.0128761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132627	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000019
J	Sapiezynski, P; Stopczynski, A; Gatej, R; Lehmann, S				Sapiezynski, Piotr; Stopczynski, Arkadiusz; Gatej, Radu; Lehmann, Sune			Tracking Human Mobility Using WiFi Signals	PLOS ONE			English	Article							SYSTEM	We study six months of human mobility data, including WiFi and GPS traces recorded with high temporal resolution, and find that time series of WiFi scans contain a strong latent location signal. In fact, due to inherent stability and low entropy of human mobility, it is possible to assign location to WiFi access points based on a very small number of GPS samples and then use these access points as location beacons. Using just one GPS observation per day per person allows us to estimate the location of, and subsequently use, WiFi access points to account for 80% of mobility across a population. These results reveal a great opportunity for using ubiquitous WiFi routers for high-resolution outdoor positioning, but also significant privacy implications of such side-channel location tracking.	[Sapiezynski, Piotr; Stopczynski, Arkadiusz; Lehmann, Sune] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Stopczynski, Arkadiusz] MIT, Media Lab, Cambridge, MA 02139 USA; [Gatej, Radu] Univ Copenhagen, Dept Econ, Copenhagen, Denmark; [Lehmann, Sune] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	Technical University of Denmark; Massachusetts Institute of Technology (MIT); University of Copenhagen; University of Copenhagen; Niels Bohr Institute	Sapiezynski, P (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	pisa@dtu.dk		Lehmann, Sune/0000-0001-6099-2345	Villum Foundation; Young Investigator programme; High Resolution Networks; University of Copenhagen through the Social Fabric grant [UCPH2016]; Villum Fonden [00007192] Funding Source: researchfish	Villum Foundation(Villum Fonden); Young Investigator programme; High Resolution Networks; University of Copenhagen through the Social Fabric grant; Villum Fonden(Villum Fonden)	This work was supported by Villum Foundation, http://villumfoundation.dk/C12576AB0041F11B/0/4F7615B6F43A8EA5C1257AEF003D9930? OpenDocument, Young Investigator programme 2012, High Resolution Networks (SL) and University of Copenhagen, http://dsin.ku.dk/news/ucph_funds/, through the UCPH2016 Social Fabric grant (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achara J P, 2014, P 2014 ACM C SEC PRI, P231, DOI 10.1145/2627393.2627399; [Anonymous], 2014, SMARTPHONE OS MARKET; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferris B., 2006, P ROB SCI SYST AUG, P1; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Kawaguchi N, 2009, LECT NOTES COMPUT SC, V5518, P638, DOI 10.1007/978-3-642-02481-8_94; Kitamura R, 2000, TRANSPORTATION, V27, P25, DOI 10.1023/A:1005259324588; Krumme C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01645; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02983; Lim CH, 2007, IEEE T CONSUM ELECTR, V53, P618, DOI 10.1109/TCE.2007.381737; Rekimoto J, 2007, LECT NOTES COMPUT SC, V4718, P35, DOI 10.1007/978-3-540-75160-1_3; Staiano J, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P583, DOI 10.1145/2632048.2632074; Strandburg KJ, 2014, PRIVACY, BIG DATA, AND THE PUBLIC GOOD: FRAMEWORKS FOR ENGAGEMENT, P5; Sun LJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05099	23	70	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130824	10.1371/journal.pone.0130824	http://dx.doi.org/10.1371/journal.pone.0130824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132115	gold, Green Submitted, Green Published			2022-12-26	WOS:000358153000083
J	Song, K; Herzog, BH; Fu, JX; Sheng, MJ; Bergstrom, K; McDaniel, JM; Kondo, Y; McGee, S; Cai, XF; Li, P; Chen, H; Xia, LJ				Song, Kai; Herzog, Brett H.; Fu, Jianxin; Sheng, Minjia; Bergstrom, Kirk; McDaniel, J. Michael; Kondo, Yuji; McGee, Samuel; Cai, Xiaofeng; Li, Ping; Chen, Hong; Xia, Lijun			Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY TUMORIGENESIS; MUCINS; GLYCOSYLATION; EXPRESSION; ANTIGENS; MUC1; INDUCTION; PROGNOSIS; ONCOGENE; SURVIVAL	Mucin-type core 1-derived O-glycans, one of the major types of O-glycans, are highly expressed in mammary gland epithelium. Abnormal O-glycans such as Tn antigen are found in over 90% of breast cancers; however, the in vivo role of these aberrant O-glycans in the etiology of breast cancer is unclear. We generated mice with mammary epithelial specific deletion of core 1-derived O-glycans. By crossing with two spontaneous mouse breast cancer models, we determined that loss of core 1-derived O-glycans delays the onset and progression of breast cancer development. Deficiency of core 1 O-glycosylation impaired the localization of Muc1, a major O-glycoprotein, on the apical surfaces of mammary epithelium. Signaling mediated by Muc1, which is critical for breast cancer development, was also defective in the absence of core 1 O-glycans. This study reveals an unexpected role of core 1-derived O-glycans in breast cancer development in mice.	[Song, Kai; Herzog, Brett H.; Fu, Jianxin; Sheng, Minjia; Bergstrom, Kirk; McDaniel, J. Michael; Kondo, Yuji; McGee, Samuel; Cai, Xiaofeng; Chen, Hong; Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Herzog, Brett H.; Chen, Hong; Xia, Lijun] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Fu, Jianxin; Xia, Lijun] Soochow Univ, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis,Minist Hlth, Jiangsu Inst Hematol,Collaborat Innovat Ctr Hemat, Suzhou 215006, Peoples R China; [Sheng, Minjia] Jilin Univ, China Japan Union Hosp, Changchun 130033, Peoples R China; [Li, Ping] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Soochow University - China; Jilin University; China Pharmaceutical University	Chen, H (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	hong-chen@omrf.org; lijun-xia@omrf.org	Regan, Clinton/E-6250-2012; Cai, Xiaofeng/ABI-4780-2020; Bergstrom, Kirk/AAZ-8856-2021	Cai, Xiaofeng/0000-0002-0646-5218	National Institutes of Health [GM103441, HL085607, HL093242, HL118676]; Department of Defense [W81XWH-11-1-0226]; Oklahoma Center for the Advancement of Science and Technology [HR13-160, HR13-020]; National Natural Science Foundation of China [81470825, 31400692]; Jiangsu Provincial Special Program of Medical Science [BL2012005]; Jiangsu Province's Key Medical Center [ZX201102]; Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMKF201401]; American Heart Association [SDG7410022, SDG0835544N, 15EIA22210014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118676, R01HL093242, P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Oklahoma Center for the Advancement of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Jiangsu Province's Key Medical Center; Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM103441, HL085607, HL093242, HL118676), Department of Defense (W81XWH-11-1-0226), Oklahoma Center for the Advancement of Science and Technology (HR13-160, HR13-020), National Natural Science Foundation of China (81470825, 31400692), Jiangsu Provincial Special Program of Medical Science (BL2012005), Jiangsu Province's Key Medical Center (ZX201102), Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (SKLNMKF201401), and American Heart Association (SDG7410022, SDG0835544N, 15EIA22210014). The authors declare that they have no conflicts of interest with the contents of this article.	Al Masri A, 2005, ONCOGENE, V24, P5799, DOI 10.1038/sj.onc.1208738; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Cao R, 2012, J PROTEOME RES, V11, P4013, DOI 10.1021/pr300058z; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chou CH, 2015, ONCOTARGET, V6, P6123, DOI 10.18632/oncotarget.3045; Denkert C, 2013, J CLIN ONCOL, V31, P836, DOI 10.1200/JCO.2012.47.1698; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gouyer V, 2001, FRONT BIOSCI, V6, pD1235, DOI 10.2741/gouyer; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Loi S, 2014, J CLIN ONCOL, V32, P2935, DOI 10.1200/JCO.2014.56.7677; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Milde-Langosch K, 2015, BREAST CANCER RES TR, V151, P515, DOI 10.1007/s10549-015-3425-0; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SPRINGER GF, 1979, J SURG ONCOL, V11, P95, DOI 10.1002/jso.2930110204; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144	29	24	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20159	20166		10.1074/jbc.M115.654483	http://dx.doi.org/10.1074/jbc.M115.654483			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124270	hybrid, Green Published			2022-12-26	WOS:000359608900018
J	Apenteng, OO; Ismail, NA				Apenteng, Ofosuhene O.; Ismail, Noor Azina			A Markov Chain Monte Carlo Approach to Estimate AIDS after HIV Infection	PLOS ONE			English	Article							MODEL; TRANSMISSION; EPIDEMIC; DISEASE; SPREAD	The spread of human immunodeficiency virus (HIV) infection and the resulting acquired immune deficiency syndrome (AIDS) is a major health concern in many parts of the world, and mathematical models are commonly applied to understand the spread of the HIV epidemic. To understand the spread of HIV and AIDS cases and their parameters in a given population, it is necessary to develop a theoretical framework that takes into account realistic factors. The current study used this framework to assess the interaction between individuals who developed AIDS after HIV infection and individuals who did not develop AIDS after HIV infection (pre-AIDS). We first investigated how probabilistic parameters affect the model in terms of the HIV and AIDS population over a period of time. We observed that there is a critical threshold parameter, R-0, which determines the behavior of the model. If R-0 <= 1, there is a unique disease-free equilibrium; if R-0 < 1, the disease dies out; and if R-0 > 1, the disease-free equilibrium is unstable. We also show how a Markov chain Monte Carlo (MCMC) approach could be used as a supplement to forecast the numbers of reported HIV and AIDS cases. An approach using a Monte Carlo analysis is illustrated to understand the impact of model-based predictions in light of uncertain parameters on the spread of HIV. Finally, to examine this framework and demonstrate how it works, a case study was performed of reported HIV and AIDS cases from an annual data set in Malaysia, and then we compared how these approaches complement each other. We conclude that HIV disease in Malaysia shows epidemic behavior, especially in the context of understanding and predicting emerging cases of HIV and AIDS.	[Apenteng, Ofosuhene O.; Ismail, Noor Azina] Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia	Universiti Malaya	Ismail, NA (corresponding author), Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia.	nazina@um.edu.my	ISMAIL, NOOR AZINA/B-5341-2010	ISMAIL, NOOR AZINA/0000-0001-8032-2162; Apenteng, Ofosuhene O./0000-0001-9991-1709	University Malaya Research Grant, Demographic Network Modeling of The Spread of Infectious Diseases, under Social Network Dynamics Program, Equitable Society Research Cluster, University of Malaya [RP004J-13ICT]	University Malaya Research Grant, Demographic Network Modeling of The Spread of Infectious Diseases, under Social Network Dynamics Program, Equitable Society Research Cluster, University of Malaya	This work was supported by the University Malaya Research Grant, RP004J-13ICT: Demographic Network Modeling of The Spread of Infectious Diseases, under the Social Network Dynamics Program, Equitable Society Research Cluster, University of Malaya.	2012, 2012, MAL 2012 GLOB AIDS R; [Anonymous], 2013, TEXTS STAT SCI SERIE; Apenteng OO, 2009, DEMOGRAPHIC MODELLIN; Brun R, 2001, WATER RESOUR RES, V37, P1015, DOI 10.1029/2000WR900350; de Arazoza H, 2002, IMA J MATH APPL MED, V19, P221; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hyman JM, 1989, MATH COMPUT MODEL, V12, P1180; Jones James Holland, 2007, NOTES R0; Kakehashi M, 1999, IMA J MATH APPL MED, V16, P111; Kim J-H, 2009, DYNAMIC PARTNERSHIPS; Laine M., 2008, ADAPTIVE MCMC METHOD; Merli MG, 2006, POP STUD-J DEMOG, V60, P1, DOI 10.1080/00324720500436060; Naresh R, 2006, APPL MATH COMPUT, V178, P262, DOI 10.1016/j.amc.2005.11.041; Nyabadza F, 2011, NONLINEAR ANAL-REAL, V12, P2091, DOI 10.1016/j.nonrwa.2010.12.024; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; ROMIEU I, 1991, HUM BIOL, V63, P683; Silva CJ, 2013, MATH BIOSCI, V244, P154, DOI 10.1016/j.mbs.2013.05.005; Slimi R, 2009, APPL MATH MODEL, V33, P1072, DOI 10.1016/j.apm.2007.12.028; Soetaert K, 2009, A PRACTICAL GUIDE TO; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; World Health Organization, 2014, GLOB SUMM HIV AIDS E	23	3	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131950	10.1371/journal.pone.0131950	http://dx.doi.org/10.1371/journal.pone.0131950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147199	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600170
J	Gul, T; Islam, S; Shah, RA; Khalid, A; Khan, I; Shafie, S				Gul, Taza; Islam, Saeed; Shah, Rehan Ali; Khalid, Asma; Khan, Ilyas; Shafie, Sharidan			Unsteady MHD Thin Film Flow of an Oldroyd-B Fluid over an Oscillating Inclined Belt	PLOS ONE			English	Article							HOMOTOPY PERTURBATION METHOD; ASYMPTOTIC METHOD; NONLINEAR OSCILLATORS; STARTING SOLUTIONS; MOTIONS	This paper studies the unsteady magnetohydrodynamics (MHD) thin film flow of an incompressible Oldroyd-B fluid over an oscillating inclined belt making a certain angle with the horizontal. The problem is modeled in terms of non-linear partial differential equations with some physical initial and boundary conditions. This problem is solved for the exact analytic solutions using two efficient techniques namely the Optimal Homotopy Asymptotic Method (OHAM) and Homotopy Perturbation Method (HPM). Both of these solutions are presented graphically and compared. This comparison is also shown in tabular form. An excellent agreement is observed. The effects of various physical parameters on velocity have also been studied graphically.	[Gul, Taza; Islam, Saeed] Abdul Wali Khan Univ, Dept Math, Mardan, Kpk, Pakistan; [Shah, Rehan Ali] Univ Engn Technol, Dept Math, Peshawar, Kpk, Pakistan; [Khan, Ilyas] Majmaah Univ, Coll Engn, Dept Basic Sci, Majmaah 11952, Saudi Arabia; [Khalid, Asma; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai Johor 81310, Malaysia	Abdul Wali Khan University; University of Engineering & Technology Peshawar; Majmaah University; Universiti Teknologi Malaysia	Gul, T (corresponding author), Abdul Wali Khan Univ, Dept Math, Mardan, Kpk, Pakistan.	sharidan@utm.my	Khan, Ilyas/C-8770-2019; Gul, Taza/R-7774-2019; Saeed, Islam/AAD-6067-2020	Khan, Ilyas/0000-0002-2056-9371; Gul, Taza/0000-0003-1376-8345; Saeed, Islam/0000-0001-5263-4871				Aksel N, 2006, Z ANGEW MATH PHYS, V57, P815, DOI 10.1007/s00033-006-0063-8; Anakira N. R., 2013, MATH PROBL ENG, V2013, P1; Anjum A, 2012, COMMUN NONLINEAR SCI, V17, P472, DOI 10.1016/j.cnsns.2011.05.004; Burdujan L, 2011, SERIES MATH ITS APPL, V3, P23; Fetecau C, 2007, APPL MATH MODEL, V31, P647, DOI 10.1016/j.apm.2005.11.032; Fetecau C, 2008, J NON-NEWTON FLUID, V153, P191, DOI 10.1016/j.jnnfm.2008.02.005; Ganji D.D., 2009, INT J NONLINEAR SCI, V7, P399; Ghosh AK, 2009, COMPUT APPL MATH, V28, P365, DOI 10.1590/S1807-03022009000300006; Ghosh AK, 2009, ACTA ASTRONAUT, V64, P272, DOI 10.1016/j.actaastro.2008.07.016; Ghosh AK, 2004, OPEN J FLUID DYNAMIC, V4, P226; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097552; Gul T, 2013, J APPL MATH, DOI 10.1155/2013/707286; Hayat T, 2001, INT J ENG SCI, V39, P135, DOI 10.1016/S0020-7225(00)00026-4; He JH, 2006, PHYS LETT A, V350, P87, DOI 10.1016/j.physleta.2005.10.005; He JH, 2005, CHAOS SOLITON FRACT, V26, P827, DOI 10.1016/j.chaos.2005.03.007; He JH, 2004, APPL MATH COMPUT, V151, P287, DOI 10.1016/S0096-3003(03)00341-2; He JH, 2005, CHAOS SOLITON FRACT, V26, P695, DOI 10.1016/j.chaos.2005.03.006; He JH, 2009, COMPUT MATH APPL, V57, P410, DOI 10.1016/j.camwa.2008.06.003; Ilyas K., 2011, INT J MATH MATH SCI, V2011, P408132, DOI [10.1155/2011/408132, DOI 10.1155/2011/408132]; Jamshad S., 2014, J APPL ENVIRON BIOL, V4, P41; Kashkari B.S., 2014, APPL MATH SCI, V8, P875, DOI [10.12988/ams.2014.312706, DOI 10.12988/AMS.2014.312706]; Khan I, 2012, SPEC TOP REV POROUS, V3, P89, DOI 10.1615/SpecialTopicsRevPorousMedia.v3.i1.80; Khan M, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/8/084701; Lie L, 2012, ADV MAT RES, V335, P83; Mabood F, 2014, COMPUT FLUIDS, V100, P72, DOI 10.1016/j.compfluid.2014.05.009; Mabood F, 2013, SAINS MALAYS, V42, P863; Marinca V.., 2013, SCI RES ESSAYS, V8, P161, DOI DOI 10.5897/SRE11.1630; Marinca V, 2008, CENT EUR J PHYS, V6, P648, DOI [10.2478/s11534-008-0061-x, 10.2478/S11534-008-0061-x]; Marinca V, 2014, ADV MATH PHYS, V2014, DOI 10.1155/2014/417643; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; Nofel TA, 2014, APPL MATH, V5, P852; Qi HT, 2009, APPL MATH MODEL, V33, P4184, DOI 10.1016/j.apm.2009.03.002; Shah RA., 2011, INT J ADV RES COMPUT, V3, P1; Shahid N, 2012, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2012-48; Siddiqui AM, 2008, CHAOS SOLITON FRACT, V35, P140, DOI 10.1016/j.chaos.2006.05.026	36	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0126698	10.1371/journal.pone.0126698	http://dx.doi.org/10.1371/journal.pone.0126698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147287	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600009
J	Khan, A; Prince, M; Brayne, C; Prina, AM				Khan, A.; Prince, M.; Brayne, C.; Prina, A. M.			Lifetime Prevalence and Factors Associated with Head Injury among Older People in Low and Middle Income Countries: A 10/66 Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RISK-FACTORS; FOLLOW-UP; DEMENTIA; POPULATION; ADULTS; EPIDEMIOLOGY; DISABILITY	Introduction Traumatic brain injury (TBI) is a growing public health problem around the world, yet there is little information on the prevalence of head injury in low and middle income countries (LMICs). We utilised data collected by the 10/66 research group to investigate the lifetime prevalence of head injury in defined sites in low and middle income countries, its risk factors and its relationship with disability. Methods We analysed data from one-phase cross-sectional surveys of all residents aged 65 years and older (n = 16430) distributed across twelve sites in eight low and middle income countries (China, Cuba, Dominican Republic, India, Venezuela, Mexico, Peru, and Puerto Rico). Self-reported cases of head injury with loss of consciousness were identified during the interview. A sensitivity analysis including data provided by informants of people with dementia was also used to estimate the impact of this information on the estimates. Prevalence ratios (PR) from Poisson regressions were used to identify associated risk factors. Results The standardised lifetime prevalence of TBI ranged from 0.3% in China to 14.6% in rural Mexico and Venezuela. Being male (PR: 1.6, 95% CI: 1.29-1.82), younger (PR: 0.95, 95% CI: 0.92-0.99), with lower education (PR 0.91, 95% CI: 0.86-0.96), and having fewer assets (PR 0.92, 95% CI: 0.88-0.96), was associated with a higher prevalence of TBI when pooling estimates across sites. Discussion Our analysis revealed that the prevalence of TBI in LMICs is similar to that of developed nations. Considering the growing impact of TBI on health resources in these countries, there is an urgent need for further research.	[Khan, A.; Brayne, C.; Prina, A. M.] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England; [Prince, M.; Prina, A. M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, Hlth Serv & Populat Res Dept, London SE5 8AF, England	University of Cambridge; University of London; King's College London	Prina, AM (corresponding author), Univ Cambridge, Inst Publ Hlth, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.	matthew.prina@kcl.ac.uk	Prina, Matthew/B-4188-2013; Brayne, Carol/AAA-4285-2020; Prince, Martin J/A-9170-2010	Prina, Matthew/0000-0001-6698-3263; Brayne, Carol/0000-0001-5307-663X; Prince, Martin J/0000-0003-1379-7146	Wellcome Trust (UK) [GR066133]; World Health Organization; US Alzheimer's Association [IIRG - 04 - 1286]; Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; Medical Research Council [MR/K021907/1]; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; MRC [MR/K021907/1] Funding Source: UKRI	Wellcome Trust (UK)(Wellcome Trust); World Health Organization(World Health Organization); US Alzheimer's Association(Alzheimer's Association); Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela); NIHR Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The 10/66 Dementia Research Group population based surveys were supported by: the Wellcome Trust (UK) (GR066133); the World Health Organization; the US Alzheimer's Association (IIRG - 04 - 1286); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarrollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). RS is funded by the NIHR Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Matthew Prina is funded by the Medical Research Council (Grant number = MR/K021907/1).	Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hsiao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002621; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kraus J, 1996, EPIDEMIOLOGY OF BRAI; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; Lu TH, 2012, INJURY PREV, V18, P150, DOI 10.1136/injuryprev-2011-040135; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Prina AM, 2011, PSYCHOL MED, V41, P2047, DOI 10.1017/S0033291711000444; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith K, 2010, AUST NZ J PSYCHIAT, V44, P888, DOI 10.3109/00048674.2010.491816; Sousa RM, 2010, INT J METH PSYCH RES, V19, P1, DOI 10.1002/mpr.299; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timmons SD, 2012, J NEUROSURG SCI, V56, P191; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; World Health Organization, 2006, NEUR DIS PUBL HLTH C	43	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132229	10.1371/journal.pone.0132229	http://dx.doi.org/10.1371/journal.pone.0132229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26146992	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600222
J	Pratumvinit, B; Wongkrajang, P; Wataganara, T; Hanyongyuth, S; Nimmannit, A; Chatsiricharoenkul, S; Manonukul, K; Reesukumal, K				Pratumvinit, Busadee; Wongkrajang, Preechaya; Wataganara, Tuangsit; Hanyongyuth, Sithikan; Nimmannit, Akarin; Chatsiricharoenkul, Somruedee; Manonukul, Kotchamol; Reesukumal, Kanit			Maternal Vitamin D Status and Its Related Factors in Pregnant Women in Bangkok, Thailand	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; D LEVEL; SEASONAL-VARIATION; D SUPPLEMENTATION; D INSUFFICIENCY; EARLY-CHILDHOOD; AIR-POLLUTION; PRETERM BIRTH; RISK	Background There are few data focusing on the prevalence of vitamin D deficiency in tropical countries. Objectives We determined the vitamin D status in pregnant women and examined the factors associated with vitamin D deficiency. Design and Methods A cross-sectional study of 147 pregnant Thai women aged 18-45 years at Siriraj Hospital (a university hospital in Bangkok, Thailand) was undertaken. Clinical data and plasma levels of 25-hydroxyvitamin D [25(OH) D], intact parathyroid hormone (iPTH), calcium, albumin, phosphate and magnesium were obtained in pregnant women at delivery. Results The prevalence of hypovitaminosis D [defined as 25(OH) D < 75 nmol/L] in pregnant women at delivery was 75.5%(95% confidence interval (CI), 67.7-82.2%). Of these, vitamin D insufficiency [defined as 25(OH) D 50-74.9 nmol/L] was found in 41.5%(95% CI, 33.4-49.9%) and vitamin D deficiency [25(OH) D < 50 nmol/L] was found in 34.0% (95% CI, 26.4-42.3%) of women. The mean 25(OH) D concentration was 61.6 +/- 19.3 nmol/L. The correlation between 25(OH) D and iPTH was weak (r = -0.29, P<0.01). Factors associated with vitamin D deficiency by multiple logistic regression were: pre-pregnancy body mass index (BMI in kg/m(2), odds ratio (OR), 0.88, 95% CI 0.80-0.97, P = 0.01) and season of blood collection (winter vs. rainy, OR, 2.62, 95% CI 1.18-5.85, P = 0.02). Conclusions Vitamin D deficiency is common among pregnant Thai women. The prevalence of vitamin D deficiency increased in women who had a lower pre-pregnancy BMI and whose blood was collected in the winter. Vitamin D supplementation may need to be implemented as routine antenatal care.	[Pratumvinit, Busadee; Wongkrajang, Preechaya; Hanyongyuth, Sithikan; Manonukul, Kotchamol; Reesukumal, Kanit] Mahidol Univ, Siriraj Hosp, Dept Clin Pathol, Fac Med, Bangkok 10700, Thailand; [Wataganara, Tuangsit] Mahidol Univ, Div Maternal Fetal Med, Dept Obstet & Gynecol, Fac Med,Siriraj Hosp, Bangkok 10700, Thailand; [Nimmannit, Akarin] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, Bangkok 10700, Thailand; [Chatsiricharoenkul, Somruedee] Mahidol Univ, Dept Pharmacol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Reesukumal, K (corresponding author), Mahidol Univ, Siriraj Hosp, Dept Clin Pathol, Fac Med, Bangkok 10700, Thailand.	kanit.ree@mahidol.ac.th	Wataganara, Tuangsit/H-9956-2019	Wataganara, Tuangsit/0000-0001-7172-053X; Pratumvinit, Busadee/0000-0002-5220-0552	Siriraj Research Development Fund [R015432041]; Faculty of Medicine, Siriraj Hospital, Mahidol University	Siriraj Research Development Fund; Faculty of Medicine, Siriraj Hospital, Mahidol University	This study was supported by the Siriraj Research Development Fund (R015432041). BP, PW, TW, SC, AN, and KR each received Chalermprakiart grants from the Faculty of Medicine, Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi P, 2014, MATERN CHILD NUTR, V10, P206, DOI 10.1111/mcn.12058; Achkar M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.009; Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Al Emadi Samar, 2013, Qatar Med J, V2013, P32, DOI 10.5339/qmj.2013.7; [Anonymous], 2012, PEDIATRICS, DOI [DOI 10.1542/peds.2011-3289, 10.1542/peds.2011-3289]; Aronsson CA, 2013, PUBLIC HEALTH NUTR, V16, P1390, DOI 10.1017/S1368980013000293; Bartoszewicz Z, 2013, GINEKOL POL, V84, P363; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bodnar LM, 2007, J NUTR, V137, P2437, DOI 10.1093/jn/137.11.2437; Bodnar LM, 2015, OBSTET GYNECOL, V125, P439, DOI 10.1097/AOG.0000000000000621; Bodnar LM, 2014, EPIDEMIOLOGY, V25, P207, DOI 10.1097/EDE.0000000000000039; Bodnar LM, 2014, AM J EPIDEMIOL, V179, P168, DOI 10.1093/aje/kwt237; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Bowyer L, 2009, CLIN ENDOCRINOL, V70, P372, DOI 10.1111/j.1365-2265.2008.03316.x; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; Chaipraditkul N., 2013, ETHICS SCI ENV POLIT, V13, P27, DOI DOI 10.3354/ESEP00134; Charatcharoenwitthaya N, 2013, CLIN ENDOCRINOL, V78, P126, DOI 10.1111/j.1365-2265.2012.04470.x; Cho GJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.015; Dovnik A, 2014, EUR J OBSTET GYN R B, V181, P6, DOI 10.1016/j.ejogrb.2014.07.019; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; El Rifai NM, 2014, J MATERN-FETAL NEO M, V27, P1064, DOI 10.3109/14767058.2013.849240; Farrant HJW, 2009, EUR J CLIN NUTR, V63, P646, DOI 10.1038/ejcn.2008.14; Gernand AD, 2014, OBSTET GYNECOL, V123, P40, DOI 10.1097/AOG.0000000000000049; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Grant WB, 2008, SOLAR RAD HUMAN HLTH, P167; Gur EB, 2014, J TURK-GER GYNECOL A, V15, P149, DOI 10.5152/jtgga.2014.13048; Gur EB, 2014, EUR J OBSTET GYN R B, V179, P110, DOI 10.1016/j.ejogrb.2014.05.017; Hanieh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099005; Hanna Bassam, 2009, Oman Med J, V24, P188, DOI 10.5001/omj.2009.37; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Holick MF, 1995, AM J CLIN NUTR S, V61, p638S, DOI DOI 10.1093/ajcn/61.3.638S; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hosseinpanah F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-519; Jani Rati, 2014, Biomed Res Int, V2014, P892162, DOI 10.1155/2014/892162; Janjai S, 2010, INT J CLIMATOL, V30, P1893, DOI 10.1002/joc.2006; Karlsson T, 2015, CLIN NUTR, V34, P892, DOI 10.1016/j.clnu.2014.09.012; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Lechtermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105558; Lehotay DC, 2013, CLIN BIOCHEM, V46, P1489, DOI 10.1016/j.clinbiochem.2013.05.051; Liu XM, 2011, ARCH GYNECOL OBSTET, V283, P65, DOI 10.1007/s00404-009-1288-5; Lund CC., SURG GYNECOL OBSTET, V79, P352; Luque-Fernandez MA, 2014, PAEDIATR PERINAT EP, V28, P166, DOI 10.1111/ppe.12103; Luxwolda MF, 2013, EUR J NUTR, V52, P1115, DOI 10.1007/s00394-012-0421-6; Magnus MC, 2013, PAEDIATR PERINAT EP, V27, P532, DOI 10.1111/ppe.12080; Manicourt DH, 2008, J CLIN ENDOCR METAB, V93, P3893, DOI 10.1210/jc.2007-2663; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mirzaei F, 2011, ANN NEUROL, V70, P30, DOI 10.1002/ana.22456; Mohamed HJJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100705; Molina PE, 2013, ENDOCRINE PHYSL; Napartivaumnuay Navaporn, 2013, Journal of the Medical Association of Thailand, V96, pS69; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Nimitphong H, 2009, ENDOCRINE, V36, P205, DOI 10.1007/s12020-009-9216-9; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Robinson M, 2014, ARCH WOMEN MENT HLTH, V17, P213, DOI 10.1007/s00737-014-0422-y; Rojroongwasinkul N, 2013, BRIT J NUTR, V110, pS36, DOI 10.1017/S0007114513002110; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Seamans KM, 2009, AM J CLIN NUTR, V89, p1997S, DOI 10.3945/ajcn.2009.27230D; Shin Youn Ho, 2013, Korean J Pediatr, V56, P439, DOI 10.3345/kjp.2013.56.10.439; Song SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085081; Stelmach I, 2015, RESP MED, V109, P38, DOI 10.1016/j.rmed.2014.10.016; Tomedi LE, 2013, DIABETIC MED, V30, P1033, DOI 10.1111/dme.12229; van den Berg G, 2013, EUR J NUTR, V52, P273, DOI 10.1007/s00394-012-0327-3; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; Voorhees A. Scotr, 2008, Journal of Environmental Assessment Policy and Management, V10, P265, DOI 10.1142/S1464333208003093; Vu TTH, 2012, MATERN CHILD NUTR, V8, P533, DOI 10.1111/j.1740-8709.2011.00327.x; Wagner CL, 2015, J STEROID BIOCHEM, V148, P256, DOI 10.1016/j.jsbmb.2014.11.013; Watcharavitoon P, 2013, AEROSOL AIR QUAL RES, V13, P1741, DOI 10.4209/aaqr.2012.11.0305; Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x; Wei SQ, 2014, CURR OPIN OBSTET GYN, V26, P438, DOI 10.1097/GCO.0000000000000117; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; Weinert LS, 2015, MATERN CHILD HLTH J, V19, P94, DOI 10.1007/s10995-014-1499-7; Willix C, 2015, AUST FAM PHYSICIAN, V44, P141; Xiao JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117748; Zhou J, 2014, EUR J CLIN NUTR, V68, P925, DOI 10.1038/ejcn.2014.99; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	81	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131126	10.1371/journal.pone.0131126	http://dx.doi.org/10.1371/journal.pone.0131126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147381	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600064
J	Couleau, N; Falla, J; Beillerot, A; Battaglia, E; D'Innocenzo, M; Plancon, S; Laval-Gilly, P; Bennasroune, A				Couleau, N.; Falla, J.; Beillerot, A.; Battaglia, E.; D'Innocenzo, M.; Plancon, S.; Laval-Gilly, P.; Bennasroune, A.			Effects of Endocrine Disruptor Compounds, Alone or in Combination, on Human Macrophage-Like THP-1 Cell Response	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BISPHENOL-A; IN-VITRO; IMMUNE-RESPONSE; BLOOD-SERUM; CHEMICALS; DIFFERENTIATION; MIXTURES; EXPOSURE; 4-NONYLPHENOL	The aim of the present study was to evaluate the immunological effects on human macrophages of four endocrine disruptor compounds (EDCs) using the differentiated human THP-1 cell line as a model. We studied first the effects of these EDCs, including Bisphenol A (BPA), di-ethylhexyl-phthalate (DEHP), dibutyl phthalate (DBP) and 4-tert-octylphenol (4-OP), either alone or in combination, on cytokine secretion, and phagocytosis. We then determined whether or not these effects were mediated by estrogen receptors via MAPK pathways. It was found that all four EDCs studied reduced strongly the phagocytosis of the differentiated THP-1 cells and that several of these EDCs disturbed also TNF-alpha, IL-1 beta and IL-8 cytokine secretions. Furthermore, relative to control treatment, decreased ERK 1/2 phosphorylation was always associated with EDCs treatments-either alone or in certain combinations (at 0.1 mu M for each condition). Lastly, as treatments by an estrogen receptor antagonist suppressed the negative effects on ERK 1/2 phosphorylation observed in cells treated either alone with BPA, DEHP, 4-OP or with the combined treatment of BPA and DEHP, we suggested that estrogen receptor-dependent pathway is involved in mediating the effects of EDCs on human immune system. Altogether, these results advocate that EDCs can disturb human immune response at very low concentrations.	[Couleau, N.; Falla, J.; Laval-Gilly, P.; Bennasroune, A.] Univ Lorraine, CNRS, IUT Thionville Yutz, LIEC,Espace Cormontaigne,UMR 7360, Yutz, France; [Beillerot, A.; D'Innocenzo, M.] IUT Thionville Yutz, Impasse Alfred Kastler Espace Cormontaigne, Yutz, France; [Battaglia, E.] Univ Lorraine, CNRS, LIEC, UMR 7360, Metz, France; [Plancon, S.] Univ Luxembourg, Calcium Signaling & Inflammat Grp, Life Sci Res Unit, Luxembourg, Luxembourg	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of Luxembourg	Bennasroune, A (corresponding author), Univ Lorraine, CNRS, IUT Thionville Yutz, LIEC,Espace Cormontaigne,UMR 7360, Yutz, France.	amar.bennasroune@univ-lorraine.fr	LAVAL-GILLY, Philippe/J-8118-2013; laval-gilly, philippe/AAF-1997-2019	LAVAL-GILLY, Philippe/0000-0003-3162-3043; laval-gilly, philippe/0000-0003-3162-3043				ABRINK M, 1994, LEUKEMIA, V8, P1579; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Asimakopoulos AG, 2012, TOXICOL LETT, V210, P141, DOI 10.1016/j.toxlet.2011.07.032; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Ballesteros-Gomez A, 2009, J CHROMATOGR A, V1216, P449, DOI 10.1016/j.chroma.2008.06.037; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P725, DOI 10.1016/S0145-305X(01)00033-7; Benachour N, 2007, TOXICOL APPL PHARM, V222, P129, DOI 10.1016/j.taap.2007.03.033; Bennasroune A, 2012, INT J IMMUNOPATH PH, V25, P365, DOI 10.1177/039463201202500206; Byun JA, 2005, ENVIRON TOXICOL PHAR, V19, P19, DOI 10.1016/j.etap.2004.02.006; Cabas I, 2012, DEV COMP IMMUNOL, V36, P547, DOI 10.1016/j.dci.2011.09.011; Canesi L, 2007, AQUAT TOXICOL, V81, P36, DOI 10.1016/j.aquatox.2006.10.010; Charles GD, 2002, TOXICOL APPL PHARM, V180, P11, DOI 10.1006/taap.2001.9346; Chen X, 2013, FOOD CHEM TOXICOL, V59, P325, DOI 10.1016/j.fct.2013.06.016; Chen XJ, 2013, TOXICOL IN VITRO, V27, P2249, DOI 10.1016/j.tiv.2013.09.018; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DINARELLO CA, 1991, BLOOD, V77, P1627; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Fenichel P, 2013, ANN ENDOCRINOL-PARIS, V74, P211, DOI 10.1016/j.ando.2013.04.002; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231; Genuis SJ, 2012, SCI WORLD J, DOI 10.1100/2012/615068; Glue C, 2002, TOXICOL IN VITRO, V16, P657, DOI 10.1016/S0887-2333(02)00082-6; Goulaouic S, 2008, J IMMUNOTOXICOL, V5, P337, DOI 10.1080/15476910802371016; Grodzki ACG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054926; Guo ZY, 2010, BIOMED CHROMATOGR, V24, P1094, DOI 10.1002/bmc.1410; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hao CJ, 2012, TOXICOL APPL PHARM, V263, P102, DOI 10.1016/j.taap.2012.06.003; Hiller-Sturmhofel S, 1998, ALCOHOL HEALTH RES W, V22, P153; Hung CH, 2010, ENVIRON HEALTH PERSP, V118, P67, DOI 10.1289/ehp.0901011; Inoue K, 2010, FREE RADICAL BIO MED, V48, P924, DOI 10.1016/j.freeradbiomed.2010.01.013; Kaufman RH, 2000, OBSTET GYNECOL, V96, P483, DOI 10.1016/S0029-7844(00)00959-5; Kim SK, 2006, TOXICOL SCI, V94, P310, DOI 10.1093/toxsci/kfl114; Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Kortenkamp A, 2011, STATE ART ASSESSMENT; Kosarac I, 2012, J CHROMATOGR B, V898, P90, DOI 10.1016/j.jchromb.2012.04.023; Kruger T, 2008, TOXICOLOGY, V246, P112, DOI 10.1016/j.tox.2007.12.028; Kuan YH, 2012, INT ENDOD J, V45, P619, DOI 10.1111/j.1365-2591.2012.02017.x; Kuroda N, 2003, J PHARMACEUT BIOMED, V30, P1743, DOI 10.1016/S0731-7085(02)00516-2; Leyva-Illades D, 2010, INFECT IMMUN, V78, P2454, DOI 10.1128/IAI.01341-09; Li DM, 2010, REPROD TOXICOL, V30, P438, DOI 10.1016/j.reprotox.2010.06.003; Ma L, 2009, TRENDS ENDOCRIN MET, V20, P357, DOI 10.1016/j.tem.2009.03.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Muller AK, 2003, HUMAN EXPOSURE SELEC; Ohnishi T, 2008, FEMS IMMUNOL MED MIC, V52, P293, DOI 10.1111/j.1574-695X.2007.00355.x; Phelan PE, 2005, J VIROL, V79, P1842, DOI 10.1128/JVI.79.3.1842-1852.2005; Rajapakse N, 2004, ENVIRON SCI TECHNOL, V38, P6343, DOI 10.1021/es049681e; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038448; Saint-Laurent L, 2004, PHTALATES ETAT CONNA; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Singh S, 2012, INT J MOL SCI, V13, P10143, DOI 10.3390/ijms130810143; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Valkusz Z, 2011, PHYSIOL BEHAV, V103, P421, DOI 10.1016/j.physbeh.2011.03.016; Van Miller JP, 2005, HUM ECOL RISK ASSESS, V11, P319, DOI 10.1080/10807030590925812; van Wezel AP, 2000, ECOTOX ENVIRON SAFE, V46, P305, DOI 10.1006/eesa.2000.1930; Vazquez-Duhalt R., 2006, Applied Ecology and Environmental Research, V4, P1; Watanabe H, 2003, INT IMMUNOPHARMACOL, V3, P1601, DOI 10.1016/S1567-5769(03)00182-6; Yoshitake J, 2008, NITRIC OXIDE-BIOL CH, V18, P223, DOI 10.1016/j.niox.2008.01.003	65	45	45	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131428	10.1371/journal.pone.0131428	http://dx.doi.org/10.1371/journal.pone.0131428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133781	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400047
J	Gordts, SC; Ferir, G; D'huys, T; Petrova, MI; Lebeer, S; Snoeck, R; Andrei, G; Schols, D				Gordts, Stephanie C.; Ferir, Geoffrey; D'huys, Thomas; Petrova, Mariya I.; Lebeer, Sarah; Snoeck, Robert; Andrei, Graciela; Schols, Dominique			The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX-VIRUS; CARBOHYDRATE-BINDING AGENTS; DC-SIGN; DRUG-RESISTANCE; DENDRITIC CELLS; GENITAL HERPES; IN-VITRO; PRO 2000; T-CELLS	Objectives Lignosulfonic acid (LA), a low-cost lignin-derived polyanionic macromolecule, was extensively studied for its anti-HIV and anti-HSV activity in various cellular assays, its mechanism of viral inhibition and safety profile as potential microbicide. Results LA demonstrated potent inhibitory activity of HIV replication against a wide range of R5 and X4 HIV strains and prevented the uptake of HIV by bystander CD4(+) T cells from persistently infected T cells in vitro (IC50: 0.07 - 0.34 mu M). LA also inhibited HSV-2 replication in vitro in different cell types (IC50: 0.42 - 1.1 mu M) and in rodents in vivo. Furthermore, LA neutralized the HIV-1 and HSV-2 DC-SIGN-mediated viral transfer to CD4(+) T cells (IC50:similar to 1 mu M). In addition, dual HIV-1/HSV-2 infection in T cells was potently blocked by LA (IC50: 0.71 mu M). No antiviral activity was observed against the non-enveloped viruses Coxsackie type B4 and Reovirus type 1. LA is defined as a HIV entry inhibitor since it interfered with gp120 binding to the cell surface of T cells. Pretreatment of PBMCs with LA neither increased expression levels of cellular activation markers (CD69, CD25 and HLA-DR), nor enhanced HIV-1 replication. Furthermore, we found that LA had non-antagonistic effects with acyclovir, PRO2000 or LabyA1 (combination index (CI): 0.46 - 1.03) in its anti-HSV-2 activity and synergized with tenofovir (CI: 0.59) in its anti-HIV-1 activity. To identify mechanisms of LA resistance, we generated in vitro a mutant HIV-1 NL4.3(LAresistant) virus, which acquired seven mutations in the HIV-1 envelope glycoproteins: S160N, V170N, Q280H and R389T in gp120 and K77Q, N113D and H132Y in gp41. Additionally, HIV-1 NL4.3(LAresistant) virus showed cross-resistance with feglymycin, enfuvirtide, PRO2000 and mAb b12, four well-described HIV binding/fusion inhibitors. Importantly, LA did not affect the growth of vaginal Lactobacilli strains. Conclusion Overall, these data highlight LA as a potential and unique low-cost microbicide displaying broad anti-HIV and anti-HSV activity.	[Gordts, Stephanie C.; Ferir, Geoffrey; D'huys, Thomas; Snoeck, Robert; Andrei, Graciela; Schols, Dominique] Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Petrova, Mariya I.; Lebeer, Sarah] Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium; [Petrova, Mariya I.; Lebeer, Sarah] Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium	KU Leuven; KU Leuven; University of Antwerp	Ferir, G (corresponding author), Univ Leuven, Rega Inst Med Res, Leuven, Belgium.	dominique.schols@rega.kuleuven.be	Petrova, Mariya/U-8087-2019; Andrei, Graciela/V-7721-2017; Schols, Dominique/AAC-1309-2021; Schols, Dominique/S-9057-2017; Lebeer, Sarah/S-9951-2019; Lebeer, Sarah/D-5156-2014; Snoeck, Robert/V-3867-2017; D'huys, Thomas/F-5936-2018	Andrei, Graciela/0000-0003-2609-4896; Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; Lebeer, Sarah/0000-0002-9400-6918; Lebeer, Sarah/0000-0002-9400-6918; Snoeck, Robert/0000-0002-7586-5434; D'huys, Thomas/0000-0002-0871-5604	KU Leuven (GOA) [10/014, PF/10/018]; Foundation of Scientific Research (FWO) [G-048508, G-0528-12]; Foundation Dormeur, Vaduz; CHAARM project European Commission [242135]	KU Leuven (GOA)(KU Leuven); Foundation of Scientific Research (FWO)(FWO); Foundation Dormeur, Vaduz; CHAARM project European Commission	This work was supported by the KU Leuven (GOA 10/014 and PF/10/018), the Foundation of Scientific Research (FWO no. G-048508 and G-0528-12), the Foundation Dormeur, Vaduz and the CHAARM project (No. 242135) of the European Commission.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Agarwal HK, 2010, BIOORG MED CHEM LETT, V20, P6993, DOI 10.1016/j.bmcl.2010.09.133; Andrei G, 2013, CURR OPIN INFECT DIS, V26, P551, DOI 10.1097/QCO.0000000000000015; Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; Baeten J, 2013, ANNU REV MED, V64, P219, DOI 10.1146/annurev-med-050911-163701; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Bourne N, 1999, J INFECT DIS, V180, P203, DOI 10.1086/314853; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Derby N, 2011, CURR OPIN HIV AIDS, V6, P379, DOI 10.1097/COH.0b013e3283499d63; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996; Duan R, 2008, J INFECT DIS, V198, P659, DOI 10.1086/590668; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Este JA, 1997, MOL PHARMACOL, V52, P98, DOI 10.1124/mol.52.1.98; Ferir G, 2012, J ANTIVIR ANTIRETROV, V4, P103, DOI DOI 10.4172/JAA.1000054; Ferir G, 2012, AIDS RES HUM RETROV, V28, P1513, DOI [10.1089/aid.2012.0026, 10.1089/AID.2012.0026]; Ferir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064010; Ferir G, 2012, VIROLOGY, V433, P308, DOI 10.1016/j.virol.2012.08.007; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Geijtenbeek TBH, 2003, APMIS, V111, P698, DOI 10.1034/j.1600-0463.2003.11107803.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Goel N, 2002, J VIROL METHODS, V106, P153, DOI 10.1016/S0166-0934(02)00160-X; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; Hoorelbeke B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064132; Huskens D, 2007, VIROLOGY, V360, P294, DOI 10.1016/j.virol.2006.10.027; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; KUCERA L S, 1989, Viral Immunology, V2, P11, DOI 10.1089/vim.1989.2.11; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; Leydet A, 1996, J MED CHEM, V39, P1626, DOI 10.1021/jm950358j; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109; McCubbins N., 1983, ENV PROTECTION SERVI, VXVIII, P119; McMahon MA, 2011, J VIROL, V85, P4618, DOI 10.1128/JVI.02423-10; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Neumann T, 2005, VIROLOGY, V333, P251, DOI 10.1016/j.virol.2004.12.035; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Petrova MI, 2013, J ANTIMICROB CHEMOTH, V68, P2026, DOI 10.1093/jac/dkt152; Petrova MI, 2013, FEMS MICROBIOL REV, V37, P762, DOI 10.1111/1574-6976.12029; Pirrone V, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-33; Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176; Princen Katrien, 2004, Retrovirology, V1, P2, DOI 10.1186/1742-4690-1-2; Qiu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035906; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Segarra TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027675; Shattock RJ, 2002, NAT MED, V8, P425, DOI 10.1038/nm0502-425; Stefanidou M, 2013, J VIROL, V87, P1443, DOI 10.1128/JVI.01302-12; SUZUKI H, 1989, BIOCHEM BIOPH RES CO, V160, P367, DOI 10.1016/0006-291X(89)91665-3; Thurman AR, 2012, INT J STD AIDS, V23, P613, DOI 10.1258/ijsa.2012.011356; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tollner TL, 2003, BIOL REPROD, V68, P664, DOI 10.1095/biolreprod.102.009175; Tollner TL, 2002, J ANDROL, V23, P889; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; Vermeire K, 2004, AIDS, V18, P2115, DOI 10.1097/00002030-200411050-00003; VOCAC JA, 1968, EUR J PHARMACOL, V4, P99, DOI 10.1016/0014-2999(68)90016-2; VOCAC JA, 1969, ARCH INT PHARMACOD T, V177, P150; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Zaneveld LJD, 2002, BIOL REPROD, V66, P886, DOI 10.1095/biolreprod66.4.886; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	73	39	40	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131219	10.1371/journal.pone.0131219	http://dx.doi.org/10.1371/journal.pone.0131219			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132818	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000105
J	Kim, SK; Kim, H; Koh, GY; Lim, DS; Yu, DY; Kim, MD; Park, MS; Lim, JS				Kim, Sang Kyum; Kim, Honsoul; Koh, Gou Young; Lim, Dae-Sik; Yu, Dae-Yeul; Kim, Man Deuk; Park, Mi-Suk; Lim, Joon Seok			Mouse Hepatic Tumor Vascular Imaging by Experimental Selective Angiography	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; INTRAARTERIAL INJECTION; ARTERIAL PORTOGRAPHY; DYSPLASTIC NODULES; LIVER; CT; MICROANGIOGRAPHY; ANGIOGENESIS	Purpose Human hepatocellular carcinoma (HCC) has unique vascular features, which require selective imaging of hepatic arterial perfusion and portal venous perfusion with vascular catheterization for sufficient evaluation. Unlike in humans, vessels in mice are too small to catheterize, and the importance of separately imaging the feeding vessels of tumors is frequently overlooked in hepatic tumor models. The purpose of this study was to perform selective latex angiography in several mouse liver tumor models and assess their suitability. Materials and Methods In several ectopic (Lewis lung carcinoma, B16/F10 melanoma cell lines) and spontaneous liver tumor (Albumin-Cre/MST1(fl/fl)/MST2(fl/fl), Albumin-Cre/WW45(fl/fl), and H-ras12V genetically modified mouse) models, the heart left ventricle and/or main portal vein of mice was punctured, and latex dye was infused to achieve selective latex arteriography and/or portography. Results H-ras12V transgenic mice (a HCC and hepatic adenoma model) developed multiple liver nodules that displayed three different perfusion patterns (portal venous or hepatic artery perfusion predominant, mixed perfusion), indicating intra-tumoral vascular heterogeneity. Selective latex angiography revealed that the Lewis lung carcinoma implant model and the Albumin-Cre/WW45(fl/fl) model reproduced conventional angiography findings of human HCC. Specifically, these mice developed tumors with abundant feeding arteries but no portal venous perfusion. Conclusion Different hepatic tumor models showed different tumor vessel characteristics that influence the suitability of the model and that should be considered when designing translational experiments. Selective latex angiography applied to certain mouse tumor models (both ectopic and spontaneous) closely simulated typical characteristics of human HCC vascular imaging.	[Kim, Sang Kyum] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Honsoul; Kim, Man Deuk; Park, Mi-Suk; Lim, Joon Seok] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Natl Res Lab Vasc Biol & Stem Cell, Taejon 305701, South Korea; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Taejon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, H (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	pine0205@yuhs.ac	Koh, Gou Young/C-1615-2011; Lim, Dae-Sik/C-1599-2011; Lim, Joon Seok/R-7753-2019	Lim, Dae-Sik/0000-0003-2356-7555; Park, Mi-Suk/0000-0001-5817-2444; Lim, Joon seok/0000-0002-0334-5042; Kim, Man-Deuk/0000-0002-3575-5847; Kim, Sang Kyum/0000-0003-0768-9923	Radiological Research Foundation of Korea [2012-01]	Radiological Research Foundation of Korea	H.K. has received a grant from the research fund of the Radiological Research Foundation of Korea (2012-01). The funder does not have an official website.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Buijs M, 2008, AM J ROENTGENOL, V191, P285, DOI 10.2214/AJR.07.2467; Chen JA, 2010, HEPATOL INT, V4, P537, DOI 10.1007/s12072-010-9192-4; Debbaut C, 2014, J ANAT, V224, P509, DOI 10.1111/joa.12156; Hayashi M, 2002, RADIOLOGY, V225, P143, DOI 10.1148/radiol.2251011298; Hayashi M, 1999, AM J ROENTGENOL, V172, P969, DOI 10.2214/ajr.172.4.10587130; HIMENO H, 1994, J PATHOL, V174, P217, DOI 10.1002/path.1711740311; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Kitao A, 2009, RADIOLOGY, V252, P605, DOI 10.1148/radiol.2522081414; Kobayashi S, 2004, J HEPATOL, V40, P405, DOI 10.1016/j.jhep.2003.11.029; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; MATSUI O, 1985, J COMPUT ASSIST TOMO, V9, P19, DOI 10.1097/00004728-198501000-00004; Matsui O, 2011, ABDOM IMAGING, V36, P264, DOI 10.1007/s00261-011-9685-1; Mitchell DG, 2015, HEPATOLOGY, V61, P1056, DOI 10.1002/hep.27304; Moon EY, 2006, EUR J PHARMACOL, V530, P270, DOI 10.1016/j.ejphar.2005.11.053; Nakamura K, 2007, HUM PATHOL, V38, P1532, DOI 10.1016/j.humpath.2007.03.002; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Park YN, 2000, ARCH PATHOL LAB MED, V124, P1061; Sakamoto H, 2014, ACTA RADIOL; Tajima T, 2002, AM J ROENTGENOL, V178, P885, DOI 10.2214/ajr.178.4.1780885; Tang YH, 2014, METHODS MOL BIOL, V1135, P317, DOI 10.1007/978-1-4939-0320-7_26; UEDA K, 1992, HUM PATHOL, V23, P619, DOI 10.1016/0046-8177(92)90316-U; Walter TJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4272; Wang AG, 2005, J HEPATOL, V43, P836, DOI 10.1016/j.jhep.2005.04.012; Wang HJ, 2008, EUR RADIOL, V18, P1422, DOI 10.1007/s00330-008-0904-2; Wu X, 2009, ACTA RADIOL, V50, P276, DOI 10.1080/02841850802647021; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131687	10.1371/journal.pone.0131687	http://dx.doi.org/10.1371/journal.pone.0131687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131558	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000135
J	Lawrenson, K; Pakzamir, E; Liu, B; Lee, JM; Delgado, MK; Duncan, K; Gayther, SA; Liu, S; Roman, L; Mhawech-Fauceglia, P				Lawrenson, Kate; Pakzamir, Elham; Liu, Biao; Lee, Janet M.; Delgado, Melissa K.; Duncan, Kara; Gayther, Simon A.; Liu, Song; Roman, Lynda; Mhawech-Fauceglia, Paulette			Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium	PLOS ONE			English	Article							CLEAR-CELL CARCINOMAS; EXPRESSION; CANCER; RNA; DIAGNOSIS; SUBTYPES; STAGE; PURE	Background The molecular biology and cellular origins of mixed type endometrial carcinomas (MT-ECs) are poorly understood, and a Type II component of 10 percent or less may confer poorer prognoses. Methodology/Principal Findings We studied 10 cases of MT-EC (containing endometrioid and serous differentiation), 5 pure low-grade endometrioid adenocarcinoma (EAC) and 5 pure uterine serous carcinoma (USC). Endometrioid and serous components of the MT-ECs were macrodissected and the expression of 60 candidate genes compared between MT-EC, pure USC and pure EAC. We found that four genes were differentially expressed when MT-ECs were compared to pure low-grade EAC: CDKN2A (P = 0.006), H19 (P = 0.010), HOMER2 (P = 0.009) and TNNT1 (P = 0.006). Also while we found that even though MT-ECs closely resembled the molecular profiles of pure USCs, they also exhibit lower expression of PAX8 compared to all pure cases combined (P = 0.035). Conclusion Our data suggest that MT-EC exhibits the closest molecular and epidemiological similarities to pure USC and supports clinical observations that suggest patients with MT-EC should receive the same treatment as patients with pure serous carcinoma. Novel specific markers of MT-EC could be of diagnostic utility and could represent novel therapeutic targets in the future.	[Lawrenson, Kate; Pakzamir, Elham; Lee, Janet M.; Delgado, Melissa K.; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Duncan, Kara; Mhawech-Fauceglia, Paulette] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Liu, Biao; Liu, Song] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Roman, Lynda] Univ So Calif, Dept Gynecol Oncol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Roswell Park Cancer Institute; University of Southern California	Mhawech-Fauceglia, P (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	pfauceglia@hotmail.com		Lawrenson, Kate/0000-0002-6469-2515	National Cancer Institute [K99/R00 1K99CA184415, P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA016056, P30CA014089, K99CA184415] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute grant award K99/R00 1K99CA184415 This project was performed within the Norris Cancer Centre at University of Southern California, which is supported in part by award number P30CA014089 from the National Cancer Institute.	Ajima R, 2007, BIOCHEM BIOPH RES CO, V356, P851, DOI 10.1016/j.bbrc.2007.03.060; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Berteaux N, 2004, J ENDOCRINOL, V183, P69, DOI 10.1677/joe.1.05696; Chafe S, 2000, INT J RADIAT ONCOL, V48, P1433, DOI 10.1016/S0360-3016(00)00791-4; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fader AN, 2009, GYNECOL ONCOL, V115, P244, DOI 10.1016/j.ygyno.2009.07.030; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gilks CB, 2013, AM J SURG PATHOL, V37, P874, DOI 10.1097/PAS.0b013e31827f576a; Halperin R, 2002, EUR J GYNAECOL ONCOL, V23, P300; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Hicks ML, 1998, CANCER, V83, P2629, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madison T, 2004, AM J PUBLIC HEALTH, V94, P2104, DOI 10.2105/AJPH.94.12.2104; Medrzycki M, 2014, CANCER RES, V74, P6463, DOI 10.1158/0008-5472.CAN-13-2922; Mhawech-Fauceglia P, 2012, BRIT J CANCER, V107, P370, DOI 10.1038/bjc.2012.241; Mhawech-Fauceglia P, 2013, HISTOPATHOLOGY, V62, P976, DOI 10.1111/his.12096; Mhawech-Fauceglia P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018066; Mhawech-Fauceglia P, 2010, AM J CLIN PATHOL, V133, P899, DOI 10.1309/AJCPQDQXJ4FNRFQB; Mori Y, 2011, ENDOCR-RELAT CANCER, V18, P465, DOI 10.1530/ERC-11-0083; Quddus MR, 2010, REPROD SCI, V17, P673, DOI 10.1177/1933719110368433; Roelofsen T, 2012, OBSTET GYNECOL, V120, P1371, DOI [10.1097/AOG.0b013e318273732e, http://10.1097/AOG.0b013e318273732e]; Roelofsen T, 2011, EXPERT REV ANTICANC, V11, P71, DOI 10.1586/ERA.10.199; Soslow RA, 2007, AM J SURG PATHOL, V31, P979, DOI 10.1097/PAS.0b013e31802ee494; Tanos V, 1999, EUR J OBSTET GYN R B, V85, P7, DOI 10.1016/S0301-2115(98)00275-9; Yemelyanova A, 2009, AM J SURG PATHOL, V33, P1504, DOI 10.1097/PAS.0b013e3181ac35f5	27	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130909	10.1371/journal.pone.0130909	http://dx.doi.org/10.1371/journal.pone.0130909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132201	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000085
J	Liu, YQ; Chen, MM; Su, JF; Ma, HF; Zheng, XX; Li, Q; Shi, SL; Qin, L				Liu, Yanqun; Chen, Miaomiao; Su, Junfang; Ma, Hongfang; Zheng, Xixi; Li, Qun; Shi, Shenglin; Qin, Li			Identification and Characterization of a Novel Microvitellogenin from the Chinese Oak Silkworm Antheraea pernyi	PLOS ONE			English	Article							TOBACCO HORNWORM; KK-42-BINDING PROTEIN; SEQUENCE; GENE; VITELLOGENIN; EXPRESSION; BIOSYNTHESIS	Microvitellogenin (mVg) is a relatively small vitellogenic protein only characterized in the eggs of the lepidopteran insects Manduca sexta and Bombyx mori. In the present study, we report a novel mVg (ApmVg) isolated from the Chinese oak silkworm Antheraea pernyi. The obtained ApmVg cDNA sequence contains an open reading frame of 783 bp encoding a protein of 260 amino acids with a predicted molecular weight of 29.96 kDa. This gene does not contain introns. Structural analysis revealed that this protein shares putative conserved domains with the lepidopteran low-molecular weight lipoprotein, which belongs to the lipoprotein_11 superfamily. The protein sequence of ApmVg exhibits 48% sequence identity with mVg from M. sexta and 40-47% sequence identity with the 30K lipoproteins from B. mori. Phylogenetic analysis suggests that ApmVg is a novel member of the lepidopteran low-molecular weight lipoproteins. Transcriptional analysis indicated that ApmVg mRNA is mainly expressed in the fat body (both female and male) during post-diapause development of the pupal stage, and it was also detected in ovaries and spermaries in smaller amounts. RT-PCR and Western blot analyses revealed that ApmVg is synthesized by the fat body and secreted into hemolymph and ultimately accumulates in eggs. The ApmVg transcript can be detected in the fat bodies of female pupae four days after treatment with 20-hydroxyecdysone and shows an expression pattern distinct from that of vitellogenin(Vg), which is detectable throughout diapausing and in post-diapause development. ApmVg decreased dramatically during embryonic development. These results represent the first study of mVg outside M. sexta and B. mori and provide insight into the physiological role and evolution of mVgs.	[Liu, Yanqun; Ma, Hongfang; Zheng, Xixi; Li, Qun; Shi, Shenglin; Qin, Li] Shenyang Agr Univ, Dept Sericulture, Shenyang 110161, Liaoning, Peoples R China; [Liu, Yanqun; Chen, Miaomiao] Sericultural Inst Liaoning Prov, Fengcheng, Liaoning, Peoples R China; [Su, Junfang] Guangzhou Univ Chinese Med, Sch Basic Med, Guangzhou, Guangdong, Peoples R China	Shenyang Agricultural University; Guangzhou University of Chinese Medicine	Liu, YQ (corresponding author), Shenyang Agr Univ, Dept Sericulture, Shenyang 110161, Liaoning, Peoples R China.	liuyanqun@syau.edu.cn; shishenglin@126.com		Liu, Yan-Qun/0000-0001-9025-1986	National Natural Science Foundation of China [31372372]; Liaoning Excellent Talents Project in University [2012060]; Tianzhushan Scholar Project of Shenyang Agricultural University [2014-02-04]; Young Scholar Foundation of Shenyang Agricultural University [20101009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Excellent Talents Project in University; Tianzhushan Scholar Project of Shenyang Agricultural University; Young Scholar Foundation of Shenyang Agricultural University	This work was partially supported by grants from the National Natural Science Foundation of China (31372372), Liaoning Excellent Talents Project in University (2012060) and Tianzhushan Scholar Project of Shenyang Agricultural University (2014-02-04) to YL, and Young Scholar Foundation of Shenyang Agricultural University (20101009) to QL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Arunkumar KP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-338; Chen MM, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu030; DUAN J, 2009, NUCLEIC ACIDS RES, P1, DOI DOI 10.1093/NAR/GKP829; IZUMI S, 1981, BIOCHIM BIOPHYS ACTA, V670, P222, DOI 10.1016/0005-2795(81)90013-1; JIANG Z, 1986, BIOCHIM BIOPHYS ACTA, V882, P427; KAWOOYA JK, 1983, BIOCHEM BIOPH RES CO, V117, P643, DOI 10.1016/0006-291X(83)91249-4; KAWOOYA JK, 1986, J BIOL CHEM, V261, P844; Li YP, 2009, INT J BIOL SCI, V5, P451; Liu CL, 2002, CANYE KEXUE, V28, P199; Liu YQ, 2012, ANN ENTOMOL SOC AM, V105, P718, DOI 10.1603/AN12009; Liu YQ, 2015, J INSECT PHYSIOL, V74, P38, DOI 10.1016/j.jinsphys.2015.02.003; Liu YQ, 2010, J INSECT SCI, V10, P1, DOI 10.1673/031.010.14140; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MX, 1990, CANYE KEXUE, V16, P219; MINE E, 1983, DEV BIOL, V97, P329, DOI 10.1016/0012-1606(83)90090-8; OSIR EO, 1986, ARCH INSECT BIOCHEM, V3, P513, DOI 10.1002/arch.940030603; Peigler Richard S., 2012, Tropical Lepidoptera Research, V22, P93; Singh NK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083963, 10.1371/journal.pone.0073005]; Sun Q, 2007, INSECT SCI, V14, P5, DOI 10.1111/j.1744-7919.2007.00121.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telfer W.H., 1981, Scientific Papers of the Institute of Organic and Physical Chemistry of Wroclaw Technical University, P637; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tufail M, 2005, REPRO BIOL, V12, P1; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; WANG X, 1988, J BIOL CHEM, V263, P8851; WANG XY, 1989, GENE, V80, P259, DOI 10.1016/0378-1119(89)90290-4; Xu YM, 2011, INSECT BIOCHEM MOLEC, V41, P572, DOI 10.1016/j.ibmb.2011.03.009; Zhang Y, 2012, INSECT BIOCHEM MOLEC, V42, P827, DOI 10.1016/j.ibmb.2012.07.006; Zhang Y, 2012, FUNCT INTEGR GENOMIC, V12, P705, DOI 10.1007/s10142-012-0281-4; Zhong BX, 2005, ACTA BIOCH BIOPH SIN, V37, P355, DOI 10.1111/j.1745-7270.2005.00044.x; Zhu BJ, 2010, AFR J BIOTECHNOL, V9, P811	32	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131751	10.1371/journal.pone.0131751	http://dx.doi.org/10.1371/journal.pone.0131751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126120	gold, Green Published, Green Submitted			2022-12-26	WOS:000358151300052
J	Collins, B; Capewell, S; O'Flaherty, M; Timpson, H; Razzaq, A; Cheater, S; Ireland, R; Bromley, H				Collins, Brendan; Capewell, Simon; O'Flaherty, Martin; Timpson, Hannah; Razzaq, Abdul; Cheater, Sylvia; Ireland, Robin; Bromley, Helen			Modelling the Health Impact of an English Sugary Drinks Duty at National and Local Levels	PLOS ONE			English	Article							SWEETENED BEVERAGES; ECONOMIC BURDEN; OBESITY; RISK; UK; ADOLESCENTS; CONSUMPTION; PREVALENCE; CHILDREN; ADULTS	Background Increasing evidence associates excess refined sugar intakes with obesity, Type 2 diabetes and heart disease. Worryingly, the estimated volume of sugary drinks purchased in the UK has more than doubled between 1975 and 2007, from 510ml to 1140ml per person per week. We aimed to estimate the potential impact of a duty on sugar sweetened beverages (SSBs) at a local level in England, hypothesising that a duty could reduce obesity and related diseases. Methods and Findings We modelled the potential impact of a 20% sugary drinks duty on local authorities in England between 2010 and 2030. We synthesised data obtained from the British National Diet and Nutrition Survey (NDNS), drinks manufacturers, Office for National Statistics, and from previous studies. This produced a modelled population of 41 million adults in 326 lower tier local authorities in England. This analysis suggests that a 20% SSB duty could result in approximately 2,400 fewer diabetes cases, 1,700 fewer stroke and coronary heart disease cases, 400 fewer cancer cases, and gain some 41,000 Quality Adjusted Life Years (QALYs) per year across England. The duty might have the biggest impact in urban areas with young populations. Conclusions This study adds to the growing body of evidence suggesting health benefits for a duty on sugary drinks. It might also usefully provide results at an area level to inform local price interventions in England.	[Collins, Brendan] Univ Liverpool, Sch Management, Liverpool L69 3BX, Merseyside, England; [Capewell, Simon; O'Flaherty, Martin; Bromley, Helen] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Timpson, Hannah] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Razzaq, Abdul] Trafford Council, Trafford, England; [Cheater, Sylvia; Ireland, Robin] Hlth Equal Grp, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Liverpool John Moores University	Collins, B (corresponding author), Univ Liverpool, Sch Management, Liverpool L69 3BX, Merseyside, England.	brenc@liv.ac.uk	Shao, Ruitai/AAU-7642-2021; PAN, ZEQIANG/X-6341-2018	O'Flaherty, Martin/0000-0001-8944-4131; Timpson, Hannah/0000-0002-5266-6715	North West of England Directors of Public Health; Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	North West of England Directors of Public Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors received no specific funding for this work. An initial piece of work was funded by North West of England Directors of Public Health.	Aguilar F, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3496; Ambrosini GL, 2013, AM J CLIN NUTR, V98, P327, DOI 10.3945/ajcn.112.051383; Bates G, 2014, TOP TEN FOR NUMBER T; Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; DiNicolantonio JJ, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000167; Farmer AJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13150; Frieden TR, 2010, HEALTH AFFAIR, V29, P357, DOI 10.1377/hlthaff.2010.0039; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; HM Government, 2011, HEALTHY LIVES HEALTH; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Lofstedt RE, 2008, RISK MANAG-UK, V10, P257, DOI 10.1057/rm.2008.11; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Marshall TA, 2013, J AM DENT ASSOC, V144, P1148, DOI 10.14219/jada.archive.2013.0033; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Pan A, 2011, CURR OPIN CLIN NUTR, V14, P385, DOI 10.1097/MCO.0b013e328346df36; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Tiffin R, 2015, HEALTH ECON, V24, P583, DOI 10.1002/hec.3046; Timpson H, 2013, EXPLORING THE ACCEPT; Trueman P, 2010, INT J CLIN PRACT, V64, P775, DOI 10.1111/j.1742-1241.2010.02349.x; Trueman P, 2007, BOWEL CANCER SERVICE; UK Faculty of Public Health, 2013, DUT SUG SWEET BEV PO; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; WRAP [Waste and Resources Action Programme], 2013, FINAL REPORT HOUSEHO; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229	31	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130770	10.1371/journal.pone.0130770	http://dx.doi.org/10.1371/journal.pone.0130770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121677	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358150400061
J	Gutierrez, EE; Maldonado, JE; Radosavljevic, A; Molinari, J; Patterson, BD; Martinez, JM; Rutter, AR; Hawkins, MTR; Garcia, FJ; Helgen, KM				Gutierrez, Eliecer E.; Maldonado, Jesus E.; Radosavljevic, Aleksandar; Molinari, Jesus; Patterson, Bruce D.; Martinez-C, Juan M.; Rutter, Amy R.; Hawkins, Melissa T. R.; Garcia, Franger J.; Helgen, Kristofer M.			The Taxonomic Status of Mazama bricenii and the Significance of the Tachira Depression for Mammalian Endemism in the Cordillera de Merida, Venezuela	PLOS ONE			English	Article							SAMPLING BIAS; GEOGRAPHIC DISTRIBUTIONS; SPECIES DISTRIBUTIONS; MODEL COMPLEXITY; CLIMATE-CHANGE; AMERICAN DEER; NICHE MODELS; BROCKET DEER; RODENTIA; MITOCHONDRIAL	We studied the taxonomy and biogeography of Mazama bricenii, a brocket deer classified as Vulnerable by the IUCN, drawing on qualitative and quantitative morphology and sequences of the mitochondrial cytochrome-b gene. We used Ecological Niche Modeling (ENM) to evaluate the hypothesis that M. bricenii of the Venezuelan Cordillera de Merida (CM) might have become isolated from populations of its putative sister species, Mazama rufina, in the Colombian Cordillera Oriental (CO). This hypothesis assumes that warm, dry climatic conditions in the Tachira Depression were unsuitable for the species. Our analyses did not reveal morphological differences between specimens geographically attributable to M. bricenii and M. rufina, and phylogenetic analyses of molecular data recovered M. bricenii nested within the diversity of M. rufina. These results indicate that M. bricenii should be regarded as a junior synonym of M. rufina. ENM analyses revealed the existence of suitable climatic conditions for M. rufina in the Tachira Depression during the last glacial maximum and even at present, suggesting that gene flow between populations in the CO and CM may have occurred until at least the beginning of the current interglacial period and may continue today. Because this pattern might characterize other mammals currently considered endemic to the CM, we examined which of these species match two criteria that we propose herein to estimate if they can be regarded as endemic to the CM with confidence: (1) that morphological or molecular evidence exists indicating that the putative endemic taxon is distinctive from congeneric populations in the CO; and (2) that the putative endemic taxon is restricted to either cloud forest or paramo, or both. Only Aepeomys reigi, Cryptotis meridensis, and Nasuella meridensis matched both criteria; hence, additional research is necessary to assess the true taxonomic status and distribution of the remaining species thought to be CM endemics.	[Gutierrez, Eliecer E.; Maldonado, Jesus E.; Hawkins, Melissa T. R.; Helgen, Kristofer M.] Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, Washington, DC 20560 USA; [Gutierrez, Eliecer E.; Maldonado, Jesus E.; Hawkins, Melissa T. R.] Smithsonian Conservat Biol Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Washington, DC USA; [Radosavljevic, Aleksandar] Northwestern Univ, Plant Biol & Conservat, Evanston, IL USA; [Radosavljevic, Aleksandar] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Molinari, Jesus] Univ Los Andes, Fac Ciencias, Dept Biol, Merida 5101, Venezuela; [Patterson, Bruce D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Martinez-C, Juan M.] Univ Antioquia, Grp Mastozool & Colecc Teriol, Inst Biol, Medellin, Colombia; [Rutter, Amy R.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Hawkins, Melissa T. R.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Garcia, Franger J.] Univ Carabobo, Dept Biol, Lab Museo Zool, Valencia, Carabobo, Venezuela	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Northwestern University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Los Andes Venezuela; Field Museum of Natural History (Chicago); Universidad de Antioquia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Mason University	Gutierrez, EE (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, Washington, DC 20560 USA.	GutierrezE@si.edu	Patterson, Bruce D/O-5068-2019; Gutiérrez, Eliécer/D-5703-2014; Maldonado, Jesus/AIE-8664-2022; Helgen, Kristofer M./AAB-8348-2019	Patterson, Bruce D/0000-0002-2249-7260; Gutiérrez, Eliécer/0000-0001-6790-8185; Maldonado, Jesus/0000-0002-4282-1072; Helgen, Kristofer M./0000-0002-8776-4040; Molinari, Jesus/0000-0002-9393-5483; Martinez Ceron, Juan Manuel/0000-0002-8906-9420	Peter Buck Postdoctoral Fellowship by National Museum of Natural History (NMNH), Smithsonian Institution; Small Grants Program by National Museum of Natural History (NMNH), Smithsonian Institution; Systematics Research Fund Program of the Systematics Association; Linnean Society of London; National Science Foundation (REU) through internship program Natural History Research Experiences, NMNH [EAR-1062692]	Peter Buck Postdoctoral Fellowship by National Museum of Natural History (NMNH), Smithsonian Institution; Small Grants Program by National Museum of Natural History (NMNH), Smithsonian Institution; Systematics Research Fund Program of the Systematics Association; Linnean Society of London; National Science Foundation (REU) through internship program Natural History Research Experiences, NMNH(National Science Foundation (NSF))	Funding: This work was funded by a Peter Buck Postdoctoral Fellowship (to EEG) and funds from the Small Grants Program (to KMH, EEG, JEM), both provided by the National Museum of Natural History (NMNH), Smithsonian Institution; and by a grant from the Systematics Research Fund Program of the Systematics Association and Linnean Society of London (to JEM, EEG, KMH). The National Science Foundation (REU Site, EAR-1062692) provided funding through the internship program Natural History Research Experiences, NMNH (to ARR, advised by EEG and KMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA M, 1995, CYTOGENET CELL GENET, V69, P44, DOI 10.1159/000133935; Aguilera M, 2000, J MAMMAL, V81, P52, DOI 10.1093/jmammal/81.1.52; Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Allen JA, 1915, B AM MUS NAT HIST, V34, P521; Anderson RP, 2012, STUD NEOTROP FAUNA E, V47, P157, DOI 10.1080/01650521.2012.745295; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Anderson RP, 2009, B AM MUS NAT HIST, P33; Anderson Robert P., 2000, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P613; Anderson RP, 1999, Z SAUGETIERKD, V64, P121; [Anonymous], 1993, WHITEHEAD ENCY DEER; [Anonymous], 2014, R LANG ENV STAT COMP; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Barrio Javier, 2010, Mastozool. neotrop., V17, P117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beolens B., 2009, EPONYM DICT MAMMALS; Bisbal E. Francisco J., 1991, Acta Biologica Venezuelica, V13, P89; Bisbal F.J., 1989, P339; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Bornholdt R, 2013, ZOOL J LINN SOC-LOND, V167, P449, DOI 10.1111/j.1096-3642.2012.00859.x; Brooks TM, 2010, NATURE, V467, P540, DOI 10.1038/467540a; CABRERA A., 1961, REV MUSEO ARGENTINO, V4, P309, DOI DOI 10.22179/REVMACN.13.214; Castano JH, 2010, B EVALUACION BIOL, P45; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Czernay S, 1987, NEUE BREHM BUCHEREI, V581, P1; Daavalos LM, 2014, J MAMMAL, V95, P781, DOI 10.1644/14-MAMM-A-107; Dietrich JR, 1993, THESIS U BASEL; Duarte JMB, 2010, NEOTROPICAL CERVIDOL; Duarte JMB, 2008, MOL PHYLOGENET EVOL, V49, P17, DOI 10.1016/j.ympev.2008.07.009; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fernandez-Mazuecos M, 2013, NEW PHYTOL, V198, P1274, DOI 10.1111/nph.12220; Geist V., 1998, DEER WORLD THEIR EVO; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Groves C, 2011, UNGULATE TAXONOMY; Groves C.P., 1987, P21; Grubb P, 2005, MAMMAL SPECIES WORLD; Gutierrez EE, 2008, J MAMMAL, V89, P292, DOI 10.1644/06-MAMM-A-452R.1; Gutierrez EE, 2014, ECOGRAPHY, V37, P741, DOI 10.1111/ecog.00620; Gutierrez EE, 2013, NATURE, V495, P314, DOI 10.1038/495314e; Gutierrez EE, 2011, MAMMALIA, V75, P381, DOI 10.1515/MAMM.2011.051; Gutierrez EE, 2010, AM MUS NOVIT, P1, DOI 10.1206/708.1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Handley C.O. Jr., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Helgen KM, 2008, ZOOL J LINN SOC-LOND, V154, P353, DOI 10.1111/j.1096-3642.2008.00416.x; Helgen KM, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.324.5827; Helgen Kristofer M., 2009, Small Carnivore Conservation, V41, P65; Hershkovitz P, 1982, FIELDIANA ZOOL, V1330, P1; Hershkovitz P., 1992, FIELDIANA ZOOLOGY, V70, P1, DOI DOI 10.5962/BHL.TITLE.3521; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; James J, 2008, CONSERV GENET, V9, P927, DOI 10.1007/s10592-007-9410-3; JORGE W, 1977, CYTOLOGIA, V42, P711, DOI 10.1508/cytologia.42.711; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Linares O., 1998, MAMIFEROS VENEZUELA; Lizcano J, 2010, NEOTROPICAL CERVIDOL, P181; Lydekker R., 1915, TRAGULIDAE CHEVROTAI, VIV; Marquez EJ, 2000, Z SAUGETIERKD, V65, P84; Mittermeier R. A, 2011, HDB MAMMALS WORLD, P350; Molina M, 1999, CAN J ZOOL, V77, P632, DOI 10.1139/cjz-77-4-632; Molinari J, 2007, MEMORIA FDN SALLE CI, V167, P29; Mousseau T, 2011, BIOL J LINN SOC, V102, P311, DOI 10.1111/j.1095-8312.2010.01568.x; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Ochoa J, 2001, MAMM BIOL, V66, P228; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polziehn RO, 2002, MOL PHYLOGENET EVOL, V22, P342, DOI 10.1006/mpev.2001.1065; Prado Joyce R., 2013, Arquivos de Zoologia (Sao Paulo), V44, P1; Pucheran J., 1851, REV MAGASIN ZOOLOGIE, V2, P561; Quiroga-Carmona Marcial, 2012, Zootaxa, V3441, P1; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Revelle W., 2014, PSYCH PROCEDURES PER; Rodríguez-Posada Miguel E, 2014, Mastozool. neotrop., V21, P367; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROSSI RV, 2005, THESIS U SAO PAULO; Rumiz DI, 2007, J ZOOL, V271, P428, DOI 10.1111/j.1469-7998.2006.00226.x; Sanchez HJ, 2012, M FUND SALLE CIENCIA, V173, P173; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Solari Sergio, 2013, Mastozool. neotrop., V20, P301; Soley-Guardia M, 2014, J BIOGEOGR, V41, P1390, DOI 10.1111/jbi.12297; Soriano PJ, 1999, INTERCIENCIA, V24, P17; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATE G. H. H., 1932, AMER MUS NOVITATES, V581, P1; TATE G. H. H., 1939, BULL AMER MUS NAT HIST, V76, P151; Thomas O., 1901, Annals of Natural History, V(7), P246; Thomas O., 1898, Annals of Natural History, V(7), P451; Thomas O., 1908, Annals & Magazine of Natural History Series 8, V1; THOMAS O., 1916, ANN MAGAZINE NATURAL, V18, P294, DOI DOI 10.1080/00222931608693851; Tirira D., 2001, LIBRO ROJO MAMIFEROS, V1; Trolle M, 2004, DEER NEWS, V19, P2; Van der Hammen T., 1986, HIGH ALTITUDE TROPIC; VUILLEUMIER F, 1978, Bulletin of the American Museum of Natural History, V162, P47; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Weber M, 2003, ECOSCIENCE, V10, P443, DOI 10.1080/11956860.2003.11682792; Wemmer C, 1998, DEER STATUS SURVERY; Williams Daniel F., 1993, Special Publication American Society of Mammalogists, V10, P38; Wisely SM, 2004, CONSERV GENET, V5, P105, DOI 10.1023/B:COGE.0000014061.04963.da; Woodman N, 2002, P BIOL SOC WASH, V115, P249; Zwickl DJ., 2006, THESIS	107	17	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129113	10.1371/journal.pone.0129113	http://dx.doi.org/10.1371/journal.pone.0129113			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121688	Green Submitted, gold, Green Published			2022-12-26	WOS:000358150400016
J	Martin, J; Ortega, J; Lopez, P				Martin, Jose; Ortega, Jesus; Lopez, Pilar			Interpopulational Variations in Sexual Chemical Signals of Iberian Wall Lizards May Allow Maximizing Signal Efficiency under Different Climatic Conditions	PLOS ONE			English	Article							FEMORAL GLAND SECRETIONS; FEMALE MATE CHOICE; CHEMOSENSORY RESPONSES; PRECLOACAL SECRETIONS; DISTINCT POPULATIONS; PODARCIS-HISPANICA; HEALTH STATE; SCENT MARKS; RECOGNITION; BEHAVIOR	Sexual signals used in intraspecific communication are expected to evolve to maximize efficacy under a given climatic condition. Thus, chemical secretions of lizards might evolve in the evolutionary time to ensure that signals are perfectly tuned to local humidity and temperature conditions affecting their volatility and therefore their persistence and transmission through the environment. We tested experimentally whether interpopulational altitudinal differences in chemical composition of femoral gland secretions of male Iberian wall lizards (Podarcis hispanicus) have evolved to maximize efficacy of chemical signals in different environmental conditions. Chemical analyses first showed that the characteristics of chemical signals of male lizards differed between two populations inhabiting environments with different climatic conditions in spite of the fact that these two populations are closely related genetically. We also examined experimentally whether the temporal attenuation of the chemical stimuli depended on simulated climatic conditions. Thus, we used tongue-flick essays to test whether female lizards were able to detect male scent marks maintained under different conditions of temperature and humidity by chemosensory cues alone. Chemosensory tests showed that chemical signals of males had a lower efficacy (i.e. detectability and persistence) when temperature and dryness increase, but that these effects were more detrimental for signals of the highest elevation population, which occupies naturally colder and more humid environments. We suggest that the abiotic environment may cause a selective pressure on the form and expression of sexual chemical signals. Therefore, interpopulational differences in chemical profiles of femoral secretions of male P. hispanicus lizards may reflect adaptation to maximize the efficacy of the chemical signal in different climates.	[Martin, Jose; Ortega, Jesus; Lopez, Pilar] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Martin, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Jose Gutierrez Abascal 2, Madrid, Spain.	Jose.Martin@mncn.csic.es	Giménez, Jesús Ortega/B-4637-2017; Lopez, Pilar/K-6221-2014; Martin, Jose/B-1073-2014	Giménez, Jesús Ortega/0000-0001-6599-1675; Lopez, Pilar/0000-0001-6577-1509; Martin, Jose/0000-0001-6648-3998	Spanish Ministerio de Ciencia e Innovacion [MICIIN-CGL2011-24150/BOS]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funding was provided by Spanish Ministerio de Ciencia e Innovacion, MICIIN-CGL2011-24150/BOS (www.mineco.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baeckens S, 2015, BIOL J LINN SOC, V114, P44, DOI 10.1111/bij.12414; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Carazo P, 2007, ANIM BEHAV, V74, P895, DOI 10.1016/j.anbehav.2007.02.011; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Carretero MA, 2008, INTEGR ZOOL, V3, P247, DOI 10.1111/j.1749-4877.2008.00102.x; COOPER WE, 1994, J CHEM ECOL, V20, P439, DOI 10.1007/BF02064449; COOPER WE, 1990, J CHEM ECOL, V16, P45, DOI 10.1007/BF01021267; Cooper WE, 1998, J CHEM ECOL, V24, P841; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; EPPLE G, 1980, J CHEM ECOL, V6, P735, DOI 10.1007/BF00990398; Escobar CA, 2001, J CHEM ECOL, V27, P1677, DOI 10.1023/A:1010470611061; Escobar CM, 2003, J CHEM ECOL, V29, P629, DOI 10.1023/A:1022858919037; Fox SF, 2003, LIZARD SOCIAL BEHAVIOR, P310; FRASER DR, 1995, LANCET, V345, P104, DOI 10.1016/S0140-6736(95)90067-5; Gabirot M, 2014, ADV ZOOL, V2014; Gabirot Marianne, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/698520; Gabirot M, 2013, ANN ZOOL FENN, V50, P225, DOI 10.5735/085.050.0406; Gabirot M, 2013, CURR ZOOL, V59, P210, DOI 10.1093/czoolo/59.2.210; Gabirot M, 2012, HERPETOL J, V22, P139; Gabirot M, 2012, CHEMOECOLOGY, V22, P65, DOI 10.1007/s00049-011-0100-8; Gabirot M, 2010, BIOCHEM SYST ECOL, V38, P521, DOI 10.1016/j.bse.2010.05.008; Gorley C.K., 2006, GETTING STARTED PRIM; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Heathcote RJP, 2014, BEHAV ECOL SOCIOBIOL, V68, P861, DOI 10.1007/s00265-014-1700-4; Huey R.B., 1982, Biology of Reptilia, V12, P25; Iraeta P, 2011, BIOL J LINN SOC, V104, P318, DOI 10.1111/j.1095-8312.2011.01739.x; Kaliontzopoulou A, 2011, BIOL J LINN SOC, V103, P779, DOI 10.1111/j.1095-8312.2011.01703.x; Khannoon ER, 2011, CHEMOECOLOGY, V21, P143, DOI 10.1007/s00049-011-0076-4; Kopena R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019410; Lopez P, 2005, BIOL LETT-UK, V1, P404, DOI 10.1098/rsbl.2005.0360; Lopez P, 2006, J CHEM ECOL, V32, P473, DOI 10.1007/s10886-005-9012-9; Lopez P, 1998, ETHOLOGY, V104, P809, DOI 10.1111/j.1439-0310.1998.tb00033.x; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V51, P461, DOI 10.1007/s00265-001-0447-x; Lopez P, 2001, ETHOLOGY, V107, P901, DOI 10.1046/j.1439-0310.2001.00724.x; Lopez P, 2011, BEHAV ECOL SOCIOBIOL, V65, P1891, DOI 10.1007/s00265-011-1198-y; Lopez P, 2009, NATURWISSENSCHAFTEN, V96, P65, DOI 10.1007/s00114-008-0451-3; Martin J, 2000, P ROY SOC B-BIOL SCI, V267, P1265, DOI 10.1098/rspb.2000.1137; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; Martin J, 2006, CHEMOECOLOGY, V16, P31, DOI 10.1007/s00049-005-0326-4; Martin J, 2007, BEHAV ECOL SOCIOBIOL, V62, P173, DOI 10.1007/s00265-007-0451-x; Martin J, 2007, BIOL LETTERS, V3, P125, DOI 10.1098/rsbl.2006.0589; Martin J, 2006, P ROY SOC B-BIOL SCI, V273, P2619, DOI 10.1098/rspb.2006.3619; Martin J, 2015, HORM BEHAV, V68, P14, DOI 10.1016/j.yhbeh.2014.06.009; Martin J, 2013, FUNCT ECOL, V27, P1332, DOI 10.1111/1365-2435.12128; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030108; Martin J, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P141; Martin J, 2006, J HERPETOL, V40, P556, DOI 10.1670/0022-1511(2006)40[556:CRBFIW]2.0.CO;2; Martins EP, 2006, J CHEM ECOL, V32, P881, DOI 10.1007/s10886-006-9029-8; Mason R.T., 1992, P114; Mason RT, 2010, J COMP PHYSIOL A, V196, P729, DOI 10.1007/s00359-010-0551-3; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCDONOUGH LM, 1989, J CHEM ECOL, V15, P779, DOI 10.1007/BF01015176; Muller-Schwarze D, 2006, CHEM ECOLOGY VERTEBR; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Pinho C, 2007, BIOL J LINN SOC, V91, P121, DOI 10.1111/j.1095-8312.2007.00774.x; Regnier F.E., 1977, P115; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; van Oudenhove L, 2012, J CHEM ECOL, V38, P802, DOI 10.1007/s10886-012-0130-x; Oudenhove L, 2011, NATURWISSENSCHAFTEN, V98, P1009, DOI 10.1007/s00114-011-0852-6; Weldon PJ, 2008, NAT PROD REP, V25, P738, DOI 10.1039/b509854h; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	69	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131492	10.1371/journal.pone.0131492	http://dx.doi.org/10.1371/journal.pone.0131492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121693	gold, Green Published, Green Submitted			2022-12-26	WOS:000358150400115
J	Ma, HW; Butler, MR; Thapa, A; Belcher, J; Yang, F; Baehr, W; Biel, M; Michalakis, S; Ding, XQ				Ma, Hongwei; Butler, Michael R.; Thapa, Arjun; Belcher, Josh; Yang, Fan; Baehr, Wolfgang; Biel, Martin; Michalakis, Stylianos; Ding, Xi-Qin			cGMP/Protein Kinase G Signaling Suppresses Inositol 1,4,5-Trisphosphate Receptor Phosphorylation and Promotes Endoplasmic Reticulum Stress in Photoreceptors of Cyclic Nucleotide-gated Channel-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RETINAL DEGENERATION; INDUCED APOPTOSIS; CALCIUM INFLUX; CONE FUNCTION; CA2+ RELEASE; MOUSE MODEL; CELL-DEATH; CROSS-TALK; LONG-TERM	Photoreceptor cyclic nucleotide-gated (CNG) channels play a pivotal role in phototransduction. Mutations in the cone CNG channel subunits CNGA3 and CNGB3 are associated with achromatopsia and cone dystrophies. We have shown endoplasmic reticulum (ER) stress-associated apoptotic cone death and increased phosphorylation of the ER Ca2+ channel inositol 1,4,5-trisphosphate receptor 1 (IP(3)R1) in CNG channel-deficient mice. We also presented a remarkable elevation of cGMP and an increased activity of the cGMP-dependent protein kinase (protein kinase G, PKG) in CNG channel deficiency. This work investigated whether cGMP/PKG signaling regulates ER stress and IP3R1 phosphorylation in CNG channel-deficient cones. Treatment with PKG inhibitor and deletion of guanylate cyclase-1 (GC1), the enzyme producing cGMP in cones, were used to suppress cGMP/PKG signaling in cone-dominant Cnga3(-/-)/Nrl(-/-) mice. We found that treatment with PKG inhibitor or deletion of GC1 effectively reduced apoptotic cone death, increased expression levels of cone proteins, and decreased activation of Muller glial cells. Furthermore, we observed significantly increased phosphorylation of IP3R1 and reduced ER stress. Our findings demonstrate a role of cGMP/PKG signaling in ER stress and ER Ca2+ channel regulation and provide insights into the mechanism of cone degeneration in CNG channel deficiency.	[Ma, Hongwei; Butler, Michael R.; Thapa, Arjun; Belcher, Josh; Yang, Fan; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Baehr, Wolfgang] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Biel, Martin; Michalakis, Stylianos] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Biel, Martin; Michalakis, Stylianos] Univ Munich, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany	University of Oklahoma System; University of Oklahoma Health Sciences Center; Utah System of Higher Education; University of Utah; University of Munich; University of Munich	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Regan, Clinton/E-6250-2012; Michalakis, Stylianos/M-4677-2019; Yang, Fan/I-5735-2019; Michalakis, Stylianos/W-2094-2018; Biel, Martin/G-1175-2014	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052	National Institutes of Health [P30EY021725, T32EY023202, R01EY019490, R01EY08123, R01EY019298]; Deutsche Forschungsgemeinschaft; NATIONAL EYE INSTITUTE [T32EY023202, R01EY019490, R01EY008123, R01EY019298, P30EY021725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants P30EY021725, T32EY023202, R01EY019490, R01EY08123, and R01EY019298. This work was also supported by the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Arguin G, 2007, J ENDOCRINOL, V192, P659, DOI 10.1677/JOE-06-0179; Bai GR, 2006, BIOCHEM BIOPH RES CO, V348, P1319, DOI 10.1016/j.bbrc.2006.07.208; Baldridge WH, 1998, J NEUROPHYSIOL, V79, P3012, DOI 10.1152/jn.1998.79.6.3012; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; Carvalho LS, 2011, HUM MOL GENET, V20, P3161, DOI 10.1093/hmg/ddr218; Chao CC, 2012, J CELL BIOCHEM, V113, P1377, DOI 10.1002/jcb.24010; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Fallahian F, 2011, FEBS J, V278, P3360, DOI 10.1111/j.1742-4658.2011.08260.x; Feng XD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5487; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kohl S, 2015, NAT GENET, V47, P757, DOI 10.1038/ng.3319; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45; Matveev AV, 2010, BIOCHEMISTRY-US, V49, P1628, DOI 10.1021/bi901960u; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Michel M, 2011, LEARN MEMORY, V18, P108, DOI 10.1101/lm.2063611; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG221, DOI 10.1152/ajpgi.00401.2002; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szikra T, 2008, J PHYSIOL-LONDON, V586, P4859, DOI 10.1113/jphysiol.2008.160051; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tegeder I, 2004, P NATL ACAD SCI USA, V101, P3253, DOI 10.1073/pnas.0304076101; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Tosi J, 2011, J CELL MOL MED, V15, P1778, DOI 10.1111/j.1582-4934.2010.01201.x; Varsanyi B, 2007, INVEST OPHTH VIS SCI, V48, P2249, DOI 10.1167/iovs.06-1173; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Zhao TT, 2010, ADV EXP MED BIOL, V664, P575, DOI 10.1007/978-1-4419-1399-9_66	54	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20880	20892		10.1074/jbc.M115.641159	http://dx.doi.org/10.1074/jbc.M115.641159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26124274	Green Published, hybrid			2022-12-26	WOS:000360011800024
J	Boerlijst, MC; de Roos, AM				Boerlijst, Maarten C.; de Roos, Andre M.			Competition and Facilitation between a Disease and a Predator in a Stunted Prey Population	PLOS ONE			English	Article							LIGULA-INTESTINALIS CESTODA; ROACH RUTILUS-RUTILUS; PSEUDOPHYLLIDEA; PARASITES; ECOLOGY; HOST	The role of diseases and parasites has received relatively little attention in modelling ecological dynamics despite mounting evidence of their importance in structuring communities. In contrast to predators, parasites do not necessarily kill their host but instead they may change host life history. Here, we study the impact of a parasite that selectively infects juvenile prey individuals and prevents them from maturing into adults. The model is inspired by the Ligula intestinalis tape worm and its cyprinid fish host Rutilis rutilis. We demonstrate that the parasite can promote as well as demote the so-called stunting in its host population, that is, the accumulation of juvenile prey, which leads to strong exploitation competition and consequently to a bottleneck in maturation. If competition between infected and uninfected individuals is strong, stunting will be enhanced and bistability between a stunted and nonstunted prey population occurs. In this case, the disease competes with the predator of its host species, possibly leading to predator extinction. In contrast, if the competition between infected and uninfected individuals is weak, the stunting is relieved, and epi-zoonotic cycles will occur, with recurrent epidemic outbreaks. Here, the disease facilitates the predator, and predator density will be substantially increased. We discuss the implications of our results for the dynamics and structure of the natural Ligula-Roach system.	[Boerlijst, Maarten C.; de Roos, Andre M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Theoret Ecol, NL-1090 GE Amsterdam, Netherlands	University of Amsterdam	Boerlijst, MC (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Theoret Ecol, POB 94248, NL-1090 GE Amsterdam, Netherlands.	M.C.Boerlijst@uva.nl	De Roos, Andre M./A-1590-2008	De Roos, Andre M./0000-0002-6944-2048				Amundsen PA, 2009, J ANIM ECOL, V78, P563, DOI 10.1111/j.1365-2656.2008.01518.x; Boerlijst MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062033; Carter V, 2005, REPRODUCTION, V130, P939, DOI 10.1530/rep.1.00742; Collinge SK, 2006, DIS ECOLOGY COMMUNIT; de Roos A.M., 2013, MONOGRAPHS POPULATIO; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; de Roos AM, 2003, P ROY SOC B-BIOL SCI, V270, P611, DOI 10.1098/rspb.2002.2286; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Dobson AR, 2006, SFI S SCI C, P119; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Heins DC, 2011, J PARASITOL, V97, P371, DOI 10.1645/GE-2699.1; Hoole D, 2010, PARASITOLOGY, V137, P425, DOI 10.1017/S0031182010000107; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kennedy CR, 2009, PARASITOLOGY, V136, P1653, DOI 10.1017/S0031182009005794; Kennedy C. R., 1996, Field Studies, V8, P685; Kennedy CR, 2001, PARASITOLOGY, V123, P257, DOI 10.1017/S0031182001008538; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Loot G, 2001, J PARASITOL, V87, P1002, DOI 10.1645/0022-3395(2001)087[1002:PMORRR]2.0.CO;2; Loot G, 2001, ARCH HYDROBIOL, V152, P511; Loot G, 2006, BIOL J LINN SOC, V89, P99, DOI 10.1111/j.1095-8312.2006.00661.x; Ohlberger J, 2011, ECOLOGY, V92, P2175, DOI 10.1890/11-0410.1; Osfeld RS, 2008, INFECT DIS ECOL EFFE; Thomas F., 2005, PARASITISM ECOSYSTEM; van Kooten T, 2005, J THEOR BIOL, V237, P67, DOI 10.1016/j.jtbi.2005.03.032; Ylikarjula J, 1999, EVOL ECOL, V13, P433, DOI 10.1023/A:1006755702230	25	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132251	10.1371/journal.pone.0132251	http://dx.doi.org/10.1371/journal.pone.0132251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147293	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600225
J	Hobbs, JPA; Frisch, AJ; Newman, SJ; Wakefield, CB				Hobbs, Jean-Paul A.; Frisch, Ashley J.; Newman, Stephen J.; Wakefield, Corey B.			Selective Impact of Disease on Coral Communities: Outbreak of White Syndrome Causes Significant Total Mortality of Acropora Plate Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; INDO-PACIFIC; BAND DISEASE; WATER-FLOW; AUSTRALIA; CONSERVATION; BIODIVERSITY; ISLANDS; TAXA	Coral diseases represent a significant and increasing threat to coral reefs. Among the most destructive diseases is White Syndrome (WS), which is increasing in distribution and prevalence throughout the Indo-Pacific. The aim of this study was to determine taxonomic and spatial patterns in mortality rates of corals following the 2008 outbreak of WS at Christmas Island in the eastern Indian Ocean. WS mainly affected Acropora plate corals and caused total mortality of 36% of colonies across all surveyed sites and depths. Total mortality varied between sites but was generally much greater in the shallows (0-96% of colonies at 5 m depth) compared to deeper waters (0-30% of colonies at 20 m depth). Site-specific mortality rates were a reflection of the proportion of corals affected by WS at each site during the initial outbreak and were predicted by the initial cover of live Acropora plate cover. The WS outbreak had a selective impact on the coral community. Following the outbreak, live Acropora plate coral cover at 5 m depth decreased significantly from 7.0 to 0.8%, while the cover of other coral taxa remained unchanged. Observations five years after the initial outbreak revealed that total Acropora plate cover remained low and confirmed that corals that lost all their tissue due to WS did not recover. These results demonstrate that WS represents a significant and selective form of coral mortality and highlights the serious threat WS poses to coral reefs in the Indo-Pacific.	[Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia; [Frisch, Ashley J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Newman, Stephen J.; Wakefield, Corey B.] Govt Western Australia, Dept Fisheries, Western Australian Fisheries & Marine Res Labs, North Beach, WA, Australia	Curtin University; James Cook University; Government of Western Australia; Western Australian Fisheries & Marine Research Laboratories	Hobbs, JPA (corresponding author), Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia.	jp.hobbs@curtin.edu.au	Hobbs, Jean-Paul/I-8743-2012; Newman, Stephen/C-4507-2016	Hobbs, Jean-Paul/0000-0003-0331-354X; Newman, Stephen/0000-0002-5324-5568	Parks Australia North; Wet 'n' Dry Adventures	Parks Australia North; Wet 'n' Dry Adventures	Logistical and financial support for this study was provided by Parks Australia North and Wet 'n' Dry Adventures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; ANTONIUS A, 1985, Marine Ecology, V6, P197, DOI 10.1111/j.1439-0485.1985.tb00322.x; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Dalton SJ, 2006, CORAL REEFS, V25, P37, DOI 10.1007/s00338-005-0039-8; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Hartfield M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003277; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hobbs JPA, 2010, DIS AQUAT ORGAN, V89, P1, DOI 10.3354/dao02181; Hobbs JPA, 2014, MAR POLICY, V44, P149, DOI 10.1016/j.marpol.2013.08.020; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2011, CORAL REEFS, V30, P485, DOI 10.1007/s00338-010-0708-0; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Miller MW, 2007, CORAL REEFS, V26, P97, DOI 10.1007/s00338-006-0165-y; Muller EM, 2009, CORAL REEFS, V28, P757, DOI 10.1007/s00338-009-0504-x; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Richards ZT, 2014, RAFFLES B ZOOL, P376; Richards ZT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083965; Richards ZT, 2013, CORAL REEFS, V32, P287, DOI 10.1007/s00338-012-0963-3; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Roff G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026829; Ryan NM, 2014, RAFFLES B ZOOL, P399; SOONG KY, 1992, BIOL BULL, V183, P418, DOI 10.2307/1542018; Speed CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069863; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Veron J.E.N, 1986, CORALS AUSTR INDO PA; Williams GJ, 2011, DIS AQUAT ORGAN, V94, P89, DOI 10.3354/dao02323; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	39	18	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132528	10.1371/journal.pone.0132528	http://dx.doi.org/10.1371/journal.pone.0132528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147291	Green Published, gold, Green Accepted			2022-12-26	WOS:000358157600297
J	Maggiorani, D; Dissard, R; Belloy, M; Saulnier-Blache, JS; Casemayou, A; Ducasse, L; Gres, S; Belliere, J; Caubet, C; Bascands, JL; Schanstra, JP; Buffin-Meyer, B				Maggiorani, Damien; Dissard, Romain; Belloy, Marcy; Saulnier-Blache, Jean-Sebastien; Casemayou, Audrey; Ducasse, Laure; Gres, Sandra; Belliere, Julie; Caubet, Cecile; Bascands, Jean-Loup; Schanstra, Joost P.; Buffin-Meyer, Benedicte			Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; HYDRODYNAMIC-FORCES; ACTIN CYTOSKELETON; TIGHT JUNCTIONS; PRIMARY CILIUM; KIDNEY; EXPRESSION; FIBROSIS; HYPERFILTRATION; TYPE-1	Tubular epithelial cells in the kidney are continuously exposed to urinary fluid shear stress (FSS) generated by urine movement and recent in vitro studies suggest that changes of FSS could contribute to kidney injury. However it is unclear whether FSS alters the epithelial characteristics of the renal tubule. Here, we evaluated in vitro and in vivo the influence of FSS on epithelial characteristics of renal proximal tubular cells taking the organization of junctional complexes and the presence of the primary cilium as markers of epithelial phenotype. Human tubular cells (HK-2) were subjected to FSS (0.5 Pa) for 48h. Control cells were maintained under static conditions. Markers of tight junctions (Claudin-2, ZO-1), Par polarity complex (Pard6), adherens junctions (E-Cadherin, beta-Catenin) and the primary cilium (alpha-acetylated Tubulin) were analysed by quantitative PCR, Western blot or immunocytochemistry. In response to FSS, Claudin-2 disappeared and ZO-1 displayed punctuated and discontinuous staining in the plasma membrane. Expression of Pard6 was also decreased. Moreover, E-Cadherin abundance was decreased, while its major repressors Snail1 and Snail2 were overexpressed, and beta-Catenin staining was disrupted along the cell periphery. Finally, FSS subjected-cells exhibited disappeared primary cilium. Results were confirmed in vivo in a uninephrectomy (8 months) mouse model where increased FSS induced by adaptive hyperfiltration in remnant kidney was accompanied by both decreased epithelial gene expression including ZO-1, E-cadherin and beta-Catenin and disappearance of tubular cilia. In conclusion, these results show that proximal tubular cells lose an important number of their epithelial characteristics after long term exposure to FSS both in vitro and in vivo. Thus, the changes in urinary FSS associated with nephropathies should be considered as potential insults for tubular cells leading to disorganization of the tubular epithelium.	[Maggiorani, Damien; Dissard, Romain; Belloy, Marcy; Saulnier-Blache, Jean-Sebastien; Casemayou, Audrey; Ducasse, Laure; Gres, Sandra; Belliere, Julie; Caubet, Cecile; Bascands, Jean-Loup; Schanstra, Joost P.; Buffin-Meyer, Benedicte] Fac Med Toulouse, INSERM, U1048, F-31073 Toulouse, France; [Maggiorani, Damien; Dissard, Romain; Belloy, Marcy; Saulnier-Blache, Jean-Sebastien; Casemayou, Audrey; Ducasse, Laure; Gres, Sandra; Belliere, Julie; Caubet, Cecile; Bascands, Jean-Loup; Schanstra, Joost P.; Buffin-Meyer, Benedicte] Univ Toulouse 3, Inst Metab & Cardiovasc Dis I2MC, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Buffin-Meyer, B (corresponding author), Fac Med Toulouse, INSERM, U1048, U317, F-31073 Toulouse, France.	benedicte.buffin-meyer@inserm.fr	Buffin-Meyer, Bénédicte/X-7705-2018; Schanstra, Joost P/X-7724-2018; Saulnier-Blache, Jean Sebastien/X-7729-2018	Buffin-Meyer, Bénédicte/0000-0002-4805-1558; Schanstra, Joost P/0000-0002-7471-372X; Saulnier-Blache, Jean Sebastien/0000-0002-8971-7723; Bascands, Jean-loup/0000-0002-1667-5913	association 111 des Arts (France)	association 111 des Arts (France)	The authors thank the association 111 des Arts (France) for funding. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed A, 2014, KIDNEY INT; Ardura JA, 2010, J AM SOC NEPHROL, V21, P237, DOI 10.1681/ASN.2009050462; Belliere J, 2014, J AM SOC NEPHROL; Blantz RC, 2014, ADV CHRONIC KIDNEY D, V21, P297, DOI 10.1053/j.ackd.2014.03.006; Bolati D, 2012, J RENAL NUTR, V22, P176, DOI 10.1053/j.jrn.2011.10.015; Bondeva T, 2012, AM J NEPHROL, V35, P442, DOI 10.1159/000337922; BONVALET JP, 1981, J PHYSIOL-LONDON, V318, P85; BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Carrisoza-Gaytan R, 2014, AM J PHYSIOL-RENAL, V307, pF195, DOI 10.1152/ajprenal.00634.2013; Cattaneo I, 2011, CELL PHYSIOL BIOCHEM, V28, P673, DOI 10.1159/000335813; Dankers PYW, 2011, J CONTROL RELEASE, V152, P177, DOI 10.1016/j.jconrel.2011.01.034; Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020; Denker BM, 2011, J AM SOC NEPHROL, V22, P622, DOI 10.1681/ASN.2010090922; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Duan Y, 2010, P NATL ACAD SCI USA, V107, P21860, DOI 10.1073/pnas.1015751107; Eddy AA, 2002, AM J PHYSIOL-RENAL, V283, pF209, DOI 10.1152/ajprenal.00032.2002; Essig M, 2001, AM J PHYSIOL-RENAL, V281, pF751, DOI 10.1152/ajprenal.2001.281.4.F751; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Frohlich EM, 2012, INTEGR BIOL-UK, V4, P75, DOI 10.1039/c1ib00096a; Gonzalez J, 2013, M S-MED SCI, V29, P279, DOI 10.1051/medsci/2013293014; Grabias BM, 2014, AM J PHYSIOL-RENAL, V306, pF473, DOI 10.1152/ajprenal.00503.2013; Grabias BM, 2012, FASEB J, V26, P4131, DOI 10.1096/fj.12-207324; Hinnebusch BF, 2002, J GASTROINTEST SURG, V6, P403, DOI 10.1016/S1091-255X(01)00076-2; Holtzclaw JD, 2010, AM J PHYSIOL-RENAL, V299, pF507, DOI 10.1152/ajprenal.00222.2010; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Huang B, 2012, CELLS TISSUES ORGANS, V195, P296, DOI 10.1159/000327530; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Jansen JHW, 2004, J CELL BIOCHEM, V93, P542, DOI 10.1002/jcb.20162; Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9; Kim MK, 2013, INT J CLIN EXP PATHO, V6, P1747; Kolb RJ, 2004, HYPERTENSION, V44, P352, DOI 10.1161/01.HYP.0000136645.90116.1a; Krouwer VJD, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-12; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Luo DD, 2009, NEPHROL DIAL TRANSPL, V24, P2655, DOI 10.1093/ndt/gfp208; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Makino A, 2006, AM J PHYSIOL-CELL PH, V290, pC1633, DOI 10.1152/ajpcell.00576.2005; Martin JA, 2004, J GERONTOL A-BIOL, V59, P324; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miravete M, 2012, AM J PHYSIOL-RENAL, V302, pF1409, DOI 10.1152/ajprenal.00409.2011; Miravete M, 2011, BIOCHEM BIOPH RES CO, V407, P813, DOI 10.1016/j.bbrc.2011.03.105; Molina-Jijon E, 2014, FREE RADICAL BIO MED, V72, P162, DOI 10.1016/j.freeradbiomed.2014.03.040; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Rozycki M, 2014, MOL BIOL CELL, V25, P643, DOI 10.1091/mbc.E13-07-0429; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Satriano J, 2010, AM J PHYSIOL-CELL PH, V299, pC374, DOI 10.1152/ajpcell.00096.2010; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Sharma A, 2014, NEPHRON CLIN PRACT, V127, P94, DOI 10.1159/000363721; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Szaszi K, 2014, INT REV CEL MOL BIO, V308, P205, DOI 10.1016/B978-0-12-800097-7.00006-3; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945; Verghese E, 2008, NEPHROL DIAL TRANSPL, V23, P834, DOI 10.1093/ndt/gfm743; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; Vongwiwatana A, 2005, AM J TRANSPLANT, V5, P1367, DOI 10.1111/j.1600-6143.2005.00843.x; Wang SX, 2013, AM J PHYSIOL-RENAL, V305, pF1085, DOI 10.1152/ajprenal.00399.2013; Warboys CM, 2014, ARTERIOSCL THROM VAS, V34, P985, DOI 10.1161/ATVBAHA.114.303415; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6; Xiao C, 2010, AM J PHYSIOL-GASTR L, V299, pG1252, DOI 10.1152/ajpgi.00512.2009; Yang GK, 2014, DIABETES CARE, V37, P2774, DOI 10.2337/dc14-0798; YOSHIDA Y, 1988, KIDNEY INT, V33, P855, DOI 10.1038/ki.1988.77	73	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131416	10.1371/journal.pone.0131416	http://dx.doi.org/10.1371/journal.pone.0131416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146837	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600095
J	Beaney, KE; Cooper, JA; Shahid, SU; Ahmed, W; Qamar, R; Drenos, F; Crockard, MA; Humphries, SE				Beaney, Katherine E.; Cooper, Jackie A.; Shahid, Saleem Ullah; Ahmed, Waqas; Qamar, Raheel; Drenos, Fotios; Crockard, Martin A.; Humphries, Steve E.			Clinical Utility of a Coronary Heart Disease Risk Prediction Gene Score in UK Healthy Middle Aged Men and in the Pakistani Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; ASSOCIATION; LOCUS; METAANALYSIS; VALIDATION; VARIANTS; EPIDEMIC	Background Numerous risk prediction algorithms based on conventional risk factors for Coronary Heart Disease (CHD) are available but provide only modest discrimination. The inclusion of genetic information may improve clinical utility. Methods We tested the use of two gene scores (GS) in the prospective second Northwick Park Heart Study (NPHSII) of 2775 healthy UK men (284 cases), and Pakistani case-control studies from Islamabad/Rawalpindi (321 cases/228 controls) and Lahore (414 cases/219 controls). The 19-SNP GS included SNPs in loci identified by GWAS and candidate gene studies, while the 13-SNP GS only included SNPs in loci identified by the CARDIoGRAMplusC4D consortium. Results In NPHSII, the mean of both gene scores was higher in those who went on to develop CHD over 13.5 years of follow-up (19-SNP p=0.01, 13-SNP p=7x10(-3)). In combination with the Framingham algorithm the GSs appeared to show improvement in discrimination (increase in area under the ROC curve, 19-SNP p=0.48, 13-SNP p=0.82) and risk classification (net reclassification improvement (NRI), 19-SNP p=0.28, 13-SNP p=0.42) compared to the Framingham algorithm alone, but these were not statistically significant. When considering only individuals who moved up a risk category with inclusion of the GS, the improvement in risk classification was statistically significant (19-SNP p=0.01, 13-SNP p=0.04). In the Pakistani samples, risk allele frequencies were significantly lower compared to NPHSII for 13/19 SNPs. In the Islamabad study, the mean gene score was higher in cases than controls only for the 13-SNP GS (2.24 v 2.34, p=0.04). There was no association with CHD and either score in the Lahore study. Conclusion The performance of both GSs showed potential clinical utility in European men but much less utility in subjects from Pakistan, suggesting that a different set of risk loci or SNPs may be required for risk prediction in the South Asian population.	[Beaney, Katherine E.; Cooper, Jackie A.; Drenos, Fotios; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, British Heart Fdn Labs, Ctr Cardiovasc Genet, London, England; [Shahid, Saleem Ullah] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan; [Ahmed, Waqas] Univ Haripur, Dept Microbiol, Haripur, Pakistan; [Qamar, Raheel] COMSATS Inst Informat Technol, Islamabad, Pakistan; [Drenos, Fotios] Univ Bristol, Sch Social & Community Med, Integrat Epidemiol Unit, Bristol, Avon, England; [Crockard, Martin A.] Randox Labs Ltd, Mol Diagnost Grp, Crumlin, Ireland	University of London; University College London; University of Punjab; COMSATS University Islamabad (CUI); University of Bristol; Randox Laboratories	Humphries, SE (corresponding author), UCL, Inst Cardiovasc Sci, British Heart Fdn Labs, Ctr Cardiovasc Genet, Univ St, London, England.	steve.humphries@ucl.ac.uk	ahmed, waqas/AAD-9962-2020	Humphries, Stephen E/0000-0002-8221-6547; Drenos, Fotios/0000-0003-2469-5516	Medical Research Council CASE award with Randox Laboratories [1270920]; Higher Education Commisson Pakistan [IRSIP 24 BMS 41]; British Heart Foundation [RG008/08]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; British Medical Research Council; US National Institutes of Health [NHLBI 33014]; Du Pont Pharma, Wilmington Delaware; Medical Research Council [MC_UU_12013/5, 1270920] Funding Source: researchfish; MRC [MC_UU_12013/5] Funding Source: UKRI	Medical Research Council CASE award with Randox Laboratories(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Education Commisson Pakistan; British Heart Foundation(British Heart Foundation); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Du Pont Pharma, Wilmington Delaware; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KEB is supported by a Medical Research Council CASE award (1270920) with Randox Laboratories. SUS is supported by Higher Education Commisson Pakistan (IRSIP 24 BMS 41). SEH is a British Heart Foundation Professor and he and JAC are supported by the British Heart Foundation (RG008/08) and by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. NPHSII was supported by the British Medical Research Council, the US National Institutes of Health [grant number NHLBI 33014] and Du Pont Pharma, Wilmington Delaware. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2014, R LANG ENV STAT COMP; Aziz KU, 2008, PAK HEART J, V41, P11; Bakhru A, 2005, PLOS MED, V2, P528, DOI 10.1371/journal.pmed.0020160; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Casas JP, 2006, ANN HUM GENET, V70, P145, DOI 10.1111/j.1469-1809.2005.00241.x; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooper JA, 2005, ATHEROSCLEROSIS, V181, P93, DOI 10.1016/j.atherosclerosis.2004.12.026; Davies RW, 2010, CIRC-CARDIOVASC GENE, V3, P468, DOI 10.1161/CIRCGENETICS.110.946269; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Harrison SC, 2012, EUR HEART J, V33, P881, DOI 10.1093/eurheartj/ehr075; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hughes MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040922; IBMCorp, 2013, IBM SPSS STAT WIND V; Iqbal R, 2014, MOL BIOL REP, V41, P1545, DOI 10.1007/s11033-013-3000-x; Jafar TH, 2008, HEART, V94, P408, DOI 10.1136/hrt.2007.120774; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; MILLER GJ, 1995, THROMB HAEMOSTASIS, V73, P82; National Clinical Guideline Center, 2014, LIP MOD CARD RISK AS; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Sagoo GS, 2008, AM J EPIDEMIOL, V168, P1233, DOI 10.1093/aje/kwn235; Saleheen D, 2010, ARTERIOSCL THROM VAS, V30, P1467, DOI 10.1161/ATVBAHA.109.197210; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Schierer A, 2012, PHARMACOGENET GENOM, V22, P95, DOI 10.1097/FPC.0b013e32834dc9ef; StataCorp, 2013, STAT STAT SOFTW REL; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Talmud PJ, 2005, J BIOL CHEM, V280, P28215, DOI 10.1074/jbc.M502144200; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	44	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130754	10.1371/journal.pone.0130754	http://dx.doi.org/10.1371/journal.pone.0130754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133560	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400026
J	Carnemolla, A; Lazell, H; Moussaoui, S; Bates, GP				Carnemolla, Alisia; Lazell, Hayley; Moussaoui, Saliha; Bates, Gillian P.			In Vivo Profiling Reveals a Competent Heat Shock Response in Adult Neurons: Implications for Neurodegenerative Disorders	PLOS ONE			English	Article							HUNTINGTON DISEASE; STRESS-RESPONSE; REGULATORY DIFFERENCES; GENE-TRANSCRIPTION; MOUSE; PROTEIN; CELLS; DYSFUNCTION; IMPAIRMENT; TRIALS	The heat shock response (HSR) is the main pathway used by cells to counteract proteotoxicity. The inability of differentiated neurons to induce an HSR has been documented in primary neuronal cultures and has been proposed to play a critical role in ageing and neurodegeneration. However, this accepted dogma has not been demonstrated in vivo. We used BAC transgenic mice generated by the Gene Expression Nervous System Atlas project to investigate the capacity of striatal medium sized spiny neurons to induce an HSR as compared to that of astrocytes and oligodendrocytes. We found that all cell populations were competent to induce an HSR upon HSP90 inhibition. We also show the presence and relative abundance of heat shock-related genes and proteins in these striatal cell populations. The identification of a competent HSR in adult neurons supports the development of therapeutics that target the HSR pathway as treatments for neurodegenerative disorders.	[Carnemolla, Alisia; Lazell, Hayley; Bates, Gillian P.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England; [Moussaoui, Saliha] Novartis Inst Biomed Sci, Neurosci Discovery, CH-4002 Basel, Switzerland	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Novartis	Bates, GP (corresponding author), Kings Coll London, Guys Hosp, Dept Med & Mol Genet, 8th Floor Tower Wing, London SE1 9RT, England.	gillian.bates@kcl.ac.uk	Carnemolla, Alisia/AAV-2154-2021; Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305	Medical Research Council [G0801314]; Novartis; MRC [G0801314] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (G0801314). Novartis provided support in the form of salary for author SM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Batulan Z, 2003, J NEUROSCI, V23, P5789; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bouchama A, 2001, INTENS CARE MED, V27, P680, DOI 10.1007/s001340100906; Carnemolla A, 2014, HUM MOL GENET, V23, P3641, DOI 10.1093/hmg/ddu073; Crook ZR, 2012, P NATL ACAD SCI USA, V109, P7487, DOI 10.1073/pnas.1204542109; DHOPESH VP, 1976, NEW ENGL J MED, V294, P557; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Gay L, 2013, GENE DEV, V27, P98, DOI 10.1101/gad.205278.112; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Kaarniranta K, 2002, MOL BRAIN RES, V101, P136, DOI 10.1016/S0169-328X(02)00179-1; Khong T, 2011, MOL CANCER THER, V10, P1909, DOI 10.1158/1535-7163.MCT-11-0174; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Marcuccilli CJ, 1996, J NEUROSCI, V16, P478; Menezes DL, 2012, MOL CANCER THER, V11, P730, DOI 10.1158/1535-7163.MCT-11-0667; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Zhou PZ, 2013, P NATL ACAD SCI USA, V110, P15395, DOI 10.1073/pnas.1304124110	30	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131985	10.1371/journal.pone.0131985	http://dx.doi.org/10.1371/journal.pone.0131985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134141	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400089
J	Colson, KE; Zuniga-Brenes, P; Rios-Zertuche, D; Conde-Glez, CJ; Gagnier, MC; Palmisano, E; Ranganathan, D; Usmanova, G; Salvatierra, B; Nazar, A; Tristao, I; Monin, ES; Anderson, BW; Haakenstad, A; Murphy, T; Lim, S; Hernandez, B; Lozano, R; Iriarte, E; Mokdad, AH				Colson, K. Ellicott; Zuniga-Brenes, Paola; Rios-Zertuche, Diego; Conde-Glez, Carlos J.; Gagnier, Marielle C.; Palmisano, Erin; Ranganathan, Dharani; Usmanova, Gulnoza; Salvatierra, Benito; Nazar, Austreberta; Tristao, Ignez; Sanchez Monin, Emmanuelle; Anderson, Brent W.; Haakenstad, Annie; Murphy, Tasha; Lim, Stephen; Hernandez, Bernardo; Lozano, Rafael; Iriarte, Emma; Mokdad, Ali H.			Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamerica 2015	PLOS ONE			English	Article							DRIED BLOOD SPOTS; VACCINATION COVERAGE; VALIDITY; PROGRESS; CHILDREN; FUTURE; CARDS	Timely and accurate measurement of population protection against measles is critical for decision-making and prevention of outbreaks. However, little is known about how survey-based estimates of immunization (crude coverage) compare to the seroprevalence of antibodies (effective coverage), particularly in low-resource settings. In poor areas of Mexico and Nicaragua, we used household surveys to gather information on measles immunization from child health cards and caregiver recall. We also collected dried blood spots (DBS) from children aged 12 to 23 months to compare crude and effective coverage of measles immunization. We used survey-weighted logistic regression to identify individual, maternal, household, community, and health facility characteristics that predict gaps between crude coverage and effective coverage. We found that crude coverage was significantly higher than effective coverage (83% versus 68% in Mexico; 85% versus 50% in Nicaragua). A large proportion of children (19% in Mexico; 43% in Nicaragua) had health card documentation of measles immunization but lacked antibodies. These discrepancies varied from 0% to 100% across municipalities in each country. In multivariate analyses, card-positive children in Mexico were more likely to lack antibodies if they resided in urban areas or the jurisdiction of De Los Llanos. In contrast, card-positive children in Nicaragua were more likely to lack antibodies if they resided in rural areas or the North Atlantic region, had low weight-for-age, or attended health facilities with a greater number of refrigerators. Findings highlight that reliance on child health cards to measure population protection against measles is unwise. We call for the evaluation of immunization programs using serological methods, especially in poor areas where the cold chain is likely to be compromised. Identification of within-country variation in effective coverage of measles immunization will allow researchers and public health professionals to address challenges in current immunization programs.	[Colson, K. Ellicott] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Gagnier, Marielle C.; Palmisano, Erin; Usmanova, Gulnoza; Haakenstad, Annie; Lim, Stephen; Hernandez, Bernardo; Lozano, Rafael; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Zuniga-Brenes, Paola; Rios-Zertuche, Diego; Tristao, Ignez; Sanchez Monin, Emmanuelle; Iriarte, Emma] Inter Amer Dev Bank, Salud Mesoamer 2015, Panama City, Panama; [Conde-Glez, Carlos J.; Lozano, Rafael] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Ranganathan, Dharani] George Washington Univ, Washington, DC USA; [Salvatierra, Benito; Nazar, Austreberta] El Colegio Frontera Sur Mexico, San Cristobal de las Casa, Chiapas, Mexico; [Anderson, Brent W.] Cty Napa Hlth & Human Serv, Dept Publ Hlth, Napa, CA USA; [Murphy, Tasha] Univ Washington, Sch Social Work, Seattle, WA 98195 USA	University of California System; University of California Berkeley; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Instituto Nacional de Salud Publica; George Washington University; El Colegio de la Frontera Sur (ECOSUR); University of Washington; University of Washington Seattle	Iriarte, E (corresponding author), Inter Amer Dev Bank, Salud Mesoamer 2015, Panama City, Panama.	emmai@iadb.org; mokdaa@uw.edu	Lozano, Rafael/T-5352-2018; Mokdad, Ali H./AAD-1232-2022; Rios-Zertuche, Diego/AAG-2710-2020; Prado, Bernardo Hernandez/AAG-9292-2019	Lozano, Rafael/0000-0002-7356-8823; Mokdad, Ali H./0000-0002-4994-3339; Rios-Zertuche, Diego/0000-0003-1853-728X; Prado, Bernardo Hernandez/0000-0002-5960-8841	Bill AMP; Melinda Gates Foundation; Spanish Agency for International Development Cooperation; Carlos Slim Health Institute	Bill AMP; Melinda Gates Foundation(CGIAR); Spanish Agency for International Development Cooperation(Spanish Government); Carlos Slim Health Institute	Funding for this study came from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/), the Spanish Agency for International Development Cooperation (http://www.aecid.es/EN/aecid), and the Carlos Slim Health Institute (http://www.salud.carlosslim.org/english/). Funds were managed and disbursed by the Inter-American Development Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Collaborative Study by the Ministries of Health of Brazil Chile Costa Rica Ecuador and the Pan American Health Organization, 1982, B PAN AM HLTH ORG, P16; Colson KE, 2015, J MED VIROL IN PRESS; Cutts FT, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001404; de Quadros CA, 2003, J INFECT DIS, V187, pS102, DOI 10.1086/368032; Division of Reproductive Health-Centers for Disease Control and Prevention (CDC) National Institute for Development Information (Nicaragua), 2007, NIC REPR HLTH SURV 2; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Hayford KT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1211; Helfand RF, 1999, CLIN DIAGN LAB IMMUN, V6, P178, DOI 10.1128/CDLI.6.2.178-180.1999; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luman ET, 2009, VACCINE, V27, P2534, DOI 10.1016/j.vaccine.2008.10.002; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Mexican Ministry of Health, 2006, EFF COV HLTH SYST ME; Miles M, 2013, VACCINE, V31, P1560, DOI 10.1016/j.vaccine.2012.10.089; Ministry of Health (Nicaragua) National Institute for Development Information (Nicaragua), 2012, NIC NAT DEM HLTH SUR; Ministry of Health (Nicaragua) National Institute for Development Information (Nicaragua), 2005, LIV STAND MEAS SURV; Mokdad AH, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0034-4; National Institute for Public Health (Mexico), 2006, MEX NAT SURV HLTH NU; National Institute of Public Health (Mexico), 2012, MEX NAT SURV HLTH NU; National Institute of Statistics and Censuses (Nicaragua) Ministry of Health (Nicaragua) Macro International Inc., 2001, NIC DEM HLTH SURV 20; National Research Council (US), 2008, BIOSOCIAL SURVEYS; Novello F, 1996, J VIROL METHODS, V61, P73, DOI 10.1016/0166-0934(96)02071-X; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Pomelova V. G., 2007, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P10; Ruiz-Gomez J, 2007, SALUD PUBLICA MEXICO, V49, pS370, DOI 10.1590/S0036-36342007000900008; Samoilovich Ye. O., 2008, Voprosy Virusologii, V53, P46; Santos JI, 2004, J INFECT DIS, V189, pS243, DOI 10.1086/378520; Snijdewind IJM, 2012, ANTIVIR RES, V93, P309, DOI 10.1016/j.antiviral.2011.12.011; Spooner N, 2010, BIOANALYSIS, V2, P1343, DOI [10.4155/bio.10.111, 10.4155/BIO.10.111]; Waibale P, 1999, INT J EPIDEMIOL, V28, P341, DOI 10.1093/ije/28.2.341; World Health Organization, 2009, IMM BAS IMM SER MOD; World Health Organization (WHO), 2014, WHO VACC PREV DIS MO; World Health Organization (WHO), REP MEASL CAS INC RA	34	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130697	10.1371/journal.pone.0130697	http://dx.doi.org/10.1371/journal.pone.0130697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136239	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400023
J	Fukuma, R; Yanagisawa, T; Yorifuji, S; Kato, R; Yokoi, H; Hirata, M; Saitoh, Y; Kishima, H; Kamitani, Y; Yoshimine, T				Fukuma, Ryohei; Yanagisawa, Takufumi; Yorifuji, Shiro; Kato, Ryu; Yokoi, Hiroshi; Hirata, Masayuki; Saitoh, Youichi; Kishima, Haruhiko; Kamitani, Yukiyasu; Yoshimine, Toshiki			Closed-Loop Control of a Neuroprosthetic Hand by Magnetoencephalographic Signals	PLOS ONE			English	Article							2-DIMENSIONAL MOVEMENT TRAJECTORIES; INDIVIDUAL FINGER MOVEMENTS; MEG; RECORDINGS; SYSTEM; GRASP; ARM	Objective A neuroprosthesis using a brain-machine interface (BMI) is a promising therapeutic option for severely paralyzed patients, but the ability to control it may vary among individual patients and needs to be evaluated before any invasive procedure is undertaken. We have developed a neuroprosthetic hand that can be controlled by magnetoencephalographic (MEG) signals to noninvasively evaluate subjects' ability to control a neuroprosthesis. Method Six nonparalyzed subjects performed grasping or opening movements of their right hand while the slow components of the MEG signals (SMFs) were recorded in an open-loop condition. The SMFs were used to train two decoders to infer the timing and types of movement by support vector machine and Gaussian process regression. The SMFs were also used to calculate estimated slow cortical potentials (eSCPs) to identify the origin of motor information. Finally, using the trained decoders, the subjects controlled a neuroprosthetic hand in a closed-loop condition. Results The SMFs in the open-loop condition revealed movement-related cortical field characteristics and successfully inferred the movement type with an accuracy of 75.0 +/- 12.9% (mean +/- SD). In particular, the eSCPs in the sensorimotor cortex contralateral to the moved hand varied significantly enough among the movement types to be decoded with an accuracy of 76.5 +/- 10.6%, which was significantly higher than the accuracy associated with eSCPs in the ipsilateral sensorimotor cortex (58.1 +/- 13.7%; p = 0.0072, paired two-tailed Student's t-test). Moreover, another decoder using SMFs successfully inferred when the accuracy was the greatest. Combining these two decoders allowed the neuroprosthetic hand to be controlled in a closed-loop condition. Conclusions Use of real-time MEG signals was shown to successfully control the neuroprosthetic hand. The developed system may be useful for evaluating movement-related slow cortical potentials of severely paralyzed patients to predict the efficacy of invasive BMI.	[Fukuma, Ryohei; Yanagisawa, Takufumi; Hirata, Masayuki; Saitoh, Youichi; Kishima, Haruhiko; Yoshimine, Toshiki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka, Japan; [Fukuma, Ryohei; Yanagisawa, Takufumi; Kamitani, Yukiyasu] ATR Computat Neurosci Labs, Dept Neuroinformat, Kyoto, Japan; [Fukuma, Ryohei; Kamitani, Yukiyasu] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Yanagisawa, Takufumi; Yorifuji, Shiro] Osaka Univ, Grad Sch Med, Div Funct Diagnost Sci, Suita, Osaka, Japan; [Kato, Ryu] Yokohama Natl Univ, Div Syst Res, Yokohama, Kanagawa 240, Japan; [Yokoi, Hiroshi] Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo 182, Japan; [Saitoh, Youichi] Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, Suita, Osaka, Japan; [Kamitani, Yukiyasu] Kyoto Univ, Grad Sch Informat, Kyoto, Japan	Osaka University; Nara Institute of Science & Technology; Osaka University; Yokohama National University; University of Electro-Communications - Japan; Osaka University; Kyoto University	Yanagisawa, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka, Japan.	tyanagisawa@nsurg.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24700419]; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS); Strategic Research Program for Brain Sciences (SRPBS) from Japan Agency for Medical Research and Development (AMED); "HISHO 30" Top Thirty Young Researchers of Osaka University program; ImPACT Program from Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS); Strategic Research Program for Brain Sciences (SRPBS) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); "HISHO 30" Top Thirty Young Researchers of Osaka University program; ImPACT Program from Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	Funding was provided to T. Yanagisawa and YK by the Grants-in-Aid for Scientific Research (KAKENHI) program (24700419) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) and the Strategic Research Program for Brain Sciences (SRPBS) from the Japan Agency for Medical Research and Development (AMED), the "HISHO 30" Top Thirty Young Researchers of Osaka University program, and the ImPACT Program from the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe HA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00121; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Bradberry TJ, 2009, NEUROIMAGE, V47, P1691, DOI 10.1016/j.neuroimage.2009.06.023; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Horki P, 2011, MED BIOL ENG COMPUT, V49, P567, DOI 10.1007/s11517-011-0750-2; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Lembke G, 2014, BIOMED OPT EXPRESS, V5, P876, DOI 10.1364/BOE.5.000876; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054658; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Quandt F, 2012, NEUROIMAGE, V59, P3316, DOI 10.1016/j.neuroimage.2011.11.053; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Rasmussen CE, 2010, J MACH LEARN RES, V11, P3011; Rasmussen CE, 2006, INT J NEURAL SYSTEMS; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Shah VK, 2013, PHYS MED BIOL, V58, P8153, DOI 10.1088/0031-9155/58/22/8153; Shen GH, 2014, EUR J NEUROSCI, V39, P2071, DOI 10.1111/ejn.12547; Soekadar SR, 2011, IEEE T NEUR SYS REH, V19, P542, DOI 10.1109/TNSRE.2011.2166809; Sugata H, 2012, BRAIN RES, V1468, P29, DOI 10.1016/j.brainres.2012.05.053; Thomas E, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/031001; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Waldert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049266; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Whelan R, 2014, BIOL PSYCHIAT, V75, P746, DOI 10.1016/j.biopsych.2013.05.014; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Yanagisawa T, 2011, J NEUROSURG, V114, P1715, DOI 10.3171/2011.1.JNS101421; Yeom HG, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026006	38	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131547	10.1371/journal.pone.0131547	http://dx.doi.org/10.1371/journal.pone.0131547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134845	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400054
J	Walker, BS; Nelson, RE; Jackson, BR; Grenache, DG; Ashwood, ER; Schmidt, RL				Walker, Brandon S.; Nelson, Richard E.; Jackson, Brian R.; Grenache, David G.; Ashwood, Edward R.; Schmidt, Robert L.			A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States	PLOS ONE			English	Article							CELL-FREE DNA; LIVE BIRTH PREVALENCE; DOWN-SYNDROME; POPULATION; DIAGNOSIS; TRISOMY-13; SURVIVAL; IMPLEMENTATION; 1ST-TRIMESTER; AMNIOCENTESIS	Background Non-invasive prenatal testing (NIPT) is a relatively new technology for diagnosis of fetal aneuploidies. NIPT is more accurate than conventional maternal serum screening (MSS) but is also more costly. Contingent NIPT may provide a cost-effective alternative to universal NIPT screening. Contingent screening used a two-stage process in which risk is assessed by MSS in the first stage and, based on a risk cutoff, high-risk pregnancies are referred for NIPT. The objective of this study was to (1) determine the optimum MSS risk cutoff for contingent NIPT and (2) compare the cost effectiveness of optimized contingent NIPT to universal NIPT and conventional MSS. Study Design Decision-analytic model using micro-simulation and probabilistic sensitivity analysis. We evaluated cost effectiveness from three perspectives: societal, governmental, and payer. Results From a societal perspective, universal NIPT dominated both contingent NIPT and MSS. From a government and payer perspective, contingent NIPT dominated MSS. Compared to contingent NIPT, adopting a universal NIPT would cost $203,088 for each additional case detected from a government perspective and $263,922 for each additional case detected from a payer perspective. Conclusions From a societal perspective, universal NIPT is a cost-effective alternative to MSS and contingent NIPT. When viewed from narrower perspectives, contingent NIPT is less costly than universal NIPT and provides a cost-effective alternative to MSS.	[Walker, Brandon S.; Jackson, Brian R.; Grenache, David G.; Ashwood, Edward R.; Schmidt, Robert L.] ARUP Labs, Salt Lake City, UT USA; [Nelson, Richard E.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Jackson, Brian R.; Grenache, David G.] Dept Pathol, Salt Lake City, UT USA; [Ashwood, Edward R.; Schmidt, Robert L.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Schmidt, RL (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	Robert.Schmidt@hsc.utah.edu						Agarwal A, 2013, PRENATAL DIAG, V33, P521, DOI 10.1002/pd.4101; Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; [Anonymous], PERS CONS EXP IND; [Anonymous], 2012, TREEAGE PRO 2012; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Baker D, 2004, GENET MED, V6, P211, DOI 10.1097/01.GIM.0000132684.94642.A0; Benn PA, 1998, PRENATAL DIAG, V18, P319, DOI 10.1002/(SICI)1097-0223(199804)18:4<319::AID-PD261>3.0.CO;2-Q; Bestwick JP, 2013, J MED SCREEN, V20, P57, DOI 10.1177/0969141313484904; Beulen L, 2014, EUR J OBSTET GYN R B, V182, P53, DOI 10.1016/j.ejogrb.2014.08.028; Bishop J, 1997, AM J EPIDEMIOL, V145, P134; Brewer C M, 2002, J Med Genet, V39, pe54, DOI 10.1136/jmg.39.9.e54; Briggs A, 2006, DECISION MODELLING H; Bureau of Labor Statistics, EMPL COST IND; Caruso TM, 1998, GENET MED, V1, P22; Centers for Disease Control and Prevention. National Center for Health Statistics, 2012, VITALSTATS; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Comas C, 2014, J MATERN-FETAL NEO M, V12, P1; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; Cunningham GC, 1999, GENET MED, V1, P199; Currier R, 2012, PRENATAL DIAG, V32, P1077, DOI 10.1002/pd.3961; Day SM, 2005, DEV MED CHILD NEUROL, V47, P171, DOI 10.1017/S0012162205000319; de la Vega Alberto, 2002, P R Health Sci J, V21, P233; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Forrester MB, 1999, PRENATAL DIAG, V19, P136, DOI 10.1002/(SICI)1097-0223(199902)19:2<136::AID-PD479>3.3.CO;2-Q; Forrester MB, 2002, TERATOLOGY, V66, pS7, DOI 10.1002/tera.90003; Forrester MB, 1999, GENET TEST, V3, P335, DOI 10.1089/gte.1999.3.335; Garfield SS, 2012, J MANAG CARE MED, V15, P32; Gil MM, 2014, FETAL DIAGN THER, V35, P156, DOI 10.1159/000358326; Gil MM, 2013, ULTRASOUND OBST GYN, V42, P34, DOI 10.1002/uog.12504; Gold MR, 1996, COST EFFECTIVENESS H; Horger EO, 2001, AM J OBSTET GYNECOL, V185, P279, DOI 10.1067/mob.2001.116737; Hui L, 2015, ULTRASOUND OBST GYN, V45, P10, DOI 10.1002/uog.14699; Jones RK, 2011, PERSPECT SEX REPRO H, V43, P41, DOI 10.1363/4304111; Kazerouni NN, 2009, OBSTET GYNECOL, V114, P50, DOI 10.1097/AOG.0b013e3181a9479e; Knight GJ, 2005, PRENATAL DIAG, V25, P1162, DOI 10.1002/pd.1305; Kramer RL, 1998, AM J MED GENET, V79, P172, DOI 10.1002/(SICI)1096-8628(19980923)79:3<172::AID-AJMG4>3.0.CO;2-P; Kucik JE, 2013, PEDIATRICS, V131, pE27, DOI 10.1542/peds.2012-1616; Langreth R, 2013, MYRIAD GENE PATENT R; Lewis C, 2014, BJOG-INT J OBSTET GY, V121, P582, DOI 10.1111/1471-0528.12579; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Morris JK, 2008, AM J MED GENET A, V146A, P827, DOI 10.1002/ajmg.a.32220; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Niedrist D, 2006, AM J MED GENET A, V140A, P952, DOI 10.1002/ajmg.a.31172; O'Leary P, 2013, AUST NZ J OBSTET GYN, V53, P425, DOI 10.1111/ajo.12136; Ohno M, 2013, PRENATAL DIAG, V33, P630, DOI 10.1002/pd.4156; Palomaki GE, 2013, ARCH PATHOL LAB MED, V137, P921, DOI 10.5858/arpa.2012-0319-CP; Perni SC, 2006, AM J OBSTET GYNECOL, V194, P127, DOI 10.1016/j.ajog.2005.06.068; Perry S, 2007, COMMUNITY GENET, V10, P227, DOI 10.1159/000106561; Platt LD, 2004, OBSTET GYNECOL, V104, P661, DOI 10.1097/01.AOG.0000139832.79658.b9; Priest JH, 1998, J MED SCREEN, V5, P178, DOI 10.1136/jms.5.4.178; Rasmussen SA, 2003, PEDIATRICS, V111, P777, DOI 10.1542/peds.111.4.777; Savva GM, 2010, PRENATAL DIAG, V30, P57, DOI 10.1002/pd.2403; Shaffer BL, 2006, PRENATAL DIAG, V26, P667, DOI 10.1002/pd.1462; Song K, 2013, J MATERN-FETAL NEO M, V26, P1180, DOI 10.3109/14767058.2013.770464; StataCorp, 2011, STATA STATISTICAL SO; Vendola C, 2010, AM J MED GENET A, V152A, P360, DOI 10.1002/ajmg.a.33156; Waitzman N., 1996, COST BIRTH DEFECTS E; WAITZMAN NJ, 2005, NEURAL TUBE DEFECTS, P342; Wald N, 2004, PRENATAL DIAG, V24, P150, DOI 10.1002/pd.840; WALD N, 2000, ANTENATAL NEONATAL S; Wald NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058732; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Walker BS, 2014, PRENAT DIAGN; Wang E, 2013, PRENATAL DIAG, V33, P662, DOI 10.1002/pd.4119; Won RH, 2005, PRENATAL DIAG, V25, P608, DOI 10.1002/pd.1243; Wray AM, 2007, INT J GYNECOL OBSTET, V96, P103, DOI 10.1016/j.ijgo.2006.11.005; Wu JH, 2013, AM J MED GENET A, V161, P2512, DOI 10.1002/ajmg.a.36127	69	27	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131402	10.1371/journal.pone.0131402	http://dx.doi.org/10.1371/journal.pone.0131402			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133556	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400046
J	Xia, ZQ; Liu, F; Zhang, J; Liu, L				Xia, Zhiqiang; Liu, Fang; Zhang, Jian; Liu, Li			Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MALIGNANT GLIOMA; GLIOBLASTOMA; PROLIFERATION; MICRORNAS; CANCER; TEMOZOLOMIDE; METASTASIS; INHIBITION; GTPASES	Gliomas are the most common malignant primary brain tumors in adults and exhibit a spectrum of aberrantly aggressive phenotype. Although increasing evidence indicated that the deregulation of microRNAs (miRNAs) contributes to tumorigenesis and invasion, little is known about the roles of miR-204-5p in human gliomas. In the present study, the expression of miR-204-5p in clinical glioma tissues was measured by qRT-PCR. The effects of miR-204-5p on glioma cell growth and metastasis were examined by overexpressing or inhibiting miR-204-5p. We found that the expression level of miR-204-5p was significantly reduced in clinical glioma tissues compared with normal brain tissues. Moreover, we revealed that the introduction of miR-204-5p dramatically suppressed glioma cell growth, migration and invasion. Furthermore, mechanistic investigations revealed that RAB22A, a member of the RAS oncogene family, is a direct functional target of miR-204-5p in gliomas. In vivo, restoring miR-204-5p expression in glioma cells suppressed tumorigenesis and increased overall host survival. Our findings suggest that miR-204-5p is a cancer suppressor miRNA and overexpression of miR-204-5p is a novel glioma treatment strategy.	[Xia, Zhiqiang; Liu, Li] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Microbiol, Beijing 100730, Peoples R China; [Xia, Zhiqiang; Liu, Li] Peking Union Med Coll, Sch Basic Med, Beijing 100730, Peoples R China; [Liu, Fang; Zhang, Jian] Suzhou Wuzhong Hosp, Suzhou 210031, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Microbiol, Beijing 100730, Peoples R China.	lliu234@163.com			National Natural Science Foundation of China [30871283, 81171944]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (Grant No. 30871283 and 81171944).	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bao W, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-155; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Besse A, 2013, TUMOR BIOL, V34, P1969, DOI 10.1007/s13277-013-0772-5; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dontula Ranadheer, 2013, Genes Cancer, V4, P285, DOI 10.1177/1947601913500141; Emdad L, 2012, FUTURE ONCOL, V8, P343, DOI [10.2217/FON.12.16, 10.2217/fon.12.16]; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gulati N, 2009, INT J ONCOL, V35, P731, DOI 10.3892/ijo_00000386; Guo P, 2013, ONCOL REP, V30, P870, DOI 10.3892/or.2013.2526; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Kasimanickam VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099433; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Liu LY, 2015, BIOCHEM BIOPH RES CO, V457, P621, DOI 10.1016/j.bbrc.2015.01.037; Liu S, 2014, J CELL BIOCHEM, V115, P1368, DOI 10.1002/jcb.24786; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Mesa R, 2001, J CELL SCI, V114, P4041; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Nan Y, 2010, BRAIN RES, V1359, P14, DOI 10.1016/j.brainres.2010.08.074; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Okamoto I, 2005, NEOPLASIA, V7, P303, DOI 10.1593/neo.04514; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peng Y, 2014, BIOSCIENCE REP, V34, P247, DOI 10.1042/BSR20140020; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Qiu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1331, DOI 10.1159/000354531; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.280; Sacconi A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.160; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shi L, 2014, NEUROMOL MED, V16, P517, DOI 10.1007/s12017-014-8305-y; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Wang L, 2014, ONCOTARGET, V5, P5416, DOI 10.18632/oncotarget.2116; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Wei XT, 2016, MOL NEUROBIOL, V53, P163, DOI 10.1007/s12035-014-8993-1; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu S, 2012, ONCOGENE, V31, P3866, DOI 10.1038/onc.2011.551; Yamashita D, 2015, CANCER RES, V75, P1123, DOI 10.1158/0008-5472.CAN-14-0938; Yan Y, 2015, FEBS LETT, V589, P756, DOI 10.1016/j.febslet.2015.02.005; Yan ZY, 2015, TUMOR BIOL, V36, P5323, DOI 10.1007/s13277-015-3193-9; Yang ZY, 2014, INT J CLIN EXP PATHO, V7, P7563; Yin D, 2013, ONCOGENE, V32, P1155, DOI 10.1038/onc.2012.132; Yin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116759; Yin Y, 2014, CLIN CANCER RES, V20, P6187, DOI 10.1158/1078-0432.CCR-14-1030; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang BB, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0331-y; Zhang R, 2016, MOL NEUROBIOL, V53, P1452, DOI 10.1007/s12035-014-9079-9; Zhang R, 2015, J NEURO-ONCOL, V121, P63, DOI 10.1007/s11060-014-1607-y; Zhang Y, 2014, ONCOTARGET, V5, P12291, DOI 10.18632/oncotarget.2577	64	41	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132399	10.1371/journal.pone.0132399	http://dx.doi.org/10.1371/journal.pone.0132399			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134825	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400114
J	Bachhuber, MA; McGinty, EE; Kennedy-Hendricks, A; Niederdeppe, J; Barry, CL				Bachhuber, Marcus A.; McGinty, Emma E.; Kennedy-Hendricks, Alene; Niederdeppe, Jeff; Barry, Colleen L.			Messaging to Increase Public Support for Naloxone Distribution Policies in the United States: Results from a Randomized Survey Experiment	PLOS ONE			English	Article							EMERGENCY MEDICAL-SERVICES; HEROIN OVERDOSE; OPIOID OVERDOSE; INTRANASAL NALOXONE; OPIATE OVERDOSE; DRUG-USERS; PREVENTION; PEOPLE; PROGRAM; DEATHS	Background Barriers to public support for naloxone distribution include lack of knowledge, concerns about potential unintended consequences, and lack of sympathy for people at risk of overdose. Methods A randomized survey experiment was conducted with a nationally-representative web-based survey research panel (GfK KnowledgePanel). Participants were randomly assigned to read different messages alone or in combination: 1) factual information about naloxone; 2) pre-emptive refutation of potential concerns about naloxone distribution; and 3) a sympathetic narrative about a mother whose daughter died of an opioid overdose. Participants were then asked if they support or oppose policies related to naloxone distribution. For each policy item, logistic regression models were used to test the effect of each message exposure compared with the no-exposure control group. Results The final sample consisted of 1,598 participants (completion rate: 72.6%). Factual information and the sympathetic narrative alone each led to higher support for training first responders to use naloxone, providing naloxone to friends and family members of people using opioids, and passing laws to protect people who administer naloxone. Participants receiving the combination of the sympathetic narrative and factual information, compared to factual information alone, were more likely to support all policies: providing naloxone to friends and family members (OR: 2.0 [95% CI: 1.4 to 2.9]), training first responders to use naloxone (OR: 2.0 [95% CI: 1.2 to 3.4]), passing laws to protect people if they administer naloxone (OR: 1.5 [95% CI: 1.04 to 2.2]), and passing laws to protect people if they call for medical help for an overdose (OR: 1.7 [95% CI: 1.2 to 2.5]). Conclusions All messages increased public support, but combining factual information and the sympathetic narrative was most effective. Public support for naloxone distribution can be improved through education and sympathetic portrayals of the population who stands to benefit from these policies.	[Bachhuber, Marcus A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; [Bachhuber, Marcus A.; Barry, Colleen L.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Bachhuber, Marcus A.] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA; [McGinty, Emma E.; Kennedy-Hendricks, Alene; Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [McGinty, Emma E.; Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Niederdeppe, Jeff] Cornell Univ, Dept Commun, Ithaca, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University	Bachhuber, MA (corresponding author), Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA.	marcus.bachhuber@gmail.com		Bachhuber, Marcus/0000-0002-5610-8382	American International Group, Inc.; National Institute on Drug Abuse [R01DA026414]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026414] Funding Source: NIH RePORTER	American International Group, Inc.; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by an unrestricted research grant from American International Group, Inc., and by the National Institute on Drug Abuse (R01DA026414). The funding bodies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; [Anonymous], 2012, MMWR-MORBID MORTAL W, V61, P101; Barry CL, 2014, PSYCHIAT SERV, V65, P1269, DOI 10.1176/appi.ps.201400140; Barry CL, 2009, MILBANK Q, V87, P7, DOI 10.1111/j.1468-0009.2009.00546.x; Bazazi AR, 2010, J HEALTH CARE POOR U, V21, P1108, DOI 10.1353/hpu.2010.0935; Beletsky L, 2007, J URBAN HEALTH, V84, P126, DOI 10.1007/s11524-006-9120-z; Beletsky L, 2012, JAMA-J AM MED ASSOC, V308, P1863, DOI 10.1001/jama.2012.14205; Burris S, 2006, AIDS, V20, P117, DOI 10.1097/01.aids.0000194806.81917.19; Burris S., 2009, DREXEL LAW REV, V1, P273; Burstein P, 2003, POLIT RES QUART, V56, P29, DOI 10.1177/106591290305600103; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Dasgupta N, 2014, DRUG ALCOHOL DEPEN, V145, P238, DOI 10.1016/j.drugalcdep.2014.10.005; Davidson PJ, 2003, J URBAN HEALTH, V80, P261, DOI 10.1093/jurban/jtg029; Davis CS, 2014, ACAD EMERG MED, V21, P1173, DOI 10.1111/acem.12485; Davis CS, 2014, AM J PUBLIC HEALTH, V104, pE7, DOI 10.2105/AJPH.2014.302062; Davis MM, 2005, HEALTH AFFAIR, V24, P770, DOI 10.1377/hlthaff.24.3.770; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Enteen L, 2010, J URBAN HEALTH, V87, P931, DOI 10.1007/s11524-010-9495-8; GfK, 2013, KNOWLEDGEPANEL DES S; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Gross K, 2008, POLIT PSYCHOL, V29, P169, DOI 10.1111/j.1467-9221.2008.00622.x; Heckman CJ, 2013, JAMA DERMATOL, V149, P825, DOI 10.1001/jamadermatol.2013.515; Hedegaard Holly, 2015, NCHS Data Brief, P1; Hewlett Leanne, 2013, J Opioid Manag, V9, P369, DOI 10.5055/jom.2013.0179; JARLAIS DCD, 1995, AM J PUBLIC HEALTH, V85, P1577; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Kreuter MW, 2007, ANN BEHAV MED, V33, P221, DOI 10.1007/BF02879904; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Maxwell S, 2006, J ADDICT DIS, V25, P89, DOI 10.1300/J069v25n03_11; Morone JA, 1997, J HEALTH POLIT POLIC, V22, P993, DOI 10.1215/03616878-22-4-993; Mutz DC, 2011, POPULATION-BASED SURVEY EXPERIMENTS, P1; O'Keefe DJ, 2015, COMMUNICATIONS YB, V22, P209; PAONE D, 1995, INT J ADDICT, V30, P1647, DOI 10.3109/10826089509104419; Piper TM, 2008, SUBST USE MISUSE, V43, P858, DOI 10.1080/10826080701801261; Ray B, 2015, DRUG ALCOHOL DEPEN, V146, P107, DOI 10.1016/j.drugalcdep.2014.10.026; Rothman EF, 2008, PEDIATRICS, V122, pE298, DOI 10.1542/peds.2007-3412; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Squiers LB, 2013, AM J PREV MED, V45, P182, DOI 10.1016/j.amepre.2013.04.005; Strang J, 1996, BRIT MED J, V312, P1435, DOI 10.1136/bmj.312.7044.1435; The Network for Public Health Law, 2014, LEG INT RED OV MORT; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; Tobin KE, 2005, ADDICTION, V100, P397, DOI 10.1111/j.1360-0443.2005.00975.x; Trust for America's Health, 2013, PRESCRIPTION DRUG AB; Wagner KD, 2010, INT J DRUG POLICY, V21, P186, DOI 10.1016/j.drugpo.2009.01.003; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Walley AY, 2013, J SUBST ABUSE TREAT, V44, P241, DOI 10.1016/j.jsat.2012.07.004	49	47	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130050	10.1371/journal.pone.0130050	http://dx.doi.org/10.1371/journal.pone.0130050			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26132859	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000050
J	Neuvonen, AM; Putkonen, M; Oversti, S; Sundell, T; Onkamo, P; Sajantila, A; Palo, JU				Neuvonen, Anu M.; Putkonen, Mikko; Oversti, Sanni; Sundell, Tarja; Onkamo, Palvi; Sajantila, Antti; Palo, Jukka U.			Vestiges of an Ancient Border in the Contemporary Genetic Diversity of North-Eastern Europe	PLOS ONE			English	Article							NEOLITHIC TRANSITION; HUNTER-GATHERERS; HUMAN MTDNA; DNA; ORIGINS; FINNS; POLYMORPHISMS; FINLAND; RECOLONIZATION; DIFFUSION	It has previously been demonstrated that the advance of the Neolithic Revolution from the Near East through Europe was decelerated in the northernmost confines of the continent, possibly as a result of space and resource competition with lingering Mesolithic populations. Finland was among the last domains to adopt a farming lifestyle, and is characterized by substructuring in the form of a distinct genetic border dividing the northeastern and southwestern regions of the country. To explore the origins of this divergence, the geographical patterns of mitochondrial and Y-chromosomal haplogroups of Neolithic and Mesolithic ancestry were assessed in Finnish populations. The distribution of these uniparental markers revealed a northeastern bias for hunter-gatherer haplogroups, while haplogroups associated with the farming lifestyle clustered in the southwest. In addition, a correlation could be observed between more ancient mitochondrial haplogroup age and eastern concentration. These results coupled with prior archeological evidence suggest the genetic northeast/southwest division observed in contemporary Finland represents an ancient vestigial border between Mesolithic and Neolithic populations undetectable in most other regions of Europe.	[Neuvonen, Anu M.; Putkonen, Mikko; Sajantila, Antti; Palo, Jukka U.] Univ Helsinki, Dept Forens Med, Lab Forens Biol, FI-00014 Helsinki, Finland; [Oversti, Sanni] Univ Turku, Dept Biol, Sect Genet & Physiol, Turku 20014, Finland; [Oversti, Sanni; Sundell, Tarja; Onkamo, Palvi] Univ Helsinki, Dept Biosci, FI-00014 Helsinki, Finland; [Sundell, Tarja] Univ Helsinki, Dept Philosophy Hist Culture & Art Studies, FI-00014 Helsinki, Finland; [Sajantila, Antti] Univ N Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Inst Appl Genet, Ft Worth, TX 76107 USA	University of Helsinki; University of Turku; University of Helsinki; University of Helsinki; University of North Texas System; University of North Texas Health Science Center	Neuvonen, AM (corresponding author), Univ Helsinki, Dept Forens Med, Lab Forens Biol, POB 40,Kytosuontie 11, FI-00014 Helsinki, Finland.	anu.neuvonen@helsinki.fi	Sajantila, Antti/AAY-9084-2021	Sajantila, Antti/0000-0003-4117-5248; Oversti, Sanni/0000-0001-7118-1281	Finnish Foundations' Professor Pool Grant; Finnish Population Genetics Graduate School; University of Helsinki; Finnish Concordia Fund; Academy of Finland [133056]	Finnish Foundations' Professor Pool Grant; Finnish Population Genetics Graduate School; University of Helsinki; Finnish Concordia Fund; Academy of Finland(Academy of Finland)	This work was supported by The Finnish Foundations' Professor Pool Grant (http://www.professoripooli.fi;, Paulo Foundation; AS), The Finnish Population Genetics Graduate School (http://www.oulu.fi/biology/PopGenSchool/; AMN, MP), the University of Helsinki (AMN, TS), The Finnish Concordia Fund (http://www.konkordia-liitto.com/, TS), and the Academy of Finland grant no. 133056 (http://www.aka.fi/fi/A/; PO, SO, MP, TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Alenius T, 2013, GEOARCHAEOLOGY, V28, P1, DOI 10.1002/gea.21428; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ammermann A.J., 1984, NEOLITHIC TRANSITION; Bentley RA, 2003, ANTIQUITY, V77, P63, DOI 10.1017/S0003598X00061342; Blauer A, 2013, J ARCHAEOL SCI, V40, P1646, DOI 10.1016/j.jas.2012.10.033; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Denisova GA, 1999, AM J HUM GENET, V65, pA200; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fort J, 2012, P NATL ACAD SCI USA, V109, P18669, DOI 10.1073/pnas.1200662109; Fu Q, 2012, PLOS ONE, V7; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Isern N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051106; Isern N, 2012, J ARCHAEOL SCI, V39, P3671, DOI 10.1016/j.jas.2012.06.027; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Lahermo P, 1999, EUR J HUM GENET, V7, P447, DOI 10.1038/sj.ejhg.5200316; Lahtinen M, 2013, EUR J ARCHAEOL, V16, P660, DOI 10.1179/1461957113Y.000000000040; Laitinen V, 2002, HUM HERED, V53, P68, DOI 10.1159/000057985; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Lemmen C, 2011, J ARCHAEOL SCI, V38, P3459, DOI 10.1016/j.jas.2011.08.008; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Meinila M, 2001, HUM HERED, V52, P160, DOI 10.1159/000053372; Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230; Nunes M., 1987, FENNOSC ARCHAEOL, V4, P3; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Palo JU, 2009, EUR J HUM GENET, V17, P1336, DOI 10.1038/ejhg.2009.53; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; SAJANTILA A, 1995, NAT GENET, V11, P359, DOI 10.1038/ng1295-359; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shennan S, 2013, J ARCHAEOL METHOD TH, V20, P300, DOI 10.1007/s10816-012-9154-3; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soini Heidi K, 2012, BMC Res Notes, V5, P350, DOI 10.1186/1756-0500-5-350; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Tresset A, 2011, CR BIOL, V334, P182, DOI 10.1016/j.crvi.2010.12.010; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vuorela T., 1976, ATLAS FINNISH FOLK C, P151; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Zerjal T, 1997, AM J HUM GENET, V60, P1174; ZVELEBIL M, 1991, J WORLD PREHIST, V5, P233, DOI 10.1007/BF00974991; ZVELEBIL M, 1989, ANTIQUITY, V63, P379, DOI 10.1017/S0003598X00076110	72	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130331	10.1371/journal.pone.0130331	http://dx.doi.org/10.1371/journal.pone.0130331			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1CG	26132657	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000062
J	Patel, K; Konduru, K; Patra, AK; Chandel, DS; Panigrahi, P				Patel, Ketki; Konduru, Kavitha; Patra, Alok K.; Chandel, Dinesh S.; Panigrahi, Pinaki			Trends and determinants of gastric bacterial colonization of preterm neonates in a NICU setting	PLOS ONE			English	Article							REAL-TIME PCR; 16S RIBOSOMAL-RNA; HELICOBACTER-PYLORI INFECTION; GRADIENT GEL-ELECTROPHORESIS; INFLAMMATORY-BOWEL-DISEASE; BIRTH-WEIGHT INFANTS; BOTTLE-FED INFANTS; NECROTIZING ENTEROCOLITIS; ESCHERICHIA-COLI; FECAL MICROBIOTA	Background Newborn gastrointestinal (GI) tract is considered sterile but rapidly acquires a diverse microbiota from its intimate environment. Early acquisition of a bacterial species in the upper GI tract may play a role in establishing the colonic microbiota. There is paucity of molecular data on the upper GI tract microbiota in preterm neonates. Methods Gastric aspirates from 22 neonates with an average gestational age 27.7 weeks (+/- 2.8), weighing 973.2 grams (+/- 297.9) admitted to a neonatal intensive care unit were collected prospectively from weeks 1-4 of life. All samples were evaluated for microbiota using 16S rRNA-based Denaturing Gradient Gel Electrophoresis. Bacterial species colonization and its association with maternal and neonatal demographics, and neonatal clinical characteristics were analyzed. Results Bacteroides spp. was the predominant species in all four weeks. Bifidobacterium spp. colonization was significantly higher in exclusively breast milk fed compared to partially breast milk (PBM) fed neonates in first (p = 0.03) and third (p = 0.03) week of life. Anaerobic bacteria colonization decreased from first through fourth week of life (p = 0.03). Aerobic bacteria colonization was highly dynamic throughout the four week period. Premature rupture of membrane (p = 0.05) and birth outside of study hospital (p = 0.006) influenced the acquisition of bacteria in the first week of life. Birth weight was positively correlated with total number of bacterial species (p = 0.002) and anaerobes (p = 0.004) in PBM-fed neonates during the fourth week of life. H. pylori and Ureaplasma were not detected in any of our samples. Conclusion Gastric bacterial colonization in preterm neonates is unstable during early weeks of life. Delayed oral feeding and use of antibiotics may be responsible for paucity of bacterial species. Monitoring of the gastric microbiota and concurrent examination of stool microbiota may yield important information on the utility of gastric signature patterns for predicting colon microbiota that may drive GI and immune dysfunctions.	[Patel, Ketki; Patra, Alok K.; Panigrahi, Pinaki] Univ Nebraska, Coll Publ Hlth, Med Ctr, Dept Epidemiol, Omaha, NE 68182 USA; [Konduru, Kavitha] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Chandel, Dinesh S.] Univ Nebraska, Coll Publ Hlth, Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE 68182 USA; [Chandel, Dinesh S.; Panigrahi, Pinaki] Univ Nebraska, Coll Publ Hlth, Med Ctr, Dept Pediat, Omaha, NE 68182 USA; [Chandel, Dinesh S.; Panigrahi, Pinaki] Univ Nebraska, Coll Publ Hlth, Med Ctr, Ctr Global Hlth & Dev, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; University System of Maryland; University of Maryland Baltimore; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Panigrahi, P (corresponding author), Univ Nebraska, Coll Publ Hlth, Med Ctr, Dept Epidemiol, Omaha, NE 68182 USA.	ppanigrahi@unmc.edu			National Institute of Health (NIH) [R01 HD 053719]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053719] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported in part by the National Institute of Health (NIH) grant R01 HD 053719 awarded to PP (www.nih.gov). Additional institutional support from the Department of Pediatrics, University of Maryland, Baltimore, MD, and the Center for Global Health and Development, University of Nebraska Medical Center, College of Public Health, Omaha, NE, were utilized for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL MJ, 1978, J PEDIATR-US, V92, P589, DOI 10.1016/S0022-3476(78)80296-0; BENNET R, 1986, PEDIATR INFECT DIS J, V5, P533, DOI 10.1097/00006454-198609000-00009; BLAKEY JL, 1982, J MED MICROBIOL, V15, P519, DOI 10.1099/00222615-15-4-519; BROOK I, 1979, PEDIATRICS, V63, P451; Butel MJ, 2007, J PEDIATR GASTR NUTR, V44, P577, DOI 10.1097/MPG.0b013e3180406b20; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chang JY, 2011, J PEDIATR GASTR NUTR, V53, P512, DOI 10.1097/MPG.0b013e318227e518; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Espinoza MGC, 2011, J CLIN MICROBIOL, V49, P1650, DOI 10.1128/JCM.00461-10; Cunningham SA, 2013, INT J BACTERIOLOGY; DELLAGRAMMATICAS HD, 1983, ARCH DIS CHILD, V58, P115, DOI 10.1136/adc.58.2.115; Donskey CJ, 2003, J MICROBIOL METH, V54, P249, DOI 10.1016/S0167-7012(03)00059-9; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Gold BD, 2000, J PEDIATR GASTR NUTR, V31, P490, DOI 10.1097/00005176-200011000-00007; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; GUPTA S, 1994, PEDIATR INFECT DIS J, V13, P728, DOI 10.1097/00006454-199408000-00010; Haarman M, 2006, APPL ENVIRON MICROB, V72, P2359, DOI 10.1128/AEM.72.4.2359-2365.2006; HALL MA, 1990, ARCH DIS CHILD, V65, P185, DOI 10.1136/adc.65.2.185; Hoy CM, 2000, J CLIN MICROBIOL, V38, P4539, DOI 10.1128/JCM.38.12.4539-4547.2000; Huijsdens XW, 2002, J CLIN MICROBIOL, V40, P4423, DOI 10.1128/JCM.40.12.4423-4427.2002; Jones V, 2010, EARLY HUM DEV, V86, P167, DOI 10.1016/j.earlhumdev.2009.11.005; Khalifa MM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-2; Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05; Lin Hai-long, 2011, Huanjing Kexue, V32, P1505; Liu Y, 2008, INT J FOOD MICROBIOL, V125, P230, DOI 10.1016/j.ijfoodmicro.2008.03.005; LUNDEQUIST B, 1985, ACTA PAEDIATR SCAND, V74, P45, DOI 10.1111/j.1651-2227.1985.tb10919.x; Ma Y, 2012, REGION ANESTH PAIN M, V37, P99, DOI 10.1097/AAP.0b013e31823ebc74; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Makhoul IR, 2002, ISRAEL MED ASSOC J, V4, P98; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Milisavljevic V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-49; Millar M, 2003, ARCH DIS CHILD-FETAL, V88, pF354, DOI 10.1136/fn.88.5.F354; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEALE KR, 1995, ALIMENT PHARM THER, V9, P77; Normann E, 2013, ACTA PAEDIATR, V102, P129, DOI 10.1111/apa.12059; Ogilvie LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035053; Oue S, 2009, ARCH DIS CHILD-FETAL, V94, pF17, DOI 10.1136/adc.2008.138321; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park HK, 2005, J MICROBIOL, V43, P345; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Sha SM, 2013, DIAGN MICR INFEC DIS, V75, P245, DOI 10.1016/j.diagmicrobio.2012.11.022; Sherman MP, 2010, CLIN PERINATOL, V37, P565, DOI 10.1016/j.clp.2010.05.006; Tan TY, 2001, J CLIN MICROBIOL, V39, P4529, DOI 10.1128/JCM.39.12.4529-4531.2001; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921	52	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0114664	10.1371/journal.pone.0114664	http://dx.doi.org/10.1371/journal.pone.0114664			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132213	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000001
J	Hu, LS; Hao, CY; Fan, R; Wu, BD; Tan, LH; Wu, HS				Hu, Lisong; Hao, Chaoyun; Fan, Rui; Wu, Baoduo; Tan, Lehe; Wu, Huasong			De Novo Assembly and Characterization of Fruit Transcriptome in Black Pepper (Piper nigrum)	PLOS ONE			English	Article							RNA-SEQ DATA; QUINOLIZIDINE ALKALOID BIOSYNTHESIS; CELL-SUSPENSION CULTURES; INTERNAL CONTROL GENES; ROOT TRANSCRIPTOME; HOUSEKEEPING GENES; NORMALIZATION; GENOME; IDENTIFICATION; ANTIOXIDANT	Black pepper is one of the most popular and oldest spices in the world and valued for its pungent constituent alkaloids. Pinerine is the main bioactive compound in pepper alkaloids, which perform unique physiological functions. However, the mechanisms of piperine synthesis are poorly understood. This study is the first to describe the fruit transcriptome of black pepper by sequencing on Illumina HiSeq 2000 platform. A total of 56,281,710 raw reads were obtained and assembled. From these raw reads, 44,061 unigenes with an average length of 1,345 nt were generated. During functional annotation, 40,537 unigenes were annotated in Gene Ontology categories, Kyoto Encyclopedia of Genes and Genomes pathways, Swiss-Prot database, and Nucleotide Collection (NR/NT) database. In addition, 8,196 simple sequence repeats (SSRs) were detected. In a detailed analysis of the transcriptome, housekeeping genes for quantitative polymerase chain reaction internal control, polymorphic SSRs, and lysine/ornithine metabolism-related genes were identified. These results validated the availability of our database. Our study could provide useful data for further research on piperine synthesis in black pepper.	[Hu, Lisong; Hao, Chaoyun; Fan, Rui; Wu, Baoduo; Tan, Lehe; Wu, Huasong] CATAS, Spice & Beverage Res Inst, Wanning 571533, Hainan, Peoples R China; [Hu, Lisong; Hao, Chaoyun; Tan, Lehe; Wu, Huasong] Minist Agr, Key Lab Genet Resources Utilizat Spice & Beverage, Wanning 571533, Hainan, Peoples R China; [Fan, Rui; Wu, Baoduo; Tan, Lehe; Wu, Huasong] Hainan Prov Key Lab Genet Improvement & Qual Regu, Wanning 571533, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wu, HS (corresponding author), CATAS, Spice & Beverage Res Inst, Wanning 571533, Hainan, Peoples R China.	w341458267@163.com			Ministry of Agriculture of the People's Republic of China [2015NWB046, 15RZZYS-13]	Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	Funding: This project was funded by the Ministry of Agriculture of the People's Republic of China (2015NWB046, 15RZZYS-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113993; Bunsupa S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00239; Bunsupa S, 2012, PLANT CELL, V24, P1202, DOI 10.1105/tpc.112.095885; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; GEISLER JG, 1990, PHYTOCHEMISTRY, V29, P489, DOI 10.1016/0031-9422(90)85102-L; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gulcin I, 2005, INT J FOOD SCI NUTR, V56, P491, DOI 10.1080/09637480500450248; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; JOSE J, 1985, CYTOLOGIA, V50, P301, DOI 10.1508/cytologia.50.301; Joy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056694; Krishnamoorthy B., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105003; Liu DG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115128, 10.1371/journal.pone.0086976]; Long Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1111; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; McNamara FN, 2005, BRIT J PHARMACOL, V144, P781, DOI 10.1038/sj.bjp.0706040; Mehmood MH, 2010, J MED FOOD, V13, P1086, DOI 10.1089/jmf.2010.1065; Nair KPP, 2011, ELSEV INSIGHT, P1; Okumura Y, 2009, BIOSCIENCE BIOTECHNO, V74, P1068; OKWUTE SK, 2013, INT J CHEM, V5, P99; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Platel K, 2000, NAHRUNG, V44, P42, DOI 10.1002/(SICI)1521-3803(20000101)44:1&lt;42::AID-FOOD42&gt;3.0.CO;2-D; Prasad NS, 2004, PROSTAG LEUKOTR ESS, V70, P521, DOI 10.1016/j.plefa.2003.11.006; Raja PB, 2008, MATER LETT, V62, P2977, DOI 10.1016/j.matlet.2008.01.087; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Szoke E, 2013, ALKALOIDS DERIVED LY, P303; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tu LL, 2007, CHINESE SCI BULL, V52, P3110, DOI 10.1007/s11434-007-0461-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VASAVIRAMA K, 2014, INT J PHARM PHARM SC, V6, P34; Vijayan K., 2000, PHARM TOXICOLOGY CLI, P455; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WINK M, 1987, PLANTA MED, V53, P509, DOI 10.1055/s-2006-962797; WINK M, 1979, FEBS LETT, V101, P343, DOI 10.1016/0014-5793(79)81040-6; Zarai Z, 2013, LWT-FOOD SCI TECHNOL, V50, P634, DOI 10.1016/j.lwt.2012.07.036; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhou XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106932; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	43	28	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129822	10.1371/journal.pone.0129822	http://dx.doi.org/10.1371/journal.pone.0129822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121657	Green Published, gold, Green Submitted			2022-12-26	WOS:000358150400024
J	Liu, HT; Tang, J; Du, YP; Lee, CA; Golczak, M; Muthusamy, A; Antonetti, DA; Veenstra, AA; Amengual, J; von Lintig, J; Palczewski, K; Kern, TS				Liu, Haitao; Tang, Jie; Du, Yunpeng; Lee, Chieh Allen; Golczak, Marcin; Muthusamy, Arivalagan; Antonetti, David A.; Veenstra, Alexander A.; Amengual, Jaume; von Lintig, Johannes; Palczewski, Krzysztof; Kern, Timothy S.			Retinylamine Benefits Early Diabetic Retinopathy in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; endothelium; inflammation; reactive oxygen species (ROS); retina; hyperglycemia; retinal pigment epithelium; retinylamine	RETINAL ENDOTHELIAL-CELLS; INSULIN-DEPENDENT DIABETICS; MOUSE MODEL; VISUAL FUNCTION; CAPILLARY DEGENERATION; MACULAR DEGENERATION; SUPEROXIDE-DISMUTASE; ADULT RATS; VITAMIN-A; P38 MAPK	Background: The development of diabetic retinopathy (DR) is incompletely understood. Administered retinylamine is stored in the retinal pigmented epithelium (RPE) where it affects the ocular visual cycle. Results: Retinylamine inhibited vascular and neural lesions of early DR. Conclusion: Both the RPE and visual cycle are novel targets for the inhibition of DR. Significance: Vision-related processes can contribute to DR. Recent evidence suggests an important role for outer retinal cells in the pathogenesis of diabetic retinopathy (DR). Here we investigated the effect of the visual cycle inhibitor retinylamine (Ret-NH2) on the development of early DR lesions. Wild-type (WT) C57BL/6J mice (male, 2 months old when diabetes was induced) were made diabetic with streptozotocin, and some were given Ret-NH2 once per week. Lecithin-retinol acyltransferase (LRAT)-deficient mice and P23H mutant mice were similarly studied. Mice were euthanized after 2 (WT and Lrat(-/-)) and 8 months (WT) of study to assess vascular histopathology, accumulation of albumin, visual function, and biochemical and physiological abnormalities in the retina. Non-retinal effects of Ret-NH2 were examined in leukocytes treated in vivo. Superoxide generation and expression of inflammatory proteins were significantly increased in retinas of mice diabetic for 2 or 8 months, and the number of degenerate retinal capillaries and accumulation of albumin in neural retina were significantly increased in mice diabetic for 8 months compared with nondiabetic controls. Administration of Ret-NH2 once per week inhibited capillary degeneration and accumulation of albumin in the neural retina, significantly reducing diabetes-induced retinal superoxide and expression of inflammatory proteins. Superoxide generation also was suppressed in Lrat(-/-) diabetic mice. Leukocytes isolated from diabetic mice treated with Ret-NH2 caused significantly less cytotoxicity to retinal endothelial cells ex vivo than did leukocytes from control diabetics. Administration of Ret-NH2 once per week significantly inhibited the pathogenesis of lesions characteristic of early DR in diabetic mice. The visual cycle constitutes a novel target for inhibition of DR.	[Liu, Haitao; Tang, Jie; Du, Yunpeng; Lee, Chieh Allen; Veenstra, Alexander A.; Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Golczak, Marcin; Amengual, Jaume; von Lintig, Johannes; Palczewski, Krzysztof; Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Muthusamy, Arivalagan; Antonetti, David A.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Kern, Timothy S.] Vet Affairs Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Kern, TS (corresponding author), Case Western Reserve Univ, 441 Wood Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	tsk@case.edu	Regan, Clinton/E-6250-2012; Liu, Haitao/AAY-3944-2021	Liu, Haitao/0000-0002-3757-779X; von Lintig, Johannes/0000-0002-2079-2143; antonetti, david/0000-0003-1130-6577	National Institutes of Health [EY00300, EY022938, R24 EY024864, EY023948, R24 EY021126, P30 EY011373]; Department of Veteran Affairs; NATIONAL EYE INSTITUTE [P30EY011373, R01EY023948, R24EY024864, R01EY012021, R01EY000300, R01EY022938, R24EY021126, R56EY000300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants EY00300, EY022938, and R24 EY024864 (to T. S. K.); EY023948 (to M. G.); R24 EY021126 (to K. P.), and P30 EY011373 (a core grant). This work was also supported by the Department of Veteran Affairs. K. P. and M. G. are inventors of United States Patent Number 8722669, "Compounds and Methods of Treating Ocular Disorders," and United States Patent Number 20080275134, " Methods for Treatment of Retinal Degenerative Disease," issued to Case Western Reserve University (CWRU), whose values may be affected by this publication. CWRU may license this technology for commercial development. K. P. is a member of the scientific board of Vision Medicine, Inc., involved in developing visual cycle modulators, and their values may be affected by this publication. The other authors declare that they have no conflicts of interest with the contents of this article.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Arden GB, 2012, DOC OPHTHALMOL, V124, P15, DOI 10.1007/s10633-011-9305-y; BANFORD D, 1994, OPHTHAL PHYSL OPT, V14, P339, DOI 10.1111/j.1475-1313.1994.tb00122.x; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Berkowitz BA, 2015, FASEB J, V29, P554, DOI 10.1096/fj.14-254953; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P1880, DOI 10.1167/iovs.08-2958; BRINCHMANNHANSEN O, 1993, ACTA OPHTHALMOL, V71, P230; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; de Gooyer TE, 2006, INVEST OPHTH VIS SCI, V47, P5561, DOI 10.1167/iovs.06-0647; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Du YP, 2015, FASEB J, V29, P2194, DOI 10.1096/fj.14-269431; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golden JB, 2013, CYTOKINE, V62, P195, DOI 10.1016/j.cyto.2013.03.013; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; HAMMES HP, 1994, DIABETOLOGIA, V37, P32; HAMMES HP, 1995, DIABETOLOGIA, V38, P656, DOI 10.1007/s001250050333; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jackson GR, 2012, BRIT J OPHTHALMOL, V96, P699, DOI 10.1136/bjophthalmol-2011-300467; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kaul K, 2010, CURR DIABETES REV, V6, P294, DOI 10.2174/157339910793360851; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kern TS, 2007, DIABETES, V56, P373, DOI 10.2337/db05-1621; Kern TS, 2010, AM J PATHOL, V176, P2550, DOI 10.2353/ajpath.2010.091062; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Kern TS, 2001, DIABETES, V50, P1636, DOI 10.2337/diabetes.50.7.1636; Kern TS, 2010, OCULAR DIS MECH MANA, P506; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Kowluru RA, 2000, CURR EYE RES, V21, P814, DOI 10.1076/ceyr.21.4.814.5545; Lee CA, 2014, INVEST OPHTH VIS SCI, V55, P2904, DOI 10.1167/iovs.13-11659; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Liu HT, 2015, INVEST OPHTH VIS SCI, V56, P647, DOI 10.1167/iovs.14-15220; LOVASIK JV, 1988, AM J OPTOM PHYS OPT, V65, P236; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4540, DOI 10.1167/iovs.06-0215; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4917, DOI 10.1167/iovs.09-3581; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puntel A, 2015, BIOMATERIALS, V44, P103, DOI 10.1016/j.biomaterials.2014.12.019; Puro Donald G, 2002, Trans Am Ophthalmol Soc, V100, P339; RANDOLPH RK, 1991, J BIOL CHEM, V266, P16453; Reddy VP, 2006, DRUG DISCOV TODAY, V11, P646, DOI 10.1016/j.drudis.2006.05.016; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; SCHMITT MC, 1993, BIOL REPROD, V49, P972, DOI 10.1095/biolreprod49.5.972; Su XJ, 2003, MOL VIS, V9, P171; Talahalli R, 2013, J LEUKOCYTE BIOL, V93, P135, DOI 10.1189/jlb.0112025; Talahalli R, 2010, INVEST OPHTH VIS SCI, V51, P1699, DOI 10.1167/iovs.09-3557; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thornalley PJ, 2000, BIOCHEM PHARMACOL, V60, P55, DOI 10.1016/S0006-2952(00)00287-2; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Tian P, 2013, MOL VIS, V19, P2092; Veenstra AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078405; Viberti G, 1997, LANCET, V350, P214; Wang YM, 2012, J INVEST DERMATOL, V132, P2067, DOI 10.1038/jid.2012.112; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang JY, 2015, MOL PHARMACOL, V87, P477, DOI 10.1124/mol.114.096560; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zheng L, 2009, FRONT BIOSCI-LANDMRK, V14, P3974, DOI [10.2735/3505, 10.2741/3505]; Zolfaghari R, 2002, BIOCHEM J, V368, P621, DOI 10.1042/BJ20020918; Zolfaghari R, 2002, J NUTR, V132, P1160, DOI 10.1093/jn/132.6.1160	81	37	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21568	21579		10.1074/jbc.M115.655555	http://dx.doi.org/10.1074/jbc.M115.655555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26139608	hybrid, Green Published			2022-12-26	WOS:000360637600030
J	Garcia-Belincon, M; Sanchez-Osuna, M; Martinez-Escardo, L; Granados-Colomina, C; Pascual-Guiral, S; Iglesias-Guimarais, V; Casanelles, E; Ribas, J; Yuste, VJ				Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Martinez-Escardo, Laura; Granados-Colomina, Carla; Pascual-Guiral, Sonia; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Ribas, Judit; Yuste, Victor J.			An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-APOPTOSIS SWITCH; HUMAN PROMONOCYTIC CELLS; MOLECULAR-MECHANISMS; HYDROGEN-PEROXIDE; GLUTATHIONE DEPLETION; HIPPOCAMPAL-NEURONS; DNA FRAGMENTATION; CORTICAL-NEURONS; CANCER-CELLS; IN-VITRO	Apoptosis is triggered by the activation of caspases and characterized by chromatin condensation and nuclear fragmentation (type II nuclear morphology). Necrosis is depicted by a gain in cell volume (oncosis), swelling of organelles, plasma membrane leakage, and subsequent loss of intracellular contents. Although considered as different cell death entities, there is an overlap between apoptosis and necrosis. In this sense, mounting evidence suggests that both processes can be morphological expressions of a common biochemical network known as "apoptosis-necrosis continuum." To gain insight into the events driving the apoptosis-necrosis continuum, apoptotically proficient cells were screened facing several apoptotic inducers for the absence of type II apoptotic nuclear morphologies. Chelerythrine was selected for further studies based on its cytotoxicity and the lack of apoptotic nuclear alterations. Chelerythrine triggered an early plasma membrane leakage without condensed chromatin aggregates. Ultrastructural analysis revealed that chelerythrine-mediated cytotoxicity was compatible with a necrotic-like type of cell death. Biochemically, chelerythrine induced the activation of caspases. Moreover, the inhibition of caspases prevented chelerythrine-triggered necrotic-like cell death. Compared with staurosporine, chelerythrine induced stronger caspase activation detectable at earlier times. After using a battery of chemicals, we found that high concentrations of thiolic antioxidants fully prevented chelerythrine-driven caspase activation and necrotic-like cell death. Lower amounts of thiolic antioxidants partially prevented chelerythrine-mediated cytotoxicity and allowed cells to display type II apoptotic nuclear morphology correlating with a delay in caspase-3 activation. Altogether, these data support that an early and pronounced activation of caspases can drive cells to undergo a form of necrotic-like regulated cell death.	[Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Martinez-Escardo, Laura; Granados-Colomina, Carla; Pascual-Guiral, Sonia; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death,Senescence & Survival Grp,Unit Med, E-08193 Barcelona, Spain; [Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Martinez-Escardo, Laura; Granados-Colomina, Carla; Pascual-Guiral, Sonia; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, E-08193 Barcelona, Spain; [Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenrat, E-08193 Barcelona, Spain; [Ribas, Judit] Univ Lleida, Cell Death Regulat Noncoding RNA Grp, Dept Expt Med, Inst Recerca Biomed Lleida,Pharmacol Unit, Lleida 25198, Spain	Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; CIBERNED; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Ribas, Judit/B-3362-2011; Yuste, Victor J./C-7071-2008; Martínez-Escardó, Laura/AAL-6999-2021	Ribas, Judit/0000-0003-0834-2577; Yuste, Victor J./0000-0001-5322-9261; Martínez-Escardó, Laura/0000-0003-2979-4804; Pascual Guiral, Sonia/0000-0001-5791-3095	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (MICINN/FEDER) [SAF2011-24081]; Ministerio de Economia y Competitividad/FEDER Grant [SAF2012-31485]; Generalitat de Catalunya [2009-SGR-346, 2014-SGR-1609]; MICINN [BES-2009-028572, BES-2011-044769]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (MICINN/FEDER); Ministerio de Economia y Competitividad/FEDER Grant; Generalitat de Catalunya(Generalitat de Catalunya); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This work was supported in part by Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (MICINN/FEDER) Grant SAF2011-24081, Ministerio de Economia y Competitividad/FEDER Grant SAF2012-31485, and Generalitat de Catalunya Grants 2009-SGR-346 and 2014-SGR-1609. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Formacion de Personal Investigador Fellowship BES-2009-028572 from MICINN.; Recipient of Formacion de Personal Investigador Fellowship BES-2011-044769 from MICINN.; Supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya).; Supported by the Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia).	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Beyer C, 2013, AUTOIMMUNITY, V46, P298, DOI 10.3109/08916934.2012.750297; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Casanelles E, 2013, BBA-MOL CELL RES, V1833, P1085, DOI 10.1016/j.bbamcr.2013.01.014; Debiton E, 2003, CANCER CHEMOTH PHARM, V51, P474, DOI 10.1007/s00280-003-0609-9; Dursun B, 2006, AM J PHYSIOL-RENAL, V291, pF578, DOI 10.1152/ajprenal.00455.2005; Edelstein CL, 1999, J AM SOC NEPHROL, V10, P1940; FERNANDES RS, 1994, BIOCHEM PHARMACOL, V48, P675, DOI 10.1016/0006-2952(94)90044-2; Fujita R, 2003, CELL DEATH DIFFER, V10, P782, DOI 10.1038/sj.cdd.4401239; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Iglesias-Guimarais V, 2013, J BIOL CHEM, V288, P9200, DOI 10.1074/jbc.M112.411371; Iglesias-Guimarais V, 2012, J BIOL CHEM, V287, P7766, DOI 10.1074/jbc.M111.290718; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lopez-Meraz ML, 2010, EPILEPSIA, V51, P56, DOI 10.1111/j.1528-1167.2010.02611.x; Lopez-Meraz ML, 2010, NEUROBIOL DIS, V37, P394, DOI 10.1016/j.nbd.2009.10.019; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Meurette O, 2007, CANCER RES, V67, P218, DOI 10.1158/0008-5472.CAN-06-1610; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Niquet J, 2006, NEUROSCIENCE, V141, P77, DOI 10.1016/j.neuroscience.2006.03.073; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pena FJ, 2003, THERIOGENOLOGY, V60, P677, DOI 10.1016/S0093-691X(03)00081-5; Penaloza C, 2006, HISTOCHEM CELL BIOL, V126, P149, DOI 10.1007/s00418-006-0214-1; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Radakovic-Fijan S, 1999, J INVEST DERMATOL, V112, P264, DOI 10.1046/j.1523-1747.1999.00533.x; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Sanchez-Osuna M, 2014, J BIOL CHEM, V289, P18752, DOI 10.1074/jbc.M114.550020; Sancho P, 2006, APOPTOSIS, V11, P673, DOI 10.1007/s10495-006-5879-3; Schild H., 2003, MOL IMAGING BIOL, V5, P2; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Troyano A, 2001, J BIOL CHEM, V276, P47107, DOI 10.1074/jbc.M104516200; Tschopp J., 2003, NAT IMMUNOL, V4, P416; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wan KF, 2008, J BIOL CHEM, V283, P8423, DOI 10.1074/jbc.M707687200; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Yasuhara S, 2003, J HISTOCHEM CYTOCHEM, V51, P873, DOI 10.1177/002215540305100703; Yoon S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.450; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zeiss CJ, 2003, VET PATHOL, V40, P481, DOI 10.1354/vp.40-5-481; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	60	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20841	20855		10.1074/jbc.M115.644179	http://dx.doi.org/10.1074/jbc.M115.644179			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26124276	Green Published, hybrid			2022-12-26	WOS:000360011800021
J	Swisa, A; Granot, Z; Tamarina, N; Sayers, S; Bardeesy, N; Philipson, L; Hodson, DJ; Wikstrom, JD; Rutter, GA; Leibowitz, G; Glaser, B; Dor, Y				Swisa, Avital; Granot, Zvi; Tamarina, Natalia; Sayers, Sophie; Bardeesy, Nabeel; Philipson, Louis; Hodson, David J.; Wikstrom, Jakob D.; Rutter, Guy A.; Leibowitz, Gil; Glaser, Benjamin; Dor, Yuval			Loss of Liver Kinase B1 (LKB1) in Beta Cells Enhances Glucose-stimulated Insulin Secretion Despite Profound Mitochondrial Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT PHOSPHORYLATION; ENERGY-METABOLISM; PANCREATIC-ISLETS; GLUTAMATE ACTS; AMPK; MTOR; AUTOPHAGY; POLARITY; PATHWAY; HYPERINSULINISM	The tumor suppressor liver kinase B1 (LKB1) is an important regulator of pancreatic beta cell biology. LKB1-dependent phosphorylation of distinct AMPK(adenosine monophosphate-activated protein kinase) family members determines proper beta cell polarity and restricts beta cell size, total beta cell mass, and glucose-stimulated insulin secretion (GSIS). However, the full spectrum of LKB1 effects and the mechanisms involved in the secretory phenotype remain incompletely understood. We report here that in the absence of LKB1 in beta cells, GSIS is dramatically and persistently improved. The enhancement is seen both in vivo and in vitro and cannot be explained by altered cell polarity, increased beta cell number, or increased insulin content. Increased secretion does require membrane depolarization and calcium influx but appears to rely mostly on a distal step in the secretion pathway. Surprisingly, enhanced GSIS is seen despite profound defects in mitochondrial structure and function in LKB1-deficient beta cells, expected to greatly diminish insulin secretion via the classic triggering pathway. Thus LKB1 is essential for mitochondrial homeostasis in beta cells and in parallel is a powerful negative regulator of insulin secretion. This study shows that beta cells can be manipulated to enhance GSIS to supra-normal levels even in the face of defective mitochondria and without deterioration over months.	[Swisa, Avital; Granot, Zvi; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Tamarina, Natalia; Philipson, Louis] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sayers, Sophie; Hodson, David J.; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol & Funct Genom, Div Diabet Endocrinol & Metab, Dept Med, London SW7 2AZ, England; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Wikstrom, Jakob D.; Leibowitz, Gil; Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, IL-91120 Jerusalem, Israel; [Wikstrom, Jakob D.] Karolinska Univ Hosp, Karolinska Inst, Unit Dermatol & Venereol, Dept Med, S-17177 Stockholm, Sweden	Hebrew University of Jerusalem; University of Chicago; Imperial College London; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Karolinska Institutet; Karolinska University Hospital	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	yuvald@ekmd.huji.ac.il	Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000; Hodson, David/0000-0002-8641-8568; Rutter, Guy/0000-0001-6360-0343	National Institutes of Health (NIDDK) [P60 DK20595]; Juvenile Diabetes Research Foundation; Beta Cell Biology Consortium; Helmsley Charitable Trust; European Research Commission (European Research Council consolidator grant); BIRAX; DON foundation; Israel Science Foundation; Israel Science Foundation [41.11]; USAID American Schools and Hospitals Abroad Program; Innovative Medicines Initiative Joint Undertaking [155005]; European Union's Seventh Framework Programme (FP7); Adams foundation; Ariane de Rothschild Women Doctoral Program; DiabetesUK [BDA 12/0004431]; Svenska Sallskapet for Medicinsk Forskning (SSMF); Royal Society Wolfson Research Merit Awards; MRC Programme [MR/J0003042/1]; Diabetes UK [11/0004210]; Biotechnology and Biological Sciences Research Council [BB/J015873/1];  [WT098424AIA]; Medical Research Council [MR/K001981/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [MR/K001981/1] Funding Source: UKRI	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Beta Cell Biology Consortium; Helmsley Charitable Trust; European Research Commission (European Research Council consolidator grant); BIRAX; DON foundation; Israel Science Foundation(Israel Science Foundation); Israel Science Foundation(Israel Science Foundation); USAID American Schools and Hospitals Abroad Program(United States Agency for International Development (USAID)); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); Adams foundation; Ariane de Rothschild Women Doctoral Program; DiabetesUK(Diabetes UK); Svenska Sallskapet for Medicinsk Forskning (SSMF); Royal Society Wolfson Research Merit Awards(Royal Society of London); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant P60 DK20595 (NIDDK; to P. I. Graeme Bell). This work was also supported by grants from the Juvenile Diabetes Research Foundation, Beta Cell Biology Consortium, The Helmsley Charitable Trust, the European Research Commission (European Research Council consolidator grant), BIRAX, the DON foundation, the Israel Science Foundation, and the I-CORE Program of The Israel Science Foundation #41.11 (to Y. D.). This work was also supported in part by a grant from USAID American Schools and Hospitals Abroad Program for the upgrading of the Hebrew University Medical School Flow Cytometry laboratory. The work leading to this publication received support from the Innovative Medicines Initiative Joint Undertaking under Grant 155005 (IMIDIA), resources of which are composed of a financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution (to G. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of fellowships from the Adams foundation and the Ariane de Rothschild Women Doctoral Program.; Recipient of an R. D. Lawrence Fellowship from DiabetesUK (BDA 12/0004431).; Funded by a post-doctoral fellowship from the Svenska Sallskapet for Medicinsk Forskning (SSMF).; Supported by Wellcome Trust Senior Investigator (WT098424AIA) and Royal Society Wolfson Research Merit Awards, an MRC Programme (MR/J0003042/1), Diabetes UK (11/0004210), and Biotechnology and Biological Sciences Research Council (BB/J015873/1) project grants.	Alejandro EU, 2015, MOL ASPECTS MED, V42, P19, DOI 10.1016/j.mam.2014.12.002; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Dalboge LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082813; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Fu A, 2015, DIABETOLOGIA, V58, P1513, DOI 10.1007/s00125-015-3579-7; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hodson DJ, 2014, MOL ENDOCRINOL, V28, P860, DOI 10.1210/me.2014-1038; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kassem S, 2010, NEW ENGL J MED, V362, P1348, DOI 10.1056/NEJMc0909845; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nie J, 2013, P NATL ACAD SCI USA, V110, P13857, DOI 10.1073/pnas.1307698110; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Storto M, 2006, MOL PHARMACOL, V69, P1234, DOI 10.1124/mol.105.018390; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Ui A, 2014, ONCOGENE, V33, P1640, DOI 10.1038/onc.2013.125; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wikstrom JD, 2013, MOL ENDOCRINOL, V27, P1706, DOI 10.1210/me.2013-1109; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Zhou YS, 2010, J BIOL CHEM, V285, P33718, DOI 10.1074/jbc.M110.136846	70	27	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20934	20946		10.1074/jbc.M115.639237	http://dx.doi.org/10.1074/jbc.M115.639237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26139601	Green Published, hybrid			2022-12-26	WOS:000360011800028
J	Qu, Y; Han, BC; Yu, Y; Yao, WW; Bose, S; Karlan, BY; Giuliano, AE; Cui, XJ				Qu, Ying; Han, Bingchen; Yu, Yi; Yao, Weiwu; Bose, Shikha; Karlan, Beth Y.; Giuliano, Armando E.; Cui, Xiaojiang			Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; IN-VITRO; MYOEPITHELIAL CELLS; GENE-EXPRESSION; GLAND; LINES; PROLIFERATION; MORPHOGENESIS; MARKERS	Breast cancer is the most common cancer in women and a leading cause of cancer-related deaths for women worldwide. Various cell models have been developed to study breast cancer tumorigenesis, metastasis, and drug sensitivity. The MCF10A human mammary epithelial cell line is a widely used in vitro model for studying normal breast cell function and transformation. However, there is limited knowledge about whether MCF10A cells reliably represent normal human mammary cells. MCF10A cells were grown in monolayer, suspension (mammosphere culture), three-dimensional (3D) "on-top" Matrigel, 3D "cell-embedded" Matrigel, or mixed Matrigel/collagen I gel. Suspension culture was performed with the MammoCult medium and low-attachment culture plates. Cells grown in 3D culture were fixed and subjected to either immunofluorescence staining or embedding and sectioning followed by immunohistochemistry and immunofluorescence staining. Cells or slides were stained for protein markers commonly used to identify mammary progenitor and epithelial cells. MCF10A cells expressed markers representing luminal, basal, and progenitor phenotypes in two-dimensional (2D) culture. When grown in suspension culture, MCF10A cells showed low mammosphere-forming ability. Cells in mammospheres and 3D culture expressed both luminal and basal markers. Surprisingly, the acinar structure formed by MCF10A cells in 3D culture was positive for both basal markers and the milk proteins beta-casein and alpha-lactalbumin. MCF10A cells exhibit a unique differentiated phenotype in 3D culture which may not exist or be rare in normal human breast tissue. Our results raise a question as to whether the commonly used MCF10A cell line is a suitable model for human mammary cell studies.	[Qu, Ying; Han, Bingchen; Yu, Yi; Giuliano, Armando E.; Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Karlan, Beth Y.; Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Bose, Shikha] Cedars Sinai Med Ctr, Dept Pathol, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Yao, Weiwu] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Shanghai Jiao Tong University	Cui, XJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	Xiaojiang.cui@cshs.org			National Institutes of Health [CA151610]; Avon Foundation [02-2014-063]; David Salomon Translational Breast Cancer Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; Margie and Robert E. Petersen Foundation; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; David Salomon Translational Breast Cancer Research Fund; Fashion Footwear Charitable Foundation of New York, Inc.; Margie and Robert E. Petersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (CA151610), the Avon Foundation (02-2014-063), David Salomon Translational Breast Cancer Research Fund to XC, and the Fashion Footwear Charitable Foundation of New York, Inc. and the Margie and Robert E. Petersen Foundation to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Batistatou A, 2003, IN VIVO, V17, P573; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chimal-Ramirez GK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/279505; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duss S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3673; Gerdes MJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00366; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Knudsen KA, 2005, J CELL BIOCHEM, V95, P488, DOI 10.1002/jcb.20419; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2012, TISSUE ENG PT A, V18, P520, DOI [10.1089/ten.tea.2011.0317, 10.1089/ten.TEA.2011.0317]; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Liu Y, 2014, BRIT J CANCER, V110, P2063, DOI 10.1038/bjc.2014.105; Lombardo Y, 2012, P NATL ACAD SCI USA, V109, P16558, DOI 10.1073/pnas.1206268109; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Manuel Iglesias J, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0077281; Moriya T, 2009, PATHOLOGY, V41, P68, DOI 10.1080/00313020802563544; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Putti TC, 2005, MODERN PATHOL, V18, P26, DOI 10.1038/modpathol.3800255; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Santagata S, 2014, J CLIN INVEST, V124, P859, DOI 10.1172/JCI70941; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Sonnenschein C, 2008, SEMIN CANCER BIOL, V18, P372, DOI 10.1016/j.semcancer.2008.03.012; SOULE HD, 1990, CANCER RES, V50, P6075; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; Tulsyan S, 2014, CANCER CHEMOTH PHARM, V74, P1065, DOI 10.1007/s00280-014-2588-4; Vares G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077124; Vegfors J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053119; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13	45	118	121	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131285	10.1371/journal.pone.0131285	http://dx.doi.org/10.1371/journal.pone.0131285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147507	Green Published, gold			2022-12-26	WOS:000358157600084
J	Yang, TT; Lo, CP; Tsai, PS; Wu, SY; Wang, TF; Chen, YW; Jiang-Shieh, YF; Kuo, YM				Yang, Ting-Ting; Lo, Chen-Peng; Tsai, Pei-Shan; Wu, Shih-Ying; Wang, Tzu-Feng; Chen, Yun-Wen; Jiang-Shieh, Ya-Fen; Kuo, Yu-Min			Aging and Exercise Affect Hippocampal Neurogenesis via Different Mechanisms	PLOS ONE			English	Article							ADULT NEUROGENESIS; DENTATE GYRUS; NEURONS; CELLS; RAT; PROLIFERATION	The rate of neurogenesis is determined by 1) the number of neural stem/progenitor cells (NSCs), 2) proliferation of NSCs, 3) neuron lineage specification, and 4) survival rate of the newborn neurons. Aging lowers the rate of hippocampal neurogenesis, while exercise (Ex) increases this rate. However, it remains unclear which of the determinants are affected by aging and Ex. We characterized the four determinants in different age groups (3, 6, 9, 12, 21 months) of mice that either received one month of Ex training or remained sedentary. Bromodeoxyuridine (BrdU) was injected two hours before sacrificing the mice to label the proliferating cells. The results showed that the number of newborn neurons massively decreased (>95%) by the time the mice reached nine months of age. The number of NSC was mildly reduced during aging, while Ex delayed such decline. The proliferation rates were greatly decreased by the time the mice were 9-month-old and Ex could not improve the rates. The rates of neuron specification were decreased during aging, while Ex increased the rates. The survival rate was not affected by age or Ex. Aging greatly reduced newborn neuron maturation, while Ex potently enhanced it. In conclusion, age-associated decline of hippocampal neurogenesis is mainly caused by reduction of NSC proliferation. Although Ex increases the NSC number and neuron specification rates, it doesn't restore the massive decline of NSC proliferation rate. Hence, the effect of Ex on the rate of hippocampal neurogenesis during aging is limited, but Ex does enhance the maturation of newborn neurons.	[Yang, Ting-Ting; Wang, Tzu-Feng; Chen, Yun-Wen] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Lo, Chen-Peng; Wu, Shih-Ying; Kuo, Yu-Min] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tsai, Pei-Shan; Wang, Tzu-Feng; Chen, Yun-Wen; Jiang-Shieh, Ya-Fen; Kuo, Yu-Min] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 70101, Taiwan	I Shou University; National Cheng Kung University; National Cheng Kung University	Yang, TT (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan.	tingting.taiwan@gmail.com; kuoym@mail.ncku.edu.tw	Kuo, Yu-Min/A-9050-2013; Ting-Ting, YANG/E-6009-2010	Kuo, Yu-Min/0000-0003-4867-2482; Ting-Ting, YANG/0000-0001-5975-8359; Wu, Shih-Ying/0000-0002-0439-0806	Ministry of Science and Technology of Taiwan, Republic of China [102-2314-B-214-006-MY3, 101-2320-B-006-006-MY3]	Ministry of Science and Technology of Taiwan, Republic of China	This work was supported by Ministry of Science and Technology 102-2314-B-214-006-MY3 (TTY) and 101-2320-B-006-006-MY3 (YMK) of Taiwan, Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Aizawa K, 2011, NEUROBIOL AGING, V32, P140, DOI 10.1016/j.neurobiolaging.2008.12.011; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Amrein I, 2004, HIPPOCAMPUS, V14, P1000, DOI 10.1002/hipo.20018; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Huang TY, 2012, J APPL PHYSIOL, V113, P889, DOI 10.1152/japplphysiol.01363.2011; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lin TW, 2012, NEUROBIOL LEARN MEM, V97, P140, DOI 10.1016/j.nlm.2011.10.006; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Tsai SF, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00027; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Wu SY, 2011, BRAIN BEHAV IMMUN, V25, P135, DOI 10.1016/j.bbi.2010.09.006	27	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132152	10.1371/journal.pone.0132152	http://dx.doi.org/10.1371/journal.pone.0132152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147302	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600207
J	Kippenberger, S; Zoller, N; Kleemann, J; Muller, J; Kaufmann, R; Hofmann, M; Bernd, A; Meissner, M; Valesky, E				Kippenberger, Stefan; Zoeller, Nadja; Kleemann, Johannes; Mueller, Jutta; Kaufmann, Roland; Hofmann, Matthias; Bernd, August; Meissner, Markus; Valesky, Eva			STAT6-Dependent Collagen Synthesis in Human Fibroblasts Is Induced by Bovine Milk	PLOS ONE			English	Article							GROWTH-FACTOR-I; FIBRONECTIN MESSENGER-RNAS; CONJUGATED LINOLEIC-ACID; FACTOR-BETA; MECHANICAL STRETCH; DERMAL FIBROBLASTS; BINDING-PROTEINS; GENE-EXPRESSION; IGF-I; INSULIN	Since the domestication of the urus, 10.000 years ago, mankind utilizes bovine milk for different purposes. Besides usage as a nutrient also the external application of milk on skin has a long tradition going back to at least the ancient Aegypt with Cleopatra VII as a great exponent. In order to test whether milk has impact on skin physiology, cultures of human skin fibroblasts were exposed to commercial bovine milk. Our data show significant induction of proliferation by milk (max. 2,3-fold, EC50: 2,5% milk) without toxic effects. Surprisingly, bovine milk was identified as strong inducer of collagen 1A1 synthesis at both, the protein (4-fold, EC50: 0,09% milk) and promoter level. Regarding the underlying molecular pathways, we show functional activation of STAT6 in a p44/42 and p38-dependent manner. More upstream, we identified IGF-1 and insulin as key factors responsible for milk-induced collagen synthesis. These findings show that bovine milk contains bioactive molecules that act on human skin cells. Therefore, it is tempting to test the herein introduced concept in treatment of atrophic skin conditions induced e.g. by UV light or corticosteroids.	[Kippenberger, Stefan; Zoeller, Nadja; Kleemann, Johannes; Mueller, Jutta; Kaufmann, Roland; Hofmann, Matthias; Bernd, August; Meissner, Markus; Valesky, Eva] Goethe Univ Frankfurt, Dept Dermatol Venereol & Allergy, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Kippenberger, S (corresponding author), Goethe Univ Frankfurt, Dept Dermatol Venereol & Allergy, D-60054 Frankfurt, Germany.	kippenberger@em.uni-frankfurt.de	Kleemann, Johannes/ABH-9877-2022	Hofmann, Matthias/0000-0003-4107-7197; Meissner, Markus/0000-0002-5630-587X				Adebamowo CA, 2005, J AM ACAD DERMATOL, V52, P207, DOI 10.1016/j.jaad.2004.08.007; Adebamowo CA, 2008, J AM ACAD DERMATOL, V58, P787, DOI 10.1016/j.jaad.2007.08.049; Belury MA, 2002, J NUTR, V132, P2995, DOI 10.1093/jn/131.10.2995; Blum JW, 2008, ADV EXP MED BIOL, V606, P397, DOI 10.1007/978-0-387-74087-4_16; Buttner C, 2004, J CELL PHYSIOL, V198, P248, DOI 10.1002/jcp.10395; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Dennis CL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007366.pub2; Falanga V, 1998, J INVEST DERMATOL, V111, P1193, DOI 10.1046/j.1523-1747.1998.00431.x; Ganmaa D, 2001, MED HYPOTHESES, V57, P510, DOI 10.1054/mehy.2001.1380; GILLERY P, 1992, J CELL PHYSIOL, V152, P389, DOI 10.1002/jcp.1041520221; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HANSON LA, 1985, PEDIATRICS, V75, P172; Harrison CA, 2006, BRIT J DERMATOL, V154, P401, DOI 10.1111/j.1365-2133.2005.07022.x; HOFFMANN B, 1977, J ANIM SCI, V45, P635, DOI 10.2527/jas1977.453635x; Hoppe C, 2009, BRIT J NUTR, V102, P1047, DOI 10.1017/S0007114509338829; JENNESS R, 1974, J INVEST DERMATOL, V63, P109, DOI 10.1111/1523-1747.ep12678111; Jouan PN, 2006, INT DAIRY J, V16, P1408, DOI 10.1016/j.idairyj.2006.06.007; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; KREAM BE, 1985, ENDOCRINOLOGY, V116, P296, DOI 10.1210/endo-116-1-296; Krupsky M, 1996, CONNECT TISSUE RES, V34, P53, DOI 10.3109/03008209609028893; Kumura H, 2012, J DAIRY SCI, V95, P3629, DOI 10.3168/jds.2011-5304; Mansson Helena Lindmark, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1821; Maruyama K, 2009, ASIAN PAC J CANCER P, V10, P6; Melnik B, 2009, J DTSCH DERMATOL GES, V7, P364, DOI 10.1111/j.1610-0387.2009.07019.x; Olsan EE, 2011, P NATL ACAD SCI USA, V108, P18067, DOI 10.1073/pnas.1111966108; Osorio EY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004165; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; ROSEN DM, 1983, ENDOCRINOLOGY, V112, P992, DOI 10.1210/endo-112-3-992; Sparks AL, 2003, J DAIRY SCI, V86, P2022, DOI 10.3168/jds.S0022-0302(03)73791-6; Takeda K, 1997, J MOL MED-JMM, V75, P317, DOI 10.1007/s001090050117; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; YATEMAN ME, 1993, J ENDOCRINOL, V137, P151, DOI 10.1677/joe.0.1370151; Zeng WP, 2013, IMMUNOLOGY, V140, P31, DOI 10.1111/imm.12121; Zhou XR, 2008, GROWTH HORM IGF RES, V18, P361, DOI 10.1016/j.ghir.2008.01.001; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131783	10.1371/journal.pone.0131783	http://dx.doi.org/10.1371/journal.pone.0131783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134630	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400073
J	Schuerman, WL; Meyer, A; McQueen, JM				Schuerman, William L.; Meyer, Antje; McQueen, James M.			Do We Perceive Others Better than Ourselves? A Perceptual Benefit for Noise-Vocoded Speech Produced by an Average Speaker	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; LEXICAL INFORMATION; ENGLISH R; RECOGNITION; TALKER; ACQUISITION; PREDICTIONS; INTEGRATION; KNOWLEDGE; CONTRAST	In different tasks involving action perception, performance has been found to be facilitated when the presented stimuli were produced by the participants themselves rather than by another participant. These results suggest that the same mental representations are accessed during both production and perception. However, with regard to spoken word perception, evidence also suggests that listeners' representations for speech reflect the input from their surrounding linguistic community rather than their own idiosyncratic productions. Furthermore, speech perception is heavily influenced by indexical cues that may lead listeners to frame their interpretations of incoming speech signals with regard to speaker identity. In order to determine whether word recognition evinces similar self-advantages as found in action perception, it was necessary to eliminate indexical cues from the speech signal. We therefore asked participants to identify noise-vocoded versions of Dutch words that were based on either their own recordings or those of a statistically average speaker. The majority of participants were more accurate for the average speaker than for themselves, even after taking into account differences in intelligibility. These results suggest that the speech representations accessed during perception of noise-vocoded speech are more reflective of the input of the speech community, and hence that speech perception is not necessarily based on representations of one's own speech.	[Schuerman, William L.; Meyer, Antje; McQueen, James M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [McQueen, James M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [McQueen, James M.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen	Schuerman, WL (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	Will.Schuerman@mpi.nl	McQueen, James M./B-2212-2010	McQueen, James M./0000-0003-3734-6286; Schuerman, William/0000-0001-9123-2891				Allen JS, 2004, J ACOUST SOC AM, V115, P3171, DOI 10.1121/1.1701898; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bartoli E, 2015, CEREB CORTEX, V25, P281, DOI 10.1093/cercor/bht257; Beijering K., 2008, LINGUISTICS NETHERLA, V25, P13, DOI [10.1075/avt.25.05bei, DOI 10.1075/AVT.25.05BEI]; Boersma Paul, 2002, GLOT INT, V5, P341; BORDEN G, 1983, LANG LEARN, V33, P499, DOI 10.1111/j.1467-1770.1983.tb00946.x; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; Bradlow AR, 1999, J ACOUST SOC AM, V106, P2074, DOI 10.1121/1.427952; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; BROWN R, 1960, CHILD DEV, V31, P1; Brunelliere A, 2013, BRAIN LANG, V125, P82, DOI 10.1016/j.bandl.2013.01.007; Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490; Casserly ED, 2010, WIRES COGN SCI, V1, P629, DOI 10.1002/wcs.63; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Devlin JT, 2007, BRAIN, V130, P610, DOI 10.1093/brain/awl331; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Ghyselinck M, 2000, PSYCHOL BELG, V40, P77; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Halle M, 1959, P SEMINAR SPEECH COM, VII; Hannemann R, 2007, BRAIN RES, V1153, P134, DOI 10.1016/j.brainres.2007.03.069; Heald SLM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00035; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Johnson K, 1999, J PHONETICS, V27, P359, DOI 10.1006/jpho.1999.0100; Knoblich G, 2002, Q J EXP PSYCHOL-A, V55, P1027, DOI 10.1080/02724980143000631; Knoblich G, 2001, PSYCHOL SCI, V12, P467, DOI 10.1111/1467-9280.00387; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; Lopez S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03407; MACKAIN KS, 1981, APPL PSYCHOLINGUIST, V2, P369, DOI 10.1017/S0142716400009796; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; NEAREY TM, 1989, J ACOUST SOC AM, V85, P2088, DOI 10.1121/1.397861; Niedzielski N, 1999, J LANG SOC PSYCHOL, V18, P62, DOI 10.1177/0261927X99018001005; Niziolek Caroline A., 2013, Journal of the Acoustical Society of America, V134, DOI 10.1121/1.4831274; Nusbaum H., 1997, TALKER VARIABILITY S, P109; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Poeppel D, 2011, LANG COGNITIVE PROC, V26, P935, DOI 10.1080/01690965.2010.493301; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1007/978-3-642-75348-0_7; Remez RE, 2011, J EXP PSYCHOL HUMAN, V37, P968, DOI 10.1037/a0020734; Scott SK, 2013, BIRDSONG, SPEECH, AND LANGUAGE: EXPLORING THE EVOLUTION OF MIND AND BRAIN, P277; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; SHELDON A, 1982, APPL PSYCHOLINGUIST, V3, P243, DOI 10.1017/S0142716400001417; SHELDON A, 1985, LANG LEARN, V35, P107, DOI 10.1111/j.1467-1770.1985.tb01018.x; Sohoglu E, 2012, J NEUROSCI, V32, P8443, DOI 10.1523/JNEUROSCI.5069-11.2012; Strand EA, 1996, NATURAL LANGUAGE PROCESSING AND SPEECH TECHNOLOGY, P14; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Tye-Murray N, 2013, PSYCHON B REV, V20, P115, DOI 10.3758/s13423-012-0328-5; Vongphoe M, 2005, J ACOUST SOC AM, V118, P1055, DOI 10.1121/1.1944507; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Zhang T, 2010, EAR HEARING, V31, P63, DOI 10.1097/AUD.0b013e3181b7190c	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0129731	10.1371/journal.pone.0129731	http://dx.doi.org/10.1371/journal.pone.0129731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CS	26134279	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400010
J	Wang, SY; Wei, YH; Shieh, DB; Lin, LL; Cheng, SP; Wang, PW; Chuang, JH				Wang, Shuo-Yu; Wei, Yau-Huei; Shieh, Dar-Bin; Lin, Li-Ling; Cheng, Shih-Ping; Wang, Pei-Wen; Chuang, Jiin-Haur			2-Deoxy-D-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells	PLOS ONE			English	Article							TUMOR METABOLISM; BRAF MUTATION; CANCER; 2-DEOXYGLUCOSE; RESTRICTION; INHIBITION; CYTOTOXICITY; CISPLATIN; DEATH; TRIAL	Tumor cells display a shift in energy metabolism from oxidative phosphorylation to aerobic glycolysis. A subset of papillary thyroid carcinoma (PTC) is refractory to surgery and radioactive iodine ablation. Doxorubicin and sorafenib are the drugs of choice for treating advanced thyroid cancer but both induce adverse effects. In this study, we assessed the anti-cancer activity of 2-deoxy-D-glucose (2-DG) alone and in combination with doxorubicin or sorafenib in PTC cell lines with (BCPAP) and without (CG3) the BRAF(V600E) mutation. BCPAP cells were more glycolytic than CG3 cells, as evidenced by their higher extracellular L-lactate production, lower intracellular ATP level, lower oxygen consumption rate (OCR), and lower ratio of OCR/extracellular acidification rate. However, dose-dependent reduction in cell viability, intracellular ATP depletion, and extracellular L-lactate production were observed after 2-DG treatment. Regression analysis showed that cell growth in both cell lines was dependent on ATP generation. 2-DG increased the chemosensitivity of BCPAP and CG3 cell lines to doxorubicin and sorafenib. These results demonstrate that the therapeutic effects of low combined doses of 2-DG and doxorubicin or sorafenib are similar to those of high doses of doxorubicin or sorafenib alone in PTC cell lines regardless of the BRAF(V600E) mutation.	[Wang, Shuo-Yu] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan; [Wang, Shuo-Yu; Chuang, Jiin-Haur] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan; [Wei, Yau-Huei] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Shieh, Dar-Bin] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Lin, Li-Ling] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Lin, Li-Ling; Chuang, Jiin-Haur] Kaohsiung Chang Gung Mem Hosp, Div Pediat Surg, Dept Surg, Kaohsiung, Taiwan; [Cheng, Shih-Ping] Mackay Mem Hosp, Dept Surg, Taipei, Taiwan; [Wang, Pei-Wen] Kaohsiung Chang Gung Mem Hosp, Dept Internal & Nucl Med, Kaohsiung, Taiwan	Chi Mei Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Mackay Medical College; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Mackay Memorial Hospital; Chang Gung Memorial Hospital	Chuang, JH (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan.	jhchuang@cgmh.org.tw	Wei, Yau-Huei/ABA-6841-2021; Cheng, Shih-Ping/Q-3014-2018	Wei, Yau-Huei/0000-0002-6429-2546; Cheng, Shih-Ping/0000-0002-6301-5096; Lin, Li-Ling/0000-0001-9891-5900	Chang Gung Memorial Hospital [CMRPG891091-93]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The manuscript was supported by the Chang Gung Memorial Hospital (Grant Numbers CMRPG891091-93).	Aft RL, 2003, CANCER RES, V63, P5496; Brose MS, 2014, LANCET, V384, P319, DOI 10.1016/S0140-6736(14)60421-9; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Chuang JH, 2013, INT J BIOCHEM CELL B, V45, P944, DOI 10.1016/j.biocel.2013.01.019; Coleman MC, 2008, FREE RADICAL BIO MED, V44, P322, DOI 10.1016/j.freeradbiomed.2007.08.032; Dearling JLJ, 2004, J NUCL MED, V45, P101; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Farooque A, 2009, J CANCER RES THER, V5, P32, DOI 10.4103/0973-1482.55138; Feng C, 2013, J CLIN ENDOCR METAB, V98, pE1524, DOI 10.1210/jc.2012-4258; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Goldberg L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.24; Grabellus F, 2012, THYROID, V22, P377, DOI 10.1089/thy.2011.0401; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Lane Mark A, 2007, Methods Mol Biol, V371, P143; Lin JD, 1996, J SURG ONCOL, V63, P112, DOI 10.1002/(SICI)1096-9098(199610)63:2<112::AID-JSO8>3.3.CO;2-4; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; SHIMAOKA K, 1985, CANCER, V56, P2155, DOI 10.1002/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E; Silva AS, 2012, CANCER RES, V72, P6362, DOI 10.1158/0008-5472.CAN-12-2235; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vilalta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-58; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Zhang FJ, 2009, J CANCER RES THER, V5, P41, DOI 10.4103/0973-1482.55140; Zhang XD, 2006, ANTICANCER RES, V26, P3561	44	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130959	10.1371/journal.pone.0130959	http://dx.doi.org/10.1371/journal.pone.0130959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134286	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400030
J	Cheng, HW; Chen, YF; Yang, Y; Chen, XQ; Guo, XL; Du, AF				Cheng, Haiwei; Chen, Yifei; Yang, Yi; Chen, Xueqiu; Guo, Xiaolu; Du, Aifang			Characterization of Anti-Citrinin Specific ScFvs Selected from Non-Immunized Mouse Splenocytes by Eukaryotic Ribosome Display	PLOS ONE			English	Article							IN-VITRO SELECTION; ENZYME-IMMUNOASSAY; ESCHERICHIA-COLI; FRAGMENT SCFV; ANTIBODIES; LIBRARIES; AFFINITY; EVOLUTION; OCHRATOXIN; MYCOTOXINS	Single chain variable fragments (scFvs) against citrinin (CIT) were selected from a scFv library constructed from the splenocytes of non-immunized mice by an improved eukaryotic ribosome display technology in this study. Bovine serum albumin (BSA)/ CIT-BSA and ovalbumin (OVA)/ CIT-OVA were used as the antigens to select specific anti-CIT scFvs. Eukaryotic in situ RT-PCR method was used to recover the selected mRNA after every affinity selection. After six rounds of ribosome display, expression vector pTIG-TRX carrying specific scFv DNAs were constructed and transformed into Escherichia coli BL21 (DE3) for protein expression. Thirteen positive clones were selected out of which three (designated 23, 68 and 109) showed high binding activity and specificity to CIT by indirect ELISA, while no clone showed binding activity with carrier proteins. The three scFvs showed high specificity to CIT and the cross reactivity with other mycotoxins was below 0.01% as determined by indirect competitive ELISA. These specific scFvs offer a potential novel immunoassay method for CIT residues. This study confirmed the effectiveness of the improved eukaryotic ribosome display system and could be used as a reference for the selection of scFvs specific to other small molecules using ribosome display.	[Du, Aifang] Zhejiang Univ, Coll Anim Sci, Inst Prevent Vet Med, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Anim Sci, Zhejiang Prov Key Lab Prevent Vet Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Du, AF (corresponding author), Zhejiang Univ, Coll Anim Sci, Inst Prevent Vet Med, Hangzhou 310003, Zhejiang, Peoples R China.	afdu@zju.edu.cn	Chen, Yi/HIR-2608-2022		National High Technology Research and Development Program (863 Program) [2012AA101602]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	This research was supported by National High Technology Research and Development Program (863 Program) (No. 2012AA101602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson D, 1999, J AOAC INT, V82, P1353; Amstutz P, 2002, J AM CHEM SOC, V124, P9396, DOI 10.1021/ja025870q; AREVALO JH, 1993, J MOL BIOL, V231, P103, DOI 10.1006/jmbi.1993.1260; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Betina V, 1989, BIOACTIVE MOL, P114; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; BLANC PJ, 1995, BIOTECHNOL LETT, V17, P291, DOI 10.1007/BF01190639; Charlton K, 2001, BIOSENS BIOELECTRON, V16, P639, DOI 10.1016/S0956-5663(01)00192-0; Comerio R, 1998, INT J FOOD MICROBIOL, V42, P219, DOI 10.1016/S0168-1605(98)00081-6; DAMODARA.C, 1973, ANAL BIOCHEM, V52, P482, DOI 10.1016/0003-2697(73)90052-3; EIBANNA AA, 1987, SYSTEMATIC APPL MICR, V10, P42; GIMENO A, 1983, J ASSOC OFF ANA CHEM, V66, P85; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hanes J, 1999, FEBS LETT, V450, P105, DOI 10.1016/S0014-5793(99)00475-5; Hanes J, 2000, NAT BIOTECHNOL, V12; He MY, 2007, NAT METHODS, V4, P281, DOI 10.1038/NMETH1001; He Mingyue, 2004, Methods Mol Biol, V248, P177; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; He MY, 1997, NUCLEIC ACIDS RES, V25, P5132, DOI 10.1093/nar/25.24.5132; He MY, 2005, J IMMUNOL METHODS, V297, P73, DOI 10.1016/j.jim.2004.11.022; He MY, 1999, J IMMUNOL METHODS, V231, P105, DOI 10.1016/S0022-1759(99)00144-1; Hetherington AC, 1931, PHILOS T R SOC LON B, V220, P269, DOI 10.1098/rstb.1931.0025; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; JACKSON LK, 1978, APPL ENVIRON MICROB, V36, P408, DOI 10.1128/AEM.36.3.408-411.1978; Jermutus L, 2001, P NATL ACAD SCI USA, V98, P75, DOI 10.1073/pnas.011311398; KONONENKO GP, 2007, ZH ANAL KHIM, V62, P769; Lamla T, 2003, J MOL BIOL, V329, P381, DOI 10.1016/S0022-2836(03)00432-7; Lamla T, 2001, FEBS LETT, V502, P35, DOI 10.1016/S0014-5793(01)02660-6; Lee MS, 2004, J IMMUNOL METHODS, V284, P147, DOI 10.1016/j.jim.2003.10.009; Li F, 2010, PROTEIN PEPTIDE LETT, V17, P585, DOI 10.2174/092986610791112729; Manabe M., 2001, Mycotoxins, V51, P25, DOI 10.2520/myco.51.25; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Moghaddam A, 2001, J IMMUNOL METHODS, V254, P169, DOI 10.1016/S0022-1759(01)00413-6; PHILLIPS RD, 1980, J CHROMATOGR, V190, P419, DOI 10.1016/S0021-9673(00)88247-3; Qi YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006427; RATH S, 1988, J IMMUNOL METHODS, V106, P245, DOI 10.1016/0022-1759(88)90204-9; Reinhard H, 1999, J CHROMATOGR A, V862, P147, DOI 10.1016/S0021-9673(99)00929-2; Rothe A, 2008, BIOL CHEM, V389, P433, DOI 10.1515/BC.2008.045; Rothe A, 2007, J BIOTECHNOL, V130, P448, DOI 10.1016/j.jbiotec.2007.05.012; Sheedy C, 2007, BIOTECHNOL ADV, V25, P333, DOI 10.1016/j.biotechadv.2007.02.003; Shu PY, 2002, ANAL SCI, V18, P283, DOI 10.2116/analsci.18.283; Sun YA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033186; Takahashi F, 2002, FEBS LETT, V514, P106, DOI 10.1016/S0014-5793(02)02334-7; Tuomi T, 2001, ANALYST, V126, P1545, DOI 10.1039/b103790k; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Yan XH, 2005, INDIAN J BIOCHEM BIO, V42, P350; Yang L, 2009, J AGR FOOD CHEM, V57, P8927, DOI 10.1021/jf9019536; Yau KYF, 2003, J IMMUNOL METHODS, V281, P161, DOI 10.1016/j.jim.2003.07.011; Yuan SL, 2004, PROTEIN EXPRES PURIF, V38, P51, DOI 10.1016/j.pep.2004.08.004; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200; Zhou JM, 2002, J AM CHEM SOC, V124, P538, DOI 10.1021/ja011885x	51	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131482	10.1371/journal.pone.0131482	http://dx.doi.org/10.1371/journal.pone.0131482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131718	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000122
J	Huerlimann, R; Zenger, KR; Jerry, DR; Heimann, K				Huerlimann, Roger; Zenger, Kyall R.; Jerry, Dean R.; Heimann, Kirsten			Phylogenetic Analysis of Nucleus-Encoded Acetyl-CoA Carboxylases Targeted at the Cytosol and Plastid of Algae	PLOS ONE			English	Article							PHOTOSYNTHETIC EUKARYOTES; CHROMALVEOLATE PLASTIDS; APICOMPLEXAN PARASITES; CHROMERA-VELIA; ENDOSYMBIOSIS; EVOLUTION; SECONDARY; GENES; GREEN; CRYPTOPHYTES	The understanding of algal phylogeny is being impeded by an unknown number of events of horizontal gene transfer (HGT), and primary and secondary/tertiary endosymbiosis. Through these events, previously heterotrophic eukaryotes developed photosynthesis and acquired new biochemical pathways. Acetyl-CoA carboxylase (ACCase) is a key enzyme in the fatty acid synthesis and elongation pathways in algae, where ACCase exists in two locations (cytosol and plastid) and in two forms (homomeric and heteromeric). All algae contain nucleus-encoded homomeric ACCase in the cytosol, independent of the origin of the plastid. Nucleus-encoded homomeric ACCase is also found in plastids of algae that arose from a secondary/tertiary endosymbiotic event. In contrast, plastids of algae that arose from a primary endosymbiotic event contain heteromeric ACCase, which consists of three nucleus-encoded and one plastid-encoded subunits. These properties of ACCase provide the potential to inform on the phylogenetic relationships of hosts and their plastids, allowing different hypothesis of endosymbiotic events to be tested. Alveolata (Dinoflagellata and Apicomplexa) and Chromista (Stramenopiles, Haptophyta and Cryptophyta) have traditionally been grouped together as Chromalveolata, forming the red lineage. However, recent genetic evidence groups the Stramenopiles, Alveolata and green plastid containing Rhizaria as SAR, excluding Haptophyta and Cryptophyta. Sequences coding for plastid and cytosol targeted homomeric ACCases were isolated from Isochrysis aff. galbana (TISO), Chromera velia and Nannochloropsis oculata, representing three taxonomic groups for which sequences were lacking. Phylogenetic analyses show that cytosolic ACCase strongly supports the SAR grouping. Conversely, plastidial ACCase groups the SAR with the Haptophyta, Cryptophyta and Prasinophyceae (Chlorophyta). These two ACCase based, phylogenetic relationships suggest that the plastidial homomeric ACCase was acquired by the Haptophyta, Cryptophyta and SAR, before the photosynthetic Rhizaria acquired their green plastid. Additionally, plastidial ACCase was derived by HGT from an ancestor or relative of the Prasinophyceae and not by duplication of cytosolic ACCase.	[Huerlimann, Roger; Zenger, Kyall R.; Jerry, Dean R.; Heimann, Kirsten] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Huerlimann, Roger; Zenger, Kyall R.; Jerry, Dean R.; Heimann, Kirsten] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Huerlimann, Roger; Heimann, Kirsten] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Huerlimann, R (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.	roger.huerlimann@jcu.edu.au	Huerlimann, Roger/AAD-1498-2019; Zenger, Kyall R/ABD-2101-2020; Heimann, Kirsten/M-4814-2019; Jerry, Dean R/B-3053-2012; Heimann, Kirsten/N-1512-2013	Huerlimann, Roger/0000-0002-6020-334X; Zenger, Kyall R/0000-0001-6817-8786; Heimann, Kirsten/0000-0003-2691-9659; Heimann, Kirsten/0000-0003-2691-9659; Jerry, Dean/0000-0003-3735-1798				Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Archibald JM, 2012, ADV BOT RES, V64, P87, DOI 10.1016/B978-0-12-391499-6.00003-7; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Baumgarten S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-704; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Bazzani S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-118; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bodyl A, 2009, TRENDS ECOL EVOL, V24, P119, DOI 10.1016/j.tree.2008.11.003; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Dagan T, 2009, SCIENCE, V324, P1651, DOI 10.1126/science.1175765; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2009, BIOESSAYS, V31, P1273, DOI 10.1002/bies.200900117; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Frommolt R, 2008, MOL BIOL EVOL, V25, P2653, DOI 10.1093/molbev/msn206; Gornicki P, 2003, INT J PARASITOL, V33, P885, DOI 10.1016/S0020-7519(03)00133-4; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Huerlimann R, 2014, GENE, V543, P204, DOI 10.1016/j.gene.2014.04.022; Huerlimann R, 2013, CRIT REV BIOTECHNOL, V33, P49, DOI 10.3109/07388551.2012.668671; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Louie T, 2010, BIOORG MED CHEM LETT, V20, P4611, DOI 10.1016/j.bmcl.2010.06.007; MacRae JI, 2012, CURR PHARM DESIGN, V18, P3490; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nakayama T, 2009, CURR BIOL, V19, pR284, DOI 10.1016/j.cub.2009.02.043; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; Petersen J, 2006, J MOL EVOL, V62, P143, DOI 10.1007/s00239-004-0305-3; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Wernegreen JJ, 2012, CURR BIOL, V22, pR555, DOI 10.1016/j.cub.2012.06.010; Woehle C, 2011, GENOME BIOL EVOL, V3, P1220, DOI 10.1093/gbe/evr100; Zuther E, 1999, P NATL ACAD SCI USA, V96, P13387, DOI 10.1073/pnas.96.23.13387	44	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131099	10.1371/journal.pone.0131099	http://dx.doi.org/10.1371/journal.pone.0131099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131555	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000358153000093
J	Szalkai, B; Varga, B; Grolmusz, V				Szalkai, Balazs; Varga, Balint; Grolmusz, Vince			Graph Theoretical Analysis Reveals: Women's Brains Are Better Connected than Men's	PLOS ONE			English	Article							TRACTOGRAPHY; ASSOCIATION; NETWORKS; SEX	Deep graph-theoretic ideas in the context with the graph of the World Wide Web led to the definition of Google's PageRank and the subsequent rise of the most popular search engine to date. Brain graphs, or connectomes, are being widely explored today. We believe that non-trivial graph theoretic concepts, similarly as it happened in the case of the World Wide Web, will lead to discoveries enlightening the structural and also the functional details of the animal and human brains. When scientists examine large networks of tens or hundreds of millions of vertices, only fast algorithms can be applied because of the size constraints. In the case of diffusion MRI-based structural human brain imaging, the effective vertex number of the connectomes, or brain graphs derived from the data is on the scale of several hundred today. That size facilitates applying strict mathematical graph algorithms even for some hard-to-compute (or NP-hard) quantities like vertex cover or balanced minimum cut. In the present work we have examined brain graphs, computed from the data of the Human Connectome Project, recorded from male and female subjects between ages 22 and 35. Significant differences were found between the male and female structural brain graphs: we show that the average female connectome has more edges, is a better expander graph, has larger minimal bisection width, and has more spanning trees than the average male connectome. Since the average female brain weighs less than the brain of males, these properties show that the female brain has better graph theoretical properties, in a sense, than the brain of males. It is known that the female brain has a smaller gray matter/white matter ratio than males, that is, a larger white matter/gray matter ratio than the brain of males; this observation is in line with our findings concerning the number of edges, since the white matter consists of myelinated axons, which, in turn, roughly correspond to the connections in the brain graph. We have also found that the minimum bisection width, normalized with the edge number, is also significantly larger in the right and the left hemispheres in females: therefore, the differing bisection widths are independent from the difference in the number of edges.	[Szalkai, Balazs; Varga, Balint; Grolmusz, Vince] Eotvos Lorand Univ, PIT Bioinformat Grp, H-1117 Budapest, Hungary; [Grolmusz, Vince] Uratim Ltd, H-1118 Budapest, Hungary	Eotvos Lorand University	Grolmusz, V (corresponding author), Eotvos Lorand Univ, PIT Bioinformat Grp, H-1117 Budapest, Hungary.	grolmusz@pitgroup.org	Varga, Bálint/AAC-4316-2021; Szalkai, Balázs/I-4315-2017	Varga, Bálint/0000-0001-8827-6754; Szalkai, Balázs/0000-0002-0920-5083; Grolmusz, Vince/0000-0001-9456-8876	 [1U54MH091657]		Data were provided in part by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.	Achterberg T, 2008, LECT NOTES COMPUT SC, V5015, P6, DOI 10.1007/978-3-540-68155-7_4; Achterberg T, 2009, MATH PROGRAM COMPUT, V1, P1, DOI 10.1007/s12532-008-0001-1; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Agosta F, 2014, NEUROBIOL AGING, V35, P2646, DOI 10.1016/j.neurobiolaging.2014.05.017; Alexander-Bloch AF, 2014, BIOL PSYCHIAT, V76, P438, DOI 10.1016/j.biopsych.2014.02.010; Baker JT, 2014, JAMA PSYCHIAT, V71, P109, DOI 10.1001/jamapsychiatry.2013.3469; Ball G, 2014, P NATL ACAD SCI USA, V111, P7456, DOI 10.1073/pnas.1324118111; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Batalle D, 2013, NEUROIMAGE, V83, P901, DOI 10.1016/j.neuroimage.2013.07.045; Besson P, 2014, NEUROIMAGE, V100, P135, DOI 10.1016/j.neuroimage.2014.04.071; Bonilha L, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/215380; Chung FR, 1997, SPECTRAL GRAPH THEOR, V92; Craddock RC, 2013, NEUROIMAGE, V82, P127, DOI 10.1016/j.neuroimage.2013.05.072; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Feng LH, 2013, MATCH-COMMUN MATH CO, V69, P629; Fine C, 2014, SCIENCE, V346, P915, DOI 10.1126/science.1262061; Ford LR, 1956, CAN J MATH, V8, P399, DOI [10.4153/CJM-1956-045-5, 10.4153/CJM-1956-045-5., DOI 10.4153/CJM-1956-045-5]; Garey M. R., 1976, Theoretical Computer Science, V1, P237, DOI 10.1016/0304-3975(76)90059-1; Ghasemi J, 2013, INFORM SCIENCES, V223, P205, DOI 10.1016/j.ins.2012.08.026; Girard G, 2014, NEUROIMAGE, V98, P266, DOI 10.1016/j.neuroimage.2014.04.074; Graham DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00044; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; HOCHBAUM DS, 1982, SIAM J COMPUT, V11, P555, DOI 10.1137/0211045; Hoel PG., 1984, INTRO MATH STAT; HOLM S, 1979, SCAND J STAT, V6, P65; Hoory S, 2006, B AM MATH SOC, V43, P439, DOI 10.1090/S0273-0979-06-01126-8; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, pE638, DOI 10.1073/pnas.1323601111; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Joel D, 2014, P NATL ACAD SCI USA, V111, pE637, DOI 10.1073/pnas.1323319111; Kirchhoff G, 1847, ANN PHYS CHEM, P72; Lawler E.L., 2001, COMBINATORIAL OPTIMI; Li R, 2013, MATCH-COMMUN MATH CO, V70, P163; Lovasz L., 2007, COMBINATORIAL PROBLE, V2nd; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Ortiz A, 2014, INFORM SCIENCES, V262, P117, DOI 10.1016/j.ins.2013.10.002; Prufer H., 1918, ARCH MATH LOGIK GR, V27, P742; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; Tarjan R. E., 1983, CBMS NSF REGIONAL C, V44; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; WONNACOTT R. J., 1972, INTRO STAT	43	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130045	10.1371/journal.pone.0130045	http://dx.doi.org/10.1371/journal.pone.0130045			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132764	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000049
J	Umeno, A; Yoshino, K; Hashimoto, Y; Shichiri, M; Kataoka, M; Yoshida, Y				Umeno, Aya; Yoshino, Kohzoh; Hashimoto, Yoshiko; Shichiri, Mototada; Kataoka, Masatoshi; Yoshida, Yasukazu			Multi-Biomarkers for Early Detection of Type 2 Diabetes, Including 10-and 12-(Z, E)-Hydroxyoctadecadienoic Acids, Insulin, Leptin, and Adiponectin	PLOS ONE			English	Article							HYDROXY FATTY-ACIDS; LIPID-PEROXIDATION; OXIDATIVE STRESS; LINOLEIC-ACID; HYDROXYOCTADECADIENOIC ACID; PLASMA; ERYTHROCYTES; LIPOPROTEINS; RESISTANCE; MELLITUS	We have previously found that fasting plasma levels of totally assessed 10- and 12-(Z, E)-hydroxyoctadecadienoic acid (HODE) correlated well with levels of glycated hemoglobin (HbA1c) and glucose during oral glucose tolerance tests (OGTT); these levels were determined via liquid chromatography-mass spectrometry after reduction and saponification. However, 10- and 12-(Z, E)-HODE alone cannot perfectly detect early impaired glucose tolerance (IGT) and/or insulin resistance, which ultimately lead to diabetes. In this study, we randomly recruited healthy volunteers (n = 57) who had no known history of any diseases, and who were evaluated using the OGTT, the HODE biomarkers, and several additional proposed biomarkers, including retinol binding protein 4 (RBP4), adiponectin, leptin, insulin, glycoalbumin, and high sensitivity-C-reactive protein. The OGTT revealed that our volunteers included normal individuals (n = 44; Group N), "high-normal" individuals (fasting plasma glucose 100-109 mg/dL) with IGT (n = 11; Group HN+IGT), and diabetic individuals (n = 2; Group D). We then used these groups to evaluate the potential biomarkers for the early detection of type 2 diabetes. Plasma levels of RBP4 and glycoalbumin were higher in Group HN+IGT, compared to those in Group N, and fasting levels of 10- and 12-(Z, E)-HODE/linoleic acids were significantly correlated with levels of RBP4 (p = 0.003, r = 0.380) and glycoalbumin (p = 0.006, r = 0.316). Furthermore, we developed a stepwise multiple linear regression models to predict the individuals' insulin resistance index (the Matsuda Index 3). Fasting plasma levels of 10- and 12-(Z, E)-HODE/linoleic acids, glucose, insulin, and leptin/adiponectin were selected as the explanatory variables for the models. The risks of type 2 diabetes, early IGT, and insulin resistance were perfectly predicted by comparing fasting glucose levels to the estimated Matsuda Index 3 (fasting levels of 10- and 12-(Z, E)-HODE/linoleic acids, insulin, and leptin/adiponectin).	[Umeno, Aya; Hashimoto, Yoshiko; Kataoka, Masatoshi; Yoshida, Yasukazu] Natl Inst Adv Ind Sci & Technol, HRI, Takamatsu, Kagawa 7610395, Japan; [Yoshino, Kohzoh; Shichiri, Mototada] Natl Inst Adv Ind Sci & Technol, HRI, Ikeda, Osaka 5638577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Yoshida, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, HRI, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.	yoshida-ya@aist.go.jp	Shichiri, Mototada/L-9276-2018; YOSHIDA, YASUKAZU/H-8510-2016; Kataoka, Masatoshi/M-6925-2018	Shichiri, Mototada/0000-0003-1108-7597; YOSHIDA, YASUKAZU/0000-0001-6034-2502; Kataoka, Masatoshi/0000-0001-9779-8319	Oil&Fat Industry Kaikan; Japan Society for the Promotion of Science (JSPS) [15K16538]; Adaptable and Seamless Technology Transfer Program through target-driven R&D, Japan Science and Technology Agency (JST)	Oil&Fat Industry Kaikan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology Transfer Program through target-driven R&D, Japan Science and Technology Agency (JST)	This work was partially supported by Grant-in-Aid of Foundation, Oil&Fat Industry Kaikan, a grant from the program Grant-in Aid for Young Scientists (B) 15K16538 from the Japan Society for the Promotion of Science (JSPS), and Adaptable and Seamless Technology Transfer Program through target-driven R&D, Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa Ogawa Y, 2015, FREE RAD BI IN PRESS; Badway JA, 1988, J BIOL CHEM, V263, P9692; Basu S, 2004, FREE RADICAL RES, V38, P105, DOI 10.1080/10715760310001646895; Cho H, 2003, ANAL BIOCHEM, V318, P47, DOI 10.1016/S0003-2697(03)00140-4; Choi HJ, 2013, DIABETES RES CLIN PR, V99, pE27, DOI 10.1016/j.diabres.2012.01.005; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Gunderson EP, 2014, METABOLISM, V63, P941, DOI 10.1016/j.metabol.2014.04.006; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hirashima Y, 2012, NEUROSURGERY, V70, P602, DOI 10.1227/NEU.0b013e3182333c69; Inouye M, 1999, BBA-MOL CELL BIOL L, V1438, P204, DOI 10.1016/S1388-1981(99)00052-9; Jialal I, 2014, METAB SYNDR RELAT D, V12, P227, DOI 10.1089/met.2014.0013; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Kadowaki Takashi, 2008, Journal of the Japan Diabetes Society, V51, P281; KANOFSKY JR, 1988, J BIOL CHEM, V263, P14171; Kawai T, 2013, ANAL CHEM, V85, P6587, DOI 10.1021/ac400667e; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Lee Ji Woo, 2013, Ann Pediatr Endocrinol Metab, V18, P208, DOI 10.6065/apem.2013.18.4.208; Liu W, 2010, CHEM RES TOXICOL, V23, P986, DOI 10.1021/tx1000943; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; Murotomi K, 2015, FREE RADICAL RES, V49, P133, DOI 10.3109/10715762.2014.985218; Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Shichiri M, 2011, FREE RADICAL BIO MED, V50, P1801, DOI 10.1016/j.freeradbiomed.2011.03.023; Uelgen Fatma, 2010, Archives of Physiology and Biochemistry, V116, P57, DOI 10.3109/13813451003631421; Umeno A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063542; Wu Y, 2009, J LIPID RES, V50, P1479, DOI 10.1194/jlr.P900014-JLR200; Yoshida Y, 2007, LIPIDS, V42, P439, DOI 10.1007/s11745-007-3037-5; Yoshida Y, 2006, BBA-GEN SUBJECTS, V1760, P1558, DOI 10.1016/j.bbagen.2006.06.007; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Yoshida Y, 2009, NEUROBIOL AGING, V30, P174, DOI 10.1016/j.neurobiolaging.2007.06.012	33	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130971	10.1371/journal.pone.0130971	http://dx.doi.org/10.1371/journal.pone.0130971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132231	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000086
J	Yu, YQ; Zhou, X; Wang, HB; Hu, XP; Zhu, XQ; Xu, LY; Zhang, C; Sun, ZW				Yu, Yongqiang; Zhou, Xia; Wang, Haibao; Hu, Xiaopeng; Zhu, Xiaoqun; Xu, Liyan; Zhang, Chao; Sun, Zhongwu			Small-World Brain Network and Dynamic Functional Distribution in Patients with Subcortical Vascular Cognitive Impairment	PLOS ONE			English	Article							WHITE-MATTER; DEMENTIA; DISEASE; CONNECTIVITY; DIAGNOSIS; BEHAVIOR; FMRI	To investigate the topological properties of the functional connectivity and their relationships with cognition impairment in subcortical vascular cognitive impairment (SVCI) patients, resting-state fMRI and graph theory approaches were employed in 23 SVCI patients and 20 healthy controls. Functional connectivity between 90 brain regions was estimated using bivariate correlation analysis and thresholded to construct a set of undirected graphs. Moreover, all of them were subjected to a battery of cognitive assessment, and the correlations between graph metrics and cognitive performance were further analyzed. Our results are as follows: functional brain networks of both SVCI patients and controls showed small-world attributes over a range of thresholds (0.15 <= sparsity <= 0.40). However, global topological organization of the functional brain networks in SVCI was significantly disrupted, as indicated by reduced global and local efficiency, clustering coefficients and increased characteristic path lengths relative to normal subjects. The decreased activity areas in SVCI predominantly targeted in the frontal-temporal lobes, while subcortical regions showed increased topological properties, which are suspected to compensate for the inefficiency of the functional network. We also demonstrated that altered brain network properties in SVCI are closely correlated with general cognitive and praxis dysfunction. The disruption of whole-brain topological organization of the functional connectome provides insight into the functional changes in the human brain in SVCI.	[Yu, Yongqiang; Wang, Haibao; Hu, Xiaopeng; Xu, Liyan] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China; [Zhou, Xia; Zhu, Xiaoqun; Zhang, Chao; Sun, Zhongwu] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Sun, ZW (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	sunzhwu@hotmail.com	xu, li/GNH-3667-2022		Ministry of Science and Technology of China [2007CB512306]; Education and Research Foundation of Anhui Province [KJ2011A170]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Education and Research Foundation of Anhui Province	This work was supported by grants from the Ministry of Science and Technology of China (2007CB512306) and Education and Research Foundation of Anhui Province (KJ2011A170). They play roles in the data collection and analysis.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achiron A, 2013, BRAIN STRUCT FUNCT, V218, P943, DOI 10.1007/s00429-012-0440-3; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; de Mendonca A, 2005, EUR J NEUROL, V12, P125; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; Erkinjuntti T, 2003, INT PSYCHOGERIATR, V15, P23, DOI 10.1017/S1041610203008925; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Fazekas F, 1998, DEMENT GERIATR COGN, V9, P2, DOI 10.1159/000051182; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fu JL, 2012, ACTA RADIOL, V53, P312, DOI 10.1258/ar.2011.110272; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Kim SH, 2011, J NEUROIMAGING, V21, P317, DOI 10.1111/j.1552-6569.2010.00527.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lord LD, 2012, NEUROIMAGE-CLIN, V1, P91, DOI 10.1016/j.nicl.2012.09.008; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; PANTONI L, 1995, STROKE, V26, P1293, DOI 10.1161/01.STR.26.7.1293; Park JH, 2014, NEUROBIOL AGING, V35, P254, DOI 10.1016/j.neurobiolaging.2013.06.026; Qian SW, 2013, BRAIN COGNITION, V83, P121, DOI 10.1016/j.bandc.2013.07.013; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Seo SW, 2010, J NEUROIMAGING, V20, P37, DOI 10.1111/j.1552-6569.2008.00293.x; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Sun YW, 2011, BEHAV BRAIN RES, V223, P388, DOI 10.1016/j.bbr.2011.05.006; Sun ZW, 2007, EUR J NEUROL, V14, P150, DOI 10.1111/j.1468-1331.2006.01579.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044758; Zhao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033540; Zhu CY, 2009, IEEE ENG MED BIO, P6818, DOI 10.1109/IEMBS.2009.5334483	38	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131893	10.1371/journal.pone.0131893	http://dx.doi.org/10.1371/journal.pone.0131893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132397	gold, Green Submitted, Green Published			2022-12-26	WOS:000358153000144
J	Alampour-Rajabi, S; El Bounkari, O; Rot, A; Muller-Newen, G; Bachelerie, F; Gawaz, M; Weber, C; Schober, A; Bernhagen, J				Alampour-Rajabi, Setareh; El Bounkari, Omar; Rot, Antal; Mueller-Newen, Gerhard; Bachelerie, Francoise; Gawaz, Meinrad; Weber, Christian; Schober, Andreas; Bernhagen, Juergen			MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis	FASEB JOURNAL			English	Article						chemokine receptor; chemokine; receptor complex; CD74; cytokine	MIGRATION INHIBITORY FACTOR; CHEMOKINE RECEPTOR; CELL-MIGRATION; BETA-ARRESTIN; CXCL12; ACTIVATION; SURVIVAL; LIGAND; CD74; DIMERIZATION	Macrophage migration-inhibitory factor (MIF) is a pleiotropic cytokine with chemokine-like functions and is a mediator in numerous inflammatory conditions. Depending on the context, MIF signals through 1 or more of its receptors cluster of differentiation (CD) 74, CXC-motif chemokine receptor (CXCR)2, and CXCR4. In addition, heteromeric receptor complexes have been identified. We characterized the atypical chemokine receptor CXCR7 as a novel receptor for MIF. MIF promoted human CXCR7 internalization up to 40%, peaking at 50-400 nM and 30 min, but CXCR7 internalization by MIF was not dependent on CXCR4. Yet, by coimmunoprecipitation, fluorescence microscopy, and a proximity ligation assay, CXCR7 was found to engage in MIF receptor complexes with CXCR4 and CD74, both after ectopic overexpression and in endogenous conditions in a human B-cell line. Receptor competition binding and coimmunoprecipitation studies combined with sulfo-SBED-biotintransfer provided evidence for a direct interaction between MIF and CXCR7. Finally, we demonstrated MIF/CXCR7-mediated functional responses. Blockade of CXCR7 suppressed MIF-mediated ERK- and zeta-chain-associated protein kinase (ZAP)-70 activation (from 2.1- to 1.2-fold and from 2.5- to 1.6-fold, respectively) and fully abrogated primary murine B-cell chemotaxis triggered by MIF, but not by CXCL12. B cells from Cxcr7(-/-) mice exhibited an ablated transmigration response to MIF, indicating that CXCR7 is essential for MIF-promoted B-cell migration. Our findings provide biochemical and functional evidence that MIF is an alternative ligand of CXCR7 and suggest a functional role of the MIF-CXCR7 axis in Blymphocyte migration.	[Alampour-Rajabi, Setareh; El Bounkari, Omar; Bernhagen, Juergen] Rhine Westphalia Tech Univ Aachen RWTH, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Mueller-Newen, Gerhard] Rhine Westphalia Tech Univ Aachen RWTH, Inst Biochem & Mol Biol, Aachen, Germany; [Mueller-Newen, Gerhard; Bernhagen, Juergen] Rhine Westphalia Tech Univ Aachen RWTH, IZKF, Aachen, Germany; [Rot, Antal] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Bachelerie, Francoise] Univ Paris 11, INSERM, UMR S 996, Lab Excellence Res Medicat & Innovat Therapeut, Clamart, France; [Gawaz, Meinrad] Univ Tubingen, Med Klin 3, Kardiol & Kreislauferkrankungen, Tubingen, Germany; [Weber, Christian; Schober, Andreas] Klinikum Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany; [Bernhagen, Juergen] Univ Munich, August Lenz Stiftung, Munich, Germany; [Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Weber, Christian] Partner Site Munich Heart Alliance, Deutches Zentrum Herz Kreislauf Forsch DZHK, Munich, Germany	University of York - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Eberhard Karls University of Tubingen; University of Munich; University of Munich; Maastricht University; German Centre for Cardiovascular Research; Munich Heart Alliance	Bernhagen, J (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Sch Med, Pauwelsstr 30, D-52074 Aachen, Germany.	jbernha-gen@ukaachen.de	BACHELERIE, FRANCOISE/F-8823-2013; Weber, Christian/AAW-2153-2020; Schober, Andreas/B-2866-2013	BACHELERIE, FRANCOISE/0000-0002-0399-3277; Weber, Christian/0000-0003-4610-8714; Schober, Andreas/0000-0001-7798-136X; Rot, Antal/0000-0002-9730-6166	Deutsche Forschungsgemeinschaft (DFG) [DFG-FOR809, SFB1123, KFO274]; Rhine-Westphalia Technical University of Aachen (RWTH) START Grant [691138]; Agence Nationale de la Recherche (Investissements d'Avenir) [ANR-10-LABX-0033-LERMIT]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rhine-Westphalia Technical University of Aachen (RWTH) START Grant; Agence Nationale de la Recherche (Investissements d'Avenir)(French National Research Agency (ANR))	The authors thank Dr. Madhumita Chatterjee (University of Tubingen, Tubingen, Germany) for stimulating discussions regarding this study. This study was supported by Deutsche Forschungsgemeinschaft (DFG) Grants DFG-FOR809 and SFB1123 (to J.B., C.W., and A.S.), and KFO274 (to M.G.), by Rhine-Westphalia Technical University of Aachen (RWTH) START Grant 691138 (to O.E.B); the Immunohistochemistry and Confocal Microscopy Unit, a core facility of Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University. F.B. is a member of the Laboratory of Excellence in Research on Medication and Innovative Therapeutics supported by a grant from Agence Nationale de la Recherche (Investissements d'Avenir -ANR-10-LABX-0033-LERMIT). The authors report no conflicts of interest.	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; Chatterjee M, 2013, J THROMB HAEMOST, V11, P1954, DOI 10.1111/jth.12404; Chatterjee M, 2014, CIRC RES, V115, P939, DOI 10.1161/CIRCRESAHA.115.305171; Chatterjee M, 2014, FASEB J, V28, P2864, DOI 10.1096/fj.14-249730; Costantini S, 2013, CYTOKINE, V64, P316, DOI 10.1016/j.cyto.2013.05.024; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Humpert ML, 2014, EUR J IMMUNOL, V44, P694, DOI 10.1002/eji.201343907; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Kleemann R, 2002, J INTERF CYTOK RES, V22, P351, DOI 10.1089/107999002753675785; Kraemer S, 2013, CURR MED CHEM, V20, P2524, DOI 10.2174/09298673113209990117; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Kumar R., 2012, CELL IMMUNOL, V290, P251; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; LAW NM, 1994, BIOCHEM BIOPH RES CO, V201, P458, DOI 10.1006/bbrc.1994.1723; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Lue HQ, 2011, CELL SIGNAL, V23, P135, DOI 10.1016/j.cellsig.2010.08.013; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rath D, 2014, EUR HEART J, V35, P386, DOI 10.1093/eurheartj/eht448; Ray P, 2012, INT J BIOCHEM CELL B, V44, P669, DOI 10.1016/j.biocel.2012.01.007; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shachar I, 2011, LEUKEMIA LYMPHOMA, V52, P1446, DOI 10.3109/10428194.2011.565437; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tillmann S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00115; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Watanabe K, 2010, ARTHRITIS RHEUM-US, V62, P3211, DOI 10.1002/art.27650; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	68	87	87	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4497	4511		10.1096/fj.15-273904	http://dx.doi.org/10.1096/fj.15-273904			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26139098				2022-12-26	WOS:000364514700010
J	Huygens, C; Lienart, S; Dedobbeleer, O; Stockis, J; Gauthy, E; Coulie, PG; Lucas, S				Huygens, Caroline; Lienart, Stephanie; Dedobbeleer, Olivier; Stockis, Julie; Gauthy, Emilie; Coulie, Pierre G.; Lucas, Sophie			Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor beta 1 (TGF-beta 1) Production in Human Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROGNOSTIC MARKER; LATENT TGF-BETA; POOR-PROGNOSIS; FOXP3 GENE; OVEREXPRESSION; SURFACE; EXPRESSION; RECEPTOR; GARP; IDENTIFICATION	Production of active TGF-beta 1 is one mechanism by which human regulatory T cells (Tregs) suppress immune responses. This production is regulated by glycoprotein A repetitions predominant (GARP), a transmembrane protein present on stimulated Tregs but not on other T lymphocytes (Th and CTLs). GARP forms disulfide bonds with proTGF-beta 1, favors its cleavage into latent inactive TGF-beta 1, induces the secretion and surface presentation of GARP.latent TGF-beta 1 complexes, and is required for activation of the cytokine in Tregs. We explored whether additional Treg-specific protein(s) associated with GARP.TGF-beta 1 complexes regulate TGF-beta 1 production in Tregs. We searched for such proteins by yeast two-hybrid assay, using GARP as a bait to screen a human Treg cDNA library. We identified lysosomal-associated transmembrane protein 4B (LAPTM4B), which interacts with GARP in mammalian cells and is expressed at higher levels in Tregs than in Th cells. LAPTM4B decreases cleavage of proTGF-beta 1, secretion of soluble latent TGF-beta 1, and surface presentation of GARP.TGF-beta 1 complexes by Tregs but does not contribute to TGF-beta 1 activation. Therefore, LAPTM4B binds to GARP and is a negative regulator of TGF-beta 1 production in human Tregs. It may play a role in the control of immune responses by decreasing Treg immunosuppression.	[Lucas, Sophie] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Lucas, S (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 74,B1-74-04, B-1200 Brussels, Belgium.	sophie.lucas@uclouvain.be		Stockis, Julie/0000-0003-4911-6891; Lucas, Sophie/0000-0003-1287-7996	Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan [Action 29_024]; Fonds National pour la Recherche Scientifique (Belgium); Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees ARC (Belgium) [09/14-021]; Fonds J. Maisin (Belgium); Televie grant (Belgium)	Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan; Fonds National pour la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees ARC (Belgium); Fonds J. Maisin (Belgium); Televie grant (Belgium)	This work was supported by grants from the Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming and by grants from the Belgian Cancer Plan (Action 29_024), the Fonds National pour la Recherche Scientifique (Belgium), the Fondation contre le Cancer (Belgium), the Fondation Salus Sanguinis (Belgium), and the Actions de Recherche Concertees ARC 09/14-021 (Belgium) and the Fonds J. Maisin (Belgium). The authors declare that they have no conflict of interest with the contents of the article.; Supported by a Televie grant (Belgium).	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bourne GL, 2011, J IMMUNOL METHODS, V364, P101, DOI 10.1016/j.jim.2010.11.008; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; de Vries IJM, 2011, CLIN CANCER RES, V17, P841, DOI 10.1158/1078-0432.CCR-10-2227; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fan HH, 2012, IMMUNOLOGY, V136, P218, DOI 10.1111/j.1365-2567.2012.03573.x; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gauthy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076186; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kang Y, 2012, AM J SURG, V204, P677, DOI 10.1016/j.amjsurg.2012.02.003; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Milkereit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027478; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ocklenburg F, 2006, LAB INVEST, V86, P724, DOI 10.1038/labinvest.3700432; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003161; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Stockis J, 2009, EUR J IMMUNOL, V39, P869, DOI 10.1002/eji.200838807; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; Tang H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0974-8; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; Zhang G, 2012, J INT MED RES, V40, P1275, DOI 10.1177/147323001204000406; Zhang HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091069; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025	52	16	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20105	20116		10.1074/jbc.M115.655340	http://dx.doi.org/10.1074/jbc.M115.655340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26126825	Green Published, hybrid			2022-12-26	WOS:000359608900014
J	Barbosa-Ferreira, JM; Mady, C; Ianni, BM; Lopes, HF; Ramires, FJA; Salemi, VMC; Grupi, CJ; Hachul, DT; Fernandes, F				Barbosa-Ferreira, Joao Marcos; Mady, Charles; Ianni, Barbara Maria; Lopes, Heno Ferreira; Alvarez Ramires, Felix Jose; Cury Salemi, Vera Maria; Grupi, Cesar Jose; Hachul, Denise Tessariol; Fernandes, Fabio			Dysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; ADIPOSE-TISSUE; ADIPONECTIN CONCENTRATION; SYSTOLIC DYSFUNCTION; INSULIN-RESISTANCE; SERUM-LEVELS; LEPTIN; INFLAMMATION; FAILURE; GLUCOSE	Background Chagas disease (CD) induces autonomic dysfunction and inflammatory activity, which may promote metabolic abnormalities. We studied metabolism and his correlation with Autonomic Nervous System (ANS) and inflammation in CD. Methods and Results Sixty subjects were divided into 4 groups: control group (CG), IF (indeterminate form) group; ECG group (ECG abnormalities and normal left ventricular systolic function), and LVD group (left ventricular sistolic dysfunction). Levels of adiponectin, leptin, insulin, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) were assayed in serum samples by ELISA. ANS was assessed by heart rate variability in frequency domain in 24-hour Holter and postural tilt test (rest and orthostatic position). High frequency (HFr) component values were used to estimate parasympathetic activity and low frequency (LFr) component, sympathetic activity. Analyzes were made of the correlations of each of the metabolic parameters (leptin and adiponectin) with the inflammatory cytokines (interleukin-6 and TNF-alpha) and with the ANS assessment measurements. No significant differences were observed in leptin and insulin levels. Adiponectin was higher in ECG and LVD groups: [CG = 4766.5 (5529.5), IF = 4003.5 (2482.5), ECG = 8376.5 (8388.5), LVD = 8798 (4188.0) ng/mL, p<0.001)]. IL-6 and TNF-alpha were higher in LVD group: [IL-6: CG = 1.85 (6.41); IF = 1.58 (1.91); ECG = 1.0 (1.57); LVD= 31.44 (72.19) pg/ml; p = 0.001. TNF-alpha: CG = 22.57 (88.2); IF = 19.31 (33.16); ECG = 12.45 (3.07); LVD = 75.15 (278.57) pg/ml; p = 0.04]. Adiponectin levels had a positive association with the HFr component (r = 0.539; p = 0.038) and an inverse association with the LFr component (r = -0.539; p = 0.038) in ECG group. Leptin levels had a negative association with the HFr component (r = -0.632; p = 0.011) and a positive association with the LFr component (r = 0.632; p = 0.011) in LVD group. Conclusions We found increased adiponectin levels in Chagas' heart disease with systolic dysfunction and in patients with ECG abnormalities and normal systolic function at rest. Adipocytokines levels (adiponectin and leptin) were associated with ANS parameters in Chagas' heart disease.	[Barbosa-Ferreira, Joao Marcos; Mady, Charles; Ianni, Barbara Maria; Alvarez Ramires, Felix Jose; Cury Salemi, Vera Maria; Fernandes, Fabio] Univ Sao Paulo, Fac Med, Hosp Clin, Cardiomyopathy Unit,Heart Inst InCor, Sao Paulo, Brazil; [Lopes, Heno Ferreira] Univ Sao Paulo, Fac Med, Hosp Clin, Hypertens Unit,Heart Inst InCor, Sao Paulo, Brazil; [Lopes, Heno Ferreira] Univ Nove Julho UNINOVE, Sao Paulo, Brazil; [Grupi, Cesar Jose] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Electrocardiol Unit, Sao Paulo, Brazil; [Hachul, Denise Tessariol] Univ Sao Paulo, Fac Med, Hosp Clin, Clin Arrhythmia Unit,Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade de Sao Paulo	Barbosa-Ferreira, JM (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Cardiomyopathy Unit,Heart Inst InCor, Sao Paulo, Brazil.	jmbemfica@hotmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Ramires, Felix JA/D-5996-2012; Ianni, Barbara Maria/C-7689-2012; Lopes, Heno/H-9825-2013; Salemi, Vera MC/C-9104-2013; Salemi, Vera/AAY-5024-2020; Ferreira, João/AAO-6824-2020; Mady, Charles/C-8870-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; Ramires, Felix JA/0000-0003-2437-2485; Ianni, Barbara Maria/0000-0002-1588-5492; Lopes, Heno/0000-0002-9591-3093; Salemi, Vera MC/0000-0002-7152-1810; Mady, Charles/0000-0002-8838-199X; Tessariol Hachul, Denise/0000-0001-5338-3242	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/16887-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant number 2009/16887-9, and is part of the thesis of doctoral submitted by Joao Marcos Barbosa-Ferreira, from Faculdade de Medicina da Universidade de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Barbosa-Ferreira Joao Marcos, 2013, Expert Opin Med Diagn, V7, P113, DOI 10.1517/17530059.2013.735229; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 2010, MOL CELL ENDOCRINOL, P318; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bloom HL, 2014, HEART INT, V9, P15, DOI 10.5301/HEART.2014.12496; Bobbert P, 2011, EUR HEART J, V32, P1134, DOI 10.1093/eurheartj/ehq498; Camm AJ, 1996, CIRCULATION, V93, P1043; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Davila DF, 1998, INT J CARDIOL, V66, P123, DOI 10.1016/S0167-5273(98)00212-5; Delporte ML, 2002, BIOCHEM J, V367, P677, DOI 10.1042/BJ20020610; Dieplinger B, 2009, CLIN BIOCHEM, V42, P1190, DOI 10.1016/j.clinbiochem.2009.02.023; Doehner W, 2014, J AM COLL CARDIOL, V64, P1388, DOI 10.1016/j.jacc.2014.04.083; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Fernandes F, 2007, BRAZ J MED BIOL RES, V40, P1631, DOI 10.1590/S0100-879X2007001200006; Filippatos GS, 2000, INT J CARDIOL, V76, P117, DOI 10.1016/S0167-5273(00)00397-1; Fu MQ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-106; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Grassi G, 2002, J HYPERTENS, V20, P1487, DOI 10.1097/00004872-200208000-00008; GUARIENTO ME, 1993, BRAZ J MED BIOL RES, V26, P491; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hausberg M, 2002, J HYPERTENS, V20, P1633, DOI 10.1097/00004872-200208000-00027; Ianni B M, 2001, Arq Bras Cardiol, V77, P59; Imai J, 2006, OBESITY, V14, P1132, DOI 10.1038/oby.2006.130; Iwen KA, 2011, METABOLISM, V60, P430, DOI 10.1016/j.metabol.2010.03.011; Karki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028146; Khan RS, 2012, CIRC-HEART FAIL, V5, P340, DOI 10.1161/CIRCHEARTFAILURE.111.964031; Lam JCM, 2008, SLEEP, V31, P1721, DOI 10.1093/sleep/31.12.1721; Lieb DC, 2012, EXP DIABETES RES, DOI 10.1155/2012/878760; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Ferreira AVM, 2011, MICROBES INFECT, V13, P1002, DOI 10.1016/j.micinf.2011.06.002; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Molina RBG, 2006, INT J CARDIOL, V113, P188, DOI 10.1016/j.ijcard.2005.11.010; Moro C, 2007, DIABETOLOGIA, V50, P1038, DOI 10.1007/s00125-007-0614-3; Murdoch DR, 1999, HEART, V82, P352, DOI 10.1136/hrt.82.3.352; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Nagajyothi F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003118; Nagajyothi F, 2013, AM J PATHOL, V182, P886, DOI 10.1016/j.ajpath.2012.11.027; OLIVEIRA LCM, 1993, BRAZ J MED BIOL RES, V26, P1187; Paolisso G, 2000, J CLIN ENDOCR METAB, V85, P1810, DOI 10.1210/jc.85.5.1810; Paulo Araujo J, 2009, EUR J HEART FAIL, V11, P567, DOI 10.1093/eurjhf/hfp046; Prata A, 2001, LANCET INFECT DIS, V1, P92, DOI [10.1016/S1473-3099(01)00065-2, DOI 10.1016/S1473-3099(01)00065-2]; Ribeiro ALP, 2001, AM HEART J, V141, P260, DOI 10.1067/mhj.2001.111406; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Schulze PC, 2011, J CARD FAIL, V17, P1004, DOI 10.1016/j.cardfail.2011.08.010; Schulze PC, 2003, EUR J HEART FAIL, V5, P33, DOI 10.1016/S1388-9842(02)00177-0; Simoes MV, 2000, AM J CARDIOL, V86, P975, DOI 10.1016/S0002-9149(00)01133-4; Skurk C, 2008, EUR HEART J, V29, P1168, DOI 10.1093/eurheartj/ehn136; Takahashi N, 2007, METABOLISM, V56, P919, DOI 10.1016/j.metabol.2007.02.005; Takano H, 2009, INT J CARDIOL, V132, P221, DOI 10.1016/j.ijcard.2007.11.040; Tanida M, 2007, EXP BIOL MED, V232, P390; Trayhurn P, 1998, P NUTR SOC, V57, P413, DOI 10.1079/PNS19980060; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Van Berendoncks An M, 2011, Curr Heart Fail Rep, V8, P113, DOI 10.1007/s11897-011-0056-6; Wajchenberg BL, 2009, ARQ BRAS ENDOCRINOL, V53, P145, DOI 10.1590/S0004-27302009000200005; Wakabayashi S, 2004, DIABETES CARE, V27, P2392, DOI 10.2337/diacare.27.10.2392; WHO, 2012, WORLD MALARIA REPORT 2012, P1	59	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131447	10.1371/journal.pone.0131447	http://dx.doi.org/10.1371/journal.pone.0131447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147101	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600097
J	Goldberg, BE; Mongodin, EF; Jones, CE; Chung, M; Fraser, CM; Tate, A; Zeichner, SL				Goldberg, Brittany E.; Mongodin, Emmanuel F.; Jones, Cheron E.; Chung, Michelle; Fraser, Claire M.; Tate, Anupama; Zeichner, Steven L.			The Oral Bacterial Communities of Children with Well-Controlled HIV Infection and without HIV Infection	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; HEALTHY-CHILDREN; MICROBIOTA; DIVERSITY; CAVITY; DENTITION; PLAQUE; SURFACES; DISEASE	The oral microbial community (microbiota) plays a critical role in human health and disease. Alterations in the oral microbiota may be associated with disorders such as gingivitis, periodontitis, childhood caries, alveolar osteitis, oral candidiasis and endodontic infections. In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi's sarcoma, oral warts and other diseases. Here, we used 454 pyrosequencing of bacterial 16S rRNA genes to examine the oral microbiome of saliva, mucosal and tooth samples from HIV-positive and negative children. Patient demographics and clinical characteristics were collected from a cross-section of patients undergoing routine dental care. Multiple specimens from different sampling sites in the mouth were collected for each patient. The goal of the study was to observe the potential diversity of the oral microbiota among individual patients, sample locations, HIV status and various dental characteristics. We found that there were significant differences in the microbiome among the enrolled patients, and between sampling locations. The analysis was complicated by uneven enrollment in the patient cohorts, with only five HIV-negative patients enrolled in the study and by the rapid improvement in the health of HIV-infected children between the time the study was conceived and completed. The generally good oral health of the HIV-negative patients limited the number of dental plaque samples that could be collected. We did not identify significant differences between well-controlled HIV-positive patients and HIV-negative controls, suggesting that well-controlled HIV-positive patients essentially harbor similar oral flora compared to patients without HIV. Nor were significant differences in the oral microbiota identified between different teeth or with different dental characteristics. Additional studies are needed to better characterize the oral microbiome in children and those with poorly-controlled HIV infections.	[Goldberg, Brittany E.] Childrens Natl Med Ctr, Div Pediat Infect Dis, Washington, DC 20010 USA; [Mongodin, Emmanuel F.; Jones, Cheron E.; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Chung, Michelle; Tate, Anupama] Childrens Natl Med Ctr, Div Pediat Dent, Washington, DC 20010 USA; [Fraser, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Zeichner, Steven L.] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Childrens Res Inst, Washington, DC 20010 USA; [Zeichner, Steven L.] George Washington Univ, Sch Med, Dept Pediat & Microbiol, Washington, DC USA; [Zeichner, Steven L.] George Washington Univ, Sch Med, Dept Immunol, Washington, DC USA; [Zeichner, Steven L.] George Washington Univ, Sch Med, Dept Trop Med, Washington, DC USA	Children's National Health System; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Children's National Health System; University System of Maryland; University of Maryland Baltimore; Children's National Health System; George Washington University; George Washington University; George Washington University	Zeichner, SL (corresponding author), Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Childrens Res Inst, Washington, DC 20010 USA.	zeichner@gwu.org	Mongodin, Emmanuel/AAF-1850-2020	Mongodin, Emmanuel/0000-0003-3833-7437	National Institute of Dental and Craniofacial Research, National Institutes of Health [R56DE021570]; District of Columbia Developmental Center for AIDS Research (DC-CFAR); National Institute for Allergy and Infectious Diseases; National Institutes of Health [P30AI087714]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE021570] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); District of Columbia Developmental Center for AIDS Research (DC-CFAR); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant, R56DE021570, from the National Institute of Dental and Craniofacial Research, National Institutes of Health, and in part by funding from the District of Columbia Developmental Center for AIDS Research (DC-CFAR), from the National Institute for Allergy and Infectious Diseases, with funding from other institutes of the National Institutes of Health, P30AI087714, and a gift from the Conner Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; [Anonymous], CARRANZAS CLIN PERIO; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centers for Disease Prevention and Control, 1994, MMWR RECOMM REP, V43; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Cortelli JR, 2008, J CLIN MICROBIOL, V46, P1322, DOI 10.1128/JCM.02051-07; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dang AT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-153; Del Toro Agnes, 1996, Pediatric Dentistry, V18, P114; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jiang W, 2008, 15 C RETR OPP INF BO; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Kamma JJ, 2000, J PERIODONTAL RES, V35, P33, DOI 10.1034/j.1600-0765.2000.035001033.x; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kline MW, 1996, PEDIATRICS, V97, P380; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Navazesh M, 2005, ORAL SURG ORAL MED O, V100, P701, DOI 10.1016/j.tripleo.2004.10.011; Nokta Mostafa, 2008, Curr HIV/AIDS Rep, V5, P5, DOI 10.1007/s11904-008-0002-8; Ooshima T, 2003, COMMUNITY DENT ORAL, V31, P417, DOI 10.1046/j.1600-0528.2003.00112.x; Papaioannou W, 2009, ORAL MICROBIOL IMMUN, V24, P183, DOI 10.1111/j.1399-302X.2008.00493.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; RAMBERG PW, 1994, J CLIN PERIODONTOL, V21, P490, DOI 10.1111/j.1600-051X.1994.tb00413.x; Ramos-Gomez F J, 1999, J Clin Pediatr Dent, V23, P85; Salako NO, 2004, MED PRIN PRACT, V13, P191, DOI 10.1159/000078314; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wessel SW, 2014, J DENT RES, V93, P84, DOI 10.1177/0022034513511822; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	42	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131615	10.1371/journal.pone.0131615	http://dx.doi.org/10.1371/journal.pone.0131615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146997	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600114
J	Henriques, A; Blasco, H; Fleury, MC; Corcia, P; Echaniz-Laguna, A; Robelin, L; Rudolf, G; Lequeu, T; Bergaentzle, M; Gachet, C; Pradat, PF; Marchioni, E; Andres, CR; Tranchant, C; de Aguilar, JLG; Loeffler, JP				Henriques, Alexandre; Blasco, Helene; Fleury, Marie-Celine; Corcia, Philippe; Echaniz-Laguna, Andoni; Robelin, Laura; Rudolf, Gabrielle; Lequeu, Thiebault; Bergaentzle, Martine; Gachet, Christian; Pradat, Pierre-Francois; Marchioni, Eric; Andres, Christian R.; Tranchant, Christine; de Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe			Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; BODY-MASS INDEX; FATTY-ACIDS; PLASMA; SURVIVAL; DIET; ALS; HYPERMETABOLISM; PHOSPHOLIPIDS; DYSLIPIDEMIA	Growing evidence supports a link between fatty acid metabolism and amyotrophic lateral sclerosis (ALS). Here we determined the fatty acid composition of blood lipids to identify markers of disease progression and survival. We enrolled 117 patients from two clinical centers and 48 of these were age and gender matched with healthy volunteers. We extracted total lipids from serum and blood cells, and separated fatty acid methyl esters by gas chromatography. We measured circulating biochemical parameters indicative of the metabolic status. Association between fatty acid composition and clinical readouts was studied, including ALS functional rating scale-revised (ALSFRS-R), survival, disease duration, site of onset and body mass index. Palmitoleate (16:1) and oleate (18:1) levels, and stearoyl-CoA desaturase indices (16:1/16:0 and 18:1/18:0) significantly increased in blood cells from ALS patients compared to healthy controls. Palmitoleate levels and 16:1/16:0 ratio in blood cells, but not body mass index or leptin concentrations, negatively correlated with ALSFRS-R decline over a six-month period (p<0.05). Multivariate Cox analysis, with age, body mass index, site of onset and ALSFRS-R as covariables, showed that blood cell 16:1/16:0 ratio was an independent prognostic factor for survival (hazard ratio=0.1 per unit of ratio, 95% confidence interval=0.01-0.57, p=0.009). In patients with high 16:1/16:0 ratio, survival at blood collection was extended by 10 months, as compared to patients with low ratio. The 16:1/16:0 index is an easy-to-handle parameter that predicts survival of ALS patients independently of body mass index. It therefore deserves further validation in larger cohorts for being used to assess disease outcome and effects of disease-modifying drugs.	[Henriques, Alexandre; Echaniz-Laguna, Andoni; Robelin, Laura; Lequeu, Thiebault; de Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] INSERM, Mecanismes Centraux & Peripher Neurodegenerescenc, U1118, Strasbourg, France; [Henriques, Alexandre; Robelin, Laura; Lequeu, Thiebault; de Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] Univ Strasbourg, UMR S1118, Federat Med Translat, Strasbourg, France; [Blasco, Helene; Corcia, Philippe; Andres, Christian R.] Univ Tours, INSERM, U930, Neurogenet & Neurometab, Tours, France; [Blasco, Helene; Andres, Christian R.] CHRU Tours, Lab Biochim & Biol Mol, Tours, France; [Fleury, Marie-Celine; Echaniz-Laguna, Andoni; Rudolf, Gabrielle; Tranchant, Christine] Hop Univ Strasbourg, Serv Neurol, Federat Med Transrat, Strasbourg, France; [Corcia, Philippe] CHRU Tours, Ctr SLA, Tours, France; [Bergaentzle, Martine; Marchioni, Eric] Univ Strasbourg, Equipe Chim Analyt Mol BioAct, Illkirch Graffenstaden, France; [Bergaentzle, Martine; Marchioni, Eric] CNRS, UMR 7178, Strasbourg, France; [Gachet, Christian] Univ Strasbourg, INSERM, UMR S949, Etab Francais Sang Alsace, Strasbourg, France; [Pradat, Pierre-Francois] Hop La Pitie Salpetriere, AP HP, Ctr Referent Malad Rare SLA, Federat Malad Syst Nerveux, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Tours; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	de Aguilar, JLG (corresponding author), INSERM, Mecanismes Centraux & Peripher Neurodegenerescenc, U1118, Strasbourg, France.	gonzalez@unistra.fr; loeffler@unistra.fr	berg, tine/HGB-3621-2022; LOEFFLER, Jean-Philippe/AAS-4401-2020; Gachet, Christian/H-9156-2016	Rudolf, Gabrielle/0000-0002-2050-3911; Andres, Christian/0000-0002-5062-3156; blasco, helene/0000-0001-6107-0035; BERGAENTZLE, Martine/0000-0003-4238-3698; tranchant, christine/0000-0002-2895-1292	Thierry Latran Foundation; European Community's Health Seventh Framework Programme [259867]; "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" (ARSLA); Andre combat la SLA; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE)	Thierry Latran Foundation; European Community's Health Seventh Framework Programme; "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" (ARSLA); Andre combat la SLA; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE)	This work was supported by funds from Thierry Latran Foundation, European Community's Health Seventh Framework Programme under grant agreement No. 259867 (Euro-MOTOR), "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" (ARSLA), "Andre combat la SLA" and "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taan O, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-64; Arsic A, 2012, APPL PHYSIOL NUTR ME, V37, P40, DOI [10.1139/h11-125, 10.1139/H11-125]; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chio A, 2009, NEUROLOGY, V73, P1681, DOI 10.1212/WNL.0b013e3181c1df1e; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; de Mello VDF, 2009, EUR J NUTR, V48, P447, DOI 10.1007/s00394-009-0033-y; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dorst J, 2013, AMYOTROPH LAT SCL FR, V14, P533, DOI 10.3109/21678421.2013.823999; Dube JJ, 2011, DIABETOLOGIA, V54, P1147, DOI 10.1007/s00125-011-2065-0; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Falcao-Pires I, 2012, DRUG DISCOV TODAY, V17, P880, DOI 10.1016/j.drudis.2012.04.007; Friesen RW, 2009, J NUTR, V139, P2344, DOI 10.3945/jn.109.112565; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Gordon PH, 2013, NEURODEGENER DIS, V12, P81, DOI 10.1159/000341316; HOLMAN RT, 1995, J NUTR, V125, P901; Hussain G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00144; Hussain G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064525; Jawaid A, 2010, AMYOTROPH LATERAL SC, V11, P542, DOI 10.3109/17482968.2010.482592; Lindauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067783; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853; Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474; Matthan NR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000764; Olivan S, 2014, J NUTR BIOCHEM, V25, P885, DOI 10.1016/j.jnutbio.2014.04.005; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Pupillo E, 2014, ANN NEUROL, V75, P287, DOI 10.1002/ana.24096; Reich-Slotky R, 2013, AMYOTROPH LAT SCL FR, V14, P212, DOI 10.3109/21678421.2013.770028; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Schmitt F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00025; Sutedja NA, 2011, J NEUROL NEUROSUR PS, V82, P638, DOI 10.1136/jnnp.2010.236752; Tepsic J, 2009, EUR J APPL PHYSIOL, V107, P359, DOI 10.1007/s00421-009-1131-5; Turner MR, 2012, BRAIN, V135, P2883, DOI 10.1093/brain/aws144; Turyn J, 2010, MOL CELL BIOCHEM, V345, P181, DOI 10.1007/s11010-010-0571-x; VANDENBOOM MAP, 1994, BBA-LIPID LIPID MET, V1215, P314, DOI 10.1016/0005-2760(94)90059-0; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; Vinknes KJ, 2013, OBESITY, V21, pE294, DOI 10.1002/oby.20011; Wills AM, 2014, LANCET, V383, P2065, DOI 10.1016/S0140-6736(14)60222-1; Wood KE, 2014, PROSTAG LEUKOTR ESS, V90, P133, DOI 10.1016/j.plefa.2013.12.010; Yun Jung-Mi, 2012, Prev Nutr Food Sci, V17, P158, DOI 10.3746/pnf.2012.17.2.158; Zak A, 2005, PHYSIOL RES, V54, P443, DOI 10.33549/physiolres.930643	46	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131512	10.1371/journal.pone.0131512	http://dx.doi.org/10.1371/journal.pone.0131512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147510	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600102
J	Johnson, KL; Ramm, S; Kappel, C; Ward, S; Leyser, O; Sakamoto, T; Kurata, T; Bevan, MW; Lenhard, M				Johnson, Kim L.; Ramm, Sascha; Kappel, Christian; Ward, Sally; Leyser, Ottoline; Sakamoto, Tomoaki; Kurata, Tetsuya; Bevan, Michael W.; Lenhard, Michael			The Tinkerbell (Tink) Mutation Identifies the Dual-Specificity MAPK Phosphatase INDOLE-3-BUTYRIC ACID-RESPONSE5 (IBR5) as a Novel Regulator of Organ Size in Arabidopsis	PLOS ONE			English	Article							CLASS-I; PROTEIN PHOSPHATASE; AUXIN; RESPONSES; THALIANA; KINASE; GROWTH; INTERACTS; DISTINCT; PATHWAY	Mitogen-activated dual-specificity MAPK phosphatases are important negative regulators in the MAPK signalling pathways responsible for many essential processes in plants. In a screen for mutants with reduced organ size we have identified a mutation in the active site of the dual-specificity MAPK phosphatase INDOLE-3-BUTYRIC ACID-RESPONSE5 (IBR5) that we named tinkerbell (tink) due to its small size. Analysis of the tink mutant indicates that IBR5 acts as a novel regulator of organ size that changes the rate of growth in petals and leaves. Organ size and shape regulation by IBR5 acts independently of the KLU growth-regulatory pathway. Microarray analysis of tink/ibr5-6 mutants identified a likely role for this phosphatase in male gametophyte development. We show that IBR5 may influence the size and shape of petals through auxin and TCP growth regulatory pathways.	[Johnson, Kim L.] Univ Melbourne, ARC Ctr Excellence Plant Cell Walls, Sch Bot, Parkville, Vic 3010, Australia; [Ramm, Sascha; Kappel, Christian; Lenhard, Michael] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Ward, Sally; Leyser, Ottoline] Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England; [Sakamoto, Tomoaki; Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Bevan, Michael W.] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	University of Melbourne; University of Potsdam; University of Cambridge; Nara Institute of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lenhard, M (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	michael.lenhard@uni-potsdam.de	Johnson, Kim/AAB-5696-2022; Lenhard, Michael/J-1554-2015; Leyser, Ottoline/AAC-5577-2019	Johnson, Kim/0000-0001-6917-7742; Sakamoto, Tomoaki/0000-0002-1583-0993; Kappel, Christian/0000-0002-1450-1864; Leyser, Ottoline/0000-0003-2161-3829	Biotechnology and Biological Sciences Research Council; Australian Research Council, Centre of Excellence in Plant Cell Walls; BBSRC [BB/K017225/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017225/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Research Council, Centre of Excellence in Plant Cell Walls(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported in part by the Biotechnology and Biological Sciences Research Council grant and the Australian Research Council, Centre of Excellence in Plant Cell Walls (to KJ).	Aguilar-Martinez JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00406; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Gonzalez Besteiro MA, 2013, PLANT J, V73, P1034, DOI 10.1111/tpj.12095; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gupta R, 1998, PLANT J, V16, P581, DOI 10.1046/j.1365-313x.1998.00327.x; Hepworth J, 2014, CURR OPIN PLANT BIOL, V17, P36, DOI 10.1016/j.pbi.2013.11.005; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Jayaweera T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102301; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Kieffer M, 2011, PLANT J, V68, P147, DOI 10.1111/j.1365-313X.2011.04674.x; Krizek BA, 2003, NUCLEIC ACIDS RES, V31, P1859, DOI 10.1093/nar/gkg292; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Lumbreras V, 2010, PLANT J, V63, P1017, DOI 10.1111/j.1365-313X.2010.04297.x; Mayank P, 2012, PLANT J, V72, P89, DOI 10.1111/j.1365-313X.2012.05061.x; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pytela J, 2010, PLANTA, V231, P1311, DOI 10.1007/s00425-010-1135-8; Reina-Pinto JJ, 2010, PLANT J, V61, P166, DOI 10.1111/j.1365-313X.2009.04043.x; Sauret-Gueto S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001550; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smekalova V, 2014, BIOTECHNOL ADV, V32, P2, DOI 10.1016/j.biotechadv.2013.07.009; Steiner E, 2012, PLANT CELL, V24, P96, DOI 10.1105/tpc.111.093518; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Strader LC, 2008, GENETICS, V180, P2019, DOI 10.1534/genetics.108.091512; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Szecsi Judit, 2014, Methods Mol Biol, V1110, P191, DOI 10.1007/978-1-4614-9408-9_8; Uberti-Manassero NG, 2012, J EXP BOT, V63, P809, DOI 10.1093/jxb/err305; Valsecchi I, 2013, MOL BIOSYST, V9, P2282, DOI 10.1039/c3mb70128j; Viola IL, 2012, J BIOL CHEM, V287, P347, DOI 10.1074/jbc.M111.256271; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200	42	13	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131103	10.1371/journal.pone.0131103	http://dx.doi.org/10.1371/journal.pone.0131103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147117	Green Published, gold			2022-12-26	WOS:000358157600061
J	Lee, TF; Chao, PJ; Chang, LY; Ting, HM; Huang, YJ				Lee, Tsair-Fwu; Chao, Pei-Ju; Chang, Liyun; Ting, Hui-Min; Huang, Yu-Jie			Developing Multivariable Normal Tissue Complication Probability Model to Predict the Incidence of Symptomatic Radiation Pneumonitis among Breast Cancer Patients	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; VOLUME HISTOGRAM ANALYSIS; LEAST ABSOLUTE SHRINKAGE; DOSE-VOLUME; CONFORMAL RADIOTHERAPY; SELECTION OPERATOR; RATED XEROSTOMIA; GRADING SYSTEM; STICKY SALIVA; NTCP MODELS	Purpose Symptomatic radiation pneumonitis (SRP), which decreases quality of life (QoL), is the most common pulmonary complication in patients receiving breast irradiation. If it occurs, acute SRP usually develops 4-12 weeks after completion of radiotherapy and presents as a dry cough, dyspnea and low-grade fever. If the incidence of SRP is reduced, not only the QoL but also the compliance of breast cancer patients may be improved. Therefore, we investigated the incidence SRP in breast cancer patients after hybrid intensity modulated radiotherapy (IMRT) to find the risk factors, which may have important effects on the risk of radiation-induced complications. Methods In total, 93 patients with breast cancer were evaluated. The final endpoint for acute SRP was defined as those who had density changes together with symptoms, as measured using computed tomography. The risk factors for a multivariate normal tissue complication probability model of SRP were determined using the least absolute shrinkage and selection operator (LASSO) technique. Results Five risk factors were selected using LASSO: the percentage of the ipsilateral lung volume that received more than 20-Gy (IV20), energy, age, body mass index (BMI) and T stage. Positive associations were demonstrated among the incidence of SRP, IV20, and patient age. Energy, BMI and T stage showed a negative association with the incidence of SRP. Our analyses indicate that the risk of SPR following hybrid IMRT in elderly or low-BMI breast cancer patients is increased once the percentage of the ipsilateral lung volume receiving more than 20-Gy is controlled below a limitation. Conclusions We suggest to define a dose-volume percentage constraint of IV20<37% (or AIV20<310cc) for the irradiated ipsilateral lung in radiation therapy treatment planning to maintain the incidence of SPR below 20%, and pay attention to the sequelae especially in elderly or low-BMI breast cancer patients. (AIV20: the absolute ipsilateral lung volume that received more than 20 Gy (cc).	[Lee, Tsair-Fwu; Chao, Pei-Ju; Ting, Hui-Min] Natl Kaohsiung Univ Appl Sci, Med Phys & Informat Lab Elect Engn, Kaohsiung 80778, Taiwan; [Lee, Tsair-Fwu] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung 807, Taiwan; [Chao, Pei-Ju; Ting, Hui-Min; Huang, Yu-Jie] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung 83305, Taiwan; [Chao, Pei-Ju; Ting, Hui-Min; Huang, Yu-Jie] Chang Gung Univ, Coll Med, Kaohsiung 83305, Taiwan; [Chang, Liyun] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 82445, Taiwan	National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; I Shou University	Huang, YJ (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung 83305, Taiwan.	yjhuang5657@gmail.com	chao, P/GSD-8001-2022	Lee, Tsair-Fwu/0000-0002-3112-3594	Ministry of Science and Technology (MOST) of the Executive Yuan of the Republic of China [NSC-101-2221-E-151-007-MY3]	Ministry of Science and Technology (MOST) of the Executive Yuan of the Republic of China	This study was supported financially by a grant from the Ministry of Science and Technology (MOST) of the Executive Yuan of the Republic of China, (NSC-101-2221-E-151-007-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2012, AM J RESP CRIT CARE, V185, pA5727; Abe O, 2005, LANCET, V366, P2087; Allen AM, 2005, CANCER J, V11, P390, DOI 10.1097/00130404-200509000-00006; ARRIAGADA R, 1989, RADIOTHER ONCOL, V14, P1, DOI 10.1016/0167-8140(89)90002-9; Beetz I, 2012, RADIOTHER ONCOL, V105, P101, DOI 10.1016/j.radonc.2012.03.004; Beetz I, 2012, RADIOTHER ONCOL, V105, P94, DOI 10.1016/j.radonc.2011.11.006; Choi YW, 2004, RADIOGRAPHICS, V24, P985, DOI 10.1148/rg.244035160; Colombani C, 2013, J DAIRY SCI, V96, P575, DOI 10.3168/jds.2011-5225; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; El Naqa I, 2006, INT J RADIAT ONCOL, V64, P1275, DOI 10.1016/j.ijrobp.2005.11.022; Fu WH, 2004, BIO-MED MATER ENG, V14, P123; Gagliardi G, 2000, INT J RADIAT ONCOL, V46, P373, DOI 10.1016/S0360-3016(99)00420-4; Goldman Ulla Blom, 2010, RADIAT ONCOL, V5, P1; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; HARDMAN PDJ, 1994, RADIOTHER ONCOL, V30, P33, DOI 10.1016/0167-8140(94)90007-8; Hassaballa HA, 2005, CHEST, V128, P1448, DOI 10.1378/chest.128.3.1448; Hernando ML, 2001, INT J RADIAT ONCOL, V51, P650, DOI 10.1016/S0360-3016(01)01685-6; Hooning MJ, 2006, INT J RADIAT ONCOL, V64, P1081, DOI 10.1016/j.ijrobp.2005.10.022; IKEZOE J, 1988, AM J ROENTGENOL, V150, P765, DOI 10.2214/ajr.150.4.765; Johansson S, 1998, RADIOTHER ONCOL, V49, P41, DOI 10.1016/S0167-8140(98)00064-4; Kahan Z, 2007, INT J RADIAT ONCOL, V68, P673, DOI 10.1016/j.ijrobp.2006.12.016; Lee TF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06217; Lee TF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/143020; Lee TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089700; Lind PARM, 2000, EUR RADIOL, V10, P484; Lind PARM, 2001, BREAST CANCER RES TR, V68, P199, DOI 10.1023/A:1012292019599; Lind PARM, 1999, INT J RADIAT ONCOL, V43, P489, DOI 10.1016/S0360-3016(98)00414-3; Mansouri S, 2014, ASIAN PAC J CANCER P, V15, P4727, DOI 10.7314/APJCP.2014.15.11.4727; Mayo CS, 2005, INT J RADIAT ONCOL, V61, P922, DOI 10.1016/j.ijrobp.2004.10.033; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Michalski A, 2014, MED DOSIM, V39, P163, DOI 10.1016/j.meddos.2013.12.003; Ramella S, 2010, INT J RADIAT ONCOL, V76, P110, DOI 10.1016/j.ijrobp.2009.01.036; Ramsey SD, 2000, CANCER-AM CANCER SOC, V88, P1294, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.3.CO;2-D; Rancati T, 2007, RADIOTHER ONCOL, V82, P308, DOI 10.1016/j.radonc.2006.12.001; Taghian AG, 2001, J NATL CANCER I, V93, P1806, DOI 10.1093/jnci/93.23.1806; Teppola P, 2013, ANAL CHIM ACTA, V768, P57, DOI 10.1016/j.aca.2013.01.005; Theuws JCM, 1998, RADIOTHER ONCOL, V48, P33, DOI 10.1016/S0167-8140(98)00019-X; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Tsougos I, 2005, PHYS MED BIOL, V50, P3535, DOI 10.1088/0031-9155/50/15/004; van der Schaaf A, 2012, RADIOTHER ONCOL, V105, P115, DOI 10.1016/j.radonc.2011.12.006; Wennberg B, 2002, INT J RADIAT ONCOL, V52, P1196, DOI 10.1016/S0360-3016(01)02770-5; Xu CJ, 2012, INT J RADIAT ONCOL, V84, pE123, DOI 10.1016/j.ijrobp.2012.02.022; Xu CJ, 2012, INT J RADIAT ONCOL, V82, pE677, DOI 10.1016/j.ijrobp.2011.09.036; Xu J, 2013, IET COMPUT VIS, V7, P48, DOI 10.1049/iet-cvi.2011.0193	46	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131736	10.1371/journal.pone.0131736	http://dx.doi.org/10.1371/journal.pone.0131736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147496	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600137
J	Martinez-Garcia, R; Murgui, C; Hernandez-Garcia, E; Lopez, C				Martinez-Garcia, Ricardo; Murgui, Clara; Hernandez-Garcia, Emilio; Lopez, Cristobal			Pattern Formation in Populations with Density-Dependent Movement and Two Interaction Scales	PLOS ONE			English	Article							YOUNG MUSSEL BEDS; SPATIAL-PATTERNS; COLLECTIVE MOTION; SELF-ORGANIZATION; DECISION-MAKING; ECOSYSTEMS; MECHANISMS; VEGETATION; SYSTEMS; MODEL	We study the spatial patterns formed by a system of interacting particles where the mobility of any individual is determined by the population crowding at two different spatial scales. In this way we model the behavior of some biological organisms (like mussels) that tend to cluster at short ranges as a defensive strategy, and strongly disperse if there is a high population pressure at large ranges for optimizing foraging. We perform stochastic simulations of a particle-level model of the system, and derive and analyze a continuous density description (a nonlinear diffusion equation). In both cases we show that this interplay of scale-dependent-behaviors gives rise to a rich formation of spatial patterns ranging from labyrinths to periodic cluster arrangements. In most cases these clusters have the very peculiar appearance of ring-like structures, i.e., organisms arranging in the perimeter of the clusters, which we discuss in detail.	[Martinez-Garcia, Ricardo; Murgui, Clara; Hernandez-Garcia, Emilio; Lopez, Cristobal] CSIC UIB, IFISC, Palma De Mallorca, Spain; [Martinez-Garcia, Ricardo] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Princeton University	Martinez-Garcia, R (corresponding author), CSIC UIB, IFISC, Campus UIB, Palma De Mallorca, Spain.	ricardom@princeton.edu	Martinez-Garcia, Ricardo/J-4836-2013; Hernandez-Garcia, Emilio/B-1271-2008; López, Cristóbal/R-5410-2018	Martinez-Garcia, Ricardo/0000-0003-2765-8147; Hernandez-Garcia, Emilio/0000-0002-9568-8287; López, Cristóbal/0000-0002-3445-4284	JAEPredoc program of Consejo Superior de Investigacion Cientificas; IFISC-Intro program of Instituto de Fisica Interdisciplinar y Sistemas Complejos; Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional [FIS2012-30634, CTM2012-39025-C02-01]	JAEPredoc program of Consejo Superior de Investigacion Cientificas; IFISC-Intro program of Instituto de Fisica Interdisciplinar y Sistemas Complejos; Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional	RMG was supported by the JAEPredoc program of Consejo Superior de Investigacion Cientificas. CM was supported by the IFISC-Intro program of Instituto de Fisica Interdisciplinar y Sistemas Complejos. EHG and CL are supported by Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional through grant no. FIS2012-30634 (INTENSE@COSYP) and no. CTM2012-39025-C02-01 (ESCOLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INDIVIDUAL BASED MOD; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Bonachela JA, 2015, SCIENCE, V347, P651, DOI 10.1126/science.1261487; Borgogno F, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000256; Burger M, 2013, PHYSICA D, V260, P145, DOI 10.1016/j.physd.2012.11.003; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dean DS, 1996, J PHYS A-MATH GEN, V29, pL613, DOI 10.1088/0305-4470/29/24/001; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Fernandez-Oto C, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0009; Flierl G, 1999, J THEOR BIOL, V196, P397, DOI 10.1006/jtbi.1998.0842; Heinsalu E, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/40011; Hernandez-Garcia E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016216; JUDSON OP, 1994, TRENDS ECOL EVOL, V9, P9, DOI 10.1016/0169-5347(94)90225-9; Juergens N, 2013, SCIENCE, V339, P1618, DOI 10.1126/science.1222999; Krapivsky P., 2010, KINETIC VIEW STAT PH; Krause J, 2002, LIVING GROUPS; Lefever R, 1997, B MATH BIOL, V59, P263, DOI 10.1007/BF02462004; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu QX, 2013, P NATL ACAD SCI USA, V110, P11905, DOI 10.1073/pnas.1222339110; Liu QX, 2012, P ROY SOC B-BIOL SCI, V279, P2744, DOI 10.1098/rspb.2012.0157; Lopez C, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.012102; Lopez U, 2012, INTERFACE FOCUS, V2, P693, DOI 10.1098/rsfs.2012.0033; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Martinez-Garcia R, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0068; Martinez-Garcia R, 2013, GEOPHYS RES LETT, V40, P6143, DOI 10.1002/2013GL058797; Martinez-Garcia R, 2013, J THEOR BIOL, V333, P156, DOI 10.1016/j.jtbi.2013.05.024; Martinez-Garcia R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.248106; Medvinsky AB, 2002, SIAM REV, V44, P311, DOI 10.1137/S0036144502404442; Mendez V, 2014, SPRINGER SER SYNERG, P1, DOI 10.1007/978-3-642-39010-4; Mendez V, 2012, J THEOR BIOL, V309, P113, DOI 10.1016/j.jtbi.2012.06.015; Murray, 2002, MATH BIOL I INTRO IN; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Pigolotti S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258101; Raghib M, 2010, J THEOR BIOL, V264, P893, DOI 10.1016/j.jtbi.2010.02.030; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Schellinck J, 2011, ECOL MODEL, V222, P1897, DOI 10.1016/j.ecolmodel.2011.03.013; Sheffer E, 2011, J THEOR BIOL, V273, P138, DOI 10.1016/j.jtbi.2010.12.028; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viswanathan G. M., 2011, PHYS FORAGING; Wang RH, 2009, J R SOC INTERFACE, V6, P705, DOI 10.1098/rsif.2008.0439; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Young WR, 2001, NATURE, V412, P328, DOI 10.1038/35085561	46	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132261	10.1371/journal.pone.0132261	http://dx.doi.org/10.1371/journal.pone.0132261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147351	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600226
J	Solje, E; Aaltokallio, H; Koivumaa-Honkanen, H; Suhonen, NM; Moilanen, V; Kiviharju, A; Traynor, B; Tienari, PJ; Hartikainen, P; Remes, AM				Solje, Eino; Aaltokallio, Heidi; Koivumaa-Honkanen, Heli; Suhonen, Noora M.; Moilanen, Virpi; Kiviharju, Anna; Traynor, Bryan; Tienari, Pentti J.; Hartikainen, Paivi; Remes, Anne M.			The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; FRONTOTEMPORAL DEMENTIA; DIAGNOSTIC-CRITERIA; BEHAVIORAL VARIANT; ALS; SENSITIVITY; MUTATIONS; FEATURES; FTD	Background The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria. Objective The objective of the study was to evaluate the applicability of the FTDC criteria and assess the psychiatric history of these patients. Methods The study examined 36 patients carrying the C9ORF72 expansion and suffering from bvFTD (N = 32) or from bvFTD with motor neuron disease (bvFTD-MND, N = 4). Neuropsychological, neuropsychiatric, structural brain imaging and PET/SPECT data were evaluated. Results We found 0.75 sensitivity (SD 0.44, 95% CI 0.57-0.87) for possible bvFTD and 0.64 (SD 0.44, 95% CI 0.57-0.87) for probable bvFTD. The sensitivity was even higher in bvFTD patients without MND, i.e., 0.81 for possible bvFTD and 0.69 for probable bvFTD. PET/SPECT was normal in 17.6% of scanned patients with bvFTD. A history of psychiatric symptoms (psychotic and/or mood symptoms) was detected in 61% of cases. Conclusions The FTDC possible and probable bvFTD criteria seem to identify the majority of the C9ORF72 expansion carriers with bvFTD, even though they exhibit only a limited number of behavioral criteria but a significant amount of psychiatric symptoms. The presence of a normal PET/SPECT does not exclude the possibility the C9ORF72 associated bvFTD.	[Solje, Eino; Aaltokallio, Heidi; Remes, Anne M.] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Koivumaa-Honkanen, Heli] Univ Eastern Finland, Inst Clin Med Psychiat, Kuopio, Finland; [Koivumaa-Honkanen, Heli] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland; [Koivumaa-Honkanen, Heli] South Savonia Hosp Dist, Dept Psychiat, Mikkeli, Finland; [Koivumaa-Honkanen, Heli] North Karelia Cent Hosp, Dept Psychiat, Joensuu, Finland; [Koivumaa-Honkanen, Heli] SOSTERI, Dept Psychiat, Savonlinna, Finland; [Koivumaa-Honkanen, Heli] SOTE, Dept Psychiat, Iisalmi, Finland; [Koivumaa-Honkanen, Heli] Lapland Hosp Dist, Dept Psychiat, Rovaniemi, Finland; [Suhonen, Noora M.; Moilanen, Virpi] Oulu Univ Hosp, Dept Neurol, Oulu, Finland; [Kiviharju, Anna; Tienari, Pentti J.] Univ Helsinki, Dept Neurol, Cent Hosp, Mol Neurol,Res Programs Unit, Helsinki, Finland; [Traynor, Bryan] NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Traynor, Bryan] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD USA; [Hartikainen, Paivi; Remes, Anne M.] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oulu; University of Helsinki; Helsinki University Central Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Kuopio University Hospital; University of Eastern Finland	Remes, AM (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.	anne.remes@uef.fi	Koivumaa-Honkanen, Heli TJ/L-1274-2015; Tienari, Pentti J/A-4893-2012	Solje, Eino/0000-0001-9940-9524	Kuopio University Hospital; Helsinki University Central Hospital; Finnish Academy; Sigrid Juselius Foundation; Finnish Medical Foundation; Finnish Alzheimer's Research Foundation; Intramural Research Programs of the NIH and National Institute on Aging [Z01-AG000949-02]; ALS Association, AriSLA, Packard Center for ALS research, FIGC, Microsoft Research; Myasthenia Gravis Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000949] Funding Source: NIH RePORTER	Kuopio University Hospital; Helsinki University Central Hospital; Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Medical Foundation; Finnish Alzheimer's Research Foundation; Intramural Research Programs of the NIH and National Institute on Aging; ALS Association, AriSLA, Packard Center for ALS research, FIGC, Microsoft Research(Microsoft); Myasthenia Gravis Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Kuopio University Hospital, Helsinki University Central Hospital, the Finnish Academy, the Sigrid Juselius Foundation, the Finnish Medical Foundation, the Finnish Alzheimer's Research Foundation, the Intramural Research Programs of the NIH and National Institute on Aging (Z01-AG000949-02), the ALS Association, AriSLA, Packard Center for ALS research, FIGC, Microsoft Research and the Myasthenia Gravis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Chare L, 2014, J NEUROL NEUROSURG P; Costa S, 2013, AM J ALZHEIMERS DIS, V28, P469, DOI 10.1177/1533317513488918; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Devenney E, 2014, JAMA NEUROL, V71, P331, DOI 10.1001/jamaneurol.2013.6002; Ghosh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060999; Harris JM, 2013, NEUROLOGY, V80, P1881, DOI 10.1212/WNL.0b013e318292a342; Kaivorinne AL, 2013, DEMENT GER COGN D EX, V3, P251, DOI 10.1159/000351859; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Rascovsky K, 2007, ALZ DIS ASSOC DIS, V21, pS14, DOI 10.1097/WAD.0b013e31815c3445; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Sha SJ, 2012, NEUROLOGY, V79, P1002, DOI 10.1212/WNL.0b013e318268452e; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355	18	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131817	10.1371/journal.pone.0131817	http://dx.doi.org/10.1371/journal.pone.0131817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146826	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600149
J	Giang, CND; Sebesvari, Z; Renaud, F; Rosendahl, I; Minh, QH; Amelung, W				Chau Nguyen Dang Giang; Sebesvari, Zita; Renaud, Fabrice; Rosendahl, Ingrid; Quang Hoang Minh; Amelung, Wulf			Occurrence and Dissipation of the Antibiotics Sulfamethoxazole, Sulfadiazine, Trimethoprim, and Enrofloxacin in the Mekong Delta, Vietnam	PLOS ONE			English	Article							AQUATIC ENVIRONMENT; VETERINARY ANTIBIOTICS; RISK-ASSESSMENT; DRINKING-WATER; FATE; DEGRADATION; IDENTIFICATION; SULFONAMIDES; SURFACE; SOILS	The Mekong Delta in Vietnam has seen a rapid development and intensification of aquaculture in the last decades, with a corresponding widespread use of antibiotics. This study provides information on current antibiotic use in freshwater aquaculture, as well as on resulting antibiotic concentrations in the aquatic environment of the Mekong Delta. Two major production steps, fish hatcheries and mature fish cultivation, were surveyed (50 fish farm interviews) for antibiotic use. Different water sources, including surface water, ground-water and piped water (164 water samples) were systematically screened for antibiotic residues. To better understand antibiotic fate under tropical conditions, the dissipation behavior of selected antibiotics in the aquatic environment was investigated for the first time in mesocosm experiments. None of the investigated antibiotics were detected in groundwater and piped water samples. Surface water, which is still often used for drinking and domestic purposes by local populations, contained median concentrations of 21 ng L-1 sulfamethoxazole (SMX), 4 ng L-1 sulfadiazine (SDZ), 17 ng L-1 trimethoprim (TRIM), and 12 ng L-1 enrofloxacin (ENRO). These concentrations were lower than the predicted no effect concentrations (PNECs) and minimum inhibitory concentrations (MICs), suggesting limited antibiotic-related risk to aquatic ecosystems in the monitored systems. The dissipation half-lives of the studied antibiotics ranged from <1 to 44 days, depending on the availability of sunlight and sediment. Among the studied antibiotics TRIM was the most persistent in water systems. TRIM was not susceptible to photodegradation, while the dissipation of ENRO and SDZ was influenced by photolysis. The recorded dissipation models gave good predictions of the occurrence and concentrations of TRIM, ENRO and SDZ in surface water. In summary, the currently measured concentrations of the investigated antibiotics are unlikely to cause immediate risks to the aquatic environment, yet the persistence of these antibiotics is of concern and might lead to chronic exposure of aquatic organisms as well as humans.	[Chau Nguyen Dang Giang; Sebesvari, Zita; Renaud, Fabrice] United Nations Univ, Inst Environm & Human Secur UNU EHS, D-53113 Bonn, Germany; [Chau Nguyen Dang Giang; Rosendahl, Ingrid; Amelung, Wulf] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, D-53115 Bonn, Germany; [Chau Nguyen Dang Giang] Hue Univ, Coll Sci, Dept Chem, Hue, Vietnam; [Quang Hoang Minh] Ctr Nat Resource & Environm Monitoring, Dept Nat Resources & Environment Thua Thien Hue P, Hue, Vietnam	University of Bonn; Hue University	Giang, CND (corresponding author), United Nations Univ, Inst Environm & Human Secur UNU EHS, Pl Vereinten Nationen 1, D-53113 Bonn, Germany.	titan.envi@gmail.com	Amelung, Wulf/H-2136-2013; Renaud, Fabrice/M-3249-2017	Amelung, Wulf/0000-0002-4920-4667; Renaud, Fabrice/0000-0002-0830-1196; Sebesvari, Zita/0000-0001-7686-1227	Federal Ministry of Education and Research, Germany (BMBF) [0330777 A]	Federal Ministry of Education and Research, Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants (0330777 A) from the Federal Ministry of Education and Research, Germany (BMBF, http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy R, 2004, CHEMOSPHERE, V57, P505, DOI 10.1016/j.chemosphere.2004.06.024; Andrieu M, 2015, CHEMOSPHERE, V119, P407, DOI 10.1016/j.chemosphere.2014.06.062; BJORKLUND HV, 1991, AQUACULTURE, V97, P85, DOI 10.1016/0044-8486(91)90281-B; Boreen AL, 2004, ENVIRON SCI TECHNOL, V38, P3933, DOI 10.1021/es0353053; Bosma R. H., 2009, ENV IMPACT ASSESSMEN; Boxall ABA, 2006, J AGR FOOD CHEM, V54, P2288, DOI 10.1021/jf053041t; Carballo E., 2008, SMALL SCALE FRESHWAT; Chau NDG, 2015, ENVIRON SCI POLLUT R, V22, P9042, DOI 10.1007/s11356-014-4034-x; CIARLONE AE, 1990, MICROCHEM J, V42, P250, DOI 10.1016/0026-265X(90)90050-F; Ciglasch H, 2006, J AGR FOOD CHEM, V54, P8551, DOI 10.1021/jf061521u; COYNE R, 1994, AQUACULTURE, V123, P31, DOI 10.1016/0044-8486(94)90117-1; Dalkmann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045397; Dolar D, 2013, SEP PURIF TECHNOL, V115, P1, DOI 10.1016/j.seppur.2013.04.042; Dung TT., 2008, GAA, V11, P77; European Commission, 2003, TECHN GUID DOC RIS 2, P99; Forster M, 2009, ENVIRON SCI TECHNOL, V43, P1824, DOI 10.1021/es8026538; General Statistical Office (GSO), 2014, STAT YB VIETN 2013; General Statistics Office, 2008, RES SURV HOUS STAND; General Statistics Office, 2012, STAT YB VIETN 2012; Gobel A, 2005, J CHROMATOGR A, V1085, P179, DOI 10.1016/j.chroma.2005.05.051; Golet EM, 2002, ANAL CHEM, V74, P5455, DOI 10.1021/ac025762m; IMO, 2016, GUID DEV SHIP EN EFF; Jechalke S, 2014, TRENDS MICROBIOL, V22, P536, DOI 10.1016/j.tim.2014.05.005; Jessick AM, 2013, ACS SYM SER, V1126, P161; Koschorreck J, 2002, TOXICOL LETT, V131, P117, DOI 10.1016/S0378-4274(02)00047-4; Laabs V, 2007, CHEMOSPHERE, V67, P975, DOI 10.1016/j.chemosphere.2006.10.067; Le TX, 2004, MAR POLLUT BULL, V49, P922, DOI 10.1016/j.marpolbul.2004.06.016; Lemanska-Malinowska N, 2013, ARCH ENVIRON PROT, V39, P79, DOI 10.2478/aep-2013-0027; Li ZH, 2009, VET MED-CZECH, V54, P295, DOI 10.17221/97/2009-VETMED; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Liu F, 2010, ENVIRON CHEM, V7, P370, DOI 10.1071/EN09160; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; Managaki S, 2007, ENVIRON SCI TECHNOL, V41, P8004, DOI 10.1021/es0709021; Mekong River Commission, 2009, MRC MAN INF BOOKL SE; Nepejchalova L, 2008, ACTA VET BRNO, V77, P461, DOI 10.2754/avb200877030461; Papich M.G., 2009, VET PHARM THERAPEUTI, P835; Perisa M, 2013, ENVIRON SCI POLLUT R, V20, P8934, DOI 10.1007/s11356-013-1836-1; Toan PV, 2013, SCI TOTAL ENVIRON, V452, P28, DOI 10.1016/j.scitotenv.2013.02.026; Phan LT, 2009, AQUACULTURE, V296, P227, DOI 10.1016/j.aquaculture.2009.08.017; Phuong NT, 2010, SUCCESS STORIES IN ASIAN AQUACULTURE, P131, DOI 10.1007/978-90-481-3087-0_7; Reis N., 2012, ASEAS AUSTRIAN J S E, V5, P10; Rico A, 2012, REV AQUACULT, V4, P75, DOI 10.1111/j.1753-5131.2012.01062.x; Rosendahl I, 2012, J ENVIRON QUAL, V41, P1275, DOI 10.2134/jeq2011.0459; Rosendahl I, 2009, J ENVIRON MONITOR, V11, P1157, DOI 10.1039/b903470f; Salmon SA, 2000, AVIAN DIS, V44, P85, DOI 10.2307/1592511; Serrano P.H., 2005, FAO FISHERIES TECHNI, P97; Sukul P, 2007, REV ENVIRON CONTAM T, V191, P131, DOI 10.1007/978-0-387-69163-3_5; Thai KP, 2009, J FAC AGR KYUSHU U, V54, P513; Thiele-Bruhn S, 2003, J PLANT NUTR SOIL SC, V166, P145, DOI 10.1002/jpln.200390023; Trieu TTN, 2014, AQUACULT INT, V22, P469, DOI 10.1007/s10499-013-9656-3; TT-BNN, 2009, CIRC PROM LIST DRUGS; University of Hertfordshire, 2011, VSDB VET SUBST DAT; US EPA, 2011, FIN GUID INC WAT TRE; Wang XG, 2011, AFR J BIOTECHNOL, V10, P6456; Wetzstein HG, 1997, APPL ENVIRON MICROB, V63, P4272, DOI 10.1128/AEM.63.11.4272-4281.1997; Wetzstein HG, 1999, APPL ENVIRON MICROB, V65, P1556; WIGGINS GL, 1970, APPL MICROBIOL, V20, P893, DOI 10.1128/AEM.20.6.893-898.1970; Wilbers GJ, 2014, SCI TOTAL ENVIRON, V485, P653, DOI 10.1016/j.scitotenv.2014.03.049; WUST J, 1978, ANTIMICROB AGENTS CH, V14, P384, DOI 10.1128/AAC.14.3.384; Yang JF, 2009, J ENVIRON SCI HEAL B, V44, P241, DOI 10.1080/03601230902728245	60	93	98	5	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131855	10.1371/journal.pone.0131855	http://dx.doi.org/10.1371/journal.pone.0131855			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135396	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000358154400078
J	Negen, J; Nardini, M				Negen, James; Nardini, Marko			Four-Year-Olds Use a Mixture of Spatial Reference Frames	PLOS ONE			English	Article							MENTAL OBJECT ROTATION; YOUNG-CHILDREN; INFANTS; MODEL; ORIENTATION; INTEGRATION; MEMORY; REORIENTATION; 6-MONTH-OLD; ABILITIES	Keeping track of unseen objects is an important spatial skill. In order to do this, people must situate the object in terms of different frames of reference, including body position (egocentric frame of reference), landmarks in the surrounding environment (extrinsic frame reference), or other attached features (intrinsic frame of reference). Nardini et al. hid a toy in one of 12 cups in front of children, turned the array when they were not looking, and then asked them to point to the cup with the toy. This forced children to use the intrinsic frame (information about the array of cups) to locate the hidden toy. Three-year-olds made systematic errors by using the wrong frame of reference, 4-year-olds were at chance, and only 5- and 6-year-olds were successful. Can we better understand the developmental change that takes place at four years? This paper uses a modelling approach to re-examine the data and distinguish three possible strategies that could lead to the previous results at four years: (1) Children were choosing cups randomly, (2) Children were pointing between the egocentric/extrinsic-cued location and the correct target, and (3) Children were pointing near the egocentric/extrinsic-cued location on some trials and near the target on the rest. Results heavily favor the last possibility: 4-year-olds were not just guessing or trying to combine the available frames of reference. They were using the intrinsic frame on some trials, but not doing so consistently. These insights suggest that accounts of improving spatial performance at 4 years need to explain why there is a mixture of responses. Further application of the selected model also suggests that children become both more reliant on the correct frame and more accurate with any chosen frame as they mature.	[Negen, James; Nardini, Marko] Univ Durham, Dept Psychol, Durham DH1 3LE, County Durham, England	Durham University	Negen, J (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, County Durham, England.	jnegen@gmail.com	Nardini, Marko/C-1905-2008	Nardini, Marko/0000-0001-6614-7775; Negen, James/0000-0001-7258-5691	James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program [220020240]	James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program	The work was supported by grant 220020240 from the James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program, URLs: https://www.jsmf.org/ and https://www.jsmf.org/grants/2010004/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACREDOLO LP, 1980, DEV PSYCHOL, V16, P312, DOI 10.1037/0012-1649.16.4.312; ACREDOLO LP, 1978, DEV PSYCHOL, V14, P224, DOI 10.1037/0012-1649.14.3.224; BLADES M, 1994, J GENET PSYCHOL, V155, P201, DOI 10.1080/00221325.1994.9914772; Bremner AJ, 2006, INFANT BEHAV DEV, V29, P1, DOI 10.1016/j.infbeh.2005.06.003; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Cheng K, 2013, PSYCHON B REV, V20, P1033, DOI 10.3758/s13423-013-0416-1; CLIFTON RK, 1981, CHILD DEV, V52, P833, DOI 10.1111/j.1467-8624.1981.tb03121.x; COX MV, 1985, J CHILD LANG, V12, P611, DOI 10.1017/S0305000900006681; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; FANTZ RL, 1963, SCIENCE, V140, P296, DOI 10.1126/science.140.3564.296; Frick A, 2014, TRENDS COGN SCI, V18, P536, DOI 10.1016/j.tics.2014.05.011; Frick A, 2013, J EXP CHILD PSYCHOL, V115, P708, DOI 10.1016/j.jecp.2013.04.001; Goodman N, PROBABILISTIC MODELS; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kaufman J, 1999, DEVELOPMENTAL SCI, V2, P432, DOI 10.1111/1467-7687.00087; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Lee M.D., 2013, BAYESIAN COGNITIVE M; Levinson S. C., 2003, SPACE LANGUAGE COGNI; Lew AR, 2000, CHILD DEV, V71, P1179, DOI 10.1111/1467-8624.00222; Mohring W, 2013, CHILD DEV, V84, P1554, DOI 10.1111/cdev.12065; MOREAU T, 1978, PERCEPT MOTOR SKILL, V46, P427, DOI 10.2466/pms.1978.46.2.427; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; Nardini M, 2006, COGNITION, V101, P153, DOI 10.1016/j.cognition.2005.09.005; Newcombe N, 1998, COGNITIVE DEV, V13, P185, DOI 10.1016/S0885-2014(98)90038-7; Noda M, 2010, EUR J DEV PSYCHOL, V7, P746, DOI 10.1080/17405620903465771; Piaget J., 1963, CHILDS CONCEPTION SP; Piaget J, 1937, CONSTRUCTION REALITY; Ribordy F, 2013, COGNITIVE PSYCHOL, V66, P1, DOI 10.1016/j.cogpsych.2012.08.001; Spelke ES, 2011, ATTENTION PERFORM, P287, DOI 10.1016/B978-0-12-385948-8.00018-9; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 1999, BEST NG WINBUGS 1 2; Vanpaemel W, 2012, PSYCHON B REV, V19, P1047, DOI 10.3758/s13423-012-0300-4; Ward EJ, 2008, ECOL MODEL, V211, P1, DOI 10.1016/j.ecolmodel.2007.10.030	39	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131984	10.1371/journal.pone.0131984	http://dx.doi.org/10.1371/journal.pone.0131984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133990	Green Published, Green Accepted, gold			2022-12-26	WOS:000358154400088
J	Demir, K; Kattan, WE; Zou, MJ; Durmaz, E; BinEssa, H; Nalbantoglu, O; Al-Rijjal, RA; Meyer, B; Ozkan, B; Shi, YF				Demir, Korcan; Kattan, Walaa E.; Zou, Minjing; Durmaz, Erdem; BinEssa, Huda; Nalbantoglu, Ozlem; Al-Rijjal, Roua A.; Meyer, Brian; Ozkan, Behzat; Shi, Yufei			Novel CYP27B1 Gene Mutations in Patients with Vitamin D-Dependent Rickets Type 1A	PLOS ONE			English	Article							D-DEFICIENCY RICKETS; D 1-ALPHA-HYDROXYLASE DEFICIENCY; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; D BIOSYNTHESIS; D 25-HYDROXYLASE; ENZYME-ACTIVITY; HUMAN-DISEASE; METABOLISM; DISORDERS; FAMILY	The CYP27B1 gene encodes 25-hydroxyvitamin D-1a-hydroxylase. Mutations of this gene cause vitamin D-dependent rickets type 1A (VDDR-IA, OMIM 264700), which is a rare autosomal recessive disorder. To investigate CYP27B1 mutations, we studied 8 patients from 7 unrelated families. All coding exons and intron-exon boundaries of CYP27B1 gene were amplified by PCR from peripheral leukocyte DNA and subsequently sequenced. Homozygous mutations in the CYP27B1 gene were found in all the patients and heterozygous mutations were present in their normal parents. One novel single nucleotide variation (SNV, c. 1215 T>C, p. R379R in the last nucleotide of exon 7) and three novel mutations were identified:, a splice donor site mutation (c. 1215+2T>A) in intron 7, a 16-bp deletion in exon 6 (c. 1022-1037del16), and a 2-bp deletion in exon 5 (c. 934_935delAC). Both c. 1215 T>C and c. 1215+2T>A were present together in homozygous form in two unrelated patients, and caused exon 7 skipping. However, c. 1215 T>C alone has no effect on pre-mRNA splicing. The skipping of exon 7 resulted in a shift of downstream reading frame and a premature stop codon 57 amino acids from L380 (p. L380Afs*57). The intra-exon deletions of c. 1022-1037del16 and c. 934_935delAC also resulted in a frameshift and the creation of premature stop codons at p. T341Rfs*5, and p. T312Rfs*19, respectively, leading to the functional inactivation of the CYP27B1 gene. Clinically, all the patients required continued calcitriol treatment and the clinical presentations were consistent with the complete loss of vitamin D1a-hydroxylase activity. In conclusion, three novel mutations have been identified. All of them caused frameshift and truncated proteins. The silent c. 1215 T>C SNV has no effect on pre-mRNA splicing and it is likely a novel SNP. The current study further expands the CYP27B1 mutation spectrum.	[Demir, Korcan; Nalbantoglu, Ozlem; Ozkan, Behzat] Dr Behcet Uz Childrens Hosp, Div Pediat Endocrinol, Izmir, Turkey; [Kattan, Walaa E.] Alfaisal Univ, Coll Sci & Gen Studies, Riyadh, Saudi Arabia; [Kattan, Walaa E.; Zou, Minjing; BinEssa, Huda; Al-Rijjal, Roua A.; Meyer, Brian; Shi, Yufei] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Durmaz, Erdem] Sifa Univ, Bornova Hlth Applicat & Res Ctr, Dept Pediat Endocrinol, Izmir, Turkey	Izmir Dr Behcet Uz Children's Disease & Surgery Training & Research Hospital; Alfaisal University; King Faisal Specialist Hospital & Research Center; Sifa University	Shi, YF (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	yufei@kfshrc.edu.sa	Nalbantoğlu, Özlem/CAF-1682-2022; demir, korcan/F-5371-2012; Shi, Yufei/ABG-5228-2020	demir, korcan/0000-0002-8334-2422; Shi, Yufei/0000-0002-6999-0191; ozkan, Behzat/0000-0002-9153-8409	KACST [11-BIO1434-20]; King Faisal Specialist Hospital and Research Centre [2111101]	KACST; King Faisal Specialist Hospital and Research Centre	The study was partially funded by a grant from KACST 11-BIO1434-20 (http://www.kacst.edu.sa/en/Pages/default.aspx) and King Faisal Specialist Hospital and Research Centre (#2111101). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom G, 2005, ANN NY ACAD SCI, V1040, P53, DOI 10.1196/annals.1327.005; Al Mutair AN, 2012, J CLIN ENDOCR METAB, V97, pE2022, DOI 10.1210/jc.2012-1340; Alzahrani AS, 2010, J CLIN ENDOCR METAB, V95, P4176, DOI 10.1210/jc.2009-2278; Babiker Amir M I, 2014, BMC Res Notes, V7, P783, DOI 10.1186/1756-0500-7-783; BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; CLEMENS TL, 1982, CLIN CHIM ACTA, V121, P301, DOI 10.1016/0009-8981(82)90239-X; Durmaz E, 2012, CLIN ENDOCRINOL, V77, P363, DOI 10.1111/j.1365-2265.2012.04394.x; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FRASER D, 1973, NEW ENGL J MED, V289, P817, DOI 10.1056/NEJM197310182891601; Fu GK, 1997, MOL ENDOCRINOL, V11, P1961, DOI 10.1210/me.11.13.1961; GRAY RW, 1978, J CLIN ENDOCR METAB, V46, P756, DOI 10.1210/jcem-46-5-756; Gupta RP, 2005, J CLIN ENDOCR METAB, V90, P1210, DOI 10.1210/jc.2004-0966; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kim CJ, 2007, J CLIN ENDOCR METAB, V92, P3177, DOI 10.1210/jc.2006-2664; Kitanaka S, 1999, J CLIN ENDOCR METAB, V84, P4111, DOI 10.1210/jc.84.11.4111; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Miller WL, 1999, ENDOCRIN METAB CLIN, V28, P825, DOI 10.1016/S0889-8529(05)70104-3; Miller WL, 2000, TRENDS ENDOCRIN MET, V11, P315, DOI 10.1016/S1043-2760(00)00287-3; Miller WL, 2003, ENDOCRIN DEV, V6, P156; Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096; Miller WL, 2001, BEST PRACT RES CL EN, V15, P95, DOI 10.1053/beem.2001.0122; Porcu L, 2002, J ENDOCRINOL INVEST, V25, P557, DOI 10.1007/BF03345500; Shaw NJ, 2003, ENDOCRIN DEV, V6, P93; Shi YF, 2006, J CLIN ENDOCR METAB, V91, P2373, DOI 10.1210/jc.2006-0155; Vanhooke JL, 2006, P NATL ACAD SCI USA, V103, P75, DOI 10.1073/pnas.0509734103; VICCHIO D, 1993, BIOL MASS SPECTROM, V22, P53, DOI 10.1002/bms.1200220107; Wang JT, 1998, AM J HUM GENET, V63, P1694, DOI 10.1086/302156; Wang XM, 2002, J CLIN ENDOCR METAB, V87, P2424, DOI 10.1210/jc.87.6.2424; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S	35	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131376	10.1371/journal.pone.0131376	http://dx.doi.org/10.1371/journal.pone.0131376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132292	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000115
J	Dutoit-Lefevre, V; Dubucquoi, S; Launay, D; Sobanski, V; Dussart, P; Chafey, P; Broussard, C; Duban-Deweer, S; Vermersch, P; Prin, L; Lefranc, D				Dutoit-Lefevre, Virginie; Dubucquoi, Sylvain; Launay, David; Sobanski, Vincent; Dussart, Patricia; Chafey, Philippe; Broussard, Cedric; Duban-Deweer, Sophie; Vermersch, Patrick; Prin, Lionel; Lefranc, Didier			An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies	PLOS ONE			English	Article							PROTEOMICS-BASED IDENTIFICATION; TUMOR-ASSOCIATED ANTIGEN; BREAST-CANCER PATIENTS; RENAL-CELL CARCINOMA; ALPHA-ENOLASE; ANTIENDOTHELIAL CELL; TARGET ANTIGENS; ANTIFIBROBLAST ANTIBODIES; CANDIDATE AUTOANTIGENS; AUTOIMMUNE HEPATITIS	Serological proteome analysis (SERPA) combines classical proteomic technology with effective separation of cellular protein extracts on two-dimensional gel electrophoresis, western blotting, and identification of the antigenic spot of interest by mass spectrometry. A critical point is related to the antigenic target characterization by mass spectrometry, which depends on the accuracy of the matching of antigenic reactivities on the protein spots during the 2D immunoproteomic procedures. The superimposition, based essentially on visual criteria of antigenic and protein spots, remains the major limitation of SERPA. The introduction of fluorescent dyes in proteomic strategies, commonly known as 2D-DIGE (differential in-gel electrophoresis), has boosted the qualitative capabilities of 2D electrophoresis. Based on this 2D-DIGE strategy, we have improved the conventional SERPA by developing a new and entirely fluorescence-based bi-dimensional immunoproteomic (FBIP) analysis, performed with three fluorescent dyes. To optimize the alignment of the different antigenic maps, we introduced a landmark map composed of a combination of specific antibodies. This methodological development allows simultaneous revelation of the antigenic, landmark and proteomic maps on each immunoblot. A computer-assisted process using commercially available software automatically leads to the superimposition of the different maps, ensuring accurate localization of antigenic spots of interest.	[Dutoit-Lefevre, Virginie; Dubucquoi, Sylvain; Dussart, Patricia; Prin, Lionel] Ctr Hosp Reg Univ, Inst Immunol, Ctr Biol Pathol & Genet, Lille, France; [Dutoit-Lefevre, Virginie; Dubucquoi, Sylvain; Launay, David; Sobanski, Vincent; Dussart, Patricia; Vermersch, Patrick; Prin, Lionel; Lefranc, Didier] INSERM, LIRIC, UMR 995, F-59045 Lille, France; [Dutoit-Lefevre, Virginie; Dubucquoi, Sylvain; Launay, David; Sobanski, Vincent; Dussart, Patricia; Duban-Deweer, Sophie; Vermersch, Patrick; Prin, Lionel; Lefranc, Didier] Univ Lille Nord France, EA 2686, Lille, France; [Launay, David; Sobanski, Vincent] Ctr Hosp Reg Univ, Serv Med Interne & Immunol Clin, Ctr Natl Reference Malad Rares, Lille, France; [Chafey, Philippe; Broussard, Cedric] INSERM, U1016, Inst Cochin, Paris, France; [Chafey, Philippe; Broussard, Cedric] CNRS, UMR 8104, Paris, France; [Chafey, Philippe; Broussard, Cedric] Univ Paris 05, Sorbonne Paris Cite, Plate Forme Prote 3P5, Paris, France; [Duban-Deweer, Sophie] UArtois, EA 2465, LBHE, Lens, France; [Vermersch, Patrick] Ctr Hosp Reg Univ, Serv Neurol D, Lille, France	Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille	Dubucquoi, S (corresponding author), Ctr Hosp Reg Univ, Inst Immunol, Ctr Biol Pathol & Genet, Lille, France.	virginiedutoitlefevre@gmail.com	Sobanski, Vincent/Q-6411-2016; Sobanski, Vincent/U-5676-2019; Dubucquoi, Sylvain/I-5756-2018; Launay, David/A-5270-2018; Launay, David/H-1674-2016	Sobanski, Vincent/0000-0003-3083-2441; Dubucquoi, Sylvain/0000-0002-8962-3719; Launay, David/0000-0003-1840-1817; Launay, David/0000-0003-1840-1817; Broussard, Cedric/0000-0001-9508-2341	Action de Recherche Concertee d'Initiative Regionale [09.26.0082]; Programme Hospitalier de Recherche Clinique [2008/1926]; association "Max de Vie, Max d'Amour"; Societe Nationale Francaise de Medecine Interne; Pfizer; Merck Serono; association "Capucine"	Action de Recherche Concertee d'Initiative Regionale; Programme Hospitalier de Recherche Clinique; association "Max de Vie, Max d'Amour"; Societe Nationale Francaise de Medecine Interne; Pfizer(Pfizer); Merck Serono(Merck & Company); association "Capucine"	This study was funded in part by 'Action de Recherche Concertee d'Initiative Regionale' (ARCir no. 09.26.0082), Programme Hospitalier de Recherche Clinique (PHRC no. 2008/1926), the associations "Max de Vie, Max d'Amour" and "Capucine", the Societe Nationale Francaise de Medecine Interne, Pfizer and Merck Serono. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras L, 2004, PROTEOMICS, V4, P2184, DOI 10.1002/pmic.200300732; Ballot E, 2003, CLIN CHEM, V49, P634, DOI 10.1373/49.4.634; Beleoken E, 2013, HEPATOLOGY, V57, P689, DOI 10.1002/hep.26024; Beyer NH, 2007, SCAND J CLIN LAB INV, V67, P696, DOI 10.1080/00365510701342062; Bunk S, 2008, J IMMUNOL, V180, P5490, DOI 10.4049/jimmunol.180.8.5490; Bussone G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3336; Canelle L, 2005, J IMMUNOL METHODS, V299, P77, DOI 10.1016/j.jim.2005.01.015; Caron M, 2007, MOL CELL PROTEOMICS, V6, P1115, DOI 10.1074/mcp.R600016-MCP200; Cottrell TR, 2012, J IMMUNOL METHODS, V385, P35, DOI 10.1016/j.jim.2012.07.024; Croci S, 2010, PROTEOMICS, V10, P3835, DOI 10.1002/pmic.200900643; Cui JW, 2005, MOL CELL PROTEOMICS, V4, P1718, DOI 10.1074/mcp.M400165-MCP200; De Monte L, 2008, J PROTEOME RES, V7, P504, DOI 10.1021/pr070360m; Desmetz C, 2008, J PROTEOME RES, V7, P3830, DOI 10.1021/pr800130d; Donoghue PM, 2006, PROTEOMICS, V6, P6400, DOI 10.1002/pmic.200600139; Farinazzo A, 2011, J NEUROIMMUNOL, V232, P63, DOI 10.1016/j.jneuroim.2010.10.004; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Fujita Y, 2006, CLIN CANCER RES, V12, P6415, DOI 10.1158/1078-0432.CCR-06-1315; Garaguso I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050025; Goeb V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2644; Grandjean M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076508; Guilpain P, 2007, ANN NY ACAD SCI, V1109, P538, DOI 10.1196/annals.1398.060; Hamrita B, 2008, CLIN CHIM ACTA, V393, P95, DOI 10.1016/j.cca.2008.03.017; He YJ, 2007, PROTEOM CLIN APPL, V1, P336, DOI 10.1002/prca.200600718; Howie SEM, 2011, CURR OPIN INFECT DIS, V24, P56, DOI 10.1097/QCO.0b013e3283421081; Huguet S, 2004, PROTEOMICS, V4, P1341, DOI 10.1002/pmic.200300757; Iizuka N, 2010, LUPUS, V19, P717, DOI 10.1177/0961203309357764; Kahn JE, 2011, J PROTEOME RES, V10, P1468, DOI 10.1021/pr100836p; Katsumata Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005330; Kimura A, 2010, NEUROLOGY, V74, P1372, DOI 10.1212/WNL.0b013e3181dad590; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Klade CS, 2001, PROTEOMICS, V1, P890, DOI 10.1002/1615-9861(200107)1:7<890::AID-PROT890>3.0.CO;2-Z; Klein-Scory S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-70; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Le Marechal C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-35; Le Naour F, 2002, MOL CELL PROTEOMICS, V1, P197, DOI 10.1074/mcp.M100029-MCP200; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; Lefranc D, 2004, J IMMUNOL, V172, P669, DOI 10.4049/jimmunol.172.1.669; Lefranc D, 2007, ARTHRITIS RHEUM-US, V56, P3420, DOI 10.1002/art.22863; Li L, 2008, J PROTEOME RES, V7, P611, DOI 10.1021/pr070525r; Li QA, 2011, J INVEST DERMATOL, V131, P727, DOI 10.1038/jid.2010.341; Lichtenfels R, 2003, BBA-PROTEINS PROTEOM, V1646, P21, DOI 10.1016/S1570-9639(02)00547-2; Lind SB, 2010, BIOCHEM BIOPH RES CO, V401, P581, DOI 10.1016/j.bbrc.2010.09.104; Liu J, 2009, TOXICOL APPL PHARM, V240, P393, DOI 10.1016/j.taap.2009.07.031; Lupi I, 2008, CLIN ENDOCRINOL, V69, P269, DOI 10.1111/j.1365-2265.2008.03180.x; Massa O, 2013, J PROTEOMICS, V82, P263, DOI 10.1016/j.jprot.2013.02.030; Minden J, 2007, BIOTECHNIQUES, V43, P739, DOI 10.2144/000112653; Nakanishi T, 2006, J CHROMATOGR B, V838, P15, DOI 10.1016/j.jchromb.2006.04.009; Okunuki Y, 2007, EXP EYE RES, V84, P823, DOI 10.1016/j.exer.2007.01.003; Peng B, 2013, J PROTEOME RES, V12, P1789, DOI 10.1021/pr3011342; Petersen A, 2006, PROTEOMICS, V6, P6317, DOI 10.1002/pmic.200600173; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Rauch J, 2008, PROTEOM CLIN APPL, V2, P355, DOI 10.1002/prca.200780064; Regent A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3388; Sakurai T, 2011, J NEUROIMMUNOL, V233, P175, DOI 10.1016/j.jneuroim.2010.11.003; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Servettaz A, 2008, PROTEOMICS, V8, P1000, DOI 10.1002/pmic.200700794; Seyffert N, 2012, VET MICROBIOL, V157, P439, DOI 10.1016/j.vetmic.2012.01.016; Stulik J, 2003, PROTEOMICS, V3, P951, DOI 10.1002/pmic.200300370; Suzuki Ayako, 2010, Cancer Genomics & Proteomics, V7, P17; Tamesa MS, 2009, ELECTROPHORESIS, V30, P2168, DOI 10.1002/elps.200800675; Terrier B, 2010, ANN RHEUM DIS, V69, P428, DOI 10.1136/ard.2008.104299; Terrier B, 2008, AM J RESP CRIT CARE, V177, P1128, DOI 10.1164/rccm.200707-1015OC; Tomaino B, 2007, J PROTEOME RES, V6, P4025, DOI 10.1021/pr070281a; Unwin RD, 2003, PROTEOMICS, V3, P45, DOI 10.1002/pmic.200390008; Xia Q, 2008, J PROTEOME RES, V7, P1963, DOI 10.1021/pr700861s; Yang F, 2007, J PROTEOME RES, V6, P751, DOI 10.1021/pr0602287; Zephir H, 2006, J NEUROIMMUNOL, V179, P53, DOI 10.1016/j.jneuroim.2006.06.016; Zhu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013915	69	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132142	10.1371/journal.pone.0132142	http://dx.doi.org/10.1371/journal.pone.0132142			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132557	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000160
J	Lange, DC; Glidden, D; Secemsky, EA; Ordovas, K; Deeks, SG; Martin, JN; Bolger, AF; Hsue, PY				Lange, David C.; Glidden, David; Secemsky, Eric A.; Ordovas, Karen; Deeks, Steven G.; Martin, Jeffrey N.; Bolger, Ann F.; Hsue, Priscilla Y.			Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; INTIMA-MEDIA THICKNESS; ALL-CAUSE MORTALITY; VALVE CALCIFICATION; PREDICTIVE-VALUE; RISK; DISEASE; MORBIDITY; EVENTS	Background HIV infection increases cardiovascular risk. Coronary artery calcification (CAC) and mitral annular calcification (MAC) identify patients at risk for cardiovascular disease (CVD). The purpose of this study was to examine the association between MAC, CAC and mortality in HIV-infected individuals. Methods and Results We studied 152 asymptomatic HIV-infected individuals with transthoracic echocardiography (TTE) and computed tomography (CT). MAC was identified on TTE using standardized criteria. Presence of CAC, CAC score and CAC percentiles were determined using the modified Agatston criteria. Mortality data was obtained from the Social Security and National Death Indices (SSDI/NDI). The median age was 49 years; 87% were male. The median duration of HIV was 16 years; 84% took antiretroviral therapy; 64% had an undetectable viral load. CVD risk factors included hypertension (35%), smoking (62%) and dyslipidemia (35%). Twenty-five percent of individuals had MAC, and 42% had CAC. Over a median follow-up of 8 years, 11 subjects died. Subjects with CAC had significantly higher mortality compared to those with MAC only or no MAC. The Harrell's C-statistic of CAC was 0.66 and increased to 0.75 when MAC was added (p = 0.05). MAC, prior CVD, age and HIV viral load were independently associated with higher age-and gender-adjusted CAC percentiles in an adjusted model (p < 0.05 for all). Conclusion In HIV patients, the presence of MAC, traditional risk factors and HIV viral load were independently associated with CAC. Presence of CAC and MAC may be useful in identifying HIV-infected individuals at higher risk for death.	[Lange, David C.] Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Los Angeles, CA 90048 USA; [Glidden, David] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Secemsky, Eric A.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Ordovas, Karen] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV, AIDS Posit Hlth Program, San Francisco, CA 94143 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bolger, Ann F.; Hsue, Priscilla Y.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Hsue, PY (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.	phsue@medsfgh.ucsf.edu	Glidden, David/AAD-4730-2020	Glidden, David/0000-0001-5888-1419; Deeks, Steven/0000-0001-6371-747X	National Heart, Lung and Blood Institute [RO1 HL095130, RO1 HL091526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095130, R01HL091526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Heart, Lung and Blood Institute RO1 HL095130 (P.Y.H.) and the National Heart, Lung and Blood Institute RO1 HL091526 (P.Y.H.).	Acarturk E, 2003, ANGIOLOGY, V54, P561, DOI 10.1177/000331970305400505; Adler Y, 1998, AM J CARDIOL, V82, P1183, DOI 10.1016/S0002-9149(98)00596-7; Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; [Anonymous], 2014, WORLD AIDS DAY 2014; [Anonymous], 2013, JOINT UN PROGR HIV A; Antiretroviral Therapy Cohort Collaboration, 1996, CLIN INFECT DIS, V50, P1387; Appay Victor, 2005, Curr Infect Dis Rep, V7, P473, DOI 10.1007/s11908-005-0050-9; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; ARONOW WS, 1991, GERIATRICS, V46, P73; Atar S, 2003, HEART, V89, P161, DOI 10.1136/heart.89.2.161; BENJAMIN EJ, 1992, NEW ENGL J MED, V327, P374, DOI 10.1056/NEJM199208063270602; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI 10.1016/j.jcmg.2009.03.009; Boon A, 1997, HEART, V78, P472, DOI 10.1136/hrt.78.5.472; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Caron M, 2008, ANTIVIR THER, V13, P27; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Fitch KV, 2010, JAIDS-J ACQ IMM DEF, V55, P495, DOI 10.1097/QAI.0b013e3181edab0b; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Fox CS, 2004, ATHEROSCLEROSIS, V173, P291, DOI 10.1016/j.atherosclerosis.2003.12.018; Fox E, 2004, AM HEART J, V148, P979, DOI 10.1016/j.ahj.2004.05.048; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; FULKERSON PK, 1979, AM J MED, V66, P967, DOI 10.1016/0002-9343(79)90452-2; Graham G, 2012, ATHEROSCLEROSIS, V225, P432, DOI 10.1016/j.atherosclerosis.2012.08.014; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Guaraldi G, 2012, INT J CARDIOVAS IMAG, V28, P935, DOI 10.1007/s10554-011-9898-y; Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080; Halliburton SS, 2002, CLEV CLIN J MED, V69, pS6, DOI 10.3949/ccjm.69.Suppl_3.S6; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Hsue PY, 2010, CIRC-HEART FAIL, V3, P132, DOI 10.1161/CIRCHEARTFAILURE.109.854943; Hsue Priscilla Y, 2008, Circulation, V118, pe41, DOI 10.1161/CIRCULATIONAHA.107.189626; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Kamensky G, 2001, J Cardiol, V37 Suppl 1, P21; KORN D, 1962, NEW ENGL J MED, V267, P900, DOI 10.1056/NEJM196211012671802; Mangili A, 2006, CLIN INFECT DIS, V43, P1482, DOI 10.1086/509575; Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528; NESTICO PF, 1984, AM HEART J, V107, P989, DOI 10.1016/0002-8703(84)90840-8; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pearce D, 2012, AM J CARDIOL, V110, P1078, DOI 10.1016/j.amjcard.2012.05.045; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Raggi P, 2000, CIRCULATION, V101, P850, DOI 10.1161/01.CIR.101.8.850; Shemesh J, 2011, AM J HYPERTENS, V24, P681, DOI 10.1038/ajh.2011.28; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6	49	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130592	10.1371/journal.pone.0130592	http://dx.doi.org/10.1371/journal.pone.0130592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132465	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000075
J	Perrard, A; Loope, KJ				Perrard, Adrien; Loope, Kevin J.			Patriline Differences Reveal Genetic Influence on Forewing Size and Shape in a Yellowjacket Wasp (Hymenoptera: Vespidae: Vespula flavopilosa Jacobson, 1978)	PLOS ONE			English	Article							WING SHAPE; GEOMETRIC MORPHOMETRICS; MICROSATELLITE LOCI; BODY-SIZE; KIN SELECTION; INSECT WINGS; DROSOPHILA; VENATION; EVOLUTION; PATTERN	The wing venation is frequently used as a morphological marker to distinguish biological groups among insects. With geometric morphometrics, minute shape differences can be detected between closely related species or populations, making this technique useful for taxonomy. However, the direct influence of genetic differences on wing morphology has not been explored within colonies of social insects. Here, we show that the father's genotype has a direct effect on wing morphology in colonies of social wasps. Using geometric morphometrics on the venation pattern, we found significant differences in wing size and shape between patrilines of yellowjackets, taking allometry and measurement error into account. The genetic influence on wing size accounted for a small part of the overall size variation, but venation shape was highly structured by the differences between patrilines. Overall, our results showed a strong genetic influence on wing morphology likely acting at multiple levels of venation pattern development. This confirmed the pertinence of this marker for taxonomic purposes and suggests this phenotype as a potentially useful marker for phylogenies. This also raises doubts about the strength of selective pressures on this phenotype, which highlights the need to understand better the role of wing venation shape in insect flight.	[Perrard, Adrien] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Loope, Kevin J.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	American Museum of Natural History (AMNH); Cornell University	Perrard, A (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	perrard@mnhn.fr		Loope, Kevin J./0000-0002-1206-5640; Perrard, Adrien/0000-0002-4279-9987	Animal Behaviour Research Grant (Cornell University); Gerstner scholarship; Kalbfleisch Fellowship (American Museum of Natural History); Graduate Research Fellowship (National Science Foundation) [DGE-1144153]	Animal Behaviour Research Grant (Cornell University); Gerstner scholarship; Kalbfleisch Fellowship (American Museum of Natural History); Graduate Research Fellowship (National Science Foundation)(National Science Foundation (NSF))	Microsatellite genotyping was funded by an Animal Behaviour Research Grant (Cornell University; http://www.nbb.cornell.edu/). AP benefited from a Gerstner scholarship and a Kalbfleisch Fellowship (American Museum of Natural History; http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/postdoctoral-fellowships). KJL benefited from a Graduate Research Fellowship (National Science Foundation, DGE-1144153; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2011, J HUM EVOL, V60, P240, DOI 10.1016/j.jhevol.2010.02.003; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; [Anonymous], 1971, INSECT SOC; Baylac M, 2003, BIOL J LINN SOC, V80, P89, DOI 10.1046/j.1095-8312.2003.00221.x; BAYLAC M, 2012, RMORPH R GEOMETRIC M; Bethoux Olivier, 2008, Alavesia, V2, P219; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Camara M, 2006, J MED ENTOMOL, V43, P853, DOI 10.1603/0022-2585(2006)43[853:GAMEFP]2.0.CO;2; Catalano SA, 2012, SYST BIOL, V61, P392, DOI 10.1093/sysbio/syr119; Catalano SA, 2010, CLADISTICS, V26, P539, DOI 10.1111/j.1096-0031.2010.00302.x; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Crozatier M, 2004, TRENDS GENET, V20, P498, DOI 10.1016/j.tig.2004.07.013; Daly D, 2002, MOL ECOL NOTES, V2, P273, DOI 10.1046/j.1471-8286.2002.00220.x; de Celis JF, 2003, INT J DEV BIOL, V47, P653; Debat V, 2003, EVOLUTION, V57, P2773, DOI 10.1111/j.0014-3820.2003.tb01519.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dehon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108865; Dirks JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043411; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Fjerdingstad EJ, 2005, MOL ECOL, V14, P3123, DOI 10.1111/j.1365-294X.2005.02648.x; Foster KR, 2001, BEHAV ECOL SOCIOBIOL, V50, P1, DOI 10.1007/s002650100336; Garcia Z, 2012, ZOOMORPHOLOGY, V131, P25, DOI 10.1007/s00435-011-0142-z; Goodisman MAD, 2007, MOL ECOL, V16, P2589, DOI 10.1111/j.1365-294X.2007.03316.x; Hasegawa E, 2002, MOL ECOL NOTES, V2, P306, DOI 10.1046/j.1471-8286.2002.00224.x; Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001; Houle D, 2013, EVOLUTION, V67, P1116, DOI 10.1111/j.1558-5646.2012.01838.x; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Klingenberg CP, 2010, EVOLUTION, V64, P2935, DOI 10.1111/j.1558-5646.2010.01030.x; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Kovacs JL, 2010, INSECT SOC, V57, P53, DOI 10.1007/s00040-009-0050-0; Kovacs JL, 2012, ENVIRON ENTOMOL, V41, P1612, DOI 10.1603/EN12023; Loope KJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0277-x; Matsuda S, 2013, INSECT BIOCHEM MOLEC, V43, P466, DOI 10.1016/j.ibmb.2013.02.008; Mezey JG, 2005, EVOLUTION, V59, P1027; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Monteiro LR, 2002, EVOLUTION, V56, P563, DOI 10.1111/j.0014-3820.2002.tb01367.x; Mountcastle AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0531; Nel A, 2012, J MORPHOL, V273, P480, DOI 10.1002/jmor.11036; Outomuro D, 2015, J EVOLUTION BIOL, V28, P791, DOI 10.1111/jeb.12605; Perrard A, 2014, J EVOLUTION BIOL, V27, P2665, DOI 10.1111/jeb.12523; Perrard A, 2012, J EVOLUTION BIOL, V25, P1389, DOI 10.1111/j.1420-9101.2012.02527.x; Pretorius E, 2005, AUST J ENTOMOL, V44, P113, DOI 10.1111/j.1440-6055.2005.00464.x; R Development Core Team, R LANG ENV STAT COMP; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, TPSDIG V2 16; ROSS KG, 1986, NATURE, V323, P798, DOI 10.1038/323798a0; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sharkey MJ, 2002, ZOOL SCR, V31, P57, DOI 10.1046/j.0300-3256.2001.00081.x; Shimmi O, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0264; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Spradbery J.P., 1973, ACCOUNT BIOL NATURAL; THOREN PA, 1995, INSECT MOL BIOL, V4, P141, DOI 10.1111/j.1365-2583.1995.tb00019.x; Tofilski A, 2004, J INSECT SCI, V4, DOI [10.1093/JIS/4.1.17, 10.1093/jis/4.1.17]; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Villemant C, 2007, SYST ENTOMOL, V32, P625, DOI 10.1111/j.1365-3113.2007.00389.x; WEBER KE, 1990, GENETICS, V126, P975; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	61	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130064	10.1371/journal.pone.0130064	http://dx.doi.org/10.1371/journal.pone.0130064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131549	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000051
J	Sahibzada, N; Mangel, AW; Tatge, JE; Dretchen, KL; Franz, MR; Virmani, R; Gillis, RA				Sahibzada, Niaz; Mangel, Allen W.; Tatge, Jaclyn E.; Dretchen, Kenneth L.; Franz, Michael R.; Virmani, Renu; Gillis, Richard A.			Rhythmic Aortic Contractions Induced by Electrical Stimulation In Vivo in the Rat	PLOS ONE			English	Article							SMOOTH-MUSCLE; ARTERY; INVIVO; RABBIT; TONE	For over a century, the behavior of the aorta and other large arteries has been described as passive elastic tubes in which no active contraction occurs in the smooth muscle wall. In response to pulsatile pressure changes, the vessels undergo a 'passive' elastic dilatation-contraction cycle, described as a "Windkessel" effect. However, Mangel and colleagues have presented evidence that is contrary to this view. They reported that in the rabbit, the aorta undergoes rhythmic 'active' (contraction) during the cardiac cycle; but these findings have been largely ignored. In the present study, we observed spontaneous contractions in synchrony with the heartbeat in another species (rat). In addition we demonstrate that aorta contractions are of neurogenic origin. Electrical stimulation of the aorta evoked contractions that occur at a rate that is in the range of the animal's heartbeat and are suppressed by tetrodotoxin and the alpha-adrenergic receptor blocker, phentolamine. Altogether, these findings indicate that aortic contractions are under neural control from the heart.	[Sahibzada, Niaz; Tatge, Jaclyn E.; Dretchen, Kenneth L.; Gillis, Richard A.] Georgetown Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Mangel, Allen W.] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Franz, Michael R.] Vet Affairs Med Ctr, Div Cardiol, Washington, DC 20422 USA; [Virmani, Renu] CVPath Inst, Gaithersburg, MD 20878 USA	Georgetown University; Research Triangle Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); CVPath Institute	Gillis, RA (corresponding author), Georgetown Univ, Sch Med, Dept Physiol & Pharmacol, 3900 Reservoir Rd NW, Washington, DC 20007 USA.	gillisr@georgetown.edu		mangel, allen/0000-0002-5430-1402; Sahibzada, Niaz/0000-0002-4169-370X	RTI Health Solutions	RTI Health Solutions	Funding for this project was provided by RTI Health Solutions to NS and RAG. RTI is a not-for-profit research institute. AWM was involved in designing the experiment and in writing the paper.	Berra-Romani R, 2005, AM J PHYSIOL-HEART C, V289, pH137, DOI 10.1152/ajpheart.01156.2004; BEVAN JA, 1962, J PHARMACOL EXP THER, V137, P213; GENTILE BJ, 1985, CIRC RES, V56, P690, DOI 10.1161/01.RES.56.5.690; HAYASHIDA N, 1986, JPN J PHYSIOL, V36, P783, DOI 10.2170/jjphysiol.36.783; LOMBARD JH, 1982, AM J PHYSIOL, V242, pH967, DOI 10.1152/ajpheart.1982.242.6.H967; MANGEL A, 1981, NATURE, V289, P692, DOI 10.1038/289692a0; MANGEL A, 1982, SCIENCE, V215, P1627, DOI 10.1126/science.7071582; Mangel A, 1983, VASCULAR NEUROEFFECT, P347; NILSSON H, 1986, ACTA PHYSIOL SCAND, V126, P121, DOI 10.1111/j.1748-1716.1986.tb07795.x; Pakdeechote P, 2007, EUR J PHARMACOL, V563, P180, DOI 10.1016/j.ejphar.2007.02.011; PATIL PN, 1972, EUR J PHARMACOL, V19, P79, DOI 10.1016/0014-2999(72)90079-9; PETERSON LH, 1960, CIRC RES, V8, P622, DOI 10.1161/01.RES.8.3.622; RAVI K, 1987, J AUTONOM NERV SYST, V18, P33, DOI 10.1016/0165-1838(87)90132-9; ROSS G, 1980, CARDIOVASC RES, V14, P613, DOI 10.1093/cvr/14.10.613; RUSHMER RF, 1955, AM J PHYSIOL, V183, P545, DOI 10.1152/ajplegacy.1955.183.3.545; SAGAWA K, 1990, J MOL CELL CARDIOL, V22, P253, DOI 10.1016/0022-2828(90)91459-K; Van Bortel L.M., 2014, BLOOD PRESSURE ARTER, P23; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; Wiggers CJ, 1938, AM J PHYSIOL, V124, P603, DOI 10.1152/ajplegacy.1938.124.3.603	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130255	10.1371/journal.pone.0130255	http://dx.doi.org/10.1371/journal.pone.0130255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132172	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000057
J	Zhang, KX; Zhang, JH; Zhou, YM; Chen, C; Li, W; Ma, L; Zhang, LC; Zhao, JX; Gan, WB; Zhang, LH; Tang, PF				Zhang, Kexue; Zhang, Jinhui; Zhou, Yanmei; Chen, Chao; Li, Wei; Ma, Lei; Zhang, Licheng; Zhao, Jingxin; Gan, Wenbiao; Zhang, Lihai; Tang, Peifu			Remodeling the Dendritic Spines in the Hindlimb Representation of the Sensory Cortex after Spinal Cord Hemisection in Mice	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; PRIMARY SOMATOSENSORY CORTEX; ADULT MACAQUE MONKEYS; NEUROPATHIC PAIN; INTRACORTICAL MICROSTIMULATION; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; CEREBRAL-CORTEX; NERVE LESIONS; INJURY	Spinal cord injury (SCI) can induce remodeling of multiple levels of the cerebral cortex system especially in the sensory cortex. The aim of this study was to assess, in vivo and bilaterally, the remodeling of dendritic spines in the hindlimb representation of the sensory cortex after spinal cord hemisection. Thy1-YFP transgenic mice were randomly divided into the control group and the SCI group, and the spinal vertebral plates (T11-T12) of all mice were excised. Next, the left hemisphere of the spinal cord (T12) was hemisected in the SCI group. The hindlimb representations of the sensory cortex in both groups were imaged bilaterally on the day before (0d), and three days (3d), two weeks (2w), and one month (1m) after the SCI. The rates of stable, newly formed, and eliminated spines were calculated by comparing images of individual dendritic spine in the same areas at different time points. In comparison to the control group, the rate of newly formed spines in the contralateral sensory cortex of the SCI group increased at three days and two weeks after injury. The rates of eliminated spines in the bilateral sensory cortices increased and the rate of stable spines in the bilateral cortices declined at two weeks and one month. From three days to two weeks, the stable rates of bilaterally stable spines in the SCI group decreased. In comparison to the control group and contralateral cortex in the SCI group, the re-emerging rate of eliminated spines in ipsilateral cortex of the SCI group decreased significantly. The stable rates of newly formed spines in bilateral cortices of the SCI group decreased from two weeks to one month. We found that the remodeling in the hindlimb representation of the sensory cortex after spinal cord hemisection occurred bilaterally. This remodeling included eliminating spines and forming new spines, as well as changing the reorganized regions of the brain cortex after the SCI over time. Soon after the SCI, the cortex was remodeled by increasing spine formation in the contralateral cortex. Then it was remodeled prominently by eliminating spines of bilateral cortices. Spinal cord hemisection also caused traditional stable spines to become unstable and led the eliminated spines even more hard to recur especially in the ipsilateral cortex of the SCI group. In addition, it also made the new formed spines unstable.	[Zhang, Kexue; Zhang, Jinhui; Chen, Chao; Zhang, Licheng; Zhao, Jingxin; Zhang, Lihai; Tang, Peifu] Gen Hosp Chinese PLA, Dept Orthopaed, Beijing 100853, Peoples R China; [Zhou, Yanmei; Li, Wei; Ma, Lei] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Ctr Drug Discovery, Shenzhen 518055, Peoples R China; [Gan, Wenbiao] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Peking University; University Town of Shenzhen; New York University	Gan, WB (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA.	wenbiao.gan@med.nyu.edu; zhanglihai301@gmail.com; pftang301@163.com	zhang, jinhui/GXF-6528-2022; zhang, jin/GXV-9154-2022	Tang, Peifu/0000-0003-4279-1704; ma, lei/0000-0001-9673-0224; Zhao, Jing-xin/0000-0002-5385-3969				Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Blanco JE, 2007, EXP NEUROL, V203, P333, DOI 10.1016/j.expneurol.2006.08.017; Chen YL, 2014, NEURON, V83, P431, DOI 10.1016/j.neuron.2014.05.027; Darian-Smith C, 2009, NEUROSCIENTIST, V15, P149, DOI 10.1177/1073858408331372; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Elbert T, 2004, NEUROSCIENTIST, V10, P129, DOI 10.1177/1073858403262111; Endo T, 2009, NEUROSCIENTIST, V15, P291, DOI 10.1177/1073858408329508; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Ghosh A, 2012, CEREB CORTEX, V22, P1309, DOI 10.1093/cercor/bhr191; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Girlanda P, 2000, NEUROLOGY, V55, P975, DOI 10.1212/WNL.55.7.975; Goldshmit Y, 2008, J NEUROTRAUM, V25, P449, DOI 10.1089/neu.2007.0392; Green JB, 1998, NEUROLOGY, V50, P1115, DOI 10.1212/WNL.50.4.1115; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gwak YS, 2011, NEUROPHARMACOLOGY, V60, P799, DOI 10.1016/j.neuropharm.2010.12.030; Gwak YS, 2010, J PHYSIOL SCI, V60, P59, DOI 10.1007/s12576-009-0066-2; Harms KJ, 2007, BRAIN RES, V1184, P65, DOI 10.1016/j.brainres.2006.02.094; Humanes-Valera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069655; Jayaraman A, 2006, SPINAL CORD, V44, P680, DOI 10.1038/sj.sc.3101892; Jiang YQ, 2013, EUR J NEUROSCI, V38, P3702, DOI 10.1111/ejn.12372; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kambi N, 2011, J NEUROSCI, V31, P3696, DOI 10.1523/JNEUROSCI.5187-10.2011; Kao T, 2009, J NEUROSCI, V29, P7549, DOI 10.1523/JNEUROSCI.2474-08.2009; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Kim BG, 2008, J COMP NEUROL, V508, P473, DOI 10.1002/cne.21686; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lau BYB, 2011, EXP NEUROL, V228, P283, DOI 10.1016/j.expneurol.2011.02.003; Lemtiri-Chlieh F, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-126; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Munera A, 2012, NEUROSCIENCE, V223, P140, DOI 10.1016/j.neuroscience.2012.07.063; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Ni Z, 2010, J NEUROPHYSIOL, V103, P65, DOI 10.1152/jn.00732.2009; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Paxinos G, 2001, MOUSE BRAIN STEREOTA, P21; Qi HX, 2000, J NEUROPHYSIOL, V84, P2133, DOI 10.1152/jn.2000.84.4.2133; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; SANES JN, 1990, EXP BRAIN RES, V79, P479; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Strong MK, 2009, EXP NEUROL, V217, P96, DOI 10.1016/j.expneurol.2009.01.020; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tan AM, 2012, EXP NEUROL, V235, P142, DOI 10.1016/j.expneurol.2011.08.026; Tan AM, 2011, EXP NEUROL, V232, P222, DOI 10.1016/j.expneurol.2011.08.028; Tan AM, 2008, J NEUROSCI, V28, P13173, DOI 10.1523/JNEUROSCI.3142-08.2008; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Weishaupt N, 2013, EXP NEUROL, V247, P241, DOI 10.1016/j.expneurol.2013.05.003; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Wyatt RM, 2012, NAT NEUROSCI, V15, P949, DOI 10.1038/nn.3134; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Yang G, 2012, DEV NEUROBIOL, V72, P1391, DOI 10.1002/dneu.20996; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	59	8	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132077	10.1371/journal.pone.0132077	http://dx.doi.org/10.1371/journal.pone.0132077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132157	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000154
J	Baskaran, P; Rodelsperger, C				Baskaran, Praveen; Roedelsperger, Christian			Microevolution of Duplications and Deletions and Their Impact on Gene Expression in the Nematode Pristionchus pacificus	PLOS ONE			English	Article							COPY-NUMBER VARIATION; CAENORHABDITIS-ELEGANS; DRAFT GENOME; EVOLUTION; MUTATIONS; DIVERSITY; DOSAGE; SEQ	The evolution of diversity across the animal kingdom has been accompanied by tremendous gene loss and gain. While comparative genomics has been fruitful to characterize differences in gene content across highly diverged species, little is known about the microevolution of structural variations that cause these differences in the first place. In order to investigate the genomic impact of structural variations, we made use of genomic and transcriptomic data from the nematode Pristionchus pacificus, which has been established as a satellite model to Caenorhabditis elegans for comparative biology. We exploit the fact that P. pacificus is a highly diverse species for which various genomic data including the draft genome of a sister species P. exspectatus is available. Based on resequencing coverage data for two natural isolates we identified large (> 2kb) deletions and duplications relative to the reference strain. By restriction to completely syntenic regions between P. pacificus and P. exspectatus, we were able to polarize the comparison and to assess the impact of structural variations on expression levels. We found that while loss of genes correlates with lack of expression, duplication of genes has virtually no effect on gene expression. Further investigating expression of individual copies at sites that segregate between the duplicates, we found in the majority of cases only one of the copies to be expressed. Nevertheless, we still find that certain gene classes are strongly depleted in deletions as well as duplications, suggesting evolutionary constraint acting on synteny. In summary, our results are consistent with a model, where most structural variations are either deleterious or neutral and provide first insights into the microevolution of structural variations in the P. pacificus genome.	[Baskaran, Praveen; Roedelsperger, Christian] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany	Max Planck Society	Rodelsperger, C (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany.	christian.roedelsperger@tuebingen.mpg.de	, roedelsberg/Q-3831-2019	, roedelsberg/0000-0002-7905-9675; Baskaran, Praveen/0000-0003-2275-3516	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society.	Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Bumbarger DJ, 2013, CELL, V152, P109, DOI 10.1016/j.cell.2012.12.013; Chain FJJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004830; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Katju V, 2003, GENETICS, V165, P1793; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Markov GV, 2015, J MOL EVOL, V80, P18, DOI 10.1007/s00239-014-9651-y; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Maydan JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-62; Mayer MG, PLOS GENETI IN PRESS; Mayer WE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-13; McGaughran A, 2013, ECOL EVOL, V3, P5209, DOI 10.1002/ece3.902; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Ohno S., 1970, P1; Ragsdale EJ, 2013, CELL, V155, P922, DOI 10.1016/j.cell.2013.09.054; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rodelsperger C, 2014, GENETICS, V196, P1153, DOI 10.1534/genetics.113.159855; Rodelsperger C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-239; Rodelsperger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008861; Rogozin IB, 2014, GENET RES INT, V2014, DOI 10.1155/2014/516508; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Schuster-Bockler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009474; Sinha A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-254; Srinivasan J, 2003, MOL GENET GENOMICS, V269, P715, DOI 10.1007/s00438-003-0881-8; Srinivasan J, 2013, GENETICS, V193, P1279, DOI 10.1534/genetics.112.148809; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vergara IA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-255; Weller AM, 2014, GENETICS, V196, P1145, DOI 10.1534/genetics.113.159863; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhou J, 2011, GENOME BIOL EVOL, V3, P1014, DOI 10.1093/gbe/evr023	42	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131136	10.1371/journal.pone.0131136	http://dx.doi.org/10.1371/journal.pone.0131136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125626	gold, Green Submitted, Green Published			2022-12-26	WOS:000358151300036
J	Wang, SJ; Lv, W; Song, WG				Wang, Shujie; Lv, Wei; Song, Weiguo			Behavior of Ants Escaping from a Single-Exit Room	PLOS ONE			English	Article							ANIMAL-WELFARE; ORGANIZATION; PEDESTRIANS; EVACUATION; FASTER	To study the rules of ant behavior and group-formation phenomena, we examined the behaviors of Camponotus japonicus, a species of large ant, in a range of situations. For these experiments, ants were placed inside a rectangular chamber with a single exit that also contained a filter paper soaked in citronella oil, a powerful repellent. The ants formed several groups as they moved toward the exit to escape. We measured the time intervals between individual escapes in six versions of the experiment, each containing an exit of a different width, to quantify the movement of the groups. As the ants exited the chamber, the time intervals between individual escapes changed and the frequency distribution of the time intervals exhibited exponential decay. We also investigated the relationship between the number of ants in a group and the group flow rate.	[Wang, Shujie; Song, Weiguo] Univ Sci & Technol China, State Key Lab Fire Sci, Hefei, Anhui, Peoples R China; [Lv, Wei] Wuhan Univ Technol, Ctr Crisis & Hazard Res, Wuhan, Hunan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wuhan University of Technology	Song, WG (corresponding author), Univ Sci & Technol China, State Key Lab Fire Sci, Hefei, Anhui, Peoples R China.	wgsong@ustc.edu.cn			National Natural Science Foundation of China [51178445, 51120165001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20133402110009]; National Basic Research Program of China [2012CB719705]; Key Technologies R&D Program of China during the 12th Five-year Plan Period [2012BAK13B01]; Fundamental Research Funds for the Central Universities [WK2320000014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Basic Research Program of China(National Basic Research Program of China); Key Technologies R&D Program of China during the 12th Five-year Plan Period; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Support was provided by the National Natural Science Foundation of China (No. 51178445 and 51120165001), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20133402110009), National Basic Research Program of China (No. 2012CB719705), Key Technologies R&D Program of China during the 12th Five-year Plan Period (2012BAK13B01) and the Fundamental Research Funds for the Central Universities (WK2320000014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler E, 2005, AM NAT, V166, P643, DOI 10.1086/498139; Boari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081082; Burd M, 2003, INSECT SOC, V50, P3, DOI 10.1007/s000400300001; BURR IW, 1974, APPL STAT METHODS; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Fraser D, 2009, APPL ANIM BEHAV SCI, V118, P108, DOI 10.1016/j.applanim.2009.02.020; Gago PA, 2013, TRAFFIC GRANULAR FLO, P317; Garcimartin A, 2014, TRANSP RES PROC, V2, P760, DOI 10.1016/j.trpro.2014.09.085; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; John A, 2004, J THEOR BIOL, V231, P279, DOI 10.1016/j.jtbi.2004.06.022; John A, 2007, PEDESTRIAN EVACUATIO, P465; John A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.108001; Kretz T, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10001; Lund V, 2006, APPL ANIM BEHAV SCI, V97, P37, DOI 10.1016/j.applanim.2005.11.017; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Oettler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059739; Parisi DR, 2007, PHYSICA A, V385, P343, DOI 10.1016/j.physa.2007.06.033; Parisi DR, 2015, SAFETY SCI, V72, P274, DOI 10.1016/j.ssci.2014.09.014; Perez GJ, 2002, PHYSICA A, V312, P609, DOI 10.1016/S0378-4371(02)00987-1; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Saloma C, 2003, P NATL ACAD SCI USA, V100, P11947, DOI 10.1073/pnas.2031912100; Saloma C., 2007, PEDESTRIAN EVACUATIO, V2005, P471; Shiwakoti N, 2009, TRANSPORT RES REC, P31, DOI 10.3141/2137-04; Soria SA, 2012, SAFETY SCI, V50, P1584, DOI 10.1016/j.ssci.2012.03.010	24	22	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131784	10.1371/journal.pone.0131784	http://dx.doi.org/10.1371/journal.pone.0131784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125191	gold, Green Submitted, Green Published			2022-12-26	WOS:000358151300054
J	Kim, N; Lee, JO; Lee, HJ; Kim, HI; Kim, JK; Lee, YW; Lee, SK; Kim, SJ; Park, SH; Kim, HS				Kim, Nami; Lee, Jung Ok; Lee, Hye Jeong; Kim, Hyung Ip; Kim, Joong Kwan; Lee, Yong Woo; Lee, Soo Kyung; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo			Endogenous Ligand for GPR120, Docosahexaenoic Acid, Exerts Benign Metabolic Effects on the Skeletal Muscles via AMP-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CHAIN FATTY-ACIDS; INSULIN-SECRETION; SIGNALING PATHWAYS; GLUCOSE-TRANSPORT; COUPLED RECEPTORS; UPSTREAM KINASE; CONTRACTION; GLUT4; MICE	Docosahexaenoic acid (DHA) is an endogenous ligand of G protein-coupled receptor 120 (GPR120). However, the mechanisms underlying DHA action are poorly understood. In this study, DHA stimulated glucose uptake in the skeletal muscles in an AMP-activated protein kinase (AMPK)-dependent manner. GPR120-mediated increase in intracellular Ca2+ was critical for DHA-mediated AMPK phosphorylation and glucose uptake. In addition, DHA stimulated GLUT4 translocation AMPK-dependently. Inhibition of AMPK and Ca2+/calmodulin-dependent protein kinase kinase blocked DHA-induced glucose uptake. DHA and GW9508, a GPR120 agonist, increased GPR120 expression. DHA-mediated glucose uptake was not observed in GPR120 knockdown conditions. DHA increased AMPK phosphorylation, glucose uptake, and intracellular Ca2+ concentration in primary cultured myoblasts. Taken together, these results indicated that the beneficial metabolic role of DHA was attributed to its ability to regulate glucose via the GPR120-mediated AMPK pathway in the skeletal muscles.	[Kim, Nami; Lee, Jung Ok; Lee, Hye Jeong; Kim, Hyung Ip; Kim, Joong Kwan; Lee, Yong Woo; Lee, Soo Kyung; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Dept Anat, Coll Med, Seoul 136701, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, HS (corresponding author), Korea Univ, Dept Anat, Coll Med, Seoul 136701, South Korea.	anatomykim@korea.ac.kr			National Research Foundation of Korea - Korean government [NRF-2013R1A2A2A05004796]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This study was supported by Grant NRF-2013R1A2A2A05004796 from the National Research Foundation of Korea, which is funded by the Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Attar-Bashi NM, 2007, PROSTAG LEUKOTR ESS, V76, P121, DOI 10.1016/j.plefa.2006.11.002; Cornall LM, 2011, CELL PHYSIOL BIOCHEM, V28, P949, DOI 10.1159/000335820; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Gutierrez-Martin Y, 2005, BBA-BIOMEMBRANES, V1711, P33, DOI 10.1016/j.bbamem.2005.02.017; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudson BD, 2014, J BIOL CHEM, V289, P20345, DOI 10.1074/jbc.M114.561449; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kato T, 2002, CANCER LETT, V187, P169, DOI 10.1016/S0304-3835(02)00432-9; Kelley DS, 2009, J NUTR, V139, P495, DOI 10.3945/jn.108.100354; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Ning Y, 2008, BRIT J PHARMACOL, V155, P1056, DOI 10.1038/bjp.2008.337; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P552, DOI 10.1358/dnp.2008.21.10.1314058; Pawlosky RJ, 2009, J LIPID RES, V50, P154, DOI 10.1194/jlr.M800322-JLR200; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; Rossetti L, 1997, J CLIN INVEST, V100, P1831, DOI 10.1172/JCI119711; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schonberg SA, 2006, FEBS J, V273, P2749, DOI 10.1111/j.1742-4658.2006.05292.x; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Tsao TS, 1996, DIABETES, V45, P28, DOI 10.2337/diabetes.45.1.28; Tsao TS, 2001, FASEB J, V15, P958, DOI 10.1096/fj.00-0381; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	43	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20438	20447		10.1074/jbc.M115.657379	http://dx.doi.org/10.1074/jbc.M115.657379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134561	hybrid, Green Published			2022-12-26	WOS:000359608900041
J	Gossmann, R; Langer, K; Mulac, D				Gossmann, Rebecca; Langer, Klaus; Mulac, Dennis			New Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) Nanoparticles	PLOS ONE			English	Article							DRUG-DELIVERY; ORAL DELIVERY; MODEL; SURFACTANTS; ESTRADIOL; CELLS	Over the last few decades the establishment of nanoparticles as suitable drug carriers with the transport of drugs across biological barriers such as the gastrointestinal barrier moved into the focus of many research groups. Besides drug transport such carrier systems are well suited for the protection of drugs against enzymatic and chemical degradation. The preparation of biocompatible and biodegradable nanoparticles based on poly(lactic-co-glycolic acid) (PLGA) is intensively described in literature, while especially nanoparticles with cationic properties show a promising increased cellular uptake. This is due to the electrostatic interaction between the cationic surface and the negatively charged lipid membrane of the cells. Even though several studies achieved the successful preparation of nanoparticles stabilized with the cationic surfactants such as didodecyldimethylammonium bromide (DMAB), in most cases insufficient attention was paid to a precise analytical characterization of the nanoparticle system. The aim of the present work was to overcome this deficit by presenting a new perspective in the formulation and characterization of DMAB-stabilized PLGA nanoparticles. Therefore these nanoparticles were carefully examined with regard to particle diameter, zeta potential, the effect of variation in stabilizer concentration, residual DMAB content, and electrolyte stability. Without any steric stabilization, the DMAB-modified nanoparticles were sensitive to typical electrolyte concentrations of biological environments due to compression of the electrical double layer in conjunction with a decrease in zeta potential. To handle this problem, the present study proposed two modifications to enable electrolyte stability. Both polyvinyl alcohol (PVA) and polyethylene glycol (PEG) modified DMAB-PLGA-nanoparticles were stable during electrolyte addition. Furthermore, in contrast to unmodified DMAB-PLGA-nanoparticles and free DMAB, such modifications led to a lower cytotoxic activity against Caco-2 cells. In conclusion this study offers a closer and critical point of view on preparation, in vitro and analytical evaluation of DMAB-stabilized PLGA nanoparticles for the physiological use.	[Gossmann, Rebecca; Langer, Klaus; Mulac, Dennis] Univ Munster, Inst Pharmaceut Technol & Biopharm, D-48149 Munster, Germany	University of Munster	Gossmann, R (corresponding author), Univ Munster, Inst Pharmaceut Technol & Biopharm, Corrensstr 48, D-48149 Munster, Germany.	mulac.dennis@wwu.de		Langer, Klaus/0000-0002-0203-7478				ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578; Amidi M, 2006, J CONTROL RELEASE, V111, P107, DOI 10.1016/j.jconrel.2005.11.014; [Anonymous], 2004, REV ONCOL; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322; Bhardwaj V, 2009, PHARM RES-DORDR, V26, P2495, DOI 10.1007/s11095-009-9965-4; Borrego E, 1999, INT J ENVIRON AN CH, V75, P181, DOI 10.1080/03067319908047310; Chen HB, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9741-8; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L; Fagerholm U, 2007, J PHARM PHARMACOL, V59, P905, DOI 10.1211/jpp.59.7.0001; Fay F, 2010, BIOMATERIALS, V31, P4214, DOI 10.1016/j.biomaterials.2010.01.143; Florence A. T., 2006, PHYSICOCHEMICAL PRIN; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Kagan L, 2008, EXPERT OPIN DRUG DEL, V5, P681, DOI [10.1517/17425247.5.6.681, 10.1517/17425247.5.6.681 ]; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Kusumoto K, 2010, J CONTROL RELEASE, V147, P246, DOI 10.1016/j.jconrel.2010.07.114; LOWRY JB, 1979, J PHARM SCI, V68, P110, DOI 10.1002/jps.2600680138; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Muta H, 2001, POLYMER, V42, P6313, DOI 10.1016/S0032-3861(01)00098-2; Panyam J, 2012, ADV DRUG DELIVER REV, V64, P61, DOI 10.1016/j.addr.2012.09.023; PARRIS N, 1980, J LIQ CHROMATOGR, V3, P1743, DOI 10.1080/01483918008064765; Peetla C, 2009, LANGMUIR, V25, P2369, DOI 10.1021/la803361y; Ruddy K, 2009, CA-CANCER J CLIN, V59, P56, DOI 10.3322/caac.20004; Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158; Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X; Shibukawa M, 1999, J CHROMATOGR A, V830, P321, DOI 10.1016/S0021-9673(98)00939-X; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096; Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c; Xu AR, 2012, INT J NANOMED, V7, P3547, DOI 10.2147/IJN.S32188	32	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0127532	10.1371/journal.pone.0127532	http://dx.doi.org/10.1371/journal.pone.0127532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147338	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600010
J	Kohlscheen, S; Wintterle, S; Schwarzer, A; Kamp, C; Brugman, MH; Breuer, DC; Busche, G; Baum, C; Modlich, U				Kohlscheen, Saskia; Wintterle, Sabine; Schwarzer, Adrian; Kamp, Christel; Brugman, Martijn H.; Breuer, Daniel C.; Buesche, Guntram; Baum, Christopher; Modlich, Ute			Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance	PLOS ONE			English	Article							SEVERE APLASTIC-ANEMIA; C-MPL; GENE-EXPRESSION; SELF-RENEWAL; MICE LACKING; BONE-MARROW; RECEPTOR; THROMBOCYTOPENIA; MUTATIONS; MEGAKARYOCYTOPOIESIS	Thrombopoietin (Thpo) signals via its receptor Mpl and regulates megakaryopoiesis, hematopoietic stem cell (HSC) maintenance and post-transplant expansion. Mpl expression is tightly controlled and deregulation of Thpo/Mpl-signaling is linked to hematological disorders. Here, we constructed an intracellular-truncated, signaling-deficient Mpl protein which is presented on the cell surface (dnMpl). The transplantation of bone marrow cells retrovirally transduced to express dnMpl into wildtype mice induced thrombocytopenia, and a progressive loss of HSC. The aplastic BM allowed the engraftment of a second BM transplant without further conditioning. Functional analysis of the truncated Mpl in vitro and in vivo demonstrated no internalization after Thpo binding and the inhibition of Thpo/Mpl-signaling in wildtype cells due to dominant-negative (dn) effects by receptor competition with wildtype Mpl for Thpo binding. Intracellular inhibition of Mpl could be excluded as the major mechanism by the use of a constitutive-dimerized dnMpl. To further elucidate the molecular changes induced by Thpo/Mpl-inhibition on the HSC-enriched cell population in the BM, we performed gene expression analysis of Lin-Sca1+cKit+ (LSK) cells isolated from mice transplanted with dnMpl transduced BM cells. The gene expression profile supported the exhaustion of HSC due to increased cell cycle progression and identified new and known downstream effectors of Thpo/Mpl-signaling in HSC (namely TIE2, ESAM1 and EPCR detected on the HSC-enriched LSK cell population). We further compared gene expression profiles in LSK cells of dnMpl mice with human CD34+ cells of aplastic anemia patients and identified similar deregulations of important stemness genes in both cell populations. In summary, we established a novel way of Thpo/Mpl inhibition in the adult mouse and performed in depth analysis of the phenotype including gene expression profiling.	[Kohlscheen, Saskia; Modlich, Ute] LOEWE Ctr Cell & Gene Therapy Frankfurt Main, Res Grp Gene Modificat Stem Cells, Langen, Germany; [Kohlscheen, Saskia; Modlich, Ute] Paul Ehrlich Inst, Langen, Germany; [Kohlscheen, Saskia; Wintterle, Sabine; Schwarzer, Adrian; Breuer, Daniel C.; Baum, Christopher; Modlich, Ute] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Kamp, Christel] Paul Ehrlich Inst, Dept Biostat, Langen, Germany; [Brugman, Martijn H.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Buesche, Guntram] Hannover Med Sch, Inst Pathol, Hannover, Germany	Paul Ehrlich Institute; Hannover Medical School; Paul Ehrlich Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School	Modlich, U (corresponding author), LOEWE Ctr Cell & Gene Therapy Frankfurt Main, Res Grp Gene Modificat Stem Cells, Langen, Germany.	Ute.modlich@pei.de	Brugman, Martijn/F-3389-2011; Schwarzer, Adrian/AAA-2571-2022	Brugman, Martijn/0000-0003-2675-2705; Modlich, Ute/0000-0001-8018-4118; Kamp, Christel/0000-0001-9997-6772; Schwarzer, Adrian/0000-0001-5684-2280	Deutsche Forschungsgemeinschaft (Excellence Cluster REBIRTH) [MO860]; LOEWE Center for Cell and Gene Therapy, Frankfurt; Hannover Biomedical Research School stipend	Deutsche Forschungsgemeinschaft (Excellence Cluster REBIRTH)(German Research Foundation (DFG)); LOEWE Center for Cell and Gene Therapy, Frankfurt; Hannover Biomedical Research School stipend	This work was supported by Deutsche Forschungsgemeinschaft (MO860 and Excellence Cluster REBIRTH) and LOEWE Center for Cell and Gene Therapy, Frankfurt. S.K. was supported by a Hannover Biomedical Research School stipend.	Alexander W S, 1996, Stem Cells, V14 Suppl 1, P124; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Arai F, 2009, ANN NY ACAD SCI, V1176, P36, DOI 10.1111/j.1749-6632.2009.04561.x; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139; Bradley HL, 2004, BLOOD, V103, P2965, DOI 10.1182/blood-2003-08-2963; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheung AMS, 2013, BLOOD, V122, P3129, DOI 10.1182/blood-2013-06-508432; Coers J, 2004, J BIOL CHEM, V279, P36397, DOI 10.1074/jbc.M401386200; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; de Graaf CA, 2011, CELL CYCLE, V10, P1582, DOI 10.4161/cc.10.10.15619; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Desmond R, 2014, BLOOD, V123, P1818, DOI 10.1182/blood-2013-10-534743; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fehse B, 2000, MOL THER, V1, P448, DOI 10.1006/mthe.2000.0068; Fischer U, 2012, HAEMATOL-HEMATOL J, V97, P1304, DOI 10.3324/haematol.2011.056705; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heckl D, 2011, BLOOD, V117, P3737, DOI 10.1182/blood-2010-09-308262; Ihara K, 1999, P NATL ACAD SCI USA, V96, P3132, DOI 10.1073/pnas.96.6.3132; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; King S, 2005, BRIT J HAEMATOL, V131, P636, DOI 10.1111/j.1365-2141.2005.05819.x; KUTER DJ, 1995, BLOOD, V85, P2720, DOI 10.1182/blood.V85.10.2720.bloodjournal85102720; Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Meyer J, 1998, BLOOD, V91, P1901, DOI 10.1182/blood.V91.6.1901.1901_1901_1908; Meyer J, 2002, GROWTH FACTORS, V20, P131, DOI 10.1080/0897719021000058139; Olnes MJ, 2012, NEW ENGL J MED, V367, P11, DOI 10.1056/NEJMoa1200931; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Qian SG, 1998, BLOOD, V92, P2189, DOI 10.1182/blood.V92.6.2189; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudo T, 2012, J IMMUNOL, V189, P200, DOI 10.4049/jimmunol.1200056; Townsley DM, 2013, INT J HEMATOL, V98, P48, DOI 10.1007/s12185-013-1352-6; Vainchenker W, 2011, NEW MUTATIONS AND PA; Walne AJ, 2012, HAEMATOL-HEMATOL J, V97, P524, DOI 10.3324/haematol.2011.052787; Wicke DC, 2010, MOL THER, V18, P343, DOI 10.1038/mt.2009.233; Yan XQ, 1999, EXP HEMATOL, V27, P1409, DOI 10.1016/S0301-472X(99)00069-7; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126	54	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131866	10.1371/journal.pone.0131866	http://dx.doi.org/10.1371/journal.pone.0131866			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147434	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600155
J	Peron, M; Lovisa, F; Poli, E; Basso, G; Bonvini, P				Peron, Marica; Lovisa, Federica; Poli, Elena; Basso, Giuseppe; Bonvini, Paolo			Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; INFLAMMATORY MYOFIBROBLASTIC TUMOR; HEPATOCYTE GROWTH-FACTOR; FACTOR-I RECEPTOR; TYROSINE KINASE; LUNG-CANCER; C-MET; MONOCLONAL-ANTIBODIES; ACTIVATING MUTATIONS; ACQUIRED-RESISTANCE	Background Receptor tyrosine kinases (RTKs) have a central role in cancer initiation and progression, since changes in their expression and activity potentially results in cell transformation. This concept is essential from a therapeutic standpoint, as clinical evidence indicates that tumours carrying deregulated RTKs are particularly susceptible to their activity but also to their inhibition. Rhabdomyosarcoma (RMS) is an aggressive childhood cancer where emerging therapies rely on the use kinase inhibitors, and among druggable kinases ALK represents a potential therapeutic target to commit efforts against. However, the functional relevance of ALK in RMS is not known, likewise the multi-component deregulated RTK profile to which ALK belongs. Methods In this study we used RMS cell lines representative of the alveolar and embrional histotype and looked at ALK intracellular localization, activity and cell signalling. Results We found that ALK was properly located at the plasma membrane of RMS cells, though in an unphosphorylated and inactive state due to intracellular tyrosine phosphatases (PTPases) activity. Indeed, increase of ALK phosphorylation was observed upon PTPase inhibition, as well as after ligand binding or protein overexpression. In these conditions, ALK signalling proceeded through the MAPK/ERK and PI3K/AKT pathways, and it was susceptible to ATP-competitive inhibitors exposure. However, drug-induced growth inhibition, cell cycle arrest and apoptosis did not correlate with ALK expression only, but relied also on the expression of other RTKs with akin drug binding affinity. Indeed, analysis of baseline and inducible RTK phosphorylation confirmed that RMS cells were susceptible to ALK kinase inhibitors even in the absence of the primary intended target, due to the presence of compensatory RTKs signalling pathways. Conclusions These data, hence, provided evidences of a potentially active role of ALK in RMS cells, but also suggest caution in considering ALK a major therapeutic target in this malignancy, particularly if expression and activity cannot be accurately determined.	[Peron, Marica; Lovisa, Federica; Poli, Elena; Basso, Giuseppe; Bonvini, Paolo] Azienda Osped Univ Padova, Clin Oncoematol Pediat Padova, Padua, Italy; [Bonvini, Paolo] Ist Ric Pediat Citta Speranza, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; Fondazione Citta della Speranza	Bonvini, P (corresponding author), Azienda Osped Univ Padova, Clin Oncoematol Pediat Padova, Padua, Italy.	paolo.bonvini@unipd.it	Bonvini, Paolo/J-9877-2018	Bonvini, Paolo/0000-0003-2889-108X; BASSO, GIUSEPPE/0000-0002-2634-9302; LOVISA, FEDERICA/0000-0001-9570-6150	Fondazione Citta della Speranza; MIUR (Ministero Istruzione Universita e Ricerca); AIRC (Associazione Italiana per la Ricerca sul Cancro)	Fondazione Citta della Speranza; MIUR (Ministero Istruzione Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR)); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Fondazione Citta della Speranza (PB and FL), MIUR (Ministero Istruzione Universita e Ricerca), and by AIRC (Associazione Italiana per la Ricerca sul Cancro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Armistead PM, 2007, CANCER, V110, P2293, DOI 10.1002/cncr.23038; Bonvini P, 2002, CANCER RES, V62, P1559; Bonvini P, 2013, BRIT J CANCER, V109, P3084, DOI 10.1038/bjc.2013.653; Boutterin MC, 2013, CELL SIGNAL, V25, P1505, DOI 10.1016/j.cellsig.2013.02.020; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Cessna MH, 2002, MODERN PATHOL, V15, P931, DOI 10.1097/01.MP.0000026615.04130.1F; Chen JY, 2013, J MED CHEM, V56, P5673, DOI 10.1021/jm401005u; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; Crose Lisa E. S., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/756982; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Diomedi-Camassei F, 2008, CLIN CANCER RES, V14, P4119, DOI 10.1158/1078-0432.CCR-07-4446; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ehnman M, 2013, CANCER RES, V73, P2139, DOI 10.1158/0008-5472.CAN-12-1646; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Ganti R, 2006, MODERN PATHOL, V19, P1213, DOI 10.1038/modpathol.3800636; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Huang F, 2010, CANCER RES, V70, P7221, DOI 10.1158/0008-5472.CAN-10-0391; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Iwama E, 2014, ONCOTARGETS THER, V7, P375, DOI 10.2147/OTT.S38868; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Knight JDR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000982; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072220; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Lovly CM, 2011, CANCER RES, V71, P4920, DOI 10.1158/0008-5472.CAN-10-3879; Lukasiewicz E, 2009, FOLIA HISTOCHEM CYTO, V47, P485, DOI 10.2478/v10042-009-0108-x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; Mazot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033581; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Nishimura R, 2013, CANCER SCI, V104, P856, DOI 10.1111/cas.12173; Okamoto W, 2012, MOL CANCER THER, V11, P1557, DOI 10.1158/1535-7163.MCT-11-0934; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Rees H, 2006, GROWTH FACTORS, V24, P197, DOI 10.1080/08977190600759923; Rodig SJ, 2010, CURR OPIN INVEST DR, V11, P1477; Sabbatini P, 2009, MOL CANCER THER, V8, P2811, DOI 10.1158/1535-7163.MCT-09-0423; Schlessinger J, 2014, COLD SPRING HARB PER, P6; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun Ke, 2007, Chinese Journal of Pathology, V36, P605; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; van Gaal JC, 2012, J CLIN ONCOL, V30, P308, DOI 10.1200/JCO.2011.37.8588; Volinsky N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009043; Wagner JP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003994; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Yano S, 2012, CANCER SCI, V103, P1189, DOI 10.1111/j.1349-7006.2012.02279.x; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590; Yoshida A, 2013, MOD PATHOL; Zou HY, 2012, MOL CANCER THER, V11, P1036, DOI 10.1158/1535-7163.MCT-11-0839	84	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132330	10.1371/journal.pone.0132330	http://dx.doi.org/10.1371/journal.pone.0132330			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147305	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600243
J	Ferdous, SM; Rahman, MS				Ferdous, S. M.; Rahman, M. Sohel			An Integer Programming Formulation of the Minimum Common String Partition Problem	PLOS ONE			English	Article								We consider the problem of finding a minimum common string partition (MCSP) of two strings, which is an NP-hard problem. The MCSP problem is closely related to genome comparison and rearrangement, an important field in Computational Biology. In this paper, we map the MCSP problem into a graph applying a prior technique and using this graph, we develop an Integer Linear Programming (ILP) formulation for the problem. We implement the ILP formulation and compare the results with the state-of-the-art algorithms from the literature. The experimental results are found to be promising.	[Ferdous, S. M.] AUST, Dept Comp Sci & Engn, Dhaka, Bangladesh; [Ferdous, S. M.; Rahman, M. Sohel] Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, AlEDA Grp, Dhaka, Bangladesh	Ahsanullah University of Science & Technology (AUST); Bangladesh University of Engineering & Technology (BUET)	Ferdous, SM (corresponding author), AUST, Dept Comp Sci & Engn, Dhaka, Bangladesh.	smferdous.cse@aust.edu	Rahman, Mohammad Saifur/GZM-5483-2022; Ferdous, S M/AAB-2247-2021; Ferdous, S M/E-4508-2016; Rahman, Mohammad Sohelur/AAJ-7376-2020	Rahman, Mohammad Saifur/0000-0002-9887-4456; Ferdous, S M/0000-0001-5078-0031; Rahman, Mohammad Sohelur/0000-0002-4489-2202; Rahman, M. Sohel/0000-0001-9419-6478				Achterberg T, 2009, MATH PROGRAM COMPUT, V1, P1, DOI 10.1007/s12532-008-0001-1; Blum C, 2015, EUR J OPER RES, V242, P769, DOI 10.1016/j.ejor.2014.10.049; Blum C, 2014, LECT NOTES COMPUT SC, V8457, P145, DOI 10.1007/978-3-319-07644-7_11; Bulteau Laurent, 2013, Algorithms in Bioinformatics. 13th International Workshop, WABI 2013. Proceedings: LNCS 8126, P244, DOI 10.1007/978-3-642-40453-5_19; Bulteau L, MINIMUM COMMON STRIN, P102; Chen X, 2005, IEEE ACM T COMPUT BI, V2, P302, DOI 10.1109/TCBB.2005.48; Chrobak M, 2005, ACM T ALGORITHMS, V1, P350, DOI 10.1145/1103963.1103971; Damaschke P, 2008, LECT N BIOINFORMAT, V5251, P87, DOI 10.1007/978-3-540-87361-7_8; Dorigo M, 1999, ARTIF LIFE, V5, P137, DOI 10.1162/106454699568728; Ferdous S. M., 2013, Advances in Swarm Intelligence. 4th International Conference, ICSI 2013. Proceedings, P306, DOI 10.1007/978-3-642-38703-6_36; Ferdous S.M., 2014, CORR; Ferdous SM, 2014, MAX MIN ANT CO UNPUB; Goldstein A, 2005, ELECTRON J COMB, V12; He D, 2007, LECT N BIOINFORMAT, V4463, P441; Jiang HT, 2010, LECT NOTES COMPUT SC, V6213, P45, DOI 10.1007/978-3-642-14553-7_7; Miltenberger M, COMMUNICATION; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Swenson K. M., 2008, ACM J EXPT ALGORITHM, V12, P3, DOI [DOI 10.1145/1227161.1402297, 10.1145/1227161.1402297]; Villesen P., 2007, FABOX ONLINE FASTA S; WATTERSON GA, 1982, J THEOR BIOL, V99, P1, DOI 10.1016/0022-5193(82)90384-8	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130266	10.1371/journal.pone.0130266	http://dx.doi.org/10.1371/journal.pone.0130266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134848	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400014
J	Lee, HO; Mustafa, A; Hudes, GR; Kruger, WD				Lee, Hyung-Ok; Mustafa, Aladdin; Hudes, Gary R.; Kruger, Warren D.			Hydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN; INDUCED APOPTOSIS; CANCER-CELLS; IN-VITRO; AUTOPHAGY; MTOR; INHIBITION; PHOSPHORYLATION; ACTIVATION; THERAPY	mTOR inhibitors are used to treat metastatic renal cell cancer (RCC), but most patients eventually become resistant. One possible mechanism for resistance is upregulation of autophagy, a pathway that helps recycle intracellular proteins and promotes cell survival. Hydroxychloroquine (HCQ), a potent autophagy inhibitor used to treat malaria and autoimmune disorders, is currently being studied in the context of cancer treatment. Here, we have investigated the effects of HCQ on three different renal carcinoma derived cell lines. We found that HCQ treatment inhibits RCC cell growth, promotes apoptosis, inhibits mitochondrial oxygen consumption, and increases rates of glycolysis. To understand the molecular mechanism behind these effects, we examined various nodes in the mTOR pathway and compared the effects of HCQ with the effects of the mTOR inhibitor RAD001. A key downstream readout of the pathway, phospho-S6 protein, was inhibited by both HCQ and RAD001. However, the upstream kinase, P70S6K was only inhibited by RAD001 and not HCQ, suggesting that the block by HCQ was downstream of P70S6K. Treatment with the proteasome inhibitor bortezomib restored phospho-S6 levels, suggesting that the reduction of phospho-S6 is caused by increased degradation of phospho-S6, but not total S6. Surprisingly, treatment with other autophagy inhibitors did not exhibit the same effects. Our findings suggest that HCQ causes the down-regulation of phospho-S6 in RCC cell lines via a novel mechanism that is not shared with other autophagy inhibitors.	[Lee, Hyung-Ok; Mustafa, Aladdin; Hudes, Gary R.; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	Kruger, Warren/Y-2541-2018	kruger, warren/0000-0002-4990-3695	NIH [CA06927]; Robert Kruger Fund at Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Kruger Fund at Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by NIH core grant CA06927 and money provided by the Robert Kruger Fund at Fox Chase Cancer Center. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x; BORDEN EC, 1982, CANCER RES, V42, P4948; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Bray K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041831; Cai YC, 2013, INT J MOL MED, V31, P904, DOI 10.3892/ijmm.2013.1282; Calabretta B, 2011, LEUKEMIA LYMPHOMA, V52, P54, DOI 10.3109/10428194.2010.546913; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; Fogh J, 1978, Natl Cancer Inst Monogr, P5; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Ito H, 2005, INT J ONCOL, V26, P1401; Iwenofu OH, 2008, MODERN PATHOL, V21, P231, DOI 10.1038/modpathol.3800995; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Jemal A, 2009, CANC STAT; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kurmasheva RT, 2006, BRIT J CANCER, V95, P955, DOI 10.1038/sj.bjc.6603353; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Robb VA, 2007, J UROLOGY, V177, P346, DOI 10.1016/j.juro.2006.08.076; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Swampillai AL, 2012, CLIN ONCOL-UK, V24, P387, DOI 10.1016/j.clon.2011.09.010; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; WILLIAMS RD, 1978, IN VITRO CELL DEV B, V14, P779, DOI 10.1007/BF02617972; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047	36	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131464	10.1371/journal.pone.0131464	http://dx.doi.org/10.1371/journal.pone.0131464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134285	Green Submitted, gold, Green Published			2022-12-26	WOS:000358154400050
J	Subbian, S; Tsenova, L; Kim, MJ; Wainwright, HC; Visser, A; Bandyopadhyay, N; Bader, JS; Karakousis, PC; Murrmann, GB; Bekker, LG; Russell, DG; Kaplan, G				Subbian, Selvakumar; Tsenova, Liana; Kim, Mi-Jeong; Wainwright, Helen C.; Visser, Annalie; Bandyopadhyay, Nirmalya; Bader, Joel S.; Karakousis, Petros C.; Murrmann, Gabriele B.; Bekker, Linda-Gail; Russell, David G.; Kaplan, Gilla			Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; TISSUE INHIBITORS; MATRIX METALLOPROTEINASES; EXPRESSION; INFECTION; OSTEOPONTIN; DISEASE; BIOMARKERS; RESISTANCE	The formation and maintenance of granulomas is central to the host response to Mycobacterium tuberculosis (Mtb) infection. It is widely accepted that the lungs of patients with tuberculosis (TB) usually contain multiple infection foci, and that the granulomas evolve and differentiate independently, resulting in considerable heterogeneity. Although gene expression profiles of human blood cells have been proposed as biomarkers of Mtb infection and/or active disease, the immune profiles of discrete lesion types has not been studied extensively. Using histology, immunopathology and genome-wide transcriptome analysis, we explored the immunological profile of human lung TB granulomas. We show that although the different granulomas share core similarities in their immunological/inflammatory characteristics, they also exhibit significant divergence. Despite similar numbers of CD68(+) macrophages in the different lesions, the extent of immune reactivity, as determined by the density of CD3(+) T cells in the macrophage rich areas, and the extent of fibrosis, shows considerable variation. Both quantitative and qualitative differences among significantly differentially expressed genes (SDEG) were noted in each of the lesion types studied. Further, network/pathway analysis of SDEG revealed differential regulation of inflammatory response, immune cell trafficking, and cell mediated immune response in the different lesions. Our data highlight the formidable challenges facing ongoing efforts to identify peripheral blood biomarkers due to the diversity of lesion types and complexity of local immune responses in the lung.	[Subbian, Selvakumar; Tsenova, Liana] Rutgers State Univ, Rutgers Biomed & Hlth Sci, PHRI, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07102 USA; [Tsenova, Liana] NYC Coll Technol, Dept Biol Sci, Brooklyn, NY USA; [Kim, Mi-Jeong] Harvard Univ, Sch Med, Joslin Diabet Ctr, Dept Immunobiol, Boston, MA 02115 USA; [Wainwright, Helen C.; Visser, Annalie] Univ Cape Town, Fac Hlth Sci, Div Anat Pathol, ZA-7925 Cape Town, South Africa; [Bandyopadhyay, Nirmalya; Bader, Joel S.] Johns Hopkins Univ, High Throughput Biol Ctr, Dept Biomed Engn, Baltimore, MD USA; [Bandyopadhyay, Nirmalya; Bader, Joel S.] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Ctr TB Res, Baltimore, MD 21205 USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Murrmann, Gabriele B.] Med Ctr Leeuwarden, Dept Gen & Thorac Surg, Leeuwarden, Netherlands; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Bekker, Linda-Gail] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Kaplan, Gilla] Bill & Melinda Gates Fdn, Seattle, WA USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Cape Town; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical Center Leeuwarden; University of Cape Town; University of Cape Town; Cornell University; Bill & Melinda Gates Foundation	Subbian, S (corresponding author), Rutgers State Univ, Rutgers Biomed & Hlth Sci, PHRI, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07102 USA.	subbiase@njms.rutgers.edu	Russell, David G/D-4533-2009; Karakousis, Petros Constantine/AAR-7899-2020; Bekker, Linda-Gail/AAZ-8929-2020; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; Subbian, Selvakumar/0000-0003-2021-8632; BEKKER, LINDA-GAIL/0000-0002-0755-4386	National Institute of Health [AI067027, HL055936, AI054338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054338, R01AI067027] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Health to DGR (AI067027 and HL055936) and GK (AI054338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9; Almeida CD, 2009, MEM I OSWALDO CRUZ, V104, P1039, DOI 10.1590/S0074-02762009000700018; Andersson J, 2007, INFECT IMMUN, V75, P5210, DOI 10.1128/IAI.00624-07; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blum KS, 2007, IMMUNOL LETT, V108, P45, DOI 10.1016/j.imlet.2006.10.009; Brighenti S, 2012, J INFECT DIS, V205, pS316, DOI 10.1093/infdis/jis043; Cardona PJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868246; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Danaviah S, 2013, TUBERCULOSIS, V93, P432, DOI 10.1016/j.tube.2013.02.009; Dannenberg AM, 2006, PATHOGENESIS OF HUMAN PULMONARY TUBERCULOSIS: INSIGHTS FROM THE RABBIT MODEL, P1; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Dhanasekaran S, 2013, GENES IMMUN, V14, P356, DOI 10.1038/gene.2013.26; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Flynn J. L., 2010, PULMONARY TUBERCULOS; Flynn JL, 2008, EXPT ANIMAL MODELS T; Fukusumi Munehisa, 2013, BMC Res Notes, V6, P320, DOI 10.1186/1756-0500-6-320; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Grassi M, 2006, CLIN IMMUNOL, V121, P100, DOI 10.1016/j.clim.2006.06.008; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guglielmetti L, 2013, INT J TUBERC LUNG D, V17, P825, DOI 10.5588/ijtld.12.0361; Hashemian SM, 2014, J INFLAMM, P11; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Iglesias D, 2005, EUR RESPIR J, V25, P104, DOI 10.1183/09031936.04.00010504; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Juffermans NP, 2001, CLIN INFECT DIS, V32, P650, DOI 10.1086/318701; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kaplan G., 2010, COLOR ATLAS COMP PAT, P107; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Khajoee V, 2006, CLIN EXP IMMUNOL, V143, P260, DOI 10.1111/j.1365-2249.2005.02985.x; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Koopman G, 1997, AIDS RES HUM RETROV, V13, P227, DOI 10.1089/aid.1997.13.227; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Kubler A, 2014, J PATHOL; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu S, 2015, INFLAMM BOWEL DIS, V21, P154, DOI 10.1097/MIB.0000000000000217; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Miranda MS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139127; Modlin RL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007402; Nahid P, 2011, AM J RESP CRIT CARE, V184, P972, DOI 10.1164/rccm.201105-0827WS; Nau GJ, 2000, AM J PATHOL, V157, P37, DOI 10.1016/S0002-9440(10)64514-2; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; Nikitina IY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043733; O'Regan AW, 2001, AM J RESP CRIT CARE, V164, P2243, DOI 10.1164/ajrccm.164.12.2104139; Ong CWM, 2014, AM J RESP CRIT CARE, V190, P9, DOI 10.1164/rccm.201311-2106PP; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Price NM, 2003, J IMMUNOL, V171, P5579, DOI 10.4049/jimmunol.171.10.5579; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reece ST, 2012, CURR OPIN MICROBIOL, V15, P63, DOI 10.1016/j.mib.2011.10.006; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2013, CURR OPIN MICROBIOL, V16, P78, DOI 10.1016/j.mib.2012.11.007; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Siawaya JFD, 2009, CYTOKINE, V47, P132, DOI 10.1016/j.cyto.2009.05.016; Siddiqui MR, 2002, J INFECT DIS, V186, P260, DOI 10.1086/341204; Subbian S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-60; Subbian S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-16; Subbian S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110016; Sundararajan S, 2012, HUM IMMUNOL, V73, P985, DOI 10.1016/j.humimm.2012.07.042; Tkach KE, 2014, ELIFE, V3, DOI 10.7554/eLife.01944; Ugarte-Gil CA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061333, 10.1371/journal.pone.0069514]; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Welsh KJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/307631; Zhang Y, 2015, INT IMMUNOL	73	51	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132249	10.1371/journal.pone.0132249	http://dx.doi.org/10.1371/journal.pone.0132249			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133981	gold, Green Published			2022-12-26	WOS:000358154400108
J	Moreira, ALDM; de Oliveira, CJB; de Oliveira, HB; Campos, DB; Guerra, RR; Costa, FGP; Givisiez, PEN				de Barros Moreira Filho, Alexandre Lemos; Bruno de Oliveira, Celso Jose; de Oliveira, Heraldo Bezerra; Campos, Danila Barreiro; Guerra, Ricardo Romao; Perazzo Costa, Fernando Guilherme; Naves Givisiez, Patricia Emilia			High Incubation Temperature and Threonine Dietary Level Improve Ileum Response Against Post-Hatch Salmonella Enteritidis Inoculation in Broiler Chicks	PLOS ONE			English	Article							MATERNAL ANTIBODY TRANSFER; THERMAL MANIPULATIONS; LATE EMBRYOGENESIS; FEED RESTRICTION; GENE-EXPRESSION; MUCIN SYNTHESIS; SMALL-INTESTINE; GOBLET CELLS; HEAT-STRESS; LAYING HENS	This study assessed the effect of both embryonic thermal manipulation and dietary threonine level on the response of broilers inoculated with Salmonella Enteritidis, considering bacterial counts in the cecal contents, intestinal morphology, mucin and heat shock protein 70 gene expression, body weight and weight gain. Thermal manipulation was used from 11 days of incubation until hatch, defining three treatments: standard (37.7 degrees C), continuous high temperature (38.7 degrees C) and continuous low temperature (36.7 degrees C). After hatch, chicks were distributed according to a 3x2+1 factorial arrangement (three temperatures and two threonine levels and one sham-inoculated control). At two days of age, all chicks were inoculated with Salmonella Enteritidis, except for the sham-inoculated control group. There was no interaction between the factors on any analyses. High temperature during incubation was able to reduce colonization by Salmonella Enteritidis in the first days, reducing both Salmonella counts and the number of positive birds. It also increased mucin expression and decreased Hsp70 expression compared with other inoculated groups. High temperature during incubation and high threonine level act independently to reduce the negative effects associated to Salmonella Enteritidis infection on intestinal morphology and performance, with results similar to sham-inoculated birds. The findings open new perspectives for practical strategies towards the pre-harvest Salmonella control in the poultry industry.	[de Barros Moreira Filho, Alexandre Lemos; Bruno de Oliveira, Celso Jose; de Oliveira, Heraldo Bezerra; Perazzo Costa, Fernando Guilherme; Naves Givisiez, Patricia Emilia] Fed Univ Paraiba UFPB, Ctr Agrarian Sci, Dept Anim Sci, Areia, PB, Brazil; [Campos, Danila Barreiro; Guerra, Ricardo Romao] Fed Univ Paraiba UFPB, Ctr Agrarian Sci, Dept Vet Sci, Areia, PB, Brazil		Givisiez, PEN (corresponding author), Fed Univ Paraiba UFPB, Ctr Agrarian Sci, Dept Anim Sci, Areia, PB, Brazil.	patriciagivisiez@gmail.com	de Oliveira, Celso José Bruno/V-2167-2019; GIVISIEZ, PATRICIA/V-2140-2019; Campos, Danila B/F-6602-2014; Barreiro Campos, Danila/V-4179-2017	de Oliveira, Celso José Bruno/0000-0002-7761-0697; GIVISIEZ, PATRICIA/0000-0002-2480-1780; Perazzo, Fernando/0000-0003-4075-1792; Barreiro Campos, Danila/0000-0003-1426-4392; Guerra, Ricardo/0000-0001-8226-8606	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [486641/2011-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico funded the research (grants 486641/2011-2) (http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altekruse SF, 2006, EMERG INFECT DIS, V12, P1848; Azzam MMM, 2011, POULTRY SCI, V90, P2251, DOI 10.3382/ps.2011-01574; Bar-Shira E., 2005, Israel Journal of Veterinary Medicine, V60, P42; Collin A, 2007, POULTRY SCI, V86, P795, DOI 10.1093/ps/86.5.795; Corzo A, 2007, J APPL POULTRY RES, V16, P574, DOI 10.3382/japr.2007-00046; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; de Oliveira FA, 2009, FOOD CONTROL, V20, P606, DOI 10.1016/j.foodcont.2008.08.014; Faure M, 2005, J NUTR, V135, P486, DOI 10.1093/jn/135.3.486; Faure M, 2006, J NUTR, V136, P1558, DOI 10.1093/jn/136.6.1558; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Forder REA, 2007, POULTRY SCI, V86, P2396, DOI 10.3382/ps.2007-00222; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; Gharaibeh S, 2008, POULTRY SCI, V87, P1550, DOI 10.3382/ps.2008-00119; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Law GK, 2007, AM J PHYSIOL-GASTR L, V292, pG1293, DOI 10.1152/ajpgi.00221.2006; Lieevin-Le Moal V, 2006, CLIN MICROBIOL REV, V19, P315; Liew PK, 2003, POULTRY SCI, V82, P1879, DOI 10.1093/ps/82.12.1879; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Loyau T, 2015, ANIMAL, V14, P1; Malago JJ, 2002, CELL STRESS CHAPERON, V7, P191, DOI 10.1379/1466-1268(2002)007<0191:THSRAC>2.0.CO;2; Molenaar R, 2011, POULTRY SCI, V90, P1257, DOI 10.3382/ps.2010-00684; Molenaar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059637; Norup LR, 2008, ANIMAL, V2, P265, DOI 10.1017/S1751731107001097; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickler L, 2012, PESQUI VET BRASIL, V32, P27, DOI 10.1590/S0100-736X2012000100006; Piestun Y, 2008, POULTRY SCI, V87, P1516, DOI 10.3382/ps.2008-00030; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; Santos EG, 2013, J APPL MICROBIOL, V114, P1158, DOI 10.1111/jam.12108; Shinder D, 2011, POULTRY SCI, V90, P633, DOI 10.3382/ps.2010-01089; Smith AL, 2008, AVIAN IMMUNOLOGY, P243, DOI 10.1016/B978-012370634-8.50016-0; Soleimani AF, 2012, POULTRY SCI, V91, P340, DOI 10.3382/ps.2011-01703; Star L, 2009, POULTRY SCI, V88, P2253, DOI 10.3382/ps.2008-00373; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Uni Z, 2000, BRIT POULTRY SCI, V41, P410, DOI 10.1080/713654958; Uni Z, 2003, POULTRY SCI, V82, P320, DOI 10.1093/ps/82.2.320; Van Immerseel F, 2009, WORLD POULTRY SCI J, V65, P367, DOI 10.1017/S0043933909000270; Walstra I, 2010, POULTRY SCI, V89, P1502, DOI 10.3382/ps.2009-00568; Yadgary L, 2012, POULTRY SCI, V91, P444, DOI 10.3382/ps.2011-01669; Yahav S, 2004, POULTRY SCI, V83, P1959, DOI 10.1093/ps/83.12.1959; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091; Zaefarian F., 2008, International Journal of Poultry Science, V7, P1207; 2009, EFSA J, V9, P1	44	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131474	10.1371/journal.pone.0131474	http://dx.doi.org/10.1371/journal.pone.0131474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131553	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000121
J	McCormick, S; He, Q; Stern, J; Khodarev, N; Weichselbaum, R; Skelly, CL				McCormick, Susan; He, Qi; Stern, Jordan; Khodarev, Nikolai; Weichselbaum, Ralph; Skelly, Christopher L.			Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; KAPPA-B-ALPHA; ATHEROSCLEROTIC CORONARY-ARTERIES; THYMIDINE KINASE GENE; VEIN GRAFT FAILURE; LOW SHEAR-STRESS; NEOINTIMAL HYPERPLASIA; BALLOON ANGIOPLASTY; VASCULAR INJURY	Intimal hyperplasia (IH) is the primary cause of vein bypass graft failure. The smooth muscle cell (SMC) is a key element of IH as it phenotypically switches from a contractile to a synthetic state which can become pathological. R7020, which is an engineered strain of Herpes Simplex Virus-1, inhibits IH in animal models. Although it has many characteristics which make it a strong candidate for use as a prophylactic agent how it inhibits IH is not well understood. The objective of this study was to identify modes of action used by R7020 to function in blood vessels that may also contribute to its inhibition of IH. The cytopathic effect of R7020 on SMCs was determined in vitro and in a rabbit IH model. In vitro assays with R7020 infected SMCs were used to quantify the effect of dose on the release kinetics of the virus as well as the effects of R7020 on cell viability and the adhesion of peripheral blood mononuclear cells (PBMCs) to SMCs in the absence and presence of tumor necrosis factor alpha (TNF-alpha). The observed cytopathic effect, which included R7020 positive filopodia that extend from cell to cell and the formation of syncytia, suggests that R7020 remains cell associated after egress and spreads cell to cell instead of by diffusion through the extracellular fluid. This would allow the virus to rapidly infect vascular cells while evading the immune system. The directionality of the filopodia in vivo suggests that the virus preferentially travels from the media towards the intima targeting SMCs that would lead to IH. The formation of syncytia would inhibit SMC proliferation as incorporated cells are not able to multiply. It was also observed that R7020 induced the fusion of PBMCs with syncytia suggesting the virus may limit the effect of macrophages on IH. Furthermore, R7020 inhibited the proliferative effect of TNF-alpha, an inflammatory cytokine associated with increased IH. Thus, the results of this study suggest that R7020 inhibits IH through multiple mechanisms.	[McCormick, Susan; He, Qi; Stern, Jordan; Skelly, Christopher L.] Univ Chicago, Dept Surg, Vasc Surg Sect, Chicago, IL 60637 USA; [Khodarev, Nikolai; Weichselbaum, Ralph] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Khodarev, Nikolai; Weichselbaum, Ralph] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Skelly, CL (corresponding author), Univ Chicago, Dept Surg, Vasc Surg Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	cskelly@surgery.bsd.uchicago.edu	Skelly, Christopher/ABD-6187-2020		NIH [K-08-HL091053]; American Vascular Association/American College of Surgeons; NHLBI Jointly Sponsored Mentored Clinical Scientist Development Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091053] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Vascular Association/American College of Surgeons; NHLBI Jointly Sponsored Mentored Clinical Scientist Development Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Skelly is funded by NIH K-08-HL091053 as well by the American Vascular Association/American College of Surgeons and NHLBI Jointly Sponsored Mentored Clinical Scientist Development Award. The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the NHLBI or the NIH.	Akhtar J, 2008, INVEST OPHTH VIS SCI, V49, P4026, DOI 10.1167/iovs.08-1807; Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; BAINES JD, 1991, J VIROL, V65, P6414, DOI 10.1128/JVI.65.12.6414-6424.1991; Baldwin ZK, 2005, J VASC SURG, V41, P115, DOI 10.1016/j.jvs.2004.10.026; Bishop GG, 2001, CIRCULATION, V103, P1906, DOI 10.1161/01.cir.103.14.1906; BOND VC, 1984, VIROLOGY, V132, P368, DOI 10.1016/0042-6822(84)90042-4; Borst EM, 2013, ANTIMICROB AGENTS CH, V57, P4751, DOI 10.1128/AAC.00854-13; Browne H, 2001, J GEN VIROL, V82, P1419, DOI 10.1099/0022-1317-82-6-1419; BZIK DJ, 1984, VIROLOGY, V137, P185, DOI 10.1016/0042-6822(84)90022-9; Cadoz M, 1992, 32 INT C ANT AG CHEM, P167; CAI WZ, 1988, J MOL BIOL, V201, P575, DOI 10.1016/0022-2836(88)90639-0; Choudhary Samiksha, 2013, Open Virol J, V7, P41, DOI 10.2174/1874357901307010041; Christiansen JF, 2004, ANN THORAC SURG, V77, P1575, DOI 10.1016/j.athoracsur.2003.10.107; CLAUSELL N, 1994, CIRCULATION, V89, P2768, DOI 10.1161/01.CIR.89.6.2768; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; CLOWES AW, 1983, LAB INVEST, V49, P208; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Conte MS, 2005, J VASC SURG, V42, P456, DOI 10.1016/j.jvs.2005.05.001; COUFFINHAL T, 1993, ARTERIOSCLER THROMB, V13, P407, DOI 10.1161/01.ATV.13.3.407; Curi MA, 2003, J VASC SURG, V37, P1294, DOI 10.1016/S0741-5214(02)75333-0; Danenberg HD, 2002, CIRCULATION, V105, P2917, DOI 10.1161/01.CIR.0000018168.15904.BB; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVISPOYNTER N, 1994, J VIROL, V68, P7586, DOI 10.1128/JVI.68.11.7586-7590.1994; DELUCA N, 1982, VIROLOGY, V122, P411, DOI 10.1016/0042-6822(82)90240-9; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Dixit R, 2008, NEUROSCI LETT, V440, P113, DOI 10.1016/j.neulet.2008.05.031; DOLTER KE, 1994, J VIROL, V68, P8277, DOI 10.1128/JVI.68.12.8277-8281.1994; ENGEL JP, 1993, VIROLOGY, V192, P112, DOI 10.1006/viro.1993.1013; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; Fong Y, 2009, MOL THER, V17, P389, DOI 10.1038/mt.2008.240; Fullerton DA, 1999, ANN THORAC SURG, V67, P1231; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; HANKE H, 1994, EUR HEART J, V15, P691, DOI 10.1093/oxfordjournals.eurheartj.a060569; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; HANSSON GK, 1991, CIRCULATION, V84, P1266, DOI 10.1161/01.CIR.84.3.1266; HUTCHINSON L, 1992, J VIROL, V66, P2240, DOI 10.1128/JVI.66.4.2240-2250.1992; IRMIERE AF, 1989, VIROLOGY, V168, P210, DOI 10.1016/0042-6822(89)90260-2; JACOBSON JG, 1989, J VIROL, V63, P1839, DOI 10.1128/JVI.63.4.1839-1843.1989; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kemeny N, 2006, HUM GENE THER, V17, P1214, DOI 10.1089/hum.2006.17.1214; KERN WH, 1981, AM J SURG PATHOL, V5, P491, DOI 10.1097/00000478-198107000-00008; La Boissiere S, 2004, J VIROL, V78, P8002, DOI 10.1128/JVI.78.15.8002-8014.2004; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Manka D, 2001, CIRCULATION, V103, P1000; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Maruzuru Y, 2014, J VIROL, V88, P7445, DOI 10.1128/JVI.01057-14; Meyerson SL, 2001, J VASC SURG, V34, P90, DOI 10.1067/mva.2001.114819; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Oh MJ, 2010, BIOCHEM BIOPH RES CO, V391, P176, DOI 10.1016/j.bbrc.2009.11.027; PALMER H, 1992, LAB INVEST, V66, P715; PERSON S, 1985, GENE, V35, P279, DOI 10.1016/0378-1119(85)90006-X; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; POGUEGEILE KL, 1987, VIROLOGY, V157, P67, DOI 10.1016/0042-6822(87)90314-X; Pollman MJ, 1997, CIRCULATION, V96, P3132; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; ROIZMAN B, 1962, P NATL ACAD SCI USA, V48, P228, DOI 10.1073/pnas.48.2.228; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Roque M, 2002, ARTERIOSCL THROM VAS, V22, P554, DOI 10.1161/hq0402.105720; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUYECHAN WT, 1979, J VIROL, V29, P677; SANDERS PG, 1982, J GEN VIROL, V63, P277, DOI 10.1099/0022-1317-63-2-277; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Selzman CH, 1999, ANN THORAC SURG, V67, P1227, DOI 10.1016/S0003-4975(99)00252-0; Selzman CH, 1999, CIRC RES, V84, P867; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Skelly CL, 2013, GENE THER, V20, P215, DOI 10.1038/gt.2012.26; Skelly CL, 2007, P NATL ACAD SCI USA, V104, P12474, DOI 10.1073/pnas.0705429104; Skelly CL, 2001, GENE THER, V8, P1840, DOI 10.1038/sj.gt.3301597; Smyth SS, 2001, CIRCULATION, V103, P2501; Spiguel LRP, 2010, J SURG RES, V161, P146, DOI 10.1016/j.jss.2008.11.001; Sylwester A, 1997, J IMMUNOL, V158, P3996; SZILAGYI DE, 1973, ANN SURG, V178, P232, DOI 10.1097/00000658-197309000-00002; Tanaka H, 1996, ARTERIOSCL THROM VAS, V16, P12, DOI 10.1161/01.ATV.16.1.12; TANAKA H, 1995, AM J PATHOL, V147, P617; THYBERG J, 1995, CELL TISSUE RES, V281, P421; Tiwari V, 2015, MOLECULES, V20, P2707, DOI 10.3390/molecules20022707; Tiwari V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/651691; Tiwari V, 2010, J GEN VIROL, V91, P3002, DOI 10.1099/vir.0.024166-0; van Leeuwen H, 2002, J VIROL, V76, P3471, DOI 10.1128/JVI.76.7.3471-3481.2002; VLODAVER Z, 1971, Circulation, V44, P719; Wang ZB, 2005, AM J PHYSIOL-HEART C, V288, pH293, DOI 10.1152/ajpheart.00165.2004; WEISE K, 1987, J GEN VIROL, V68, P1909, DOI 10.1099/0022-1317-68-7-1909; WHITTEMORE AD, 1981, ANN SURG, V193, P35, DOI 10.1097/00000658-198101000-00006; Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P2402, DOI 10.1161/ATVBAHA.111.235622; Zhang ZZ, 2010, VIROLOGY, V406, P280, DOI 10.1016/j.virol.2010.07.030; Zhu BH, 2002, ARTERIOSCL THROM VAS, V22, P450, DOI 10.1161/hq0302.105377	94	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130264	10.1371/journal.pone.0130264	http://dx.doi.org/10.1371/journal.pone.0130264			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132411	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000060
J	Pryor, LE; Brendgen, M; Tremblay, RE; Pingault, JB; Liu, XC; Dubois, L; Touchette, E; Falissard, B; Boivin, M; Cote, SM				Pryor, Laura E.; Brendgen, Mara; Tremblay, Richard E.; Pingault, Jean-Baptiste; Liu, Xuecheng; Dubois, Lise; Touchette, Evelyne; Falissard, Bruno; Boivin, Michel; Cote, Sylvana M.			Early Risk Factors of Overweight Developmental Trajectories during Middle Childhood	PLOS ONE			English	Article							BODY-MASS INDEX; SHORT-SLEEP DURATION; FAMILY ASSESSMENT DEVICE; BMI Z-SCORE; LONGITUDINAL ANALYSIS; FETAL ORIGINS; WEIGHT-GAIN; PHYSICAL AGGRESSION; BEHAVIOR PROBLEMS; PRESCHOOL-CHILD	Background Research is needed to identify early life risk factors associated with different developmental paths leading to overweight by adolescence. Objectives To model heterogeneity in overweight development during middle childhood and identify factors associated with differing overweight trajectories. Methods Data was drawn from the Quebec Longitudinal Study of Child Development (QLSCD; 1998-2010). Trained research assistants measured height and weight according to a standardized protocol and conducted yearly home interviews with the child's caregiver (mother in 98% of cases). Information on several putative early life risk factors for the development of overweight were obtained, including factors related to the child's perinatal, early behavioral family and social environment. Group-based trajectories of the probability of overweight (6-12 years) were identified with a semiparametric method (n=1678). Logistic regression analyses were used to identify early risk factors (5 months-5 years) associated with each trajectory. Results Three trajectories of overweight were identified: "early-onset overweight" (11.0 %), "lateonset overweight" (16.6%) and "never overweight" (72.5%). Multinomial analyses indicated that children in the early and late-onset group, compared to the never overweight group, had 3 common types of risk factors: parental overweight, preschool overweight history, and large size for gestational age. Maternal overprotection (OR=1.12, CI: 1.01-1.25), short nighttime sleep duration (OR=1.66, CI: 1.07-2.57), and immigrant status (OR=2.01, CI: 1.05-3.84) were factors specific to the early-onset group. Finally, family food insufficiency (OR=1.81, CI: 1.00-3.28) was weakly associated with membership in the late-onset trajectory group. Conclusions The development of overweight in childhood follows two different trajectories, which have common and distinct risk factors that could be the target of early preventive interventions.	[Pryor, Laura E.; Pingault, Jean-Baptiste; Cote, Sylvana M.] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Pryor, Laura E.; Brendgen, Mara; Tremblay, Richard E.; Liu, Xuecheng; Touchette, Evelyne; Boivin, Michel; Cote, Sylvana M.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Pryor, Laura E.; Brendgen, Mara; Tremblay, Richard E.; Liu, Xuecheng; Touchette, Evelyne; Boivin, Michel; Cote, Sylvana M.] Univ Laval, Quebec City, PQ, Canada; [Pryor, Laura E.; Brendgen, Mara; Tremblay, Richard E.; Pingault, Jean-Baptiste; Cote, Sylvana M.] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Brendgen, Mara] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Tremblay, Richard E.; Boivin, Michel; Cote, Sylvana M.] Tomsk State Univ, Inst Genet Neurobiol & Social Fdn Child Dev, Tomsk 634050, Russia; [Dubois, Lise] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Touchette, Evelyne] Univ Quebec Trois Rivieres, Dept Psychoeduc, Trois Rivieres, PQ GA9 5H7, Canada; [Falissard, Bruno] INSERM, Natl Inst Hlth & Med Res, U669, Paris, France; [Boivin, Michel] Univ Laval, Sch Psychol, Quebec City, PQ, Canada; [Tremblay, Richard E.; Pingault, Jean-Baptiste; Cote, Sylvana M.] Univ Montreal, Int Lab Child & Adolescent Mental Hlth Dev, Montreal, PQ, Canada; [Tremblay, Richard E.; Pingault, Jean-Baptiste; Cote, Sylvana M.] INSERM, French Natl Inst Hlth & Med Res, Paris, France	Universite de Montreal; Universite de Montreal; Laval University; University of Quebec; University of Quebec Montreal; University College Dublin; Tomsk State University; University of Ottawa; University of Quebec; University of Quebec Trois Rivieres; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Laval University; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm)	Pryor, LE (corresponding author), INSERM, Pierre Louis Inst Epidemiol & Publ Hlth iPLESP, Social Epidemiol Res Grp ERES, UMR S 1136, Paris, France.	laura.pryor@inserm.fr	Côté, Sylvana M./T-4600-2019; Cote, Silvana Maria/O-1356-2014; Tremblay, Richard E./O-1360-2014	Côté, Sylvana M./0000-0001-7944-0647; Pingault, Jean-Baptiste/0000-0003-2557-4716; Boivin, Michel/0000-0001-8621-9844	Canadian Institutes of Health Research; Ste Justine Hospital Research Center; Quebec Government's Ministry of Health and Ministry of Family Affaires; Lucie and Andre Chagnon Foundation; Quebec Health Research Fund (FQRS); Quebec Research Fund for Society and Culture (FQRSC); Canada's Social Science and Humanities Research Council; Canadian Institutes for Health Research; St-Justine Research Centre; Quebec Statistics Institute (ISQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ste Justine Hospital Research Center; Quebec Government's Ministry of Health and Ministry of Family Affaires; Lucie and Andre Chagnon Foundation; Quebec Health Research Fund (FQRS); Quebec Research Fund for Society and Culture (FQRSC); Canada's Social Science and Humanities Research Council; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); St-Justine Research Centre; Quebec Statistics Institute (ISQ)	1. This study was conducted with help from a PhD scholarship from the Canadian Institutes of Health Research (LP) and the Ste Justine Hospital Research Center (LP). http://www.cihr-irsc.gc.ca/e/193.html http:/www.chu-sainte-justine.org/research/ The larger QLSCD study was also supported by funding from the Quebec Government's Ministry of Health and Ministry of Family Affaires, The Lucie and Andre Chagnon Foundation, the Quebec Health Research Fund (FQRS), The Quebec Research Fund for Society and Culture (FQRSC), Canada's Social Science and Humanities Research Council, the Canadian Institutes for Health Research, the St-Justine Research Centre and the Quebec Statistics Institute (ISQ). (RET) http://www.msss.gouv.qc.ca/en/ http://fondationchagnon.org/en/index.aspx http://www.frqs.gouv.qc.ca/en/ http://www.frqsc.gouv.qc.ca/fr/accueil.php http://www.sshrc-crsh.gc.ca/homeaccueil-eng.aspx http://www.stat.gouv.qc.ca 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Martinez JA, 2012, P NUTR SOC, V71, P276, DOI 10.1017/S0029665112000055; [Anonymous], 2007, QUEB LONG STUD CHILD; [Anonymous], 2009, QUEB LONG STUD CHI A; [Anonymous], 1999, QUEST PERS MOST KNOW; Balistreri KS, 2011, MATERN CHILD HLTH J, V15, P610, DOI 10.1007/s10995-010-0622-7; Barker ED, 2008, ARCH GEN PSYCHIAT, V65, P1185, DOI 10.1001/archpsyc.65.10.1185; BATES JE, 1979, CHILD DEV, V50, P794, DOI 10.1111/j.1467-8624.1979.tb02428.x; BEHAR L, 1974, DEV PSYCHOL, V10, P601, DOI 10.1037/h0037058; Berkey CS, 2007, ANN EPIDEMIOL, V17, P44, DOI 10.1016/j.annepidem.2006.07.014; Boivin M, 2005, J CHILD PSYCHOL PSYC, V46, P612, DOI 10.1111/j.1469-7610.2004.00375.x; Breier BH, 2001, MOL CELL ENDOCRINOL, V185, P73, DOI 10.1016/S0303-7207(01)00634-7; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Calkins K, 2011, CURR PROB PEDIATR AD, V41, P158, DOI 10.1016/j.cppeds.2011.01.001; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047065; Carter PJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2712; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Chen XG, 2012, ADOLESC HEALTH MED T, V3, P33, DOI 10.2147/AHMT.S30178; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; Cote SM, 2009, J CHILD PSYCHOL PSYC, V50, P1201, DOI 10.1111/j.1469-7610.2009.02099.x; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; Datar A, 2004, ARCH PEDIAT ADOL MED, V158, P804, DOI 10.1001/archpedi.158.8.804; Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Dubois L, 2006, SOC SCI MED, V63, P1503, DOI 10.1016/j.socscimed.2006.04.002; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Eisenmann JC, 2011, OBES REV, V12, pe73, DOI 10.1111/j.1467-789X.2010.00820.x; El-Sayed AM, 2011, ETHNIC DIS, V21, P47; Entringer S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/632548; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Garden FL, 2012, NUTRIENTS, V4, P1382, DOI 10.3390/nu4101382; Geoffroy MC, 2013, J PEDIATR-US, V162, P753, DOI 10.1016/j.jpeds.2012.09.026; Giles P, 2004, LOW INCOME MEASUREME; Gillman MW, 2013, NEW ENGL J MED, V369, P2173, DOI 10.1056/NEJMp1310577; Glavin K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-160; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guo SS, 2000, INT J OBESITY, V24, P1628, DOI 10.1038/sj.ijo.0801461; Guo SS, 2002, AM J CLIN NUTR, V76, P653, DOI 10.1093/ajcn/76.3.653; Haga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051896; Hancock K., 2012, THESIS; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hejazi S, 2011, GLOBAL PERSPECTIVES ON CHILDHOOD OBESITY: CURRENT STATUS, CONSEQUENCES AND PREVENTION, P21, DOI 10.1016/B978-0-12-374995-6.10003-9; Hirschler V, 2008, ARCH MED RES, V39, P796, DOI 10.1016/j.arcmed.2008.08.003; Huang DYC, 2013, J ADOLESCENCE, V36, P139, DOI 10.1016/j.adolescence.2012.10.005; Huang JS, 2007, MATERN CHILD HLTH J, V11, P461, DOI 10.1007/s10995-006-0141-8; Huang RC, 2011, DIABETES CARE, V34, P1019, DOI 10.2337/dc10-1809; Jansen PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069676; Jette M, 2000, LONGITUDINAL STUDY O; Johannsson E, 2006, INT J OBESITY, V30, P1265, DOI 10.1038/sj.ijo.0803253; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lane SP, 2013, BRIT J HEALTH PSYCH, V18, P66, DOI 10.1111/j.2044-8287.2012.02078.x; Larson NI, 2011, AM J PREV MED, V40, P166, DOI 10.1016/j.amepre.2010.10.028; Lavallee C., 2004, ENQUETE SOCIALE SANT; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Lumeng JC, 2003, PEDIATRICS, V112, P1138, DOI 10.1542/peds.112.5.1138; Magee CA, 2013, PEDIATR OBES, V8, P189, DOI 10.1111/j.2047-6310.2012.00112.x; Maher EJ, 2008, PEDIATRICS, V122, P322, DOI 10.1542/peds.2007-2233; Murrin CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-81; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2014, ANN NUTR METAB, V65, P205, DOI 10.1159/000360229; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Brien M, 2007, INT J OBESITY, V31, P1469, DOI 10.1038/sj.ijo.0803611; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Patro B, 2013, ANN NUTR METAB, V63, P32, DOI 10.1159/000350313; Plante N, 2004, PONDERATION DONNEES; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rhee KE, 2006, PEDIATRICS, V117, P2047, DOI 10.1542/peds.2005-2259; Sabin MA, 2015, J PAEDIATR CHILD H, V51, P82, DOI 10.1111/jpc.12819; Seguin L, 2007, PEDIATRICS, V119, pE1063, DOI 10.1542/peds.2006-1750; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Smith AJ, 2011, INT J PEDIATR OBES, V6, pE97, DOI 10.3109/17477166.2010.530664; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Suglia SF, 2012, PEDIATRICS, V129, pE1173, DOI 10.1542/peds.2011-2456; Taveras EM, 2008, ARCH PEDIAT ADOL MED, V162, P305, DOI 10.1001/archpedi.162.4.305; Touchette E, 2008, SLEEP, V31, P1507, DOI 10.1093/sleep/31.11.1507; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; von Kries R, 2014, OBESITY FACTS, V7, P77, DOI 10.1159/000362190; Wang YF, 2006, AM J CLIN NUTR, V84, P707, DOI 10.1093/ajcn/84.4.707; Ziyab AH, 2014, J EPIDEMIOL COMMUN H, V68, P934, DOI 10.1136/jech-2014-203808	95	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131231	10.1371/journal.pone.0131231	http://dx.doi.org/10.1371/journal.pone.0131231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121682	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000358150400088
J	Keeler, AB; Schreiner, D; Weiner, JA				Keeler, Austin B.; Schreiner, Dietmar; Weiner, Joshua A.			Protein Kinase C Phosphorylation of a gamma-Protocadherin C-terminal Lipid Binding Domain Regulates Focal Adhesion Kinase Inhibition and Dendrite Arborization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR SLICE CULTURES; PURKINJE-CELLS; HOMOPHILIC INTERACTION; CYTOPLASMIC DOMAIN; SEQUENCE-ANALYSIS; BIPOLAR DISORDER; SPINAL-CORD; GENE; ALPHA; MECHANISMS	The gamma-protocadherins (gamma-Pcdhs) are a family of 22 adhesion molecules with multiple critical developmental functions, including the proper formation of dendritic arbors by forebrain neurons. The gamma-Pcdhs bind to and inhibit focal adhesion kinase (FAK) via a constant C-terminal cytoplasmic domain shared by all 22 proteins. In cortical neurons lacking the gamma-Pcdhs, aberrantly high activity of FAK and of PKC disrupts dendrite arborization. Little is known, however, about how gamma-Pcdh function is regulated by other factors. Here we show that PKC phosphorylates a serine residue situated within a phospholipid binding motif at the shared gamma-Pcdh C terminus. Western blots using a novel phospho-specific antibody against this site suggest that a portion of gamma-Pcdh proteins is phosphorylated in the cortex in vivo. We find that PKC phosphorylation disrupts both phospholipid binding and the gamma-Pcdh inhibition of (but not binding to) FAK. Introduction of a non-phosphorylatable (S922A) gamma-Pcdh construct into wild-type cortical neurons significantly increases dendrite arborization. This same S922A construct can also rescue dendrite arborization defects in gamma-Pcdh null neurons cell autonomously. Consistent with these data, introduction of a phosphomimetic (S/D) gamma-Pcdh construct or treatment with a PKC activator reduces dendrite arborization in wild-type cortical neurons. Together, these data identify a novel mechanism through which gamma-Pcdh control of a signaling pathway important for dendrite arborization is regulated.	[Keeler, Austin B.; Schreiner, Dietmar; Weiner, Joshua A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Keeler, Austin B.; Weiner, Joshua A.] Univ Iowa, Neurosci Grad Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Weiner, JA (corresponding author), Univ Iowa, Dept Biol, 143 Biol Bldg, Iowa City, IA 52242 USA.	joshua-weiner@uiowa.edu	Weiner, Joshua/AAA-6532-2021; Regan, Clinton/E-6250-2012	Keeler, Austin/0000-0002-6148-0891; Weiner, Joshua/0000-0002-3352-2847	National Institutes of Health [R01NS055272]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS055272 (to J. A. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anitha A, 2013, J PSYCHIATR NEUROSCI, V38, P192, DOI 10.1503/jpn.120058; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Chen J, 2009, J BIOL CHEM, V284, P2880, DOI 10.1074/jbc.M807417200; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Fernandez-Monreal M, 2010, EUR J NEUROSCI, V32, P921, DOI 10.1111/j.1460-9568.2010.07386.x; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Garrett AM, 2012, NEURON, V74, P269, DOI 10.1016/j.neuron.2012.01.028; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gundlfinger A, 2003, J NEUROBIOL, V57, P95, DOI 10.1002/neu.10259; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Lachman HM, 2008, PSYCHIAT GENET, V18, P110, DOI 10.1097/YPG.0b013e3282fa1838; Ledderose J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01514; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x; O'Leary R, 2011, MOL BIOL CELL, V22, P4362, DOI 10.1091/mbc.E11-04-0283; Pedrosa E, 2008, SCHIZOPHR RES, V102, P210, DOI 10.1016/j.schres.2008.04.013; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Prasad T, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00054; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Schalm SS, 2010, P NATL ACAD SCI USA, V107, P13894, DOI 10.1073/pnas.1007182107; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Schrenk K, 2002, NEUROSCIENCE, V110, P675, DOI 10.1016/S0306-4522(01)00559-0; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Suo L, 2012, J MOL CELL BIOL, V4, P362, DOI 10.1093/jmcb/mjs034; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00045; YU FX, 1992, J BIOL CHEM, V267, P14616; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	45	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20674	20686		10.1074/jbc.M115.642306	http://dx.doi.org/10.1074/jbc.M115.642306			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26139604	Green Published, hybrid			2022-12-26	WOS:000360011800004
J	Del Pozo, S; Lindenbergh, R; Rodriguez-Gonzalvez, P; Blom, JK; Gonzalez-Aguilera, D				Del Pozo, Susana; Lindenbergh, Roderik; Rodriguez-Gonzalvez, Pablo; Blom, Jan Kees; Gonzalez-Aguilera, Diego			Discrimination between Sedimentary Rocks from Close-Range Visible and Very-Near-Infrared Images	PLOS ONE			English	Article							TERRESTRIAL LIDAR; FRANCE; NOIRES; FIELD	Variation in the mineral composition of rocks results in a change of their spectral response capable of being studied by imaging spectroscopy. This paper proposes the use of a low-cost handy sensor, a calibrated visible-very near infrared (VIS-VNIR) multispectral camera for the recognition of different geological formations. The spectral data was recorded by a Tetracam Mini-MCA-6 camera mounted on a field-based platform covering six bands in the spectral range of 0.530-0.801 mu m. Twelve sedimentary formations were selected in the Rhone-Alpes region (France) to analyse the discrimination potential of this camera for rock types and close-range mapping applications. After proper corrections and data processing, a supervised classification of the multispectral data was performed trying to distinguish four classes: limestones, marlstones, vegetation and shadows. After a maximum-likelihood classification, results confirmed that this camera can be efficiently exploited to map limestone-marlstone alternations in geological formations with this mineral composition.	[Del Pozo, Susana; Rodriguez-Gonzalvez, Pablo; Gonzalez-Aguilera, Diego] Univ Salamanca, Polytech Sch Avila, Dept Cartog & Land Engn, Avila, Spain; [Lindenbergh, Roderik; Blom, Jan Kees] Delft Univ Technol, Dept Geosci & Remote Sensing, Delft, Netherlands	University of Salamanca; Delft University of Technology	Gonzalez-Aguilera, D (corresponding author), Univ Salamanca, Polytech Sch Avila, Dept Cartog & Land Engn, Avila, Spain.	daguilera@usal.es	Del Pozo Aguilera, Susana/L-2011-2017; Rodríguez-Gonzálvez, Pablo/H-8820-2015	Del Pozo Aguilera, Susana/0000-0003-4869-3742; Rodríguez-Gonzálvez, Pablo/0000-0002-2657-813X; Blom, Jan Kees/0000-0002-4573-8813; Gonzalez-Aguilera, Diego/0000-0002-8949-4216; Lindenbergh, Roderik/0000-0001-8655-5266				Antoine P, 1995, ENG GEOL, V40, P223, DOI 10.1016/0013-7952(95)00053-4; Bellian JA, 2005, J SEDIMENT RES, V75, P166, DOI 10.2110/jsr.2005.013; BHATIA MR, 1986, CONTRIB MINERAL PETR, V92, P181, DOI 10.1007/BF00375292; Boulila S, 2010, BASIN RES, V22, P717, DOI 10.1111/j.1365-2117.2009.00429.x; Buckley SJ, 2013, COMPUT GEOSCI-UK, V54, P249, DOI 10.1016/j.cageo.2013.01.018; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; Davis SM, 1978, REMOTE SENSING QUANT, P1; Del Pozo S, 2014, REMOTE SENS-BASEL, V6, P1918, DOI 10.3390/rs6031918; Dematte JAM, 1999, SOIL SCI SOC AM J, V63, P327, DOI 10.2136/sssaj1999.03615995006300020010x; Fardin N, 2004, INT J ROCK MECH MIN, V41, P329, DOI 10.1016/S1365-1609(03)00111-4; Franceschi M, 2009, ISPRS J PHOTOGRAMM, V64, P522, DOI 10.1016/j.isprsjprs.2009.03.003; Haneberg W., 2006, P 57 ANN HIGHW GEOL; Johnsson M.J., 1993, PROCESSES CONTROLLIN, V284, P1, DOI DOI 10.1130/SPE284-P1; Kobayashi C, 2010, ANDEAN GEOL, V37, P433, DOI 10.5027/andgeoV37n2-a09; Kurz TH, 2013, INT J REMOTE SENS, V34, P1798, DOI 10.1080/01431161.2012.727039; Kurz TH, 2012, SEDIMENTOLOGY, V59, P623, DOI 10.1111/j.1365-3091.2011.01269.x; Kurz TH, 2011, PHOTOGRAMM REC, V26, P212, DOI 10.1111/j.1477-9730.2011.00632.x; Lagacherie P, 2008, REMOTE SENS ENVIRON, V112, P825, DOI 10.1016/j.rse.2007.06.014; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; Lillesand T.M., 2015, REMOTE SENSING IMAGE, V7th; Mccaffrey KJW, 2005, J GEOL SOC LONDON, V162, P927, DOI 10.1144/0016-764905-017; Moran MS, 2001, REMOTE SENS ENVIRON, V78, P71, DOI 10.1016/S0034-4257(01)00250-4; Olkkonen M, 2011, I-PERCEPTION, V2, P1014, DOI 10.1068/i0480; Phan TSH, 1993, PROPRIETES PHYS CARA; Rameil N, 2008, SEDIMENT GEOL, V212, P70, DOI 10.1016/j.sedgeo.2008.10.004; Reichelt K, 2005, LATE APTIAN ALBIAN V; Richards J.A., 2006, REMOTE SENSING DIGIT; ROSER BP, 1986, J GEOL, V94, P635, DOI 10.1086/629071; Rossel RAV, 2009, GEODERMA, V150, P253, DOI 10.1016/j.geoderma.2009.01.025; Smith GM, 1999, INT J REMOTE SENS, V20, P2653, DOI 10.1080/014311699211994; Tonon F., 2006, LASER PHOTOGRAMMETRI; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; van der Meer FD, 2012, INT J APPL EARTH OBS, V14, P112, DOI 10.1016/j.jag.2011.08.002; Xu X., 2000, LEAD EDGE, V19, P197, DOI [10.1190/1.1438576, DOI 10.1190/1.1438576]	34	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132471	10.1371/journal.pone.0132471	http://dx.doi.org/10.1371/journal.pone.0132471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147309	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600279
J	Kerschan-Schindl, K; Thalmann, MM; Weiss, E; Tsironi, M; Foger-Samwald, U; Meinhart, J; Skenderi, K; Pietschmann, P				Kerschan-Schindl, Katharina; Thalmann, Markus M.; Weiss, Elisabeth; Tsironi, Maria; Foeger-Samwald, Ursula; Meinhart, Johann; Skenderi, Katerina; Pietschmann, Peter			Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race	PLOS ONE			English	Article							BONE TURNOVER MARKERS; HUMAN SKELETAL-MUSCLE; MESSENGER-RNA; PHYSICAL-ACTIVITY; MINERAL DENSITY; UP-REGULATION; MYOSTATIN; EXERCISE; SCLEROSTIN; EXPRESSION	Background Regular physical activities have a positive effect on the muscular skeletal system but over-strenuous exercise may be different. Transiently suppressed bone formation and increased bone resorption after participation in a 246-km ultradistance race has been demonstrated. Purpose The aim of this study was to analyze effects of the Spartathlon race on novel musculoskeletal markers. Methods Venous blood samples were obtained before and immediately after the race from 19 participants of the Spartathlon. From 9 runners who were available 3 days after the start blood was drawn for a third time. Serum levels of myostatin, an inhibitor of myogenic differentiation, and its opponent follistatin as well as sclerostin and dickkopf-1, both of them inhibitors of the wnt signaling pathway, and markers of bone turnover were determined. Results Serum levels of myostatin were significantly higher after the race. Serum follistatin only showed a transient increase. Sclerostin levels did not significantly differ before and after the race, whereas dickkopf-1 levels were significantly decreased. At follow-up a decrement of sclerostin and dickkopf-1 levels was seen. Serum cathepsin K levels did not change. Conclusion The increase of serum levels of myostatin appears to reflect muscle catabolic processes induced by overstrenuous exercise. After the short-term uncoupling of bone turnover participation in an ultradistance race seems to initiate a long-term positive effect on bone indicated by the low-level inhibition of the Wnt/beta-catenin signaling pathway.	[Kerschan-Schindl, Katharina] Med Univ Vienna, Dept Phys Med & Rehabil, Vienna, Austria; [Thalmann, Markus M.] Hosp Hietzing, Dept Cardiovasc Surg, Vienna, Austria; [Weiss, Elisabeth; Foeger-Samwald, Ursula; Pietschmann, Peter] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Tsironi, Maria] Univ Peloponnese, Sch Nursing, Sparta, Greece; [Meinhart, Johann] Karl Landsteiner Inst Cardiovasc Surg Res, Vienna, Austria; [Skenderi, Katerina] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece	Medical University of Vienna; Hietzing Hospital; Medical University of Vienna; University of Peloponnese; Harokopio University Athens	Kerschan-Schindl, K (corresponding author), Med Univ Vienna, Dept Phys Med & Rehabil, Vienna, Austria.	Katharina.Kerschan-Schindl@meduniwien.ac.at		Foger-Samwald, Ursula/0000-0002-3135-2194	Austrian Society of Rheumatology and Rheumatic Diseases; Karl Landsteiner Institute for Cardiovascular Surgical Research	Austrian Society of Rheumatology and Rheumatic Diseases; Karl Landsteiner Institute for Cardiovascular Surgical Research	This work was supported by the following grants: Austrian Society of Rheumatology and Rheumatic Diseases and the Karl Landsteiner Institute for Cardiovascular Surgical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2011, MED SCI SPORT EXER, V43, P1828, DOI 10.1249/MSS.0b013e3182178bb4; Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152; Ardawi MSM, 2012, J CLIN ENDOCR METAB, V97, P3691, DOI 10.1210/jc.2011-3361; Bayod S, 2014, BRAIN RES, V1543, P38, DOI 10.1016/j.brainres.2013.10.048; Bergstrom I, 2012, J BONE MINER METAB, V30, P202, DOI 10.1007/s00774-011-0304-6; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Crespo R, 1999, CALCIFIED TISSUE INT, V64, P287, DOI 10.1007/s002239900620; Dalbo VJ, 2013, EUR J NUTR, V52, P477, DOI 10.1007/s00394-012-0349-x; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; Drysdale IP, 2007, J CLIN DENSITOM, V10, P179, DOI 10.1016/j.jocd.2007.02.001; Fazeli PK, 2013, OSTEOPOROSIS INT, V24, P2433, DOI 10.1007/s00198-013-2353-2; Gorgens SW, 2013, ARCH PHYSIOL BIOCHEM, V119, P75, DOI 10.3109/13813455.2013.768270; Goussetis E, 2009, BLOOD CELL MOL DIS, V42, P294, DOI 10.1016/j.bcmd.2009.01.003; Hansen J, 2011, ENDOCRINOLOGY, V152, P164, DOI 10.1210/en.2010-0868; Hind K, 2006, BONE, V39, P880, DOI 10.1016/j.bone.2006.03.012; Hulmi JJ, 2007, MED SCI SPORT EXER, V39, P289, DOI 10.1249/01.mss.0000241650.15006.6e; Jensky NE, 2007, EUR J APPL PHYSIOL, V101, P473, DOI 10.1007/s00421-007-0521-9; Jeukendrup AE, 2000, CLIN SCI, V98, P47, DOI 10.1042/CS19990258; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Kerschan-Schindl K, 2009, BONE, V45, P1079, DOI 10.1016/j.bone.2009.07.088; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; MALM HT, 1993, CALCIFIED TISSUE INT, V52, P209, DOI 10.1007/BF00298720; Margeli A, 2005, J CLIN ENDOCR METAB, V90, P3914, DOI 10.1210/jc.2004-2346; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mouzopoulos G, 2007, INT J SPORTS MED, V28, P576, DOI 10.1055/s-2007-964841; Ochi E, 2011, J STRENGTH COND RES, V25, P2283, DOI 10.1519/JSC.0b013e3181f1592e; Papassotiriou I, 2008, EUR J CLIN INVEST, V38, P276, DOI 10.1111/j.1365-2362.2008.01935.x; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pereira BC, 2014, INT J SPORTS MED, V35, P139, DOI 10.1055/s-0033-1349077; Pinho RA, 2010, CLIN J SPORT MED, V20, P306, DOI 10.1097/JSM.0b013e3181e413df; Schiffer T, 2011, INT J SPORTS MED, V32, P683, DOI 10.1055/s-0031-1279732; Sipos W, 2008, EXP GERONTOL, V43, P578, DOI 10.1016/j.exger.2008.03.008; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wilks DC, 2009, BONE, V45, P91, DOI 10.1016/j.bone.2009.03.660; Willoughby DS, 2004, J SPORT SCI MED, V3, P226; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P574, DOI 10.1249/01.MSS.0000121952.71533.EA; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	39	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132478	10.1371/journal.pone.0132478	http://dx.doi.org/10.1371/journal.pone.0132478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147574	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600282
J	Li, HQ; Hedmer, M; Karedal, M; Bjork, J; Stockfelt, L; Tinnerberg, H; Albin, M; Broberg, K				Li, Huiqi; Hedmer, Maria; Karedal, Monica; Bjork, Jonas; Stockfelt, Leo; Tinnerberg, Hakan; Albin, Maria; Broberg, Karin			A Cross-Sectional Study of the Cardiovascular Effects of Welding Fumes	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; ISCHEMIC-HEART-DISEASE; INCREASES ARTERIAL STIFFNESS; WORKPLACE PROTECTION FACTORS; SHORT-TERM EXPOSURE; ENDOTHELIAL FUNCTION; ULTRAFINE PARTICLES; VASCULAR FUNCTION; RATE-VARIABILITY; OCCUPATIONAL-EXPOSURE	Objectives Occupational exposure to particulate air pollution has been associated with an increased risk of cardiovascular disease. However, the risk to welders working today remains unclear. We aimed to elucidate the cardiovascular effects of exposure to welding fumes. Methods In a cross-sectional study, structured interviews and biological sampling were conducted for 101 welders and 127 controls (all non-smoking males) from southern Sweden. Personal breathing zone sampling of respirable dust was performed. Blood pressure (BP) and endothelial function (using peripheral arterial tonometry) were measured. Plasma and serum samples were collected from peripheral blood for measurement of C-reactive protein, low-density lipoprotein, homocysteine, serum amyloid A, and cytokines. Results Welders were exposed to 10-fold higher levels of particles than controls. Welders had significantly higher BP compared to controls, an average of 5 mm Hg higher systolic and diastolic BP (P <= 0.001). IL-8 was 3.4 ng/L higher in welders (P=0.010). Years working as a welder were significantly associated with increased BP (beta=0.35, 95%CI 0.13 - 0.58, P=0.0024 for systolic BP; beta=0.32, 95%CI 0.16-0.48, P<0.001 for diastolic BP, adjusted for BMI) but exposure to respirable dust was not associated with BP. No clear associations occurred between welding and endothelial function, or other effect markers. Conclusions A modest increase in BP was found among welders compared to controls suggesting that low-to-moderate exposure to welding fumes remains a risk factor for cardiovascular disease.	[Li, Huiqi; Hedmer, Maria; Karedal, Monica; Tinnerberg, Hakan; Albin, Maria; Broberg, Karin] Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden; [Bjork, Jonas] Lund Univ, Competence Ctr Clin Res, Lund, Sweden; [Stockfelt, Leo] Univ Gothenburg, Sahlgrenska Univ Hosp & Acad, Dept Occupat & Environm Med, Gothenburg, Sweden; [Broberg, Karin] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, S-10401 Stockholm, Sweden	Lund University; Lund University; Sahlgrenska University Hospital; University of Gothenburg; Karolinska Institutet	Broberg, K (corresponding author), Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden.	karin.broberg@ki.se	Li, Huiqi/GRF-0591-2022; Li, Huiqi/AAE-7786-2019	Li, Huiqi/0000-0002-1127-0829; Hedmer, Maria/0000-0002-7422-2621; Broberg, Karin/0000-0002-5862-468X; Bjork, Jonas/0000-0003-1883-2000; Karedal, Monica/0000-0002-5936-2829	Swedish Council for Working Life and Social Research [2009-1888]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by The Swedish Council for Working Life and Social Research [2009-1888]. http://www.forte.se/. KB received the funding.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Andujar P, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-23; Antonini JM, 2003, CRIT REV TOXICOL, V33, P61, DOI 10.1080/713611032; Auchincloss AH, 2008, ENVIRON HEALTH PERSP, V116, P486, DOI 10.1289/ehp.10899; Barregard L, 2006, INHAL TOXICOL, V18, P845, DOI 10.1080/08958370600685798; Bonetti PO, 2011, ATHEROSCLEROSIS, V215, P218, DOI 10.1016/j.atherosclerosis.2010.12.011; Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Brauner EV, 2007, ENVIRON HEALTH PERSP, V115, P1177, DOI 10.1289/ehp.9984; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brook RD, 2009, J AM SOC HYPERTENS, V3, P332, DOI 10.1016/j.jash.2009.08.005; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938; Egan BM, 2008, CURR HYPERTENS REP, V10, P359, DOI 10.1007/s11906-008-0068-0; Fang SC, 2008, EPIDEMIOLOGY, V19, P217, DOI 10.1097/EDE.0b013e31816334dc; Forchhammer L, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-7; Gidhagen L, 2013, J EXPO SCI ENV EPID, V23, P306, DOI 10.1038/jes.2012.122; GOLLER JW, 1985, AM IND HYG ASSOC J, V46, P89, DOI 10.1202/0002-8894(1985)046<0089:ACOIOF>2.3.CO;2; Han DH, 2002, IND HEALTH, V40, P328, DOI 10.2486/indhealth.40.328; Hedmer M, 2014, INT ARCH OCC ENV HEA, V87, P623, DOI 10.1007/s00420-013-0896-3; Ibfelt E, 2010, OCCUP ENVIRON MED, V67, P772, DOI 10.1136/oem.2009.051086; Janssen LL, 2007, J OCCUP ENVIRON HYG, V4, P698, DOI 10.1080/15459620701517764; Jarvela M, 2013, INT J OCCUP MED ENV, V26, P220, DOI 10.2478/s13382-013-0097-z; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kim JY, 2005, OCCUP ENVIRON MED, V62, P157, DOI 10.1136/oem.2004.014795; Konttinen J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-83; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Lehnert M, 2012, ANN OCCUP HYG, V56, P557, DOI 10.1093/annhyg/mes025; Lin CP, 2009, FRONT BIOSCI-LANDMRK, V14, P3836, DOI [10.2735/3492, 10.2741/3492]; Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Meier R, 2014, ENVIRON HEALTH PERSP, V122, P726, DOI 10.1289/ehp.1307100; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mocevic E, 2015, INT ARCH OCC ENV HEA, V88, P259, DOI 10.1007/s00420-014-0965-2; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Park SK, 2008, AM J RESP CRIT CARE, V178, P283, DOI 10.1164/rccm.200708-1286OC; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2011, J AIR WASTE MANAGE, V61, P858, DOI 10.3155/1047-3289.61.8.858; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Robinson SC, 1939, ARCH INTERN MED, V62, P409, DOI 10.1001/archinte.1939.00190030002001; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Scharrer E, 2007, INT ARCH OCC ENV HEA, V80, P265, DOI 10.1007/s00420-006-0127-2; Schneider A, 2008, ENVIRON HEALTH PERSP, V116, P1666, DOI 10.1289/ehp.11666; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Sjogren B, 2002, INT J OCCUP ENV HEAL, V8, P309; St-Pierre AC, 2005, ATHEROSCLEROSIS, V182, P315, DOI 10.1016/j.atherosclerosis.2005.02.009; Stark M, 2009, CYTOKINE, V46, P290, DOI 10.1016/j.cyto.2009.02.012; Suadicani P, 2002, J CARDIOVASC RISK, V9, P191, DOI 10.1097/00043798-200208000-00003; Swedish Work Environment Authority, 2011, OCC EXP LIM, V2011, P18; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Unosson J, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-20; Vinzents PS, 2005, ENVIRON HEALTH PERSP, V113, P1485, DOI 10.1289/ehp.7562; Wiebert P, 2012, OCCUP ENVIRON MED, V69, P651, DOI 10.1136/oemed-2011-100285; Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256	60	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131648	10.1371/journal.pone.0131648	http://dx.doi.org/10.1371/journal.pone.0131648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147298	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600117
J	Li, Z; Zheng, WL; Li, HK; Li, CX; Gong, ZY				Li, Zhen; Zheng, Weiling; Li, Hankun; Li, Caixia; Gong, Zhiyuan			Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes	PLOS ONE			English	Article							COMPARATIVE FUNCTIONAL GENOMICS; GROWTH-FACTOR-ALPHA; PYRUVATE-KINASE M2; ENERGY-METABOLISM; MOUSE MODELS; LIVER-CANCER; TUMORIGENESIS; BIOGENESIS; ACTIVATION; ADDICTION	Previously we have generated inducible liver tumor models by transgenic expression of Myc or xmrk (activated EGFR homolog) oncogenes in zebrafish. To investigate the interaction of the two oncogenes, we crossed the two transgenic lines and observed more severe and faster hepatocarcinogenesis in Myc/xmrk double transgenic zebrafish than either single transgenic fish. RNA-Seq analyses revealed distinct changes in many molecular pathways among the three types of liver tumors. In particular, we found dramatic alteration of cancer metabolism based on the uniquely enriched pathways in the Myc/xmrk tumors. Critical glycolytic genes including hk2, pkm and ldha were significantly up-regulated in Myc/xmrk tumors but not in either single oncogene-induced tumors, suggesting a potential Warburg effect. In RT-qPCR analyses, the specific pkm2 isoformin Warburg effect was found to be highly enriched in the Myc/xmrk tumors but not in Myc or xmrk tumors, consistent with the observations in many human cancers with Warburg effect. Moreover, the splicing factor genes (hnrnpa1, ptbp1a, ptbp1b and sfrs3b) responsible for generating the pkm isoform were also greatly up-regulated in the Myc/xmrk tumors. As Pkm2 isoform is generally inactive and causes incomplete glycolysis to favor anabolism and tumor growth, by treatment with a Pkm2-specific activator, TEPP-46, we further demonstrated that activation of Pkm2 suppressed the growth of oncogenic liver as well as proliferation of liver cells. Collectively, our Myc/xmrk zebrafish model suggests synergetic effect of EGFR and MYC in triggering Warburg effect in the HCC formation and may provide a promising in vivo model for Warburg effect.	[Li, Zhen; Zheng, Weiling; Li, Hankun; Li, Caixia; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Li, Caixia/0000-0003-2190-655X	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a grant from National Medical Research Council of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Calvisi DF, 2005, J HEPATOL, V42, P842, DOI 10.1016/j.jhep.2005.01.029; Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Desai S, 2013, ONCOTARGET; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Huang XQ, 2012, FUTURE ONCOL, V8, P21, DOI [10.2217/FON.11.137, 10.2217/fon.11.137]; Ito Y, 2001, BRIT J CANCER, V84, P1377, DOI 10.1054/bjoc.2000.1580; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lee JS, 2005, CARCINOGENESIS, V26, P1013, DOI 10.1093/carcin/bgi030; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Li Z, 2012, J HEPATOL, V56, P419, DOI 10.1016/j.jhep.2011.07.025; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MURAKAMI H, 1993, CANCER RES, V53, P1719; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Nilsson LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002573; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; SANDGREN EP, 1989, ONCOGENE, V4, P715; SantoniRugiu E, 1996, AM J PATHOL, V149, P407; Shachaf CM, 2005, CANCER RES, V65, P4471, DOI 10.1158/0008-5472.CAN-05-1172; Sun LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117249; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h; Zheng WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091179	45	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132319	10.1371/journal.pone.0132319	http://dx.doi.org/10.1371/journal.pone.0132319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147004	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600240
J	Rossoni, RD; Barbosa, JO; Vilela, SFG; dos Santos, JD; de Barros, PP; Prata, MCD; Anbinder, AL; Fuchs, BB; Jorge, AOC; Mylonakis, E; Junqueira, JC				Rossoni, Rodnei Dennis; Barbosa, Junia Oliveira; Godinho Vilela, Simone Furgeri; dos Santos, Jessica Diane; de Barros, Patrcia Pimentel; de Azevedo Prata, Marcia Cristina; Anbinder, Ana Lia; Fuchs, Beth Burgwyn; Cardoso Jorge, Antonio Olavo; Mylonakis, Eleftherios; Junqueira, Juliana Campos			Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis	PLOS ONE			English	Article							EXPERIMENTAL ORAL CANDIDIASIS; ENTERICA SEROVAR TYPHIMURIUM; GALLERIA-MELLONELLA; PATHOGENICITY MECHANISMS; INFECTIOUS-DISEASE; ANIMAL-MODELS; COLONIZATION; SURFACES; THERAPY; ELEGANS	In this study, we evaluated the interactions between Candida albicans, Candida krusei and Candida glabrata in mixed infections. Initially, these interactions were studied in biofilms formed in vitro. CFU/mL values of C. albicans were lower in mixed biofilms when compared to the single biofilms, verifying 77% and 89% of C. albicans reduction when this species was associated with C. glabrata and C. krusei, respectively. After that, we expanded this study for in vivo host models of experimental candidiasis. G. mellonella larvae were inoculated with monotypic and heterotypic Candida suspensions for analysis of survival rate and quantification of fungal cells in the haemolymph. In the groups with single infections, 100% of the larvae died within 18 h after infection with C. albicans. However, interaction groups achieved 100% mortality after 72 h of infection by C. albicans-C. glabrata and 96 h of infection by C. albicans-C. krusei. C. albicans CFU/mL values from larvae hemolymph were lower in the interacting groups compared with the monoespecies group after 12 h of infection. In addition, immunosuppressed mice were also inoculated with monotypic and heterotypic microbial suspensions to induce oral candidiasis. C. albicans CFU/mL values recovered from oral cavity of mice were higher in the group with single infection by C. albicans than the groups with mixed infections by C. albicans-C. glabrata and C. albicans-C. krusei. Moreover, the group with single infection by C. albicans had a higher degree of hyphae and epithelial changes in the tongue dorsum than the groups with mixed infections. We concluded that single infections by C. albicans were more harmful for animal models than mixed infections with non-albicans species, suggesting that C. albicans establish competitive interactions with C. krusei and C. glabrata during biofilm formation and development of experimental candidiasis.	[Rossoni, Rodnei Dennis; Barbosa, Junia Oliveira; Godinho Vilela, Simone Furgeri; dos Santos, Jessica Diane; de Barros, Patrcia Pimentel; Anbinder, Ana Lia; Cardoso Jorge, Antonio Olavo; Junqueira, Juliana Campos] Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil; [de Azevedo Prata, Marcia Cristina] Embrapa Gado Leite, Juiz De Fora, MG, Brazil; [Fuchs, Beth Burgwyn; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA	Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Rossoni, RD (corresponding author), Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil.	dennisrossoni@hotmail.com	Junqueira, Juliana/GQZ-4509-2022; Junqueira, Juliana Campos/Q-3108-2019; de Barros, Patrícia Pimentel/M-8160-2019; Anbinder, Ana Lia/B-8816-2012; De Barros, Patrícia Pimentel/B-3496-2016; Rossoni, Rodnei D/K-2390-2013	Junqueira, Juliana Campos/0000-0001-6646-6856; de Barros, Patrícia Pimentel/0000-0003-4885-2811; Anbinder, Ana Lia/0000-0003-3930-4274; De Barros, Patrícia Pimentel/0000-0003-4885-2811; Rossoni, Rodnei D/0000-0002-9977-3040; dos Santos, Jessica Diane/0000-0003-0769-2938	State of Sao Paulo Research Foundation [2012/02184-9, 2012/19915-6, 2011/15194-0, 2011/10071-7]	State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	JCJ was supported by The State of Sao Paulo Research Foundation - Regular Research Awards, Grant numbers: 2012/02184-9 and 2012/19915-6. RDR was supported by The State of Sao Paulo Research Foundation - Scholarships - Master, Grant number: 2011/15194-0. JDdS was supported by The State of Sao Paulo Research Foundation Scholarships - Scientific Initiation, Grant number: 2011/10071-7.	Alves CT, 2014, J INFECTION, V69, P396, DOI 10.1016/j.jinf.2014.06.002; Arvanitis M, 2014, METHODS MOL BIOL, V1147, P159, DOI 10.1007/978-1-4939-0467-9_11; Arvanitis M, 2013, CURR OPIN PHARMACOL, V13, P769, DOI 10.1016/j.coph.2013.08.002; Costa ACBP, 2012, OR SURG OR MED OR PA, V114, P67, DOI 10.1016/j.oooo.2012.02.002; Chamilos G, 2007, LANCET INFECT DIS, V7, P42, DOI 10.1016/S1473-3099(06)70686-7; Chibebe J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-217; Chibebe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055926; Costa ACBP, 2013, VIRULENCE, V4, P391, DOI 10.4161/viru.25199; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; de Repentigny L, 2004, CURR OPIN MICROBIOL, V7, P324, DOI 10.1016/j.mib.2004.06.001; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Fuchs BB, 2010, MICROBES INFECT, V12, P488, DOI 10.1016/j.micinf.2010.03.001; Hebecker B, 2014, EXPERT REV ANTI-INFE, V12, P867, DOI 10.1586/14787210.2014.916210; Hu LY, 2015, J MED MICROBIOL, V64, P74, DOI 10.1099/jmm.0.080200-0; Junqueira JC, 2005, MICROBIOL IMMUNOL, V49, P199, DOI 10.1111/j.1348-0421.2005.tb03721.x; Junqueira JC, 2012, REV INST MED TROP SP, V54, P17, DOI 10.1590/S0036-46652012000100004; Junqueira JC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-247; Junqueira JC, 2012, ADV EXP MED BIOL, V710, P95, DOI 10.1007/978-1-4419-5638-5_10; Kim Y, 2011, EUKARYOT CELL, V10, P782, DOI 10.1128/EC.00014-11; Kirkpatrick WR, 2000, J CLIN MICROBIOL, V38, P902, DOI 10.1128/JCM.38.2.902-904.2000; KOGAN G, 1988, CARBOHYD RES, V184, P171, DOI 10.1016/0008-6215(88)80015-6; Komerik N, 2003, ANTIMICROB AGENTS CH, V47, P932, DOI 10.1128/AAC.47.3.932-940.2003; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Mellado E, 2000, DIAGN MICR INFEC DIS, V38, P21, DOI 10.1016/S0732-8893(00)00165-6; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Pathak AK, 2012, J APPL ORAL SCI, V20, P70, DOI 10.1590/S1678-77572012000100013; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; Pereira-Cenci T, 2008, ARCH ORAL BIOL, V53, P755, DOI 10.1016/j.archoralbio.2008.02.015; Rossoni RD, 2013, BRAZ ORAL RES, V27, P484, DOI 10.1590/S1806-83242013000600007; Samaranayake YH, 2001, CLIN MICROBIOL REV, V14, P398, DOI 10.1128/CMR.14.2.398-429.2001; Sanchez-Vargas LO, 2013, ARCH ORAL BIOL, V58, P1318, DOI 10.1016/j.archoralbio.2013.06.006; Scorzoni L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060047; Seneviratne CJ, 2009, ARCH ORAL BIOL, V54, P1052, DOI 10.1016/j.archoralbio.2009.08.002; Silva S, 2013, MED MYCOL, V51, P178, DOI 10.3109/13693786.2012.700492; Souza RC, 2010, LASER MED SCI, V25, P385, DOI 10.1007/s10103-009-0706-z; Takakura N, 2003, MICROBIOL IMMUNOL, V47, P321, DOI 10.1111/j.1348-0421.2003.tb03403.x; Tampakakis E, 2009, EUKARYOT CELL, V8, P732, DOI 10.1128/EC.00016-09; Thein ZM, 2007, ARCH ORAL BIOL, V52, P1200, DOI 10.1016/j.archoralbio.2007.06.007; Thompson GR, 2010, ORAL SURG ORAL MED O, V109, P488, DOI 10.1016/j.tripleo.2009.11.026; Vilela SFG, 2015, VIRULENCE, V6, P29, DOI 10.4161/21505594.2014.981486; Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836; Zomorodian K, 2011, MED MYCOL, V49, P208, DOI 10.3109/13693786.2010.507605	43	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131700	10.1371/journal.pone.0131700	http://dx.doi.org/10.1371/journal.pone.0131700			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146832	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600131
J	Burriss, RP; Troscianko, J; Lovell, PG; Fulford, AJC; Stevens, M; Quigley, R; Payne, J; Saxton, TK; Rowland, HM				Burriss, Robert P.; Troscianko, Jolyon; Lovell, P. George; Fulford, Anthony J. C.; Stevens, Martin; Quigley, Rachael; Payne, Jenny; Saxton, Tamsin K.; Rowland, Hannah M.			Changes in Women's Facial Skin Color over the Ovulatory Cycle are Not Detectable by the Human Visual System	PLOS ONE			English	Article							MENSTRUAL-CYCLE; SEXUAL-SELECTION; CONCEALED OVULATION; ESTROGEN-LEVELS; FEMALE; ATTRACTIVENESS; EVOLUTION; BLOOD; PREFERENCES; FERTILE	Human ovulation is not advertised, as it is in several primate species, by conspicuous sexual swellings. However, there is increasing evidence that the attractiveness of women's body odor, voice, and facial appearance peak during the fertile phase of their ovulatory cycle. Cycle effects on facial attractiveness may be underpinned by changes in facial skin color, but it is not clear if skin color varies cyclically in humans or if any changes are detectable. To test these questions we photographed women daily for at least one cycle. Changes in facial skin redness and luminance were then quantified by mapping the digital images to human long, medium, and shortwave visual receptors. We find cyclic variation in skin redness, but not luminance. Redness decreases rapidly after menstrual onset, increases in the days before ovulation, and remains high through the luteal phase. However, we also show that this variation is unlikely to be detectable by the human visual system. We conclude that changes in skin color are not responsible for the effects of the ovulatory cycle on women's attractiveness.	[Burriss, Robert P.; Saxton, Tamsin K.] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Troscianko, Jolyon; Stevens, Martin] Univ Exeter, Ctr Ecol & Conservat, Penryn TR10 9FE, England; [Lovell, P. George] Abertay Univ, Div Psychol, Dundee DD1 1HG, Scotland; [Lovell, P. George] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9JP, Fife, Scotland; [Fulford, Anthony J. C.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1E 7HT, England; [Fulford, Anthony J. C.; Quigley, Rachael; Payne, Jenny; Rowland, Hannah M.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Rowland, Hannah M.] Zool Soc London, Inst Zool, London NW1 4RY, England	Northumbria University; University of Exeter; University of Abertay Dundee; University of St Andrews; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Zoological Society of London	Burriss, RP (corresponding author), Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	rob@robertburriss.com	Rowland, Hannah/D-8114-2012	Rowland, Hannah/0000-0002-1040-555X; Lovell, Paul George/0000-0003-2959-5370; Troscianko, Jolyon/0000-0001-9071-2594; Saxton, Tamsin/0000-0002-9902-5624; Burriss, Robert/0000-0002-5030-3638; Stevens, Martin/0000-0001-7768-3426	Anniversary Research Fellowship at Northumbria University; David Philips Research Fellowship - Biological Sciences Research Council (BBSRC) [BB/G022887/1]; Junior Research Fellowship at Churchill College, University of Cambridge; Institute Research Fellowship at the Institute of Zoology; BBSRC [BB/G022887/2, BB/G022887/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022887/2, BB/G022887/1] Funding Source: researchfish	Anniversary Research Fellowship at Northumbria University; David Philips Research Fellowship - Biological Sciences Research Council (BBSRC); Junior Research Fellowship at Churchill College, University of Cambridge; Institute Research Fellowship at the Institute of Zoology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RPB is supported by an Anniversary Research Fellowship at Northumbria University. MS and JT were supported by a David Philips Research Fellowship awarded to MS by the Biological Sciences Research Council (BBSRC) (BB/G022887/1). HMR was supported by a Junior Research Fellowship at Churchill College, University of Cambridge, and is supported by an Institute Research Fellowship at the Institute of Zoology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliende ME, 2002, FERTIL STERIL, V78, P90, DOI 10.1016/S0015-0282(02)03167-9; BAIRD DD, 1995, EPIDEMIOLOGY, V6, P547, DOI 10.1097/00001648-199509000-00015; BAIRD DT, 1974, J CLIN ENDOCR METAB, V38, P1009, DOI 10.1210/jcem-38-6-1009; BAKOS O, 1994, ACTA OBSTET GYN SCAN, V73, P790, DOI 10.3109/00016349409072507; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; Beall AT, 2013, PSYCHOL SCI, V24, P1837, DOI 10.1177/0956797613476045; Bleske-Rechek A, 2011, EVOL PSYCHOL-US, V9, P336; BLISS C. I., 1958, BULL CONNECTICUT AGRIC EXPT STA, V615, P1; Bobst C, 2014, HORM BEHAV, V66, P487, DOI 10.1016/j.yhbeh.2014.06.015; Bobst C, 2012, HORM BEHAV, V62, P413, DOI 10.1016/j.yhbeh.2012.07.008; Brainard D., 2003, SCI COLOR; Brincat MP, 2000, MATURITAS, V35, P107, DOI 10.1016/S0378-5122(00)00097-9; Bryant GA, 2009, BIOL LETTERS, V5, P12, DOI 10.1098/rsbl.2008.0507; BUXTON CL, 1948, J CLIN ENDOCRINOL, V8, P544, DOI 10.1210/jcem-8-7-544; Campbell B. G., 1974, HUMAN EVOLUTION; Cantu SM, 2014, PSYCHOL SCI, V25, P431, DOI 10.1177/0956797613508413; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Charkoudian N, 1999, J APPL PHYSIOL, V87, P1719, DOI 10.1152/jappl.1999.87.5.1719; Cobey KD, 2013, BIOL PSYCHOL, V94, P513, DOI 10.1016/j.biopsycho.2013.09.011; Coetzee V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099629; Cole LA, 2009, FERTIL STERIL, V91, P522, DOI 10.1016/j.fertnstert.2007.11.073; Cox NJ, 2006, STATA J, V6, P561, DOI 10.1177/1536867X0600600408; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; Direito A, 2013, FERTIL STERIL, V99, P279, DOI 10.1016/j.fertnstert.2012.08.047; Dubuc C, 2009, INT J PRIMATOL, V30, P777, DOI 10.1007/s10764-009-9369-7; Duda P, 2013, J HUM EVOL, V65, P424, DOI 10.1016/j.jhevol.2013.07.009; Durante KM, 2008, PERS SOC PSYCHOL B, V34, P1451, DOI 10.1177/0146167208323103; Ecochard R, 2000, HUM REPROD, V15, P752, DOI 10.1093/humrep/15.4.752; Fehring RJ, 2006, JOGNN-J OBST GYN NEO, V35, P376, DOI 10.1111/j.1552-6909.2006.00051.x; Fernandez JR, 2009, PHILOS T R SOC A, V367, P431, DOI 10.1098/rsta.2008.0231; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fujita S, 2004, AM J PRIMATOL, V64, P367, DOI 10.1002/ajp.20086; Fulford AJC, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-15; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gildersleeve K, 2014, PSYCHOL BULL, V140, P1205, DOI 10.1037/a0035438; Gueguen N, 2012, PSYCHOL REC, V62, P541, DOI 10.1007/BF03395819; Hahn AC, 2012, BIOL LETTERS, V8, P864, DOI 10.1098/rsbl.2012.0338; Harris CR, 2013, SEX ROLES, V69, P525, DOI 10.1007/s11199-013-0302-3; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Haselton MG, 2011, CURR DIR PSYCHOL SCI, V20, P87, DOI 10.1177/0963721411402668; Havlicek J, 2006, ETHOLOGY, V112, P81, DOI 10.1111/j.1439-0310.2006.01125.x; Higham JP, 2008, HORM BEHAV, V53, P452, DOI 10.1016/j.yhbeh.2007.11.019; Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Hrdy S.B., 1987, P370; Huchard E, 2009, P ROY SOC B-BIOL SCI, V276, P1889, DOI 10.1098/rspb.2008.1923; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones BC, 2008, ARCH SEX BEHAV, V37, P78, DOI 10.1007/s10508-007-9268-y; Jones BC, 2015, PSYCHONEUROENDOCRINO, V56, P29, DOI 10.1016/j.psyneuen.2015.02.021; Kuukasjarvi S, 2004, BEHAV ECOL, V15, P579, DOI 10.1093/beheco/arh050; Laeng B, 2007, HORM BEHAV, V52, P520, DOI 10.1016/j.yhbeh.2007.07.013; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lefevre CE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0633; Lefevre CE, 2015, Q J EXP PSYCHOL, V68, P284, DOI 10.1080/17470218.2014.944194; Leongomez JD, 2015, EVOL HUM BEHAV, V35, P489, DOI [10.1016/j.evolhumbehav.2014.06.008, DOI 10.1016/J.EV0LHUMBEHAV.2014.06.008]; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; LIU D, 1992, DIABETOLOGIA, V35, P287, DOI 10.1007/BF00400932; Marsh EE, 2011, J CLIN ENDOCR METAB, V96, P3199, DOI 10.1210/jc.2011-1314; MCGUINNESS B, 1961, BRIT MED J, V2, P563, DOI 10.1136/bmj.2.5251.563; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Miller G, 2007, EVOL HUM BEHAV, V28, P375, DOI 10.1016/j.evolhumbehav.2007.06.002; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Oberzaucher E., 2012, J EVOL PSYCHOL, V10, P163, DOI [10.1556/JEP.10.2012.4.1, DOI 10.1556/JEP.10.2012.4.1]; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Pawlowski B, 1999, CURR ANTHROPOL, V40, P257, DOI 10.1086/200017; Pelletier G, 2004, HISTOL HISTOPATHOL, V19, P629, DOI 10.14670/HH-19.629; Pierard GE, 1998, J EUR ACAD DERMATOL, V10, P1; Pipitone RN, 2008, EVOL HUM BEHAV, V29, P268, DOI 10.1016/j.evolhumbehav.2008.02.001; Pisanski K, 2014, HORM BEHAV, V66, P493, DOI 10.1016/j.yhbeh.2014.07.006; Probst F, 2016, Q J EXP PSYCHOL, V69, P89, DOI 10.1080/17470218.2015.1024696; Puts DA, 2013, HORM BEHAV, V63, P13, DOI 10.1016/j.yhbeh.2012.11.007; Puts DA, 2006, HUM NATURE-INT BIOS, V17, P114, DOI 10.1007/s12110-006-1023-x; R Core Team, 2013, R A LANGUAGE AND ENV, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Re DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017859; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Roney JR, 2008, HORM BEHAV, V53, P14, DOI 10.1016/j.yhbeh.2007.09.008; Roney JR, 2011, PSYCHONEUROENDOCRINO, V36, P742, DOI 10.1016/j.psyneuen.2010.10.010; Samson N, 2011, SWISS J PSYCHOL, V70, P199, DOI 10.1024/1421-0185/a000057; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setchell JM, 2006, P ROY SOC B-BIOL SCI, V273, P2395, DOI 10.1098/rspb.2006.3573; Shah M G, 2001, Am J Clin Dermatol, V2, P143; SILLENTULLBERG B, 1993, AM NAT, V141, P1, DOI 10.1086/285458; SNELL RS, 1966, J INVEST DERMATOL, V47, P147, DOI 10.1038/jid.1966.119; StataCorp, 2011, STATA STATISTICAL SO; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00014; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; STEWART DE, 1989, ACTA PSYCHIAT SCAND, V79, P400, DOI 10.1111/j.1600-0447.1989.tb10276.x; Stirnemann JJ, 2013, HUM REPROD, V28, P1110, DOI 10.1093/humrep/des449; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Tan KW, 2013, PERCEPTION, V42, P733, DOI 10.1068/p7499; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Thornton MJ, 2005, EXPERT OPIN THER TAR, V9, P617, DOI 10.1517/14728222.9.3.617; Thornton MJ, 2003, J INVEST DERM SYMP P, V8, P100, DOI 10.1046/j.1523-1747.2003.12181.x; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Tombs S, 2004, EVOL HUM BEHAV, V25, P221, DOI 10.1016/j.evolhumbehav.2004.05.001; VANDENBERGHE PL, 1986, ETHNIC RACIAL STUD, V9, P87, DOI 10.1080/01419870.1986.9993516; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Welling LLM, 2014, EVOL PSYCHOL-SER, P243, DOI 10.1007/978-1-4939-0314-6_13; Whitehead RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032988; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Wood W, 2014, EMOT REV, V6, P229, DOI 10.1177/1754073914523073; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807	113	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0130093	10.1371/journal.pone.0130093	http://dx.doi.org/10.1371/journal.pone.0130093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134671	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400013
J	Singh, S; Pandey, S; Bhatt, AN; Chaudhary, R; Bhuria, V; Kalra, N; Soni, R; Roy, BG; Saluja, D; Dwarakanath, BS				Singh, Saurabh; Pandey, Sanjay; Bhatt, Anant Narayan; Chaudhary, Richa; Bhuria, Vikas; Kalra, Namita; Soni, Ravi; Roy, Bal Gangadhar; Saluja, Daman; Dwarakanath, Bilikere S.			Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; CALORIE RESTRICTION; CARBOHYDRATE RESTRICTION; CANCER RADIOTHERAPY; GLUCOSE-METABOLISM; MAMMARY CARCINOMAS; OXIDATIVE STRESS; PROSTATE-CANCER; PROLIFERATION; 2-DEOXYGLUCOSE	Background Dietary energy restriction (DER) has been well established as a potent anticancer strategy. Non-adoption of restricted diet for an extended period has limited its practical implementation in humans with a compelling need to develop agents that mimic effects similar to DER, without reduction in actual dietary intake. Glycolytic inhibitor, 2-deoxy-D-glucose (2-DG), has recently been shown to possess potential as an energy restriction mimetic agent (ERMA). In the present study we evaluated the effect of dietary 2-DG administration on a mouse tumor model, with a focus on several potential mechanisms that may account for the inhibition of tumorigenesis. Methodology/Principal Findings Swiss albino strain 'A' mice were administered with 0.2% and 0.4% w/v 2-DG in drinking water for 3 months prior to tumor implantation (Ehrlich's ascites carcinoma; EAC) and continued till the termination of the study with no adverse effects on general physiology and animal growth. Dietary 2-DG significantly reduced the tumor incidence, delayed the onset, and compromised the tumor growth along with enhanced survival. We observed reduced blood glucose and serum insulin levels along with decreased proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine positive (BrdU(+)) tumor cells in 2-DG fed mice. Also, reduced levels of certain key players of metabolic pathways such as phosphatidylinositol 3-kinase (PI3K), phosphorylated-Akt and hypoxia inducible factor-1 alpha (HIF-1 alpha) were also noted in tumors of 2-DG fed mice. Further, decrease in CD4(+)/CD8(+) ratio and T-regulatory cells observed in 2-DG fed mice suggested enhanced antitumor immunity and T cell effector function. Conclusion/Significance These results strongly suggest that dietary 2-DG administration in mice, at doses easily achievable in humans, suitably modulates several pleotrophic factors mimicking DER and inhibits tumorigenesis, emphasizing the use of ERMAs as a promising cancer preventive strategy.	[Singh, Saurabh; Pandey, Sanjay; Bhatt, Anant Narayan; Bhuria, Vikas; Kalra, Namita; Soni, Ravi; Roy, Bal Gangadhar; Dwarakanath, Bilikere S.] Inst Nucl Med & Allied Sci, Div Radiat Biosci, Delhi, India; [Singh, Saurabh; Pandey, Sanjay; Chaudhary, Richa; Saluja, Daman] Univ Delhi, Med Biotechnol Lab, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); University of Delhi	Dwarakanath, BS (corresponding author), Inst Nucl Med & Allied Sci, Div Radiat Biosci, Brig SK Mazumdar Rd, Delhi, India.	dwarakanathdrbs@gmail.com	Pandey, Sanjay/AAQ-4396-2020; Singh, Saurabh/AAG-1129-2021	Dwarakanath, Bilikere S./0000-0001-6988-2601; Pandey, Sanjay/0000-0003-2948-1816	Defence Research and Development Organisation (DRDO), Government of India [INM 301, 311/1.4, INM-301, INM-311]; University Grants Commission	Defence Research and Development Organisation (DRDO), Government of India(Defence Research & Development Organisation (DRDO)); University Grants Commission(University Grants Commission, India)	This work was supported by grants (INM 301 and 311/1.4) funded by Defence Research and Development Organisation (DRDO), Government of India. SS received fellowship from University Grants Commission. This work was supported by grants INM-301 and INM-311 from Defence Research and Development Organization (DRDO), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; BASERGA R, 1994, CELL, V79, P927, DOI 10.1016/0092-8674(94)90023-X; BLECHER M, 1961, ANAL BIOCHEM, V2, P30, DOI 10.1016/0003-2697(61)90036-7; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Caso J, 2013, PROSTATE, V73, P449, DOI 10.1002/pros.22586; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Chen JC, 1998, J GERONTOL A-BIOL, V53, pB330, DOI 10.1093/gerona/53A.5.B330; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; De Lorenzo MS, 2011, CARCINOGENESIS, V32, P1381, DOI 10.1093/carcin/bgr107; Dunn SE, 1997, CANCER RES, V57, P4667; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Dwarakanath BS, 2005, BIOMEDICINE, V24, P36; Dwarakanath BS, 1999, INT NUCL INFORM SYST, V31; Farooque A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108131; Farooque A, 2009, J CANCER RES THER, V5, P32, DOI 10.4103/0973-1482.55138; Fernandes G, 1997, J CLIN IMMUNOL, V17, P85, DOI 10.1023/A:1027344730553; Goldstein D S, 1992, Clin Auton Res, V2, P359, DOI 10.1007/BF01831392; Gupta S, 2009, J CANCER RES THER, V5, P16, DOI 10.4103/0973-1482.55135; Hadley EC, 2001, J GERONTOL A-BIOL, V56, P5, DOI 10.1093/gerona/56.suppl_1.5; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; JHA B, 1992, INT J RADIAT BIOL, V62, P409, DOI 10.1080/09553009214552291; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KALANT N, 1988, MECH AGEING DEV, V46, P89, DOI 10.1016/0047-6374(88)90117-0; Kaleoglu O., 1977, TIP FAKULTESI MECMUA, V40, P978; KLEIN S, 1992, AM J PHYSIOL, V262, pE631, DOI 10.1152/ajpendo.1992.262.5.E631; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lakka SS, 2005, BRAIN PATHOL, V15, P327; Lane MA, 1998, J ANTI-AGING MED, V1, P327, DOI [10.1089/rej.1.1998.1.327, DOI 10.1089/REJ.1.1998.1.327]; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Lin X, 2003, CANCER RES, V63, P3413; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Mukherjee P, 2004, CLIN CANCER RES, V10, P5622, DOI 10.1158/1078-0432.CCR-04-0308; ROSS MH, 1971, J NATL CANCER I, V47, P1095; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Soare A, 2011, AGING-US, V3, P374, DOI 10.18632/aging.100280; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; STEINBACH G, 1994, CANCER RES, V54, P1194; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Thompson HJ, 2004, CANCER RES, V64, P1541, DOI 10.1158/0008-5472.CAN-03-3108; Varady KA, 2008, FASEB J, V22, P2090, DOI 10.1096/fj.07-098178; Venkataramanaa Neelam K, 2013, Asian J Neurosurg, V8, P9, DOI 10.4103/1793-5482.110274; Venkatraman Jaya T., 1994, Aging Immunology and Infectious Disease, V5, P13; Wan RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1186, DOI 10.1152/ajpheart.00932.2003; Wang LN, 2014, J INTEGR MED-JIM, V12, P20, DOI 10.1016/S2095-4964(14)60003-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618; Wilker E, 2005, MOL CARCINOGEN, V44, P137, DOI 10.1002/mc.20132; Woodward GE., 1952, J FRANKLIN I, V254, P259, DOI DOI 10.1016/0016-0032(52)90482-1; Workman P, 1998, BRIT J CANCER, V77, P1; Yang XJ, 2010, CLIN CANCER RES, V16, P2833, DOI 10.1158/1078-0432.CCR-10-0059; Zhu ZJ, 2005, CANCER RES, V65, P7023, DOI 10.1158/0008-5472.CAN-05-0453; Zhu Zongjian, 2011, J Carcinog, V10, P17	62	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132089	10.1371/journal.pone.0132089	http://dx.doi.org/10.1371/journal.pone.0132089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135741	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400100
J	Tan, DG; Fu, LL; Han, BY; Sun, XP; Zheng, P; Zhang, JM				Tan, Deguan; Fu, Lili; Han, Bingyin; Sun, Xuepiao; Zheng, Peng; Zhang, Jiaming			Identification of an Endophytic Antifungal Bacterial Strain Isolated from the Rubber Tree and Its Application in the Biological Control of Banana Fusarium Wilt	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; SERRATIA; OXYSPORUM; DISEASE; RESISTANT; INOCULATION; CHITINASES; GENOMICS; GENUS	Banana Fusarium wilt (also known as Panama disease) is one of the most disastrous plant diseases. Effective control methods are still under exploring. The endophytic bacterial strain ITBB B5-1 was isolated from the rubber tree, and identified as Serratia marcescens by morphological, biochemical, and phylogenetic analyses. This strain exhibited a high potential for biological control against the banana Fusarium disease. Visual agar plate assay showed that ITBB B5-1 restricted the mycelial growth of the pathogenic fungus Fusarium oxysporum f.sp. cubense race 4 (FOC4). Microscopic observation revealed that the cell wall of the FOC4 mycelium close to the co-cultured bacterium was partially decomposed, and the conidial formation was prohibited. The inhibition ratio of the culture fluid of ITBB B5-1 against the pathogenic fungus was 95.4% as estimated by tip culture assay. Chitinase and glucanase activity was detected in the culture fluid, and the highest activity was obtained at Day 2 and Day 3 of incubation for chitinase and glucanase, respectively. The filtrated cell-free culture fluid degraded the cell wall of FOC4 mycelium. These results indicated that chitinase and glucanase were involved in the antifungal mechanism of ITBB B5-1. The potted banana plants that were inoculated with ITBB B5-1 before infection with FOC4 showed 78.7% reduction in the disease severity index in the green house experiments. In the field trials, ITBB B5-1 showed a control effect of approximately 70.0% against the disease. Therefore, the endophytic bacterial strain ITBB B5-1 could be applied in the biological control of banana Fusarium wilt.	[Tan, Deguan; Fu, Lili; Han, Bingyin; Sun, Xuepiao; Zhang, Jiaming] CATAS, Inst Trop Biosci & Biotechnol, MOA Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan Province, Peoples R China; [Zheng, Peng] Lijiang Teachers Coll, Lijiang 674110, Yunnan Province, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Zhang, JM (corresponding author), CATAS, Inst Trop Biosci & Biotechnol, MOA Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan Province, Peoples R China.	zhangjiaming@itbb.org.cn	Zhang, Jiaming/GSD-8224-2022		Natural Science Foundation of China [31471561]; Natural Science Foundation of Hainan Province [309051]; National Nonprofit Institute Research Grant of CATAS-ITBB [ITBB110307]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province; National Nonprofit Institute Research Grant of CATAS-ITBB	This work was supported by the Natural Science Foundation of China under Grant number 31471561, the Natural Science Foundation of Hainan Province under Grant number 309051, and the National Nonprofit Institute Research Grant of CATAS-ITBB under Grant number ITBB110307.	Ajithkumar B, 2003, INT J SYST EVOL MICR, V53, P253, DOI 10.1099/ijs.0.02158-0; Bruton BD, 1998, PLANT DIS, V82, P512, DOI 10.1094/PDIS.1998.82.5.512; CAB I, 2005, FUS OX F SP CUB PAN; Cao LX, 2005, FEMS MICROBIOL LETT, V247, P147, DOI 10.1016/j.femsle.2005.05.006; Chaverri P, 2011, MYCOLOGIA, V103, P139, DOI 10.3852/10-078; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; FINK W, 1988, PLANT PHYSIOL, V88, P270, DOI 10.1104/pp.88.2.270; Forsyth LM, 2006, MYCOL RES, V110, P929, DOI 10.1016/j.mycres.2006.03.008; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Frankowski J, 2001, ARCH MICROBIOL, V176, P421, DOI 10.1007/s002030100347; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Ghag SB, 2014, MOL BIOL REP, V41, P7929, DOI 10.1007/s11033-014-3687-3; Grimm D, 2008, SCIENCE, V322, P1046, DOI 10.1126/science.322.5904.1046; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Huang YH, 2012, EUR J PLANT PATHOL, V134, P87, DOI 10.1007/s10658-012-0024-3; Huang Y, 2015, PEST MANAG SCI, V71, P415, DOI 10.1002/ps.3820; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Gutierrez-Roman MI, 2012, WORLD J MICROB BIOT, V28, P145, DOI 10.1007/s11274-011-0803-6; Jones DR, 2009, ACTA HORTIC, V828, P21, DOI 10.17660/ActaHortic.2009.828.1; Kalbe C, 1996, MICROBIOL RES, V151, P433, DOI 10.1016/S0944-5013(96)80014-0; Kalivoda EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071267; Lian J, 2009, BIOL CONTROL, V51, P427, DOI 10.1016/j.biocontrol.2009.08.002; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; Nel B, 2007, CROP PROT, V26, P697, DOI 10.1016/j.cropro.2006.06.008; Orjeda G., 1998, INIBAP TECHNICAL GUI, V3; Paul JY, 2011, PLANT BIOTECHNOL J, V9, P1141, DOI 10.1111/j.1467-7652.2011.00639.x; Ploetz R, 1997, AUSTRALAS PLANT PATH, V26, P239, DOI 10.1071/AP97039; Ploetz R.C, 1999, DIS BANANA ABACA ENS, P143; Ploetz R.C., 2000, PLANT HLTH PROGR, DOI [10.1094/PHP-2000-1204-1001-HM, DOI 10.1094/PHP-2000-1204-1001-HM]; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Ploetz RC, 2000, DIS BANANA ABACA ENS; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Saravanan T, 2003, CROP PROT, V22, P1117, DOI 10.1016/S0261-2194(03)00146-7; Smith MK, 2006, AUST J EXP AGR, V46, P107, DOI 10.1071/EA04175; Someya Nobutaka, 2007, Biocontrol Science, V12, P1; Swarupa V, 2014, PLANTA, V239, P735, DOI 10.1007/s00425-013-2024-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/482623; Wang K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/397142; WANG Z, 2006, PLANT QUAR, V20, P198; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Wu W, 2008, J IRON STEEL RES INT, V15, P15, DOI 10.1016/S1006-706X(08)60004-7; Xu F, 2011, 3 INT C CHEM BIOL EN; Xu LB, 2010, CHINESE J TROPICAL A, V30, P38; YABE K, 1988, APPL ENVIRON MICROB, V54, P2096, DOI 10.1128/AEM.54.8.2096-2100.1988; Yi SM, 2014, WORLD J MICROB BIOT, V30, P451, DOI 10.1007/s11274-013-1464-4; Yip MK, 2011, PLANT BIOTECHNOL REP, V5, P245, DOI 10.1007/s11816-011-0179-y; Zhang H, 2013, J CHEM ECOL, V39, P243, DOI 10.1007/s10886-013-0243-x; Zhang JM, 2008, EUR J PHYCOL, V43, P185, DOI 10.1080/09670260701718462; [郑鹏 Zheng Peng], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P832; [郑鹏 Zheng Peng], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P314	52	20	23	6	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131974	10.1371/journal.pone.0131974	http://dx.doi.org/10.1371/journal.pone.0131974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133557	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400086
J	Bergen, AW; Michel, M; Nishita, D; Krasnow, R; Javitz, HS; Conneely, KN; Lessov-Schlaggar, CN; Hops, H; Zhu, AZX; Baurley, JW; McClure, JB; Hall, SM; Baker, TB; Conti, DV; Benowitz, NL; Lerman, C; Tyndale, RF; Swan, GE				Bergen, Andrew W.; Michel, Martha; Nishita, Denise; Krasnow, Ruth; Javitz, Harold S.; Conneely, Karen N.; Lessov-Schlaggar, Christina N.; Hops, Hyman; Zhu, Andy Z. X.; Baurley, James W.; McClure, Jennifer B.; Hall, Sharon M.; Baker, Timothy B.; Conti, David V.; Benowitz, Neal L.; Lerman, Caryn; Tyndale, Rachel F.; Swan, Gary E.		Transdisciplinary Res Canc Lung Re	Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; TREATMENT-SEEKING SMOKERS; HUMAN LIVER-MICROSOMES; SMOKING-CESSATION; REPLACEMENT THERAPY; CYP2B6 GENOTYPE; FAGERSTROM TEST; C-OXIDATION; TOBACCO USE; BUPROPION	The Nicotine Metabolite Ratio (NMR, ratio of trans-3'-hydroxycotinine and cotinine), has previously been associated with CYP2A6 activity, response to smoking cessation treatments, and cigarette consumption. We searched for drug metabolizing enzyme and transporter (DMET) gene variation associated with the NMR and prospective abstinence in 2,946 participants of laboratory studies of nicotine metabolism and of clinical trials of smoking cessation therapies. Stage I was a meta-analysis of the association of 507 common single nucleotide polymorphisms (SNPs) at 173 DMET genes with the NMR in 449 participants of two laboratory studies. Nominally significant associations were identified in ten genes after adjustment for intragenic SNPs; CYP2A6 and two CYP2A6 SNPs attained experiment-wide significance adjusted for correlated SNPs (CYP2A6 P-ACT=4.1E-7, rs4803381 P-ACT=4.5E-5, rs1137115, P-ACT=1.2E-3). Stage II was mega-regression analyses of 10 DMET SNPs with pretreatment NMR and prospective abstinence in up to 2,497 participants from eight trials. rs4803381 and rs1137115 SNPs were associated with pretreatment NMR at genome-wide significance. In post-hoc analyses of CYP2A6 SNPs, we observed nominally significant association with: abstinence in one pharmacotherapy arm; cigarette consumption among all trial participants; and lung cancer in four case: control studies. CYP2A6 minor alleles were associated with reduced NMR, CPD, and lung cancer risk. We confirmed the major role that CYP2A6 plays in nicotine metabolism, and made novel findings with respect to genome-wide significance and associations with CPD, abstinence and lung cancer risk. Additional multivariate analyses with patient variables and genetic modeling will improve prediction of nicotine metabolism, disease risk and smoking cessation treatment prognosis.	[Bergen, Andrew W.; Nishita, Denise; Krasnow, Ruth; Javitz, Harold S.] SRI Int, Ctr Hlth Sci, Menlo Pk, CA 94025 USA; [Michel, Martha] Univ Calif San Francisco, Acad Res Syst, San Francisco, CA 94143 USA; [Conneely, Karen N.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Lessov-Schlaggar, Christina N.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hops, Hyman; Swan, Gary E.] Oregon Res Inst, Eugene, OR 97403 USA; [Zhu, Andy Z. X.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Baurley, James W.] BioRealm LLC, Monument, CO USA; [McClure, Jennifer B.] Grp Hlth Res Inst, Seattle, WA USA; [Hall, Sharon M.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Baker, Timothy B.] Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Conti, David V.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Lerman, Caryn] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Tyndale, Rachel F.] Univ Toronto, Ctr Addict & Mental Hlth, Cambell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Tyndale, Rachel F.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Tyndale, Rachel F.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Swan, Gary E.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Palo Alto, CA 94304 USA	SRI International; University of California System; University of California San Francisco; Emory University; Washington University (WUSTL); Oregon Research Institute; University of Toronto; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Southern California; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Stanford University	Bergen, AW (corresponding author), SRI Int, Ctr Hlth Sci, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	andrew.bergen@sri.com	Lerman, Caryn/AHC-5180-2022	Bergen, Andrew/0000-0002-1237-7644; Tyndale, Rachel/0000-0003-1297-2053	Medco Health Solutions, Inc.; Affymetrix, Inc.; SRI International; National Institute of Drug Abuse; National Cancer Institute, of the United States Department of Health and Human Services [HHSN271201300004C, R01 DA03706, R01s DA16752, DA18691, DA15732, DA9253, P50 CA84724, K05 CA139871, P50 DA19706, R01s CA71358, DA11170, PGRN U01 DA20830, R21 DA33813]; University of California Tobacco Related Diseases Research Program [7PT2004]; Centre for Addiction and Mental Health; endowed Chair in Addictions; National Cancer Institute [00301145, 01621009, 01621022, 00332644, 00326781, 00322205]; National Institute of Drug Abuse [00087880, 00086385]; NATIONAL CANCER INSTITUTE [P50CA084724, K05CA139871, R01CA071358] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA033813, R01DA015732, R01DA003706, R01DA011170, P50DA019706, U01DA020830] Funding Source: NIH RePORTER	Medco Health Solutions, Inc.; Affymetrix, Inc.; SRI International; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Cancer Institute, of the United States Department of Health and Human Services; University of California Tobacco Related Diseases Research Program(University of California System); Centre for Addiction and Mental Health; endowed Chair in Addictions; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, by: a Research Agreement between Medco Health Solutions, Inc., Affymetrix, Inc., and SRI International; grants and a contract from the National Institute of Drug Abuse, and grants from the National Cancer Institute, of the United States Department of Health and Human Services [R21 DA33813 to AWB; NIH/NIDA Contract No. HHSN271201300004C to JWB; R01 DA03706 to HH; R01s DA16752, DA18691, DA15732 and DA9253 to SH; P50 CA84724, K05 CA139871 and P50 DA19706 to TBB; R01s CA71358 and DA11170 to GES; and PGRN U01 DA20830 to NLB (2005-2010), and to RFT and CL (2010-2015)]; a grant from the University of California Tobacco Related Diseases Research Program (7PT2004 to NLB); by the Centre for Addiction and Mental Health (RFT); and by an endowed Chair in Addictions (RFT). Clinical trials (NCT Trial IDs) 00301145, 01621009, 01621022 and 00332644 were funded by the National Cancer Institute, 00087880 and 00086385 were funded by the National Institute of Drug Abuse, and 00326781 and 00322205 were funded by the National Cancer Institute and by the National Institute of Drug Abuse. Varenicline and nominal support for recruiting clinical trial 00301145 participants was provided by Pfizer. GlaxoSmithKline provided medication for clinical trials 01621022 and 00332644. Medco Health Solutions, Inc. and Affymetrix, Inc. participated with SRI International in the selection of the two clinical laboratory metabolic studies, of the metabolic outcome, and of the DMET Plus Array for genotyping and Affymetrix performed the DMET Plus Array genotyping of the two clinical laboratory metabolic study DNA samples. No other funders or sponsors had any other role in the design of the laboratory studies, the randomized controlled trials or of this two-stage study, the collection, analysis, or interpretation of data, the writing of, or the decision to submit the ms. BioRealm, LLC provided support in the form of a salary for author JWB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergen AW, 2013, PHARMACOGENET GENOM, V23, P94, DOI 10.1097/FPC.0b013e32835cdabd; Bloom AJ, 2013, PHARMACOGENET GENOM, V23, P706, DOI [10.1097/FPC.0b013e32835c3b48, 10.1097/FPC.0000000000000011]; Bloom AJ, 2013, PHARMACOGENET GENOM, V23, P107, DOI 10.1097/FPC.0b013e32835caf7d; Bloom J, 2011, PHARMACOGENET GENOM, V21, P403, DOI 10.1097/FPC.0b013e328346e8c0; Chang MH, 2009, AM J EPIDEMIOL, V169, P54, DOI 10.1093/aje/kwn286; Chen LS, 2014, ADDICTION, V109, P128, DOI 10.1111/add.12353; Chenoweth MJ, 2014, PHARMACOGENET GENOM, V24, P172, DOI 10.1097/FPC.0000000000000031; Conneely KN, 2010, GENET EPIDEMIOL, V34, P739, DOI 10.1002/gepi.20538; Conneely KN, 2007, AM J HUMAN GENETICS, V81; Deeken J, 2009, CURR OPIN MOL THER, V11, P260; Dempsey D, 2004, CLIN PHARMACOL THER, V76, P64, DOI 10.1016/j.clpt.2004.02.011; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Falcone M, 2011, NICOTINE TOB RES, V13, P498, DOI 10.1093/ntr/ntr012; Gauderman W. J., 2006, QUANTO COMPUTER PROG; Haberl M, 2005, PHARMACOGENET GENOM, V15, P609, DOI 10.1097/01.fpc.0000171517.22258.f1; Hall SM, 2008, NICOTINE TOB RES, V10, P463, DOI 10.1080/14622200801901922; Hall SM, 2009, ADDICTION, V104, P1043, DOI 10.1111/j.1360-0443.2009.02548.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Lee AM, 2007, BIOL PSYCHIAT, V62, P635, DOI 10.1016/j.biopsych.2006.10.005; Lee AM, 2007, CANCER EPIDEM BIOMAR, V16, P1312, DOI 10.1158/1055-9965.EPI-07-0188; Lerman C, 2006, NEUROPSYCHOPHARMACOL, V31, P231, DOI 10.1038/sj.npp.1300861; Lerman C, 2006, CLIN PHARMACOL THER, V79, P600, DOI 10.1016/j.clpt.2006.02.006; McCarthy DE, 2008, NICOTINE TOB RES, V10, P717, DOI 10.1080/14622200801968343; Messina ES, 1997, J PHARMACOL EXP THER, V282, P1608; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mwenifumbo JC, 2008, HUM MUTAT, V29, P679, DOI 10.1002/humu.20698; Nakajima M, 1996, J PHARMACOL EXP THER, V277, P1010; Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212; Nishita DM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-71; Piper ME, 2007, NICOTINE TOB RES, V9, P947, DOI 10.1080/14622200701540820; Piper ME, 2009, ARCH GEN PSYCHIAT, V66, P1253, DOI 10.1001/archgenpsychiatry.2009.142; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabe-Hesketh S, 2008, BIOMETRICS, V64, P280, DOI 10.1111/j.1541-0420.2007.00803.x; Ring HZ, 2007, PHARMACOGENET GENOM, V17, P1007, DOI 10.1097/01.fpc.0000220560.59972.33; Rubin DB, 2004, MULTIPLE IMPUTATION; Schnoll R. A., 2015, LANCET RESP MED, V3, P131; Sim SC, 2014, HUMAN CYTOCHROME P45; Strasser AA, 2011, CANCER EPIDEM BIOMAR, V20, P234, DOI 10.1158/1055-9965.EPI-10-0674; Swan GE, 2010, AM J PREV MED, V38, P482, DOI 10.1016/j.amepre.2010.01.024; Swan GE, 2004, TWIN RES, V7, P435, DOI 10.1375/twin.7.5.435; Swan GE, 2003, CANCER EPIDEM BIOMAR, V12, P994; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	47	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0126113	10.1371/journal.pone.0126113	http://dx.doi.org/10.1371/journal.pone.0126113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132489	Green Published, gold			2022-12-26	WOS:000358153000004
J	Lesmerises, R; Rebouillat, L; Dussault, C; St-Laurent, MH				Lesmerises, Remi; Rebouillat, Lucie; Dussault, Claude; St-Laurent, Martin-Hugues			Linking GPS Telemetry Surveys and Scat Analyses Helps Explain Variability in Black Bear Foraging Strategies	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; MOUNTAIN NATIONAL-PARK; BOREAL FOREST; BROWN BEARS; HABITAT SELECTION; STABLE-ISOTOPES; SNOWSHOE HARE; FOOD-HABITS; DIETS; POPULATION	Studying diet is fundamental to animal ecology and scat analysis, a widespread approach, is considered a reliable dietary proxy. Nonetheless, this method has weaknesses such as non-random sampling of habitats and individuals, inaccurate evaluation of excretion date, and lack of assessment of inter-individual dietary variability. We coupled GPS telemetry and scat analyses of black bears Ursus americanus Pallas to relate diet to individual characteristics and habitat use patterns while foraging. We captured 20 black bears (6 males and 14 females) and fitted them with GPS/Argos collars. We then surveyed GPS locations shortly after individual bear visits and collected 139 feces in 71 different locations. Fecal content (relative dry matter biomass of ingested items) was subsequently linked to individual characteristics (sex, age, reproductive status) and to habitats visited during foraging bouts using Brownian bridges based on GPS locations prior to feces excretion. At the population level, diet composition was similar to what was previously described in studies on black bears. However, our individual-based method allowed us to highlight different intra-population patterns, showing that sex and female reproductive status had significant influence on individual diet. For example, in the same habitats, females with cubs did not use the same food sources as lone bears. Linking fecal content (i.e., food sources) to habitat previously visited by different individuals, we demonstrated a potential differential use of similar habitats dependent on individual characteristics. Females with cubs-of-the-year tended to use old forest clearcuts (6-20 years old) to feed on bunchberry, whereas females with yearling foraged for blueberry and lone bears for ants. Coupling GPS telemetry and scat analyses allows for efficient detection of inter-individual or inter-group variations in foraging strategies and of linkages between previous habitat use and food consumption, even for cryptic species. This approach could have interesting ecological implications, such as supporting the identification of habitats types abundant in important food sources for endangered species targeted by conservation measures or for management actions for depredating animals.	[Lesmerises, Remi] Univ Quebec, Ctr Northen Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Rebouillat, Lucie] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Dussault, Claude] Minist Forets, Direct Gest Faune Saguenay Lac St Jean, Quebec City, PQ, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Forest Res, Ctr Northen Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada	University of Quebec; University of Quebec; University of Quebec	St-Laurent, MH (corresponding author), Univ Quebec, Ctr Forest Res, Ctr Northen Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	martin-hugues_st-laurent@uqar.ca			Fonds de recherche du Quebec - Nature et technologies; Fonds de la recherche forestiere du Saguenay-Lac-St-Jean; Natural Sciences and Engineering Research Council of Canada (Discovery Grant) [386661-2010]; Ministere des Forets, de la Faune et des Parcs du Quebec; Universite du Quebec a Rimouski; Resolute Forest Products Inc.	Fonds de recherche du Quebec - Nature et technologies; Fonds de la recherche forestiere du Saguenay-Lac-St-Jean; Natural Sciences and Engineering Research Council of Canada (Discovery Grant)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministere des Forets, de la Faune et des Parcs du Quebec; Universite du Quebec a Rimouski; Resolute Forest Products Inc.	This project was funded by the Fonds de recherche du Quebec - Nature et technologies (http://www.frqnt.gouv.qc.ca/), the Fonds de la recherche forestiere du Saguenay-Lac-St-Jean (http://www.foretboreale.com/), the Natural Sciences and Engineering Research Council of Canada (Discovery Grant #386661-2010; http://www.nserccrsng.gc.ca/), the Ministere des Forets, de la Faune et des Parcs du Quebec (http://www.mffp.gouv.qc.ca/), Resolute Forest Products Inc. (http://www.resolutefp.com/) and the Universite du Quebec a Rimouski (http://www.uqar.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RA, 2009, CAN J ZOOL, V87, P1000, DOI 10.1139/Z09-088; Baldwin Roger A., 2009, Human-Wildlife Conflicts, V3, P271; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Brodeur V, 2008, CAN J ZOOL, V86, P1307, DOI 10.1139/Z08-118; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Calenge C, 2015, HOME RANGE ESTIMATIO; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Elfstrom M, 2014, BIOL CONSERV, V178, P128, DOI 10.1016/j.biocon.2014.08.003; Elfstrom M, 2013, WILDLIFE BIOL, V19, P317, DOI 10.2981/12-121; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; ESRI, 2010, ARCGIS DESKTOP 10 0; Farley SD, 1995, CAN J ZOOL, V73, P2216, DOI 10.1139/z95-262; FERRON J, 1992, CAN J ZOOL, V70, P2178, DOI 10.1139/z92-294; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Fuller G, 2011, ZOO BIOL, V30, P379, DOI 10.1002/zoo.20339; Giroux MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049719; Hewitt DG, 1996, WILDLIFE SOC B, V24, P547; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hunter S. A., 2011, THESIS; KEITH LB, 1966, CAN J ZOOLOG, V44, P953, DOI 10.1139/z66-097; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; LECOUNT A. L., 1987, INT C BEAR RES MANAG, V7, P75, DOI DOI 10.2307/3872610; Lesmerises R, 2015, DATA FROM LINKING GP; Litvaitis JA, 2000, METH C CONS, P165; MACCRACKEN JG, 1987, J WILDLIFE MANAGE, V51, P278, DOI 10.2307/3801003; Martins Q, 2011, J ZOOL, V283, P81, DOI 10.1111/j.1469-7998.2010.00757.x; MCINNIS ML, 1983, J RANGE MANAGE, V36, P302, DOI 10.2307/3898474; Mosnier A, 2008, ECOSCIENCE, V15, P485, DOI 10.2980/15-4-3100; Noyce KV, 1997, CAN J ZOOL, V75, P1671, DOI 10.1139/z97-794; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Panasci M, 2011, J WILDLIFE MANAGE, V75, P1616, DOI 10.1002/jwmg.221; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; R Development Core Team, 2013, LANG ENV STAT COMP; RAINE RM, 1990, INT C BEAR, V8, P297; Ramon-Laca A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092043; Robitaille A., 1998, PAYSAGES REGIONAUX D; ROGERS LL, 1987, WILDLIFE MONOGR, P1; ROGERS LL, 1990, INT C BEAR, V8, P321; Sanders K. D., 1980, J RANGE MANAGE, V33, P146, DOI DOI 10.2307/3898431; SMITH DW, 1994, AM MIDL NAT, V132, P248, DOI 10.2307/2426580; Spaulding R, 2000, WILDLIFE SOC B, V28, P947; Steyaert SMJG, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0624; Tambling CJ, 2012, J ZOOL, V286, P102, DOI 10.1111/j.1469-7998.2011.00856.x; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090	52	20	21	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129857	10.1371/journal.pone.0129857	http://dx.doi.org/10.1371/journal.pone.0129857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132204	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000043
J	Shigemizu, D; Aiba, T; Nakagawa, H; Ozaki, K; Miya, F; Satake, W; Toda, T; Miyamoto, Y; Fujimoto, A; Suzuki, Y; Kubo, M; Tsunoda, T; Shimizu, W; Tanaka, T				Shigemizu, Daichi; Aiba, Takeshi; Nakagawa, Hidewaki; Ozaki, Kouichi; Miya, Fuyuki; Satake, Wataru; Toda, Tatsushi; Miyamoto, Yoshihiro; Fujimoto, Akihiro; Suzuki, Yutaka; Kubo, Michiaki; Tsunoda, Tatsuhiko; Shimizu, Wataru; Tanaka, Toshihiro			Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; CARDIAC RYANODINE RECEPTOR; SEQUENCING DATA; CALCIUM-CHANNEL; CA2+ RELEASE; WHOLE-GENOME; SUDDEN-DEATH; ASSOCIATION; VARIANTS; ARRHYTHMIAS	Long QT syndrome (LQTS) is an arrhythmogenic disorder that can lead to sudden death. To date, mutations in 15 LQTS-susceptibility genes have been implicated. However, the genetic cause for approximately 20% of LQTS patients remains elusive. Here, we performed whole-exome sequencing analyses on 59 LQTS and 61 unaffected individuals in 35 families and 138 unrelated LQTS cases, after genetic screening of known LQTS genes. Our systematic analysis of familial cases and subsequent verification by Sanger sequencing identified 92 candidate mutations in 88 genes for 23 of the 35 families (65.7%): these included eleven de novo, five recessive (two homozygous and three compound heterozygous) and seventy-three dominant mutations. Although no novel commonly mutated gene was identified other than known LQTS genes, protein-protein interaction (PPI) network analyses revealed ten new pathogenic candidates that directly or indirectly interact with proteins encoded by known LQTS genes. Furthermore, candidate gene based association studies using an independent set of 138 unrelated LQTS cases and 587 controls identified an additional novel candidate. Together, mutations in these new candidates and known genes explained 37.1% of the LQTS families (13 in 35). Moreover, half of the newly identified candidates directly interact with calmodulin (5 in 11; comparison with all genes; p=0.042). Subsequent variant analysis in the independent set of 138 cases identified 16 variants in the 11 genes, of which 14 were in calmodulin-interacting genes (87.5%). These results suggest an important role of calmodulin and its interacting proteins in the pathogenesis of LQTS.	[Shigemizu, Daichi; Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Aiba, Takeshi; Shimizu, Wataru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan; [Nakagawa, Hidewaki; Fujimoto, Akihiro] RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Yokohama, Kanagawa, Japan; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Satake, Wataru; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan; [Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Suzuki, Yutaka] Univ Tokyo, Div Biosyst Sci, Dept Computat Biol, Chiba, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Tanaka, Toshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Div, Tokyo, Japan	RIKEN; National Cerebral & Cardiovascular Center - Japan; RIKEN; RIKEN; Kobe University; National Cerebral & Cardiovascular Center - Japan; University of Tokyo; RIKEN; Nippon Medical School; Tokyo Medical & Dental University (TMDU)	Shimizu, W (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan.	wshimizu@nms.ac.jp; toshitan@src.riken.jp	Kubo, Michiaki/N-7947-2015; Tanaka, Toshihiro/J-9310-2014; Tsunoda, Tatsuhiko/K-2061-2014	Tanaka, Toshihiro/0000-0001-6201-9784; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ozaki, Kouichi/0000-0003-0028-1570; Miya, Fuyuki/0000-0001-6758-2015	Ministry of Health, Labour and Welfare, Japan [H24-033, H26-040]; Grants-in-Aid for Scientific Research [25713015] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Drs. W. Shimizu, TA, YM, and T. Tanaka were supported in part by the Research Grant for the Cardiovascular Diseases (H24-033, H26-040) from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Berggard T, 2006, J PROTEOME RES, V5, P669, DOI 10.1021/pr050421l; Boczek NJ, 2013, CIRC-CARDIOVASC GENE, V6, P279, DOI 10.1161/CIRCGENETICS.113.000138; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Drimba L, 2013, N-S ARCH PHARMACOL, V386, P435, DOI 10.1007/s00210-013-0845-4; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gandini MA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187757; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; Hino A, 2012, CARDIOVASC RES, V96, P433, DOI 10.1093/cvr/cvs271; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Iwata Y, 1998, FEBS LETT, V423, P173, DOI 10.1016/S0014-5793(98)00085-4; Jiang DW, 2010, CHANNELS, V4, P302, DOI 10.4161/chan.4.4.12666; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kauferstein S, 2011, INT J CARDIOL, V146, P249, DOI 10.1016/j.ijcard.2010.10.062; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meli AC, 2011, CIRC RES, V109, P281, DOI 10.1161/CIRCRESAHA.111.244970; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishio Y, 2009, J AM COLL CARDIOL, V54, P812, DOI 10.1016/j.jacc.2009.06.005; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwartz PJ, 2011, CIRCULATION, V124, P2181, DOI 10.1161/CIRCULATIONAHA.111.062182; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Shigemizu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02161; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Team RDC, 2009, R LANG ENV STAT COMP; Tester DJ, 2007, HEART RHYTHM, V4, P733, DOI 10.1016/j.hrthm.2007.02.026; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; van Noord C, 2010, EUR J ENDOCRINOL, V162, P241, DOI 10.1530/EJE-09-0878; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200	53	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130329	10.1371/journal.pone.0130329	http://dx.doi.org/10.1371/journal.pone.0130329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132555	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000061
J	Bull, LN; Hu, DL; Shah, S; Temple, L; Silva, K; Huntsman, S; Melgar, J; Geiser, MT; Sanford, U; Ortiz, JA; Lee, RH; Kusanovic, JP; Ziv, E; Vargas, JE				Bull, Laura N.; Hu, Donglei; Shah, Sohela; Temple, Luisa; Silva, Karla; Huntsman, Scott; Melgar, Jennifer; Geiser, Mary T.; Sanford, Ukina; Ortiz, Juan A.; Lee, Richard H.; Kusanovic, Juan P.; Ziv, Elad; Vargas, Juan E.			Intrahepatic Cholestasis of Pregnancy (ICP) in US Latinas and Chileans: Clinical features, Ancestry Analysis, and Admixture Mapping	PLOS ONE			English	Article							PHOSPHOLIPID TRANSPORTER ABCB4; LOCAL ANCESTRY; GENE VARIANTS; MDR3; SUSCEPTIBILITY; INFERENCE; LOCUS; RISK	In the Americas, women with Indigenous American ancestry are at increased risk of intrahepatic cholestasis of pregnancy (ICP), relative to women of other ethnicities. We hypothesized that ancestry-related genetic factors contribute to this increased risk. We collected clinical and laboratory data, and performed biochemical assays on samples from U.S. Latinas and Chilean women, with and without ICP. The study sample included 198 women with ICP (90 from California, U.S., and 108 from Chile) and 174 pregnant control women (69 from California, U.S., and 105 from Chile). SNP genotyping was performed using Affymetrix arrays. We compared overall genetic ancestry between cases and controls, and used a genome-wide admixture mapping approach to screen for ICP susceptibility loci. We identified commonalities and differences in features of ICP between the 2 countries and determined that cases had a greater proportion of Indigenous American ancestry than did controls (p = 0.034). We performed admixture mapping, taking country of origin into account, and identified one locus for which Native American ancestry was associated with increased risk of ICP at a genome-wide level of significance (P = 3.1 x 10(-5), P-corrected = 0.035). This locus has an odds ratio of 4.48 (95% CI: 2.21-9.06) for 2 versus zero Indigenous American chromosomes. This locus lies on chromosome 2, with a 10 Mb 95% confidence interval which does not contain any previously identified hereditary 'cholestasis genes.' Our results indicate that genetic factors contribute to the risk of developing ICP in the Americas, and support the utility of clinical and genetic studies of ethnically mixed populations for increasing our understanding of ICP.	[Bull, Laura N.; Shah, Sohela; Temple, Luisa; Melgar, Jennifer; Geiser, Mary T.; Sanford, Ukina] Univ Calif San Francisco, Dept Med, Liver Ctr Lab, San Francisco, CA 94110 USA; [Bull, Laura N.; Hu, Donglei; Shah, Sohela; Temple, Luisa; Huntsman, Scott; Melgar, Jennifer; Geiser, Mary T.; Sanford, Ukina; Ziv, Elad] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Hu, Donglei; Huntsman, Scott; Ziv, Elad] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; [Silva, Karla; Kusanovic, Juan P.] Hosp Dr Sotero del Rio, Ctr Res & Innovat Maternal Fetal Med, Puente Alto, Chile; [Silva, Karla; Ortiz, Juan A.; Kusanovic, Juan P.] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Puente Alto, Chile; [Ortiz, Juan A.] Clnn Santa Maria, Dept Obstet & Gynecol, Santiago, Chile; [Lee, Richard H.] Los Angeles Cty Univ Southern Calif, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA USA; [Kusanovic, Juan P.] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, Santiago, Chile; [Vargas, Juan E.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Vargas, Juan E.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Pontificia Universidad Catolica de Chile; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bull, LN (corresponding author), Univ Calif San Francisco, Dept Med, Liver Ctr Lab, San Francisco, CA 94110 USA.	Laura.Bull@ucsf.edu	Kusanovic, Juan Pedro/R-8616-2019; Kusanovic, Juan Pedro/AAM-5782-2020	Kusanovic, Juan Pedro/0000-0003-0640-2070	UCSF Liver Center [P30 DK026743]; U.S. National Institutes of Health;  [K24 CA169004];  [R01 DK58214]; NATIONAL CANCER INSTITUTE [K24CA169004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058214, P30DK026743] Funding Source: NIH RePORTER	UCSF Liver Center; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by R01 DK58214 and accompanying ARRA supplement (to LNB), K24 CA169004 (to EZ) and by a Tool and Technology grant from the UCSF Liver Center (P30 DK026743, to LNB). All of this funding is from the U.S. National Institutes of Health.	Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub2; Anzivino C, 2013, DIGEST LIVER DIS, V45, P226, DOI 10.1016/j.dld.2012.08.011; Arrese Marco, 2006, Ann Hepatol, V5, P202; Bacq Y, 2009, J MED GENET, V46, P711, DOI 10.1136/jmg.2009.067397; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Castano G, 2010, ALIMENT PHARM THER, V31, P583, DOI 10.1111/j.1365-2036.2009.04210.x; Dixon PH, 2009, GUT, V58, P537, DOI 10.1136/gut.2008.159541; Dixon PH, 2014, AM J GASTROENTEROL, V109, P76, DOI 10.1038/ajg.2013.406; Eloranta ML, 2001, CLIN GENET, V60, P42, DOI 10.1034/j.1399-0004.2001.600106.x; Fejerman L, 2012, HUM MOL GENET, V21, P1907, DOI 10.1093/hmg/ddr617; FISK NM, 1988, BRIT J OBSTET GYNAEC, V95, P1137, DOI 10.1111/j.1471-0528.1988.tb06791.x; Floreani A, 2008, DIGEST LIVER DIS, V40, P366, DOI 10.1016/j.dld.2007.10.016; Floreani A, 2006, ALIMENT PHARM THERAP, V23, P1649, DOI 10.1111/j.1365-2036.2006.02869.x; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; He H, 2011, HEPATOLOGY, V53, P548, DOI 10.1002/hep.24047; Laifer S A, 2001, J Matern Fetal Med, V10, P131, DOI 10.1080/714052719; Lee RH, 2006, J PERINATOL, V26, P527, DOI 10.1038/sj.jp.7211545; Lee YS, 2012, J GASTROEN HEPATOL, V27, P75, DOI 10.1111/j.1440-1746.2011.07007.x; Martineau M, 2014, EUR J OBSTET GYNECOL; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; Meier Y, 2008, WORLD J GASTROENTERO, V14, P38, DOI 10.3748/wjg.14.38; Pasaniuc B, 2013, BIOINFORMATICS, V29, P1407, DOI 10.1093/bioinformatics/btt166; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Pauli-Magnus C, 2004, PHARMACOGENETICS, V14, P91, DOI 10.1097/00008571-200402000-00003; Rook M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028343; Schneider G, 2007, HEPATOLOGY, V45, P150, DOI 10.1002/hep.21500; Sookoian S, 2008, J HEPATOL, V48, P125, DOI 10.1016/j.jhep.2007.08.015; Tavian D, 2009, DIGEST LIVER DIS, V41, P671, DOI 10.1016/j.dld.2008.12.101; Wasmuth HE, 2007, GUT, V56, P265, DOI 10.1136/gut.2006.092742; Williamson C, 2014, OBSTET GYNECOL, V124, P120, DOI 10.1097/AOG.0000000000000346	32	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131211	10.1371/journal.pone.0131211	http://dx.doi.org/10.1371/journal.pone.0131211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126184	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300039
J	Francis, WR; Shaner, NC; Christianson, LM; Powers, ML; Haddock, SHD				Francis, Warren R.; Shaner, Nathan C.; Christianson, Lynne M.; Powers, Meghan L.; Haddock, Steven H. D.			Occurrence of Isopenicillin-N-Synthase Homologs in Bioluminescent Ctenophores and Implications for Coelenterazine Biosynthesis	PLOS ONE			English	Article							MNEMIOPSIS-LEIDYI; CYPRIDINA LUCIFERIN; MAXIMUM-LIKELIHOOD; GENOME; EVOLUTION; MODEL; SEA	The biosynthesis of the luciferin coelenterazine has remained a mystery for decades. While not all organisms that use coelenterazine appear to make it themselves, it is thought that ctenophores are a likely producer. Here we analyze the transcriptome data of 24 species of ctenophores, two of which have published genomes. The natural precursors of coelenterazine have been shown to be the amino acids L-tyrosine and L-phenylalanine, with the most likely biosynthetic pathway involving cyclization and further modification of the tripeptide Phe-Tyr-Tyr ("FYY"). Therefore, we searched the ctenophore transcriptome data for genes with the short peptide "FYY" as part of their coding sequence. We recovered a group of candidate genes for coelenterazine biosynthesis in the luminous species which encode a set of highly conserved non-heme iron oxidases similar to isopenicillin-N-synthase. These genes were absent in the transcriptomes and genome of the two non-luminous species. Pairwise identities and substitution rates reveal an unusually high degree of identity even between the most unrelated species. Additionally, two related groups of non-heme iron oxidases were found across all ctenophores, including those which are non-luminous, arguing against the involvement of these two gene groups in luminescence. Important residues for iron-binding are conserved across all proteins in the three groups, suggesting this function is still present. Given the known functions of other members of this protein superfamily are involved in heterocycle formation, we consider these genes to be top candidates for laboratory characterization or gene knockouts in the investigation of coelenterazine biosynthesis.	[Francis, Warren R.; Christianson, Lynne M.; Powers, Meghan L.; Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Francis, Warren R.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Shaner, Nathan C.] Scintillon Inst, San Diego, CA 92121 USA	Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz	Haddock, SHD (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	haddock@mbari.org		Shaner, Nathan/0000-0002-0148-0769; Francis, Warren/0000-0003-3473-4726	NIGMS [5R01GM087198-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087198] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS: 5R01GM087198-04 (see http://projectreporter.nih.gov/project_info_description.cfm?aid=8296563&icde=21255180).	Allman GJ, 1862, P ROY SOC EDINB, V4, P518; BUSKEY EJ, 1991, J PLANKTON RES, V13, P885, DOI 10.1093/plankt/13.4.885; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAMPBELL AK, 1990, MAR BIOL, V104, P219, DOI 10.1007/BF01313261; Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; FREEMAN G, 1973, DEV BIOL, V31, P61, DOI 10.1016/0012-1606(73)90321-7; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Haddock SHD, 2001, P NATL ACAD SCI USA, V98, P11148, DOI 10.1073/pnas.201329798; Haddock SHD, 1999, MAR BIOL, V133, P571, DOI 10.1007/s002270050497; Haddock SHD, 1995, BIOL BULL-US, V189, P356, DOI 10.2307/1542153; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Harvey E.N., 1952, BIOLUMINESCENCE; Harvey EN, 1926, AM J PHYSIOL, V77, P548, DOI 10.1152/ajplegacy.1926.77.3.548; HORI K, 1977, P NATL ACAD SCI USA, V74, P4285, DOI 10.1073/pnas.74.10.4285; Kato S, 2007, HETEROCYCLES, V72, P673; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kishi T, 1966, TETRAHEDRON LETT, V7, P3427, DOI [10.1016/S0040-4039(01)82806-9, DOI 10.1016/S0040-4039(01)82806-9]; Krichevsky A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015461; MCCAPRA F, 1972, J CHEM SOC CHEM COMM, P894, DOI 10.1039/c39720000894; MOROZ LL, 2014, NATURE, V17, P1, DOI DOI 10.1038/NATURE13400; Oba Y, 2009, BIOCHEM BIOPH RES CO, V390, P684, DOI 10.1016/j.bbrc.2009.10.028; Pang K., 2008, CSH PROTOC, DOI DOI 10.1101/PDB.PROT5085; Peters AW, 1905, J EXP ZOOL, V2, P103, DOI 10.1002/jez.1400020103; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Roelofs D, 2013, MOL BIOL EVOL, V30, P541, DOI 10.1093/molbev/mss269; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Schulz M. H., 2012, BIOINF ADV ACCESS, V28, P1; SHIMOMURA O, 1975, P NATL ACAD SCI USA, V72, P1546, DOI 10.1073/pnas.72.4.1546; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; THOMSON CM, 1995, J MAR BIOL ASSOC UK, V75, P165, DOI 10.1017/S0025315400015277; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	18	18	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0128742	10.1371/journal.pone.0128742	http://dx.doi.org/10.1371/journal.pone.0128742			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125183	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300005
J	Sampson, JF; Hasegawa, E; Mulki, L; Suryawanshi, A; Jiang, SH; Chen, WS; Rabinovich, GA; Connor, KM; Panjwani, N				Sampson, James F.; Hasegawa, Eiichi; Mulki, Lama; Suryawanshi, Amol; Jiang, Shuhong; Chen, Wei-Sheng; Rabinovich, Gabriel A.; Connor, Kip M.; Panjwani, Noorjahan			Galectin-8 Ameliorates Murine Autoimmune Ocular Pathology and Promotes a Regulatory T Cell Response	PLOS ONE			English	Article							LEISHMANIA-MAJOR INFECTION; STEM-CELLS; IN-VIVO; DISEASE; UVEITIS; UVEORETINITIS; TH17; INFLAMMATION; SUPPRESSES; TOLERANCE	Galectins have emerged as potent immunoregulatory agents that control chronic inflammation through distinct mechanisms. Here, we report that treatment with Galectin-8 (Gal-8), a tandem-repeat member of the galectin family, reduces retinal pathology and prevents photoreceptor cell damage in a murine model of experimental autoimmune uveitis. Gal-8 treatment increased the number of regulatory T cells (Treg) in both the draining lymph node (dLN) and the inflamed retina. Moreover, a greater percentage of Treg cells in the dLN and retina of Gal-8 treated animals expressed the inhibitory coreceptor cytotoxic T lymphocyte antigen (CTLA)-4, the immunosuppressive cytokine IL-10, and the tissue-homing integrin CD103. Treg cells in the retina of Gal-8-treated mice were primarily inducible Treg cells that lack the expression of neuropilin-1. In addition, Gal-8 treatment blunted production of inflammatory cytokines by retinal T helper type (T-H) 1 and T(H)17 cells. The effect of Gal-8 on T cell differentiation and/or function was specific for tissues undergoing an active immune response, as Gal-8 treatment had no effect on T cell populations in the spleen. Given the need for rational therapies for managing human uveitis, Gal-8 emerges as an attractive therapeutic candidate not only for treating retinal autoimmune diseases, but also for other T(H)1-and T(H)17-mediated inflammatory disorders.	[Sampson, James F.; Panjwani, Noorjahan] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Immunol, Boston, MA 02111 USA; [Hasegawa, Eiichi; Mulki, Lama; Connor, Kip M.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02114 USA; [Suryawanshi, Amol; Panjwani, Noorjahan] Tufts Univ, Sch Med, New England Eye Ctr, Dept Ophthalmol, Boston, MA 02111 USA; [Jiang, Shuhong] Tufts Univ, JM USDA HNRCA, Lab Nutr & Vis Res, Boston, MA 02111 USA; [Jiang, Shuhong; Panjwani, Noorjahan] Peoples Hosp Inner Mongolia, Dept Ophthalmol, Hohhot, Peoples R China; [Chen, Wei-Sheng] Tufts Univ, Sackler Sch Grad Biomed Sci, Cell Mol & Dev Biol, Boston, MA 02111 USA; [Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Lab Inmunopatol, IBYME, RA-1033 Buenos Aires, DF, Argentina	Tufts University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Tufts University; Tufts University; United States Department of Agriculture (USDA); Tufts University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Connor, KM (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02114 USA.	kip_connor@meei.harvard.edu; Noorjahan.panjwani@tufts.edu	Jiang, Shuhong/AAQ-7147-2021; Suryawanshi, Amol/J-3787-2019; Jiang, Shuhong/C-1596-2019	Suryawanshi, Amol/0000-0001-5031-5818; Jiang, Shuhong/0000-0003-3659-5950; Connor, Kip/0000-0002-2048-9080	National Eye Institute [R01EY007088, R01EY009349, R01EY022084-01/S1]; Mass Lions Eye Research fund; New England Corneal Transplant Fund; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY007088, R01EY022084, R01EY009349] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Mass Lions Eye Research fund; New England Corneal Transplant Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was generously supported by National Eye Institute (https://www.nei.nih.gov/) Grants R01EY007088 (NP), R01EY009349 (NP), R01EY022084-01/S1 (KMC), Mass Lions Eye Research fund (NP), New England Corneal Transplant Fund (NP) and an unrestricted award from Research to Prevent Blindness (http://www.rpbusa.org/rpb/NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Avichezer D, 2003, J EXP MED, V198, P1665, DOI 10.1084/jem.20030413; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; CASPI RR, 1988, J IMMUNOL, V140, P1490; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; Diskin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044400; Fermino ML, 2013, EUR J IMMUNOL, V43, P1806, DOI 10.1002/eji.201343381; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Grajewski RS, 2006, J EXP MED, V203, P851, DOI 10.1084/jem.20050429; Haruta H, 2011, INVEST OPHTH VIS SCI, V52, P3264, DOI 10.1167/iovs.10-6272; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Ilhan F, 2008, CAN J OPHTHALMOL, V43, P105, DOI 10.3129/i07-179; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Lee DJ, 2009, INT IMMUNOPHARMACOL, V9, P1079, DOI 10.1016/j.intimp.2009.05.001; Li G, 2013, CLIN EXP IMMUNOL, V173, P28, DOI 10.1111/cei.12080; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Massardo L, 2009, LUPUS, V18, P539, DOI 10.1177/0961203308099973; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Quattroni P, 2012, CELL MICROBIOL, V14, P1657, DOI 10.1111/j.1462-5822.2012.01838.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Ruggieri S, 2012, OCUL IMMUNOL INFLAMM, V20, P255, DOI 10.3109/09273948.2012.681830; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sun B, 2000, EXP EYE RES, V70, P493, DOI 10.1006/exer.1999.0808; Sun B, 1997, J IMMUNOL, V159, P1004; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; Tsai CM, 2011, J IMMUNOL, V187, P1643, DOI 10.4049/jimmunol.1100297; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yin H, 2009, J NEUROIMMUNOL, V215, P43, DOI 10.1016/j.jneuroim.2009.08.002; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	48	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130772	10.1371/journal.pone.0130772	http://dx.doi.org/10.1371/journal.pone.0130772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126176	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300025
J	Yang, CH; Chou, KT; Chung, MB; Chuang, KS; Huang, TC				Yang, Chin-Hua; Chou, Kuei-Ting; Chung, Mu-Bai; Chuang, K. S.; Huang, Tzung-Chi			Automatic Detection of Calcaneal-Fifth Metatarsal Angle Using Radiograph: A Computer-Aided Diagnosis of Flat Foot for Military New Recruits in Taiwan	PLOS ONE			English	Article							MEDIAL LONGITUDINAL ARCH; CHILDREN; FOOTPRINTS	Flatfoot (pes planus) is one of the most important physical examination items for military new recruits in Taiwan. Currently, the diagnosis of flatfoot is mainly based on radiographic examination of the calcaneal-fifth metatarsal (CA-MT5) angle, also known as the arch angle. However, manual measurement of the arch angle is time-consuming and often inconsistent between different examiners. In this study, seventy male military new recruits were studied. Lateral radiographic images of their right and left feet were obtained, and mutual information (MI) registration was used to automatically calculate the arch angle. Images of two critical bones, the calcaneus and the fifth metatarsal bone, were isolated from the lateral radiographs to form reference images, and were then compared with template images to calculate the arch angle. The result of this computer-calculated arch angle was compared with manual measurement results from two radiologists, which showed that our automatic arch angle measurement method had a high consistency. In addition, this method had a high accuracy of 97% and 96% as compared with the measurements of radiologists A and B, respectively. The findings indicated that our MI registration measurement method cannot only accurately measure the CA-MT5 angle, but also saves time and reduces human error. This method can increase the consistency of arch angle measurement and has potential clinical application for the diagnosis of flatfoot.	[Yang, Chin-Hua; Chung, Mu-Bai] Tao Yuan Gen Hosp, Dept Radiol, Minist Hlth & Welf, Taoyuan, Taiwan; [Yang, Chin-Hua; Chuang, K. S.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chou, Kuei-Ting; Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Huang, Tzung-Chi] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	National Tsing Hua University; China Medical University Taiwan; Asia University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		Tao Yuan General Hospital, Ministry of Health and Welfare, Taiwan [PTH10343]	Tao Yuan General Hospital, Ministry of Health and Welfare, Taiwan	This study was financially supported by the Tao Yuan General Hospital, Ministry of Health and Welfare, Taiwan (PTH10343). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertani A, 1999, CLIN BIOMECH, V14, P484, DOI 10.1016/S0268-0033(98)90099-7; CAVANAGH PR, 1987, J BIOMECH, V20, P547, DOI 10.1016/0021-9290(87)90255-7; Chang HW, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-76; Cobey J C, 1981, Foot Ankle, V2, P30; Gilmour JC, 2001, FOOT ANKLE INT, V22, P493, DOI 10.1177/107110070102200607; HARRIS RI, 1948, J BONE JOINT SURG BR, V30, P624, DOI 10.1302/0301-620X.30B4.624; HARRIS RL, 1948, J BONE JOINT SURG AM, V30-A, P116, DOI 10.2106/00004623-194830010-00013; HAWES MR, 1992, FOOT ANKLE, V13, P22, DOI 10.1177/107110079201300104; KAYE RA, 1991, FOOT ANKLE, V11, P244, DOI 10.1177/107110079101100414; Mickle KJ, 2006, OBESITY, V14, P1949, DOI 10.1038/oby.2006.227; National Conscription Agency Ministry of the Interior Republic of China (Taiwan), MIL SERV LAW ART 33; Nester CJ, 2000, FOOT ANKLE INT, V21, P578, DOI 10.1177/107110070002100709; ROSE GK, 1985, J BONE JOINT SURG BR, V67, P71, DOI 10.1302/0301-620X.67B1.3968149; SALTZMAN CL, 1995, ARCH PHYS MED REHAB, V76, P45, DOI 10.1016/S0003-9993(95)80041-7; Sofka CM, 2013, J MAGN RESON IMAGING, V37, P556, DOI 10.1002/jmri.23792; Villarroya MA, 2009, EUR J PEDIATR, V168, P559, DOI 10.1007/s00431-008-0789-8	16	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131387	10.1371/journal.pone.0131387	http://dx.doi.org/10.1371/journal.pone.0131387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126115	Green Submitted, gold, Green Published			2022-12-26	WOS:000358151300045
J	Kitanishi, K; Cracan, V; Banerjee, R				Kitanishi, Kenichi; Cracan, Valentin; Banerjee, Ruma			Engineered and Native Coenzyme B-12-dependent Isovaleryl-CoA/Pivalyl-CoA Mutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIVALIC ACID; FATTY-ACID; ENZYME; COBALAMIN; ADENOSYLCOBALAMIN; BIOSYNTHESIS; SUBSTRATE; CATALYSIS; INSIGHTS; PATHWAY	Adenosylcobalamin-dependent isomerases catalyze carbon skeleton rearrangements using radical chemistry. We have recently demonstrated that an isobutyryl-CoA mutase variant, IcmF, a member of this enzyme family that catalyzes the interconversion of isobutyryl-CoA and n-butyryl-CoA also catalyzes the interconversion between isovaleryl-CoA and pivalyl-CoA, albeit with low efficiency and high susceptibility to inactivation. Given the biotechnological potential of the isovaleryl-CoA/pivalyl-CoA mutase (PCM) reaction, we initially attempted to engineer IcmF to be a more proficient PCM by targeting two active site residues predicted based on sequence alignments and crystal structures, to be key to substrate selectivity. Of the eight mutants tested, the F598A mutation was the most robust, resulting in an similar to 17-fold increase in the catalytic efficiency of the PCM activity and a concomitant similar to 240-fold decrease in the isobutyryl-CoA mutase activity compared with wild-type IcmF. Hence, mutation of a single residue in IcmF tuned substrate specificity yielding an similar to 4000-fold increase in the specificity for an unnatural substrate. However, the F598A mutant was even more susceptible to inactivation than wild-type IcmF. To circumvent this limitation, we used bioinformatics analysis to identify an authentic PCM in genomic databases. Cloning and expression of the putative AdoCbl-dependent PCM with an alpha(2)beta(2) heterotetrameric organization similar to that of isobutyryl-CoA mutase and a recently characterized archaeal methylmalonyl-CoA mutase, allowed demonstration of its robust PCM activity. To simplify kinetic analysis and handling, a variant PCM-F was generated in which the alpha beta sub-units were fused into a single polypeptide via a short 11-amino acid linker. The fusion protein, PCM-F, retained high PCM activity and like PCM, was resistant to inactivation. Neither PCM nor PCM-F displayed detectable isobutyryl-CoA mutase activity, demonstrating that PCM represents a novel 5' -deoxyadenosylcobalamin-dependent acyl-CoA mutase. The newly discovered PCM and the derivative PCM-F, have potential applications in bioremediation of pivalic acid found in sludge, in stereospecific synthesis of C5 carboxylic acids and alcohols, and in the production of potential commodity and specialty chemicals.	[Kitanishi, Kenichi; Cracan, Valentin; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Regan, Clinton/E-6250-2012; Kitanishi, Kenichi/I-3323-2014	Kitanishi, Kenichi/0000-0002-2110-8104; Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [DK45776]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776 (to R. B.) and a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science (to K. K). The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee R., 1999, Chemistry and biochemistry of B12., P707; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2001, BIOCHEMISTRY-US, V40, P6191, DOI 10.1021/bi0104423; Bode HB, 2009, CHEMBIOCHEM, V10, P128, DOI 10.1002/cbic.200800219; Chen HP, 1997, BIOCHEMISTRY-US, V36, P14939, DOI 10.1021/bi971374g; Cracan V, 2012, BIOCHEMISTRY-US, V51, P6039, DOI 10.1021/bi300827v; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; Ensign SA, 1998, ARCH MICROBIOL, V169, P179, DOI 10.1007/s002030050558; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Frey PA, 2014, ACCOUNTS CHEM RES, V47, P540, DOI 10.1021/ar400194k; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; HAY BP, 1987, J AM CHEM SOC, V109, P8012, DOI 10.1021/ja00260a011; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Padmakumar R, 1995, BIOFACTORS, V5, P83; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Probian C, 2003, APPL ENVIRON MICROB, V69, P1866, DOI 10.1128/AEM.69.3.1866-1870.2003; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Rezanka T, 2012, APPL MICROBIOL BIOT, V95, P1371, DOI 10.1007/s00253-012-4267-x; Rezanka T, 2011, ENVIRON MICROBIOL, V13, P1577, DOI 10.1111/j.1462-2920.2011.02465.x; ROHWERDER T, 2007, VITAMIN B NEW RES, P81; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Toraya T, 1999, J BIOL CHEM, V274, P3372, DOI 10.1074/jbc.274.6.3372; Toraya T, 2014, ARCH BIOCHEM BIOPHYS, V544, P40, DOI 10.1016/j.abb.2013.11.002; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vlasie MD, 2003, J AM CHEM SOC, V125, P5431, DOI 10.1021/ja029420+; Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; Yaneva N, 2012, J BIOL CHEM, V287, P15502, DOI 10.1074/jbc.M111.314690	39	8	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20466	20476		10.1074/jbc.M115.646299	http://dx.doi.org/10.1074/jbc.M115.646299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134562	hybrid, Green Published			2022-12-26	WOS:000359608900044
J	Guarino, F; Cicatelli, A; Brundu, G; Heinze, B; Castiglione, S				Guarino, Francesco; Cicatelli, Angela; Brundu, Giuseppe; Heinze, Berthold; Castiglione, Stefano			Epigenetic Diversity of Clonal White Poplar (Populus alba L.) Populations: Could Methylation Support the Success of Vegetative Reproduction Strategy?	PLOS ONE			English	Article							DNA-METHYLATION; STRESS; CONSERVATION; BIODIVERSITY; MYCORRHIZAL; HOTSPOTS; GENOMES; ORIGIN; MEMORY	The widespread poplar populations of Sardinia are vegetatively propagated and live in different natural environments forming large monoclonal stands. The main goals of the present study were: i) to investigate/measure the epigenetic diversity of the poplar populations by determining their DNA methylation status; ii) to assess if and how methylation status influences population clustering; iii) to shed light on the changes that occur in the epigenome of ramets of the same poplar clone. To these purposes, 83 white poplar trees were sampled at different locations on the island of Sardinia. Methylation sensitive amplified polymorphism analysis was carried out on the genomic DNA extracted from leaves at the same juvenile stage. The study showed that the genetic biodiversity of poplars is quite limited but it is counterbalanced by epigenetic inter-population molecular variability. The comparison between MspI and HpaII DNA fragmentation profiles revealed that environmental conditions strongly influence hemi-methylation of the inner cytosine. The variable epigenetic status of Sardinian white poplars revealed a decreased number of population clusters. Landscape genetics analyses clearly demonstrated that ramets of the same clone were differentially methylated in relation to their geographic position. Therefore, our data support the notion that studies on plant biodiversity should no longer be restricted to genetic aspects, especially in the case of vegetatively propagated plant species.	[Guarino, Francesco; Cicatelli, Angela; Castiglione, Stefano] Univ Salerno, Dipartimento Chim & Biol, Fisciano, Italy; [Brundu, Giuseppe] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy; [Heinze, Berthold] Austrian Fed Res Ctr Forests, Dept Forest Genet, Vienna, Austria	University of Salerno; University of Sassari	Castiglione, S (corresponding author), Univ Salerno, Dipartimento Chim & Biol, Fisciano, Italy.	scastiglione@unisa.it	Heinze, Berthold/A-8734-2011; Brundu, Giuseppe/C-6772-2012; Guarino, Francesco/AAB-3663-2019	Heinze, Berthold/0000-0002-7571-9138; Brundu, Giuseppe/0000-0003-3076-4098; Guarino, Francesco/0000-0001-8536-4257; Castiglione, Stefano/0000-0002-0632-4677; Cicatelli, Angela/0000-0001-6996-3495	Italian Ministry of Environment, Land and Sea Protection; People's Republic of China; Italian Ministry for Education, University and Research [PRIN 2003077418]; EC under the Trees4Future project [284181]	Italian Ministry of Environment, Land and Sea Protection; People's Republic of China; Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); EC under the Trees4Future project	The research was financed by the Italian Ministry of Environment, Land and Sea Protection within the project "Research and development in biotechnology applied to the protection of the environment" in collaboration with the People's Republic of China to SC, and by the Italian Ministry for Education, University and Research (PRIN 2003077418) to SC and to FG for the PhD course in System biology of University of Salerno. Financial support by the Transnational Access to Research Infrastructures activity in the 7th Framework Programme of the EC under the Trees4Future project (no. 284181) for conducting the research is gratefully acknowledged to FG.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Alvarez ME, 2010, MOL PLANT PATHOL, V11, P563, DOI [10.1111/J.1364-3703.2010.00621.X, 10.1111/j.1364-3703.2010.00621.x]; Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Brundu G, 2008, ANN BOT-LONDON, V102, P997, DOI 10.1093/aob/mcn192; Chen M, 2010, DEV GROWTH DIFFER, V52, P555, DOI 10.1111/j.1440-169X.2010.01192.x; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cicatelli A, 2014, ENVIRON SCI POLLUT R, V21, P1723, DOI 10.1007/s11356-013-2072-4; Cicatelli A, 2012, ENVIRON EXP BOT, V75, P25, DOI 10.1016/j.envexpbot.2011.08.012; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Dickmann DI, 2001, POPLAR CULTURE N AM, p1e42; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2011, INTEGRATED SOFTWARE; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Fussi B, 2012, EUR J FOREST RES, V131, P347, DOI 10.1007/s10342-011-0506-4; Fussi B, 2010, TREE GENET GENOMES, V6, P439, DOI 10.1007/s11295-009-0262-5; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G., 2011, POPULATION GENETICS; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Kovarik A, 1997, GENE, V204, P25, DOI 10.1016/S0378-1119(97)00503-9; Labra M, 2004, CHEMOSPHERE, V54, P1049, DOI 10.1016/j.chemosphere.2003.10.024; Labra M, 2002, PLANT BIOSYST, V136, P269, DOI 10.1080/11263500212331351179; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lantuejoul C, 2002, GEOSTATISTICAL SIMULATION, P1; Latzel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3875; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Ma KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063977; Ma KF, 2012, TREE GENET GENOMES, V8, P1407, DOI 10.1007/s11295-012-0527-2; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Michalakis Y, 1996, GENETICS, V142, P1061; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; Peterson Chris J., 1997, P263; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pritchard JK, 2000, GENETICS, V155, P945; Putiri EL, 2011, CLIN EPIGENETICS, V2, P299, DOI 10.1007/s13148-010-0017-z; QUEZEL P, 1985, PLANT CONSERVATION M, P9; Santos-del-Blanco L, 2013, TREE GENET GENOMES, V9, P499, DOI 10.1007/s11295-012-0574-8; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060364; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; Thellier M, 2013, PLANT BIOLOGY, V15, P1, DOI 10.1111/j.1438-8677.2012.00674.x; Trewavas A, 2003, ANN BOT-LONDON, V92, P1, DOI 10.1093/aob/mcg101; Van Oosten MJ, 2014, CRIT REV PLANT SCI, V33, P64, DOI 10.1080/07352689.2014.852920; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WAGNER I, 1981, BIOCHIM BIOPHYS ACTA, V654, P52, DOI 10.1016/0005-2787(81)90135-0; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zhao Y, 2012, J GENET GENOMICS, V39, P307, DOI 10.1016/j.jgg.2012.02.009	62	34	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131480	10.1371/journal.pone.0131480	http://dx.doi.org/10.1371/journal.pone.0131480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147352	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600100
J	Roberts-Crowley, ML; Rittenhouse, AR				Roberts-Crowley, Mandy L.; Rittenhouse, Ann R.			Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium Channels	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; ARACHIDONIC-ACID RELEASE; RAT SYMPATHETIC NEURONS; D-2 DOPAMINE-RECEPTORS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; PROGENITOR CELLS; COORDINATED EXPRESSION; MUSCARINIC INHIBITION; STRIATAL ASTROCYTES	In medium spiny neurons (MSNs) of the striatum, dopamine D-2 receptors (D(2)Rs) specifically inhibit the Ca(v)1.3 subtype of L-type Ca2+ channels (LTCs). MSNs are heterogeneous in their expression of dopamine receptors making the study of D2R pathways difficult in primary neurons. Here, we employed the ST14A cell line, derived from embryonic striatum and characterized to have properties of MSNs, to study Ca(v)1.3 current and its modulation by neurotransmitters. Round, undifferentiated ST14A cells exhibited little to no endogenous Ca2+ current while differentiated ST14A cells expressed endogenous Ca2+ current. Transfection with LTC subunits produced functional Ca(v)1.3 current from round cells, providing a homogeneous model system compared to native MSNs for studying D2R pathways. However, neither endogenous nor recombinant Ca(v)1.3 current was modulated by the D2R agonist quinpirole. We confirmed D2R expression in ST14A cells and also detected D(1)Rs, D(4)Rs, D(5)Rs, G(q), calcineurin and phospholipase A(2) using RT-PCR and/or Western blot analysis. Phospholipase C beta-1 (PLC beta-1) expression was not detected by Western blot analysis which may account for the lack of LTC modulation by D(2)Rs. These findings raise caution about the assumption that the presence of G-protein coupled receptors in cell lines indicates the presence of complete signaling cascades. However, exogenous arachidonic acid inhibited recombinant Ca(v)1.3 current indicating that channels expressed in ST14A cells are capable of modulation since they respond to a known signaling molecule downstream of D(2)Rs. Thus, ST14A cells provide a MSN-like cell line for studying channel modulation and signaling pathways that do not involve activation of PLC beta-1.	[Roberts-Crowley, Mandy L.; Rittenhouse, Ann R.] Univ Massachusetts, Sch Med, Dept Physiol, Program Neurosci, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Rittenhouse, AR (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Program Neurosci, Worcester, MA 01655 USA.	Ann.Rittenhouse@umassmed.edu			National Institute of Health [R01-NS34195]; American Heart Association [9940225N]; University of Massachusetts Medical School; National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA) [5 TS32 NS07366-09]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034195] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Massachusetts Medical School; National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (http://www.nih.gov/) grant #R01-NS34195, and American Heart Association (http://www.heart.org/HEARTORG/) grant #9940225N, and funding from the University of Massachusetts Medical School (umassmed.edu) to ARR. Also the National Institute of Health Ruth L. Kirschstein National Research Service Award (NRSA) (http://grants.nih.gov/training/nrsa.htm) grant #5 TS32 NS07366-09 to MLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren-Beekendorf JA, 2004, J RECEPT SIG TRANSD, V24, P117, DOI 10.1081/LRST-200029953; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; Bajorat R, 2005, J NEUROSCI RES, V82, P206, DOI 10.1002/jnr.20643; Bari M, 2013, FEBS J, V280, P3376, DOI 10.1111/febs.12329; Basselin M, 2008, NEUROCHEM RES, V33, P1373, DOI 10.1007/s11064-008-9595-y; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Bhattacharjee AK, 2006, J CEREBR BLOOD F MET, V26, P1378, DOI 10.1038/sj.jcbfm.9600290; Bhattacharjee AK, 2007, NEUROIMAGE, V37, P1112, DOI 10.1016/j.neuroimage.2007.06.012; Bhattacharjee AK, 2005, PSYCHOPHARMACOLOGY, V180, P735, DOI 10.1007/s00213-005-2208-4; Bitner RS, 2006, NEUROPHARMACOLOGY, V50, P521, DOI 10.1016/j.neuropharm.2005.10.009; Blanchet F, 1999, SYNAPSE, V31, P140, DOI 10.1002/(SICI)1098-2396(199902)31:2<140::AID-SYN7>3.3.CO;2-U; Bosch M, 2004, EXP NEUROL, V190, P42, DOI 10.1016/j.expneurol.2004.06.027; Bottcher T, 2003, J NEUROSCI RES, V73, P42, DOI 10.1002/jnr.10624; Cattaneo E, 1996, J BIOL CHEM, V271, P23374, DOI 10.1074/jbc.271.38.23374; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cocco L, 2011, ADV ENZYME REGUL, V51, P2, DOI 10.1016/j.advenzreg.2010.09.015; Cocco L, 2010, ADV ENZYME REGUL, V50, P2, DOI 10.1016/j.advenzreg.2009.10.007; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Gao L, 2006, J NEUROSCI, V26, P6259, DOI 10.1523/JNEUROSCI.0481-06.2006; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hirota K, 1997, NEUROSCI LETT, V223, P169, DOI 10.1016/S0304-3940(97)13434-6; Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007; Kang S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2149; KANTERMAN RY, 1991, MOL PHARMACOL, V39, P364; Kuppers E, 2000, MOL BRAIN RES, V81, P19, DOI 10.1016/S0169-328X(00)00156-X; Lange C, 2006, NEURODEGENER DIS, V3, P76, DOI 10.1159/000092097; Levant B, 2002, LIFE SCI, V71, P2691, DOI 10.1016/S0024-3205(02)02109-4; Lin JY, 2004, EUR J NEUROSCI, V20, P1219, DOI 10.1111/j.1460-9568.2004.03576.x; Lin ZX, 1996, J MOL NEUROSCI, V7, P257, DOI 10.1007/BF02737063; Liu LW, 2006, J NEUROSCI, V26, P11588, DOI 10.1523/JNEUROSCI.2102-06.2006; Liu LW, 2000, J PHYSIOL-LONDON, V525, P391, DOI 10.1111/j.1469-7793.2000.00391.x; Liu LW, 2004, EUR BIOPHYS J BIOPHY, V33, P255, DOI 10.1007/s00249-003-0387-7; Liu LW, 2003, P NATL ACAD SCI USA, V100, P295, DOI 10.1073/pnas.0136826100; Liu LW, 2001, AM J PHYSIOL-CELL PH, V280, pC1293, DOI 10.1152/ajpcell.2001.280.5.C1293; Martella G, 2011, NEUROSCIENCE, V177, P240, DOI 10.1016/j.neuroscience.2010.12.057; Mink J W, 2001, Adv Neurol, V85, P113; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moreland RB, 2004, BIOCHEM PHARMACOL, V68, P761, DOI 10.1016/j.bcp.2004.05.019; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Rouach N, 2002, P NATL ACAD SCI USA, V99, P1023, DOI 10.1073/pnas.022257499; SCHINELLI S, 1994, J NEUROCHEM, V62, P944; SPECTOR AA, 1975, J LIPID RES, V16, P165; Strauss U, 2003, HIDDEN SODIUM CURREN; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; TENCE M, 1994, J PHARMACOL EXP THER, V269, P646; Torres JM, 2003, MOL CELL BIOCHEM, V250, P125, DOI 10.1023/A:1024902419502; Varani K, 2001, FASEB J, V15, P1245, DOI 10.1096/fj.00-0730fje; Weinelt S, 2003, J NEUROSCI RES, V71, P228, DOI 10.1002/jnr.10477; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; Zanassi P, 1998, NEUROSCI LETT, V247, P83, DOI 10.1016/S0304-3940(98)00262-6; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	69	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132469	10.1371/journal.pone.0132469	http://dx.doi.org/10.1371/journal.pone.0132469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147123	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600277
J	Eggers, SDZ; Horn, AKE; Roeber, S; Hartig, W; Nair, G; Reich, DS; Leigh, RJ				Eggers, Scott D. Z.; Horn, Anja K. E.; Roeber, Sigrun; Haertig, Wolfgang; Nair, Govind; Reich, Daniel S.; Leigh, R. John			Saccadic Palsy following Cardiac Surgery: Possible Role of Perineuronal Nets	PLOS ONE			English	Article							ASCENDING AORTA DISSECTION; SYNDROME RESEMBLING PSP; OCULAR MOTOR APRAXIA; EYE-MOVEMENTS; EXTRACELLULAR-MATRIX; OMNIPAUSE NEURONS; BURST NEURONS; VERTICAL SACCADES; PREMOTOR NEURONS; FEEDBACK-CONTROL	Objective Perineuronal nets (PN) form a specialized extracellular matrix around certain highly active neurons within the central nervous system and may help to stabilize synaptic contacts, promote local ion homeostasis, or play a protective role. Within the ocular motor system, excitatory burst neurons and omnipause neurons are highly active cells that generate rapid eye movements - saccades; both groups of neurons contain the calcium-binding protein parvalbumin and are ensheathed by PN. Experimental lesions of excitatory burst neurons and omnipause neurons cause slowing or complete loss of saccades. Selective palsy of saccades in humans is reported following cardiac surgery, but such cases have shown normal brainstem neuroimaging, with only one clinicopathological study that demonstrated paramedian pontine infarction. Our objective was to test the hypothesis that lesions of PN surrounding these brainstem saccade-related neurons may cause saccadic palsy. Methods Together with four controls we studied the brain of a patient who had developed a permanent selective saccadic palsy following cardiac surgery and died several years later. Sections of formalin-fixed paraffin-embedded brainstem blocks were applied to double-immunoperoxidase staining of parvalbumin and three different components of PN. Triple immunofluorescence labeling for all PN components served as internal controls. Combined immunostaining of parvalbumin and synaptophysin revealed the presence of synapses. Results Excitatory burst neurons and omnipause neurons were preserved and still received synaptic input, but their surrounding PN showed severe loss or fragmentation. Interpretation Our findings support current models and experimental studies of the brainstem saccade-generating neurons and indicate that damage to PN may permanently impair the function of these neurons that the PN ensheathe. How a postulated hypoxic mechanism could selectively damage the PN remains unclear. We propose that the well-studied saccadic eye movement system provides an accessible model to evaluate the role of PN in health and disease.	[Eggers, Scott D. Z.] Mayo Clin, Dept Neurol, Minneapolis, MN 55455 USA; [Horn, Anja K. E.] Univ Munich, Inst Anat & Cell Biol 1, Munich, Germany; [Horn, Anja K. E.; Roeber, Sigrun] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Roeber, Sigrun] Univ Munich, Inst Neuropathol & Pr Res, Munich, Germany; [Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Nair, Govind; Reich, Daniel S.] NINDS, NIH, Bethesda, MD 20892 USA; [Leigh, R. John] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA	Mayo Clinic; University of Munich; University of Munich; University of Munich; Leipzig University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Case Western Reserve University	Eggers, SDZ (corresponding author), Mayo Clin, Dept Neurol, Minneapolis, MN 55455 USA.	eggers.scott@mayo.edu	Reich, Daniel S./E-5701-2010	Reich, Daniel S./0000-0002-2628-4334; Nair, Govind/0000-0003-3725-615X; Horn, Anja/0000-0001-7797-1516	Mayo Foundation for Medical Education and Research; Intramural Research Program of the National Institute of Neurological Disorders and Stroke [1 ZIA NS003119 05]; BMBF [IFBLMU 01EO0901, Brain-Net-01GI0505]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003119] Funding Source: NIH RePORTER	Mayo Foundation for Medical Education and Research; Intramural Research Program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Mayo Foundation for Medical Education and Research, Intramural Research Program of the National Institute of Neurological Disorders and Stroke (1 ZIA NS003119 05), and BMBF (IFBLMU 01EO0901, Brain-Net-01GI0505).	Antonio-Santos Aileen, 2007, Semin Ophthalmol, V22, P33, DOI 10.1080/08820530701193275; Bernat JL, 2004, NEUROLOGY, V63, P1141, DOI 10.1212/WNL.63.6.1141; Bhidayasiri R, 2001, NEUROLOGY, V57, P2070, DOI 10.1212/WNL.57.11.2070; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bruckner G, 2008, NEUROSCIENCE, V151, P489, DOI 10.1016/j.neuroscience.2007.10.033; Burnside ER, 2014, NEUROPATH APPL NEURO, V40, P26, DOI 10.1111/nan.12114; Daye PM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-125; DEHAENE I, 1991, NEUROLOGY, V41, P414, DOI 10.1212/WNL.41.3.414; Devere TR, 1997, J NEURO-OPHTHALMOL, V17, P189; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Dityatev A, 2010, EPILEPSIA, V51, P61, DOI 10.1111/j.1528-1167.2010.02612.x; Eggers SDZ, 2008, NEUROLOGY, V70, P318, DOI 10.1212/01.wnl.0000287139.01789.97; Eggers SDZ, 2015, ANN NY ACAD SCI, V1343, P113, DOI 10.1111/nyas.12666; Epsztein J, 2006, J NEUROSCI, V26, P7082, DOI 10.1523/JNEUROSCI.1666-06.2006; EVINGER C, 1982, J NEUROPHYSIOL, V47, P827, DOI 10.1152/jn.1982.47.5.827; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Geiner S, 2008, PROG BRAIN RES, V171, P575, DOI 10.1016/S0079-6123(08)00683-3; HANSON MR, 1986, ANN NEUROL, V20, P209, DOI 10.1002/ana.410200206; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; HARTIG W, 1995, BRAIN RES, V698, P265, DOI 10.1016/0006-8993(95)01016-O; HENN V, 1984, BRAIN, V107, P619, DOI 10.1093/brain/107.2.619; Hobohm C, 2005, J NEUROSCI RES, V80, P539, DOI 10.1002/jnr.20459; Horn AK, 2003, J COMP NEUROL, V455, P341, DOI 10.1002/cne.10495; Horn AKE, 1998, J COMP NEUROL, V392, P413; HORN AKE, 1994, J NEUROSCI, V14, P2032; HORN AKE, 1995, J COMP NEUROL, V359, P350, DOI 10.1002/cne.903590212; HUNTLEY DT, 1993, DEV MED CHILD NEUROL, V35, P631; Kaneko CRS, 1996, J NEUROPHYSIOL, V75, P2229, DOI 10.1152/jn.1996.75.6.2229; Kim EJ, 2010, J NEURO-OPHTHALMOL, V30, P268, DOI 10.1097/WNO.0b013e3181e08b20; Kim EJ, 2014, J CLIN NEUROL, V10, P367, DOI 10.3988/jcn.2014.10.4.367; Leigh JR, 2015, NEUROLOGY EYE MOVEME; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; McRae PA, 2012, EUR J NEUROSCI, V36, P3471, DOI 10.1111/j.1460-9568.2012.08268.x; Miura K, 2006, J COMPUT NEUROSCI, V20, P25, DOI 10.1007/s10827-006-4258-y; Mokri B, 2004, NEUROLOGY, V62, P971, DOI 10.1212/01.WNL.0000115170.40838.9B; Mueller A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086154; Nandipati S, 2013, TREMOR OTHER HYPERKI, V3; Ngwa EC, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00002; PIERROTDESEILLIGNY C, 1988, ANN NEUROL, V23, P199, DOI 10.1002/ana.410230216; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; ROBINSON RO, 1988, ARCH DIS CHILD, V63, P1466, DOI 10.1136/adc.63.12.1466; Rottach KG, 1997, VISION RES, V37, P3627, DOI 10.1016/S0042-6989(96)00066-1; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P679, DOI 10.1152/jn.00886.2000; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Solomon D, 2008, ANN NEUROL, V63, P355, DOI 10.1002/ana.21201; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; SPENCER RF, 1989, J NEUROSCI, V9, P2718; STRASSMAN A, 1987, EXP BRAIN RES, V67, P436; SUZUKI Y, 1995, EXP BRAIN RES, V106, P215; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062; Tomsak RL, 2002, ANN NY ACAD SCI, V956, P430, DOI 10.1111/j.1749-6632.2002.tb02847.x; Tsien RY, 2013, P NATL ACAD SCI USA, V110, P12456, DOI 10.1073/pnas.1310158110; Valenzuela CF, 2010, INT REV NEUROBIOL, V91, P339, DOI 10.1016/S0074-7742(10)91011-8; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; Vaughan C, 2008, NEUROLOGY, V71, P1746, DOI 10.1212/01.wnl.0000339374.92578.37; WICAL BS, 1990, PEDIATR NEUROL, V6, P202; Yee R. D., 2007, T AM OPHTHAL SOC, V105, P158; Yee Robert Donald, 2007, Trans Am Ophthalmol Soc, V105, P152; ZACKON DH, 1991, CAN J OPHTHALMOL, V26, P316	64	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132075	10.1371/journal.pone.0132075	http://dx.doi.org/10.1371/journal.pone.0132075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135580	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400099
J	Li, LP; Liu, YN; Wang, XP; Fang, JY; Wang, QC; Zhang, BG; Xiao, PG; Mohammat, A; Terwei, A				Li, Liping; Liu, Yining; Wang, Xiangping; Fang, Jingyun; Wang, Qingchun; Zhang, Bengang; Xiao, Peigen; Mohammat, Anwar; Terwei, Andre			Different Effects of Regional Species Pool on Plant Diversity between Forest and Grassland Biomes in Arid Northwest China	PLOS ONE			English	Article							GLOBAL PATTERNS; MOIST FORESTS; RICHNESS; CLIMATE; EVOLUTIONARY; COMMUNITIES; GRADIENT; HISTORY; ENERGY; SCALE	Species pool hypothesis is broadly known and frequently tested in various regions and vegetation types. However it has not been tested in the arid Xinjiang region of China due to lack of data. Here with systematic data from references and field survey, we comprehensively examined species pool hypothesis in this region. Took species richness in 0.1 degrees x 0.1 degrees grid cells as regional species richness (RSR) which were obtained from the distribution maps of vascular plant species, and took species diversity of 190 and 103 plots in forest and grassland biomes across Xinjiang as local species richness (LSR), together with the digitalized soil pH and climate data, we tested the species pool hypothesis in this region. We found that: (1) the average RSR was higher in mountains than that in basins and it was negatively correlated with soil pH in mountains while positively correlated with soil pH in basins in Xinjiang; (2) RSR showed a positive correlation with mean annual precipitation (MAP) while showed a hump-shaped pattern with mean annual temperature (MAT); and the changing patterns of LSR were different for forest and grassland along the geographical and climate gradients; (3) LSR of forest was more affected by RSR than by climate, while on the contrary, LSR of grassland was more affected by climate than by RSR. Our results validated the species pool hypothesis in revealing that RSR had a significant role in shaping LSR patterns in addition to climate. We concluded that the relative effects of climate vs. RSR on LSR differed markedly between the forest and grassland communities across Xinjiang. Our results also showed that RSR revealed a contrasting relationship with soil pH in mountains and in basins, which might reflect differences in evolutionary processes of various habitats. In summary, our research systematically analyzed the correlation of species richness in regional and local scales in Xinjiang which provides more insights into the understanding of species pool hypothesis.	[Li, Liping; Zhang, Bengang; Xiao, Peigen] Chinese Acad Med Sci, Peking Union Med Coll, Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ,Inst Med Plant Dev, Beijing 100730, Peoples R China; [Liu, Yining; Fang, Jingyun] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Dept Ecol,Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Wang, Xiangping] Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Wang, Qingchun] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Zhang, Bengang] Xinjiang Inst Chinese & Ethn Med, Urumqi, Peoples R China; [Mohammat, Anwar] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Terwei, Andre] German Fed Inst Hydrol, Dept Ecol Interact, Koblenz, Germany	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Peking University; Beijing Forestry University; Beijing Forestry University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Zhang, BG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ,Inst Med Plant Dev, Beijing 100730, Peoples R China.	bgzhang@implad.ac.cn	Wang, Xiangping/D-6153-2013; Li, Liping/C-2574-2011	Li, Liping/0000-0002-5550-1932; liu, yining/0000-0001-5768-2039	China Postdoctoral Science Foundation [2014M550028]; Postdoctoral Science Foundation of Chinese Academy of Medical Sciences (Medicinal plant richness dynamics of Beijing mountainous areas in ten years); National Natural Science Foundation of China [31370620]; Project of Beijing Municipal Science & Technology Commission [Z121100000312107]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Chinese Academy of Medical Sciences (Medicinal plant richness dynamics of Beijing mountainous areas in ten years); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This research was funded by China Postdoctoral Science Foundation (2014M550028), Postdoctoral Science Foundation of Chinese Academy of Medical Sciences (Medicinal plant richness dynamics of Beijing mountainous areas in ten years), National Natural Science Foundation of China (31370620), and Project of Beijing Municipal Science & Technology Commission (Z121100000312107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chytry M, 2007, GLOBAL ECOL BIOGEOGR, V16, P668, DOI 10.1111/j.1466-8238.2007.00320.x; Commissione Redactorum Florae Xinjiangensis, 1992, FLOR XINJ; Cornell HV, 2008, CORAL REEFS, V27, P145, DOI 10.1007/s00338-007-0303-1; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; ERIKSSON O, 1993, OIKOS, V68, P371, DOI 10.2307/3544854; Fang JingYun, 2009, Biodiversity Science, V17, P605, DOI 10.3724/SP.J.1003.2009.09141; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; *I SOIL SCI, 1986, SOIL ATL CHIN; Laanisto L, 2008, GLOBAL ECOL BIOGEOGR, V17, P320, DOI 10.1111/j.1466-8238.2007.00375.x; LATHAM RE, 1993, OIKOS, V67, P325, DOI 10.2307/3545479; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; [李利平 Li Liping], 2011, [干旱区研究, Arid Zone Research], V28, P40; [李利平 Li Liping], 2011, [干旱区研究, Arid Zone Research], V28, P60; Marteinsdottir B, 2014, J PLANT ECOL, V7, P347, DOI 10.1093/jpe/rtt032; MOHAMMAT A, 2006, THESIS PEKING U BEIJ; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; R Development Core Team, 2014, R LANG ENV STAT COMP; Ricklefs RE, 1999, OIKOS, V86, P369, DOI 10.2307/3546454; Schuster B, 2003, FOLIA GEOBOT, V38, P367, DOI 10.1007/BF02803245; Szava-Kovats RC, 2013, ECOLOGY, V94, P1986, DOI 10.1890/13-0244.1; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Wang SP, 2012, ECOGRAPHY, V35, P1168, DOI 10.1111/j.1600-0587.2012.00045.x; Wang XP, 2006, FOREST ECOL MANAG, V234, P264, DOI 10.1016/j.foreco.2006.07.007; Wang XP, 2012, ECOGRAPHY, V35, P1176, DOI 10.1111/j.1600-0587.2012.00126.x; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Xinjiang Integrated Survey Team & Institute of Botany Chinese Academy of Sciences, 1978, VEG ITS UT XINJ; Yan GR, 2001, NO HORTICULTURE, P24; Zeleny D, 2010, ECOGRAPHY, V33, P578, DOI 10.1111/j.1600-0587.2009.05762.x; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024; Zobel M, 2011, GLOBAL ECOL BIOGEOGR, V20, P251, DOI 10.1111/j.1466-8238.2010.00593.x; Zobel M, 1998, APPL VEG SCI, V1, P55, DOI 10.2307/1479085	35	6	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131982	10.1371/journal.pone.0131982	http://dx.doi.org/10.1371/journal.pone.0131982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133782	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400087
J	Mesnage, R; Defarge, N; Rocque, LM; de Vendomois, JS; Seralini, GE				Mesnage, Robin; Defarge, Nicolas; Rocque, Louis-Marie; de Vendomois, Joel Spiroux; Seralini, Gilles-Eric			Laboratory Rodent Diets Contain Toxic Levels of Environmental Contaminants: Implications for Regulatory Tests	PLOS ONE			English	Article							RISK-ASSESSMENT; BISPHENOL-A; IN-VITRO; EXPOSURE; PESTICIDES; CHEMICALS; RATS; DIBENZOFURANS; DELTAMETHRIN; VEGETABLES	The quality of diets in rodent feeding trials is crucial. We describe the contamination with environmental pollutants of 13 laboratory rodent diets from 5 continents. Measurements were performed using accredited methodologies. All diets were contaminated with pesticides (1-6 out of 262 measured), heavy metals (2-3 out of 4, mostly lead and cadmium), PCDD/Fs (1-13 out of 17) and PCBs (5-15 out of 18). Out of 22 GMOs tested for, Roundup-tolerant GMOs were the most frequently detected, constituting up to 48% of the diet. The main pesticide detected was Roundup, with residues of glyphosate and AMPA in 9 of the 13 diets, up to 370 ppb. The levels correlated with the amount of Roundup-tolerant GMOs. Toxic effects of these pollutants on liver, neurodevelopment, and reproduction are documented. The sum of the hazard quotients of the pollutants in the diets (an estimator of risk with a threshold of 1) varied from 15.8 to 40.5. Thus the chronic consumption of these diets can be considered at risk. Efforts toward safer diets will improve the reliability of toxicity tests in biomedical research and regulatory toxicology.	[Mesnage, Robin; Defarge, Nicolas; Seralini, Gilles-Eric] Univ Caen, Inst Biol, EA2608, F-14032 Caen, France; [Mesnage, Robin; Defarge, Nicolas; Seralini, Gilles-Eric] Network Risks Qual & Sustainable Environm MRSH, F-14032 Caen, France; [Mesnage, Robin; Defarge, Nicolas; Rocque, Louis-Marie; de Vendomois, Joel Spiroux; Seralini, Gilles-Eric] CRIIGEN, F-75008 Paris, France	Universite de Caen Normandie	Seralini, GE (corresponding author), Univ Caen, Inst Biol, EA2608, F-14032 Caen, France.	gilles-eric.seralini@unicaen.fr	Mesnage, Robin/AAD-8641-2019	Mesnage, Robin/0000-0003-1732-4741	CRIIGEN; Foundation Lea Nature and Malongo; JMG Foundation and Foundations Charles Leopold Mayer for the Progress of Humankind; Nature Vivante; Denis Guichard; Institute Bio Forschung Austria; Sustainable Food Alliance; Sevene Pharma	CRIIGEN; Foundation Lea Nature and Malongo; JMG Foundation and Foundations Charles Leopold Mayer for the Progress of Humankind; Nature Vivante; Denis Guichard; Institute Bio Forschung Austria; Sustainable Food Alliance; Sevene Pharma	The authors have received funding for this and earlier research from CRIIGEN, the Foundation Lea Nature and Malongo, the JMG Foundation and Foundations Charles Leopold Mayer for the Progress of Humankind, Nature Vivante, Denis Guichard, Institute Bio Forschung Austria, and the Sustainable Food Alliance. The laboratory received funding from Sevene Pharma in the last five years to study the detoxifying capacity of plant extracts on Roundup residues, bisphenol A and atrazin. Prof Seralini participated in and received payment for a lecture organized by Sevene Pharma.	[Anonymous], 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2579; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bocio A, 2005, ENVIRON RES, V97, P1, DOI 10.1016/j.envres.2004.01.012; Brix AE, 2005, TOXICOL PATHOL, V33, P477, DOI 10.1080/01926230590961836; Cabello G, 2001, ENVIRON HEALTH PERSP, V109, P471, DOI 10.2307/3454705; Delaney B, 2014, FOOD CHEM TOXICOL, V66, P173, DOI 10.1016/j.fct.2014.01.042; Delistraty D, 2013, SCI TOTAL ENVIRON, V445, P14, DOI 10.1016/j.scitotenv.2012.12.028; Eitzer BD, 2013, J AGR FOOD CHEM; EPA, 2002, EPA738R01004; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3313; European Food Safety Authority (EFSA), 2012, EFSA J, V10, P1004; Fernandez-Gonzalez R, 2013, CRIT REV FOOD SCI NU, V55, P1590, DOI DOI 10.1080/10408398.2012.710279; Ferre-Huguet N, 2008, BIOL TRACE ELEM RES, V123, P66, DOI 10.1007/s12011-008-8113-z; George J, 2010, J PROTEOMICS, V73, P951, DOI 10.1016/j.jprot.2009.12.008; GIKNIS M. L. A, 2011, NEOPLASTIC NONNEOPLA; GIKNIS M. L. A., 2004, COMPILATION SPONTANE; Heindel JJ, 2008, ENVIRON HEALTH PERSP, V116, P389, DOI 10.1289/ehp.10524; Heinemann JA MM, 2013, INT J AGRI SUSTAIN, V12, P1; Hilbeck A, 2015, ENVIRON SCI EUR, V27, DOI 10.1186/s12302-014-0034-1; HORWITZ W, 1982, ANAL CHEM, V54, pA67, DOI 10.1021/ac00238a002; Howdeshell KL, 2003, ENVIRON HEALTH PERSP, V111, P1180, DOI 10.1289/ehp.5993; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; Jeong SH, 2006, TOXICOLOGY, V220, P189, DOI 10.1016/j.tox.2006.01.005; Jobling S, 2009, ENVIRON HEALTH PERSP, V117, P797, DOI 10.1289/ehp.0800197; Kortenkamp A, 2008, INT J ANDROL, V31, P233, DOI 10.1111/j.1365-2605.2007.00862.x; Kozul CD, 2008, CHEM-BIOL INTERACT, V173, P129, DOI 10.1016/j.cbi.2008.02.008; Kuroiwa Y, 2013, J TOXICOL PATHOL, V26, P227, DOI 10.1293/tox.26.227; Lauridsen C, 2008, J SCI FOOD AGR, V88, P720, DOI 10.1002/jsfa.3142; Lazarini CA, 2001, NEUROTOXICOL TERATOL, V23, P665, DOI 10.1016/S0892-0362(01)00170-2; Linsinger TPJ, 2006, TRAC-TREND ANAL CHEM, V25, P1125, DOI 10.1016/j.trac.2006.11.002; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Mercurio P, 2014, MAR POLLUT BULL, V85, P385, DOI 10.1016/j.marpolbul.2014.01.021; Mesnage R, 2014, FOOD CHEM TOXICOL, V72, P322, DOI 10.1016/j.fct.2014.07.003; Mesnage R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179691; Monosson E, 2005, ENVIRON HEALTH PERSP, V113, P383, DOI 10.1289/ehp.6987; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; National Institutes of Health (NIH), 2011, GUID CAR US LAB AN; NEWBERNE PM, 1975, FED PROC, V34, P209; Nishi K, 2013, FOOD CHEM TOXICOL, V62, P732, DOI 10.1016/j.fct.2013.10.006; Nougadere A, 2011, FOOD CHEM TOXICOL, V49, P1484, DOI 10.1016/j.fct.2011.03.024; NTP, 2011, SPEC COND STUD EV RE; OECD, 2012, 116ENVJMMONO201147 O, P47; RAO GN, 1987, FUND APPL TOXICOL, V9, P329, DOI 10.1016/0272-0590(87)90055-8; Rodriguez-Vivas RI, 2013, VET PARASITOL, V197, P288, DOI 10.1016/j.vetpar.2013.07.018; Ronchetti SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081101; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; Schecter AJ, 1996, CHEMOSPHERE, V32, P501, DOI 10.1016/0045-6535(95)00328-2; Seralini Gilles-Eric, 2014, Environmental Sciences Europe, V26, DOI 10.1186/s12302-014-0014-5; Sharma RK, 2009, FOOD CHEM TOXICOL, V47, P583, DOI 10.1016/j.fct.2008.12.016; Shukla Y, 2001, TOXICOLOGY, V163, P1, DOI 10.1016/S0300-483X(00)00416-9; Singh SB, 2009, J AGR FOOD CHEM, V57, P11277, DOI 10.1021/jf903624v; Soffritti M, 2008, BASIC CLIN PHARMACOL, V102, P118, DOI 10.1111/j.1742-7843.2007.00200.x; SOTO AM, 1991, ENVIRON HEALTH PERSP, V92, P167, DOI 10.1289/ehp.9192167; StataCorp, 2013, STAT STAT SOFTW REL; Tennekes H, 2004, REGUL TOXICOL PHARM, V40, P18, DOI 10.1016/j.yrtph.2004.04.003; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Thongprakaisang S, 2013, FOOD CHEM TOXICOL, V59, P129, DOI 10.1016/j.fct.2013.05.057; US EPA, 2011, PEST IND SAL US REP; US EPA, 1989, EPA540189002 A, V1; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Verwei M, 2006, TOXICOL LETT, V165, P79, DOI 10.1016/j.toxlet.2006.01.017; Weiss B, 2005, ENVIRON HEALTH PERSP, V113, P1120, DOI 10.1289/ehp.7816; Zeljenkova D, 2014, ARCH TOXICOL	64	42	47	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0128429	10.1371/journal.pone.0128429	http://dx.doi.org/10.1371/journal.pone.0128429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133768	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400007
J	Quach, AT; Oluwole, O; King, WA; Revay, T				Quach, Anh T.; Oluwole, Olutobi; King, William Allan; Revay, Tamas			The Porcine TSPY Gene Is Tricopy but Not a Copy Number Variant	PLOS ONE			English	Article							TESTIS-SPECIFIC PROTEIN; HUMAN Y-CHROMOSOME; DIGITAL PCR; ENCODED TSPY; EXPRESSION; DNA; EVOLUTIONARY; FERTILITY; MOUSE	The testis-specific protein Y-encoded (TSPY) gene is situated on the mammalian Y-chromosome and exhibits some remarkable biological characteristics. It has the highest known copy number (CN) of all protein coding genes in the human and bovine genomes (up to 74 and 200, respectively) and also shows high individual variability. Although the biological function of TSPY has not yet been elucidated, its specific expression in the testis and several identified binding domains within the protein suggests roles in male reproduction. Here we describe the porcine TSPY, as a multicopy gene with three copies located on the short arm of the Y-chromosome with no variation at three exon loci among 20 animals of normal reproductive health from four breeds of domestic pigs (Pietrain, Landrace, Duroc and Yorkshire). To further investigate the speculation that porcine TSPY is not a copy number variant, we have included five Low-fertility boars and five boars with exceptional High-fertility records. Interestingly, there was no difference between the High-and Low-fertile groups, but we detected slightly lower TSPY CN at all three exons (2.56-2.85) in both groups, as compared to normal animals, which could be attributed to technical variability or somatic mosaicism. The results are based on both relative quantitative real-time PCR (qPCR) and droplet digital PCR (ddPCR). Chromosomal localization of the porcine TSPY was done using fluorescence in situ hybridization (FISH) with gene specific PCR probes.	[Quach, Anh T.; Oluwole, Olutobi; King, William Allan; Revay, Tamas] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Revay, T (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	trevay@uoguelph.ca	Revay, Tamas/AAU-7731-2020		National Science and Engineering Research Council; Canada Research Chair's Program; Vietnam International Education Development - Ministry of Education and Training scholarship	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair's Program(Canada Research Chairs); Vietnam International Education Development - Ministry of Education and Training scholarship	The authors acknowledge the funding for the National Science and Engineering Research Council (WAK, http://www.nserc-crsng.gc.ca), the Canada Research Chair's Program (WAK, http://www.chairs-chaires.gc.ca) and the Vietnam International Education Development - Ministry of Education and Training scholarship (ATQ, http://www.vied.vn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Dechend F, 1998, CYTOGENET CELL GENET, V83, P270, DOI 10.1159/000015169; Giachini C, 2009, J CLIN ENDOCR METAB, V94, P4016, DOI 10.1210/jc.2009-1029; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hamilton CK, 2012, SEX DEV, V6, P231, DOI 10.1159/000338938; Hamilton CK, 2009, SEX DEV, V3, P205, DOI 10.1159/000228721; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huggett JF, 2013, CLIN CHEM, V59, P1691, DOI 10.1373/clinchem.2013.214742; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Kido T, 2014, HUM PATHOL, V45, P1847, DOI 10.1016/j.humpath.2014.05.002; Krausz C, 2010, GENES-BASEL, V1, P308, DOI 10.3390/genes1020308; Lau YFC, 2009, BIRTH DEFECTS RES C, V87, P114, DOI 10.1002/bdrc.20144; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mukherjee A, 2015, ANIM BIOTECHNOL, V26, P65, DOI 10.1080/10495398.2014.887020; Nickkholgh B, 2010, FERTIL STERIL, V94, P1744, DOI 10.1016/j.fertnstert.2009.09.051; Paria N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021374; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Quilter CR, 2002, MAMM GENOME, V13, P588, DOI 10.1007/s00335-002-3026-1; Raap A K, 2001, Curr Protoc Cytom, VChapter 8, DOI 10.1002/0471142956.cy0801s00; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Revay T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1473-9; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schubert S, 2010, GENES-BASEL, V1, P244, DOI 10.3390/genes1020244; Shen Y, 2013, HUM MOL GENET, V22, P1679, DOI 10.1093/hmg/ddt004; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Soh YQS, 2014, CELL, V159, P800, DOI 10.1016/j.cell.2014.09.052; Speel Ernst J M, 2006, Methods Mol Biol, V326, P33; TRIBOUT T, 2000, TECHNIPORC, V23, P19; Vodicka R, 2007, REPROD BIOMED ONLINE, V14, P579, DOI 10.1016/S1472-6483(10)61049-8; Vogel T, 1998, CHROMOSOME RES, V6, P35, DOI 10.1023/A:1009214307764; Xue YL, 2011, GENES-BASEL, V2, P36, DOI 10.3390/genes2010036	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131745	10.1371/journal.pone.0131745	http://dx.doi.org/10.1371/journal.pone.0131745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133983	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400068
J	Mardi, M; Farsad, LK; Gharechahi, J; Salekdeh, GH				Mardi, Mohsen; Farsad, Laleh Karimi; Gharechahi, Javad; Salekdeh, Ghasem Hosseini			In-Depth Transcriptome Sequencing of Mexican Lime Trees Infected with Candidatus Phytoplasma aurantifolia	PLOS ONE			English	Article							WITCHES-BROOM DISEASE; GENE-EXPRESSION; RNA-SEQ; CELL-WALL; PLANT DEVELOPMENT; DEFENSE; TOOL; BIOSYNTHESIS; IMMUNITY; PECTIN	Witches' broom disease of acid lime greatly affects the production of Mexican lime in Iran. It is caused by a phytoplasma (Candidatus Phytoplasma aurantifolia). However, the molecular mechanisms that underlie phytoplasma pathogenicity and the mode of interactions with host plants are largely unknown. Here, high-throughput transcriptome sequencing was conducted to explore gene expression signatures associated with phytoplasma infection in Mexican lime trees. We assembled 78,185 unique transcript sequences (unigenes) with an average length of 530 nt. Of these, 41,805 (53.4%) were annotated against the NCBI non-redundant (nr) protein database using a BLASTx search (e-value <= 1e-5). When the abundances of unigenes in healthy and infected plants were compared, 2,805 transcripts showed significant differences (false discovery rate <= 0.001 and log(2) ratio >= 1.5). These differentially expressed genes (DEGs) were significantly enriched in 43 KEGG metabolic and regulatory pathways. The up-regulated DEGs were mainly categorized into pathways with possible implication in plant-pathogen interaction, including cell wall biogenesis and degradation, sucrose metabolism, secondary metabolism, hormone biosynthesis and signalling, amino acid and lipid metabolism, while down-regulated DEGs were predominantly enriched in ubiquitin proteolysis and oxidative phosphorylation pathways. Our analysis provides novel insight into the molecular pathways that are deregulated during the host-pathogen interaction in Mexican lime trees infected by phytoplasma. The findings can be valuable for unravelling the molecular mechanisms of plant-phytoplasma interactions and can pave the way for engineering lime trees with resistance to witches' broom disease.	[Mardi, Mohsen; Farsad, Laleh Karimi; Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Tehran, Iran; [Gharechahi, Javad] Baqiyatallah Univ Med Sci, Chem Injuries Res Ctr, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Royan Inst Stem Cell Biol & Technol, ACECR, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran	Baqiyatallah University of Medical Sciences (BMSU); Academic Center for Education, Culture & Research (ACECR)	Salekdeh, GH (corresponding author), Agr Biotechnol Res Inst Iran, Dept Syst Biol, Tehran, Iran.	h_salekdeh@abrii.ac.ir	Gharechahi, Javad/GLT-7685-2022; Salekdeh, Ghasem Hosseini/E-4198-2012; Mardi, Mohsen/M-5829-2017	Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Mardi, Mohsen/0000-0002-4718-7701; Gharechahi, Javad/0000-0001-7018-4085	agricultural Biotechnology Institute of Iran	agricultural Biotechnology Institute of Iran	The authors acknowledge funding support from the agricultural Biotechnology Institute of Iran (http://www.abrii.ac.ir/en/Home.aspx).	Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Alhudaib K, 2009, CROP PROT, V28, P13, DOI 10.1016/j.cropro.2008.08.007; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Belien T, 2006, MOL PLANT MICROBE IN, V19, P1072, DOI 10.1094/MPMI-19-1072; Bove J., 1986, FAO Plant Protection Bulletin, V34, P217; BOVE J, 1988, P INT ORG CITR VIR, V10, P307; Bove J. M., 2000, Proceedings of the 14th Conference of the International Organization of Citrus Virologists, Campinas, Sao Paulo State, Brazil, 13-18 September 1998, P207; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cantu D, 2008, TRENDS PLANT SCI, V13, P610, DOI 10.1016/j.tplants.2008.09.002; Cheng AX, 2007, J INTEGR PLANT BIOL, V49, P179, DOI 10.1111/j.1744-7909.2007.00395.x; Chohan N, 2009, J PHYTOLOGY, V2, P49; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Chung KR, 2009, CITRUS DIS EXOTIC FL, P1; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gao LL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-340; Garnier M, 1991, P 11 C IOCV DEP PLAN, p448A; Ghosh D. K., 1999, Plant Disease, V83, P302, DOI 10.1094/PDIS.1999.83.3.302D; Ghosh D, 2013, J PLANT BIOCHEM BIOT, V22, P343, DOI 10.1007/s13562-012-0160-z; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Harris LJ, 2005, PLANT MOL BIOL, V59, P881, DOI 10.1007/s11103-005-1674-8; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Junqueira A, 2004, PHYSIOL MOL PLANT P, V65, P181, DOI 10.1016/j.pmpp.2005.01.005; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Lepka P, 1999, PHYSIOL MOL PLANT P, V55, P59, DOI 10.1006/pmpp.1999.0202; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080238; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Ma W, 2008, PLANT PHYSIOL, V148, P818, DOI 10.1104/pp.108.125104; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Moeder W, 2011, MOL PLANT, V4, P442, DOI 10.1093/mp/ssr018; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mou HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077217; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Sugio A, 2011, ANNU REV PHYTOPATHOL, V49, P175, DOI 10.1146/annurev-phyto-072910-095323; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Taheri F, 2011, MOL BIOSYST, V7, P3028, DOI 10.1039/c1mb05268c; Tanaka N, 2006, PLANT CELL ENVIRON, V29, P619, DOI 10.1111/j.1365-3040.2005.01441.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang DL, 2008, MOL PLANT, V1, P528, DOI 10.1093/mp/ssn021; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zamharir MG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-1; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036; Zi JC, 2014, ANNU REV PLANT BIOL, V65, P259, DOI 10.1146/annurev-arplant-050213-035705; ZREIK L, 1995, INT J SYST BACTERIOL, V45, P449, DOI 10.1099/00207713-45-3-449	81	30	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130425	10.1371/journal.pone.0130425	http://dx.doi.org/10.1371/journal.pone.0130425			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132073	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000068
J	Tait, AH; Raubenheimer, D; Green, MP; Cupido, CL; Gluckman, PD; Vickers, MH				Tait, Alice H.; Raubenheimer, David; Green, Mark P.; Cupido, Cinda L.; Gluckman, Peter D.; Vickers, Mark H.			Successive Generations in a Rat Model Respond Differently to a Constant Obesogenic Environment	PLOS ONE			English	Article							INTERGENERATIONAL TRANSMISSION; DEVELOPMENTAL PLASTICITY; NUTRITION TRANSITION; PROTEIN RESTRICTION; METABOLIC SYNDROME; BODY-COMPOSITION; GUT MICROBIOME; HUMAN HEALTH; RICH DIET; OBESITY	Research has shown that if a mother experiences a transitory perturbation to her environment during pregnancy or lactation, there are transgenerational consequences often involving a disordered metabolic phenotype in first generation offspring with recovery across subsequent generations. In contrast, little is known about the nature of the transgenerational response of offspring when a mother experiences a perturbation that is not transitory but instead persists across generations. Our study, using a rat model, subjected the parental generation to a change in environment and concomitant shift from a grain-based to obesogenic diets to generate an adipose phenotype in first generation offspring emulating a common scenario in human urbanisation and migration. We then investigated whether the obese phenotype was stable across generations when maintained in the transitioned environment, and whether dietary macronutrient balance affected the response. We found that second and third generation offspring had a reduced body fat to lean mass ratio and a reduced appetite relative to first generation offspring, irrespective of dietary macronutrient balance. The trajectory of this response is suggestive of a reduction in chronic disease risk across generations. This is one of the first studies, to our knowledge, to investigate the transgenerational response following parental transition to a persistent obesogenic environment, and to demonstrate that successive generations respond differently to this constant environment.	[Tait, Alice H.; Green, Mark P.; Cupido, Cinda L.; Gluckman, Peter D.; Vickers, Mark H.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Tait, Alice H.; Green, Mark P.; Cupido, Cinda L.; Gluckman, Peter D.; Vickers, Mark H.] Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland 1, New Zealand; [Tait, Alice H.; Raubenheimer, David] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Green, Mark P.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia	University of Auckland; University of Auckland; Massey University; University of Sydney; University of Sydney; University of Sydney; University of Melbourne	Vickers, MH (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	m.vickers@auckland.ac.nz		GREEN, MARK/0000-0002-6076-9781; Vickers, Mark/0000-0003-4876-9356; Raubenheimer, David/0000-0001-9050-1447	Health Research Council of New Zealand [05/244]; Gravida: National Centre for Growth and Development; Tertiary Education Commission of New Zealand; Maurice Paykel Research Trust	Health Research Council of New Zealand(Health Research Council of New Zealand); Gravida: National Centre for Growth and Development; Tertiary Education Commission of New Zealand; Maurice Paykel Research Trust	Funding was provided by the Health Research Council of New Zealand, Project 05/244 (http://www.hrc.govt.nz/) Public good funding. The authors also acknowledge funding support from Gravida: National Centre for Growth and Development, the Tertiary Education Commission of New Zealand and the Maurice Paykel Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANASTASIA JV, 1990, FOOD CHEM TOXICOL, V28, P147, DOI 10.1016/0278-6915(90)90003-6; Andrews Zane B, 2014, Front Neurosci, V8, P312, DOI 10.3389/fnins.2014.00312; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bateson P, 2001, INT J EPIDEMIOL, V30, P928, DOI 10.1093/ije/30.5.928; Benyshek DC, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-26; Bilsborough S, 2006, INT J SPORT NUTR EXE, V16, P129, DOI 10.1123/ijsnem.16.2.129; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; Delavari M, 2013, ETHNIC HEALTH, V18, P66, DOI 10.1080/13557858.2012.698255; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Drake AJ, 2010, TRENDS ENDOCRIN MET, V21, P206, DOI 10.1016/j.tem.2009.11.006; Drewnowski A, 2007, EPIDEMIOL REV, V29, P160, DOI 10.1093/epirev/mxm011; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fuster, 2010, PROMOTING CARDIOVASC; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Harrison M, 2009, BRIT J NUTR, V101, P1020, DOI 10.1017/S0007114508057607; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jaremka LM, 2014, PSYCHONEUROENDOCRINO, V48, P178, DOI 10.1016/j.psyneuen.2014.06.018; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kaplan SA, 2015, J IMMIGR MINOR HEALT, V17, P255, DOI 10.1007/s10903-013-9873-x; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Langley-Evans SC, 2006, ADV EXP MED BIOL, V573, P87; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Lien EL, 2001, FOOD CHEM TOXICOL, V39, P385, DOI 10.1016/S0278-6915(00)00142-3; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; MORLEY JE, 1983, LIFE SCI, V32, P2169; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; RAUBENHEIMER D, 1994, FUNCT ECOL, V8, P783, DOI 10.2307/2390238; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; RUTTEN AAJJL, 1992, FOOD CHEM TOXICOL, V30, P601, DOI 10.1016/0278-6915(92)90194-P; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; Stern S, 2012, CELL REP, V1, P528, DOI 10.1016/j.celrep.2012.03.012; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; Tamashiro KLK, 2007, PHYSIOL BEHAV, V91, P440, DOI 10.1016/j.physbeh.2007.04.004; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vyssotski D. L., 2011, EVOLOCUS, V1, P1; Wardle J, 2007, OBES REV, V8, P73, DOI 10.1111/j.1467-789X.2007.00322.x; Welch CC, 1996, BRAIN RES, V721, P126, DOI 10.1016/0006-8993(96)00151-5	56	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129779	10.1371/journal.pone.0129779	http://dx.doi.org/10.1371/journal.pone.0129779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131906	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000039
J	Zhang, W; Yuan, Y; Yang, S; Huang, JJ; Huang, LQ				Zhang, Wei; Yuan, Yuan; Yang, Shuo; Huang, Jianjun; Huang, Luqi			ITS2 Secondary Structure Improves Discrimination between Medicinal "Mu Tong" Species when Using DNA Barcoding	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; NUCLEAR RIBOSOMAL DNA; SEQUENCE ALIGNMENT; STRUCTURE PREDICTION; COMMON CORE; RNA; PHYLOGENY; PROTEIN; TOOL; RECONSTRUCTION	DNA barcoding is a promising species identification method, but it has proved difficult to find a standardized DNA marker in plant. Although the ITS/ ITS2 RNA transcript has been proposed as the core barcode for seed plants, it has been criticized for being too conserved in some species to provide enough information or too variable in some species to align it within the different taxa ranks. We selected 30 individuals, representing 16 species and four families, to explore whether ITS2 can successfully resolve species in terms of secondary structure. Secondary structure was predicted using Mfold software and sequence-structure was aligned by MARNA. RNAstat software transformed the secondary structures into 28 symbol code data for maximum parsimony ( MP) analysis. The results showed that the ITS2 structures in our samples had a common four-helix folding type with some shared motifs. This conserved structure facilitated the alignment of ambiguous sequences from divergent families. The structure alignment yielded a MP tree, in which most topological relationships were congruent with the tree constructed using nucleotide sequence data. When the data was combined, we obtained a well-resolved and highly supported phylogeny, in which individuals of a same species were clustered together into a monophyletic group. As a result, the different species that are often referred to as the herb "Mu tong" were successfully identified using short fragments of 250 bp ITS2 sequences, together with their secondary structure. Thus	[Zhang, Wei; Yang, Shuo; Huang, Jianjun] Shandong Univ Weihai, Marine Coll, Weihai, Shandong, Peoples R China; [Zhang, Wei; Yuan, Yuan; Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, State Key Lab Dao Di Herbs, Beijing, Peoples R China	Shandong University; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS	Huang, LQ (corresponding author), China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, State Key Lab Dao Di Herbs, Beijing, Peoples R China.	huangluqi01@126.com	ZHANG, WEI/AAJ-2716-2020		Specific funds of Traditional Chinese Medicine industry [201407003]; Independent Innovation Fund for Youth of Shandong University (Weihai) [2012ZRYQ006]; Special funds by Marine College of Shandong University (Weihai)	Specific funds of Traditional Chinese Medicine industry; Independent Innovation Fund for Youth of Shandong University (Weihai); Special funds by Marine College of Shandong University (Weihai)	This study was funded by Specific funds of Traditional Chinese Medicine industry (201407003), Independent Innovation Fund for Youth of Shandong University (Weihai) (2012ZRYQ006), Special funds by Marine College of Shandong University (Weihai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, B MAR SCI, V81, P335; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Billoud B, 2000, MOL BIOL EVOL, V17, P1435, DOI 10.1093/oxfordjournals.molbev.a026244; Blackburne BP, 2013, MOL BIOL EVOL, V30, P642, DOI 10.1093/molbev/mss256; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Hall BG, 2005, MOL BIOL EVOL, V22, P792, DOI 10.1093/molbev/msi066; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heubl G., 2013, EVIDENCE RATIONAL BA, P27, DOI DOI 10.1007/978-3-7091-0442-2_2; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li W. H, 1997, MOL EVOLUTION; Ma HW, 2008, ORG DIVERS EVOL, V8, P182, DOI 10.1016/j.ode.2007.09.001; Mugridge NB, 2000, MOL BIOL EVOL, V17, P1842, DOI 10.1093/oxfordjournals.molbev.a026285; NAKANISHI T, 1982, PHYTOCHEMISTRY, V21, P1759, DOI 10.1016/S0031-9422(82)85055-3; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Siebert S, 2005, BIOINFORMATICS, V21, P3352, DOI 10.1093/bioinformatics/bti550; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Subbotin SA, 2007, MOL PHYLOGENET EVOL, V43, P881, DOI 10.1016/j.ympev.2006.09.019; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453; Wolf Matthias, 2005, In Silico Biol, V5, P291; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055927; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	36	38	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131185	10.1371/journal.pone.0131185	http://dx.doi.org/10.1371/journal.pone.0131185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132382	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000101
J	Luo, JW; Qi, Y				Luo, Jiawei; Qi, Yi			Identification of Essential Proteins Based on a New Combination of Local Interaction Density and Protein Complexes	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; INTERACTION NETWORKS; ESSENTIAL GENES; MODULAR NATURE; YEAST; PREDICTION; DATABASE; INTEGRATION; EUKARYOTES; CENTRALITY	Background Computational approaches aided by computer science have been used to predict essential proteins and are faster than expensive, time-consuming, laborious experimental approaches. However, the performance of such approaches is still poor, making practical applications of computational approaches difficult in some fields. Hence, the development of more suitable and efficient computing methods is necessary for identification of essential proteins. Method In this paper, we propose a new method for predicting essential proteins in a protein interaction network, local interaction density combined with protein complexes (LIDC), based on statistical analyses of essential proteins and protein complexes. First, we introduce a new local topological centrality, local interaction density (LID), of the yeast PPI network; second, we discuss a new integration strategy for multiple bioinformatics. The LIDC method was then developed through a combination of LID and protein complex information based on our new integration strategy. The purpose of LIDC is discovery of important features of essential proteins with their neighbors in real protein complexes, thereby improving the efficiency of identification. Results Experimental results based on three different PPI(protein-protein interaction) networks of Saccharomyces cerevisiae and Escherichia coli showed that LIDC outperformed classical topological centrality measures and some recent combinational methods. Moreover, when predicting MIPS datasets, the better improvement of performance obtained by LIDC is over all nine reference methods (i.e., DC, BC, NC, LID, PeC, CoEWC, WDC, ION, and UC). Conclusions LIDC is more effective for the prediction of essential proteins than other recently developed methods.	[Luo, Jiawei; Qi, Yi] Hunan Univ, Coll Comp Sci & Elect Engn, Changsha 410082, Hunan, Peoples R China	Hunan University	Luo, JW (corresponding author), Hunan Univ, Coll Comp Sci & Elect Engn, Changsha 410082, Hunan, Peoples R China.	luojiawei@hnu.edu.cn			National Natural Science Foundation of China [61240046]; Hunan Provincial Natural Science Foundation of China [13JJ2017]; Scientific and Technological Research Program of Chongqing Municipal Education Commission of China [KJ1401124]; Science Foundation of Chongqing University of Arts and Sciences in China [Y2012RJ53]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Scientific and Technological Research Program of Chongqing Municipal Education Commission of China; Science Foundation of Chongqing University of Arts and Sciences in China	This work was supported by: 1 No. 61240046, National Natural Science Foundation of China, www.nsfc.gov.cn, JWL YQ; 2 No. 13JJ2017, Hunan Provincial Natural Science Foundation of China, www.hnst.gov.cn/zxgz/zkjj, JWL; 3 No. KJ1401124, Scientific and Technological Research Program of Chongqing Municipal Education Commission of China, www.cqjw.gov.cn/site/html/cqjwportal/portal/index/index.htm, YQ; and 4 No. Y2012RJ53, Science Foundation of Chongqing University of Arts and Sciences in China, www.cqwu.net, YQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Andorf CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056833; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gill N, 2014, J COMPUT BIOL, V21, P456, DOI 10.1089/cmb.2013.0158; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Hsing M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-80; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lewis NE, 2009, J BACTERIOL, V191, P3437, DOI 10.1128/JB.00034-09; Li M, 2017, IEEE ACM T COMPUT BI, V14, P370, DOI 10.1109/TCBB.2015.2394487; Li M, 2015, IEEE ACM T COMPUT BI, V12, P372, DOI 10.1109/TCBB.2014.2361350; Li M, 2014, METHODS, V67, P325, DOI 10.1016/j.ymeth.2014.02.016; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Ren J, 2011, LECT N BIOINFORMAT, V6674, P12, DOI 10.1007/978-3-642-21260-4_6; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Ryan CJ, 2013, GENOME BIOL EVOL, V5, P1049, DOI 10.1093/gbe/evt074; Tang XW, 2014, IEEE ACM T COMPUT BI, V11, P407, DOI 10.1109/TCBB.2013.2295318; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Wang HD, 2009, MOL CELL PROTEOMICS, V8, P1361, DOI 10.1074/mcp.M800490-MCP200; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wuchty S, 2014, P NATL ACAD SCI USA, V111, P7156, DOI 10.1073/pnas.1311231111; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xiao QH, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S3-S1; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058763; Zhao BH, 2014, IEEE T NANOBIOSCI, V13, P415, DOI 10.1109/TNB.2014.2337912; Zhong JC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S7; Zhu C, 2014, ADV EXP MED BIOL, V799, P69, DOI 10.1007/978-1-4614-8778-4_4; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	44	42	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131418	10.1371/journal.pone.0131418	http://dx.doi.org/10.1371/journal.pone.0131418			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125187	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300047
J	Cui, Y; Qin, LL; Wu, J; Qu, X; Hou, C; Sun, WY; Li, SY; Vaughan, ATM; Li, JJ; Liu, JK				Cui, Yang; Qin, Lili; Wu, Jing; Qu, Xuan; Hou, Chen; Sun, Wenyan; Li, Shiyong; Vaughan, Andrew T. M.; Li, Jian Jian; Liu, Jiankang			SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells	PLOS ONE			English	Article							FATTY-ACID OXIDATION; BREAST-CANCER; MITOCHONDRIAL SIRTUINS; LACTATE-DEHYDROGENASE; SUPEROXIDE-DISMUTASE; REACTIVE OXYGEN; TUMOR-GROWTH; METABOLISM; EXPRESSION; DEACETYLATES	SIRT3 is a key NAD(+)-dependent protein deacetylase in the mitochondria of mammalian cells, functioning to prevent cell aging and transformation via regulation of mitochondrial metabolic homeostasis. However, SIRT3 is also found to express in some human tumors; its role in these SIRT3-expressing tumor cells needs to be elucidated. This study demonstrated that the expression of SIRT3 was elevated in a group of gastric cancer cells compared to normal gastric epithelial cells. Although SIRT3 expression levels were increased in the gastric tumor tissues compared to the adjacent non-tumor tissues, SIRT3 positive cancer cells were more frequently detected in the intestinal type gastric cancers than the diffuse type gastric cancers, indicating that SIRT3 is linked with subtypes of gastric cancer. Overexpression of SIRT3 promoted cell proliferation and enhanced ATP generation, glucose uptake, glycogen formation, MnSOD activity and lactate production, which were inhibited by SIRT3 knockdown, indicating that SIRT3 plays a role in reprogramming the bioenergetics in gastric tumor cells. Further analysis revealed that SIRT3 interacted with and deacetylated the lactate dehydrogenase A (LDHA), a key protein in regulating anaerobic glycolysis, enhancing LDHA activity. In consistence, a cluster of glycolysis-associated genes was upregulated in the SIRT3-overexpressing gastric tumor cells. Thus, in addition to the well-documented SIRT3-mediated mitochondrial homeostasis in normal cells, SIRT3 may enhance glycolysis and cell proliferation in SIRT3-expressing cancer cells.	[Cui, Yang; Wu, Jing; Qu, Xuan; Hou, Chen; Sun, Wenyan; Liu, Jiankang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Ctr Mitochondrial Biol & Med,Minist Educ, Xian 710049, Peoples R China; [Cui, Yang; Wu, Jing; Qu, Xuan; Hou, Chen; Sun, Wenyan; Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Life Sci, Xian 710049, Peoples R China; [Qin, Lili; Vaughan, Andrew T. M.; Li, Jian Jian] Univ Calif Davis, Dept Radiat Oncol, NCI Designated Compress Canc Ctr, Sacramento, CA 95817 USA; [Li, Shiyong] Emory Univ, Dept Clin Pathol, Atlanta, GA 30322 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University of California System; University of California Davis; Emory University	Li, JJ (corresponding author), Univ Calif Davis, Dept Radiat Oncol, NCI Designated Compress Canc Ctr, Sacramento, CA 95817 USA.	jijli@ucdavis.edu; j.liu@mail.xjtu.edu.cn	Liu, Jiankang/A-1610-2011; Qin, Lili/J-7481-2016	Li, Jian Jian/0000-0003-3694-9675; Li, Shiyong/0000-0002-7052-5203; Sun, Wenyan/0000-0002-3186-5002	National Natural Science Foundation of China [30930105, 31070740]; National 12-5 Support Plan Project of the Ministry of Science and Technology of China [2012BAH30F03]; 985 Project of Xi'an Jiaotong University; 211 Project of Xi'an Jiaotong University; National Cancer Institute RO1 grant [CA152313-01-A1]; NATIONAL CANCER INSTITUTE [R01CA152313] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 12-5 Support Plan Project of the Ministry of Science and Technology of China; 985 Project of Xi'an Jiaotong University; 211 Project of Xi'an Jiaotong University; National Cancer Institute RO1 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partially supported by the National Natural Science Foundation of China, Key Program (30930105), National 12-5 Support Plan Project of the Ministry of Science and Technology of China (2012BAH30F03), the National Natural Science Foundation of China (31070740), the 985 and 211 Projects of Xi'an Jiaotong University (JKL), and National Cancer Institute RO1 grant CA152313-01-A1 (JJL).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Duru N, 2012, CLIN CANCER RES, V18, P6634, DOI 10.1158/1078-0432.CCR-12-1436; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Hallows William C, 2008, Biochem J, V411, pe11, DOI 10.1042/BJ20080336; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Li SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010486; Li X, 2008, FREE RADICAL BIO MED, V44, P1465, DOI 10.1016/j.freeradbiomed.2008.01.004; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shackelford R, 2013, ANTICANCER RES, V33, P3047; Shimazu T, 2010, MECH AGEING DEV, V131, P511, DOI 10.1016/j.mad.2010.05.001; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang L, 2013, BIOCHEM PHARMACOL, V86, P726, DOI 10.1016/j.bcp.2013.06.032; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005; Zhao Y, 2013, ANN DIAGN PATHOL, V17, P483, DOI 10.1016/j.anndiagpath.2013.06.001	45	58	59	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129834	10.1371/journal.pone.0129834	http://dx.doi.org/10.1371/journal.pone.0129834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121691	Green Published, gold			2022-12-26	WOS:000358150400025
J	Vasen, G; Battistone, MA; Croci, DO; Brukman, NG; Munoz, MW; Stupirski, JC; Rabinovich, GA; Cuasnicu, PS				Vasen, Gustavo; Agustina Battistone, Maria; Croci, Diego O.; Brukman, Nicolas G.; Weigel Munoz, Mariana; Stupirski, Juan C.; Rabinovich, Gabriel A.; Cuasnicu, Patricia S.			The galectin-1-glycan axis controls sperm fertilizing capacity by regulating sperm motility and membrane hyperpolarization	FASEB JOURNAL			English	Article						acrosome reaction; capacitation; fertilization; glycosylation	MATERNAL-FETAL INTERFACE; ZONA-PELLUCIDA; MOUSE SPERM; AUXILIARY SUBUNIT; ACROSOME REACTION; HUMAN SPERMATOZOA; VOLUME REGULATION; FLOW-CYTOMETRY; N-GLYCANS; IN-VITRO	Lectin-glycan recognition systems play central roles in many physiologic and pathologic processes. We identified a role for galectin-1 (Gal-1), a highly conserved glycan-binding protein, in the control of sperm function. We found that Gal-1 is expressed in the epididymis and associates with sperm during epididymal maturation. Exposure of sperm to Gal-1 resulted in glycan-dependent modulation of the acrosome reaction (AR), a key event in the fertilization process. Gal-1-deficient (Lgals1(-/-)) mice revealed the essential contribution of this lectin for full sperm fertilizing ability both in vitro and in vivo. Mechanistically, Lgals1(-/-) sperm exhibited defects in their ability to develop hyperactivation, a vigorous motility required for penetration of the egg vestments. Moreover, Lgals1(-/-) sperm showed a decreased ability to control cell volume and to undergo progesterone-induced AR, phenotypes that were rescued by exposure of the cells to recombinant Gal-1. Interestingly, the AR defect was associated with a deficiency in sperm membrane potential hyperpolarization. Our study highlights the relevance of the Gal-1-glycan axis in sperm function with critical implications in mammalian reproductive biology.	[Vasen, Gustavo; Agustina Battistone, Maria; Croci, Diego O.; Brukman, Nicolas G.; Weigel Munoz, Mariana; Stupirski, Juan C.; Rabinovich, Gabriel A.; Cuasnicu, Patricia S.] Inst Biol & Med Expt IBYME CONICET, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Cuasnicu, PS (corresponding author), Inst Biol & Med Expt IBYME CONICET, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.	pcuasnicu@ibyme.conicet.gov.ar	Croci, Diego/AAJ-5709-2021; Brukman, Nicolas/ABD-4071-2020	Croci, Diego/0000-0002-8623-0645; Brukman, Nicolas Gaston/0000-0002-9865-2503; Vasen, Gustavo/0000-0002-5968-2312	World Health Organization-Research Management Group [H9/TSA/037]; Argentinean National Scientific and Technical Research Council (CONICET) [PIP 2009-290]; National Agency for Promotion of Scientific and Technological Investigations [PICT 2011-2023, PICT 2012-2440]; Fundacion Sales	World Health Organization-Research Management Group; Argentinean National Scientific and Technical Research Council (CONICET); National Agency for Promotion of Scientific and Technological Investigations; Fundacion Sales	The authors thank D.J. Cohen for critical reading. This study was supported by grants from World Health Organization-Research Management Group (H9/TSA/037 to P.S.C.), the Argentinean National Scientific and Technical Research Council (CONICET) (PIP 2009-290 to P.S.C.), the National Agency for Promotion of Scientific and Technological Investigations (PICT 2011-2023 to P.S.C., PICT 2012-2440 to G.A.R.), and Fundacion Sales (to G.A.R). G.A.R. and P.S.C. share senior authorship.	Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Boryshpolets S, 2015, HUM REPROD, V30, P884, DOI 10.1093/humrep/dev002; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brewis IA, 2000, J ANDROL, V21, P238; Busso D, 2007, BIOL REPROD, V76, P701, DOI 10.1095/biolreprod.106.056770; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Copits BA, 2014, J PHYSIOL-LONDON, V592, P2079, DOI 10.1113/jphysiol.2013.269597; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Dettin L, 2003, BIOL REPROD, V68, P51, DOI 10.1095/biolreprod.102.006361; Easton RL, 2000, J BIOL CHEM, V275, P7731, DOI 10.1074/jbc.275.11.7731; Escoffier J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127266; Figueiras-Fierro D, 2013, J CELL PHYSIOL, V228, P590, DOI 10.1002/jcp.24166; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; Freitag N, 2013, P NATL ACAD SCI USA, V110, P11451, DOI 10.1073/pnas.1303707110; Hasegawa A, 2008, AM J REPROD IMMUNOL, V60, P187, DOI 10.1111/j.1600-0897.2008.00611.x; Hoodbhoy T, 2005, J BIOL CHEM, V280, P12721, DOI 10.1074/jbc.M413569200; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006; Karmakar S, 2005, J BIOL CHEM, V280, P28623, DOI 10.1074/jbc.M414140200; Kolundzic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028514; Kopcow HD, 2008, P NATL ACAD SCI USA, V105, P18472, DOI 10.1073/pnas.0809233105; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Lee MY, 2009, CELL MOL LIFE SCI, V66, P1467, DOI 10.1007/s00018-009-8691-8; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Mortimer ST, 1996, HUM REPROD, V11, P1049; Okabe M, 2007, CELL MOL LIFE SCI, V64, P1945, DOI 10.1007/s00018-007-7037-7; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Phillips B, 1996, BIOL REPROD, V55, P548, DOI 10.1095/biolreprod55.3.548; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Ramhorst RE, 2012, GLYCOBIOLOGY, V22, P1374, DOI 10.1093/glycob/cws104; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; Tirado-Gonzalez I, 2013, MOL HUM REPROD, V19, P43, DOI 10.1093/molehr/gas043; Towbin H, 1992, Biotechnology, V24, P145; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Walzel H, 2004, GLYCOBIOLOGY, V14, P871, DOI 10.1093/glycob/cwh101; Wang JF, 2009, J IMMUNOL, V182, P4036, DOI 10.4049/jimmunol.0802981; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291; Williams SA, 2011, ENDOCRINOLOGY, V152, P1057, DOI 10.1210/en.2010-0917; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Xin AJ, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-10; Yang CT, 2011, P NATL ACAD SCI USA, V108, P19419, DOI 10.1073/pnas.1111104108; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Yeung CH, 2002, BIOL REPROD, V67, P269, DOI 10.1095/biolreprod67.1.269; Yeung CH, 2009, BIOL REPROD, V80, P350, DOI 10.1095/biolreprod.108.071928; Zeng XH, 2015, P NATL ACAD SCI USA, V112, P2599, DOI 10.1073/pnas.1423869112; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108	58	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4189	4200		10.1096/fj.15-270975	http://dx.doi.org/10.1096/fj.15-270975			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26136479				2022-12-26	WOS:000361367300009
J	Gurel, PS; Mu, A; Guo, BQ; Shu, R; Mierke, DF; Higgs, HN				Gurel, Pinar S.; Mu, A.; Guo, Bingqian; Shu, Rui; Mierke, Dale F.; Higgs, Henry N.			Assembly and Turnover of Short Actin Filaments by the Formin INF2 and Profilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP HYDROLYSIS; ACANTHAMOEBA PROFILIN; ENDOPLASMIC-RETICULUM; NUCLEOTIDE EXCHANGE; BOUND NUCLEOTIDE; MOUSE FORMIN; ADP-ACTIN; POLYMERIZATION; NUCLEATION; MECHANISM	INF2 (inverted formin 2) is a formin protein with unique biochemical effects on actin. In addition to the common formin ability to accelerate actin nucleation and elongation, INF2 can also sever filaments and accelerate their depolymerization. Although we understand key attributes of INF2-mediated severing, we do not understand the mechanism by which INF2 accelerates depolymerization subsequent to severing. Here, we show that INF2 can create short filaments (<60 nm) that continuously turn over actin subunits through a combination of barbed end elongation, severing, and WH2 motif-mediated depolymerization. This pseudo-steady state condition occurs whether starting from actin filaments or monomers. The rate-limiting step of the cycle is nucleotide exchange of ADP for ATP on actin monomers after release from the INF2/actin complex. Profilin addition has two effects: 1) to accelerate filament turnover 6-fold by accelerating nucleotide exchange and 2) to shift the equilibrium toward polymerization, resulting in longer filaments. In sum, our findings show that the combination of multiple interactions of INF2 with actin can work in concert to increase the ATP turnover rate of actin. Depending on the ratio of INF2: actin, this increased flux can result in rapid filament depolymerization or maintenance of short filaments. We also show that high concentrations of cytochalasin D accelerate ATP turnover by actin but through a different mechanism from that of INF2.	[Gurel, Pinar S.; Mu, A.; Shu, Rui; Higgs, Henry N.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Guo, Bingqian; Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Higgs, HN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu	A, Mu/U-7936-2019; Regan, Clinton/E-6250-2012	Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [R01 GM069818, T32 GM008704]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818, T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM069818 (to H. N. H.) and T32 GM008704 (to P. S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; BUBB MR, 1991, J BIOL CHEM, V266, P3820; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; CARLIER MF, 1988, FEBS LETT, V235, P211, DOI 10.1016/0014-5793(88)81264-X; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Guo BQ, 2014, CHEM COMMUN, V50, P12037, DOI 10.1039/c4cc04399e; Gurel PS, 2014, CURR BIOL, V24, pR660, DOI 10.1016/j.cub.2014.05.033; Gurel PS, 2014, CURR BIOL, V24, P156, DOI 10.1016/j.cub.2013.12.018; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hatch AL, 2014, J CELL SCI, V127, P4549, DOI 10.1242/jcs.153791; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; McCullagh M, 2014, J AM CHEM SOC, V136, P13053, DOI 10.1021/ja507169f; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; OHM T, 1994, BBA-PROTEIN STRUCT M, V1208, P8, DOI 10.1016/0167-4838(94)90153-8; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Selden LA, 1999, BIOCHEMISTRY-US, V38, P2769, DOI 10.1021/bi981543c; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l	44	17	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22494	22506		10.1074/jbc.M115.670166	http://dx.doi.org/10.1074/jbc.M115.670166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26124273	hybrid, Green Published			2022-12-26	WOS:000361171500017
J	Arora, K; Cheng, J; Nichols, RA				Arora, Komal; Cheng, Justin; Nichols, Robert A.			Nicotinic Acetylcholine Receptors Sensitize a MAPK-linked Toxicity Pathway on Prolonged Exposure to beta-Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); c-Jun N-terminal kinase (JNK); extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); nicotinic acetylcholine receptors (nAChR)	N-TERMINAL KINASE; HIPPOCAMPAL SLICE CULTURES; ALZHEIMERS-DISEASE; PROTEIN-KINASE; FYN-KINASE; MOUSE MODEL; IN-VIVO; INDUCED PHOSPHORYLATION; INDUCED NEUROTOXICITY; SYNAPTIC DYSFUNCTION	Background: Signaling pathways involved in the sensitization by target receptors of -amyloid-triggered neurotoxicity have not been identified. Results: Exposure to -amyloid in the presence of nicotinic receptors led to ERK activation followed by JNK activation and increased PHF-tau. Conclusion: -amyloid neurotoxicity entails activation of discrete intracellular signaling pathways. Significance: Activation of select signaling pathways by -amyloid may be an early event in Alzheimer disease. Among putative downstream synaptic targets of -amyloid (A) are signaling molecules involved in synaptic function, memory formation and cognition, such as the MAP kinases, MKPs, CaMKII, CREB, Fyn, and Tau. Here, we assessed the activation and interaction of signaling pathways upon prolonged exposure to A in model nerve cells expressing nicotinic acetylcholine receptors (nAChRs). Our goal was to characterize the steps underlying sensitization of the nerve cells to neurotoxicity when A-target receptors are present. Of particular focus was the connection of the activated signaling molecules to oxidative stress. Differentiated neuroblastoma cells expressing mouse 42-nAChRs were exposed to A(1-42) for intervals from 30 min to 3 days. The cells and cell-derived protein extracts were then probed for activation of signaling pathway molecules (ERK, JNK, CaMKII, CREB, MARCKS, Fyn, tau). Our results show substantial, progressive activation of ERK in response to nanomolar A exposure, starting at the earliest time point. Increased ERK activation was followed by JNK activation as well as an increased expression of PHF-tau, paralleled by increased levels of reactive oxygen species (ROS). The impact of prolonged A on the levels of pERK, pJNK, and ROS was attenuated by MEK-selective and JNK-selective inhibitors. In addition, the MEK inhibitor as well as a JNK inhibitor attenuated A-induced nuclear fragmentation, which followed the changes in ROS levels. These results demonstrate that the presence of nAChRs sensitizes neurons to the neurotoxic action of A through the timed activation of discrete intracellular signaling molecules, suggesting pathways involved in the early stages of Alzheimer disease.	[Arora, Komal; Cheng, Justin; Nichols, Robert A.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa	Nichols, RA (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	robert.nichols@hawaii.edu			Hawaii Community Foundation [09ADVC-45413]; National Institute on Aging [AG21586]; National Institute for General Medical Sciences [P20 GM103466]; National Institute on Minority Health and Health Disparities [G12MD007601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER	Hawaii Community Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants (to R. A. N.) from the Hawaii Community Foundation (09ADVC-45413), the National Institute on Aging (AG21586) and the National Institute for General Medical Sciences (P20 GM103466). Additional support for the microscopy core at the University of Hawaii was provided by a Research Center for Minority Institutions grant from the National Institute on Minority Health and Health Disparities (G12MD007601). The authors declare that they have no conflicts of interest with the contents of this article.	Arora K, 2013, J BIOL CHEM, V288, P11175, DOI 10.1074/jbc.M113.453746; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Balleza-Tapia H, 2009, MINI-REV MED CHEM, V9, P724, DOI 10.2174/138955709788452784; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Blum S, 1999, J NEUROSCI, V19, P3535; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Ferrer I, 2001, BRAIN PATHOL, V11, P144; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Gubbins EJ, 2010, BRAIN RES, V1328, P1, DOI 10.1016/j.brainres.2010.02.083; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Khan GM, 2010, EUR J NEUROSCI, V31, P788, DOI 10.1111/j.1460-9568.2010.07116.x; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Liao DZ, 2014, EUR J NEUROSCI, V39, P1202, DOI 10.1111/ejn.12504; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; LU Q, 1993, J NEUROSCI RES, V35, P439, DOI 10.1002/jnr.490350411; Mazzitelli S, 2011, J NEUROSCI, V31, P16969, DOI 10.1523/JNEUROSCI.4491-11.2011; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nakayama H, 2001, J NEUROCHEM, V79, P489, DOI 10.1046/j.1471-4159.2001.00602.x; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pei JJ, 2001, J ALZHEIMERS DIS, V3, P41, DOI 10.3233/JAD-2001-3107; Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592; Ramin M, 2011, BEHAV BRAIN RES, V217, P424, DOI 10.1016/j.bbr.2010.11.017; Rapoport M, 2000, J NEUROCHEM, V74, P125, DOI 10.1046/j.1471-4159.2000.0740125.x; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Schafe GE, 1999, LEARN MEMORY, V6, P97; Sclip A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.559; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Sherrin T, 2010, J NEUROSCI, V30, P13348, DOI 10.1523/JNEUROSCI.3492-10.2010; Smolen P, 2006, BIOPHYS J, V90, P2760, DOI 10.1529/biophysj.105.072470; Steiner RC, 2007, J NEUROCHEM, V103, P666, DOI 10.1111/j.1471-4159.2007.04799.x; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Tong M, 2011, J BIOL CHEM, V286, P34373, DOI 10.1074/jbc.M111.241299; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Yang K, 2011, J ALZHEIMERS DIS, V27, P243, DOI 10.3233/JAD-2011-110353; Yao MZ, 2005, J NEUROSCI, V25, P1149, DOI 10.1523/JNEUROSCI.4736-04.2005; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	53	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21409	21420		10.1074/jbc.M114.634162	http://dx.doi.org/10.1074/jbc.M114.634162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26139609	Green Published, hybrid			2022-12-26	WOS:000360637600018
J	Maguire, SE; Rhoades, S; Chen, WF; Sengupta, A; Yue, ZF; Lim, JC; Mitchell, CH; Weljie, AM; Sehgal, A				Maguire, Sarah E.; Rhoades, Seth; Chen, Wen-Feng; Sengupta, Arjun; Yue, Zhifeng; Lim, Jason C.; Mitchell, Claire H.; Weljie, Aalim M.; Sehgal, Amita			Independent Effects of gamma-Aminobutyric Acid Transaminase (GABAT) on Metabolic and Sleep Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-AMINOBUTYRATE AMINOTRANSFERASE; GLUTAMINE; CELLS; CYCLE	Breakdown of the major sleep-promoting neurotransmitter, gamma-aminobutyric acid (GABA), in the GABA shunt generates catabolites that may enter the tricarboxylic acid cycle, but it is unknown whether catabolic by-products of the GABA shunt actually support metabolic homeostasis. In Drosophila, the loss of the specific enzyme that degrades GABA, GABA transaminase (GABAT), increases sleep, and we show here that it also affects metabolism such that flies lacking GABAT fail to survive on carbohydrate media. Expression of GABAT in neurons or glia rescues this phenotype, indicating a general metabolic function for this enzyme in the brain. As GABA degradation produces two catabolic products, glutamate and succinic semialdehyde, we sought to determine which was responsible for the metabolic phenotype. Through genetic and pharmacological experiments, we determined that glutamate, rather than succinic semialdehyde, accounts for the metabolic phenotype of gabat mutants. This is supported by biochemical measurements of catabolites in wild-type and mutant animals. Using in vitro labeling assays, we found that inhibition of GABAT affects energetic pathways. Interestingly, we also observed that gaba mutants display a general disruption in bioenergetics as measured by altered levels of tricarboxylic acid cycle intermediates, NAD(+)/NADH, and ATP levels. Finally, we report that the effects of GABAT on sleep do not depend upon glutamate, indicating that GABAT regulates metabolic and sleep homeostasis through independent mechanisms. These data indicate a role of the GABA shunt in the development of metabolic risk and suggest that neurological disorders caused by altered glutamate or GABA may be associated with metabolic disruption.	[Maguire, Sarah E.; Sehgal, Amita] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Lim, Jason C.; Mitchell, Claire H.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Rhoades, Seth; Sengupta, Arjun; Weljie, Aalim M.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Chen, Wen-Feng; Yue, Zhifeng; Sehgal, Amita] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Sehgal, Amita] Univ Penn, Perelman Sch Med, Dept Cell & Mol Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine	Sehgal, A (corresponding author), Dept Neurosci, 10-136 Smilow Ctr Translat Res,Bldg 421, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu	Regan, Clinton/E-6250-2012; Weljie, Aalim/V-6952-2019; Sengupta, Arjun/AAS-8787-2021; Sengupta, Arjun/R-5802-2019	Weljie, Aalim/0000-0002-7145-4494; Sengupta, Arjun/0000-0003-2210-1876; Rhoades, Seth/0000-0001-7864-447X	National Institutes of Health [HL07953]; Pharmacology T32 Training Grant [T32 GM008076, EY015537, 2P40OD010949-10A1]; NATIONAL EYE INSTITUTE [R01EY015537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacology T32 Training Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Training Grant HL07953 (to S. E. M.), Pharmacology T32 Training Grant T32 GM008076 (to S. R.), Grant EY015537 (to C. H. M.), and Grant 2P40OD010949-10A1 (to The Drosophila Genomics Resource Center). The authors declare that they have no conflicts of interest with the contents of this article.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; BALAZS R, 1970, BIOCHEM J, V116, P445; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Brosnan ME, 2009, AM J CLIN NUTR, V90, p857S, DOI 10.3945/ajcn.2009.27462Z; Chen WF, 2015, MOL PSYCHIATR, V20, P240, DOI 10.1038/mp.2014.11; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; FOWLER LJ, 1972, BIOCHEM J, V130, P569, DOI 10.1042/bj1300569; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; JAEKEN J, 1984, NEUROPEDIATRICS, V15, P165, DOI 10.1055/s-2008-1052362; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Medina-Kauwe LK, 1999, J INHERIT METAB DIS, V22, P414, DOI 10.1023/A:1005500122231; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Qu H, 2001, J NEUROSCI RES, V66, P885, DOI 10.1002/jnr.10055; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Studart-Guimaraes C, 2007, PLANT PHYSIOL, V145, P626, DOI 10.1104/pp.107.103101; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	26	20	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20407	20416		10.1074/jbc.M114.602276	http://dx.doi.org/10.1074/jbc.M114.602276			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26124278	hybrid, Green Published			2022-12-26	WOS:000359608900038
J	Pedersen, JT; Falhof, J; Ekberg, K; Buch-Pedersen, MJ; Palmgren, M				Pedersen, Jesper Torbol; Falhof, Janus; Ekberg, Kira; Buch-Pedersen, Morten Jeppe; Palmgren, Michael			Metal Fluoride Inhibition of a P-type H+ Pump STABILIZATION OF THE PHOSPHOENZYME INTERMEDIATE CONTRIBUTES TO POST-TRANSLATIONAL PUMP ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PLASMA-MEMBRANE; SARCOPLASMIC-RETICULUM CA2+-ATPASE; C-TERMINAL END; FLUOROALUMINATE COMPLEXES; SACCHAROMYCES-CEREVISIAE; INORGANIC-PHOSPHATE; REGULATORY DOMAIN; CRYSTAL-STRUCTURE; DELETION ANALYSIS; CALCIUM-ATPASE	The plasma membrane H+-ATPase is a P-type ATPase responsible for establishing electrochemical gradients across the plasma membrane in fungi and plants. This essential proton pump exists in two activity states: an autoinhibited basal state with a low turnover rate and a low H+/ATP coupling ratio and an activated state in which ATP hydrolysis is tightly coupled to proton transport. Here we characterize metal fluorides as inhibitors of the fungal enzyme in both states. In contrast to findings for other P-type ATPases, inhibition of the plasma membrane H+-ATPase by metal fluorides was partly reversible, and the stability of the inhibition varied with the activation state. Thus, the stability of the ATPase inhibitor complex decreased significantly when the pump transitioned from the activated to the basal state, particularly when using beryllium fluoride, which mimics the bound phosphate in the E2P conformational state. Taken together, our results indicate that the phosphate bond of the phosphoenzyme intermediate of H+-ATPases is labile in the basal state, which may provide an explanation for the low H+/ATP coupling ratio of these pumps in the basal state.	[Pedersen, Jesper Torbol; Falhof, Janus; Ekberg, Kira; Buch-Pedersen, Morten Jeppe; Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1871 Frederiksberg, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Ekberg, K (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg, Denmark.	kiek@plen@ku.dk; palmgren@plen.ku.dk	Pedersen, Jesper Torbøl/AAX-5500-2020; Palmgren, Michael/A-9808-2013	Pedersen, Jesper Torbøl/0000-0003-3094-1461; Palmgren, Michael/0000-0002-9982-6114	Danish Strategic Research Council ("FungalFight")	Danish Strategic Research Council ("FungalFight")	This work was supported by the Danish Strategic Research Council ("FungalFight"). The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2012, P NATL ACAD SCI USA, V109, P18401, DOI 10.1073/pnas.1212294109; Abe K, 2010, J STRUCT BIOL, V170, P60, DOI 10.1016/j.jsb.2009.12.008; AMORY A, 1982, J BIOL CHEM, V257, P2509; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Baunsgaard L, 1996, PLANT J, V10, P451, DOI 10.1046/j.1365-313X.1996.10030451.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buch-Pedersen MJ, 2009, PFLUG ARCH EUR J PHY, V457, P573, DOI 10.1007/s00424-008-0503-8; COLL RJ, 1992, J BIOL CHEM, V267, P21584; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; DAIHO T, 1993, BIOCHEMISTRY-US, V32, P10021, DOI 10.1021/bi00089a018; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; ERASO P, 1994, J BIOL CHEM, V269, P10393; FACANHA AR, 1995, PLANT PHYSIOL, V108, P241, DOI 10.1104/pp.108.1.241; Fuglsang AT, 2014, PLANT J, V80, P951, DOI 10.1111/tpj.12680; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0; KANAZAWA T, 1973, J BIOL CHEM, V248, P3163; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lefebvre B, 2003, PROG NUCLEIC ACID RE, V74, P203, DOI 10.1016/S0079-6603(03)01014-6; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; MARTIN DW, 1981, BIOCHEMISTRY-US, V20, P4597, DOI 10.1021/bi00519a013; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; Miranda M, 2001, J BIOL CHEM, V276, P22485, DOI 10.1074/jbc.M102332200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; MURPHY AJ, 1993, J BIOL CHEM, V268, P23307; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; RAPINLEGROUX C, 1994, BBA-BIOENERGETICS, V1184, P127, DOI 10.1016/0005-2728(94)90162-7; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SETOYOUNG D, 1991, J BIOL CHEM, V266, P1383; SLAYMAN CL, 1987, J BIOENERG BIOMEMBR, V19, P1; Takahashi K, 2012, PLANT PHYSIOL, V159, P632, DOI 10.1104/pp.112.196428; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Tomasi N, 2009, PLANT CELL ENVIRON, V32, P465, DOI 10.1111/j.1365-3040.2009.01938.x; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Wielandt AG, 2015, J BIOL CHEM, V290, P16281, DOI 10.1074/jbc.M114.617746; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yang YQ, 2010, PLANT CELL, V22, P1313, DOI 10.1105/tpc.109.069609	56	11	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20396	20406		10.1074/jbc.M115.639385	http://dx.doi.org/10.1074/jbc.M115.639385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26134563	hybrid, Green Published			2022-12-26	WOS:000359608900037
J	Torrent, J; Lange, R; Rezaei, H				Torrent, Joan; Lange, Reinhard; Rezaei, Human			The Volumetric Diversity of Misfolded Prion Protein Oligomers Revealed by Pressure Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE OLIGOMERS; SCRAPIE; HYDRATION; KINETICS; INSIGHTS; DISEASE; CONFORMATIONS; MOLECULES; PATHWAYS; STRAINS	Protein oligomerization has been associated with a wide range of diseases. High pressure approaches offer a powerful tool for deciphering the underlying molecular mechanisms by revealing volume changes associated with the misfolding and assembly reactions. We applied high pressure to induce conformational changes in three distinct beta-sheet-rich oligomers of the prion protein PrP, a protein characterized by a variety of infectious quaternary structures that can propagate stably and faithfully and cause diseases with specific phenotypic traits. We show that pressure induces dissociation of the oligomers and leads to a lower volume monomeric PrP state that refolds into the native conformation after pressure release. By measuring the different pressure and temperature sensitivity of the tested PrP oligomers, we demonstrate significantly different void volumes in their quaternary structure. In addition, by focusing on the kinetic and energetic behavior of the pressure-induced dissociation of one specific PrP oligomer, we reveal a large negative activation volume and an increase in both apparent activation enthalpy and entropy. This suggests a transition state ensemble that is less structured and significantly more hydrated than the oligomeric state. Finally, we found that site-specific fluorescent labeling allows monitoring of the transient population of a kinetic intermediate in the dissociation reaction. Our results indicate that defects in atomic packing may deserve consideration as a new factor that influences differences between PrP assemblies and that could be relevant also for explaining the origin of prion strains.	[Torrent, Joan; Rezaei, Human] INRA, UR892, Virol Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France; [Lange, Reinhard] Univ Montpellier, Inst Natl Rech Agron, UMR1208, Ingn Agropolymeres & Technol Emergentes, F-34095 Montpellier, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Montpellier	Torrent, J (corresponding author), INRA, UR892, Virol Immunol Mol, Domaine Vilvert, F-78350 Jouy En Josas, France.	joan.torrent@inserm.fr		TORRENT, Joan/0000-0002-6908-4084				Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Cavaliere P, 2013, BBA-MOL BASIS DIS, V1832, P20, DOI 10.1016/j.bbadis.2012.09.005; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Chich JF, 2010, J MOL BIOL, V397, P1017, DOI 10.1016/j.jmb.2010.02.013; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; El Moustaine D, 2011, J BIOL CHEM, V286, P13448, DOI 10.1074/jbc.M110.192872; Font J, 2006, BIOPHYS J, V91, P2264, DOI 10.1529/biophysj.106.082552; Forst P, 2000, RHEOL ACTA, V39, P566, DOI 10.1007/s003970000114; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Laferriere F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003702; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Torrent J, 2006, BBA-PROTEINS PROTEOM, V1764, P489, DOI 10.1016/j.bbapap.2006.01.002; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916; VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Woenckhaus J, 2001, BIOPHYS J, V80, P1518, DOI 10.1016/S0006-3495(01)76124-3	36	6	6	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20417	20426		10.1074/jbc.M115.661710	http://dx.doi.org/10.1074/jbc.M115.661710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26126829	hybrid, Green Published			2022-12-26	WOS:000359608900039
J	Dominiak-Felden, G; Gobbo, C; Simondon, F				Dominiak-Felden, Geraldine; Gobbo, Corrado; Simondon, Francois			Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; ANOGENITAL WARTS; UNITED-STATES; IMPACT; HEALTH; WOMEN; POPULATION; MANAGEMENT; GERMANY; BURDEN	Genital warts (GWs) are common, with about 5% to 10% of people having at least one episode in their lifetime. They develop about 2-3 months after infection with human papillomavirus (HPV) genotypes 6 and 11. The prophylactic quadrivalent HPV vaccine (qHPV), protects against HPV6/11 infections and diseases. In Belgium, HPV vaccines started to be reimbursed in 2007 and have been fully reimbursed since December 2008 for women 12 to 18 years old. This study aimed at evaluating the real-life benefit of qHPV vaccine introduction in Belgium on GWs by measuring both vaccine impact (VI) at a population level and the direct effect of the qHPV vaccine at an individual level (vaccine effectiveness (VE)), using data from a large sick-fund (MLOZ) reimbursement database. A first reimbursement for imiquimod (most common first-line GWs treatment in Belgium) was used as a surrogate for a first GWs episode; reimbursement of qHPV vaccine was used as surrogate for vaccination. VI was estimated by comparing the incidence of GWs before and after qHPV vaccine introduction in Belgium (ecologic evaluation). VE was assessed by comparing GWs incidences in vaccinated vs. unvaccinated women, among women eligible for HPV vaccination. VI was evaluated in 9,223,384 person-years. Overall, GWs incidence rates decreased significantly between the pre- and post-vaccination periods (-8.1% (95% CI: -15.3; -0.3) for men and women aged 18-59 years. This decrease was highest in women targeted by the HPV vaccination programme (-72.1% (95% CI: -77.9; -64.7) in women aged 16-22 years, with a 43% vaccine uptake in 2013). A significant decrease was also observed in men aged 16-22 years (-51.1%, 95% CI: -67.6; -26.2), suggesting herd-protection. VE was evaluated in 369,881 person-years. Age-adjusted VE for fully vaccinated women was 88.0% (95% CI: 79.4; 93.0). VE was higher when the first dose was given younger and remained high for over 4 years post-vaccination in all ages. High VI and VE of the qHPV vaccine were observed in a real-life setting in Belgium.	[Dominiak-Felden, Geraldine; Simondon, Francois] Sanofi Pasteur MSD, Franchise Dev Dept, Lyon, France; [Gobbo, Corrado] Sanofi Pasteur MSD, Diegem, Belgium	Sanofi-Aventis; Sanofi France	Dominiak-Felden, G (corresponding author), Sanofi Pasteur MSD, Franchise Dev Dept, Lyon, France.	gdominiak@spmsd.com		Simondon, Francois/0000-0003-0395-1314	Sanofi Pasteur MSD	Sanofi Pasteur MSD	This study was funded by Sanofi Pasteur MSD who commercialise the quadrivalent HPV vaccine in Europe. All authors work for Sanofi Pasteur MSD. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Annemans Lieven, 2008, J Med Econ, V11, P135, DOI 10.3111/13696990801961611; Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Beutner KR, 1999, CLIN INFECT DIS, V28, pS37, DOI 10.1086/514722; Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; Desai S, 2011, SEX TRANSM INFECT, V87, P464, DOI 10.1136/sti.2010.048421; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Dinh TH, 2008, SEX TRANSM DIS, V35, P357, DOI 10.1097/OLQ.0b013e3181632d61; Dominiak-Felden G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1065; European Medicines Agency, GARDASIL SUMMARY PRO; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Flagg EW, 2013, AM J PUBLIC HEALTH, V103, P1428, DOI 10.2105/AJPH.2012.301182; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Hanquet G, 2013, VACCINE, V31, P5634, DOI 10.1016/j.vaccine.2013.07.006; Hillemanns P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-76; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kraut AA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-360; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Lawrence S, 2009, INT J STD AIDS, V20, P696, DOI 10.1258/ijsa.2009.009120; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Leval A, 2012, J INFECT DIS, V206, P860, DOI 10.1093/infdis/jis405; Liu B, 2014, SEX TRANSM INFECT, V90, P532, DOI 10.1136/sextrans-2013-051307; Mariani L, 2015, ADV THER, V32, P10, DOI 10.1007/s12325-015-0178-4; Marra F, 2009, SEX TRANSM INFECT, V85, P111, DOI 10.1136/sti.2008.030999; Mikolajczyk RT, 2013, SEX TRANSM DIS, V40, P28, DOI 10.1097/OLQ.0b013e3182756efd; Moreau N, 2013, SECONDARY SCH CHILDR; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Oliphant J, 2011, NEW ZEAL MED J, V124, P51; Oriel JD, 1971, SEXUALLY TRANSMIT S1, V76, pS21; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Verbrugge R, 2014, SEXUALLY TRANSMITTED; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; von Krogh G, 2001, EJD, V11, P4; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	37	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132404	10.1371/journal.pone.0132404	http://dx.doi.org/10.1371/journal.pone.0132404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147096	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600259
J	Ikeda, K; Takahashi, M; Sato, S; Igarashi, H; Ishizuka, T; Yawo, H; Arata, S; Southard-Smith, EM; Kawakami, K; Onimaru, H				Ikeda, Keiko; Takahashi, Masanori; Sato, Shigeru; Igarashi, Hiroyuki; Ishizuka, Toru; Yawo, Hiromu; Arata, Satoru; Southard-Smith, E. Michelle; Kawakami, Kiyoshi; Onimaru, Hiroshi			A Phox2b BAC Transgenic Rat Line Useful for Understanding Respiratory Rhythm Generator Neural Circuitry	PLOS ONE			English	Article							CENTRAL HYPOVENTILATION SYNDROME; STEM-SPINAL-CORD; HOMEOBOX GENE PHOX2B; CRE RECOMBINASE ACTIVITY; CENTRAL-NERVOUS-SYSTEM; RETROTRAPEZOID NUCLEUS; NEWBORN RATS; PREBOTZINGER COMPLEX; VENTRAL MEDULLA; CAROTID-BODY	The key role of the respiratory neural center is respiratory rhythm generation to maintain homeostasis through the control of arterial blood pCO(2)/pH and pO(2) levels. The neuronal network responsible for respiratory rhythm generation in neonatal rat resides in the ventral side of the medulla and is composed of two groups; the parafacial respiratory group (pFRG) and the pre-Botzinger complex group (preBotC). The pFRG partially overlaps in the retrotrapezoid nucleus (RTN), which was originally identified in adult cats and rats. Part of the pre-inspiratory (Pre-I) neurons in the RTN/pFRG serves as central chemoreceptor neurons and the CO2 sensitive Pre-I neurons express homeobox gene Phox2b. Phox2b encodes a transcription factor and is essential for the development of the sensory-motor visceral circuits. Mutations in human PHOX2B cause congenital hypoventilation syndrome, which is characterized by blunted ventilatory response to hypercapnia. Here we describe the generation of a novel transgenic (Tg) rat harboring fluorescently labeled Pre-I neurons in the RTN/pFRG. In addition, the Tg rat showed fluorescent signals in autonomic enteric neurons and carotid bodies. Because the Tg rat expresses inducible Cre recombinase in PHOX2B-positive cells during development, it is a potentially powerful tool for dissecting the entire picture of the respiratory neural network during development and for identifying the CO2/O-2 sensor molecules in the adult central and peripheral nervous systems.	[Ikeda, Keiko] Hyogo Coll Med, Div Biol, Nishinomiya, Hyogo 6638501, Japan; [Ikeda, Keiko; Takahashi, Masanori; Sato, Shigeru; Kawakami, Kiyoshi] Jichi Med Univ, Ctr Mol Med, Div Biol, Shimotsuke, Tochigi, Japan; [Igarashi, Hiroyuki; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Dept Physiol & Pharmacol, Sendai, Miyagi 980, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Ishizuka, Toru; Yawo, Hiromu] JST CREST, Sendai, Miyagi, Japan; [Arata, Satoru] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo, Japan; [Southard-Smith, E. Michelle] Vanderbilt Univ, Sch Med, Dept Med, Div Med Genet, Nashville, TN 37212 USA; [Onimaru, Hiroshi] Showa Univ, Sch Med, Dept Physiol, Shinagawa Ku, Tokyo 142, Japan	Hyogo College of Medicine; Jichi Medical University; Tohoku University; Tohoku University; Showa University; Vanderbilt University; Showa University	Ikeda, K (corresponding author), Hyogo Coll Med, Div Biol, Nishinomiya, Hyogo 6638501, Japan.	kiikeda@hyo-med.ac.jp	Yawo, Hiromu/I-4871-2015; Ishizuka, Toru/L-8191-2017; Sato, Shigeru/ABE-2090-2020	Yawo, Hiromu/0000-0002-4299-3288; Ishizuka, Toru/0000-0003-4405-8792; Southard-Smith, E Michelle/0000-0003-4718-5869	MEXT (Ministry of Education, Culture, Sports, Science and Technology); Grants-in-Aid for Scientific Research [15K15025, 25430012, 15H01413] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Naito Foundation, https://www.naito-f.or.jp/jp/joseikn/jo_index.php?data = detail&grant_id=KEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities 2012-2015 (Showa University of Medicine, Jichi Medical University, Hyogo College of Medicine), preparation of reagent, equipments, performing experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2011, J NEUROSCI, V31, P16410, DOI 10.1523/JNEUROSCI.3280-11.2011; Abe K, 2004, EXP ANIM TOKYO, V53, P311, DOI 10.1538/expanim.53.311; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Bayliss DA, 2015, PFLUG ARCH EUR J PHY, V467, P917, DOI 10.1007/s00424-014-1633-9; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cinelli E, 2013, J NEUROSCI, V33, P9104, DOI 10.1523/JNEUROSCI.0299-13.2013; CONNELLY CA, 1990, AM J PHYSIOL, V258, pL33, DOI 10.1152/ajplung.1990.258.2.L33; Corpening JC, 2008, DEV DYNAM, V237, P1119, DOI 10.1002/dvdy.21498; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; Dercksen VJ, 2008, MATH VIS, P3, DOI 10.1007/978-3-540-72630-2_1; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Dubreuil V, 2009, PHILOS T R SOC B, V364, P2477, DOI 10.1098/rstb.2009.0085; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gaultier C, 2004, PEDIATR RES, V55, P729, DOI 10.1203/01.PDR.0000115677.78759.C5; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GONZALEZ C, 1979, BRAIN RES, V172, P572, DOI 10.1016/0006-8993(79)90591-2; Goridis C, 2010, RESP PHYSIOL NEUROBI, V173, P312, DOI 10.1016/j.resp.2010.03.014; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Gozal D, 1998, PEDIATR PULM, V26, P273; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2008, J APPL PHYSIOL, V105, P404, DOI 10.1152/japplphysiol.90452.2008; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Guyenet PG, 2010, RESP PHYSIOL NEUROBI, V173, P244, DOI 10.1016/j.resp.2010.02.005; Guyenet PG, 2009, RESP PHYSIOL NEUROBI, V168, P59, DOI 10.1016/j.resp.2009.02.001; Guyenet PG, 2005, J NEUROSCI, V25, P8938, DOI 10.1523/JNEUROSCI.2415-05.2005; Haming D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026543; HELLSTROM S, 1975, ACTA PHYSIOL SCAND, V93, P540, DOI 10.1111/j.1748-1716.1975.tb05846.x; Hirsch MR, 2013, GENESIS, V51, P506, DOI 10.1002/dvg.22393; Hoekstra EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052118; Igarashi H, 2014, PROGRAM NO 657 18 20; Ikeda K, 2007, DEV BIOL, V311, P53, DOI 10.1016/j.ydbio.2007.08.020; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Kang BJ, 2007, J COMP NEUROL, V503, P627, DOI 10.1002/cne.21409; Kawai A, 2006, J PHYSIOL-LONDON, V572, P525, DOI 10.1113/jphysiol.2005.102533; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; McGaughey DM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-8; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; MILLER AD, 1994, FRONT NEUROENDOCRIN, V15, P301, DOI 10.1006/frne.1994.1012; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Mutolo D, 2007, NEUROSCIENCE, V150, P720, DOI 10.1016/j.neuroscience.2007.09.028; Mutolo D, 2010, NEUROSCIENCE, V169, P1136, DOI 10.1016/j.neuroscience.2010.06.004; Mutolo D, 2011, J NEUROSCI, V31, P13323, DOI 10.1523/JNEUROSCI.2764-11.2011; Muyrers JPP, 2000, EMBO REP, V1, P239, DOI 10.1093/embo-reports/kvd049; Nattie E, 1999, PROG NEUROBIOL, V59, P299, DOI 10.1016/S0301-0082(99)00008-8; Nattie EE, 2002, J PHYSIOL-LONDON, V544, P603, DOI 10.1113/jphysiol.2002.020032; Onimaru H, 2012, NEUROSCIENCE, V212, P131, DOI 10.1016/j.neuroscience.2012.03.037; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, ADV EXP MED BIOL, V605, P104; Onimaru H, 2007, J PHYSIOL-LONDON, V584, P271, DOI 10.1113/jphysiol.2007.136572; Onimaru H, 2006, J NEUROPHYSIOL, V96, P55, DOI 10.1152/jn.01175.2005; Onimaru H, 2014, PROG BRAIN RES, V209, P57, DOI 10.1016/B978-0-444-63274-6.00004-7; Onimaru H, 2012, J PHYSIOL-LONDON, V590, P1615, DOI 10.1113/jphysiol.2011.222687; Onimaru H, 2009, RESP PHYSIOL NEUROBI, V168, P13, DOI 10.1016/j.resp.2009.03.007; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; Pan TCF, 2010, COMP BIOCHEM PHYS A, V157, P382, DOI [10.1016/J.cbpa.2010.08.018, 10.1016/j.cbpa.2010.08.018]; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; PEARCE RA, 1989, NEUROSCI LETT, V101, P138, DOI 10.1016/0304-3940(89)90520-X; Putnam RW, 2010, J APPL PHYSIOL, V108, P1796, DOI 10.1152/japplphysiol.01169.2009; Richerson GB, 2005, EXP PHYSIOL, V90, P259, DOI 10.1113/expphysiol.2005.029843; Rosin DL, 2006, J COMP NEUROL, V499, P64, DOI 10.1002/cne.21105; Shimizu S, 2014, HANDB EXP PHARMACOL, V223, P767, DOI 10.1007/978-3-319-05161-1_3; Smith CA, 2006, J APPL PHYSIOL, V100, P13, DOI 10.1152/japplphysiol.00926.2005; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spengler CM, 2001, RESP PHYSIOL, V129, P247, DOI 10.1016/S0034-5687(01)00294-8; Stornetta RL, 2006, J NEUROSCI, V26, P10305, DOI 10.1523/JNEUROSCI.2917-06.2006; Stranahan AM, 2011, BEHAV NEUROSCI, V125, P791, DOI 10.1037/a0025133; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takahashi M, 2011, MECH DEVELOP, V128, P289, DOI 10.1016/j.mod.2011.04.001; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Takakura ACT, 2006, J PHYSIOL-LONDON, V572, P503, DOI 10.1113/jphysiol.2005.103788; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Vicario I, 2000, AM J PHYSIOL-CELL PH, V278, pC490, DOI 10.1152/ajpcell.2000.278.3.C490; Weese-Mayer DE, 2005, RESP PHYSIOL NEUROBI, V149, P73, DOI 10.1016/j.resp.2005.06.010; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Wong-Riley MTT, 2013, RESP PHYSIOL NEUROBI, V185, P156, DOI 10.1016/j.resp.2012.05.026; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	93	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132475	10.1371/journal.pone.0132475	http://dx.doi.org/10.1371/journal.pone.0132475			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147470	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600281
J	Kurbatova, N; Mason, JC; Morgan, H; Meehan, TF; Karp, NA				Kurbatova, Natalja; Mason, Jeremy C.; Morgan, Hugh; Meehan, Terrence F.; Karp, Natasha A.			PhenStat: A Tool Kit for Standardized Analysis of High Throughput Phenotypic Data	PLOS ONE			English	Article							KNOCKOUT MICE; RAT GENETICS; MOUSE; CONSORTIUM; GENOME; RESOURCES; PROJECT; POINT	The lack of reproducibility with animal phenotyping experiments is a growing concern among the biomedical community. One contributing factor is the inadequate description of statistical analysis methods that prevents researchers from replicating results even when the original data are provided. Here we present PhenStat - a freely available R package that provides a variety of statistical methods for the identification of phenotypic associations. The methods have been developed for high throughput phenotyping pipelines implemented across various experimental designs with an emphasis on managing temporal variation. PhenStat is targeted to two user groups: small-scale users who wish to interact and test data from large resources and large-scale users who require an automated statistical analysis pipeline. The software provides guidance to the user for selecting appropriate analysis methods based on the dataset and is designed to allow for additions and modifications as needed. The package was tested on mouse and rat data and is used by the International Mouse Phenotyping Consortium (IMPC). By providing raw data and the version of PhenStat used, resources like the IMPC give users the ability to replicate and explore results within their own computing environment.	[Kurbatova, Natalja; Mason, Jeremy C.; Meehan, Terrence F.] EMBL European Bioinformat Inst, Hinxton, Cambs, England; [Morgan, Hugh] Med Res Council Harwell, Harwell, Oxon, England; [Karp, Natasha A.] Wellcome Trust Sanger Inst, Mouse Informat Grp, Hinxton, Cambs, England	European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Wellcome Trust Sanger Institute	Kurbatova, N (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	natalja@ebi.ac.uk		Mason, Justin/0000-0001-7783-1660; /0000-0002-2796-5123; Karp, Natasha/0000-0002-8404-2907; Kurbatova, Natalja/0000-0002-3973-2909; Meehan, Terrence/0000-0003-1980-3228	Wellcome Trust [WT098051]; National Institutes of Health [1 U54 HG006370-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Wellcome Trust (grant number: WT098051, http:/www.wellcome.ac.ukFundingindex.htm) and the National Institutes of Health (grant number: 1 U54 HG006370-01, http:/grants.nih.govgrantsoer.htm).	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; [Anonymous], 2012, NATURE, V483, P509, DOI DOI 10.1038/483509A; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Clark RA, 2012, J PSYCHOPHARMACOL, V26, P1136, DOI 10.1177/0269881111420313; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Cook MN, 2007, MAMM GENOME, V18, P559, DOI 10.1007/s00335-007-9035-3; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Flanagan KL, 2014, T ROY SOC TROP MED H, V108, P385, DOI 10.1093/trstmh/tru079; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Karp NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111239; Karp NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052410; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Lees H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100916; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; R Development Core Team, R LANG ENV STAT COMP; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; West B. T., 2014, LINEAR MIXED MODELS; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022	31	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131274	10.1371/journal.pone.0131274	http://dx.doi.org/10.1371/journal.pone.0131274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147094	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600079
J	Sun, L; Chen, FJ; Peng, G				Sun, Liu; Chen, Fengjiao; Peng, Gang			Conserved Noncoding Sequences Regulate lhx5 Expression in the Zebrafish Forebrain	PLOS ONE			English	Article							LIM-HOMEOBOX GENE; IN-SITU HYBRIDIZATION; DORSAL SPINAL-CORD; PROSOMERIC MODEL; CELL DIFFERENTIATION; BINDING-SITES; GLI PROTEINS; HOMEODOMAIN; EVOLUTION; GENOME	The LIM homeobox family protein Lhx5 plays important roles in forebrain development in the vertebrates. The lhx5 gene exhibits complex temporal and spatial expression patterns during early development but its transcriptional regulation mechanisms are not well understood. Here, we have used transgenesis in zebrafish in order to define regulatory elements that drive lhx5 expression in the forebrain. Through comparative genomic analysis we identified 10 non-coding sequences conserved in five teleost species. We next examined the enhancer activities of these conserved non-coding sequences with Tol2 transposon mediated transgenesis. We found a proximately located enhancer gave rise to robust reporter EGFP expression in the forebrain regions. In addition, we identified an enhancer located at approximately 50 kb upstream of lhx5 coding region that is responsible for reporter gene expression in the hypothalamus. We also identify an enhancer located approximately 40 kb upstream of the lhx5 coding region that is required for expression in the prethalamus (ventral thalamus). Together our results suggest discrete enhancer elements control lhx5 expression in different regions of the forebrain.	[Sun, Liu; Chen, Fengjiao; Peng, Gang] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sun, Liu; Chen, Fengjiao; Peng, Gang] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Peng, G (corresponding author), Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	gangpeng@fudan.edu.cn	sun, liu/U-5553-2019	sun, liu/0000-0002-1459-9478; peng, gang/0000-0001-6625-5426	National Natural Science Foundation of China [30970948, 31371099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 30970948 and 31371099 to GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday AW, 2011, DEV BIOL, V357, P450, DOI 10.1016/j.ydbio.2011.03.007; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Bachy I, 2001, J NEUROSCI, V21, P7620, DOI 10.1523/JNEUROSCI.21-19-07620.2001; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Ericson J, 1998, DEVELOPMENT, V125, P1005; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036516; Green EK, 2003, PSYCHIAT GENET, V13, P97, DOI 10.1097/00041444-200306000-00007; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Houston DW, 2003, DEVELOPMENT, V130, P2695, DOI 10.1242/dev.00509; Inoue J, 2013, DEV GROWTH DIFFER, V55, P668, DOI 10.1111/dgd.12074; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Langeland JA, 2006, INT J BIOL SCI, V2, P110; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-2; Lim LS, 2010, STEM CELLS, V28, P1961, DOI 10.1002/stem.527; Liu F, 2013, DEVELOPMENT, V140, P1111, DOI 10.1242/dev.080226; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Makki N, 2011, DEV BIOL, V357, P295, DOI 10.1016/j.ydbio.2011.06.042; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miquelajauregui A, 2010, J NEUROSCI, V30, P10551, DOI 10.1523/JNEUROSCI.5563-09.2010; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Nakagawa Y, 2001, J NEUROSCI, V21, P2711, DOI 10.1523/JNEUROSCI.21-08-02711.2001; Okada T, 2008, DEV BIOL, V320, P92, DOI 10.1016/j.ydbio.2008.04.034; Osorio J, 2005, DEV BIOL, V288, P100, DOI 10.1016/j.ydbio.2005.08.042; Paylor R, 2001, PHYSIOL BEHAV, V73, P781, DOI 10.1016/S0031-9384(01)00515-7; Pearson CA, 2011, DEVELOPMENT, V138, P2613, DOI 10.1242/dev.062794; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Puelles L, 2013, TRENDS NEUROSCI, V36, P570, DOI 10.1016/j.tins.2013.06.004; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; Sanek NA, 2008, DEV BIOL, V317, P325, DOI 10.1016/j.ydbio.2008.02.029; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TOYAMA R, 1995, DEV BIOL, V170, P583, DOI 10.1006/dbio.1995.1238; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Winata CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003852; Zhang CW, 2012, J NEUROSCI, V32, P12589, DOI 10.1523/JNEUROSCI.6518-11.2012; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104; Zhao YG, 2000, GENE, V260, P95, DOI 10.1016/S0378-1119(00)00466-2; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	59	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132525	10.1371/journal.pone.0132525	http://dx.doi.org/10.1371/journal.pone.0132525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147098	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600295
J	Tagawa, M; Ogata, A; Hamano, T				Tagawa, Miho; Ogata, Ai; Hamano, Takayuki			Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CONVERTING ENZYME-INHIBITORS; ARTERY-BYPASS SURGERY; RECEPTOR BLOCKER USE; RISK-FACTORS; CARDIAC-SURGERY; INTRAVENOUS ENALAPRILAT; CARDIOTHORACIC SURGERY; CROSS-VALIDATION; VENOUS-PRESSURE	Background and Objectives Pre- and/or intra-operative use of diuretics, angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin II receptor blockers (ARB) constitutes a potentially modifiable risk factor for postoperative acute kidney injury (AKI). It has been studied whether use of these drugs predicts AKI after cardiac surgery. The objective of this study was to examine whether administration of these agents was independently associated with AKI after non-cardiac surgery. Design, Setting, Participants, and Measurements This was a retrospective observational study. Inclusion criteria were adult patients (age >= 18) who underwent non-cardiac surgery under general anesthesia from 2007 to 2009 at Kyoto Katsura Hospital. Exclusion criteria were urological surgery, missing creatinine values, and preoperative dialysis. The exposures of interest were pre- and/or intra-operative use of diuretics or ACE-I/ARB. Outcome variables were postoperative AKI as defined by the AKI Network (increase in creatinine >= 0.3 mg/dL or 150% within 48 hours, or urine output < 0.5 ml/kg/hour for > 6 hours). Multivariable logistic regression analyses were conducted and adjusted for potential confounders. Propensity scores (PS) for receiving diuretics or ACE-I/ARB therapy were estimated and PS adjustment, PS matching, and inverse probability weighting were performed. Results There were 137 AKI cases (5.0%) among 2,725 subjects. After statistical adjustment for patient and surgical characteristics, odds (95% CI) of postoperative AKI were 2.07 (1.10-3.89) (p = 0.02) and 0.89 (0.56-1.42) (p = 0.63) in users of diuretics and ACE-I/ARB, respectively, compared with non-users. PS adjustment, PS matching, and inverse probability weighting yielded similar results. The effect size of diuretics was significantly greater in the patients with lower propensity for diuretic use (p for interaction < 0.1). Conclusions Prescription of diuretics, but not ACE-I/ARB, was independently associated with postoperative AKI after non-cardiac surgery, especially in patients with low propensity for diuretic use. It might be reasonable to withhold preoperative diuretics in these patients.	[Tagawa, Miho] Kyoto Katsura Hosp, Dept Nephrol, Nishikyo Ku, Kyoto 6158256, Japan; [Tagawa, Miho] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6348522, Japan; [Ogata, Ai] Kyoto City Hosp, Dept Nephrol, Nakagyo Ku, Mibu, Tochigi 6048845, Japan; [Hamano, Takayuki] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka 5650871, Japan	Nara Medical University; Kyoto City Hospital; Osaka University	Tagawa, M (corresponding author), Kyoto Katsura Hosp, Dept Nephrol, Nishikyo Ku, 17 Yamada Hirao Cho, Kyoto 6158256, Japan.	tagawa_miho@yahoo.co.jp	Hamano, TAKAYUKI/AAZ-4837-2021	Hamano, TAKAYUKI/0000-0002-2100-9106				Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Anand IS, 2013, CLIN J AM SOC NEPHRO, V8, P1800, DOI 10.2215/CJN.04090413; Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107; Benedetto U, 2008, ANN THORAC SURG, V86, P1160, DOI 10.1016/j.athoracsur.2008.06.018; Brown JR, 2006, CIRCULATION, V114, pI409, DOI 10.1161/CIRCULATIONAHA.105.000596; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Coca SG, 2013, NEPHROL DIAL TRANSPL, V28, P2787, DOI 10.1093/ndt/gft405; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Duncan JL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2958; Eriksen BO, 2003, NEPHROL DIAL TRANSPL, V18, P77, DOI 10.1093/ndt/18.1.77; FIRTH JD, 1988, LANCET, V1, P1033; Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x; Grayson AD, 2003, ANN THORAC SURG, V75, P1829, DOI 10.1016/S0003-4975(03)00166-8; Ishikawa S, 2012, ANESTH ANALG, V114, P1256, DOI 10.1213/ANE.0b013e31824e2d20; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lee EH, 2014, J CARDIOTHOR VASC AN, V28, P936, DOI 10.1053/j.jvca.2013.12.006; Licker M, 2011, ANN THORAC SURG, V91, P844, DOI 10.1016/j.athoracsur.2010.10.037; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Molitoris BA, 2007, NAT CLIN PRACT NEPHR, V3, P439, DOI 10.1038/ncpneph0551; Nielson E, 2014, J HOSP MED, V9, P283, DOI 10.1002/jhm.2155; Parolari A, 2012, ANN THORAC SURG, V93, P584, DOI 10.1016/j.athoracsur.2011.09.073; Provenchere S, 2003, ANESTH ANALG, V96, P1258, DOI 10.1213/01.ANE.0000055803.92191.69; PUSCHETT JB, 1994, CARDIOLOGY, V84, P4, DOI 10.1159/000176450; Ryckwaert F, 2001, BRIT J ANAESTH, V86, P169, DOI 10.1093/bja/86.2.169; Seabra VF, 2010, CLIN J AM SOC NEPHRO, V5, P1734, DOI 10.2215/CJN.02800310; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Shah M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-53; Teixeira C, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/132175; Thakar Charuhas V, 2003, Hemodial Int, V7, P143, DOI 10.1046/j.1492-7535.2003.00029.x; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Ulucay C, 2012, GERIATR ORTHOP SURG, V3, P150, DOI 10.1177/2151458512473827; van Kuijk JP, 2010, CLIN J AM SOC NEPHRO, V5, P1198, DOI 10.2215/CJN.00020110; Wagner F, 2003, CRIT CARE MED, V31, P1421, DOI 10.1097/01.CCM.0000063050.66813.39; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801; Winton FR, 1931, J PHYSIOL-LONDON, V72, P49, DOI 10.1113/jphysiol.1931.sp002761; Yacoub R, 2013, AM J KIDNEY DIS, V62, P1077, DOI 10.1053/j.ajkd.2013.04.018; Yoo YC, 2010, CIRC J, V74, P1852, DOI 10.1253/circj.CJ-10-0261	41	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132507	10.1371/journal.pone.0132507	http://dx.doi.org/10.1371/journal.pone.0132507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146836	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600293
J	Zhang, S; Lu, Z; Mao, WQ; Ahmed, AA; Yang, HL; Zhou, JH; Jennings, N; Rodriguez-Aguayo, C; Lopez-Berestein, G; Miranda, R; Qiao, W; Baladandayuthapani, V; Li, ZF; Sood, AK; Liu, JS; Le, XF; Bast, RC				Zhang, Shu; Lu, Zhen; Mao, Weiqun; Ahmed, Ahmed A.; Yang, Hailing; Zhou, Jinhua; Jennings, Nicholas; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Miranda, Roberto; Qiao, Wei; Baladandayuthapani, Veera; Li, Zongfang; Sood, Anil K.; Liu, Jinsong; Le, Xiao-Feng; Bast, Robert C., Jr.			CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1-and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis	PLOS ONE			English	Article							DEPENDENT KINASE-5; TUMOR-SUPPRESSOR; ANDROGEN RECEPTOR; IN-VITRO; PATHWAY; GROWTH; EXPRESSION; P27(KIP1); DEATH; P53	Cyclin-dependent kinase 5 (CDK5) is a cytoplasmic serine/threonine kinase. Knockdown of CDK5 enhances paclitaxel sensitivity in human ovarian cancer cells. This study explores the mechanisms by which CDK5 regulates paclitaxel sensitivity in human ovarian cancers. Multiple ovarian cancer cell lines and xenografts were treated with CDK5 small interfering RNA (siRNA) with or without paclitaxel to examine the effect on cancer cell viability, cell cycle arrest and tumor growth. CDK5 protein was measured by immunohistochemical staining of an ovarian cancer tissue microarray to correlate CDK5 expression with overall patient survival. Knockdown of CDK5 with siRNAs inhibits activation of AKT which significantly correlates with decreased cell growth and enhanced paclitaxel sensitivity in ovarian cancer cell lines. In addition, CDK5 knockdown alone and in combination with paclitaxel induced G1 cell cycle arrest and caspase 3 dependent apoptotic cell death associated with post-translational upregulation and nuclear translocation of TP53 and p27(Kip1) as well as TP53-dependent transcriptional induction of p21(Cip1) in wild type TP53 cancer cells. Treatment of HEYA8 and A2780 wild type TP53 xenografts in nu/nu mice with CDK5 siRNA and paclitaxel produced significantly greater growth inhibition than either treatment alone. Increased expression of CDK5 in human ovarian cancers correlates inversely with overall survival. CDK5 modulates paclitaxel sensitivity by regulating AKT activation, the cell cycle and caspase-dependent apoptosis. CDK5 inhibition can potentiate paclitaxel activity in human ovarian cancer cells.	[Zhang, Shu; Lu, Zhen; Mao, Weiqun; Ahmed, Ahmed A.; Yang, Hailing; Zhou, Jinhua; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Le, Xiao-Feng; Bast, Robert C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Zhang, Shu; Li, Zongfang] Xi An Jiao Tong Univ, Dept Gen Surg, Sch Med, Affiliated Hosp 2, Xian 710049, Shaanxi, Peoples R China; [Miranda, Roberto; Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Qiao, Wei; Baladandayuthapani, Veera] Univ Texas MD Anderson Canc Ctr, Bioinformat Comp Biol, Houston, TX 77030 USA; [Jennings, Nicholas; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Le, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	xfle@live.co; rbast@mdanderson.org	Sood, Anoop Kumar/A-7344-2013; Bast, Robert C/E-6585-2011	Sood, Anoop Kumar/0000-0001-5702-4108; Bast, Robert C/0000-0003-4621-8462; Lu, Zhen/0000-0002-9596-0148; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Zhang, Shu/0000-0003-0928-6503	Anne and Henry Zarrow Foundation; Cancer Prevention and Research Institute of Texas [RP110-595]; National Foundation for Cancer Research; MD Anderson SPORE in Ovarian Cancer [NCI P50 CA83639, U54 CA151668, UH2 TR000943-01]; RGK Foundation; MD Anderson NCI CCSG [P30 CA16672]; MRC [G0902418] Funding Source: UKRI; Medical Research Council [G0902418] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA083639, U54CA151668, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000943] Funding Source: NIH RePORTER	Anne and Henry Zarrow Foundation; Cancer Prevention and Research Institute of Texas; National Foundation for Cancer Research; MD Anderson SPORE in Ovarian Cancer; RGK Foundation; MD Anderson NCI CCSG; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Anne and Henry Zarrow Foundation and kind gifts from Stuart and Gayle Lynn Zarrow, as well as grants from the Cancer Prevention and Research Institute of Texas RP110-595, the National Foundation for Cancer Research, the MD Anderson SPORE in Ovarian Cancer NCI P50 CA83639, U54 CA151668, UH2 TR000943-01, the RGK Foundation, and the MD Anderson NCI CCSG P30 CA16672 (Flow Cytometry and Research Animal Support Facilities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Ahuja HS, 1997, DEV GENET, V21, P258, DOI 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6; Ajay AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-204; Alama A, 1996, GYNECOL ONCOL, V62, P82, DOI 10.1006/gyno.1996.0194; BENARD J, 1985, CANCER RES, V45, P4970; Brinkkoetter PT, 2010, KIDNEY INT, V77, P690, DOI 10.1038/ki.2009.548; Brinkkoetter PT, 2009, J CLIN INVEST, V119, P3089, DOI 10.1172/JCI37978; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Demelash A, 2012, MOL BIOL CELL, V23, P2856, DOI 10.1091/mbc.E10-12-1010; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Eggers JP, 2011, CLIN CANCER RES, V17, P6140, DOI 10.1158/1078-0432.CCR-10-2288; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Fujiwara Y, 2007, MOL CANCER THER, V6, P1133, DOI 10.1158/1535-7163.MCT-06-0639; Geuna E, 2015, EXPERT OPIN INV DRUG, V24, P421, DOI 10.1517/13543784.2015.1008132; Gorrini C, 2014, P NATL ACAD SCI USA, V111, P4472, DOI 10.1073/pnas.1324136111; Hsu FN, 2013, AM J PHYSIOL-ENDOC M, V305, pE975, DOI 10.1152/ajpendo.00615.2012; Hsu FN, 2011, J BIOL CHEM, V286, P33141, DOI 10.1074/jbc.M111.252080; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Kasemeier-Kulesa JC, 2008, DEV DYNAM, V237, P2657, DOI 10.1002/dvdy.21613; Kuo HS, 2009, CHINESE J PHYSIOL, V52, P23, DOI 10.4077/CJP.2009.AMG067; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Le XF, 2011, JNCI-J NATL CANCER I, V103, P1403, DOI 10.1093/jnci/djr280; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051592; Lee JH, 2007, J CELL PHYSIOL, V210, P784, DOI 10.1002/jcp.20899; Lee KY, 2004, MOL CELLS, V17, P17; Levacque Z, 2012, CELL CYCLE, V11, P4093, DOI 10.4161/cc.21886; Lin E, 2014, CELL PHYSIOL BIOCHEM, V33, P1620, DOI 10.1159/000358724; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Liu JL, 2011, MED ONCOL, V28, P673, DOI 10.1007/s12032-010-9510-7; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Odajima J, 2011, DEV CELL, V21, P655, DOI 10.1016/j.devcel.2011.08.009; Ogino S, 2014, ONCOGENE, V33, P2949, DOI 10.1038/onc.2013.244; Peterson DW, 2010, P NATL ACAD SCI USA, V107, P2884, DOI 10.1073/pnas.0912718107; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Pozo K, 2013, CANCER CELL, V24, P499, DOI 10.1016/j.ccr.2013.08.027; Rea K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.353; Rosen DG, 2006, CANCER-AM CANCER SOC, V106, P1925, DOI 10.1002/cncr.21767; Schmid G, 2006, MOL NEUROBIOL, V34, P27; Schmidt M, 2001, GYNECOL ONCOL, V80, P145, DOI 10.1006/gyno.2000.6040; Selvendiran K, 2011, CANCER BIOL THER, V12, P837, DOI 10.4161/cbt.12.9.17713; Shelton SB, 2004, J NEUROCHEM, V88, P1313, DOI 10.1111/j.1471-4159.2003.02328.x; SIMON WE, 1983, J NATL CANCER I, V70, P839; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Sun AM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-47; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Upadhyay AK, 2008, CURR CANCER DRUG TAR, V8, P741, DOI 10.2174/156800908786733405; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wen Z, 2014, J MOL NEUROSCI, V52, P384, DOI 10.1007/s12031-013-0162-x; WILSON AP, 1984, J NATL CANCER I, V72, P513; Wissing MD, 2014, ONCOL REP, V32, P419, DOI 10.3892/or.2014.3174; Wu PC, 2008, J OCUL PHARMACOL TH, V24, P25, DOI 10.1089/jop.2007.0044; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zhang J, 2011, CELL CYCLE, V10, P1208, DOI 10.4161/cc.10.8.15328; Zhang JW, 2002, J NEUROCHEM, V81, P307, DOI 10.1046/j.1471-4159.2002.00824.x; Zheng YL, 2010, MOL BIOL CELL, V21, P3601, DOI 10.1091/mbc.E10-01-0054	55	15	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131833	10.1371/journal.pone.0131833	http://dx.doi.org/10.1371/journal.pone.0131833			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146988	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600150
J	Deng, JF; Ding, GD; Gao, GL; Wu, B; Zhang, YQ; Qin, SG; Fan, WH				Deng, Jifeng; Ding, Guodong; Gao, Guanglei; Wu, Bin; Zhang, Yuqing; Qin, Shugao; Fan, Wenhui			The Sap Flow Dynamics and Response of Hedysarum scoparium to Environmental Factors in Semiarid Northwestern China	PLOS ONE			English	Article							NIGHTTIME WATER-USE; STOMATAL CONDUCTANCE; EDDY COVARIANCE; DESERT REGION; TRANSPIRATION; BALANCE; TREES; FLUX; EVAPOTRANSPIRATION; CANOPY	Hedysarum scopariumis an important, fast-growing and drought-resistant shrub that has been extensively used for grassland restoration and preventing desertification in semiarid regions of northwestern China. The primary objective of this study was to investigate the diurnal and seasonal variations in stem sap flow (J(s)) and its relation to environmental factors. The stem heat balance method was applied to plants that were approximately 17 years old (with diameters of 25, 16, 13, and 9 mm at ground level and heights of 3.1, 1.8, 1.7 and 1.4 m) and growing under natural conditions. The vertical soil temperature profile (ST), soil surface heat flux (SoilG), volumetric soil moisture content (SWC) and meteorological variables such as solar radiation (R-n), air temperature (T-a), vapour pressure deficit (VPD), wind speed (W-s) relative humidity (RH) and precipitation (P) were simultaneously measured at a meteorological station on site. Results indicated that J(s) varied regularly during the diurnal and seasonal term. The nocturnal J(s) was substantial, with a seasonal variation similar to the patterns of daytime J(s). The magnitude of J(s) changed considerably between sunny and rainy days. Redundancy (RDA) and Kendall's tau analysis suggested that daily J(s) in large plants was more sensitive to environmental factors, and the variation in daily J(s) during the growing season could be described by a multiple linear regression against environmental variables including T-a, VPD, Ws, RH, ST, and SoilG. While the nocturnal J(s) in smaller plants was more sensitive to meteorological factors. T-a, VPD, and W-s were significantly correlated with nighttime J(s). The hourly nighttime sap flow rate of H. scoparium corresponded closely to T-a and VPD following a non-linear pattern. The results of this study can be used to estimate the transpiration of H. scoparium.	[Deng, Jifeng; Ding, Guodong; Gao, Guanglei; Wu, Bin; Zhang, Yuqing; Qin, Shugao; Fan, Wenhui] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing 100083, Peoples R China; [Ding, Guodong; Gao, Guanglei; Wu, Bin; Zhang, Yuqing; Qin, Shugao] Beijing Forestry Univ, Key Lab Soil & Water Conservat & Desertificat Com, Minist Educ, Beijing 100083, Peoples R China	Beijing Forestry University; Beijing Forestry University	Ding, GD (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing 100083, Peoples R China.	dingguodong@bjfu.edu.cn	GAO, Guang-Lei/X-7720-2019; Deng, Jifeng/J-6725-2019	Deng, Jifeng/0000-0001-5496-5009	National Basic Research Program of China [2013CB429906]; National Technology & Science Support Program of China [2012BAD16B02]; Fundamental Research Funds for the Central Universities [BJFU-TD2011-04]	National Basic Research Program of China(National Basic Research Program of China); National Technology & Science Support Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by one of National Basic Research Program of China (2013CB429906) (http://www.973.gov.cn/English/Index.aspx), the National Technology & Science Support Program of China (2012BAD16B02) and The Fundamental Research Funds for the Central Universities (BJFU-TD2011-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Badalotti A, 2000, ANN FOREST SCI, V57, P623, DOI 10.1051/forest:2000146; Benyon RG, 1999, TREE PHYSIOL, V19, P853; Berger BW, 2001, J ATMOS OCEAN TECH, V18, P529, DOI 10.1175/1520-0426(2001)018<0529:LTCDFF>2.0.CO;2; Chuang YL, 2006, ECOL MODEL, V191, P447, DOI 10.1016/j.ecolmodel.2005.03.027; Daley MJ, 2006, TREE PHYSIOL, V26, P411, DOI 10.1093/treephys/26.4.411; Daudet FA, 1999, AGR FOREST METEOROL, V97, P171, DOI 10.1016/S0168-1923(99)00079-9; Dawson TE, 2007, TREE PHYSIOL, V27, P561, DOI 10.1093/treephys/27.4.561; Dzikiti S, 2007, J EXP BOT, V58, P1893, DOI 10.1093/jxb/erm023; Edwards WRN, 1997, TREE PHYSIOL, V17, P65; Ffolliott PF, 2003, J ARID ENVIRON, V55, P595, DOI 10.1016/S0140-1963(02)00290-2; Fisher JB, 2007, TREE PHYSIOL, V27, P597, DOI 10.1093/treephys/27.4.597; Giorio P, 2003, ENVIRON EXP BOT, V49, P9, DOI 10.1016/S0098-8472(02)00044-8; Goldstein G, 1998, PLANT CELL ENVIRON, V21, P397, DOI 10.1046/j.1365-3040.1998.00273.x; GREEN SR, 1989, AGR FOREST METEOROL, V48, P251, DOI 10.1016/0168-1923(89)90072-5; HEILMAN JL, 1990, HORTSCIENCE, V25, P465, DOI 10.21273/HORTSCI.25.4.465; Hogg EH, 1997, TREE PHYSIOL, V17, P501; Huang L, 2010, HYDROL PROCESS, V24, P1248, DOI 10.1002/hyp.7584; IRITZ Z, 1994, J HYDROL, V157, P235, DOI 10.1016/0022-1694(94)90107-4; Kigalu JM, 2007, AGR WATER MANAGE, V90, P224, DOI 10.1016/j.agwat.2007.03.005; Kluitenberg GJ, 2004, AGR FOREST METEOROL, V126, P169, DOI 10.1016/j.agrformet.2004.05.008; Liu B, 2011, ECOHYDROLOGY, V4, P448, DOI 10.1002/eco.151; Mac Nish RD, 2000, AGR FOREST METEOROL, V105, P271, DOI 10.1016/S0168-1923(00)00196-9; Marks CO, 2007, TREE PHYSIOL, V27, P577, DOI 10.1093/treephys/27.4.577; McDowell NG, 2008, ECOHYDROLOGY, V1, P193, DOI 10.1002/eco.20; Moore GW, 2008, TREE PHYSIOL, V28, P521, DOI 10.1093/treephys/28.4.521; Mott KA, 2010, PLANT CELL ENVIRON, V33, P1084, DOI 10.1111/j.1365-3040.2010.02129.x; Nadezhdina N, 1999, TREE PHYSIOL, V19, P885; Naithani KJ, 2012, J HYDROL, V464, P176, DOI 10.1016/j.jhydrol.2012.07.008; Nicolas E, 2005, AGR WATER MANAGE, V72, P131, DOI 10.1016/j.agwat.2004.09.008; Novick KA, 2009, AGR FOREST METEOROL, V149, P1491, DOI 10.1016/j.agrformet.2009.04.005; O'Brien JJ, 2004, PLANT CELL ENVIRON, V27, P551, DOI 10.1111/j.1365-3040.2003.01160.x; Pfautsch S, 2010, FOREST ECOL MANAG, V259, P1190, DOI 10.1016/j.foreco.2010.01.006; Qu YP, 2007, HYDROL PROCESS, V21, P1363, DOI 10.1002/hyp.6314; Sellin A, 2010, ECOHYDROLOGY, V3, P467, DOI 10.1002/eco.133; Snyder KA, 2003, J EXP BOT, V54, P861, DOI 10.1093/jxb/erg082; STEINBERG S, 1989, J AM SOC HORTIC SCI, V114, P466; Wang H, 2012, J PLANT ECOL, V5, P294, DOI 10.1093/jpe/rtr025; Wang XP, 2012, J HYDROL, V454, P152, DOI 10.1016/j.jhydrol.2012.06.003; Williams DG, 2004, AGR FOREST METEOROL, V125, P241, DOI 10.1016/j.agrformet.2004.04.008; Xia GM, 2008, HYDROL PROCESS, V22, P1197, DOI 10.1002/hyp.6690; Xu XY, 1998, COMMUN SOIL SCI PLAN, V29, P1, DOI 10.1080/00103629809369924; Yue GY, 2008, AGR FOREST METEOROL, V148, P1668, DOI 10.1016/j.agrformet.2008.05.019	43	17	20	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131683	10.1371/journal.pone.0131683	http://dx.doi.org/10.1371/journal.pone.0131683			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136229	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400063
J	Cao, C; Xu, ST; Wang, LC				Cao, Chen; Xu, Shutan; Wang, Lincong			An Algorithm for Protein Helix Assignment Using Helix Geometry	PLOS ONE			English	Article							SECONDARY STRUCTURE ASSIGNMENT; COORDINATE DATA; IDENTIFICATION; FEATURES	Helices are one of the most common and were among the earliest recognized secondary structure elements in proteins. The assignment of helices in a protein underlies the analysis of its structure and function. Though the mathematical expression for a helical curve is simple, no previous assignment programs have used a genuine helical curve as a model for helix assignment. In this paper we present a two-step assignment algorithm. The first step searches for a series of bona fide helical curves each one best fits the coordinates of four successive backbone C-alpha atoms. The second step uses the best fit helical curves as input to make helix assignment. The application to the protein structures in the PDB (protein data bank) proves that the algorithm is able to assign accurately not only regular a-helix but also 3(10) and Pi helices as well as their left-handed versions. One salient feature of the algorithm is that the assigned helices are structurally more uniform than those by the previous programs. The structural uniformity should be useful for protein structure classification and prediction while the accurate assignment of a helix to a particular type underlies structurefunction relationship in proteins.	[Cao, Chen; Xu, Shutan; Wang, Lincong] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, LC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China.	wlincong@hotmail.com		Cao, Chen/0000-0001-5343-808X				Andersen C.A., 2009, STRUCTURAL BIOINFORM, V44, P459; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; COLLOCH N, 1993, PROTEIN ENG, V6, P377, DOI 10.1093/protein/6.4.377; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Goriely Alain, 2008, Biophysical Reviews and Letters, V3, P77, DOI 10.1142/S1793048008000629; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; King SM, 1999, PROTEINS, V35, P313, DOI 10.1002/(SICI)1097-0134(19990515)35:3<313::AID-PROT5>3.3.CO;2-T; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Konagurthu AS, 2012, BIOINFORMATICS, V28, pI97, DOI 10.1093/bioinformatics/bts223; LEVITT M, 1977, J MOL BIOL, V114, P181, DOI 10.1016/0022-2836(77)90207-8; Majumdar I, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-202; Martin J, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-17; Nagy G, 2014, J CHEM INF MODEL, V54, P266, DOI 10.1021/ci400541d; Novotny M, 2005, J MOL BIOL, V347, P231, DOI 10.1016/j.jmb.2005.01.037; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; SHIMANOUCHI T, 1955, J CHEM PHYS, V23, P707, DOI 10.1063/1.1742083; SKLENAR H, 1989, PROTEINS, V6, P46, DOI 10.1002/prot.340060105; Taylor WR, 2001, J MOL BIOL, V310, P1135, DOI 10.1006/jmbi.2001.4817; Wang LC, 1997, J BIOL CHEM, V272, P1541, DOI 10.1074/jbc.272.3.1541; Xu ST, 2014, LECT N BIOINFORMAT, V8394, P356, DOI 10.1007/978-3-319-05269-4_29	26	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129674	10.1371/journal.pone.0129674	http://dx.doi.org/10.1371/journal.pone.0129674			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132394	gold, Green Submitted, Green Published			2022-12-26	WOS:000358153000032
J	Chen, A; McKinley, SA; Shi, F; Wang, SM; Mucha, PJ; Harit, D; Forest, MG; Lai, SK				Chen, Alex; McKinley, Scott A.; Shi, Feng; Wang, Simi; Mucha, Peter J.; Harit, Dimple; Forest, M. Gregory; Lai, Samuel K.			Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; VAGINAL FLUID; IGA; MUCOSAL; VIRUS; HIV-1; NEUTRALIZATION; TRANSMISSION; INFECTION; DIFFUSION	Secretory immunoglobulin A (slgA), a dimeric antibody found in high quantities in the gastrointestinal mucosa, is broadly associated with mucosal immune protection. A distinguishing feature of sIgA is its ability to crosslink pathogens, thereby creating pathogen/sIgA aggregates that are too large to traverse the dense matrix ofmucin fibers in mucus layers overlying epithelial cells and consequently reducing infectivity. Here, we use modeling to investigate this mechanism of "immune exclusion" based on sIgA-mediated agglutination, in particular the potential use of sIgA to agglutinate HIV in cervicovaginal mucus (CVM) and prevent HIV transmission. Utilizing reported data on HIV diffusion in CVM and semen, we simulate HIV collision kinetics in physiologically- thick mucus layers-a necessary first step for sIgA-induced aggregation. We find that even at the median HIV load in semen of acutely infected individuals possessing high viral titers, over 99% of HIV virions will penetrate CVM and reach the vaginal epithelium without colliding with another virion. These findings imply that agglutination is unlikely to be the dominantmechanism of sIgA-mediated protection against HIV or other sexually transmitted pathogens. Rather, we surmise that agglutination is most effective against pathogens either present at exceedingly high concentrations or that possess motility mechanisms other than Brownian diffusion that significantly enhance encounter rates.	[Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory] Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA; [Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory] Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC 27599 USA; [McKinley, Scott A.] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Harit, Dimple; Lai, Samuel K.] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Forest, M. Gregory; Lai, Samuel K.] Univ N Carolina, NCSU Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill	Lai, SK (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	lai@unc.edu	Shi, Feng/H-9103-2019	Shi, Feng/0000-0001-5369-6695; Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [R21AI093242, U19AI096398]; National Science Foundation [DMS-1122483, DMS-1100281, DMS-0645369, DMR-1151477]; Simons Foundation [245653]; Packard Foundation; startup funds from the Eshelman School of Pharmacy; Lineberger Comprehensive Cancer Center at the University of North Carolina-Chapel Hill; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093242, U19AI096398] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1462992] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Packard Foundation(The David & Lucile Packard Foundation); startup funds from the Eshelman School of Pharmacy; Lineberger Comprehensive Cancer Center at the University of North Carolina-Chapel Hill; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health (http://www.nih.gov/) grants R21AI093242 (SKL) and U19AI096398 (SKL); National Science Foundation (http://www.nsf.gov/) DMS-1122483 (MGF), DMS-1100281 (MGF), DMS-0645369 (PJM) and CAREER Award DMR-1151477 (SKL); Simons Foundation (https://www.simonsfoundation.org/) Project Number 245653 (SAM), Packard Foundation (http://www.packard.org/) (SKL), and startup funds from the Eshelman School of Pharmacy (https://pharmacy.unc.edu/) and Lineberger Comprehensive Cancer Center at the University of North Carolina-Chapel Hill (https://unclineberger.org/) (SKL). The authors declare no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mously N, 2009, FERTIL STERIL, V92, P1606, DOI 10.1016/j.fertnstert.2008.08.128; Alexander R, 2007, CURR HIV RES, V5, P588, DOI 10.2174/157016207782418452; [Anonymous], 1916, PHYS Z, V17, P85; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Belyakov IM, 2011, CURR MED CHEM, V18, P3953, DOI 10.2174/092986711796957293; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chen A, 2014, BIOPHYS J, V106, P2028, DOI 10.1016/j.bpj.2014.02.038; CHILDERS NK, 1989, ANNU REV MICROBIOL, V43, P503, DOI 10.1146/annurev.mi.43.100189.002443; Cone R, 1999, HDB MUCOSAL IMMUNOLO, V3, P43; Flores R, 2008, CANCER EPIDEM BIOMAR, V17, P3573, DOI 10.1158/1055-9965.EPI-08-0467; Geonnotti AR, 2006, BIOPHYS J, V91, P2121, DOI 10.1529/biophysj.106.086322; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hur EM, 2012, BLOOD, V120, P4571, DOI 10.1182/blood-2012-04-422303; IMAI H, 1988, CLIN EXP IMMUNOL, V73, P479; Jamison P L, 1988, J Sex Res, V24, P177, DOI 10.1080/00224498809551408; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; McKinley SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100598; Northrup SH, 1992, P NATL ACAD SCI USA, V89, P3338; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Redner S, 2001, GUIDE 1 PASSAGE PROC; Rehan N, 1975, Fertil Steril, V26, P492; Roche AM, 2015, MUCOSAL IMMUNOL, V8, P176, DOI 10.1038/mi.2014.55; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; Smoluchowski M., 1916, Z PHYS, V17, P557; STONE A, 1959, AM J OBSTET GYNECOL, V78, P279, DOI 10.1016/0002-9378(59)90173-5; Szeri AJ, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2973188; Wang YY, 2014, MUCOSAL IMMUNOL, V7, P1036, DOI 10.1038/mi.2013.120; Watkins JD, 2013, AIDS, V27, pF13, DOI 10.1097/QAD.0b013e328360eac6; Woof JM, 2011, MUCOSAL IMMUNOL, V4, P590, DOI 10.1038/mi.2011.39; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	41	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131351	10.1371/journal.pone.0131351	http://dx.doi.org/10.1371/journal.pone.0131351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132216	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000114
J	Nang, EEK; van Dam, RM; Tan, CS; Mueller-Riemenschneider, F; Lim, YT; Ong, KZ; Ee, S; Lee, J; Tai, ES				Nang, Ei Ei Khaing; van Dam, Rob M.; Tan, Chuen Seng; Mueller-Riemenschneider, Falk; Lim, Yi Ting; Ong, Kai Zhi; Ee, Siqing; Lee, Jeannette; Tai, E. Shyong			Association of Television Viewing Time with Body Composition and Calcified Subclinical Atherosclerosis in Singapore Chinese	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; MULTIETHNIC ASIAN POPULATION; DISEASE RISK-FACTORS; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIORS; ALL-CAUSE; MORTALITY; CALCIUM; OBESITY	Objective Sedentary behavior such as television viewing may be an independent risk factor for coronary heart disease. However, few studies have assessed the impact of television viewing time on coronary artery calcification and it remains unclear how body fat contributes to this relationship. The aim of this study is to evaluate the association between television viewing time and subclinical atherosclerosis and whether effects on visceral or subcutaneous fat may mediate any associations observed. Methods This was a cross-sectional study of 398 Chinese participants (192 men and 206 women) from Singapore prospective study. Participants were free from known cardiovascular diseases and underwent interview, health screening, computed tomography scans of coronary arteries and abdomen. Spearman's correlation was used to test the correlation between television viewing time, physical activity, body composition and abdominal fat distribution. The association between television viewing time and subclinical atherosclerosis was assessed by multiple logistic regression analysis. Results In men, television viewing time was significantly correlated with higher body fat mass index, percent body fat, subcutaneous and visceral fat. These associations were in the same direction, but weaker and not statistically significant in women. Television viewing time (hours/day) was associated with subclinical atherosclerosis in men (odds ratio: 1.41, 95% CI: 1.03-1.93) but no significant association was observed in women (odds ratio: 0.88, 95% CI: 0.59-1.31) after adjusting for potential socio-demographic and lifestyle confounders. Further adjustments for biological factors did not affect these associations. Conclusions Television viewing time was associated with greater adiposity and higher subcutaneous and visceral fat in men. TV viewing time was also associated with subclinical atherosclerosis in men and the potential mechanisms underlying this association require further investigation.	[Nang, Ei Ei Khaing; van Dam, Rob M.; Tan, Chuen Seng; Mueller-Riemenschneider, Falk; Lee, Jeannette; Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [van Dam, Rob M.; Mueller-Riemenschneider, Falk; Tai, E. Shyong] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [van Dam, Rob M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Mueller-Riemenschneider, Falk] Charite, Inst Social Med Epidemiol & Hlth Econ, Med Ctr, Berlin, Germany; [Lim, Yi Ting; Ong, Kai Zhi; Ee, Siqing] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Harvard University; Harvard T.H. Chan School of Public Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National University of Singapore	Nang, EEK (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	nang_ei_ei_khaing@nuhs.edu.sg	van Dam, Rob M/F-9674-2010; Tan, Chuen Seng/K-1078-2013; Tan, Chuen Seng/I-6854-2019; Khaing, Nang Ei Ei/C-2219-2011	van Dam, Rob M/0000-0002-7354-8734; Tan, Chuen Seng/0000-0002-6513-2309; Tan, Chuen Seng/0000-0002-6513-2309; Khaing, Nang Ei Ei/0000-0002-5361-0481; Tai, E Shyong/0000-0003-2929-8966; Muller-Riemenschneider, Falk/0000-0003-1402-7477	Singapore Consortium of Cohort Studies - A*STAR Biomedical Research Council [05/1/21/19/425]; Ministry Of Health, Singapore	Singapore Consortium of Cohort Studies - A*STAR Biomedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry Of Health, Singapore(Ministry of Health-Singapore)	This study was supported by the Singapore Consortium of Cohort Studies, which was funded by A*STAR Biomedical Research Council (grant 05/1/21/19/425) and Ministry Of Health, Singapore.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122; Altenburg TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057749; Alvey NJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000788; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Choi SY, 2010, ATHEROSCLEROSIS, V213, P273, DOI 10.1016/j.atherosclerosis.2010.07.052; Craiem D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109584; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; Delaney JAC, 2013, ATHEROSCLEROSIS, V230, P278, DOI 10.1016/j.atherosclerosis.2013.07.045; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; DiTomasso D, 2010, ATHEROSCLEROSIS, V208, P531, DOI 10.1016/j.atherosclerosis.2009.08.015; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamer M, 2012, ARTERIOSCL THROM VAS, V32, P500, DOI 10.1161/ATVBAHA.111.236877; Hassapidou M, 2013, HORM-INT J ENDOCRINO, V12, P265, DOI 10.14310/horm.2002.1410; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Basterra-Gortari FJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000864; Jensky NE, 2011, OBESITY, V19, P2418, DOI 10.1038/oby.2011.70; Ki M, 2011, ATHEROSCLEROSIS, V219, P361, DOI 10.1016/j.atherosclerosis.2011.07.109; Kim Y, 2013, INT J EPIDEMIOL, V42, P1040, DOI 10.1093/ije/dyt108; Kozakova M, 2010, EUR HEART J, V31, P1511, DOI 10.1093/eurheartj/ehq092; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Lesser IA, 2012, J OBES, V2012, DOI 10.1155/2012/703941; Lim S, 2012, INT J CARDIOL, V155, P126, DOI 10.1016/j.ijcard.2011.05.054; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Michos Erin D, 2009, Prev Cardiol, V12, P72, DOI 10.1111/j.1751-7141.2008.00023.x; Molenaar EA, 2009, DIABETES CARE, V32, P505, DOI 10.2337/dc08-1382; Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70; Nang EEK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-141; Nang EEK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-644; Nang EEK, 2009, AM J EPIDEMIOL, V169, P1454, DOI 10.1093/aje/kwp076; Ng AC, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.12; Ohashi N, 2009, ATHEROSCLEROSIS, V202, P192, DOI 10.1016/j.atherosclerosis.2008.04.019; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Sasai H, 2010, DIABETES RES CLIN PR, V88, P34, DOI 10.1016/j.diabres.2009.12.018; Sesso HD, 2000, CIRCULATION, V102, P975, DOI 10.1161/01.CIR.102.9.975; Tamura H, 2011, ACTA MED OKAYAMA, V65, P21; Taylor AJ, 2002, MED SCI SPORT EXER, V34, P228, DOI 10.1097/00005768-200202000-00008; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wijndaele K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020058; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132161	10.1371/journal.pone.0132161	http://dx.doi.org/10.1371/journal.pone.0132161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132754	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000162
J	Bang, OY; Ryoo, S; Kim, SJ; Yoon, CH; Cha, J; Yeon, JY; Kim, KH; Kim, GM; Chung, CS; Lee, KH; Shin, HJ; Ki, CS; Jeon, P; Kim, JS; Hong, SC				Bang, Oh Young; Ryoo, Sookyung; Kim, Suk Jae; Yoon, Chang Hyo; Cha, Jihoon; Yeon, Je Young; Kim, Keon Ha; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho; Shin, Hyung Jin; Ki, Chang-Seok; Jeon, Pyoung; Kim, Jong-Soo; Hong, Seung Chyul			Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians?	PLOS ONE			English	Article							MAJOR ARTERY STENOSIS/OCCLUSION; NORTHERN MANHATTAN; CLINICAL-FEATURES; RNF213; PROGRESSION; VARIANT; STROKE; RISK; C.14576G-GREATER-THAN-A; ATHEROSCLEROSIS	Background Both Moyamoya disease (MMD) and intracranial atherosclerotic stenosis (ICAS) are more prevalent in Asians than in Westerners. We hypothesized that a substantial proportion of patients with adult-onset MMD were misclassified as having ICAS, which may in part explain the high prevalence of intracranial atherosclerotic stroke in Asians. Method We analyzed 352 consecutive patients with ischemic events within the MCA distribution and relevant intracranial arterial stenosis, but no demonstrable carotid or cardiac embolism sources. Conventional angiography was performed in 249 (70.7%) patients, and the remains underwent MRA. The occurrence of the c.14429G>A (p.Arg4810Lys) variant in ring finger protein 213 (RNF213) was analyzed. This gene was recently identified as a susceptibility gene for MMD in East Asians. Results The p.Arg4810Lys variant was observed in half of patients with intracranial stenosis (176 of 352, 50.0%), in no healthy control subjects (n = 51), and in 3.2% of stroke control subjects (4 of 124 patients with other etiologies). The presence of basal collaterals, bilateral involvement on angiography, and absence of diabetes were independently associated with the presence of the RNF213 variant. Among 131 patients who met all three diagnostic criteria and were diagnosed with MMD, three-fourths (75.6%) had this variant. However, a significant proportion of patients who met two criteria (57.7%), one criterion (28.6%), or no criteria (20.0%) also had this variant. Some of them developed typical angiographic findings of MMD on follow-up angiography. Conclusions Careful consideration of MMD is needed when diagnosing ICAS because differential therapeutic strategies are required for these diseases and due to the limitations of the current diagnostic criteria for MMD.	[Bang, Oh Young; Ryoo, Sookyung; Kim, Suk Jae; Yoon, Chang Hyo; Kim, Gyeong-Moon; Chung, Chin-Sang; Lee, Kwang Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Cha, Jihoon; Kim, Keon Ha; Jeon, Pyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea; [Yeon, Je Young; Shin, Hyung Jin; Kim, Jong-Soo; Hong, Seung Chyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Bang, OY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	neuroboy50@naver.com; pyoung.jeon@samsung.com	ki, cs/O-5931-2014; Ki, Chang-Seok/G-7559-2014	Ki, Chang-Seok/0000-0001-7679-8731; Cha, Jihoon/0000-0002-1662-8041; Yeon, Je Young/0000-0003-4603-8103	Korean Healthcare Technology R&D project, Ministry of Health Welfare [HI14C15310000]	Korean Healthcare Technology R&D project, Ministry of Health Welfare	This study was supported by the Korean Healthcare Technology R&D project, Ministry of Health & Welfare (HI14C15310000).	Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Bang OY, 2014, J STROKE, V16, P27, DOI 10.5853/jos.2014.16.1.27; Bang OY, 2009, J NEUROL SCI, V284, P40, DOI 10.1016/j.jns.2009.03.033; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Chaturvedi S, 2007, NEUROLOGY, V69, P2063, DOI 10.1212/01.wnl.0000279338.18776.26; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Drazin D, 2009, CLIN NEUROL NEUROSUR, V111, P913, DOI 10.1016/j.clineuro.2009.08.012; Duan L, 2012, STROKE, V43, P56, DOI 10.1161/STROKEAHA.111.621300; Eicker S, 2011, J NEUROINTERV SURG, V3, P160, DOI 10.1136/jnis.2010.003004; Forouhi NG, 2006, ATHEROSCLEROSIS SUPP, V7, P11, DOI 10.1016/j.atherosclerosissup.2006.01.003; Fujimura M, 2014, J STROKE, V16, P65, DOI 10.5853/jos.2014.16.2.65; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kelly ME, 2006, CEREBROVASC DIS, V22, P109, DOI 10.1159/000093238; Khan N, 2011, CEREBROVASC DIS, V31, P147, DOI 10.1159/000320253; Kim YJ, 2013, EUR J NEUROL, V20, P1311, DOI 10.1111/ene.12202; Kleinloog R, 2012, J NEUROL NEUROSUR PS, V83, P531, DOI 10.1136/jnnp-2011-301387; Kraemer M, 2008, STROKE, V39, P3193, DOI 10.1161/STROKEAHA.107.513408; Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99; Liu WY, 2012, NEUROL MED-CHIR, V52, P299, DOI 10.2176/nmc.52.299; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Liu Wanyang, 2010, Environmental Health and Preventive Medicine, V15, P94, DOI 10.1007/s12199-009-0116-7; Mak W, 2005, MED HYPOTHESES, V65, P637, DOI 10.1016/j.mehy.2005.05.017; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Miyawaki S, 2012, STROKE, V43, P3371, DOI 10.1161/STROKEAHA.112.663864; Natarajan SK, 2011, J NEUROINTERV SURG, V3, P369, DOI 10.1136/jnis.2011.004754; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ryoo S, 2014, STROKE, V45, P2457, DOI 10.1161/STROKEAHA.114.004761; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Smith ER, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E17; Starke RM, 2012, NEUROSURGERY, V71, P93, DOI 10.1227/NEU.0b013e318253ab8e; Yeon JY, 2011, STROKE, V42, P2973, DOI 10.1161/STROKEAHA.111.622522	35	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130663	10.1371/journal.pone.0130663	http://dx.doi.org/10.1371/journal.pone.0130663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125557	gold, Green Published, Green Submitted			2022-12-26	WOS:000358151300020
J	Boros, G; Miko, E; Muramatsu, H; Weissman, D; Emri, E; van der Horst, GTJ; Szegedi, A; Horkay, I; Emri, G; Kariko, K; Remenyik, E				Boros, Gabor; Miko, Edit; Muramatsu, Hiromi; Weissman, Drew; Emri, Eszter; van der Horst, Gijsbertus T. J.; Szegedi, Andrea; Horkay, Iren; Emri, Gabriella; Kariko, Katalin; Remenyik, Eva			Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA	PLOS ONE			English	Article							ULTRAVIOLET-B IRRADIATION; INDUCED DNA-DAMAGE; CELL-CYCLE ARREST; N-TERMINAL KINASE; SKIN-CANCER; XERODERMA-PIGMENTOSUM; WAVELENGTH DEPENDENCE; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; CDK INHIBITORS	Major biological effects of UVB are attributed to cyclobutane pyrimidine dimers (CPDs), the most common photolesions formed on DNA. To investigate the contribution of CPDs to UVB-induced changes of gene expression, a model system was established by transfecting keratinocytes with pseudouridine-modified mRNA (psi-mRNA) encoding CPD-photolyase. Microarray analyses of this model system demonstrated that more than 50% of the gene expression altered by UVB was mediated by CPD photolesions. Functional classification of the gene targets revealed strong effects of CPDs on the regulation of the cell cycle and transcriptional machineries. To confirm the microarray data, cell cycle-regulatory genes, CCNE1 and CDKN2B that were induced exclusively by CPDs were selected for further investigation. Following UVB irradiation, expression of these genes increased significantly at both mRNA and protein levels, but not in cells transfected with CPD-photolyase psi-mRNA and exposed to photoreactivating light. Treatment of cells with inhibitors of c-Jun N-terminal kinase (JNK) blocked the UVB-dependent upregulation of both genes suggesting a role for JNK in relaying the signal of UVB-induced CPDs into transcriptional responses. Thus, photolyase mRNA-based experimental platform demonstrates CPD-dependent and-independent events of UVB-induced cellular responses, and, as such, has the potential to identify novel molecular targets for treatment of UVB-mediated skin diseases.	[Boros, Gabor; Miko, Edit; Emri, Eszter; Szegedi, Andrea; Horkay, Iren; Emri, Gabriella; Remenyik, Eva] Univ Debrecen, Fac Med, Dept Dermatol, Debrecen, Hungary; [Muramatsu, Hiromi; Kariko, Katalin] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Weissman, Drew] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [van der Horst, Gijsbertus T. J.] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands; [Szegedi, Andrea] Univ Debrecen, Fac Med, Dept Dermatol Allergol, Debrecen, Hungary	University of Debrecen; University of Pennsylvania; University of Pennsylvania; Erasmus University Rotterdam; Erasmus MC; University of Debrecen	Emri, G (corresponding author), Univ Debrecen, Fac Med, Dept Dermatol, Debrecen, Hungary.	gemri@med.unideb.hu	van der Horst, Gijsbertus TJ/E-3661-2015; Emri, Eszter/ABE-9363-2020	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Dr. Boros, Gabor/0000-0002-8668-9800	National Institutes of Health [R01NS029331, R42HL87688, R01AI50484, R21DE019059]; Hungarian Scientific Research Fund [OTKA K105872, OTKA K108421]; National Research Grant [TAMOP-4.2.2-A-11/1/KONV-2012-0031]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL087688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (grant numbers R01NS029331 and R42HL87688 to K.K.; R01AI50484 and R21DE019059 to D.W.), the Hungarian Scientific Research Fund (OTKA K105872 to E.R., OTKA K108421 to A.SZ.) and National Research Grant (TAMOP-4.2.2-A-11/1/KONV-2012-0031 to E.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2003, DNA CELL BIOL, V22, P665, DOI 10.1089/104454903770238148; Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586; Assefa Z, 1997, J INVEST DERMATOL, V108, P886, DOI 10.1111/1523-1747.ep12292595; Balogh A, 2008, J PHOTOCH PHOTOBIO B, V93, P133, DOI 10.1016/j.jphotobiol.2008.07.010; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; Berardesca E, 2012, MOL MED REP, V5, P570, DOI 10.3892/mmr.2011.673; Berton TP, 2001, J INVEST DERMATOL, V117, P1171, DOI 10.1046/j.0022-202x.2001.01536.x; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Boros G, 2013, J PHOTOCH PHOTOBIO B, V129, P93, DOI 10.1016/j.jphotobiol.2013.09.010; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Brash DE, 2001, J INVEST DERMATOL, V117, P1234, DOI 10.1046/j.0022-202x.2001.01554.x; Brash DE, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P136; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Cleaver JE, 2003, CELL CYCLE, V2, P310, DOI 10.4161/cc.2.4.436; Courdavault S, 2005, DNA REPAIR, V4, P836, DOI 10.1016/j.dnarep.2005.05.001; da Costa RMA, 2005, ONCOGENE, V24, P1359, DOI 10.1038/sj.onc.1208288; De Craene B, 2014, CELL DEATH DIFFER, V21, P310, DOI 10.1038/cdd.2013.148; DEGRUIJL FR, 1993, CANCER RES, V53, P53; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Einspahr Janine G., 1999, Neoplasia (New York), V1, P468, DOI 10.1038/sj.neo.7900061; Elsayed YA, 2001, ONCOLOGIST, V6, P517, DOI 10.1634/theoncologist.6-6-517; Emri G, 2000, J INVEST DERMATOL, V115, P435, DOI 10.1046/j.1523-1747.2000.00057.x; FREEMAN SE, 1989, P NATL ACAD SCI USA, V86, P5605, DOI 10.1073/pnas.86.14.5605; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Goukassian DA, 1999, J INVEST DERMATOL, V112, P25, DOI 10.1046/j.1523-1747.1999.00468.x; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; HOLBROOK NJ, 1991, NEW BIOL, V3, P825; Hudson LG, 2007, MOL CARCINOGEN, V46, P257, DOI 10.1002/mc.20257; Humeniuk R, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2012.44; Humeniuk R, 2014, STEM CELLS, V32, P1361, DOI 10.1002/stem.1635; Hunt KK, 2005, SEMIN CANCER BIOL, V15, P319, DOI 10.1016/j.semcancer.2005.04.007; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jans J, 2006, MOL CELL BIOL, V26, P8515, DOI 10.1128/MCB.00807-06; Jiao J, 2014, CARCINOGENESIS, V35, P1310, DOI 10.1093/carcin/bgu020; Kanellou P, 2008, CANCER LETT, V264, P145, DOI 10.1016/j.canlet.2008.01.042; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kim YJ, 2011, HEAD NECK-J SCI SPEC, V33, P1458, DOI 10.1002/hed.21611; Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010; Koehler K, 2011, EUR J CELL BIOL, V90, P565, DOI 10.1016/j.ejcb.2010.10.017; KRIPKE ML, 1992, P NATL ACAD SCI USA, V89, P7516, DOI 10.1073/pnas.89.16.7516; Laud K, 2006, J MED GENET, V43, P39, DOI 10.1136/jmg.2005.033498; Lee KM, 2005, BRIT J DERMATOL, V152, P52, DOI 10.1111/J.1365-2133.2005.06412.X; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; LEHMANN AR, 1995, TRENDS BIOCHEM SCI, V20, P402, DOI 10.1016/S0968-0004(00)89088-X; LI YF, 1993, P NATL ACAD SCI USA, V90, P4389, DOI 10.1073/pnas.90.10.4389; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-135; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Murakami T, 2001, J DERMATOL SCI, V27, P121, DOI 10.1016/S0923-1811(01)00124-4; Nelson AM, 2009, DERM-ENDOCRINOL, V1, P177, DOI 10.4161/derm.1.3.8258; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Pils D, 2014, EUR J CANCER, V50, P99, DOI 10.1016/j.ejca.2013.09.011; Prasad NB, 2014, MODERN PATHOL, V27, P945, DOI 10.1038/modpathol.2013.217; Quan TH, 2005, J BIOL CHEM, V280, P8079, DOI 10.1074/jbc.M409647200; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; Sauroja I, 2000, GENE CHROMOSOME CANC, V28, P404, DOI 10.1002/1098-2264(200008)28:4<404::AID-GCC6>3.0.CO;2-P; Scheitz CJF, 2013, J CELL BIOCHEM, V114, P985, DOI 10.1002/jcb.24453; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Simbulan-Rosenthal CM, 2005, ONCOGENE, V24, P5443, DOI 10.1038/sj.onc.1208709; Sobolewski Cyril, 2010, Int J Cell Biol, V2010, P215158, DOI 10.1155/2010/215158; Soto Martinez Jose Luis, 2005, Clin Transl Oncol, V7, P156, DOI 10.1007/BF02708753; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Stubbert LJ, 2009, CELL CYCLE, V8, P2995; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Takao J, 2002, PHOTODERMATOL PHOTO, V18, P5, DOI 10.1034/j.1600-0781.2002.180102.x; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Valery C, 2001, J INVEST DERMATOL, V117, P1471, DOI 10.1046/j.0022-202x.2001.01607.x; Vosooghi M, 2014, EXPERT OPIN DRUG DIS, V9, P255, DOI 10.1517/17460441.2014.883377; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Xiang F, 2014, JAMA DERMATOL, V150, P1063, DOI 10.1001/jamadermatol.2014.762; Xie JJ, 2014, ONCOTARGET, V5, P8569, DOI 10.18632/oncotarget.2322; Yarosh D, 2001, LANCET, V357, P926, DOI 10.1016/S0140-6736(00)04214-8; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhang JY, 2012, AM J CANCER RES, V2, P691; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zhang ZK, 2014, MOL MED REP, V9, P1049, DOI 10.3892/mmr.2014.1908	88	6	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131141	10.1371/journal.pone.0131141	http://dx.doi.org/10.1371/journal.pone.0131141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121660	Green Submitted, Green Published, gold			2022-12-26	WOS:000358150400078
J	Hegde, PM; Dutta, A; Sengupta, S; Mitra, J; Adhikari, S; Tomkinson, AE; Li, GM; Boldogh, I; Hazra, TK; Mitra, S; Hegde, ML				Hegde, Pavana M.; Dutta, Arijit; Sengupta, Shiladitya; Mitra, Joy; Adhikari, Sanjay; Tomkinson, Alan E.; Li, Guo-Min; Boldogh, Istvan; Hazra, Tapas K.; Mitra, Sankar; Hegde, Muralidhar L.			The C-terminal Domain (CTD) of Human DNA Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at the Replicating Genome DOMINANT NEGATIVE FUNCTION OF THE CTD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; STRAND BREAK REPAIR; AP-ENDONUCLEASE; OXIDIZED BASES; MULTIPROTEIN COMPLEX; OXIDATIVE DAMAGE; MAMMALIAN-CELLS; IDENTIFICATION; MITOCHONDRIA	The human DNA glycosylase NEIL1 was recently demonstrated to initiate prereplicative base excision repair (BER) of oxidized bases in the replicating genome, thus preventing mutagenic replication. A significant fraction of NEIL1 in cells is present in large cellular complexes containing DNA replication and other repair proteins, as shown by gel filtration. However, how the interaction of NEIL1 affects its recruitment to the replication site for prereplicative repair was not investigated. Here, we show that NEIL1 binarily interacts with the proliferating cell nuclear antigen clamp loader replication factor C, DNA polymerase delta, and DNA ligase I in the absence of DNA via its non-conserved C-terminal domain (CTD); replication factor C interaction results in similar to 8-fold stimulation of NEIL1 activity. Disruption of NEIL1 interactions within the BERosome complex, as observed for a NEIL1 deletion mutant (N311) lacking the CTD, not only inhibits complete BER in vitro but also prevents its chromatin association and reduced recruitment at replication foci in S phase cells. This suggests that the interaction of NEIL1 with replication and other BER proteins is required for efficient repair of the replicating genome. Consistently, the CTD polypeptide acts as a dominant negative inhibitor during in vitro repair, and its ectopic expression sensitizes human cells to reactive oxygen species. We conclude that multiple interactions among BER proteins lead to large complexes, which are critical for efficient BER in mammalian cells, and the CTD interaction could be targeted for enhancing drug/radiation sensitivity of tumor cells.	[Hegde, Pavana M.; Dutta, Arijit; Sengupta, Shiladitya; Mitra, Joy; Adhikari, Sanjay; Mitra, Sankar; Hegde, Muralidhar L.] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX 77030 USA; [Dutta, Arijit; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hazra, Tapas K.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Li, Guo-Min] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Mitra, Sankar; Hegde, Muralidhar L.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Hegde, Muralidhar L.] Houston Methodist Neurol Inst, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico; University of New Mexico; University of Kentucky; University of Kentucky; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Mitra, S (corresponding author), Houston Methodist Res Inst, Dept Radiat Oncol, 6550 Fannin St,Smith 8-04, Houston, TX 77030 USA.	smitra2@houstonmethodist.org; mlhegde@houstonmethodist.org	Mitra, Joy/AAH-5977-2020; Classen, Scott/AAY-8176-2020; Dutta, Arijit/I-1604-2019; Regan, Clinton/E-6250-2012; Sengupta, Shiladitya/L-5951-2015	Mitra, Joy/0000-0002-5985-0582; Dutta, Arijit/0000-0002-5675-0092; Li, Guo-Min/0000-0002-9842-4578; Hegde, Muralidhar/0000-0001-7333-8123; Sengupta, Shiladitya/0000-0001-9558-2741; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health [R01 NS088645, R01 CA158910, R01 GM105090, P01 CA092584, R01 NS073976, R01 ES018948, R01 GM57479, R01 CA167181]; Muscular Dystrophy Association [MDA 294842]; ALS Association [15-IIP-204]; Alzheimer's Association [NIRG-12-242135]; NATIONAL CANCER INSTITUTE [R01CA167181, R01CA158910, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105090, R01GM057479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073976, R01NS088645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); ALS Association; Alzheimer's Association(Alzheimer's Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS088645 (to M. L. H.), R01 CA158910, R01 GM105090, and P01 CA092584 (to S. M.), R01 NS073976 (to T. K. H.), R01 ES018948 (to I. B.), R01 GM57479 (to A. E. T), and R01 CA167181 (to G. M. L). This work was also supported by Muscular Dystrophy Association Grant MDA 294842, ALS Association Grant 15-IIP-204), and Alzheimer's Association Grant NIRG-12-242135) (to M. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari S, 2008, ANTI-CANCER AGENT ME, V8, P351, DOI 10.2174/187152008784220366; Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Bartels M, 2007, J IMMUNOL, V179, P7605, DOI 10.4049/jimmunol.179.11.7605; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bulgar AD, 2010, LEUKEMIA, V24, P1795, DOI 10.1038/leu.2010.166; Chatterjee M, 2012, J BIOL CHEM, V287, DOI [10.1074/jbc.M112.415067, 10.1074/jbc.M111.272179]; CHIU RW, 1975, J BIOL CHEM, V250, P7951; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Dutta A, 2015, CELL MOL LIFE SCI, V72, P1679, DOI 10.1007/s00018-014-1820-z; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Furqan M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-90; Geertsema HJ, 2013, CURR OPIN STRUC BIOL, V23, P788, DOI 10.1016/j.sbi.2013.06.018; Hashiguchi K, 2007, NUCLEIC ACIDS RES, V35, P2913, DOI 10.1093/nar/gkm115; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; He ZG, 1997, NUCLEIC ACIDS RES, V25, P1136, DOI 10.1093/nar/25.6.1136; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2013, P NATL ACAD SCI USA, V110, pE3090, DOI 10.1073/pnas.1304231110; Hegde ML, 2012, BIOMOLECULES, V2, P564, DOI 10.3390/biom2040564; Hegde ML, 2013, J MOL BIOL, V425, P2359, DOI 10.1016/j.jmb.2013.03.030; Hegde ML, 2012, J BIOL CHEM, V287, P34202, DOI 10.1074/jbc.M112.384032; Hegde ML, 2010, CELL MOL LIFE SCI, V67, P3573, DOI 10.1007/s00018-010-0485-5; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Koczor CA, 2009, METHODS MOL BIOL, V554, P233, DOI 10.1007/978-1-59745-521-3_15; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; MILLS AD, 1989, J CELL SCI, V94, P471; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; Nischan N, 2015, ANGEW CHEM INT EDIT, V54, P1950, DOI 10.1002/anie.201410006; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rodriguez K, 1998, J BIOL CHEM, V273, P34180, DOI 10.1074/jbc.273.51.34180; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Shokolenko IN, 2005, DNA REPAIR, V4, P511, DOI 10.1016/j.dnarep.2004.11.009; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Theriot CA, 2010, DNA REPAIR, V9, P643, DOI 10.1016/j.dnarep.2010.02.014; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003	47	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20919	20933		10.1074/jbc.M115.642918	http://dx.doi.org/10.1074/jbc.M115.642918			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26134572	hybrid, Green Published			2022-12-26	WOS:000360011800027
J	Lissner, MM; Thomas, BJ; Wee, K; Tong, AJ; Kollmann, TR; Smale, ST				Lissner, Michelle M.; Thomas, Brandon J.; Wee, Kathleen; Tong, Ann-Jay; Kollmann, Tobias R.; Smale, Stephen T.			Age-Related Gene Expression Differences in Monocytes from Human Neonates, Young Adults, and Older Adults	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; DENDRITIC CELLS; RNA-SEQ; RESPONSES; TRANSCRIPTION; IMMUNITY; FETAL; INDUCTION; BINDING; DEFECT	A variety of age-related differences in the innate and adaptive immune systems have been proposed to contribute to the increased susceptibility to infection of human neonates and older adults. The emergence of RNA sequencing (RNA-seq) provides an opportunity to obtain an unbiased, comprehensive, and quantitative view of gene expression differences in defined cell types from different age groups. An examination of ex vivo human monocyte responses to lipopolysaccharide stimulation or Listeria monocytogenes infection by RNA-seq revealed extensive similarities between neonates, young adults, and older adults, with an unexpectedly small number of genes exhibiting statistically significant age-dependent differences. By examining the differentially induced genes in the context of transcription factor binding motifs and RNA-seq data sets from mutant mouse strains, a previously described deficiency in interferon response factor-3 activity could be implicated in most of the differences between newborns and young adults. Contrary to these observations, older adults exhibited elevated expression of inflammatory genes at baseline, yet the responses following stimulation correlated more closely with those observed in younger adults. Notably, major differences in the expression of constitutively expressed genes were not observed, suggesting that the age-related differences are driven by environmental influences rather than cell-autonomous differences in monocyte development.	[Lissner, Michelle M.; Thomas, Brandon J.; Tong, Ann-Jay; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Wee, Kathleen; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada	University of California System; University of California Los Angeles; University of British Columbia	Kollmann, TR (corresponding author), Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada.	tkollmann@cw.bc.ca; smale@mednet.ucla.edu		Kollmann, Tobias/0000-0003-2403-9762	National Institutes of Health [R01GM086372, P50AR063030, T32GM008042, T32CA009120]; Canadian Institutes of Health Research; Burroughs Wellcome Fund; British Columbia Children's Hospital Foundation; Michael Smith Foundation for Health Research; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372, T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); British Columbia Children's Hospital Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health (www.nih.gov) grants R01GM086372 (S.T.S.), P50AR063030 (S.T.S.), T32GM008042 (B.J.T.), and T32CA009120 (A.J.T.), and also by grants from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) (K.W., T.R.K.), Burroughs Wellcome Fund (www.bwfund.org) (T.R.K.), British Columbia Children's Hospital Foundation (www.bcchf.ca) (T.R.K.), and the Michael Smith Foundation for Health Research (www.msfhr.org) (T.R.K.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; De Wit D, 2003, J AUTOIMMUN, V21, P277, DOI 10.1016/j.jaut.2003.08.003; Fortin CF, 2008, REJUV RES, V11, P873, DOI 10.1089/rej.2008.0750; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; HALL JM, 1995, BLOOD, V86, P2829; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2013, FEIGIN CHERRYS TXB P, P1329; Krow-Lucal ER, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00314; Krow-Lucal ER, 2014, BLOOD, V123, P1897, DOI 10.1182/blood-2013-11-536094; Lavoie PM, 2010, J INFECT DIS, V202, P1754, DOI 10.1086/657143; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Levy O, 2013, VACCINE, V31, P2500, DOI 10.1016/j.vaccine.2012.10.016; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Vanden Eijnden S, 2006, EUR J IMMUNOL, V36, P21, DOI 10.1002/eji.200535467; Way SS, 2003, J IMMUNOL, V171, P533, DOI 10.4049/jimmunol.171.2.533; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	35	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132061	10.1371/journal.pone.0132061	http://dx.doi.org/10.1371/journal.pone.0132061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147648	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600193
J	Marcsa, B; Denes, R; Voros, K; Racz, G; Sasvari-Szekely, M; Ronai, Z; Toro, K; Keszler, G				Marcsa, Boglarka; Denes, Reka; Voeroes, Krisztina; Racz, Gergely; Sasvari-Szekely, Maria; Ronai, Zsolt; Toero, Klara; Keszler, Gergely			A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease	PLOS ONE			English	Article							VENTRICULAR-ARRHYTHMIAS; VARIANTS; PROMOTER; MUTATION; PHENOTYPES; MORTALITY; RISK	Cardiac death remains one of the leading causes of mortality worldwide. Recent research has shed light on pathophysiological mechanisms underlying cardiac death, and several genetic variants in novel candidate genes have been identified as risk factors. However, the vast majority of studies performed so far investigated genetic associations with specific forms of cardiac death only (sudden, arrhythmogenic, ischemic etc.). The aim of the present investigation was to find a genetic marker that can be used as a general, powerful predictor of cardiac death risk. To this end, a case-control association study was performed on a heterogeneous cohort of cardiac death victims (n=360) and age-matched controls (n=300). Five single nucleotide polymorphisms (SNPs) from five candidate genes (beta2 adrenergic receptor, nitric oxide synthase 1 adaptor protein, ryanodine receptor 2, sodium channel type V alpha subunit and transforming growth factor-beta receptor 2) that had previously been shown to associate with certain forms of cardiac death were genotyped using sequence-specific real-time PCR probes. Logistic regression analysis revealed that the CC genotype of the rs11720524 polymorphism in the SCN5A gene encoding a subunit of the cardiac voltage-gated sodium channel occurred more frequently in the highly heterogeneous cardiac death cohort compared to the control population (p=0.019, odds ratio: 1.351). A detailed subgroup analysis uncovered that this effect was due to an association of this variant with cardiac death in chronic ischemic heart disease (p=0.012, odds ratio = 1.455). None of the other investigated polymorphisms showed association with cardiac death in this context. In conclusion, our results shed light on the role of this non-coding polymorphism in cardiac death in ischemic cardiomyopathy. Functional studies are needed to explore the pathophysiological background of this association.	[Marcsa, Boglarka; Denes, Reka; Voeroes, Krisztina; Sasvari-Szekely, Maria; Ronai, Zsolt; Keszler, Gergely] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Toero, Klara] Semmelweis Univ, Dept Forens & Insurance Med, H-1085 Budapest, Hungary; [Racz, Gergely] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University	Keszler, G (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	keszler.gergely@med.semmelweis-univ.hu	Ronai, Zsolt/A-2473-2008	Ronai, Zsolt/0000-0002-0909-7932	Hungarian Scientific Research Fund [OTKA K-83766]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The present study was supported financially by the OTKA K-83766 research grant from the Hungarian Scientific Research Fund (www.otka.hu) (receiving author: Zsolt Ronai). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934; Arakawa J, 2014, HEART VESSELS; Baas AF, 2010, EUR J HUM GENET, V18, P240, DOI 10.1038/ejhg.2009.141; Becker ML, 2009, BRIT J CLIN PHARMACO, V67, P61, DOI 10.1111/j.1365-2125.2008.03325.x; Bezzina CR, 2006, CIRCULATION, V113, P338, DOI 10.1161/CIRCULATIONAHA.105.580811; Blayney LM, 2009, PHARMACOL THERAPEUT, V123, P151, DOI 10.1016/j.pharmthera.2009.03.006; Boehringer T, 2014, MOL MED REP, V10, P2039, DOI 10.3892/mmr.2014.2401; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Choi Yu Mi, 2012, Korean J Pediatr, V55, P18, DOI 10.3345/kjp.2012.55.1.18; Cutler MJ, 2011, TRENDS PHARMACOL SCI, V32, P174, DOI 10.1016/j.tips.2010.12.001; Earle N, 2014, HEART RHYTHM, V11, P76, DOI 10.1016/j.hrthm.2013.10.005; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Flevari P, 2012, AM HEART J, V164, P530, DOI 10.1016/j.ahj.2012.07.006; Francia P, 2013, J INTERV CARD ELECTR, V38, P169, DOI 10.1007/s10840-013-9827-1; Gavin MC, 2011, HEART RHYTHM, V8, P704, DOI 10.1016/j.hrthm.2011.01.003; Han PD, 2011, AM J PHYSIOL-HEART C, V301, pH1588, DOI 10.1152/ajpheart.01153.2010; Imamichi Y, 2014, BBA-GENE REGUL MECH, V1839, P33, DOI 10.1016/j.bbagrm.2013.11.005; Israel Carsten W, 2014, Indian Heart J, V66 Suppl 1, pS10, DOI 10.1016/j.ihj.2014.01.005; Jamshidi Y, 2012, J AM COLL CARDIOL, V60, P841, DOI 10.1016/j.jacc.2012.03.031; Kelly BB, 2012, MT SINAI J MED, V79, P632, DOI 10.1002/msj.21345; Klaver EC, 2011, INT J CARDIOL, V152, P162, DOI 10.1016/j.ijcard.2010.12.051; Kolettis TM, 2013, CURR OPIN PHARMACOL, V13, P210, DOI 10.1016/j.coph.2013.01.001; Kotyuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080613; Kulminski AM, 2010, REJUV RES, V13, P13, DOI 10.1089/rej.2009.0905; Lakatos K, 2002, MOL PSYCHIATR, V7, P27, DOI 10.1038/sj/mp/4000986; Maekawa K, 2005, ANN HUM GENET, V69, P413, DOI 10.1046/j.1529-8817.2005.00167.x; Miller Dori, 2014, Adv Pharmacol, V70, P367, DOI 10.1016/B978-0-12-417197-8.00012-2; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Nakajima S, 2013, INTERNAL MED, V52, P1805, DOI 10.2169/internalmedicine.52.0085; Park JK, 2012, HEART RHYTHM, V9, P1090, DOI 10.1016/j.hrthm.2012.02.023; Petersen M, 2011, BRIT J CLIN PHARMACO, V71, P556, DOI 10.1111/j.1365-2125.2010.03868.x; Ran YQ, 2010, CLIN SCI, V119, P215, DOI 10.1042/CS20090656; Schwark T, 2011, INT J LEGAL MED, V125, P891, DOI 10.1007/s00414-010-0537-2; Son MK, 2013, J KOREAN MED SCI, V28, P1021, DOI 10.3346/jkms.2013.28.7.1021; Treuer Adriana V, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P37; Tseng ZH, 2009, HEART RHYTHM, V6, P1745, DOI 10.1016/j.hrthm.2009.08.031; Yang P, 2008, EUR J HUM GENET, V16, P350, DOI 10.1038/sj.ejhg.5201952; Zeng ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078382; Zhang YM, 2014, PEDIATR CARDIOL, V35, P295, DOI 10.1007/s00246-013-0773-6	40	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132137	10.1371/journal.pone.0132137	http://dx.doi.org/10.1371/journal.pone.0132137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146998	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600204
J	Mennitti, LV; Oyama, LM; de Oliveira, JL; Hachul, ACL; Santamarina, AB; de Santana, AA; Okuda, MH; Ribeiro, EB; do Nascimento, CMDO; Pisani, LP				Mennitti, Lais Vales; Oyama, Lila Missae; de Oliveira, Juliana Lopez; Losinskas Hachul, Ana Claudia; Santamarina, Aline Boveto; de Santana, Aline Alves; Okuda, Marcos Hiromu; Ribeiro, Eliane Beraldi; da Penha Oller do Nascimento, Claudia Maria; Pisani, Luciana Pellegrini			Maternal Supplementation with Oligofructose (10%) during Pregnancy and Lactation Leads to Increased Pro-Inflammatory Status of the 21-D-Old Offspring	PLOS ONE			English	Article							HYDROGENATED FAT INTAKE; KAPPA-B PATHWAY; METABOLIC ENDOTOXEMIA; ADIPOSE-TISSUE; GUT MICROBIOTA; HUMAN-MILK; ADIPONECTIN; PREBIOTICS; DISEASE; ACIDS	Previously, we showed that oligofructose (10%) supplementation during pregnancy and lactation increased endotoxemia in 21-d-old pups. The present study evaluated the effect of 10% oligofructose diet supplementation during pregnancy and lactation in the presence or absence of hydrogenated vegetable fat on the pro-inflammatory status of 21-d-old offspring. On the first day of pregnancy, female Wistar rats were divided into the following groups: control diet (C), control diet supplemented with 10% oligofructose (CF), diet enriched with hydrogenated vegetable fat (T) or diet enriched with hydrogenated vegetable fat supplemented with 10% oligofructose (TF). Diets were maintained during pregnancy and lactation. Serum TNF-alpha (tumor necrosis factor alpha) was assessed using a specific kit. Protein expression was determined by Western Blotting, and the relative mRNA levels were analyzed by RTPCR (real-time polymerase chain reaction). We observed that 10% oligofructose supplementation during pregnancy and lactation increased offspring's IL-6R (interleukin-6 receptor) mRNA levels in the liver and RET (retroperitoneal white adipose tissue) and decreased (adiponectin receptor 2) and ADIPOR1 (adiponectin receptor 1) gene expression in liver and EDL (extensor digital longus)/SOL (soleus) muscles of CF group. Additionally, TF group presented with increased serum TNF-alpha, protein expression of p-NF kappa Bp65 (phosphorylated form of nuclear factor kappa B p65 subunit) in liver and IL-6R mRNA levels in RET. These findings were accompanied by decreased levels of ADIPOR1 mRNA in the EDL and SOL muscles of the TF group. In conclusion, supplementing the dam's diet with 10% of oligofructose during pregnancy and lactation, independent of hydrogenated vegetable fat addition, contributes to the increased pro-inflammatory status of 21-d-old offspring, possibly through the activation of the TLR4 (toll like receptor 4) pathway.	[Mennitti, Lais Vales] Univ Fed Sao Paulo, Programa Pos Grad Interdisciplinar Ciencias Saude, Santos, SP, Brazil; [Pisani, Luciana Pellegrini] Univ Fed Sao Paulo, Inst Saude Sociedade, Dept Biociencias, Santos, SP, Brazil; [Oyama, Lila Missae; de Oliveira, Juliana Lopez; Losinskas Hachul, Ana Claudia; Santamarina, Aline Boveto; de Santana, Aline Alves; Okuda, Marcos Hiromu; Ribeiro, Eliane Beraldi; da Penha Oller do Nascimento, Claudia Maria] Univ Fed Sao Paulo, Dept Fisiol, Disciplina Fisiol Nutr, Escola Paulista Med, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Pisani, LP (corresponding author), Univ Fed Sao Paulo, Inst Saude Sociedade, Dept Biociencias, Rua Silva Jardim 136, Santos, SP, Brazil.	lucianapisani@gmail.com	Pisani, Luciana Pellegrini/B-3038-2015; Oyama, Lila M/B-7609-2012; Santamarina, Aline/AAI-7639-2020; Ribeiro, Eliane B/C-8124-2012; Hachul, Ana C. L./N-4082-2017	Ribeiro, Eliane B/0000-0002-3071-9134; Hachul, Ana C. L./0000-0003-4044-9382; Lopez de Oliveira, Juliana/0000-0003-2841-5980; Pisani, Luciana/0000-0001-6579-6167; Mennitti, Lais Vales/0000-0002-9326-7649	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/19426-2]; CAPES; CNPq; FAPESP	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, no 2011/19426-2). CAPES and CNPq granted scholarships and FAPESP has financed the research.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Champ M, 2009, CURR OPIN CLIN NUTR, V12, P565, DOI 10.1097/MCO.0b013e328331b4aa; Cummings JH, 2002, BRIT J NUTR, V87, pS145, DOI 10.1079/BJN/2002530; Damaskos D, 2008, BRIT J CLIN PHARMACO, V65, P453, DOI 10.1111/j.1365-2125.2008.03096.x; de Oliveira JL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-22; Dehghan P, 2014, NUTRITION, V30, P418, DOI 10.1016/j.nut.2013.09.005; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Gebauer SK, 2007, LIPIDS, V42, P787, DOI 10.1007/s11745-007-3095-8; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kelly G, 2008, ALTERN MED REV, V13, P315; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lira FS, 2012, CYTOKINE, V57, P98, DOI 10.1016/j.cyto.2011.10.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Hachul ACL, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-59; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Mennitti LV, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-26; Morley R, 2001, CLIN EXP PHARMACOL P, V28, P962, DOI 10.1046/j.1440-1681.2001.03557.x; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; Nakamura YK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-60; Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pimentel GD, 2012, J NUTR BIOCHEM, V23, P265, DOI 10.1016/j.jnutbio.2010.12.003; Pisani LP, 2008, NUTRITION, V24, P255, DOI 10.1016/j.nut.2007.12.001; Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberfroid MB, 1998, ANNU REV NUTR, V18, P117, DOI 10.1146/annurev.nutr.18.1.117; Rudloff S, 2012, ADV NUTR, V3, p398S, DOI 10.3945/an.111.001594; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Villarreal-Molina MT, 2012, BIOCHIMIE, V94, P2143, DOI 10.1016/j.biochi.2012.06.030; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Zhou YA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-2	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132038	10.1371/journal.pone.0132038	http://dx.doi.org/10.1371/journal.pone.0132038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147005	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600186
J	Bocquillon, P; Bourriez, JL; Palmero-Soler, E; Defebvre, L; Derambure, P; Dujardin, K				Bocquillon, Perrine; Bourriez, Jean-Louis; Palmero-Soler, Ernesto; Defebvre, Luc; Derambure, Philippe; Dujardin, Kathy			Impaired Early Attentional Processes in Parkinson's Disease: A High-Resolution Event-Related Potentials Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; RESPONSE-INHIBITION; GO/NO-GO; DIAGNOSTIC-CRITERIA; SOURCE LOCALIZATION; BRAIN ACTIVATIONS; TARGET DETECTION; VISUAL TARGET; CONFLICT; TASK	Introduction The selection of task-relevant information requires both the focalization of attention on the task and resistance to interference from irrelevant stimuli. A previous study using the P3 component of the event-related potentials suggested that a reduced ability to resist interference could be responsible for attention disorders at early stages of Parkinson's disease (PD), with a possible role of the dorsolateral prefrontal cortex (DLPFC). Methods Our objective was to better determine the origin of this impairment, by studying an earlier ERP component, the N2, and its subcomponents, as they reflect early inhibition processes and as they are known to have sources in the anterior cingulate cortex (ACC), which is involved together with the DLPFC in inhibition processes. Fifteen early-stage PD patients and 15 healthy controls (HCs) performed a three-stimulus visual oddball paradigm, consisting in detecting target inputs amongst standard stimuli, while resisting interference from distracter ones. A 128-channel electroencephalogram was recorded during this task and the generators of the N2 subcomponents were identified using standardized weighted low-resolution electromagnetic tomography (swLORETA). Results PD patients displayed fewer N2 generators than HCs in both the DLPFC and the ACC, for all types of stimuli. In contrast to controls, PD patients did not show any differences between their generators for different N2 subcomponents. Conclusion Our data suggest that impaired inhibition in PD results from dysfunction of the DLPFC and the ACC during the early stages of attentional processes.	[Bocquillon, Perrine; Bourriez, Jean-Louis; Derambure, Philippe] Univ Lille, Med Ctr, Dept Clin Neurophysiol, Lille, France; [Bourriez, Jean-Louis; Defebvre, Luc; Derambure, Philippe; Dujardin, Kathy] Univ Lille, INSERM, U1171, Troubles Cognitifs Degeneratifs & Vasc, Lille, France; [Palmero-Soler, Ernesto] Eemagine Med Imaging Solut GmbH, Berlin, Germany; [Defebvre, Luc; Dujardin, Kathy] Univ Lille, Med Ctr, Neurol & Movement Disorders Dept, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Bocquillon, P (corresponding author), Univ Lille, Med Ctr, Dept Clin Neurophysiol, Lille, France.	perrine.bocquillon@chru-lille.fr	Derambure, Philippe/AAK-8546-2020; Dujardin, Kathy/H-5037-2011	Dujardin, Kathy/0000-0002-0110-574X	France Parkinson association; Eemagine Medical Imaging Solutions GmbH	France Parkinson association; Eemagine Medical Imaging Solutions GmbH	This work was supported by a grant from France Parkinson association, received by KD, LD. URL: http://www.franceparkinson.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Eemagine Medical Imaging Solutions GmbH provided support in the form of salaries for authors [EPS] at the time of the study, but this company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, DOI [10.1176/appi.books.9780890423349., DOI 10.1176/APPI.BOOKS.9780890423349]; Anderer P, 2003, NEUROBIOL AGING, V24, P463, DOI 10.1016/S0197-4580(02)00058-1; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Aotsuka A, 1996, Electromyogr Clin Neurophysiol, V36, P215; Arndt S, 1996, J CEREBR BLOOD F MET, V16, P1271, DOI 10.1097/00004647-199611000-00023; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bekker EM, 2005, COGNITIVE BRAIN RES, V22, P221, DOI 10.1016/j.cogbrainres.2004.08.011; Beste C, 2010, NEUROPSYCHOLOGIA, V48, P366, DOI 10.1016/j.neuropsychologia.2009.09.023; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Bocquillon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034239; Bocquillon P, 2011, CLIN NEUROPHYSIOL, V122, P1991, DOI 10.1016/j.clinph.2011.03.014; BODISWOLLNER I, 1995, J NEURAL TRANSM-PARK, V9, P197, DOI 10.1007/BF02259661; Bokura H, 2005, NEUROPSYCHOLOGIA, V43, P967, DOI 10.1016/j.neuropsychologia.2004.08.010; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Cebolla AM, 2011, NEUROIMAGE, V54, P1297, DOI 10.1016/j.neuroimage.2010.08.060; Chaudhuri KR, 2011, PARKINSONISM RELAT D, V17, P717, DOI 10.1016/j.parkreldis.2011.02.018; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cools R, 2010, J COGNITIVE NEUROSCI, V22, P848, DOI 10.1162/jocn.2009.21227; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Dujardin K, 2008, FONCTIONS EXECUTIVES, P121; Dujardin K, 2013, MOVEMENT DISORD, V28, P183, DOI 10.1002/mds.25311; EBMEIER KP, 1992, BIOL PSYCHOL, V33, P73, DOI 10.1016/0301-0511(92)90007-H; EBMEIER KP, 1992, ELECTROEN CLIN NEURO, V84, P440, DOI 10.1016/0168-5597(92)90031-6; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GESELOWI.DB, 1967, BIOPHYS J, V7, P1, DOI 10.1016/S0006-3495(67)86571-8; Helenius P, 2010, NEUROIMAGE, V53, P619, DOI 10.1016/j.neuroimage.2010.06.059; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; HORNYKIEWICZ O, 1982, PROG BRAIN RES, V55, P419; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; JOHNSON R, 1978, ELECTROEN CLIN NEURO, V44, P424, DOI 10.1016/0013-4694(78)90027-5; Jonkman LM, 2007, CLIN NEUROPHYSIOL, V118, P1069, DOI 10.1016/j.clinph.2007.01.017; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Kropotov JD, 2011, NEUROIMAGE, V57, P565, DOI 10.1016/j.neuroimage.2011.04.060; Kropotov JD, 2009, NEUROREPORT, V20, P1592, DOI 10.1097/WNR.0b013e3283309cbd; Kulisevsky J, 2008, MOVEMENT DISORD, V23, P1889, DOI 10.1002/mds.22246; Ladouceur CD, 2007, DEVELOPMENTAL SCI, V10, P874, DOI 10.1111/j.1467-7687.2007.00639.x; Lagopoulos J, 1997, NEUROL RES, V19, P609; Lagopoulos J, 1998, MOVEMENT DISORD, V13, P262, DOI 10.1002/mds.870130211; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; Matthews SC, 2005, NEUROREPORT, V16, P755, DOI 10.1097/00001756-200505120-00020; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Naatanen R, 1986, Electroencephalogr Clin Neurophysiol Suppl, V38, P169; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; ODONNELL BF, 1987, BIOL PSYCHOL, V24, P23, DOI 10.1016/0301-0511(87)90097-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PEKKONEN E, 1995, ELECTROEN CLIN NEURO, V95, P47, DOI 10.1016/0013-4694(94)00304-4; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Ruchsow M, 2002, NEUROSCI LETT, V325, P203, DOI 10.1016/S0304-3940(02)00288-4; RUMBACH L, 1993, J NEUROL SCI, V116, P148, DOI 10.1016/0022-510X(93)90319-T; Sawaki R, 2008, CLIN NEUROPHYSIOL, V119, P1300, DOI 10.1016/j.clinph.2008.01.107; Sawaki R, 2009, J COGNITIVE NEUROSCI, V21, P359, DOI 10.1162/jocn.2008.21022; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Strobel A, 2008, NEUROIMAGE, V40, P869, DOI 10.1016/j.neuroimage.2007.10.065; Tachibana H, 1997, J NEUROL SCI, V149, P47, DOI 10.1016/S0022-510X(97)05372-0; Takeda M, 1993, Nihon Ronen Igakkai Zasshi, V30, P363; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tommasi G, 2014, J COGNITIVE NEUROSCI, P1; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004	96	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131654	10.1371/journal.pone.0131654	http://dx.doi.org/10.1371/journal.pone.0131654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CS	26135906	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400061
J	Ji, NJ; Li, L; Lin, LX; Lin, SJ				Ji, Nanjing; Li, Ling; Lin, Lingxiao; Lin, Senjie			Screening for Suitable Reference Genes for Quantitative Real-Time PCR in Heterosigma akashiwo (Raphidophyceae)	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; HARMFUL ALGAL BLOOMS; RT-PCR; RNA QUANTITATION; MARINE DIATOM; DIEL CYCLE; RED TIDE; EXPRESSION; VALIDATION; QUANTIFICATION	The raphidophyte Heterosigma akashiwo is a globally distributed harmful alga that has been associated with fish kills in coastal waters. To understand the mechanisms of H. akashiwo bloom formation, gene expression analysis is often required. To accurately characterize the expression levels of a gene of interest, proper reference genes are essential. In this study, we assessed ten of the previously reported algal candidate genes (rpL17-2, rpL23, cox2, cal, tua, tub, ef1, 18S, gapdh, and mdh) for their suitability as reference genes in this species. We used qRT-PCR to quantify the expression levels of these genes in H. akashiwo grown under different temperatures, light intensities, nutrient concentrations, and time points over a diel cycle. The expression stability of these genes was evaluated using geNorm and NormFinder algorithms. Although none of these genes exhibited invariable expression levels, cal, tub, rpL17-2 and rpL23 expression levels were the most stable across the different conditions tested. For further validation, these selected genes were used to normalize the expression levels of ribulose-1, 5-bisphosphate carboxylase/oxygenase large unite (HrbcL) over a diel cycle. Results showed that the expression of HrbcL normalized against each of these reference genes was the highest at midday and lowest at midnight, similar to the diel patterns typically documented for this gene in algae. While the validated reference genes will be useful for future gene expression studies on H. akashiwo, we expect that the procedure used in this study may be helpful to future efforts to screen reference genes for other algae.	[Ji, Nanjing; Li, Ling; Lin, Lingxiao; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Xiamen University; University of Connecticut	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016		National Natural Science Foundation of China [41176091, 41330959]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grant 41176091 and 41330959 (http://www.nsfc.gov.cn/publish/portal1/) to SL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelfi MG, 2014, J EXP MAR BIOL ECOL, V451, P74, DOI 10.1016/j.jembe.2013.11.003; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Bender SJ, 2012, PROTIST, V163, P232, DOI 10.1016/j.protis.2011.07.008; Blanco EP, 2013, HARMFUL ALGAE, V24, P80, DOI 10.1016/j.hal.2013.02.001; Boldt L., 2009, P 11 ICRS, P118; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; CHANG FH, 1990, NEW ZEAL J MAR FRESH, V24, P461, DOI 10.1080/00288330.1990.9516437; Chung CC, 2008, APPL ENVIRON MICROB, V74, P6521, DOI 10.1128/AEM.01481-08; Coyne KJ, 2010, J PHYCOL, V46, P135, DOI 10.1111/j.1529-8817.2009.00781.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davis AK, 2006, EUKARYOT CELL, V5, P1157, DOI 10.1128/EC.00042-06; Dong MT, 2012, CURR GENET, V58, P13, DOI 10.1007/s00294-011-0361-3; Dundas J, 2012, THEOR BIOSCI, V131, P215, DOI 10.1007/s12064-012-0152-5; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Guo R, 2012, EUR J PROTISTOL, V48, P199, DOI 10.1016/j.ejop.2011.11.001; Harvey EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046438; Harvey EL, 2011, LIMNOL OCEANOGR, V56, P371, DOI 10.4319/lo.2011.56.1.0371; Hoagland P, 2006, ECOL STU AN, V189, P391, DOI 10.1007/978-3-540-32210-8_30; HONJO T, 1993, DEV MAR BIO, V3, P33; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Khan S, 1997, AQUAC RES, V28, P9, DOI 10.1111/j.1365-2109.1997.tb01309.x; Kianianmomeni A, 2013, MOL BIOL REP, V40, P6691, DOI 10.1007/s11033-013-2784-z; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Main CR, 2014, HARMFUL ALGAE, V37, P92, DOI 10.1016/j.hal.2014.05.014; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Mou S, 2014, J PLANT BIOCHEM BIOT, P1; Paul JH, 2000, MAR BIOTECHNOL, V2, P429; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichard SL, 1996, MAR ECOL PROG SER, V139, P257, DOI 10.3354/meps139257; PORTIS AR, 1992, ANNU REV PLANT PHYS, V43, P415, DOI 10.1146/annurev.pp.43.060192.002215; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Shi XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071232; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Smayda T.J., 1998, PHYSL ECOLOGY HARMFU, P113; Strom SL, 2013, J PHYCOL, V49, P20, DOI 10.1111/jpy.12013; Stuart RK, 2009, APPL ENVIRON MICROB, V75, P5047, DOI 10.1128/AEM.00271-09; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tobin ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076663; Twiner MJ, 2005, HARMFUL ALGAE, V4, P789, DOI 10.1016/j.hal.2004.12.006; Twiner MJ, 2001, LIMNOL OCEANOGR, V46, P1400, DOI 10.4319/lo.2001.46.6.1400; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Wang GP, 2010, MOL BIOTECHNOL, V46, P49, DOI 10.1007/s12033-010-9274-5; WATANABE M, 1988, J PHYCOL, V24, P22; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104124; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Zhang C, 2014, HARMFUL ALGAE, V39, P26, DOI 10.1016/j.hal.2014.06.005; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	57	20	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132183	10.1371/journal.pone.0132183	http://dx.doi.org/10.1371/journal.pone.0132183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133173	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400104
J	Tian, T; Yu, S; Liu, L; Xue, FZ; Yuan, CZ; Wang, M; Ji, CY; Ma, DX				Tian, Tian; Yu, Shuang; Liu, Lu; Xue, Fuzhong; Yuan, Cunzhong; Wang, Min; Ji, Chunyan; Ma, Daoxin			The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations	PLOS ONE			English	Article							TGF-BETA; PERIPHERAL-BLOOD; INTERLEUKIN 22; TH17 CELLS; CANCER; INFLAMMATION; SUPPRESSION; FREQUENCIES; POPULATION; CYTOKINE	Background T helper (Th) cells immune regulation is important for the pathogenesis of acute myeloid leukemia (AML). Recurrent Th abnormalities in AML peripheral blood were reported, while the comprehensive status of various Th subsets is rarely investigated in bone marrow (BM) microenvironment which is the origin of AML leukemic blast cells. Methods BM was extracted from 48 newly-diagnosed (ND), 34 complete-remission (CR), 19 relapsed-refractory AML patients and 15 controls. Slight iron deficiency anemia patients were used as controls. Th subsets frequencies were examined by flow cytometry. BM plasma Th-associated cytokines levels were determined by ELISA. The expression of key transcription factor was examined by RT-PCR. Results Th22, Th17, Th1, Th2 cells, IL-22 and RORC expression were significantly decreased, while Treg cells, related cytokine IL-10 and transcription factor Foxp3 were markedly elevated in ND compared to CR patients or controls. Meanwhile, the imbalanced Th1/Th2 and Th17/Treg ratio were observed in ND and relapsed-refractory patients. Negative correlation between Th1 or Th2 and peripheralWBC, between Th17/Treg or Th1/Th2 and leukemic blast existed in ND patients. Moreover, chemotherapy ameliorated these variations. Conclusion Th subsets in BM are distinct for different stages of AML and chemotherapy partly ameliorates the abnormality. Our findings suggest that these cells and cytokines may be implicated in AML pathogenesis and provided therapeutic insights.	[Tian, Tian; Yu, Shuang; Liu, Lu; Wang, Min; Ji, Chunyan; Ma, Daoxin] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Yuan, Cunzhong] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Ma, DX (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	daoxinma@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020	Xue, Fuzhong/0000-0003-0378-7956	Tai Shan Scholar Foundation; National Natural Science Foundation of China [81070407, 81170515, 81070422]; Outstanding Young Scientist Research Award Foundation of Shandong Province [BS2009SW014]; Independent Innovation Foundation of Shandong University [2009TS063]	Tai Shan Scholar Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scientist Research Award Foundation of Shandong Province; Independent Innovation Foundation of Shandong University	This work was supported by grants from the Tai Shan Scholar Foundation, National Natural Science Foundation of China (No. 81070407, No. 81170515, No. 81070422), Outstanding Young Scientist Research Award Foundation of Shandong Province (BS2009SW014), and Independent Innovation Foundation of Shandong University (2009TS063).	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chen BA, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-21; CHESON BD, 1990, J CLIN ONCOL, V8, P813, DOI 10.1200/JCO.1990.8.5.813; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Ersvaer Elisabeth, 2010, BMC Immunol, V11, P38, DOI 10.1186/1471-2172-11-38; Flynn RJ, 2008, INT J PARASITOL, V38, P1673, DOI 10.1016/j.ijpara.2008.05.008; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Hu Y, 2012, HUM IMMUNOL, V73, P629, DOI 10.1016/j.humimm.2012.04.015; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; Linehan DC, 2005, IMMUNOL RES, V32, P155, DOI 10.1385/IR:32:1-3:155; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; NAPOLI VM, 1986, AM J CLIN PATHOL, V86, P788, DOI 10.1093/ajcp/86.6.788; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Schwarzenberger P, 2002, J CELL BIOCHEM, P88, DOI 10.1002/jcb.10054; Shao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051339; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Stassen M, 2012, ANN NY ACAD SCI, V1247, P56, DOI 10.1111/j.1749-6632.2011.06351.x; Szczepanski MJ, 2009, CLIN CANCER RES, V15, P3325, DOI 10.1158/1078-0432.CCR-08-3010; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang XB, 2005, EUR J HAEMATOL, V75, P468, DOI 10.1111/j.1600-0609.2005.00537.x; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Wu H, 2012, ONCOL LETT, V3, P1119, DOI 10.3892/ol.2012.614; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang L, 2012, J ENG FIBER FABR, V7, P7; Zhang SH, 2011, INT J CANCER, V129, P1373, DOI 10.1002/ijc.25791; Zhu XP, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-17	39	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131761	10.1371/journal.pone.0131761	http://dx.doi.org/10.1371/journal.pone.0131761			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134277	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400070
J	Chien, CY; Liu, CC; Po, HL; Yen, CH; Hou, CJY; Kuo, JY; Hung, CL; Wang, SS; Yeh, HI; Lam, CSP				Chien, Chen-Yen; Liu, Chuan-Chuan; Po, Helen L.; Yen, Chih-Hsuan; Hou, Charles Jia-Yin; Kuo, Jen-Yuan; Hung, Chung-Lieh; Wang, Shoei-Shen; Yeh, Hung-I; Lam, Carolyn S. P.			The Relationship among Carotid Artery Remodeling, Cardiac Geometry, and Serum N-Terminal Pro-B-Type Natriuretic Peptide Level in Asymptomatic Asians: Sex-Differences and Longitudinal GEE Study	PLOS ONE			English	Article							DIASTOLIC HEART-FAILURE; INTIMA-MEDIA THICKNESS; LEFT-VENTRICULAR MASS; EJECTION FRACTION; AMERICAN-SOCIETY; BLOOD-PRESSURE; HYPERTENSION; ENLARGEMENT; DISEASE; AGE	Background Carotid artery remodeling is known to be associated with a variety of cardiovascular diseases. However, there is limited information regarding gender differences in carotid remodeling. We sought to investigate the associations among blood pressure (BP), carotid artery remodeling and cardiac geometries, and further explore gender differences. Materials and Methods In a large cohort of asymptomatic adults undergoing routine health screening with repeated observations, we related measures of carotid artery diameter (CCAD) to various BP components, cardiac geometries and blood N-terminal pro-brain natriuretic peptide (NT-proBNP) level, both from baseline cross-sectional and longitudinal dataset using generalized estimating equations (GEE). Results A total of 2,914 person-visits (baseline: n= 998, mean age: 47 +/- 8.9 years, 34% female) were studied (median: 6 +/- 1.73 years follow up). We observed that CCAD was larger in men (p< 0.01) and positively related to baseline age or all blood pressure components (including systolic BP [SBP], diastolic BP [DBP] and pulse pressure [PP], all p< 0.01) even after accounting for clinical covariates, which did not change significantly at follow up (repeatvisit longitudinal GEE models). At baseline, per each increased unit of CCAD was associated with elevated LV mass index (beta-coef: 6.72, with odds ratio [OR]: 1.47, 95% CI: 1.06 to 2.07 for ventricular hypertrophy; AUROC: 0.65, CCAD cut-off: 7.25mm) and NT-proBNP (Acoef: 5.35, OR: 4.22, 95% CI: 1.42 to 12.6 for >= 300pg/mL; AUROC: 0.79, CCAD cut-off: 7.95mm, all p< 0.05), which remained significant in multi-variate and longitudinal models. There was a prominent sex interaction (p for interaction with age and systolic BP: 0.004 and 0.028 respectively), where the longitudinal associations of age and systolic BP with increasing CCAD as more pronounced in women than men. Conclusion These data demonstrated that carotid artery remodeling may parallel subclinical biomarker of cardiac dysfunction, and further showed greater effects of aging and higher blood pressure on such remodeling process in women than men. Further study is warranted to understand how this predisposition of elderly hypertensive women to vascular remodeling may play a role in clinical settings.	[Chien, Chen-Yen] Mackay Mem Hosp, Div Cardiovasc Surg, Taipei, Taiwan; [Chien, Chen-Yen; Liu, Chuan-Chuan; Yen, Chih-Hsuan; Hou, Charles Jia-Yin; Kuo, Jen-Yuan; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Med Coll, New Taipei City, Taiwan; [Liu, Chuan-Chuan] Mackay Mem Hosp, Hlth Evaluat Ctr, Taipei, Taiwan; [Liu, Chuan-Chuan] Yuanpei Univ Sci & Technol, Dept Med Technol, Hsinchu, Taiwan; [Liu, Chuan-Chuan; Hung, Chung-Lieh] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei 10764, Taiwan; [Po, Helen L.] Mackay Mem Hosp, Dept Neurol, Taipei, Taiwan; [Yen, Chih-Hsuan; Hou, Charles Jia-Yin; Kuo, Jen-Yuan; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Mem Hosp, Dept Internal Med, Div Cardiovasc, Taipei, Taiwan; [Chien, Chen-Yen; Yen, Chih-Hsuan; Hou, Charles Jia-Yin; Kuo, Jen-Yuan; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Hung, Chung-Lieh] Kainan Univ, Dept Hlth Ind Management, Taoyuan, Taiwan; [Hung, Chung-Lieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wang, Shoei-Shen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lam, Carolyn S. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117595, Singapore	Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital; National Taiwan University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Nan Kai University Technology; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National University of Singapore	Hung, CL (corresponding author), Mackay Med Coll, New Taipei City, Taiwan.	jotaro3791@gmail.com	Lam, Carolyn SP/ABD-6810-2021; Kuo, Jen-Yuan/AAX-5448-2021	Lam, Carolyn SP/0000-0003-1903-0018; Wang, Shoei-Shen/0000-0003-3201-4143	Mackay Memorial Hospital, Taipei, Taiwan	Mackay Memorial Hospital, Taipei, Taiwan	This work was supported by research grants from the Mackay Memorial Hospital, Taipei, Taiwan.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bella JN, 1999, HYPERTENSION, V33, P793, DOI 10.1161/01.HYP.33.3.793; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; BonithonKopp C, 1996, STROKE, V27, P654, DOI 10.1161/01.STR.27.4.654; Borlaug BA, 2009, J AM COLL CARDIOL, V54, P410, DOI 10.1016/j.jacc.2009.05.013; Chen AA, 2006, EUR HEART J, V27, P839, DOI 10.1093/eurheartj/ehi811; Chen CH, 2001, J AM COLL CARDIOL, V38, P2028, DOI 10.1016/S0735-1097(01)01651-5; Chen CH, 1998, J AM COLL CARDIOL, V32, P1221, DOI 10.1016/S0735-1097(98)00374-X; Chironi G, 2003, ARTERIOSCL THROM VAS, V23, P1460, DOI 10.1161/01.ATV.0000083342.98342.22; Crouse JR, 1996, STROKE, V27, P69, DOI 10.1161/01.STR.27.1.69; de Simone G, 2008, EUR HEART J, V29, P741, DOI 10.1093/eurheartj/ehm605; Godia EC, 2007, J ULTRAS MED, V26, P1157, DOI 10.7863/jum.2007.26.9.1157; Henry RMA, 2004, STROKE, V35, P671, DOI 10.1161/01.STR.0000115752.58601.0B; Iannuzzi A, 2003, HYPERTENSION, V41, P289, DOI 10.1161/01.HYP.0000049425.64091.0A; Lam CSP, 2010, CIRCULATION, V122, P884, DOI 10.1161/CIRCULATIONAHA.110.937839; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Langille BL, 1995, FLOW DEPENDENT REGUL, P277; Liao ZY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003053; LOSORDO DW, 1994, CIRCULATION, V89, P2570, DOI 10.1161/01.CIR.89.6.2570; Montalcini T, 2011, NUTR METAB CARDIOVAS, V21, P830, DOI 10.1016/j.numecd.2010.02.009; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Polak JF, 1996, STROKE, V27, P2012, DOI 10.1161/01.STR.27.11.2012; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Roberts AW, 2009, DIABETES VASC DIS RE, V6, P153, DOI 10.1177/1479164109338774; Sasaki R, 2002, HYPERTENS RES, V25, P373, DOI 10.1291/hypres.25.373; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Unthank JL, 1996, CIRC RES, V79, P1015, DOI 10.1161/01.RES.79.5.1015; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; Vasan RS, 1996, ARCH INTERN MED, V156, P1789, DOI 10.1001/archinte.156.16.1789; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131440	10.1371/journal.pone.0131440	http://dx.doi.org/10.1371/journal.pone.0131440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132728	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000119
J	Huang, BT; Lu, JY; Lin, PX; Chen, JZ; Kuang, Y; Chen, CZ				Huang, Bao-Tian; Lu, Jia-Yang; Lin, Pei-Xian; Chen, Jian-Zhou; Kuang, Yu; Chen, Chuang-Zhen			Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free Beams	PLOS ONE			English	Article							MODULATED ARC THERAPY; RADIATION-THERAPY; PHOTON BEAMS; TUMORS; ACCELERATOR; IMRT	Purpose To investigate the performance of using partial arc (PA) and full arc with avoidance sectors (FAAS) in stereotactic body radiotherapy (SBRT) of peripheral lung cancer with flattening filter free (FFF) beams. Methods Eighteen patients with primary (T1 or T2) non-small-cell lung cancer (NSCLC) or lung metastatic were selected for this study. Nine patients with a gross tumor volume (GTV) <= 10 cc were designated as the small tumor group. The other nine patients with a GTV between 10 cc and 44 cc were assigned to the large tumor group. The treatment plans were generated in eighteen patients using PA and FAAS techniques, respectively, and delivered with a Varian TrueBeam Linac. Dosimetry of the target and organs at risk (OARs), monitor unit (MU), out-of-field dose, and delivery time were statistically analyzed. Delta4 and portal dosimetry were employed to evaluate the delivery accuracy. Results For the small tumor group, compared with the PA plans, the FAAS plans significantly achieved a lower MU/fraction, out-of-field dose and a shorter treatment time (p<0.05), but the target dose was slightly higher than that delivered by PA plans (p<0.05). For the large tumor group, the PA plans significantly attained a shorter treatment time (p<0.05), whereas MU/fraction, out-of-field dose and dose to OARs were comparable between the two plans (p>0.05). Furthermore, all plans generated from the eighteen patients achieved a high pass rate in patient-specific quality assurance, with all the gamma indices greater than 97% at the Gamma(3mm), (3%) threshold. Conclusion This study suggests that the FAAS technique is more beneficial for the small tumor patients undergoing lung SBRT with FFF beams because of its higher treatment efficiency and MU reduction. However, for the large tumor patients, the PA technique is recommended due to its higher treatment efficiency.	[Huang, Bao-Tian; Lu, Jia-Yang; Chen, Jian-Zhou; Chen, Chuang-Zhen] Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China; [Lin, Pei-Xian] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Nosocomial Infect Management, Shantou, Guangdong, Peoples R China; [Kuang, Yu] Univ Nevada Las Vegas, Med Phys Program, Las Vegas, NV 89154 USA	Shantou University; Shantou University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Chen, CZ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China.	stccz@139.com	Chen, Jianzhou/AAW-1443-2021		Shantou University Medical College Clinical Research Enhancement Initiative [201424]; NIH/NIGMS [U54 GM104944]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104944] Funding Source: NIH RePORTER	Shantou University Medical College Clinical Research Enhancement Initiative; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the Shantou University Medical College Clinical Research Enhancement Initiative (201424) and NIH/NIGMS grant (U54 GM104944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongers EM, 2013, RADIOTHER ONCOL, V109, P95, DOI 10.1016/j.radonc.2013.10.011; Brown JM, 2010, INT J RADIAT ONCOL, V78, P323, DOI 10.1016/j.ijrobp.2010.04.070; Cerfolio RJ, 2009, ANN THORAC SURG, V88, P917, DOI 10.1016/j.athoracsur.2009.05.040; Chi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059729; Cozzi L, 2008, RADIOTHER ONCOL, V89, P180, DOI 10.1016/j.radonc.2008.06.013; Dunlap NE, 2010, INT J RADIAT ONCOL, V76, P796, DOI 10.1016/j.ijrobp.2009.02.027; Fiandra C, 2013, MED PHYS, V40, DOI 10.1118/1.4816300; Georg D, 2011, MED PHYS, V38, P1280, DOI 10.1118/1.3554643; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hall EJ, 2006, INT J RADIAT ONCOL, V65, P1, DOI 10.1016/j.ijrobp.2006.01.027; Holt A, 2011, INT J RADIAT ONCOL, V81, P1560, DOI 10.1016/j.ijrobp.2010.09.014; Hoogeman MS, 2008, INT J RADIAT ONCOL, V70, P609, DOI 10.1016/j.ijrobp.2007.08.066; Kry SF, 2010, PHYS MED BIOL, V55, P2155, DOI 10.1088/0031-9155/55/8/003; Lang S, 2013, RADIOTHER ONCOL, V106, P255, DOI 10.1016/j.radonc.2012.12.012; Le QT, 2006, J THORAC ONCOL, V1, P802, DOI 10.1097/01243894-200610000-00008; Ma LJ, 2009, INT J RADIAT ONCOL, V75, P1261, DOI 10.1016/j.ijrobp.2009.04.027; McGrath SD, 2010, RADIOTHER ONCOL, V95, P153, DOI 10.1016/j.radonc.2009.12.039; Nicolini G, 2012, INT J RADIAT ONCOL, V84, P553, DOI 10.1016/j.ijrobp.2011.12.041; Ong CL, 2012, INT J RADIAT ONCOL, V83, pE137, DOI 10.1016/j.ijrobp.2011.12.014; Ong CL, 2010, RADIOTHER ONCOL, V97, P437, DOI 10.1016/j.radonc.2010.09.027; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Palma DA, 2010, CANCER TREAT REV, V36, P393, DOI 10.1016/j.ctrv.2010.01.004; Peguret N, 2013, RADIOTHER ONCOL, V107, P419, DOI 10.1016/j.radonc.2013.04.019; Purdie TG, 2007, INT J RADIAT ONCOL, V68, P243, DOI 10.1016/j.ijrobp.2006.12.022; Radiation Therapy Oncology Group, 2012, RAND PHAS 2 STUD COM; Verbakel WFAR, 2009, RADIOTHER ONCOL, V93, P122, DOI 10.1016/j.radonc.2009.05.020; Wang LL, 2014, PHYS MED BIOL, V59, pN113, DOI 10.1088/0031-9155/59/13/N113; Zwahlen DR, 2012, INT J RADIAT ONCOL, V83, P1655, DOI 10.1016/j.ijrobp.2011.10.019	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0127501	10.1371/journal.pone.0127501	http://dx.doi.org/10.1371/journal.pone.0127501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131554	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000009
J	Reyes-Leon, A; Juarez-Velazquez, R; Medrano-Hernandez, A; Cuenca-Roldan, T; Salas-Labadia, C; Navarrete-Meneses, MDP; Rivera-Luna, R; Lopez-Hernandez, G; Paredes-Aguilera, R; Perez-Vera, P				Reyes-Leon, Adriana; Juarez-Velazquez, Rocio; Medrano-Hernandez, Alma; Cuenca-Roldan, Teresa; Salas-Labadia, Consuelo; del Pilar Navarrete-Meneses, Mara; Rivera-Luna, Roberto; Lopez-Hernandez, Gerardo; Paredes-Aguilera, Rogelio; Perez-Vera, Patricia			Expression of Ik6 and Ik8 Isoforms and Their Association with Relapse and Death in Mexican Children with Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							DIFFERENT IKAROS ISOFORMS; GENETIC ALTERATIONS; IKZF1 DELETION; ERG DELETION; CHILDHOOD; MARKER; IMPACT; RISK	Expression of the 6 and 8 dominant-negative Ikaros isoforms in pediatric patients with acute lymphoblastic leukemia has been associated with a high risk of relapse and death; due to these isoforms disrupting the differentiation and proliferation of lymphoid cells. The aim of this study was to know the frequency of Ik6 and Ik8 in 113 Mexican ALL-children treated within the National Popular Medical Insurance Program to determine whether there was an association with relapse-free survival, event-free survival and overall survival, and to assess its usefulness in the initial stratification of patients. The expression of these isoforms was analyzed using specific primer sets and nested RT-PCR. The detected transcripts were classified according to the isoforms's sizes reported. A non-expected band of 300 bp from one patient was analyzed by sequencing. Twenty-six patients expressed Ik6 and/or Ik8 and one of them expressed a variant of Ik8 denominated Ik8-deleted. Although the presence of them was not statistically associated with lower relapse free survival (p = 0.432), event free survival (p = 0.667) or overall survival (p = 0.531), inferior overall survival was observed in patients that expressed these isoforms and showed high or standard risk by age and white blood-cell count at diagnosis. Of the 26 patients Ik6+ and/or Ik8+, 14 did not present adverse events; from them 6 were exclusively Ik6+ and/or Ik8+, and 8 were positive for the other Ikaros isoforms (Ik1, Ik2, Ik5, Ik3A, Ik4, Ik4A, Ik7). In the patients studied, the expression of Ik6 and Ik8 did not constitute an independent prognostic factor for relapse or death related to disease; therefore, they could not be used in the initial risk stratification.	[Reyes-Leon, Adriana; Juarez-Velazquez, Rocio; Medrano-Hernandez, Alma; Cuenca-Roldan, Teresa; Salas-Labadia, Consuelo; del Pilar Navarrete-Meneses, Mara; Perez-Vera, Patricia] Inst Nacl Pediat, Dept Genet Humana, Lab Cultivo Tejidos, Mexico City, DF, Mexico; [Rivera-Luna, Roberto] Inst Nacl Pediat, Subdirecc Hematooncol, Mexico City, DF, Mexico; [Lopez-Hernandez, Gerardo] Hosp El Nino Poblano, Puebla, Mexico; [Paredes-Aguilera, Rogelio] Inst Nacl Pediat, Serv Hematol, Mexico City, DF, Mexico		Perez-Vera, P (corresponding author), Inst Nacl Pediat, Dept Genet Humana, Lab Cultivo Tejidos, Mexico City, DF, Mexico.	pperezvera@yahoo.com		JUAREZ VELAZQUEZ, MARIA DEL ROCIO/0000-0002-2825-4729; salas, consuelo/0000-0002-3301-7357	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA [FONSECSSA/IMSS/ISSSTE/44402]; FONDOS FEDERALES	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FONDOS FEDERALES	Funding was provided by CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA FONSECSSA/IMSS/ISSSTE/44402, and FONDOS FEDERALES 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng B, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/797968; Clappier E, 2014, LEUKEMIA, V28, P70, DOI 10.1038/leu.2013.277; Iacobucci I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040934; Juarez-Velazquez R, 2014, LEUKEMIA LYMPHOMA, V55, P2305, DOI 10.3109/10428194.2013.878458; Meleshko AN, 2008, BLOOD CELL MOL DIS, V41, P278, DOI 10.1016/j.bcmd.2008.06.006; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan C, 2008, LEUKEMIA LYMPHOMA, V49, P847, DOI 10.1080/10428190801947500; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2012, HEMATOL-AM SOC HEMAT, P389, DOI 10.1182/asheducation-2012.1.389; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Olivero S, 2000, BRIT J HAEMATOL, V110, P826, DOI 10.1046/j.1365-2141.2000.02297.x; Olsson L, 2015, GENE CHROMOSOME CANC, V54, P315, DOI 10.1002/gcc.22245; Palmi C, 2013, HAEMATOLOGICA, V98, pE164, DOI 10.3324/haematol.2013.099077; Palmi C, 2013, HAEMATOLOGICA, V98, P1226, DOI 10.3324/haematol.2012.075432; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Rivera-Luna R, 2013, INT J CANCER, V132, P1646, DOI 10.1002/ijc.27771; RiveraLuna R, 1997, ARCH MED RES, V28, P233; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Takanashi M, 2002, BRIT J HAEMATOL, V117, P525, DOI 10.1046/j.1365-2141.2002.03487.x; Uckun FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080732; van der Veer A, 2013, BLOOD, V122, P2622, DOI 10.1182/blood-2012-10-462358; Yang YL, 2011, CANCER SCI, V102, P1874, DOI 10.1111/j.1349-7006.2011.02031.x; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Zaliova M, 2014, LEUKEMIA, V28, P182, DOI 10.1038/leu.2013.282	29	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130756	10.1371/journal.pone.0130756	http://dx.doi.org/10.1371/journal.pone.0130756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131904	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000081
J	Scolnick, JA; Dimon, M; Wang, IC; Huelga, SC; Amorese, DA				Scolnick, Jonathan A.; Dimon, Michelle; Wang, I-Ching; Huelga, Stephanie C.; Amorese, Douglas A.			An Efficient Method for Identifying Gene Fusions by Targeted RNA Sequencing from Fresh Frozen and FFPE Samples	PLOS ONE			English	Article							TRANSCRIPTS; ALGORITHM	Fusion genes are known to be key drivers of tumor growth in several types of cancer. Traditionally, detecting fusion genes has been a difficult task based on fluorescent in situ hybridization to detect chromosomal abnormalities. More recently, RNA sequencing has enabled an increased pace of fusion gene identification. However, RNA-Seq is inefficient for the identification of fusion genes due to the high number of sequencing reads needed to detect the small number of fusion transcripts present in cells of interest. Here we describe a method, Single Primer Enrichment Technology (SPET), for targeted RNA sequencing that is customizable to any target genes, is simple to use, and efficiently detects gene fusions. Using SPET to target 5701 exons of 401 known cancer fusion genes for sequencing, we were able to identify known and previously unreported gene fusions from both fresh-frozen and formalin-fixed paraffin-embedded (FFPE) tissue RNA in both normal tissue and cancer cells.	[Scolnick, Jonathan A.; Dimon, Michelle; Wang, I-Ching; Huelga, Stephanie C.; Amorese, Douglas A.] NuGEN Technol Inc, San Carlos, CA 94070 USA		Amorese, DA (corresponding author), NuGEN Technol Inc, San Carlos, CA 94070 USA.	damorese@nugen.com	scolnick, jonathan/AAY-2878-2020		NuGEN Technologies	NuGEN Technologies	NuGEN Technologies provided funding for this work. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chinnaiyan A, 2011, US patent US, Patent No. 20130096021; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2015, NAT GENET, V47, P13, DOI 10.1038/ng.3146; Forbes S, 2014, NUCL ACIDS RES ADV A; Ha KCH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-75; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim P, 2010, NUCLEIC ACIDS RES, V38, pD81, DOI 10.1093/nar/gkp982; Liehr T, 2010, ADV MAR GENOMICS, V1, P315, DOI 10.1007/978-90-481-3919-4_32; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0	16	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128916	10.1371/journal.pone.0128916	http://dx.doi.org/10.1371/journal.pone.0128916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132974	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000022
J	Desmet, CM; Djurkin, A; Dos Santos-Goncalvez, AM; Dong, RH; Kmiec, MM; Kobayashi, K; Rychert, K; Beun, S; Leprince, JG; Leloup, G; Leveque, P; Gallez, B				Desmet, Celine M.; Djurkin, Andrej; Dos Santos-Goncalvez, Ana Maria; Dong, Ruhong; Kmiec, Maciej M.; Kobayashi, Kyo; Rychert, Kevin; Beun, Sebastien; Leprince, Julian G.; Leloup, Gaetane; Leveque, Philippe; Gallez, Bernard			Tooth Retrospective Dosimetry Using Electron Paramagnetic Resonance: Influence of Irradiated Dental Composites	PLOS ONE			English	Article							IN-VIVO EPR; LARGE POPULATIONS; RADIATION; BIODOSIMETRY; MANAGEMENT; RESINS; SPECTROMETRY; TRIAGE; GLASS	In the aftermath of a major radiological accident, the medical management of overexposed individuals will rely on the determination of the dose of ionizing radiations absorbed by the victims. Because people in the general population do not possess conventional dosimeters, after the fact dose reconstruction methods are needed. Free radicals are induced by radiations in the tooth enamel of victims, in direct proportion to dose, and can be quantified using Electron Paramagnetic Resonance (EPR) spectrometry, a technique that was demonstrated to be very appropriate for mass triage. The presence of dimethacrylate based restorations on teeth can interfere with the dosimetric signal from the enamel, as free radicals could also be induced in the various composites used. The aim of the present study was to screen irradiated composites for a possible radiation-induced EPR signal, to characterize it, and evaluate a possible interference with the dosimetric signal of the enamel. We investigated the most common commercial composites, and experimental compositions, for a possible class effect. The effect of the dose was studied between 10 Gy and 100 Gy using high sensitivity X-band spectrometer. The influence of this radiation-induced signal from the composite on the dosimetric signal of the enamel was also investigated using a clinical L-Band EPR spectrometer, specifically developed in the EPR center at Dartmouth College. In X-band, a radiation-induced signal was observed for high doses (25-100 Gy); it was rapidly decaying, and not detected after only 24h post irradiation. At 10 Gy, the signal was in most cases not measurable in the commercial composites tested, with the exception of 3 composites showing a significant intensity. In L-band study, only one irradiated commercial composite influenced significantly the dosimetric signal of the tooth, with an overestimation about 30%. In conclusion, the presence of the radiation-induced signal from dental composites should not significantly influence the dosimetry for early dose assessment.	[Desmet, Celine M.; Leveque, Philippe; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium; [Djurkin, Andrej; Beun, Sebastien] Catholic Univ Louvain, Sch Dent & Stomatol, B-1200 Brussels, Belgium; [Dos Santos-Goncalvez, Ana Maria; Leprince, Julian G.; Leloup, Gaetane] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat Res Grp, B-1200 Brussels, Belgium; [Dong, Ruhong; Kmiec, Maciej M.; Kobayashi, Kyo; Rychert, Kevin] Geisel Sch Med Dartmouth, EPR Ctr Study Viable Syst, Hanover, NH USA; [Leprince, Julian G.; Leloup, Gaetane; Gallez, Bernard] Catholic Univ Louvain, Ctr Res & Engn Biomat CRIBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Dartmouth College; Universite Catholique Louvain	Gallez, B (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium.	Bernard.gallez@uclouvain.be	Leprince, Julian G/A-8489-2012; Leprince, Julian/O-7942-2019	Leprince, Julian/0000-0001-7396-0019	National Institutes of Health [U19AI091173]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by The National Institutes of Health, grant number U19AI091173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsbury EA, 2011, RADIAT PROT DOSIM, V147, P573, DOI 10.1093/rpd/ncq499; Bassinet C, 2010, HEALTH PHYS, V98, P400, DOI 10.1097/01.HP.0000346330.72296.51; Bushberg JT, 2007, J EMERG MED, V32, P71, DOI 10.1016/j.jemermed.2006.05.034; Chen MH, 2010, J DENT RES, V89, P549, DOI 10.1177/0022034510363765; Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Fattibene P, 2014, RADIAT ENVIRON BIOPH, V53, P311, DOI 10.1007/s00411-014-0533-x; Fattibene P, 2010, APPL RADIAT ISOTOPES, V68, P2033, DOI 10.1016/j.apradiso.2010.05.016; Gancheva V, 2006, SPECTROCHIM ACTA A, V63, P875, DOI 10.1016/j.saa.2005.10.019; Grace MB, 2010, HEALTH PHYS, V98, P172, DOI 10.1097/01.HP.0000348001.60905.c0; IAEA, 2011, CYT DOS APPL PREP RE; International Atomic Energy Agency (IAEA), 2012, PREP RESP NUCL RAD E; Koerner JF, 2014, HEALTH PHYS, V106, P645, DOI 10.1097/HP.0000000000000053; Kulka U, 2012, RADIAT PROT DOSIM, V151, P621, DOI 10.1093/rpd/ncs157; Lamblin G, 2010, ACTA BIOMATER, V6, P3193, DOI 10.1016/j.actbio.2010.03.001; Leprince J, 2009, ACTA BIOMATER, V5, P2518, DOI 10.1016/j.actbio.2009.04.034; Leprince JG, 2013, DENT MATER, V29, P139, DOI 10.1016/j.dental.2012.11.005; Leveque P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062225; NATO/STO, 2012, BIOLOGICAL EFFECTS O; NCRP, 2001, 138 NCRP NAT COUNC R; Neumaier S, 2014, RADIAT PROT DOSIM, V160, P297, DOI 10.1093/rpd/ncu002; NIH/NIAID, 2005, NIH STRAT PLAN RES A; OTTAVIANI MF, 1992, DENT MATER, V8, P118, DOI 10.1016/0109-5641(92)90066-L; Repin M, 2014, RADIAT PROT DOSIM, V159, P105, DOI 10.1093/rpd/ncu161; Rothkamm K, 2013, RADIAT RES, V180, P111, DOI 10.1667/RR3231.1; Sideridou I, 2003, BIOMATERIALS, V24, P655, DOI 10.1016/S0142-9612(02)00380-0; Swartz HM, 2007, RADIAT MEAS, V42, P1075, DOI 10.1016/j.radmeas.2007.05.023; Swartz HM, 2014, RADIAT ENVIRON BIOPH, V53, P221, DOI 10.1007/s00411-014-0522-0; Trompier F, 2009, ANN I SUPER SANITA, V45, P287; Truffier-Boutry D, 2003, J POLYM SCI POL CHEM, V41, P1691, DOI 10.1002/pola.10692; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Williams BB, 2014, RADIAT ENVIRON BIOPH, V53, P335, DOI 10.1007/s00411-014-0534-9; Williams BB, 2011, RADIAT MEAS, V46, P772, DOI 10.1016/j.radmeas.2011.03.009; Williams BB, 2011, INT J RADIAT BIOL, V87, P766, DOI 10.3109/09553002.2011.583316; Williams BB, 2010, HEALTH PHYS, V98, P327, DOI 10.1097/HP.0b013e3181a6de5d	34	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131913	10.1371/journal.pone.0131913	http://dx.doi.org/10.1371/journal.pone.0131913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125565	gold, Green Submitted, Green Published			2022-12-26	WOS:000358151300063
J	Aurelius, O; Johansson, R; Bagenholm, V; Lundin, D; Tholander, F; Balhuizen, A; Beck, T; Sahlin, M; Sjoberg, BM; Mulliez, E; Logan, DT				Aurelius, Oskar; Johansson, Renzo; Bagenholm, Viktoria; Lundin, Daniel; Tholander, Fredrik; Balhuizen, Alexander; Beck, Tobias; Sahlin, Margareta; Sjoberg, Britt-Marie; Mulliez, Etienne; Logan, Derek T.			The Crystal Structure of Thermotoga maritima Class III Ribonucleotide Reductase Lacks a Radical Cysteine Pre-Positioned in the Active Site	PLOS ONE			English	Article							PYRUVATE FORMATE-LYASE; SUBSTRATE-SPECIFICITY REGULATION; IRON-SULFUR CENTER; ESCHERICHIA-COLI; DIPHOSPHATE REDUCTASE; ALLOSTERIC REGULATION; LACTOCOCCUS-LACTIS; REACTION-MECHANISM; ACTIVATING ENZYME; PROTEIN R1	Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to deoxyribonucleotides, the building blocks for DNA synthesis, and are found in all but a few organisms. RNRs use radical chemistry to catalyze the reduction reaction. Despite RNR having evolved several mechanisms for generation of different kinds of essential radicals across a large evolutionary time frame, this initial radical is normally always channelled to a strictly conserved cysteine residue directly adjacent to the substrate for initiation of substrate reduction, and this cysteine has been found in the structures of all RNRs solved to date. We present the crystal structure of an anaerobic RNR from the extreme thermophile Thermotoga maritima (tmNrdD), alone and in several complexes, including with the allosteric effector dATP and its cognate substrate CTP. In the crystal structure of the enzyme as purified, tmNrdD lacks a cysteine for radical transfer to the substrate pre-positioned in the active site. Nevertheless activity assays using anaerobic cell extracts from T. maritima demonstrate that the class III RNR is enzymatically active. Other genetic and microbiological evidence is summarized indicating that the enzyme is important for T. maritima. Mutation of either of two cysteine residues in a disordered loop far from the active site results in inactive enzyme. We discuss the possible mechanisms for radical initiation of substrate reduction given the collected evidence from the crystal structure, our activity assays and other published work. Taken together, the results suggest either that initiation of substrate reduction may involve unprecedented conformational changes in the enzyme to bring one of these cysteine residues to the expected position, or that alternative routes for initiation of the RNR reduction reaction may exist. Finally, we present a phylogenetic analysis showing that the structure of tmNrdD is representative of a new RNR subclass IIIh, present in all Thermotoga species plus a wider group of bacteria from the distantly related phyla Firmicutes, Bacteroidetes and Proteobacteria.	[Aurelius, Oskar; Johansson, Renzo; Bagenholm, Viktoria; Balhuizen, Alexander; Logan, Derek T.] Lund Univ, Dept Biochem & Struct Biol, S-22100 Lund, Sweden; [Lundin, Daniel; Sahlin, Margareta; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Tholander, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden; [Beck, Tobias] Univ Gottingen, Dept Inorgan Chem, D-37073 Gottingen, Germany; [Mulliez, Etienne] CEA Grenoble, Inst Rech Technol & Sci Vivant iRTSV, Grp Biocatalyse, LCBM, F-38054 Grenoble 09, France	Lund University; Stockholm University; Karolinska Institutet; University of Gottingen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Aurelius, O (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Box 124, S-22100 Lund, Sweden.	derek.logan@biochemistry.lu.se	Beck, Tobias/K-3738-2014; Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019	Beck, Tobias/0000-0001-7398-3982; Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Balhuizen, Alexander/0000-0001-7581-121X; Lundin, Daniel/0000-0002-8779-6464; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Research Council [2011-5770, 2013-2978]; Carl Trygger Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation	The work was funded by grants from the Swedish Research Council (www.vr.se) to DTL (2011-5770) and BMS (2013-2978), as well the Carl Trygger Foundation (www.carltryggersstiftelse.se) to BMS.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Ahmad MF, 2012, J MOL BIOL, V419, P315, DOI 10.1016/j.jmb.2012.03.014; Andersson J, 2001, J BIOL CHEM, V276, P40457, DOI 10.1074/jbc.M106863200; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Himo F, 2000, CHEM PHYS LETT, V328, P270, DOI 10.1016/S0009-2614(00)00932-5; Hioe J, 2011, CHEM-EUR J, V17, P3781, DOI 10.1002/chem.201002620; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; Johnson MR, 2006, APPL ENVIRON MICROB, V72, P811, DOI 10.1128/AEM.72.1.811-818.2006; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larsson KM, 2010, ACS CHEM BIOL, V5, P933, DOI 10.1021/cb1000845; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; Latif H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003485; Logan DT, 2003, P NATL ACAD SCI USA, V100, P3826, DOI 10.1073/pnas.0736456100; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Logan DT, 2008, RIBONUCLEOTIDE REDUC, P185; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Martins BM, 2011, J AM CHEM SOC, V133, P14666, DOI 10.1021/ja203344x; Montero CI, 2007, APPL ENVIRON MICROB, V73, P5058, DOI 10.1128/AEM.00453-07; MULLIEZ E, 1995, P NATL ACAD SCI USA, V92, P8759, DOI 10.1073/pnas.92.19.8759; MULLIEZ E, 1993, J BIOL CHEM, V268, P2296; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; PETERSSON L, 1980, J BIOL CHEM, V255, P6706; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; STUBBE J, 1983, J BIOL CHEM, V258, P1625; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; SUN XY, 1995, J BIOL CHEM, V270, P2443, DOI 10.1074/jbc.270.6.2443; TAMAO Y, 1973, BIOCHEMISTRY-US, V12, P24, DOI 10.1021/bi00725a005; THELANDER L, 1974, J BIOL CHEM, V249, P4858; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; Torrents E, 2001, J BIOL CHEM, V276, P33488, DOI 10.1074/jbc.M103743200; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Uppsten M, 2003, J MOL BIOL, V330, P87, DOI 10.1016/S0022-2836(03)00538-2; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Wei YF, 2014, P NATL ACAD SCI USA, V111, pE3756, DOI 10.1073/pnas.1414396111; Wei YF, 2014, J AM CHEM SOC, V136, P9001, DOI 10.1021/ja5030194; Xu H, 2006, P NATL ACAD SCI USA, V103, P4022, DOI 10.1073/pnas.0600443103; Young P, 1996, J BIOL CHEM, V271, P20770, DOI 10.1074/jbc.271.34.20770	55	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128199	10.1371/journal.pone.0128199	http://dx.doi.org/10.1371/journal.pone.0128199			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147435	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600011
J	Ban, L; Fleming, KM; Doyle, P; Smeeth, L; Hubbard, RB; Fiaschi, L; Tata, LJ				Ban, Lu; Fleming, Kate M.; Doyle, Pat; Smeeth, Liam; Hubbard, Richard B.; Fiaschi, Linda; Tata, Laila J.			Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; IN-UTERO EXPOSURE; FETAL MALFORMATIONS; PREGNANCY OUTCOMES; UK-EPILEPSY; WOMEN; RISK; ANTAGONISTS; VALPROATE; INFANTS	Background Antenatal antiepileptic drug (AED) use has been found to be associated with increased major congenital anomaly (CA) risks. However whether such AED-associated risks were different according to periconceptional high dose (5mg daily) folic acid supplementation is still unclear. Methods We included 258,591 singleton live-born children ofmothers aged 15-44 years in 1990-2013 from The Health Improvement Network, a large UK primary care database. We identified all major CAs according to the European Surveillance of Congenital Anomalies classification. Absolute risks and adjusted odds ratios (aOR) were calculated comparing children of mothers prescribed AEDs to those without such prescriptions, stratified by folic acid prescriptions around the time of conception (one month before conception to two months post-conception). Results CA risk was 476/10,000 in children of mothers with first trimester AEDs compared with 269/10,000 in those without AEDs equating to an aOR of 1.82, 95% confidence interval 1.30-2.56. The highest system-specific risks were for heart anomalies (198/10,000 and 79/10,000 respectively, aOR 2.49,1.47-4.21). Sodium valproate and lamotrigine were both associated with increased risks of any CA (aOR 2.63,1.46-4.74 and aOR 2.01,1.12-3.59 respectively) and system-specific risks. Stratification by folic acid supplementation did not show marked reductions in AED-associated risks (e.g. for CAs overall aOR 1.75, 1.01-3.03 in the high dose folic acid group and 1.94, 95% CI 1.21-3.13 in the low dose or no folic acid group); however, the majority of mothers taking AEDs only initiated high dose folic acid from the second month of pregnancy. Conclusions Children of mothers with AEDs in the first trimester of pregnancy have a 2-fold increased risk of major CA compared to those unexposed. We found no evidence that prescribed high dose folic acid supplementation reduced such AED-associated risks. Although statistical power was limited, prescribing of folic acid too late for it to be effective during the organogenic period or selective prescribing to those with more severe morbidity may explain these findings.	[Ban, Lu; Fleming, Kate M.; Hubbard, Richard B.; Fiaschi, Linda; Tata, Laila J.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Doyle, Pat; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England	University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Tata, LJ (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	laila.tata@nottingham.ac.uk	Fiaschi, Linda/AAB-4905-2022; Fleming, Kate M/A-6475-2010; Smeeth, Liam/X-5862-2018; Tata, Laila/J-5227-2012	Fiaschi, Linda/0000-0002-3780-5895; Fleming, Kate M/0000-0002-6572-5016; Smeeth, Liam/0000-0002-9168-6022; Ban, Lu/0000-0001-9388-9141; Tata, Laila/0000-0002-6404-8658	Wellcome Trust [86101/Z/08/Z]; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a grant from Wellcome Trust, http://www.wellcome.ac.uk/ (PI: LJT; grant number: 86101/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, INVESTIGATING USE ME; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Ban L, 2015, BJOG-INT J OBSTET GY, V122, P1833, DOI 10.1111/1471-0528.13102; BINOCAR, 2012, CONG AN STAT 2010 EN; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cassina M, 2013, REPROD TOXICOL, V39, P50, DOI 10.1016/j.reprotox.2013.04.002; Chen YH, 2009, ARCH NEUROL-CHICAGO, V66, P979, DOI 10.1001/archneurol.2009.142; Confidential Enquiry into Maternal and Child Health ( CEMACH), 2009, PER MORT 2007 UK; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Department of Health, 2011, AB STAT ENGL WAL 201; Diav-Citrin O, 2008, CNS DRUGS, V22, P325, DOI 10.2165/00023210-200822040-00004; EUR-Lex, 2012, CHART FUND RIGHTS EU; European Surveillance of Congenital Anomalies, 2015, EUROCAT PREV TABL; Grosse SD, 2007, BIRTH DEFECTS RES A, V79, P737, DOI 10.1002/bdra.20394; Harden CL, 2009, NEUROLOGY, V73, P133, DOI 10.1212/WNL.0b013e3181a6b312; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hernandez-Diaz S, 2001, AM J EPIDEMIOL, V153, P961, DOI 10.1093/aje/153.10.961; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581; Jentink J, 2010, PHARMACOEPIDEM DR S, V19, P803, DOI 10.1002/pds.1975; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Joint Formulary Committee, 2012, BRITISH NATIONAL FOR; Kaaja E, 2003, NEUROLOGY, V60, P575, DOI 10.1212/01.WNL.0000044157.28073.DC; Kulaga S, 2011, SEIZURE-EUR J EPILEP, V20, P667, DOI 10.1016/j.seizure.2011.06.012; LEPPIK IE, 1990, POSTGRAD MED, V88, P253, DOI 10.1080/00325481.1990.11716375; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Linnebank M, 2011, ANN NEUROL, V69, P352, DOI 10.1002/ana.22229; Man SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052339; Mawhinney E, 2012, SEIZURE-EUR J EPILEP, V21, P215, DOI 10.1016/j.seizure.2012.01.005; Mawhinney E, 2013, NEUROLOGY, V80, P400, DOI 10.1212/WNL.0b013e31827f0874; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Molgaard-Nielsen D, 2011, JAMA-J AM MED ASSOC, V305, P1996, DOI 10.1001/jama.2011.624; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; NICE, 2011, CG62 ANT CAR NICE GU; NICE, CG137 EP FULL GUID; Prajapati B, OPTOMETRY TODAY 0716; QueisserLuft A, 1996, AM J MED GENET, V63, P268, DOI 10.1002/(SICI)1096-8628(19960503)63:1<268::AID-AJMG45>3.0.CO;2-J; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Sokal R, 2013, BIRTH DEFECTS RES A, V97, P546, DOI 10.1002/bdra.23150; Thomas SV, 2008, PEDIATR CARDIOL, V29, P604, DOI 10.1007/s00246-007-9161-4; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; World Health Organization(WHO), BMI CLASS	48	28	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131130	10.1371/journal.pone.0131130	http://dx.doi.org/10.1371/journal.pone.0131130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147467	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358157600065
J	Kuijper, SJM; Hartman, CA; Hendriks, P				Kuijper, Sanne J. M.; Hartman, Catharina A.; Hendriks, Petra			Who Is He? Children with ASD and ADHD Take the Listener into Account in Their Production of Ambiguous Pronouns	PLOS ONE			English	Article							ATTENTION-DEFICIT HYPERACTIVITY; SPECTRUM DISORDERS; AUTISM; LANGUAGE; ADULTS; INFORMATION; ABILITIES; CHOICE; MODEL	During conversation, speakers constantly make choices about how specific they wish to be in their use of referring expressions. In the present study we investigate whether speakers take the listener into account or whether they base their referential choices solely on their own representation of the discourse. We do this by examining the cognitive mechanisms that underlie the choice of referring expression at different discourse moments. Furthermore, we provide insights into how children with Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) use referring expressions and whether their use differs from that of typically developing (TD) children. Children between 6 and 12 years old (ASD: n=46; ADHD: n=37; TD: n=38) were tested on their production of referring expressions and on Theory of Mind, response inhibition and working memory. We found support for the view that speakers take the listener into account when choosing a referring expression: Theory of Mind was related to referential choice only at those moments when speakers could not solely base their choice on their own discourse representation to be understood. Working memory appeared to be involved in keeping track of the different referents in the discourse. Furthermore, we found that TD children as well as children with ASD and children with ADHD took the listener into account in their choice of referring expression. In addition, children with ADHD were less specific than TD children in contexts with more than one referent. The previously observed problems with referential choice in children with ASD may lie in difficulties in keeping track of longer and more complex discourses, rather than in problems with taking into account the listener.	[Kuijper, Sanne J. M.; Hendriks, Petra] Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol Emot Regulat I, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Kuijper, SJM (corresponding author), Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands.	s.j.m.kuijper@rug.nl		Hendriks, Petra/0000-0002-7584-4078	Netherlands Organisation for Scientific Research (NWO) [277-70-005]; NWO	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	This investigation was supported by a grant from the Netherlands Organisation for Scientific Research (NWO grant no. 277-70-005, URL: http://www.nwo.nl/). SK and PH both received funding from NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ARIEL M, 1988, J LINGUIST, V24, P65, DOI 10.1017/S0022226700011567; Arnold J. E., 1998, THESIS; Arnold JE, 2004, J MEM LANG, V51, P55, DOI 10.1016/j.jml.2004.03.006; Arnold JE, 2000, COGNITION, V76, pB13, DOI 10.1016/S0010-0277(00)00073-1; Arnold JE, 2009, COGNITION, V110, P131, DOI [10.1016/j.cognition.2008.10.016, DOI 10.1016/J.C0GNITION.2008.10.016]; Arnold JE, 2007, J MEM LANG, V56, P521, DOI 10.1016/j.jml.2006.09.007; Baltaxe CAM, 1996, EUR J DISORDER COMM, V31, P245; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Baron-Cohen S., 1993, UNDERSTANDING OTHER; Brennan S. E., 1987, 25th Annual Meeting of the Association for Computational Linguistics. Proceedings of the Conference, P155; Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947; Charman T., 2001, EMOT BEHAV DIFFICULT, V6, P31, DOI [10.1080/13632750100507654, DOI 10.1080/13632750100507654]; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; Dunn L.M., 1981, PEABODY PICTURE VOCA; Dyck MJ, 2001, EUR CHILD ADOLES PSY, V10, P105, DOI 10.1007/s007870170033; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P1437, DOI 10.1111/j.1469-7610.2004.00326.x; Givon Talmy, 1983, TOPIC CONTINUITY DIS, P1, DOI [10.1075/tsl.3, DOI 10.1075/TSL.3.01GIV]; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; GROSZ BJ, 1995, COMPUT LINGUIST, V21, P203; Gundel J. K., 2007, ZAS PAPERS LINGUISTI, V48, P1; GUNDEL JK, 1993, LANGUAGE, V69, P274, DOI 10.2307/416535; Heck RH, 2012, QUANT METH SER; Hendriks P., 2008, J LOGIC LANG INFORM, V17, P443, DOI [DOI 10.1007/S10849-008-9065-6, DOI 10.1080/13825585.2011.607228]; Hendriks P, 2011, PICTURE STORYBOOKS A; Hendriks P, 2014, LANG COGN NEUROSCI, V29, P391, DOI 10.1080/01690965.2013.766356; Hill EL, 2004, DEV REV, V24, P189, DOI 10.1016/j.dr.2004.01.001; Hollebrandse B, 2014, SYNTHESE, V191, P321, DOI 10.1007/s11229-012-0169-9; Ickowicz A, 2006, CAN J PSYCHIAT, V51, P325, DOI 10.1177/070674370605100508; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kaiser Elsi, 2011, PROCESSING ACQUISITI, P323; Karmiloff-Smith Annette, 1985, LANG COGNITIVE PROC, V1, P61, DOI DOI 10.1080/01690968508402071; Kort W., 2002, WISC 3 NL; Kuijper SJ, 2014, PRONOUN PROCES UNPUB; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lord C., 1999, ADOS AUTISM DIAGNOST; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Novogrodsky R, 2013, CLIN LINGUIST PHONET, V27, P85, DOI 10.3109/02699206.2012.742567; Nyden A, 2001, DEV MED CHILD NEUROL, V43, P165, DOI 10.1017/S0012162201000329; Purvis KL, 1997, J ABNORM CHILD PSYCH, V25, P133, DOI 10.1023/A:1025731529006; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Rutter M., 2003, AUTISM DIAGNOSTIC IN, DOI DOI 10.1002/aur.1329; TAGERFLUSBERG H, 1995, BRIT J DEV PSYCHOL, V13, P45, DOI 10.1111/j.2044-835X.1995.tb00663.x; TANNOCK R, 1993, J ABNORM CHILD PSYCH, V21, P103, DOI 10.1007/BF00910492; Tannock R, 2002, COMMUNICATION, P1; van den Wildenberg WPM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00145; van Rij J, 2013, TOP COGN SCI, V5, P564, DOI 10.1111/tops.12029; van Rij J, 2010, J CHILD LANG, V37, P731, DOI 10.1017/S0305000909990560; Vogels J, 2014, THESIS TILBURG U TIL; Wigglesworth G, 1997, J CHILD LANG, V24, P279, DOI 10.1017/S0305000997003048; Wubs Ellen., 2009, P 3 C GENERATIVE APP, P313; ZENTALL SS, 1988, J ABNORM CHILD PSYCH, V16, P657, DOI 10.1007/BF00913476	54	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132408	10.1371/journal.pone.0132408	http://dx.doi.org/10.1371/journal.pone.0132408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26147200	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600260
J	Lecocq, A; Kryger, P; Vejsnaes, F; Jensen, AB				Lecocq, Antoine; Kryger, Per; Vejsnaes, Flemming; Jensen, Annette Bruun			Weight Watching and the Effect of Landscape on Honeybee Colony Productivity: Investigating the Value of Colony Weight Monitoring for the Beekeeping Industry	PLOS ONE			English	Article							POLLINATION SERVICES; BEES; ABUNDANCE; MAIZE; CITY	Over the last few decades, a gradual departure away from traditional agricultural practices has resulted in alterations to the composition of the countryside and landscapes across Europe. In the face of such changes, monitoring the development and productivity of honey bee colonies from different sites can give valuable insight on the influence of landscape on their productivity and might point towards future directions for modernized beekeeping practices. Using data on honeybee colony weights provided by electronic scales spread across Denmark, we investigated the effect of the immediate landscape on colony productivity. In order to extract meaningful information, data manipulation was necessary prior to analysis as a result of different management regimes or scales malfunction. Once this was carried out, we were able to show that colonies situated in landscapes composed of more than 50% urban areas were significantly more productive than colonies situated in those with more than 50% agricultural areas or those in mixed areas. As well as exploring some of the potential reasons for the observed differences, we discuss the value of weight monitoring of colonies on a large scale.	[Lecocq, Antoine; Jensen, Annette Bruun] Univ Copenhagen, Dept Plants & Environm Sci PLEN, DK-1871 Frederiksberg C, Denmark; [Kryger, Per] Aarhus Univ, Dept Agroecol Entomol & Plant Pathol, DK-4200 Slagelse, Denmark; [Vejsnaes, Flemming] Danish Beekeepers Assoc, DK-4180 Soro, Denmark	University of Copenhagen; Aarhus University	Lecocq, A (corresponding author), Univ Copenhagen, Dept Plants & Environm Sci PLEN, DK-1871 Frederiksberg C, Denmark.	antoine@plen.ku.dk	Jensen, Annette Bruun/AAH-1732-2021; Jensen, Annette B/G-7558-2014; Kryger, Per/C-1773-2013; Kryger, Per/H-4600-2019	Jensen, Annette Bruun/0000-0002-2044-2274; Jensen, Annette B/0000-0002-2044-2274; Kryger, Per/0000-0001-5306-3230; Kryger, Per/0000-0001-5306-3230; Lecocq, Antoine/0000-0002-8013-0221				Ahrne K., 2008, THESIS SWEDISH U AGR; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; BURRILL RM, 1981, APIDOLOGIE, V12, P319, DOI 10.1051/apido:19810402; Couvillon MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093495; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Di Pasquale G., 2013, PLOS ONE, V8, DOI DOI 10.1371/journal.pone.0072016; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Geslin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063421; Hein Lars, 2009, Open Ecology Journal, V2, P74, DOI 10.2174/1874213000902010074; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Hocherl N, 2012, J INSECT PHYSIOL, V58, P278, DOI 10.1016/j.jinsphys.2011.12.001; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Kluser S, 2010, GLOBAL HONEY BEE COL; Kryger P., 2011, 150 DJF AARH U, P65; Le Feon V, 2010, AGR ECOSYST ENVIRON, V137, P143, DOI 10.1016/j.agee.2010.01.015; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; MCLELLAN AR, 1977, J APPL ECOL, V14, P401, DOI 10.2307/2402553; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Odgaard MV, 2011, AGR ECOSYST ENVIRON, V142, P291, DOI 10.1016/j.agee.2011.05.026; Odoux JF, 2014, J APICULT RES, V53, P57, DOI 10.3896/IBRA.1.53.1.05; Pardee GL, 2014, URBAN ECOSYST, V17, P641, DOI 10.1007/s11252-014-0349-0; PETERS KA, 2012, DRAKE J AGR L, V17, P597; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; Ritter W., 2006, 4 FAO AGR FOOD ENG; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Schneider A, 2003, PHOTOGRAMM ENG REM S, V69, P1377, DOI 10.14358/PERS.69.12.1377; Schofield H., 2010, BBC; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Tommasi D, 2004, CAN ENTOMOL, V136, P851; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Zheng HQ, 2014, J ECON ENTOMOL, V107, P2037, DOI 10.1603/EC13520	43	27	28	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132473	10.1371/journal.pone.0132473	http://dx.doi.org/10.1371/journal.pone.0132473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147392	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600280
J	Reis, GSM; de Almeida, AAF; de Almeida, NM; de Castro, AV; Mangabeira, PAO; Pirovani, CP				Monteiro Reis, Graciele Santos; Furtado de Almeida, Alex-Alan; de Almeida, Nicolle Moreira; de Castro, Andressa Vieira; Oliveira Mangabeira, Pedro Antonio; Pirovani, Carlos Priminho			Molecular, Biochemical and Ultrastructural Changes Induced by Pb Toxicity in Seedlings of Theobroma cacao L.	PLOS ONE			English	Article							LIPID-PEROXIDATION; MONILIOPHTHORA-PERNICIOSA; ANTIOXIDATIVE ENZYMES; PROTEIN EXTRACTION; LEAD TOLERANCE; EXCESS LEAD; PLANTS; STRESS; ACCUMULATION; LEAVES	Pb is a metal which is highly toxic to plants and animals, including humans. High concentrations of Pb have been observed in beans of T. cacao, as well as in its products. In this work, we evaluated the molecular, biochemical, and ultrastructural alterations in mature leaves and primary roots of seedlings of two progenies of T. cacao, obtained from seed germination in different concentrations of Pb (0, 0.05, 0.1, 0.2, 0.4, 0.8 g L-1), in the form of Pb(NO3)(2). The progenies resulted from self-fertilization of Catongo and a cross of CCN-10 x SCA-6. The Pb, supplied via seminal, caused alterations in the ultrastructures of the mesophyll cells and in the amount of starch grains in the chloroplasts. The dosage of substances reactive to thiobarbituric acid showed that Pb induced lipid peroxidation. The activity of guaiacol peroxidases and the expression of genes associated to synthetase of phytochelatin, SOD-cyt and PER increased in response to Pb. In addition, there was alteration in the expression of stress-related proteins. The progeny of CCN-10 x SCA-6 was more tolerant to Pb stress when compared to Catongo, since: (i) it accumulated more Pb in the roots, preventing its translocation to the shoot; (ii) it presented higher activity of peroxidases in the roots, which are enzymes involved in the elimination of excess of reactive oxygen species; and (iii) increased expression of the gene in the phytochelatin biosynthesis route. The results of the proteomic analysis were of paramount importance to differentiate the defense mechanisms used by both progenies of T. cacao.	[Monteiro Reis, Graciele Santos; Furtado de Almeida, Alex-Alan; de Almeida, Nicolle Moreira; de Castro, Andressa Vieira; Oliveira Mangabeira, Pedro Antonio; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Dept Biol Sci, BR-45662900 Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz	Reis, GSM (corresponding author), Univ Estadual Santa Cruz, Dept Biol Sci, Campus Soane Nazare Andrade,Rodovia Jorge Amado, BR-45662900 Ilheus, BA, Brazil.	alexalan@uesc.br	Mangabeira, Pedro A O/I-7742-2014; Pirovani, Carlos Priminho/N-1153-2019; Pirovani, Carlos P/J-3426-2017	Mangabeira, Pedro A O/0000-0001-6563-4539; Pirovani, Carlos Priminho/0000-0002-6176-4069; Pirovani, Carlos P/0000-0002-6176-4069	CAPES; Universidad e Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento CientIfico and Tecnologico (CNPq), Brazil	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidad e Estadual de Santa Cruz (UESC); Conselho Nacional de Desenvolvimento CientIfico and Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We gratefully acknowledge the financial support provided by CAPES and Universidad e Estadual de Santa Cruz (UESC). The second author gratefully acknowledges the Conselho Nacional de Desenvolvimento CientIfico and Tecnologico (CNPq), Brazil, for the concession of a scientific productivity fellowship. We thank Dr. Claudia Fortes Ferreira for their excellent review and constructive comments.	Anjum NA, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P1, DOI 10.1007/978-90-481-9404-9; Anjum NA, 2012, ENVIRON EXP BOT, V75, P307, DOI 10.1016/j.envexpbot.2011.07.002; Anunciacao DS, 2011, FOOD ANAL METHOD, V4, P286, DOI 10.1007/s12161-010-9172-2; Aravind Parameswaran, 2005, Braz. J. Plant Physiol., V17, P3, DOI 10.1590/S1677-04202005000100002; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Basile A, 2013, ENVIRON POLLUT, V182, P209, DOI 10.1016/j.envpol.2013.07.014; Benavides María P., 2005, Braz. J. Plant Physiol., V17, P21, DOI 10.1590/S1677-04202005000100003; Bertolde FZ, 2014, GENET MOL RES, V13, P5036, DOI 10.4238/2014.July.4.19; Bovenkamp GL, 2013, ENVIRON SCI TECHNOL, V47, P4375, DOI 10.1021/es302408m; Brandazza A, 2004, FEBS LETT, V572, P3, DOI 10.1016/j.febslet.2004.07.003; Brunet J, 2009, CHEMOSPHERE, V77, P1113, DOI 10.1016/j.chemosphere.2009.07.058; Camillo LR, 2013, PLANT PHYSIOL BIOCH, V73, P254, DOI 10.1016/j.plaphy.2013.10.009; Cenkci S, 2010, ENVIRON EXP BOT, V67, P467, DOI 10.1016/j.envexpbot.2009.10.001; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Cosio C, 2005, J EXP BOT, V56, P765, DOI 10.1093/jxb/eri062; DANTAS NA, 2005, PHYTOPATHOLOGY, V30, P380; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Gopal R, 2008, CHEMOSPHERE, V70, P1539, DOI 10.1016/j.chemosphere.2007.08.043; Gramacho I.C.P., 1992, CULTIVO BENEFICIAMEN; Gupta DK, 2013, ENVIRON SCI POLLUT R, V20, P2150, DOI 10.1007/s11356-013-1485-4; Gupta DK, 2010, J HAZARD MATER, V177, P437, DOI 10.1016/j.jhazmat.2009.12.052; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hu JZ, 2007, RUSS J PLANT PHYSL+, V54, P414, DOI 10.1134/S1021443707030181; International Cocoa Organization (ICCO), 2013, WORLD COC EC PRES; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Jung C, 2003, PLANT SOIL, V252, P301, DOI 10.1023/A:1024775803759; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kim YY, 2002, PHYSIOL PLANTARUM, V116, P368, DOI 10.1034/j.1399-3054.2002.1160312.x; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Lamhamdi M, 2011, CR BIOL, V334, P118, DOI 10.1016/j.crvi.2010.12.006; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malecka A, 2008, ACTA PHYSIOL PLANT, V30, P629, DOI 10.1007/s11738-008-0159-1; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; McLaughlin M.J., 1999, CADMIUM SOIL PLANTS; Medeiros AG, 1965, COMBATE PODRIDAO PAR; Menu-Bouaouiche L, 2003, BIOCHIMIE, V85, P123, DOI 10.1016/S0300-9084(03)00058-0; Monteiro WR, 2012, GENETIC IMPROVEMENT; Moraes CL, 2011, THESIS U FEDERAL PEL; Nautiyal N, 2012, ACTA PHYSIOL PLANT, V34, P977, DOI 10.1007/s11738-011-0894-6; Paivoke AEA, 2002, ENVIRON EXP BOT, V48, P61, DOI 10.1016/S0098-8472(02)00011-4; Piechalak A, 2008, BIOL PLANTARUM, V52, P565, DOI 10.1007/s10535-008-0112-6; Piechalak A, 2002, PHYTOCHEMISTRY, V60, P153, DOI 10.1016/S0031-9422(02)00067-5; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; Pourrut B., 2013, HEAVY METAL STRESS P, P121, DOI DOI 10.1007/978-3-642-38469-1_7; Qureshi MI, 2005, ENVIRON EXP BOT, V53, P185, DOI 10.1016/j.envexpbot.2004.03.014; Rankin CW, 2005, ENVIRON HEALTH PERSP, V113, P1344, DOI 10.1289/ehp.8009; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Reddy AM, 2005, CHEMOSPHERE, V60, P97, DOI 10.1016/j.chemosphere.2004.11.092; Rehem BC, 2011, PHOTOSYNTHETICA, V49, P127, DOI 10.1007/s11099-011-0021-3; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Romanowska E, 2008, BIOL PLANTARUM, V52, P80, DOI 10.1007/s10535-008-0012-9; Rossato VL, 2010, PLUCHEASAGITTALIS HA; Rucinska-Sobkowiak R, 2013, ENVIRON EXP BOT, V87, P100, DOI 10.1016/j.envexpbot.2012.09.012; Semane B, 2007, PHYSIOL PLANTARUM, V129, P519, DOI 10.1111/j.1399-3054.2006.00822.x; Shahid M, 2012, J HAZARD MATER, V219, P1, DOI 10.1016/j.jhazmat.2012.01.060; Silva FAC, 2013, GENET MOL RES, V12, P4855, DOI 10.4238/2013.October.22.5; Silva LF, 1969, P 2 INT COC RES C, P412; Singh RP, 1997, CHEMOSPHERE, V34, P2467, DOI 10.1016/S0045-6535(97)00087-8; Sinha P, 2006, CHEMOSPHERE, V65, P651, DOI 10.1016/j.chemosphere.2006.01.068; Tian SK, 2011, ENVIRON POLLUT, V159, P782, DOI 10.1016/j.envpol.2010.11.020; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Walliwalagedara C, 2010, PHYTOCHEMISTRY, V71, P1460, DOI 10.1016/j.phytochem.2010.05.018; Wang C, 2011, ECOTOX ENVIRON SAFE, V74, P1297, DOI 10.1016/j.ecoenv.2011.03.005; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Wierzbicka M, 1999, ENVIRON POLLUT, V104, P41, DOI 10.1016/S0269-7491(98)00156-0; Xiong ZT, 1997, ENVIRON POLLUT, V97, P275, DOI 10.1016/S0269-7491(97)00086-9; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Yan ZZ, 2010, AQUAT BOT, V92, P112, DOI 10.1016/j.aquabot.2009.10.014; Yang YL, 2010, ECOTOX ENVIRON SAFE, V73, P1982, DOI 10.1016/j.ecoenv.2010.08.041; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zaier H, 2010, ANAL CHIM ACTA, V671, P48, DOI 10.1016/j.aca.2010.04.054; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhao FJ, 2000, PLANT CELL ENVIRON, V23, P507, DOI 10.1046/j.1365-3040.2000.00569.x; Zou TJ, 2011, J HAZARD MATER, V186, P683, DOI 10.1016/j.jhazmat.2010.11.053	82	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129696	10.1371/journal.pone.0129696	http://dx.doi.org/10.1371/journal.pone.0129696			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26146994	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600024
J	Pappano, WN; Guo, J; He, YP; Ferguson, D; Jagadeeswaran, S; Osterling, DJ; Gao, WQ; Spence, JK; Pliushchev, M; Sweis, RF; Buchanan, FG; Michaelides, MR; Shoemaker, AR; Tse, C; Chiang, GG				Pappano, William N.; Guo, Jun; He, Yupeng; Ferguson, Debra; Jagadeeswaran, Sujatha; Osterling, Donald J.; Gao, Wenqing; Spence, Julie K.; Pliushchev, Marina; Sweis, Ramzi F.; Buchanan, Fritz G.; Michaelides, Michael R.; Shoemaker, Alexander R.; Tse, Chris; Chiang, Gary G.			The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia	PLOS ONE			English	Article							DNA METHYLATION; DRUG DISCOVERY; CHEMICAL PROBE; G9A; CELLS; GLP; TRANSFORMATION; REVERSAL	Histone methyltransferases are epigenetic regulators that modify key lysine and arginine residues on histones and are believed to play an important role in cancer development and maintenance. These epigenetic modifications are potentially reversible and as a result this class of enzymes has drawn great interest as potential therapeutic targets of small molecule inhibitors. Previous studies have suggested that the histone lysine methyltransferase G9a (EHMT2) is required to perpetuate malignant phenotypes through multiple mechanisms in a variety of cancer types. To further elucidate the enzymatic role of G9a in cancer, we describe herein the biological activities of a novel peptide-competitive histone methyltransferase inhibitor, A-366, that selectively inhibits G9a and the closely related GLP (EHMT1), but not other histone methyltransferases. A-366 has significantly less cytotoxic effects on the growth of tumor cell lines compared to other known G9a/GLP small molecule inhibitors despite equivalent cellular activity on methylation of H3K9me2. Additionally, the selectivity profile of A-366 has aided in the discovery of a potentially important role for G9a/GLP in maintenance of leukemia. Treatment of various leukemia cell lines in vitro resulted in marked differentiation and morphological changes of these tumor cell lines. Furthermore, treatment of a flank xenograft leukemia model with A-366 resulted in growth inhibition in vivo consistent with the profile of H3K9me2 reduction observed. In summary, A-366 is a novel and highly selective inhibitor of G9a/GLP that has enabled the discovery of a role for G9a/GLP enzymatic activity in the growth and differentiation status of leukemia cells.	[Pappano, William N.; Guo, Jun; He, Yupeng; Ferguson, Debra; Jagadeeswaran, Sujatha; Osterling, Donald J.; Gao, Wenqing; Spence, Julie K.; Pliushchev, Marina; Sweis, Ramzi F.; Buchanan, Fritz G.; Michaelides, Michael R.; Shoemaker, Alexander R.; Tse, Chris; Chiang, Gary G.] AbbVie Inc, Discovery Res, N Chicago, IL 60064 USA	AbbVie	Chiang, GG (corresponding author), AbbVie Inc, Discovery Res, 1 North Waukegan Rd, N Chicago, IL 60064 USA.	gary.chiang@abbvie.com		Chiang, Gary/0000-0003-3004-7400; Pappano, William/0000-0003-2848-2219	AbbVie	AbbVie(AbbVie)	All authors are employees of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Degos L, 2001, ONCOGENE, V20, P7140, DOI 10.1038/sj.onc.1204763; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Liu F, 2013, J MED CHEM, V56, P8931, DOI 10.1021/jm401480r; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Pappano WN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-314; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Sweis RF, 2014, ACS MED CHEM LETT, V5, P205, DOI 10.1021/ml400496h; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15	31	55	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131716	10.1371/journal.pone.0131716	http://dx.doi.org/10.1371/journal.pone.0131716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147105	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600133
J	Wu, CC; Huang, KF; Yang, TY; Li, YL; Wen, CL; Hsu, SL; Chen, TH				Wu, Chun-Chi; Huang, Keh-Feng; Yang, Tsung-Ying; Li, Ya-Ling; Wen, Chi-Luan; Hsu, Shih-Lan; Chen, Tzu-Hsiu			The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							CYCLE ARREST; COLORECTAL-CANCER; INDUCED APOPTOSIS; DNA-DAMAGE; CARCINOMA; CHEMOTHERAPY; IRINOTECAN; CISPLATIN; PATHWAYS; PROTEIN	Koelreuteria henryi Dummer, an endemic plant of Taiwan, has been used as a folk medicine for the treatment of hepatitis, enteritis, cough, pharyngitis, allergy, hypertension, hyperlipidemia, and cancer. Austrobailignan-1, a natural lignan derivative isolated from Koelreuteria henryi Dummer, has anti-oxidative and anti-cancer properties. However, the effects of austrobailignan-1 on human cancer cells have not been studied yet. Here, we showed that austrobailignan-1 inhibited cell growth of human non-small cell lung cancer A549 and H1299 cell lines in both dose- and time-dependent manners, the IC50 value (48 h) of austrobailignan-1 were 41 and 22 nM, respectively. Data from flow cytometric analysis indicated that treatment with austrobailignan-1 for 24 h retarded the cell cycle at the G2/M phase. The molecular event of austrobailignan-1-mediated G2/M phase arrest was associated with the increase of p21(Waf1/Cip1) and p27(Kip1) expression, and decrease of Cdc25C expression. Moreover, treatment with 100 nM austrobailignan-1 for 48 h resulted in a pronounced release of cytochrome c followed by the activation of caspase-2, -3, and -9, and consequently induced apoptosis. These events were accompanied by the increase of PUMA and Bax, and the decrease of Mcl-1 and Bcl-2. Furthermore, our study also showed that austrobailignan-1 was a topoisomerase 1 inhibitor, as evidenced by a relaxation assay and induction of a DNA damage response signaling pathway, including ATM, and Chk1, Chk2,YH2AX phosphorylated activation. Overall, our results suggest that austrobailignan-1 is a novel DNA damaging agent and displays a topoisomerase I inhibitory activity, causes DNA strand breaks, and consequently induces DNA damage response signaling for cell cycle G2/M arrest and apoptosis in a p53 independent manner.	[Wu, Chun-Chi] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wu, Chun-Chi] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Huang, Keh-Feng] Providence Univ, Dept Appl Chem, Taichung 43309, Taiwan; [Yang, Tsung-Ying] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Yang, Tsung-Ying] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Li, Ya-Ling; Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Wen, Chi-Luan] Taiwan Seed Improvement & Propagat Stn, Council Agr, Propagat Technol Sect, Taichung, Taiwan; [Chen, Tzu-Hsiu] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Providence University - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chia Nan University of Pharmacy & Science	Chen, TH (corresponding author), Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan.	hsiu@mail.cnu.edu.tw			Taichung Veterans General Hospital [TCVGH1033209C, TCVGH-1027305D, TCVGH-1027319D]	Taichung Veterans General Hospital	This work was supported in part by grants from the Taichung Veterans General Hospital (TCVGH1033209C) to Tsung-Ying Yang, MD, PhD, as well as from the Taichung Veterans General Hospital (TCVGH-1027305D), and TCVGH-1027319D to Dr. Shih-Lan Hsu.	Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Barni S, 2013, REV RECENT CLIN TRIA, V8, P101, DOI 10.2174/15748871113089990042; Beretta GL, 2008, MINI-REV MED CHEM, V8, P856, DOI 10.2174/138955708785132774; Beretta GL, 2008, TARGETING TOPOISOMER; Bo S, 2014, FOOD CHEM TOXICOL, V68, P61, DOI 10.1016/j.fct.2014.03.007; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Cao Y, 2010, ANTICANCER RES, V30, P3911; Chen KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097888; Chen MC, 2012, CANCER SCI, V103, P80, DOI 10.1111/j.1349-7006.2011.02103.x; Cheng SB, 2012, J AGR FOOD CHEM, V60, P9620, DOI 10.1021/jf301882b; Chiang YY, 2013, INT J MOL MED, V32, P577, DOI 10.3892/ijmm.2013.1441; Chuang CY, 2010, J AGR FOOD CHEM, V58, P2943, DOI 10.1021/jf9043265; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P163, DOI 10.1016/0304-419X(89)90041-3; Department of Health T, 2005, VIT STAT VIT STAT; Du Z, 2012, TUMORI, V99, P57; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; El-Deiry WS, 1998, SEMINARS CANC BIOL; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FONSECA SF, 1980, PHYTOCHEMISTRY, V19, P1527, DOI 10.1016/S0031-9422(00)82115-9; Fu YR, 2006, MITOCHONDRION, V6, P211, DOI 10.1016/j.mito.2006.07.005; Fukuda M, 1996, CANCER RES, V56, P789; Grossi F, 2001, CRIT REV ONCOL HEMAT, V37, P61, DOI 10.1016/S1040-8428(00)00098-6; Haug K, 2008, ANTICANCER RES, V28, P583; He HY, 2011, MOLECULES, V16, P10685, DOI 10.3390/molecules161210685; Hsieh YC, 2010, CHEM RES TOXICOL, V23, P1256, DOI 10.1021/tx100116a; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kamal A, 2013, BIOORGAN MED CHEM, V21, P5198, DOI 10.1016/j.bmc.2013.06.033; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Khadka DB, 2011, BIOORGAN MED CHEM, V19, P724, DOI 10.1016/j.bmc.2010.10.057; Kocher S, 2013, RADIOTHER ONCOL, V108, P409, DOI 10.1016/j.radonc.2013.06.024; Korbakis D, 2009, TUMOR BIOL, V30, P100, DOI 10.1159/000218160; Kumler I, 2013, BREAST CANCER RES TR, V138, P347, DOI 10.1007/s10549-013-2476-3; Lai JM, 2009, EUR J PHARMACOL, V623, P1, DOI 10.1016/j.ejphar.2009.08.031; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Le Treut J, 2013, ANN ONCOL, V24, P1548, DOI 10.1093/annonc/mdt009; Lee JG, 2013, FOOD CHEM TOXICOL, V55, P214, DOI 10.1016/j.fct.2012.12.026; Lee TH, 2009, J NAT MED-TOKYO, V63, P209, DOI 10.1007/s11418-009-0314-z; Legarza K, 2006, ANTICANCER RES, V26, P3301; Letai A, 2009, J CELL BIOL, V185, P189, DOI 10.1083/jcb.200903134; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li G, 2004, BIOL PHARM BULL, V27, P1147, DOI 10.1248/bpb.27.1147; Lien JC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/453679; Lin CB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/326096; Lin CY, 2014, MOL MED REPORTS; MacKenzie SH, 2012, ADV EXP MED BIOL, V747, P55, DOI 10.1007/978-1-4614-3229-6_4; Mizutani H, 2002, J BIOL CHEM, V277, P30684, DOI 10.1074/jbc.M204353200; Mukherjee T, 2012, NAT PROD COMMUN, V7, P767; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Provinciali M, 2013, CURR PHARM DESIGN, V19, P1699; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rios J.L., 2002, STUDIES NATURAL PROD, V26, P183, DOI DOI 10.1016/S1572-5995(02)80008-4); Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; SONG YN, 1994, J NAT PROD, V57, P1670, DOI 10.1021/np50114a008; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Sun HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036808; Takeba Y, 2007, BIOL PHARM BULL, V30, P1400, DOI 10.1248/bpb.30.1400; Thomas A, 2014, ONCOGENE; Turner T, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140008; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang T, 2004, WORLD J GASTROENTERO, V10, P2205; Wesierska-Gadek J, 2011, CURR PHARM DESIGN, V17, P256; White Y, 2011, ANTICANCER RES, V31, P4251; Wu CC, 2011, BIOCHEM BIOPH RES CO, V405, P168, DOI 10.1016/j.bbrc.2011.01.001; Wu J, 2010, ACTA PHARMACOL SIN, V31, P93, DOI 10.1038/aps.2009.183; Wu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112220; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao Y, 2013, CANCER SCI, V104, P1062, DOI 10.1111/cas.12182	75	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132052	10.1371/journal.pone.0132052	http://dx.doi.org/10.1371/journal.pone.0132052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147394	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600190
J	Yang, XY; Zheng, KD; Lin, K; Zheng, GF; Zou, H; Wang, JM; Lin, YY; Chuka, CM; Ge, RS; Zhai, WT; Wang, JG				Yang, Xin Yu; Zheng, Kai Di; Lin, Ke; Zheng, Guifeng; Zou, Hai; Wang, Jian Min; Lin, Yao Yao; Chuka, Chifundo Martha; Ge, Ren Shan; Zhai, Weitao; Wang, Jian Guang			Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study	PLOS ONE			English	Article							SYNOVIAL-FLUID; HYPOXIA; ANGIOGENESIS; PATHOGENESIS; PROFILES	Objectives To explore the pathogenesis of rheumatoid arthritis (RA), the different metabolites were screened in synovial fluid by metabolomics. Methods Synovial fluid from 25 RA patients and 10 normal subjects were analyzed by GC/TOF MS analysis so as to give a broad overview of synovial fluid metabolites. The metabolic profiles of RA patients and normal subjects were compared using multivariate statistical analysis. Different proteins were verified by qPCR and western blot. Different metabolites were verified by colorimetric assay kit in 25 inactive RA patients, 25 active RA patients and 20 normal subjects. The influence of hypoxia-inducible factor (HIF)-1 alpha pathway on catabolism was detected by HIF-1 alpha knockdown. Results A subset of 58 metabolites was identified, in which the concentrations of 7 metabolites related to energy metabolism were significantly different as shown by importance in the projection (VIP) (VIP >= 1) and Student's t-test (p<0.05). In the 7 metabolites, the concentration of glucose was decreased, and the concentration of lactic acid was increased in the synovial fluid of RA patients than normal subjects verified by colorimetric assay Kit. Receiver operator characteristic (ROC) analysis shows that the concentration of glucose and lactic acid in synovial fluid could be used as dependable biomarkers for the diagnosis of active RA, provided an AUC of 0.906 and 0.922. Sensitivity and specificity, which were determined by cut-off points, reached 84% and 96% in sensitivity and 95% and 85% in specificity, respectively. The verification of different proteins identified in our previous proteomic study shows that the enzymes of anaerobic catabolism were up-regulated (PFKP and LDHA), and the enzymes of aerobic oxidation and fatty acid oxidation were down-regulated (CS, DLST, PGD, ACSL4, ACADVL and HADHA) in RA patients. The expression of HIF-1 alpha and the enzymes of aerobic oxidation and fatty acid oxidation were decreased and the enzymes of anaerobic catabolism were increased in FLS cells after HIF-1 alpha knockdown. Conclusion It was found that enhanced anaerobic catabolism and reduced aerobic oxidation regulated by HIF pathway are newly recognized factors contributing to the progression of RA, and low glucose and high lactic acid concentration in synovial fluid may be the potential biomarker of RA.	[Yang, Xin Yu] Wenzhou Med Univ, Sch Pharmaceut Sci, Dept Med Chem, Wenzhou, Peoples R China; [Zheng, Kai Di; Lin, Ke; Zheng, Guifeng; Zou, Hai; Lin, Yao Yao; Chuka, Chifundo Martha; Ge, Ren Shan; Wang, Jian Guang] Wenzhou Med Univ, Sch Basic Med Sci, Dept Biochem, Wenzhou, Peoples R China; [Wang, Jian Min] Jiamusi Cent Hosp, Dept Rheumatol, Jiamusi, Peoples R China; [Zhai, Weitao] Shanghai Guanghua Special Hosp Rheumatoid Arthrit, Dept Orthopaed Surg, Shanghai, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhai, WT (corresponding author), Shanghai Guanghua Special Hosp Rheumatoid Arthrit, Dept Orthopaed Surg, Shanghai, Peoples R China.	wtzhai@yahoo.com.cn; wz_wjg@163.com	wang, jian/GVS-0711-2022		Natural Science Foundations; Health Bureau funding of Zhejiang Province [R13H060001, LY12H28003, 2012KYB123, 2013KYB170]; National Natural Science Foundation of China [81201375, 81472055]; Zhejiang College Student Innovative Research Team [2015R413064]	Natural Science Foundations; Health Bureau funding of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang College Student Innovative Research Team	This project was supported by The Natural Science Foundations and the Health Bureau funding of Zhejiang Province (Grant No. R13H060001, LY12H28003 and 2012KYB123, 2013KYB170), the National Natural Science Foundation of China (Grant No. 81201375 and 81472055), Zhejiang College Student Innovative Research Team (Grant No. 2015R413064).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bodamyali T, 1998, ANN RHEUM DIS, V57, P703, DOI 10.1136/ard.57.12.703; Distler JHW, 2004, ARTHRITIS RHEUM-US, V50, P10, DOI 10.1002/art.11425; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Giatromanolaki A, 2003, ARTHRITIS RES THER, V5, pR193, DOI 10.1186/ar756; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gu Y, 2012, MOL BIOSYST, V8, P1535, DOI 10.1039/c2mb25022e; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HENDERSON B, 1979, ANN RHEUM DIS, V38, P63, DOI 10.1136/ard.38.1.63; Hitchon CA, 2009, RHEUMATOL INT, V29, P1205, DOI 10.1007/s00296-009-0865-z; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; KONDO S, 1974, J INVEST DERMATOL, V62, P503; Li X, 2010, METABOLOMICS, V6, P109, DOI 10.1007/s11306-009-0184-0; Mobasheri A, 2005, HISTOL HISTOPATHOL, V20, P1327, DOI 10.14670/HH-20.1327; MOSSMAN SS, 1981, NEW ZEAL MED J, V93, P115; NAUGHTON D, 1993, FEBS LETT, V317, P135, DOI 10.1016/0014-5793(93)81508-W; NAUGHTON DP, 1993, FEBS LETT, V332, P221, DOI 10.1016/0014-5793(93)80636-9; Okamoto H, 2008, FEBS J, V275, P4463, DOI 10.1111/j.1742-4658.2008.06582.x; Pan XY, 2011, J PROTEOME RES, V10, P3493, DOI 10.1021/pr200114v; Pap T, 2000, ARTHRITIS RHEUM, V43, P2531, DOI 10.1002/1529-0131(200011)43:11<2531::AID-ANR21>3.0.CO;2-V; Procaccini C, 2012, TRENDS IMMUNOL, V33, P1, DOI 10.1016/j.it.2011.09.002; Salaffi F, 2000, RHEUMATOLOGY, V39, P90, DOI 10.1093/rheumatology/39.1.90; SEWELL KL, 1993, LANCET, V341, P283, DOI 10.1016/0140-6736(93)92627-6; Spies CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3885; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stobbe MD, 2012, FASEB J, V26, P3625, DOI 10.1096/fj.11-203091; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Taylor PC, 2005, CURR OPIN RHEUMATOL, V17, P293, DOI 10.1097/01.bor.0000155361.83990.5b; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Wang JG, 2012, ARTHRITIS RHEUM-US, V64, P993, DOI 10.1002/art.33425; Wang ZG, 2012, EXP THER MED, V4, P165, DOI 10.3892/etm.2012.567; Wietmarschen H. van, 2012, British Journal of Medicine and Medical Research, V2, P469; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021	39	62	70	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132695	10.1371/journal.pone.0132695	http://dx.doi.org/10.1371/journal.pone.0132695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147000	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600312
J	Jumelle, C; Mauclair, C; Houzet, J; Bernard, A; He, ZG; Forest, F; Peoc'h, M; Acquart, S; Gain, P; Thuret, G				Jumelle, Clotilde; Mauclair, Cyril; Houzet, Julien; Bernard, Aurelien; He, Zhiguo; Forest, Fabien; Peoc'h, Michel; Acquart, Sophie; Gain, Philippe; Thuret, Gilles			Delivery of Molecules into Human Corneal Endothelial Cells by Carbon Nanoparticles Activated by Femtosecond Laser	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; EXPRESSION	Corneal endothelial cells (CECs) form a monolayer at the innermost face of the cornea and are the engine of corneal transparency. Nevertheless, they are a vulnerable population incapable of regeneration in humans, and their diseases are responsible for one third of corneal grafts performed worldwide. Donor corneas are stored in eye banks for security and quality controls, then delivered to surgeons. This period could allow specific interventions to modify the characteristics of CECs in order to increase their proliferative capacity, increase their resistance to apoptosis, or release immunosuppressive molecules. Delivery of molecules specifically into CECs during storage would therefore open up new therapeutic perspectives. For clinical applications, physical methods have a more favorable individual and general benefit/risk ratio than most biological vectors, but are often less efficient. The delivery of molecules into cells by carbon nanoparticles activated by femtosecond laser pulses is a promising recent technique developed on non-adherent cells. The nanoparticles are partly consummated by the reaction releasing CO and H-2 gas bubbles responsible for the shockwave at the origin of cell transient permeation. Our aim was to develop an experimental setting to deliver a small molecule (calcein) into the monolayer of adherent CECs. We confirmed that increased laser fluence and time exposure increased uptake efficiency while keeping cell mortality below 5%. We optimized the area covered by the laser beam by using a motorized stage allowing homogeneous scanning of the cell culture surface using a spiral path. Calcein uptake reached median efficiency of 54.5% (range 50.3-57.3) of CECs with low mortality (0.5%, range (0.55-1.0)). After sorting by flow cytometry, CECs having uptaken calcein remained viable and presented normal morphological characteristics. Delivery of molecules into CECs by carbon nanoparticles activated by femtosecond laser could prove useful for future cell or tissue therapy.	[Jumelle, Clotilde; Bernard, Aurelien; He, Zhiguo; Forest, Fabien; Peoc'h, Michel; Gain, Philippe; Thuret, Gilles] Fac Med, Corneal Graft Biol Engn & Imaging Lab, EA2521, SFR143, St Etienne, France; [Mauclair, Cyril; Houzet, Julien] Hubert Curien Lab, UMR CNRS 5516, Pole Opt Rhone Alpes, St Etienne, France; [Mauclair, Cyril] GIE Manutech Ultrafast Surfacing Design, St Etienne, France; [Forest, Fabien; Peoc'h, Michel] Univ Hosp, Dept Pathol, St Etienne, France; [Gain, Philippe; Thuret, Gilles] Univ Hosp, Dept Ophthalmol, St Etienne, France; [Acquart, Sophie] Etab Francais Sang Loire Auvergne, Eye Bank, St Etienne, France; [Thuret, Gilles] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet; CHU de St Etienne; CHU de St Etienne; Institut Universitaire de France	Thuret, G (corresponding author), Fac Med, Corneal Graft Biol Engn & Imaging Lab, EA2521, SFR143, St Etienne, France.	gilles.thuret@univ-st-etienne.fr	Forest, Fabien/O-7054-2019	Forest, Fabien/0000-0001-7582-3923; Peoc'h, michel/0000-0001-5453-0021	Federation des Aveugles de France; Jean Monnet University; Fondation de l'Avenir [ET7-468]; Equipex MANUTECH-USD of the Communaute d'universites et etablissements (Comue) de Lyon Saint-Etienne [ANR-10-EQPX-36-01]	Federation des Aveugles de France; Jean Monnet University; Fondation de l'Avenir; Equipex MANUTECH-USD of the Communaute d'universites et etablissements (Comue) de Lyon Saint-Etienne	This work was supported by grants from the Federation des Aveugles de France 2012, Jean Monnet University (appel a projet 2012), the Fondation de l'Avenir ET7-468, and by the Equipex MANUTECH-USD (ANR-10-EQPX-36-01) of the Communaute d'universites et etablissements (Comue) de Lyon Saint-Etienne, operated by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart J, 2012, BIOMATERIALS, V33, P2345, DOI 10.1016/j.biomaterials.2011.11.062; Campolmi N, 2014, CORNEA, V33, P597, DOI 10.1097/ICO.0000000000000124; Chakravarty P, 2010, NAT NANOTECHNOL, V5, P607, DOI [10.1038/nnano.2010.126, 10.1038/NNANO.2010.126]; Dannowski H, 2005, EXP EYE RES, V80, P93, DOI 10.1016/j.exer.2004.08.024; DOUKAS AG, 1993, ULTRASOUND MED BIOL, V19, P137, DOI 10.1016/0301-5629(93)90006-A; Fuchsluger TA, 2011, GENE THER, V18, P778, DOI 10.1038/gt.2011.20; Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011; Hao JS, 2009, EXP EYE RES, V89, P934, DOI 10.1016/j.exer.2009.08.001; He ZG, 2011, MOL VIS, V17, P3494; He ZG, 2010, OPHTHALMIC RES, V43, P43, DOI 10.1159/000246577; Hudde T, 1999, GENE THER, V6, P939, DOI 10.1038/sj.gt.3300886; Hudde T, 2000, CORNEA, V19, P369, DOI 10.1097/00003226-200005000-00022; Klebe S, 2000, CLIN EXP OPHTHALMOL, V28, P58, DOI 10.1046/j.1442-9071.2000.00255.x; Klebe S, 2001, TRANSPLANTATION, V71, P1214, DOI 10.1097/00007890-200105150-00006; McAlister JC, 2005, INVEST OPHTH VIS SCI, V46, P3597, DOI 10.1167/iovs.04-0551; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Oliva MS, 2012, INDIAN J OPHTHALMOL, V60, P423, DOI 10.4103/0301-4738.100540; Oral HB, 1997, GENE THER, V4, P639, DOI 10.1038/sj.gt.3300443; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pels L, 1997, BRIT J OPHTHALMOL, V81, P523, DOI 10.1136/bjo.81.7.523; Shin YJ, 2011, CURR EYE RES, V36, P1116, DOI 10.3109/02713683.2011.614372; Sonoda S, 2006, INVEST OPHTH VIS SCI, V47, P558, DOI 10.1167/iovs.05-0889; Tan PH, 2001, TRANSPLANTATION, V71, P552, DOI 10.1097/00007890-200102270-00011; Wang X, 2000, GENE THER, V7, P196, DOI 10.1038/sj.gt.3301075; WILSON SE, 1995, INVEST OPHTH VIS SCI, V36, P32; Zhao M, 2012, OPHTHALMIC RES, V48, P124, DOI 10.1159/000334981; Zhao M, 2008, INVEST OPHTH VIS SCI, V49, P550, DOI 10.1167/iovs.07-1037	27	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132023	10.1371/journal.pone.0132023	http://dx.doi.org/10.1371/journal.pone.0132023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134986	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400095
J	Kelly, KJ; Zhang, JZ; Han, L; Kamocka, M; Miller, C; Gattone, VH; Dominguez, JH				Kelly, K. J.; Zhang, Jizhong; Han, Ling; Kamocka, Malgorzata; Miller, Caroline; Gattone, Vincent H., II; Dominguez, Jesus H.			Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy	PLOS ONE			English	Article							REPERFUSION-INDUCED ACUTE; STEM-CELLS; PCK RAT; MESENCHYMAL TRANSITION; MEMBRANE-VESICLES; EPITHELIAL-CELLS; GROWTH-FACTOR; DISEASE; DOMINANT; MODEL	Autosomal recessive polycystic kidney disease is a truly catastrophic monogenetic disease, causing death and end stage renal disease in neonates and children. Using PCK female rats, an orthologous model of autosomal recessive polycystic kidney disease harboring mutant Pkhd1, we tested the hypothesis that intravenous renal cell transplantation with normal Sprague Dawley male kidney cells would improve the polycystic kidney disease phenotype. Cytotherapy with renal cells expressing wild type Pkhd1 and tubulogenic serum amyloid A1 had powerful and sustained beneficial effects on renal function and structure in the polycystic kidney disease model. Donor cell engraftment and both mutant and wild type Pkhd1 were found in treated but not control PCK kidneys 15 weeks after the final cell infusion. To examine the mechanisms of global protection with a small number of transplanted cells, we tested the hypothesis that exosomes derived from normal Sprague Dawley cells can limit the cystic phenotype of PCK recipient cells. We found that renal exosomes originating from normal Sprague Dawley cells carried and transferred wild type Pkhd1 mRNA to PCK cells in vivo and in vitro and restricted cyst formation by cultured PCK cells. The results indicate that transplantation with renal cells containing wild type Pkhd1 improves renal structure and function in autosomal recessive polycystic kidney disease and may provide an intra-renal supply of normal Pkhd1mRNA.	[Kelly, K. J.; Zhang, Jizhong; Han, Ling; Kamocka, Malgorzata; Dominguez, Jesus H.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Miller, Caroline; Gattone, Vincent H., II] Indiana Univ, Sch Med, Dept Anat, Indianapolis, IN USA; [Dominguez, Jesus H.] Vet Affairs Med Ctr, Dept Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kelly, KJ (corresponding author), Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA.	kajkelly@iu.edu			National Institutes of Health [DK082739]; Paul Teschan Research Fund of Dialysis Clinics, Inc.; US Department of Defense [PR110473]; US Department of Veterans' Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082739] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Teschan Research Fund of Dialysis Clinics, Inc.; US Department of Defense(United States Department of Defense); US Department of Veterans' Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Funding included National Institutes of Health DK082739 (KJK), Paul Teschan Research Fund of Dialysis Clinics, Inc. (KJK), US Department of Defense PR110473 (JHD) and US Department of Veterans' Affairs (JHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello-Reuss E, 2001, KIDNEY INT, V60, P37, DOI 10.1046/j.1523-1755.2001.00768.x; Blazer-Yost BL, 2010, PPAR RES, V2010, DOI [10.1155/2010/785369, 10.1155/2010/274376]; Canaud G, 2010, AM J TRANSPLANT, V10, P1701, DOI 10.1111/j.1600-6143.2010.03152.x; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chambers AE, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-64; Chea SW, 2009, YONSEI MED J, V50, P105, DOI 10.3349/ymj.2009.50.1.105; Chen L, 2014, HEPATOLOGY, V59, P1118, DOI 10.1002/hep.26768; Davis ID, 2001, SEMIN NEPHROL, V21, P430, DOI 10.1053/snep.2001.24937; Dell KMR, 1993, GENEREVIEWS; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Feng Z, 2010, NEPHROL DIAL TRANSPL, V25, P3874, DOI 10.1093/ndt/gfq603; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; GATTONE VH, 1995, AM J KIDNEY DIS, V25, P302, DOI 10.1016/0272-6386(95)90013-6; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gattone VH, 2009, KIDNEY INT, V76, P178, DOI 10.1038/ki.2009.147; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; He J, 2012, NEPHROLOGY, V17, P493, DOI 10.1111/j.1440-1797.2012.01589.x; Hogan MC, 2014, KIDNEY INT, V85, P1225, DOI 10.1038/ki.2013.422; Humphreys BD, 2014, CURR OPIN NEPHROL HY, V23, P25, DOI 10.1097/01.mnh.0000437332.31418.e0; Kaimori JY, 2008, J AM SOC NEPHROL, V19, P416, DOI 10.1681/ASN.2008010033; Kelly KJ, 2013, AM J PHYSIOL-RENAL, V305, pF1804, DOI 10.1152/ajprenal.00097.2013; Kelly KJ, 2012, AM J PHYSIOL-RENAL, V303, pF357, DOI 10.1152/ajprenal.00680.2011; Kelly KJ, 2010, AM J PHYSIOL-RENAL, V299, pF453, DOI 10.1152/ajprenal.00050.2010; Kelly KJ, 2009, AM J PHYSIOL-RENAL, V296, pF1355, DOI 10.1152/ajprenal.90622.2008; KELLY KJ, 1994, P NATL ACAD SCI USA, V91, P812, DOI 10.1073/pnas.91.2.812; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Lager DJ, 2001, KIDNEY INT, V59, P126, DOI 10.1046/j.1523-1755.2001.00473.x; Mason SB, 2010, ANAT REC, V293, P1279, DOI 10.1002/ar.21166; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; O'Meara CC, 2012, PHYSIOL GENOMICS, V44, P741, DOI 10.1152/physiolgenomics.00187.2011; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Peterson KM, 2013, AM J NEPHROL, V38, P233, DOI 10.1159/000354236; Richards WG, 1998, J CLIN INVEST, V101, P935, DOI 10.1172/JCI2071; Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686; Seckert CK, 2009, J VIROL, V83, P8869, DOI 10.1128/JVI.00870-09; Sweeney WE, 2000, KIDNEY INT, V57, P33, DOI 10.1046/j.1523-1755.2000.00829.x; Sweeney WE, 2006, CELL TISSUE RES, V326, P671, DOI 10.1007/s00441-006-0226-0; Tao YX, 2008, J AM SOC NEPHROL, V19, P749, DOI 10.1681/ASN.2006121378; Togawa H, 2011, AM J PHYSIOL-RENAL, V300, pF511, DOI 10.1152/ajprenal.00038.2010; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Torres VE, 2003, KIDNEY INT, V64, P1573, DOI 10.1046/j.1523-1755.2003.00256.x; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Turturici G, 2014, AM J PHYSIOL-CELL PH, V306, pC621, DOI 10.1152/ajpcell.00228.2013; US Renal Data System, 2013, USRDS 2013 ANN DAT R; van Koppen Arianne, 2012, PLoS One, V7, pe38746, DOI 10.1371/journal.pone.0038746; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Weber GF, 2013, MED HYPOTHESES, V80, P613, DOI 10.1016/j.mehy.2013.01.037; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Woo YM, 2013, BMB REP, V46, P338, DOI 10.5483/BMBRep.2013.46.7.151; Yamaleyeva LM, 2012, STEM CELL TRANSL MED, V1, P373, DOI 10.5966/sctm.2011-0048	53	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131677	10.1371/journal.pone.0131677	http://dx.doi.org/10.1371/journal.pone.0131677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26136112	Green Published, gold			2022-12-26	WOS:000358154400062
J	Raval, A; Behbehani, GK; Nguyen, LXT; Thomas, D; Kusler, B; Garbuzov, A; Ramunas, J; Holbrook, C; Park, CY; Blau, H; Nolan, GP; Artandi, SE; Mitchell, BS				Raval, Aparna; Behbehani, Gregory K.; Le Xuan Truong Nguyen; Thomas, Daniel; Kusler, Brenda; Garbuzov, Alina; Ramunas, John; Holbrook, Colin; Park, Christopher Y.; Blau, Helen; Nolan, Garry P.; Artandi, Steven E.; Mitchell, Beverly S.			Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice	PLOS ONE			English	Article							CELL MASS CYTOMETRY; BONE-MARROW FAILURE; STEM-CELLS; DYSKERATOSIS-CONGENITA; MYELODYSPLASTIC SYNDROMES; SELF-RENEWAL; REVERSE-TRANSCRIPTASE; APLASTIC-ANEMIA; HUMAN-DISEASE; DNA-DAMAGE	Telomere shortening is common in bone marrow failure syndromes such as dyskeratosis congenita (DC), aplastic anemia (AA) and myelodysplastic syndromes (MDS). However, improved knowledge of the lineage-specific consequences of telomere erosion and restoration of telomere length in hematopoietic progenitors is required to advance therapeutic approaches. We have employed a reversible murine model of telomerase deficiency to compare the dependence of erythroid and myeloid lineage differentiation on telomerase activity. Fifth generation Tert-/-(G5 Tert-/-) mice with shortened telomeres have significant anemia, decreased erythroblasts and reduced hematopoietic stem cell (HSC) populations associated with neutrophilia and increased myelopoiesis. Intracellular multiparameter analysis by mass cytometry showed significantly reduced cell proliferation and increased sensitivity to activation of DNA damage checkpoints in erythroid progenitors and in erythroidbiased CD150hi HSC, but not in myeloid progenitors. Strikingly, Cre-inducible reactivation of telomerase activity restored hematopoietic stem and progenitor cell (HSPC) proliferation, normalized the DNA damage response, and improved red cell production and hemoglobin levels. These data establish a direct link between the loss of TERT activity, telomere shortening and defective erythropoiesis and suggest that novel strategies to restore telomerase function may have an important role in the treatment of the resulting anemia.	[Raval, Aparna; Behbehani, Gregory K.; Le Xuan Truong Nguyen; Thomas, Daniel; Kusler, Brenda; Mitchell, Beverly S.] Stanford Univ, Dept Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Raval, Aparna; Behbehani, Gregory K.; Le Xuan Truong Nguyen; Thomas, Daniel; Kusler, Brenda; Mitchell, Beverly S.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Behbehani, Gregory K.; Ramunas, John; Holbrook, Colin; Blau, Helen; Nolan, Garry P.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Thomas, Daniel; Ramunas, John; Holbrook, Colin; Blau, Helen] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94035 USA; [Garbuzov, Alina] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Artandi, Steven E.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Stanford University; Stanford University	Mitchell, BS (corresponding author), Stanford Univ, Dept Med, Stanford Canc Inst, Stanford, CA 94305 USA.	beverlym@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	Leukemia and Lymphoma Society SCOR award; Rachford and Carlota A. Harris Endowed Chair; NIH [PN2EY018228, 0158 G KB065, U19 AI057229, P01 CA034233-22A1, HHSN272200700038C, 1R01CA130826, RFA CA 09-011, RFA CA 09-009]; CIRM grant [DR1-01477]; Developmental Cancer Research Award (DCRA) from the Stanford Cancer Institute; NIH Director's Transformative Research Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR063963]; National Heart, Lung, and Blood Institute [U01HL100397]; National Institute on Aging [AG044815-01]; University of Maryland [SR00002307]; NHLBI [U01HL099997]; Baxter Foundation; California Institute of Regenerative Medicine [TR3-05501]; Australian National Health and Medical Research Council Overseas Biomedical Research Fellowship; NATIONAL CANCER INSTITUTE [R35CA197563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society SCOR award; Rachford and Carlota A. Harris Endowed Chair; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM grant; Developmental Cancer Research Award (DCRA) from the Stanford Cancer Institute; NIH Director's Transformative Research Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Maryland; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Baxter Foundation; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Australian National Health and Medical Research Council Overseas Biomedical Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a Leukemia and Lymphoma Society SCOR award to B.S.M. GPN was supported by the Rachford and Carlota A. Harris Endowed Chair as well as NIH grants PN2EY018228, 0158 G KB065, U19 AI057229, P01 CA034233-22A1, HHSN272200700038C, 1R01CA130826, RFA CA 09-011, RFA CA 09-009 and CIRM grant USC DR1-01477. G.K.B. was supported by the Developmental Cancer Research Award (DCRA) from the Stanford Cancer Institute. JR, CH, and HMB are supported by NIH Director's Transformative Research Award R01AR063963 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute grant U01HL100397; a grant from the National Institute on Aging AG044815-01; University of Maryland, Baltimore subaward SR00002307 (on NHLBI grant U01HL099997); and funding from the Baxter Foundation. HMB is supported by California Institute of Regenerative Medicine award TR3-05501. D.T. is supported by an Australian National Health and Medical Research Council Overseas Biomedical Research Fellowship. R.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is a New York Stem Cell Foundation Robertson Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Alter BP, 2015, HAEMATOLOGICA, V100, P49, DOI 10.3324/haematol.2014.114389; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Behbehani GK, 2014, CYTOM PART A, V85A, P1011, DOI 10.1002/cyto.a.22573; Behbehani GK, 2012, CYTOM PART A, V81A, P552, DOI 10.1002/cyto.a.22075; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cui SY, 2014, MOL CELL BIOL, V34, P1956, DOI 10.1128/MCB.00247-14; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; De Meyer T, 2008, AGING CELL, V7, P700, DOI 10.1111/j.1474-9726.2008.00419.x; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hedrich HJ, 2012, LAB MOUSE, pxxi; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Lange K, 2010, GENE CHROMOSOME CANC, V49, P260, DOI 10.1002/gcc.20737; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Ornatsky O, 2006, J IMMUNOL METHODS, V308, P68, DOI 10.1016/j.jim.2005.09.020; Ornatsky OI, 2008, J ANAL ATOM SPECTROM, V23, P463, DOI 10.1039/b710510j; Pang WW, 2012, CURR OPIN HEMATOL, V19, P133, DOI 10.1097/MOH.0b013e3283522471; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Prade-Houdellier N, 2007, LEUKEMIA, V21, P2304, DOI 10.1038/sj.leu.2404874; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Ramunas J, 2015, FASEB J, V29, P1930, DOI 10.1096/fj.14-259531; Raval A, 2011, LEUKEMIA OFFICIAL J, DOI [10.1038/leu.2011.270, DOI 10.1038/LEU.2011.270]; Rigolin GM, 2004, EUR J HAEMATOL, V73, P351, DOI 10.1111/j.1600-0609.2004.00305.x; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Scheinberg P, 2010, JAMA-J AM MED ASSOC, V304, P1358, DOI 10.1001/jama.2010.1376; Schuller CE, 2007, LEUKEMIA, V21, P983, DOI 10.1038/sj.leu.2404631; Sekulovic S, 2011, BLOOD, V118, P1766, DOI 10.1182/blood-2010-11-319632; Sieglova Z, 2004, LEUKEMIA RES, V28, P1013, DOI 10.1016/j.leukres.2003.11.020; Song ZF, 2012, AGING CELL, V11, P449, DOI 10.1111/j.1474-9726.2012.00802.x; Song ZF, 2010, BLOOD, V115, P1481, DOI 10.1182/blood-2009-08-237230; Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	60	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131722	10.1371/journal.pone.0131722	http://dx.doi.org/10.1371/journal.pone.0131722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133370	gold, Green Published			2022-12-26	WOS:000358154400065
J	Schmidt, M; Horn, S; Ehlers, K; Wilhelm, C; Schnetter, R				Schmidt, Maria; Horn, Susanne; Ehlers, Katrin; Wilhelm, Christian; Schnetter, Reinhard			Guanchochroma wildpretii gen. et spec. nov (Ochrophyta) Provides New Insights into the Diversification and Evolution of the Algal Class Synchromophyceae	PLOS ONE			English	Article							3 GENETIC COMPARTMENTS; PHYLOGENETIC ANALYSES; MOLECULAR PHYLOGENY; PLASTID DIVISION; RELATIVE RATES; RIBOSOMAL-RNA; GREEN PLANTS; GC-CONTENT; MARINE; RED	A new relative of the chrysophyte genus Chrysopodocystis was found in Tenerife and termed Guanchochroma wildpretii. This unicellular alga was most noticeably discernible from Chrysopodocystis socialis (the only species of this genus) by the presence of a cyst-like stage with a multilayered lorica, which also functions as a dispersal unit and shows secondary wall growth. Secondary expansion of loricae (cell casings not involved in cell division, usually with a more or less pronounced opening) has never been observed previously and marks a unique feature of the new taxon. Plastids are non-randomly distributed within cells of G. wildpretii. 18S rRNA gene analyses identified the two species as sister lineages and placed them in a monophyletic group with the Synchromophyceae, a heterokont algal (Ochrophyta) class characterized by the presence of chloroplast complexes. Yet, neither Chrysopodocystis nor Guanchochroma showed this feature in ultrastructure analyses. Additionally, their 18S rRNA genes possessed distinct inserts, the highest GC-content known for Ochrophyta and exceptionally long branches on the Ochrophyta 18S rDNA phylogenetic tree, suggesting substantially increased substitution rates along their branch compared to Synchromophyceae. Plastid marker data (rbcL) recovered a monophyletic clade of Chrysopodocystis, Guanchochroma and Synchromophyceae as well, yet with lower supports for internal split order due to limited resolution of the marker. Evidence for the sequence of events leading to the formation of the plastid complex of Synchromophyceae still remains ambiguous because of the apparently short timeframe in which they occurred.	[Schmidt, Maria; Wilhelm, Christian] Univ Leipzig, Dept Plant Physiol, D-04103 Leipzig, Germany; [Horn, Susanne] Univ Klinikum Essen, Dermatol Klin, Forsch Lab, D-45447 Essen, Germany; [Ehlers, Katrin; Schnetter, Reinhard] Univ Giessen, Inst Bot, D-35392 Giessen, Germany	Leipzig University; University of Duisburg Essen; Justus Liebig University Giessen	Schmidt, M (corresponding author), Univ Leipzig, Dept Plant Physiol, Johannisallee 21-23, D-04103 Leipzig, Germany.	MariaSchmidt83@yahoo.de		Schmidt, Maria/0000-0002-9479-3659	German Research Foundation (Deutsche Forschungsgesellschaft) [Wi 764/15-1]	German Research Foundation (Deutsche Forschungsgesellschaft)(German Research Foundation (DFG))	The project was funded by the German Research Foundation (Deutsche Forschungsgesellschaft, Wi 764/15-1).	BILLARD C, 1978, B SOC BOT FR, V125, P307, DOI 10.1080/00378941.1978.10839455; Bromham L, 2005, MOL BIOL EVOL, V22, P1393, DOI 10.1093/molbev/msi133; Brosnan S, 2005, J PHYCOL, V41, P590, DOI 10.1111/j.1529-8817.2005.00068.x; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Davies TJ, 2004, P ROY SOC B-BIOL SCI, V271, P2195, DOI 10.1098/rspb.2004.2849; DERIJK P, 1992, NUCLEIC ACIDS RES, V20, P2075, DOI 10.1093/nar/20.suppl.2075; Dorrell RG, 2012, J CELL SCI, V125, P1865, DOI 10.1242/jcs.102285; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Escobar JS, 2011, MOL BIOL EVOL, V28, P2561, DOI 10.1093/molbev/msr079; Ettl H, 1980, GRUNDRISS ALLGEMEINE; Galtier N, 2001, GENETICS, V159, P907; Grant J, 2009, PROTIST, V160, P376, DOI 10.1016/j.protis.2009.01.001; GRELL KG, 1990, EUR J PROTISTOL, V26, P37, DOI 10.1016/S0932-4739(11)80387-1; GRELL KG, 1990, ARCH PROTISTENKD, V138, P257, DOI 10.1016/S0003-9365(11)80033-3; GRELL KG, 1989, ARCH PROTISTENKD, V137, P177, DOI 10.1016/S0003-9365(89)80023-5; Guiry M, 2012, WORLD WIDE ELECT PUB; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hirakawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023193; HOLM S, 1979, SCAND J STAT, V6, P65; Horn S, 2007, PROTIST, V158, P277, DOI 10.1016/j.protis.2007.02.004; Hua JM, 2012, PROTIST, V163, P105, DOI 10.1016/j.protis.2011.04.003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Knapp S, 2011, BMC EVOL BIOL, V11, DOI [10.1186/1471-2148-11-251, 10.1186/1471-2148-11-250]; Koch C, 2011, PLANT BIOLOGY, V13, P801, DOI 10.1111/j.1438-8677.2010.00427.x; Leadbeater BSC, 2008, PROTIST, V159, P259, DOI 10.1016/j.protis.2007.09.005; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Lynch M, 2007, ORIGINS GENOME ARCHI; Marin B, 2005, PROTIST, V156, P425, DOI 10.1016/j.protis.2005.09.001; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MCFADDEN GI, 1995, ARCH PROTISTENKD, V145, P231, DOI 10.1016/S0003-9365(11)80318-0; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Miyagishima S, 2011, PLANT PHYSIOL, V155, P1533, DOI 10.1104/pp.110.170688; Murakami R, 2009, PROTIST, V160, P41, DOI 10.1016/j.protis.2008.09.002; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; O'Kelly CJ, 2001, EUR J PHYCOL, V36, P51, DOI 10.1080/09670260110001735198; Ota S, 2005, PHYCOL RES, V53, P275, DOI 10.1111/j.1440-183.2005.00395.x; Ota S, 2012, PROTIST, V163, P91, DOI 10.1016/j.protis.2011.02.004; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Preisfeld A, 2000, J PHYCOL, V36, P220, DOI 10.1046/j.1529-8817.2000.99091.x; Pribyl P, 2012, J PHYCOL, V48, P231, DOI 10.1111/j.1529-8817.2011.01109.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmidt M, 2012, PROTIST, V163, P544, DOI 10.1016/j.protis.2011.11.009; SCHNETTER R, 1984, Cryptogamie Algologie, V5, P73; Schweizer M, 2008, MAR MICROPALEONTOL, V66, P233, DOI 10.1016/j.marmicro.2007.10.003; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Skaloud P, 2013, NORD J BOT, V31, P385, DOI 10.1111/j.1756-1051.2013.00119.x; Smith DR, 2012, MOL PHYLOGENET EVOL, V65, P339, DOI 10.1016/j.ympev.2012.06.017; Smith DR, 2012, J EUKARYOT MICROBIOL, V59, P181, DOI 10.1111/j.1550-7408.2011.00601.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAJIMA F, 1993, GENETICS, V135, P599; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van de Peer Y, 1998, NUCLEIC ACIDS RES, V26, P179, DOI 10.1093/nar/26.1.179; Von der Heyden S, 2004, EUR J PHYCOL, V39, P343, DOI 10.1080/09670260400005567; Weatherill K, 2007, J PHYCOL, V43, P535, DOI 10.1111/j.1529-8817.2007.00356.x; Wei L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-534; Wenderoth K, 1999, EUR J PHYCOL, V34, P97, DOI 10.1017/S0967026299001961; WILHELM C, 1995, J WATER SUPPLY RES T, V44, P132; Woehle C, 2011, GENOME BIOL EVOL, V3, P1220, DOI 10.1093/gbe/evr100; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131821	10.1371/journal.pone.0131821	http://dx.doi.org/10.1371/journal.pone.0131821			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135124	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400076
J	Wang, F; Li, ST; Zhao, H; Bian, L; Chen, L; Zhang, Z; Zhong, X; Ma, LX; Yu, XL				Wang, Fei; Li, Shuntang; Zhao, Hui; Bian, Lu; Chen, Liang; Zhang, Zhen; Zhong, Xing; Ma, Lixin; Yu, Xiaolan			Expression and Characterization of the RKOD DNA Polymerase in Pichia pastoris	PLOS ONE			English	Article							PYROCOCCUS-FURIOSUS; PROTEIN EXPRESSION; ESCHERICHIA-COLI; CHAIN-REACTION; IN-VITRO; PCR; CLONING; EVOLUTION; GLYCOSYLATION; PURIFICATION	The present study assessed high-level expression of the KOD DNA polymerase in Pichia pastoris. Thermococcus kodakaraensis KOD1 is a DNA polymerase that is widely used in PCR. The DNA coding sequence of KOD was optimized based on the codon usage bias of P. pastoris and synthesized by overlapping PCR, and the nonspecific DNA-binding protein Sso7d from the crenarchaeon Sulfolobus solfataricus was fused to the C-terminus of KOD. The resulting novel gene was cloned into a pHBM905A vector and introduced into P. pastoris GS115 for secretory expression. The yield of the target protein reached approximately 250 mg/l after a 6-d induction with 1% (v/v) methanol in shake flasks. This yield is much higher than those of other DNA polymerases expressed heterologously in Escherichia coli. The recombinant enzyme was purified, and its enzymatic features were studied. Its specific activity was 19,384 U/mg. The recombinant KOD expressed in P. pastoris exhibited excellent thermostability, extension rate and fidelity. Thus, this report provides a simple, efficient and economic approach to realize the production of a high-performance thermostable DNA polymerase on a large scale. This is the first report of the expression in yeast of a DNA polymerase for use in PCR.	[Wang, Fei; Li, Shuntang; Zhao, Hui; Bian, Lu; Chen, Liang; Zhang, Zhen; Ma, Lixin; Yu, Xiaolan] Hubei Univ, Coll Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Hubei Key Lab Ind Biotechnol, Wuhan, Peoples R China; [Zhong, Xing] Hubei Univ, Zhixing Coll, Dept Bioengn, Wuhan, Peoples R China	Hubei University; Hubei University	Ma, LX (corresponding author), Hubei Univ, Coll Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Hubei Key Lab Ind Biotechnol, Wuhan, Peoples R China.	malixing@hubu.edu.cn; yxiaolan@163.com			 [2013CB910801];  [2012FFA034];  [2014070504020239];  [31172320];  [31340036]	; ; ; ; 	This work was supported by grants No. 2013CB910801: http://english.iee.cas.cn/rh/rps/201005/t20100510_53822.html, No. 2012FFA034, http://www.hbstd.gov.cn/index.htm, No. 2014070504020239, http://www.whst.gov.cn/, No. 31172320 and 31340036, http://www.physics.sjtu.edu.cn/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Benson LM, 2003, J AM SOC MASS SPECTR, V14, P601, DOI 10.1016/S1044-0305(03)00148-X; Boer E, 2007, APPL MICROBIOL BIOT, V77, P513, DOI 10.1007/s00253-007-1209-0; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chattopadhyay S, 2009, BIOCHEM BIOPH RES CO, V389, P484, DOI 10.1016/j.bbrc.2009.09.004; CHEN GQ, 1994, J AM CHEM SOC, V116, P8799, DOI 10.1021/ja00098a045; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Clark SE, 2004, PROTEIN ENG DES SEL, V17, P245, DOI 10.1093/protein/gzh028; Dabrowski S, 1998, PROTEIN EXPRES PURIF, V14, P131, DOI 10.1006/prep.1998.0945; ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5; Fujiwara S, 1998, BIOTECHNOL ANN REV, V4, P259, DOI 10.1016/S1387-2656(08)70073-5; GRIPPO P, 1971, J BIOL CHEM, V246, P6867; Jahic M, 2006, BIOTECHNOL PROGR, V22, P1465, DOI 10.1021/bp060171t; Kim DJ, 2002, J BIOCHEM MOL BIOL, V35, P320; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni183; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MCCLEARY BV, 1978, CARBOHYD RES, V67, P213, DOI 10.1016/S0008-6215(00)83743-X; MROCZKOWSKI BS, 1994, J BIOL CHEM, V269, P13522; MURAMATS.T, 1971, J BIOL CHEM, V246, P5534; Murphy MB, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng110; Musheev MU, 2006, ANAL CHIM ACTA, V564, P91, DOI 10.1016/j.aca.2005.09.069; Nishioka M, 2001, J BIOTECHNOL, V88, P141, DOI 10.1016/S0168-1656(01)00275-9; Pavlov AR, 2002, P NATL ACAD SCI USA, V99, P13510, DOI 10.1073/pnas.202127199; Rao B, 2010, YEAST, V27, P285, DOI 10.1002/yea.1753; Sambrook J, 2001, MOL CLONING LAB MANU; Shen XF, 2012, VACCINE, V30, P6946, DOI 10.1016/j.vaccine.2012.02.071; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Somera AF, 2009, J MICROBIOL, V47, P270, DOI 10.1007/s12275-008-0286-9; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; Wang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120458; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Wu Q, 2010, BIOTECHNOL LETT, V32, P439, DOI 10.1007/s10529-009-0166-3; Zhang GM, 2006, BIOCATAL BIOTRANSFOR, V24, P371, DOI 10.1080/10242420600768771	35	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131757	10.1371/journal.pone.0131757	http://dx.doi.org/10.1371/journal.pone.0131757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134129	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400069
J	Creecy, A; Russ, PK; Solinas, F; Wright, DW; Haselton, FR				Creecy, Amy; Russ, Patricia K.; Solinas, Francesca; Wright, David W.; Haselton, Frederick R.			Tuberculosis Biomarker Extraction and Isothermal Amplification in an Integrated Diagnostic Device	PLOS ONE			English	Article							MICROSCOPY CENTERS; SPUTUM; RNA	In this study, we integrated magnetic bead-based sample preparation and isothermal loop mediated amplification (LAMP) of TB in a single tube. Surrogate sputum samples produced by the Program for Appropriate Technology in Health containing inactivated TB bacteria were used to test the diagnostic. In order to test the sample preparation method, samples were lysed, and DNA was manually extracted and eluted into water in the tube. In a thermal cycler, LAMP amplified TB DNA from 10(3) TB cells/mL of sputum at 53.5 +/- 3.3 minutes, 10(4) cells/mL at 46.3 +/- 2.2 minutes, and 10(5) cells/mL at 41.6 +/- 1.9 minutes. Negative control samples did not amplify. Next, sample preparation was combined with in-tubing isothermal LAMP amplification by replacing the water elution chamber with a LAMP reaction chamber. In this intermediate configuration, LAMP amplified 10(3) cells/mL at 74 +/- 10 minutes, 10(4) cells/mL at 60 +/- 9 minutes, and 10(5) TB cells/mL of sputum at 54 +/- 9 minutes. Two of three negative controls did not amplify; one amplified at 100 minutes. In the semi-automated system, DNA was eluted directly into an isothermal reaction solution containing the faster Opti-Gene DNA polymerase. The low surrogate sputum concentration, 103 TB cells/mL, amplified at 52.8 +/- 3.3 minutes, 10(4) cells/mL at 45.4 +/- 11.3 minutes, and 10(5) cells/mL at 31.8 +/- 2.9 minutes. TB negative samples amplified at 66.4 +/- 7.4 minutes. This study demonstrated the feasibility of a single tube design for integrating sample preparation and isothermal amplification, which with further development could be useful for point-of-care applications, particularly in a low-resource setting.	[Creecy, Amy; Russ, Patricia K.; Solinas, Francesca; Haselton, Frederick R.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Wright, David W.; Haselton, Frederick R.] Vanderbilt Univ, Dept Chem, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Haselton, FR (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	rick.haselton@vanderbilt.edu			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this research was provided by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). Funding was received by DWW and FRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NM, 2014, ANALYST, V139, P1644, DOI 10.1039/c3an02261g; Adams NM, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4788922; Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Aryan E, 2013, J INFECTION, V66, P487, DOI 10.1016/j.jinf.2013.02.005; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Bordelon H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068369; Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009; Davis KM, 2014, ANALYST, V139, P3026, DOI 10.1039/c4an00338a; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; GonzalezyMerchand JA, 1996, FEMS MICROBIOL LETT, V135, P71; HOBBY GL, 1973, ANTIMICROB AGENTS CH, V4, P94, DOI 10.1128/AAC.4.2.94; Jain A, 2002, MOL BIOL TODAY, V3, P43; Kaewphinit T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/926230; Kumar P, 2014, J INFECTION, V69, P607, DOI 10.1016/j.jinf.2014.08.017; Majamanda J, 2013, MALAWI MED J, V25, P101; McNerney R, 2015, INT J INFECT DIS, V32, P81, DOI 10.1016/j.ijid.2015.01.012; Mhimbira Francis A, 2015, J Clin Microbiol, V53, P1342, DOI 10.1128/JCM.03037-14; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ou XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094544; WHO, 2014, GLOB TUB REP 2014; Willey S, 2008, PRESCOTTS MICROBIOLO	21	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130260	10.1371/journal.pone.0130260	http://dx.doi.org/10.1371/journal.pone.0130260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132307	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000059
J	Zhang, YL; Luo, GB; Liu, DC; Wang, DZ; Yang, WL; Sun, JZ; Zhang, AM; Zhan, KH				Zhang, Yanlin; Luo, Guangbin; Liu, Dongcheng; Wang, Dongzhi; Yang, Wenlong; Sun, Jiazhu; Zhang, Aimin; Zhan, Kehui			Genome-, Transcriptome- and Proteome-Wide Analyses of the Gliadin Gene Families in Triticum urartu	PLOS ONE			English	Article							EXERCISE-INDUCED ANAPHYLAXIS; WEIGHT GLUTENIN SUBUNIT; T-CELL EPITOPES; CELIAC-DISEASE; EVOLUTIONARY ANALYSIS; COMMON WHEAT; MOLECULAR CHARACTERIZATION; GRAIN DEVELOPMENT; AEGILOPS GENOMES; HEXAPLOID WHEATS	Gliadins are the major components of storage proteins in wheat grains, and they play an essential role in the dough extensibility and nutritional quality of flour. Because of the large number of the gliadin family members, the high level of sequence identity, and the lack of abundant genomic data for Triticum species, identifying the full complement of gliadin family genes in hexaploid wheat remains challenging. Triticum urartu is a wild diploid wheat species and considered the A-genome donor of polyploid wheat species. The accession PI428198 (G1812) was chosen to determine the complete composition of the gliadin gene families in the wheat A-genome using the available draft genome. Using a PCR-based cloning strategy for genomic DNA and mRNA as well as a bioinformatics analysis of genomic sequence data, 28 gliadin genes were characterized. Of these genes, 23 were alpha-gliadin genes, three were gamma-gliadin genes and two were omega-gliadin genes. An RNA sequencing (RNA-Seq) survey of the dynamic expression patterns of gliadin genes revealed that their synthesis in immature grains began prior to 10 days post-anthesis (DPA), peaked at 15 DPA and gradually decreased at 20 DPA. The accumulation of proteins encoded by 16 of the expressed gliadin genes was further verified and quantified using proteomic methods. The phylogenetic analysis demonstrated that the homologs of these alpha-gliadin genes were present in tetraploid and hexaploid wheat, which was consistent with T. urartu being the A-genome progenitor species. This study presents a systematic investigation of the gliadin gene families in T. urartu that spans the genome, transcriptome and proteome, and it provides new information to better understand the molecular structure, expression profiles and evolution of the gliadin genes in T. urartu and common wheat.	[Zhang, Yanlin; Zhang, Aimin; Zhan, Kehui] Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Grain Crops Henan, Zhengzhou, Peoples R China; [Luo, Guangbin; Liu, Dongcheng; Wang, Dongzhi; Yang, Wenlong; Sun, Jiazhu; Zhang, Aimin] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Luo, Guangbin; Wang, Dongzhi] Univ Chinese Acad Sci, Beijing, Peoples R China	Henan Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, AM (corresponding author), Henan Agr Univ, Coll Agron, Collaborat Innovat Ctr Grain Crops Henan, Zhengzhou, Peoples R China.	amzhang@genetics.ac.cn; kh486@163.com		Wang, Dongzhi/0000-0001-9751-7329	National Key Basic Research Program from Ministry of Science and Technology of The People's Republic of China [2014CB138100]; National Natural Science Foundation of China [31371610]; Ministry of Agriculture of China for transgenic research from Minister of Agriculture of The People's Republic of China [2014ZX08009-003]	National Key Basic Research Program from Ministry of Science and Technology of The People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China for transgenic research from Minister of Agriculture of The People's Republic of China	This work was supported by the National Key Basic Research Program (2014CB138100) from Ministry of Science and Technology of The People's Republic of China (http://www.most.gov.cn/), National Natural Science Foundation of China (31371610) (http://www.nsfc.gov.cn/) and the Ministry of Agriculture of China for transgenic research (2014ZX08009-003) from Minister of Agriculture of The People's Republic of China (http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach SB, 2007, J CEREAL SCI, V46, P169, DOI 10.1016/j.jcs.2007.02.001; Alvarez JB, 2013, THEOR APPL GENET, V126, P1703, DOI 10.1007/s00122-013-2085-x; Anderson OD, 1997, THEOR APPL GENET, V95, P50, DOI 10.1007/s001220050531; Anderson OD, 1997, THEOR APPL GENET, V95, P59, DOI 10.1007/s001220050532; Anderson OD, 2001, THEOR APPL GENET, V103, P323, DOI 10.1007/s00122-001-0551-3; Anderson OD, 2001, THEOR APPL GENET, V103, P307, DOI 10.1007/s001220100576; Anderson OD, 2013, FUNCT INTEGR GENOMIC, V13, P261, DOI 10.1007/s10142-013-0321-8; Anderson OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052139; Battais F, 2005, ALLERGY, V60, P815, DOI 10.1111/j.1398-9995.2005.00795.x; BAUM M, 1991, CHROMOSOMA, V101, P1, DOI 10.1007/BF00360680; Biagi F, 1999, ALIMENT PHARM THERAP, V13, P945; Bittner C, 2008, J ALLERGY CLIN IMMUN, V121, P744, DOI 10.1016/j.jaci.2007.09.051; Caballero L, 2008, PLANT BREEDING, V127, P548, DOI 10.1111/j.1439-0523.2008.01512.x; Caballero L, 2009, GENET RESOUR CROP EV, V56, P1117, DOI 10.1007/s10722-009-9434-2; Chen GX, 2014, FUNCT INTEGR GENOMIC, V14, P149, DOI 10.1007/s10142-013-0353-0; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Clarke BC, 2003, THEOR APPL GENET, V106, P629, DOI 10.1007/s00122-002-1091-1; Cornell HJ, 2001, AMINO ACIDS, V21, P243, DOI 10.1007/s007260170010; COX TS, 1994, CROP SCI, V34, P339, DOI 10.2135/cropsci1994.0011183X003400020005x; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; Dong LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013548; DuPont FM, 2004, THEOR APPL GENET, V108, P1299, DOI 10.1007/s00122-003-1565-9; Goryunova SV, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-215; Gupta RB, 1996, J EXP BOT, V47, P1377, DOI 10.1093/jxb/47.9.1377; Hamer RJ, 2000, ROY SOC CH, P125, DOI 10.1039/9781847552372-00125; HARBERD NP, 1985, MOL GEN GENET, V198, P234, DOI 10.1007/BF00383001; Hsia CC, 2001, THEOR APPL GENET, V103, P37, DOI 10.1007/s00122-001-0552-2; Huang YY, 2012, FUNCT INTEGR GENOMIC, V12, P199, DOI 10.1007/s10142-011-0243-2; Ikeda TM, 2006, THEOR APPL GENET, V112, P327, DOI 10.1007/s00122-005-0131-z; Joppa LR, 1997, CROP SCI, V37, P1586, DOI 10.2135/cropsci1997.0011183X003700050030x; Kasarda DD, 1999, CEREAL CHEM, V76, P548, DOI 10.1094/CCHEM.1999.76.4.548; Kawaura K, 2005, PLANT PHYSIOL, V139, P1870, DOI 10.1104/pp.105.070722; Kawaura K, 2012, FUNCT INTEGR GENOMIC, V12, P341, DOI 10.1007/s10142-012-0269-0; Khatkar BS, 2002, J CEREAL SCI, V35, P299, DOI 10.1006/jcrs.2001.0429; Kooy-Winkelaar Y, 2011, J IMMUNOL, V187, P5123, DOI 10.4049/jimmunol.1101179; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li J, 2013, J APPL GENET, V54, P157, DOI 10.1007/s13353-013-0139-z; Li J, 2012, GENOME, V55, P513, DOI [10.1139/G2012-038, 10.1139/g2012-038]; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Loponen J., 2006, THESIS U HELSINKI; Ma ZC, 2007, RUSS J GENET+, V43, P1286, DOI 10.1134/S1022795407110117; Mamone G, 2005, PROTEOMICS, V5, P2859, DOI 10.1002/pmic.200401168; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Maruyama N, 1998, EUR J BIOCHEM, V255, P739, DOI 10.1046/j.1432-1327.1998.2550739.x; Matsuo H, 2005, J IMMUNOL, V175, P8116, DOI 10.4049/jimmunol.175.12.8116; Matsuo H, 2004, J BIOL CHEM, V279, P12135, DOI 10.1074/jbc.M311340200; NietoTaladriz MT, 1996, THEOR APPL GENET, V93, P780, DOI 10.1007/BF00224076; OKITA TW, 1985, J BIOL CHEM, V260, P8203; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Piston F, 2006, J CEREAL SCI, V43, P120, DOI 10.1016/j.jcs.2005.07.002; Piston F, 2009, MOL BREEDING, V23, P655, DOI 10.1007/s11032-009-9263-1; Qi PF, 2013, GENETICA, V141, P303, DOI 10.1007/s10709-013-9729-2; Qi PF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-168; Qiu YC, 2005, THEOR APPL GENET, V111, P1524, DOI 10.1007/s00122-005-0081-5; REEVES CD, 1987, GENE, V52, P257, DOI 10.1016/0378-1119(87)90052-7; SABELLI PA, 1991, THEOR APPL GENET, V83, P209, DOI 10.1007/BF00226253; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Salentijn EMJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-277; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; SHEWRY PR, 1995, J PLANT PHYSIOL, V145, P620, DOI 10.1016/S0176-1617(11)81273-3; Shewry PR, 1997, J SCI FOOD AGR, V73, P397, DOI [10.1002/(SICI)1097-0010(199704)73:4&lt;397::AID-JSFA758&gt;3.0.CO;2-Q, 10.1002/(SICI)1097-0010(199704)73:4<397::AID-JSFA758>3.0.CO;2-Q]; Singh G., 2003, PLANT MOL BIOL REP, V21, P93, DOI DOI 10.1007/BF02773401; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Stern M, 2001, EUR J GASTROEN HEPAT, V13, P741, DOI 10.1097/00042737-200106000-00023; TAKUMI S, 1993, JPN J GENET, V68, P73, DOI 10.1266/jjg.68.73; TATHAM AS, 1995, J CEREAL SCI, V22, P1, DOI 10.1016/S0733-5210(05)80002-5; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1; Wieser H., 2006, GLUTEN PROTEINS, P13; Xie ZZ, 2010, THEOR APPL GENET, V121, P1239, DOI 10.1007/s00122-010-1384-8; Xu JH, 2009, THEOR APPL GENET, V119, P1397, DOI 10.1007/s00122-009-1143-x; Zhang XF, 2011, THEOR APPL GENET, V122, P1503, DOI 10.1007/s00122-011-1550-7; Zhuang QQ, 2012, J APPL GENET, V53, P125, DOI 10.1007/s13353-011-0075-8	74	20	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131559	10.1371/journal.pone.0131559	http://dx.doi.org/10.1371/journal.pone.0131559			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132381	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000129
J	Aerne, BL; Gailite, I; Sims, D; Tapon, N				Aerne, Birgit L.; Gailite, Ieva; Sims, David; Tapon, Nicolas			Hippo Stabilises Its Adaptor Salvador by Antagonising the HECT Ubiquitin Ligase Herc4	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; CELL-CYCLE EXIT; PROMOTES APOPTOSIS; SIZE-CONTROL; PROLIFERATION ARREST; DROSOPHILA HOMOLOG; SIGNALING PATHWAY; BANTAM MICRORNA; GROWTH-CONTROL; TISSUE-GROWTH	Signalling through the Hippo (Hpo) pathway involves a kinase cascade, which leads to the phosphorylation and inactivation of the pro-growth transcriptional co-activator Yorkie (Yki). Despite the identification of a large number of pathway members and modulators, our understanding of the molecular events that lead to activation of Hpo and the downstream kinase Warts (Wts) remain incomplete. Recently, targeted degradation of several Hpo pathway components has been demonstrated as a means of regulating pathway activity. In particular, the stability of scaffold protein Salvador (Sav), which is believed to promote Hpo/Wts association, is crucially dependent on its binding partner Hpo. In a cell-based RNAi screen for ubiquitin regulators involved in Sav stability, we identify the HECT domain protein Herc4 (HECT and RLD domain containing E3 ligase) as a Sav E3 ligase. Herc4 expression promotes Sav ubiquitylation and degradation, while Herc4 depletion stabilises Sav. Interestingly, Hpo reduces Sav/Herc4 interaction in a kinase-dependent manner. This suggests the existence of a positive feedback loop, where Hpo stabilises its own positive regulator by antagonising Herc4-mediated degradation of Sav.	[Aerne, Birgit L.; Gailite, Ieva; Tapon, Nicolas] Francis Crick Inst, Lincolns Inn Fields Lab, Apoptosis & Proliferat Control Lab, London, England; [Sims, David] Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England	Francis Crick Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Tapon, N (corresponding author), Francis Crick Inst, Lincolns Inn Fields Lab, Apoptosis & Proliferat Control Lab, 44 Lincolns Inn Fields, London, England.	nic.tapon@crick.ac.uk		Tapon, Nicolas/0000-0001-5267-6510	Cancer Research UK [17064]; The Francis Crick Institute [10436, 10176, 10175] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); The Francis Crick Institute	This work was funded by Cancer Research UK (number 17064).	Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Deng YT, 2013, DEV BIOL, V375, P152, DOI 10.1016/j.ydbio.2012.12.017; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Ho LL, 2010, DEV BIOL, V337, P274, DOI 10.1016/j.ydbio.2009.10.042; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lignitto L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2791; Lin JI, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003813; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Moya IM, 2014, CELL RES, V24, P137, DOI 10.1038/cr.2014.6; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Park BH, 2011, BMB REP, V44, P584, DOI 10.5483/BMBRep.2011.44.9.584; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Song MS, 2008, ONCOGENE, V27, P3176, DOI 10.1038/sj.onc.1210971; Stevens TJ, 2008, PROTEINS, V70, P378, DOI 10.1002/prot.21521; Suryaraja R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.91; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Wu D, 2013, BIOCHEM BIOPH RES CO, V433, P538, DOI 10.1016/j.bbrc.2013.03.023; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; XU TA, 1995, DEVELOPMENT, V121, P1053; Yeung B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061027; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Yue T, 2012, DEV CELL, V22, P255, DOI 10.1016/j.devcel.2011.12.011; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou H, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-113	61	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131113	10.1371/journal.pone.0131113	http://dx.doi.org/10.1371/journal.pone.0131113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125558	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300034
J	Alawi, KM; Aubdool, AA; Liang, LH; Wilde, E; Vepa, A; Psefteli, MP; Brain, SD; Keeble, JE				Alawi, Khadija M.; Aubdool, Aisah A.; Liang, Lihuan; Wilde, Elena; Vepa, Abhinav; Psefteli, Maria-Paraskevi; Brain, Susan D.; Keeble, Julie E.			The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature	FASEB JOURNAL			English	Article						TRPV1; thermogenesis; brown adipose tissue	BROWN ADIPOSE-TISSUE; ADRENERGIC-RECEPTOR; CAPSAICIN RECEPTOR; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; ADAPTIVE THERMOGENESIS; INFLAMMATORY RESPONSE; TRPV1 ANTAGONIST; THYROID-HORMONE; COLD-EXPOSURE; D-AMPHETAMINE	Transient receptor potential vanilloid 1 (TRPV1) is involved in sensory nerve nociceptive signaling. Recently, it has been discovered that TRPV1 receptors also regulate basal body temperature in multiple species from mice to humans. In the present study, we investigated whether TRPV1 modulates basal sympathetic nervous system (SNS) activity. C57BL6/J wild-type (WT) mice and TRPV1 knockout (KO) mice were implanted with radiotelemetry probes for measurement of core body temperature. AMG9810 (50 mg/kg) or vehicle (2% DMSO/5% Tween 80/10 ml/kg saline) was injected intraperitoneally. Adrenoceptor antagonists or vehicle (5 ml/kg saline) was injected subcutaneously. In WT mice, the TRPV1 antagonist, AMG9810, caused significant hyperthermia, associated with increased noradrenaline concentrations in brown adipose tissue. The hyperthermia was significantly attenuated by the beta-adrenoceptor antagonist propranolol, the mixed alpha- /beta-adrenoceptor antagonist labetalol, and the alpha(1)-adrenoceptor antagonist prazosin. TRPV1 KO mice have a normal basal body temperature, indicative of developmental compensation. D-Amphetamine (potent sympathomimetic) caused hyperthermia in WT mice, which was reduced in TRPV1 KO mice, suggesting a decreased sympathetic drive in KOs. This study provides new evidence that TRPV1 controls thermoregulation upstream of the SNS, providing a potential therapeutic target for sympathetic hyperactivity thermoregulatory disorders.	[Alawi, Khadija M.; Vepa, Abhinav; Psefteli, Maria-Paraskevi; Keeble, Julie E.] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Alawi, Khadija M.; Aubdool, Aisah A.; Liang, Lihuan; Wilde, Elena; Brain, Susan D.] Kings Coll London, British Heart Fdn, Cardiovasc Ctr Excellence, London SE1 9NH, England; [Alawi, Khadija M.; Aubdool, Aisah A.; Liang, Lihuan; Wilde, Elena; Brain, Susan D.] Kings Coll London, Ctr Integrat Biomed, Cardiovasc Div, London SE1 9NH, England	University of London; King's College London; University of London; King's College London; University College London; University of London; King's College London	Keeble, JE (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Franklin Wilins Bldg,150 Stamford St, London SE1 9NH, England.	julie.keeble@kcl.ac.uk		Brain, Susan/0000-0002-9684-8342; PSEFTELI, PARASKEVI-MARIA/0000-0001-8892-3800; Aubdool, Dr. Aisah/0000-0002-4712-9421; Keeble, Julie/0000-0002-8891-1129; Vepa, Abhinav/0000-0001-5858-1109	Medical Research Council; Biotechnology and Biological Sciences Research Council Capacity Building Award in Integrative Mammalian Biology; British Heart Foundation; National Centre for Replacement, Reduction, and Refinement; Versus Arthritis [20264, 19296] Funding Source: researchfish; National Centre for the Replacement [NC/K001531/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council Capacity Building Award in Integrative Mammalian Biology(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); National Centre for Replacement, Reduction, and Refinement; Versus Arthritis(Versus Arthritis); National Centre for the Replacement	K.M.A. was supported by the Medical Research Council. A. A. A., J.E.K., and L.L. were supported by a Biotechnology and Biological Sciences Research Council Capacity Building Award in Integrative Mammalian Biology. A. A. A. was further supported by the British Heart Foundation. E.W. was supported by the National Centre for Replacement, Reduction, and Refinement.	Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732; Bankson MG, 2001, J PHARMACOL EXP THER, V297, P846; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bexis S, 2008, BRIT J PHARMACOL, V153, P591, DOI 10.1038/sj.bjp.0707590; Bexis S, 2009, BRIT J PHARMACOL, V158, P259, DOI 10.1111/j.1476-5381.2009.00186.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carvalho F, 2001, ARCH TOXICOL, V75, P465, DOI 10.1007/s002040100264; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen BY, 2012, FASEB J, V26, P2531, DOI 10.1096/fj.11-199505; Connor TJ, 2004, IMMUNOLOGY, V111, P357, DOI 10.1111/j.0019-2805.2004.01847.x; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Darracq L, 1998, J NEUROSCI, V18, P2729; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Docherty JR, 2010, BRIT J PHARMACOL, V160, P1029, DOI 10.1111/j.1476-5381.2010.00722.x; FABER JE, 1988, CIRC RES, V62, P37, DOI 10.1161/01.RES.62.1.37; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; FoellmiAdams LA, 1996, BIOCHEM PHARMACOL, V52, P693, DOI 10.1016/0006-2952(96)00345-0; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; GULATI N, 1980, ARCH INT PHARMACOD T, V246, P251; GULATI OP, 1980, ARCH INT PHARMACOD T, V243, P255; Honore P, 2009, PAIN, V142, P27, DOI 10.1016/j.pain.2008.11.004; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lowell BB, 1997, ANNU REV MED, V48, P307; Marshall NJ, 2013, HYPERTENSION, V61, P246, DOI 10.1161/HYPERTENSIONAHA.112.201434; Mills EM, 2003, NATURE, V426, P403, DOI 10.1038/426403a; MILNER RE, 1989, AM J PHYSIOL, V256, pR42, DOI 10.1152/ajpregu.1989.256.1.R42; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; MOELLER H, 1964, Nature, V201, P1233; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; RIVA E, 1991, BRIT J PHARMACOL, V104, P823, DOI 10.1111/j.1476-5381.1991.tb12513.x; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; RUBIO A, 1995, ENDOCRINOLOGY, V136, P3267, DOI 10.1210/en.136.8.3267; RUBIO A, 1995, ENDOCRINOLOGY, V136, P3277, DOI 10.1210/en.136.8.3277; Ryu V, 2015, J NEUROSCI, V35, P2181, DOI 10.1523/JNEUROSCI.3306-14.2015; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Schmidt LS, 2010, PSYCHOPHARMACOLOGY, V207, P547, DOI 10.1007/s00213-009-1685-2; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Steiner AA, 2007, J NEUROSCI, V27, P7459, DOI 10.1523/JNEUROSCI.1483-07.2007; Tamayo N, 2008, J MED CHEM, V51, P2744, DOI 10.1021/jm7014638; TARIQ M, 1989, LIFE SCI, V44, P951, DOI 10.1016/0024-3205(89)90494-3; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tuominen JA, 1996, J INTERN MED, V239, P399, DOI 10.1046/j.1365-2796.1996.473824000.x; Ueta CB, 2012, J ENDOCRINOL, V214, P359, DOI 10.1530/JOE-12-0155; Westermann Jurgen, 2002, Clin Lab, V48, P61; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAMAHARA J, 1985, J PHARMACOBIO-DYNAM, V8, P591; Yamashita H, 2008, J BIOCHEM, V143, P385, DOI 10.1093/jb/mvm233; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541	58	44	46	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4285	4298		10.1096/fj.15-272526	http://dx.doi.org/10.1096/fj.15-272526			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26136480	hybrid, Green Published			2022-12-26	WOS:000361367300018
J	Xhabija, B; Vacratsis, PO				Xhabija, Besa; Vacratsis, Panayiotis O.			Receptor-mediated Endocytosis 8 Utilizes an N-terminal Phosphoinositide-binding Motif to Regulate Endosomal Clathrin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); clathrin; endocytosis; protein motif; protein sorting; protein-protein interaction; PI(3)P; RME-8; SNX1; retrograde transport	DOMAIN PROTEIN RME-8; MANNOSE 6-PHOSPHATE RECEPTORS; FYVE DOMAIN; PX DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; INTEGRIN-BINDING; SORTING NEXIN-1; COATED VESICLES	Background: RME-8 is involved in clathrin removal at early endosomes. Results: RME-8 possesses a novel PI(3)P-binding motif within its N terminus. Conclusion: Association of RME-8 with PI(3)P is required for endosomal clathrin removal and alters the steady state localization of retrograde transport cargo CI-MPR. Significance: Regulation of PI(3)P association or PI(3)P levels is likely critical for controlling early endosomal organizational activities. Receptor-mediated endocytosis 8 (RME-8) is a DnaJ domain containing protein implicated in translocation of Hsc70 to early endosomes for clathrin removal during retrograde transport. Previously, we have demonstrated that RME-8 associates with early endosomes in a phosphatidylinositol 3-phosphate (PI(3)P)-dependent fashion. In this study, we have now identified amino acid determinants required for PI(3)P binding within a region predicted to adopt a pleckstrin homology-like fold in the N terminus of RME-8. The ability of RME-8 to associate with PI(3)P and early endosomes is largely abolished when residues Lys(17), Trp(20), Tyr(24), or Arg(26) are mutated resulting in diffuse cytoplasmic localization of RME-8 while maintaining the ability to interact with Hsc70. We also provide evidence that RME-8 PI(3)P binding regulates early endosomal clathrin dynamics and alters the steady state localization of the cation-independent mannose 6-phosphate receptor. Interestingly, RME-8 endosomal association is also regulated by the PI(3)P-binding protein SNX1, a member of the retromer complex. Wild type SNX1 restores endosomal localization of RME-8 W20A, whereas a SNX1 variant deficient in PI(3)P binding disrupts endosomal localization of wild type RME-8. These results further highlight the critical role for PI(3)P in the RME-8-mediated organizational control of various endosomal activities, including retrograde transport.	[Xhabija, Besa; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Windsor	Vacratsis, PO (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	vacratsi@uwindsor.ca	Xhabija, Besa/GOP-2447-2022	Xhabija, Besa/0000-0002-4784-2454	Canadian Institutes of Health Research [123241]; University of Windsor Golden Jubilee Health Research Award; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Windsor Golden Jubilee Health Research Award; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported in part by Operating Grant 123241 from Canadian Institutes of Health Research (to P. O. V.) and by a University of Windsor Golden Jubilee Health Research Award (to P. O. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Graduate Scholarship.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Busse RA, 2013, AUTOPHAGY, V9, P770, DOI 10.4161/auto.23978; CHANG FN, 1978, BIOCHIM BIOPHYS ACTA, V518, P89, DOI 10.1016/0005-2787(78)90118-1; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Ellson CD, 2002, J CELL SCI, V115, P1099; Fujibayashi A, 2008, CELL STRUCT FUNCT, V33, P35, DOI 10.1247/csf.07045; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; Koumandou VL, 2013, EUKARYOT CELL, V12, P330, DOI 10.1128/EC.00273-12; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon SK, 2001, CURR BIOL, V11, pR49, DOI 10.1016/S0960-9822(01)00010-0; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; McGough IJ, 2013, J CELL SCI, V126, P45, DOI 10.1242/jcs.112904; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Popoff V, 2009, TRAFFIC, V10, P1868, DOI 10.1111/j.1600-0854.2009.00993.x; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Scheele U, 2003, J BIOL CHEM, V278, P25357, DOI 10.1074/jbc.M303738200; Seaman Matthew Nj, 2014, Commun Integr Biol, V7, pe29483, DOI 10.4161/cib.29483; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Silady RA, 2004, PLANT PHYSIOL, V136, P3095, DOI 10.1104/pp.104.050583; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050; Xhabija B, 2011, FEBS LETT, V585, P1722, DOI 10.1016/j.febslet.2011.04.016; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	53	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21676	21689		10.1074/jbc.M115.644757	http://dx.doi.org/10.1074/jbc.M115.644757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26134565	Green Published, hybrid			2022-12-26	WOS:000360637600039
J	De Meester, N; Dos Santos, GAP; Rigaux, A; Valdes, Y; Derycke, S; Moens, T				De Meester, Nele; Dos Santos, Giovanni A. P.; Rigaux, Annelien; Valdes, Yirina; Derycke, Sofie; Moens, Tom			Daily Temperature Fluctuations Alter Interactions between Closely Related Species of Marine Nematodes	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; FREE-LIVING MARINE; FOOD AVAILABILITY; COEXISTENCE; GROWTH; ENVIRONMENT; COMPETITION; COMPLEX; FITNESS; FACILITATION	In addition to an increase in mean temperature, climate change models predict decreasing amplitudes of daily temperature fluctuations. In temperate regions, where daily and seasonal fluctuations are prominent, such decreases in daily temperature fluctuations can have a pronounced effect on the fitness of species and on the outcome of species interactions. In this study, the effect of a temperature regime with daily fluctuations versus a constant temperature on the fitness and interspecific interactions of three cryptic species of the marine nematode species complex of Litoditis marina (Pm I, Pm III and Pm IV) were investigated. In a lab experiment, different combinations of species (monospecific treatment: Pm I and Pm IV and Pm III alone; two-species treatment: Pm I + Pm IV; three-species treatment: Pm I + Pm IV + Pm III) were subjected to two different temperature regimes: one constant and one fluctuating temperature. Our results showed that fluctuating temperature had minor or no effects on the population fitness of the three species in monocultures. In contrast, interspecific interactions clearly influenced the fitness of all three species, both positively and negatively. Temperature regime did have a substantial effect on the interactions between the species. In the two-species treatment, temperature regime altered the interaction from a sort of mutualism to commensalism. In addition, the strength of the interspecific interactions changed depending on the temperature regime in the three-species treatment. This experiment confirms that interactions between the species can change depending on the abiotic environment; these results show that it is important to incorporate the effect of fluctuations on interspecific interactions to predict the effect of climate change on biodiversity.	[De Meester, Nele; Rigaux, Annelien; Derycke, Sofie; Moens, Tom] Univ Ghent, Dept Biol, Marine Biol Unit, B-9000 Ghent, Belgium; [De Meester, Nele; Rigaux, Annelien; Derycke, Sofie] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium; [Dos Santos, Giovanni A. P.; Valdes, Yirina] Univ Fed Pernambuco, UFPE, CCB, Dept Zool, Recife, PE, Brazil	Ghent University; Ghent University; Universidade Federal de Pernambuco	De Meester, N (corresponding author), Univ Ghent, Dept Biol, Marine Biol Unit, B-9000 Ghent, Belgium.	nele.demeester@ugent.be	Moens, Tom/AAB-8701-2019; dos Santos, Giovanni/I-6539-2015	dos Santos, Giovanni/0000-0003-4761-7182	Flemish Fund for Scientific Research (FWO) [3G040407]; Ghent University [011060002, 01GA1911 W]	Flemish Fund for Scientific Research (FWO)(FWO); Ghent University(Ghent University)	Funding for this research was obtained from the Flemish Fund for Scientific Research (FWO) through project 3G040407, and from Ghent University through projects 011060002 and 01GA1911 W.	Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ATKINSON D, 1996, ANIMALS TEMPERATURE, P183; Begon M., 2009, POPULATION ECOLOGY U; Benton TG, 2000, EVOL ECOL RES, V2, P769; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brakefield PM, 1997, P ROY SOC B-BIOL SCI, V264, P717, DOI 10.1098/rspb.1997.0102; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Cossins A. R., 1987, TEMPERATURE BIOL ANI; Darwin C, 1859, ORIGIN SPECIES MEANS; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; De Meester N, TEMPERATURE SA UNPUB; De Meester N, 2015, OIKOS, V124, P561, DOI 10.1111/oik.01779; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2012, MOL ECOL RESOUR, V12, P607, DOI 10.1111/j.1755-0998.2012.03128.x; Derycke S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-1; Descamps-Julien B, 2005, ECOLOGY, V86, P2815, DOI 10.1890/04-1700; dos Santos GAP, 2008, J EXP MAR BIOL ECOL, V355, P27, DOI 10.1016/j.jembe.2007.11.015; dos Santos GAP, 2009, MAR BIOL, V156, P629, DOI 10.1007/s00227-008-1114-9; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; HANSKI I, 1983, J ANIM ECOL, V52, P263, DOI 10.2307/4599; HIGASHI M, 1989, AM NAT, V133, P288, DOI 10.1086/284919; JOHNSON LL, 1977, J EXP MAR BIOL ECOL, V28, P141, DOI 10.1016/0022-0981(77)90113-7; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; Martinez JG, 2012, APPL SOIL ECOL, V56, P10, DOI 10.1016/j.apsoil.2012.02.001; Moens T, 2005, AQUAT MICROB ECOL, V40, P77, DOI 10.3354/ame040077; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Mougi A, 2005, ECOL RES, V20, P581, DOI 10.1007/s11284-005-0070-9; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Peng YQ, 2008, SYMBIOSIS, V45, P9; Petavy G, 2001, PHYSIOL ENTOMOL, V26, P351, DOI 10.1046/j.0307-6962.2001.00255.x; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; R Core Team, 2018, R LANG ENV STAT COMP; Rojas-Echenique J, 2011, ECOLOGY, V92, P1174; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; Vanfleteren JR, 1980, NEMATODES BIOL MODEL, V2, P47; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x	48	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131625	10.1371/journal.pone.0131625	http://dx.doi.org/10.1371/journal.pone.0131625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147103	Green Published, gold			2022-12-26	WOS:000358157600115
J	Wei, YQ; Wang, DG; Yang, H; Cao, H				Wei, You-quan; Wang, Dian-gang; Yang, Hao; Cao, Heng			Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							CLOPIDOGREL RESPONSIVENESS; PLATELET-AGGREGATION; INTERVENTION; POLYMORPHISM; INHIBITION; REACTIVITY; GENOTYPE; OUTCOMES; DISEASE; RISK	Background The cytochrome P450 (CYP450) 2C19 681 genotypes affect the antiplatelet activity of clopidogrel. We investigated the correlation of CYP 2C19 681G > A mutation with clopidogrel resistance (CR). Additionally, we studied the effect of CR on clinical prognosis of patients with acute coronary syndrome (ACS). Methods One hundred ten ACS patients undergoing percutaneous coronary intervention, who were followed-up for 1 year, were included in the study. The patients were co-administered aspirin 100 mg/d and clopidogrel 75mg/d following a loading dose of 300 mg. CR was assessed on the basis of polymorphism observed in the CYP2C19 subgroup. Results Patients in GG genotype group exhibited greater inhibition of platelet aggregation than patients in GA and AA genotype groups (16.2 +/- 10.1%; 10.2 +/- 9.9%; 8.0 +/- 5.9%, respectively, p < 0.01). CYP2C19 681GG genotype group was associated with lower CR than CYP2C19 681A allele (GA + AA) group (9/59 vs. (12+ 5)/51; p = 0.009). Over a follow-up of 12 months, the incidence of recurrent angina, acute myocardial infarction, and intra-stent thrombosis in CYP2C19 681 GG carriers was significantly lower than that in CYP2C19 681A allele (GA + AA) group (2/59 vs. 8/51, 1/59 vs. 6/51, 0 vs. 4/51, respectively, p < 0.05). Conclusion CYP 2C19*2 is associated with reduced clopidogrel antiplatelet activity and might be an important marker for poor prognosis of ACS.	[Wei, You-quan; Yang, Hao; Cao, Heng] Wannan Med Coll, Affiliated Hosp 1, Dept Cardiol, Wuhu, Peoples R China; [Wang, Dian-gang] Second Peoples Hosp Huangchuan Cty, Dept Cardiol, Xinyang, Peoples R China	Wannan Medical College	Cao, H (corresponding author), Wannan Med Coll, Affiliated Hosp 1, Dept Cardiol, Wuhu, Peoples R China.	ablationer@aliyun.com			Natural Science Research of Anhui Province College, Anhui, China, HC [kj2011A263]	Natural Science Research of Anhui Province College, Anhui, China, HC	This work was supported by grants from the Key Project of Natural Science Research of Anhui Province College (kj2011A263), Anhui, China, HC.	Bhatt DL, 2012, EUR HEART J, V33, P2143, DOI 10.1093/eurheartj/ehs059; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Gurbel PA, 2005, J AM COLL CARDIOL, V45, P1392, DOI 10.1016/j.jacc.2005.01.030; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Jaremo P, 2002, J INTERN MED, V252, P233, DOI 10.1046/j.1365-2796.2002.01027.x; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Nelson David R., 2009, Human Genomics, V4, P59; Price MJ, 2012, J AM COLL CARDIOL, V59, P1928, DOI 10.1016/j.jacc.2011.11.068; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Rothenbacher D, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-61; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Smith SMG, 2007, J AM COLL CARDIOL, V49, p375A; Speed WC, 2009, PHARMACOGENOMICS J, V9, P283, DOI 10.1038/tpj.2009.10; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056	19	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132561	10.1371/journal.pone.0132561	http://dx.doi.org/10.1371/journal.pone.0132561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147597	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600301
J	Furukawa, J; Tsuda, M; Okada, K; Kimura, T; Piao, J; Tanaka, S; Shinohara, Y				Furukawa, Jun-ichi; Tsuda, Masumi; Okada, Kazue; Kimura, Taichi; Piao, Jinhua; Tanaka, Shinya; Shinohara, Yasuro			Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to Malignancy	PLOS ONE			English	Article							TIME-OF-FLIGHT; STEM-CELL DIFFERENTIATION; N-LINKED OLIGOSACCHARIDE; HAMSTER-KIDNEY CELLS; MASS-SPECTROMETRY; ABERRANT GLYCOSYLATION; QUANTITATIVE GLYCOMICS; GLIOBLASTOMA-MULTIFORME; BISECTING-GLCNAC; SIALIC ACIDS	Cancer cells frequently express glycans at different levels and/or with fundamentally different structures from those expressed by normal cells, and therefore elucidation and manipulation of these glycosylations may provide a beneficial approach to cancer therapy. However, the relationship between altered glycosylation and causal genetic alteration(s) is only partially understood. Here, we employed a unique approach that applies comprehensive glycomic analysis to a previously described multistep tumorigenesis model. Normal human astrocytes were transformed via the serial introduction of hTERT, SV40ER, HRasV12, and myrAKT, thereby mimicking human brain tumor grades I-IV. More than 160 glycans derived from three major classes of cell surface glycoconjugates (N-and O-glycans on glycoproteins, and glycosphingolipids) were quantitatively explored, and specific glycosylation patterns related to malignancy were systematically identified. The sequential introduction of hTERT, SV40ER, H-RasV12, and myrAKT led to (i) temporal expression of pauci-mannose/mono-antennary type N-glycans and GD3 (hTERT); (ii) switching from ganglio-to globo-series glycosphingolipids and the appearance of Neu5Gc (hTERT and SV40ER); (iii) temporal expression of bisecting GlcNAc residues, a2,6-sialylation, and stage-specific embryonic antigen-4, accompanied by suppression of core 2 O-glycan biosynthesis (hTERT, SV40ER and Ras); and (iv) increased expression of (neo) lacto-series glycosphingolipids and fucosylated N-glycans (hTERT, SV40ER, Ras and AKT). These sequential and transient glycomic alterations may be useful for tumor grade diagnosis and tumor prognosis, and also for the prediction of treatment response.	[Furukawa, Jun-ichi; Okada, Kazue; Piao, Jinhua; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Med & Funct Glyc, Sapporo, Hokkaido, Japan; [Furukawa, Jun-ichi; Okada, Kazue; Piao, Jinhua; Shinohara, Yasuro] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan; [Tsuda, Masumi; Kimura, Taichi; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Tanaka, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan.	tanaka@med.hokudai.ac.jp; yshinohara@sci.hokudai.ac.jp	Tanaka, Shinya/AAO-8771-2021; Tanaka, Shinya/D-3586-2011	Tanaka, Shinya/0000-0001-6470-3301; 	Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aoyanagi E, 2010, APPL IMMUNOHISTO M M, V18, P518, DOI 10.1097/PAI.0b013e3181e3bf0d; Arita H, 2013, ACTA NEUROPATHOL, V126, P939, DOI 10.1007/s00401-013-1203-9; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Califice S, 2004, INT J ONCOL, V25, P983; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; DENNIS JW, 1989, ONCOGENE, V4, P853; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Fujitani N, 2011, J BIOL CHEM, V286, P41669, DOI 10.1074/jbc.M111.301796; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Furukawa J, 2011, ANAL CHEM, V83, P9060, DOI 10.1021/ac2019848; Ghaderi D, 2012, BIOTECHNOL GENET ENG, V28, P147, DOI 10.5661/bger-28-147; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hakomori S, 1996, CANCER RES, V56, P5309; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Holst S, 2013, MOL CELL PROTEOMICS, V12, P3081, DOI 10.1074/mcp.M113.030387; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kita Y, 2007, MOL CELL PROTEOMICS, V6, P1437, DOI 10.1074/mcp.T600063-MCP200; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Kizuka Y, 2014, J BIOL CHEM, V289, P11253, DOI 10.1074/jbc.M114.554311; Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200; Kozak RP, 2014, ANAL BIOCHEM, V453, P29, DOI 10.1016/j.ab.2014.02.030; Kroes RA, 2007, J NEUROCHEM, V103, P14, DOI 10.1111/j.1471-4159.2007.04780.x; Liang YJ, 2013, P NATL ACAD SCI USA, V110, P4968, DOI 10.1073/pnas.1302825110; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Lou YW, 2014, P NATL ACAD SCI USA, V111, P2482, DOI 10.1073/pnas.1400283111; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Merrill AH, 2005, GLYCOBIOLOGY, V15, p15G, DOI 10.1093/glycob/cwi070; Miura Y, 2007, CHEM-EUR J, V13, P4797, DOI 10.1002/chem.200601872; Naven TJP, 1996, RAPID COMMUN MASS SP, V10, P1361, DOI 10.1002/(SICI)1097-0231(199608)10:11<1361::AID-RCM642>3.0.CO;2-A; OGISO M, 1991, NEUROSCIENCE, V41, P167, DOI 10.1016/0306-4522(91)90207-5; PIERCE M, 1986, J BIOL CHEM, V261, P772; Pinho SS, 2013, TRENDS MOL MED, V19, P664, DOI [10.1016/j.molmed.2013, 10.1016/j.molmed.2013.07.003]; Powell AK, 1996, RAPID COMMUN MASS SP, V10, P1027; Reardon DA, 2006, J CLIN ONCOL, V24, P1253, DOI 10.1200/JCO.2005.04.5302; Rebbaa A, 1999, CLIN CANCER RES, V5, P3661; SAKAMOTO J, 1986, CANCER RES, V46, P1553; SANTER UV, 1984, CANCER RES, V44, P3730; Sarkar M, 2010, P NATL ACAD SCI USA, V107, P9677, DOI 10.1073/pnas.1004431107; Sasai K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-36; Sheng Y, 1997, INT J CANCER, V73, P850, DOI 10.1002/(SICI)1097-0215(19971210)73:6<850::AID-IJC15>3.0.CO;2-8; Sonoda Y, 2001, CANCER RES, V61, P6674; Stubbs HJ, 1996, BIOCHEMISTRY-US, V35, P937, DOI 10.1021/bi9513719; Tsuchiya N, 2005, INT J ONCOL, V27, P1231; Uematsu R, 2005, MOL CELL PROTEOMICS, V4, P1977, DOI 10.1074/mcp.M500203-MCP200; Uematsu R, 2009, MOL CELL PROTEOMICS, V8, P232, DOI 10.1074/mcp.M800145-MCP200; YAMAMOTO H, 1995, GLYCOCONJUGATE J, V12, P848, DOI 10.1007/BF00731247; Yamamoto H, 2000, CANCER RES, V60, P134; YAMASHITA K, 1984, J BIOL CHEM, V259, P834; Yang XP, 2003, CANCER RES, V63, P7753; Yates AJ, 1999, J NEUROPATH EXP NEUR, V58, P1250, DOI 10.1097/00005072-199912000-00006; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x	55	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0128300	10.1371/journal.pone.0128300	http://dx.doi.org/10.1371/journal.pone.0128300			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132161	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000014
J	Rathnayake, N; Gustafsson, A; Norhammar, A; Kjellstrom, B; Klinge, B; Ryden, L; Tervahartiala, T; Sorsa, T				Rathnayake, Nilminie; Gustafsson, Anders; Norhammar, Anna; Kjellstrom, Barbro; Klinge, Bjorn; Ryden, Lars; Tervahartiala, Taina; Sorsa, Timo		PAROKRANK Steering Grp	Salivary Matrix Metalloproteinase-8 and-9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease)	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; NEUTROPHIL COLLAGENASE; UNIVERSAL DEFINITION; MATRIX-METALLOPROTEINASE-9; INVOLVEMENT; INHIBITION; PREVALENCE; ACTIVATION; BIOMARKER; TIMPS	Background and Objective Matrix metalloproteinase (MMP) -8, -9 and myeloperoxidase (MPO) are inflammatory mediators. The potential associations between MMP-8, -9, MPO and their abilities to reflect cardiovascular risk remains to be evaluated in saliva. The objective of this study was to investigate the levels and associations of salivary MMP-8, -9, MPO and tissue inhibitors of metalloproteinase (TIMP)-1 in myocardial infarction (MI) patients and controls with or without periodontitis. Materials and Methods 200 patients with a first MI admitted to coronary care units in Sweden from May 2010 to December 2011 and 200 controls matched for age, gender, residential area and without previous MI were included. Dental examination and saliva sample collection was performed 6-10 weeks after the MI in patients and at baseline in controls. The biomarkers MMP -8, -9, MPO and TIMP-1 were analyzed by time-resolved immunofluorescence assay (IFMA), Western blot and Enzyme-Linked ImmunoSorbent Assay (ELISA). Results After compensation for gingivitis, gingival pockets and smoking, the mean salivary levels of MMP-8 (543 vs 440 ng/mL, p = 0.003) and MPO (1899 vs 1637 ng/mL, p = 0.02) were higher in non-MI subjects compared to MI patients. MMP-8, -9 and MPO correlated positively with clinical signs of gingival/periodontal inflammation while TIMP-1 correlated mainly negatively with these signs. The levels of latent and active forms of MMP-8 did not differ between the MI and non-MI groups. Additionally, MMP-8, MPO levels and MMP-8/TIMP-1 ratio were significantly higher in men compared to women with MI. Conclusions This study shows that salivary levels of the analyzed biomarkers are associated with periodontal status. However, these biomarkers could not differentiate between patients with or without a MI. These findings illustrate the importance to consider the influence of oral conditions when analyzing levels of inflammatory salivary biomarkers.	[Rathnayake, Nilminie; Gustafsson, Anders; Klinge, Bjorn; Sorsa, Timo] Karolinska Inst, Dept Dent Med, Div Periodontol, Stockholm, Sweden; [Norhammar, Anna; Kjellstrom, Barbro; Ryden, Lars] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden; [Tervahartiala, Taina; Sorsa, Timo] Univ Helsinki, Helsinki Univ Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Sorsa, Timo] Univ Helsinki, Helsinki Univ Cent Hosp, Dept Periodontol, Helsinki, Finland; [Klinge, Bjorn] Malmo Univ, Fac Odontol, Dept Periodontol, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Malmo University	Rathnayake, N (corresponding author), Karolinska Inst, Dept Dent Med, Div Periodontol, Stockholm, Sweden.	Nilminie.Rathnayake@ki.se	Kjellström, Barbro/AAR-3484-2020; Klinge, Bjorn/ABA-7045-2021	Kjellström, Barbro/0000-0002-7936-1209; Norhammar, Anna/0000-0002-4467-0132	Swedish National Graduate School in Odontological Science; Swedish Dental Society, AFA Insurance; Heart and Lung Foundation; Stockholm County Council (ALF project), VR Research Funding; Academy of Finland and Helsinki University Central Hospital Research Foundation	Swedish National Graduate School in Odontological Science; Swedish Dental Society, AFA Insurance; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF project), VR Research Funding; Academy of Finland and Helsinki University Central Hospital Research Foundation(Academy of Finland)	The study was financially supported by the Swedish National Graduate School in Odontological Science, the Swedish Dental Society, AFA Insurance, the Heart and Lung Foundation, the Stockholm County Council (ALF project), VR Research Funding and the Academy of Finland and Helsinki University Central Hospital Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Buduneli E, 2011, J PERIODONTOL, V82, P716, DOI 10.1902/jop.2010.100492; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Furuholm J, 2006, J PERIODONTAL RES, V41, P486, DOI 10.1111/j.1600-0765.2006.00900.x; Gomes Sabrina C, 2009, Acta odontol. latinoam., V22, P201; Guan WH, 2011, ACTA NEUROCHIR SUPPL, V111, P295, DOI 10.1007/978-3-7091-0693-8_49; Gursoy UK, 2013, J CLIN PERIODONTOL, V40, P18, DOI 10.1111/jcpe.12020; HEMMILA I, 1984, ANAL BIOCHEM, V137, P335, DOI 10.1016/0003-2697(84)90095-2; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hernandez M, 2010, J PERIODONTOL, V81, P1644, DOI 10.1902/jop.2010.100196; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hugoson A, 2008, J CLIN PERIODONTOL, V35, P338, DOI 10.1111/j.1600-051X.2008.01279.x; Ikitimur B, 2010, FUTUR CARDIOL, V6, P693, DOI [10.2217/fca.10.75, 10.2217/FCA.10.75]; Ingman T, 1996, J CLIN PERIODONTOL, V23, P1127, DOI 10.1111/j.1600-051X.1996.tb01814.x; Lenglet S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/659282; Leppilahti JM, 2014, J CLIN PERIODONTOL, V41, P348, DOI 10.1111/jcpe.12223; Loria V, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/135625; Mantyla P, 2006, J PERIODONTAL RES, V41, P503, DOI 10.1111/j.1600-0765.2006.00897.x; Mantyla P, 2012, J PERIODONTAL RES, V47, P345, DOI 10.1111/j.1600-0765.2011.01439.x; Meschiari CA, 2013, CLIN CHIM ACTA, V421, P140, DOI 10.1016/j.cca.2013.03.008; Nagase H, 1997, BIOL CHEM, V378, P151; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Palm F, 2014, INNATE IMMUN-LONDON, V20, P511, DOI 10.1177/1753425913501214; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Rautelin HI, 2009, ANN MED, V41, P208, DOI 10.1080/07853890802482452; Richards Derek, 2014, Evid Based Dent, V15, P70, DOI 10.1038/sj.ebd.6401037; Rugina Mihaela, 2007, Roum Arch Microbiol Immunol, V66, P10; SAARI H, 1990, BIOCHEM BIOPH RES CO, V171, P979, DOI 10.1016/0006-291X(90)90780-Q; Sakamoto W, 2008, CLIN BIOCHEM, V41, P584, DOI 10.1016/j.clinbiochem.2007.12.025; Schindhelm RK, 2009, CLIN CHEM, V55, P1462, DOI 10.1373/clinchem.2009.126029; SMITH QT, 1986, J PERIODONTAL RES, V21, P45, DOI 10.1111/j.1600-0765.1986.tb01437.x; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Sorsa T, 2011, PHARMACOL RES, V63, P108, DOI 10.1016/j.phrs.2010.10.005; Spallarossa P, 2008, ATHEROSCLEROSIS, V198, P458, DOI 10.1016/j.atherosclerosis.2007.11.030; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Uitto VJ, 2003, PERIODONTOL 2000, V31, P77, DOI 10.1034/j.1600-0757.2003.03106.x; Verstappen J, 2006, J DENT RES, V85, P1074, DOI 10.1177/154405910608501202; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Yamamoto D, 2009, CURR MED CHEM, V16, P1349, DOI 10.2174/092986709787846514; Yokota T, 2010, HEART VESSELS, V25, P460, DOI 10.1007/s00380-010-0013-4	42	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0126370	10.1371/journal.pone.0126370	http://dx.doi.org/10.1371/journal.pone.0126370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132583	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000005
J	Thomas, S; Fisher, KH; Snowden, JA; Danson, SJ; Brown, S; Zeidler, MP				Thomas, Sally; Fisher, Katherine H.; Snowden, John A.; Danson, Sarah J.; Brown, Stephen; Zeidler, Martin P.			Methotrexate Is a JAK/STAT Pathway Inhibitor	PLOS ONE			English	Article							TYROSINE KINASE JAK2; RHEUMATOID-ARTHRITIS; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; CONSTITUTIVE ACTIVATION; LYMPHOCYTIC-LEUKEMIA; AVAILABLE THERAPY; STAT3 MUTATIONS; MYELOFIBROSIS; DROSOPHILA	Background The JAK/STAT pathway transduces signals from multiple cytokines and controls haematopoiesis, immunity and inflammation. In addition, pathological activation is seen in multiple malignancies including the myeloproliferative neoplasms (MPNs). Given this, drug development efforts have targeted the pathway with JAK inhibitors such as ruxolitinib. Although effective, high costs and side effects have limited its adoption. Thus, a need for effective low cost treatments remains. Methods & Findings We used the low-complexity Drosophila melanogaster pathway to screen for small molecules that modulate JAK/STAT signalling. This screen identified methotrexate and the closely related aminopterin as potent suppressors of STAT activation. We show that methotrexate suppresses human JAK/STAT signalling without affecting other phosphorylation-dependent pathways. Furthermore, methotrexate significantly reduces STAT5 phosphorylation in cells expressing JAK2 V617F, a mutation associated with most human MPNs. Methotrexate acts independently of dihydrofolate reductase (DHFR) and is comparable to the JAK1/2 inhibitor ruxolitinib. However, cells treated with methotrexate still retain their ability to respond to physiological levels of the ligand erythropoietin. Conclusions Aminopterin and methotrexate represent the first chemotherapy agents developed and act as competitive inhibitors of DHFR. Methotrexate is also widely used at low doses to treat inflammatory and immune-mediated conditions including rheumatoid arthritis. In this low-dose regime, folate supplements are given to mitigate side effects by bypassing the biochemical requirement for DHFR. Although independent of DHFR, the mechanism-of-action underlying the low-dose effects of methotrexate is unknown. Given that multiple pro-inflammatory cytokines signal through the pathway, we suggest that suppression of the JAK/STAT pathway is likely to be the principal anti-inflammatory and immunosuppressive mechanism-of-action of low-dose methotrexate. In addition, we suggest that patients with JAK/STAT-associated haematological malignancies may benefit from low-dose methotrexate treatments. While the JAK1/2 inhibitor ruxolitinib is effective, a (sic)43,200 annual cost precludes widespread adoption. With an annual methotrexate cost of around (sic)32, our findings represent an important development with significant future potential.	[Thomas, Sally; Fisher, Katherine H.; Zeidler, Martin P.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; [Thomas, Sally; Fisher, Katherine H.; Zeidler, Martin P.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Thomas, Sally; Snowden, John A.; Danson, Sarah J.] Univ Sheffield, Acad Unit Clin Oncol, Sheffield S10 2TN, S Yorkshire, England; [Snowden, John A.] Royal Hallamshire Hosp, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England; [Danson, Sarah J.] Weston Pk Hosp, Sheffield Expt Canc Med Ctr, Sheffield S10 2SJ, S Yorkshire, England; [Brown, Stephen] Univ Sheffield, Dept Biomed Sci, Sheffield RNAi Screening Facil, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Weston Park Hospital; University of Sheffield	Zeidler, MP (corresponding author), Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England.	m.zeidler@sheffield.ac.uk		Brown, Stephen/0000-0002-7581-7491; Zeidler, Martin/0000-0003-2942-1135; SNOWDEN, JOHN/0000-0001-6819-3476; Fisher, Katherine/0000-0002-2751-156X	MRC Pump Priming grant [G0802527]; joint Yorkshire Cancer Research / Cancer Research-United Kingdom clinical PhD Fellowship [132594]; EU Framework 7 funding [201666]; Cancer Research-United Kingdom Senior Cancer Research Fellowship [C24089/A8301]; Wellcome Trust equipment award [084757]	MRC Pump Priming grant; joint Yorkshire Cancer Research / Cancer Research-United Kingdom clinical PhD Fellowship; EU Framework 7 funding; Cancer Research-United Kingdom Senior Cancer Research Fellowship; Wellcome Trust equipment award	This work was supported by: An MRC (http://www.mrc.ac.uk) Pump Priming grant (Ref: G0802527) which supported the original small molecule library purchase. A Wellcome Trust (http://www.wellcome.ac.uk) equipment award to the Sheffield RNAi Screening Facility and SB (Ref: 084757). A joint Yorkshire Cancer Research (http://yorkshirecancerresearch.org.uk) / Cancer ResearchUnited Kingdom (http://www.cancerresearchuk.org) clinical PhD Fellowship to ST (Ref: 132594) EU Framework 7 funding (http://cordis.europa.eu/fp7/home_en.html) for the 'Cancer Pathways' project which supported KHF (Ref: 201666). A Cancer Research-United Kingdom (http://www.cancerresearchuk.org) Senior Cancer Research Fellowship to MPZ (Ref: C24089/A8301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2011, BLOOD, V118, P1610, DOI 10.1182/blood-2011-02-335042; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bain BJ, 2014, BRIT J HAEMATOL, V166, P809, DOI 10.1111/bjh.12963; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BOOKBINDER SA, 1984, CLIN EXP RHEUMATOL, V2, P185; Cochet O, 2006, CELL SIGNAL, V18, P449, DOI 10.1016/j.cellsig.2005.05.010; Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3; DIXON KH, 1991, CANCER COMMUN-US, V3, P357, DOI 10.3727/095535491820873687; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Fisher KH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-506; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hobl EL, 2012, CLIN THER, V34, P1195, DOI 10.1016/j.clinthera.2012.03.059; Hodge LS, 2014, BLOOD, V123, P1055, DOI 10.1182/blood-2013-08-521963; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jelkmann W, 2009, NEPHROL DIAL TRANSPL, V24, P1366, DOI 10.1093/ndt/gfp058; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Kim BH, 2010, BRIT J HAEMATOL, V148, P132, DOI 10.1111/j.1365-2141.2009.07925.x; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lamy T, 2011, BLOOD, V117, P2764, DOI 10.1182/blood-2010-07-296962; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; LEVITZKI A, 1990, BIOCHEM PHARMACOL, V40, P913, DOI 10.1016/0006-2952(90)90474-Y; LI JC, 1984, P NATL ACAD SCI-BIOL, V81, P5694, DOI 10.1073/pnas.81.18.5694; MCEVOY GK, 2005, AM HOSP FORMULARY SE; Mesa RA, 2014, HAEMATOLOGICA, V99, P292, DOI 10.3324/haematol.2013.087650; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Passamonti F, 2014, BLOOD, V123, P1833, DOI 10.1182/blood-2013-12-544411; Radtke S, 2013, BLOOD, V121, P5145, DOI 10.1182/blood-2013-01-480335; Reilly JT, 2014, BRIT J HAEMATOL, V167, P418, DOI 10.1111/bjh.12985; Rosenthal A, 2014, EXPERT OPIN PHARMACO, V15, P1265, DOI 10.1517/14656566.2014.913024; Rozovski U, 2014, BLOOD, V123, P3797, DOI 10.1182/blood-2013-10-534073; Shilling AD, 2010, DRUG METAB DISPOS, V38, P2023, DOI 10.1124/dmd.110.033787; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Stec W, 2013, MOL BIOL CELL, V24, P3000, DOI 10.1091/mbc.E13-05-0275; Verstovsek S, 2014, CANCER-AM CANCER SOC, V120, P513, DOI 10.1002/cncr.28441; Visentin M, 2012, HEMATOL ONCOL CLIN N, V26, P629, DOI 10.1016/j.hoc.2012.02.002; Wade R, 2013, PHARMACOECONOMICS, V31, P841, DOI 10.1007/s40273-013-0083-0; Walker JG, 2005, J RHEUMATOL, V32, P1650; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Whittle SL, 2004, RHEUMATOLOGY, V43, P267, DOI 10.1093/rheumatology/keh088	51	86	89	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130078	10.1371/journal.pone.0130078	http://dx.doi.org/10.1371/journal.pone.0130078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131691	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358153000052
J	Hirota, M; Miyagawa, S; Kanda, H; Endo, T; Lohmann, TK; Miyoshi, T; Morimoto, T; Fujikado, T				Hirota, Masakazu; Miyagawa, Suguru; Kanda, Hiroyuki; Endo, Takao; Lohmann, Tibor Karl; Miyoshi, Tomomitsu; Morimoto, Takeshi; Fujikado, Takashi			Slow Cone Reflectance Changes during Bleaching Determined by Adaptive Optics Scanning Laser Ophthalmoscope in Living Human Eyes	PLOS ONE			English	Article							VISUAL-PIGMENT REGENERATION; INTRINSIC SIGNALS; OUTER SEGMENT; RECOVERY; ADAPTATION; RETINA; OXIDATION; MACAQUE; CYCLE	To investigate the changes in the reflectance of human cone photoreceptors by an adaptive optics scanning laser ophthalmoscope (AO-SLO) during photobleaching. A custom-built AO-SLO with an observation light of 840-nm was used to measure the cone densities and the reflectance changes during bleaching by 630 nm red light emitting diodes. Measurements were made at 1 degrees and 3 degrees temporal to the fovea within an area of 1 degrees x 1 degrees in 8 eyes of 8 normal subjects. After dark-adaptation, images of the cone mosaics were recorded continuously for 5-min before, 5-min during, and after 5-min of light stimulation with a sampling rate of 5-Hz. The first positive peak (P1) was observed at 72.2 +/- 15.0-s and a second positive peak (P2) at 257.5 +/- 34.5-s at 1 degrees. The increase of the reflectance of P1 was significantly larger at 1 degrees (34.4 +/- 13.9%) than at 3 degrees (26.0 +/- 10.5%; P = 0.03, Wilcoxon's signed rank test). The average cone density at 1 degrees (51123.13 +/- 1401.23 cells/mm(2)) was significantly larger than that at 3 degrees (30876.13 +/- 1459.28 cells/mm(2); P < 0.001, Wilcoxon's signed rank test). The changes in the reflectance of the cones during bleaching by red light had two peaks. The two peaks may be caused by regeneration of cone photopigment during bleaching.	[Hirota, Masakazu; Miyagawa, Suguru; Kanda, Hiroyuki; Lohmann, Tibor Karl; Morimoto, Takeshi; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan; [Miyagawa, Suguru] Topcon Corp, R&D Dept, Fundamental Technol Sec, Itabashi Ku, Tokyo, Japan; [Endo, Takao] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan; [Lohmann, Tibor Karl] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Ophthalmol, Aachen, Nordrhein Westf, Germany; [Miyoshi, Tomomitsu] Osaka Univ, Dept Integrat Physiol, Grad Sch Med & Frontier Biosci, Suita, Osaka, Japan	Osaka University; Topcon Corporation; Osaka University; RWTH Aachen University; RWTH Aachen University Hospital; Osaka University	Fujikado, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan.	fujikado@ophthal.med.osaka-u.ac.jp	Hirota, Masakazu/ABE-3358-2020	Hirota, Masakazu/0000-0003-1420-9844	KAKNHI from the Ministry of Education, Culture, Sports, Science and Technology Japan [25293354]; Health Labour Sciences Research Grant from the Ministry of Health, Labor, and Welfare Japan [H24 medical devise 004]; Asian CORE Program from the Japan Society for the Promotion of Science; Topcon Corporation; Grants-in-Aid for Scientific Research [25245065] Funding Source: KAKEN	KAKNHI from the Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labour Sciences Research Grant from the Ministry of Health, Labor, and Welfare Japan(Ministry of Health, Labour and Welfare, Japan); Asian CORE Program from the Japan Society for the Promotion of Science; Topcon Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKNHI (25293354) from the Ministry of Education, Culture, Sports, Science and Technology Japan; Health Labour Sciences Research Grant (H24 medical devise 004) from the Ministry of Health, Labor, and Welfare Japan; Translational Research Network Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and Asian CORE Program from the Japan Society for the Promotion of Science. Topcon Corporation provided support in the form of salaries for SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Bizheva K, 2006, P NATL ACAD SCI USA, V103, P5066, DOI 10.1073/pnas.0506997103; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; DeLint PJ, 2000, INVEST OPHTH VIS SCI, V41, P282; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Garlipp MA, 2013, EXP EYE RES, V113, P192, DOI 10.1016/j.exer.2013.02.003; Grieve K, 2008, INVEST OPHTH VIS SCI, V49, P713, DOI 10.1167/iovs.07-0837; Hofer H, 2006, J NEUROSCI, V26, P722; HOLLINS M, 1973, J GEN PHYSIOL, V62, P430, DOI 10.1085/jgp.62.4.430; HOOD C, 1971, J PHYSIOL-LONDON, V217, P213, DOI 10.1113/jphysiol.1971.sp009567; Horiguchi M, 1998, BRIT J OPHTHALMOL, V82, P1007, DOI 10.1136/bjo.82.9.1007; Ito Y, 1997, JPN J OPHTHALMOL, V41, P255, DOI 10.1016/S0021-5155(97)00044-0; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Jonnal RS, 2010, OPT EXPRESS, V18, P5257, DOI 10.1364/OE.18.005257; Kazato Y, 2010, JPN J OPHTHALMOL, V54, P349, DOI 10.1007/s10384-010-0826-9; KEUNEN JEE, 1987, INVEST OPHTH VIS SCI, V28, P985; Koh S, 2002, AM J OPHTHALMOL, V134, P115, DOI 10.1016/S0002-9394(02)01430-7; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Liem ATA, 1996, SURV OPHTHALMOL, V41, P37, DOI 10.1016/S0039-6257(97)81994-7; Masella BD, 2014, INVEST OPHTH VIS SCI, V55, P7525, DOI 10.1167/iovs.13-13795; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Montes-Mico R, 2004, OPHTHALMOLOGY, V111, P758, DOI 10.1016/j.ophtha.2003.06.027; Muniz A, 2007, EXP EYE RES, V85, P175, DOI 10.1016/j.exer.2007.05.003; Nojgaard JK, 2005, TOXICOL LETT, V156, P241, DOI 10.1016/j.toxlet.2004.11.013; Obata R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091873; PEPPERBERG DR, 1988, P NATL ACAD SCI USA, V85, P5531, DOI 10.1073/pnas.85.15.5531; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Roorda A, 2007, INVEST OPHTH VIS SCI, V48, P2297, DOI 10.1167/iovs.06-1450; RUSHTON W A, 1959, Ann R Coll Surg Engl, V25, P79; RUSHTON WAH, 1957, NATURE, V179, P571, DOI 10.1038/179571a0; Sandberg MA, 1999, INVEST OPHTH VIS SCI, V40, P2457; Schallek J, 2009, INVEST OPHTH VIS SCI, V50, P4873, DOI 10.1167/iovs.08-3291; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tsunoda K, 2009, JPN J OPHTHALMOL, V53, P297, DOI 10.1007/s10384-009-0686-3; VANNORREN D, 1989, VISION RES, V29, P369, DOI 10.1016/0042-6989(89)90085-0; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wolkoff P, 2006, INDOOR AIR, V16, P258, DOI 10.1111/j.1600-0668.2006.00429.x; Wood A, 2011, GRAEF ARCH CLIN EXP, V249, P1359, DOI 10.1007/s00417-011-1627-7; Yamaguchi T, 2012, OPT LETT, V37, P2496, DOI 10.1364/OL.37.002496; Yamashita Tsutomu, 2013, Nippon Ganka Gakkai Zasshi, V117, P963	42	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131485	10.1371/journal.pone.0131485	http://dx.doi.org/10.1371/journal.pone.0131485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121666	gold, Green Published, Green Submitted			2022-12-26	WOS:000358150400114
J	Mansur, A; Steinau, M; Popov, AF; Milenovic, S; Bireta, C; Weymann, A; Schotola, H; Wiese, CH; Beissbarth, T; Tzvetkov, M; Hinz, J				Mansur, Ashham; Steinau, Maximilian; Popov, Aron Frederik; Milenovic, Sinisa; Bireta, Christian; Weymann, Alexander; Schotola, Hanna; Wiese, Christoph H.; Beissbarth, Tim; Tzvetkov, Mladen; Hinz, Jose			Genetic Polymorphisms in Endothelin-1 as Predictors for Long-Term Survival and the Cardiac Index in Patients Undergoing On-Pump Cardiac Surgery	PLOS ONE			English	Article							BLOOD-PRESSURE; PLASMA ENDOTHELIN; ATHEROSCLEROSIS; LYS198ASN; VARIANT	Genetic variants within the endothelin-1 gene (EDN1) have been associated with several cardiovascular diseases and may act as genetic prognostic markers. Here, we explored the overall relevance of EDN1 polymorphisms for long-term survival in patients undergoing on-pump cardiac surgery. A prospectively collected cohort of 455 Caucasian patients who underwent cardiac surgery with cardiopulmonary bypass was followed up for 5 years. The obtained genotypes and inferred haplotypes were analyzed for their associations with the five-year mortality rate (primary endpoint). The EDN1 T-1370G and K198N genotype distributions did not deviate from Hardy-Weinberg equilibrium and the major allele frequencies were 83% and 77%, respectively. The cardiovascular risk factors were equally distributed in terms of the different genotypes and haplotypes associated with the two polymorphisms. The five-year mortality rate did not differ among the different EDN1 T-1370G and K198N genotypes and haplotypes. Haplotype analysis revealed that carriers of the G-T (compound EDN1 T-1370G G/K198N T) haplotype had a higher cardiac index than did non-carriers (p = 0.0008); however, this difference did not reach significance after adjusting for multiple testing. The results indicate that common variations in EDN1 do not act as prognostic markers for long-term survival in patients undergoing on-pump cardiac surgery.	[Mansur, Ashham; Steinau, Maximilian; Milenovic, Sinisa; Schotola, Hanna; Hinz, Jose] Univ Gottingen, Univ Med Ctr, Dept Anesthesiol, D-37075 Gottingen, Germany; [Popov, Aron Frederik; Weymann, Alexander] Royal Brompton & Harefield Hosp, Dept Cardiothorac Transplantat & Mech Support, London UB9 6JH, England; [Bireta, Christian] Univ Gottingen, Univ Med Ctr, Dept Thorac Cardiovasc Surg, D-37075 Gottingen, Germany; [Wiese, Christoph H.] Univ Regensburg, Dept Anesthesiol, D-93053 Regensburg, Germany; [Beissbarth, Tim] Univ Gottingen, Univ Med Ctr, Dept Med Stat, D-37075 Gottingen, Germany; [Tzvetkov, Mladen] Univ Gottingen, Univ Med Ctr, Inst Clin Pharmacol, D-37075 Gottingen, Germany	University of Gottingen; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; University of Gottingen; University of Regensburg; University of Gottingen; University of Gottingen	Mansur, A (corresponding author), Univ Gottingen, Univ Med Ctr, Dept Anesthesiol, Robert Koch Str 40, D-37075 Gottingen, Germany.	ashham.mansur@med.uni-goettingen.de	Popov, Aron-Frederik/AAA-9933-2020; Weymann, Alexander/AAQ-5115-2021	Popov, Aron-Frederik/0000-0003-4226-3004; Tzvetkov, Mladen/0000-0003-1670-5534; Mansur, Ashham/0000-0002-0322-2480	German Research Foundation (DFG); Open Access Publication Funds of Gottingen University	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of Gottingen University	This study was supported by the German Research Foundation (DFG) and the Open Access Publication Funds of Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2001, HYPERTENSION, V38, P1321, DOI 10.1161/hy1101.095333; Cullen JP, 2001, EUR J PHARMACOL, V417, P157, DOI 10.1016/S0014-2999(01)00905-0; Dong YB, 2004, HYPERTENSION, V44, P884, DOI 10.1161/01.HYP.0000147824.08621.a6; Frey UH, 2014, ANESTHESIOLOGY, V120, P1109, DOI 10.1097/ALN.0000000000000189; Iglarz M, 2002, HYPERTENSION, V39, P209, DOI 10.1161/hy0202.103442; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Jin JJ, 2003, HYPERTENSION, V41, P163, DOI 10.1161/01.HYP.0000043680.75107.CF; KOHNO M, 1990, AM J MED, V88, P614, DOI 10.1016/0002-9343(90)90527-K; LEVIN ER, 1995, NEW ENGL J MED, V333, P356, DOI 10.1056/NEJM199508103330607; Liakopoulos OJ, 2006, THORAC CARDIOV SURG, V54, P233, DOI 10.1055/s-2005-873012; LUSCHER TF, 1989, J CARDIOVASC PHARM, V14, pS63; Minami S, 2001, HYPERTENS RES, V24, P663, DOI 10.1291/hypres.24.663; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Osswald BR, 1999, EUR J CARDIO-THORAC, V15, P401, DOI 10.1016/S1010-7940(99)00029-9; Pinto-Sietsma SJ, 2003, J AM SOC NEPHROL, V14, P2596, DOI 10.1097/01.ASN.0000089827.03201.8E; Podgoreanu MV, 2006, CIRCULATION, V114, pI275, DOI 10.1161/CIRCULATIONAHA.105.001032; SCHIFFRIN EL, 1991, AM J HYPERTENS, V4, P303, DOI 10.1093/ajh/4.4.303; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; STEVENS PA, 1995, J CARDIOVASC PHARM, V26, pS9; Tanaka C, 2004, HYPERTENS RES, V27, P367, DOI 10.1291/hypres.27.367; Tiret L, 1999, HYPERTENSION, V33, P1169, DOI 10.1161/01.HYP.33.5.1169; Tzvetkov MV, 2010, PHARMACOGENOMICS, V11, P449, DOI [10.2217/pgs.10.14, 10.2217/PGS.10.14]; VANHOUTTE PM, 1993, HYPERTENSION, V21, P747, DOI 10.1161/01.HYP.21.6.747; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhu G, 2008, GENES IMMUN, V9, P23, DOI 10.1038/sj.gene.6364441	26	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131155	10.1371/journal.pone.0131155	http://dx.doi.org/10.1371/journal.pone.0131155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121692	Green Published, gold, Green Submitted			2022-12-26	WOS:000358150400079
J	Kinney, SRM; Carlson, L; Ser-Dolansky, J; Thompson, C; Shah, S; Gambrah, A; Xing, W; Schneider, SS; Mathias, CB				Kinney, Shannon R. M.; Carlson, Logan; Ser-Dolansky, Jennifer; Thompson, Chelsea; Shah, Sagar; Gambrah, Amos; Xing, Wei; Schneider, Sallie S.; Mathias, Clinton B.			Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy	PLOS ONE			English	Article							MAST-CELLS; AIRWAY INFLAMMATION; ACTIVATION; COLITIS; HYPERRESPONSIVENESS; INDUCTION; PATHWAYS; MEDIATE; CURRY; TRIAL	IgE antibodies and mast cells play critical roles in the establishment of allergic responses to food antigens. Curcumin, the active ingredient of the curry spice turmeric, has anti-inflammatory properties, and thus may have the capacity to regulate Th2 cells and mucosal mast cell function during allergic responses. We assessed whether curcumin ingestion during oral allergen exposure can modulate the development of food allergy using a murine model of ovalbumin (OVA)-induced intestinal anaphylaxis. Herein, we demonstrate that frequent ingestion of curcumin during oral OVA exposure inhibits the development of mastocytosis and intestinal anaphylaxis in OVA-challenged allergic mice. Intragastric (i.g.) exposure to OVA in sensitized BALB/c mice induced a robust IgE-mediated response accompanied by enhanced OVA-IgE levels, intestinal mastocytosis, elevated serum mMCP-1, and acute diarrhea. In contrast, mice exposed to oral curcumin throughout the experimental regimen appeared to be normal and did not exhibit intense allergic diarrhea or a significant enhancement of OVA-IgE and intestinal mast cell expansion and activation. Furthermore, allergic diarrhea, mast cell activation and expansion, and Th2 responses were also suppressed in mice exposed to curcumin during the OVA-challenge phase alone, despite the presence of elevated levels of OVA-IgE, suggesting that curcumin may have a direct suppressive effect on intestinal mast cell activation and reverse food allergy symptoms in allergen-sensitized individuals. This was confirmed by observations that curcumin attenuated the expansion of both adoptively transferred bone marrow-derived mast cells (BMMCs), and inhibited their survival and activation during cell culture. Finally, the suppression of intestinal anaphylaxis by curcumin was directly linked with the inhibition of NF-kappa B activation in curcumin-treated allergic mice, and curcumin inhibited the phosphorylation of the p65 subunit of NF-kappa B in BMMCs. In summary, our data demonstrates a protective role for curcumin during allergic responses to food antigens, suggesting that frequent ingestion of this spice may modulate the outcome of disease in susceptible individuals.	[Kinney, Shannon R. M.; Carlson, Logan; Thompson, Chelsea; Shah, Sagar; Gambrah, Amos; Mathias, Clinton B.] Western New England Univ, Dept Pharmaceut & Adm Sci, Coll Pharm, Springfield, MA 01119 USA; [Ser-Dolansky, Jennifer; Schneider, Sallie S.] Baystate Med Ctr, Pioneer Valley Life Sci Inst, Springfield, MA 01199 USA; [Xing, Wei] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA	Western New England University; Baystate Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Mathias, CB (corresponding author), Western New England Univ, Dept Pharmaceut & Adm Sci, Coll Pharm, Springfield, MA 01119 USA.	clinton.mathias@wne.edu	Kinney, Shannon/AAW-5301-2021	Mathias, Clinton/0000-0002-0223-4842	National Institutes of Health [NIAID R15AI107668]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health NIAID R15AI107668 (www.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2010, MED RES REV, V30, P818, DOI 10.1002/med.20188; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Bayet-Robert M, 2010, CANCER BIOL THER, V9, P8, DOI 10.4161/cbt.9.1.10392; Bischoff S, 2004, CURR OPIN GASTROEN, V20, P156, DOI 10.1097/00001574-200403000-00018; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Bryce PJ, 2009, EXPERT REV CLIN IMMU, V5, P225, DOI 10.1586/ECI.09.6; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Choi YH, 2010, ANAT CELL BIOL, V43, P36, DOI 10.5115/acb.2010.43.1.36; Chung SH, 2012, MOL VIS, V18, P1966; Cong YZ, 2009, EUR J IMMUNOL, V39, P3134, DOI 10.1002/eji.200939052; Eigenmann PA, 2002, PEDIAT ALLERG IMM-UK, V13, P162, DOI 10.1034/j.1399-3038.2002.01015.x; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Ganeshan K, 2009, J ALLERGY CLIN IMMUN, V123, P231, DOI 10.1016/j.jaci.2008.10.011; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Jobin C, 1999, J IMMUNOL, V163, P3474; Johnston LK, 2014, J IMMUNOL, V192, P2529, DOI 10.4049/jimmunol.1303026; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Karaman M, 2011, ARCH MED RES, V42, P79, DOI 10.1016/j.arcmed.2011.01.011; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kliem C, 2012, J BIOL CHEM, V287, P10200, DOI 10.1074/jbc.M111.318733; Knight AK, 2007, AM J PHYSIOL-GASTR L, V293, pG1234, DOI 10.1152/ajpgi.00323.2007; Kurup VP, 2008, MOL NUTR FOOD RES, V52, P1031, DOI 10.1002/mnfr.200700293; Kurup Viswanath P, 2007, Clin Mol Allergy, V5, P1, DOI 10.1186/1476-7961-5-1; Kurup VP, 2006, J ALLERGY CLIN IMMUN, V117, pS203, DOI 10.1016/j.jaci.2005.12.802; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Larmonier CB, 2008, AM J PHYSIOL-GASTR L, V295, pG1079, DOI 10.1152/ajpgi.90365.2008; Lee JH, 2008, J ALLERGY CLIN IMMUN, V121, P1225, DOI 10.1016/j.jaci.2007.12.1160; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Ma CH, 2013, FITOTERAPIA, V87, P57, DOI 10.1016/j.fitote.2013.02.014; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mathias CB, 2014, CLIN EXP ALLERGY, V44, P589, DOI 10.1111/cea.12271; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; Mathias CB, 2009, J IMMUNOL, V182, P2416, DOI 10.4049/jimmunol.0801569; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Oyoshi MK, 2014, J ALLERGY CLIN IMMUN, V133, P309, DOI 10.1016/j.jaci.2013.12.1045; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Ram A, 2003, BIOL PHARM BULL, V26, P1021, DOI 10.1248/bpb.26.1021; Rogers NM, 2010, CLIN EXP IMMUNOL, V162, P460, DOI 10.1111/j.1365-2249.2010.04232.x; Salh B, 2003, AM J PHYSIOL-GASTR L, V285, pG235, DOI 10.1152/ajpgi.00449.2002; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2009, ANNU REV MED, V60, P261, DOI 10.1146/annurev.med.60.042407.205711; Singla V, 2014, J CROHNS COLITIS, V8, P208, DOI 10.1016/j.crohns.2013.08.006; Taylor Rebecca A, 2011, Altern Med Rev, V16, P152; Thakare VN, 2013, INT IMMUNOPHARMACOL, V17, P18, DOI 10.1016/j.intimp.2013.04.025; West CE, 2010, CURR OPIN PEDIATR, V22, P635, DOI 10.1097/MOP.0b013e32833d96ef	50	25	29	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132467	10.1371/journal.pone.0132467	http://dx.doi.org/10.1371/journal.pone.0132467			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147007	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600276
J	Briand, MJ; Bonnet, X; Goiran, C; Guillou, G; Letourneur, Y				Briand, Marine J.; Bonnet, Xavier; Goiran, Claire; Guillou, Gael; Letourneur, Yves			Major Sources of Organic Matter in a Complex Coral Reef Lagoon: Identification from Isotopic Signatures (delta C-13 and delta N-15)	PLOS ONE			English	Article							SOUTH-WEST LAGOON; STABLE-ISOTOPE; POSIDONIA-OCEANICA; FOOD WEBS; MARINE MACROALGAE; CARBON ISOTOPES; DIET; RATIOS; DISCRIMINATION; VARIABILITY	A wide investigation was conducted into the main organic matter (OM) sources supporting coral reef trophic networks in the lagoon of New Caledonia. Sampling included different reef locations (fringing, intermediate and barrier reef), different associated ecosystems (mangroves and seagrass beds) and rivers. In total, 30 taxa of macrophytes, plus pools of particulate and sedimentary OM (POM and SOM) were sampled. Isotopic signatures (C and N) of each OM sources was characterized and the composition of OM pools assessed. In addition, spatial and seasonal variations of reef OM sources were examined. Mangroves isotopic signatures were the most C-depleted (-30.17 +/- 0.41 parts per thousand) and seagrass signatures were the most C-enriched (-4.36 +/- 0.72 parts per thousand). Trichodesmium spp. had the most N-depleted signatures (-0.14 +/- 0.03 parts per thousand) whereas mangroves had the most N-enriched signatures (6.47 +/- 0.41 parts per thousand). The composition of POM and SOM varied along a coast-to-barrier reef gradient. River POM and marine POM contributed equally to coastal POM, whereas marine POM represented 90% of the POM on barrier reefs, compared to 10% river POM. The relative importance of river POM, marine POM and mangroves to the SOM pool decreased from fringing to barrier reefs. Conversely, the relative importance of seagrass, Trichodesmium spp. and macroalgae increased along this gradient. Overall, spatial fluctuations in POM and SOM were much greater than in primary producers. Seasonal fluctuations were low for all OM sources. Our results demonstrated that a large variety of OM sources sustain coral reefs, varying in their origin, composition and role and suggest that delta C-13 was a more useful fingerprint than delta N-15 in this endeavour. This study also suggested substantial OM exchanges and trophic connections between coral reefs and surrounding ecosystems. Finally, the importance of accounting for environmental characteristics at small temporal and spatial scales before drawing general patterns is highlighted.	[Briand, Marine J.; Goiran, Claire; Letourneur, Yves] Univ La Nouvelle Caledonie, Lab LIVE, Noumea 98851, New Caledonia; [Briand, Marine J.; Goiran, Claire; Letourneur, Yves] Univ La Nouvelle Caledonie, LABEX Corail, Noumea 98851, New Caledonia; [Bonnet, Xavier] ULR, CNRS, Ctr Etudes Biol Chize, UMR 7372, F-79360 Villiers En Bois, France; [Guillou, Gael] Univ La Rochelle, UMR CNRS LIENSs 7266, Dept Littoral Environm & Societes, F-17042 La Rochelle 1, France	Universite Nouvelle Caledonie; Universite Nouvelle Caledonie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Letourneur, Y (corresponding author), Univ La Nouvelle Caledonie, Lab LIVE, BP R4, Noumea 98851, New Caledonia.	yves.letourneur@univ-nc.nc	LETOURNEUR, Yves/B-4387-2012; Letourneur, Yves/V-6843-2019; BRIAND, MARINE/G-1101-2018; Goiran, Claire/Y-5201-2019; Goiran, Claire/L-1257-2015	LETOURNEUR, Yves/0000-0003-3157-1976; Letourneur, Yves/0000-0003-3157-1976; BRIAND, MARINE/0000-0003-2792-3238; Goiran, Claire/0000-0002-1649-4418; Goiran, Claire/0000-0002-1649-4418; Bonnet, Xavier/0000-0001-6150-8199	Ecole Doctorale du Pacifique [ED 469]; Fondation Total; Universite de la Nouvelle Caledonie	Ecole Doctorale du Pacifique; Fondation Total; Universite de la Nouvelle Caledonie	This work is a part of the first author's PhD thesis, granted by the Ecole Doctorale du Pacifique (ED 469) and was supported by the Fondation Total (http://fondation.total.com/), no grant number attributed. Funds were received by YL via the Universite de la Nouvelle Caledonie. Funds were used to buy materials required and to pay stable isotope analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaru D, 2007, MAR POLLUT BULL, V54, P1385, DOI 10.1016/j.marpolbul.2007.05.022; Bautista-Vega AA, 2008, J FISH BIOL, V73, P2402, DOI 10.1111/j.1095-8649.2008.02093.x; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Boudouresque C., 2006, BIOL MAR MEDITERR, V13, P109; Bujan S, 2000, CR ACAD SCI III-VIE, V323, P225, DOI 10.1016/S0764-4469(00)00130-X; Cebrian J, 1997, MAR ECOL PROG SER, V155, P29, DOI 10.3354/meps155029; CEBRIAN J, 1994, FUNCT ECOL, V8, P518, DOI 10.2307/2390077; CHARPY-ROUBAUD C, 1990, Marine Microbial Food Webs, V4, P31; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Cresson P, 2014, MAR ECOL PROG SER, V509, P15, DOI 10.3354/meps10866; Cresson P, 2012, MAR POLLUT BULL, V64, P1112, DOI 10.1016/j.marpolbul.2012.04.003; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dromard CR, 2013, J EXP MAR BIOL ECOL, V440, P116, DOI 10.1016/j.jembe.2012.12.011; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fourqurean JW, 2007, MAR BIOL, V151, P219, DOI 10.1007/s00227-006-0473-3; FRY B, 1977, GEOCHIM COSMOCHIM AC, V41, P1875, DOI 10.1016/0016-7037(77)90218-6; Fry B., 2008, STABLE ISOTOPE ECOLO; Harmelin-Vivien M, 2008, CONT SHELF RES, V28, P1911, DOI 10.1016/j.csr.2008.03.002; Harriague AC, 2007, CHEM ECOL, V23, P263, DOI 10.1080/02757540701379527; Hata H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-185; Hemminga MA, 1996, MAR ECOL PROG SER, V140, P285, DOI 10.3354/meps140285; Jacquet S, 2006, MAR ECOL PROG SER, V320, P65, DOI 10.3354/meps320065; Jennerjahn TC, 2002, NATURWISSENSCHAFTEN, V89, P23, DOI 10.1007/s00114-001-0283-x; Jouon A, 2006, CONT SHELF RES, V26, P1395, DOI 10.1016/j.csr.2005.11.014; Kennedy H, 2004, ESTUAR COAST SHELF S, V60, P59, DOI 10.1016/j.ecss.2003.11.019; Kevekordes K, 2006, PHYCOLOGIA, V45, P442, DOI 10.2216/05-55.1.; Knox GA, 1986, ESTUARINE ECOSYSTEMS; Lapointe BE, 2005, HARMFUL ALGAE, V4, P1106, DOI 10.1016/j.hal.2005.06.002; Lepoint G, 2000, MAR BIOL, V136, P513, DOI 10.1007/s002270050711; Letourneur Y, 2013, CORAL REEFS, V32, P1091, DOI 10.1007/s00338-013-1073-6; Letourneur Y, 2000, ENVIRON BIOL FISH, V57, P377, DOI 10.1023/A:1007658830339; MABERLY SC, 1992, OECOLOGIA, V91, P481, DOI 10.1007/BF00650320; MANN KH, 1988, LIMNOL OCEANOGR, V33, P910, DOI 10.4319/lo.1988.33.4_part_2.0910; Marconi M, 2011, J PHYCOL, V47, P1023, DOI 10.1111/j.1529-8817.2011.01045.x; Martineau C, 2004, LIMNOL OCEANOGR, V49, P1679, DOI 10.4319/lo.2004.49.5.1679; Mercado JM, 2009, ESTUAR COAST SHELF S, V85, P449, DOI 10.1016/j.ecss.2009.09.005; Olsen Y, 2001, CONT SHELF RES, V21, P2043, DOI 10.1016/S0278-4343(01)00041-3; Ostrom Peggy H., 1993, Topics in Geobiology, V11, P785; Ouillon S, 2010, MAR POLLUT BULL, V61, P269, DOI 10.1016/j.marpolbul.2010.06.023; Papadimitriou S, 2005, ORG GEOCHEM, V36, P949, DOI 10.1016/j.orggeochem.2004.12.002; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; POLUNIN NVC, 1992, J EXP MAR BIOL ECOL, V164, P1, DOI 10.1016/0022-0981(92)90132-T; RAU GH, 1992, MAR ECOL PROG SER, V84, P1, DOI 10.3354/meps084001; Raven JA, 2002, ANN BOT-LONDON, V90, P525, DOI 10.1093/aob/mcf171; Raven JA, 2002, FUNCT PLANT BIOL, V29, P355, DOI 10.1071/PP01201; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Rodier M, 2008, J EXP MAR BIOL ECOL, V358, P20, DOI 10.1016/j.jembe.2008.01.016; Rolff C, 2000, MAR ECOL PROG SER, V197, P81, DOI 10.3354/meps197081; Sakka A, 2002, J PLANKTON RES, V24, P301, DOI 10.1093/plankt/24.4.301; STEPHENSON RL, 1984, MAR BIOL, V81, P223, DOI 10.1007/BF00393216; Tesi T, 2007, ESTUAR COAST SHELF S, V73, P431, DOI 10.1016/j.ecss.2007.02.008; Uitz J, 2010, GLOBAL BIOGEOCHEM CY, V24, P1944; Underwood AJ, 1997, LANDSCAPE URBAN PLAN, V37, P137, DOI 10.1016/S0169-2046(97)80000-X; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Vizzini S, 2006, ESTUAR COAST SHELF S, V66, P459, DOI 10.1016/j.ecss.2005.10.004; Vizzini S, 2003, MAR BIOL, V142, P1009, DOI 10.1007/s00227-003-1027-6; Vizzini S, 2002, ACTA OECOL, V23, P277, DOI 10.1016/S1146-609X(02)01156-6; Volkman JK, 2002, J OCEANOGR, V58, P265, DOI 10.1023/A:1015809708632; Wang WL, 2003, BOT BULL ACAD SINICA, V44, P107; Yoneyama T, 1995, STABLE ISOTOPES BIOS, P92; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	66	33	33	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131555	10.1371/journal.pone.0131555	http://dx.doi.org/10.1371/journal.pone.0131555			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134985	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400055
J	Yang, BL; Cai, BZ; Deng, PY; Wu, XQ; Guan, YL; Zhang, B; Cai, WJ; Schaper, J; Schaper, W				Yang, Baolin; Cai, Baizhen; Deng, Panyue; Wu, Xiaoqiong; Guan, Yinglu; Zhang, Bin; Cai, Weijun; Schaper, Jutta; Schaper, Wolfgang			Nitric Oxide Increases Arterial Endotheial Permeability through Mediating VE-Cadherin Expression during Arteriogenesis	PLOS ONE			English	Article							FLUID SHEAR-STRESS; IN-VIVO; ADHERENS JUNCTIONS; CELL JUNCTIONS; VASCULAR-PERMEABILITY; SYNTHASE ACTIVITY; RABBIT HINDLIMB; TIGHT JUNCTIONS; ANGIOGENESIS; GROWTH	Macrophage invasion is an important event during arteriogenesis, but the underlying mechanism is still only partially understood. The present study tested the hypothesis that nitric oxide (NO) and VE-cadherin, two key mediators for vascular permeability, contribute to this event in a rat ischemic hindlimb model. In addition, the effect of NO on expression of VE-caherin and endothelial permeability was also studied in cultured HUVECs. We found that: 1) in normal arteriolar vessels (NAV), eNOS was moderately expressed in endothelial cells (EC) and iNOS was rarely detected. In contrast, in collateral vessels (CVs) induced by simple femoral artery ligation, both eNOS and iNOS were significantly upregulated (P<0.05). Induced iNOS was found mainly in smooth muscle cells, but also in other vascular cells and macrophages; 2) in NAV VE-cadherin was strongly expressed in EC. In CVs, VE-cadherin was significantly downregulated, with a discontinuous and punctate pattern. Administration of nitric oxide donor DETA NONOate (NONOate) further reduced the amounts of Ve-cadherin in CVs, whereas NO synthase inhibitor L-NAME inhibited downregulation of VE-cadherin in CVs; 3) in normal rats Evans blue extravasation (EBE) was low in the musculus gracilis, FITC-dextron leakage was not detected in the vascular wall and few macrophages were observed in perivascular space. In contrast, EBE was significantly increased in femoral artery ligation rats, FITC-dextron leakage and increased amounts of macrophages were detected in CVs, which were further enhanced by administration of NONOate, but inhibited by L-NAME supplement; 4) in vitro experiments confirmed that an increase in NO production reduced VE-cadherin expression, correlated with increases in the permeability of HUVECs. In conclusion, our data for the first time reveal the expression profile of VE-cadherin and alterations of vascular permeability in CVs, suggesting that NO-mediated VE-cadherin pathway may be one important mechanism responsible, at least in part, for macrophage invasion during arteriogenesis.	[Yang, Baolin; Deng, Panyue; Guan, Yinglu; Zhang, Bin; Cai, Weijun] Cent S Univ, Sch Basic Med, Dept Histol & Embryol, Changsha 410078, Hunan, Peoples R China; [Cai, Baizhen] Cent S Univ, Dept Intens Care Unit, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China; [Wu, Xiaoqiong] Cent S Univ, Sch Basic Med, Dept Anat & Neurobiol, Changsha 410013, Hunan, Peoples R China; [Yang, Baolin] Nanchang Univ, Sch Basic Med, Dept Anat, Nanchang 330006, Jiangxi, Peoples R China; [Schaper, Jutta; Schaper, Wolfgang] Max Planck Inst Heart & Lung Res, Arteriogenesis Res Grp, D-61231 Bad Nauheim, Germany	Central South University; Central South University; Central South University; Nanchang University; Max Planck Society	Deng, PY (corresponding author), Cent S Univ, Sch Basic Med, Dept Histol & Embryol, Changsha 410078, Hunan, Peoples R China.	pydeng@csu.edu.cn; caiweijun@csu.edu.cn; jutta.schaper@mpi-bn.mpg.de; wolfgang.schaper@mpi-bn.mpg.de	Guan, Yinglu/AAJ-4118-2021		National Natural Science Foundation of China [81370248, 30971532, 81301997]; Shenghua Scholar Program of Central South University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenghua Scholar Program of Central South University	This work was partly supported by the grants from the National Natural Science Foundation of China (No: 81370248, 30971532 and 81301997) and the Shenghua Scholar Program of Central South University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Bruce AC, 2014, ARTERIOSCLER THROMB; Cai WJ, 2009, MOL CELL BIOCHEM, V322, P161, DOI 10.1007/s11010-008-9953-8; Cai WJ, 2004, MOL CELL BIOCHEM, V264, P193, DOI 10.1023/B:MCBI.0000044388.27953.a0; Cai WJ, 2000, J MOL CELL CARDIOL, V32, P997, DOI 10.1006/jmcc.2000.1137; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Feng D, 1999, MICROCIRCULATION, V6, P23, DOI 10.1080/713773925; Gonzalez D, 2003, BIOCHEM BIOPH RES CO, V304, P113, DOI 10.1016/S0006-291X(03)00546-1; Gotsch U, 1997, J CELL SCI, V110, P583; Govers R, 2002, BIOCHEM J, V361, P193, DOI 10.1042/0264-6021:3610193; Hama S, 2006, INT ENDOD J, V39, P179, DOI 10.1111/j.1365-2591.2006.01068.x; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Li R, PLOS ONE, V7, DOI [10. 1371/journal.pone.0037195, DOI 10.1371/JOURNAL.PONE]; Mees B, 2007, ARTERIOSCL THROM VAS, V27, P1926, DOI 10.1161/ATVBAHA.107.145375; Miao H, 2005, J VASC RES, V42, P77, DOI 10.1159/000083094; MITSUMATA M, 1993, AM J PHYSIOL, V265, pH3, DOI 10.1152/ajpheart.1993.265.1.H3; Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504; Ogunrinade O, 2002, ANN BIOMED ENG, V30, P430, DOI 10.1114/1.1467924; SCHAPER J, 1976, VIRCHOWS ARCH A, V370, P193, DOI 10.1007/BF00427580; SCHAPER W, 1976, CIRCULATION, V53, P57; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; SHYY YJ, 1994, P NATL ACAD SCI USA, V91, P4678, DOI 10.1073/pnas.91.11.4678; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Troidl K, 2010, J CARDIOVASC PHARM, V55, P153, DOI 10.1097/FJC.0b013e3181c9556f; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; WALPOLA PL, 1993, AM J PATHOL, V142, P1392; Yang BL, 2013, ACTA HISTOCHEM CYTOC, V46, P1, DOI 10.1267/ahc.12025	40	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0127931	10.1371/journal.pone.0127931	http://dx.doi.org/10.1371/journal.pone.0127931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133549	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400006
J	Hakansson, K; Bachert, C; Konge, L; Thomsen, SF; Pedersen, AE; Poulsen, SS; Martin-Bertelsen, T; Winther, O; Backer, V; von Buchwald, C				Hakansson, Kare; Bachert, Claus; Konge, Lars; Thomsen, Simon Francis; Pedersen, Anders Elm; Poulsen, Steen Seier; Martin-Bertelsen, Tomas; Winther, Ole; Backer, Vibeke; von Buchwald, Christian			Airway Inflammation in Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways Concept Further Supported	PLOS ONE			English	Article								Background It has been established that patients with chronic rhinosinusitis with nasal polyps (CRSwNP) often have co-existing asthma. Objective We aimed to test two hypotheses: (i) upper and lower airway inflammation in CRSwNP is uniform in agreement with the united airways concept; and (ii) bronchial inflammation exists in all CRSwNP patients irrespective of clinical asthma status. Methods We collected biopsies from nasal polyps, inferior turbinates and bronchi of 27 CRSwNP patients and 6 controls. All participants were evaluated for lower airway disease according to international guidelines. Inflammatory cytokines were investigated using a Th1/Th2 assay including 14 chemokines and cytokines; tissue concentrations were normalized according to tissue weight and total protein concentration. Individual cytokines and multivariate inflammatory profiles were compared between biopsy sites and between patients and controls. Results We found significantly higher concentrations of Th2 cytokines in nasal polyps compared to inferior turbinate and bronchial biopsies. In addition, we showed that the inflammatory profile of nasal polyps and bronchial biopsies correlated significantly (p<0.01). From the Th2 cytokines measured, IL-13 was significantly increased in bronchial biopsies from CRSwNP patients with, but not without asthma. Conclusion Our findings support the united airways concept; however, we did not find evidence for subclinical bronchial inflammation in CRSwNP patients without asthma. Finally, this study indicates for the first time that nasal polyps potentially play an important role in the airway inflammation rather than being a secondary phenomenon.	[Hakansson, Kare; von Buchwald, Christian] Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Bachert, Claus] Ghent Univ Hosp, Upper Airways Res Lab, Ghent, Belgium; [Bachert, Claus] Karolinska Inst, ENT Dept, Stockholm, Sweden; [Konge, Lars; Backer, Vibeke] Univ Copenhagen, Ctr Clin Educ, Copenhagen, Denmark; [Konge, Lars; Backer, Vibeke] Capital Reg Denmark, Copenhagen, Denmark; [Thomsen, Simon Francis] Univ Copenhagen, Bispebjerg Hosp, Dept Resp Med L, Copenhagen, Denmark; [Pedersen, Anders Elm] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Poulsen, Steen Seier] Univ Copenhagen, Dept Biomed Sci, Endocrinol Res Sect, Copenhagen, Denmark; [Martin-Bertelsen, Tomas; Winther, Ole] Univ Copenhagen, Dept Biol, Bioinformat Ctr BINF, Copenhagen, Denmark; [Martin-Bertelsen, Tomas; Winther, Ole] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Winther, Ole] DTU Compute Tech Univ Denmark DTU, Sect Cognit Syst, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Ghent University; Ghent University Hospital; Karolinska Institutet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Hakansson, K (corresponding author), Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark.	kaare.haakansson@regionh.dk	von Buchwald, Christian/D-5336-2016; Backer, Vibeke/AAQ-9379-2021; Bachert, Claus/J-8825-2012	von Buchwald, Christian/0000-0001-6753-8129; Martin-Bertelsen, Tomas/0000-0002-5842-8187; Winther, Ole/0000-0002-1966-3205; Poulsen, Steen Seier/0000-0003-4419-4911; Pedersen, Anders Elm/0000-0003-4705-1801	Candy Foundation; Orelaege Hans Skouby's og Hustru Emma Skouby's Foundation; Novo Nordisk Fonden [NNF10SA1016550] Funding Source: researchfish	Candy Foundation; Orelaege Hans Skouby's og Hustru Emma Skouby's Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors would like to gratefully acknowledge Candy Foundation and Orelaege Hans Skouby's og Hustru Emma Skouby's Foundation for supporting their work. Both of these are non-profit organisation and neither was involved in the conception, execution, and interpretation or publication strategy of this study.	Ardehali MM, 2009, OTOLARYNG HEAD NECK, V140, P748, DOI 10.1016/j.otohns.2009.01.027; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Bachert C, 2000, AM J RHINOL, V14, P279, DOI 10.2500/105065800781329573; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bateman ND, 2005, CLIN OTOLARYNGOL, V30, P221, DOI 10.1111/j.1365-2273.2005.00969.x; Braunstahl GJ, 2003, ALLERGY, V58, P1235, DOI 10.1046/j.0105-4538.2003.00354.x; British Thoracic Society Bronchoscopy Guidelines Committee, THORAX S1, V56, pi1; Dhong HJ, ACTA OTOLARYNGOL, V125, P169; Ediger D, 2005, CLIN EXP ALLERGY, V35, P319, DOI 10.1111/j.1365-2222.2005.02194.x; Fabbri LM, 2003, EUR RESPIR J, V22, P1, DOI 10.1183/09031936.03.00063703; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; GOOD P., 2005, PERMUTATION PARAMETR, V3rd, P766; Granstrom G, ACTA OTOLARYNGOL S, V492, P22; Hakansson K, AM J RHINOLOGY ALLER, V28, P383; Han DH, 2009, ALLERGY, V64, P118, DOI 10.1111/j.1398-9995.2008.01841.x; Haruna S, 2004, AM J RHINOL, V18, P165, DOI 10.1177/194589240401800307; KANAI N, 1994, AM J RESP CRIT CARE, V150, P1094, DOI 10.1164/ajrccm.150.4.7921442; Klossek JM, 2005, ALLERGY, V60, P233, DOI 10.1111/j.1398-9995.2005.00688.x; Lamblin C, 2001, AM J RESP CRIT CARE, V163, P1226, DOI 10.1164/ajrccm.163.5.2004197; Lamblin C, 1999, J ALLERGY CLIN IMMUN, V104, P85, DOI 10.1016/S0091-6749(99)70118-1; LARSEN K, 1994, ACTA OTO-LARYNGOL, V114, P556, DOI 10.3109/00016489409126104; Larsen K, ALLERGY ASTHMA P, V17, P243; Larsen K, EUR ARCH OTORHINOLAR, V254, pS85; Ragab A, 2005, RHINOLOGY, V43, P11; SNIJDEWINT FGM, 1995, IMMUNOPHARMACOLOGY, V29, P93, DOI 10.1016/0162-3109(94)00048-K; Staikuniene J, MEDICINA KAUNAS, V44, P257; Team R, 2013, R LANG ENV STAT COMP; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Tsicopoulos A, 2004, J ALLERGY CLIN IMMUN, V113, P462, DOI 10.1016/j.jaci.2003.12.009; Wallwork B, 2002, LARYNGOSCOPE, V112, P1827, DOI 10.1097/00005537-200210000-00022; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	32	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0127228	10.1371/journal.pone.0127228	http://dx.doi.org/10.1371/journal.pone.0127228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132710	Green Published, gold			2022-12-26	WOS:000358153000006
J	Heinonsalo, J; Sun, H; Santalahti, M; Backlund, K; Hari, P; Pumpanen, J				Heinonsalo, Jussi; Sun, Hui; Santalahti, Minna; Backlund, Kirsi; Hari, Pertti; Pumpanen, Jukka			Evidences on the Ability of Mycorrhizal Genus Piloderma to Use Organic Nitrogen and Deliver It to Scots Pine	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; CARBON; FOREST; GENES; ROOT; MATTER; IDENTIFICATION; DECOMPOSITION; MECHANISMS; LIMITATION	Ectomycorrhizal (ECM) symbiosis has been proposed to link plant photosynthesis and soil organic matter (SOM) decomposition through the production of fungal enzymes which promote SOM degradation and nitrogen (N) uptake. However, laboratory and field evidence for the existence of these processes are rare. Piloderma sp., a common ECM genus in boreal forest soil, was chosen as model mycorrhiza for this study. The abundance of Piloderma sp. was studied in root tips and soil over one growing season and in winter. Protease production was measured from ectomycorrhiza and soil solution in the field and pure fungal cultures. We also tested the effect of Piloderma olivaceum on host plant organic N nutrition in the laboratory. The results showed that Piloderma sp. was highly abundant in the field and produced extracellular proteases, which correlated positively with the gross primary production, temperature and soil respiration. In the laboratory, Piloderma olivaceum could improve the ability of Pinus sylvestris L. to utilize N from extragenous proteins. We suggest that ECM fungi, although potentially retaining N in their hyphae, are important in forest C and N cycling due to their ability to access proteinaeous N. As Piloderma sp. abundance appeared to be seasonally highly variable, recycling of fungal-bound N after hyphal death may therefore be of primary importance for the N cycling in boreal ecosystems.	[Heinonsalo, Jussi; Sun, Hui; Santalahti, Minna; Backlund, Kirsi] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Sun, Hui; Hari, Pertti; Pumpanen, Jukka] Univ Helsinki, Dept Forest Sci, Helsinki, Finland	University of Helsinki; University of Helsinki	Heinonsalo, J (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	jussi.heinonsalo@helsinki.fi	Pumpanen, Jukka/B-1254-2012	Pumpanen, Jukka/0000-0003-4879-3663; Santalahti, Minna E/0000-0002-3004-1714; Heinonsalo, Jussi/0000-0001-8516-1388	Academy of Finland [263858, 130984, 218094, 255576, ICOS 271878, ICOS-Finland 281255, ICOS-ERIC 281250]; Research Funds of the University of Helsinki [490127]; Academy of Finland Finnish Centre of Excellence program [1118615]	Academy of Finland(Academy of Finland); Research Funds of the University of Helsinki; Academy of Finland Finnish Centre of Excellence program	This research was supported by grants from the Academy of Finland to JH (263858), JP (130984, 218094 and 255576) and KB (ICOS 271878, ICOS-Finland 281255 and ICOS-ERIC 281250). HS and MS were supported by the Research Funds of the University of Helsinki (490127). In addition, this study was part of the Academy of Finland Finnish Centre of Excellence program (project 1118615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; ABUZINADAH RA, 1986, NEW PHYTOL, V103, P481, DOI 10.1111/j.1469-8137.1986.tb02886.x; Alberton O, 2005, NEW PHYTOL, V167, P859, DOI 10.1111/j.1469-8137.2005.01458.x; Aubinet M., 2012, EDDY COVARIANCE PRAC; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Boberg JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092897; Bodeker ITM, 2014, NEW PHYTOL, V203, P245, DOI 10.1111/nph.12791; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; BROWN MT, 1985, NEW PHYTOL, V99, P101, DOI 10.1111/j.1469-8137.1985.tb03640.x; Brzostek ER, 2011, ECOLOGY, V92, P892, DOI 10.1890/10-1803.1; Buee M, 2007, SOIL BIOL BIOCHEM, V39, P1947, DOI 10.1016/j.soilbio.2007.02.016; Chalot M, 1998, FEMS MICROBIOL REV, V22, P21, DOI 10.1111/j.1574-6976.1998.tb00359.x; Chen DM, 2003, NEW PHYTOL, V157, P547, DOI 10.1046/j.1469-8137.2003.00687.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; Drigo B, 2012, SOIL BIOL BIOCHEM, V49, P4, DOI 10.1016/j.soilbio.2012.02.003; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Franklin O, 2014, NEW PHYTOL, V203, P657, DOI 10.1111/nph.12840; Friedel JK, 2002, SOIL BIOL BIOCHEM, V34, P315, DOI 10.1016/S0038-0717(01)00185-7; Heinonsalo J, 2004, PLANT SOIL, V259, P111, DOI 10.1023/B:PLSO.0000020939.64205.c4; Heinonsalo J, 2012, FUNGAL ECOL, V5, P261, DOI 10.1016/j.funeco.2011.07.008; Heinonsalo J, 2007, CAN J FOREST RES, V37, P415, DOI 10.1139/X06-213; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Ilvesniemi H, 2000, GEODERMA, V94, P109, DOI 10.1016/S0016-7061(99)00082-8; Jain A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003519; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Kohler A, 2015, NAT GENET, V47, P410, DOI 10.1038/ng.3223; Kolari P, 2009, BOREAL ENVIRON RES, V14, P761; Kulmala L, 2014, AGR FOREST METEOROL, V188, P33, DOI 10.1016/j.agrformet.2013.12.003; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; LEAKE JR, 1990, MYCOL RES, V94, P993, DOI 10.1016/S0953-7562(09)81318-X; Lindahl BD, 2015, NEW PHYTOL, V205, P1443, DOI 10.1111/nph.13201; Linden A, 2014, PLANT SOIL, V377, P145, DOI 10.1007/s11104-013-1987-3; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Modess O, 1941, SYMB BOT UPSAL, V5, P1; Nannipieri P, 2006, SOIL BIOL, V8, P75; Nasholm T, 2013, NEW PHYTOL, V198, P214, DOI 10.1111/nph.12139; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Phillips LA, 2014, ISME J, V8, P699, DOI 10.1038/ismej.2013.195; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Pumpanen J, 2015, BOREAL ENV IN PRESS; Rineau F, 2013, ISME J, V7, P2010, DOI 10.1038/ismej.2013.91; Rineau F, 2012, ENVIRON MICROBIOL, V14, P1477, DOI 10.1111/j.1462-2920.2012.02736.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shah F, 2013, NEW PHYTOL, V200, P875, DOI 10.1111/nph.12425; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stevenson F.J., 1986, CYCLES SOIL CARBON N; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Villarreal-Ruiz L, 2004, NEW PHYTOL, V164, P183, DOI 10.1111/j.1469-8137.2004.01167.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]	56	22	22	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131561	10.1371/journal.pone.0131561	http://dx.doi.org/10.1371/journal.pone.0131561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132469	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000130
J	Liu, XQ; Hu, ZQ; Zhou, B; Li, X; Tao, R				Liu, Xiqiang; Hu, Zhiqiu; Zhou, Bin; Li, Xiang; Tao, Ran			Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury	PLOS ONE			English	Article							HEPATIC ISCHEMIA/REPERFUSION INJURY; ACUTE LUNG INJURY; HYDROXYSAFFLOR YELLOW; NETWORK PHARMACOLOGY; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; UP-REGULATION; MICE; PROTECTS; INJECTION	The Chinese herb preparation Xuebijing injection (XBJ) has been widely used in the management of various septic disorders or inflammation-related conditions, however the molecular mechanism of its anti-inflammatory effect remains largely elusive. In the current study, we found that XBJ treatment potently ameliorated mouse hepatic ischemia-reperfusion (IR) injury, manifested as decreased liver function tests (LDH, ALT, AST), improved inflammation and less hepatocyte apoptosis. Notably, XBJ markedly inhibited inflammasome activation and IL-1 production in mouse livers subjected to IRI, even in the absence of Kupffer cells, suggesting Kupffer cells are not necessary for hepatic inflammasome activation upon Redox-induced sterile inflammation. This finding led us to investigate the role of XBJ on hepatocyte apoptosis and inflammasome activation using an in vitro hydrogen peroxide (H2O2)-triggered hepatocyte injury model. Our data clearly demonstrated that XBJ potently inhibited apoptosis, as well as caspase-1 cleavage and IL-1 beta production in a time-and dose-dependent manner in isolated hepatocytes, suggesting that in addition to its known modulatory effect on NF-kappa B-dependent inflammatory gene expression, it also has a direct impact on hepatocyte inflammasome activation. The current study not only deepens our understanding of how XBJ ameliorates inflammation and apoptosis, but also has immediate practical significance in many clinical situations such as partial hepatectomy, liver transplantation, etc.	[Liu, Xiqiang; Tao, Ran] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Surg, Shanghai 200030, Peoples R China; [Hu, Zhiqiu] Fudan Univ, Minhang Hosp, Dept Surg, Shanghai 200433, Peoples R China; [Zhou, Bin] Zhejiang Prov Peoples Hosp ZJPPH, Dept Cardiothorac Surg, Hangzhou, Zhejiang, Peoples R China; [Li, Xiang] Zhejiang Med Coll, Fac Basic Med, Dept Pharmacol, Hangzhou, Zhejiang, Peoples R China; [Tao, Ran] Zhejiang Prov Peoples Hosp ZJPPH, Dept Hepatobiliary Pancreat Surg, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Fudan University; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Tao, R (corresponding author), Zhejiang Prov Peoples Hosp ZJPPH, Dept Hepatobiliary Pancreat Surg, 14th Floor,Bldg 1,158 Shangtang Rd, Hangzhou, Zhejiang, Peoples R China.	taohdac9@hotmail.com			National Nature and Science Foundation (NSF) [81001324, 81373163]; "Oriental Scholar" Endowed Professorship grant from the Municipal Scientific Committee of Shanghai; "SMG-Rising Star" grant from Shanghai Jiaotong University; interim start funding from ZJPPH	National Nature and Science Foundation (NSF); "Oriental Scholar" Endowed Professorship grant from the Municipal Scientific Committee of Shanghai; "SMG-Rising Star" grant from Shanghai Jiaotong University; interim start funding from ZJPPH	This work was supported by National Nature and Science Foundation (NSF) grant (81001324, 81373163 to RT), "Oriental Scholar" Endowed Professorship grant from the Municipal Scientific Committee of Shanghai (to RT), "SMG-Rising Star" grant from Shanghai Jiaotong University (to RT) and an interim start funding from ZJPPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Cardinal J, 2009, HEPATOLOGY, V50, P565, DOI 10.1002/hep.23021; Chen L, 2013, NEUROCHEM RES, V38, P2268, DOI 10.1007/s11064-013-1135-8; Deng J., 2013, COCHRANE DB SYST REV, V7; Dong H, 2013, PHARM BIOL; Gong Bei-lei, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P543; Han B, 2013, EUR J PHARMACOL, V714, P83, DOI 10.1016/j.ejphar.2013.06.011; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Huang H, 2011, PHYTOCHEM ANALYSIS, V22, P330, DOI 10.1002/pca.1284; Ji HF, 2013, HEPATOLOGY, V57, P1225, DOI 10.1002/hep.25802; Jiang M, 2013, J ETHNOPHARMACOL, V147, P426, DOI 10.1016/j.jep.2013.03.032; Jiang SJ, 2014, INT J CLIN EXP PATHO, V7, P2595; Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320; Kato A, 2002, AM J PATHOL, V161, P1797, DOI 10.1016/S0002-9440(10)64456-2; Kim HJ, 2013, J PHARMACOL EXP THER, V346, P465, DOI 10.1124/jpet.113.205732; Li CC, 2012, EUR J PHARM SCI, V46, P397, DOI 10.1016/j.ejps.2012.03.003; Li DG, 2014, INT J MOL SCI, V15, P10541, DOI 10.3390/ijms150610541; Li J, 2013, NEUROSCI LETT, V535, P51, DOI 10.1016/j.neulet.2012.12.056; Liu Ming-wei, 2014, BMC Complement Altern Med, V14, P498, DOI 10.1186/1472-6882-14-498; Liu MW, 2014, INT J MOL MED, V34, P1492, DOI 10.3892/ijmm.2014.1943; Liu Q, 2014, PHARM BIOL, V52, P1085, DOI 10.3109/13880209.2013.877491; Liu SX, 2012, INT J CARDIOL, V160, P95, DOI 10.1016/j.ijcard.2011.03.033; Liu YL, 2014, INT IMMUNOPHARMACOL, V23, P649, DOI 10.1016/j.intimp.2014.10.018; Llacuna L, 2010, HEPATOLOGY, V52, P1371, DOI 10.1002/hep.23833; Llacuna L, 2009, AM J PATHOL, V174, P1776, DOI 10.2353/ajpath.2009.080857; Lutz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115603; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qi F, 2011, J TRADIT CHIN MED, V31, P46, DOI 10.1016/S0254-6272(11)60011-3; Qi ZF, 2014, TRANSL STROKE RES, V5, P501, DOI 10.1007/s12975-014-0346-x; Sakai N, 2012, HEPATOLOGY, V56, P1468, DOI 10.1002/hep.25768; Sakai N, 2012, HEPATOLOGY, V55, P888, DOI 10.1002/hep.24756; Serafin A, 2004, HEPATOLOGY, V39, P688, DOI 10.1002/hep.20089; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun JP, 2010, EXP LUNG RES, V36, P211, DOI 10.3109/01902140903312123; Takehara T, 1999, GASTROENTEROLOGY, V117, P661, DOI 10.1016/S0016-5085(99)70460-9; Taniai H, 2004, HEPATOLOGY, V39, P1544, DOI 10.1002/hep.20217; Tsutsui H, 2014, INT J MOL SCI, V15, P7711, DOI 10.3390/ijms15057711; Ueki S, 2011, HEPATOLOGY, V54, P216, DOI 10.1002/hep.24360; Wang CY, 2013, PHYTOMEDICINE, V20, P592, DOI 10.1016/j.phymed.2013.02.001; Wang CY, 2013, TOXICOL APPL PHARM, V272, P895, DOI 10.1016/j.taap.2013.07.021; Wang YY, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-251; Wang YX, 2014, EXP THER MED, V8, P1593, DOI 10.3892/etm.2014.1949; Wei LL, 2014, INFLAMM RES, V63, P485, DOI 10.1007/s00011-014-0720-x; Wree A, 2013, HEPATOLOGY; Wu L., 2013, DATABASE, V2013; Wu Y, 2012, BIOL PHARM BULL, V35, P515, DOI 10.1248/bpb.35.515; Yin QQ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/310194; Yu HC, 2011, HEPATOLOGY, V54, P979, DOI 10.1002/hep.24469; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036; Zhu P, 2011, HUM GENE THER, V22, P853, DOI 10.1089/hum.2010.145	55	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131436	10.1371/journal.pone.0131436	http://dx.doi.org/10.1371/journal.pone.0131436			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132490	gold, Green Submitted, Green Published			2022-12-26	WOS:000358153000117
J	Pang, XM; Liu, JT; Li, YX; Zhao, JJ; Zhang, XL				Pang, Xiaoming; Liu, Juntian; Li, Yuxia; Zhao, Jingjing; Zhang, Xiaolu			Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPAR gamma. Expression and ROS-ERK1/2/p38 Signal Pathway	PLOS ONE			English	Article							KAPPA-B ACTIVATION; PLASMA HOMOCYSTEINE; RISK-FACTOR; ENDOTHELIAL-CELLS; INDUCED MIGRATION; ATHEROSCLEROSIS; DISEASE; INFLAMMATION; HYPERHOMOCYSTEINEMIA; TRANSITION	Atherosclerosis is an inflammatory disease. As an inflammatory molecule, C-reactive protein (CRP) plays a direct role in atherogenesis. It is known that the elevated plasma homocysteine (Hcy) level is an independent risk factor for atherosclerosis. We previously reported that Hcy produces a pro-inflammatory effect by inducing CRP expression in vascular smooth muscle cells (VSMCs). In the present study, we observed effect of emodin on Hcy-induced CRP expression in rat VSMCs and molecular mechanisms. The in vitro results showed that pretreatment of VSMCs with emodin inhibited Hcy-induced mRNA and protein expression of CRP in a concentration-dependent manner. The in vivo experiments displayed that emodin not only inhibited CRP expression in the vessel walls in mRNA and protein levels, but also reduced the circulating CRP level in hyperhomocysteinemic rats. Further study revealed that emodin diminished Hcy-stimulated generation of reactive oxygen species (ROS), attenuated Hcy-activated phosphorylation of ERK1/2 and p38, and upregulated Hcy-inhibited expression of peroxisome proliferator-activated receptor gamma (PPAR.) in VSMCs. These demonstrate that emodin is able to inhibit Hcy-induced CRP generation in VSMCs, which is related to interfering with ROS-ERK1/2/p38 signal pathway and upregulating PPAR. expression. The present study provides new evidence for the anti-inflammatory and anti-atherosclerotic effects of emodin.	[Pang, Xiaoming; Liu, Juntian; Zhao, Jingjing; Zhang, Xiaolu] Xi An Jiao Tong Univ, Sch Med, Dept Pharmacol, Xian 710049, Peoples R China; [Pang, Xiaoming; Li, Yuxia] Cent Hosp Zibo, Dept Clin Pharm, Zibo, Peoples R China	Xi'an Jiaotong University	Liu, JT (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Pharmacol, Xian 710049, Peoples R China.	ljt@mail.xjtu.edu.cn						Bautista LE, 2002, J CLIN EPIDEMIOL, V55, P882, DOI 10.1016/S0895-4356(02)00434-1; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Choi JS, 2000, J AGR FOOD CHEM, V48, P6347, DOI 10.1021/jf000936r; Devaraj S, 2009, CLIN CHEM, V55, P229, DOI 10.1373/clinchem.2008.108886; Doronzo G, 2010, THROMB RES, V125, pE23, DOI 10.1016/j.thromres.2009.08.015; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; HADRAVA V, 1989, HYPERTENSION, V13, P589, DOI 10.1161/01.HYP.13.6.589; Han CJ, 2010, ATHEROSCLEROSIS, V212, P206, DOI 10.1016/j.atherosclerosis.2010.05.020; Heo SK, 2010, VASC PHARMACOL, V53, P28, DOI 10.1016/j.vph.2010.03.002; Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45; Kumar A, 1998, ONCOGENE, V17, P913, DOI 10.1038/sj.onc.1201998; Li HL, 2005, INT J MOL MED, V16, P41; Li L, 2008, CLIN EXP PHARMACOL P, V35, P1471, DOI 10.1111/j.1440-1681.2008.05025.x; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Meng L, 2012, INT J MOL MED, V29, P999, DOI 10.3892/ijmm.2012.940; Morita H, 2001, CIRCULATION, V103, P133; Pang XM, 2014, ATHEROSCLEROSIS, V236, P73, DOI 10.1016/j.atherosclerosis.2014.06.021; Papatheodorou L, 2007, ANTIOXID REDOX SIGN, V9, P1941, DOI 10.1089/ars.2007.1750; Peng N, 2007, ATHEROSCLEROSIS, V193, P292, DOI 10.1016/j.atherosclerosis.2006.09.007; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Srinivas G, 2007, MED RES REV, V27, P591, DOI 10.1002/med.20095; Sung KC, 2003, AM J HYPERTENS, V16, P429, DOI 10.1016/S0895-7061(03)00566-1; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Zhou MX, 2008, TOHOKU J EXP MED, V215, P61, DOI 10.1620/tjem.215.61; Zhu B, 2011, MOL MED REP, V4, P505, DOI 10.3892/mmr.2011.444	27	21	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131295	10.1371/journal.pone.0131295	http://dx.doi.org/10.1371/journal.pone.0131295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131983	Green Submitted, Green Published, gold			2022-12-26	WOS:000358153000110
J	Wysocki, MA; Feranec, RS; Tseng, ZJ; Bjornsson, CS				Wysocki, M. Aleksander; Feranec, Robert S.; Tseng, Zhijie Jack; Bjornsson, Christopher S.			Using a Novel Absolute Ontogenetic Age Determination Technique to Calculate the Timing of Tooth Eruption in the Saber-Toothed Cat, Smilodon fatalis	PLOS ONE			English	Article							RANCHO-LA-BREA; SEXUAL-DIMORPHISM; GROWTH; BEHAVIOR; CANINE; REPRODUCTION; EVOLUTION; MAMMALS; SIZE; LION	Despite the superb fossil record of the saber-toothed cat, Smilodon fatalis, ontogenetic age determination for this and other ancient species remains a challenge. The present study utilizes a new technique, a combination of data from stable oxygen isotope analyses and micro-computed tomography, to establish the eruption rate for the permanent upper canines in Smilodon fatalis. The results imply an eruption rate of 6.0 millimeters per month, which is similar to a previously published average enamel growth rate of the S. fatalis upper canines (5.8 millimeters per month). Utilizing the upper canine growth rate, the upper canine eruption rate, and a previously published tooth replacement sequence, this study calculates absolute ontogenetic age ranges of tooth development and eruption in S. fatalis. The timing of tooth eruption is compared between S. fatalis and several extant conical-toothed felids, such as the African lion (Panthera leo). Results suggest that the permanent dentition of S. fatalis, except for the upper canines, was fully erupted by 14 to 22 months, and that the upper canines finished erupting at about 34 to 41 months. Based on these developmental age calculations, S. fatalis individuals less than 4 to 7 months of age were not typically preserved at Rancho La Brea. On the whole, S. fatalis appears to have had delayed dental development compared to dental development in similar-sized extant felids. This technique for absolute ontogenetic age determination can be replicated in other ancient species, including non-saber-toothed taxa, as long as the timing of growth initiation and growth rate can be determined for a specific feature, such as a tooth, and that growth period overlaps with the development of the other features under investigation.	[Wysocki, M. Aleksander] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Feranec, Robert S.] New York State Museum & Sci Serv, Res & Collect Div, Albany, NY 12230 USA; [Tseng, Zhijie Jack] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Bjornsson, Christopher S.] Neural Stem Cell Inst, Rensselaer, NY USA	Clemson University; American Museum of Natural History (AMNH)	Feranec, RS (corresponding author), New York State Museum & Sci Serv, Res & Collect Div, Albany, NY 12230 USA.	robert.feranec@nysed.gov			Society of Vertebrate Paleontology; U.C. Berkeley Department of Integrative Biology; American Museum of Natural History's Theodore Roosevelt Grant; NSF DDIG; NSF [DEB-1257572]; American Museum of Natural History	Society of Vertebrate Paleontology; U.C. Berkeley Department of Integrative Biology; American Museum of Natural History's Theodore Roosevelt Grant; NSF DDIG(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); American Museum of Natural History	Funding for this study was provided by the Society of Vertebrate Paleontology, U.C. Berkeley Department of Integrative Biology, American Museum of Natural History's Theodore Roosevelt Grant, and an NSF DDIG to RSF. ZJT is supported by NSF DEB-1257572 and a Frick postdoctoral fellowship from the American Museum of Natural History. Logistical support was provided by the NY State Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEN W A, 1985, Contributions in Science (Los Angeles), P1; AKERSTEN WA, 1983, PALEOBIOLOGY, V9, P211, DOI 10.1017/S0094837300007648; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; ALBERCH P, 1980, AM ZOOL, V20, P653; Ant?n M., 2013, SABERTOOTH; Biknevicius Audrone R., 1996, P393; Binder WJ, 2010, J VERTEBR PALEONTOL, V30, P255, DOI 10.1080/02724630903413016; Binder WJ, 2002, J VERTEBR PALEONTOL, V22, P423, DOI 10.1671/0272-4634(2002)022[0423:TVITFA]2.0.CO;2; Carbone C, 2009, BIOL LETTERS, V5, P81, DOI 10.1098/rsbl.2008.0526; Christiansen P, 2005, J MORPHOL, V266, P369, DOI 10.1002/jmor.10384; Christiansen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048352; Christiansen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029699; CROWE DM, 1975, J MAMMAL, V56, P177, DOI 10.2307/1379615; CURRIER M J P, 1983, Mammalian Species, P1, DOI 10.2307/3503951; Elbroch M., 2006, ANIMAL SKULLS GUIDE; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Ewer, 1998, CARNIVORES; Feranec Robert S., 2005, Bulletin of the Florida Museum of Natural History, V45, P369; Feranec RS, 2008, PALAIOS, V23, P566, DOI 10.2110/palo.2007.p07-079r; Feranec RS, 2004, PALAEOGEOGR PALAEOCL, V206, P303, DOI 10.1016/j.palaeo.2004.01.009; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; GAUNT W. A., 1959, ACTA ANAT, V38, P187; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; GONYEA W J, 1976, Paleobiology, V2, P332; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haas Sarah K., 2005, Mammalian Species, P1; HARRIS JM, 2001, TERRA, V38, P12; Haynes G, 1991, MAMMOTHS MASTODONTS, DOI [10.1126/science.1236573, DOI 10.1126/SCIENCE.1236573]; HEMMER H, 1972, Mammalian Species, V20, P1; Hoogesteijn Rafael, 1996, Bulletin of the Florida Museum of Natural History, V39, P195; JACKSON DL, 1988, J WILDLIFE MANAGE, V52, P515, DOI 10.2307/3801602; Kierdorf H, 2012, ANAT HISTOL EMBRYOL, V41, P419, DOI 10.1111/j.1439-0264.2012.01151.x; Knospe C, 2002, ANAT HISTOL EMBRYOL, V31, P37, DOI 10.1046/j.1439-0264.2002.00360.x; Krausman Paul R., 2005, Mammalian Species, P1; Kruuk H., 1972, P1; Kurten B., 1980, PLEISTOCENE MAMMALS; Lariviere Serge, 1997, Mammalian Species, V563, P1, DOI 10.2307/3504533; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; Martin LD, 2000, NATURWISSENSCHAFTEN, V87, P41, DOI 10.1007/s001140050007; MATTHEWS L. HARRISON, 1939, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P1; MAZAK V, 1981, Mammalian Species, P1, DOI 10.2307/3504004; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; McHorse BK, 2012, PALAEOGEOGR PALAEOCL, V329, P118, DOI 10.1016/j.palaeo.2012.02.022; Meachen-Samuels JA, 2010, J ZOOL, V280, P271, DOI 10.1111/j.1469-7998.2009.00659.x; Merriam J.C., 1932, CARNEGIE I WASHINGTO, V442, P1; MILLAR JS, 1981, EVOLUTION, V35, P1149, DOI 10.1111/j.1558-5646.1981.tb04986.x; MILLS M G L, 1982, Mammalian Species, P1, DOI 10.2307/3504059; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Pretzer SD, 2008, THERIOGENOLOGY, V70, P300, DOI 10.1016/j.theriogenology.2008.04.029; Rawn-Schatzinger V., 1983, Journal of Vertebrate Paleontology, V3, P49, DOI 10.1080/02724634.1983.10011958; Ray Justina C., 1995, Mammalian Species, V488, P1; RIEGER I, 1981, Mammalian Species, P1; RIGGS ELMER S., 1934, TRANS AMER PHILOSOPH SOC, V24, P1, DOI 10.2307/3231954; Rountrey AN, 2012, QUATERN INT, V255, P196, DOI 10.1016/j.quaint.2011.06.006; Sanchez-Villagra MR, 2002, J EXP ZOOL, V294, P264, DOI 10.1002/jez.10147; Schaller G. C., 1967, DEER TIGER STUDY WIL; Schaller GB, 1972, SERENGETI LION STUDY, DOI [10.1371/journal.pone.0125944, DOI 10.1371/JOURNAL.PONE.0125944]; SEYMOUR K L, 1989, Mammalian Species, P1, DOI 10.2307/3504096; Shaw CA, 2000, COMMUNICATION; Simpson G. G., 1941, AM MUS NOVIT, V1120; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; Sone K, 2008, MAMM BIOL, V73, P350, DOI 10.1016/j.mambio.2007.04.006; Spencer LM, 2003, PALEOBIOLOGY, V29, P561, DOI 10.1666/0094-8373(2003)029<0561:TAOLMR>2.0.CO;2; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stein Andrew B., 2013, Mammalian Species, P30, DOI 10.1644/900.1; Stock C, 1972, PALAEONTOLOGY, V20, P11; STOCK CHESTER, 1929, JOUR MAMMALOGY, V10, P281, DOI 10.2307/1374112; Stuart C.T., 1986, Saugetierkundliche Mitteilungen, V32, P217; Sunquist ME, 2002, WILD CATS WORLD; Tejada-Flores A.E., 1984, Journal of Vertebrate Paleontology, V4, P114; TUMLISON R, 1987, Mammalian Species, P1, DOI 10.2307/3503985; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Van Valkenburgh B, 2002, J VERTEBR PALEONTOL, V22, P164, DOI 10.1671/0272-4634(2002)022[0164:SDSBAI]2.0.CO;2; VANVALKENBURGH B, 1987, J ZOOL, V212, P379; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Watts HE, 2009, P ROY SOC B-BIOL SCI, V276, P2291, DOI 10.1098/rspb.2009.0268; WEMMER C, 1981, J MAMMAL, V62, P342, DOI 10.2307/1380710; Wroe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066888; Yokohama-Tamaki T, 2006, DEVELOPMENT, V133, P1359, DOI 10.1242/dev.02307; Zambelli D, 2006, THERIOGENOLOGY, V66, P135, DOI 10.1016/j.theriogenology.2006.04.004	83	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129847	10.1371/journal.pone.0129847	http://dx.doi.org/10.1371/journal.pone.0129847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132165	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000042
J	Alvarez, M; Reynaert, N; Chavez, MN; Aedo, G; Araya, F; Hopfner, U; Fernandez, J; Allende, ML; Egana, JT				Alvarez, Marjorie; Reynaert, Nicole; Chavez, Myra N.; Aedo, Geraldine; Araya, Francisco; Hopfner, Ursula; Fernandez, Juan; Allende, Miguel L.; Egana, Jose T.			Generation of Viable Plant-Vertebrate Chimeras	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CHLAMYDOMONAS-REINHARDTII; ZEBRAFISH MODEL; OXYGEN	The extreme dependence on external oxygen supply observed in animals causes major clinical problems and several diseases are related to low oxygen tension in tissues. The vast majority of the animals do not produce oxygen but a few exceptions have shown that photosynthetic capacity is physiologically compatible with animal life. Such symbiotic photosynthetic relationships are restricted to a few aquatic invertebrates. In this work we aimed to explore if we could create a chimerical organism by incorporating photosynthetic eukaryotic cells into a vertebrate animal model. Here, the microalgae Chlamydomonas reinhardtii was injected into zebrafish eggs and the interaction and viability of both organisms were studied. Results show that microalgae were distributed into different tissues, forming a fish-alga chimera organism for a prolonged period of time. In addition, microscopic observation of injected algae, in vivo expression of their mRNA and re-growth of the algae ex vivo suggests that they survived to the developmental process, living for several days after injection. Moreover microalgae did not trigger a significant inflammatory response in the fish. This work provides additional evidence to support the possibility that photosynthetic vertebrates can be engineered.	[Alvarez, Marjorie; Reynaert, Nicole; Chavez, Myra N.; Aedo, Geraldine; Allende, Miguel L.; Egana, Jose T.] Univ Chile, Fac Ciencias, FONDAP Ctr Genome Regulat, Santiago, Chile; [Chavez, Myra N.; Hopfner, Ursula; Egana, Jose T.] Tech Univ Munich, Univ Hosp Rechts Isar, Fac Med, Dept Plast & Hand Surg, D-80290 Munich, Germany; [Araya, Francisco; Fernandez, Juan] Univ Chile, Fac Ciencias, Dept Biol, Lab Dev Cell Biol, Santiago, Chile; [Egana, Jose T.] Pontificia Univ Catolica Chile, Sch Engn, Sch Med, Inst Med & Biol Engn, Santiago, Chile; [Egana, Jose T.] Pontificia Univ Catolica Chile, Sch Biol Sci, Santiago, Chile	Universidad de Chile; Technical University of Munich; Universidad de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Allende, ML (corresponding author), Univ Chile, Fac Ciencias, FONDAP Ctr Genome Regulat, Santiago, Chile.	mallende@u.uchile.cl; tomasega@gmail.com	Allende, Miguel L/C-5167-2008; Rosas, Myra Noemi Chavez/W-1744-2019	Allende, Miguel L/0000-0002-2783-2152; Rosas, Myra Noemi Chavez/0000-0002-2132-2653; Alvarez Mejia, Marjorie Babol/0000-0003-2809-9439; Egana, Jose Tomas/0000-0003-2624-6992	FONDAP [15090007]; ICGEB [CRP/CHI11-01]; CIRM-BMBF Early Translational II Award; German Research Foundation (DFG); Technische Universitat Munchen	FONDAP; ICGEB; CIRM-BMBF Early Translational II Award; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	MA and JTE were funded by grants from FONDAP 15090007 and ICGEB CRP/CHI11-01. JTE was funded by a CIRM-BMBF Early Translational II Award. This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapakis CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018877; de Negri A, 1876, BER DEUT CHEM GESELL, V9, P84; Fernandez J, 2013, DEV DYNAM, V242, P503, DOI 10.1002/dvdy.23943; Fuentes R, 2010, DEV DYNAM, V239, P2172, DOI 10.1002/dvdy.22349; Haffter P, 1996, DEVELOPMENT, V123, P1; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Joseph P., 1772, PHILOS T R SOC LOND, V62, P147; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; Menger MD, 2007, TRANSPL P, V39, P485, DOI 10.1016/j.transproceed.2007.01.022; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; Moshal KS, 2010, TRENDS CARDIOVAS MED, V20, P114, DOI 10.1016/j.tcm.2010.10.001; NASS MMK, 1969, SCIENCE, V165, P1128, DOI 10.1126/science.165.3898.1128; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Raven JA, 2009, J EXP BOT, V60, P3975, DOI 10.1093/jxb/erp282; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rumpho ME, 2011, J EXP BIOL, V214, P303, DOI 10.1242/jeb.046540; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Schenck TL, 2015, ACTA BIOMATER, V15, P39, DOI 10.1016/j.actbio.2014.12.012; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Werner R, 2002, CHRONOBIOL INT, V19, P325, DOI 10.1081/CBI-120002981	24	15	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130295	10.1371/journal.pone.0130295	http://dx.doi.org/10.1371/journal.pone.0130295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126202	Green Published, gold, Green Submitted			2022-12-26	WOS:000358151300011
J	Belaunzaran, OM; Kleber, S; Schauer, S; Hausmann, M; Nicholls, F; Van den Broek, M; Payeli, S; Ciurea, A; Milling, S; Stenner, F; Shaw, J; Kollnberger, S; Bowness, P; Petrausch, U; Renner, C				Belaunzaran, Osiris Marroquin; Kleber, Sascha; Schauer, Stefan; Hausmann, Martin; Nicholls, Flora; Van den Broek, Maries; Payeli, Sravan; Ciurea, Adrian; Milling, Simon; Stenner, Frank; Shaw, Jackie; Kollnberger, Simon; Bowness, Paul; Petrausch, Ulf; Renner, Christoph			HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; DECREASED CLINICAL-RESPONSE; FREE H CHAINS; HLA CLASS-I; ANKYLOSING-SPONDYLITIS; HLA-B27-TRANSGENIC RATS; HEAVY-CHAINS; MONOCLONAL-ANTIBODY; TH17 CELLS; TNF-ALPHA	Objectives HLA-B27 is a common genetic risk factor for the development of Spondyloarthritides (SpA). HLA-B27 can misfold to form cell-surface heavy chain homodimers (B27(2)) and induce pro-inflammatory responses that may lead to SpA pathogenesis. The presence of B27(2) can be detected on leukocytes of HLA-B27+ Ankylosing spondylitis (AS) patients and HLA-B27 transgenic rats. We characterized a novel B27(2)-specific monoclonal antibody to study its therapeutic use in HLA-B27 associated disorders. Methods The monoclonal HD5 antibody was selected from a phage library to target cell-surface B272 homodimers and characterized for affinity, specificity and ligand binding. The immune modulating effect of HD5 was tested in HLA-B27 transgenic rats. Onset and progression of disease profiles were monitored during therapy. Cell-surface B27(2) and expansion of pro-inflammatory cells from blood, spleen and draining lymph nodes were assessed by flow cytometry. Results HD5 bound B27(2) with high specificity and affinity (K-d = 0.32 nM). HD5 blocked cell-surface interaction of B27(2) with immune regulatory receptors KIR3DL2, LILRB2 and Pirb. In addition, HD5 modulated the production of TNF from CD4+ T-cells by limiting B27(2) interactions in vitro. In an HLA-B27 transgenic rat model repetitive dosing of HD5 reduced the expansion of pro-inflammatory CD4+ T-cells, and decreased the levels of soluble TNF and number of cell-surface B27(2) molecules. Conclusion HD5 predominantly inhibits early TNF production and expansion of pro-inflammatory CD4+ T-cells in HLA-B27 transgenic rats. Monoclonal antibodies targeting cell-surface B27(2) propose a new concept for the modulation of inflammatory responses in HLA-B27 related disorders.	[Belaunzaran, Osiris Marroquin; Kleber, Sascha; Van den Broek, Maries; Payeli, Sravan; Petrausch, Ulf; Renner, Christoph] Univ Zurich Hosp, Div Oncol, CH-8091 Zurich, Switzerland; [Schauer, Stefan] Univ Zurich, Swiss Fed Inst Technol Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Hausmann, Martin] Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Nicholls, Flora] Univ Zurich, Cent Biol Lab, Zurich, Switzerland; [Ciurea, Adrian] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland; [Milling, Simon] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Stenner, Frank; Renner, Christoph] Univ Basel Hosp, Dept Oncol, CH-4031 Basel, Switzerland; [Shaw, Jackie; Kollnberger, Simon; Bowness, Paul] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Petrausch, Ulf] Univ Zurich Hosp, Dept Clin Immunol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Glasgow; University of Basel; University of Oxford; University of Zurich; University Zurich Hospital	Renner, C (corresponding author), Univ Zurich Hosp, Div Oncol, CH-8091 Zurich, Switzerland.	christoph.renner@unibas.ch	Bowness, Paul/AAH-2484-2019; van den Broek, Maries/L-6532-2019; van den Broek, Maries/G-4128-2016	van den Broek, Maries/0000-0002-9489-3692; Stenner, Frank/0000-0003-4541-8817; bowness, paul/0000-0003-4597-0484; Ciurea, Adrian/0000-0002-7870-7132	Ludwig Institute for Cancer Research; Arthritis Research UK; Oxford National Institute for Health Research Biomedical Research Centre; Biomedical Research Unit; Pablo Frolich Foundation; Albert Boni Foundation; Versus Arthritis [20816, 19611] Funding Source: researchfish	Ludwig Institute for Cancer Research; Arthritis Research UK(Versus Arthritis); Oxford National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Biomedical Research Unit; Pablo Frolich Foundation; Albert Boni Foundation; Versus Arthritis(Versus Arthritis)	This study was supported by Ludwig Institute for Cancer Research (CR), Arthritis Research UK (SK, JS), the Oxford National Institute for Health Research Biomedical Research Centre and Biomedical Research Unit (PB), Pablo Frolich Foundation (UP, CR) and the Albert Boni Foundation (CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 1999, J IMMUNOL, V162, P5045; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Bird LA, 2003, EUR J IMMUNOL, V33, P748, DOI 10.1002/eji.200323678; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; BREWERTON DA, 1973, LANCET, V2, P996, DOI 10.1016/S0140-6736(73)91091-X; Chan AT, 2005, ARTHRITIS RHEUM, V52, P3586, DOI 10.1002/art.21395; de Vries MK, 2009, ANN RHEUM DIS, V68, P1787, DOI 10.1136/ard.2009.109702; de Vries MK, 2007, ANN RHEUM DIS, V66, P1252, DOI 10.1136/ard.2007.072397; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Feng Y, 2012, J RHEUMATOL, V39, P574, DOI 10.3899/jrheum.101257; Giles J, 2012, J IMMUNOL, V188, P6184, DOI 10.4049/jimmunol.1102711; Glatigny S, 2012, ARTHRITIS RHEUM-US, V64, P110, DOI 10.1002/art.33321; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Her M, 2013, CURR OPIN RHEUMATOL, DOI [10.1097/BOR.0b013e3283620177, DOI 10.1097/B0R.0B013E3283620177]; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Institute for Laboratory Animal Research (U.S.), REC ALL PAIN LAB AN; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Khan MA, 2002, ANN INTERN MED, V136, P896, DOI 10.7326/0003-4819-136-12-200206180-00011; Khare SD, 1996, J CLIN INVEST, V98, P2746, DOI 10.1172/JCI119100; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Kollnberger S, 2007, EUR J IMMUNOL, V37, P1313, DOI 10.1002/eji.200635997; Layh-Schmitt G, 2013, ARTHRITIS RHEUM-US, V65, P2123, DOI 10.1002/art.38001; Lories RJU, 2006, CURR OPIN RHEUMATOL, V18, P342, DOI 10.1097/01.bor.0000231900.81677.c5; May E, 2003, J IMMUNOL, V170, P1099, DOI 10.4049/jimmunol.170.2.1099; McHugh K, 2014, ANN RHEUM DIS, V73, P763, DOI 10.1136/annrheumdis-2012-203080; Milia AF, 2011, J CELL MOL MED, V15, P270, DOI 10.1111/j.1582-4934.2009.00984.x; Milia AF, 2009, J CELL MOL MED, V13, P164, DOI 10.1111/j.1582-4934.2008.00310.x; Nechansky A, 2010, EXPERT OPIN DRUG DIS, V5, P1067, DOI 10.1517/17460441.2010.514326; Payeli SK, 2012, ARTHRITIS RHEUM-US, V64, P3139, DOI 10.1002/art.34538; Poddubnyy D, 2014, ANN RHEUM DIS, V73, P817, DOI 10.1136/annrheumdis-2013-204248; Rath HC, 2002, PATHOBIOLOGY, V70, P131, DOI 10.1159/000068144; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sieper J, 2006, BEST PRACT RES CL RH, V20, P401, DOI 10.1016/j.berh.2006.02.001; Sieper J, 2012, NAT REV RHEUMATOL, V8, P280, DOI 10.1038/nrrheum.2012.40; Singh R, 2007, J RHEUMATOL, V34, P2285; STAM NJ, 1986, J IMMUNOL, V137, P2299; TAUROG JD, 1993, J IMMUNOL, V150, P4168; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; Turner MJ, 2007, ARTHRITIS RHEUM, V56, P215, DOI 10.1002/art.22295; Wang XW, 2009, RHEUMATOL INT, V29, P1343, DOI 10.1007/s00296-009-0883-x; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wendling D, 2007, JOINT BONE SPINE, V74, P304, DOI 10.1016/j.jbspin.2006.11.005; Wong-Baeza I, 2013, J IMMUNOL, V190, P3216, DOI 10.4049/jimmunol.1202926	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130811	10.1371/journal.pone.0130811	http://dx.doi.org/10.1371/journal.pone.0130811			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125554	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000358151300027
J	Dong, D; Thomas, N; Thierry, B; Vreugde, S; Prestidge, CA; Wormald, PJ				Dong, Dong; Thomas, Nicky; Thierry, Benjamin; Vreugde, Sarah; Prestidge, Clive A.; Wormald, Peter-John			Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm	PLOS ONE			English	Article							IN-VITRO ACTIVITY; CHRONIC RHINOSINUSITIS; BACTERIAL BIOFILMS; SURFACE-PROPERTIES; NANOPARTICLES; ACCUMULATION; PENETRATION; FORMULATION; INFECTIONS; MECHANISMS	Background Staphylococcus aureus and Pseudomonas aeruginosa are major pathogens in chronic rhinosinusitis (CRS) and their biofilms have been associated with poorer postsurgical outcomes. This study investigated the distribution and anti-biofilm effect of cationic (+) and anionic (-) phospholipid liposomes with different sizes (unilamellar and multilamellar vesicle, ULV and MLV respectively) on S. aureus and P. aeruginosa biofilms. Method Specific biofilm models for S. aureus ATCC 25923 and P. aeruginosa ATCC 15692 were established. Liposomal distribution was determined by observing SYTO9 stained biofilm exposed to DiI labeled liposomes using confocal scanning laser microscopy, followed by quantitative image analysis. The anti-biofilm efficacy study was carried out by using the alamarBlue assay to test the relative viability of biofilm treated with various liposomes for 24 hours and five minutes. Results The smaller ULVs penetrated better than larger MLVs in both S. aureus and P. aeruginosa biofilm. Except that + ULV and -ULV displayed similar distribution in S. aureus biofilm, the cationic liposomes adhered better than their anionic counterparts. Biofilm growth was inhibited at 24-hour and five-minute exposure time, although the decrease of viability for P. aeruginosa biofilm after liposomal treatment did not reach statistical significance. Conclusion The distribution and anti-biofilm effects of cationic and anionic liposomes of different sizes differed in S. aureus and P. aeruginosa biofilms. Reducing the liposome size and formulating liposomes as positively charged enhanced the penetration and inhibition of S. aureus and P. aeruginosa biofilms.	[Dong, Dong; Vreugde, Sarah; Wormald, Peter-John] Queen Elizabeth Hosp, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia; [Dong, Dong; Vreugde, Sarah; Wormald, Peter-John] Univ Adelaide, Adelaide, SA, Australia; [Thomas, Nicky; Thierry, Benjamin; Prestidge, Clive A.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, Australia; [Dong, Dong] Zhengzhou Univ, Affiliated Hosp 1, Rhinol Dept, Zhengzhou 450052, Peoples R China	University of Adelaide; University of South Australia; Zhengzhou University	Wormald, PJ (corresponding author), Queen Elizabeth Hosp, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia.	peterj.wormald@adelaide.edu.au	Thierry, benjamin/B-2785-2009; Dong, Dong/AAI-1403-2020; Thomas, Nicky/D-1708-2016	Thierry, benjamin/0000-0002-6757-2842; Thomas, Nicky/0000-0001-8920-1391; Prestidge, Clive/0000-0001-5401-7535; Vreugde, Sarah/0000-0003-4719-9785	National Health and Medical Research Council of Australia (NHMRC) [GNT1047576]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from The National Health and Medical Research Council of Australia (NHMRC: GNT1047576) [http://www.nhmrc.gov.au/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Ahmed K, 2002, J LIPOSOME RES, V12, P285, DOI 10.1081/LPR-120016195; Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Andar AU, 2014, PHARM RES-DORDR, V31, P401, DOI 10.1007/s11095-013-1171-8; BANGHAM AD, 1965, J MOL BIOL, V13, P253, DOI 10.1016/S0022-2836(65)80094-8; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Boase S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-210; Cottenye N, 2013, BIOFOULING, V29, P817, DOI 10.1080/08927014.2013.807505; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Dong D, 2014, LARYNGOSCOPE, V124, P1071, DOI 10.1002/lary.24424; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Foreman A, 2012, CURR ALLERGY ASTHM R, V12, P127, DOI 10.1007/s11882-012-0246-7; Foreman A, 2011, LARYNGOSCOPE, V121, P1085, DOI 10.1002/lary.21438; Forier K, 2014, J CONTROL RELEASE, V195, P21, DOI 10.1016/j.jconrel.2014.07.061; Forier K, 2014, J CONTROL RELEASE, V190, P607, DOI 10.1016/j.jconrel.2014.03.055; FRESTA M, 1995, J PHARM SCI, V84, P895, DOI 10.1002/jps.2600840721; Fresta M, 1996, ANTIMICROB AGENTS CH, V40, P2865, DOI 10.1128/AAC.40.12.2865; Furneri PM, 2000, ANTIMICROB AGENTS CH, V44, P2458, DOI 10.1128/AAC.44.9.2458-2464.2000; Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Ha KR, 2008, LARYNGOSCOPE, V118, P535, DOI 10.1097/MLG.0b013e31815bf2e3; Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004; Hamblin KA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00079; Hinna A, 2016, J LIPOSOME RES, V26, P11, DOI 10.3109/08982104.2015.1022556; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Jardeleza C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092117; Lai SK, 2011, BIOMATERIALS, V32, P6285, DOI 10.1016/j.biomaterials.2011.05.008; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Li H, 2012, EUR ARCH OTO-RHINO-L, V269, P155, DOI 10.1007/s00405-011-1683-y; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Montagna MT, 2014, J MED MICROBIOL, V63, P1638, DOI 10.1099/jmm.0.075507-0; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Obonyo M, 2012, MOL PHARMACEUT, V9, P2677, DOI 10.1021/mp300243w; Parmentier J, 2012, INT J PHARMACEUT, V437, P253, DOI 10.1016/j.ijpharm.2012.08.018; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Powell LC, 2014, AM J RESP CELL MOL, V50, P483, DOI 10.1165/rcmb.2013-0287OC; Rehman ZU, 2013, APPL ENVIRON MICROB, V79, P3264, DOI 10.1128/AEM.00460-13; Rogers SA, 2010, ANTIMICROB AGENTS CH, V54, P2112, DOI 10.1128/AAC.01418-09; Sandt C, 2007, J ANTIMICROB CHEMOTH, V60, P1281, DOI 10.1093/jac/dkm382; Singhal D, 2011, LARYNGOSCOPE, V121, P1578, DOI 10.1002/lary.21805; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; SONOHARA R, 1995, BIOPHYS CHEM, V55, P273, DOI 10.1016/0301-4622(95)00004-H; Sudagidan M, 2010, MIKROBIYOL BUL, V44, P93; Xu XM, 2011, INT J PHARMACEUT, V419, P52, DOI 10.1016/j.ijpharm.2011.07.012	47	50	53	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131806	10.1371/journal.pone.0131806	http://dx.doi.org/10.1371/journal.pone.0131806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125555	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358151300055
J	Si, MR; Wang, JB; Xiao, X; Guan, JY; Zhang, YL; Ding, W; Chaudhry, MT; Wang, Y; Shen, XH				Si, Meiru; Wang, Jianbo; Xiao, Xiao; Guan, Jingyuan; Zhang, Yaoling; Ding, Wei; Chaudhry, Muhammad Tausif; Wang, Yao; Shen, Xihui			Ohr Protects Corynebacterium glutamicum against Organic Hydroperoxide Induced Oxidative Stress	PLOS ONE			English	Article							RESISTANCE PROTEIN; FUNCTIONAL-CHARACTERIZATION; DEPENDENT PEROXIDASE; GENE; EXPRESSION; REPRESSOR; REDUCTASE; IDENTIFICATION; XANTHOMONAS; MYCOTHIOL	Ohr, a bacterial protein encoded by the Organic Hydroperoxide Resistance (ohr) gene, plays a critical role in resistance to organic hydroperoxides. In the present study, we show that the Cys-based thiol-dependent Ohr of Corynebacterium glutamicum decomposes organic hydroperoxides more efficiently than hydrogen peroxide. Replacement of either of the two Cys residues of Ohr by a Ser residue resulted in drastic loss of activity. The electron donors supporting regeneration of the peroxidase activity of the oxidized Ohr of C. glutamicum were principally lipoylated proteins (LpdA and Lpd/SucB). A.ohr mutant exhibited significantly decreased resistance to organic hydroperoxides and marked accumulation of reactive oxygen species (ROS) in vivo; protein carbonylation was also enhanced notably. The resistance to hydrogen peroxide also decreased, but protein carbonylation did not rise to any great extent. Together, the results unequivocally show that Ohr is essential for mediation of organic hydroperoxide resistance by C. glutamicum.	[Si, Meiru; Xiao, Xiao; Zhang, Yaoling; Ding, Wei; Shen, Xihui] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wang, Jianbo; Guan, Jingyuan; Wang, Yao] Northwest A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling 712100, Shaanxi, Peoples R China; [Chaudhry, Muhammad Tausif] Pakistan Council Sci & Ind Res, Natl Phys & Stand Lab, Environm Analyt Lab, Islamabad, Pakistan	Northwest A&F University - China; Northwest A&F University - China; National Physical & Standards Laboratory (NPSL); PCSIR Laboratories Complex	Wang, Y (corresponding author), Northwest A&F Univ, Coll Life Sci, Dept Biochem & Mol Biol, Yangling 712100, Shaanxi, Peoples R China.	yaowang@nwsuaf.edu.cn; xihuishen@nwsuaf.edu.cn	DING, Wei/CVK-8505-2022	DING, Wei/0000-0002-1847-244X	National High Technology Research and Development Program of China (863 program) [2013AA102802]; National Natural Science Foundation of China [31270078, 31170100]; Fundamental Research Funds for the Central Universities; Northwest AF University [Z111021006, Z111021007]; Key Science and Technology R&D Program of Shaanxi Province, China [2014K02-12-01]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Northwest AF University; Key Science and Technology R&D Program of Shaanxi Province, China	This work was supported by the National High Technology Research and Development Program of China (863 program, grant 2013AA102802), the National Natural Science Foundation of China (31270078 and 31170100), Fundamental Research Funds for the Central Universities, Northwest A&F University (Z111021006 and Z111021007) and Key Science and Technology R&D Program of Shaanxi Province, China (2014K02-12-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1992, ARCH BIOCHEM BIOPHYS, V294, P55, DOI 10.1016/0003-9861(92)90136-K; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; BROER S, 1993, APPL ENVIRON MICROB, V59, P316; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Caswell CC, 2012, J BACTERIOL, V194, P5065, DOI 10.1128/JB.00873-12; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chuchue T, 2006, J BACTERIOL, V188, P842, DOI 10.1128/JB.188.3.842-851.2006; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Neto JFD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047090; Ehira S, 2009, J BACTERIOL, V191, P2964, DOI 10.1128/JB.00112-09; El Shafey HM, 2008, MICROBIOL RES, V163, P80, DOI 10.1016/j.micres.2006.05.005; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Jenkins C, 2008, J BACTERIOL, V190, P2206, DOI 10.1128/JB.01685-07; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Lee JY, 2013, BIOTECHNOL LETT, V35, P709, DOI 10.1007/s10529-012-1135-9; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Li N, 2014, ENVIRON MICROBIOL, V16, P1821, DOI 10.1111/1462-2920.12418; Liu YB, 2013, ARCH MICROBIOL, V195, P419, DOI 10.1007/s00203-013-0889-3; Meireles DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099492; Miller J.H., 1993, TRENDS BIOCHEM SCI L, V18, P193; Mongkolsuk S, 1998, J BACTERIOL, V180, P2636, DOI 10.1128/JB.180.10.2636-2643.1998; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ochsner UA, 2001, J BACTERIOL, V183, P773, DOI 10.1128/JB.183.2.773-778.2001; Oh SY, 2007, J BACTERIOL, V189, P6284, DOI 10.1128/JB.00632-07; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Schurig-Briccio LA, 2009, ARCH BIOCHEM BIOPHYS, V483, P106, DOI 10.1016/j.abb.2008.12.009; Shea RJ, 2002, INFECT IMMUN, V70, P794, DOI 10.1128/IAI.70.2.794-802.2002; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Si M, 2015, APPL ENVIRON MICROB; Si MR, 2014, APPL ENVIRON MICROB, V80, P1750, DOI 10.1128/AEM.03654-13; Si MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115075; Sukchawalit R, 2001, J BACTERIOL, V183, P4405, DOI 10.1128/JB.183.15.4405-4412.2001; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Teramoto H, 2013, FEBS J, V280, P3298, DOI 10.1111/febs.12312; Vinckx T, 2011, BIOMETALS, V24, P523, DOI 10.1007/s10534-010-9403-4; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005	43	21	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131634	10.1371/journal.pone.0131634	http://dx.doi.org/10.1371/journal.pone.0131634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121694	Green Published, gold, Green Submitted			2022-12-26	WOS:000358150400133
J	Jonker, SS; Louey, S; Giraud, GD; Thornburg, KL; Faber, JJ				Jonker, Sonnet S.; Louey, Samantha; Giraud, George D.; Thornburg, Kent L.; Faber, J. Job			Timing of cardiomyocyte growth, maturation, and attrition in perinatal sheep	FASEB JOURNAL			English	Article						apoptosis; cell number; fetus; neonate; proliferation	CARDIAC MYOCYTES; FETAL SHEEP; POSTNATAL MATURATION; ARTERIAL-PRESSURE; DNA-SYNTHESIS; PLOIDY LEVEL; ADULT SHEEP; CELL-DEATH; HEART; APOPTOSIS	Studies in altricial rodents attribute dramatic changes in perinatal cardiomyocyte growth, maturation, and attrition to stimuli associated with birth. Our purpose was to determine whether birth is a critical trigger controlling perinatal cardiomyocyte growth, maturation and attrition in a precocial large mammal, sheep (Ovis aries). Hearts from 0-61 d postnatal lambs were dissected or enzymatically dissociated. Cardiomyocytes were measured by micromorphometry, cell cycle activity assessed by immunohistochemistry, and nuclear number counted after DNA staining. Integration of this new data with published fetal data from our laboratory demonstrate that a newly appreciated >30% decrease in myocyte number occurred in the last 10 d of gestation (P < 0.0005) concomitant with an increase in cleaved poly (ADP-ribose) polymerase 1 (P < 0.05), indicative of apoptosis. Bisegmental linear regressions show that most changes in myocyte growth kinetics occur before birth (median = 15.2 d; P < 0.05). Right ventricular but not left ventricular cell number increases in the neonate, by 68% between birth and 60 d postnatal (P = 0.028). We conclude that in sheep few developmental changes in cardiomyocytes result from birth, excepting the different postnatal degrees of free wall hypertrophy between the ventricles. Furthermore, myocyte number is reduced in both ventricles immediately before term, but proliferation increases myocyte number in the neonatal right ventricle.	[Jonker, Sonnet S.; Louey, Samantha; Giraud, George D.; Thornburg, Kent L.; Faber, J. Job] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, Portland, OR 97239 USA; [Giraud, George D.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Jonker, SS (corresponding author), Oregon Hlth & Sci Univ, 3303 SW Bond Ave,Mailcode CH14T, Portland, OR 97239 USA.	jonkers@ohsu.edu	; Louey, Samantha/A-1381-2009	Jonker, Sonnet/0000-0002-1097-2562; Louey, Samantha/0000-0002-2628-0085	Eunice Kennedy Shriver National Institute of Child Health and Human Development; Office of the Director of the U.S. National Institutes of Health (NIH) [P01-HD-34430, K12-HD-043488, R01-HD-071068]; M. Lowell Edwards Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071068, K12HD043488, P01HD034430] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director of the U.S. National Institutes of Health (NIH); M. Lowell Edwards Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Kevin Hearn and Adrienne Wilburn for technical assistance, and Debra Anderson for editorial assistance. The Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Office of the Director of the U.S. National Institutes of Health (NIH), under award numbers P01-HD-34430, K12-HD-043488 and R01-HD-071068, and the M. Lowell Edwards Endowment funded this research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adler C P, 1975, Recent Adv Stud Cardiac Struct Metab, V6, P343; ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6; Adler CP, 1996, VIRCHOWS ARCH, V429, P159; Austin A, 1995, J ANAT, V187, P641; Bensley JG, 2010, EUR HEART J, V31, P2058, DOI 10.1093/eurheartj/ehq104; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bishopric NH, 2002, PEDIATR RES, V52, P322, DOI 10.1203/01.PDR.0000025655.48089.B9; BRILLANTES AMB, 1994, CIRC RES, V75, P503, DOI 10.1161/01.RES.75.3.503; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Carabello BA, 2002, J CARD FAIL, V8, pS258, DOI 10.1054/jcaf.2002.129250; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Choi JH, 2002, PEDIATR RES, V52, P325, DOI 10.1203/01.PDR.0000025654.32501.3D; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; DAWES GS, 1980, J PHYSIOL-LONDON, V309, P405, DOI 10.1113/jphysiol.1980.sp013516; Fernandez E, 2001, DEV DYNAM, V221, P302, DOI 10.1002/dvdy.1139; Fisher D. A., 1994, TXB FETAL PHYSL, P359; *GRAPHPAD SOFTW IN, F TEST WORKS COMP MO; Hamaguchi S, 2013, J PHARMACOL SCI, V123, P167, DOI 10.1254/jphs.13099FP; James TN, 1998, ANNU REV PHYSIOL, V60, P309, DOI 10.1146/annurev.physiol.60.1.309; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Jonker SS, 2007, AM J PHYSIOL-REG I, V292, pR913, DOI 10.1152/ajpregu.00484.2006; KAJSTURA J, 1995, EXP CELL RES, V219, P110, DOI 10.1006/excr.1995.1211; Karimi M, 2004, J THORAC CARDIOV SUR, V127, P490, DOI 10.1016/j.jtcvs.2003.07.052; KLIEGMAN RM, 1981, PEDIATR RES, V15, P945, DOI 10.1203/00006450-198106000-00013; Lewandowski AJ, 2013, CIRCULATION, V128, P713, DOI 10.1161/CIRCULATIONAHA.113.002583; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; PINSON CW, 1987, J DEV PHYSIOL, V9, P253; RUDOLPH AM, 1970, CIRCULATION, V41, P343, DOI 10.1161/01.CIR.41.2.343; Rudolph AM, 2001, CONGENITAL DIS HEART, P3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SMOLICH JJ, 1989, AM J PHYSIOL, V257, pH1, DOI 10.1152/ajpheart.1989.257.1.H1; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; TEITEL DF, 1987, PEDIATR RES, V22, P557, DOI 10.1203/00006450-198711000-00017; Walker D. W., 1994, TXB FETAL PHYSL, P298; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	40	38	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4346	4357		10.1096/fj.15-272013	http://dx.doi.org/10.1096/fj.15-272013			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26139099	Green Published			2022-12-26	WOS:000361367300023
J	da Costa, G; Ribeiro-Silva, C; Ribeiro, R; Gilberto, S; Gomes, RA; Ferreira, A; Mateus, E; Barroso, E; Coelho, AV; Freire, AP; Cordeiro, C				da Costa, Goncalo; Ribeiro-Silva, Cristina; Ribeiro, Raquel; Gilberto, Samuel; Gomes, Ricardo A.; Ferreira, Antonio; Mateus, Elia; Barroso, Eduardo; Coelho, Ana V.; Freire, Ana Ponces; Cordeiro, Carlos			Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease	PLOS ONE			English	Article							DOMINO LIVER-TRANSPLANTATION; RESONANCE MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; EXTRACELLULAR CHAPERONE; QUANTITATIVE-ANALYSIS; PROTEOMIC ANALYSIS; MONOZYGOTIC TWINS; PLASMA-PROTEINS; 2 PAIRS; POLYNEUROPATHY	Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. We discovered, using a differential proteomics approach, that extracellular chaperones such as fibrinogen, clusterin, haptoglobin, alpha-1-anti-trypsin and 2-macroglobulin are overrepresented in transthyretin amyloidosis. Our data shows that a complex network of extracellular chaperones are over represented in human plasma and we speculate that they act synergistically to cope with amyloid prone proteins. Proteostasis may thus be as important as point mutations in transthyretin amyloidosis.	[da Costa, Goncalo; Ribeiro-Silva, Cristina; Ribeiro, Raquel; Gilberto, Samuel; Ferreira, Antonio; Freire, Ana Ponces; Cordeiro, Carlos] FCUL, Ctr Quim Bioquim, Lisbon, Portugal; [Gomes, Ricardo A.; Coelho, Ana V.] Inst Tecnol Quim & Biol, Oeiras, Portugal; [Mateus, Elia; Barroso, Eduardo] Hosp Curry Cabral, Unidade Transplantacao, Lisbon, Portugal	Universidade de Lisboa	da Costa, G (corresponding author), FCUL, Ctr Quim Bioquim, Lisbon, Portugal.	gmcosta@fc.ul.pt; cacordeiro@fc.ul.pt	FT-ICR-MS, Lisboa/T-5273-2018; Ferreira, António EN/E-6488-2012; Coelho, Ana V Varela/O-3977-2014; Ferreira, Antonio/GXH-7620-2022; Costa, Goncalo/G-9100-2014; Coelho, Ana V/H-8885-2012; Gomes, Ricardo/E-8379-2012	Ferreira, António EN/0000-0002-9625-8115; Coelho, Ana V Varela/0000-0002-6143-4203; Ferreira, Antonio/0000-0001-5239-8020; Costa, Goncalo/0000-0001-8732-4478; Coelho, Ana V/0000-0002-6143-4203; Gomes, Ricardo/0000-0001-7155-0059; Mateus, Elia/0000-0001-8632-3983; Ponces-Freire, Ana/0000-0003-2280-8193; /0000-0002-2102-1949; Barroso, Eduardo/0000-0001-9059-7362; Cordeiro, Carlos/0000-0001-6327-8606	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/41037/2007, SFRH/BPD/73779/2010, IF/00359/2014, PEst-OE/QUI/UI0612/2011, PTDC/QUI/123060/2010, REDE/1501/REM/2005]; amyloidosis foundation	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); amyloidosis foundation	Work was supported by grants SFRH/BPD/41037/2007 (R.A.G.) and SFRH/BPD/73779/2010 and IF/00359/2014 (G.C), PEst-OE/QUI/UI0612/2011, PTDC/QUI/123060/2010 and REDE/1501/REM/2005 from the Fundacao para a Ciencia e a Tecnologia, and also by the 2011 Junior Research grant from the amyloidosis foundation.	ANDRADE C, 1952, BRAIN, V75, P408, DOI 10.1093/brain/75.3.408; Azoulay D, 1999, J AM COLL SURGEONS, V189, P584, DOI 10.1016/S1072-7515(99)00208-2; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Campos A, 2009, EUR J PLANT PATHOL, V125, P603, DOI 10.1007/s10658-009-9509-0; Da Costa G, 2009, AMYLOID, V16, P201, DOI 10.3109/13506120903421561; da Costa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024850; da Costa G, 2010, PROTEOM CLIN APPL, V4, P674, DOI 10.1002/prca.200900118; Donners MMPC, 2005, J PATHOL, V206, P39, DOI 10.1002/path.1749; Fountoulakis M, 2004, AMINO ACIDS, V27, P249, DOI 10.1007/s00726-004-0141-1; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Furtado A, 1997, TRANSPL P, V29, P467, DOI 10.1016/S0041-1345(96)00206-0; GOLLIN PA, 1992, NEUROREPORT, V3, P201, DOI 10.1097/00001756-199202000-00020; Greene MJ, 2011, AM J PATHOL, V178, P61, DOI 10.1016/j.ajpath.2010.11.015; Guerreiro A, 2012, AMYLOID, V19, P74, DOI 10.3109/13506129.2012.668500; Holmgren G, 2005, J MED GENET, V42, P953, DOI 10.1136/jmg.2005.033720; Holmgren G, 2004, J INTERN MED, V256, P453, DOI 10.1111/j.1365-2796.2004.01399.x; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Hyung SJ, 2010, ACS CHEM BIOL, V5, P1137, DOI 10.1021/cb100144v; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; IKEDA S, 1992, EUR NEUROL, V32, P308, DOI 10.1159/000116850; JANCIAUSKIENE S, 1995, BIOL CHEM H-S, V376, P415, DOI 10.1515/bchm3.1995.376.7.415; Karsan A, 2005, CLIN CHEM, V51, P1525, DOI 10.1373/clinchem.2005.050708; Kitchens WH, 2011, TRANSPLANT REV-ORLAN, V25, P167, DOI 10.1016/j.trre.2011.04.002; Kume H, 2014, MOL CELL PROTEOMICS, V13, P1471, DOI 10.1074/mcp.M113.037093; Lamy E, 2011, J ANIM PHYSIOL AN N, V95, P304, DOI 10.1111/j.1439-0396.2010.01055.x; Lamy E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-65; Liao PC, 2007, PROTEOM CLIN APPL, V1, P506, DOI 10.1002/prca.200600684; Lim A, 2003, PROTEIN SCI, V12, P1775, DOI 10.1110/ps.0349703; Liz MA, 2004, J BIOL CHEM, V279, P21431, DOI 10.1074/jbc.M402212200; Macario AJL, 2007, ANN NY ACAD SCI, V1113, P178, DOI 10.1196/annals.1391.009; Magalhaes J, 2011, J NEUROPATH EXP NEUR, V70, P1097, DOI 10.1097/NEN.0b013e31823a44f4; Marin-Gomez LM, 2010, TRANSPL P, V42, P644, DOI 10.1016/j.transproceed.2010.02.012; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; Monteiro E, 2004, J HEPATOL, V41, P188, DOI 10.1016/j.jhep.2004.06.004; Mullan GM, 2013, CURR ALZHEIMER RES, V10, P973; Munar-Ques M, 1999, J MED GENET, V36, P629; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nepomuceno AI, 2004, CLIN CHEM, V50, P1535, DOI 10.1373/clinchem.2004.033274; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Ribeiro-Silva C, 2011, AMYLOID, V18, P191, DOI 10.3109/13506129.2011.614295; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Sousa MM, 2004, LAB INVEST, V84, P865, DOI 10.1038/labinvest.3700107; Stangou AJ, 2005, NEW ENGL J MED, V352, P2356, DOI 10.1056/NEJM200506023522219; Tang HD, 2009, BIOCHEMISTRY-US, V48, P3967, DOI 10.1021/bi900015n; Tang HD, 2009, BIOCHEM BIOPH RES CO, V378, P662, DOI 10.1016/j.bbrc.2008.11.112; Teixeira AC, 2013, J CELL MOL MED, V17, P429, DOI 10.1111/jcmm.12024; Torricelli C, 2004, J MOL ENDOCRINOL, V33, P335, DOI 10.1677/jme.1.01530; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Varshney A, 2010, AMINO ACIDS, V39, P899, DOI 10.1007/s00726-010-0524-4; Weiss Walter, 2009, Methods Mol Biol, V564, P13, DOI 10.1007/978-1-60761-157-8_2; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zsila F, 2010, BIOCHEM BIOPH RES CO, V393, P242, DOI 10.1016/j.bbrc.2010.01.110	65	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0125392	10.1371/journal.pone.0125392	http://dx.doi.org/10.1371/journal.pone.0125392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147092	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600007
J	Giopanou, I; Lilis, I; Papaleonidopoulos, V; Marazioti, A; Spella, M; Vreka, M; Papadaki, H; Stathopoulos, GT				Giopanou, Ioanna; Lilis, Ioannis; Papaleonidopoulos, Vassilios; Marazioti, Antonia; Spella, Magda; Vreka, Malamati; Papadaki, Helen; Stathopoulos, Georgios T.			Comprehensive Evaluation of Nuclear Factor-kappa B Expression Patterns in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PANCREATIC-CANCER; PROSTATE-CANCER; TARGET GENES; IKK-BETA; ACTIVATION; CARCINOMA; SURVIVAL; INFLAMMATION; ANGIOGENESIS	Nuclear factor (NF)-kappa B signalling is required for lung adenocarcinoma development in mice, and both of its subunits RelA and RelB were independently reported to be highly expressed in human non-small cell lung cancer (NSCLC). To comprehensively examine NF-kappa B expression in NSCLC, we analyzed serial sections of primary tumor samples from 77 well-documented patients (36 adenocarcinomas, 40 squamous cell carcinomas and 3 large cell carcinomas) for immunoreactivity of RelA, RelB, P50, and P52/P100. Tumor and intratumoral stroma areas were discriminated based on proliferating cell nuclear antigen immunoreactivity and inflammatory infiltration was assessed in intratumoral stroma areas. NF-kappa B immunoreactivity was quantified by intensity, extent, and nuclear localization and was cross-examined with tumor cell proliferation, inflammatory infiltration, and clinical-pathologic data. We found that the expression of the different NF-kappa B subunits was not concordant, warranting our integral approach. Overall, RelA, RelB, and P50 were expressed at higher levels compared with P52/P100. However, RelA and P50 were predominantly expressed in intratumoral stroma, but RelB in tumor cells. Importantly, tumor area RelA expression was correlated with the intensity of inflammatory infiltration, whereas RelB expression was identified in proliferating tumor cells. Using multiple logistic regression, we identified that tumor RelB expression was an independent predictor of lymph node metastasis, and tumor P50 was an independent predictor of TNM6 stage IIB or higher, whereas tumor RelA was an independent predictor of inflammatory infiltration. We conclude that pathologic studies of NF-kappa B expression in cancer should include multiple pathway components. Utilizing such an approach, we identified intriguing associations between distinct NF-kappa B subunits and clinical and pathologic features of NSCLC.	[Giopanou, Ioanna; Lilis, Ioannis; Papaleonidopoulos, Vassilios; Marazioti, Antonia; Spella, Magda; Vreka, Malamati; Stathopoulos, Georgios T.] Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Rion, Achaia, Greece; [Papadaki, Helen] Univ Patras, Fac Med, Dept Anat, Rion, Achaia, Greece; [Stathopoulos, Georgios T.] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany; [Stathopoulos, Georgios T.] Helmholtz Zentrum Munchen, Munich, Germany	University of Patras; University of Patras; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stathopoulos, GT (corresponding author), Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Rion, Achaia, Greece.	gstathop@upatras.gr	Stathopoulos, Georgios/AAE-6884-2020; Stathopoulos, Georgios/D-6576-2013	MARAZIOTI, ANTONIA/0000-0002-1978-1121; Giopanou, Ioanna/0000-0003-4393-7517; Stathopoulos, Georgios/0000-0002-9215-6461	European Research Council [260524]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by a European Research Council 2010 Starting Independent Investigator Grant (grant number #260524 to G.T.S.; http://erc.europa.eu/kras-mutation-interactions-host-immunity-malignant-pleural-effusion). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Chen F, 1999, CLIN CHEM, V45, P7; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darb-Esfahani S, 2010, HISTOPATHOLOGY, V56, P727, DOI 10.1111/j.1365-2559.2010.03544.x; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Dimitrakopoulos FID, 2012, VIRCHOWS ARCH, V460, P515, DOI 10.1007/s00428-012-1230-2; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fanucchi MP, 2006, J CLIN ONCOL, V24, P5025, DOI 10.1200/JCO.2006.06.1853; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gasparian AV, 2002, J CELL SCI, V115, P141; Gilmore T.D., 2006, ONCOGENE, V25; Guo QQ, 2009, PANCREAS, V38, pE75, DOI 10.1097/MPA.0b013e3181987d86; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Ismail H, 2004, PROSTATE, V58, P308, DOI 10.1002/pros.10335; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Karabela SP, 2012, CARCINOGENESIS, V33, P859, DOI 10.1093/carcin/bgs024; Karst AM, 2009, INT J CANCER, V124, P494, DOI 10.1002/ijc.23973; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Li ZP, 2005, J IMMUNOL, V174, P205, DOI 10.4049/jimmunol.174.1.205; Maity PC, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.8; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Nottingham LK, 2014, ONCOGENE, V33, P1135, DOI 10.1038/onc.2013.49; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shen A, 2009, NEUROSURGERY, V65; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smith SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106966; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Umemura N, 2012, CANCER RES, V72, P45, DOI 10.1158/0008-5472.CAN-11-1484; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Weichert W, 2007, BRIT J CANCER, V97, P523, DOI 10.1038/sj.bjc.6603878; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yu LL, 2004, WORLD J GASTROENTERO, V10, P3255, DOI 10.3748/wjg.v10.i22.3255; Zhou SN, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-288	51	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132527	10.1371/journal.pone.0132527	http://dx.doi.org/10.1371/journal.pone.0132527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147201	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600296
J	Howard, JK; Klausmeyer, KR; Fesenmyer, KA; Furnish, J; Gardali, T; Grantham, T; Katz, JVE; Kupferberg, S; McIntyre, P; Moyle, PB; Ode, PR; Peek, R; Quinones, RM; Rehn, AC; Santos, N; Schoenig, S; Serpa, L; Shedd, JD; Slusark, J; Viers, JH; Wright, A; Morrison, SA				Howard, Jeanette K.; Klausmeyer, Kirk R.; Fesenmyer, Kurt A.; Furnish, Joseph; Gardali, Thomas; Grantham, Ted; Katz, Jacob V. E.; Kupferberg, Sarah; McIntyre, Patrick; Moyle, Peter B.; Ode, Peter R.; Peek, Ryan; Quinones, Rebecca M.; Rehn, Andrew C.; Santos, Nick; Schoenig, Steve; Serpa, Larry; Shedd, Jackson D.; Slusark, Joe; Viers, Joshua H.; Wright, Amber; Morrison, Scott A.			Patterns of Freshwater Species Richness, Endemism, and Vulnerability in California	PLOS ONE			English	Article							GLOBAL DECLINE; UNITED-STATES; CONSERVATION; BIODIVERSITY; EXTINCTIONS; CHALLENGES; THREATS	The ranges and abundances of species that depend on freshwater habitats are declining worldwide. Efforts to counteract those trends are often hampered by a lack of information about species distribution and conservation status and are often strongly biased toward a few well-studied groups. We identified the 3,906 vascular plants, macroinvertebrates, and vertebrates native to California, USA, that depend on fresh water for at least one stage of their life history. We evaluated the conservation status for these taxa using existing government and non-governmental organization assessments (e.g., endangered species act, NatureServe), created a spatial database of locality observations or distribution information from similar to 400 data sources, and mapped patterns of richness, endemism, and vulnerability. Although nearly half of all taxa with conservation status (n = 1,939) are vulnerable to extinction, only 114 (6%) of those vulnerable taxa have a legal mandate for protection in the form of formal inclusion on a state or federal endangered species list. Endemic taxa are at greater risk than non-endemics, with 90% of the 927 endemic taxa vulnerable to extinction. Records with spatial data were available for a total of 2,276 species (61%). The patterns of species richness differ depending on the taxonomic group analyzed, but are similar across taxonomic level. No particular taxonomic group represents an umbrella for all species, but hotspots of high richness for listed species cover 40% of the hotspots for all other species and 58% of the hotspots for vulnerable freshwater species. By mapping freshwater species hotspots we show locations that represent the top priority for conservation action in the state. This study identifies opportunities to fill gaps in the evaluation of conservation status for freshwater taxa in California, to address the lack of occurrence information for nearly 40% of freshwater taxa and nearly 40% of watersheds in the state, and to implement adequate protections for freshwater taxa where they are currently lacking.	[Howard, Jeanette K.; Klausmeyer, Kirk R.; Serpa, Larry; Shedd, Jackson D.; Morrison, Scott A.] Nature Conservancy, San Francisco, CA 94123 USA; [Fesenmyer, Kurt A.] Trout Unltd, Boise, ID USA; [Furnish, Joseph] US Forest Serv, USDA, Vallejo, CA USA; [Gardali, Thomas] Point Blue Conservat Sci, Petaluma, CA USA; [Grantham, Ted; Katz, Jacob V. E.; Moyle, Peter B.; Peek, Ryan; Quinones, Rebecca M.; Santos, Nick] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Grantham, Ted; Katz, Jacob V. E.; Moyle, Peter B.; Peek, Ryan; Quinones, Rebecca M.; Santos, Nick] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Kupferberg, Sarah] Univ Calif Berkeley, Integrat Biol, Berkeley, CA 94720 USA; [McIntyre, Patrick; Rehn, Andrew C.; Schoenig, Steve; Slusark, Joe] Calif Dept Fish & Wildlife, Biogeog Data Branch, Sacramento, CA USA; [Ode, Peter R.] Calif Dept Fish & Wildlife, Aquat Bioassessment Lab, Rancho Cordova, CA USA; [Viers, Joshua H.] Univ Calif Merced, Sch Engn, Merced, CA USA; [Wright, Amber] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	Nature Conservancy; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Merced; University of Hawaii System; University of Hawaii Manoa	Howard, JK (corresponding author), Nature Conservancy, San Francisco, CA 94123 USA.	jeanette_howard@tnc.org	Kupferberg, Sarah J/L-5084-2013; Viers, Joshua/ABC-1851-2020; Peek, Ryan/H-4906-2015	Viers, Joshua/0000-0001-7957-7942; Peek, Ryan/0000-0002-9577-6885; Santos, Nicholas/0000-0001-5853-402X; Wright, Amber/0000-0002-9078-0324; Kupferberg, Sarah/0000-0002-7273-712X; McIntyre, Patrick/0000-0002-7800-6416	U. S. Bureau of Land Management	U. S. Bureau of Land Management	We thank The Nature Conservancy for supporting development of this database and this research, with additional support from the U. S. Bureau of Land Management. With the exception of the authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Amphibian and Reptile Species of Special Concern (ARSSC), 2009, CAL AMPH REPT SPEC S; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; California Department of Fish and Wildlife, 2014, STAT FED LIST END TH; California Native Plant Society, 2010, CNPS INV RAR END PLA; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; Comrack L., 2008, 200803 CAL DEP FISH; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Department of Water Resources (DWR), 2013, DWR B, V160-09; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Faber Langendoen DJ, 2012, NATURESERVE CONSERVA; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Grantham TE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084012; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hanak E., 2011, MANAGING CALIFORNIAS; Hermoso V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059662; Johnson PD, 2013, FISHERIES, V38, P247, DOI 10.1080/03632415.2013.785396; Lund J.R., 2010, COMP FUTURES SACRAME; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sabo JL, 2010, P NATL ACAD SCI USA, V107, P21263, DOI 10.1073/pnas.1009734108; Santos NR, 2014, ENVIRON MODELL SOFTW, V53, P13, DOI 10.1016/j.envsoft.2013.10.024; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; The Nature Conservancy, 2014, CAL FRESHW SPEC DAT; Turak E, 2011, FRESHWATER BIOL, V56, P1, DOI 10.1111/j.1365-2427.2010.02515.x; U.S. Army Corps of Engineers, 2014, NAT WETL PLANT LIST; U.S. Department of the Interior Bureau of Land Management, 2013, SPEC STAT SPEC; U.S. Fish and Wildlife Service, 2008, BIRDS CONS CONC; U.S. Fish and Wildlife Service, 2013, SPEC OF CONC; UC Davis Center for Watershed Sciences, 2014, DATABASE; US Fish and Wildlife Service, 2014, END SPEC; USDA Forest Service, 2008, WAT FISH WILDL AIR R; USDA Natural Resources Conservation Service, 2009, WAT BOUND DAT; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wilcove DS, 2005, FRONT ECOL ENVIRON, V3, P414, DOI 10.2307/3868657; WILLIAMS JD, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:CSOFMO>2.0.CO;2; World Wildlife Fund, 2014, LIVING PLANET REPORT; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x	45	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130710	10.1371/journal.pone.0130710	http://dx.doi.org/10.1371/journal.pone.0130710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147215	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600044
J	Kasai, S; Ito, A; Shindo, K; Toyoshi, T; Bando, M				Kasai, Shunji; Ito, Akemi; Shindo, Kaori; Toyoshi, Tohru; Bando, Masahiro			High-Dose alpha-Tocopherol Supplementation Does Not Induce Bone Loss in Normal Rats	PLOS ONE			English	Article							VITAMIN-E; OVARIECTOMIZED RATS; OXIDATIVE STRESS; MINERAL DENSITY; SERUM CONCENTRATIONS; PREDICT MORTALITY; HIP FRACTURE; ELDERLY-MEN; WOMEN; OSTEOPOROSIS	Oxidative stress affects bone turnover. Preventative effects of antioxidants such as vitamin E on reduced bone mineral density and fractures associated with aging, osteoporosis, and smoking have been examined in animals and humans. The effects of vitamin E (alpha-tocopherol; alpha T) on bone health have yielded conflicting and inconclusive results from animal studies. In this study, to determine the bone effects of alpha T, we investigated the in vivo effects of alpha T on the bone mineral density, bone mass, bone microstructure, bone resorption, and osteogenesis through peripheral quantitative computed tomography (pQCT) measurements, micro-computed tomography (micro-CT) analyses, and bone histomorphometry of lumbar vertebrae and femurs in normal female Wistar rats fed diets containing alpha T in different quantities (0, 30, 120, or 600 mg/kg diet) for 8 weeks. To validate our hypotheses regarding bone changes, we examined ovariectomized rats as an osteoporosis model and control sham-operated rats in parallel. As expected, ovariectomized rats had reduced bone mineral density in lumbar vertebrae and the distal metaphyses of their femurs, reduced bone mass and deteriorated microstructure of cancellous bones in the vertebral body and distal femur metaphyses, and reduced bone mass due to resorption-dominant enhanced bone turnover in secondary cancellous bones in these sites. In comparison, alpha T administered to normal rats, even at the highest dose, did not induce reduced bone mineral density of lumbar vertebrae and femurs or a reduced bone mass or fragile microstructure of cancellous bones of the vertebral body and distal femur metaphyses. Instead, alpha T-fed rats showed a tendency for an osteogenesis-dominant bone mass increase in secondary cancellous bones in the vertebral body, in which active bone remodeling occurs. Thus, alpha T consumption may have beneficial effects on bone health.	[Kasai, Shunji] Eisai & Co Ltd, Customer Joy Dept, Vitamin Informat & Technol Sect E, Tokyo, Japan; [Ito, Akemi] Ito Bone Histomorphometry Inst, Niigata, Japan; [Shindo, Kaori] Canon Lifecare Solut Inc, Tokyo, Japan; [Toyoshi, Tohru] Nihon Biores Inc, Study Dept, Gifu, Japan; [Bando, Masahiro] Eisai & Co Ltd, Eisai Prod Creat Syst, Tsukuba, Ibaraki, Japan	Eisai Co Ltd; Nihon Bioresearch Inc; Eisai Co Ltd	Kasai, S (corresponding author), Eisai & Co Ltd, Customer Joy Dept, Vitamin Informat & Technol Sect E, Tokyo, Japan.	s-kasai@hhc.eisai.co.jp			Eisai Co., Ltd.; Ito Bone Histomorphometry Institute; Canon Lifecare Solutions Inc.; Nihon Bioresearch Inc.	Eisai Co., Ltd.(Eisai Co Ltd); Ito Bone Histomorphometry Institute; Canon Lifecare Solutions Inc.; Nihon Bioresearch Inc.	This study was financially supported by Eisai Co., Ltd. Ito Bone Histomorphometry Institute, Canon Lifecare Solutions Inc., and Nihon Bioresearch Inc. did support in the form of salaries to authors (IS, KS, and TT) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BLACK D, 1989, CALCIFIED TISSUE INT, V44, P343, DOI 10.1007/BF02556315; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Hermizi H, 2009, CALCIFIED TISSUE INT, V84, P65, DOI 10.1007/s00223-008-9190-x; Holvik K, 2014, OSTEOPOROSIS INT, V25, P2545, DOI 10.1007/s00198-014-2802-6; IOM, 2000, DIET REF INT VIT C V; Iwaniec UT, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P985; Iwaniec UT, 2013, FREE RADICAL BIO MED, V65, P1209, DOI 10.1016/j.freeradbiomed.2013.09.004; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; Mata-Granados JM, 2013, J BONE MINER METAB, V31, P455, DOI 10.1007/s00774-013-0432-2; Mehat MZ, 2010, J BONE MINER METAB, V28, P503, DOI 10.1007/s00774-010-0159-2; Melhus H, 1999, J BONE MINER RES, V14, P129, DOI 10.1359/jbmr.1999.14.1.129; Michaelsson K, 2014, AM J CLIN NUTR, V99, P107, DOI 10.3945/ajcn.113.064691; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Muhammad N, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/161527; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; Norazlina M, 2000, EXP CLIN ENDOCR DIAB, V108, P305, DOI 10.1055/s-2000-7758; Ostman B, 2009, FREE RADICAL BIO MED, V47, P668, DOI 10.1016/j.freeradbiomed.2009.05.031; Otomo H, 2004, J BONE MINER METAB, V22, P404, DOI 10.1007/s00774-004-0502-6; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; SEEDOR JG, 1991, J BONE MINER RES, V6, P339; Shiraishi A, 2002, CALCIFIED TISSUE INT, V71, P69, DOI 10.1007/s00223-001-2090-y; Shuid AN, 2010, J BONE MINER METAB, V28, P149, DOI 10.1007/s00774-009-0122-2; SUDA N, 1993, BIOCHIM BIOPHYS ACTA, V1157, P318, DOI 10.1016/0304-4165(93)90116-P; Suzuki T, 2010, OSTEOPOROSIS INT, V21, P71, DOI 10.1007/s00198-009-0970-6; TURNER RT, 1987, J BONE MINER RES, V2, P115; VILLANUEVA AR, 1989, STAIN TECHNOL, V64, P129, DOI 10.3109/10520298909106985; WRONSKI TJ, 1986, BONE, V7, P119, DOI 10.1016/8756-3282(86)90683-6; WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007; WRONSKI TJ, 1989, BONE, V10, P295, DOI 10.1016/8756-3282(89)90067-7; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Wronski TJ, 1992, CELLS MAT S1, P69; Zhang JJ, 2006, AM J EPIDEMIOL, V163, P9, DOI 10.1093/aje/kwj005	39	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132059	10.1371/journal.pone.0132059	http://dx.doi.org/10.1371/journal.pone.0132059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147575	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600192
J	Lima, CX; Souza, DG; Amaral, FA; Fagundes, CT; Rodrigues, IPS; Alves, JC; Kosco-Vilbois, M; Ferlin, W; Shang, LM; Elson, G; Teixeira, MM				Lima, Cristiano Xavier; Souza, Danielle Gloria; Amaral, Flavio Almeida; Fagundes, Caio Tavares; Stopa Rodrigues, Irla Paula; Alves-Filho, Jose Carlos; Kosco-Vilbois, Marie; Ferlin, Walter; Shang, Limin; Elson, Greg; Teixeira, Mauro Martins			Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis	PLOS ONE			English	Article							SEPTIC SHOCK; NEUTROPHIL MIGRATION; ATTENUATES SEPSIS; RECEPTOR; MORTALITY; HYDROCORTISONE; DYSFUNCTION; ANTAGONIST; PROTECTION; INFECTION	Introduction Toll-like receptors (TLRs) play an important role in the recognition of microbial products and in host defense against infection. However, the massive release of inflammatory mediators into the bloodstream following TLR activation following sepsis is thought to contribute to disease pathogenesis. Methods Here, we evaluated the effects of preventive or therapeutic administration of monoclonal antibodies (mAbs) targeting either TLR2 or TLR4 in a model of severe polymicrobial sepsis induced by cecal ligation and puncture in mice. Results Pre-treatment with anti-TLR2 or anti-TLR4 mAb alone showed significant protection from sepsis-associated death. Protective effects were observed even when the administration of either anti-TLR2 or anti-TLR4 alone was delayed (i.e., 3 h after sepsis induction). Delayed administration of either mAb in combination with antibiotics resulted in additive protection. Conclusion Although attempts to translate preclinical findings to clinical sepsis have failed so far, our preclinical experiments strongly suggest that there is a sufficient therapeutic window within which patients with ongoing sepsis could benefit from combined antibiotic plus anti-TLR2 or anti-TLR4 mAb treatment.	[Lima, Cristiano Xavier; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Fac Med, BR-30130100 Belo Horizonte, MG, Brazil; [Souza, Danielle Gloria; Amaral, Flavio Almeida; Fagundes, Caio Tavares; Stopa Rodrigues, Irla Paula; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; [Alves-Filho, Jose Carlos] Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil; [Kosco-Vilbois, Marie; Ferlin, Walter; Shang, Limin; Elson, Greg] NovImmune SA, CH-1228 Geneva, Switzerland	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; NovImmune SA	Lima, CX (corresponding author), Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena 190,Sala 203, BR-30130100 Belo Horizonte, MG, Brazil.	cristianoxlima@gmail.com	LIMA, CRISTIANO/AAH-9402-2021; Amaral, Flávio Almeida/C-3768-2018; Alves-Filho, Jose Carlos/B-5814-2008; Lima, Cristiano/B-1874-2013; Teixeira, Mauro M/A-4587-2008; Fagundes, Caio/AAK-9336-2020	Amaral, Flávio Almeida/0000-0002-1695-0612; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Teixeira, Mauro M/0000-0002-6944-3008; Fagundes, Caio/0000-0002-6747-5233; XAVIER LIMA, CRISTIANO/0000-0001-7724-890X	National Research Council of Brazil (CNPq, Brazil); Fundacao do Amparo a Pesquisas de Minas Gerais (FAPEMIG); European Community Seventh Framework Programme [FP72007-2013, HEALTH-F4-2011-281608]; NovImmune	National Research Council of Brazil (CNPq, Brazil); Fundacao do Amparo a Pesquisas de Minas Gerais (FAPEMIG); European Community Seventh Framework Programme(European Commission); NovImmune	This work received financial support from the National Research Council of Brazil (CNPq, Brazil), Fundacao do Amparo a Pesquisas de Minas Gerais (FAPEMIG), and from the European Community Seventh Framework Programme [FP72007-2013] under grant agreement number HEALTH-F4-2011-281608. NovImmune provided support in the form of salaries for some authors (MKV, WF, LS, GE), but had no role in study design, data collection and	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Casserly B, 2012, CRIT CARE MED, V40, P1417, DOI 10.1097/CCM.0b013e31823e9f45; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Finfer S, 2008, INTENS CARE MED, V34, P1935, DOI 10.1007/s00134-008-1266-6; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Garcia CC, 2010, DISCOV MED, V10, P479; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Ishii Ken J, 2004, Curr Infect Dis Rep, V6, P361, DOI 10.1007/s11908-004-0034-1; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kimmoun A, 2011, SHOCK, V36, P633, DOI 10.1097/SHK.0b013e318237a37b; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; Martin EL, 2010, AM J RESP CRIT CARE, V182, P762, DOI 10.1164/rccm.201001-0088OC; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3	32	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132336	10.1371/journal.pone.0132336	http://dx.doi.org/10.1371/journal.pone.0132336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147469	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600245
J	Ali, A; Na, ML; Svensson, MND; Magnusson, M; Welin, A; Schwarze, JC; Mohammad, M; Josefsson, E; Pullerits, R; Jin, T				Ali, Abukar; Na, Manli; Svensson, Mattias N. D.; Magnusson, Malin; Welin, Amanda; Schwarze, Jan-Christoph; Mohammad, Majd; Josefsson, Elisabet; Pullerits, Rille; Jin, Tao			IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice	PLOS ONE			English	Article							ACUTE GOUTY-ARTHRITIS; RISK-FACTORS; DOUBLE-BLIND; INTERLEUKIN-1; ANAKINRA; DISEASE; CANAKINUMAB; CYTOKINES	Background Interleukin-1 receptor antagonist (IL-1Ra) is the primary therapy against autoinflammatory syndromes with robust efficacy in reducing systemic inflammation and associated organ injury. However, patients receiving IL-1Ra might be at increased risk of acquiring serious infections. Aims To study whether IL-1Ra treatment deteriorates Staphylococcus aureus (S. aureus) septic arthritis and sepsis in mice. Method NMRI mice were treated with anakinra (IL-1Ra) daily for 7 days before intravenous inoculation with S. aureus strain Newman in both arthritogenic and lethal doses. The clinical course of septic arthritis, histopathological and radiological changes of the joints, as well as the mortality were compared between IL-1Ra treated and control groups. Results IL-1Ra treated mice developed more frequent and severe clinical septic arthritis. Also, the frequency of polyarthritis was significantly higher in the mice receiving IL-1Ra therapy. In line with the data from clinical arthritis, both histological and radiological signs of septic arthritis were more pronounced in IL-1Ra treated group compared to controls. Importantly, the mortality of IL-1Ra treated mice was significantly higher than PBS treated controls. Conclusion IL-1Ra treatment significantly aggravated S. aureus induced septic arthritis and increased the mortality in these mice.	[Ali, Abukar; Na, Manli; Svensson, Mattias N. D.; Magnusson, Malin; Welin, Amanda; Schwarze, Jan-Christoph; Mohammad, Majd; Josefsson, Elisabet; Pullerits, Rille; Jin, Tao] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Gothenburg	Ali, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	abukar.ahmed.ali@rheuma.gu.se	Pullerits, Rille/AAD-2050-2019; Jin, Tao/K-3323-2015; Na, Manli/AAM-9864-2020; Pullerits, Rille/ABC-0141-2022; Svensson, Mattias N.D./A-9827-2012	Pullerits, Rille/0000-0002-5383-9817; Jin, Tao/0000-0001-9039-0628; Svensson, Mattias N.D./0000-0001-8077-9824; Ali, Abukar/0000-0002-1963-3356; Na, Manli/0000-0002-7306-8941; Mohammad, Majd/0000-0002-3672-2991	Swedish Medical Research Council; Swedish Medical Society; Stiftelsen Clas Groschinskys Minnesfond; IngaBritt and Arne Lundberg Foundation; Swedish Association Against Rheumatism; Professor Nanna Svartz Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; University of Gothenburg	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Medical Society; Stiftelsen Clas Groschinskys Minnesfond; IngaBritt and Arne Lundberg Foundation; Swedish Association Against Rheumatism; Professor Nanna Svartz Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; University of Gothenburg	This work was supported by the Swedish Medical Research Council, the Swedish Medical Society, the Stiftelsen Clas Groschinskys Minnesfond, the IngaBritt and Arne Lundberg Foundation, the Swedish Association Against Rheumatism, the Professor Nanna Svartz Foundation, the Scandinavian Society for Antimicrobial Chemotherapy Foundation, the Royal Society of Arts and Sciences in Gothenburg, the Wilhelm and Martina Lundgren Foundation and the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Ali A, 2015, J INFECT DIS, V212, P1308, DOI 10.1093/infdis/jiv212; Ali A, 2015, ARTHRITIS RHEUMATOL, V67, P107, DOI 10.1002/art.38902; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; Cao YH, 2012, INT IMMUNOPHARMACOL, V13, P28, DOI 10.1016/j.intimp.2012.02.014; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Davidsson L, 2013, J IMMUNOL METHODS, V393, P8, DOI 10.1016/j.jim.2013.03.013; Dinarello CA, 2003, VACCINE, V21, pS24, DOI 10.1016/S0264-410X(03)00196-8; DUBOST JJ, 1993, MEDICINE, V72, P296, DOI 10.1097/00005792-199309000-00002; EPSTEIN JH, 1986, J RHEUMATOL, V13, P1105; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; Fitzgerald AA, 2005, ARTHRITIS RHEUM-US, V52, P1794, DOI 10.1002/art.21061; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Garcia-Arias M, 2011, BEST PRACT RES CL RH, V25, P407, DOI 10.1016/j.berh.2011.02.001; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Hultgren OH, 2002, J IMMUNOL, V168, P5207, DOI 10.4049/jimmunol.168.10.5207; Jesus AA, 2014, ANNU REV MED, V65, P223, DOI 10.1146/annurev-med-061512-150641; Kaandorp CJE, 1995, ARTHRITIS RHEUM, V38, P1819, DOI 10.1002/art.1780381215; Kaandorp CJE, 1997, ARTHRITIS RHEUM-US, V40, P884, DOI 10.1002/art.1780400516; Kwiecinski J, 2013, J INFECT DIS, V208, P990, DOI 10.1093/infdis/jit288; Kwiecinski J, 2013, INFECT IMMUN, V81, P1114, DOI 10.1128/IAI.01334-12; Labrousse D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097546; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; LEFF JA, 1994, AM J PHYSIOL, V266, pL2, DOI 10.1152/ajplung.1994.266.1.L2; MANGAN DF, 1991, J IMMUNOL, V147, P3408; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; Naumann L, 2010, ANN RHEUM DIS, V69, P466, DOI 10.1136/ard.2009.108068; Neel A, 2014, AUTOIMMUN REV, V13, P1035, DOI 10.1016/j.autrev.2014.08.031; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Schlesinger N, 2012, ANN RHEUM DIS, V71, P1839, DOI 10.1136/annrheumdis-2011-200908; Schlesinger N, 2011, ANN RHEUM DIS, V70, P1264, DOI 10.1136/ard.2010.144063; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Sgroi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025442; ULICH TR, 1991, AM J PATHOL, V138, P521; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; WANKOWICZ Z, 1988, J LEUKOCYTE BIOL, V43, P349, DOI 10.1002/jlb.43.4.349; Zhou ZY, 2012, AUTOIMMUN REV, V11, P699, DOI 10.1016/j.autrev.2011.12.005	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131645	10.1371/journal.pone.0131645	http://dx.doi.org/10.1371/journal.pone.0131645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26135738	Green Published, gold, Green Submitted			2022-12-26	WOS:000358154400060
J	Ligabue-Braun, R; Sachett, LG; Pol-Fachin, L; Verli, H				Ligabue-Braun, Rodrigo; Sachett, Liana Guimaraes; Pol-Fachin, Laercio; Verli, Hugo			The Calcium Goes Meow: Effects of Ions and Glycosylation on Fel d 1, the Major Cat Allergen	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GROMOS FORCE-FIELD; BINDING PROTEIN; D-I; UTEROGLOBIN; GLYCOBIOLOGY; CONVERGENCE; 53A6(GLYC); PARAMETERS; SOLVATION	The major cat allergen, Fel d 1, is a structurally complex protein with two N-glycosylation sites that may be filled by different glycoforms. In addition, the protein contains three putative Ca2+ binding sites. Since the impact of these Fel d 1 structure modifications on the protein dynamics, physiology and pathology are not well established, the present work employed computational biology techniques to tackle these issues. While conformational effects brought upon by glycosylation were identified, potentially involved in cavity volume regulation, our results indicate that only the central Ca2+ ion remains coordinated to Fel d 1 in biological solutions, impairing its proposed role in modulating phospholipase A(2) activity. As these results increase our understanding of Fel d 1 structural biology, they may offer new support for understanding its physiological role and impact into cat-promoted allergy.	[Ligabue-Braun, Rodrigo; Sachett, Liana Guimaraes; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil; [Pol-Fachin, Laercio] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Pernambuco	Verli, H (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil.	hverli@cbiot.ufrgs.br	Verli, Hugo/AAZ-2148-2021; Ligabue-Braun, Rodrigo/U-3832-2019; Verli, Hugo/G-8703-2012	Verli, Hugo/0000-0002-4796-8620; Ligabue-Braun, Rodrigo/0000-0002-2555-9754	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior); FAPERGS (Fundacao de Amparo aPesquisa do Estado do Rio Grande do Sul); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco) [APQ-0398-1.06/13]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS (Fundacao de Amparo aPesquisa do Estado do Rio Grande do Sul)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior), FAPERGS (Fundacao de Amparo aPesquisa do Estado do Rio Grande do Sul), and FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco, grant number APQ-0398-1.06/13).	ANDERSSON O, 1994, J BIOL CHEM, V269, P19081; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barnes HJ, 1996, J MOL BIOL, V256, P392, DOI 10.1006/jmbi.1996.0094; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; Bienboire-Frosini C, 2012, VET J, V193, P162, DOI 10.1016/j.tvjl.2011.09.031; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carrer P, 2001, SCI TOTAL ENVIRON, V270, P33, DOI 10.1016/S0048-9697(00)00791-9; Chowdhury B, 2002, BIOCHEM BIOPH RES CO, V295, P877, DOI 10.1016/S0006-291X(02)00767-2; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeAndrade AD, 1996, CLIN EXP ALLERGY, V26, P178, DOI 10.1111/j.1365-2222.1996.tb00077.x; Dharmage SC, 2012, CURR ALLERGY ASTHM R, V12, P413, DOI 10.1007/s11882-012-0288-x; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; ERJAVEC F, 1987, AGENTS ACTIONS, V20, P188, DOI 10.1007/BF02074665; Virgens MYF, 2014, J BIOMOL STRUCT DYN, V32, P567, DOI 10.1080/07391102.2013.780982; Fernandes CL, 2010, CARBOHYD RES, V345, P663, DOI 10.1016/j.carres.2009.12.018; Fernandes CL, 2014, J BIOMOL STRUCT DYN, V32, P1092, DOI 10.1080/07391102.2013.809604; Frank M, 2010, CELL MOL LIFE SCI, V67, P2749, DOI 10.1007/s00018-010-0352-4; Gronlund H, 2010, INT ARCH ALLERGY IMM, V151, P265, DOI 10.1159/000250435; Grossfield A, 2007, PROTEINS, V67, P31, DOI 10.1002/prot.21308; Hagey LR, 2007, DEV PRIMATOL-PROG PR, P253, DOI 10.1007/978-0-387-34810-0_12; HARD T, 1995, NAT STRUCT BIOL, V2, P983, DOI 10.1038/nsb1195-983; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hsieh MJ, 2010, J PHYS CHEM B, V114, P2886, DOI 10.1021/jp906701s; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Huang RYC, 2013, BIOCHEMISTRY-US, V52, P7127, DOI 10.1021/bi4011094; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; Kaiser L, 2007, J MOL BIOL, V370, P714, DOI 10.1016/j.jmb.2007.04.074; Kay AB, 2000, BRIT MED BULL, V56, P843, DOI 10.1258/0007142001903481; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Knapp B, 2011, J COMPUT BIOL, V18, P997, DOI 10.1089/cmb.2010.0237; Krane S, 2003, NATURWISSENSCHAFTEN, V90, P60, DOI 10.1007/s00114-002-0394-z; Kristensen AK, 1997, BIOL CHEM, V378, P899; LARSSON L, 1978, CLIN CHEM, V24, P1962; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MOPAC Manual, 2005, MOPAC MANUAL; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NORD M, 1995, FEBS LETT, V374, P403, DOI 10.1016/0014-5793(95)01159-C; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Platts-Mills TAE, 2011, IMMUNOL REV, V242, P51, DOI 10.1111/j.1600-065X.2011.01021.x; Pol-Fachin L, 2014, J COMPUT CHEM, V35, P2087, DOI 10.1002/jcc.23721; Pol-Fachin L, 2012, J CHEM THEORY COMPUT, V8, P4681, DOI 10.1021/ct300479h; Pol-Fachin L, 2011, PROTEINS, V79, P2735, DOI 10.1002/prot.23102; Pyrkosz AB, 2010, J MOL BIOL, V397, P1350, DOI 10.1016/j.jmb.2010.02.003; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Seppala U, 2005, J BIOL CHEM, V280, P3208, DOI 10.1074/jbc.M410668200; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Stewart J, 2008, MOPAC2009 STEWARD CO; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart JJP, 1996, INT J QUANTUM CHEM, V58, P133, DOI 10.1002/(SICI)1097-461X(1996)58:2<133::AID-QUA2>3.0.CO;2-Z; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Svanes C, 2003, J ALLERGY CLIN IMMUN, V112, P289, DOI 10.1067/mai.2003.1596; VAILES LD, 1994, J ALLERGY CLIN IMMUN, V93, P22, DOI 10.1016/0091-6749(94)90229-1; van Gunsteren WF, 2006, ANGEW CHEM INT EDIT, V45, P4064, DOI 10.1002/anie.200502655; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	61	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0132311	10.1371/journal.pone.0132311	http://dx.doi.org/10.1371/journal.pone.0132311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134118	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400109
J	Ma, BX; Ban, XQ; Huang, B; He, JS; Tian, J; Zeng, H; Chen, YX; Wang, YW				Ma, Bingxin; Ban, Xiaoquan; Huang, Bo; He, Jingsheng; Tian, Jun; Zeng, Hong; Chen, Yuxin; Wang, Youwei			Interference and Mechanism of Dill Seed Essential Oil and Contribution of Carvone and Limonene in Preventing Sclerotinia Rot of Rapeseed	PLOS ONE			English	Article							ANETHUM-GRAVEOLENS L.; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; CONSTITUENTS; MONOTERPENES; PEPPERMINT; FUNGI	This study aimed to evaluate the inhibitory effects of dill (Anethum graveolens L.) seed essential oil against Sclerotinia sclerotiorum and its mechanism of action. The antifungal activities of the two main constituents, namely carvone and limonene, were also measured. Mycelial growth and sclerotial germination were thoroughly inhibited by dill seed essential oil at the 1.00 mu L/mL under contact condition and 0.125 mu L/mL air under vapor condition. Carvone also contributed more than limonene in inhibiting the growth of S. sclerotiorum. Carvone and limonene synergistically inhibited the growth of the fungus. In vivo experiments, the essential oil remarkably suppressed S. sclerotiorum, and considerable morphological alterations were observed in the hyphae and sclerotia. Inhibition of ergosterol synthesis, malate dehydrogenase, succinate dehydrogenase activities, and external medium acidification were investigated to elucidate the antifungal mechanism of the essential oil. The seed essential oil of A. graveolens can be extensively used in agriculture for preventing the oilseed crops fungal disease.	[Ma, Bingxin; Ban, Xiaoquan; Huang, Bo; He, Jingsheng; Tian, Jun; Zeng, Hong; Chen, Yuxin; Wang, Youwei] Wuhan Univ, Sch Pharmaceut Sci, Inst TCM & Nat Prod, Wuhan 430072, Peoples R China	Wuhan University	Wang, YW (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Inst TCM & Nat Prod, Wuhan 430072, Peoples R China.	wyw@whu.edu.cn		Tian, Jun/0000-0003-2371-3153	Commonweal Specialized Research Fund of China Agriculture [201103016]; Nanjing 321 plan [20130729]; Project of the National Twelve-Five Year Research Program of China [2012BAI29B03]; National MEGA Project on Major Drug Development [2011ZX09401-302]; Key Program of Natural Science Foundation of Hubei Province of China [2010CBB02301]; Fundamental Research Funds for the Central Universities [2014306020205]	Commonweal Specialized Research Fund of China Agriculture; Nanjing 321 plan; Project of the National Twelve-Five Year Research Program of China; National MEGA Project on Major Drug Development; Key Program of Natural Science Foundation of Hubei Province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Commonweal Specialized Research Fund of China Agriculture (201103016, to YW), Nanjing 321 plan for Bringing in technological leading talents (20130729, to YW), the Project of the National Twelve-Five Year Research Program of China (2012BAI29B03, to YW), the National MEGA Project on Major Drug Development (2011ZX09401-302, to YW), the Key Program of Natural Science Foundation of Hubei Province of China (2010CBB02301, to YW), and the Fundamental Research Funds for the Central Universities (2014306020205, to BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailer J, 2001, IND CROP PROD, V14, P229, DOI 10.1016/S0926-6690(01)00088-7; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; Bouwmeester HJ, 1995, J AGR FOOD CHEM, V43, P3057, DOI 10.1021/jf00060a013; Chandra S, 2014, J PLANT GROWTH REGUL, V33, P849, DOI 10.1007/s00344-014-9436-y; Dayan FE, 2012, PEST MANAG SCI, V68, P519, DOI 10.1002/ps.2332; Demirci B, 2006, J AGR FOOD CHEM, V54, P3146, DOI 10.1021/JF053222V; Diao WR, 2013, J AGR FOOD CHEM, V61, P6044, DOI 10.1021/jf4007856; Edris AE, 2003, NAHRUNG, V47, P117, DOI 10.1002/food.200390021; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Hajhashemi V, 2008, PHYTOTHER RES, V22, P372, DOI 10.1002/ptr.2329; Hu XJ, 2005, APPL MICROBIOL BIOT, V68, P802, DOI 10.1007/s00253-005-1938-x; Hung CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083091; Jirovetz L, 2003, J AGR FOOD CHEM, V51, P3854, DOI 10.1021/jf030004y; JONES D, 1969, NATURE, V224, P287, DOI 10.1038/224287a0; Kordali S, 2007, ALLELOPATHY J, V19, P373; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056202; Kumar V, 2014, IND CROP PROD, V55, P70, DOI 10.1016/j.indcrop.2014.02.003; Lazutka JR, 2001, FOOD CHEM TOXICOL, V39, P485, DOI 10.1016/S0278-6915(00)00157-5; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v; MAHRAN G H, 1992, International Journal of Pharmacognosy, V30, P139; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Marei GIK, 2012, PESTIC BIOCHEM PHYS, V103, P56, DOI 10.1016/j.pestbp.2012.03.004; Palaniyandi SA, 2013, APPL MICROBIOL BIOT, V97, P9621, DOI 10.1007/s00253-013-5206-1; Pascual A, 2010, PLANT DIS, V94, P885, DOI 10.1094/PDIS-94-7-0885; Perry NB, 1999, J AGR FOOD CHEM, V47, P2048, DOI 10.1021/jf981170m; Pitarokili D, 2002, J AGR FOOD CHEM, V50, P6688, DOI 10.1021/jf020422n; Rafii F, 2007, CHEMOTHERAPY, V53, P21, DOI 10.1159/000098246; Robert TR, 1974, MOL GEN GENET, V132, P73; RODRIGUEZ RJ, 1985, BIOCHIM BIOPHYS ACTA, V837, P336, DOI 10.1016/0005-2760(85)90057-8; Santos PAG, 2002, BIOTECHNOL LETT, V24, P1031, DOI 10.1023/A:1015653701265; Singh G, 2005, J FOOD SCI, V70, pM208, DOI 10.1111/j.1365-2621.2005.tb07190.x; Soylu S, 2007, J APPL MICROBIOL, V103, P1021, DOI 10.1111/j.1365-2672.2007.03310.x; Tanaka K, 2014, J AGR FOOD CHEM, V62, P1469, DOI 10.1021/jf404531t; Tatsadjieu NL, 2009, FOOD CONTROL, V20, P161, DOI 10.1016/j.foodcont.2008.03.008; Tegegne G, 2008, CROP PROT, V27, P1052, DOI 10.1016/j.cropro.2007.12.007; Tian J, 2014, IND CROP PROD, V60, P151, DOI 10.1016/j.indcrop.2014.05.045; Tian J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030147, 10.1371/journal.pone.0035164]; Tian J, 2011, FOOD CONTROL, V22, P1992, DOI 10.1016/j.foodcont.2011.05.018; Tripathi A, 2009, WORLD J MICROB BIOT, V25, P503, DOI 10.1007/s11274-008-9916-y; Wan MG, 2008, BIOL CONTROL, V46, P552, DOI 10.1016/j.biocontrol.2008.05.015; Yin YN, 2009, J PHYTOPATHOL, V157, P465, DOI 10.1111/j.1439-0434.2009.01543.x	42	32	37	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131733	10.1371/journal.pone.0131733	http://dx.doi.org/10.1371/journal.pone.0131733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133771	Green Published, Green Submitted, gold			2022-12-26	WOS:000358154400067
J	Yang, YW; Chen, HC; Jen, WF; Liu, LY; Chang, MC				Yang, Yun-Wei; Chen, Hung-Chi; Jen, Wei-Fu; Liu, Li-Yu; Chang, Men-Chi			Comparative Transcriptome Analysis of Shoots and Roots of TNG67 and TCN1 Rice Seedlings under Cold Stress and Following Subsequent Recovery: Insights into Metabolic Pathways, Phytohormones, and Transcription Factors	PLOS ONE			English	Article							ENDOGENOUS ABSCISIC-ACID; SATIVA L SEEDLINGS; FREEZING TOLERANCE; GENE-EXPRESSION; LOW-TEMPERATURE; ORYZA-SATIVA; CHILLING TOLERANCE; FUNCTIONAL-ANALYSIS; JAPONICA RICE; SALT STRESS	Cold stress affects rice growth, quality and yield. The investigation of genome-wide gene expression is important for understanding cold stress tolerance in rice. We performed comparative transcriptome analysis of the shoots and roots of 2 rice seedlings (TNG67, cold-tolerant; and TCN1, cold-sensitive) in response to low temperatures and restoration of normal temperatures following cold exposure. TNG67 tolerated cold stress via rapid alterations in gene expression and the re-establishment of homeostasis, whereas the opposite was observed in TCN1, especially after subsequent recovery. Gene ontology and pathway analyses revealed that cold stress substantially regulated the expression of genes involved in protein metabolism, modification, translation, stress responses, and cell death. TNG67 takes advantage of energy-saving and recycling resources to more efficiently synthesize metabolites compared with TCN1 during adjustment to cold stress. During recovery, expression of OsRR4 type-A response regulators was upregulated in TNG67 shoots, whereas that of genes involved in oxidative stress, chemical stimuli and carbohydrate metabolic processes was downregulated in TCN1. Expression of genes related to protein metabolism, modification, folding and defense responses was upregulated in TNG67 but not in TCN1 roots. In addition, abscisic acid (ABA)-, polyamine-, auxin- and jasmonic acid (JA)-related genes were preferentially regulated in TNG67 shoots and roots and were closely associated with cold stress tolerance. The TFs AP2/ERF were predominantly expressed in the shoots and roots of both TNG67 and TCN1. The TNG67-preferred TFs which express in shoot or root, such as OsIAA23, SNAC2, OsWRKY1v2, 24, 53, 71, HMGB, OsbHLH and OsMyb, may be good candidates for cold stress tolerance-related genes in rice. Our findings highlight important alterations in the expression of cold-tolerant genes, metabolic pathways, and hormone-related and TF-encoding genes in TNG67 rice during cold stress and recovery. The cross-talk of hormones may play an essential role in the ability of rice plants to cope with cold stress.	[Yang, Yun-Wei; Chen, Hung-Chi; Jen, Wei-Fu; Liu, Li-Yu; Chang, Men-Chi] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan	National Taiwan University	Chang, MC (corresponding author), Natl Taiwan Univ, Dept Agron, 1 Sect 4, Taipei, Taiwan.	menchi@ntu.edu.tw		CHANG, MEN-CHI/0000-0001-8081-4298; Liu, Li-yu/0000-0001-6997-8101	Ministry of Science and Technology, Taipei, Taiwan [102-2313-B-002-004-MY3, NSC-102-2811-B-002-146]	Ministry of Science and Technology, Taipei, Taiwan	This work was supported by the Ministry of Science and Technology, Taipei, Taiwan (Grant No. 102-2313-B-002-004-MY3 to YWY and MCC and NSC-102-2811-B-002-146 to MCC) http://www.most.gov.tw/mp.aspx?mp=7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Ahamed A, 2012, PLANT CELL PHYSIOL, V53, P1445, DOI 10.1093/pcp/pcs089; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Arbona V, 2013, INT J MOL SCI, V14, P4885, DOI 10.3390/ijms14034885; Aroca R, 2001, PLANT PHYSIOL BIOCH, V39, P1067, DOI 10.1016/S0981-9428(01)01335-3; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Chawade A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081729; Chen Jia-Shing, 2014, BMC Res Notes, V7, P15, DOI 10.1186/1756-0500-7-15; Chen J, 2012, GENE, V496, P110, DOI 10.1016/j.gene.2012.01.008; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chu C., 1992, Korean Journal of Crop Science, V37, P288; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Cuevas JC, 2008, PLANT PHYSIOL, V148, P1094, DOI 10.1104/pp.108.122945; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Fennell A, 1998, J EXP BOT, V49, P879, DOI 10.1093/jexbot/49.322.879; Figueiredo DD, 2012, J EXP BOT, V63, P3643, DOI 10.1093/jxb/ers035; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gehring CA, 1997, ANN BOT-LONDON, V80, P485, DOI 10.1006/anbo.1997.0471; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hossain MA, 2011, PLANT PHYSIOL, V156, P430, DOI 10.1104/pp.111.172254; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Jung KH, 2012, J PLANT BIOL, V55, P436, DOI 10.1007/s12374-012-0270-0; Kohli A, 2013, PLANT CELL REP, V32, P945, DOI 10.1007/s00299-013-1461-y; Kurepa J, 2009, PLANT SIGNAL BEHAV, V4, P924, DOI 10.4161/psb.4.10.9469; Lee TM, 1997, PLANT SCI, V126, P1, DOI 10.1016/S0168-9452(97)00076-9; Lee TM, 1996, PLANT CELL ENVIRON, V19, P65, DOI 10.1111/j.1365-3040.1996.tb00227.x; LEE TM, 1993, PLANT CELL ENVIRON, V16, P481, DOI 10.1111/j.1365-3040.1993.tb00895.x; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Matsuda O, 2009, PLANT J, V57, P96, DOI 10.1111/j.1365-313X.2008.03663.x; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-262; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rahman A, 2013, PHYSIOL PLANTARUM, V147, P28, DOI 10.1111/j.1399-3054.2012.01617.x; REANEY MJT, 1989, CAN J BOT, V67, P3640, DOI 10.1139/b89-445; Ren HB, 2007, J INTEGR PLANT BIOL, V49, P1410, DOI 10.1111/j.1672-9072.2007.00549.x; RPd Cruz, 2013, FOOD ENERGY SECURITY, V2, P96, DOI DOI 10.1002/FES3.25; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Shibasaki K, 2009, PLANT CELL, V21, P3823, DOI 10.1105/tpc.109.069906; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tufekci M.A., 2005, J CELL MOL BIOL, V4, P9; Usadel B, 2008, PLANT CELL ENVIRON, V31, P518, DOI 10.1111/j.1365-3040.2007.01763.x; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang T, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-111; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Woeste KE, 1999, PHYSIOL PLANTARUM, V105, P478, DOI 10.1034/j.1399-3054.1999.105312.x; Wyatt SE, 2002, PLANT PHYSIOL, V130, P1426, DOI 10.1104/pp.102.010579; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zhang F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-461; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274	66	14	18	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131391	10.1371/journal.pone.0131391	http://dx.doi.org/10.1371/journal.pone.0131391			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26133169	Green Submitted, Green Published, gold			2022-12-26	WOS:000358154400044
J	Bag, A; Chattopadhyay, RR				Bag, Anwesa; Chattopadhyay, Rabi Ranjan			Evaluation of Synergistic Antibacterial and Antioxidant Efficacy of Essential Oils of Spices and Herbs in Combination	PLOS ONE			English	Article							IN-VITRO; ANTIMICROBIAL PROPERTIES; GROWTH; ASSAY; FRUIT; FOOD	The present study was carried out to evaluate the possible synergistic interactions on antibacterial and antioxidant efficacy of essential oils of some selected spices and herbs [ bay leaf, black pepper, coriander (seed and leaf), cumin, garlic, ginger, mustard, onion and turmeric] in combination. Antibacterial combination effect was evaluated against six important food-borne bacteria (Bacillus cereus, Listeria monocytogenes, Micrococcus luteus, Staphylococcus aureus, Escherichia coli and Salmonella typhimurium) using microbroth dilution, checkerboard titration and time-kill methods. Antioxidant combination effect was assessed by DPPH free radical scavenging method. Total phenolic content was measured by FolinCiocalteu method. Bioactivity -guided fractionation of active essential oils for isolation of bioactive compounds was done using TLC-bioautography assay and chemical characterization (qualitative and quantitative) of bioactive compounds was performed using DARTMS and HPLC analyses. Cytotoxic potential was evaluated by brine shrimp lethality assay as well as MTT assay using human normal colon cell line. Results showed that among the possible combinations tested only coriander/cumin seed oil combination showed synergistic interactions both in antibacterial (FICI : 0.25-0.50) and antioxidant (CI : 0.79) activities. A high positive correlation between total phenolic content and antibacterial activity against most of the studied bacteria (R-2 = 0.688 -0.917) as well as antioxidant capacity (R-2 = 0.828) was also observed. TLC-bioautography-guided screening and subsequent combination studies revealed that two compounds corresponding to R-f values 0.35 from coriander seed oil and 0.53 from cumin seed oil exhibited both synergistic antibacterial and antioxidant activities. The bioactive compound corresponding to R-f 0.35 from coriander seed oil was identified as linalool (68.69%) and the bioactive compound corresponding to Rf 0.53 from cumin seed oil was identified as p-coumaric acid (7.14%) by DART-MS and HPLC analyses. The coriander/cumin seed oil combination did not show any cytotoxic effect both in brine shrimp lethality as well as human normal colon cell line assays. The LC50 in brine shrimp lethality assay was found to be 4945.30 mu g/ml and IC50 in human normal colon cell line was > 1000 mu g/ml. The results provide evidence that coriander/cumin seed oil combination might indeed be used as a potential source of safe and effective natural antimicrobial and antioxidant agents in pharmaceutical and food industries.	[Bag, Anwesa; Chattopadhyay, Rabi Ranjan] Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Bag, A (corresponding author), Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, India.	anwesa.bag@gmail.com			University Grants Commission, New Delhi, India [F.15-1/2012-13/PDFWM-2012-13-GE-WES-18557(SA-II)]	University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported by the University Grants Commission, New Delhi, India provided Post Doctoral Fellowship [F.15-1/2012-13/PDFWM-2012-13-GE-WES-18557(SA-II)] to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADESHINA GO, 2011, INT J PHARM BIO SCI, V2, P289; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chernestove ES, 2014, DRUG TEST ANAL, V2, P292; Chernetsova ES, 2010, J ANAL CHEM+, V65, P1537, DOI 10.1134/S1061934810140157; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI S; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Grob K, 2007, J CHROMATOGR A, V1150, P93, DOI 10.1016/j.chroma.2006.10.043; Gu LH, 2009, LWT-FOOD SCI TECHNOL, V42, P131, DOI 10.1016/j.lwt.2008.04.006; Hara-Kudo Y, 2004, J FOOD PROTECT, V67, P2820, DOI 10.4315/0362-028X-67.12.2820; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Karthikeyan R, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/201386; Kumar S, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-112; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P92, DOI 10.1128/AAC.35.1.92; McDonald S, 2001, FOOD CHEM, V73, P73, DOI 10.1016/S0308-8146(00)00288-0; MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Morlock GE, 2014, J CHROMATOGR A, V1328, P104, DOI 10.1016/j.chroma.2013.12.053; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; National Committee for Clinical Laboratory Standards, 1993, M2M5 NCCLS; Okeke MI, 2001, J ETHNOPHARMACOL, V78, P119, DOI 10.1016/S0378-8741(01)00307-5; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Russell NJ, 2003, FOOD PRESERVATIVES, P18; Shahverdi AR, 2007, J CHROMATOGR B, V850, P528, DOI 10.1016/j.jchromb.2006.11.011; Shan B, 2007, INT J FOOD MICROBIOL, V117, P112, DOI 10.1016/j.ijfoodmicro.2007.03.003; Sherman N., 2005, MICROBIOLOGY LAB MAN, V81, P265; SIEUWERTS AM, 1995, EUR J CLIN CHEM CLIN, V33, P813; Smith-Palmer A, 1998, LETT APPL MICROBIOL, V26, P118, DOI 10.1046/j.1472-765X.1998.00303.x; Szabo MR, 2010, INT J FOOD PROP, V13, P535, DOI 10.1080/10942910802713149; Wang MF, 1998, J AGR FOOD CHEM, V46, P4869, DOI 10.1021/jf980614b; World Health Organization, 1984, WHO TECHN REP SER, V705; Xia EQ, 2010, MOLECULES, V15, P4890, DOI 10.3390/molecules15074890	32	95	97	6	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131321	10.1371/journal.pone.0131321	http://dx.doi.org/10.1371/journal.pone.0131321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132146	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000112
J	Benchimol, M; Peres, CA				Benchimol, Maira; Peres, Carlos A.			Widespread Forest Vertebrate Extinctions Induced by a Mega Hydroelectric Dam in Lowland Amazonia	PLOS ONE			English	Article							LAND-BRIDGE ISLANDS; HABITAT FRAGMENTATION; LOCAL EXTINCTIONS; SPECIES RICHNESS; RESPONSES; LANDSCAPE; AREA; BIRDS; BIODIVERSITY; HYDROPOWER	Mega hydropower projects in tropical forests pose a major emergent threat to terrestrial and freshwater biodiversity worldwide. Despite the unprecedented number of existing, under-construction and planned hydroelectric dams in lowland tropical forests, long-term effects on biodiversity have yet to be evaluated. We examine how medium and large-bodied assemblages of terrestrial and arboreal vertebrates (including 35 mammal, bird and tortoise species) responded to the drastic 26-year post-isolation history of archipelagic alteration in landscape structure and habitat quality in a major hydroelectric reservoir of Central Amazonia. The Balbina Hydroelectric Dam inundated 3,129 km(2) of primary forests, simultaneously isolating 3,546 land-bridge islands. We conducted intensive biodiversity surveys at 37 of those islands and three adjacent continuous forests using a combination of four survey techniques, and detected strong forest habitat area effects in explaining patterns of vertebrate extinction. Beyond clear area effects, edge-mediated surface fire disturbance was the most important additional driver of species loss, particularly in islands smaller than 10 ha. Based on species-area models, we predict that only 0.7% of all islands now harbor a species-rich vertebrate assemblage consisting of >= 80% of all species. We highlight the colossal erosion in vertebrate diversity driven by a man-made dam and show that the biodiversity impacts of mega dams in lowland tropical forest regions have been severely overlooked. The geopolitical strategy to deploy many more large hydropower infrastructure projects in regions like lowland Amazonia should be urgently reassessed, and we strongly advise that long-term biodiversity impacts should be explicitly included in pre-approval environmental impact assessments.	[Benchimol, Maira; Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Benchimol, Maira] Univ Estadual Santa Cruz, Lab Ecol Aplicada Conservacao, PPG Ecol & Conservacao Biodivers, Ilheus, BA, Brazil; [Benchimol, Maira] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil	University of East Anglia; Universidade Estadual de Santa Cruz; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Benchimol, M (corresponding author), Univ Estadual Santa Cruz, Lab Ecol Aplicada Conservacao, PPG Ecol & Conservacao Biodivers, Rodovia Jorge Amado Km 16, Ilheus, BA, Brazil.	mairabs02@gmail.com; c.peres@uea.ac.uk	Benchimol, Maíra MB/I-7664-2014; Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./B-1276-2013; Peres, Carlos A./ABE-8361-2020	Benchimol, Maíra MB/0000-0002-1238-1619; Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765	Brazilian Ministry of Education doctoral studentship (CAPES) [080410/0]; Brazilian Ministry of Education (CAPES) [PVE 004/2012]; Wildlife Conservation Society Research Fellowship; Rufford Small Grant Foundation [9856-1]; Conservation Food and Health Foundation; Idea Wild; ARPA; Amazonas Distribuidora de Energia S.A; Associacao Comunidade Waimiri-Atroari; NERC [NE/J01401X/1]; Natural Environment Research Council [NE/J01401X/1] Funding Source: researchfish	Brazilian Ministry of Education doctoral studentship (CAPES); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wildlife Conservation Society Research Fellowship; Rufford Small Grant Foundation; Conservation Food and Health Foundation; Idea Wild; ARPA; Amazonas Distribuidora de Energia S.A; Associacao Comunidade Waimiri-Atroari; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work received funding from the following sources: Funding: Brazilian Ministry of Education doctoral studentship (CAPES), Author: MB, Number: 080410/0, Website: http://www.capes.gov.br/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: Brazilian Ministry of Education (CAPES), Author: CAP, Number: PVE 004/2012, Website: http://www.capes.gov.br/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: Wildlife Conservation Society Research Fellowship, Author: MB, Website: http://programs.wcs.org/rfp/Home. aspx, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: The Rufford Small Grant Foundation, Author: MB, Number: 9856-1, Website: http://www.rufford.org/rsg/projects/ma%C3%ADra_benchimol, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: Conservation Food and Health Foundation, Author: MB CAP, Website: http://cfhfoundation. grantsmanagement08.com/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: Idea Wild, Author: MB, Website: http://www.ideawild.org/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: ARPA, Author: MB CAP, Website: http://programaarpa.gov.br/en/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: Amazonas Distribuidora de Energia S.A, Author: MB CAP, Website: http://www.amazonasenergia.gov.br/cms/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: Associacao Comunidade Waimiri-Atroari, Author: MB CAP, Website: http://www.waimiriatroari.org.br/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Funding: NERC, Author: CAP, Number: NE/J01401X/1, Website: http://www.nerc.ac.uk/, Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho Clever J.R., 2011, Oecologia Australis, V15, P593; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Ansar A, 2014, ENERG POLICY, V69, P43, DOI 10.1016/j.enpol.2013.10.069; Barlow J, 2004, PHILOS T R SOC B, V359, P367, DOI 10.1098/rstb.2003.1423; Barton K, 2020, MUMIN MULTIMODEL INF; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benchimol M, 2015, J ECOL, V103, P408, DOI 10.1111/1365-2745.12371; Benchimol M, 2014, BIOTROPICA, V46, P470, DOI 10.1111/btp.12122; Benchimol M, 2013, DIVERS DISTRIB, V19, P1339, DOI 10.1111/ddi.12111; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Cosson JF, 1999, BIOL CONSERV, V91, P213, DOI 10.1016/S0006-3207(99)00091-9; De Souza-Mazurek RR, 2000, BIODIVERS CONSERV, V9, P579, DOI 10.1023/A:1008999201747; Diamond J, 2001, SCIENCE, V294, P1847, DOI 10.1126/science.1067012; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eisenberg J. F., 1989, MAMMALS NEOTROPICS, V3; Emer C, 2013, CONSERV BIOL, V27, P763, DOI 10.1111/cobi.12045; EMMONS LH, 1990, NEOTROPICAL RAINFORE; Esselman PC, 2010, ECOL SOC, V15; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2012, NAT CLIM CHANGE, V2, P382, DOI 10.1038/nclimate1540; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; IUCN (International Union for Conservation of Nature), 2012, IUCN RED LIST THREAT; Kareiva PM, 2012, P NATL ACAD SCI USA, V109, P5553, DOI 10.1073/pnas.1203263109; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Lees AC, 2006, BIOL CONSERV, V133, P198, DOI 10.1016/j.biocon.2006.06.005; Lima JR, 2015, BIOTROPICA, V47, P369, DOI 10.1111/btp.12205; Lomolino MV, 2001, PROG PHYS GEOG, V25, P1; MAC ARTHUR ROBERT H., 1967; Malcolm JR, 2000, CONSERV BIOL, V14, P1623, DOI [10.1046/j.1523-1739.2000.99070.x, 10.1111/j.1523-1739.2000.99070.x]; Matthews TJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P847, DOI 10.1111/geb.12269; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McGarigal K., 2014, FRAGSTATS V4 SPATIAL; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Palmeirim AF, 2014, BIOL CONSERV, V174, P30, DOI 10.1016/j.biocon.2014.03.015; PERES CA, 1999, MAMMALS NEOTROPICS C; Peres Carlos A., 1999, Neotropical Primates, V7, P11; Peres Carlos A., 2006, P105; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2013, PETCHEY GROUP WEBSIT; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Sampaio R, 2010, BIODIVERS CONSERV, V19, P2421, DOI 10.1007/s10531-010-9848-3; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; TERBORGH J, 1992, BIOTROPICA, V24, P283, DOI 10.2307/2388523; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Urquiza-Haas T, 2009, BIOL CONSERV, V142, P134, DOI 10.1016/j.biocon.2008.10.007; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Watling JI, 2006, CONSERV BIOL, V20, P1016, DOI 10.1111/j.1523-1739.2006.00482.x; WRIGHT SJ, 1994, OIKOS, V71, P279, DOI 10.2307/3546277; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	62	90	91	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129818	10.1371/journal.pone.0129818	http://dx.doi.org/10.1371/journal.pone.0129818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132139	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358153000041
J	De Allegri, M; Agier, I; Tiendrebeogo, J; Louis, VR; Ye, M; Mueller, O; Sarker, M				De Allegri, Manuela; Agier, Isabelle; Tiendrebeogo, Justin; Louis, Valerie Renee; Ye, Maurice; Mueller, Olaf; Sarker, Malabika			Factors Affecting the Uptake of HIV Testing among Men: A Mixed-Methods Study in Rural Burkina Faso	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HEALTH-INSURANCE; PREGNANT-WOMEN; ANTENATAL CARE; DETERMINANTS; PARTICIPATION; POPULATION; PREVENTION; PROGRAM; INFECTION	Background This study aimed to explore factors shaping the decision to undergo Human Immunodeficiency Virus (HIV) testing among men in rural Burkina Faso. Methods The study took place in 2009 in the Nouna Health District and adopted a triangulation mixed methods design. The quantitative component relied on data collected through a structured survey on a representative sample of 1130 households. The qualitative component relied on 38 in-depth interviews, with men purposely selected to represent variation in testing decision, age, and place of residence. A two-part model was conducted, with two distinct outcome variables, i.e. "being offered an HIV test" and "having done an HIV test". The qualitative data analysis relied on inductive coding conducted by three independent analysts. Result Of the 937 men, 357 had been offered an HIV test and 97 had taken the test. Younger age, household wealth, living in a village under demographic surveillance, and knowing that HIV testing is available at primary health facilities were all positively associated with the probability of being offered an HIV test. Household wealth and literacy were found to be positively associated, and distance was found to be negatively associated with the probability of having taken an HIV test. Qualitative findings indicated that the limited uptake of HIV testing was linked to poor knowledge on service availability and to low risk perceptions. Conclusion With only 10% of the total sample ever having tested for HIV, our study confirmed that male HIV testing remains unacceptably low in Sub-Saharan Africa. This results from a combination of health system factors, indicating general barriers to access, and motivational factors, such as one's own knowledge of service availability and risk perceptions. Our findings suggested that using antenatal care and curative services as the exclusive entry points into HIV testing may not be sufficient to reach large portions of the male population. Thus, additional strategies are urgently needed to increase service uptake.	[De Allegri, Manuela; Louis, Valerie Renee; Mueller, Olaf] Heidelberg Univ, Fac Med, Inst Publ Hlth, Heidelberg, Germany; [Agier, Isabelle] Univ Montreal, Res Ctr, Ctr Hosp, Sch Publ Hlth,ESPUM,CRCHUM, Montreal, PQ, Canada; [Tiendrebeogo, Justin] Ctr Rech Sante de Nouna, Nouna, Burkina Faso; [Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	Ruprecht Karls University Heidelberg; Universite de Montreal; Bangladesh Rural Advancement Committee BRAC; BRAC University	Sarker, M (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	malabika@bracu.ac.bd	Ye, Maurice/AAG-8660-2021	Sarker, Malabika/0000-0001-7293-8805	German Research Society, DFG [SFB544]	German Research Society, DFG(German Research Foundation (DFG))	Data collection was made possible thanks to the financial support of the German Research Society, DFG, projects D4 and A6 of the SFB544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiden F, 2005, AIDS CARE, V17, P648, DOI 10.1080/09540120412331319688; Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Collenberg E, 2006, J MED VIROL, V78, P683, DOI 10.1002/jmv.20593; Conrad P, 2012, TROP MED INT HEALTH, V17, P300, DOI 10.1111/j.1365-3156.2011.02923.x; Conserve D, 2013, AM J MENS HEALTH, V7, P450, DOI 10.1177/1557988312468146; Creswell J. W., 2010, DESIGNING CONDUCTING; De Allegri M, 2010, HEALTH POLICY IN PRE; De Allegri M, 2012, INT J HLTH PLANNING; De Allegri M, 2006, B WORLD HEALTH ORGAN, V84, P852; De Allegri M, 2012, J PUBLIC HEALTH POL, V33, P439, DOI 10.1057/jphp.2012.27; Dong HJ, 2008, EUR J HEALTH ECON, V9, P41, DOI 10.1007/s10198-006-0031-4; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kirakoya-Samadoulougou F, 2013, INT J STD AIDS, V24, P651, DOI 10.1177/0956462413479896; Kirakoya-Samadoulougou F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-540; Kouyate B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-50; Krishnan V, 2010, PRINCIPAL COMPONENTS; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Le Coeur S, 2009, SOC SCI MED, V69, P846, DOI 10.1016/j.socscimed.2009.05.042; MacPhail C, 2009, AIDS CARE, V21, P456, DOI 10.1080/09540120802282586; MacPherson P, 2012, TROP MED INT HEALTH, V17, P507, DOI 10.1111/j.1365-3156.2011.02946.x; Makwiza I, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-13; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Ministere de la Sante du Burkina Faso, 2006, DIRECTIVES NATIONALE; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Muller O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003182; Nguyen HV, 2014, J HEALTH PSYCHOL, V19, P1066, DOI 10.1177/1359105313483645; Njau B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-838; Obermeyer CM, 2013, TROP MED INT HEALTH, V18, P1110, DOI 10.1111/tmi.12155; Obermeyer CM, 2009, SOC SCI MED, V69, P877, DOI 10.1016/j.socscimed.2009.07.003; Ostermann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092100; Pokhrel S, 2010, SOC SCI MED IN PRESS; Ridde V, 2015, EUR J HEALTH ECON, V16, P55, DOI 10.1007/s10198-013-0553-5; Sarker M, 2007, TROP MED INT HEALTH, V12, P1475, DOI 10.1111/j.1365-3156.2007.01956.x; Sarker M, 2005, AIDS BEHAV, V9, P243, DOI 10.1007/s10461-005-3905-z; Sauerborn R, 1996, Health Transit Rev, V6, P131; Sie A, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5284; UNAIDS, 2006, EPIDEMIOLOGICAL FACT; United Nations General Assembly, 2006, UNITED NATIONS GENER; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wang Q, 2015, HEALTH POLICY PLANN, V30, P242, DOI 10.1093/heapol/czu004; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; WINSHIP C, 1992, ANNU REV SOCIOL, V18, P327, DOI 10.1146/annurev.so.18.080192.001551; World Health Organization UNAIDS UNICEF, 2010, TOWARDS UNIVERSAL AC; Ye Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-8	52	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0130216	10.1371/journal.pone.0130216	http://dx.doi.org/10.1371/journal.pone.0130216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1CG	26132114	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000055
J	Grinnage-Pulley, T; Zhang, QJ				Grinnage-Pulley, Tara; Zhang, Qijing			Genetic Basis and Functional Consequences of Differential Expression of the CmeABC Efflux Pump in Campylobacter jejuni Isolates	PLOS ONE			English	Article							FLUOROQUINOLONE-RESISTANT CAMPYLOBACTER; MULTIPLE-ANTIBIOTIC-RESISTANCE; MUTATION-RATES; IN-VIVO; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; MACROLIDE RESISTANCE; SELECTION PRESSURE; CMER FUNCTIONS; IDENTIFICATION	The CmeABC multidrug efflux transporter of Campylobacter jejuni plays a key role in antimicrobial resistance and is suppressed by CmeR, a transcriptional regulator of the TetR family. Overexpression of CmeABC has been observed in laboratory-generated mutants, but it is unknown if this phenotype occurs naturally in C. jejuni isolates and if it has any functional consequences. To answer these questions, expression of cmeABC in natural isolates obtained from broiler chickens, turkeys and humans was examined, and the genetic mechanisms and role of cmeABC differential expression in antimicrobial resistance was determined. Among the 64 C. jejuni isolates examined in this study, 43 and 21 were phenotypically identified as overexpression (OEL) and wild-type expression (WEL) levels. Representative mutations of the cmeABC promoter and/or CmeR-coding sequence were analyzed using electrophoretic mobility shift assays and transcriptional fusion assays. Reduced CmeR binding to the mutated cmeABC promoter sequences or decreased CmeR levels increased cmeABC expression. Several examined amino acid substitutions in CmeR did not affect its binding to the cmeABC promoter, but a mutation that led to C-terminal truncation of CmeR abolished its DNA-binding activity. Interestingly, some OEL isolates harbored no mutations in known regulatory elements, suggesting that cmeABC is also regulated by unidentified mechanisms. Overexpression of cmeABC did not affect the susceptibility of C. jejuni to most tested antimicrobials except for chloramphenicol, but promoted the emergence of ciprofloxacin-resistant mutants under antibiotic selection. These results link CmeABC overexpression in natural C. jejuni isolates to various mutations and indicate that this phenotypic change promotes the emergence of antibiotic-resistant mutants under selection pressure. Thus, differential expression of CmeABC may facilitate Campylobacter adaptation to antibiotic treatments.	[Grinnage-Pulley, Tara; Zhang, Qijing] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA	Iowa State University	Zhang, QJ (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	zhang123@iastate.edu		Grinnage-Pulley, Tara/0000-0002-7797-4642	Fort Dodge Animal Health Fellowship; Pfizer Animal Health Scholarship for a Combined DVM-PhD program; National Institute of Allergy and Infectious Diseases [U54AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER	Fort Dodge Animal Health Fellowship; Pfizer Animal Health Scholarship for a Combined DVM-PhD program; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	TGP received a Fort Dodge Animal Health Fellowship and a Pfizer Animal Health Scholarship for a Combined DVM-PhD program, and a Career Development Grant from the National Institute of Allergy and Infectious Diseases (Award Number U54AI057160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Disease, the National Institutes of Health, Pfizer, or Fort Dodge.	Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Cagliero C, 2007, FEMS MICROBIOL LETT, V267, P89, DOI 10.1111/j.1574-6968.2006.00558.x; Cagliero C, 2006, ANTIMICROB AGENTS CH, V50, P3893, DOI 10.1128/AAC.00616-06; Cagliero C, 2006, J ANTIMICROB CHEMOTH, V58, P168, DOI 10.1093/jac/dkl212; Centers for Disease Control and Prevention, 2013, EST FOODB ILLN US201; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; CLSI, 2020, PERFORMANCE STANDARD, V5th ed.; Crane GJ, 1996, MUTAT RES-FUND MOL M, V354, P171, DOI 10.1016/0027-5107(96)00009-7; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Ge BL, 2005, ANTIMICROB AGENTS CH, V49, P3347, DOI 10.1128/AAC.49.8.3347-3354.2005; Gibreel A, 2007, ANTIMICROB AGENTS CH, V51, P3212, DOI 10.1128/AAC.01592-06; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Han J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000083; Han J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00021; Hao HH, 2013, ANTIMICROB AGENTS CH, V57, P1369, DOI 10.1128/AAC.01927-12; Huang SX, 2005, FOODBORNE PATHOG DIS, V2, P12, DOI 10.1089/fpd.2005.2.12; Hyytiainen H, 2012, ANTIMICROB AGENTS CH, V56, P1148, DOI 10.1128/AAC.06228-11; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Lei HT, 2011, PROTEIN SCI, V20, P712, DOI 10.1002/pro.602; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Luangtongkum T, 2006, APPL ENVIRON MICROB, V72, P3600, DOI 10.1128/AEM.72.5.3600-3607.2006; Luo N, 2003, ANTIMICROB AGENTS CH, V47, P390, DOI 10.1128/AAC.47.1.390-394.2003; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; Luria SE, 1943, GENETICS, V28, P491; McDermott PF, 2004, MICROB DRUG RESIST, V10, P124, DOI 10.1089/1076629041310064; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Oakland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020084; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Pope CF, 2008, ANTIMICROB AGENTS CH, V52, P1209, DOI 10.1128/AAC.01152-07; Qiagen, 2003, HDB HIGH LEV EXPR PU, VThird; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Ross AGP, 2013, NEW ENGL J MED, V368, P1817, DOI 10.1056/NEJMra1207777; Taylor EV, 2013, EPIDEMIOL INFECT, V141, P987, DOI 10.1017/S0950268812001744; Wang GE, 2001, ANTIMICROB AGENTS CH, V45, P727, DOI 10.1128/AAC.45.3.727-733.2001; Wosten MMSM, 1998, J BACTERIOL, V180, P594; Yan MG, 2006, J ANTIMICROB CHEMOTH, V58, P1154, DOI 10.1093/jac/dkl412	51	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131534	10.1371/journal.pone.0131534	http://dx.doi.org/10.1371/journal.pone.0131534			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132196	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000127
J	Iturrate, I; Grizou, J; Omedes, J; Oudeyer, PY; Lopes, M; Montesano, L				Iturrate, Inaki; Grizou, Jonathan; Omedes, Jason; Oudeyer, Pierre-Yves; Lopes, Manuel; Montesano, Luis			Exploiting Task Constraints for Self-Calibrated Brain-Machine Interface Control Using Error-Related Potentials	PLOS ONE			English	Article								This paper presents a new approach for self-calibration BCI for reaching tasks using error-related potentials. The proposed method exploits task constraints to simultaneously calibrate the decoder and control the device, by using a robust likelihood function and an adhoc planner to cope with the large uncertainty resulting from the unknown task and decoder. The method has been evaluated in closed-loop online experiments with 8 users using a previously proposed BCI protocol for reaching tasks over a grid. The results show that it is possible to have a usable BCI control from the beginning of the experiment without any prior calibration. Furthermore, comparisons with simulations and previous results obtained using standard calibration hint that both the quality of recorded signals and the performance of the system were comparable to those obtained with a standard calibration approach.	[Iturrate, Inaki] Ecole Polytech Fed Lausanne, CNBI, CH-1015 Lausanne, Switzerland; [Iturrate, Inaki] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet CNP, CH-1015 Lausanne, Switzerland; [Grizou, Jonathan; Oudeyer, Pierre-Yves; Lopes, Manuel] Flowers Team, Inria, Ensta ParisTech Lab, Bourdeaux, France; [Iturrate, Inaki; Omedes, Jason; Montesano, Luis] Univ Zaragoza, Inst Invest Ingn Sistemas I3A, Zaragoza, Spain	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Inria; University of Zaragoza	Iturrate, I (corresponding author), Ecole Polytech Fed Lausanne, CNBI, CH-1015 Lausanne, Switzerland.	inaki.iturrate@epfl.ch	Iturrate, Inaki/B-2396-2018; Lopes, Manuel/D-1608-2010	Lopes, Manuel/0000-0002-6238-8974; Iturrate, Inaki/0000-0001-7781-7826; Grizou, Jonathan/0000-0002-2211-4389	INRIA; Conseil Regional d'Aquitaine; European Research Council [EXPLORERS 24007]; Spanish Ministry of Science [DPI2011-25892]; Diputacion General de Aragon-FSE grupo T04; Swiss National Centres of Competence in Research (NCCRs) "Robotics"; "EPFL Fellows" fellowship programme; Marie Curie, FP7 [291771]	INRIA; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Diputacion General de Aragon-FSE grupo T04; Swiss National Centres of Competence in Research (NCCRs) "Robotics"; "EPFL Fellows" fellowship programme; Marie Curie, FP7	This work has been partially supported by INRIA, Conseil Regional d'Aquitaine and the European Research Council grant EXPLORERS 24007 (JG, PYO, ML); by the Spanish Ministry of Science via DPI2011-25892, and by Diputacion General de Aragon-FSE grupo T04 (JO, LM); and by Swiss National Centres of Competence in Research (NCCRs) "Robotics," and by the "EPFL Fellows" fellowship programme co-funded by Marie Curie, FP7 Grant agreement no. 291771 (II).	Barto AG, 1998, REINFORCEMENT LEARNI; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Chavarriaga R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00208; Chavarriaga R, 2010, IEEE T NEUR SYS REH, V18, P381, DOI 10.1109/TNSRE.2010.2053387; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Fazli S, 2009, NEURAL NETWORKS, V22, P1305, DOI 10.1016/j.neunet.2009.06.003; Grizou J, 2014, AAAI CONF ARTIF INTE, P1213; Grizou J, 2014, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P290; Iturrate I, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026024; ITURRATE I, 2013, CONF PROC IEEE ENG M, P5258, DOI DOI 10.1109/EMBC.2013.6610735; Iturrate I, 2011, IEEE ENG MED BIO, P6369, DOI 10.1109/IEMBS.2011.6091572; Kindermans PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102504; Kindermans PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033758; Krauledat M, 2006, ADV NEURAL INFORM PR, P753; Ledoit O, 2004, J PORTFOLIO MANAGE, V30, P110, DOI 10.3905/jpm.2004.110; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2011, 5 INT BRAIN COMP INT, P176; Lotte F, 2010, INT CONF ACOUST SPEE, P614, DOI 10.1109/ICASSP.2010.5495183; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; OMEDES J, 2013, CONF PROC IEEE ENG M, P5263; Orsborn AL, 2014, NEURON, V82, P1380, DOI 10.1016/j.neuron.2014.04.048; Orsborn AL, 2012, IEEE T NEUR SYS REH, V20, P468, DOI 10.1109/TNSRE.2012.2185066; Rubin D. B., 2003, BAYESIAN DATA ANALYS; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6	29	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131491	10.1371/journal.pone.0131491	http://dx.doi.org/10.1371/journal.pone.0131491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131890	Green Submitted, gold, Green Published			2022-12-26	WOS:000358153000123
J	Karim, S; Ribeiro, JMC				Karim, Shahid; Ribeiro, Jose M. C.			An Insight into the Sialome of the Lone Star Tick, Amblyomma americanum, with a Glimpse on Its Time Dependent Gene Expression	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; IXODES-SCAPULARIS; PROTEIN DATABASE; SALIVARY-GLANDS; VECTOR; GENERATION; ASSEMBLER; IXODIDAE; PROGRAM; ABYSS	Hard ticks feed for several days or weeks on their hosts. Blood feeding is assisted by tick saliva, which is injected in the host skin regularly, alternating with blood ingestion. Tick saliva contains hundreds or thousands of different peptides and other bioactive compounds that assist feeding by inhibiting their hosts' blood clotting, platelet aggregation, vasoconstriction, as well as pain and itching. Immunomodulatory and antimicrobial peptides are also found in tick saliva. Molecular characterization of tick salivary compounds, or its sialome (from the Greek sialos = saliva), helps identification of possible antigens that might confer anti-tick immunity, as well as identifying novel pharmacologically active compounds. Amblyomma americanum is a major nuisance tick in Eastern and Southern US, being a vector of Theileria and Ehrlichia bacteria to animals and humans. Presently we report an RNA-seq study concerning the salivary glands of adult female A. americanum ticks, which involved sequencing of four libraries collected at different times of feeding. A total of 5,792 coding sequences were deduced from the transcriptome assembly, 3,139 of which were publicly deposited, expanding from the previously available 146 salivary sequences found in GenBank. A remarkable time-dependent transcript expression was found, mostly related to secretory products, supporting the idea that ticks may have several "sialomes" that are expressed at different times during feeding. The molecular nature of this sialome switching remains unknown.	[Karim, Shahid] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Ribeiro, Jose M. C.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	University of Southern Mississippi; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ribeiro, JMC (corresponding author), NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	jribeiro@niaid.nih.gov		Ribeiro, Jose/0000-0002-9107-0818; Karim, Shahid/0000-0001-5596-3304	Department of State award (PakistanUnited States Science and Technology Cooperation) [PGA-P21049]; National Institutes of General Medical Sciences award [P20RR016476]; Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health, USA; National Institute of Allergy and Infectious Diseases award, United States [AI099919]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI099910, ZIAAI000810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Department of State award (PakistanUnited States Science and Technology Cooperation); National Institutes of General Medical Sciences award; Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases award, United States; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Department of State award #PGA-P21049 (PakistanUnited States Science and Technology Cooperation) to SK and the National Institutes of General Medical Sciences award # P20RR016476 to the MS-INBRE core facility. JMCR was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This work was supported by grants from the National Institute of Allergy and Infectious Diseases award # AI099919, United States	Adamson SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082012; Aljamali MN, 2009, INSECT MOL BIOL, V18, P129, DOI 10.1111/j.1365-2583.2009.00863.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Friesen KJ, 2009, J INSECT PHYSIOL, V55, P936, DOI 10.1016/j.jinsphys.2009.06.007; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jasinskas A, 2007, APPL ENVIRON MICROB, V73, P334, DOI 10.1128/AEM.02009-06; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kotsyfakis M, 2008, J IMMUNOL, V181, P5209, DOI 10.4049/jimmunol.181.8.5209; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Liu YC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-354; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; MORGAN JF, 1950, P SOC EXP BIOL MED, V73, P1, DOI 10.3181/00379727-73-17557; MORGAN JF, 1955, J NATL CANCER I, V16, P557; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Pichu S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-32; Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x; Schwarz A, 2014, MOL CELL PROTEOMICS, V13, P2725, DOI 10.1074/mcp.M114.039289; Schwarz A, 2013, FASEB J, V27, P4745, DOI 10.1096/fj.13-232140; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SONENSHINE D, 1992, BIOL TICKS; Warnes GR, 2015, R PACKAGE VERSION 21, V2	33	73	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131292	10.1371/journal.pone.0131292	http://dx.doi.org/10.1371/journal.pone.0131292			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26131772	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000109
J	Kim, C; Sohn, JH; Jang, MU; Kim, SH; Choi, MG; Ryu, OH; Lee, S; Choi, HC				Kim, Chulho; Sohn, Jong-Hee; Jang, Min Uk; Kim, Sung-Hun; Choi, Moon-Gi; Ryu, Ohk-Hyun; Lee, Sungwha; Choi, Hui-Chul			Association between Visit-to-Visit Glucose Variability and Cognitive Function in Aged Type 2 Diabetic Patients: A Cross-Sectional Study	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; OXIDATIVE STRESS; ENDOTHELIAL-CELL; PLASMA-GLUCOSE; RISK; PERFORMANCE; DEMENTIA; HYPERGLYCEMIA; HYPOGLYCEMIA; MANAGEMENT	Background and Purpose Diabetes is associated with cognitive decline as well as the development of dementia. Although mean blood glucose levels are typically used to assess the status of diabetic patients, glucose variability is also involved in the manifestation of macro-and microvascular complications in this population. Thus, the present study sought to determine whether visit-to-visit glucose variability contributes to cognitive decline in patients with type 2 diabetes. Methods The present study assessed 68 patients with type 2 diabetes using several validated neuropsychological measures. All patients had no cerebrovascular disease, history of hypoglycemia, psychiatric conditions, or other medical illnesses. Standard deviations (SDs) and coefficients of variance (CVs) of the patients' blood glucose (after fasting and 2 hours postprandial; FBS and PP2), and glycated hemoglobin (HbA1c) values were used as indices of glucose variability. The cognitive outcome parameters were transformed with z-scores and entered into a multiple linear regression model that included educational status, age, sex, vascular risk factors, and mean glucose parameters as covariates. Results The mean age of the total patient population was 70.9 years; 46 (67.6%) of the patients were men, and the median follow-up duration at our endocrinology outpatient clinic was 4.8 years. The mean FBS and PP2 glucose levels of the patients were 132 mg/dL and 199 mg/dL, respectively, and the mean HbA1c level was 8.0%. A univariable analysis revealed that only the PP2 value was associated with the Mini-Mental State Examination (MMSE) score, and multivariable analysis revealed that a high SD and/or CV for PP2 glucose were associated with low scores on the Rey Complex Figure Copy test and/or the Verbal Learning Test. Additionally, a high SD and a higher CV for HbA1c level were significantly associated with low MMSE and Digit Span test scores even after adjusting for mean HbA1c values. Conclusions The present data indicate that a greater degree of visit-to-visit glucose variability influenced specific types of cognitive function in type 2 diabetic patients independently of mean blood glucose levels. Future studies should focus on whether reductions in glycemic variability will improve the cognitive decline observed in type 2 diabetic patients.	[Kim, Chulho; Sohn, Jong-Hee; Jang, Min Uk; Choi, Hui-Chul] Hallym Univ, Sacred Heart Hosp, Dept Neurol, Chuncheon Si, South Korea; [Kim, Sung-Hun] Kangwon Natl Univ, Coll Med, Dept Neurol, Chunchon, South Korea; [Choi, Moon-Gi; Ryu, Ohk-Hyun; Lee, Sungwha] Hallym Univ, Sacred Heart Hosp, Div Endocrinol & Metab, Chuncheon Si, South Korea	Hallym University; Kangwon National University; Hallym University	Choi, HC (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Neurol, Chuncheon Si, South Korea.	dohchi@hallym.or.kr	Kim, Chulho/AAC-8708-2022	Kim, Chulho/0000-0001-8762-8340	Korea Drug Company, limited [2012-50]; Hallym University Specialization Fund [HRF-S-51]	Korea Drug Company, limited; Hallym University Specialization Fund	This study was supported by a grant from the Korea Drug Company, limited (2012-50), and by Hallym University Specialization Fund (HRF-S-51). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2006, NEUROLOGY, V67, P235, DOI 10.1212/01.wnl.0000224760.22802.e8; Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071; [Anonymous], 1995, DIABETES, V44, P968; Bie-Olsen LG, 2009, J NEUROSCI RES, V87, P1922, DOI 10.1002/jnr.22002; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Cox DJ, 2005, DIABETES CARE, V28, P71, DOI 10.2337/diacare.28.1.71; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Garber AJ, 2013, ENDOCR PRACT, V19, P100, DOI 10.4158/EP12325.OR; Geijselaers SLC, 2015, LANCET DIABETES ENDO, V3, P75, DOI 10.1016/S2213-8587(14)70148-2; Jeha George S, 2005, Diabetes Technol Ther, V7, P876, DOI 10.1089/dia.2005.7.876; Kang Y., 2012, SEOUL NEUROPSYCHOLOG, V2nd; Kerti L, 2013, NEUROLOGY, V81, P1746, DOI 10.1212/01.wnl.0000435561.00234.ee; Kielstein JT, 2013, NEW ENGL J MED, V369, P1863, DOI 10.1056/NEJMc1311765; Kilpatrick ES, 2010, DIABETIC MED, V27, P868, DOI 10.1111/j.1464-5491.2010.02929.x; Kilpatrick ES, 2008, DIABETES CARE, V31, P2198, DOI 10.2337/dc08-0864; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Kudva Yogish C, 2007, Endocr Pract, V13, P244; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Lin CC, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0165-7; Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323; Messier C, 2011, BEHAV BRAIN RES, V222, P81, DOI 10.1016/j.bbr.2011.03.023; Monnier L, 2011, DIABETES TECHNOL THE, V13, P813, DOI 10.1089/dia.2011.0049; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Riby LM, 2008, BRIT J NUTR, V100, P1128, DOI 10.1017/S0007114508971324; Rizzo MR, 2010, DIABETES CARE, V33, P2169, DOI 10.2337/dc10-0389; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Takao T, 2010, DIABETES RES CLIN PR, V89, P296, DOI 10.1016/j.diabres.2010.03.027; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Zhong Y, 2012, BIOMED ENVIRON SCI, V25, P1, DOI 10.3967/0895-3988.2012.01.001	36	26	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132118	10.1371/journal.pone.0132118	http://dx.doi.org/10.1371/journal.pone.0132118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132234	gold, Green Published, Green Submitted			2022-12-26	WOS:000358153000157
J	Montenegro-Montero, A; Goity, A; Larrondo, LF				Montenegro-Montero, Alejandro; Goity, Alejandra; Larrondo, Luis F.			The bZIP Transcription Factor HAC-1 Is Involved in the Unfolded Protein Response and Is Necessary for Growth on Cellulose in Neurospora crassa	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-ASSOCIATED DEGRADATION; MODEL FILAMENTOUS FUNGUS; MESSENGER-RNA; ASPERGILLUS-NIDULANS; TRICHODERMA-REESEI; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE PROTEIN; SECRETION STRESS; ASCOMYCETE FUNGI	High protein secretion capacity in filamentous fungi requires an extremely efficient system for protein synthesis, folding and transport. When the folding capacity of the endoplasmic reticulum (ER) is exceeded, a pathway known as the unfolded protein response (UPR) is triggered, allowing cells to mitigate and cope with this stress. In yeast, this pathway relies on the transcription factor Hac1, which mediates the up-regulation of several genes required under these stressful conditions. In this work, we identified and characterized the ortholog of the yeast HAC1 gene in the filamentous fungus Neurospora crassa. We show that its mRNA undergoes an ER stress-dependent splicing reaction, which in N. crassa removes a 23 nt intron and leads to a change in the open reading frame. By disrupting the N. crassa hac-1 gene, we determined it to be crucial for activating UPR and for proper growth in the presence of ER stress-inducing chemical agents. Neurospora is naturally found growing on dead plant material, composed primarily by lignocellulose, and is a model organism for the study of plant cell wall deconstruction. Notably, we found that growth on cellulose, a substrate that requires secretion of numerous enzymes, imposes major demands on ER function and is dramatically impaired in the absence of hac-1, thus broadening the range of physiological functions of the UPR in filamentous fungi. Growth on hemicellulose however, another carbon source that necessitates the secretion of various enzymes for its deconstruction, is not impaired in the mutant nor is the amount of proteins secreted on this substrate, suggesting that secretion, as a whole, is unaltered in the absence of hac-1. The characterization of this signaling pathway in N. crassa will help in the study of plant cell wall deconstruction by fungi and its manipulation may result in important industrial biotechnological applications.	[Montenegro-Montero, Alejandro; Goity, Alejandra; Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Nucleus Fungal Integrat & Synthet Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Larrondo, LF (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Nucleus Fungal Integrat & Synthet Biol, Alameda 340, Santiago, Chile.	llarrondo@bio.puc.cl	Montenegro-Montero, Alejandro/H-4863-2015; Larrondo, Luis/J-1086-2016	Montenegro-Montero, Alejandro/0000-0003-3780-4072; Larrondo, Luis/0000-0002-8832-7109	Millennium Nucleus for Fungal Integrative and Synthetic Biology [NC120043]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1131030]	Millennium Nucleus for Fungal Integrative and Synthetic Biology; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by Millennium Nucleus for Fungal Integrative and Synthetic Biology to LFL (URL: http://www.iniciativamilenio.cl/centros/nucleos_det.php?id=134), Grant Number: NC120043; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) to LFL, (URL: http://w1.conicyt.cl/bases/fondecyt/personas/3/0/30225.html) Grant number: 1131030.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Archer DB, 2006, MYCOTA, V13, P75; Arias P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-390; Arvas M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-32; Benz JP, 2014, MOL MICROBIOL, V91, P275, DOI 10.1111/mmi.12459; Bernard B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042779; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bouws H, 2008, APPL MICROBIOL BIOT, V80, P381, DOI 10.1007/s00253-008-1572-5; Brown NA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-91; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Cheon SA, 2014, VIRULENCE, V5, P341, DOI 10.4161/viru.26774; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Collen A, 2005, BIOTECHNOL BIOENG, V89, P335, DOI 10.1002/bit.20350; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conesa A, 2001, FUNGAL GENET BIOL, V33, P155, DOI 10.1006/fgbi.2001.1276; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Dementhon K, 2006, EUKARYOT CELL, V5, P2161, DOI 10.1128/EC.00253-06; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Fordyce PM, 2012, P NATL ACAD SCI USA, V109, pE3084, DOI 10.1073/pnas.1212457109; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Guillemette T, 2014, VIRULENCE, V5, P357, DOI 10.4161/viru.26772; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Heimel K, 2013, PLANT CELL, V25, P4262, DOI 10.1105/tpc.113.115899; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hill TW, 2006, MYCOLOGIA, V98, P399, DOI 10.3852/mycologia.98.3.399; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hooks KB, 2011, RNA BIOL, V8, P552, DOI 10.4161/rna.8.4.15396; Cornejo VH, 2013, IUBMB LIFE, V65, P962, DOI 10.1002/iub.1224; Ilmen M, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-30; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; Kramer Cas, 2007, Methods Mol Biol, V362, P291; Krishnan K, 2014, VIRULENCE, V5, P334, DOI 10.4161/viru.26571; Larrondo LF, 2015, SCIENCE, V347, DOI 10.1126/science.1257277; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Malavazi I, 2014, BRIEF FUNCT GENOMICS, V13, P456, DOI 10.1093/bfgp/elu027; Miyazaki T, 2014, VIRULENCE, V5, P365, DOI 10.4161/viru.27373; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Mulder HJ, 2009, EUKARYOT CELL, V8, P665, DOI 10.1128/EC.00131-08; Mulder HJ, 2004, MOL GENET GENOMICS, V271, P130, DOI 10.1007/s00438-003-0965-5; Nevalainen KMH, 2005, TRENDS BIOTECHNOL, V23, P468, DOI 10.1016/j.tibtech.2005.06.002; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Pincus D, 2014, P NATL ACAD SCI USA, V111, P14800, DOI 10.1073/pnas.1409588111; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Saloheimo M, 2003, MOL MICROBIOL, V47, P1149, DOI 10.1046/j.1365-2958.2003.03363.x; Saloheimo M, 2012, MICROBIOL-SGM, V158, P46, DOI 10.1099/mic.0.053132-0; Sims AH, 2005, APPL ENVIRON MICROB, V71, P2737, DOI 10.1128/AEM.71.5.2737-2747.2005; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Tian CG, 2011, MICROBIOL-SGM, V157, P747, DOI 10.1099/mic.0.045468-0; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Welihinda AA, 1998, MOL CELL BIOL, V18, P1967, DOI 10.1128/MCB.18.4.1967; Wimalasena TT, 2008, FUNGAL GENET BIOL, V45, P1235, DOI 10.1016/j.fgb.2008.06.001; Xiong Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004500; Znameroski EA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-6; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	77	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131415	10.1371/journal.pone.0131415	http://dx.doi.org/10.1371/journal.pone.0131415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132395	gold, Green Submitted, Green Published			2022-12-26	WOS:000358153000116
J	Nagai, H; Kuwahira, I; Schwenke, DO; Tsuchimochi, H; Nara, A; Ogura, S; Sonobe, T; Inagaki, T; Fujii, Y; Yamaguchi, R; Wingenfeld, L; Umetani, K; Shimosawa, T; Yoshida, K; Uemura, K; Pearson, JT; Shirai, M				Nagai, Hisashi; Kuwahira, Ichiro; Schwenke, Daryl O.; Tsuchimochi, Hirotsugu; Nara, Akina; Ogura, Sayoko; Sonobe, Takashi; Inagaki, Tadakatsu; Fujii, Yutaka; Yamaguchi, Rutsuko; Wingenfeld, Lisa; Umetani, Keiji; Shimosawa, Tatsuo; Yoshida, Ken-ichi; Uemura, Koichi; Pearson, James T.; Shirai, Mikiyasu			Pulmonary Macrophages Attenuate Hypoxic Pulmonary Vasoconstriction via beta(3)AR/iNOS Pathway in Rats Exposed to Chronic Intermittent Hypoxia	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; SYNCHROTRON-RADIATION MICROANGIOGRAPHY; BETA-ADRENOCEPTOR AGONISTS; CARDIOVASCULAR-SYSTEM; SYMPATHETIC ACTIVITY; BLOOD-PRESSURE; UP-REGULATION; ACTIVATION; BETA(3)-ADRENOCEPTOR; HYPERTENSION	Chronic intermittent hypoxia (IH) induces activation of the sympathoadrenal system, which plays a pivotal role in attenuating hypoxic pulmonary vasoconstriction (HPV) via central beta(1)-adrenergic receptors (AR) (brain) and peripheral beta(2)AR (pulmonary arteries). Prolonged hypercatecholemia has been shown to upregulate beta(3)AR. However, the relationship between IH and beta(3)AR in the modification of HPV is unknown. It has been observed that chronic stimulation of beta(3)AR upregulates inducible nitric oxide synthase (iNOS) in cardiomyocytes and that IH exposure causes expression of iNOS in RAW264.7 macrophages. iNOS has been shown to have the ability to dilate pulmonary vessels. Hence, we hypothesized that chronic IH activates beta(3)AR/iNOS signaling in pulmonary macrophages, leading to the promotion of NO secretion and attenuated HPV. Sprague-Dawley rats were exposed to IH (3-min periods of 4-21% O-2) for 8 h/d for 6 weeks. The urinary catecholamine concentrations of IH rats were high compared with those of controls, indicating activation of the sympathoadrenal system following chronic IH. Interestingly, chronic IH induced the migration of circulating monocytes into the lungs and the predominant increase in the number of proinflammatory pulmonary macrophages. In these macrophages, both beta(3)AR and iNOS were upregulated and stimulation of the beta(3)AR/iNOS pathway in vitro caused them to promote NO secretion. Furthermore, in vivo synchrotron radiation microangiography showed that HPV was significantly attenuated in IH rats and the attenuated HPV was fully restored by blockade of beta(3)AR/iNOS pathway or depletion of pulmonary macrophages. These results suggest that circulating monocyte-derived pulmonary macrophages attenuate HPV via activation of beta(3)AR/iNOS signaling in chronic IH.	[Nagai, Hisashi; Uemura, Koichi] Tokyo Med & Dent Univ, Dept Forens Med, Tokyo, Japan; [Nagai, Hisashi; Nara, Akina; Ogura, Sayoko; Yamaguchi, Rutsuko; Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Tokyo, Japan; [Nagai, Hisashi; Ogura, Sayoko; Shimosawa, Tatsuo] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Kuwahira, Ichiro] Tokai Univ, Tokyo Hosp, Dept Pulm Med, Tokyo 151, Japan; [Schwenke, Daryl O.] Univ Otago, Dept Physiol, Heart Otago, Dunedin, New Zealand; [Tsuchimochi, Hirotsugu; Sonobe, Takashi; Inagaki, Tadakatsu; Fujii, Yutaka; Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Physiol, Osaka, Japan; [Ogura, Sayoko] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Tokyo, Japan; [Wingenfeld, Lisa] Univ Munich, Inst Forens Med, Munich, Germany; [Umetani, Keiji] Japan Synchrotron Radiat Res Inst, Kobe, Hyogo, Japan; [Yoshida, Ken-ichi] Tokyo Med Univ, Dept Forens Med, Tokyo 1608402, Japan; [Pearson, James T.] Monash Univ, Monash Biomed Imaging Facil, Melbourne, Vic 3004, Australia; [Pearson, James T.] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Pearson, James T.] Australian Synchrotron, Imaging & Med therapy Beamline, Clayton, Vic, Australia	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Tokai University; University of Otago; National Cerebral & Cardiovascular Center - Japan; Nihon University; University of Munich; Japan Synchrotron Radiation Research Institute; Tokyo Medical University; Monash University; Monash University	Nagai, H (corresponding author), Tokyo Med & Dent Univ, Dept Forens Med, Tokyo, Japan.	nagai@legalmed.jp	Tsuchimochi, Hirotsugu/D-8224-2011; Pearson, James T/B-4631-2012; Sonobe, Takashi/Q-6600-2016	Tsuchimochi, Hirotsugu/0000-0001-7591-2520; Pearson, James T/0000-0002-3318-5406; Sonobe, Takashi/0000-0003-3589-0405	Japan Society for the Promotion of Science [23249038, 23590843]; Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center [22-2-3, 25-3-1]; JSPS [23650213, 24790863, 26670413, 24.2221]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was mainly supported by Grants-in-Aid for Scientific Research (No. 23249038 and 23590843) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), and was also supported in part by the Intramural Research Fund (22-2-3, 25-3-1) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center (http://www.ncvc.go.jp/english/) and Grants-in Aid for Scientific Research (No. 23650213, 24790863, 26670413 and 24.2221) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour J, 2007, ANESTHESIOLOGY, V107, P452, DOI 10.1097/01.anes.0000278909.40408.24; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Baumgardner JE, 2003, RESP PHYSIOL NEUROBI, V136, P131, DOI 10.1016/S1569-9048(03)00077-6; Birenbaum A, 2008, ANESTHESIOLOGY, V109, P1045, DOI 10.1097/ALN.0b013e31818d7e5a; Bosc LVG, 2010, J CELL MOL MED, V14, P3, DOI 10.1111/j.1582-4934.2009.00929.x; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Brixius K, 2006, CAN J PHYSIOL PHARM, V84, P1051, DOI 10.1139/Y06-033; Cheng HJ, 2001, CIRC RES, V89, P599, DOI 10.1161/hh1901.098042; Chuang IC, 2010, LUNG, V188, P199, DOI 10.1007/s00408-010-9234-7; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; Dincer UD, 2001, DIABETES, V50, P455, DOI 10.2337/diabetes.50.2.455; Dumas JP, 1999, BRIT J PHARMACOL, V127, P421, DOI 10.1038/sj.bjp.0702575; Dumas M, 1998, EUR J PHARMACOL, V348, P223, DOI 10.1016/S0014-2999(98)00146-0; Forbes A, 2007, J APPL PHYSIOL, V103, P637, DOI 10.1152/japplphysiol.00995.2006; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Germack R, 2006, J PHARMACOL EXP THER, V316, P392, DOI 10.1124/jpet.105.090597; Hasko G, 1998, BRAIN RES BULL, V45, P183, DOI 10.1016/S0361-9230(97)00337-7; Kumar GK, 2006, J PHYSIOL-LONDON, V575, P229, DOI 10.1113/jphysiol.2006.112524; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; Leuenberger UA, 2005, AUTON NEUROSCI-BASIC, V121, P87, DOI 10.1016/j.autneu.2005.06.003; Madjdpour C, 2003, AM J PHYSIOL-LUNG C, V284, pL360, DOI 10.1152/ajplung.00158.2002; Maffei A, 2007, HYPERTENSION, V50, P652, DOI 10.1161/HYPERTENSIONAHA.107.094458; Marrone O, 2002, SLEEP MED REV, V6, P175, DOI 10.1053/smrv.2001.0185; Miles PR, 1998, AM J PHYSIOL-LUNG C, V274, pL360, DOI 10.1152/ajplung.1998.274.3.L360; Moens AL, 2010, J MOL CELL CARDIOL, V48, P1088, DOI 10.1016/j.yjmcc.2010.02.011; Moniotte S, 2007, EUR J HEART FAIL, V9, P1163, DOI 10.1016/j.ejheart.2007.10.006; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; NAGAI H, 2014, INT J CLIN EXPT PHYS, V1, P307, DOI DOI 10.4103/2348-8093.149770; Nagai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110693; NANTEL F, 1993, MOL PHARMACOL, V43, P548; Nilsson MCA, 2012, INTENS CARE MED, V38, P509, DOI 10.1007/s00134-012-2482-7; Pourageaud F, 2005, N-S ARCH PHARMACOL, V372, P14, DOI 10.1007/s00210-005-1082-2; Prabhakar NR, 2012, J APPL PHYSIOL, V113, P1304, DOI 10.1152/japplphysiol.00444.2012; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P230, DOI 10.1016/j.resp.2010.08.022; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Schwenke DO, 2008, J APPL PHYSIOL, V104, P88, DOI 10.1152/japplphysiol.00610.2007; Schwenke DO, 2007, J APPL PHYSIOL, V102, P787, DOI 10.1152/japplphysiol.00596.2006; Shirai M, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0432-y; Sica AL, 2000, RESP PHYSIOL, V121, P173, DOI 10.1016/S0034-5687(00)00126-2; Sigola LB, 2000, IMMUNOLOGY, V100, P359, DOI 10.1046/j.1365-2567.2000.00029.x; Strunk V, 2001, ANESTH ANALG, V92, P681, DOI 10.1213/00000539-200103000-00025; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tamisier R, 2011, EUR RESPIR J, V37, P119, DOI 10.1183/09031936.00204209; Tsai BM, 2004, AM J PHYSIOL-REG I, V287, pR767, DOI 10.1152/ajpregu.00248.2004; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; Wang HJ, 1997, CAN J PHYSIOL PHARM, V75, P789, DOI 10.1139/cjpp-75-7-789	49	13	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131923	10.1371/journal.pone.0131923	http://dx.doi.org/10.1371/journal.pone.0131923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132492	Green Published, gold, Green Submitted			2022-12-26	WOS:000358153000145
J	Newsome, L; Morris, K; Lloyd, JR				Newsome, Laura; Morris, Katherine; Lloyd, Jonathan. R.			Uranium Biominerals Precipitated by an Environmental Isolate of Serratia under Anaerobic Conditions	PLOS ONE			English	Article							REDUCTION; U(IV); U(VI); BIOACCUMULATION; BIOREMEDIATION; IDENTIFICATION; GROUNDWATER; REOXIDATION; URANINITE; SEDIMENT	Stimulating the microbially-mediated precipitation of uranium biominerals may be used to treat groundwater contamination at nuclear sites. The majority of studies to date have focussed on the reductive precipitation of uranium as U(IV) by U(VI)- and Fe(III)-reducing bacteria such as Geobacter and Shewanella species, although other mechanisms of uranium removal from solution can occur, including the precipitation of uranyl phosphates via bacterial phosphatase activity. Here we present the results of uranium biomineralisation experiments using an isolate of Serratia obtained from a sediment sample representative of the Sellafield nuclear site, UK. When supplied with glycerol phosphate, this Serratia strain was able to precipitate 1 mM of soluble U(VI) as uranyl phosphate minerals from the autunite group, under anaerobic and fermentative conditions. Under phosphate-limited anaerobic conditions and with glycerol as the electron donor, non-growing Serratia cells could precipitate 0.5 mM of uranium supplied as soluble U(VI), via reduction to nano-crystalline U(IV) uraninite. Some evidence for the reduction of solid phase uranyl(VI) phosphate was also observed. This study highlights the potential for Serratia and related species to play a role in the bioremediation of uranium contamination, via a range of different metabolic pathways, dependent on culturing or in situ conditions.	[Newsome, Laura] Univ Manchester, Sch Earth Atmospher & Environm Sci, Res Ctr Radwaste Disposal, Manchester, Lancs, England; Univ Manchester, Sch Earth Atmospher & Environm Sci, Williamson Res Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Newsome, L (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Res Ctr Radwaste Disposal, Oxford Rd, Manchester, Lancs, England.	laura.newsome@postgrad.manchester.ac.uk	Newsome, Laura/N-1738-2019; Newsome, Laura/A-2326-2017	Newsome, Laura/0000-0002-0283-3001; Lloyd, Jonathan/0000-0002-0719-0498; Morris, Katherine/0000-0002-0716-7589	Nuclear Decommissioning Authority; Royal Society; NERC (Natural Environment Research Council) via BIGRAD consortium [NE/H007768/1]; Diamond Light Source [SP8941-2]; LENFF at Leeds University; NERC (Natural Environment Research Council) via BNFL Endowment; Natural Environment Research Council [NE/H007768/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/K001787/1] Funding Source: researchfish; NERC [NE/H007768/1] Funding Source: UKRI; STFC [ST/K001787/1] Funding Source: UKRI	Nuclear Decommissioning Authority(Swedish Nuclear Fuel & Waste Management Company (SKB)); Royal Society(Royal Society of London); NERC (Natural Environment Research Council) via BIGRAD consortium(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Diamond Light Source; LENFF at Leeds University; NERC (Natural Environment Research Council) via BNFL Endowment(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The authors acknowledge financial support from the Nuclear Decommissioning Authority (www.nda.gov.uk) via a PhD student bursary, managed by the National Nuclear Laboratory (www.nnl.co.uk). JRL acknowledges the support of the Royal Society (royalsociety.org) via an Industrial Fellowship. The authors also acknowledge financial support from NERC (Natural Environment Research Council) (www.nerc.ac.uk) via the BIGRAD consortium (NE/H007768/1) and also via a BNFL Endowment which has supported the development of the Research Centre for Radwaste Disposal. The authors acknowledge financial and technical support from LENFF at Leeds University (www.engineering.leeds.ac.uk/lennf) for TEM analysis. Beamtime at beamline B18 was funded by grant SP8941-2 from the Diamond Light Source (www.diamond.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouas A, 1998, J CONTAM HYDROL, V35, P217, DOI 10.1016/S0169-7722(98)00134-X; Adams LK, 2007, FEMS MICROBIOL LETT, V268, P151, DOI 10.1111/j.1574-6968.2007.00635.x; Beazley MJ, 2007, ENVIRON SCI TECHNOL, V41, P5701, DOI 10.1021/es070567g; Bernier-Latmani R, 2010, ENVIRON SCI TECHNOL, V44, P9456, DOI 10.1021/es101675a; Boyanov MI, 2011, ENVIRON SCI TECHNOL, V45, P8336, DOI 10.1021/es2014049; Campbell KM, 2011, ENVIRON SCI TECHNOL, V45, P8748, DOI 10.1021/es200482f; Downward L, 2007, AIP CONF PROC, V882, P129; HEALY RM, 1955, J AM CHEM SOC, V77, P5258, DOI 10.1021/ja01625a012; Imhoff J.F., 2005, BERGEYS MANUAL SYSTE, VVolume 2 (The Proteobacteria), P587, DOI DOI 10.1007/0-387-29298-5; JOHNSON DA, 1971, ANAL CHIM ACTA, V53, P73, DOI 10.1016/S0003-2670(01)80072-6; Kim CS, 2000, SCI TOTAL ENVIRON, V261, P157, DOI 10.1016/S0048-9697(00)00640-9; Kumar R, 2011, J MICROBIOL, V49, P568, DOI 10.1007/s12275-011-0366-0; Lloyd JR, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P277; Locock AJ, 2003, AM MINERAL, V88, P240; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1992, APPL ENVIRON MICROB, V58, P850, DOI 10.1128/AEM.58.3.850-856.1992; MACASKIE LE, 1992, SCIENCE, V257, P782, DOI 10.1126/science.1496397; MACASKIE LE, 1994, FEMS MICROBIOL LETT, V121, P141, DOI 10.1111/j.1574-6968.1994.tb07090.x; MACASKIE LE, 1990, J CHEM TECHNOL BIOT, V49, P357; Martinez RJ, 2007, ENVIRON MICROBIOL, V9, P3122, DOI 10.1111/j.1462-2920.2007.01422.x; Moon HS, 2007, ENVIRON SCI TECHNOL, V41, P4587, DOI 10.1021/es063063b; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Newsome L, 2014, CHEM GEOL, V363, P164, DOI 10.1016/j.chemgeo.2013.10.034; Opel K, 2007, RADIOCHIM ACTA, V95, P143, DOI 10.1524/ract.2007.95.3.143; Parkhurst D.L., 1999, 994259 WAT RES INV; Paterson-Beedle M, 2012, BIOTECHNOL BIOENG, V109, P1937, DOI 10.1002/bit.24467; Pattanapipitpaisal P, 2002, ENVIRON TECHNOL, V23, P731, DOI 10.1080/09593332308618367; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Roig MG, 1995, EV5VCT930251 EC; Rossberg A., 2014, ACREDAS ACTINIDE REF; Rossberg A, 2009, ENVIRON SCI TECHNOL, V43, P1400, DOI 10.1021/es801727w; Rui X, 2013, ENVIRON SCI TECHNOL, V47, P5668, DOI 10.1021/es305258p; Senko JM, 2002, ENVIRON SCI TECHNOL, V36, P1491, DOI 10.1021/es011240x; Thorpe CL, 2012, FEMS MICROBIOL LETT, V327, P87, DOI 10.1111/j.1574-6968.2011.02455.x; Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x; Walsh V, 2008, F BACON; Wellman DM, 2006, ENVIRON CHEM, V3, P219, DOI 10.1071/EN05023; Williams KH, 2013, CURR OPIN BIOTECH, V24, P489, DOI 10.1016/j.copbio.2012.10.008	38	21	23	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0132392	10.1371/journal.pone.0132392	http://dx.doi.org/10.1371/journal.pone.0132392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132209	Green Published, gold			2022-12-26	WOS:000358153000169
J	Akilbekova, D; Bratlie, KM				Akilbekova, Dana; Bratlie, Kaitlin M.			Quantitative Characterization of Collagen in the Fibrotic Capsule Surrounding Implanted Polymeric Microparticles through Second Harmonic Generation Imaging	PLOS ONE			English	Article							FOREIGN-BODY REACTION; EXTRACELLULAR-MATRIX; SCAR TISSUE; MICROSCOPY; BIOMATERIALS; CELLS; SKIN; BIOCOMPATIBILITY; ORIENTATION; RESPONSES	The collagenous capsule formed around an implant will ultimately determine the nature of its in vivo fate. To provide a better understanding of how surface modifications can alter the collagen orientation and composition in the fibrotic capsule, we used second harmonic generation (SHG) microscopy to evaluate collagen organization and structure generated in mice subcutaneously injected with chemically functionalized polystyrene particles. SHG is sensitive to the orientation of a molecule, making it a powerful tool for measuring the alignment of collagen fibers. Additionally, SHG arises from the second order susceptibility of the interrogated molecule in response to the electric field. Variation in these tensor components distinguishes different molecular sources of SHG, providing collagen type specificity. Here, we demonstrated the ability of SHG to differentiate collagen type I and type III quantitatively and used this method to examine fibrous capsules of implanted polystyrene particles. Data presented in this work shows a wide range of collagen fiber orientations and collagen compositions in response to surface functionalized polystyrene particles. Dimethylamino functionalized particles were able to form a thin collagenous matrix resembling healthy skin. These findings have the potential to improve the fundamental understanding of how material properties influence collagen organization and composition quantitatively.	[Akilbekova, Dana; Bratlie, Kaitlin M.] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA; [Bratlie, Kaitlin M.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Bratlie, Kaitlin M.] Ames Natl Lab, Ames, IA 50011 USA	Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Bratlie, KM (corresponding author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.	kbratlie@iastate.edu	Akilbekova, Dana/L-3319-2016	Akilbekova, Dana/0000-0003-3694-0355	National Science Foundation [CBET 1227867]; Roy J. Carver Charitable Trust [13-4265]; NSF ARI-R2 [CMMI-0963224]	National Science Foundation(National Science Foundation (NSF)); Roy J. Carver Charitable Trust; NSF ARI-R2(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Science Foundation (www.nsf.gov) under grant CBET 1227867 and the Roy J. Carver Charitable Trust (https://www.carvertrust.org/) grant 13-4265. The authors also acknowledge support from NSF ARI-R2 (CMMI-0963224) for funding the renovation of the research laboratories used for these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilbekova D, 2015, J BIOMED MAT RES A; Ambekar R, 2012, BIOMED OPT EXPRESS, V3, P2021, DOI 10.1364/BOE.3.002021; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; BAILEY AJ, 1975, BIOCHEM BIOPH RES CO, V66, P1160, DOI 10.1016/0006-291X(75)90480-5; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Bygd HC, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0041-2; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; CHAVRIER C, 1994, CLIN ORAL IMPLAN RES, V5, P117, DOI 10.1034/j.1600-0501.1994.050301.x; Chen WL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3132062; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; CHEUNG DT, 1990, MATRIX, V10, P164, DOI 10.1016/S0934-8832(11)80165-4; CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500; Dale PD, 1996, P ROY SOC B-BIOL SCI, V263, P653, DOI 10.1098/rspb.1996.0098; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; Gavin HP., 2013, LEVENBERG MARQUARDT; GAY S, 1978, ACTA CHIR SCAND, V144, P205; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hompland T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2983664; Jacob JT, 1996, J BIOMED MATER RES, V32, P181, DOI 10.1002/(SICI)1097-4636(199610)32:2<181::AID-JBM5>3.0.CO;2-P; Jenney CR, 2000, J BIOMED MATER RES, V49, P435; Kambic HE, 1986, VASCULAR GRAFT UPDAT; LIU SH, 1995, CLIN ORTHOP RELAT R, P265; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Marinucci L, 2003, J BIOMED MATER RES A, V67A, P504, DOI 10.1002/jbm.a.10082; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nadiarnykh O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-94; Nguyen-Ngoc KV, 2013, J MICROSC-OXFORD, V251, P212, DOI 10.1111/jmi.12017; Park S, 2015, J CONTROL RELEASE, V200, P125, DOI 10.1016/j.jconrel.2014.12.021; Pavone Francesco S., 2013, SOCOND HARMONIC GENE; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Shannon C, 1997, J BIOMED MATER RES, V34, P401, DOI 10.1002/(SICI)1097-4636(19970305)34:3<401::AID-JBM15>3.0.CO;2-I; Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Stuart K, 2009, BIOMACROMOLECULES, V10, P25, DOI 10.1021/bm800888u; Su PJ, 2011, BIOPHYS J, V100, P2053, DOI 10.1016/j.bpj.2011.02.015; Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841; Tiaho F, 2007, OPT EXPRESS, V15, P12286, DOI 10.1364/OE.15.012286; Tuer AE, 2013, PROC SPIE, V8588, DOI 10.1117/12.2000724; van Zuijlen PPM, 2003, BURNS, V29, P423, DOI 10.1016/S0305-4179(03)00052-4; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; Verhaegen PDHM, 2012, J MICROSC-OXFORD, V245, P82, DOI 10.1111/j.1365-2818.2011.03547.x; Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399; Yasui T, 2004, APPL OPTICS, V43, P2861, DOI 10.1364/AO.43.002861; Yasui T, 2004, J BIOMED OPT, V9, P259, DOI 10.1117/1.1644116; Yuan ZW, 2014, CHINESE J AERONAUT, V27, P160, DOI 10.1016/j.cja.2013.07.011; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580	49	29	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130386	10.1371/journal.pone.0130386	http://dx.doi.org/10.1371/journal.pone.0130386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125551	Green Submitted, Green Published, gold			2022-12-26	WOS:000358151300013
J	Das, P; Baker, KK; Dutta, A; Swain, T; Sahoo, S; Das, BS; Panda, B; Nayak, A; Bara, M; Bilung, B; Mishra, PR; Panigrahi, P; Cairncross, S; Torondel, B				Das, Padma; Baker, Kelly K.; Dutta, Ambarish; Swain, Tapoja; Sahoo, Sunita; Das, Bhabani Sankar; Panda, Bijay; Nayak, Arati; Bara, Mary; Bilung, Bibiana; Mishra, Pravas Ranjan; Panigrahi, Pinaki; Cairncross, Sandy; Torondel, Belen			Menstrual Hygiene Practices, WASH Access and the Risk of Urogenital Infection in Women from Odisha, India	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; PRETERM DELIVERY; PREVALENCE; PREGNANCY; MORBIDITY; HEALTH	Menstrual hygiene management (MHM) practices vary worldwide and depend on the individual's socioeconomic status, personal preferences, local traditions and beliefs, and access to water and sanitation resources. MHM practices can be particularly unhygienic and inconvenient for girls and women in poorer settings. Little is known about whether unhygienic MHM practices increase a woman's exposure to urogenital infections, such as bacterial vaginosis (BV) and urinary tract infection (UTI). This study aimed to determine the association of MHM practices with urogenital infections, controlling for environmental drivers. A hospital-based case-control study was conducted on 486 women at Odisha, India. Cases and controls were recruited using a syndromic approach. Vaginal swabs were collected from all the participants and tested for BV status using Amsel's criteria. Urine samples were cultured to assess UTI status. Socioeconomic status, clinical symptoms and reproductive history, and MHM and water and sanitation practices were obtained by standardised questionnaire. A total of 486 women were recruited to the study, 228 symptomatic cases and 258 asymptomatic controls. Women who used reusable absorbent pads were more likely to have symptoms of urogenital infection (AdjOR=2.3, 95% CI1.5-3.4) or to be diagnosed with at least one urogenital infection (BV or UTI) (AdjOR=2.8, 95% CI1.7-4.5), than women using disposable pads. Increased wealth and space for personal hygiene in the household were protective for BV (AdjOR=0.5, 95% CI0.3-0.9 and AdjOR=0.6, 95% CI0.3-0.9 respectively). Lower education of the participants was the only factor associated with UTI after adjusting for all the confounders (AdjOR=3.1, 95% CI1.2-7.9). Interventions that ensure women have access to private facilities with water for MHM and that educate women about safer, low-cost MHM materials could reduce urogenital disease among women. Further studies of the effects of specific practices for managing hygienically reusable pads and studies to explore other pathogenic reproductive tract infections are needed.	[Das, Padma; Dutta, Ambarish; Swain, Tapoja; Sahoo, Sunita; Das, Bhabani Sankar; Mishra, Pravas Ranjan] Asian Inst Publ Hlth, Dis Surveillance Lab, Bhubaneswar, Odisha, India; [Baker, Kelly K.] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Panda, Bijay; Nayak, Arati] Capital Hosp, Dept Obstet & Gynaecol, Bhubaneswar, Odisha, India; [Bara, Mary; Bilung, Bibiana] Ispat Gen Hosp, Dept Obstet & Gynaecol, Rourkela, Odisha, India; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Dept Epidemiol & Pediat, Ctr Global Hlth & Dev, Coll Publ Hlth, Omaha, NE USA; [Cairncross, Sandy; Torondel, Belen] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	University of Iowa; University of Nebraska System; University of Nebraska Medical Center; University of London; London School of Hygiene & Tropical Medicine	Torondel, B (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Belen.Torondel@lshtm.ac.uk		Dutta, Ambarish/0000-0002-4019-7472; Baker, Kelly/0000-0002-3774-2628	Water Supply and Sanitation Council (WSSCC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Water Supply and Sanitation Council (WSSCC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was made possible with UK aid from the Department for International Development (DfID), as part of the SHARE research programme, and support from the Water Supply and Sanitation Council (WSSCC). However the views expressed do not necessarily reflect DfID's official policies or the policies of WSSCC. The funding agencies had no involvement in study design, data collection, data analysis, and data interpretation.	Adams P, 2003, J ECONOMETRICS, V112, P3, DOI 10.1016/S0304-4076(02)00145-8; Adinma Echendu Dolly, 2008, Afr J Reprod Health, V12, P74; Aniebue UU, 2009, PAN AFR MED J, V2; Baisley K, 2009, SEX TRANSM INFECT, V85, P370, DOI 10.1136/sti.2008.035543; Balamurugan Sangeetha S, 2012, Indian J Community Med, V37, P34, DOI 10.4103/0970-0218.94020; Bhalla P, 2007, INDIAN J MED RES, V125, P167; BHATIA JC, 1995, STUD FAMILY PLANN, V26, P203, DOI 10.2307/2137846; Bhatti LI, 2002, SOC SCI MED, V54, P105, DOI 10.1016/S0277-9536(01)00012-0; Bulut A, 1997, STUD FAMILY PLANN, V28, P35, DOI 10.2307/2137969; Dasgupta A, 2008, Indian J Community Med, V33, P77, DOI 10.4103/0970-0218.40872; Dash M, 2013, J FAM COMMUNITY MED, V20, P20, DOI 10.4103/2230-8229.108180; Demba E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-12; Desai GS, 2011, J FAM WELFARE, V57, P48; Groen S, 2005, Ned Tijdschr Geneeskd, V149, P1048; Health WCoSDo Organization WH, 2008, CLOS GAP GEN HLTH EQ; Hillier SL, 1996, AM J OBSTET GYNECOL, V175, P435, DOI 10.1016/S0002-9378(96)70158-8; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; Moi H, 1990, Int J STD AIDS, V1, P86; Morison L, 2005, SEX TRANSM INFECT, V81, P242, DOI 10.1136/sti.2004.011684; Narayan K. A., 2001, ASIA PAC POPULAT J, V16, P225, DOI DOI 10.18356/65D467C6-EN; Nelson DB, 2007, FERTIL STERIL, V88, P1396, DOI 10.1016/j.fertnstert.2007.01.035; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; PAAVONEN J, 1987, BRIT J OBSTET GYNAEC, V94, P454, DOI 10.1111/j.1471-0528.1987.tb03125.x; Peters SE, 2000, CLIN PEDIATR, V39, P173, DOI 10.1177/000992280003900307; Purwar M, 2001, J OBSTET GYNAECOL RE, V27, P175, DOI 10.1111/j.1447-0756.2001.tb01248.x; Sami N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035828; Singh M M, 2001, Indian J Med Sci, V55, P209; Sparling PF, 1999, BACTERIAL VAGINOSIS; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WASSERHEIT JN, 1989, STUD FAMILY PLANN, V20, P69, DOI 10.2307/1966461; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658	34	99	99	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130777	10.1371/journal.pone.0130777	http://dx.doi.org/10.1371/journal.pone.0130777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BR	26125184	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000358151300026
J	Hsung, TC; Lo, J; Li, TS; Cheung, LK				Hsung, Tai-Chiu; Lo, John; Li, Tik-Shun; Cheung, Lim-Kwong			Automatic Detection and Reproduction of Natural Head Position in Stereo-Photogrammetry	PLOS ONE			English	Article							REPRODUCIBILITY; STEREOPHOTOGRAMMETRY; PRECISION; ACCURACY; POSTURE	The aim of this study was to develop an automatic orientation calibration and reproduction method for recording the natural head position (NHP) in stereo-photogrammetry (SP). A board was used as the physical reference carrier for true verticals and NHP alignment mirror orientation. Orientation axes were detected and saved from the digital mesh model of the board. They were used for correcting the pitch, roll and yaw angles of the subsequent captures of patients' facial surfaces, which were obtained without any markings or sensors attached onto the patient. We tested the proposed method on two commercial active (3dMD) and passive (DI3D) SP devices. The reliability of the pitch, roll and yaw for the board placement were within +/- 0.039904 degrees, +/- 0.081623 degrees, and +/- 0.062320 degrees; where standard deviations were 0.020234 degrees, 0.045645 degrees and 0.027211 degrees respectively. Conclusion: Orientation-calibrated stereo-photogrammetry is the most accurate method (angulation deviation within +/- 0.1 degrees) reported for complete NHP recording with insignificant clinical error.	[Hsung, Tai-Chiu; Lo, John; Li, Tik-Shun; Cheung, Lim-Kwong] Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Hsung, TC (corresponding author), Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Pokfulam, Hong Kong, Peoples R China.	tchsung@hku.hk		Hsung, Tai-Chiu/0000-0001-7699-1937				Bansal N, 2012, CONTEMP CLIN DENT, V3, P180, DOI 10.4103/0976-237X.96824; COOKE MS, 1990, AM J ORTHOD DENTOFAC, V97, P489, DOI 10.1016/S0889-5406(05)80029-0; Cooke MS, THESIS U HONG KONG H; Damstra J, 2010, BRIT J ORAL MAX SURG, V48, P236, DOI 10.1016/j.bjoms.2009.10.001; Emanuele T., 1998, INTRO TECHNIQUES 3 D; Graber L.W., 2012, ORTHODONTICS CURRENT, V5th ed.; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Hsung TC, 2014, J ORAL MAXIL SURG, V72, P2256, DOI 10.1016/j.joms.2014.03.025; Lubbers HT, 2010, J CRANIOFAC SURG, V21, P763, DOI 10.1097/SCS.0b013e3181d841f7; LUNDSTROM A, 1995, EUR J ORTHODONT, V17, P111, DOI 10.1093/ejo/17.2.111; Madsen DP, 2008, EUR J ORTHODONT, V30, P532, DOI 10.1093/ejo/cjn031; MOORREES CFA, 1958, AM J PHYS ANTHROPOL, V16, P213, DOI 10.1002/ajpa.1330160206; Peng L, 1999, AM J ORTHOD DENTOFAC, V116, P82, DOI 10.1016/S0889-5406(99)70306-9; Proffit W.R., 2013, CONT ORTHODONTICS, V5th ed.; Schatz EC, 2010, J CRANIOFAC SURG, V21, P1452, DOI 10.1097/SCS.0b013e3181ebcd0a; Usumez S, 2001, AM J ORTHOD DENTOFAC, V120, P664, DOI 10.1067/mod.2001.117201; Verma Sanjeev Kumar, 2012, J Oral Biol Craniofac Res, V2, P46, DOI 10.1016/S2212-4268(12)60011-6; Walker F, 2008, BRIT J ORAL MAX SURG, V46, P567, DOI 10.1016/j.bjoms.2008.02.015; Weber DW, 2013, AM J ORTHOD DENTOFAC, V143, P738, DOI 10.1016/j.ajodo.2012.11.026; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015; Westland S, 2004, COMPUTATIONAL COLOUR; Winder RJ, 2008, BRIT J ORAL MAX SURG, V46, P33, DOI 10.1016/j.bjoms.2007.09.005; Xia JJ, 2011, J ORAL MAXIL SURG, V69, P584, DOI 10.1016/j.joms.2010.10.034; Yagci A, 2011, ANGLE ORTHOD, V81, P850, DOI 10.2319/112410-686.1	24	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0130877	10.1371/journal.pone.0130877	http://dx.doi.org/10.1371/journal.pone.0130877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26125616	Green Published, Green Submitted, gold			2022-12-26	WOS:000358151300029
J	Lin, XD; Zhang, QH; Wu, ZN; Du, YJ				Lin, Xinda; Zhang, Qinhui; Wu, Zhongnan; Du, Yongjun			Identification and Differential Expression of a Candidate Sex Pheromone Receptor in Natural Populations of Spodoptera litura	PLOS ONE			English	Article							EUROPEAN CORN-BORER; FUNCTIONAL-CHARACTERIZATION; GEOGRAPHIC-VARIATION; ODORANT-RECEPTOR; ANTENNAL TRANSCRIPTOME; OLFACTORY RECEPTORS; GENETIC-VARIATION; COMMON CUTWORM; ALTERS ODOR; MOTH	Olfaction is primarily mediated by highly specific olfactory receptors (ORs), a subfamily of which are the pheromone receptors that play a key role in sexual communication and can contribute to reproductive isolation. Here we cloned and identified an olfactory receptor, SlituOR3 (Genbank NO. JN835270), from Spodoptera litura, to be the candidate pheromone receptor. It exhibited male-biased expression in the antennae, where they were localized at the base of sensilla trichoidea. Conserved orthologues of these receptors were found amongst known pheromone receptors within the Lepidoptera, and SlituOR3 were placed amongst a clade of candidate pheromone receptors in a phylogeny tree of insect ORs. SlituOR3 is required for the EAG responses to both Z9E11-14:OAc and Z9E12-14:OAc SlituOR3 showed differential expression in S. litura populations attracted to traps baited with a series of sex pheromone blends composed of different ratios of (9Z, 11E)-tetradecadienyl acetate (Z9E11-14:OAc) and (9Z, 12E)-tetradecadienyl acetate (Z9E12-14:OAc). The changes in the expression level of SlitOR3 and antennal responses after SlitOR3 silencing suggested that SlitOR3 is required for the sex pheromone signaling. We infer that variation in transcription levels of olfactory receptors may modulate sex pheromone perception in male moths and could affect both of pest control and monitoring efficiency by pheromone application after long time mass trapping with one particular ratio of blend in the field.	[Lin, Xinda] China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Qinhui; Wu, Zhongnan; Du, Yongjun] Wenzhou Med Univ, Inst Hlth & Environm Ecol, Wenzhou, Zhejiang, Peoples R China	China Jiliang University; Wenzhou Medical University	Du, YJ (corresponding author), Wenzhou Med Univ, Inst Hlth & Environm Ecol, Wenzhou, Zhejiang, Peoples R China.	dyj@wzmc.edu.cn			Special Fund for Agro-scientific Research in the Public Interest in China [201203036]; National 973 Project [2012CB11410005]	Special Fund for Agro-scientific Research in the Public Interest in China; National 973 Project(National Basic Research Program of China)	This study was funded by the Special Fund for Agro-scientific Research in the Public Interest in China (Grant No. 201203036) and National 973 Project (Project no. 2012CB11410005) to YDU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguade M, 2009, MOL BIOL EVOL, V26, P61, DOI 10.1093/molbev/msn227; Allison JD, 2006, J CHEM ECOL, V32, P621, DOI 10.1007/s10886-005-9019-2; Anderson P, 2007, CHEM SENSES, V32, P483, DOI 10.1093/chemse/bjm017; Boo K.S., 1998, Journal of Asia-Pacific Entomology, V1, P77, DOI 10.1016/S1226-8615(08)60008-4; Brigaud I, 2009, FEBS J, V276, P6537, DOI 10.1111/j.1742-4658.2009.07351.x; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Chen Xi, 2011, Acta Entomologica Sinica, V54, P881; Du YJ, 2013, ENTOMOL EXP APPL, V146, P357, DOI 10.1111/eea.12034; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; El-Sayed AM, 2003, ENVIRON ENTOMOL, V32, P470, DOI 10.1603/0046-225X-32.3.470; Ferreira T, 2014, NEURON, V81, P847, DOI 10.1016/j.neuron.2014.01.001; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gohl Thomas, 2006, Invertebrate Neuroscience, V6, P13, DOI 10.1007/s10158-005-0012-9; Grant GG, 2009, CAN ENTOMOL, V141, P129, DOI 10.4039/n09-008; Groot AT, 2010, J EVOLUTION BIOL, V23, P2731, DOI 10.1111/j.1420-9101.2010.02124.x; Groot AT, 2009, EVOLUTION, V63, P1987, DOI 10.1111/j.1558-5646.2009.00702.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Guha L, 2014, PARASITOL RES; Gupta G. P., 2005, International Journal of Tropical Insect Science, V25, P55, DOI 10.1079/IJT200551; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HANSSON BS, 1990, J CHEM ECOL, V16, P1611, DOI 10.1007/BF01014094; Howlett N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-211; Huang YP, 1998, J CHEM ECOL, V24, P2079, DOI 10.1023/A:1020737726636; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; KLUN JA, 1975, ENVIRON ENTOMOL, V4, P891, DOI 10.1093/ee/4.6.891; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Kumar A, 2011, NAT PROD RES, V25, P1680, DOI 10.1080/14786419.2010.511620; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Lassance JM, 2011, EVOLUTION, V65, P1583, DOI 10.1111/j.1558-5646.2011.01239.x; Lassance JM, 2010, J CHEM ECOL, V36, P1155, DOI 10.1007/s10886-010-9856-5; Laurent P, 2007, J ECON ENTOMOL, V100, P1797, DOI 10.1603/0022-0493(2007)100[1797:MOECBW]2.0.CO;2; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Levi-Zada A, 2014, NATURWISSENSCHAFTEN, V101, P671, DOI 10.1007/s00114-014-1206-y; Li YJ, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.120.1373; Linn CE, 2007, J CHEM ECOL, V33, P199, DOI 10.1007/s10886-006-9204-y; Liu HX, 2013, ARCH INSECT BIOCHEM, V84, P15, DOI 10.1002/arch.21109; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062094; Logan DW, 2014, BIOCHEM SOC T, V42, P861, DOI 10.1042/BST20140052; Mazor M, 2005, J CHEM ECOL, V31, P2153, DOI 10.1007/s10886-005-6082-7; McElfresh JS, 2001, ECOLOGY, V82, P3505, DOI 10.2307/2680168; McElfresh JS, 1999, J CHEM ECOL, V25, P2505, DOI 10.1023/A:1020826208715; Meagher RL, 2008, FLA ENTOMOL, V91, P517; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Miura N, 2009, INT J BIOL SCI, V5, P319; Montagne N, 2012, EUR J NEUROSCI, V36, P2588, DOI 10.1111/j.1460-9568.2012.08183.x; Murata M, 2004, ZOOL SCI, V21, P181, DOI 10.2108/zsj.21.181; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Patch HM, 2009, CHEM SENSES, V34, P305, DOI 10.1093/chemse/bjp002; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Rollmann SM, 2010, GENETICS, V186, P687, DOI 10.1534/genetics.110.119446; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sakurai T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00125; Shen You-Lian, 2009, Acta Entomologica Sinica, V52, P1290; Sun Fan, 2002, Acta Entomologica Sinica, V45, P404; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; TAMAKI Y, 1976, Japanese Journal of Applied Entomology and Zoology, V20, P81, DOI 10.1303/jjaez.20.81; Tamhankar AJ, 2003, CURR SCI INDIA, V84, P448; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unbehend M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089255; Unbehend M, 2013, J CHEM ECOL, V39, P364, DOI 10.1007/s10886-013-0263-6; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Wright GA, 2004, P ROY SOC B-BIOL SCI, V271, P147, DOI 10.1098/rspb.2003.2590; Wu ZN, 2013, INSECT SCI, V20, P175, DOI 10.1111/j.1744-7917.2011.01483.x; Wu Zhong-Nan, 2009, Acta Entomologica Sinica, V52, P610; Yan Fushun, 1994, Entomologia Sinica, V1, P53; Zhang J, 2015, CHEM SENSES, V40, P7, DOI 10.1093/chemse/bju052; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang YN, 2014, INSECT MOL BIOL, V23, P611, DOI 10.1111/imb.12109; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011; Zhou YL, 2014, J INSECT PHYSIOL, V60, P31, DOI 10.1016/j.jinsphys.2013.10.006	82	8	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0131407	10.1371/journal.pone.0131407	http://dx.doi.org/10.1371/journal.pone.0131407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126192	Green Submitted, gold, Green Published			2022-12-26	WOS:000358151300046
J	Wang, LC; Qiao, H; Cao, C; Xu, ST; Zou, SX				Wang, Lincong; Qiao, Hui; Cao, Chen; Xu, Shutan; Zou, Shuxue			An Accurate Model for Biomolecular Helices and Its Application to Helix Visualization	PLOS ONE			English	Article							SECONDARY STRUCTURE; PROGRAM; ANATOMY; TOOL	Helices are the most abundant secondary structural elements in proteins and the structural forms assumed by double stranded DNAs (dsDNA). Though the mathematical expression for a helical curve is simple, none of the previous models for the biomolecular helices in either proteins or DNAs use a genuine helical curve, likely because of the complexity of fitting backbone atoms to helical curves. In this paper we model a helix as a series of different but all bona fide helical curves; each one best fits the coordinates of four consecutive backbone C-alpha atoms for a protein or P atoms for a DNA molecule. An implementation of the model demonstrates that it is more accurate than the previous ones for the description of the deviation of a helix from a standard helical curve. Furthermore, the accuracy of the model makes it possible to correlate deviations with structural and functional significance. When applied to helix visualization, the ribbon diagrams generated by the model are less choppy or have smaller side chain detachment than those by the previous visualization programs that typically model a helix as a series of low-degree splines.	[Wang, Lincong; Qiao, Hui; Cao, Chen; Xu, Shutan; Zou, Shuxue] Jilin Univ, Coll Comp Sci & Technol, Changchun, Kagawa, Peoples R China	Jilin University	Wang, LC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun, Kagawa, Peoples R China.	wlincong@hotmail.com		Cao, Chen/0000-0001-5343-808X				ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; Goriely Alain, 2008, Biophysical Reviews and Letters, V3, P77, DOI 10.1142/S1793048008000629; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MASSIRE C, 1994, J MOL GRAPHICS, V12, P201, DOI 10.1016/0263-7855(94)80088-X; Moll A, 2006, BIOINFORMATICS, V22, P365, DOI 10.1093/bioinformatics/bti818; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRIESTLE JP, 1988, J APPL CRYSTALLOGR, V21, P572, DOI 10.1107/S0021889888005746; RICHARDSON DC, 1992, PROTEIN SCI, V1, P3; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schrodinger L., 2020, PYMOL; SHIMANOUCHI T, 1955, J CHEM PHYS, V23, P707, DOI 10.1063/1.1742083; SKLENAR H, 1989, PROTEINS, V6, P46, DOI 10.1002/prot.340060105; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Weaver TM, 2000, PROTEIN SCI, V9, P201	26	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2015	10	6							e0129653	10.1371/journal.pone.0129653	http://dx.doi.org/10.1371/journal.pone.0129653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BR	26126117	gold, Green Published, Green Submitted			2022-12-26	WOS:000358151300010
J	Ashraf, JM; Rabbani, G; Ahmad, S; Hasan, Q; Khan, RH; Alam, K; Choi, I				Ashraf, Jalaluddin Mohammad; Rabbani, Gulam; Ahmad, Saheem; Hasan, Qambar; Khan, Rizwan Hasan; Alam, Khursheed; Choi, Inho			Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products	PLOS ONE			English	Article							HUMAN DNA; PHYSICOCHEMICAL ANALYSIS; NONENZYMATIC GLYCATION; AUTOIMMUNE-RESPONSE; DIABETES-MELLITUS; ENDPRODUCTS AGES; METHYLGLYOXAL; IMMUNOGENICITY; GLYCOXIDATION; ASSAY	Advanced glycation end products (AGEs) culminate from the non-enzymatic reaction between a free carbonyl group of a reducing sugar and free amino group of proteins. 3-deoxyglucosone (3-DG) is one of the dicarbonyl species that rapidly forms several protein-AGE complexes that are believed to be involved in the pathogenesis of several diseases, particularly diabetic complications. In this study, the generation of AGEs (N-epsilon-carboxymethyl lysine and pentosidine) by 3-DG in H1 histone protein was characterized by evaluating extent of side chain modification (lysine and arginine) and formation of Amadori products as well as carbonyl contents using several physicochemical techniques. Results strongly suggested that 3-DG is a potent glycating agent that forms various intermediates and AGEs during glycation reactions and affects the secondary structure of the H1 protein. Structural changes and AGE formation may influence the function of H1 histone and compromise chromatin structures in cases of secondary diabetic complications.	[Ashraf, Jalaluddin Mohammad; Hasan, Qambar; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Rabbani, Gulam; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Ahmad, Saheem] Integral Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India; [Alam, Khursheed] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India	Yeungnam University; Aligarh Muslim University; Integral University; Aligarh Muslim University	Ashraf, JM (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	jmashraf@gmail.com; inhochoi@ynu.ac.kr	Khan, Rizwan/GXZ-5789-2022; Ashraf, Jalauddin M/P-5391-2014; Khan, Rizwan Hasan/F-8276-2014; Ahmad, Saheem/R-7016-2017; Ahmad, Saheem/T-2609-2019; Rabbani, Gulam/AAE-5629-2022	Ashraf, Jalauddin M/0000-0001-7885-2551; Khan, Rizwan Hasan/0000-0002-9965-8982; Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Rabbani, Gulam/0000-0002-5293-8231; Alam, Khursheed/0000-0001-9729-9966	National Research Foundation of Korea grant - Republic of Korea government (MSIP) [2014R1A2A2A01006324]	National Research Foundation of Korea grant - Republic of Korea government (MSIP)	This study was supported by a National Research Foundation of Korea grant funded by the Republic of Korea government (MSIP; no. 2014R1A2A2A01006324).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; AHMAD S, 2014, J IMMUNOL RES, V1, P1, DOI DOI 10.1080/02681102.2014.899961; Ahmad S, 2014, J CLIN TRANSL ENDOCR, V1, P66, DOI 10.1016/j.jcte.2014.05.002; Ahmad S, 2014, GLYCOBIOLOGY, V24, P979, DOI 10.1093/glycob/cwu057; Ahmad S, 2014, GLYCOBIOLOGY, V24, P281, DOI 10.1093/glycob/cwt109; Ahmad S, 2013, INT J BIOL MACROMOL, V62, P167, DOI 10.1016/j.ijbiomac.2013.08.037; Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; Ahmed N, 2002, BIOCHEM J, V364, P1; Akhter F, 2013, S AFR J BOT, V88, P265, DOI 10.1016/j.sajb.2013.06.024; Akhter F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113144; Akhter F, 2015, INT J BIOL MACROMOL, V72, P1222, DOI 10.1016/j.ijbiomac.2014.10.034; Akhter F, 2013, INT J BIOL MACROMOL, V58, P206, DOI 10.1016/j.ijbiomac.2013.03.036; Amiri Majd A. M., 2013, J BASIC APPL SCI RES, V3, P878; Ansari NA, 2013, ISRN BIOCH, P5; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Arshya H, 2013, BIOMED RES INT; Ashraf JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116804; Ashraf JM, 2014, IUBMB LIFE, V66, P686, DOI 10.1002/iub.1318; Ashraf JM, 2014, APPL BIOCHEM BIOTECH, V174, P398, DOI 10.1007/s12010-014-1065-1; Ashraf JM, 2012, INT J BIOL MACROMOL, V51, P604, DOI 10.1016/j.ijbiomac.2012.06.013; Ashrafa JM, 2015, CELL IMMUNOL, V293, P74, DOI 10.1016/j.cellimm.2014.12.007; Beisswenger BGK, 2005, ANN NY ACAD SCI, V1043, P201, DOI 10.1196/annals.1333.025; CervantesLaurean D, 1996, J BIOL CHEM, V271, P10461, DOI 10.1074/jbc.271.18.10461; CHANCHAL A, 2014, J PHARM RES, V8, P1387; Che WY, 1997, J BIOL CHEM, V272, P18453, DOI 10.1074/jbc.272.29.18453; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Delpierre G, 2000, DIABETES, V49, P1627, DOI 10.2337/diabetes.49.10.1627; FOJO AT, 1983, ARCH BIOCHEM BIOPHYS, V224, P636, DOI 10.1016/0003-9861(83)90251-5; Guedes S, 2011, ANAL BIOANAL CHEM, V399, P3529, DOI 10.1007/s00216-011-4679-y; GUGLIUCCI A, 1995, BIOCHEM BIOPH RES CO, V212, P56, DOI 10.1006/bbrc.1995.1935; GUGLIUCCI A, 1994, BIOCHEM BIOPH RES CO, V203, P588, DOI 10.1006/bbrc.1994.2223; Hamada Y, 1997, DIABETES CARE, V20, P1466, DOI 10.2337/diacare.20.9.1466; HODGE JE, 1955, ADV CARBOHYD CHEM, V10, P169, DOI 10.1016/S0096-5332(08)60392-6; Imteyaz M., 2011, INDIAN J BIOCH BIOPH, V48, P290; Jobst K, 1996, CLIN CHIM ACTA, V256, P203, DOI 10.1016/S0009-8981(96)06419-4; Kessel L, 2002, PHOTOCHEM PHOTOBIOL, V76, P549, DOI 10.1562/0031-8655(2002)076<0549:TRASSF>2.0.CO;2; Khan M. S., 2013, Journal of Applied Pharmaceutical Science, V3, P133; Lal S, 1997, ARCH BIOCHEM BIOPHYS, V342, P254, DOI 10.1006/abbi.1997.0117; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LIEBICH HM, 1993, BIOL MASS SPECTROM, V22, P121, DOI 10.1002/bms.1200220204; Liu Y, 2003, SPECTROCHIM ACTA A, V59, P2747, DOI 10.1016/S1386-1425(03)00055-6; LORENZEN A, 1993, ANAL BIOCHEM, V214, P346, DOI 10.1006/abio.1993.1504; McGhee JD, 1989, ANNU REV BIOCHEM, V49, P1115; Mir AR, 2014, INT J BIOL MACROMOL, V69, P260, DOI 10.1016/j.ijbiomac.2014.05.057; Misselwitz J, 2002, PEDIATR NEPHROL, V17, P316, DOI 10.1007/s00467-001-0815-9; Moinuddin, 2014, ENVIRON TOXICOL, V29, P568, DOI 10.1002/tox.21782; Mustafa I, 2012, DIABETES RES CLIN PR, V95, P98, DOI 10.1016/j.diabres.2011.09.018; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Rabbani G, 2012, CELL BIOCH BIOPHYS, V11, P9335; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Rahim M, 2014, COLLOID SURFACE B, V117, P473, DOI 10.1016/j.colsurfb.2013.12.008; REICHARD GA, 1986, DIABETES, V35, P668, DOI 10.2337/diabetes.35.6.668; Schmitt A, 2005, ANAL BIOCHEM, V346, P101, DOI 10.1016/j.ab.2005.07.035; Schmitt A, 2005, ANAL BIOCHEM, V338, P201, DOI 10.1016/j.ab.2004.12.003; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Shahab U, 2014, CHEM-BIOL INTERACT, V219, P229, DOI 10.1016/j.cbi.2014.06.012; Shahab U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053205; Shahab U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031199; Shahab U, 2012, IUBMB LIFE, V64, P340, DOI 10.1002/iub.1008; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SMITH RE, 1978, ANAL BIOCHEM, V90, P246, DOI 10.1016/0003-2697(78)90029-5; Sperling R, 1981, Adv Protein Chem, V34, P1, DOI 10.1016/S0065-3233(08)60517-3; Stefek M, 1999, REDOX REP, V4, P43, DOI 10.1179/135100099101534738; Talasz H, 2002, J CELL BIOCHEM, V85, P24, DOI 10.1002/jcb.10103; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Thorpe Sr, 2000, DEV CARDIOVASC MED, V224, P259; Trivedi I, 2012, METHODS MOL BIOL, V833, P225, DOI 10.1007/978-1-61779-477-3_14; Turk Z, 2010, PHYSIOL RES, V59, P147, DOI 10.33549/physiolres.931585; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; VONHOLT C, 1979, FEBS LETT, V100, P201, DOI 10.1016/0014-5793(79)80337-3; Zheng N, 2010, J HUAZHONG U SCI-MED, V30, P546, DOI 10.1007/s11596-010-0466-9; ZYZAK DV, 1995, ARCH BIOCHEM BIOPHYS, V316, P547, DOI 10.1006/abbi.1995.1073	73	42	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130630	10.1371/journal.pone.0130630	http://dx.doi.org/10.1371/journal.pone.0130630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121680	Green Submitted, Green Published, gold			2022-12-26	WOS:000358150400052
J	Umaer, K; Williams, N				Umaer, Khan; Williams, Noreen			Kinetoplastid Specific RNA-Protein Interactions in Trypanosoma cruzi Ribosome Biogenesis	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNALS; BINDING-PROTEINS; PRERIBOSOMAL COMPLEX; LIFE-CYCLE; BRUCEI; LOCALIZATION; IDENTIFICATION; SEQUENCE; DOMAIN; GENES	RNA binding proteins (RBP) play essential roles in the highly conserved and coordinated process of ribosome biogenesis. Our laboratory has previously characterized two essential and abundant RBPs, P34 and P37, in Trypanosoma brucei which are required for several critical steps in ribosome biogenesis. The genes for these proteins have only been identified in kinetoplastid organisms but not in the host genome. We have identified a homolog of the TbP34 and TbP37 in a T. cruzi strain (termed TcP37/NRBD). Although the N-terminal APK-rich domain and RNA recognition motifs are conserved, the C-terminal region which contains putative nuclear and nucleolar localization signals in TbP34 and TbP37 is almost entirely missing from TcP37/NRBD. We have shown that TcP37/NRBD is expressed in T. cruzi epimastigotes at the level of mature mRNA and protein. Despite the loss of the C-terminal domain, TcP37/NRBD is present in the nucleus, including the nucleolus, and the cytoplasm. TcP37/NRBD interacts directly with Tc 5S rRNA, but does not associate with polyadenylated RNA. TcP37/NRBD also associates in vivo and in vitro with large ribosomal protein TcL5 and, unlike the case of T. brucei, this association is strongly enhanced by the presence of 5S rRNA, suggesting that the loss of the C-terminal domain of TcP37/NRBD may alter the interactions within the complex. These results indicate that the unique preribosomal complex comprised of L5, 5S rRNA, and the trypanosome-specific TcP37/NRBD or TbP34 and TbP37 is functionally conserved in trypanosomes despite the differences in the C-termini of the trypanosome-specific protein components.	[Williams, Noreen] Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY USA; Univ Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Williams, N (corresponding author), Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY USA.	nw1@buffalo.edu			American Heart Association [54741]; National Institutes of Health [GM 092719, GM 110227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110227, R01GM092719] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association (http://www.heart.org) grant 54741 to N.W., and National Institutes of Health (http://www.nih.gov) grants GM 092719 and GM 110227 to N.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LA, 1995, DEV BIOL, V168, P284, DOI 10.1006/dbio.1995.1080; Bao Y, 2010, MICROBES INFECT, V12, P716, DOI 10.1016/j.micinf.2010.04.014; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; CAMPBELL DA, 1987, J MOL BIOL, V196, P113, DOI 10.1016/0022-2836(87)90514-6; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041398; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030029; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Clayton C, 2000, ACTA TROP, V75, P119, DOI 10.1016/S0001-706X(99)00084-4; DaRocha W, 2002, PARASITOL RES, V88, P292, DOI 10.1007/s00436-001-0540-0; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Devaux S, 2007, MOL BIOL CELL, V18, P1293, DOI 10.1091/mbc.E06-09-0841; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Fu SC, 2013, NUCLEIC ACIDS RES, V41, pD338, DOI 10.1093/nar/gks936; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; Gomes GG, 2004, BIOCHEM BIOPH RES CO, V322, P985, DOI 10.1016/j.bbrc.2004.08.026; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; Hellman KM, 2007, EUKARYOT CELL, V6, P1766, DOI 10.1128/EC.00119-07; HERNANDEZ R, 1988, MOL BIOCHEM PARASIT, V27, P275, DOI 10.1016/0166-6851(88)90047-3; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Muto Y, 2012, WIRES RNA, V3, P229, DOI 10.1002/wrna.1107; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Park JH, 2001, J CELL SCI, V114, P173; PARSONS M, 1989, MOL BIOCHEM PARASIT, V33, P215, DOI 10.1016/0166-6851(89)90083-2; Pitula J, 2002, BIOCHEM BIOPH RES CO, V290, P569, DOI 10.1006/bbrc.2001.6226; Pitula J, 1998, EXP PARASITOL, V88, P157, DOI 10.1006/expr.1998.4211; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schoijet AC, 2011, MOL MICROBIOL, V79, P50, DOI 10.1111/j.1365-2958.2010.07429.x; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scripture JB, 2011, BIOCHEMISTRY-US, V50, P3827, DOI 10.1021/bi200286e; SCRIPTURE JB, 1995, J BIOL CHEM, V270, P27358, DOI 10.1074/jbc.270.45.27358; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Silverman JS, 2013, TRAFFIC, V14, P1078, DOI 10.1111/tra.12094; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Umaer K, 2014, EUKARYOT CELL, V13, P727, DOI 10.1128/EC.00307-13; Wang L, 2013, EUKARYOT CELL, V12, P559, DOI 10.1128/EC.00004-13; Wang L, 2013, EUKARYOT CELL, V12, P322, DOI 10.1128/EC.00316-12; Zhang J, 1998, MOL BIOCHEM PARASIT, V92, P79, DOI 10.1016/S0166-6851(97)00228-4; Zhang J, 1997, MOL BIOCHEM PARASIT, V87, P145, DOI 10.1016/S0166-6851(97)00060-1	42	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131323	10.1371/journal.pone.0131323	http://dx.doi.org/10.1371/journal.pone.0131323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121669	gold, Green Published, Green Submitted			2022-12-26	WOS:000358150400097
J	Wang, X; Wang, J; Sun, H; Xia, SL; Duan, R; Liang, JR; Xiao, YC; Qiu, HY; Shan, GL; Jing, HQ				Wang, Xin; Wang, Jing; Sun, Hao; Xia, Shengli; Duan, Ran; Liang, Junrong; Xiao, Yuchun; Qiu, Haiyan; Shan, Guangliang; Jing, Huaiqi			Etiology of Childhood Infectious Diarrhea in a Developed Region of China: Compared to Childhood Diarrhea in a Developing Region and Adult Diarrhea in a Developed Region	PLOS ONE			English	Article							YOUNG-CHILDREN; GASTROENTERITIS; BACTERIA; 5-YEAR	In China, great differences in economy, social characteristics and hygiene exist between developing and developed regions. A comparative study of infectious diarrhea between two regions was needed. Three groups of diarrheal patients were collected: children <= 5 year-olds from Beijing (developed region) and Henan Province (developing region), and adults over 18 year-olds from Beijing. A questionnaire was used to survey and feces samples were examined for 16 enteropathogens. We enrolled 1422 children and 1047 adults from developed region and 755 children from developing region. Virus positive rates were 32.98% for children and 23.67% for adults in developed region. The most prevalent pathogen for children was rotavirus whereas for adults was norovirus. Bacterial isolation rates were 13.92% for children from developed region, while 29.14% for children from the developing regions. For the greatest difference, Shigella accounted for 50.79% and was the dominant pathogen in the developing region, whereas in the developed region it was only 1.45%. There was no significant relationship between the local levels of development with diarrheogenic Escherichia coli (DEC) categories. But it was seen the notable differences between the population with different age: enteropathogenic E. coli (EPEC) and enteroaggregative E. coli (EAggEC) were the primary classes of DEC in children from both regions, whereas it was enterotoxigenic E. coli (ETEC) in adults. The symptoms of Shigella and Salmonella infection, such as bloody stools, white blood cells (WBC) and red blood cells (RBC) positivity and fever were similar in children, which may lead to the misidentification. Yersinia enterocolitica and shiga toxin-producing E. coli (STEC) infections were firstly reported in Beijing. There was a large difference in etiology of bacterial diarrhea between children in developing and developed regions of China.	[Wang, Xin; Shan, Guangliang] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Sch Basic Med, Beijing 100730, Peoples R China; [Wang, Xin; Duan, Ran; Liang, Junrong; Xiao, Yuchun; Qiu, Haiyan; Jing, Huaiqi] Natl Inst Communicable Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Wang, Jing; Sun, Hao] Dongcheng Ctr Dis Control & Prevent, Dept Infect Dis, Beijing, Peoples R China; [Xia, Shengli] Henan Prov Ctr Dis Control & Prevent, Dept Infect Dis, Zhengzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shan, GL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Sch Basic Med, Beijing 100730, Peoples R China.	guangliang_shan@163.com; jinghuaiqi@icdc.cn	yang, qiang/GYJ-0971-2022; Zhang, Ning/GNP-1966-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Science and Technology Major Project - Ministry of Science and Technology of the People's Republic of China [2013ZX10004203-002]	National Science and Technology Major Project - Ministry of Science and Technology of the People's Republic of China	This work was supported by the National Science and Technology Major Project (2013ZX10004203-002) which was funded by Ministry of Science and Technology of the People's Republic of China (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Chan SSW, 2003, EMERG MED J, V20, P335, DOI 10.1136/emj.20.4.335; Cheng AC, 2005, J CLIN GASTROENTEROL, V39, P757, DOI 10.1097/01.mcg.0000177231.13770.07; Dong BQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110876; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; DuPont HL, 1997, AM J GASTROENTEROL, V92, P1962; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Li Hongwei, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P119; Maraki S, 2003, EUR J EPIDEMIOL, V18, P85, DOI 10.1023/A:1022528205793; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Okeke IN, 2000, J CLIN MICROBIOL, V38, P7; Olesen B, 2005, J CLIN MICROBIOL, V43, P3636, DOI 10.1128/JCM.43.8.3636-3641.2005; Podewils Laura Jean, 2004, Semin Pediatr Infect Dis, V15, P155, DOI 10.1053/j.spid.2004.05.008; Qu M, 2012, J INFECTION, V65, P214, DOI 10.1016/j.jinf.2012.04.010; Rathaur VK, 2014, J CLIN DIAGN RES, V8, pPC1, DOI 10.7860/JCDR/2014/6677.4319; Castro EDR, 2015, REV INST MED TROP SP, V57, P27, DOI 10.1590/S0036-46652015000100004; Sambe-Ba B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-580; Soli KW, 2014, INT J INFECT DIS, V27, P54, DOI 10.1016/j.ijid.2014.02.023; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Vidal M, 2005, J CLIN MICROBIOL, V43, P5362, DOI 10.1128/JCM.43.10.5362-5365.2005; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001	25	47	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142136	10.1371/journal.pone.0142136	http://dx.doi.org/10.1371/journal.pone.0142136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26134510	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600107
J	Huang, Y; Guo, F; Li, YL; Liu, YF				Huang, Yu; Guo, Feng; Li, Yongling; Liu, Yufeng			Parameter Estimation of Fractional-Order Chaotic Systems by Using Quantum Parallel Particle Swarm Optimization Algorithm	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION; SYNCHRONIZATION; IDENTIFICATION; EQUATIONS	Parameter estimation for fractional-order chaotic systems is an important issue in fractionalorder chaotic control and synchronization and could be essentially formulated as a multidimensional optimization problem. A novel algorithm called quantum parallel particle swarm optimization (QPPSO) is proposed to solve the parameter estimation for fractional-order chaotic systems. The parallel characteristic of quantum computing is used in QPPSO. This characteristic increases the calculation of each generation exponentially. The behavior of particles in quantum space is restrained by the quantum evolution equation, which consists of the current rotation angle, individual optimal quantum rotation angle, and global optimal quantum rotation angle. Numerical simulation based on several typical fractional-order systems and comparisons with some typical existing algorithms show the effectiveness and efficiency of the proposed algorithm.	[Huang, Yu; Li, Yongling] North China Elect Power Univ, Hebei Engn Res Ctr Simulat & Optimized Control Po, Baoding, Peoples R China; [Guo, Feng] Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China; [Huang, Yu; Liu, Yufeng] Tsinghua Univ, Dept Thermal Engn, State Key Lab Power Syst, Beijing 100084, Peoples R China	North China Electric Power University; Xiamen University; Tsinghua University	Guo, F (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China.	betop@xmu.edu.cn	Shi, Yunliang/AAR-3963-2021; Liu, Xiaoling/HGD-3566-2022	Fang, Xiong/0000-0002-4176-2162	Central Universities Fundamental Research Funds [12MS117]; Natural Science Foundation of Fujian Province of China [2014J01249]	Central Universities Fundamental Research Funds; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by Central Universities Fundamental Research Funds (12MS117) and the Natural Science Foundation of Fujian Province of China (No. 2014J01249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalekar S, 2010, COMMUN NONLINEAR SCI, V15, P2178, DOI 10.1016/j.cnsns.2009.08.015; Caponetto R., 2010, WORLD SCI SERIES NON; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Daftardar-Gejji V, 2010, COMPUT MATH APPL, V59, P1117, DOI 10.1016/j.camwa.2009.07.003; Dai D, 2002, ACTA PHYS SIN-CH ED, V51, P2459, DOI 10.7498/aps.51.2459; Deng WH, 2006, CHAOS, V16, DOI 10.1063/1.2401061; Diethelm K, 2002, J MATH ANAL APPL, V265, P229, DOI 10.1006/jmaa.2000.7194; Dong-Feng W, 2006, PROPORTIONAL INTEGRA; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P327, DOI 10.1016/j.cnsns.2012.07.017; Gao Y, 2014, HYPERSPECTRAL IMAGE; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Grigorenko I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.034101; He Q, 2007, CHAOS SOLITON FRACT, V34, P654, DOI 10.1016/j.chaos.2006.03.079; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Ji R, 2014, SPECTRAL SPATIAL CON; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Li CG, 2004, CHAOS SOLITON FRACT, V22, P549, DOI 10.1016/j.chaos.2004.02.035; Li CG, 2004, PHYSICA A, V341, P55, DOI 10.1016/j.physa.2004.04.113; Li LX, 2006, CHAOS SOLITON FRACT, V28, P1204, DOI 10.1016/j.chaos.2005.04.110; Lu JG, 2006, PHYS LETT A, V354, P305, DOI 10.1016/j.physleta.2006.01.068; Nielsen, 2010, QUANTUM COMPUTATION; Odibat ZM, 2010, INT J BIFURCAT CHAOS, V20, P81, DOI 10.1142/S0218127410025429; Peng B, 2009, CHAOS SOLITON FRACT, V39, P2110, DOI 10.1016/j.chaos.2007.06.084; Sheikhan M, 2013, NEURAL COMPUT APPL, V22, P361, DOI 10.1007/s00521-011-0697-0; Sheu LJ, 2008, CHAOS SOLITON FRACT, V36, P98, DOI 10.1016/j.chaos.2006.06.013; Tang YG, 2012, PHYS LETT A, V376, P457, DOI 10.1016/j.physleta.2011.12.008; Tavazoei MS, 2008, PHYSICA D, V237, P2628, DOI 10.1016/j.physd.2008.03.037; Tavazoei MS, 2007, PHYS LETT A, V367, P102, DOI 10.1016/j.physleta.2007.05.081; Tavazoei MS, 2010, NONLINEAR ANAL-REAL, V11, P332, DOI 10.1016/j.nonrwa.2008.11.008; Yassi M, 2014, DISTINGUISHING CLUST, P1	30	150	158	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2015	10	1							e0114910	10.1371/journal.pone.0114910	http://dx.doi.org/10.1371/journal.pone.0114910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4OZ	26132635	Green Published, Green Submitted, gold			2022-12-26	WOS:000348203500006
J	Geng, YQ; Zhang, JJ; Yan, YD; Yu, BW; Geng, L; Sun, T				Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Geng, Lin; Sun, Tao			Experimental and Theoretical Investigation of Crystallographic Orientation Dependence of Nanoscratching of Single Crystalline Copper	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; INDUCED DEFORMATION; SIMULATION; NANOINDENTATION; NANOSTRUCTURE; SCRATCH; FABRICATION; MICROSCOPY; EVOLUTION; ALUMINUM	In the present work, we perform experiments and molecular dynamics simulations to elucidate the underlying deformation mechanisms of single crystalline copper under the load-controlled multi-passes nanoscratching using a triangular pyramidal probe. The correlation of microscopic deformation behavior of the material with macroscopically-observed machining results is revealed. Moreover, the influence of crystallographic orientation on the nanoscratching of single crystalline copper is examined. Our simulation results indicate that the plastic deformation of single crystalline Cu under the nanoscratching is exclusively governed by dislocation mechanisms. However, there is no glissile dislocation structure formed due to the probe oscillation under the load-controlled mode. Both experiments and MD simulations demonstrate that the machined surface morphologies in terms of groove depth and surface pile-up exhibit strong crystallographic orientation dependence, because of different geometries of activated slip planes cutting with free surfaces and strain hardening abilities associated with different crystallographic orientations.	[Geng, Yanquan; Yan, Yongda] Harbin Inst Technol, Inst Robot, State Key Lab Robot & Syst, Harbin 150008, Heilongjiang, Peoples R China; [Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Sun, Tao] Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Junjie; Geng, Lin] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology	Zhang, JJ (corresponding author), Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China.	zhjj505@gmail.com; yanyongda@hit.edu.cn	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	National Natural Science Foundation of China [51222504, 51275114, 51405106]; Author of National Excellent Doctoral Dissertation of PR China [201031]; Program for New Century Excellent Talents in University [NCET-11-0812]; China Postdoctoral Science Foundation [2012M511463, 2013T60358]; Heilongjiang Postdoctoral Fund [LBH-Z11143]; National Program for Support of Top-notch Young Professors	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund; National Program for Support of Top-notch Young Professors	The authors gratefully acknowledge financial supports of the National Natural Science Foundation of China (51222504, 51275114 and 51405106), the Author of National Excellent Doctoral Dissertation of PR China (201031), the Program for New Century Excellent Talents in University (NCET-11-0812), the China Postdoctoral Science Foundation (2012M511463 and 2013T60358), the Heilongjiang Postdoctoral Fund (LBH-Z11143) and the the National Program for Support of Top-notch Young Professors.	Ciesielski PN, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-47; Dongmo LS, 2000, ULTRAMICROSCOPY, V85, P141, DOI 10.1016/S0304-3991(00)00051-6; Fanzio P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00791; FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983; Geng YQ, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4825405; Gregory JG, 2010, J MATER RES, V25, P921; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Ju SP, 2007, MOL SIMULAT, V33, P905, DOI 10.1080/08927020701392954; Komanduri R, 2000, WEAR, V240, P113, DOI 10.1016/S0043-1648(00)00358-6; Lin YC, 2014, MOL PHYS, V112, P1115, DOI 10.1080/00268976.2013.833657; Liu H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175301; Lu C, 2009, WEAR, V267, P1961, DOI 10.1016/j.wear.2009.05.006; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Nazirizadeh Y, 2013, OPT EXPRESS, V21, P18661, DOI 10.1364/OE.21.018661; Pitchuka SB, 2014, J THERM SPRAY TECHN, V23, P502, DOI 10.1007/s11666-013-0021-x; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Podymova NB, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/8/086003; Salehinia I, 2014, INT J PLASTICITY, V52, P133, DOI 10.1016/j.ijplas.2013.04.010; Salehinia I, 2013, MAT SCI ENG A-STRUCT, V588, P340, DOI 10.1016/j.msea.2013.09.059; Singh A, 2011, ACTA MATER, V59, P7311, DOI 10.1016/j.actamat.2011.08.014; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Suchowski H, 2013, SCIENCE, V342, P1223, DOI 10.1126/science.1244303; Tak M, 2014, BIOSENS BIOELECTRON, V59, P200, DOI 10.1016/j.bios.2014.03.036; Tschopp MA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715137; Tseng AA, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3609921; Tseng AA, 2010, J VAC SCI TECHNOL B, V28, P202, DOI 10.1116/1.3292944; Tseng AA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197313; Wang Y, 2004, ACTA MATER, V52, P2229, DOI 10.1016/j.actamat.2004.01.016; Wu B, 2006, NANO LETT, V6, P468, DOI 10.1021/nl052427f; Wu SL, 2013, ACS APPL MATER INTER, V5, P4769, DOI 10.1021/am400092w; Yan YD, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-212; Zhang JJ, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/19/195301; Zhang JJ, 2013, MODEL SIMUL MATER SC, V21, DOI 10.1088/0965-0393/21/6/065001; Zhang JJ, 2012, COMP MATER SCI, V59, P14, DOI 10.1016/j.commatsci.2012.02.024; Zhang JJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054109; Zhang JJ, 2009, APPL PHYS A-MATER, V94, P593, DOI 10.1007/s00339-008-4903-6; Zhang P, 2013, APPL SURF SCI, V280, P751, DOI 10.1016/j.apsusc.2013.05.056; Zheng YG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2839581	38	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131886	10.1371/journal.pone.0131886	http://dx.doi.org/10.1371/journal.pone.0131886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147506	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600156
J	Wang, XL; Qi, WW; Li, YM; Zhang, N; Dong, L; Sun, MJ; Cun, JJ; Zhang, Y; Lv, SG; Yang, QF				Wang, Xiaolong; Qi, Wenwen; Li, Yaming; Zhang, Ning; Dong, Lun; Sun, Mingjuan; Cun, Jinjing; Zhang, Yan; Lv, Shangge; Yang, Qifeng			Huaier Extract Induces Autophagic Cell Death by Inhibiting the mTOR/S6K Pathway in Breast Cancer Cells	PLOS ONE			English	Article							AQUEOUS EXTRACT; INDUCED APOPTOSIS; PROLIFERATION; ANTICANCER; DISEASE	Huaier extract is attracting increased attention due to its biological activities, including antitumor, anti-parasite and immunomodulatory effects. Here, we investigated the role of autophagy in Huaier-induced cytotoxicity in MDA-MB-231, MDA-MB-468 and MCF7 breast cancer cells. Huaier treatment inhibited cell viability in all three cell lines and induced various large membranous vacuoles in the cytoplasm. In addition, electron microscopy, MDC staining, accumulated expression of autophagy markers and flow cytometry revealed that Huaier extract triggered autophagy. Inhibition of autophagy attenuated Huaier-induced cell death. Furthermore, Huaier extract inhibited the mammalian target of the rapamycin (mTOR)/S6K pathway in breast cancer cells. After implanting MDA-MB-231 cells subcutaneously into the right flank of BALB/c nu/nu mice, Huaier extract induced autophagy and effectively inhibited xenograft tumor growth. This study is the first to show that Huaier-induced cytotoxicity is partially mediated through autophagic cell death in breast cancer cells through suppression of the mTOR/S6K pathway.	[Wang, Xiaolong; Zhang, Ning; Dong, Lun; Sun, Mingjuan; Cun, Jinjing; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Qi, Wenwen; Li, Yaming; Lv, Shangge] Shandong Univ, Sch Med, Jinan 250100, Shandong, Peoples R China; [Zhang, Yan] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Pathol Tissue Bank, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Yang, QF (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	yang, qiang/GYJ-0971-2022; Zhang, Ning/GNP-1966-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81272903, 81172529, 81072150]; Shandong Science and Technology Development Plan [2012GZC22115]; Shandong Province Scientific Technology Development Program of Traditional Chinese Medicine [2013-160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Plan; Shandong Province Scientific Technology Development Program of Traditional Chinese Medicine	This work was supported by National Natural Science Foundation of China (No. 81272903, No. 81172529, No. 81072150) and Shandong Science and Technology Development Plan (No. 2012GZC22115) to QY, Shandong Province Scientific Technology Development Program of Traditional Chinese Medicine (No. 2013-160) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Mohamed O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024537; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Barnard G, 2007, PRION, V1, P121, DOI 10.4161/pri.1.2.4439; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Harun FB, 2012, SCI WORLD J, DOI 10.1100/2012/439479; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang J, 2010, J AGR FOOD CHEM, V58, P8119, DOI 10.1021/jf100901b; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kelekar A, 2005, ANN NY ACAD SCI, V1066, P259, DOI 10.1196/annals.1363.015; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lambert JD, 2010, J AGR FOOD CHEM, V58, P10016, DOI 10.1021/jf102311t; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li CJ, 2014, TRENDS BIOTECHNOL, P1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lv HL, 2013, PARASITOL RES, V112, P193, DOI 10.1007/s00436-012-3125-1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Olaku O, 2011, EUR J CANCER, V47, P508, DOI 10.1016/j.ejca.2010.11.018; Shin SY, 2013, CARCINOGENESIS, V34, P2080, DOI 10.1093/carcin/bgt169; Stopeck AT, 2012, CLIN EXP METASTAS, V29, P807, DOI 10.1007/s10585-012-9496-y; Sun Y, 2013, CARBOHYD POLYM, V92, P577, DOI 10.1016/j.carbpol.2012.09.006; Wang J, 2012, INT J ONCOL, V41, P1101, DOI 10.3892/ijo.2012.1534; Wang XL, 2013, INT J ONCOL, V43, P321, DOI 10.3892/ijo.2013.1947; Wang XL, 2012, ONCOL REP, V28, P1167, DOI 10.3892/or.2012.1961; Xu X, 2011, ASIAN PAC J CANCER P, V12, P2251; Zhang N, 2013, J BIOL CHEM, V288, P9396, DOI 10.1074/jbc.M112.395913; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zou Y, 2014, TUMOR BIOL, P1	41	47	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2015	10	7							e0131771	10.1371/journal.pone.0131771	http://dx.doi.org/10.1371/journal.pone.0131771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CS	26134510	gold, Green Published, Green Submitted			2022-12-26	WOS:000358154400072
J	Geng, YF; Guo, DH; Li, CQ; Wang, EY; Wei, S; Wang, ZH; Yao, S; Zhao, XW; Su, MJ; Wang, XY; Wang, JF; Wu, R; Feng, L; Sun, DB				Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Feng, Li; Sun, Dongbo			Co-Circulation of the Rare CPV-2c with Unique Gln370Arg Substitution, New CPV-2b with Unique Thr440Ala Substitution, and New CPV-2a with High Prevalence and Variation in Heilongjiang Province, Northeast China	PLOS ONE			English	Article							CANINE PARVOVIRUS STRAINS; GENETIC-ANALYSIS; VP2 GENE; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; DOGS; EMERGENCE; EVOLUTION; RECOMBINATION; REVEALS	To trace evolution of canine parvovirus-2 (CPV-2), a total of 201 stool samples were collected from dogs with diarrhea in Heilongjiang province of northeast China from May 2014 to April 2015. The presence of CPV-2 in the samples was determined by PCR amplification of the VP2 gene (568 bp) of CPV-2. The results revealed that 95 samples (47.26%) were positive for CPV-2, and they showed 98.8%-100% nucleotide identity and 97.6%-100% amino acid identity. Of 95 CPV-2-positive samples, types new2a (Ser297Ala), new2b (Ser297Ala), and 2c accounted for 64.21%, 21.05%, and 14.74%, respectively. The positive rate of CPV-2 and the distribution of the new2a, new2b and 2c types exhibited differences among regions, seasons, and ages. Immunized dogs accounted for 48.42% of 95 CPV-2-positive samples. Coinfections with canine coronavirus, canine kobuvirus, and canine bocavirus were identified. Phylogenetic analysis revealed that the identified new2a, new2b, and CPV-2c strains in our study exhibited a close relationship with most of the CPV-2 strains from China; type new2a strains exhibited high variability, forming three subgroups; type new2b and CPV-2c strains formed one group with reference strains from China. Of 95 CPV-2 strains, Tyr324Ile and Thr440Ala substitutions accounted for 100% and 64.21%, respectively; all type new2b strains exhibited the Thr440Ala substitution, while the unique Gln370Arg substitution was found in all type 2c strains. Recombination analysis using entire VP2 gene indicated possible recombination events between the identified CPV-2 strains and reference strains from China. Our data revealed the co-circulation of new CPV-2a, new CPV-2b, and rare CPV-2c, as well as potential recombination events among Chinese CPV-2 strains.	[Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China; [Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin 150001, Peoples R China	Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 2 Xinyang Rd, Daqing 163319, Peoples R China.	dongbosun@126.com	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	Program for New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-016]	Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Program for New Century Excellent Talents in Heilongjiang Provincial University (grant no. 1252-NCET-016).	Bodewes R, 2014, VET MICROBIOL, V174, P1, DOI 10.1016/j.vetmic.2014.08.025; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Cavalli A, 2014, J VET DIAGN INVEST, V26, P563, DOI 10.1177/1040638714538965; Costa EM, 2014, VET MICROBIOL, V168, P8, DOI 10.1016/j.vetmic.2013.10.002; Csagola A, 2014, ARCH VIROL, V159, P2441, DOI 10.1007/s00705-014-2068-5; Decaro N, 2009, VIROLOGY, V385, P5, DOI 10.1016/j.virol.2008.12.016; Decaro N, 2007, EMERG INFECT DIS, V13, P1222, DOI 10.3201/eid1308.070505; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Decaro N, 2011, VET J, V187, P195, DOI 10.1016/j.tvjl.2009.10.027; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Dogonyaro BB, 2013, VET MICROBIOL, V165, P460, DOI 10.1016/j.vetmic.2013.04.022; Calderon MG, 2009, J VIROL METHODS, V159, P141, DOI 10.1016/j.jviromet.2009.03.013; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071; Grellet A, 2012, VET MICROBIOL, V157, P214, DOI 10.1016/j.vetmic.2011.11.012; Han SC, 2015, ARCH MICROBIOL, V197, P621, DOI 10.1007/s00203-015-1093-4; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Hong C, 2007, J VET DIAGN INVEST, V19, P535, DOI 10.1177/104063870701900512; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Ikeda Y, 2000, VIROLOGY, V278, P13, DOI 10.1006/viro.2000.0653; Jeoung SY, 2008, J VET MED SCI, V70, P719, DOI 10.1292/jvms.70.719; Kapil S, 2007, J CLIN MICROBIOL, V45, P4044, DOI 10.1128/JCM.01300-07; KELLY WR, 1978, AUST VET J, V54, P593, DOI 10.1111/j.1751-0813.1978.tb02426.x; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Lin CN, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-39; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Maya L, 2013, ARCH VIROL, V158, P1133, DOI 10.1007/s00705-012-1591-5; Meers J, 2007, AUST VET J, V85, P392, DOI 10.1111/j.1751-0813.2007.00206.x; Mesquita JR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-107; Mittal M, 2014, INFECT GENET EVOL, V23, P1, DOI 10.1016/j.meegid.2014.01.015; Mukhopadhyay HK, 2014, VIRUS GENES, V48, P89, DOI 10.1007/s11262-013-1000-5; Nandi S, 2010, RES VET SCI, V88, P169, DOI 10.1016/j.rvsc.2009.05.018; Nelson CDS, 2007, VIROLOGY, V361, P283, DOI 10.1016/j.virol.2006.11.032; Ohshima T, 2008, J VET MED SCI, V70, P769, DOI 10.1292/jvms.70.769; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921; Pedroza-Roldan C, 2015, J VET DIAGN INVEST, V27, P107, DOI 10.1177/1040638714559969; Pereira CAD, 2007, INFECT GENET EVOL, V7, P399, DOI 10.1016/j.meegid.2006.03.007; Perez R, 2007, VET MICROBIOL, V124, P147, DOI 10.1016/j.vetmic.2007.04.028; Perez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111779; Phromnoi S, 2010, VIRUS GENES, V41, P23, DOI 10.1007/s11262-010-0475-6; Pinto LD, 2012, VIRUS RES, V165, P29, DOI 10.1016/j.virusres.2012.01.001; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Raj JM, 2010, INFECT GENET EVOL, V10, P1237, DOI 10.1016/j.meegid.2010.08.005; SMITH JM, 1992, J MOL EVOL, V34, P126; Soma T, 2013, RES VET SCI, V94, P368, DOI 10.1016/j.rvsc.2012.09.013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timurkan MO, 2015, VET ITAL, V51, P39, DOI 10.12834/VetIt.263.908.3; Xu J, 2015, TRANSBOUND EMERG DIS, V62, P91, DOI 10.1111/tbed.12078; Yi L, 2016, TRANSBOUND EMERG DIS, V63, pE262, DOI 10.1111/tbed.12268; Zhang RZ, 2010, VIRUS GENES, V40, P397, DOI 10.1007/s11262-010-0466-7; Zhao YB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-272; Zhong ZJ, 2014, INT J MOL SCI, V15, P12166, DOI 10.3390/ijms150712166	55	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137288	10.1371/journal.pone.0137288	http://dx.doi.org/10.1371/journal.pone.0137288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26147506	Green Submitted, Green Published, gold			2022-12-26	WOS:000360897600031
J	Huang, Y; Pang, YH; Wang, H; Tang, ZZ; Zhou, Y; Zhang, WY; Li, XG; Tan, DM; Li, J; Lin, Y; Liu, XL; Huang, WY; Shi, YL				Huang, Yan; Pang, Yiheng; Wang, Hong; Tang, Zhengzhu; Zhou, Yan; Zhang, Weiyu; Li, Xiugui; Tan, Dongmei; Li, Jian; Lin, Ying; Liu, Xiaoling; Huang, Weiyi; Shi, Yunliang			Occurrence and Characterization of Cronobacter spp. in Dehydrated Rice Powder from Chinese Supermarket	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII; INFANT FORMULA; GENOTYPIC CHARACTERIZATION; ANTIBIOTIC SUSCEPTIBILITY; NEONATAL MENINGITIS; MILK; FOOD; IDENTIFICATION; INGREDIENTS; PREVALENCE	Cronobacter spp. are emerging food-borne pathogens and have been identified as causative agents of meningitis and necrotizing enterocolitis in infants. Dehydrated rice is popular with a wide range of people and it is frequently used as a substitute for infant milk powder to baby older than four months. The occurrence of Cronobacter spp. was investigated in 1,012 samples of dehydrated rice powder collected from 14 manufacturers in China during 2010 to 2012. The isolates were identified using fusA allele sequencing and subtyped using pulsed-field gel electrophoresis. Seventy-six samples (7.5%) contained Cronobacter spp. The prevalence among manufacturers ranged from 0-28.8%. The 76 isolates included 4 species [Cronobacter sakazakii (52 isolates) Cronobacter malonaticus (14 isolates), Cronobacter dublinensis (7 isolates), and Cronobacter muytjensii (3 isolates)]. Twenty-three unique fusA alleles and sixty-six PFGE-patterns were detected. All isolated strains were observed to be sensitive or to show intermediate susceptibility to eight tested antimicrobial agents. The study revealed serious contamination of dehydrated rice powder by Cronobacter spp., with prevalence varying among manufacturers in China. Identified Cronobacter species, fusA alleles, and subtypes were diverse.	[Huang, Yan; Wang, Hong; Tang, Zhengzhu; Zhou, Yan; Li, Xiugui; Tan, Dongmei; Shi, Yunliang] Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Nanning, Peoples R China; [Pang, Yiheng] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Li, Jian; Lin, Ying; Liu, Xiaoling; Huang, Weiyi; Shi, Yunliang] Guangxi Univ, Food Qual & Safety Ctr, Nanning 530004, Guangxi, Peoples R China; [Zhang, Weiyu; Huang, Weiyi] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi University; Guangxi University	Huang, Y (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Control & P, Nanning, Peoples R China.	huangyangxdx@163.com; syunliang2008@126.com	Shi, Yunliang/AAR-3963-2021; Liu, Xiaoling/HGD-3566-2022	Fang, Xiong/0000-0002-4176-2162	Guangxi Natural Science Foundation [2012GXNSFBA053125]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by the Guangxi Natural Science Foundation (Grant No. 2012GXNSFBA053125 to HY). The funder played role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agostoni C, 2004, J PEDIATR GASTR NUTR, V39, P320, DOI 10.1097/00005176-200410000-00002; Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; Baumgartner A, 2009, INT J FOOD MICROBIOL, V136, P189, DOI 10.1016/j.ijfoodmicro.2009.04.009; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Brengi SP, 2012, FOODBORNE PATHOG DIS, V9, P861, DOI 10.1089/fpd.2012.1161; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Chap J, 2009, INT J FOOD MICROBIOL, V136, P185, DOI 10.1016/j.ijfoodmicro.2009.08.005; Clinical and Laboratory Standards Institute, 2006, 26M100S16 CLIN LAB S; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Codex Alimentarius Commission, 2008, 66 CACRCP JOINT FAO; Corti G, 2007, J CHEMOTHERAPY, V19, P94, DOI 10.1179/joc.2007.19.1.94; El-Sharoud WM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-24; FAO/WHO, 2008, FAO MICR RISK ASS SE, V15; FAO/WHO, 2006, EXP M ENT SAK SALM P; FAO/WHO, 2004, WORKSH ENT SAK OTH M; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; Forsythe SJ, 2005, MATERN CHILD NUTR, V1, P44, DOI 10.1111/j.1740-8709.2004.00008.x; Forsythe SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1121; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Holy O, 2014, J HOSP INFECT, V86, P169, DOI 10.1016/j.jhin.2013.09.011; Iversen C, 2004, FOOD MICROBIOL, V21, P771, DOI 10.1016/j.fm.2004.01.009; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Iversen C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-94; Iversen C, 2007, APPL ENVIRON MICROB, V73, P48, DOI 10.1128/AEM.01562-06; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Kim JB, 2011, J MICROBIOL BIOTECHN, V21, P509, DOI 10.4014/jmb.1007.07059; Kim K, 2008, INT J FOOD MICROBIOL, V122, P196, DOI 10.1016/j.ijfoodmicro.2007.11.072; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Lee YD, 2012, FOOD CONTROL, V24, P225, DOI 10.1016/j.foodcont.2011.09.023; Lee YD, 2010, J MICROBIOL BIOTECHN, V20, P757, DOI 10.4014/jmb.0912.12004; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Mullane NR, 2007, INT J FOOD MICROBIOL, V116, P73, DOI 10.1016/j.ijfoodmicro.2006.12.036; MUYTJENS HL, 1983, J CLIN MICROBIOL, V18, P115, DOI 10.1128/JCM.18.1.115-120.1983; MUYTJENS HL, 1988, J CLIN MICROBIOL, V26, P743, DOI 10.1128/JCM.26.4.743-746.1988; Nazarowec-White M, 1999, J MED MICROBIOL, V48, P559, DOI 10.1099/00222615-48-6-559; NazarowecWhite M, 1997, INT J FOOD MICROBIOL, V34, P103, DOI 10.1016/S0168-1605(96)01172-5; Proudy I, 2008, J APPL MICROBIOL, V104, P26, DOI 10.1111/j.1365-2672.2007.03526.x; Restaino L, 2006, J FOOD PROTECT, V69, P315, DOI 10.4315/0362-028X-69.2.315; Richards GM, 2005, J APPL MICROBIOL, V99, P844, DOI 10.1111/j.1365-2672.2005.02656.x; Shaker R, 2007, FOOD CONTROL, V18, P1241, DOI 10.1016/j.foodcont.2006.07.020; Stock I, 2002, CLIN MICROBIOL INFEC, V8, P564, DOI 10.1046/j.1469-0691.2002.00413.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walsh D, 2011, J APPL MICROBIOL, V110, P697, DOI 10.1111/j.1365-2672.2010.04921.x	44	150	158	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0131053	10.1371/journal.pone.0131053	http://dx.doi.org/10.1371/journal.pone.0131053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	26132635	Green Published, Green Submitted, gold			2022-12-26	WOS:000358153000090
